PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dollins, DE; Xiong, JP; Endo-Streeter, S; Anderson, DE; Bansal, VS; Ponder, JW; Ren, Y; York, JD				Dollins, D. Eric; Xiong, Jian-Ping; Endo-Streeter, Stuart; Anderson, David E.; Bansal, Vinay S.; Ponder, Jay W.; Ren, Yi; York, John D.			A structural basis for lithium and substrate binding of an inositide phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; POLYPHOSPHATE 1-PHOSPHATASE; PUTATIVE TARGET; FRUCTOSE 1,6-BISPHOSPHATASE; BRAIN INOSITOL; MONOPHOSPHATASE; INHIBITION; MECHANISM; PRODUCT; ENZYME	Inositol polyphosphate 1-phosphatase (INPP1) is a prototype member of metal-dependent/lithium-inhibited phosphomonoesterase protein family defined by a conserved three-dimensional core structure. Enzymes within this family function in distinct pathways including inositide signaling, gluconeogenesis, and sulfur assimilation. Using structural and biochemical studies, we report the effect of substrate and lithium on a network of metal binding sites within the catalytic center of INPP1. We find that lithium preferentially occupies a key site involved in metal-activation only when substrate or product is added. Mutation of a conserved residue that selectively coordinates the putative lithium-binding site results in a dramatic 100-fold reduction in the inhibitory constant as compared with wild-type. Furthermore, we report the INPP1/inositol 1,4-bisphosphate complex which illuminates key features of the enzyme active site. Our results provide insights into a structural basis for uncompetitive lithium inhibition and substrate recognition and define a sequence motif for metal binding within this family of regulatory phosphatases.	[Dollins, D. Eric; Xiong, Jian-Ping; Endo-Streeter, Stuart; Anderson, David E.; York, John D.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Bansal, Vinay S.; Ren, Yi; York, John D.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Ponder, Jay W.] Washington Univ, Dept Chem, St Louis, MO USA	Duke University; Vanderbilt University; Washington University (WUSTL)	York, JD (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; York, JD (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	john.york@vanderbilt.edu		Anderson, David/0000-0001-9334-6438	HHMI; NIH [R01-HL055672, R01-GM124404]	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funds from HHMI and the NIH grants R01-HL055672, R01-GM124404 (J. D. Y.). J. D. Y. is an alumni investigator of HHMI.	Albert A, 2000, J MOL BIOL, V295, P927, DOI 10.1006/jmbi.1999.3408; ALLISON JH, 1971, NATURE-NEW BIOL, V233, P267, DOI 10.1038/newbio233267a0; Arai R, 2007, PROTEINS, V67, P732, DOI 10.1002/prot.21299; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BONE R, 1992, P NATL ACAD SCI USA, V89, P10031, DOI 10.1073/pnas.89.21.10031; BONE R, 1994, BIOCHEMISTRY-US, V33, P9460, DOI 10.1021/bi00198a011; BONE R, 1994, BIOCHEMISTRY-US, V33, P9468, DOI 10.1021/bi00198a012; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Choe JY, 2000, BIOCHEMISTRY-US, V39, P8565, DOI 10.1021/bi000574g; Choe JY, 1998, BIOCHEMISTRY-US, V37, P11441, DOI 10.1021/bi981112u; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DIEHL RE, 1990, J BIOL CHEM, V265, P5946; Dutta A, 2014, FEBS J, V281, P5309, DOI 10.1111/febs.13070; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frederick JP, 2008, P NATL ACAD SCI USA, V105, P11605, DOI 10.1073/pnas.0801182105; Ganzhorn AJ, 1996, BIOCHEMISTRY-US, V35, P10957, DOI 10.1021/bi9603837; GEE NS, 1988, BIOCHEM J, V253, P777, DOI 10.1042/bj2530777; Gill R, 2005, ACTA CRYSTALLOGR D, V61, P545, DOI 10.1107/S0907444905004038; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; HAMLIN R, 1985, METHOD ENZYMOL, V114, P416; HOWARD AJ, 1985, METHOD ENZYMOL, V114, P452; Hudson Benjamin H, 2012, Adv Biol Regul, V52, P229; INHORN RC, 1988, J BIOL CHEM, V263, P14559; INHORN RC, 1987, J BIOL CHEM, V262, P15946; INHORN RC, 1987, P NATL ACAD SCI USA, V84, P2170, DOI 10.1073/pnas.84.8.2170; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Johnson KA, 2001, BIOCHEMISTRY-US, V40, P618, DOI 10.1021/bi0016422; KE HM, 1989, P NATL ACAD SCI USA, V86, P1475, DOI 10.1073/pnas.86.5.1475; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MICHELL RH, 1992, TRENDS BIOCHEM SCI, V17, P274, DOI 10.1016/0968-0004(92)90433-A; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel S, 2002, J MOL BIOL, V320, P1087, DOI 10.1016/S0022-2836(02)00564-8; Patel S, 2002, J MOL BIOL, V315, P677, DOI 10.1006/jmbi.2001.5271; POLLACK SJ, 1994, P NATL ACAD SCI USA, V91, P5766, DOI 10.1073/pnas.91.13.5766; Spiegelberg BD, 2005, J BIOL CHEM, V280, P5400, DOI 10.1074/jbc.M407890200; Spiegelberg BD, 1999, J BIOL CHEM, V274, P13619, DOI 10.1074/jbc.274.19.13619; Stec B, 2000, NAT STRUCT BIOL, V7, P1046, DOI 10.1038/80968; Stieglitz KA, 2002, J BIOL CHEM, V277, P22863, DOI 10.1074/jbc.M201042200; Stieglitz KA, 2007, FEBS J, V274, P2461, DOI 10.1111/j.0014-2956.2007.05779.x; VILLERET V, 1995, P NATL ACAD SCI USA, V92, P8916, DOI 10.1073/pnas.92.19.8916; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; YORK JD, 1995, P NATL ACAD SCI USA, V92, P5149, DOI 10.1073/pnas.92.11.5149; YORK JD, 1994, BIOCHEMISTRY-US, V33, P13164, DOI 10.1021/bi00249a002; YORK JD, 1990, P NATL ACAD SCI USA, V87, P9548, DOI 10.1073/pnas.87.24.9548; YORK JD, 1994, J MOL BIOL, V236, P584, DOI 10.1006/jmbi.1994.1167	49	3	3	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100059	10.1074/jbc.RA120.014057	http://dx.doi.org/10.1074/jbc.RA120.014057			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33172890	gold, Green Published			2022-12-26	WOS:000672866400041
J	Chiesa, A; Ochola, E; Oreni, L; Vassalini, P; Rizzardini, G; Galli, M				Chiesa, Annacarla; Ochola, Emmanuel; Oreni, Letizia; Vassalini, Paolo; Rizzardini, Giuliano; Galli, Massimo			Hepatitis B and HIV coinfection in Northern Uganda: Is a decline in HBV prevalence on the horizon?	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; VIRUS-INFECTION; MORTALITY; IMPACT; COMBINATION; COHORT; RISK	Background The available data concerning hepatitis B virus (HBV) infection in Uganda are limited, particularly in the case of people living with HIV/AIDS (PLWH). HBV is not routinely tested when starting antiretroviral therapy (ART). We aimed to determine the prevalence, the correlates of the risk of HBV infection, and the association with outcomes of ART among PLWH attending a busy HIV clinic in a referral hospital in Northern Uganda. Patients and methods From April to June 2016, a random sample of 1000 PLWH attending the outpatients' clinic of St. Mary's Hospital, Gulu, Uganda were systematically selected to undergo a rapid hepatitis B surface antigen (HBsAg) test after administering a questionnaire in this cross-sectional study. HIV care parameters were obtained from client files. Multivariate logistic regression and general linear model were used for the analysis. Results 950 of the 985 evaluable patients (77% females; mean age 42.8 years) were receiving ART. The overall prevalence of HBsAg was 7.9% (95% confidence interval [CI] 6.2-9.6%), and was significantly lower among the females (6.8% vs 11.7%; p = 0.020). The factors independently associated with higher HBV infection were having lived in an internally displaced persons' camp (adjusted odds ratio [aOR] 1.76, 95% CI 1.03-2.98; p = 0.036) and having shared housing with HBV-infected people during childhood (aOR 3.30, 95% CI 1.49-7.32; p = 0.003). CD4+ T cell counts were significantly lower in HBV patients (p = 0.025), and co-infection was associated with a poorer CD4+ T cell response to ART (AOR 0.88; 95% CI 0.79-0.98; p = 0.030). Conclusions The observed prevalence of HBV among the PLWH may be underestimated or a signal of HBV decline in the region. The factors favouring horizontal HBV transmission identified suggest extending HBV screening and vaccine prophylaxis among PLWH.	[Chiesa, Annacarla; Oreni, Letizia; Vassalini, Paolo; Galli, Massimo] Univ Milan, L Sacco Dept Biomed & Clin Sci, Infect Dis Unit, Milan, Italy; [Ochola, Emmanuel] St Marys Hosp Lacor, Dept HIV Res & Documentat, Gulu, Uganda; [Ochola, Emmanuel] Gulu Univ, Dept Publ Hlth, Fac Med, Gulu, Uganda; [Vassalini, Paolo] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy; [Rizzardini, Giuliano] Fatebenefratelli Sacco Hosp, Infect Dis Div 1, Milan, Italy	University of Milan; Sapienza University Rome; University of Milan; Luigi Sacco Hospital	Ochola, E (corresponding author), St Marys Hosp Lacor, Dept HIV Res & Documentat, Gulu, Uganda.; Ochola, E (corresponding author), Gulu Univ, Dept Publ Hlth, Fac Med, Gulu, Uganda.	ayiga33@hotmail.com	Vassalini, Paolo/HCH-4042-2022	Vassalini, Paolo/0000-0002-6336-0455; Ochola, Emmanuel/0000-0003-0329-9477	Fondazione Piero e Lucille Corti Onlus	Fondazione Piero e Lucille Corti Onlus	AC was supported funding support from Fondazione Piero e Lucille Corti Onlus, which supported her stay in Uganda, the cost of the test kits and the facilitation of data collectors. https://fondazionecorti.it/ The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, OSGOODE HALL LAW J, V44, pii; Bayo P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005889; Bwogi J, 2009, AFR HEALTH SCI, V9, P98; Davide M, 2012, LIMESONLINE; Funk A, 2012, INT J EPIDEMIOL, V41, P1594, DOI 10.1093/ije/dys170; Gurtler LG, 2014, INTERVIROLOGY, V57, P212, DOI 10.1159/000360942; Hao GY, 2017, J MED VIROL, V89, P450, DOI 10.1002/jmv.24649; Idoko J, 2009, CLIN INFECT DIS, V49, P1268, DOI 10.1086/605675; Kang M, 2014, JAIDS-J ACQ IMM DEF, V66, P172, DOI 10.1097/QAI.0000000000000149; Kim JH, 2012, J KOREAN MED SCI, V27, P830, DOI 10.3346/jkms.2012.27.7.830; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; Ladep NG, 2013, WORLD J GASTROENTERO, V19, P1602, DOI 10.3748/wjg.v19.i10.1602; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Matthews PC, 2014, J CLIN VIROL, V61, P20, DOI 10.1016/j.jcv.2014.05.018; Ministry of Health U, 2016, UG CLIN GUID 2016 NA; Ministry of Health U, 2019, UG POP BAS HIV IMP A; Ministry of Health U, 2005, HLTH MORT SURV INT D; Monforte AD, 2001, J ACQ IMMUN DEF SYND, V28, P114, DOI 10.1097/00042560-200110010-00002; Nikolopoulos GK, 2016, J MED VIROL, V88, P466, DOI 10.1002/jmv.24357; Ocama P, 2015, AFR HEALTH SCI, V15, P328, DOI 10.4314/ahs.v15i2.4; Ochola E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-727; Olawumi H O, 2014, Ghana Med J, V48, P96; Phung BC, 2014, WORLD J GASTROENTERO, V20, P17360, DOI 10.3748/wjg.v20.i46.17360; Seremba E, 2017, VACCINE, V35, P2937, DOI 10.1016/j.vaccine.2017.04.020; Seremba E, 2017, AIDS, V31, P781, DOI 10.1097/QAD.0000000000001399; Sheng WH, 2007, CLIN INFECT DIS, V45, P1221, DOI 10.1086/522173; Soriano V, 2015, CURR HIV-AIDS REP, V12, P344, DOI 10.1007/s11904-015-0275-7; Spindler W, 2012, UNHCR CLOS CHAPT UG; St. Mary's Hospital Lacor, 2016, ANN REP FIN YEAR JUL; Stabinski L, 2015, JAIDS-J ACQ IMM DEF, V68, pS274, DOI 10.1097/QAI.0000000000000496; Sun HY, 2014, WORLD J GASTROENTERO, V20, P14598, DOI 10.3748/wjg.v20.i40.14598; Teshale EH, 2015, VACCINE, V33, P6161, DOI 10.1016/j.vaccine.2015.09.058; Thio CL, 2002, LANCET, V360, P1921, DOI 10.1016/S0140-6736(02)11913-1; UNAIDS, 2015, HIV AIDS UG COUNTR P; Wandeler G, 2013, J INFECT DIS, V208, P1454, DOI 10.1093/infdis/jit351; WHO, 2015, WHO GUID PREV CAR TR; WHO, 2007, GLOB HEP REP 2017; Wit FWNM, 2002, J INFECT DIS, V186, P23, DOI 10.1086/341084; 1996, PLASMA PHYS CONTROL, V38, pS39	39	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242278	10.1371/journal.pone.0242278	http://dx.doi.org/10.1371/journal.pone.0242278			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206693	gold, Green Published			2022-12-26	WOS:000595265900046
J	Liesner, M; Kunde, W				Liesner, Marvin; Kunde, Wilfried			Suppression of mutually incompatible proprioceptive and visual action effects in tool use	PLOS ONE			English	Article							RESPONSE-EFFECT COMPATIBILITY; TEC	Movements of a tool typically diverge from the movements of the hand manipulating that tool, such as when operating a pivotal lever where tool and hand move in opposite directions. Previous studies suggest that humans are often unaware of the position or movements of their effective body part (mostly the hand) in such situations. It has been suggested that this might be due to a "haptic neglect" of bodily sensations to decrease the interference of representations of body and tool movements. However, in principle this interference could also be decreased by neglecting sensations regarding the tool and focusing instead on body movements. While in most tool use situations the tool-related action effects are task-relevant and thus suppression of body-related rather than tool-related sensations is more beneficial for successful goal achievement, we manipulated this task-relevance in a controlled experiment. The results showed that visual, tool-related effect representations can be suppressed just as proprioceptive, body-related ones in situations where effect representations interfere, given that task-relevance of body-related effects is increased relative to tool-related ones.	[Liesner, Marvin; Kunde, Wilfried] Univ Wurzburg, Dept Psychol, Wurzburg, Germany	University of Wurzburg	Liesner, M (corresponding author), Univ Wurzburg, Dept Psychol, Wurzburg, Germany.	marvin.liesner@uni-wuerzburg.de		Liesner, Marvin/0000-0002-7301-2315	German Research Foundation, DFG [KU 1964/15-1]; Open Access Publication Fund of the University of Wuerzburg	German Research Foundation, DFG(German Research Foundation (DFG)); Open Access Publication Fund of the University of Wuerzburg	This research was funded by the German Research Foundation, DFG (https://www.dfg.de/en/index.jsp) in the form of a grant awarded to WK within the DFG Priority Program 2134 "The Active Self" (KU 1964/15-1). This publication was also supported by the Open Access Publication Fund of the University of Wuerzburg (https://www.bibliothek.uni-wuerzburg.de/forschen-publizieren/open-access/publikationsfonds/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balslev D, 2004, J NEUROSCI, V24, P9698, DOI 10.1523/JNEUROSCI.1738-04.2004; Collins T, 2008, COGNITION, V109, P363, DOI 10.1016/j.cognition.2008.10.001; Debats NB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28251-x; Debats NB, 2017, J NEUROPHYSIOL, V117, P1569, DOI 10.1152/jn.00724.2016; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Heuer H, 2012, EXP BRAIN RES, V218, P129, DOI 10.1007/s00221-012-3013-z; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; Hommel B, 2009, PSYCHOL RES-PSYCH FO, V73, P512, DOI 10.1007/s00426-009-0234-2; James W., 1890, PRINCIPLES PSYCHOL, V2, P283; Janczyk M, 2015, ATTEN PERCEPT PSYCHO, V77, P930, DOI 10.3758/s13414-014-0828-7; Janczyk M, 2012, Z PSYCHOL, V220, P16, DOI 10.1027/2151-2604/a000086; Janczyk M, 2009, HUM MOVEMENT SCI, V28, P437, DOI 10.1016/j.humov.2009.02.006; Jones SAH, 2010, NEUROPSYCHOLOGIA, V48, P3782, DOI 10.1016/j.neuropsychologia.2010.10.001; Kirsch W, 2016, ATTEN PERCEPT PSYCHO, V78, P133, DOI 10.3758/s13414-015-0997-z; Knoblich G, 2004, J EXP PSYCHOL HUMAN, V30, P657, DOI 10.1037/0096-1523.30.4.657; Kunde W, 2001, J EXP PSYCHOL HUMAN, V27, P387, DOI 10.1037//0096-1523.27.2.387; Kunde W, 2012, J EXP PSYCHOL HUMAN, V38, P703, DOI 10.1037/a0026315; LAJOIE Y, 1992, NEUROLOGY, V42, P1104, DOI 10.1212/WNL.42.5.1104; Liesner M, 2020, ATTEN PERCEPT PSYCHO, V82, P2531, DOI 10.3758/s13414-020-02013-2; Liesner M, 2020, CONSCIOUS COGN, V77, DOI 10.1016/j.concog.2019.102850; Memelink J, 2013, PSYCHOL RES-PSYCH FO, V77, P249, DOI 10.1007/s00426-012-0435-y; Musseler J, 2008, EUR J COGN PSYCHOL, V20, P211, DOI 10.1080/09541440701275815; Musseler J, 2011, HUM FACTORS, V53, P383, DOI 10.1177/0018720811408599; Musseler J, 2009, CONSCIOUS COGN, V18, P359, DOI 10.1016/j.concog.2009.02.004; Pfister R, 2019, PSYCHOL REV, V126, P153, DOI 10.1037/rev0000140; Pfister R, 2013, ADV COGN PSYCHOL, V9, P74, DOI [10.5709/acp-0133-x, 10.2478/v10053-008-0133-x]; Pfister R, 2013, EXP BRAIN RES, V224, P647, DOI 10.1007/s00221-012-3343-x; Prinz W, 1998, PSYCHOL RUNDSCH, V49, P10; Rand MK, 2019, EUR J NEUROSCI, V50, P3296, DOI 10.1111/ejn.14433; Rand MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068471; Shin YK, 2010, PSYCHOL BULL, V136, P943, DOI 10.1037/a0020541; Song JH, 2013, EXP BRAIN RES, V226, P209, DOI 10.1007/s00221-013-3426-3; Sulzenbruck S, 2012, Z PSYCHOL, V220, P3, DOI 10.1027/2151-2604/a000084; Sulzenbruck S, 2009, CONSCIOUS COGN, V18, P145, DOI 10.1016/j.concog.2008.12.001; Waszak F, 2012, NEUROSCI BIOBEHAV R, V36, P943, DOI 10.1016/j.neubiorev.2011.11.004	35	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242327	10.1371/journal.pone.0242327	http://dx.doi.org/10.1371/journal.pone.0242327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206706	Green Published, gold			2022-12-26	WOS:000595265900064
J	Wang, RX; Yin, P; Ruixia, Y; Liu, X; Luo, L; Xu, JC				Wang, Ruixue; Yin, Peng; Ruixia, Yang; Liu, Xiao; Luo, Lie; Xu, Jichen			Genome-wide profiling of alternative splicing genes in hybrid poplar (P.albaxP.glandulosa cv.84K) leaves	PLOS ONE			English	Article							POPULUS-TRICHOCARPA; TRANSCRIPTS; ARABIDOPSIS; PROTEINS	Alternative splicing (AS) is a post-transcriptional process common in plants and essential for regulation of environmental fitness of plants. In the present study, we focus on the AS events in poplar leaves to understand their effects on plant growth and development. The hybrid poplar (P.albaxP.glandulosa cv.84K) leaves were collected for RNA extraction. The extracted RNA was sequenced using on an Illumina HiSeq (TM) 2000 platform. Using the Populus trichocarpa genome as the reference, a total of 3810 AS genes were identified (9225 AS events), which accounted for 13.51% of all the expressed genes. Intron retention was the most common AS event, accounting for 43.86% of all the AS events, followed by alternative 3 ' splice sites (23.75%), alternative 5 ' splice sites (23.71%), and exon skipping (8.68%). Chromosomes 10 had the most condensed AS events (33.67 events/Mb) and chromosome 19 had the least (12.42 events/Mb). Association analysis showed that AS in the poplar leaves was positively correlated with intron length, exon number, exon length, and gene expression level, and was negatively correlated with GC content. AS genes in the poplar leaves were associated mainly with inositol phosphate metabolism and phosphatidylinositol signaling system pathways that would be significant on wooden plant production.	[Wang, Ruixue; Yin, Peng; Liu, Xiao; Xu, Jichen] Beijing Forestry Univ, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing, Peoples R China; [Wang, Ruixue; Yin, Peng; Ruixia, Yang; Liu, Xiao; Luo, Lie; Xu, Jichen] Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China	Beijing Forestry University; Beijing Forestry University	Xu, JC (corresponding author), Beijing Forestry Univ, Beijing Adv Innovat Ctr Tree Breeding Mol Design, Beijing, Peoples R China.; Xu, JC (corresponding author), Beijing Forestry Univ, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	jcxu282@sina.com			National Natural Science Foundation of China [31672189]; Beijing Forestry University Undergraduate Training Program for Inovation and Entrepreneurship [202010022062]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Forestry University Undergraduate Training Program for Inovation and Entrepreneurship	The National Natural Science Foundation of China (#31672189) and Beijing Forestry University Undergraduate Training Program for Inovation and Entrepreneurship (#202010022062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek JM, 2008, PLANT MOL BIOL, V67, P499, DOI 10.1007/s11103-008-9334-4; Bao H, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-359; Barbazuk WB, 2008, GENOME RES, V18, P1381, DOI 10.1101/gr.053678.106; Bloger TA, 2008, CELL, V134, P624, DOI [10.1016/j.cell.2008.06.027, DOI 10.1016/J.CELL.2008.06.027]; Campbell MA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-327; De Palma M, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-018-0079-1; Dong CL, 2018, PLANT CELL, V30, P2267, DOI 10.1105/tpc.18.00051; Gamazon, 2016, ALTERNATIVE SPLICING; Gonzalez-Hilarion S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32252; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Halterman DA, 2003, PLANT PHYSIOL, V131, P558, DOI 10.1104/pp.014407; Hu HY, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00048; Jordan T, 2002, TRENDS PLANT SCI, V7, P392, DOI 10.1016/S1360-1385(02)02311-7; Jung KH, 2009, RICE, V2, P44, DOI 10.1007/s12284-008-9020-9; Keren H, 2010, NAT REV GENET, V11, P345, DOI 10.1038/nrg2776; Kianianmomeni A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1117; Kim N, 2007, NUCLEIC ACIDS RES, V35, pD93, DOI 10.1093/nar/gkl884; Liu YS, 2017, CELL REP, V20, P1229, DOI 10.1016/j.celrep.2017.07.025; Luis PI, 2017, BMC GENOMICS, V18, P650, DOI [10.1186/s12864-017-4054-2, DOI 10.1186/S12864-017-4054-2]; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Parys JB, 2012, ADV EXP MED BIOL, V740, P255, DOI 10.1007/978-94-007-2888-2_11; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Sakharkar Meena Kishore, 2006, In Silico Biology, V6, P275; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Seo PJ, 2012, PLANT CELL, V24, P2427, DOI 10.1105/tpc.112.098723; Shen YT, 2014, PLANT CELL, V26, P996, DOI 10.1105/tpc.114.122739; Sureshkumar S, 2014, HEREDITAS, V151, P20, DOI 10.1111/j.1601-5223.2013.00030.x; Tai HH, 2007, PLANT CELL REP, V26, P105, DOI 10.1007/s00299-006-0213-7; Thatcher SR, 2016, PLANT PHYSIOL, V170, P586, DOI 10.1104/pp.15.01267; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang H, BIOINFORMATICS, V17, P17, DOI [10.1186/s12859-015-0864-x, DOI 10.1186/S12859-015-0864-X]; Wang XH, 2013, ENVIRON TOXICOL PHAR, V36, P288, DOI 10.1016/j.etap.2013.04.004; Wang XC, 2019, PLANT J, V97, P555, DOI 10.1111/tpj.14142; Wang Z, 2019, PLANTA, V249, P1133, DOI 10.1007/s00425-018-03073-3; Xie BB, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1251-8; Xu P, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-780; Zhang H, 2019, INT J BIOL MACROMOL, V130, P50, DOI 10.1016/j.ijbiomac.2019.02.115; Zhang H, 2019, PLANT SCI, V288, DOI 10.1016/j.plantsci.2019.05.023; Zhang RX, 2017, NUCLEIC ACIDS RES, V45, P5061, DOI 10.1093/nar/gkx267; Zheng Z, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00380; Zhu JY, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1497-9	45	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241914	10.1371/journal.pone.0241914	http://dx.doi.org/10.1371/journal.pone.0241914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206683	Green Published, gold			2022-12-26	WOS:000595265900012
J	Bifo, H; Gugsa, G; Kifleyohannes, T; Abebe, E; Ahmed, M				Bifo, Hadji; Gugsa, Getachew; Kifleyohannes, Tsegabirhan; Abebe, Engidaw; Ahmed, Meselu			Sero-prevalence and associated risk factors of bovine brucellosis in Sendafa, Oromia Special Zone surrounding Addis Ababa, Ethiopia	PLOS ONE			English	Article							CATTLE	Bovine brucellosis is an infectious bacterial disease caused by members of genus Brucella, affecting both animals and humans, and resulting in a serious economic loss in animal production sector and deterioration of public health. A cross-sectional study was conducted from November 2014 to April 2015 to determine the seroprevalence and associated risk factors of bovine brucellosis in Sendafa, Oromia Special Zone, Ethiopia. A total of 503 blood samples were collected using a simple random sampling technique from dairy cattle of above 6 months of age with no history of previous vaccination against brucellosis. All sera samples were subjected to both Rose Bengal Plate Test for screening and Complement Fixation Test for confirmation. Accordingly, the overall seroprevalence of bovine brucellosis in the study area was 0.40%. The result showed that the seroprevalence of bovine brucellosis in the study area was not statistically significant with all proposed risk factors. No reactors were observed in male animals. The seroprevalence was observed in animals without previous history of abortion. Moreover, information was gathered on individual animal and farm-level risk factors and other farm characteristics using a questionnaire. Awareness among society was poor, so the positive animals can be a potential hazard to animals and humans in the study area. Therefore, public education should be done to improve the awareness of the community on bovine brucellosis and its public health impact with due consideration on the safe consumption of food of animal origin.	[Bifo, Hadji; Kifleyohannes, Tsegabirhan] Mekelle Univ, Coll Vet Sci, Dept Vet Med, Mekelle, Ethiopia; [Gugsa, Getachew; Abebe, Engidaw; Ahmed, Meselu] Wollo Univ, Sch Vet Med, Dept Vet Med, Dessie, Ethiopia	Mekelle University	Gugsa, G (corresponding author), Wollo Univ, Sch Vet Med, Dept Vet Med, Dessie, Ethiopia.	gugsag@yahoo.com	Amede, Getachew Gugsa/AFO-9249-2022	Amede, Getachew Gugsa/0000-0003-1201-2263				Abay B, 1999, THESIS; Acha PN, 2003, ZOONOSES COMMUNICABL, V3rd, P40; Adugna K.E., 2013, REV SCI TECHNIQUES O, V32, P3; Aiello E, 1998, MERCK VET MANUAL, P998; Alemayehu AS, 2015, INT J ADV SCI TECHNI, V3, P157; Alton G, 1975, LAB TECHNIQUES BRUCE, P55; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; [Anonymous], 2020, LANCET PSYCHIAT, V7, P1, DOI 10.1016/S2215-0366(19)30483-3; [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; [Anonymous], 2016, B EPIDEMIOL, V47, P1, DOI DOI 10.1080/03740463.2015.1069049; [Anonymous], 2017, INT J RES HUMANITIES, V46, P1; [Anonymous], 2011, SHANGHAI URBAN PLANN, V2011, P1; [Anonymous], 2017, SBAAR SEND BAK ADM A; [Anonymous], 2018, BMC VET RES, V14, P1, DOI [10.1186/s12917-018-1408-1LK, 10.1186./02Fs12917-018-1408-1&atitle, DOI 10.1186/S12917-018-1408-1LK]; [Anonymous], 1994, SHAANXI SHENG ZHI SH; Asmare K, 2013, ACTA TROP, V126, P186, DOI 10.1016/j.actatropica.2013.02.015; Ataro Abera, 2019, Ethiopian Veterinary Journal, V23, P41; Bashitu L., 2015, J ADV DAIRY RES, V3, P1, DOI [10.4172/2329-888X.1000131, DOI 10.4172/2329-888X.1000131]; Berhe G, 2007, INT J APPL RES VET M, V5, P65; CARVALHO NAV, 2010, VET J, V184, P146, DOI DOI 10.1016/J.TVJL.2009.04.010; Crawford R. P., 1990, Animal brucellosis., P131; CSA (Central Statistical Authority), 2018, STAT B, VII, P1; Cui Hai-Feng, 2012, J Anal Methods Chem, V2012, P793468, DOI 10.1155/2012/793468; Debnath Shyamal, 2014, PALESTINE J MATH, V3, P27; Degefu H., 2011, ETHIOPIAN VET J, V15, P37, DOI DOI 10.4314/evj.v15i1.67683; Doganay Mehmet, 2003, International Journal of Infectious Diseases, V7, P173, DOI 10.1016/S1201-9712(03)90049-X; Editorial, 2016, NAT CLIM CHANGE, V6, P1, DOI [10.1038/nclimate2911, DOI 10.1038/s41598-016-0001-8]; European Commission, 2000, OFFICIAL METHODS OF, VC, P1, DOI 10.1108/03090550310770974; Eyob Eticha, 2018, Journal of Veterinary Medicine and Animal Health, V10, P245, DOI 10.5897/JVMAH2017.0558; Gebewo Tibeso, 2014, World Applied Sciences Journal, V31, P776; Gebreyohans T, 2004, THESIS; Gelma D, 2019, ACTA SCI MED SCI, V3, P146; Godfroid J, 2011, PREV VET MED, V102, P118, DOI 10.1016/j.prevetmed.2011.04.007; Hailu Degefu, 2011, ETHIOPIAN VET J, V15, P1; Hamdy MER, 2002, VET J, V163, P299, DOI 10.1053/tvjl.2001.0681; Hika W, 2018, ETHIOPIA INT J MICRO, V9, P45; Hunduma Dinka, 2009, American-Eurasian Journal of Agricultural and Environmental Science, V6, P508; Ibrahim N, 2010, TROP ANIM HEALTH PRO, V42, P35, DOI 10.1007/s11250-009-9382-z; Jergefa T, 2009, REV SCI TECH OIE, V28, P933; Kebede T, 2008, REV MED VET-TOULOUSE, V159, P3; Kemal KE, 2018, J ANIM PLANT SCI, V28, P1; Mantur BG, 1996, LANCET, V347, P1763, DOI 10.1016/S0140-6736(96)90839-9; McDermott JJ, 2002, VET MICROBIOL, V90, P111, DOI 10.1016/S0378-1135(02)00249-3; Megersa B, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-24; Mohammed H., 2009, THESIS; Moti Yohannes, 2012, Global Veterinaria, V8, P139; Mussie H., 2007, ETHIOPIAN VET J, V11, P42; Nielson K, 1995, VET MED, V26, P17; OIE, 2008, MANUAL DIAGNOSTIC TE, P1092; OIE, 2009, BOV BRUC MAN DIAGN T, P409; OIE; World Organisation for Animal Health, 2004, MAN STAND DIAGN TEST, V5th, P242; Pal M., 2007, ZOONOSES; Radostits OM., 2000, VET MED TXB DIS CATT, V9th, P867; Robert J, 1971, VET OBSTET GENITAL D, P108; Seleem MN, 2010, VET MICROBIOL, V140, P392, DOI 10.1016/j.vetmic.2009.06.021; Tadele T., 2004, THESIS, P88; Tadesse B., 2019, ARC J ANIMAL VET SCI, V5, P35; Tariku S, 1994, THESIS; Taye Y., 1991, THESIS, P119; Tekle M., 2016, THESIS; Tesfaye G, 2011, TROP ANIM HEALTH PRO, V43, P1001, DOI 10.1007/s11250-011-9798-0; Thrusfield M, 1995, VET EPIDEMIOLOGY, DOI [10.1136/vr.136.14.350, DOI 10.1136/VR.136.14.350]; Tolosa T., 2008, Bulletin of Animal Health and Production in Africa, V56, P25; Tolosa T., 2004, THESIS; Tsegaye Y., 2016, AM ACAD SCI RES J EN, V24, P16; Walker L.R., 1999, VET MICROBIOL, P196; Wossene N, 2020, MEDITERRANEAN J BASI, V4, P77; Yayeh T., 2003, THESIS ADDIS ABABA U; Yilma M., 2016, ACHIEVEMENTS LIFE SC, V10, P80, DOI [10.1016/j.als.2016.05.008, DOI 10.1016/J.ALS.2016.05.008]; Yitagele T, 2017, TROP ANIM HLTH PROD, V49, P599, DOI [10.1007/s11250-017-1242-7, DOI 10.1007/S11250-017-1242-7]	70	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0238212	10.1371/journal.pone.0238212	http://dx.doi.org/10.1371/journal.pone.0238212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201876	Green Published, gold, Green Submitted			2022-12-26	WOS:000595003900041
J	Tsiklidis, EJ; Sims, C; Sinno, T; Diamond, SL				Tsiklidis, Evan J.; Sims, Carrie; Sinno, Talid; Diamond, Scott L.			Using the National Trauma Data Bank (NTDB) and machine learning to predict trauma patient mortality at admission	PLOS ONE			English	Article							ARTIFICIAL NEURAL-NETWORK; GLASGOW COMA SCALE; HYPOTENSION; HEMORRHAGE; OUTCOMES; MODEL	A 400-estimator gradient boosting classifier was trained to predict survival probabilities of trauma patients. The National Trauma Data Bank (NTDB) provided 799233 complete patient records (778303 survivors and 20930 deaths) each containing 32 features, a number further reduced to only 8 features via the permutation importance method. Importantly, the 8 features can all be readily determined at admission: systolic blood pressure, heart rate, respiratory rate, temperature, oxygen saturation, gender, age and Glasgow coma score. Since death was rare, a rebalanced training set was used to train the model. The model is able to predict a survival probability for any trauma patient and accurately distinguish between a deceased and survived patient in 92.4% of all cases. Partial dependence curves (P-survival vs. feature value) obtained from the trained model revealed the global importance of Glasgow coma score, age, and systolic blood pressure while pulse rate, respiratory rate, temperature, oxygen saturation, and gender had more subtle single variable influences. Shapley values, which measure the relative contribution of each of the 8 features to individual patient risk, were computed for several patients and were able to quantify patient-specific warning signs. Using the NTDB to sample across numerous patient traumas and hospital protocols, the trained model and Shapley values rapidly provides quantitative insight into which combination of variables in an 8-dimensional space contributed most to each trauma patient's predicted global risk of death upon emergency room admission.	[Tsiklidis, Evan J.; Sinno, Talid; Diamond, Scott L.] Univ Penn, Inst Med & Engn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Sims, Carrie] Univ Penn, Dept Trauma Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Diamond, SL (corresponding author), Univ Penn, Inst Med & Engn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA.	sld@seas.upenn.edu	Sinno, Talid/N-7088-2017	Sinno, Talid/0000-0003-2489-1613	NIH [U01-HL-131053]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH U01-HL-131053 (S.L.D, T.S.) Funder website: https://report.nih.gov/Funder Information: Andrei Kindzelski (kindzelskial@nhlbi.nih.gov) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2020, INJURY, V51, P91, DOI 10.1016/j.injury.2019.10.005; Bhandarkar Prashant, 2017, Int J Crit Illn Inj Sci, V7, P14, DOI 10.4103/2229-5151.201950; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Comittee on Trauma AC of S, 2017, NTDB VERS 2016; DiRusso SM, 2000, J TRAUMA, V49, P212, DOI 10.1097/00005373-200008000-00006; Eastridge BJ, 2007, J TRAUMA, V63, P291, DOI 10.1097/TA.0b013e31809ed924; Edwards DF, 1999, NEUROLOGY, V53, P351, DOI 10.1212/WNL.53.2.351; Estahbanati HK, 2002, BURNS, V28, P579, DOI 10.1016/S0305-4179(02)00045-1; Fernandez A, 2018, J ARTIF INTELL RES, V61, P863, DOI 10.1613/jair.1.11192; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Gruen RL, 2012, LANCET, V380, P1099, DOI 10.1016/S0140-6736(12)61224-0; Haldar M, 2018, ARXIV E PRINTS, P1927; Liu NT, 2017, SHOCK, V48, P504, DOI 10.1097/SHK.0000000000000898; Liu X.-Y., 2009, IEEE T SYSTEMS MAN C, V39, P539, DOI [10.1109/TSMCB.2008.2007853, DOI 10.1109/TSMCB.2008.2007853]; Lundberg S.M, 2018, CONSISTENT INDIVIDUA; Lundberg SM, 2018, NAT BIOMED ENG, V2, P749, DOI 10.1038/s41551-018-0304-0; Marble RP, 1999, ARTIF INTELL MED, V15, P299, DOI 10.1016/S0933-3657(98)00059-1; Meredith W, 1998, J TRAUMA, V44, P839, DOI 10.1097/00005373-199805000-00016; Mitchell RJ, 2018, SCAND J TRAUMA RESUS, V26, DOI 10.1186/s13049-018-0563-5; Neal ML, 2013, NIH PUBLIC ACCESS, V7, P97; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Reisner AT, 2013, AM J PHYSIOL-HEART C, V304, pH620, DOI 10.1152/ajpheart.00621.2012; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Rogers FB, 2015, INJURY, V46, P525, DOI 10.1016/j.injury.2014.08.043; Shapley Lloyd S., 1953, CONTRIBUTIONS THEORY, P307, DOI [10.3390/atmos10110723, DOI 10.1515/9781400881970-018]; Tsiklidis E, 2018, WIRES SYST BIOL MED, V10, DOI 10.1002/wsbm.1418; Tsiklidis EJ, 2019, AM J PHYSIOL-HEART C, V317, pH73, DOI 10.1152/ajpheart.00774.2018; Ursino M, 1998, AM J PHYSIOL-HEART C, V275, pH1733, DOI 10.1152/ajpheart.1998.275.5.H1733; Walczak S, 2005, IEEE T INF TECHNOL B, V9, P468, DOI 10.1109/TITB.2005.847510; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Zenati MS, 2002, J TRAUMA, V53, P232, DOI 10.1097/00005373-200208000-00007; Zhang J, 2003, ACTA POLYM SIN, P30	33	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242166	10.1371/journal.pone.0242166	http://dx.doi.org/10.1371/journal.pone.0242166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201935	Green Published, gold			2022-12-26	WOS:000595003900042
J	Xia, WW; Fu, H; Liu, HY; Meng, FQ; Wang, KF				Xia, Weiwei; Fu, Han; Liu, Haiying; Meng, Fanqi; Wang, Kaifeng			A test-retest reliability study of assessing small cutaneous fibers by measuring current perception threshold with pin electrodes	PLOS ONE			English	Article							ELECTRICAL NERVE-STIMULATION; LONG-TERM POTENTIATION; PERIPHERAL NEUROPATHY; SENSORY FUNCTION; BLOOD-FLOW; TEMPERATURE; INVOLVEMENT; ACTIVATION; CONDUCTION; CAPSAICIN	Background The quantitative measurement of current perception threshold (CPT) has been used as a method to assess the function of nerve fibers in neuropathy diseases. The aim of this study was to assess the test-retest reliability measuring CPT using the circular pin electrodes for assessing the function of cutaneous thin nerve fibers. Methods CPT measurement was repeated on two separate days with at least one-week interval in 55 volunteers. Superficial blood flow (SBF) and skin temperature (ST) were measured on the skin in an around area concentric to the circular pin electrodes after the process of finding CPTs. The coefficient of variation (CV) and intra-class correlation coefficient (ICC) were calculated. The correlation between each two of CPT, SBF increment and ST increment was analyzed. Results No significant differences were found for CPT, SBF and ST between two sessions. SBF was found to be significantly increased after the process of finding CPT. CPT values of males were found to be higher than females. SBF increment was found to be positively correlated with ST increment. The ICC values for CPT, SBF and ST were 0.595, 0.852 and 0.728, respectively. The CV values for CPT, SBF and ST were 25.53%, 12.59% and 1.94%, respectively. Conclusions The reliability of CPT measurement using circular pin electrodes is fair, and need consistence of measurements in longitudinal studies.	[Xia, Weiwei; Liu, Haiying; Meng, Fanqi; Wang, Kaifeng] Peking Univ Peoples Hosp, Dept Spinal Surg, Beijing, Peoples R China; [Fu, Han] Chinese Peoples Liberat Army PLA Gen Hosp, Dept Resp Med, Beijing, Peoples R China		Wang, KF (corresponding author), Peking Univ Peoples Hosp, Dept Spinal Surg, Beijing, Peoples R China.	523526767@qq.com			National Key R&D Program of China [2016YFC0105606]; Peking University People's Hospital Research and Development Funds [RDY2019-12]	National Key R&D Program of China; Peking University People's Hospital Research and Development Funds	National Key R&D Program of China (2016YFC0105606):K.F.W. Peking University People's Hospital Research and Development Funds (RDY2019-12):W.W.X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES MD, 1991, J BIOMED ENG, V13, P185, DOI 10.1016/0141-5425(91)90124-P; BRAIN SD, 1988, NATURE, V335, P73, DOI 10.1038/335073a0; Chan ACY, 2016, MUSCLE NERVE, V53, P671, DOI 10.1002/mus.25082; Cramp AFL, 2000, CLIN PHYSIOL, V20, P150; Cramp AFL, 2001, ACUPUNCTURE ELECTRO, V26, P25, DOI 10.3727/036012901816356036; Dusch M, 2007, NEUROREPORT, V18, P1101, DOI 10.1097/WNR.0b013e3281e72cff; GAMSE R, 1985, EUR J PHARMACOL, V114, P61, DOI 10.1016/0014-2999(85)90520-5; Goransson LG, 2004, NEUROLOGY, V62, P774, DOI 10.1212/01.WNL.0000113732.41127.8F; HOLZER P, 1988, NEUROSCIENCE, V24, P739, DOI 10.1016/0306-4522(88)90064-4; Hugosdottir R, 2019, J NEUROPHYSIOL, V122, P1745, DOI 10.1152/jn.00390.2019; Kang EK, 2008, NEUROPHYSIOL CLIN, V38, P127, DOI 10.1016/j.neucli.2007.12.003; Klein T, 2004, J NEUROSCI, V24, P964, DOI 10.1523/JNEUROSCI.1222-03.2004; Landmann G, 2016, PAIN PRACT, V16, P273, DOI 10.1111/papr.12339; Lelic D, 2012, EUR J PAIN, V16, P827, DOI 10.1002/j.1532-2149.2011.00063.x; Lillieskold VH, 2018, CLIN NEUROPHYS PRACT, V3, P134, DOI 10.1016/j.cnp.2018.06.004; Lv SL, 2015, DIABETES RES CLIN PR, V109, P130, DOI 10.1016/j.diabres.2015.04.018; Macklin RA, 2016, SPINAL CORD, V54, P16, DOI 10.1038/sc.2015.104; MAGERL W, 1987, NEUROSCI LETT, V82, P349, DOI 10.1016/0304-3940(87)90281-3; MASSON EA, 1989, DIABETOLOGIA, V32, P724, DOI 10.1007/BF00274531; MCCARTHY PW, 1989, NEUROSCIENCE, V28, P745, DOI 10.1016/0306-4522(89)90019-5; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; Morch Carsten Dahl, 2013, Int J Physiol Pathophysiol Pharmacol, V5, P203; Morch CD, 2011, MED BIOL ENG COMPUT, V49, P385, DOI 10.1007/s11517-010-0725-8; Motogi J, 2014, NEUROSCI LETT, V570, P69, DOI 10.1016/j.neulet.2014.04.001; Mouraux A, 2010, PAIN, V150, P199, DOI 10.1016/j.pain.2010.04.026; Nielsen CS, 2009, J PAIN, V10, P231, DOI 10.1016/j.jpain.2008.09.010; Nishimura A, 2004, CLIN NEUROPHYSIOL, V115, P1921, DOI 10.1016/j.clinph.2004.03.022; Otsuru N, 2010, J PAIN, V11, P621, DOI 10.1016/j.jpain.2009.10.001; Palmer ST, 2000, SOMATOSENS MOT RES, V17, P325; Pieretti Stefano, 2016, Ann Ist Super Sanita, V52, P184, DOI 10.4415/ANN_16_02_09; PITEI DL, 1994, DIABETIC MED, V11, P872, DOI 10.1111/j.1464-5491.1994.tb00371.x; Provitera V, 2007, MUSCLE NERVE, V35, P767, DOI 10.1002/mus.20771; Quaghebeur J, 2014, SOMATOSENS MOT RES, V31, P186, DOI 10.3109/08990220.2014.911172; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; ROGERS EJ, 1978, J CLIN PSYCHIAT, V39, P431; Schmelz M, 2000, NEUROREPORT, V11, P645, DOI 10.1097/00001756-200002280-00041; Selim MM, 2010, PAIN, V151, P575, DOI 10.1016/j.pain.2010.06.034; STRIAN F, 1989, PAIN, V36, P125, DOI 10.1016/0304-3959(89)90120-6; Sumikura H, 2003, NEUROSCI LETT, V337, P147, DOI 10.1016/S0304-3940(02)01325-3; TA B, 1989, MEASUREMENT CONCEPTS, P45; Takekuma K, 2000, J Epidemiol, V10, pS33; Tigerholm J, 2019, BIOPHYS J, V117, P281, DOI 10.1016/j.bpj.2019.04.041; Xia WW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161117; Xia WW, 2016, EXP BRAIN RES, V234, P2479, DOI 10.1007/s00221-016-4653-1; Yamashita T, 2002, SPINE, V27, P1567, DOI 10.1097/00007632-200207150-00016	45	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242490	10.1371/journal.pone.0242490	http://dx.doi.org/10.1371/journal.pone.0242490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201884	Green Published, gold			2022-12-26	WOS:000595003900005
J	Goncalves, A; Soper, B; Nygard, M; Nygard, JF; Ray, P; Widemann, D; Sales, AP				Goncalves, Andre; Soper, Braden; Nygard, Mari; Nygard, Jan F.; Ray, Priyadip; Widemann, David; Sales, Ana Paula			Improving five-year survival prediction via multitask learning across HPV-related cancers	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; CLASSIFICATION; TRENDS; DNA; PREVALENCE; P16(INK4A); EXPRESSION; WORLDWIDE; LESIONS	Oncology is a highly siloed field of research in which sub-disciplinary specialization has limited the amount of information shared between researchers of distinct cancer types. This can be attributed to legitimate differences in the physiology and carcinogenesis of cancers affecting distinct anatomical sites. However, underlying processes that are shared across seemingly disparate cancers probably affect prognosis. The objective of the current study is to investigate whether multitask learning improves 5-year survival cancer patient survival prediction by leveraging information across anatomically distinct HPV related cancers. Data were obtained from the Surveillance, Epidemiology, and End Results (SEER) program database. The study cohort consisted of 29,768 primary cancer cases diagnosed in the United States between 2004 and 2015. Ten different cancer diagnoses were selected, all with a known association with HPV risk. In the analysis, the cancer diagnoses were categorized into three distinct topography groups of varying specificity. The most specific topography grouping consisted of 10 original cancer diagnoses differentiated by the first two digits of the ICD-O-3 topography code. The second topography grouping consisted of cancer diagnoses categorized into six distinct organ groups. Finally, the third topography grouping consisted of just two groups, head-neck cancers and ano-genital cancers. The tasks were to predict 5-year survival for patients within the different topography groups using 14 predictive features which were selected among descriptive variables available in the SEER database. The information from the predictive features was shared between tasks in three different ways, resulting in three distinct predictive models: 1) Information was not shared between patients assigned to different tasks (single task learning); 2) Information was shared between all patients, regardless of task (pooled model); 3) Only relevant information was shared between patients grouped to different tasks (multitask learning). Prediction performance was evaluated with Brier scores. All three models were evaluated against one another on each of the three distinct topography-defined tasks. The results showed that multitask classifiers achieved relative improvement for the majority of the scenarios studied compared to single task learning and pooled baseline methods. In this study, we have demonstrated that sharing information among anatomically distinct cancer types can lead to improved predictive survival models.	[Goncalves, Andre; Soper, Braden; Ray, Priyadip; Widemann, David; Sales, Ana Paula] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Nygard, Mari; Nygard, Jan F.] Canc Registry Norway, Oslo, Norway	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of Oslo	Goncalves, A (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	goncalves1@llnl.gov	Goncalves, Andre R/H-8065-2015; Goncalves, Andre/V-7132-2019; Soper, Braden/AAX-8778-2021	Goncalves, Andre/0000-0002-0320-280X; Nygard, Jan Franz/0000-0001-9655-7003; Soper, Braden/0000-0002-0308-708X	U.S. Department of Energy through the Lawrence Livermore National Laboratory; Cancer Registry of Norway	U.S. Department of Energy through the Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Cancer Registry of Norway	AG, BS, PR, DW, MA, AS were supported by the U.S. Department of Energy through the Lawrence Livermore National Laboratory. MN and JFN work was supported by the Cancer Registry of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany L, 2014, EUR J CANCER, V50, P2846, DOI 10.1016/j.ejca.2014.07.018; Alemany L, 2016, EUR UROL, V69, P953, DOI 10.1016/j.eururo.2015.12.007; Alemany L, 2015, INT J CANCER, V136, P98, DOI 10.1002/ijc.28963; Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Allo G, 2020, INT J GYNECOL PATHOL, V39, P391, DOI 10.1097/PGP.0000000000000620; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Argyriou A., 2007, NEURAL INFORM PROCES, V19, P41, DOI DOI 10.1007/S10994-007-5040-8; BERKSON J, 1952, J AM STAT ASSOC, V47, P501, DOI 10.2307/2281318; Caruana R, 1997, MACH LEARN, V28, P41, DOI 10.1023/A:1007379606734; Chen AH, 2010, LECT NOTES COMPUT SC, V6165, P11, DOI 10.1007/978-3-642-13923-9_2; de Sanjose S, 2013, EUR J CANCER, V49, P3450, DOI 10.1016/j.ejca.2013.06.033; Dickman PW, 2006, J INTERN MED, V260, P103, DOI 10.1111/j.1365-2796.2006.01677.x; Djajadiningrat RS, 2015, J UROLOGY, V193, P526, DOI 10.1016/j.juro.2014.08.087; Esteva A, 2019, NAT MED, V25, P24, DOI 10.1038/s41591-018-0316-z; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; Ferrandiz-Pulido C, 2013, J AM ACAD DERMATOL, V68, P73, DOI 10.1016/j.jaad.2012.05.029; Fritz A, 2000, INT CLASSIFICATION D; Gadducci A, 2015, CRIT REV ONCOL HEMAT, V93, P211, DOI 10.1016/j.critrevonc.2014.09.002; Goncalves AR, 2016, J MACH LEARN RES, V17, P1; Graf E, 1999, STAT MED, V18, P2529; Hansen BT, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019005; Jalali A., 2010, ADV NEURAL INF PROCE, V23, P964; JI S., 2009, P 26 ANN INT C MACH, P457; Kandaswamy C, 2016, J BIOMOL SCREEN, V21, P252, DOI 10.1177/1087057115623451; Kim S, 2010, INTERNATIONAL CONFERENCE ON CONTROL, AUTOMATION AND SYSTEMS (ICCAS 2010), P546; Lassen P, 2011, RADIOTHER ONCOL, V100, P49, DOI 10.1016/j.radonc.2011.02.010; Lin YZ, 2013, BIOSTATISTICS, V14, P327, DOI 10.1093/biostatistics/kxs044; Liu G, 2015, SEX TRANSM DIS, V42, P20, DOI 10.1097/OLQ.0000000000000231; Luxembourg A, 2017, CONTEMP CLIN TRIALS, V52, P54, DOI 10.1016/j.cct.2016.10.006; Lynch CM, 2017, INT J MED INFORM, V108, P1, DOI 10.1016/j.ijmedinf.2017.09.013; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; Nasman A, 2009, INT J CANCER, V125, P362, DOI 10.1002/ijc.24339; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Posner MR, 2011, ANN ONCOL, V22, P1071, DOI 10.1093/annonc/mdr006; Razzaghi H, 2018, CANCER-AM CANCER SOC, V124, P203, DOI 10.1002/cncr.30947; SEER, 2018, SURV EP END RESEER; Serup-Hansen E, 2014, J CLIN ONCOL, V32, P1812, DOI 10.1200/JCO.2013.52.3464; Simon J, 2020, INT J CANCER, V147, P461, DOI 10.1002/ijc.33006; Skolidis G, 2011, IEEE T NEURAL NETWOR, V22, P2011, DOI 10.1109/TNN.2011.2168568; Tsiatis AA, 2010, SPRINGER SERIES STAT; Urbute A, 2020, CANCER EPIDEM BIOMAR, V29, P703, DOI 10.1158/1055-9965.EPI-19-1259; Vock DM, 2016, J BIOMED INFORM, V61, P119, DOI 10.1016/j.jbi.2016.03.009; Wang P, 2019, ACM COMPUT SURV, V51, DOI 10.1145/3214306; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Weiser MR, 2011, J CLIN ONCOL, V29, P4796, DOI 10.1200/JCO.2011.36.5080; Wookey VB, 2019, ANTICANCER RES, V39, P1907, DOI 10.21873/anticanres.13299; Wotman M, 2019, AM J OTOLARYNG, V40, P705, DOI 10.1016/j.amjoto.2019.06.007; Wright JL, 2010, J UROLOGY, V183, P2213, DOI 10.1016/j.juro.2010.02.017; Yang MZ, 2013, APPL MECH MATER, V274, P423, DOI 10.4028/www.scientific.net/AMM.274.423; Zhang HN, 2013, IEEE DATA MINING, P1283, DOI 10.1109/ICDM.2013.58; Zhang JX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204162; Zhang Y, 2015, CANCER INFORM, V14, P11, DOI 10.4137/CIN.S17290	57	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0241225	10.1371/journal.pone.0241225	http://dx.doi.org/10.1371/journal.pone.0241225			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196642	Green Published, Green Submitted, gold			2022-12-26	WOS:000595266800010
J	Suslova, KG; Efimov, AV; Sokolova, AB; Napier, BA; Miller, SC				Suslova, Klara G.; Efimov, Alexander V.; Sokolova, Alexandra B.; Napier, Bruce A.; Miller, Scott C.			The effects of chronic diseases on plutonium urinary excretion in former workers of the Mayak Production Association	PLOS ONE			English	Article							DOSIMETRY SYSTEM MWDS-2013; EXTRAPULMONARY ORGAN DISTRIBUTION; FALLOUT PLUTONIUM; UNITED-STATES; LIVER; DEPOSITION; CANCERS; SAMPLES; HEALTH; MODEL	The radiochemical analysis of plutonium activity in urine is the main method for indirect estimation of doses of internal exposure from plutonium incorporation in professional workers. It was previously shown that late-in-life acute diseases, particularly those that affect the liver, can promote accelerated rates of release of plutonium from the liver with enhanced excretion rates. This initial study examines the relationships of some chronic diseases on plutonium excretion as well as the terminal relative distribution of plutonium between the liver and skeleton. Fourteen cases from former workers at the Mayak Production Association (Mayak PA) who provided from 4-9 urine plutonium bioassays for plutonium, had an autopsy conducted after death, and had sufficient clinical records to document their health status were used in this study. Enhanced plutonium excretion was associated with more serious chronic diseases, including cardiovascular diseases and other diseases that involved the liver. These chronic diseases were also associated with relatively less plutonium found in the liver relative to the skeleton determined by analyses conducted after autopsy. These data further document health conditions that affect plutonium biokinetics and organ deposition and retention patterns and suggest that health status should be considered when conducting plutonium bioassays as these may alter subsequent dosimetry and risk models.	[Suslova, Klara G.; Efimov, Alexander V.; Sokolova, Alexandra B.] Southern Urals Biophys Inst SUBI, Ozyorsk, Chelyabinsk Reg, Russia; [Napier, Bruce A.] Pacific Northwest Natl Lab, Richland, WA 99352 USA; [Miller, Scott C.] Univ Utah, Sch Med, Div Radiobiol, Dept Radiol & Imaging Sci, Salt Lake City, UT 84112 USA	Southern Urals Biophysics Institute; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Utah System of Higher Education; University of Utah	Suslova, KG (corresponding author), Southern Urals Biophys Inst SUBI, Ozyorsk, Chelyabinsk Reg, Russia.; Napier, BA (corresponding author), Pacific Northwest Natl Lab, Richland, WA 99352 USA.; Miller, SC (corresponding author), Univ Utah, Sch Med, Div Radiobiol, Dept Radiol & Imaging Sci, Salt Lake City, UT 84112 USA.	Suslova@subi.su; Bruce.Napier@pnnl.gov; Scott.Miller@hsc.utah.edu	Efimov, Alexander/AAD-4596-2021; Sokolova, Alexandra/M-6080-2019	Sokolova, Alexandra/0000-0002-6036-4178; Napier, Bruce/0000-0002-7530-4151; Efimov, Alexander/0000-0003-1110-6559; Suslova, Klara/0000-0003-0503-8916	United States Department of Energy; Federal Medical Biological Agency of the Russian Federation [AU 00000902]	United States Department of Energy(United States Department of Energy (DOE)); Federal Medical Biological Agency of the Russian Federation	The Joint Coordinating Committee for Radiation Effects Research, jointly funded by the United States Department of Energy and the Federal Medical Biological Agency of the Russian Federation, provided salary support to the authors under Project Number AU 00000902. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support and assistance of Barrett Fountos, former Program Manager, US Department of Energy, Office of Domestic and International Health Studies and Dr. Sergey Romanov, Director of the Southern Urals Biophysics Institute. This work was conducted as part of the Joint Coordinating Committee for Radiation Effects Research, Project 2.4, Mayak Worker Dosimetry. The authors express their appreciation for the many other professionals who worked over the years to provide the information used in this study.	[Anonymous], 1993, ACTA ICHTHYOL PISCAT, V23, P1, DOI DOI 10.CNKI:SUN:GSHJ.0.1993-03-000; Birchall A, 2017, RADIAT PROT DOSIM, V176, P10, DOI 10.1093/rpd/ncx014; COHEN N, 1978, J TOXICOL ENV HEALTH, V4, P825, DOI 10.1080/15287397809529703; Cohen N, 1977, PROGR REPORT RADIOAC; El Hadi H, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030567; Filipy RE, 1998, J RADIOANAL NUCL CH, V234, P171, DOI 10.1007/BF02389767; Gatiatulina ER, 2017, J TRACE ELEM MED BIO, V39, P91, DOI 10.1016/j.jtemb.2016.08.007; Gilbert ES, 2013, RADIAT RES, V179, P332, DOI 10.1667/RR3054.1; Gilbert ES, 2000, RADIAT RES, V154, P246, DOI 10.1667/0033-7587(2000)154[0246:LCIMW]2.0.CO;2; GRIFFITH WC, 1991, RADIAT PROT DOSIM, V38, P113; ICRP, 2002, ANN ICRP, V32, P1, DOI DOI 10.1016/S0146-6453(03)00002-2; KATHREN RL, 1991, HEALTH PHYS, V60, P481, DOI 10.1097/00004032-199104000-00001; Khokhryakov VF, 2000, HEALTH PHYS, V79, P63, DOI 10.1097/00004032-200007000-00011; Khokhryakov VF, 1998, J RADIOANAL NUCL CH, V234, P293, DOI 10.1007/BF02389788; KHOKHRYAKOV VF, 1994, RADIAT PROT DOSIM, V53, P235; Khokhryakov VV, 2013, HEALTH PHYS, V104, P366, DOI 10.1097/HP.0b013e31827dbf60; Koshurnikova NA, 2000, RADIAT RES, V154, P237, DOI 10.1667/0033-7587(2000)154[0237:BCIMW]2.0.CO;2; Labutina EV, 2013, HEALTH PHYS, V105, P165, DOI 10.1097/HP.0b013e31828f57df; MUSSALO H, 1980, HEALTH PHYS, V39, P245, DOI 10.1097/00004032-198008000-00011; Saner FH, 2009, EUR J MED RES, V14, P541; Sokolnikov M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117784; Sokolnikov ME, 2008, INT J CANCER, V123, P905, DOI 10.1002/ijc.23581; Suslova KG, 2017, RADIAT PROT DOSIM, V176, P117, DOI 10.1093/rpd/ncw239; Suslova KG, 2006, HEALTH PHYS, V90, P299, DOI 10.1097/01.HP.0000183759.39785.9c; Suslova KG, 1996, RADIAT PROT DOSIM, V67, P13, DOI 10.1093/oxfordjournals.rpd.a031791; Suslova KG, 2003, RADIAT PROT DOSIM, V105, P229, DOI 10.1093/oxfordjournals.rpd.a006228; Suslova KG, 2002, HEALTH PHYS, V82, P432, DOI 10.1097/00004032-200204000-00002; TAYLOR GN, 1992, HEALTH PHYS, V62, P178, DOI 10.1097/00004032-199202000-00008; Vasilenko EK, 2007, HEALTH PHYS, V93, P190, DOI 10.1097/01.HP.0000266071.43137.0e; Vostrotin V, 2017, RADIAT PROT DOSIM, V176, P106, DOI 10.1093/rpd/ncw247; Vostrotin VV, 2019, RADIAT PROT DOSIM, V184, P201, DOI 10.1093/rpd/ncy200	31	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242151	10.1371/journal.pone.0242151	http://dx.doi.org/10.1371/journal.pone.0242151			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186401	Green Submitted, Green Published, gold			2022-12-26	WOS:000593949800035
J	Denley, D; Metaxas, A; Scheibling, R				Denley, Danielle; Metaxas, Anna; Scheibling, Robert			Subregional variation in cover and diversity of hard coral (Scleractinia) in the Western Province, Solomon Islands following an unprecedented global bleaching event	PLOS ONE			English	Article							MARINE PROTECTED AREAS; CLIMATE-CHANGE; RESILIENCE; RECOVERY; IMPACTS; HISTORY; REEFS	Coral reefs are critically important marine ecosystems that are threatened worldwide by cumulative impacts of global climate change and local stressors. The Solomon Islands comprise the southwestern boundary of the Coral Triangle, the global center of coral diversity located in the Indo-Pacific, and represent a bright spot of comparatively healthy coral reef ecosystems. However, reports on the status of coral reefs in the Solomon Islands are based on monitoring conducted at 5 stations in 2003-2004 and 2006-2007, with no information on how corals in this region have responded to more recent global bleaching events and other local stressors. In this study, we compare reef condition (substrate composition) and function (taxonomic and morphological diversity of hard corals) among 15 reefs surveyed in the Western Province, Solomon Islands that span a range of local disturbance and conservation histories. Overall, we found high cover of live hard coral (15-64%) and diverse coral assemblages despite an unprecedented 36-month global bleaching event in the three years leading up to our surveys in 2018. However, there was significant variation in coral cover and diversity across the 15 reefs surveyed, suggesting that impacts of global disturbance events are moderated at smaller scales by local anthropogenic factors (fisheries extraction, land-use impacts, marine management) and environmental (hydrodynamics) conditions. Our study provides evidence that relatively healthy reefs persist at some locations in the Solomon Islands and that local stewardship practices have the potential to impact reef condition at subregional scales. As coral reef conservation becomes increasingly urgent in the face of escalating cumulative threats, prioritising sites for management efforts is critical. Based on our findings and the high dependency of Solomon Islanders on coral reef ecosystem services, we advocate that the Western Province, Solomon Islands be considered of high conservation priority.	[Denley, Danielle; Metaxas, Anna] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [Scheibling, Robert] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Denley, Danielle] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC, Canada	Dalhousie University; Dalhousie University; Simon Fraser University	Denley, D (corresponding author), Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada.; Denley, D (corresponding author), Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC, Canada.	danielle_denley@sfu.ca	Denley, Danielle/ABE-1904-2020	Metaxas, Anna/0000-0002-1935-6213; Denley, Danielle/0000-0002-2568-167X	Natural Sciences and Engineering Research Council of Canada [RGPIN2016-04878]; ARC Centre of Excellence for Environmental Decisions at the University of Queensland	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); ARC Centre of Excellence for Environmental Decisions at the University of Queensland	AM received a Discovery Grant (RGPIN2016-04878) from the Natural Sciences and Engineering Research Council of Canada (https://www.nserc-crsng.gc.ca/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Stewart Steven and the dive guides at Uepi Island Resort for assistance in the field, Grant Kelly for welcoming our project at Uepi, and C. Attridge and S. Feng for help with image processing. A.M. also thanks the ARC Centre of Excellence for Environmental Decisions at the University of Queensland for hosting her during her sabbatical leave in 2018.	Albert S, 2015, MAR POLLUT BULL, V94, P299, DOI 10.1016/j.marpolbul.2015.01.031; [Anonymous], 2021, LANG ENV STAT COMP; Aswani S, 2007, CORAL REEFS, V26, P1009, DOI 10.1007/s00338-007-0277-z; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Burke L., 2011, REEFS RISK REVISITED; Chin A, 2011, STATUS CORAL REEFS P, P65; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Darling ES, 2019, NAT ECOL EVOL, V3, P1341, DOI 10.1038/s41559-019-0953-8; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; DeVantier LM, 2006, CORAL REEFS, V25, P329, DOI 10.1007/s00338-006-0115-8; DeVantier L, 2017, DIVERSITY-BASEL, V9, DOI 10.3390/d9030025; Duke NC., 2007, CONSERVING MARINE BI; Eakin CM., 2018, B AM METEOROL SOC, V99, pS74; Edinger EN, 2000, BIOL CONSERV, V92, P1, DOI 10.1016/S0006-3207(99)00067-1; Gotelli Nicholas J., 2011, P39; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Halpern BS, 2013, CORAL REEFS, V32, P61, DOI 10.1007/s00338-012-0981-1; Hoegh-Guldberg O., 2009, CORAL TRIANGLE CLIMA; Hughes TP, 2018, NATURE, V556, P492, DOI 10.1038/s41586-018-0041-2; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Hughes TP, 2017, NATURE, V546, P82, DOI 10.1038/nature22901; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kere N., 2009, SW PACIFIC STATUS CO, P117; Lourey MJ, 2000, MAR ECOL PROG SER, V196, P179, DOI 10.3354/meps196179; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; Morris C, 2008, STATUS CORAL REEFS W, P177; NOAA Coral Reef Watch, 2018, NOAA COR REEF WATCH; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Schwarz A, 2007, WORLDFISH CTR WWF SI; Smith JE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.1985; Sulu R, 2002, STATUS CORAL REEFS W; Sulu R, 2000, CORAL REEFS PACIFIC, P249; Suparno Nono, 2019, Atoll Research Bulletin, P1; Turak E., 2006, SOLOMON ISLANDS MARI; Veron J. E., 2000, CORALS WORLD, V1; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; Wairiu M, 2007, J PAC HIST, V42, P233, DOI 10.1080/00223340701461684; Wenger AS, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aab9eb; White AT, 2014, COAST MANAGE, V42, P87, DOI 10.1080/08920753.2014.878177; Wilkinson C, 2008, STATUS CORAL REEFS W; Wilkinson C., 2004, STATUS CORAL REEFS W, V2, P337	46	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242153	10.1371/journal.pone.0242153	http://dx.doi.org/10.1371/journal.pone.0242153			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175873	gold, Green Published			2022-12-26	WOS:000593946900040
J	Goh, SSL; Lai, PSM; Liew, SM; Tan, KM; Chung, WW; Chua, SS				Goh, Sheron Sir Loon; Lai, Pauline Siew Mei; Liew, Su-May; Tan, Kit Mun; Chung, Wen Wei; Chua, Siew Siang			Development of a PATIENT-Medication Adherence Instrument (P-MAI) and a HEALTHCARE PROFESSIONAL-Medication Adherence Instrument (H-MAI) using the nominal group technique	PLOS ONE			English	Article							LOW-LITERACY PATIENTS; SELF-EFFICACY SCALE; ANTIRETROVIRAL THERAPY; PREDICTIVE-VALIDITY; VALIDATION; QUESTIONNAIRE; RELIABILITY; OUTPATIENTS; AFRICAN; HYPERTENSION	To date, several medication adherence instruments have been developed and validated worldwide. However, most instruments have only assessed medication adherence from the patient's perspective. The aim was to develop and validate the PATIENT-Medication Adherence Instrument (P-MAI) and the HEALTHCARE PROFESSIONAL-Medication Adherence Instrument (H-MAI) to assess medication adherence from the patient's and healthcare professional (HCP)'s perspectives. The P-MAI-12 and H-MAI-12 were developed using the nominal group technique. The face and content validity was determined by an expert panel and piloted. The initial version of these instruments consisted of 12 items were validated from October-December 2018 at a primary care clinic in Malaysia. Included were patients aged >= 21 years, diagnosed with diabetes mellitus, taking at least one oral hypoglycaemic agent and who could understand English. The HCPs recruited were family medicine specialists or trainees. To assess validity, exploratory factor analysis (EFA) and concurrent validity were performed; internal consistency and test-retest were performed to assess its reliability. A total of 120/158 patients (response rate = 75.9%) and 30/33 HCPs (response rate = 90.9%) agreed to participate. EFA found three problematic items in both instruments, which was then removed. The final version of the P-MAI-9 and the HMAI-9 had 9 items each with two domains (adherence = 2 items and knowledge/belief = 7 items). For concurrent validity, the total score of the P-MAI-9 and the H-MAI-9 were not significantly different (p = 0.091), indicating that medication adherence assessed from both the patient's and HCP's perspectives were similar. Both instruments achieved acceptable internal consistency (Cronbach's alpha: P-MAI-9 = 0.722; H-MAI-9 = 0.895). For the P-MAI-9, 7/9 items showed no significant difference between test and retest whereas 8/9 items in the H-MAI-9 showed significant difference at test and retest (p>0.05). In conclusion, the P-MAI-9 and H-MAI-9 had low sensitivity and high specificity suggesting that both instruments can be used for identifying patients more likely to be non-adherent to their medications.	[Goh, Sheron Sir Loon; Lai, Pauline Siew Mei; Liew, Su-May] Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia; [Tan, Kit Mun] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur, Malaysia; [Chung, Wen Wei] Univ Malaya, Med Ctr, Dept Pharm, Kuala Lumpur, Malaysia; [Chua, Siew Siang] Taylors Univ, Fac Hlth & Med Sci, Sch Pharm, Subang Jaya, Selangor, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Taylor's University	Lai, PSM (corresponding author), Univ Malaya, Fac Med, Dept Primary Care Med, Kuala Lumpur, Malaysia.	plai@ummc.edu.my	Lai, Pauline Siew Mei/B-1031-2012; Goh, Sheron Sir Loon/AAZ-6943-2021; Tan, Kit Mun/D-5301-2013; Chua, Siew Siang/AAH-9218-2021	Lai, Pauline Siew Mei/0000-0002-9940-9644; Goh, Sheron Sir Loon/0000-0003-3400-730X; Tan, Kit Mun/0000-0003-1611-3109; 	University Malaya Research Grant [RP048A-17HTM]	University Malaya Research Grant	No. Funding for this study was obtained from the University Malaya Research Grant (RP048A-17HTM) which was awarded to PSML. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2016, PATIENT PREFER ADHER, V10, P99, DOI 10.2147/PPA.S94687; Anghel Laura Alexandra, 2019, Med Pharm Rep, V92, P117, DOI 10.15386/mpr-1201; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2019, FLESCH READING EASE; [Anonymous], 2015, BMJ, V2015, ph1887; [Anonymous], 2017, ONCOGENESIS, V6, pe345; Barroso PF, 2003, JAIDS-J ACQ IMM DEF, V32, P435, DOI 10.1097/00126334-200304010-00014; Bell DJ, 2007, JAIDS-J ACQ IMM DEF, V45, P560, DOI 10.1097/QAI.0b013e3180decadb; Bezreh T, 2012, PATIENT PREFER ADHER, V6, P11, DOI 10.2147/PPA.S25971; BROOKS CM, 1994, MED CARE, V32, P298, DOI 10.1097/00005650-199403000-00008; Byerly MJ, 2008, SCHIZOPHR RES, V100, P60, DOI 10.1016/j.schres.2007.12.470; Chisholm MA, 2005, PATIENT EDUC COUNS, V59, P13, DOI 10.1016/j.pec.2004.09.003; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Chung WW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124275; Clayton CD, 2010, J PSYCHIATR PRACT, V16, P164, DOI 10.1097/01.pra.0000375712.85454.c6; de Klerk E, 2003, J RHEUMATOL, V30, P2469; Dima AL, 2017, PSYCHOL HEALTH, V32, P1288, DOI 10.1080/08870446.2017.1290248; Dolder CR, 2004, J CLIN PSYCHOPHARM, V24, P404, DOI 10.1097/01.jcp.0000130554.63254.3a; Fernandez S, 2008, J BEHAV MED, V31, P453, DOI 10.1007/s10865-008-9170-7; Fodor GJ, 2005, J HYPERTENS, V23, P1261, DOI 10.1097/01.hjh.0000170390.07321.ca; Gehi AK, 2007, ARCH INTERN MED, V167, P1798, DOI 10.1001/archinte.167.16.1798; Gellad WF, 2011, AM J GERIATR PHARMAC, V9, P11, DOI 10.1016/j.amjopharm.2011.02.004; George J, 2006, PATIENT EDUC COUNS, V64, P50, DOI 10.1016/j.pec.2005.11.010; Godin G, 2003, AIDS PATIENT CARE ST, V17, P325, DOI 10.1089/108729103322231268; Greaves Colin J, 2005, Prim Care Respir J, V14, P99, DOI 10.1016/j.pcrj.2004.09.005; Grew B, 2019, RES SOC ADMIN PHARM, V15, P673, DOI 10.1016/j.sapharm.2018.08.008; Grymonpre RE, 1998, ANN PHARMACOTHER, V32, P749, DOI 10.1345/aph.17423; Hahn SR, 2008, CURR MED RES OPIN, V24, P2127, DOI [10.1185/03007990802174769, 10.1185/03007990802174769 ]; Hayes TL, 2006, ENG MED BIOL SOC 200; Heeb RM, 2019, J PHARMA CARE HLTH S, V6, P2376; HOGAN TP, 1983, PSYCHOL MED, V13, P177, DOI 10.1017/S0033291700050182; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Hurley AE, 1997, J ORGAN BEHAV, V18, P667, DOI 10.1002/(SICI)1099-1379(199711)18:6<667::AID-JOB874>3.0.CO;2-T; Jimmy Beena, 2011, Oman Med J, V26, P155, DOI 10.5001/omj.2011.38; Jonsdottir H, 2010, J CLIN PSYCHOPHARM, V30, P169, DOI 10.1097/JCP.0b013e3181d2191e; Kalichman Seth C, 2009, J Int Assoc Physicians AIDS Care (Chic), V8, P367, DOI 10.1177/1545109709352884; Kerr Thomas, 2008, J Int Assoc Physicians AIDS Care (Chic), V7, P157, DOI 10.1177/1545109708320686; Kim M T, 2000, Prog Cardiovasc Nurs, V15, P90, DOI 10.1111/j.1751-7117.2000.tb00211.x; Kleppe M, 2015, PATIENT PREFER ADHER, V9, P355, DOI 10.2147/PPA.S76749; Knobel H, 2002, AIDS, V16, P605, DOI 10.1097/00002030-200203080-00012; Kripalani S, 2009, VALUE HEALTH, V12, P118, DOI 10.1111/j.1524-4733.2008.00400.x; Kronish IM, 2013, PROG CARDIOVASC DIS, V55, P590, DOI 10.1016/j.pcad.2013.02.001; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lambert EV, 2006, ETHNIC DIS, V16, P286; Lee S, 2017, PHARMACY, V5, DOI 10.3390/pharmacy5030052; Lewis SJ, 2002, RES SOCIAL WORK PRAC, V12, P107, DOI 10.1177/104973150201200108; Mannheimer SB, 2006, AIDS CARE, V18, P853, DOI 10.1080/09540120500465160; Martin Leslie R, 2005, Ther Clin Risk Manag, V1, P189; Martinez Carlos E. Rodriguez, 2007, Pediatric Asthma Allergy & Immunology, V20, P243, DOI 10.1089/pai.2007.001; Matza LS, 2009, ANN PHARMACOTHER, V43, P1621, DOI 10.1345/aph.1M174; McMillan SS, 2016, INT J CLIN PHARM-NET, V38, P655, DOI 10.1007/s11096-016-0257-x; Meddings J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-270; Ministry of Health, 2015, CLIN PRACTIVE GUIDEL; Mirzaei A, 2019, RES SOC ADMIN PHARM, V15, P346, DOI 10.1016/j.sapharm.2018.05.005; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Munoz-Moreno JA, 2007, AIDS RES HUM RETROV, V23, P1166, DOI 10.1089/aid.2006.0120; Ogedegbe G, 2003, J CLIN EPIDEMIOL, V56, P520, DOI 10.1016/S0895-4356(03)00053-2; Okoli C, 2004, INFORM MANAGE-AMSTER, V42, P15, DOI 10.1016/j.im.2003.11.002; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Osborne J.W., 2004, PRACT ASSESS RES EVA, V9, P9, DOI [10.7275/ktzq-jq66, DOI 10.7275/KTZQ-JQ66]; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pallant J. F., 2016, SPSS SURVIVIAL MANUA, V6; Reynolds K, 2012, ANN PHARMACOTHER, V46, P659, DOI 10.1345/aph.1Q652; Risser J, 2007, J NURS MEAS, V15, P203, DOI 10.1891/106137407783095757; Sawada N, 2012, J CLIN PSYCHIAT, V73, P311, DOI 10.4088/JCP.11m07078; Schechter CB, 2002, DIABETES SPECTRUM, V15, P170, DOI DOI 10.2337/DIASPECT.15.3.170; Schroeder K, 2006, J CLIN EPIDEMIOL, V59, P650, DOI 10.1016/j.jclinepi.2005.10.013; Sherwani SI, 2016, BIOMARK INSIGHTS, V11, P95, DOI [10.4137/BMIMI.S38440, 10.4137/BMI.S38440]; Shima R, 2015, SINGAP MED J, V56, P460, DOI 10.11622/smedj.2015069; Shruthi R, 2016, J CLIN DIAGN RES, V10, pFC40, DOI 10.7860/JCDR/2016/21908.9088; Stirratt MJ, 2015, TRANSL BEHAV MED, V5, P470, DOI 10.1007/s13142-015-0315-2; Svarstad BL, 1999, PATIENT EDUC COUNS, V37, P113, DOI 10.1016/S0738-3991(98)00107-4; Nguyen TMU, 2014, BRIT J CLIN PHARMACO, V77, P427, DOI 10.1111/bcp.12194; Thompson K, 2000, SCHIZOPHR RES, V42, P241, DOI 10.1016/S0920-9964(99)00130-9; Tsai KT, 2012, AM J GERIATR PHARMAC, V10, P61, DOI 10.1016/j.amjopharm.2011.11.005; Unni EJ, 2015, RES SOC ADMIN PHARM, V11, pE133, DOI 10.1016/j.sapharm.2009.06.005; Ursachi G, 2015, PROC ECON FINANC, V20, P679, DOI 10.1016/S2212-5671(15)00123-9; van Dijk L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-51; van Galen LS, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1047; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Wetzels G, 2006, PATIENT EDUC COUNS, V64, P151, DOI 10.1016/j.pec.2005.12.010; Willey C, 2000, CLIN THER, V22, P858, DOI 10.1016/S0149-2918(00)80058-2	83	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242051	10.1371/journal.pone.0242051	http://dx.doi.org/10.1371/journal.pone.0242051			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0LY	33175871	Green Published, gold			2022-12-26	WOS:000593946900003
J	Sharp, WC; Shea, CP; Maxwell, KE; Muller, EM; Hunt, JH				Sharp, William C.; Shea, Colin P.; Maxwell, Kerry E.; Muller, Erinn M.; Hunt, John H.			Evaluating the small-scale epidemiology of the stony-coral -tissue-loss-disease in the middle Florida Keys	PLOS ONE			English	Article							REEF; PREVALENCE; ENDOSYMBIONTS; ZOOXANTHELLAE; RESILIENCE; FAVEOLATA; DYNAMICS; OUTBREAK	Along the Florida reef tract, stony-coral-tissue-loss disease (SCTLD) has caused extensive mortality of more than 20 scleractinian coral species. The pathogen is unknown, but its epizoology indicates that the disease, facilitated by water currents, has progressed linearly along the tract, affecting reefs at the scale of hundreds of kilometers. To inform ongoing disease mitigation efforts, we examined the small-scale spatial and temporal epidemiology of SCTLD. We established a series of sites in the middle Florida Keys at offshore and inshore locations that had not yet shown signs of SCTLD. We then conducted high-frequency monitoring from February 2018 through September 2019 and documented the onset of SCTLD and its progression through the sites. SCTLD was first observed at one site during early February 2018 and by early March 2018 all sites showed signs of the disease. A dynamic multistate model suggested that disease transmission was independent of coral density and found little evidence of a positive association between a colony showing signs of SCTLD and the condition or distance to its neighboring colonies. The model did, however, indicate that the probability of a colony showing signs of SCTLD increased with increasing colony surface area. These results are consistent with the water-borne transmission of a pathogen that progressed rapidly through the survey area. However, by the end of our survey the progression of SCTLD had slowed, particularly at inshore sites. Many affected colonies no longer exhibited progressive tissue mortality typical of the disease, suggesting the existence of differentially resilient colonies or coral communities, meriting their use for future coral rescue and propagation and disease research. These results are useful for refining ongoing SCTLD mitigation strategies, particularly by determining when disease rates are sufficiently low for direct intervention efforts designed to arrest disease progression on individual coral colonies will be most effective.	[Sharp, William C.; Maxwell, Kerry E.; Hunt, John H.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Marathon, FL 33050 USA; [Shea, Colin P.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL USA; [Muller, Erinn M.] Mote Marine Lab & Aquarium, Sarasota, FL USA	Florida Fish & Wildlife Conservation Commission; Florida Fish & Wildlife Conservation Commission; Mote Marine Laboratory & Aquarium	Sharp, WC (corresponding author), Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Marathon, FL 33050 USA.	bill.sharp@myfwc.com		Muller, Erinn/0000-0002-2695-2064	Florida Department of Environmental Protection [B25636, B3AA73, B5CF1E]	Florida Department of Environmental Protection	The authors received funding for this study from Florida Department of Environmental Protection in the form of Purchase Orders No. B25636 (WS and KM), B3AA73 (WS, KM, JH) and B5CF1E (WS and KM).	Aeby G.S., 2011, Journal of Marine Biology, V2011, P1, DOI 10.1155/2011/490198; Aeby GS, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00678; Alvarez-Filip L, 2019, PEERJ, V7, DOI 10.7717/peerj.8069; Baddeley A, 2015, SPATIAL POINT PATTER; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Brandt ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057164; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Caldwell JM, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2265; Correa AMS, 2009, CORAL REEFS, V28, P437, DOI 10.1007/s00338-008-0464-6; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Florida Department of Environmental Protection, 2019, STON COR TISS LOSS S; Florida Department of Environmental Protection, 2017, COR DIS WORKSH INT M; Florida Fish and Wildlife Conservation Commission, 2019, FWCS PAN COR DIS HIG; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gintert BE, 2018, CORAL REEFS, V37, P533, DOI 10.1007/s00338-018-1678-x; Green EP, 2000, BIOL CONSERV, V96, P347, DOI 10.1016/S0006-3207(00)00073-2; Gregoire V, 2017, J APPL PHYCOL, V29, P1893, DOI 10.1007/s10811-017-1127-1; Haslun JA, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3414-z; Hobbs JPA, 2010, DIS AQUAT ORGAN, V89, P1, DOI 10.3354/dao02181; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Jackson J, 2014, STATUS TRENDS CARIBB, DOI DOI 10.1111/1365-2664.12388; Kenkel CD, 2013, MOL ECOL, V22, P4335, DOI 10.1111/mec.12391; Kenkel CD, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0014; Kramer P.R., 2019, MAP STONY CORAL TISS; LaJeunesse TC, 2014, PHYCOLOGIA, V53, P305, DOI 10.2216/13-186.1; Lirman D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023047; Lunz, 2017, INVESTIGATION CORAL; Mackenzie DI, 2009, ECOLOGY, V90, P823, DOI 10.1890/08-0141.1; Manzello DP, 2015, MAR ECOL PROG SER, V521, P81, DOI 10.3354/meps11085; Martin C, 2019, SCI NEWS; Meyer JL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02244; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Miller MW, 2007, CORAL REEFS, V26, P97, DOI 10.1007/s00338-006-0165-y; Muller EM, 2011, J EXP MAR BIOL ECOL, V397, P52, DOI 10.1016/j.jembe.2010.11.002; Muller EM, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00163; Muller EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110759; National Oceanic and Atmospheric Administration, 2018, SCI WORK TOG SOLV CO; Neely KL, 2020, PEERJ, V8, DOI 10.7717/peerj.9289; NOAA, 2018, CAS DEF STON COR TIS; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Parkinson JE, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00445; Parkinson JE, 2015, SCI REP-UK, V5, DOI 10.1038/srep15667; Plummer M., 2003, P 3 INT WORKSHOP DIS; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Precht WF, 2016, SCI REP-UK, V6, DOI 10.1038/srep31374; Rippe JP, 2019, B MAR SCI, V95, P305, DOI 10.5343/bms.2018.0034; Rodriguez-Martinez RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096140; Rosales SM, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00681; Shore A, 2019, MAR BIOL, V166, DOI 10.1007/s00227-019-3490-8; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Walker B, 2019, SE FL REEF BUILDING; Walker BK, 2018, SE FLORIDA LARGE 2 M, P1; Walton CJ, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00323; Weil E, 2004, CORAL HEALTH AND DISEASE, P35; Williams DE, 2005, MAR ECOL PROG SER, V301, P119, DOI 10.3354/meps301119; Work TM, 2006, DIS AQUAT ORGAN, V70, P155, DOI 10.3354/dao070155	58	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241871	10.1371/journal.pone.0241871	http://dx.doi.org/10.1371/journal.pone.0241871			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175886	Green Published, gold			2022-12-26	WOS:000593946900066
J	Frandsen, KEH; Haon, M; Grisel, S; Henrissat, B; Lo Leggio, L; Berrin, JG				Frandsen, Kristian E. H.; Haon, Mireille; Grisel, Sacha; Henrissat, Bernard; Lo Leggio, Leila; Berrin, Jean-Guy			Identification of the molecular determinants driving the substrate specificity of fungal lytic polysaccharide monooxygenases (LPMOs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY; CELLULOSE; DISCOVERY; CLEAVAGE; OXIDASES; BINDING	Understanding enzymatic breakdown of plant biomass is crucial to develop nature-inspired biotechnological processes. Lytic polysaccharide monooxygenases (LPMOs) are microbial enzymes secreted by fungal saprotrophs involved in carbon recycling. LPMOs modify biomass by oxidatively cleaving polysaccharides, thereby enhancing the efficiency of glycoside hydrolases. Fungal AA9 LPMOs are active on cellulose, but some members also display activity on hemicelluloses and/or oligosaccharides. Although the active site subsites are well defined for a few model LPMOs, the molecular determinants driving broad substrate specificity are still not easily predictable. Based on bioinformatic clustering and sequence alignments, we selected seven fungal AA9 LPMOs that differ in the amino-acid residues constituting their subsites. Investigation of their substrate specificities revealed that all these LPMOs are active on cellulose and cello-oligosaccharides, as well as plant cell wall-derived hemicellulosic polysaccharides, and carry out C4 oxidative cleavage. The product profiles from cello-oligosaccharide degradation suggest that the subtle differences in amino-acid sequence within the substrate-binding loop regions lead to different preferred binding modes. Our functional analyses allowed us to probe the molecular determinants of substrate binding within two AA9 LPMO subclusters. Many wood-degrading fungal species rich in AA9 genes have at least one AA9 enzyme with structural loop features that allow recognition of short beta-(1,4)-linked glucan chains. Time-course monitoring of these AA9 LPMOs on cello-oligosaccharides also provides a useful model system for mechanistic studies of LPMO catalysis. These results are valuable for the understanding of LPMO contribution to wood decaying process in nature and for the development of sustainable biorefineries.	[Frandsen, Kristian E. H.; Haon, Mireille; Grisel, Sacha; Berrin, Jean-Guy] Aix Marseille Univ, Polytech Marseille, UMR1163 BBF, INRAE, Marseille, France; [Frandsen, Kristian E. H.; Lo Leggio, Leila] Univ Copenhagen, Dept Chem, Copenhagen, Denmark; [Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol AFMB, Marseille, France; [Henrissat, Bernard] INRAE, Architecture & Fonct Macromol Biol AFMB, USC1408, Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah, Saudi Arabia	INRAE; UDICE-French Research Universities; Aix-Marseille Universite; University of Copenhagen; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Berrin, JG (corresponding author), Aix Marseille Univ, Polytech Marseille, UMR1163 BBF, INRAE, Marseille, France.	jean-guy.berrin@inrae.fr	Henrissat, Bernard/J-2475-2012; Lo Leggio, Leila/B-4287-2015; berrin, jean-guy/E-1460-2014	Henrissat, Bernard/0000-0002-3434-8588; Lo Leggio, Leila/0000-0002-5135-0882; berrin, jean-guy/0000-0001-7570-3745; Frandsen, Kristian E. H./0000-0002-7136-9820; Grisel, Sacha/0000-0001-6983-0107	Carlsberg Foundation Internationalisation Postdoc Fellowship Grants [CF16-0673, CF17-0533]; EU Marie-Curie FP7 COFUND People Programme through an AgreenSkills Fellowship [609398]; Novo Nordisk Foundation [NNF17SA0027704]	Carlsberg Foundation Internationalisation Postdoc Fellowship Grants; EU Marie-Curie FP7 COFUND People Programme through an AgreenSkills Fellowship; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by Carlsberg Foundation Internationalisation Postdoc Fellowship Grants CF16-0673 and CF17-0533 (to K. E. H. F.), EU Marie-Curie FP7 COFUND People Programme (grant agreement 609398), through an AgreenSkills Fellowship (to K. E. H. F.), and Novo Nordisk Foundation Grant NNF17SA0027704 (L. L. L.).	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Basotra N, 2019, CARBOHYD RES, V478, P46, DOI 10.1016/j.carres.2019.04.006; Bennati-Granier C, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0274-3; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Borisova AS, 2015, J BIOL CHEM, V290, P22955, DOI 10.1074/jbc.M115.660183; Breslmayr E, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1063-6; Chalak A, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1548-y; Chen C, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1156-2; Courtade G, 2018, J BIOL CHEM, V293, P13006, DOI 10.1074/jbc.RA118.004269; Couturier M, 2018, NAT CHEM BIOL, V14, P306, DOI [10.1038/nchembio.2558, 10.1038/NCHEMBIO.2558]; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; Fanuel M, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0749-5; Filiatrault-Chastel C, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1394-y; Frandsen KEH, 2019, J BIOL CHEM, V294, P17117, DOI 10.1074/jbc.RA119.009223; Frandsen KEH, 2017, CARBOHYD RES, V448, P187, DOI 10.1016/j.carres.2017.03.010; Frandsen KEH, 2016, IUCRJ, V3, P448, DOI 10.1107/S2052252516014147; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; FRY SC, 1993, PHYSIOL PLANTARUM, V89, P1; Haon M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01002; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Huttner S, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01408-19; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Jagadeeswaran G, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0701-5; Jagadeeswaran G, 2016, APPL MICROBIOL BIOT, V100, P4535, DOI 10.1007/s00253-016-7505-9; Johansen KS, 2016, TRENDS PLANT SCI, V21, P926, DOI 10.1016/j.tplants.2016.07.012; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Laurent CVFP, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246219; Lenfant N, 2017, CARBOHYD RES, V448, P166, DOI 10.1016/j.carres.2017.04.012; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Lo Leggio L, 2018, CARBOHYD RES, V469, P55, DOI 10.1016/j.carres.2018.08.009; Lo Leggio L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6961; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; McGregor N, 2016, J BIOL CHEM, V291, P1175, DOI 10.1074/jbc.M115.691659; Monclaro AV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235642; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Sabbadin F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03142-x; Simmons TJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01247-3; Span EA, 2017, ACS CHEM BIOL, V12, P1095, DOI 10.1021/acschembio.7b00016; Tandrup T, 2020, BIOCHEMISTRY-US, V59, P3347, DOI 10.1021/acs.biochem.0c00312; Tandrup T, 2018, BIOCHEM SOC T, V46, P1431, DOI 10.1042/BST20170549; Vaaje-Kolstad G, 2017, CURR OPIN STRUC BIOL, V44, P67, DOI 10.1016/j.sbi.2016.12.012; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; Walton PH, 2016, CURR OPIN CHEM BIOL, V31, P195, DOI 10.1016/j.cbpa.2016.04.001; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Westereng B, 2013, J CHROMATOGR A, V1271, P144, DOI 10.1016/j.chroma.2012.11.048; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Wu M, 2013, J BIOL CHEM, V288, P12828, DOI 10.1074/jbc.M113.459396; Yadav SK, 2019, PLANTA, V249, P1987, DOI 10.1007/s00425-019-03135-0	51	8	8	9	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100086	10.1074/jbc.RA120.015545	http://dx.doi.org/10.1074/jbc.RA120.015545			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33199373	Green Published, gold			2022-12-26	WOS:000672866400067
J	Yin, T; Yao, W; Lemenze, AD; D'Adamio, L				Yin, Tao; Yao, Wen; Lemenze, Alexander D.; D'Adamio, Luciano			Danish and British dementia ITM2b/BRI2 mutations reduce BRI2 protein stability and impair glutamatergic synaptic transmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PRECURSOR PROTEIN; KNOCK-IN MICE; MEMORY DEFICITS; APP; PROTEOLYSIS; PEPTIDE; DOMAIN; BINDS	Mutations in integral membrane protein 2B (ITM2b/BRI2) gene cause familial British and Danish dementia (FBD and FDD), autosomal dominant disorders characterized by progressive cognitive deterioration. Two pathogenic mechanisms, which may not be mutually exclusive, have been proposed for FDD and FBD: 1) loss of BRI2 function; 2) accumulation of amyloidogenic mutant BRI2-derived peptides, but the mechanistic details remain unclear. We have previously reported a physiological role of BRI2 in excitatory synaptic transmission at both presynaptic termini and postsynaptic termini. To test whether pathogenic ITM2b mutations affect these physiological BRI2 functions, we analyzed glutamatergic transmission in FDD and FBD knock-in mice, which carry pathogenic FDD and FBD mutations into the mouse endogenous Itm2b gene. We show that in both mutant lines, spontaneous glutamate release and AMPAR-mediated responses are decreased, while short-term synaptic facilitation is increased, effects similar to those observed in Itm2bKO mice. In vivo and in vitro studies show that both pathogenic mutations alter maturation of BRI2 resulting in reduced levels of functional mature BRI2 protein at synapses. Collectively, the data show that FDD and FBD mutations cause a reduction of BRI2 levels and function at synapses, which results in reduced glutamatergic transmission. Notably, other genes mutated in Familial dementia, such as APP, PSEN1/PSEN2, are implicated in glutamatergic synaptic transmission, a function that is altered by pathogenic mutations. Thus, defects in excitatory neurotransmitter release may represent a general and convergent mechanism leading to neurodegeneration. Targeting these dysfunction may offer a unique disease modifying method of therapeutic intervention in neurodegenerative disorders.	[Yin, Tao; Yao, Wen; D'Adamio, Luciano] Rutgers State Univ, Jacqueline Krieger Klein Ctr Alzheimers Dis & Neu, New Jersey Med Sch, Brain Hlth Inst,Dept Pharmacol Physiol & Neurosci, Newark, NJ 07102 USA; [Lemenze, Alexander D.] Rutgers State Univ, New Jersey Med Sch, Dept Pathol Immunol & Lab Med, Newark, NJ USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	D'Adamio, L (corresponding author), Rutgers State Univ, Jacqueline Krieger Klein Ctr Alzheimers Dis & Neu, New Jersey Med Sch, Brain Hlth Inst,Dept Pharmacol Physiol & Neurosci, Newark, NJ 07102 USA.	luciano.dadamio@rutgers.edu		D'Adamio, Luciano/0000-0002-2204-9441; Yin, Tao/0000-0003-0524-8075	NIH/NIA [R01AG052286, RF1AG064821-01, 1R01AG033007-01A109]	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	L. D. was funded by the NIH/NIA R01AG052286, RF1AG064821-01, RF1AG064821-01, 1R01AG033007-01A109. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biundo F, 2016, ONCOTARGET, V7, P11923, DOI 10.18632/oncotarget.7389; Choi SI, 2003, FASEB J, V17, P373, DOI 10.1096/fj.03-0730fje; Fanutza T, 2015, ELIFE, V4, DOI 10.7554/eLife.09743; Fotinopoulou A, 2005, J BIOL CHEM, V280, P30768, DOI 10.1074/jbc.C500231200; Fregno I, 2019, CRIT REV BIOCHEM MOL, V54, P153, DOI 10.1080/10409238.2019.1610351; Giliberto L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007900; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Lombino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057120; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2011, J ALZHEIMERS DIS, V27, P385, DOI 10.3233/JAD-2011-110785; Matsuda S, 2011, NEUROBIOL AGING, V32, P1400, DOI 10.1016/j.neurobiolaging.2009.08.005; Ren SQ, 2020, ELIFE, V9, DOI 10.7554/eLife.57513; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, J NEUROSCI, V32, P5481, DOI 10.1523/JNEUROSCI.5193-11.2012; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamayev R, 2011, EMBO J, V30, P2501, DOI 10.1038/emboj.2011.161; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tamayev R, 2010, J NEUROSCI, V30, P14915, DOI 10.1523/JNEUROSCI.3917-10.2010; Tambini MD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60800-1; Tambini MD, 2019, AGING CELL, V18, DOI 10.1111/acel.13033; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Wu B, 2013, P NATL ACAD SCI USA, V110, P15091, DOI 10.1073/pnas.1304171110; Xia D, 2015, NEURON, V85, P967, DOI 10.1016/j.neuron.2015.02.010; Yao W, 2019, J NEUROSCI, V39, P6992, DOI 10.1523/JNEUROSCI.0207-19.2019; Yao W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41340-9; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhang DW, 2010, J NEUROCHEM, V115, P1215, DOI 10.1111/j.1471-4159.2010.07011.x; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	34	6	6	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100054	10.1074/jbc.RA120.015679	http://dx.doi.org/10.1074/jbc.RA120.015679			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33172889	gold, Green Published			2022-12-26	WOS:000672866400036
J	Radzisauskiene, D; Urboniene, J; Kaubrys, G; Andruskevicius, S; Jatuzis, D; Matulyte, E; Zvirblyte-Skrebutiene, K				Radzisauskiene, Daiva; Urboniene, Jurgita; Kaubrys, Gintaras; Andruskevicius, Saulius; Jatuzis, Dalius; Matulyte, Elzbieta; Zvirblyte-Skrebutiene, Karolina			The epidemiology, clinical presentation, and predictors of severe Tick-borne encephalitis in Lithuania, a highly endemic country: A retrospective study of 1040 patients	PLOS ONE			English	Article							INVOLVEMENT; EUROPE; TBE	Introduction In recent decades, the incidence of Tick-borne encephalitis (TBE) has been increasing and posing a growing health problem because of the high costs to the healthcare system and society. The clinical manifestations are well studied but there is a lack of research analyzing the severity of the disease. Objective The aim of this study was to analyze the epidemiology and clinical presentation of severe TBE, to identify the predictors for a severe disease course, and also predictors for meningoencephalomyelitic and severe meningoencephalitic/encephalitic forms. Methods A retrospective study was conducted in the Center of Infectious Diseases and the Center of Neurology at Vilnius University Hospital Santaros Klinikos in the years 2005-2017 to describe the clinical and epidemiological features of TBE in adults. Results 1040 patients were included in the study. A total of 152/1040 (14.6%) patients had a severe course. The highest proportion of severe cases, reaching 41.2%, was reported in the 70-79 year-old age group. A total of 36/152 (23.7%) severe patients presented meningoencephalomyelitis. Myelitic patients were older, were frequently infected in their living areas, and usually reported a monophasic disease course compared with severe meningoencephalitic/encephalitic patients. Severe meningoencephalitic/encephalitic patients, compared with non-severe meningoencephalitic/encephalitic, were older, less often noticed the tick bite, and often had a monophasic course. The sequelae on discharge were observed in 810/1000 (81%) of patients. Conclusions The prognostic factors associated with a severe disease course and severe meningoencephalitic form are: older age, comorbidities, a monophasic course, a fever of 40 degrees C and above, CRP more than 30 mg/l, CSF protein more than 1 g/l, delayed immune response of TBEV IgG, pathological findings in CT. Age above 60 years, presence of CNS disease, bulbar syndrome, pleocytosis 500x10(6) /l and above, and delayed immune response of TBEV IgG are predictors of the most severe myelitic form.	[Radzisauskiene, Daiva; Matulyte, Elzbieta; Zvirblyte-Skrebutiene, Karolina] Vilnius Univ, Inst Clin Med, Fac Med, Clin Infect Dis & Dermatovenerol, Vilnius, Lithuania; [Urboniene, Jurgita] Vilnius Univ, Ctr Infect Dis, Vilnius, Lithuania; [Kaubrys, Gintaras; Andruskevicius, Saulius; Jatuzis, Dalius] Vilnius Univ, Inst Clin Med, Clin Neurol & Neurosurg, Fac Med, Vilnius, Lithuania	Vilnius University; Vilnius University; Vilnius University	Radzisauskiene, D (corresponding author), Vilnius Univ, Inst Clin Med, Fac Med, Clin Infect Dis & Dermatovenerol, Vilnius, Lithuania.	daiva730jvg@gmail.com	Jatužis, Dalius/U-8125-2019	Jatužis, Dalius/0000-0001-6159-4795; Kaubrys, Gintaras/0000-0003-4998-8403				Beaute J, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.45.1800201; Bender A, 2005, J NEUROL NEUROSUR PS, V76, P135, DOI 10.1136/jnnp.2004.040469; Bogovic P, 2018, TRAVEL MED INFECT DI, V26, P25, DOI 10.1016/j.tmaid.2018.10.003; Bogovic P, 2018, TICKS TICK-BORNE DIS, V9, P369, DOI 10.1016/j.ttbdis.2017.12.001; Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430; Bogovic P, 2010, TRAVEL MED INFECT DI, V8, P246, DOI 10.1016/j.tmaid.2010.05.011; Border JP, 2018, TICK BORNE ENCEPHALI, P75; Czupryna P, 2011, EUR J NEUROL, V18, P673, DOI 10.1111/j.1468-1331.2010.03278.x; Demina TV, 2010, J MED VIROL, V82, P965, DOI 10.1002/jmv.21765; Dinarello A, 2017, HARRISONS INFECT DIS, P114; Dobler G, 2010, VET MICROBIOL, V140, P221, DOI 10.1016/j.vetmic.2009.08.024; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; European Centre for Disease Prevention and Control, 2019, TICK BORNE ENCEPHALI; Kaiser R, 1999, BRAIN, V122, P2067, DOI 10.1093/brain/122.11.2067; Karelis G, 2012, EUR J NEUROL, V19, P62, DOI 10.1111/j.1468-1331.2011.03434.x; Kleiter I, 2006, EUR J MED RES, V11, P261; Lenhard T, 2018, TICKS TICK-BORNE DIS, V9, P882, DOI 10.1016/j.ttbdis.2018.02.021; Lenhard T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154143; Lotric-Furlan S, 2017, J INTERN MED, V282, P142, DOI 10.1111/joim.12625; Neumann B, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.485; Pichler A, 2017, J NEUROL SCI, V375, P266, DOI 10.1016/j.jns.2017.02.003; Pulkkinen LIA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10070350; Steffen R, 2016, J TRAVEL MED, V23, P1, DOI 10.1093/jtm/taw018; Valarcher JF, 2015, REV SCI TECH OIE, V34, P453	24	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0241587	10.1371/journal.pone.0241587	http://dx.doi.org/10.1371/journal.pone.0241587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211708	gold, Green Published			2022-12-26	WOS:000603518300018
J	Rydsa, JI; van den Tillaar, R				Istvan Rydsa, Johannes; van den Tillaar, Roland			The acute effect of wearable resistance load and placement upon change of direction performance in soccer players	PLOS ONE			English	Article							KINETIC ADAPTATIONS; SPRINT; ACCELERATION; STRENGTH; DEMANDS; ABILITY	The aim of the study was to examine the acute effect of different lower limb wearable resistance on placement (shank vs thigh) and various loads (1-5% of body mass) upon change of direction (COD) ability. Twelve male soccer players (age: 23.3 +/- 2.5 years; height: 179.2 +/- 7.4 cm; body mass: 78.3 +/- 7.1 kg) performed a change of direction test with different additional loads fixed on either the shank or thigh. Measurement consisted of total time, 90 degrees and 45 degrees split times. large effects of the different wearable resistance placement (p<0.05) and load (p<0.001) were found for total and split change of direction time performance. Change of direction times were higher with shank loading compared with thigh loading. It was concluded that lower limb wearable resistance loading with different loads had an acute effect upon change of direction performance in male soccer players. Furthermore, that distal placement (shank vs thigh) with similar body mass load had a larger effect upon COD performance.	[Istvan Rydsa, Johannes; van den Tillaar, Roland] Nord Univ, Dept Sport Sci & Phys Educ, Levanger, Norway	Nord University	van den Tillaar, R (corresponding author), Nord Univ, Dept Sport Sci & Phys Educ, Levanger, Norway.	roland.v.tillaar@nord.no						[Anonymous], 2009, WORLD ARCHAEOL, V41; [Anonymous], 2007, J TRACE ELEM MED BIO, V21, P77, DOI [10.1016/j.jtemb.2007.09.015, DOI 10.1016/J.JTEMB.2007.09.015]; Bennett JP, 2009, J STRENGTH COND RES, V23, P2542, DOI 10.1519/JSC.0b013e3181b86b3d; Bloomfield J, 2007, J SPORT SCI MED, V6, P63; CLAREMONT AD, 1988, MED SCI SPORT EXER, V20, P167, DOI 10.1249/00005768-198820020-00011; Condello G, 2013, INT J SPORT PHYSIOL, V8, P52, DOI 10.1123/ijspp.8.1.52; Cronin J, 2006, STRENGTH COND J, V28, P42, DOI 10.1519/1533-4295(2006)028[0042:RSTFTA]2.0.CO;2; Dogramaci SN, 2011, J STRENGTH COND RES, V25, P646, DOI 10.1519/JSC.0b013e3181c6a02e; Falch HN, 2019, SPORTS MED-OPEN, V5, DOI 10.1186/s40798-019-0223-y; Feser E., 2018, 36 INT C BIOM SPORTS; Field A, 2019, ACUTE METABOLIC RESP; Gray AJ, 2010, SPORTS MED, V40, P347, DOI 10.2165/11531400-000000000-00000; Hicks D., 2018, NEW STUD ATHL, V32, P35; Hrysomallis C, 2012, J STRENGTH COND RES, V26, P299, DOI 10.1519/JSC.0b013e3182185186; Lockie RG, 2003, J STRENGTH COND RES, V17, P760; Macadam P, 2017, SPORTS MED, V47, P887, DOI 10.1007/s40279-016-0622-x; Macadam P, 2017, J STRENGTH COND RES, V31, P1297, DOI 10.1519/JSC.0000000000001596; Macadam P, 2017, EUR J SPORT SCI, V17, P555, DOI 10.1080/17461391.2017.1298672; MARTIN PE, 1985, MED SCI SPORT EXER, V17, P427, DOI 10.1249/00005768-198508000-00004; McGuigan MR, 2012, INT J SPORT PHYSIOL, V7, P2, DOI 10.1123/ijspp.7.1.2; Meylan C, 2009, J STRENGTH COND RES, V23, P2605, DOI 10.1519/JSC.0b013e3181b1f330; Michalsik LB, 2014, INT J SPORTS MED, V35, P595, DOI 10.1055/s-0033-1358713; Newton RU, 1999, MED SCI SPORT EXER, V31, P323, DOI 10.1097/00005768-199902000-00017; Nygaard Falch H, 2020, SPORTS BIOMECHANICS; Paul DJ, 2016, SPORTS MED, V46, P421, DOI 10.1007/s40279-015-0428-2; Ropret R, 1998, EUR J APPL PHYSIOL, V77, P547, DOI 10.1007/s004210050374; Simperingham K, 2016, ISBS C P ARCH; Simperingham K., 2014, J AUSTR STRENGTH CON, V22, P69; SOULE RG, 1969, J APPL PHYSIOL, V27, P687, DOI 10.1152/jappl.1969.27.5.687; Stolen T, 2005, SPORTS MED, V35, P501; Taskin H, 2008, J STRENGTH COND RES, V22, P1481, DOI 10.1519/JSC.0b013e318181fd90; van den Tillaar R, 2016, J STRENGTH COND RES, V30, P2258, DOI 10.1519/JSC.0000000000001331; Varley MC, 2014, J SPORT SCI, V32, P1858, DOI 10.1080/02640414.2013.823227; Young WB, 2006, INT J SPORT PHYSIOL, V1, P74, DOI 10.1123/ijspp.1.2.74	34	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242493	10.1371/journal.pone.0242493	http://dx.doi.org/10.1371/journal.pone.0242493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206708	Green Published, gold			2022-12-26	WOS:000595265900002
J	Kittiskulnam, P; Tiskajornsiri, K; Katavetin, P; Chaiwatanarat, T; Eiam-Ong, S; Praditpornsilpa, K				Kittiskulnam, Piyawan; Tiskajornsiri, Krittaya; Katavetin, Pisut; Chaiwatanarat, Tawatchai; Eiam-Ong, Somchai; Praditpornsilpa, Kearkiat			The failure of glomerular filtration rate estimating equations among obese population	PLOS ONE			English	Article							BODY-SURFACE AREA; KIDNEY-DISEASE; RENAL-DISEASE; STATISTICAL-METHODS; ASSESSING AGREEMENT; GFR ESTIMATION; CYSTATIN C; CREATININE; MDRD; DIET	Background Obesity is a major public health with increasing numbers of obese individuals are at risk for kidney disease. However, the validity of serum creatinine-based glomerular filtration rate (GFR) estimating equations in obese population is yet to be determined. Methods We evaluated the performance of the reexpressed Modification of Diet in Renal Disease (MDRD), reexpressed MDRD with Thai racial factor, Thai estimated GFR (eGFR) as well as Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equations among obese patients, defined as body mass index (BMI) >= 25 kg/m(2) with the reference measured GFR (mGFR) determined by Tc-99m-diethylene triamine penta-acetic acid (Tc-99m-DTPA) plasma clearance method. Serum creatinine levels were measured using standardized enzymatic method simultaneously with GFR measurement. The statistical methods in assessing agreement for continuous data including total deviation index (TDI), concordance correlation coefficient (CCC), and coverage probability (CP) for each estimating equation were compared with the reference mGFR. Accuracy within 10% representing the percentage of estimations falling within the range of +/- 10% of mGFR values for all equations were also tested. Results A total of 240 Thai obese patients were finally recruited with mean BMI of 31.5 +/- 5.8 kg/m(2). In the total population, all eGFR equations underestimated the reference mGFR. The average TDI values were 55% indicating that 90% of the estimates falling within the range of -55 to +55% of the reference mGFR. The CP values averaged 0.23 and CCC scores ranged from 0.75 to 0.81, reflecting the low to moderate levels of agreement between each eGFR equation and the reference mGFR. The proportions of patients achieving accuracy 10% ranged from 23% for the reexpressed MDRD equation to 33% for the Thai eGFR formula. Among participants with BMI more than 35 kg/m(2) (n = 48), the mean error of all equations was extremely wide and significantly higher for all equations compared with the lower BMI category. Also, the strength of agreement evaluated by TDI, CCC, and CP were low in the subset of patients with BMI >= 35 kg/m(2). Conclusion Estimating equations generally underestimated the reference mGFR in subjects with obesity. The overall performance of GFR estimating equations demonstrated poor concordance with the reference mGFR among individuals with high BMI levels. In certain clinical settings such as decision for dialysis initiation, the direct measurements of GFR are required to establish real renal function among obese population.	[Kittiskulnam, Piyawan] Chulalongkorn Univ, Div Internal Med Nephrol, Dept Med, Fac Med, Bangkok, Thailand; [Kittiskulnam, Piyawan] Thai Red Cross Soc, King Chulalongkorn Mem Hosp, Bangkok, Thailand; [Kittiskulnam, Piyawan; Eiam-Ong, Somchai; Praditpornsilpa, Kearkiat] Chulalongkorn Univ, Special Task Force Activating Res Renal Nutr, Renal Nutr Res Grp, Off Res Affairs, Bangkok, Thailand; [Kittiskulnam, Piyawan; Katavetin, Pisut; Eiam-Ong, Somchai; Praditpornsilpa, Kearkiat] Chulalongkorn Univ, Div Nephrol, Dept Med, Fac Med, Bangkok, Thailand; [Tiskajornsiri, Krittaya] Banpaeo Hosp, Div Nephrol, Samutsakorn, Thailand; [Chaiwatanarat, Tawatchai] Chulalongkorn Univ, Div Nucl Med, Dept Radiol, Fac Med, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Thai Red Cross Society; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University	Praditpornsilpa, K (corresponding author), Chulalongkorn Univ, Special Task Force Activating Res Renal Nutr, Renal Nutr Res Grp, Off Res Affairs, Bangkok, Thailand.; Praditpornsilpa, K (corresponding author), Chulalongkorn Univ, Div Nephrol, Dept Med, Fac Med, Bangkok, Thailand.	kearkiat@hotmail.com	Praditpronsilpa, Kearkiat/AFT-5058-2022	Katavetin, Pisut/0000-0001-8779-500X	Kidney Foundation of Thailand; Special Task Force for Activating Research (STAR) in Renal Nutrition, Chulalongkorn University	Kidney Foundation of Thailand; Special Task Force for Activating Research (STAR) in Renal Nutrition, Chulalongkorn University	This study was funded by the Kidney Foundation of Thailand. This work has been made possible in part by a Special Task Force for Activating Research (STAR) in Renal Nutrition, Chulalongkorn University funded grant to Dr. Kittiskulnam.	Aekplakorn W, 2009, OBES REV, V10, P589, DOI 10.1111/j.1467-789X.2009.00626.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bouquegneau A, 2013, NEPHROL DIAL TRANSPL, V28, P122, DOI 10.1093/ndt/gft329; Chang AR, 2018, ADV CHRONIC KIDNEY D, V25, P31, DOI 10.1053/j.ackd.2017.10.007; Chew-Harris JSC, 2013, ANN CLIN BIOCHEM, V50, P39, DOI 10.1258/acb.2012.011241; Delanaye P, 2009, NEPHROL DIAL TRANSPL, V24, P3593, DOI 10.1093/ndt/gfp431; DUBOIS D, 1989, NUTRITION, V5, P303; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Evans M, 2013, NEPHROL DIAL TRANSPL, V28, P2518, DOI 10.1093/ndt/gft226; Fotheringham J, 2014, KIDNEY INT, V86, P1221, DOI 10.1038/ki.2014.112; Friedman AN, 2014, AM J NEPHROL, V39, P8, DOI 10.1159/000357231; Imai Enyu, 2007, Clin Exp Nephrol, V11, P41, DOI 10.1007/s10157-006-0453-4; Jessani S, 2014, AM J KIDNEY DIS, V63, P49, DOI 10.1053/j.ajkd.2013.07.023; Kanazawa M, 2005, WORLD REV NUTR DIET, V94, P1, DOI 10.1159/000088200; Kovesdy CP, 2017, AM J NEPHROL, V45, P283, DOI 10.1159/000458467; Lee Joo-Young, 2008, Journal of Physiological Anthropology, V27, P71, DOI 10.2114/jpa2.27.71; Lemoine S, 2014, CLIN J AM SOC NEPHRO, V9, P720, DOI 10.2215/CJN.03610413; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2013, KIDNEY INT, V83, P1001, DOI 10.1038/ki.2013.91; Lin L, 2002, J AM STAT ASSOC, V97, P257, DOI 10.1198/016214502753479392; Lopez-Martinez M, 2019, ESTIMATION GFR ADJUS, DOI [10.1038/s41366-019-0476-z, DOI 10.1038/S41366-019-0476-Z]; Lu JL, 2014, J AM SOC NEPHROL, V25, P2088, DOI 10.1681/ASN.2013070754; Luis-Lima S, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101543; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Masson I, 2013, TRANSPLANTATION, V95, P1211, DOI 10.1097/TP.0b013e318288caa6; Michels WM, 2010, CLIN J AM SOC NEPHRO, V5, P1003, DOI 10.2215/CJN.06870909; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Naour N, 2009, OBESITY, V17, P2121, DOI 10.1038/oby.2009.96; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Obermayr RP, 2008, NEPHROL DIAL TRANSPL, V23, P1265, DOI 10.1093/ndt/gfm790; Porrini E, 2019, NAT REV NEPHROL, V15, P177, DOI 10.1038/s41581-018-0080-9; Praditpornsilpa K, 2011, NEPHROL DIAL TRANSPL, V26, P2780, DOI 10.1093/ndt/gfq815; Rule AD, 2009, AM J KIDNEY DIS, V53, P932, DOI 10.1053/j.ajkd.2009.02.011; SAINSBURY EJ, 1986, EUR J CLIN PHARMACOL, V30, P243, DOI 10.1007/BF00614312; Spithoven EM, 2013, AM J KIDNEY DIS, V62, P531, DOI 10.1053/j.ajkd.2013.03.030; Stevens LA, 2007, J AM SOC NEPHROL, V18, P2749, DOI 10.1681/ASN.2007020199; Teo BW, 2018, ADV CHRONIC KIDNEY D, V25, P41, DOI 10.1053/j.ackd.2017.10.005; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586	40	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242447	10.1371/journal.pone.0242447	http://dx.doi.org/10.1371/journal.pone.0242447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206712	Green Published, gold			2022-12-26	WOS:000595265900068
J	Umesawa, Y; Atsumi, T; Fukatsu, R; Ide, M				Umesawa, Yumi; Atsumi, Takeshi; Fukatsu, Reiko; Ide, Masakazu			Decreased utilization of allocentric coordinates during reaching movement in individuals with autism spectrum disorder	PLOS ONE			English	Article							WORKING-MEMORY; NEURAL BASIS; MOTOR; REPRESENTATION; CHILDREN; CHILDHOOD; ABILITIES	Despite numerous reports of abnormalities in limb motor controls in spatial orientation in individuals with autism spectrum disorder (ASD), the underlying mechanisms have not been elucidated. We studied the influence of allocentric coordinates on ongoing reaching movements, which has been reported to strongly affect the reaching movements of typically developing (TD) individuals. ASD and TD participants observed a target presented randomly on one of the four corners of a frame on a screen. After it disappeared, another frame was presented slightly shifted leftward/rightward. The participants touched the memorized position of the target relatively congruent with a reference frame (allocentric condition) or ignoring it (egocentric condition). Results suggested that TD individuals were apt to touch the positions in allocentric manner rather than egocentric manner, while ASDs did not show this prioritization. Our findings demonstrate that decreased utilization of visual landmarks in ongoing movement may underlie motor disabilities in autism.	[Umesawa, Yumi; Atsumi, Takeshi] Kyorin Univ, Dept Med Physiol, Fac Med, Tokyo, Japan; [Umesawa, Yumi; Atsumi, Takeshi; Fukatsu, Reiko; Ide, Masakazu] Natl Rehabil Ctr Persons Disabil, Dept Rehabil Brain Funct, Res Inst, Saitama, Japan	Kyorin University	Umesawa, Y (corresponding author), Kyorin Univ, Dept Med Physiol, Fac Med, Tokyo, Japan.; Umesawa, Y; Ide, M (corresponding author), Natl Rehabil Ctr Persons Disabil, Dept Rehabil Brain Funct, Res Inst, Saitama, Japan.	umeyumi.316@gmail.com; ide-masakazu@rehab.go.jp		Ide, Masakazu/0000-0002-2704-9889; Umesawa, Yumi/0000-0001-8278-2146	JSPS [JP18K17914, JP18H03140, JP18H03663]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid from JSPS (JP18K17914, JP18H03140, JP18H03663).	Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Biagi L, 2016, DEVELOPMENTAL SCI, V19, P1075, DOI 10.1111/desc.12353; Bridgeman B, 1997, PERCEPT PSYCHOPHYS, V59, P456, DOI 10.3758/BF03211912; Chakrabarty M, 2017, J NEUROPHYSIOL, V117, P376, DOI 10.1152/jn.00451.2016; Chen Y, 2014, J NEUROSCI, V34, P12515, DOI 10.1523/JNEUROSCI.1445-14.2014; Coello Y, 2006, PERCEPT PSYCHOPHYS, V68, P278, DOI 10.3758/BF03193675; Edey R, 2016, J ABNORM PSYCHOL, V125, P879, DOI 10.1037/abn0000199; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Frith U, 2005, CONSCIOUS COGN, V14, P719, DOI 10.1016/j.concog.2005.04.006; Goodale MA, 2003, PROG BRAIN RES, V144, P131, DOI 10.1016/S0079-6123(03)14400-9; Gowen E, 2013, J AUTISM DEV DISORD, V43, P323, DOI 10.1007/s10803-012-1574-0; Green D, 2002, J CHILD PSYCHOL PSYC, V43, P655, DOI 10.1111/1469-7610.00054; Habib A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216198; Haswell CC, 2009, NAT NEUROSCI, V12, P970, DOI 10.1038/nn.2356; Izawa J, 2012, AUTISM RES, V5, P124, DOI 10.1002/aur.1222; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; Kilroy E, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9040075; Krigolson A, 2004, HUM MOVEMENT SCI, V23, P861, DOI 10.1016/j.humov.2004.10.011; Krigolson O, 2007, SPATIAL VISION, V20, P317, DOI 10.1163/156856807780919028; Kushki A, 2011, J AUTISM DEV DISORD, V41, P1706, DOI 10.1007/s10803-011-1206-0; Lederman SJ, 1998, CLIN DEV MED, P16; Lu ZJ, 2020, CORTEX, V125, P203, DOI 10.1016/j.cortex.2019.12.010; Marko MK, 2015, BRAIN, V138, P784, DOI 10.1093/brain/awu394; Miyahara M, 1997, J AUTISM DEV DISORD, V27, P595, DOI 10.1023/A:1025834211548; Nishimura N, 2019, J NEUROPHYSIOL, V122, P1849, DOI 10.1152/jn.00032.2018; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pearson A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00652; Peirce J, 2019, BEHAV RES METHODS, V51, P195, DOI 10.3758/s13428-018-01193-y; Quandt LC, 2015, WIRES COGN SCI, V6, P483, DOI 10.1002/wcs.1367; Ribordy F, 2013, COGNITIVE PSYCHOL, V66, P1, DOI 10.1016/j.cogpsych.2012.08.001; Ruggiero G, 2016, PSYCHOL RES-PSYCH FO, V80, P259, DOI 10.1007/s00426-015-0658-9; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; SMYTH MM, 1988, Q J EXP PSYCHOL-A, V40, P497, DOI 10.1080/02724988843000041; Staples KL, 2010, J AUTISM DEV DISORD, V40, P209, DOI 10.1007/s10803-009-0854-9; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; Uchimura M, 2015, EUR J NEUROSCI, V42, P1651, DOI 10.1111/ejn.12935; Uchimura M, 2013, J NEUROSCI, V33, P7595, DOI 10.1523/JNEUROSCI.5702-12.2013; Umesawa Y, 2020, J AUTISM DEV DISORD, V50, P2710, DOI 10.1007/s10803-020-04382-x; Wakabayashi Akio, 2004, Shinrigaku Kenkyu, V75, P78; Zaehle T, 2007, BRAIN RES, V1137, P92, DOI 10.1016/j.brainres.2006.12.044	41	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0236768	10.1371/journal.pone.0236768	http://dx.doi.org/10.1371/journal.pone.0236768			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206652	Green Submitted, Green Published, gold			2022-12-26	WOS:000595265900082
J	Zhou, B; Thies, S; Gudipudi, R; Ludeke, MKB; Kropp, JP; Rybski, D				Zhou, Bin; Thies, Stephan; Gudipudi, Ramana; Luedeke, Matthias K. B.; Kropp, Juergen P.; Rybski, Diego			A Gini approach to spatial CO2 emissions	PLOS ONE			English	Article							URBAN; CITIES	Combining global gridded population and fossil fuel based CO2 emission data at 1 km scale, we investigate the spatial origin of CO2 emissions in relation to the population distribution within countries. We depict the correlations between these two datasets by a quasi-Lorenz curve which enables us to discern the individual contributions of densely and sparsely populated regions to the national CO2 emissions. We observe pronounced country-specific characteristics and quantify them using an indicator resembling the Gini-index. As demonstrated by a robustness test, the Gini-index for each country arise from a compound distribution between the population and emissions which differs among countries. Relating these indices with the degree of socio-economic development measured by per capita Gross Domestic Product (GDP) at purchase power parity, we find a strong negative correlation between the two quantities with a Pearson correlation coefficient of -0.71. More specifically, this implies that in developing countries locations with large population tend to emit relatively more CO2, and in developed countries the opposite tends to be the case. Based on the relation to urban scaling, we discuss the implications for CO2 emissions from cities. Our results show that general statements with regard to the (in)efficiency of large cities should be avoided as it is subject to the socio-economic development of respective countries. Concerning the political relevance, our results suggest a differentiated spatial prioritization in deploying climate change mitigation measures in cities for developed and developing countries.	[Zhou, Bin; Thies, Stephan; Gudipudi, Ramana; Luedeke, Matthias K. B.; Kropp, Juergen P.; Rybski, Diego] Leibniz Assoc, Potsdam Inst Climate Impact Res, Potsdam, Germany; [Zhou, Bin] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Beer Sheva, Israel; [Kropp, Juergen P.] Univ Potsdam, Dept Geo & Environm Sci, Potsdam, Germany; [Rybski, Diego] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Potsdam Institut fur Klimafolgenforschung; Ben Gurion University; University of Potsdam; University of California System; University of California Berkeley	Zhou, B (corresponding author), Leibniz Assoc, Potsdam Inst Climate Impact Res, Potsdam, Germany.; Zhou, B (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Beer Sheva, Israel.	zhoub@post.bgu.ac.il	Kropp, Juergen/D-8220-2012; Lüdeke, Matthias/ABG-3798-2021	Kropp, Juergen/0000-0001-7791-3420; Gudipudi, Venkata Ramana/0000-0002-8758-9369; Rybski, Diego/0000-0001-6125-7705; Zhou, Bin/0000-0001-8853-0724	European Community's Seventh Framework Programme [308497]; Climate-KIC, the climate innovation initiative of the EU's European Institute of Innovation and Technology (EIT); Feodor Lynen Fellowship of the Alexander von Humboldt Foundation; Leibniz Association (project IMPETUS)	European Community's Seventh Framework Programme(European Commission); Climate-KIC, the climate innovation initiative of the EU's European Institute of Innovation and Technology (EIT); Feodor Lynen Fellowship of the Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Leibniz Association (project IMPETUS)	The research leading to these results has received funding from the European Community's Seventh Framework Programme under Grant Agreement 308497 (Project RAMSES) URL: https://cordis.europa.eu/project/id/308497.BZ received a Ph.D. scholarship from Climate-KIC, the climate innovation initiative of the EU's European Institute of Innovation and Technology (EIT). DR received financial support under the Feodor Lynen Fellowship of the Alexander von Humboldt Foundation and the Leibniz Association (project IMPETUS) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], **DATA OBJECT**; [Anonymous], 2014, ANN FAM MED, V12, piii; [Anonymous], **DATA OBJECT**, DOI DOI 10.7927/H4NP22DQ; Asefi-Najafabady S, 2014, J GEOPHYS RES-ATMOS, V119, DOI 10.1002/2013JD021296; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Brown M.A., 2009, POLICY SOC, V27, P285, DOI [10.1016/j.polsoc.2009.01.001, DOI 10.1016/J.POLSOC.2009.01.001]; Centre for Cities, 2015, REM EP MATR; DOXSEYWHITFIELD E, 2015, PAP APPL GEOGR, V0001; Elvidge CD, 2001, ISPRS J PHOTOGRAMM, V56, P81, DOI 10.1016/S0924-2716(01)00040-5; Elvidge CD, 1999, REMOTE SENS ENVIRON, V68, P77, DOI 10.1016/S0034-4257(98)00098-4; Elvidge CD, 2017, INT J REMOTE SENS, V38, P5860, DOI 10.1080/01431161.2017.1342050; Gini C., 1921, ECON J, V31, P124, DOI [10.2307/2223319, DOI 10.2307/2223319]; Glaeser EL, 2010, J URBAN ECON, V67, P404, DOI 10.1016/j.jue.2009.11.006; Gudipudi R, 2019, APPL ENERG, V236, P155, DOI 10.1016/j.apenergy.2018.11.054; Gudipudi R, 2016, ENERG POLICY, V91, P352, DOI 10.1016/j.enpol.2016.01.015; Gurney KR, 2009, ENVIRON SCI TECHNOL, V43, P5535, DOI 10.1021/es900806c; Hutchins MG, 2017, MITIG ADAPT STRAT GL, V22, P947, DOI 10.1007/s11027-016-9709-9; Jones C, 2014, ENVIRON SCI TECHNOL, V48, P895, DOI 10.1021/es4034364; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Kennedy C, 2009, ENVIRON SCI TECHNOL, V43, P7297, DOI 10.1021/es900213p; Lutz R, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012804; NEWMAN PWG, 1989, J AM PLANN ASSOC, V55, P24, DOI 10.1080/01944368908975398; Oda T, 2017, ODIAC FOSS FUEL CO2; Oda T, 2018, EARTH SYST SCI DATA, V10, P87, DOI 10.5194/essd-10-87-2018; Oliveira EA, 2014, SCI REP-UK, V4, DOI 10.1038/srep04235; Pfahler W., 1985, B EC RES, V37, P201; Raupach MR, 2010, ENERG POLICY, V38, P4756, DOI 10.1016/j.enpol.2009.08.021; Rayner PJ, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013439; Ribeiro HV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11184-y; Rozenfeld HD, 2008, P NATL ACAD SCI USA, V105, P18702, DOI 10.1073/pnas.0807435105; Rybski D., 2016, ARXIV160901217PHYSIC; Rybski D, 2017, ENVIRON PLAN B-URBAN, V44, P425, DOI 10.1177/0265813516638340; Schubert J, 2013, ENVIRON POLICY GOV, V23, P13, DOI 10.1002/eet.1600; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; UN HABITAT, 2011, CIT CLIM CHANG GLOB; United Kingdom Government, 2016, 2014 LOC AAUTH CARB; United Nations, 2015, STESASERA366 UN DEP; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364	39	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242479	10.1371/journal.pone.0242479	http://dx.doi.org/10.1371/journal.pone.0242479			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206711	gold, Green Submitted, Green Published			2022-12-26	WOS:000595265900043
J	Giordani, P; Perna, S; Bianchi, A; Pizzulli, A; Tripodi, S; Matricardi, PM				Giordani, Paolo; Perna, Serena; Bianchi, Annamaria; Pizzulli, Antonio; Tripodi, Salvatore; Matricardi, Paolo Maria			A study of longitudinal mobile health data through fuzzy clustering methods for functional data: The case of allergic rhinoconjunctivitis in childhood	PLOS ONE			English	Article							RHINITIS; SCORES; ASTHMA; IMPACT; MODEL	The use of mobile communication devices in health care is spreading worldwide. A huge amount of health data collected by these devices (mobile health data) is nowadays available. Mobile health data may allow for real-time monitoring of patients and delivering ad-hoc treatment recommendations. This paper aims at showing how this may be done by exploiting the potentialities of fuzzy clustering techniques. In fact, such techniques can be fruitfully applied to mobile health data in order to identify clusters of patients for diagnostic classification and cluster-specific therapies. However, since mobile health data are full of noise, fuzzy clustering methods cannot be directly applied to mobile health data. Such data must be denoised prior to analyzing them. When longitudinal mobile health data are available, functional data analysis represents a powerful tool for filtering out the noise in the data. Fuzzy clustering methods for functional data can then be used to determine groups of patients. In this work we develop a fuzzy clustering method, based on the concept of medoid, for functional data and we apply it to longitudinal mHealth data on daily symptoms and consumptions of anti-symptomatic drugs collected by two sets of patients in Berlin (Germany) and Ascoli Piceno (Italy) suffering from allergic rhinoconjunctivitis. The studies showed that clusters of patients with similar changes in symptoms were identified opening the possibility of precision medicine.	[Giordani, Paolo] Sapienza Univ Rome, Dept Stat Sci, Rome, Italy; [Perna, Serena; Pizzulli, Antonio; Matricardi, Paolo Maria] Charite Med Univ Berlin, Dept Pediat Pneumol & Immunol, Berlin, Germany; [Bianchi, Annamaria] Mazzoni Hosp, Pediat Unit, Ascoli Piceno, Italy; [Pizzulli, Antonio] Practice Pediat Pneumol & Allergol, Berlin, Germany; [Tripodi, Salvatore] Sandro Pertini Hosp, Pediat Dept, Rome, Italy; [Tripodi, Salvatore] Sandro Pertini Hosp, Pediat Allergol Unit, Rome, Italy	Sapienza University Rome; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ospedale Sandro Pertini; Ospedale Sandro Pertini	Giordani, P (corresponding author), Sapienza Univ Rome, Dept Stat Sci, Rome, Italy.	paolo.giordani@uniroma1.it	PAOLO, GIORDANI/AAA-1318-2021	PAOLO, GIORDANI/0000-0003-4091-3165	 [KS 89526153]		With respect to Financial Disclosure we state that the study was supported by Charite KS 89526153 and the research project entitled ''New developments on regression models for multivariate mixed responses'' (Sapienza University of Rome). The Informatics Platform and the APP "AllergyMonitor" have been provided by TPS (Technology Projects & Software) Production srl. No further financial support was given by TPS to this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2003, SCAND J STAT, V30, P581, DOI 10.1111/1467-9469.00350; Bezdek J. C., 1981, Pattern recognition with fuzzy objective function algorithms; BEZDEK JC, 1984, COMPUT GEOSCI, V10, P191, DOI 10.1016/0098-3004(84)90020-7; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Bouveyron C, 2015, ANN APPL STAT, V9, P1726, DOI 10.1214/15-AOAS861; Bouveyron C, 2011, ADV DATA ANAL CLASSI, V5, P281, DOI 10.1007/s11634-011-0095-6; Campello RJGB, 2006, FUZZY SET SYST, V157, P2858, DOI 10.1016/j.fss.2006.07.006; Chen CN, 2012, J MED INTERNET RES, V14, P126, DOI 10.2196/jmir.2152; Clark J, 2007, ALLERGY, V62, P1023, DOI 10.1111/j.1398-9995.2007.01469.x; Cortez NG, 2014, NEW ENGL J MED, V371, P372, DOI 10.1056/NEJMhle1403384; CRAVEN P, 1979, NUMER MATH, V31, P377, DOI 10.1007/BF01437407; de Boor C., 2001, PRACTICAL GUIDE SPLI, DOI 10.2307/2006241; Demoly P, 2006, LANCET, V368, P711, DOI 10.1016/S0140-6736(06)69263-5; Di Giuseppe E, 2013, THEOR APPL CLIMATOL, V114, P39, DOI 10.1007/s00704-012-0801-0; Dong JGJ, 2018, STAT METHODS MED RES, V27, P3785, DOI 10.1177/0962280217712088; Edgington E.S., 2007, RANDOMIZATION TESTS; Ferraro MB, 2019, R J, V11, P211; Ferraty F., 2006, SPR S STAT; Florack J, 2016, PEDIAT ALLERG IMM-UK, V27, P382, DOI 10.1111/pai.12562; Fontanella L, 2019, BIOMETRICAL J, V61, P918, DOI 10.1002/bimj.201800228; Free C, 2013, PLOS MED, V10, DOI [10.1371/journal.pmed.1001363, 10.1371/journal.pmed.1001362]; Froslie KF, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-6; Groenen P.J.F., 2007, ADV FUZZY CLUSTERING, P53, DOI [10.1002/9780470061190.ch3, DOI 10.1002/9780470061190.CH3]; Hafner D, 2011, ALLERGY, V66, P629, DOI 10.1111/j.1398-9995.2010.02531.x; Hashmi MR, 2020, J INTELL FUZZY SYST, V39, P7381, DOI 10.3233/JIFS-200761; Hashmi MR, 2020, INT J FUZZY SYST, V22, P273, DOI 10.1007/s40815-019-00763-2; HOPE ACA, 1968, J ROY STAT SOC B, V30, P582; Hoppner F, 1999, FUZZY CLUSTER ANAL M; HUBERT L, 1985, J CLASSIF, V2, P193, DOI 10.1007/BF01908075; Hullermeier E, 2012, IEEE T FUZZY SYST, V20, P546, DOI 10.1109/TFUZZ.2011.2179303; Ignaccolo R, 2008, ENVIRONMETRICS, V19, P672, DOI 10.1002/env.946; JACKSON DA, 1989, CAN J ZOOL, V67, P766, DOI 10.1139/z89-108; Jacques J, 2014, ADV DATA ANAL CLASSI, V8, P231, DOI 10.1007/s11634-013-0158-y; Kaufman L., 1990, FINDING GROUPS DATA; Krishnapuram R, 2001, IEEE T FUZZY SYST, V9, P595, DOI 10.1109/91.940971; Kroll A., 2011, J ARTIFICIAL INTELLI, V1, P283; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; Matricardi PM, 2020, ALLERGY, V75, P259, DOI 10.1111/all.13953; Naeem K, 2020, INT J BIOMATH, V13, DOI 10.1142/S1793524520500758; PAL NR, 1995, IEEE T FUZZY SYST, V3, P370, DOI 10.1109/91.413225; Pfaar O, 2018, ALLERGY, V73, P187, DOI 10.1111/all.13240; Pfaar O, 2014, ALLERGY, V69, P854, DOI 10.1111/all.12383; Pizzulli A, 2014, CLIN EXP ALLERGY, V44, P1246, DOI 10.1111/cea.12386; Precup RE, 2020, IEEE T INSTRUM MEAS, V69, P4625, DOI 10.1109/TIM.2020.2983531; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsay J. O., 2002, APPL FUNCTIONAL DATA, DOI 10.1111/j.1467-985x.2004.t01-5-.x; Ramsay J.O., 2005, FUNCTIONAL DATA ANAL; Ranalli MG, 2016, BIOMETRICAL J, V58, P1229, DOI 10.1002/bimj.201400251; Rehg JM, 2007, MOBILE HLTH SENSORS; Riaz M, 2019, INT J BIOMATH, V12, DOI 10.1142/S1793524519500803; Riaz M, 2019, J INTELL FUZZY SYST, V37, P5417, DOI 10.3233/JIFS-190550; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sorensen H, 2013, STAT MED, V32, P5222, DOI 10.1002/sim.5989; Ullah S, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-43; Umek A, 2018, FACTA UNIV-SER MECH, V16, P389, DOI 10.22190/FUME171121020U; Yuhana U., 2020, INT J ARTIF INTELL, V18, P237; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	58	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242197	10.1371/journal.pone.0242197	http://dx.doi.org/10.1371/journal.pone.0242197			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201892	Green Published, gold			2022-12-26	WOS:000595003900026
J	Shiwa, Y; Fujiwara, H; Numaguchi, M; Abdel-Rahman, MA; Nabeta, K; Kanesaki, Y; Tashiro, Y; Zendo, T; Tanaka, N; Fujita, N; Yoshikawa, H; Sonomoto, K; Shimizu-Kadota, M				Shiwa, Yuh; Fujiwara, Haruko; Numaguchi, Mao; Abdel-Rahman, Mohamed Ali; Nabeta, Keisuke; Kanesaki, Yu; Tashiro, Yukihiro; Zendo, Takeshi; Tanaka, Naoto; Fujita, Nobuyuki; Yoshikawa, Hirofumi; Sonomoto, Kenji; Shimizu-Kadota, Mariko			Transcriptome profile of carbon catabolite repression in an efficient l-(+)-lactic acid-producing bacterium Enterococcus mundtii QU25 grown in media with combinations of cellobiose, xylose, and glucose	PLOS ONE			English	Article							LACTIC-ACID; FERMENTATION	Enterococcus mundtii QU25, a non-dairy lactic acid bacterium of the phylum Firmicutes, is capable of simultaneously fermenting cellobiose and xylose, and is described as a promising strain for the industrial production of optically pure l-lactic acid (>= 99.9%) via homo-fermentation of lignocellulosic hydrolysates. Generally, Firmicutes bacteria show preferential consumption of sugar (usually glucose), termed carbon catabolite repression (CCR), while hampering the catabolism of other sugars. In our previous study, QU25 exhibited apparent CCR in a glucose-xylose mixture phenotypically, and transcriptional repression of the xylose operon encoding initial xylose metabolism genes, likely occurred in a CcpA-dependent manner. QU25 did not exhibit CCR phenotypically in a cellobiose-xylose mixture. The aim of the current study is to elucidate the transcriptional change associated with the simultaneous utilization of cellobiose and xylose. To this end, we performed RNA-seq analysis in the exponential growth phase of E. mundtii QU25 cells grown in glucose, cellobiose, and/or xylose as either sole or co-carbon sources. Our transcriptomic data showed that the xylose operon was weakly repressed in cells grown in a cellobiose-xylose mixture compared with that in cells grown in a glucose-xylose mixture. Furthermore, the gene expression of talC, the sole gene encoding transaldolase, is expected to be repressed by CcpA-mediated CCR. QU25 metabolized xylose without using transaldolase, which is necessary for homolactic fermentation from pentoses using the pentose-phosphate pathway. Hence, the metabolism of xylose in the presence of cellobiose by QU25 may have been due to 1) sufficient amounts of proteins encoded by the xylose operon genes for xylose metabolism despite of the slight repression of the operon, and 2) bypassing of the pentose-phosphate pathway without the TalC activity. Accordingly, we have determined the targets of genetic modification in QU25 to metabolize cellobiose, xylose and glucose simultaneously for application of the lactic fermentation from lignocellulosic hydrolysates.	[Shiwa, Yuh; Tanaka, Naoto; Fujita, Nobuyuki] Tokyo Univ Agr, Dept Mol Microbiol, Tokyo, Japan; [Shiwa, Yuh; Kanesaki, Yu; Yoshikawa, Hirofumi] Tokyo Univ Agr, NODAI Genome Res Ctr, Tokyo, Japan; [Fujiwara, Haruko; Numaguchi, Mao; Abdel-Rahman, Mohamed Ali; Tashiro, Yukihiro; Zendo, Takeshi; Sonomoto, Kenji] Kyushu Univ, Dept Biosci & Biotechnol, Grad Sch, Fac Agr,Div Syst Bioengn, Fukuoka, Japan; [Abdel-Rahman, Mohamed Ali] Al Azhar Univ, Fac Sci Boys, Bot & Microbiol Dept, Cairo, Egypt; [Nabeta, Keisuke; Yoshikawa, Hirofumi; Shimizu-Kadota, Mariko] Tokyo Univ Agr, Dept Biosci, Tokyo, Japan; [Shimizu-Kadota, Mariko] Musashino Univ, Dept Environm Syst Sci, Tokyo, Japan	Tokyo University of Agriculture; Tokyo University of Agriculture; Kyushu University; Egyptian Knowledge Bank (EKB); Al Azhar University; Tokyo University of Agriculture	Shimizu-Kadota, M (corresponding author), Tokyo Univ Agr, Dept Biosci, Tokyo, Japan.; Shimizu-Kadota, M (corresponding author), Musashino Univ, Dept Environm Syst Sci, Tokyo, Japan.	mskadota@musashino-u.ac.jp	Kanesaki, Yu/J-3817-2017	Kanesaki, Yu/0000-0003-3537-9789; Tashiro, Yukihiro/0000-0003-3245-7227; Zendo, Takeshi/0000-0001-5147-7026; Abdel-Rahman, Mohamed Ali/0000-0001-8610-5724	Cooperative Research Grant of the Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture	Cooperative Research Grant of the Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture	I (MS-K) received the Cooperative Research Grant of the Genome Research for BioResource, NODAI Genome Research Center, Tokyo University of Agriculture. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman MA, 2011, J BIOTECHNOL, V156, P286, DOI [10.1016/j.jbiotec.2011.06.017, 10.1016/j.jbiotec.2011.06.017                                                                                                                                                                                                                                 ]; Abdel-Rahman MA, 2011, APPL ENVIRON MICROB, V77, P1892, DOI 10.1128/AEM.02076-10; Abdel-Rahman MA, 2011, APPL MICROBIOL BIOT, V89, P1039, DOI 10.1007/s00253-010-2986-4; Ajala EO, 2020, CHEMBIOENG REV, V7, P38, DOI 10.1002/cben.201900018; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Chomvong K, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-85; de Oliveira RA, 2018, BIOCHEM ENG J, V133, P219, DOI 10.1016/j.bej.2018.03.003; Deutscher J, 2014, MICROBIOL MOL BIOL R, V78, P231, DOI 10.1128/MMBR.00001-14; Fujita Y, 2009, BIOSCI BIOTECH BIOCH, V73, P245, DOI 10.1271/bbb.80479; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Goto S, 2019, J BIOSCI BIOENG, V128, P191, DOI 10.1016/j.jbiosc.2019.01.009; Ha SJ, 2011, P NATL ACAD SCI USA, V108, P504, DOI 10.1073/pnas.1010456108; Konno H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02347; Lancet Global Health, 2019, LANCET GLOBAL HLTH, V7, pe1; Nakahigashi K, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.65; Nichols NN, 2001, APPL MICROBIOL BIOT, V56, P120, DOI 10.1007/s002530100628; Nie XQ, 2016, MOL MICROBIOL, V100, P289, DOI 10.1111/mmi.13316; Nolasco-Hipolito Cirilo, 2019, IOP Conference Series: Materials Science and Engineering, V495, DOI 10.1088/1757-899X/495/1/012049; Ohyama A, 2006, J COMPUT AIDED CHEM, V7, P102, DOI 10.2751/jcac.7.102; Parisutham V, 2017, BIORESOURCE TECHNOL, V239, P496, DOI 10.1016/j.biortech.2017.05.001; Pessione A, 2014, J BIOTECHNOL, V173, P31, DOI 10.1016/j.jbiotec.2014.01.014; Schumacher MA, 2011, NUCLEIC ACIDS RES, V39, P2931, DOI 10.1093/nar/gkq1177; Shiwa Y, 2014, DNA RES, V21, P369, DOI 10.1093/dnares/dsu003; Subramanian MR, 2015, MICROB BIOTECHNOL, V8, P221, DOI 10.1111/1751-7915.12133; Sun YQ, 2020, BIOPROC BIOSYST ENG, V43, P1717, DOI 10.1007/s00449-020-02364-y; Svec P, 2011, BERGEYS MANUAL SYSTE, V3, DOI [10.1007/978-0-387-68489-5_2, DOI 10.1007/978-0-387-68489-5_2]; Wang Y, 2015, J BIOSCI BIOENG, V119, P10, DOI 10.1016/j.jbiosc.2014.06.003; Wang Y, 2014, RSC ADV, V4, P22013, DOI 10.1039/c4ra02764g; Yanase H, 2015, RSC ADV, V5, P93283, DOI 10.1039/c5ra15028k	29	2	2	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242070	10.1371/journal.pone.0242070	http://dx.doi.org/10.1371/journal.pone.0242070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201910	gold, Green Published			2022-12-26	WOS:000595003900039
J	Caspe, SG; Livingstone, M; Frew, D; Aitchison, K; Wattegedera, SR; Entrican, G; Palarea-Albaladejo, J; McNeilly, TN; Milne, E; Sargison, ND; Chianini, F; Longbottom, D				Caspe, Sergio Gaston; Livingstone, Morag; Frew, David; Aitchison, Kevin; Wattegedera, Sean Ranjan; Entrican, Gary; Palarea-Albaladejo, Javier; McNeilly, Tom Nathan; Milne, Elspeth; Sargison, Neil Donald; Chianini, Francesca; Longbottom, David			The 1B vaccine strain of Chlamydia abortus produces placental pathology indistinguishable from a wild type infection	PLOS ONE			English	Article							TEMPERATURE-SENSITIVE MUTANTS; PSITTACI VAR-OVIS; CHLAMYDOPHILA-ABORTUS; SHEEP; PATHOGENESIS; IDENTIFICATION	Chlamydia abortus is one of the most commonly diagnosed causes of infectious abortion in small ruminants worldwide. Control of the disease (Enzootic Abortion of Ewes or EAE) is achieved using the commercial live, attenuated C. abortus 1B vaccine strain, which can be distinguished from virulent wild-type (wt) strains by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Published studies applying this typing method and whole-genome sequence analyses to cases of EAE in vaccinated and non-vaccinated animals have provided strong evidence that the 1B strain is not attenuated and can infect the placenta causing disease in some ewes. Therefore, the objective of this study was to characterise the lesions found in the placentas of ewes vaccinated with the 1B strain and to compare these to those resulting from a wt infection. A C. abortus-free flock of multiparous adult ewes was vaccinated twice, over three breeding seasons, each before mating, with the commercial C. abortus 1B vaccine strain (Cevac (R) Chlamydia, Ceva Animal Health Ltd.). In the second lambing season following vaccination, placentas (n = 117) were collected at parturition and analysed by C. abortus-specific real-time quantitative PCR (qPCR). Two placentas, from a single ewe, which gave birth to live twin lambs, were found to be positive by qPCR and viable organisms were recovered and identified as vaccine type (vt) by PCR-RFLP, with no evidence of any wt strain being present. All cotyledons from the vt-infected placentas were analysed by histopathology and immunohistochemistry and compared to those from wt-infected placentas. Both vt-infected placentas showed lesions typical of those found in a wt infection in terms of their severity, distribution, and associated intensity of antigen labelling. These results conclusively demonstrate that the 1B strain can infect the placenta, producing typical EAE placental lesions that are indistinguishable from those found in wt infected animals.	[Caspe, Sergio Gaston; Livingstone, Morag; Frew, David; Aitchison, Kevin; Wattegedera, Sean Ranjan; Entrican, Gary; McNeilly, Tom Nathan; Chianini, Francesca; Longbottom, David] Moredun Res Inst, Penicuik, Midlothian, Scotland; [Caspe, Sergio Gaston; Milne, Elspeth; Sargison, Neil Donald] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [Caspe, Sergio Gaston] Inst Nacl Tecnol Agropecuaria INTA, Estn Expt Mercedes, Mercedes, Corrientes, Argentina; [Palarea-Albaladejo, Javier] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland	Moredun Research Institute; University of Edinburgh; Instituto Nacional de Tecnologia Agropecuaria (INTA); James Hutton Institute	Caspe, SG (corresponding author), Moredun Res Inst, Penicuik, Midlothian, Scotland.; Caspe, SG (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland.; Caspe, SG (corresponding author), Inst Nacl Tecnol Agropecuaria INTA, Estn Expt Mercedes, Mercedes, Corrientes, Argentina.	gaston.caspe@moredun.ac.uk	Longbottom, David/GWZ-8448-2022; Palarea-Albaladejo, Javier/J-5591-2013; Caspe, Sergio Gaston/AAV-4537-2021	Longbottom, David/0000-0003-0086-8443; Palarea-Albaladejo, Javier/0000-0003-0162-669X; Caspe, Sergio Gaston/0000-0001-5631-3557; McNeilly, Tom/0000-0001-6469-0512; Wattegedera, Sean/0000-0002-2218-5144	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS) Strategic Research Programme, 2016-2021; Instituto Nacional de Tecnologia Agropecuaria (INTA), Argentina	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS) Strategic Research Programme, 2016-2021; Instituto Nacional de Tecnologia Agropecuaria (INTA), Argentina	ML, DF, KA, SRW, JPA, TNM, FC and DL are supported by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS) Strategic Research Programme, 2016-2021. SGC is supported by Instituto Nacional de Tecnologia Agropecuaria (INTA), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buxton D, 2002, J COMP PATHOL, V127, P133, DOI 10.1053/jcpa.2002.0573; Buxton D, 1996, J COMP PATHOL, V114, P221, DOI 10.1016/S0021-9975(96)80044-2; BUXTON D, 1990, J COMP PATHOL, V102, P221, DOI 10.1016/S0021-9975(08)80127-2; Chalmers WSK, 1997, VET REC, V141, P63, DOI 10.1136/vr.141.3.63; Entrican G, 2010, AM J REPROD IMMUNOL, V64, P287, DOI 10.1111/j.1600-0897.2010.00907.x; Essig A, 2015, CURR CLIN MICROBIOL, V2, P22, DOI 10.1007/s40588-015-0014-2; Laroucau K, 2018, VET MICROBIOL, V225, P31, DOI 10.1016/j.vetmic.2018.09.012; Laroucau K, 2010, VACCINE, V28, P5653, DOI 10.1016/j.vaccine.2010.06.064; Livingstone M, 2018, P 5 EUR M AN CHLAM O, P25; Livingstone M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177653; Livingstone M, 2009, VET MICROBIOL, V135, P134, DOI 10.1016/j.vetmic.2008.09.033; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; Longbottom D, 2018, VACCINE, V36, P3593, DOI 10.1016/j.vaccine.2018.05.042; Longbottom D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057950; Robertson A, 2018, VET REC CASE REP, V6, DOI 10.1136/vetreccr-2018-000689; Rodolakis A, 2015, VET MICROBIOL, V181, P107, DOI 10.1016/j.vetmic.2015.07.010; RODOLAKIS A, 1983, ANN RECH VET, V14, P155; RODOLAKIS A, 1983, INFECT IMMUN, V42, P525, DOI 10.1128/IAI.42.2.525-530.1983; Sachse K, 2009, VET MICROBIOL, V135, P2, DOI 10.1016/j.vetmic.2008.09.040; Sammin D, 2009, VET MICROBIOL, V135, P90, DOI 10.1016/j.vetmic.2008.09.054; Sargison ND, 2015, NEW ZEAL VET J, V63, P284, DOI 10.1080/00480169.2015.1018365; Sergeant E., EPITOOLS EPIDEMIOLOG; SPENCER WN, 1983, VET REC, V113, P535; STAMP J. T., 1950, VET REC, V62, P251; Wattegedera SR, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03025; Wheelhouse N, 2010, VACCINE, V28, P5657, DOI 10.1016/j.vaccine.2010.04.114; Wood R., 1992, Farmers Weekly, V117, P60	27	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242526	10.1371/journal.pone.0242526	http://dx.doi.org/10.1371/journal.pone.0242526			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196660	Green Published, gold			2022-12-26	WOS:000595266800025
J	Santos, CRO; Gouveia, JJD; Gouveia, GV; Bezerra, FCM; Nogueira, JF; Barauna, D				Santos, Cassia Regina Oliveira; Gouveia, Joao Jose de Simoni; Gouveia, Gisele Veneroni; Bezerra, Flavia Caroline Moreira; Nogueira, Joel Fonseca; Barauna Junior, Durval			Molecular screening for the mutation associated with canine degenerative myelopathy (SOD1:c.118G > A) in German Shepherd dogs in Brazil	PLOS ONE			English	Article							PREVALENCE	Canine Degenerative Myelopathy is a late onset recessive autosomal disease characterized by a progressive ascending degeneration of the spinal cord. Two causal mutations are associated with this disease: a transition (c.118G>A) in exon 2 of the SOD1 that was described in several breeds and a transversion (c.52A>T) in exon 1 of the same gene described in Bernese Mountain dogs. The aim of this study was to understand the impact of the SOD1:c.118G > A mutation by genotyping a population of German Shepherd dogs in Brazil. A PCR-RFLP approach was used to genotype 97 healthy individuals belonging from the Northeast (Bahia and Pernambuco states) and South (Santa Catarina state) regions of Brazil. A total of 95 individuals were successfully genotyped resulting in an observed genotype frequency (with 95% confidence interval) of: 0.758 (0.672-0.844), 0.242 (0.156-0.328) and 0.000 (0.000-0.000) for "GG", "AG" and "AA" genotypes, respectively. To our knowledge, this is the first attempt to describe the presence of the "A" allele associated with CDM (SOD1:c.118G > A) in German Shepherd dogs in Brazil and, as such, these results contribute toward important epidemiological data in this country and to the knowledge of the distribution of the aforementioned mutation worldwide.	[Santos, Cassia Regina Oliveira; Bezerra, Flavia Caroline Moreira; Nogueira, Joel Fonseca] Fed Univ Vale Sao Francisco, Postgrad Program Vet Sci Semiarid, Petrolina, PE, Brazil; [Santos, Cassia Regina Oliveira] Fed Univ Vale Sao Francisco, Univ Vet Clin, Petrolina, PE, Brazil; [Gouveia, Joao Jose de Simoni; Gouveia, Gisele Veneroni] Fed Univ Vale Sao Francisco, Dept Anim Sci, Petrolina, PE, Brazil; [Barauna Junior, Durval] Fed Univ Vale Sao Francisco, Dept Vet Med, Petrolina, PE, Brazil		Santos, CRO (corresponding author), Fed Univ Vale Sao Francisco, Postgrad Program Vet Sci Semiarid, Petrolina, PE, Brazil.; Santos, CRO (corresponding author), Fed Univ Vale Sao Francisco, Univ Vet Clin, Petrolina, PE, Brazil.	cassia.santos@univasf.edu.br	de Simoni Gouveia, João José/F-8610-2010	de Simoni Gouveia, João José/0000-0002-0438-094X; Oliveira Santos, Cassia/0000-0002-8676-6095; barauna junior, durval/0000-0002-0261-6672				AVERILL DR, 1973, J AM VET MED ASSOC, V162, P1045; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Santos FAB, 2020, GENET MOL BIOL, V43, DOI [10.1590/1678-4685-gmb-2019-0380, 10.1590/1678-4685-GMB-2019-0380]; Chang HS, 2013, J VET MED SCI, V75, P795, DOI 10.1292/jvms.12-0451; Coates JR, 2010, VET CLIN N AM-SMALL, V40, P929, DOI 10.1016/j.cvsm.2010.05.001; Dewey C.W., 2016, PRACTICAL GUIDE CANI, V3rd ed., P329; Donner J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161005; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Hill JT, 2014, DEV DYNAM, V243, P1632, DOI 10.1002/dvdy.24183; Holder Angela L, 2014, Canine Genet Epidemiol, V1, P10, DOI 10.1186/2052-6687-1-10; Ivansson EL, 2016, P NATL ACAD SCI USA, V113, pE3091, DOI 10.1073/pnas.1600084113; Kohyama M, 2017, J VET MED SCI, V79, DOI 10.1292/jvms.16-0391; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; March PA, 2009, VET PATHOL, V46, P241, DOI 10.1354/vp.46-2-241; Mizukami K, 2016, VET J, V214, P21, DOI 10.1016/j.tvjl.2016.05.004; Mizukami K, 2013, VET J, V195, P260, DOI 10.1016/j.tvjl.2012.06.014; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; O'Brien DP, 2014, J VET INTERN MED, V28, P1186, DOI 10.1111/jvim.12383; Pfahler S, 2014, ANIM GENET, V45, P309, DOI 10.1111/age.12118; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Regitano LCA, 2007, EMBRAPA, V1, P72; Santos CRO, 2020, ARQ BRAS MED VET ZOO, V72, P339, DOI 10.1590/1678-4162-11221; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turba ME, 2017, ANIM GENET, V48, P365, DOI 10.1111/age.12525; Wininger FA, 2011, J VET INTERN MED, V25, P1166, DOI [10.1111/j.1939-1676.2011.00760.x, 10.1111/j.1939-1676.2011.0760.x]; Zeiler GE, 2013, J S AFR VET ASSOC, V84, DOI 10.4102/jsava.v84i1.1005; Zeng R, 2014, J VET INTERN MED, V28, P515, DOI 10.1111/jvim.12317	28	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242347	10.1371/journal.pone.0242347	http://dx.doi.org/10.1371/journal.pone.0242347			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196688	gold, Green Published			2022-12-26	WOS:000595266800030
J	Brusa, V; Costa, M; Padola, NL; Etcheverria, A; Sampedro, F; Fernandez, PS; Leotta, GA; Signorini, ML				Brusa, Victoria; Costa, Magdalena; Padola, Nora L.; Etcheverria, Analia; Sampedro, Fernando; Fernandez, Pablo S.; Leotta, Gerardo A.; Signorini, Marcelo L.			Quantitative risk assessment of haemolytic uremic syndrome associated with beef consumption in Argentina	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; IN-GROUND BEEF; BACTERIAL CROSS-CONTAMINATION; ASSESSMENT MODEL; FEEDLOT CATTLE; UNITED-STATES; LONG-TERM; PREVALENCE; STEC; SEROTYPES	We developed a quantitative microbiological risk assessment (QMRA) of haemolytic uremic syndrome (HUS) associated with Shiga toxin-producing Escherichia coli (STEC)-contaminated beef (intact beef cuts, ground beef and commercial hamburgers) in children under 15 years of age from Argentina. The QMRA was used to characterize STEC prevalence and concentration levels in each product through the Argentinean beef supply chain, including cattle primary production, cattle transport, processing and storage in the abattoir, retail and home preparation, and consumption. Median HUS probability from beef cut, ground beef and commercial hamburger consumption was <10(-15), 5.4x10(-8) and 3.5x10(-8), respectively. The expected average annual number of HUS cases was 0, 28 and 4, respectively. Risk of infection and HUS probability were sensitive to the type of abattoir, the application or not of Hazard Analysis and Critical Control Points (HACCP) for STEC (HACCP-STEC), stx prevalence in carcasses and trimmings, storage conditions from the abattoir to retailers and home, the joint consumption of salads and beef products, and cooking preference. The QMRA results showed that the probability of HUS was higher if beef cuts (1.7x) and ground beef (1.2x) were from carcasses provided by abattoirs not applying HACCP-STEC. Thus, the use of a single sanitary standard that included the application of HACCP-STEC in all Argentinean abattoirs would greatly reduce HUS incidence. The average number of annual HUS cases estimated by the QMRA (n = 32) would explain about 10.0% of cases in children under 15 years per year in Argentina. Since other routes of contamination can be involved, including those not related to food, further research on the beef production chain, other food chains, person-to-person transmission and outbreak studies should be conducted to reduce the impact of HUS on the child population of Argentina.	[Brusa, Victoria; Costa, Magdalena; Leotta, Gerardo A.] UNLP, CONICET LA PLATA, Fac Ciencias Vet UNLP, IGEVET Inst Genet Vet Ingn Fernando N Dulout, Buenos Aires, DF, Argentina; [Padola, Nora L.; Etcheverria, Analia] UNCPBA, CONICET, CIVETAN Ctr Invest Vet Tandil, CICPBA,Fac Ciencias Vet UNCPBA, Buenos Aires, DF, Argentina; [Sampedro, Fernando] Univ Minnesota, Sch Publ Hlth, Environm Hlth Sci Div, Minneapolis, MN USA; [Fernandez, Pablo S.] Univ Politecn Cartagena, Escuela Tecn Super Ingn Agron, Cartagena, Spain; [Signorini, Marcelo L.] Consejo Nacl Invest Cient & Tecn, IdICaL Inst Invest Cadena Lactea INTA, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Minnesota System; University of Minnesota Twin Cities; Universidad Politecnica de Cartagena; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Leotta, GA (corresponding author), UNLP, CONICET LA PLATA, Fac Ciencias Vet UNLP, IGEVET Inst Genet Vet Ingn Fernando N Dulout, Buenos Aires, DF, Argentina.	gerardo.leotta@gmail.com	Etcheverría, Analía/ABC-5883-2021	Sampedro, Fernando/0000-0003-1155-2751; , Gerardo/0000-0001-8707-8932; Costa, Magdalena/0000-0003-0899-4073	Institute for the Promotion of Argentine Beef, IPCVA	Institute for the Promotion of Argentine Beef, IPCVA	This study was supported by research grants from the Institute for the Promotion of Argentine Beef, IPCVA (www.ipcva.com.ar).Findings presented in this article are the interpretation from authors and do not necessarily represent the views of the funding agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed W, 2015, ENVIRON SCI TECHNOL, V49, P3084, DOI 10.1021/es505477n; Alberta Health AG, 2018, HAEM UR SYNDR; ANDERSON ME, 1992, J FOOD SAFETY, V12, P191, DOI 10.1111/j.1745-4565.1991.tb00078.x; Andreoletti O, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3783; [Anonymous], 2008, JOINT COMMISSION PER, V8, P8; [Anonymous], 1996, BROILER IND, V59, P8; [Anonymous], 2007, MED PRAKT, V7, P9; [Anonymous], 2012, PENNSYLVANIA LEGACIE, V12, P12; [Anonymous], 2014, BIOMETRIC TECHNOLOGY, V2014, P12; [Anonymous], 2009, REGULATORY RAPPORTEU, V6, P8; [Anonymous], 2017, GAN BASED HYDROGEN S, V77, P6, DOI [10.1149/MA2017-01/27/1286, DOI 10.1149/MA2017-01/27/1286]; Arthur TM, 2007, J FOOD PROTECT, V70, P280, DOI 10.4315/0362-028X-70.2.280; ASAKURA H, 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/739139; AT M., 2007, J FOOD PROTECT, V70, P7; Baba H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225340; Bach SJ, 2004, J FOOD PROTECT, V67, P672, DOI 10.4315/0362-028X-67.4.672; Baeza Quiroz CB, 2013, AISLAMIENTO CARACTER; Barham AR, 2002, J FOOD PROTECT, V65, P280, DOI 10.4315/0362-028X-65.2.280; Barlow RS, 2006, INT J FOOD MICROBIOL, V111, P1, DOI 10.1016/j.ijfoodmicro.2006.04.039; Barril PA, 2019, LWT-FOOD SCI TECHNOL, V107, P35, DOI 10.1016/j.lwt.2019.02.074; Bibbal D, 2015, APPL ENVIRON MICROB, V81, P1397, DOI 10.1128/AEM.03315-14; [Board BoHPaDPFaN USDA  Assessment FtPR  Academies IoMotN], 2002, ESCH COL O157 H7 GRO; Bohaychuk VM, 2011, CAN VET J, V52, P1095; Bonardi S, 2015, Vet Rec Open, V2, pe000061, DOI 10.1136/vetreco-2014-000061; Bosilevac JM, 2007, J FOOD PROTECT, V70, P440, DOI 10.4315/0362-028X-70.2.440; Bosilevac JM, 2011, APPL ENVIRON MICROB, V77, P2103, DOI 10.1128/AEM.02833-10; Brusa V, 2019, FOOD SCI TECHNOL INT, V25, P491, DOI 10.1177/1082013219836326; Brusa V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183248; Buchholz U, 2011, NEW ENGL J MED, V365, P1763, DOI 10.1056/NEJMoa1106482; Cap M, 2019, REV ARGENT MICROBIOL, V51, P32, DOI 10.1016/j.ram.2018.03.005; Caruso C, 2020, CANCER DISCOV, V10, P10, DOI 10.1158/2159-8290.CD-ND2019-012; Cassin MH, 1998, INT J FOOD MICROBIOL, V41, P21, DOI 10.1016/S0168-1605(98)00028-2; CDC, 2017, MULT OUTBR SHIG TOX; CDC, 2020, FOODN FASTS HEM UR S; Centers for Disease Control and Prevention (CDC), 2016, MULT OUTBR SHIG TOX; Centers for Disease Control and Prevention (CDC), 2018, MULT OUTBR E COL O15; Chen YH, 2001, J FOOD PROTECT, V64, P72, DOI 10.4315/0362-028X-64.1.72; Cobbold RN, 2008, J FOOD PROTECT, V71, P5; Codigo Alimentarioa Argentino, 2007, AL CARN AF CARN CONS; Costa M, 2020, PREV VET MED, V176, DOI 10.1016/j.prevetmed.2020.104933; Dewell GA, 2008, J FOOD PROTECT, V71, P5; Dewsbury DM, 2015, FOODBORNE PATHOG DIS, V12, P726, DOI 10.1089/fpd.2015.1987; Di Pillo S, 2018, ESCHERICHIA COLI PRO, P77; Dogan OB, 2019, FOOD CONTROL, V100, P97, DOI 10.1016/j.foodcont.2019.01.003; Duffy G, 2005, J MICROBIOL METH, V60, P375, DOI 10.1016/j.mimet.2004.10.014; Duffy G, 2005, QUANTITATIVE RISK AS; Duffy G, 2006, MEAT SCI, V74, P76, DOI 10.1016/j.meatsci.2006.04.011; Etcheverria AI, 2010, MEAT SCI, V86, P418, DOI 10.1016/j.meatsci.2010.05.027; European Food Safety Authority, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5500; European Food Safety Authority, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2390; Evans EW, 2015, J FOOD PROTECT, V78, P738, DOI 10.4315/0362-028X.JFP-14-527; Exeni RA, 2006, MEDICINA-BUENOS AIRE, V66, P6; FAO WHO, 2004, MICR RISK ASS SER, V5, P311; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Fernandez D, 2010, LETT APPL MICROBIOL, V51, P377, DOI 10.1111/j.1472-765X.2010.02904.x; Fernandez D, 2009, J APPL MICROBIOL, V106, P1260, DOI 10.1111/j.1365-2672.2008.04088.x; Fernandez-Brando RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019136; Ferreira MRA, 2018, ARQ BRAS MED VET ZOO, V70, P1807, DOI 10.1590/1678-4162-9861; Fitness may inhibit Alzheimer's progression, 2008, DUKE MED HLTH NEWS, V14, P9; Fremaux B, 2008, VET MICROBIOL, V132, P1, DOI 10.1016/j.vetmic.2008.05.015; FSAI, 2018, INV MOST APPR Z VAL; [FSAI Microbiology], 2013, MICR SAF RAW MINC BE, P25; [FSAI MicroBiology], 2013, MICR SAF RAW MINC BE; Galli L, ESCHERICHIA COLI AM; Geue L, 2002, EPIDEMIOL INFECT, V129, P173, DOI 10.1017/S0950268802007288; Hill WE, 2011, FOODBORNE PATHOG DIS, V8, P1045, DOI 10.1089/fpd.2010.0825; Huang LH, 2012, J FOOD SCI, V77, pM217, DOI 10.1111/j.1750-3841.2012.02647.x; INDEC, 2012, CENS NAC POBL HOG B; IPCVA, 2020, EST CONS PROM; Jackson LA, 2000, ARCH INTERN MED, V160, P2380, DOI 10.1001/archinte.160.15.2380; James C, 2017, COMPR REV FOOD SCI F, V16, P160, DOI 10.1111/1541-4337.12242; Jaros P, 2018, EPIDEMIOL INFECT, V146, P1089, DOI [10.1017/S0950268818000973, 10.1017/s0950268818000973]; JEMRA, 2016, JOINT FAO WHO COR EX; Jones TH, 2014, FOOD MICROBIOL, V42, P225, DOI 10.1016/j.fm.2014.04.001; Ju WT, 2012, FOOD MICROBIOL, V32, P371, DOI 10.1016/j.fm.2012.07.017; Juneja VK, 1999, J FOOD PROTECT, V60, P4; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Kiermeier A, 2015, RISK ANAL, V35, P77, DOI 10.1111/risa.12248; Kintz E, 2019, J FOOD PROTECT, V82, P9; Kirk MD, 2015, PLOS MED, V12, DOI [10.1371/journal.pmed.1001921, 10.1371/journal.pmed.1001940]; Koutsoumanis K, 2020, EFSA J, V18, DOI 10.2903/j.efsa.2020.5967; Lammerding AM, 1999, SHIGA TOXINPRODUCING; Launders N, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.44.20624; Leotta GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162635; Llorente P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/795104; Luchansky JB, 2012, J FOOD PROTECT, V75, P62, DOI 10.4315/0362-028X.JFP-11-267; Lynch MJ, 2012, ZOONOSES PUBLIC HLTH, V59, P264, DOI 10.1111/j.1863-2378.2011.01443.x; Majowicz SE, 2014, FOODBORNE PATHOG DIS, V11, P447, DOI 10.1089/fpd.2013.1704; Masana MO, 2011, J FOOD PROTECT, V74, P2008, DOI 10.4315/0362-028X.JFP-11-189; Mather AE, 2008, APPL ENVIRON MICROB, V74, P6313, DOI 10.1128/AEM.00770-08; Meichtri L, 2004, INT J FOOD MICROBIOL, V96, P189, DOI 10.1016/j.ijfoodmicro.2004.03.018; Mellor GE, 2016, J FOOD PROTECT, V79, P1868, DOI 10.4315/0362-028X.JFP-15-507; Minihan D, 2003, J VET MED B, V50, P5; Ministerio de Salud PdlN, 2012, ENC NAC NUTR SAL 200, P54; Mir RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148518; Moher D, 2015, SYST REV, V4, DOI [10.1186/s13643-015-0087-2, 10.1186/2046-4053-4-1]; Monaghan A, 2012, FOOD MICROBIOL, V32, P223, DOI 10.1016/j.fm.2012.06.002; Montero D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00384; Montville R, 2003, APPL ENVIRON MICROB, V69, P7188, DOI 10.1128/AEM.69.12.7188-7193.2003; Morita-Ishihara T, 2016, EMERG INFECT DIS, V22, P2181, DOI 10.3201/eid2212.160783; Nauta MJ, 2001, RISK ASSESSMENT SHIG, P169; Nobili G, 2017, INT J FOOD MICROBIOL, V257, P201, DOI 10.1016/j.ijfoodmicro.2017.06.022; Olesen J, 2018, CEPHALALGIA, V38, P1, DOI 10.1177/0333102417738202; Oporto B, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268819000566, 10.1017/s0950268819000566]; Padola NL, 2004, VET MICROBIOL, V100, P3, DOI 10.1016/S0378-1135(03)00127-5; Perez Terrazzino GB, 2020, IMPLEMENTACION ACCIO; Pires SM, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S095026881900116X, 10.1017/s095026881900116x]; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Reicks AL, 2007, J FOOD PROTECT, V70, P17, DOI 10.4315/0362-028X-70.1.17; Rivas M., 2016, Escherichia coli in the Americas, P97; Rivas M, 2006, MEDICINA B AIRES, V66, P17; Rivelli Zea Sofia M, 2020, Rev Argent Microbiol, V52, P131, DOI 10.1016/j.ram.2019.07.001; Rodolpho D, 2007, BRAZ J MICROBIOL, V38, P599, DOI 10.1590/S1517-83822007000400004; Rossvoll E, 2014, MEAT SCI, V96, P695, DOI 10.1016/j.meatsci.2013.09.009; Sanz M, 2013, 13 C ARG MICR 2 C MI; Sanz ME, 1998, EUR J EPIDEMIOL, V14, P399, DOI 10.1023/A:1007427925583; Schaffner DW, 2007, J FOOD PROTECT, V70, P109, DOI 10.4315/0362-028X-70.1.109; Signorini M, 2009, INT J FOOD MICROBIOL, V132, P153, DOI 10.1016/j.ijfoodmicro.2009.04.022; Signorini M, 2018, MEAT SCI, V142, P44, DOI 10.1016/j.meatsci.2018.04.009; Signorini ML, 2009, REV ARGENT MICROBIOL, V41, P9; Smith BA, 2013, FOOD CONTROL, V29, P364, DOI 10.1016/j.foodcont.2012.03.003; Sporing SB, 1996, ESCHERICHIA COLI O15; Stanford K, 2011, J FOOD PROTECT, V74, P1605, DOI 10.4315/0362-028X.JFP-11-154; Stanford K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159866; Stringer SC, 2000, JOUMAL APPL MICROBIO, V88, P11; Stromberg ZR, 2015, FOODBORNE PATHOG DIS, V12, P631, DOI 10.1089/fpd.2015.1945; Tanaro JD, 2012, FOODBORNE PATHOG DIS, V9, P878, DOI 10.1089/fpd.2012.1182; Tanaro JD, 2010, FOODBORNE PATHOG DIS, V7, P475, DOI 10.1089/fpd.2009.0431; Teunis PF, 2008, EPIDEMIOL INFECT, V136, P10, DOI [10.1017/S0950268807008242, DOI 10.1017/S0950268807008242]; Thiry D, 2018, J APPL MICROBIOL, V124, P867, DOI 10.1111/jam.13677; Toro M, 2018, FOOD MICROBIOL, V75, P55, DOI 10.1016/j.fm.2017.10.015; Torres A.G., 2016, ESCHERICHIA COLI AM; Varcasia BM, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6040126; Venegas-Vargas C, 2016, APPL ENVIRON MICROB, V82, P5049, DOI 10.1128/AEM.00829-16; Vose D., 1996, QUANTITATIVE RISK AN; Wachtel MR, 2003, J FOOD PROTECT, V66, P1176, DOI 10.4315/0362-028X-66.7.1176; Wang LYR, 2018, FRONT MICROBIOL, V9, P24, DOI [10.3389/fmicb.2018.00024, DOI 10.3389/FMICB.2018.00024]; Wasilenko JL, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00081; 2018, INT J COMMUN SYST, V31	139	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242317	10.1371/journal.pone.0242317	http://dx.doi.org/10.1371/journal.pone.0242317			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186398	Green Published, gold			2022-12-26	WOS:000593949800039
J	Campos, LR; Petroli, M; Sztajnbok, FR; da Costa, ES; Brandao, LR; Land, MGP				Campos, Leonardo Rodrigues; Petroli, Mauricio; Sztajnbok, Flavio Roberto; da Costa, Elaine Sobral; Brandao, Leonardo Rodrigues; Land, Marcelo Gerardin Poirot			Risk factors for the development of hospital-acquired pediatric venous thromboembolism-Dealing with potentially causal and confounding risk factors using a directed acyclic graph (DAG) analysis	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; PULMONARY-EMBOLISM; UNITED-STATES; CHILDREN; COMMUNICATION; SSC	Introduction Hospital-acquired venous thromboembolism (HA-VTE) in children comprises multiple risk factors that should not be evaluated separately due to collinearity and multiple cause and effect relationships. This is one of the first case-control study of pediatric HA-VTE risk factors using a Directed Acyclic Graph (DAG) analysis. Material and methods Retrospective, case-control study with 22 cases of objectively confirmed HA-VTE and 76 controls matched by age, sex, unit of admission, and period of hospitalization. Descriptive statistics were used to define distributions of continuous variables, frequencies, and proportions of categorical variables, comparing cases and controls. Due to many potential risk factors of HA-VTE, a directed acyclic graph (DAG) model was created to identify confounding, reduce bias, and increase precision on the analysis. The final model consisted of a DAG-informed conditional logistic regression. Results In the initial conventional univariable model, the following variables were selected as potential risk factors for HA-VTE: length of stay (LOS, days), immobility, ICU admission in the last 30 days, LOS in ICU, infection, central venous catheter (CVC), number of CVCs placed, L-asparaginase, heart failure, liver failure, and nephrotic syndrome. The final model using the set of variables selected by DAG analysis revealed LOS (OR = 1.106, 95%CI = 1.021-1.198, p = 0.013), L-asparaginase (OR = 26.463, 95%CI = 1.609-435.342, p = 0.022), and nephrotic syndrome (OR = 29.127, 95%CI = 1.044-812.508, p = 0.004) as independent risk factors for HA-VTE. Conclusion The DAG-based approach was useful to clarify the influence of confounders and multiple causalities of HA-VTE. Interestingly, CVC placement-a known thrombotic risk factor highlighted in several studies-was considered a confounder, while LOS, L-asparaginase use and nephrotic syndrome were confirmed as risk factors to HA-VTE. Large confidence intervals are related to the sample size; however, the results were significant.	[Campos, Leonardo Rodrigues; Petroli, Mauricio; Sztajnbok, Flavio Roberto; da Costa, Elaine Sobral; Land, Marcelo Gerardin Poirot] Univ Fed Rio de Janeiro, Dept Pediat, Inst Puericultura Pediat Martagao Gesteira, Rio De Janeiro, Brazil; [Campos, Leonardo Rodrigues] Univ Fed Fluminense, Hosp Univ Antonio Pedro, Dept Pediat, Div Pediat Rheumatol, Niteroi, RJ, Brazil; [Petroli, Mauricio; Sztajnbok, Flavio Roberto; da Costa, Elaine Sobral; Land, Marcelo Gerardin Poirot] Univ Fed Rio de Janeiro, Fac Med, Dept Pediat, Rio De Janeiro, Brazil; [Sztajnbok, Flavio Roberto] Hosp Univ Pedro Ernesto, Div Pediat Rheumatol, Dept Pediat, Rio De Janeiro, Brazil; [Brandao, Leonardo Rodrigues] Univ Toronto, Hosp Sick Children, Dept Pediat, Toronto, ON, Canada	Universidade Federal do Rio de Janeiro; Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Campos, LR (corresponding author), Univ Fed Rio de Janeiro, Dept Pediat, Inst Puericultura Pediat Martagao Gesteira, Rio De Janeiro, Brazil.; Campos, LR (corresponding author), Univ Fed Fluminense, Hosp Univ Antonio Pedro, Dept Pediat, Div Pediat Rheumatol, Niteroi, RJ, Brazil.	camposlr@gmail.com	land, marcelo g p/O-9286-2018	land, marcelo g p/0000-0001-9792-3167; Campos, Leonardo/0000-0002-1569-7360				[Anonymous], 2018, DEF CHILDH OB OV OB; [Anonymous], 2019, INTEL 64 IA 32 ARCHI, V3; Atchison CM, 2014, J PEDIATR-US, V165, P793, DOI 10.1016/j.jpeds.2014.05.053; Biss TT, 2008, BRIT J HAEMATOL, V142, P808, DOI 10.1111/j.1365-2141.2008.07243.x; Branchford BR, 2017, J THROMB HAEMOST, V15, P2274, DOI 10.1111/jth.13848; Carpenter SL, 2019, PEDIATR NEPHROL, V34, P261, DOI 10.1007/s00467-018-4072-6; CDC, 2019, PREM BIRTH; Elwert F, 2013, HDB CAUSAL ANAL SOCI, V13, P301; Goldenberg NA, 2010, HAEMATOL-HEMATOL J, V95, P1952, DOI 10.3324/haematol.2010.026989; Grace RF, 2018, J THROMB THROMBOLYS, V45, P306, DOI 10.1007/s11239-017-1597-7; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Greenland S, 2002, INT J EPIDEMIOL, V31, P1030, DOI 10.1093/ije/31.5.1030; Greenland S, 2016, INT J EPIDEMIOL, V45, P565, DOI 10.1093/ije/dyw040; Hancock HS, 2013, CARDIOL YOUNG, V23, P344, DOI 10.1017/S1047951112001126; Kaatz S, 2015, J THROMB HAEMOST, V13, P2119, DOI 10.1111/jth.13140; Kerlin BA, 2012, AM J HEMATOL, V87, pS68, DOI 10.1002/ajh.23131; Klaassen ILM, 2019, RES PRACT THROMB HAE, V3, P234, DOI 10.1002/rth2.12182; Klaassen ILM, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0877-x; Levy-Mendelovich S, 2018, THROMB RES, V164, pS94, DOI 10.1016/j.thromres.2018.01.019; Mahajerin A, 2020, J THROMB HAEMOST, V18, P633, DOI 10.1111/jth.14697; Mahajerin A, 2015, HAEMATOLOGICA, V100, P1045, DOI 10.3324/haematol.2015.123455; Mansournia MA, 2013, INT J EPIDEMIOL, V42, P860, DOI 10.1093/ije/dyt083; Raffini L, 2009, PEDIATRICS, V124, P1001, DOI 10.1542/peds.2009-0768; Setty BA, 2012, PEDIATR BLOOD CANCER, V59, P258, DOI 10.1002/pbc.23388; Sharathkumar AA, 2012, J THROMB HAEMOST, V10, P1326, DOI 10.1111/j.1538-7836.2012.04779.x; Sharp Whitney, 2018, Methodist Debakey Cardiovasc J, V14, P237, DOI 10.14797/mdcj-14-3-237; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Wouk K, 2019, ADDICT BEHAV, V94, P109, DOI 10.1016/j.addbeh.2018.09.032	28	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242311	10.1371/journal.pone.0242311	http://dx.doi.org/10.1371/journal.pone.0242311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186402	Green Submitted, Green Published, gold			2022-12-26	WOS:000593949800043
J	Hahn, J; Fu, YP; Brown, MR; Bis, JC; de Vries, PS; Feitosa, MF; Yanek, LR; Weiss, S; Giulianini, F; Smith, AV; Guo, XQ; Bartz, TM; Becker, DM; Becker, LC; Boerwinkle, E; Brody, JA; Chen, YDI; Franco, OH; Grove, M; Harris, TB; Hofman, A; Hwang, SJ; Kral, BG; Launer, LJ; Markus, MRP; Rice, KM; Rich, SS; Ridker, PM; Rivadeneira, F; Rotter, JI; Sotoodehnia, N; Taylor, KD; Uitterlinden, AG; Volker, U; Volzke, H; Yao, J; Chasman, DI; Dorr, M; Gudnason, V; Mathias, RA; Post, W; Psaty, BM; Dehghan, A; O'Donnell, CJ; Morrison, AC				Hahn, Julie; Fu, Yi-Ping; Brown, Michael R.; Bis, Joshua C.; de Vries, Paul S.; Feitosa, Mary F.; Yanek, Lisa R.; Weiss, Stefan; Giulianini, Franco; Smith, Albert Vernon; Guo, Xiuqing; Bartz, Traci M.; Becker, Diane M.; Becker, Lewis C.; Boerwinkle, Eric; Brody, Jennifer A.; Chen, Yii-Der Ida; Franco, Oscar H.; Grove, Megan; Harris, Tamara B.; Hofman, Albert; Hwang, Shih-Jen; Kral, Brian G.; Launer, Lenore J.; Markus, Marcello R. P.; Rice, Kenneth M.; Rich, Stephen S.; Ridker, Paul M.; Rivadeneira, Fernando; Rotter, Jerome I.; Sotoodehnia, Nona; Taylor, Kent D.; Uitterlinden, Andre G.; Voelker, Uwe; Voelzke, Henry; Yao, Jie; Chasman, Daniel I.; Doerr, Marcus; Gudnason, Vilmundur; Mathias, Rasika A.; Post, Wendy; Psaty, Bruce M.; Dehghan, Abbas; O'Donnell, Christopher J.; Morrison, Alanna C.			Genetic loci associated with prevalent and incident myocardial infarction and coronary heart disease in the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium	PLOS ONE			English	Article							EXOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; SUSCEPTIBILITY LOCI; VARIANT ASSOCIATION; ARTERY-DISEASE; RISK-FACTOR; ANGPTL4; METAANALYSIS; INSIGHTS; DATABASE	Background Genome-wide association studies have identified multiple genomic loci associated with coronary artery disease, but most are common variants in non-coding regions that provide limited information on causal genes and etiology of the disease. To overcome the limited scope that common variants provide, we focused our investigation on low-frequency and rare sequence variations primarily residing in coding regions of the genome. Methods and results Using samples of individuals of European ancestry from ten cohorts within the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium, both cross-sectional and prospective analyses were conducted to examine associations between genetic variants and myocardial infarction (MI), coronary heart disease (CHD), and all-cause mortality following these events. For prevalent events, a total of 27,349 participants of European ancestry, including 1831 prevalent MI cases and 2518 prevalent CHD cases were used. For incident cases, a total of 55,736 participants of European ancestry were included (3,031 incident MI cases and 5,425 incident CHD cases). There were 1,860 all-cause deaths among the 3,751 MI and CHD cases from six cohorts that contributed to the analysis of all-cause mortality. Single variant and gene-based analyses were performed separately in each cohort and then meta-analyzed for each outcome. A low-frequency intronic variant (rs988583) in PLCL1 was significantly associated with prevalent MI (OR = 1.80, 95% confidence interval: 1.43, 2.27; P = 7.12 x 10(-7)). We conducted gene-based burden tests for genes with a cumulative minor allele count (cMAC) >= 5 and variants with minor allele frequency (MAF) < 5%. TMPRSS5 and LDLRAD1 were significantly associated with prevalent MI and CHD, respectively, and RC3H2 and ANGPTL4 were significantly associated with incident MI and CHD, respectively. No loci were significantly associated with all-cause mortality following a MI or CHD event. Conclusion This study identified one known locus (ANGPTL4) and four new loci (PLCL1, RC3H2, TMPRSS5, and LDLRAD1) associated with cardiovascular disease risk that warrant further investigation.	[Hahn, Julie; Brown, Michael R.; de Vries, Paul S.; Boerwinkle, Eric; Grove, Megan; Morrison, Alanna C.] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Fu, Yi-Ping] NHLBI, Off Biostat Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Fu, Yi-Ping; Hwang, Shih-Jen; O'Donnell, Christopher J.] NHLBI, Framingham Heart Study, NIH, Framingham, MA USA; [Bis, Joshua C.; Bartz, Traci M.; Brody, Jennifer A.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [de Vries, Paul S.; Dehghan, Abbas] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Feitosa, Mary F.] Washington Univ, Sch Med, Dept Genet, Div Stat Genom, St Louis, MO 63110 USA; [Yanek, Lisa R.; Becker, Diane M.; Becker, Lewis C.; Kral, Brian G.; Mathias, Rasika A.] Johns Hopkins Univ, Sch Med, Dept Med, GeneSTAR Res Program, Baltimore, MD 21205 USA; [Weiss, Stefan; Voelker, Uwe] Univ Med & Ernst Moritz Arndt Univ Greifswald, Interfac Inst Genet & Funct Genom, Greifswald, Germany; [Weiss, Stefan; Markus, Marcello R. P.; Voelker, Uwe; Voelzke, Henry; Doerr, Marcus] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany; [Giulianini, Franco; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Smith, Albert Vernon; Gudnason, Vilmundur] Icelandic Heart Assoc, Kovapvogur, Iceland; [Smith, Albert Vernon; Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykajvik, Iceland; [Guo, Xiuqing; Chen, Yii-Der Ida; Rotter, Jerome I.; Taylor, Kent D.; Yao, Jie] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Inst Translat Genom & Populat Sci, Dept Pediat, Torrance, CA 90509 USA; [Bartz, Traci M.; Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Franco, Oscar H.; Hofman, Albert; Launer, Lenore J.; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Harris, Tamara B.] NIA, Lab Epidemiol & Populat Sci, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Hofman, Albert; Dehghan, Abbas] Imperial Coll London, Dept Epidemiol & Biostat, London, England; [Markus, Marcello R. P.; Doerr, Marcus] Univ Med Greifswald, Dept Internal Med B, Intens Care Med, Cardiol,Pneumol,Infect Dis, Greifswald, Germany; [Rich, Stephen S.; Post, Wendy] Johns Hopkins Univ, Sch Med, Dept Med & Epidemiol, Baltimore, MD USA; [Ridker, Paul M.; Chasman, Daniel I.; O'Donnell, Christopher J.] Harvard Med Sch, Boston, MA 02115 USA; [Sotoodehnia, Nona] Univ Washington, Dept Med, Div Cardiol, Seattle, WA USA; [Uitterlinden, Andre G.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Kaiser Permanente Res Inst, Seattle, WA USA; [O'Donnell, Christopher J.] Vet Affair, VA Boston Healthcare Syst, Boston, MA USA; [O'Donnell, Christopher J.] Brigham & Womens Hosp, Cardiovasc Med Div, 75 Francis St, Boston, MA 02115 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; Washington University (WUSTL); Johns Hopkins University; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; German Centre for Cardiovascular Research; Harvard University; Brigham & Women's Hospital; Icelandic Heart Association; University of Iceland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Washington; University of Washington Seattle; Baylor College of Medicine; Erasmus University Rotterdam; Erasmus MC; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Imperial College London; Greifswald Medical School; Johns Hopkins University; Harvard University; Harvard Medical School; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Greifswald Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital	Hahn, J; Morrison, AC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Ctr Human Genet, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.	Julie.M.Hahn@uth.tmc.edu; Alanna.C.Morrison@uth.tmc.edu	Rotter, Jerome/AAY-6598-2021; Hwang, Shih-Jen/HGU-5826-2022; Franco, Óscar H/ABE-2305-2020; Smith, Albert Vernon/AHC-3838-2022; Dörr, Marcus/F-1919-2010; Gudnason, Vilmundur/K-6885-2015; Feitosa, Mary/K-8044-2012	Franco, Óscar H/0000-0002-4606-4929; Smith, Albert Vernon/0000-0003-1942-5845; Dörr, Marcus/0000-0001-7471-475X; Kral, Brian/0000-0001-9493-2084; Gudnason, Vilmundur/0000-0001-5696-0084; Feitosa, Mary/0000-0002-0933-2410; Rich, Stephen/0000-0003-3872-7793; Weiss, Stefan/0000-0002-3553-4315	National Heart, Lung and Blood Institute (NHLBI) [R01HL105756]; NIH NHLBI [R01HL141291]; American Heart Association [18CDA34110116]; NIH [N01-AG-1-2100, HHSN271201200022C]; NIA Intramural Research Program; Hjartavernd (Icelandic Heart Association); Althingi (Icelandic Parliament); Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I, HHSN268201700005I]; NIH through the American Recovery and Reinvestment Act of 2009 (ARRA) [5RC2HL102419]; NHLBI [R01HL105756, HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, U01HL080295, R01HL087652, R01HL103612, R01HL120393, U01HL130114]; National Institute of Neurological Disorders and Stroke (NINDS); National Institute on Aging (NIA) [R01AG023629]; National Center for Advancing Translational Sciences, CTSI grant [UL1TR001881]; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant [DK063491]; National Heart, Lung, and Blood Institute [R01-HL-117078, HHSN268201100037C, HL043851, HL080467, HL099355]; National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK089256]; National Institutes of Health/National Heart, Lung and Blood Institute [HL49762, HL59684, HL071025, HL58625, U01 HL72518, HL089474, HL092165, HL099747, K23HL105897, K23HL094747, HL11006, HL112064]; National Institute of Nursing Research [NR0224103, NR008153]; National Institute of Neurological Disorders and Stroke [NS062059]; National Center for Research Resources [M01RR000052]; Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Netherlands Organisation for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly [014-93-015]; Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Netherlands Organisation of Scientific Research (NWO) [175.010.2005.011, 911-03-012]; Netherlands Genomics Initiative (NGI) [NWO 050-060-810]; Netherlands Organisation for Scientific Research (NWO) [veni 916.12.154]; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung (BMBF)) [01ZZ9603, 01ZZ0103, 01ZZ0403]; German Research Foundation (Deutsche Forschungsgemeinschaft (DFG)) [GR 1912/5-1]; BMBF [03Z1CN22]; Ministry for Education, Science and Culture of the Federal State of Mecklenburg-West Pomerania; Ministry of Labor, Equal Opportunities, and Social Affairs of the Federal State of Mecklenburg-West Pomerania; National Cancer Institute [CA047988, UM1CA182913]; Amgen;  [N01-HC-25195];  [75N92020D00001];  [HHSN268201500003I];  [N01-HC-95159];  [75N92020D00005];  [N01-HC-95160];  [75N92020D00002];  [N01-HC-95161];  [75N92020D00003];  [N01-HC-95162];  [75N92020D00006];  [N01-HC-95163];  [75N92020D00004];  [N01-HC-95164];  [75N92020D00007];  [N01-HC-95165];  [N01-HC95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC95169];  [UL1-TR-000040];  [UL1-TR-001079];  [UL1TR-001420]	National Heart, Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hjartavernd (Icelandic Heart Association); Althingi (Icelandic Parliament); Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services; NIH through the American Recovery and Reinvestment Act of 2009 (ARRA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Advancing Translational Sciences, CTSI grant; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Erasmus Medical Center, Rotterdam; Erasmus University, Rotterdam; Netherlands Organisation for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly; Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands Organisation of Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Genomics Initiative (NGI); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung (BMBF))(Federal Ministry of Education & Research (BMBF)); German Research Foundation (Deutsche Forschungsgemeinschaft (DFG))(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); Ministry for Education, Science and Culture of the Federal State of Mecklenburg-West Pomerania; Ministry of Labor, Equal Opportunities, and Social Affairs of the Federal State of Mecklenburg-West Pomerania; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Amgen(Amgen); ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	No funding sources had a role in the design of the study or the analysis or interpretation of the data. Infrastructure for the CHARGE Consortium is supported in part by the National Heart, Lung and Blood Institute (NHLBI) grant R01HL105756. JH, ACM and PSdeV were supported by NIH NHLBI R01HL141291. PSdV was additionally supported by American Heart Association grant number 18CDA34110116. The views expressed in this manuscript are those of the authors and do not necessarily represent the views of the NHLBI; the National Institutes of Health; or the U.S. Department of Health and Human Services. The Age, Gene, Environment, Susceptibility Study (AGES) study has been funded by NIH contracts N01-AG-1-2100 and HHSN271201200022C, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services (contract numbers HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700004I and HHSN268201700005I). Funding support for "Building on GWAS for NHLBI-diseases: the U.S. CHARGE consortium" was provided by the NIH through the American Recovery and Reinvestment Act of 2009 (ARRA) (5RC2HL102419). Cardiovascular Health Study (CHS) research was supported by NHLBI contracts HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086; and NHLBI grants U01HL080295, R01HL087652, R01HL105756, R01HL103612, R01HL120393, and U01HL130114 with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided through R01AG023629 from the National Institute on Aging (NIA). A full list of principal CHS investigators and institutions can be found at https://chsnhlbi.org/.The provision of genotyping data was supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR001881, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The Family Heart Study (FamHS) was supported by the grant R01-HL-117078 from the National Heart, Lung, and Blood Institute, and grant R01-DK089256 from the National Institute of Diabetes and Digestive and Kidney Diseases. The Framingham Heart Study (FHS) The National Heart, Lung and Blood Institute's Framingham Heart Study is supported by contract N01-HC-25195. GeneSTAR was supported by grants from the National Institutes of Health/National Heart, Lung and Blood Institute (HL49762, HL59684, HL071025, HL58625, U01 HL72518, HL089474, HL092165, HL099747, K23HL105897, K23HL094747, HL11006, and HL112064), National Institute of Nursing Research (NR0224103, NR008153), National Institute of Neurological Disorders and Stroke (NS062059), and by a grant from the National Center for Research Resources (M01RR000052) to the Johns Hopkins General Clinical Research Center. Genotyping services were provided through the RS&G Service by the Northwest Genomics Center at the University of Washington, Department of Genome Sciences, under U.S. Federal Government contract number HHSN268201100037C from the National Heart, Lung, and Blood Institute.; MESA and the MESA SHARe projects are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts 75N92020D00001, HHSN268201500003I, N01-HC-95159, 75N92020D00005, N01-HC-95160, 75N92020D00002, N01-HC-95161, 75N92020D00003, N01-HC-95162, 75N92020D00006, N01-HC-95163, 75N92020D00004, N01-HC-95164, 75N92020D00007, N01-HC-95165, N01-HC95166, N01-HC-95167, N01-HC-95168, N01-HC95169, UL1-TR-000040, UL1-TR-001079, UL1TR-001420. Also supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR001881, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center. For the Rotterdam Study, the work was supported by the Erasmus Medical Center and Erasmus University, Rotterdam; The Netherlands Organisation for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (014-93-015, RIDE2); the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); the Municipality of Rotterdam; The Netherlands Organisation of Scientific Research (NWO) (175.010.2005.011, 911-03-012); the Netherlands Genomics Initiative (NGI) (NWO 050-060-810), the Netherlands Organisation for Scientific Research (NWO) (veni 916.12.154). SHIP is supported by the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung (BMBF); grants 01ZZ9603, 01ZZ0103, and 01ZZ0403) and the German Research Foundation (Deutsche Forschungsgemeinschaft (DFG); grant GR 1912/5-1). The Study of Health in Pomerania (SHIP) and SHIP-TREND are part of the Community Medicine Research net (CMR) of the Ernst-Moritz-Arndt University Greifswald (EMAU) which is funded by the BMBF as well as the Ministry for Education, Science and Culture and the Ministry of Labor, Equal Opportunities, and Social Affairs of the Federal State of Mecklenburg-West Pomerania. The CMR encompasses several research projects that share data from SHIP. The EMAU is a member of the Center of Knowledge Interchange (CKI) program of the Siemens AG. SNP typing of SHIP and SHIP-TREND using the Illumina Infinium HumanExome BeadChip (version v1.0) was supported by the BMBF (grant 03Z1CN22). The Women's Genome Health Study (WGHS) is supported by the National Heart, Lung, and Blood Institute (HL043851, HL080467, HL099355) and the National Cancer Institute (CA047988 and UM1CA182913), with collaborative scientific support and funding for genotyping provided by Amgen. There was no additional external funding received for this study.	Anderson CD, 2011, CIRC-CARDIOVASC GENE, V4, P188, DOI 10.1161/CIRCGENETICS.110.957928; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], **DATA OBJECT**; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; Dahabreh IJ, 2011, JAMA-J AM MED ASSOC, V305, P822, DOI 10.1001/jama.2011.163; Dai XM, 2016, WORLD J CARDIOL, V8, P1, DOI 10.4330/wjc.v8.i1.1; Dehghan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144997; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Flannick J, 2019, NATURE, V570, P71, DOI 10.1038/s41586-019-1231-2; Folsom AR, 2008, METABOLISM, V57, P1591, DOI 10.1016/j.metabol.2008.06.016; Goldstein JI, 2012, BIOINFORMATICS, V28, P2543, DOI 10.1093/bioinformatics/bts479; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Guipponi M, 2008, HUM MUTAT, V29, P130, DOI 10.1002/humu.20617; Haiman CA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003419; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Klarin D, 2017, NAT GENET, V49, P1392, DOI 10.1038/ng.3914; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lin YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14762; Liu DJ, 2017, NAT GENET, V49, P1758, DOI 10.1038/ng.3977; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Lloyd-Jones DM, 2004, JAMA-J AM MED ASSOC, V291, P2204, DOI 10.1001/jama.291.18.2204; Mahmoud O, 2020, 928077 BIORXIV; MARENBERG ME, 1994, NEW ENGL J MED, V330, P1041, DOI 10.1056/NEJM199404143301503; Morrison AC, 2016, NEW ENGL J MED, V375, P2303, DOI 10.1056/NEJMc1607380; Murabito JM, 2005, JAMA-J AM MED ASSOC, V294, P3117, DOI 10.1001/jama.294.24.3117; Natarajan P, 2016, CIRC-CARDIOVASC GENE, V9, P511, DOI 10.1161/CIRCGENETICS.116.001572; Nelson CP, 2017, NAT GENET, V49, P1385, DOI 10.1038/ng.3913; Nikpay M, 2015, NAT GENET, V47, P1121, DOI 10.1038/ng.3396; O'Donnell CJ, 2011, NEW ENGL J MED, V365, P2098, DOI 10.1056/NEJMra1105239; Pratama A, 2013, IMMUNITY, V38, P669, DOI 10.1016/j.immuni.2013.01.011; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Stein EA, 2012, NEW ENGL J MED, V366, P1108, DOI 10.1056/NEJMoa1105803; Stitziel NO, 2016, NEW ENGL J MED, V374, P1134, DOI 10.1056/NEJMoa1507652; Swerdlow DI, 2012, BRIT MED BULL, V102, P59, DOI 10.1093/bmb/lds009; van der Harst P, 2018, CIRC RES, V122, P433, DOI [10.1161/CIRCRESAHA.117.312086, 10.1161/circresaha.117.312086]; Wakil SM, 2016, CLIN GENET, V90, P518, DOI 10.1111/cge.12761; Wakil SM, 2016, ATHEROSCLEROSIS, V245, P62, DOI 10.1016/j.atherosclerosis.2015.11.019; Warren HR, 2017, NAT GENET, V49, P403, DOI 10.1038/ng.3768; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Yu B, 2016, CIRC-CARDIOVASC GENE, V9, P64, DOI 10.1161/CIRCGENETICS.115.001215; Zhu J, 2014, FRONT GENET, V5, DOI [10.3389/fgene.2014.00149, 10.3389/fgene.2014.00187]	43	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0230035	10.1371/journal.pone.0230035	http://dx.doi.org/10.1371/journal.pone.0230035			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186364	Green Published, gold, Green Submitted			2022-12-26	WOS:000593949800011
J	Jacobs, PJ; Oosthuizen, MK; Mitchell, C; Blount, JD; Bennett, NC				Jacobs, Paul J.; Oosthuizen, M. K.; Mitchell, C.; Blount, Jonathan D.; Bennett, Nigel C.			Heat and dehydration induced oxidative damage and antioxidant defenses following incubator heat stress and a simulated heat wave in wild caught four-striped field mice Rhabdomys dilectus	PLOS ONE			English	Article							EXERCISE-INDUCED DEHYDRATION; LIPID-PEROXIDATION; CLIMATE-CHANGE; CIRCULATORY MARKERS; PROTEIN OXIDATION; RAT-TISSUES; CROSS-TALK; CELL; MITOCHONDRIAL; TEMPERATURE	Heat waves are known for their disastrous mass die-off effects due to dehydration and cell damage, but little is known about the non-lethal consequences of surviving severe heat exposure. Severe heat exposure can cause oxidative stress which can have negative consequences on animal cognition, reproduction and life expectancy. We investigated the current oxidative stress experienced by a mesic mouse species, the four striped field mouse, Rhabdomys dilectus through a heat wave simulation with ad lib water and a more severe temperature exposure with minimal water. Wild four striped field mice were caught between 2017 and 2019. We predicted that wild four striped field mice in the heat wave simulation would show less susceptibility to oxidative stress as compared to a more severe heat stress which is likely to occur in the future. Oxidative stress was determined in the liver, kidney and brain using malondialdehyde (MDA) and protein carbonyl (PC) as markers for oxidative damage, and superoxide dismutase (SOD) and total antioxidant capacity (TAC) as markers of antioxidant defense. Incubator heat stress was brought about by increasing the body temperatures of animals to 39-40.8 degrees C for 6 hours. A heat wave (one hot day, followed by a 3-day heatwave) was simulated by using temperature cycle that wild four striped field mice would experience in their local habitat (determined through weather station data using temperature and humidity), with maximal ambient temperature of 39 degrees C. The liver and kidney demonstrated no changes in the simulated heat wave, but the liver had significantly higher SOD activity and the kidney had significantly higher lipid peroxidation in the incubator experiment. Dehydration significantly contributed to the increase of these markers, as is evident from the decrease in body mass after the experiment. The brain only showed significantly higher lipid peroxidation following the simulated heat wave with no significant changes following the incubator experiment. The significant increase in lipid peroxidation was not correlated to body mass after the experiment. The magnitude and duration of heat stress, in conjunction with dehydration, played a critical role in the oxidative stress experienced by each tissue, with the results demonstrating the importance of measuring multiple tissues to determine the physiological state of an animal. Current heat waves in this species have the potential of causing oxidative stress in the brain with future heat waves to possibly stress the kidney and liver depending on the hydration state of animals.	[Jacobs, Paul J.; Oosthuizen, M. K.; Bennett, Nigel C.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Pretoria, South Africa; [Mitchell, C.; Blount, Jonathan D.] Univ Exeter, Ctr Ecol & Conservat, Coll Life & Environm Sci, Penryn, Cornwall, England	University of Pretoria; University of Exeter	Jacobs, PJ (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Pretoria, South Africa.	pauljuanjacobs@gmail.com	Oosthuizen, Maria Kathleen/K-7923-2012; Blount, Jonathan/K-7695-2012	Oosthuizen, Maria Kathleen/0000-0001-6305-8283; Blount, Jonathan/0000-0002-0016-0130; Jacobs, PJ/0000-0002-2601-5337	DST-NRF SARChI research chair for Mammal Behavioural Ecology and Physiology; University of Pretoria; University of Pretoria department of research and innovation international cooperation postgraduate exchange bursary	DST-NRF SARChI research chair for Mammal Behavioural Ecology and Physiology; University of Pretoria; University of Pretoria department of research and innovation international cooperation postgraduate exchange bursary	This research was supported by a DST-NRF SARChI research chair for Mammal Behavioural Ecology and Physiology to NCB and a University of Pretoria doctoral research bursary and a University of Pretoria department of research and innovation international cooperation postgraduate exchange bursary to PJJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2006, J CHEM RES-S, P426; Altan O, 2003, BRIT POULTRY SCI, V44, P545, DOI 10.1080/00071660310001618334; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; Aramburu J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.265pe20; Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Balat A, 2012, INT J NEPHROLOGY, P2012; Balcerczyk A, 2003, FREE RADICAL RES, V37, P537, DOI 10.1080/1071576031000083189; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293; Bloomer SA, 2014, ARCH GERONTOL GERIAT, V58, P145, DOI 10.1016/j.archger.2013.07.012; Bozinovic F, 2000, J THERM BIOL, V25, P251, DOI 10.1016/S0306-4565(99)00031-5; Brocker Chad, 2012, Biomol Concepts, V3, P345; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chang CK, 2007, PROG BRAIN RES, V162, P525, DOI 10.1016/S0079-6123(06)62025-6; Chen SH, 2013, CURR NEUROPHARMACOL, V11, P129, DOI 10.2174/1570159X11311020001; Cheuvront SN, 2001, SPORTS MED, V31, P743, DOI 10.2165/00007256-200131100-00004; Conradie SR, 2019, P NATL ACAD SCI USA, V116, P14065, DOI 10.1073/pnas.1821312116; Dalle-Donne I, 2003, CLIN CHIM ACTA, V329, P23, DOI 10.1016/S0009-8981(03)00003-2; Das A, 2011, TOXICOL MECH METHOD, V21, P393, DOI 10.3109/15376516.2010.550016; Donald J., 2015, SODIUM WATER HOMEOST, P191; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Du Toit N, 2019, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2019-1.RLTS.T112168645A140971990.en, DOI 10.2305/IUCN.UK.2019-1.RLTS.T112168645A140971990.EN]; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Erel O, 2004, CLIN BIOCHEM, V37, P112, DOI 10.1016/j.clinbiochem.2003.10.014; FLANAGAN SW, 1995, AM J PHYSIOL-REG I, V268, pR28, DOI 10.1152/ajpregu.1995.268.1.R28; FOLK GE, 1991, INT J BIOMETEOROL, V35, P180, DOI 10.1007/BF01049065; Forster MJ, 1996, P NATL ACAD SCI USA, V93, P4765, DOI 10.1073/pnas.93.10.4765; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; Gardner JL, 2011, TRENDS ECOL EVOL, V26, P285, DOI 10.1016/j.tree.2011.03.005; Georgescu VP, 2017, APPL PHYSIOL NUTR ME, V42, P694, DOI 10.1139/apnm-2016-0701; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Habashy WS, 2019, INT J BIOMETEOROL, V63, P1569, DOI 10.1007/s00484-019-01769-z; HAIM A, 1980, S AFR J ZOOL, V15, P91; HAINSWOR.FR, 1968, AM J PHYSIOL, V214, P983, DOI 10.1152/ajplegacy.1968.214.5.983; HAINSWORTH FR, 1967, AM J PHYSIOL, V212, P1288, DOI 10.1152/ajplegacy.1967.212.6.1288; HALLIWELL B, 1993, AM J CLIN NUTR, V57, P715; Halliwell B, 1989, FREE RADICAL BIOL ME; Halliwell B., 2007, BIOCH OXIDATIVE STRE; Hammond KA, 2001, J EXP BIOL, V204, P1991; Hillman AR, 2011, APPL PHYSIOL NUTR ME, V36, P698, DOI [10.1139/H11-080, 10.1139/h11-080]; Hsu SF, 2006, SHOCK, V26, P210, DOI 10.1097/01.shk.0000223124.49265.10; HUBBARD RW, 1977, J APPL PHYSIOL, V42, P809, DOI 10.1152/jappl.1977.42.6.809; Hulbert AJ, 2006, J COMP PHYSIOL B, V176, P93, DOI 10.1007/s00360-005-0025-z; Jacobs PJ, 2020, J THERM BIOL, V87, DOI 10.1016/j.jtherbio.2019.102479; Johnson RJ, 2019, ANN NUTR METAB, V74, P38, DOI 10.1159/000500344; Kalmar B, 2009, ADV DRUG DELIVER REV, V61, P310, DOI 10.1016/j.addr.2009.02.003; Katalinic V, 2005, COMP BIOCHEM PHYS C, V140, P47, DOI 10.1016/j.cca.2005.01.005; Kenefick RW, 2016, AUTON NEUROSCI-BASIC, V196, P47, DOI 10.1016/j.autneu.2016.02.003; Kultz D, 2004, P NATL ACAD SCI USA, V101, P9177, DOI 10.1073/pnas.0403241101; Laitano O, 2010, EUR J APPL PHYSIOL, V110, P953, DOI 10.1007/s00421-010-1577-5; LeDoux SP, 1999, MUTAT RES-DNA REPAIR, V434, P149, DOI 10.1016/S0921-8777(99)00026-9; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; Li H, 2015, FREE RADICAL BIO MED, V87, P356, DOI 10.1016/j.freeradbiomed.2015.06.009; Lin H, 2000, ASIAN AUSTRAL J ANIM, V13, P1373, DOI 10.5713/ajas.2000.1373; Hai L, 2006, COMP BIOCHEM PHYS A, V144, P11, DOI 10.1016/j.cbpa.2006.01.032; Liu JK, 2000, J APPL PHYSIOL, V89, P21; Lochhead JJ, 2010, J CEREBR BLOOD F MET, V30, P1625, DOI 10.1038/jcbfm.2010.29; Lovegrove BG, 2014, PHYSIOL BIOCHEM ZOOL, V87, P30, DOI 10.1086/673313; LOVIS C, 1994, RENAL FAILURE, V16, P179, DOI 10.3109/08860229409044859; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; Maclean I., 2018, ECCB2018 5 EUR C CON; Malik AI, 2011, GENE, V485, P114, DOI 10.1016/j.gene.2011.06.014; McKechnie AE, 2019, PHYSIOLOGY, V34, P302, DOI 10.1152/physiol.00011.2019; McKechnie AE, 2010, BIOL LETTERS, V6, P253, DOI 10.1098/rsbl.2009.0702; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Miller AA, 2007, CLIN EXP PHARMACOL P, V34, P1037, DOI 10.1111/j.1440-1681.2007.04732.x; Mitchell D, 2018, J ANIM ECOL, V87, P956, DOI 10.1111/1365-2656.12818; MIZZEN LA, 1988, J CELL BIOL, V106, P1105, DOI 10.1083/jcb.106.4.1105; Murray IW, 2012, CAN J ZOOL, V90, P1171, DOI 10.1139/Z2012-084; Naito Y., 2010, ANTIAGING MED, V7, P36, DOI [10.3793/jaam.7.36, DOI 10.3793/jaam.7.36]; Navari-Izzo F, 1996, SUPEROXIDE GENERATIO, DOI [10.1042/bst0240447, DOI 10.1042/BST0240447]; Nussey DH, 2009, FUNCT ECOL, V23, P809, DOI 10.1111/j.1365-2435.2009.01555.x; Oliveira MF, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00945; Optimal therapy report, 2009, CAN AGENCY DRUGS TEC, V3, pe0101; Ostberg JR, 2002, INT J HYPERTHER, V18, P552, DOI 10.1080/02656730210166168; Ozbek E, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/465897; Ozturk O, 2004, LIFE SCI, V75, P1551, DOI 10.1016/j.lfs.2004.03.020; Paul C, 2009, BIOL REPROD, V80, P913, DOI 10.1095/biolreprod.108.071779; Poumadere M, 2005, RISK ANAL, V25, P1483, DOI 10.1111/j.1539-6924.2005.00694.x; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Robinson PJ, 2001, J APPL METEOROL, V40, P762, DOI 10.1175/1520-0450(2001)040<0762:OTDOAH>2.0.CO;2; Rodriguez-Estival J, 2016, ECOL INDIC, V62, P66, DOI 10.1016/j.ecolind.2015.11.019; Rosas-Rodriguez JA, 2010, LIFE SCI, V87, P515, DOI 10.1016/j.lfs.2010.08.003; RUBBO H, 1994, J BIOL CHEM, V269, P26066; Rymer TL, 2013, SUSTAINABILITY-BASEL, V5, P163, DOI 10.3390/su5010163; Sahin E, 2007, COMP BIOCHEM PHYS C, V144, P342, DOI 10.1016/j.cbpc.2006.10.009; Sassi PL, 2015, MAMM BIOL, V80, P81, DOI 10.1016/j.mambio.2014.12.005; Saunders Denis A., 2011, Pacific Conservation Biology, V17, P141; Scheffers BR, 2014, GLOBAL CHANGE BIOL, V20, P495, DOI 10.1111/gcb.12439; Schliess F, 2002, BIOL CHEM, V383, P577, DOI 10.1515/BC.2002.059; Schmidt CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103286; SCHMIDTNIELSEN K, 1948, AM J PHYSIOL, V154, P163, DOI 10.1152/ajplegacy.1948.154.1.163; SEGAR WE, 1966, AM J DIS CHILD, V112, P318, DOI 10.1001/archpedi.1966.02090130092008; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; Sharma HS, 2005, INDIAN J MED RES, V121, P621; Sies H, 2015, REDOX BIOL, V4, P180, DOI 10.1016/j.redox.2015.01.002; Skibba JL, 1997, INT J HYPERTHER, V13, P215, DOI 10.3109/02656739709012384; Slimen IB, 2014, INT J HYPERTHER, V30, P513, DOI 10.3109/02656736.2014.971446; Souch C, 2004, PROG PHYS GEOG, V28, P599, DOI 10.1191/0309133304pp428pr; SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9; Sreedhar AS, 2002, FREE RADICAL BIO MED, V32, P221, DOI 10.1016/S0891-5849(01)00796-1; Stadtman ER, 2000, ANN NY ACAD SCI, V899, P191; Stahlschmidt ZR, 2017, PHYSIOL BIOCHEM ZOOL, V90, P434, DOI 10.1086/691315; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tiidus PM, 2000, CAN J APPL PHYSIOL, V25, P274, DOI 10.1139/h00-022; Tvrda E, 2011, ACTA VET HUNG, V59, P465, DOI 10.1556/AVet.2011.034; Ullah A, 2016, SAUDI PHARM J, V24, P547, DOI 10.1016/j.jsps.2015.03.013; Vasseur DA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2612; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Wang ZM, 2001, J NUTR, V131, P2967, DOI 10.1093/jn/131.11.2967; Withers P.C., 2016, ECOLOGICAL ENV PHYSL; Yang CY, 2002, STROKE, V33, P790, DOI 10.1161/hs0102.100208; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139; Zhang HJ, 2004, FASEB J, V18, P1547, DOI 10.1096/fj.04-1629fje; Zhang Z, 2003, AM J PHYSIOL-RENAL, V285, pF688, DOI 10.1152/ajprenal.00028.2003; Zub K, 2009, P ROY SOC LOND B BIO	120	12	13	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242279	10.1371/journal.pone.0242279	http://dx.doi.org/10.1371/journal.pone.0242279			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186409	gold, Green Published			2022-12-26	WOS:000593949800042
J	Pedraza, F; Garcia-Meza, D; Tovar, H; Martorell, C				Pedraza, Fernando; Garcia-Meza, Diego; Tovar, Hugo; Martorell, Carlos			Tussocks facilitate their neighbours mainly by ameliorating extreme temperatures in tropical high mountains	PLOS ONE			English	Article							UV-B; POSITIVE INTERACTIONS; PLANT INTERACTIONS; ALPINE; STRESS; GRADIENT; TERRESTRIAL; COMPETITION; TOLERANCE; RADIATION	Facilitation by tussocks is common in high-altitude tropical environments. It is thought that facilitation results from stress amelioration, but it is unclear which of the many stressors acting in these environments is ameliorated. We aimed at determining the relative importance of different stressors as drivers of facilitation by the tussock Festuca tolucensis in Mexico. We employed eight experimental treatments to manipulate five stressors in the field: minimum temperatures by using electric radiators that kept plants warm; maximum temperatures by means of reflective sand that precluded temperature build-up during the day; UV radiation by using screens opaque to UV; poor soil properties by comparing soils from beneath tussocks and from bare ground; and low water availability by adding vermiculite to the soil. The performance (survival and growth) of Mexerion sarmentosum (a plant usually associated with Festuca) in these treatments was compared to that recorded under tussocks and in bare ground. Amelioration of extreme temperatures had the largest positive effects on Mexerion survival. UV radiation and increased soil humidity did not affect survival, although humidity increased growth rates. Nevertheless, tussocks reduced the growth of Mexerion, which is consistent with observations of competition between plants and soil microorganisms favoured by tussocks. Our results highlight the importance of the extreme daily fluctuations in temperature that characterise tropical mountains as fundamental drivers of their dynamics.	[Pedraza, Fernando; Garcia-Meza, Diego; Martorell, Carlos] Univ Nacl Autonoma Mexico, Dept Ecol Recursos & Nat, Fac Ciencias, Mexico City, DF, Mexico; [Tovar, Hugo] Inst Nacl Med Genom, Unidad Serv Bioinformat, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica	Martorell, C (corresponding author), Univ Nacl Autonoma Mexico, Dept Ecol Recursos & Nat, Fac Ciencias, Mexico City, DF, Mexico.	martorell@ciencias.unam.mx	Tovar, Hugo/AAD-8274-2021	Tovar, Hugo/0000-0002-8360-6133; Garcia-Meza, Diego/0000-0003-1959-0074	Programa de Apoyos a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico [IN217607, IN212618]	Programa de Apoyos a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico	This work received support from Programa de Apoyos a Proyectos de Investigacion e Innovacion Tecnologica-Universidad Nacional Autonoma de Mexico (https://dgapa.unam.mx/index.php/impulso-a-la-investigacion/papiit) in the form of grants (IN217607 and IN212618) awarded to CM.	[Anonymous], 1999, KOREAN J DEF ANAL, V11, P135; Anthelme F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00387; Anthelme F, 2012, PERSPECT PLANT ECOL, V14, P363, DOI 10.1016/j.ppees.2012.05.002; Anthelme F, 2012, J VEG SCI, V23, P62, DOI 10.1111/j.1654-1103.2011.01333.x; Bates D, 2014, ARXIV14065823; BILLINGS W D, 1974, Arctic and Alpine Research, V6, P129, DOI 10.2307/1550081; CALDWELL MM, 1980, ECOLOGY, V61, P600, DOI 10.2307/1937426; Callaway RM, 1998, OIKOS, V82, P202, DOI 10.2307/3546931; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Catorci A, 2011, ALPINE BOT, V121, P113, DOI 10.1007/s00035-011-0097-1; CHAPIN FS, 1979, J ECOL, V67, P169; Choler P, 2001, ECOLOGY, V82, P3295, DOI 10.1890/0012-9658(2001)082[3295:FACOGI]2.0.CO;2; Coe M. J., 1969, Zoologica Africana, V4, P101; Crawley M.J., 2007, R BOOK; DAY R J, 1971, Canadian Journal of Forest Research, V1, P151, DOI 10.1139/x71-020; Day TA, 2002, ANNU REV ECOL SYST, V33, P371, DOI 10.1146/annurev.ecolsys.33.010802.150434; Diemer M, 1996, J VEG SCI, V7, P821, DOI 10.2307/3236460; Dunn RM, 2006, PLANT SOIL, V289, P321, DOI 10.1007/s11104-006-9142-z; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; HEDBERG I, 1979, OIKOS, V33, P297, DOI 10.2307/3544006; Hedberg O, 1964, ACTA PHYTOGEOGRAPHIC, V49, P297; Heiskanen J, 1999, SCAND J FOREST RES, V14, P78, DOI 10.1080/02827589908540810; Hupp N, 2017, J VEG SCI, V28, P928, DOI 10.1111/jvs.12553; Korner C., 2003, ALPINE PLANT LIFE FU, V2nd ed.; Liancourt P, 2005, ECOLOGY, V86, P1611, DOI 10.1890/04-1398; Libardi P. L., 1983, Isotope and radiation techniques in soil physics and irrigation studies 1983., P301; Luteyn James L., 1999, Memoirs of the New York Botanical Garden, V84, P1; Maestre FT, 2004, P ROY SOC B-BIOL SCI, V271, pS331, DOI 10.1098/rsbl.2004.0181; Malatesta L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167265; Margesin R, 2009, FEMS MICROBIOL ECOL, V67, P208, DOI 10.1111/j.1574-6941.2008.00620.x; Miguel JD, 2013, COBERTURA VEGETAL MA; Mizuno K, 1998, ARCTIC ALPINE RES, V30, P340, DOI 10.2307/1552006; Monteiro JAF, 2011, FLORA, V206, P387, DOI 10.1016/j.flora.2011.01.001; Moro MJ, 1997, FUNCT ECOL, V11, P425, DOI 10.1046/j.1365-2435.1997.00106.x; Nunez CI, 1999, J VEG SCI, V10, P357, DOI 10.2307/3237064; Okada K, 2008, CERAM INT, V34, P345, DOI 10.1016/j.ceramint.2006.10.006; Patty L, 2010, FLORA, V205, P695, DOI 10.1016/j.flora.2009.12.039; Pearce RS, 2001, ANN BOT-LONDON, V87, P417, DOI 10.1006/anbo.2000.1352; Prado F.E, 2012, ENV ADAPTATIONS STRE, P57, DOI DOI 10.1007/978-1-4614-0815-4; Pugnaire FI, 2001, OIKOS, V93, P42, DOI 10.1034/j.1600-0706.2001.930104.x; R Core Team, 2021, R LANGUAGE ENV STAT; Robson TM, 2005, SOIL BIOL BIOCHEM, V37, P2205, DOI 10.1016/j.soilbio.2005.04.002; Robson TM, 2003, NEW PHYTOL, V160, P379, DOI 10.1046/j.1469-8137.2003.00898.x; Rozema J, 1997, TRENDS ECOL EVOL, V12, P22, DOI 10.1016/S0169-5347(96)10062-8; Rundel PW, 1994, TROPICAL ALPINE ENV; Salvucci ME, 2004, PHYSIOL PLANTARUM, V120, P179, DOI 10.1111/j.0031-9317.2004.0173.x; Sarmiento G, 1986, HIGH ALTITUDE TROPIC, P9; Schmidt IK, 1997, OECOLOGIA, V112, P557, DOI 10.1007/s004420050345; Schrader W.L., 2000, USING TRANSPLANTS VE; Selwyn MR, 1996, PRINCIPLES EXPT DESI; SMITH AP, 1987, ANNU REV ECOL SYST, V18, P137, DOI 10.1146/annurev.es.18.110187.001033; Therneau T. M., 2013, MODELING SURVIVAL DA, DOI 10.1007/978-1-4757-3294-8; Tovar-Romero HA, 2010, THESIS; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wood S., 2014, GAMM4 GEN ADDITIVE M	57	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242313	10.1371/journal.pone.0242313	http://dx.doi.org/10.1371/journal.pone.0242313			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186374	Green Published, gold			2022-12-26	WOS:000593949800041
J	Qiang, J; He, J; Tao, YF; Bao, JW; Zhu, JH; Xu, P				Qiang, Jun; He, Jie; Tao, Yi-Fan; Bao, Jin-Wen; Zhu, Jun-Hao; Xu, Pao			Hypoxia-induced miR-92a regulates p53 signaling pathway and apoptosis by targeting calcium-sensing receptor in genetically improved farmed tilapia (Oreochromis niloticus)	PLOS ONE			English	Article							CELL-DEATH; EXPRESSION; RESPONSES; GIFT; INDUCTION; MICRORNAS; TP53INP1; ALPHA	miR-92a miRNAs are immune molecules that regulate apoptosis (programmed cell death) during the immune response. Apoptosis helps to maintain the dynamic balance in tissues of fish under hypoxia stress. The aim of this study was to explore the role and potential mechanisms of miR-92a in the liver of tilapia under hypoxia stress. We first confirmed that CaSR (encoding a calcium-sensing receptor) is a target gene of miR-92a in genetically improved farmed tilapia (GIFT) using luciferase reporter gene assays. In GIFT under hypoxia stress, miR-92a was up-regulated and CaSR was down-regulated in a time-dependent manner. Knocked-down CaSR expression led to inhibited expression of p53, TP53INP1, and caspase-3/8, reduced the proportion of apoptotic hepatocytes, and decreased the activity of calcium ions induced by hypoxia in hepatocytes. GIFT injected in the tail vein with an miR-92a agomir showed up-regulation of miR-92a and down-regulation of CaSR, p53, TP53INP1, and caspase-3/8 genes in the liver, resulting in lower serum aspartate aminotransferase and alanine aminotransferase activities under hypoxia stress. These findings suggest that stimulation of miR-92a interferes with hypoxia-induced apoptosis in hepatocytes of GIFT by targeting CaSR, thereby alleviating liver damage. These results provide new insights into the adaptation mechanisms of GIFT to hypoxia stress.	[Qiang, Jun; He, Jie; Tao, Yi-Fan; Bao, Jin-Wen; Zhu, Jun-Hao; Xu, Pao] Chinese Acad Fishery Sci, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Freshwater Fisheries Res Ctr, Wuxi, Jiangsu, Peoples R China	Chinese Academy of Fishery Sciences; Freshwater Fisheries Research Center, CAFS; Ministry of Agriculture & Rural Affairs	Qiang, J; Xu, P (corresponding author), Chinese Acad Fishery Sci, Key Lab Freshwater Fisheries & Germplasm Resource, Minist Agr, Freshwater Fisheries Res Ctr, Wuxi, Jiangsu, Peoples R China.	qiangjunn@163.com; Xup@ffrc.cn			Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences [2018HY-XKQ02-01, 2019ZY19, 2019JBFC01]	Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences	This work was supported by the Central Public-interest Scientific Institution Basal Research Fund, Chinese Academy of Fishery Sciences (NO. 2018HY-XKQ02-01; 2019ZY19; 2019JBFC01). As the funder of the project, Jun Qiang plays an important role in the study design and preparation of the manuscript.	Hernandez-Bedolla MA, 2016, MOL CELL ENDOCRINOL, V436, P159, DOI 10.1016/j.mce.2016.07.038; Bao JW, 2018, J THERM BIOL, V73, P91, DOI 10.1016/j.jtherbio.2018.02.007; Chen BX, 2017, GENE, V624, P6, DOI 10.1016/j.gene.2017.04.023; Chen H, 2016, FISH SHELLFISH IMMUN, V55, P577, DOI 10.1016/j.fsi.2016.06.036; Diaz-Soto G, 2016, INT REV CEL MOL BIO, V327, P321, DOI 10.1016/bs.ircmb.2016.05.004; Felix-Portillo M, 2016, CHEMOSPHERE, V161, P454, DOI 10.1016/j.chemosphere.2016.07.041; Gao D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083423; Hendy GN, 2016, SEMIN CELL DEV BIOL, V49, P37, DOI 10.1016/j.semcdb.2015.11.006; Hou ZS, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135272; Jun Q, 2015, AQUAC RES, V46, P335, DOI 10.1111/are.12189; Klein GL, 2016, SEMIN CELL DEV BIOL, V49, P52, DOI 10.1016/j.semcdb.2015.08.006; Lai KP, 2020, AQUAT TOXICOL, V224, DOI 10.1016/j.aquatox.2020.105520; Liu ZH, 2005, CANCER RES, V65, P1647, DOI 10.1158/0008-5472.CAN-04-1754; Ma JD, 2018, GENE, V675, P36, DOI 10.1016/j.gene.2018.06.087; Monteiro SM, 2009, AQUAT TOXICOL, V94, P219, DOI 10.1016/j.aquatox.2009.07.008; Nunez-Hernandez DM, 2018, CHEMOSPHERE, V190, P253, DOI 10.1016/j.chemosphere.2017.09.131; Ondricek K, 2018, COMP BIOCHEM PHYS A, V224, P84, DOI 10.1016/j.cbpa.2018.07.002; Perry SF, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P1751; Qiang J, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00670; Qiang J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01422; Qiang J, 2017, FISH SHELLFISH IMMUN, V63, P367, DOI 10.1016/j.fsi.2017.02.036; Qiang J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3591-z; Qiang J, 2017, AQUAT TOXICOL, V182, P39, DOI 10.1016/j.aquatox.2016.11.009; Sheng Y, 2019, J APPL ICHTHYOL, V35, P978, DOI 10.1111/jai.13930; Shimizu S, 1996, CANCER RES, V56, P2161; Sun JL, 2020, FISH SHELLFISH IMMUN, V98, P923, DOI 10.1016/j.fsi.2019.11.056; Sun SM, 2016, FISH SHELLFISH IMMUN, V54, P68, DOI 10.1016/j.fsi.2016.03.167; Tomasini R, 2005, ONCOGENE, V24, P8093, DOI 10.1038/sj.onc.1208951; Vezzoli G, 2019, UROLITHIASIS, V47, P23, DOI 10.1007/s00240-018-1096-0; Wang Y, 2016, BIOTECHNOL LETT, V38, P1699, DOI 10.1007/s10529-016-2159-3; Yang MR, 2017, NEUROTOXICOL TERATOL, V60, P59, DOI 10.1016/j.ntt.2016.11.004; Yang RR, 2013, J IMMUNOL, V190, P1491, DOI 10.4049/jimmunol.1200801; Yu SJ, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3930-0; Zhang PJ, 2014, FISH SHELLFISH IMMUN, V38, P383, DOI 10.1016/j.fsi.2014.04.007; Zhao LL, 2020, AQUAT TOXICOL, V224, DOI 10.1016/j.aquatox.2020.105514; Zheng JY, 2019, LIFE SCI, V219, P129, DOI 10.1016/j.lfs.2019.01.014	36	3	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0238897	10.1371/journal.pone.0238897	http://dx.doi.org/10.1371/journal.pone.0238897			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180826	gold, Green Submitted, Green Published			2022-12-26	WOS:000593948000092
J	Sajulga, R; Easterly, C; Riffle, M; Mesuere, B; Muth, T; Mehta, S; Kumar, P; Johnson, J; Gruening, BA; Schiebenhoefer, H; Kolmeder, CA; Fuchs, S; Nunn, BL; Rudney, J; Griffin, TJ; Jagtap, PD				Sajulga, Ray; Easterly, Caleb; Riffle, Michael; Mesuere, Bart; Muth, Thilo; Mehta, Subina; Kumar, Praveen; Johnson, James; Gruening, Bjoern Andreas; Schiebenhoefer, Henning; Kolmeder, Carolin A.; Fuchs, Stephan; Nunn, Brook L.; Rudney, Joel; Griffin, Timothy J.; Jagtap, Pratik D.			Survey of metaproteomics software tools for functional microbiome analysis	PLOS ONE			English	Article								To gain a thorough appreciation of microbiome dynamics, researchers characterize the functional relevance of expressed microbial genes or proteins. This can be accomplished through metaproteomics, which characterizes the protein expression of microbiomes. Several software tools exist for analyzing microbiomes at the functional level by measuring their combined proteome-level response to environmental perturbations. In this survey, we explore the performance of six available tools, to enable researchers to make informed decisions regarding software choice based on their research goals. Tandem mass spectrometry-based proteomic data obtained from dental caries plaque samples grown with and without sucrose in paired biofilm reactors were used as representative data for this evaluation. Microbial peptides from one sample pair were identified by the X! tandem search algorithm via SearchGUI and subjected to functional analysis using software tools including eggNOG-mapper, MEGAN5, MetaGOmics, MetaProteomeAnalyzer (MPA), ProPHAnE, and Unipept to generate functional annotation through Gene Ontology (GO) terms. Among these software tools, notable differences in functional annotation were detected after comparing differentially expressed protein functional groups. Based on the generated GO terms of these tools we performed a peptide-level comparison to evaluate the quality of their functional annotations. A BLAST analysis against the NCBI non-redundant database revealed that the sensitivity and specificity of functional annotation varied between tools. For example, eggNOG-mapper mapped to the most number of GO terms, while Unipept generated more accurate GO terms. Based on our evaluation, metaproteomics researchers can choose the software according to their analytical needs and developers can use the resulting feedback to further optimize their algorithms. To make more of these tools accessible via scalable metaproteomics workflows, eggNOG-mapper and Unipept 4.0 were incorporated into the Galaxy platform.	[Sajulga, Ray; Easterly, Caleb; Mehta, Subina; Kumar, Praveen; Johnson, James; Rudney, Joel; Griffin, Timothy J.; Jagtap, Pratik D.] Univ Minnesota, Minneapolis, MN 55455 USA; [Riffle, Michael; Nunn, Brook L.] Univ Washington, Seattle, WA 98195 USA; [Mesuere, Bart] Univ Ghent, Ghent, Belgium; [Muth, Thilo] Fed Inst Mat Res & Testing, Berlin, Germany; [Gruening, Bjoern Andreas] Univ Freiburg, Freiburg, Germany; [Schiebenhoefer, Henning] Robert Koch Inst, Berlin, Germany; [Kolmeder, Carolin A.] Univ Helsinki, Helsinki, Finland; [Fuchs, Stephan] Robert Koch Inst, Wernigerode, Germany	University of Minnesota System; University of Minnesota Twin Cities; University of Washington; University of Washington Seattle; Ghent University; Federal Institute for Materials Research & Testing; University of Freiburg; Robert Koch Institute; University of Helsinki; Robert Koch Institute	Jagtap, PD (corresponding author), Univ Minnesota, Minneapolis, MN 55455 USA.	pjagtap@umn.edu	Easterly, Caleb/GLU-4404-2022; Mehta, Subina/ABB-5907-2020; Kumar, Praveen/ABA-3217-2021	Mehta, Subina/0000-0001-9818-0537; Kumar, Praveen/0000-0002-7818-671X; Gruning, Bjorn/0000-0002-3079-6586; Johnson, James/0000-0002-2590-4765; Schiebenhoefer, Henning/0000-0002-4471-9709; Jagtap, Pratik/0000-0003-0984-0973; Riffle, Michael/0000-0003-1633-8607; Griffin, Timothy/0000-0001-6801-2559; Mesuere, Bart/0000-0003-0610-3441; Muth, Thilo/0000-0001-8304-2684; Easterly, Caleb/0000-0001-7853-377X	National Cancer Institute Informatics Technology for Cancer Research (NCIITCR) [1U24CA199347]; National Science Foundation (U.S.) [1458524]; Extreme Science and Engineering Discovery Environment (XSEDE) [BIO170096]; Collaborative Research Centre 992 Medical Epigenetics (DFG) [SFB 992/1 2012]; German Federal Ministry of Education and Research (BMBF) [031 A538A/A538C RBC, 031L0101B/031L0101C de.NBI-epi, 031L0106 de. STAIR]	National Cancer Institute Informatics Technology for Cancer Research (NCIITCR); National Science Foundation (U.S.)(National Science Foundation (NSF)); Extreme Science and Engineering Discovery Environment (XSEDE); Collaborative Research Centre 992 Medical Epigenetics (DFG); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	T.G. National Cancer Institute Informatics Technology for Cancer Research (NCIITCR) grant 1U24CA199347 and National Science Foundation (U.S.) grant 1458524 P.D.J: Extreme Science and Engineering Discovery Environment (XSEDE) research allocation BIO170096 B.G: Collaborative Research Centre 992 Medical Epigenetics (DFG grant SFB 992/1 2012) and German Federal Ministry of Education and Research (BMBF grants 031 A538A/A538C RBC, 031L0101B/031L0101C de.NBI-epi, 031L0106 de. STAIR (de.NBI)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; [Anonymous], 2017, DZIENNIK USTAW RZECZ, V6, P2; [Anonymous], 2016, NUCLEIC ACIDS RES, V44, pD7; [Anonymous], 2017, CANCER RES, V77, pe108; Boekel J, 2015, NAT BIOTECHNOL, V33, P137, DOI 10.1038/nbt.3134; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Easterly CW, 2019, MOL CELL PROTEOMICS, V18, pS82, DOI 10.1074/mcp.RA118.001240; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; Gurdeep Singh R, 2019, J PROTEOME RES, V18, P606, DOI 10.1021/acs.jproteome.8b00716; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Heintz-Buschart A, 2018, TRENDS MICROBIOL, V26, P563, DOI 10.1016/j.tim.2017.11.002; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Huson DH, 2013, METHOD ENZYMOL, V531, P465, DOI 10.1016/B978-0-12-407863-5.00021-6; Hutchins DA, 2019, NAT REV MICROBIOL, V17, P391, DOI 10.1038/s41579-019-0178-5; Kleiner M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01544-x; Kumar P, 2020, J PROTEOME RES, V19, P2772, DOI 10.1021/acs.jproteome.0c00260; Kunath BJ, 2019, ADV EXP MED BIOL, V1073, P187, DOI 10.1007/978-3-030-12298-0_8; McIlwain S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-308; Mehta S, 67 ANN C AM SOC MASS; Mesuere B, 2015, PROTEOMICS, V15, P1437, DOI 10.1002/pmic.201400361; Muth T, 2018, ANAL CHEM, V90, P685, DOI 10.1021/acs.analchem.7b03544; Nishida O, 2018, J INTENSIVE CARE, V6, DOI 10.1186/s40560-017-0270-8; Rudney JD, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0136-z; Schiebenhoefer H, 2019, EXPERT REV PROTEOMIC, V16, P375, DOI 10.1080/14789450.2019.1609944; Schneider T, 2011, PROTEOMICS, V11, P2752, DOI 10.1002/pmic.201000679; Searle BC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07454-w; Washburne AD, 2018, NAT MICROBIOL, V3, P652, DOI 10.1038/s41564-018-0156-0; Zhang X, 2019, J PROTEOME RES, V18, P2370, DOI 10.1021/acs.jproteome.9b00054; 2002, PREZB, V30, P42	30	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241503	10.1371/journal.pone.0241503	http://dx.doi.org/10.1371/journal.pone.0241503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170893	Green Published, Green Submitted, gold			2022-12-26	WOS:000592383400038
J	Taku, O; Meiring, TL; Gustavsson, I; Phohlo, K; Garcia-Jardon, M; Mbulawa, ZZA; Businge, CB; Gyllensten, U; Williamson, AL				Taku, Ongeziwe; Meiring, Tracy L.; Gustavsson, Inger; Phohlo, Keletso; Garcia-Jardon, Mirta; Mbulawa, Zizipho Z. A.; Businge, Charles B.; Gyllensten, Ulf; Williamson, Anna-Lise			Acceptability of self- collection for human papillomavirus detection in the Eastern Cape, South Africa	PLOS ONE			English	Article							CERVICAL-CANCER; FTA CARTRIDGE; CLINICIAN; CYTOLOGY; SAMPLES; WOMEN	Human papillomavirus (HPV) testing on vaginal self-collected and cervical clinician-collected specimens shows comparable performance. Self-sampling on FTA cards is suitable for women residing in rural settings or not attending regular screening and increases participation rate in the cervical cancer screening programme. We aimed to investigate and compare high-risk (HR)-HPV prevalence in clinician-collected and self-collected genital specimens as well as two different HPV tests on the clinician collected samples. A total of 737 women were recruited from two sites, a community health clinic (n = 413) and a referral clinic (n = 324) in the Eastern Cape Province. Cervical clinician-collected (FTA cards and Digene transport medium) and vaginal self-collected specimens were tested for HR-HPV using the hpVIR assay (FTA cards) and Hybrid Capture-2 (Digene transport medium). There was no significant difference in HR-HPV positivity between clinician-collected and self-collected specimens among women from the community-based clinic (26.4% vs 27.9%, p = 0.601) or the referral clinic (83.6% vs 79.9%, p = 0.222). HPV16, HPV35, and HPV33/52/58 group were the most frequently detected genotypes at both study sites. Self-sampling for HPV testing received a high positive response of acceptance (77.2% in the community-based clinic and 83.0% in referral clinic). The overall agreement between hpVIR assay and HC-2 was 87.7% (k = 0.754). The study found good agreement between clinician-collected and self-collected genital specimens. Self-collection can have a positive impact on a cervical screening program in South Africa by increasing coverage of women in rural areas, in particular those unable to visit the clinics and women attending clinics where cytology-based programs are not functioning effectively.	[Taku, Ongeziwe; Meiring, Tracy L.; Phohlo, Keletso; Mbulawa, Zizipho Z. A.; Williamson, Anna-Lise] Univ Cape Town, Fac Hlth Sci, Dept Pathol, Div Med Virol, Cape Town, South Africa; [Taku, Ongeziwe; Meiring, Tracy L.; Phohlo, Keletso; Williamson, Anna-Lise] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Gustavsson, Inger; Gyllensten, Ulf] Uppsala Univ, Biomed Ctr, Dept Immunol Genet & Pathol, Sci Life Lab Uppsala, Uppsala, Sweden; [Garcia-Jardon, Mirta] Walter Sisulu Univ, Dept Pathol, Mthatha, South Africa; [Garcia-Jardon, Mirta] Natl Hlth Lab Serv, Mthatha, South Africa; [Mbulawa, Zizipho Z. A.; Williamson, Anna-Lise] Univ Cape Town, SAMRC Gynaecol Canc Res Ctr, Cape Town, South Africa; [Mbulawa, Zizipho Z. A.] Nelson Mandela Acad Hosp, Dept Lab Med & Pathol, Natl Hlth Lab Serv, Mthatha, Eastern Cape, South Africa; [Mbulawa, Zizipho Z. A.] Walter Sisulu Univ, Mthatha, Eastern Cape, South Africa; [Mbulawa, Zizipho Z. A.] Nelson Mandela Acad Hosp, Natl Hlth Lab Serv, Med Virol, Mthatha, South Africa; [Businge, Charles B.] Nelson Mandela Acad Hosp, Dept Obstet & Gynaecol, Mthatha, South Africa; [Businge, Charles B.] Walter Sisulu Univ, Fac Hlth Sci, Dept Obstet & Gynaecol, Mthatha, South Africa	University of Cape Town; University of Cape Town; Uppsala University; Walter Sisulu University; University of Cape Town; University of Kwazulu Natal; Walter Sisulu University; University of Kwazulu Natal; University of Kwazulu Natal; Walter Sisulu University	Williamson, AL (corresponding author), Univ Cape Town, Fac Hlth Sci, Dept Pathol, Div Med Virol, Cape Town, South Africa.; Williamson, AL (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa.; Williamson, AL (corresponding author), Univ Cape Town, SAMRC Gynaecol Canc Res Ctr, Cape Town, South Africa.	anna-lise.williamson@uct.ac.za	Phohlo, Keletso/GNP-7918-2022	Phohlo, Keletso/0000-0002-9413-5672	National Research Foundation of South Africa [64815]; SAMRC-FORTE Collaborative Research Programme - South African Medical Research Council - Swedish Research Council for Health, Working Life and Welfare; Poliomyelitis Research Foundation, South Africa	National Research Foundation of South Africa(National Research Foundation - South Africa); SAMRC-FORTE Collaborative Research Programme - South African Medical Research Council - Swedish Research Council for Health, Working Life and Welfare; Poliomyelitis Research Foundation, South Africa	This study was supported in part by the National Research Foundation of South Africa in the form of a grant awarded to ALW (64815), SAMRC-FORTE Collaborative Research Programme - South African Medical Research Council - Swedish Research Council for Health, Working Life and Welfare in the form of a grant awarded to ALW, and Poliomyelitis Research Foundation, South Africa in the form of bursaries awarded to OT and KP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AnnaLise Williamson's salary comes from National Research Foundation of South Africa (Grant Number: 64815) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Africa NnfcdoS, 2020, SUMM STAT CANC DIAGN; Allen-Leigh B, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3723-5; Arbyn M, 2015, CERVICAL CANC SCREEN, V238; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Arbyn M, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4823; Arbyn M, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009069.pub3; Awua AK, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0050-4; Bruni L, 2019, HUMAN PAPILLIMAVIRUS; Committee MSA, 2014, NAT CERV SCREEN PROG; Crofts V, 2015, INT J WOMENS HEALTH, V7, P149, DOI 10.2147/IJWH.S56307; Daley E, 2011, J COMMUN HEALTH, V36, P121, DOI 10.1007/s10900-010-9289-7; de Bie RP, 2011, J MOL DIAGN, V13, P371, DOI 10.1016/j.jmoldx.2011.02.003; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Denny L, 2015, CANC DIS CONTROL PRI, V3, DOI [10.1596/978-1-4648-0349-9_ch4, DOI 10.1596/978-1-4648-0349-9_CH4]; Dijkstra MG, 2012, J CLIN VIROL, V54, P147, DOI 10.1016/j.jcv.2012.02.022; Dols Joke A M, 2012, ISRN Obstet Gynecol, V2012, P514146, DOI 10.5402/2012/514146; Geraets DT, 2013, J CLIN VIROL, V57, P125, DOI 10.1016/j.jcv.2013.02.016; Guan YY, 2013, J VIROL METHODS, V189, P167, DOI 10.1016/j.jviromet.2012.11.010; Gustavsson I, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1216-7; Gustavsson I, 2018, BRIT J CANCER, V118, P896, DOI 10.1038/bjc.2017.485; Gustavsson I, 2011, J CLIN VIROL, V51, P251, DOI 10.1016/j.jcv.2011.05.006; Gustavsson I, 2009, J CLIN VIROL, V46, P112, DOI 10.1016/j.jcv.2009.06.021; Gustavsson I, 2009, J CLIN VIROL, V45, P85, DOI 10.1016/j.jcv.2009.04.012; Hoque Monjurul, 2008, East Afr J Public Health, V5, P111; Kitchener H, 2019, PAPILLOMAVIRUS RES, V7, P201, DOI 10.1016/j.pvr.2019.04.001; Lenselink CH, 2009, J CLIN MICROBIOL, V47, P2564, DOI 10.1128/JCM.00285-09; Lorenzi AT, 2019, PAPILLOMAVIRUS RES, V8, DOI 10.1016/j.pvr.2019.100186; Makura CBT, 2016, AIMS PUBLIC HEALTH, V3, P849, DOI 10.3934/publichealth.2016.4.849; Mao C, 2017, J WOMENS HEALTH, V26, P609, DOI 10.1089/jwh.2016.5965; McDonald AC, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00048; McDonald AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044332; Morgan K, 2019, J LOW GENIT TRACT DI, V23, P193, DOI 10.1097/LGT.0000000000000476; Murchland AR, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029158; Nene B, 2007, B WORLD HEALTH ORGAN, V85, P264, DOI 10.2471/BLT.06.031195; Ogilvie GS, 2018, JAMA-J AM MED ASSOC, V320, P43, DOI 10.1001/jama.2018.7464; Polman NJ, 2019, PREV MED, V125, P5, DOI 10.1016/j.ypmed.2019.04.025; Polman NJ, 2019, LANCET ONCOL, V20, P229, DOI 10.1016/S1470-2045(18)30763-0; Saidu R, 2019, SAMJ S AFR MED J, V109, P47, DOI [10.7196/SAMJ.2019.v109i1.13278, 10.7196/samj.2019.v109i1.13278, 10.7196/SAMJ.2018.v109i1.13278]; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sellors J. W., 2003, COLPOSCOPY TREATMENT; Sibiya M N, 2007, Curationis, V30, P48; Snellenberg S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-551; Tranberg M, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4165-4; Waller J, 2009, J MED SCREEN, V16, P199, DOI 10.1258/jms.2009.009073; WHO, 2014, COMPR CERV CANC CONT; Zhang SK, 2014, CANCER EPIDEMIOL, V38, P168, DOI 10.1016/j.canep.2014.01.004	46	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241781	10.1371/journal.pone.0241781	http://dx.doi.org/10.1371/journal.pone.0241781			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170891	Green Published, gold			2022-12-26	WOS:000592383400035
J	Fujise, K; Okubo, M; Abe, T; Yamada, H; Nishino, I; Noguchi, S; Takei, K; Takeda, T				Fujise, Kenshiro; Okubo, Mariko; Abe, Tadashi; Yamada, Hiroshi; Nishino, Ichizo; Noguchi, Satoru; Takei, Kohji; Takeda, Tetsuya			Mutant BIN1-Dynamin 2 complexes dysregulate membrane remodeling in the pathogenesis of centronuclear myopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL INSIGHTS; AMPHIPHYSIN-2 BIN1; SKELETAL-MUSCLE; DYNAMIN; DOMAIN; MUTATIONS; EXPRESSION; PHENOTYPE; FISSION	Membrane remodeling is required for dynamic cellular processes such as cell division, polarization, and motility. BAR domain proteins and dynamins are key molecules in membrane remodeling that work together for membrane deformation and fission. In striated muscles, sarcolemmal invaginations termed T-tubules are required for excitation-contraction coupling. BIN1 and DNM2, which encode a BAR domain protein BIN1 and dynamin 2, respectively, have been reported to be causative genes of centronuclear myopathy (CNM), a hereditary degenerative disease of skeletal muscle, and deformation of T-tubules is often observed in the CNM patients. However, it remains unclear how BIN1 and dynamin 2 are implicated in T-tubule biogenesis and how mutations in these molecules cause CNM to develop. Here, using an in cellulo reconstitution assay, we demonstrate that dynamin 2 is required for stabilization of membranous structures equivalent to T-tubules. GTPase activity of wild-type dynamin 2 is suppressed through interaction with BIN1, whereas that of the disease-associated mutant dynamin 2 remains active due to lack of the BIN1-mediated regulation, thus causing aberrant membrane remodeling. Finally, we show that in cellulo aberrant membrane remodeling by mutant dynamin 2 variants is correlated with their enhanced membrane fission activities, and the results can explain severity of the symptoms in patients. Thus, this study provides molecular insights into dysregulated membrane remodeling triggering the pathogenesis of DNM2-related CNM.	[Fujise, Kenshiro; Abe, Tadashi; Yamada, Hiroshi; Takei, Kohji; Takeda, Tetsuya] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Okubo, Mariko; Nishino, Ichizo; Noguchi, Satoru] Natl Inst Neurosci, Natl Ctr Neurol & Psychiat NCNP, Kodaira, Tokyo, Japan; [Okubo, Mariko] Univ Tokyo, Dept Pediat, Tokyo, Japan	Okayama University; National Center for Neurology & Psychiatry - Japan; University of Tokyo	Takei, K; Takeda, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	kohji@md.okayama-u.ac.jp; ttaKeda@okayama-u.ac.jp	YAMADA, Hiroshi/B-2251-2011; Yamada, Hiroshi/AGZ-4497-2022	YAMADA, Hiroshi/0000-0002-9328-3446; Yamada, Hiroshi/0000-0002-9328-3446	JSPS KAKENHI [18K07198, 19KK0180]; Wesco Scientific Promotion Foundation; Ryobi Teien Memory Foundation; Intramural Research Grant for Neuronal and Psychiatric Disorders of NCNP [29-4, 2-5, 28-6, 30-9]; AMED [JP19ek0109285h0003]; JSPS KAKENNHI [19H03225];  [19J12028]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Wesco Scientific Promotion Foundation; Ryobi Teien Memory Foundation(Ryobi Teien Memory Foundation); Intramural Research Grant for Neuronal and Psychiatric Disorders of NCNP; AMED; JSPS KAKENNHI; 	This work was supported by JSPS KAKENHI (18K07198 and 19KK0180), grants from Wesco Scientific Promotion Foundation and Ryobi Teien Memory Foundation for T. T. This work was also supported by Intramural Research Grant for Neuronal and Psychiatric Disorders of NCNP (29-4, 2-5 for T. T. and I. N., 28-6, 30-9 for S. N.), and AMED under Grant Numbers JP19ek0109285h0003 for I. N. and S. N. K. T. was supported by JSPS KAKENNHI (19H03225). M. O. was supported by Grant-in-Aid for JSPS Research Fellow (19J12028).	Al-Qusairi L, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-26; Antonny B, 2016, EMBO J, V35, P2270, DOI 10.15252/embj.201694613; Bohm J, 2014, BRAIN, V137, P3160, DOI 10.1093/brain/awu272; Bohm J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003430; Bohm J, 2012, HUM MUTAT, V33, P949, DOI 10.1002/humu.22067; Bohm J, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-35; Bragato C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20466; Cabrera-Serrano M, 2018, NEUROLOGY, V91, pE339, DOI 10.1212/WNL.0000000000005862; Chappie JS, 2013, J CELL SCI, V126, P2773, DOI 10.1242/jcs.108845; Chin YH, 2015, HUM MOL GENET, V24, P5542, DOI 10.1093/hmg/ddv285; Claeys KG, 2010, NEUROLOGY, V74, P519, DOI 10.1212/WNL.0b013e3181cef7f9; Cowling BS, 2017, J CLIN INVEST, V127, P4477, DOI 10.1172/JCI90542; Cowling BS, 2014, J CLIN INVEST, V124, P1350, DOI 10.1172/JCI71206; Cowling BS, 2011, AM J PATHOL, V178, P2224, DOI 10.1016/j.ajpath.2011.01.054; Daumke O, 2016, BIOPOLYMERS, V105, P580, DOI 10.1002/bip.22855; Durieux AC, 2010, HUM MOL GENET, V19, P4820, DOI 10.1093/hmg/ddq413; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Garibaldi Matteo, 2016, J Neuromuscul Dis, V3, P111; Gibbs EM, 2014, DIS MODEL MECH, V7, P157, DOI 10.1242/dmm.012286; Hohendahl A, 2017, ELIFE, V6, DOI 10.7554/eLife.26856; Hohendahl A, 2016, J STRUCT BIOL, V196, P37, DOI 10.1016/j.jsb.2016.06.015; Jungbluth H, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-26; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Klein DE, 1998, J BIOL CHEM, V273, P27725, DOI 10.1074/jbc.273.42.27725; Kojima C, 2004, EMBO J, V23, P4413, DOI 10.1038/sj.emboj.7600442; Kouwenberg Carlyn, 2017, J Neuromuscul Dis, V4, P349, DOI 10.3233/JND-170238; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Picas L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6647; Prokic I, 2014, J MOL MED, V92, P453, DOI 10.1007/s00109-014-1138-1; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; Reubold TF, 2015, NATURE, V525, P404, DOI 10.1038/nature14880; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Takeda T, 2018, ELIFE, V7, DOI 10.7554/eLife.30246; Takei K, 2001, METHOD ENZYMOL, V329, P478; Takekura H, 2001, DEV BIOL, V239, P204, DOI 10.1006/dbio.2001.0437; Toussaint A, 2011, ACTA NEUROPATHOL, V121, P253, DOI 10.1007/s00401-010-0754-2; Wang L, 2010, J BIOL CHEM, V285, P22751, DOI 10.1074/jbc.C110.130013; Warnock DE, 1996, J BIOL CHEM, V271, P22310, DOI 10.1074/jbc.271.37.22310; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355	47	10	10	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100077	10.1074/jbc.RA120.015184	http://dx.doi.org/10.1074/jbc.RA120.015184			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33187981	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400058
J	Wang, N; Chen, XL; Gao, C; Peng, M; Wang, P; Zhang, N; Li, FC; Yang, GP; Shen, QT; Li, SY; Chen, Y; Zhang, YZ; Li, CY				Wang, Ning; Chen, Xiu-Lan; Gao, Chao; Peng, Ming; Wang, Peng; Zhang, Na; Li, Fuchuan; Yang, Gui-Peng; Shen, Qing-Tao; Li, Shengying; Chen, Yin; Zhang, Yu-Zhong; Li, Chun-Yang			Crystal structures of gamma-glutamylmethylamide synthetase provide insight into bacterial metabolism of oceanic monomethylamine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE-SYNTHETASE; MARINE-BACTERIA; NITROGEN-SOURCE; METHYLAMINE; GENE; PURIFICATION; EXPRESSION; AMMONIUM; CLUSTER; CLONING	Monomethylamine (MMA) is an important climate-active oceanic trace gas and ubiquitous in the oceans. gamma-Glutamylmethylamide synthetase (GmaS) catalyzes the conversion of MMA to gamma-glutamylmethylamide, the first step in MMA metabolism in many marine bacteria. The gmaS gene occurs in similar to 23% of microbial genomes in the surface ocean and is a validated biomarker to detect MMA-utilizing bacteria. However, the catalytic mechanism of GmaS has not been studied because of the lack of structural information. Here, the GmaS from Rhodovulum sp. 12E13 (RhGmaS) was characterized, and the crystal structures of apo-RhGmaS and RhGmaS with different ligands in five states were solved. Based on structural and biochemical analyses, the catalytic mechanism of RhGmaS was explained. ATP is first bound in RhGmaS, leading to a conformational change of a flexible loop (Lys287-Ile305), which is essential for the subsequent binding of glutamate. During the catalysis of RhGmaS, the residue Arg312 participates in polarizing the gamma-phosphate of ATP and in stabilizing the gamma-glutamyl phosphate intermediate; Asp177 is responsible for the deprotonation of MMA, assisting the attack of MMA on gamma-glutamyl phosphate to produce a tetrahedral intermediate; and Glu186 acts as a catalytic base to abstract a proton from the tetrahedral intermediate to finally generate glutamylmethylamide. Sequence analysis suggested that the catalytic mechanism of RhGmaS proposed in this study has universal significance in bacteria containing GmaS. Our results provide novel insights into MMA metabolism, contributing to a better understanding of MMA catabolism in global carbon and nitrogen cycles.	[Wang, Ning; Chen, Xiu-Lan; Gao, Chao; Peng, Ming; Li, Shengying; Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Qingdao, Peoples R China; [Wang, Ning; Wang, Peng; Zhang, Yu-Zhong; Li, Chun-Yang] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China; [Wang, Ning; Wang, Peng; Zhang, Yu-Zhong; Li, Chun-Yang] Ocean Univ China, Frontiers Sci Ctr Deep Ocean Multispheres & Earth, Qingdao, Peoples R China; [Chen, Xiu-Lan; Wang, Peng; Zhang, Yu-Zhong; Li, Chun-Yang] Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Zhang, Na; Shen, Qing-Tao] ShanghaiTech Univ, Sch Life Sci & Technol, iHuman Inst, Shanghai, Peoples R China; [Li, Fuchuan] Shandong Univ, Natl Glycoengn Res Ctr, Qingdao, Peoples R China; [Li, Fuchuan] Shandong Univ, Shandong Key Lab Carbohydrate Chem & Glycobiol, Qingdao, Peoples R China; [Yang, Gui-Peng] Ocean Univ China, Frontiers Sci Ctr Deep Ocean Multispheres & Earth, Key Lab Marine Chem Theory & Technol, Minist Educ, Qingdao, Peoples R China; [Chen, Yin] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England	Shandong University; Ocean University of China; Ocean University of China; Qingdao National Laboratory for Marine Science & Technology; ShanghaiTech University; Shandong University; Shandong University; Ocean University of China; University of Warwick	Li, CY (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.; Li, CY (corresponding author), Ocean Univ China, Frontiers Sci Ctr Deep Ocean Multispheres & Earth, Qingdao, Peoples R China.; Li, CY (corresponding author), Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.	lcy@ouc.edu.cn	Yang, Gui-Peng/GZG-6468-2022	Yang, Gui-Peng/0000-0002-0107-4568; Li, Chun-Yang/0000-0002-1151-4897; Zhang, Yu-Zhong/0000-0002-2017-1005	National Science Foundation of China [91851205, 31630012, U1706207, 42076229, 31800107, 41706152]; National Key Research and Development Program of China [2018YFC1406700, 2016YFA0601303, 2018YFC1406504]; Major Scientific and Technological Innovation Project (MSTIP) of Shandong Province [2019JZZY010817]; Program of Shandong for Taishan Scholars [tspd20181203]; AoShan Talents Cultivation Program by Qingdao National Laboratory for Marine Science and Technology [2017ASTCP-OS14]; Laboratory for Marine Biology and Biotechnology [OF2019NO02]; Pilot National Laboratory for Marine Science and Technology (Qingdao); Fundamental Research Funds for the Central Universities	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Major Scientific and Technological Innovation Project (MSTIP) of Shandong Province; Program of Shandong for Taishan Scholars; AoShan Talents Cultivation Program by Qingdao National Laboratory for Marine Science and Technology; Laboratory for Marine Biology and Biotechnology; Pilot National Laboratory for Marine Science and Technology (Qingdao); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Science Foundation of China (grants 91851205, 31630012, U1706207, 42076229, 31800107, and 41706152), the National Key Research and Development Program of China (2018YFC1406700, 2016YFA0601303, 2018YFC1406504), the Major Scientific and Technological Innovation Project (MSTIP) of Shandong Province (2019JZZY010817), the Program of Shandong for Taishan Scholars (tspd20181203), AoShan Talents Cultivation Program supported by Qingdao National Laboratory for Marine Science and Technology (2017ASTCP-OS14), the grant of Laboratory for Marine Biology and Biotechnology (OF2019NO02), Pilot National Laboratory for Marine Science and Technology (Qingdao), and the Fundamental Research Funds for the Central Universities.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALMASSY RJ, 1986, NATURE, V323, P304, DOI 10.1038/323304a0; BROWN JR, 1994, J MOL EVOL, V38, P566; Carpenter LJ, 2012, CHEM SOC REV, V41, P6473, DOI 10.1039/c2cs35121h; Chen Y, 2012, ENVIRON MICROBIOL, V14, P2308, DOI 10.1111/j.1462-2920.2012.02765.x; Chen Y, 2011, P NATL ACAD SCI USA, V108, P17791, DOI 10.1073/pnas.1112928108; Chen Y, 2010, APPL ENVIRON MICROB, V76, P4530, DOI 10.1128/AEM.00739-10; Chen Y, 2010, APPL ENVIRON MICROB, V76, P4102, DOI 10.1128/AEM.00469-10; CHISTOSERDOV AY, 1994, J BACTERIOL, V176, P4052, DOI 10.1128/JB.176.13.4052-4065.1994; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gibb SW, 1999, DEEP-SEA RES PT II, V46, P593, DOI 10.1016/S0967-0645(98)00119-2; Gonzalez JM, 1997, APPL ENVIRON MICROB, V63, P4237; HUSAIN M, 1987, J BACTERIOL, V169, P1712, DOI 10.1128/jb.169.4.1712-1717.1987; Kamini, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.01866-18; KIMURA T, 1992, BIOSCI BIOTECH BIOCH, V56, P708, DOI 10.1271/bbb.56.708; Krajewski WW, 2005, P NATL ACAD SCI USA, V102, P10499, DOI 10.1073/pnas.0502248102; KUMADA Y, 1993, P NATL ACAD SCI USA, V90, P3009, DOI 10.1073/pnas.90.7.3009; Latypova E, 2010, MOL MICROBIOL, V75, P426, DOI 10.1111/j.1365-2958.2009.06989.x; LIAW SH, 1995, PROTEIN SCI, V4, P2358, DOI 10.1002/pro.5560041114; Lidbury I, 2017, ISME J, V11, P1592, DOI 10.1038/ismej.2017.31; Lidbury IDEA, 2015, ISME J, V9, P760, DOI 10.1038/ismej.2014.149; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murray DS, 2013, J BIOL CHEM, V288, P35801, DOI 10.1074/jbc.M113.519496; Poste AE, 2014, SCI TOTAL ENVIRON, V481, P274, DOI 10.1016/j.scitotenv.2014.02.066; Selje N, 2004, NATURE, V427, P445, DOI 10.1038/nature02272; Stein LY, 2017, ENVIRON MICROBIOL, V19, P2117, DOI 10.1111/1462-2920.13716; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taubert M, 2017, ENVIRON MICROBIOL, V19, P2246, DOI 10.1111/1462-2920.13709; Unno H, 2006, J BIOL CHEM, V281, P29287, DOI 10.1074/jbc.M601497200; van Rooyen JM, 2011, STRUCTURE, V19, P471, DOI 10.1016/j.str.2011.02.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wischer D, 2015, ISME J, V9, P195, DOI 10.1038/ismej.2014.102; WOODS DR, 1993, FEMS MICROBIOL REV, V11, P273, DOI 10.1111/j.1574-6976.1993.tb00001.x; Yamamoto S, 2008, BIOSCI BIOTECH BIOCH, V72, P101, DOI 10.1271/bbb.70462; Yamamoto S, 2007, BIOSCI BIOTECH BIOCH, V71, P545, DOI 10.1271/bbb.60590; Yang SY, 2020, J MICROBIOL BIOTECHN, V30, P785, DOI 10.4014/jmb.1910.10044; ZHANG XP, 1993, J BACTERIOL, V175, P5617, DOI 10.1128/JB.175.17.5617-5627.1993; Zhuang GC, 2018, ENVIRON MICROBIOL, V20, P4543, DOI 10.1111/1462-2920.14406	39	3	3	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100081	10.1074/jbc.RA120.015952	http://dx.doi.org/10.1074/jbc.RA120.015952			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33199371	Green Accepted, gold, Green Published			2022-12-26	WOS:000672866400062
J	Kerherve, HA; Harvey, LM; Eagles, AN; McLellan, C; Lovell, D				Kerherve, Hugo A.; Harvey, Leonie M.; Eagles, Alexander N.; McLellan, Chris; Lovell, Dale			Similar rates of fat oxidation during graded submaximal exercise in women of different body composition	PLOS ONE			English	Article							SKELETAL-MUSCLE; SUBSTRATE OXIDATION; LIPID-METABOLISM; ACID OXIDATION; NORMAL-WEIGHT; OBESE; OVERWEIGHT; INTENSITY; CARBOHYDRATE; MORTALITY	Background Moderate intensity exercise ranging 40-60% of maximum oxygen uptake is advised to promote energy expenditure and fat oxidation in overweight and obese people. Although fat oxidation has been shown to be highly variable among individual, there is still a relative uncertainty regarding exercise prescription for women specifically. This article aimed to determine whether indicators of body composition can be used to narrow the exercise intensity range for exercise prescription in women. Methods A total of 35 healthy women (age 30.8 +/- 9.5 yr) classified according to their BMI in normal weight (NOR; <= 24.9 kg.m(2)), overweight (OVW; 25-29.9 kg.m(2)) and obese groups (OBE; >= 30 kg.m(2)) completed a submaximal graded test (intensities eliciting similar to 30%, 40%, 50% and 60% of maximum oxygen uptake). Blood lactate, perceived exertion and absolute and relative substrate oxidation for fat (OXFAT) and carbohydrates (OXCHO) were measured at each stage. Results Perceived exertion and blood lactate increased as a function of exercise but did not differ across groups. There were no significant changes in absolute and relative OXFAT across groups, or as a function of exercise intensity. Peak OXFAT occurred at the 40%, 50% and 40% stages for NOR, OVW and OBE groups, respectively, with no significant differences across groups. Conclusion We measured no differences, but considerable inter-individual variation, in fat oxidation in women of different body composition. This result is in agreement with previous research based on exercise performed at constant rate and in independent participant groups. Our findings do not support the fat oxidation hypothesis, and further emphasise the perspective that exercise prescription should be individualised and likely be based on considerations other than substrate oxidation.	[Kerherve, Hugo A.; Harvey, Leonie M.; Eagles, Alexander N.; Lovell, Dale] Univ Sunshine Coast, Sch Sport Sci, Sippy Downs, Qld, Australia; [Kerherve, Hugo A.] Univ Rennes, Rennes, France; [McLellan, Chris] Univ Southern Queensland, Sch Hlth & Wellbeing, Ipswich, Qld, Australia	University of the Sunshine Coast; Universite de Rennes; University of Southern Queensland	Kerherve, HA (corresponding author), Univ Sunshine Coast, Sch Sport Sci, Sippy Downs, Qld, Australia.; Kerherve, HA (corresponding author), Univ Rennes, Rennes, France.	hugo.kerherve@univ-rennes2.fr						Achten J, 2004, NUTRITION, V20, P716, DOI 10.1016/j.nut.2004.04.005; Achten J, 2003, METABOLISM, V52, P747, DOI 10.1016/S0026-0495(03)00068-4; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Advanced Technology Libraries, 2010, ADV TECHNOLOGY LIB, V39, P1; [Anonymous], 1999, AM J PHYSIOL-CELL PH, V277, pC1; [Anonymous], JAMOVI VERSION 0 9; Bircher S, 2004, J SPORT SCI MED, V3, P174; Bogdanis GC, 2008, J SPORT SCI MED, V7, P525; Bordenave S, 2007, DIABETES METAB, V33, P379, DOI 10.1016/j.diabet.2007.04.003; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; CALLESESCANDON J, 1995, J APPL PHYSIOL, V78, P266, DOI 10.1152/jappl.1995.78.1.266; COLBERG SR, 1995, J CLIN INVEST, V95, P1846, DOI 10.1172/JCI117864; Devries MC, 2013, J CLIN ENDOCR METAB, V98, P4852, DOI 10.1210/jc.2013-2044; Ezell DM, 1999, INT J OBESITY, V23, P1047, DOI 10.1038/sj.ijo.0801037; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Fletcher G, 2017, AM J CLIN NUTR, V105, P864, DOI 10.3945/ajcn.116.133520; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Friedlander AL, 1998, AM J PHYSIOL-ENDOC M, V275, pE853, DOI 10.1152/ajpendo.1998.275.5.E853; Hickner RC, 2001, J APPL PHYSIOL, V90, P2319, DOI 10.1152/jappl.2001.90.6.2319; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Horowitz JF, 2000, J APPL PHYSIOL, V89, P2276, DOI 10.1152/jappl.2000.89.6.2276; HURLEY BF, 1986, J APPL PHYSIOL, V60, P562, DOI 10.1152/jappl.1986.60.2.562; Kanaley JA, 2001, EUR J APPL PHYSIOL, V85, P68, DOI 10.1007/s004210100404; KANALEY JA, 1993, J CLIN INVEST, V92, P255, DOI 10.1172/JCI116559; Kelley DE, 2001, J CLIN ENDOCR METAB, V86, P5412, DOI 10.1210/jc.86.11.5412; Kerherve HA, 2020, OBES RES CLIN PRACT, V14, P462, DOI 10.1016/j.orcp.2020.08.008; Lazzer S, 2007, CLIN ENDOCRINOL, V67, P582, DOI 10.1111/j.1365-2265.2007.02929.x; MARTIN WH, 1993, AM J PHYSIOL, V265, pE708, DOI 10.1152/ajpendo.1993.265.5.E708; Melanson EL, 2003, INT J OBESITY, V27, P196, DOI 10.1038/sj.ijo.802202; Peronnet F, 2019, OBES REV, V20, P1367, DOI 10.1111/obr.12910; Pescatello L.S., 2014, ACSMS GUIDELINES EXE, V9; Phillips SM, 1996, J APPL PHYSIOL, V81, P2182, DOI 10.1152/jappl.1996.81.5.2182; Riddell MC, 2008, J APPL PHYSIOL, V105, P742, DOI 10.1152/japplphysiol.01256.2007; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Steffan HG, 1999, EUR J APPL PHYSIOL, V80, P233, DOI 10.1007/s004210050587; Thyfault JP, 2004, AM J PHYSIOL-ENDOC M, V287, pE1076, DOI 10.1152/ajpendo.00177.2004; Tunstall RJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE66, DOI 10.1152/ajpendo.00475.2001; van Aggel-Leijssen DP, 2001, OBES RES, V9, P86, DOI 10.1038/oby.2001.11; Van Aggel-Leijssen DPC, 2002, J APPL PHYSIOL, V92, P1300, DOI 10.1152/japplphysiol.00030.2001; Venables MC, 2005, J APPL PHYSIOL, V98, P160, DOI 10.1152/japplphysiol.00662.2003; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Woodward M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071165; World Health Organization, 2015, OV OB	44	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242551	10.1371/journal.pone.0242551	http://dx.doi.org/10.1371/journal.pone.0242551			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206727	Green Published, gold			2022-12-26	WOS:000595265900038
J	Matsumura, T; Fujimoto, T; Futakuchi, A; Takihara, Y; Watanabe-Kitamura, F; Takahashi, E; Inoue-Mochita, M; Tanihara, H; Inoue, T				Matsumura, Tomoyo; Fujimoto, Tomokazu; Futakuchi, Akiko; Takihara, Yuji; Watanabe-Kitamura, Fumika; Takahashi, Eri; Inoue-Mochita, Miyuki; Tanihara, Hidenobu; Inoue, Toshihiro			TGF-beta-induced activation of conjunctival fibroblasts is modulated by FGF-2 and substratum stiffness	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; MYOFIBROBLAST ACTIVATION; MECHANICAL STRAIN; FACTOR-2; YAP; DIFFERENTIATION; PROLIFERATION; EXPRESSION; INDUCTION	Purpose This study aimed to investigate the effects of substratum stiffness on the sensitivity of human conjunctival fibroblasts to transforming growth factor (TGF)-beta, and to explore the molecular mechanism of action. Methods Human conjunctival fibroblasts were cultured on collagen-coated plastic or silicone plates. The stiffness of the silicone plates was 0.2 or 64 kPa. Cells were treated by 2.5 ng/mL TGF-beta 2 with or without fibroblast growth factor (FGF)-2 (0-100 ng/mL) for 24 h or 48 h. The protein expression levels were determined by Western blot analysis. Cell proliferation was assessed using the WST-8 assay. Results FGF-2 suppressed the TGF-beta-induced expression of alpha-smooth muscle actin (SMA) and collagen type I (Col I), but not fibronectin (FN). Both FGF-2 and TGF-beta 2 increased cell proliferation without an additive effect. The induction of alpha-SMA by TGF-beta 2 was decreased on the soft substratum, without any change in the expression level or subcellular location of Yes-associated protein/transcriptional coactivator with PDZ-binding motif (YAP/TAZ). FGF-2 suppressed TGF-beta-induced alpha-SMA expression even on the soft substratum. Conclusions FGF-2 treatment and a soft substratum suppressed TGF-beta-induced transdifferentiation of conjunctival fibroblasts into myofibroblasts. FGF-2 attenuated the TGF-beta-induced expression of alpha-SMA, even on a soft substratum.	[Matsumura, Tomoyo; Fujimoto, Tomokazu; Futakuchi, Akiko; Takihara, Yuji; Watanabe-Kitamura, Fumika; Takahashi, Eri; Inoue, Toshihiro] Kumamoto Univ, Dept Ophthalmol, Fac Life Sci, Kumamoto, Japan; [Inoue-Mochita, Miyuki] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto, Japan; [Tanihara, Hidenobu] Kumamoto Univ Hosp, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Inoue, T (corresponding author), Kumamoto Univ, Dept Ophthalmol, Fac Life Sci, Kumamoto, Japan.	noel@da2.so-net.ne.jp	Ogawa, Akiko/AAD-7683-2021	Fujimoto, Tomokazu/0000-0002-4867-1925	JSPS KAKENHI [17K11458, 17H04351]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI grants (https://www-shinsei.jsps.go.jp/kaken/): H.T. and T.I. received 17H04351 and 17K11458, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka Y, 2004, J PATHOL, V203, P710, DOI 10.1002/path.1574; Liguori TTA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34747-3; Broadway DC, 2001, J GLAUCOMA, V10, P237, DOI 10.1097/00061198-200106000-00017; Cheng GC, 1997, CIRC RES, V80, P28, DOI 10.1161/01.RES.80.1.28; Chiou AGY, 1998, SURV OPHTHALMOL, V43, P19, DOI 10.1016/S0039-6257(98)00005-8; Chui J, 2008, OCUL SURF, V6, P24, DOI 10.1016/S1542-0124(12)70103-9; Clarke MSF, 1996, FASEB J, V10, P502, DOI 10.1096/fasebj.10.4.8647349; Codelia VA, 2014, CURR BIOL, V24, P2012, DOI 10.1016/j.cub.2014.07.034; Cushing MC, 2008, FASEB J, V22, P1769, DOI 10.1096/fj.07-087627; Dale SB, 2015, CURR OPIN ALLERGY CL, V15, P467, DOI 10.1097/ACI.0000000000000197; Dolivo DM, 2017, J DERMATOL SCI, V88, P339, DOI 10.1016/j.jdermsci.2017.08.013; Dolivo DM, 2017, CYTOKINE GROWTH F R, V38, P49, DOI 10.1016/j.cytogfr.2017.09.003; Futakuchi A, 2018, INVEST OPHTH VIS SCI, V59, P3069, DOI 10.1167/iovs.18-24258; Galvin DJ, 2002, AM J PHYSIOL-RENAL, V283, pF1192, DOI 10.1152/ajprenal.00168.2002; Hinz B, 2016, EXP EYE RES, V142, P56, DOI 10.1016/j.exer.2015.07.009; Ichioka H, 2016, ODONTOLOGY, V104, P27, DOI 10.1007/s10266-015-0206-5; Kay EDP, 1998, INVEST OPHTH VIS SCI, V39, P481; Khaw P T, 1996, Curr Opin Ophthalmol, V7, P24, DOI 10.1097/00055735-199604000-00005; Kim K, 2011, BIOMATERIALS, V32, P3750, DOI 10.1016/j.biomaterials.2011.01.016; Lampi MC, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao0475; Lee S, 2019, BIOMATERIALS, V202, P26, DOI 10.1016/j.biomaterials.2019.02.021; Li CF, 2006, J BONE MINER RES, V21, P946, DOI 10.1359/JBMR.060309; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; PARIS S, 1991, ANN NY ACAD SCI, V638, P139, DOI 10.1111/j.1749-6632.1991.tb49024.x; Quinn TP, 2002, AM J PHYSIOL-LUNG C, V282, pL897, DOI 10.1152/ajplung.00044.2001; Rhoads DN, 2000, ARTERIOSCL THROM VAS, V20, P416, DOI 10.1161/01.ATV.20.2.416; ROSENBAUM J, 1995, GASTROENTEROLOGY, V109, P1986, DOI 10.1016/0016-5085(95)90767-X; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Salomão Milene Freitas Lima, 2014, Dental Press J. Orthod., V19, P67, DOI 10.1590/2176-9451.19.3.067-074.oar; Santos A, 2018, CURR RHEUMATOL REP, V20, DOI 10.1007/s11926-018-0710-z; Schlunck G, 2016, EXP EYE RES, V142, P76, DOI 10.1016/j.exer.2015.03.021; Schuliga M, 2013, AM J RESP CELL MOL, V48, P346, DOI 10.1165/rcmb.2012-0151OC; Shi HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059966; Spyrou GE, 2002, BRIT J PLAST SURG, V55, P275, DOI 10.1054/bjps.2002.3831; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vincent TL, 2004, ARTHRITIS RHEUM, V50, P526, DOI 10.1002/art.20047; Xiao L, 2012, FRONT BIOSCI-LANDMRK, V17, P2667, DOI 10.2741/4077; Zhang JM, 2009, NAT CELL BIOL, V11, P1444, DOI 10.1038/ncb1993; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	39	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242626	10.1371/journal.pone.0242626	http://dx.doi.org/10.1371/journal.pone.0242626			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206726	gold, Green Published			2022-12-26	WOS:000595265900055
J	Morovati, M; Karami, P; Amjas, FB				Morovati, Maryam; Karami, Peyman; Bahadori Amjas, Fatemeh			Accessing habitat suitability and connectivity for the westernmost population of Asian black bear (Ursus thibetanus gedrosianus, Blanford, 1877) based on climate changes scenarios in Iran	PLOS ONE			English	Article							PREDICTING SPECIES DISTRIBUTION; PROTECTED AREAS; SELECTING THRESHOLDS; VARIABLE IMPORTANCE; BRITISH-COLUMBIA; EXTINCTION RISK; RANDOM FORESTS; CIRCUIT-THEORY; CONSERVATION; LANDSCAPE	Climate change, as an emerging phenomenon, has led to changes in the distribution, movement, and even risk of extinction of various wildlife species and this has raised concerns among conservation biologists. Different species have two options in the face of climate change, either to adopt or follow their climatic niche to new places through the connectivity of habitats. The modeling of interpatch landscape communications can serve as an effective decision support tool for wildlife managers. This study was conducted to assess the effects of climate change on the distribution and habitat connectivity of the endangered subspecies of Asian black bear (Ursus thibetanus gedrosianus) in the southern and southeastern Iran. The presence points of the species were collected in Provinces of Kerman, Hormozgan, and Sistan-Baluchestan. Habitat modeling was done by the Generalized Linear Model, and 3 machine learning models including Maximum Entropy, Back Propagation based artificial Neural Network, and Support Vector Machine. In order to achieve the ensemble model, the results of the mentioned models were merged based on the method of "accuracy rate as weight" derived from their validation. To construct pseudo-absence points for the use in the mentioned models, the Ensemble model of presence-only models was used. The modeling was performed using 15 habitat variables related to climatic, vegetation, topographic, and anthropogenic parameters. The three general circulation models of BCC-CSM1, CCSM4, and MRI-CGCM3 were selected under the two scenarios of RCP2.6 and RCP8.5 by 2070. To investigate the effect of climate change on the habitat connections, the protected areas of 3 provinces were considered as focal nodes and the connections between them were established based on electrical circuit theory and Pairwise method. The true skill statistic was employed to convert the continuous suitability layers to binary suitable/unsuitable range maps to assess the effectiveness of the protected areas in the coverage of suitable habitats for the species. Due to the high power of the stochastic forest model in determining the importance of variables, this method was used. The results showed that presence/absence models were successful in the implementation and well distinguished the points of presence and pseudo-absence from each other. Based on the random forests model, the variables of Precipitation of Driest Quarter, Precipitation of Coldest Quarter, and Temperature Annual Range have the greatest impact on the habitat suitability. Comparing the modeling findings to the realities of the species distribution range indicated that the suitable habitats are located in areas with high humidity and rainfall, which are mostly in the northern areas of Bandar Abbas, south of Kerman, and west and south of Sistan-Baluchestan. The area of suitable habitats, in the MRI-CGCM3 (189731 Km(2)) and CCSM4 (179007 Km(2)) models under the RCP2.6 scenario, is larger than the current distribution (174001 Km(2)). However, in terms of the performance of protected areas, the optimal coverage of the species by the boundary of the protected areas, under each of the RCP2.6 and RCP8.5 scenarios, is less than the present time. According to the electric circuit theory, connecting the populations in the protected areas of Sistan-Baluchestan province to those in the northern Hormozgan and the southern Kerman would be based on the crossing through the heights of Sistan-Baluchestan and Hormozgan provinces and the plains between these heights would be the movement pinch points under the current and future scenarios. Populations in the protected areas of Kerman have higher quality patch connections than that of the other two provinces. The areas such as Sang-e_Mes, Kouh_Shir, Zaryab, and Bahr_Aseman in Kerman Province and Kouhbaz and Geno in Hormozgan Province can provide suitable habitats for the species in the distribution models. The findings revealed that the conservation of the heights along with the caves inside them could be a protective priority to counteract the effects of climate change on the species.	[Morovati, Maryam] Ardakan Univ, Fac Agr & Nat Resources, Dept Environm Sci & Engn, Ardakan, Iran; [Morovati, Maryam] Ardakan Univ, Med & Ind Plants Res Inst, Ardakan, Iran; [Karami, Peyman] Malayer Univ, Fac Nat Resources & Environm Sci, Dept Environm Sci, Malayer, Iran; [Bahadori Amjas, Fatemeh] Ardakan Univ, Fac Agr & Nat Resources, Ardakan, Iran		Morovati, M (corresponding author), Ardakan Univ, Fac Agr & Nat Resources, Dept Environm Sci & Engn, Ardakan, Iran.; Morovati, M (corresponding author), Ardakan Univ, Med & Ind Plants Res Inst, Ardakan, Iran.	mymorovati@ardakan.ac.ir	Morovati, Maryam/ABF-3834-2021	morovati, maryam/0000-0002-2225-0823				Abbasian M, 2019, THEOR APPL CLIMATOL, V135, P1465, DOI 10.1007/s00704-018-2456-y; Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Ahmadi M, 2017, DIVERS DISTRIB, V23, P592, DOI 10.1111/ddi.12560; Ahmadzadeh F, 2008, J NAT HIST, V42, P2379, DOI 10.1080/00222930802262741; Akhtar N, 2007, URSUS, V18, P203, DOI 10.2192/1537-6176(2007)18[203:COSBDD]2.0.CO;2; Ali A, 2017, J NAT HIST, V51, P689, DOI 10.1080/00222933.2017.1303097; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Almasieh K, 2019, EUR J WILDLIFE RES, V65, DOI 10.1007/s10344-019-1295-1; Almasieh K, 2016, URSUS, V27, P18, DOI 10.2192/URSUS-D-15-00032.1; Ancillotto L, 2020, ECOL EVOL, V10, P5785, DOI 10.1002/ece3.6317; [Anonymous], 2016, GUID US IUCN RED LIS; [Anonymous], 2018, IEOC 2018 6 INT EUR, P34; [Anonymous], 2014, CLIMATE CHANGE BIOL; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 2019, IMMUNE NETW, V19, pe34; Araujo MB, 2011, ECOL LETT, V14, P484, DOI 10.1111/j.1461-0248.2011.01610.x; Ashrafzadeh MR, 2018, MAMM BIOL, V93, P64, DOI 10.1016/j.mambio.2018.08.007; Bagli S, 2011, ENVIRON IMPACT ASSES, V31, P234, DOI 10.1016/j.eiar.2010.10.003; Baral H, 2014, ECOL INDIC, V36, P552, DOI 10.1016/j.ecolind.2013.09.022; Bertolino S, 2020, MAMMAL REV, V50, P187, DOI 10.1111/mam.12185; Bista M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203697; Bista Rabindra, 2013, Zoology and Ecology, V23, P83, DOI 10.1080/21658005.2013.774813; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown JL, 2017, PEERJ, V5, DOI 10.7717/peerj.4095; Capinha C, 2011, DIVERS DISTRIB, V17, P13, DOI 10.1111/j.1472-4642.2010.00727.x; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Carroll C, 2012, CONSERV BIOL, V26, P78, DOI 10.1111/j.1523-1739.2011.01753.x; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Chelgani SC, 2016, FUEL, V182, P754, DOI 10.1016/j.fuel.2016.06.034; Chhetri M., 2013, DISTRIBUTION ABUNDAN; Ciarniello LM, 2005, URSUS, V16, P47, DOI 10.2192/1537-6176(2005)016[0047:DBADSS]2.0.CO;2; Danoedoro P, 2010, P SEAGA, P23; de Thoisy B, 2010, BIODIVERS CONSERV, V19, P1567, DOI 10.1007/s10531-010-9787-z; Duflot R, 2018, J NAT CONSERV, V46, P38, DOI 10.1016/j.jnc.2018.08.005; Dutta T, 2016, REG ENVIRON CHANGE, V16, P53, DOI 10.1007/s10113-015-0877-z; Elith J, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P303; Elith J, 2017, REFERENCE MODULE LIF, DOI [10.1111/brv.12359, DOI 10.1111/BRV.12359]; Ervin J, 2003, BIOSCIENCE, V53, P833, DOI 10.1641/0006-3568(2003)053[0833:RAOPAM]2.0.CO;2; Escobar LE, 2015, BIOL CONSERV, V191, P400, DOI 10.1016/j.biocon.2015.06.040; ESRI, 2011, ARCGIS DESKT REL 10; Estrada E, 2008, ECOL APPL, V18, P1810, DOI 10.1890/07-1419.1; FAHIMI H., 2011, J NAT HIST, V45, P2363; Fahimi H, 2018, ZOOL MIDDLE EAST, V64, P182, DOI 10.1080/09397140.2018.1444573; Fang H, 2019, IEEE WIREL COMMUN, V26, P55, DOI 10.1109/MWC.001.1900054; Farashi Azita, 2018, Acta Ecologica Sinica, V38, P9; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Flueck J, 1987, 10 C PROB STAT ATM S; Garshelis D, 2016, IUCN RED LIST THREAT; Garshelis DL, 2016, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2008, DOI 10.2305/IUCN.UK.2008]; Ghadirian T, 2014, 23 INT C BEAR RES MA; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Grimm V., 2005, INDIVIDUAL BASED MOD; Gromping U, 2009, AM STAT, V63, P308, DOI 10.1198/tast.2009.08199; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guo QH, 2005, ECOL MODEL, V182, P75, DOI 10.1016/j.ecolmodel.2004.07.012; Guo QH, 2010, ECOGRAPHY, V33, P637, DOI 10.1111/j.1600-0587.2010.06416.x; Haggarty D, 2018, ESTUAR COAST SHELF S, V208, P191, DOI 10.1016/j.ecss.2018.05.011; Haghani A, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00142; Han H., 2017, 2016 7 IEEE INT C SO, P219, DOI [10.1109/ICSESS.2016.7883053, DOI 10.1109/ICSESS.2016.7883053]; Hapfelmeier A, 2014, INT J BIOSTAT, V10, P165, DOI 10.1515/ijb-2013-0038; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hwang DS, 2008, MITOCHONDR DNA, V19, P418, DOI 10.1080/19401730802389525; Hwang MH, 2010, URSUS, V21, P81, DOI 10.2192/09GR024.1; Ibisch P, 2002, CONSERVACION BIODIVE, P225; Ishwaran H, 2007, ELECTRON J STAT, V1, P519, DOI 10.1214/07-EJS039; Jackson CR, 2016, LANDSCAPE ECOL, V31, P1433, DOI 10.1007/s10980-016-0342-5; Jamtsho Y, 2016, GLOB ECOL CONSERV, V8, P183, DOI 10.1016/j.gecco.2016.09.004; Jiang GS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15475; Jones CC, 2010, ECOL APPL, V20, P311, DOI 10.1890/08-2261.1; Karami P, 2020, J MT SCI-ENGL, V17, P68, DOI 10.1007/s11629-019-5418-7; Karger DN, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.122; Kool JT, 2013, LANDSCAPE ECOL, V28, P165, DOI 10.1007/s10980-012-9819-z; Landguth EL, 2012, ECOGRAPHY, V35, P9, DOI 10.1111/j.1600-0587.2011.07149.x; Lemes P, 2014, BIODIVERS CONSERV, V23, P357, DOI 10.1007/s10531-013-0605-2; Lham D, 2019, ORYX, V53, P63, DOI 10.1017/S0030605317001508; Li HL, 2010, ECOL MODEL, V221, P944, DOI 10.1016/j.ecolmodel.2009.12.006; Liley SG, 2015, URSUS, V26, P1, DOI 10.2192/URSUS-D-15-00006.1; Liow LH, 2009, AM NAT, V173, P264, DOI 10.1086/595756; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Liu CR, 2013, ECOL MODEL, V249, P68, DOI 10.1016/j.ecolmodel.2012.07.003; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Louppe G, 2014, UNDERSTANDING RANDOM, DOI [10.1371/journal.pone.0093379, DOI 10.1371/JOURNAL.PONE.0093379]; Manel S, 1999, J APPL ECOL, V36, P734, DOI 10.1046/j.1365-2664.1999.00440.x; Maria B, 2017, ECOL MODEL, V359, P92, DOI 10.1016/j.ecolmodel.2017.05.021; MASOOMPOUR SJ, 2018, ASSESSMENT CMIP5 CLI; Matin SS, 2018, APPL SOFT COMPUT, V70, P980, DOI 10.1016/j.asoc.2017.06.030; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Miranda EBP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216323; Miranda LS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215229; Mohammadi S, 2019, ECOL INFORM, V52, P7, DOI 10.1016/j.ecoinf.2019.04.003; Moritz C, 2013, SCIENCE, V341, P504, DOI 10.1126/science.1237190; Nembrini S, 2018, BIOINFORMATICS, V34, P3711, DOI 10.1093/bioinformatics/bty373; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Ordiz A, 2017, OECOLOGIA, V185, P191, DOI 10.1007/s00442-017-3948-7; Paudel PK, 2015, APPL GEOGR, V56, P127, DOI 10.1016/j.apgeog.2014.11.018; Pauli BP, 2019, NAT AREA J, V39, P142, DOI 10.3375/043.039.0202; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Peterson A. T., 2011, ECOLOGICAL NICHES GE; Pinto N, 2009, LANDSCAPE ECOL, V24, P253, DOI 10.1007/s10980-008-9303-y; Piri Sahragard H, 2018, J MT SCI-ENGL, V15, P2159, DOI 10.1007/s11629-018-4898-1; Pulsford I., 2011, CONNECTIVITY CONSERV; RCore Team, 2020, R LANG ENV STAT COMP; Ribeiro BR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165073; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Rouget M, 2003, BIOL CONSERV, V112, P63, DOI 10.1016/S0006-3207(02)00395-6; Samui P, 2008, COMPUT GEOTECH, V35, P419, DOI 10.1016/j.compgeo.2007.06.014; Saura S, 2007, LANDSCAPE URBAN PLAN, V83, P91, DOI 10.1016/j.landurbplan.2007.03.005; Senay SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071218; Singleton P.H., 2002, LANDSCAPE PERMEABILI; Smeraldo S, 2020, BIODIVERS CONSERV, P1; Andrade-Diaz MS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221901; Spitz F, 1999, J APPL ECOL, V36, P317, DOI 10.1046/j.1365-2664.1999.00400.x; Stohlgren TJ, 2010, RISK ANAL, V30, P224, DOI 10.1111/j.1539-6924.2009.01343.x; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Su JH, 2018, ECOL EVOL, V8, P11887, DOI 10.1002/ece3.4645; Sutcliffe OL, 2003, LANDSCAPE URBAN PLAN, V63, P15, DOI 10.1016/S0169-2046(02)00153-6; Tanner-McAllister SL, 2017, J ENVIRON MANAGE, V204, P510, DOI 10.1016/j.jenvman.2017.09.038; Veronesi F, 2014, CARTOGR J, V51, P291, DOI 10.1179/1743277414Y.0000000100; Wilson RR, 2017, BIOL CONSERV, V214, P288, DOI 10.1016/j.biocon.2017.08.005; Yeh CC, 2014, INFORM SCIENCES, V254, P98, DOI 10.1016/j.ins.2013.07.011; Yin YJ, 2019, J GEOGR SCI, V29, P1228, DOI 10.1007/s11442-019-1655-5; Yousefi M, 2019, CONTEMP PROBL ECOL+, V12, P394, DOI 10.1134/S1995425519040127; Yusefi G.HCV, 2014, ANN M 23 INT C BEAR, P5; Zehzad B, 1999, STATUS CONSERVATION; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0; [张月丛 ZHANG Yuecong], 2008, [地理研究, Geographical Research], V27, P745; Ziaie H., 2008, FIELD GUIDE MAMMALS; Zimmermann N. E., 2017, HABITAT SUITABILITY, DOI [10.1017/9781139028271, DOI 10.1017/9781139028271]	129	6	6	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242432	10.1371/journal.pone.0242432	http://dx.doi.org/10.1371/journal.pone.0242432			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206701	Green Published, gold			2022-12-26	WOS:000595265900048
J	Baumler, W; Schicho, A; Schaible, J; Verloh, N; Senk, K; Wiggermann, P; Stroszczynski, C; Beyer, LP				Baeumler, Wolf; Schicho, Andreas; Schaible, Jan; Verloh, Niklas; Senk, Karin; Wiggermann, Phillip; Stroszczynski, Christian; Beyer, Lukas Phillip			Changes in gadoxetic-acid-enhanced MR imaging during the first year after irreversible electroporation of malignant hepatic tumors	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; LIVER METASTASES; THERMAL ABLATION; SAFETY; EFFICACY; THERAPY; MODEL	Purpose To evaluate the appearance and size of ablation zones in gadoxetic-acid-enhanced magnetic resonance imaging (MRI) during the first year after irreversible electroporation (IRE) of primary or secondary hepatic malignancies and to investigate potential correlations to clinical features. Material and methods The MRI-appearance of the ablation area was assessed 1-3 days, 6 weeks, 3 months, 6 months, 9 months and 1 year after IRE. The size of the ablation zone and signal intensities of each follow-up control were compared. Moreover, relationships between clinical features and the MRI-appearance of the ablation area 1-3 days after IRE were analyzed. Results The ablation zone size decreased from 5.6 +/- 1.4 cm (1-3 days) to 3.7 +/- 1.2 cm (1 year). A significant decrease of central hypointensities was observed in T2-blade- (3 months), T2 haste- (6 weeks; 3 months; 6 months; 1 year), T1 arterial phase- (3 months; 1 year), and diffusion-sequences (6 weeks; 3 months; 6 months; 9 months; 1 year). The unenhanced T1-sequences showed significantly increasing central hypointensities (6 weeks; 3 months; 6 months; 9 months; 1 year). Significantly increasing peripheral hypointensities were detected in T1 arterial phase- (3 months; 6 months; 9 months; 1 year) and in T1 portal venous phase-sequences (6 weeks; 3 months; 6 months; 9 months; 1 year). Peripheral hypointensities of unenhanced T1-sequences decreased significantly 1 year after IRE. 1-3 days after IRE central T1 portal venous hypo- or isointensities were detected significantly more often than hyperintensities, if more than 3 IRE electrodes were used. Conclusion Hepatic IRE results in continuous reduction of ablation zone size during the first postinterventional year. In addition to centrally decreasing T1-signal and almost steadily increasing signal in the enhanced T2 haste-, diffusion- and T1 arterial phase-sequences, there is a trend toward long-term decreasing T1 arterial- and portal venous MRI-signal intensity of the peripheral ablation area, probably representing a region of reversible electroporation.	[Baeumler, Wolf; Schicho, Andreas; Schaible, Jan; Verloh, Niklas; Senk, Karin; Stroszczynski, Christian] Univ Hosp Regensburg, Dept Radiol, Regensburg, Germany; [Wiggermann, Phillip] Hosp Braunschweig, Dept Radiol & Nucl Med, Braunschweig, Germany; [Beyer, Lukas Phillip] Ernst von Bergmann Hosp, Dept Diagnost & Intervent Radiol, Potsdam, Germany	University of Regensburg; Klinikum Ernst von Bergmann	Baumler, W (corresponding author), Univ Hosp Regensburg, Dept Radiol, Regensburg, Germany.	wolf.baeumler@ukr.de	Wiggermann, Philipp/AAY-6759-2021; Verloh, Niklas/AAS-5386-2021; Beyer, Lukas/B-2496-2019; Beyer, Lukas/AAJ-7242-2020	Verloh, Niklas/0000-0002-8424-5827; Beyer, Lukas/0000-0002-2498-920X; Baumler, Wolf/0000-0003-0594-0213				Ahmed M, 2014, J VASC INTERV RADIOL, V25, P1706, DOI 10.1016/j.jvir.2014.09.005; Barabasch A, 2017, INVEST RADIOL, V52, P23, DOI 10.1097/RLI.0000000000000301; Breen MS, 2004, J MAGN RESON IMAGING, V20, P475, DOI 10.1002/jmri.20143; Cannon R, 2013, J SURG ONCOL, V107, P544, DOI 10.1002/jso.23280; Felker ER, 2017, AM J ROENTGENOL, V208, P1141, DOI 10.2214/AJR.16.17207; Gazelle GS, 2000, RADIOLOGY, V217, P633, DOI 10.1148/radiology.217.3.r00dc26633; Granata V, 2015, AM J ROENTGENOL, V204, P1000, DOI 10.2214/AJR.14.12509; Guo Y, 2010, CANCER RES, V70, P1555, DOI 10.1158/0008-5472.CAN-09-3067; Hosein PJ, 2014, J VASC INTERV RADIOL, V25, P1233, DOI 10.1016/j.jvir.2014.04.007; Kang TW, 2014, RADIOLOGY, V270, P888, DOI 10.1148/radiol.13130753; Kim SW, 2009, KOREAN J RADIOL, V10, P366, DOI 10.3348/kjr.2009.10.4.366; Kingham TP, 2012, J AM COLL SURGEONS, V215, P379, DOI 10.1016/j.jamcollsurg.2012.04.029; Lewin JS, 1998, JMRI-J MAGN RESON IM, V8, P40, DOI 10.1002/jmri.1880080112; Meloni MF, 2011, J VASC INTERV RADIOL, V22, P947, DOI 10.1016/j.jvir.2011.03.012; Padia SA, 2016, RADIOLOGY, V278, P285, DOI 10.1148/radiol.2015150031; Philips P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076260; Sasson AR, 2002, SEMIN ONCOL, V29, P107, DOI 10.1053/sonc.2002.31676; Thomson KR, 2011, J VASC INTERV RADIOL, V22, P611, DOI 10.1016/j.jvir.2010.12.014	18	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242093	10.1371/journal.pone.0242093	http://dx.doi.org/10.1371/journal.pone.0242093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201902	gold, Green Published			2022-12-26	WOS:000595003900006
J	Henri, DA; Martinez-Levasseur, LM; Weetaltuk, S; Mallory, ML; Gilchrist, HG; Jean-Gagnon, F				Henri, Dominique A.; Martinez-Levasseur, Laura M.; Weetaltuk, Salamiva; Mallory, Mark L.; Gilchrist, H. Grant; Jean-Gagnon, Frankie			Inuit knowledge of Arctic Terns (Sterna paradisaea) and perspectives on declining abundance in southeastern Hudson Bay, Canada	PLOS ONE			English	Article							TRADITIONAL ECOLOGICAL KNOWLEDGE; CLIMATE-CHANGE; POPULATION; SEABIRDS; INDICATORS; COLONIES; NUNAVIK; TRENDS; QUEBEC; GULLS	The Arctic Tern (Sterna paradisaea; takatakiaq in Inuttitut) breeds in the circumpolar Arctic and undertakes the longest known annual migration. In recent decades, Arctic Tern populations have been declining in some parts of their range, and this has been a cause of concern for both wildlife managers and Indigenous harvesters. However, limited scientific information is available on Arctic Tern abundance and distribution, especially within its breeding range in remote areas of the circumpolar Arctic. Knowledge held by Inuit harvesters engaged in Arctic Tern egg picking can shed light on the ecology, regional abundance and distribution of this marine bird. We conducted individual interviews and a workshop involving 12 Inuit harvesters and elders from Kuujjuaraapik, Nunavik (northern Quebec), Canada, to gather their knowledge of Arctic Tern cultural importance, ecology, and stewardship. Interview contributors reported a regional decline in Arctic Tern numbers which appeared in the early 2000s on nesting islands near Kuujjuaraapik. Six possible factors were identified: (1) local harvest through egg picking; (2) nest disturbance and predation; (3) abandonment of tern nesting areas (i.e., islands that have become connected to the mainland due to isostatic rebound); (4) climate change; (5) natural abundance cycles within the Arctic Tern population; and (6) decline of the capelin (Mallotus villosus) in the region. Recommendations from Inuit contributors related to Arctic Tern stewardship and protection included: (1) conduct more research; (2) let nature take its course; (3) conduct an awareness campaign; (4) implement an egg picking ban; (5) coordinate local egg harvest; (6) start 'tern farming'; (7) protect Arctic Terns across their migration route; and (8) harvest foxes predating on terns. Our study highlighted complementarities between Inuit knowledge and ecological science, and showed that Inuit harvesters can make substantial contributions to ongoing and future Arctic tern research and management initiatives.	[Henri, Dominique A.; Martinez-Levasseur, Laura M.] Environm & Climate Change Canada, Wildlife Res Div, Montreal, PQ, Canada; [Weetaltuk, Salamiva] Local Nunavimmi Umajulivijiit Katujaqatigininga, Kuujjuaraapik, PQ, Canada; [Mallory, Mark L.] Acadia Univ, Biol Dept, Wolfville, NS, Canada; [Gilchrist, H. Grant] Environm & Climate Change Canada, Wildlife Res Div, Natl Wildlife Res Ctr, Ottawa, ON, Canada; [Jean-Gagnon, Frankie] Nunavik Marine Reg Wildlife Board, Inukjuak, PQ, Canada	Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada; Acadia University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Wildlife Research Division - Environment Canada	Henri, DA (corresponding author), Environm & Climate Change Canada, Wildlife Res Div, Montreal, PQ, Canada.	dominique.henri@canada.ca		Jean-Gagnon, Frankie/0000-0002-0280-6767; Henri, Dominique/0000-0002-1280-1919; Martinez-Levasseur, Laura M./0000-0001-8909-5250	Nunavik Marine Region Wildlife Board; Environment and Climate Change Canada	Nunavik Marine Region Wildlife Board; Environment and Climate Change Canada	This study was funded by the Nunavik Marine Region Wildlife Board (https://nmrwb.ca/) and Environment and Climate Change Canada (http://ec.gc.ca/default.asp?lang=En&n=BD3CE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, J ONCOL PRACT, V2, P67; [Anonymous], 2012, DFO CAN SCI ADVIS SE; Ban NC, 2018, NAT ECOL EVOL, V2, P1680, DOI 10.1038/s41559-018-0706-0; Barry, 2008, 16 CAFF; Berkes F, 2000, ECOL APPL, V10, P1251, DOI 10.1890/1051-0761(2000)010[1251:ROTEKA]2.0.CO;2; Berkes F., 2012, SACRED ECOLOGY TRADI; Black AL, 2006, FORAGING AREA CHARAC; Breton-Honeyman K, 2016, CAN J ZOOL, V94, P713, DOI 10.1139/cjz-2015-0259; Brindley E., 1999, Atlantic Seabirds, V1, P135; Brook RK, 2005, HUM ECOL, V10, P2; Buren AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087589; Burnham Kurt K., 2017, Seabird, V30, P39; Carscadden JE, 2002, ICES J MAR SCI, V59, P1027, DOI 10.1006/jmsc.2002.1235; Creswell J.W., 2003, RES DESIGN QUALQUAN, DOI DOI 10.2307/1523157; Danielsen F, 2014, POLAR GEOGR, V37, P69, DOI 10.1080/1088937X.2014.890960; Davis A, 2003, HUM ECOL, V31, P463, DOI 10.1023/A:1025075923297; Devlin CM, 2008, AUK, V125, P850, DOI 10.1525/auk.2008.07060; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Dorais L.-J., 1997, QUAQTAQ MODERNITY ID; Drury WH, 1960, BREEDING ACTIVITIES, P63; Egevang C, 2010, MIGRATION BREEDING B; Egevang C, 2011, WATERBIRDS, V34, P107, DOI 10.1675/063.034.0114; Egevang C, 2010, P NATL ACAD SCI USA, V107, P2078, DOI 10.1073/pnas.0909493107; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Ferguson MAD, 1997, ARCTIC, V50, P17; Fienup-Riordan Ann, 1990, ETUDES INUIT STUDIES, V14, P23; Fijn RC, 2013, ARDEA, V101, P3, DOI 10.5253/078.101.0102; Gaston AJ, 2012, POLAR BIOL, V35, P1221, DOI 10.1007/s00300-012-1168-5; Gilchrist G, 2005, ECOL SOC, V10; Gilchrist HG, 1999, BIOL CONSERV, V87, P21, DOI 10.1016/S0006-3207(98)00045-7; Gilchrist HG, 1999, ARCTIC, V52, P325; Government of Canada, 2016, CENS PROF 2016 CENSK; Government of Canada, 2018, GOVT CANADA TRICOUNC; Government of Nunavut, 2013, INC IN SOC VAL; Hatch J.J., 2002, BIRDS N AM ONLINE, DOI [10.2173/bna.707, DOI 10.2173/BNA.707]; Henri DA, 2018, ECOL SOC, V23, DOI 10.5751/ES-09289-230122; Henton J.A., 2006, GEOMATICA, V60, P173; Huntington HP, 2011, NATURE, V478, P182, DOI 10.1038/478182a; Huntington HP, 1998, ARCTIC, V51, P237, DOI 10.14430/arctic1065; Inuit Tapiriit Kanatami, 2018, INUIT STAT PROFILE, DOI [10.1021/ja501569t, DOI 10.1021/JA501569T]; Iverson SA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3128; Karetak J., 2017, INUIT QAUJIMAJATUQAN; Kutz S, 2019, SCIENCE, V364, P1135, DOI 10.1126/science.aau6170; Laidler GJ, 2006, CLIMATIC CHANGE, V78, P407, DOI 10.1007/s10584-006-9064-z; Lariviere V, 2011, VULNERABILITE ADAPTA; Maftei M, 2015, POLAR RES, V34, DOI 10.3402/polar.v34.25055; Mallory ML, 2010, ARCTIC, V63, P359; Mallory ML, 2018, ARCT SCI, V4, P624, DOI 10.1139/as-2017-0019; Mallory ML, 2017, POLAR BIOL, V40, P1515, DOI 10.1007/s00300-016-2072-1; Mallory ML, 2003, POLAR RES, V22, P399, DOI 10.1111/j.1751-8369.2003.tb00121.x; Mallory ML, 2003, ARCTIC, V56, P293; Martin D, 2007, ARCTIC, V60, P195; Nunavik-Marine-Regional-Wildlife-Board, 2018, NUN IN KNOWL OBS POL; Petersen A, 2015, ARCTIC, V68, P107, DOI 10.14430/arctic4462; Pratte I, 2016, POLAR BIOL, V39, P1597, DOI 10.1007/s00300-015-1884-8; Qikiqtani Inuit Association, 2014, QIK TRUTH COMM THEM; Service CN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101595; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Stempniewicz L, 2014, POLAR REC, V50, P216, DOI 10.1017/S0032247413000053; Tengo M, 2017, CURR OPIN ENV SUST, V26-27, P17, DOI 10.1016/j.cosust.2016.12.005; Tobias TN, 2009, ESSENTIAL DATA COLLE; Usher PJ, 2000, ARCTIC, V53, P183, DOI 10.14430/arctic849; Vader W, 1990, STUD AVIAN BIOL, V14; VONMORS I, 1993, ARCTIC ALPINE RES, V25, P15, DOI 10.2307/1551475; Wenzel GW, 2004, ARCTIC ANTHROPOL, V41, P238, DOI 10.1353/arc.2011.0067; White G, 2006, ARCTIC, V59, P401; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; 2015, GERONTOLOGIST, V55, P1	69	4	4	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242193	10.1371/journal.pone.0242193	http://dx.doi.org/10.1371/journal.pone.0242193			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ5ZL	33201915	Green Published, gold			2022-12-26	WOS:000595003900029
J	Cenek, J; Tsai, JL; Sasinka, C				Cenek, Jiri; Tsai, Jie-Li; Sasinka, Cenek			Cultural variations in global and local attention and eye-movement patterns during the perception of complex visual scenes: Comparison of Czech and Taiwanese university students	PLOS ONE			English	Article							AUTOBIOGRAPHICAL MEMORY; INDIVIDUAL-DIFFERENCES; UNITED-STATES; COGNITION; TASK; BIAS; EQUIVALENCE; CHINESE; THOUGHT; FOREST	Previous research on cross-cultural differences in visual attention has been inconclusive. Some studies have suggested the existence of systematic differences in global and local attention and context sensitivity, while others have produced negative or mixed results. The objective in this study was to examine the similarities and differences in holistic and analytic cognitive styles in a sample of Czech and Taiwanese university students. Two cognitive tasks were conducted: a Compound Figures Test and a free-viewing scene perception task which manipulated several focal objects and measured eye-movement patterns. An analysis of the reaction times in the Compound Figures Test showed no clear differences between either sample. An analysis of eye-movement metrics showed certain differences between the samples. While Czechs tended to focus relatively more on the focal objects measured by the number of fixations, the Taiwanese subjects spent more time fixating on the background. The results were consistent for scenes with one or two focal objects. The results of a correlation analysis of both tasks showed that they were unrelated. These results showed certain differences between the samples in visual perception but were not as systematic as the theory of holistic and analytic cognitive styles would suggest. An alternative model of cross-cultural differences in cognition and perception is discussed.	[Cenek, Jiri] Mendel Univ Brno, Fac Reg Dev & Int Studies, Dept Social Studies, Brno, Czech Republic; [Tsai, Jie-Li] Natl Chengchi Univ, Dept Psychol, Ctr Mind Brain & Learning, Lab Eye Movements & Reading, Taipei, Taiwan; [Sasinka, Cenek] Masaryk Univ, Fac Arts, Div Informat & Lib Studies, Brno, Czech Republic	Mendel University in Brno; National Chengchi University; Masaryk University Brno	Cenek, J (corresponding author), Mendel Univ Brno, Fac Reg Dev & Int Studies, Dept Social Studies, Brno, Czech Republic.	jiri.cenek@mendelu.cz	Šašinka, Čeněk/AAT-8643-2021; Čeněk, Jiří/D-7919-2018; Sasinka, Cenek/AAX-5558-2021	Šašinka, Čeněk/0000-0001-6319-5317; Čeněk, Jiří/0000-0002-2543-5532; 	Ministry of Education, R. O. C. (Taiwan); Czech Science Foundation [GC19-09265J]	Ministry of Education, R. O. C. (Taiwan); Czech Science Foundation(Grant Agency of the Czech Republic)	The design of this research and data gathering conducted by JC in the Republic of China (Taiwan) were supported by a Short-Term Research Award subsidy of the Ministry of Education, R. O. C. (Taiwan; https://english.moe.gov.tw/cp-24-16836-FEE8B-1.html).Data gathering in the Czech Republic conducted by CS was supported by the Czech Science Foundation (GC19-09265J: The Influence of Socio-Cultural Factors and Writing Systems on the Perception and Cognition of Complex Visual Stimuli; https://gacr.cz/en/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEgisdottir S, 2008, COUNS PSYCHOL, V36, P188, DOI 10.1177/0011000007305384; Alotaibi A, 2017, CONSCIOUS COGN, V55, P254, DOI 10.1016/j.concog.2017.09.002; [Anonymous], 2018, CLIN DIABETOLOGY, DOI DOI 10.3390/IJGI7110427; [Anonymous], 1978, US SOC PSYCHOL; Arieli S, 2018, J EXP PSYCHOL GEN, V147, P789, DOI 10.1037/xge0000444; BORNSTEIN MH, 1990, INT J BEHAV DEV, V13, P289, DOI 10.1177/016502549001300303; Caparos S, 2015, COGNITION, V134, P155, DOI 10.1016/j.cognition.2014.10.006; Caparos S, 2013, PSYCHOL SCI, V24, P206, DOI 10.1177/0956797612452569; Castelhano MS, 2009, J VISION, V9, DOI 10.1167/9.3.6; Cenek J, 2019, CESK PSYCHOL, V63, P42; CHIU LH, 1972, INT J PSYCHOL, V7, P235, DOI 10.1080/00207597208246604; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Cuneo F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203115; de Fockert JW, 2014, COGNITION EMOTION, V28, P541, DOI 10.1080/02699931.2013.839939; Dong Qiumin, 2007, J BUSINESS SOC, V20, P204; Dong XW, 2019, SOC PSYCHOL PERS SCI, V10, P966, DOI 10.1177/1948550618808868; Duan ZH, 2016, J EYE MOVEMENT RES, V9, DOI 10.16910/jemr.9.6.1; Evans K, 2009, Q J EXP PSYCHOL, V62, P276, DOI 10.1080/17470210802373720; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Greene MR, 2012, VISION RES, V62, P1, DOI 10.1016/j.visres.2012.03.019; Grossmann I, 2011, SOC PSYCHOL PERS SCI, V2, P81, DOI 10.1177/1948550610377119; Hakim N, 2017, SOC PSYCHOL PERS SCI, V8, P142, DOI 10.1177/1948550616667613; Han JJ, 1998, DEV PSYCHOL, V34, P701, DOI 10.1037/0012-1649.34.4.701; He J, 2013, PERS INDIV DIFFER, V55, P794, DOI 10.1016/j.paid.2013.06.017; Hofstede G., 2001, CULTURES CONSEQUENCE; Ishii K, 2013, ASIAN J SOC PSYCHOL, V16, P123, DOI 10.1111/ajsp.12011; Ji LJ, 2000, PERS SOC PSYCHOL B, V26, P585, DOI 10.1177/0146167200267006; Kardan O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11570-w; Kitayama S, 2006, J PERS SOC PSYCHOL, V91, P369, DOI 10.1037/0022-3514.91.3.369; Kiyokawa S, 2012, COGNITION, V124, P16, DOI 10.1016/j.cognition.2012.03.009; Knight N, 2007, J COGN CULT, V7, P283, DOI 10.1163/156853707X208512; Koster M, 2017, NEUROIMAGE, V163, P413, DOI 10.1016/j.neuroimage.2017.08.008; Kozhevnikov M, 2014, PSYCHOL SCI PUBL INT, V15, P3, DOI 10.1177/1529100614525555; Kuhnen U, 2001, J CROSS CULT PSYCHOL, V32, P365; Kukaova M., 2017, THESIS; Lacko D., 2018, THESIS; Masuda T, 2006, COGNITIVE SCI, V30, P381, DOI 10.1207/s15516709cog0000_63; Masuda T, 2016, J CROSS CULT PSYCHOL, V47, P997, DOI 10.1177/0022022116653830; McKone E, 2010, VISION RES, V50, P1540, DOI 10.1016/j.visres.2010.05.010; Miyamoto Y, 2006, PSYCHOL SCI, V17, P113, DOI 10.1111/j.1467-9280.2006.01673.x; NAVON D, 1977, COGNITIVE PSYCHOL, V9, P353, DOI 10.1016/0010-0285(77)90012-3; Nisbett RE, 2005, TRENDS COGN SCI, V9, P467, DOI 10.1016/j.tics.2005.08.004; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Norenzayan A, 2002, COGNITIVE SCI, V26, P653, DOI 10.1207/s15516709cog2605_4; Nosal CS, 1990, PSYCHOL MODELE UMYSU; Opach T, 2018, CARTOGR GEOGR INF SC, V45, P400, DOI 10.1080/15230406.2017.1364169; Orquin JL, 2018, BEHAV RES METHODS, V50, P1645, DOI 10.3758/s13428-017-0998-z; Oyserman D, 2008, PSYCHOL BULL, V134, P311, DOI 10.1037/0033-2909.134.2.311; Peng KP, 1999, AM PSYCHOL, V54, P741, DOI 10.1037/0003-066X.54.9.741; Popelka S, 2018, EYE TRACKING AND VISUALIZATION (ETVIS 2018), DOI 10.1145/3205929.3205932; Popelka S, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/9172506; R Core Team, 2017, R A LANGUAGE AND ENV; Rayner K, 2007, VISION RES, V47, P2714, DOI 10.1016/j.visres.2007.05.007; Rayner K, 2009, J EXP PSYCHOL LEARN, V35, P254, DOI 10.1037/a0013508; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Sasinka C, 2019, CARTOGR J, V56, P175, DOI 10.1080/00087041.2017.1414018; Sasinka C, 2017, ISPRS INT J GEO-INF, V6, DOI 10.3390/ijgi6120407; Spotorno S, 2011, PERCEPTION, V40, P5, DOI 10.1068/p6524; Stachon Z, 2019, CARTOGR GEOGR INF SC, V46, P82, DOI 10.1080/15230406.2018.1470575; Steinmetz KRM, 2018, MEMORY, V26, P751, DOI 10.1080/09658211.2017.1406119; Tang YC, 2018, HUM BRAIN MAPP, V39, P2147, DOI 10.1002/hbm.23994; Tutnjevic S, 2018, EUR J DEV PSYCHOL, V15, P608, DOI 10.1080/17405629.2017.1325733; Uskul AK, 2008, P NATL ACAD SCI USA, V105, P8552, DOI 10.1073/pnas.0803874105; van de Vijver F, 1997, EUR REV APPL PSYCHOL, V47, P263; Ventura P, 2008, J EXP CHILD PSYCHOL, V100, P79, DOI 10.1016/j.jecp.2008.02.001; Muhlenen A, 2018, ATTEN PERCEPT PSYCHO, V80, P1072, DOI 10.3758/s13414-018-1534-7; Vosskuhler A, 2008, BEHAV RES METHODS, V40, P1150, DOI [10.3758/BRM.40.4.1150, 10.3758/BRM.40.4.U50]; Waxman SR, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00097; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	70	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242501	10.1371/journal.pone.0242501	http://dx.doi.org/10.1371/journal.pone.0242501			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VP	33196671	Green Published, gold			2022-12-26	WOS:000595266800029
J	Winnard, PT; Vesuna, F; Muthukumar, S; Raman, V				Winnard, Paul T., Jr.; Vesuna, Farhad; Muthukumar, Sankar; Raman, Venu			Divergent organ-specific isogenic metastatic cell lines identified using multi-omics exhibit differential drug sensitivity	PLOS ONE			English	Article							PRIMARY BREAST-CANCER; PROTEIN ABUNDANCE; PROGESTERONE; DISCORDANCE; EVOLUTION; ESTROGEN; RECEPTOR; RNA	Background Monitoring and treating metastatic progression remains a formidable task due, in part, to an inability to monitor specific differential molecular adaptations that allow the cancer to thrive within different tissue types. Hence, to develop optimal treatment strategies for metastatic disease, an important consideration is the divergence of the metastatic cancer growing in visceral organs from the primary tumor. We had previously reported the establishment of isogenic human metastatic breast cancer cell lines that are representative of the common metastatic sites observed in breast cancer patients. Methods Here we have used proteomic, RNAseq, and metabolomic analyses of these isogenic cell lines to systematically identify differences and commonalities in pathway networks and examine the effect on the sensitivity to breast cancer therapeutic agents. Results Proteomic analyses indicated that dissemination of cells from the primary tumor sites to visceral organs resulted in cell lines that adapted to growth at each new site by, in part, acquiring protein pathways characteristic of the organ of growth. RNAseq and metabolomics analyses further confirmed the divergences, which resulted in differential efficacies to commonly used FDA approved chemotherapeutic drugs. This model system has provided data that indicates that organ-specific growth of malignant lesions is a selective adaptation and growth process. Conclusions The insights provided by these analyses indicate that the rationale of targeted treatment of metastatic disease may benefit from a consideration that the biology of metastases has diverged from the primary tumor biology and using primary tumor traits as the basis for treatment may not be ideal to design treatment strategies.	[Winnard, Paul T., Jr.; Vesuna, Farhad; Muthukumar, Sankar; Raman, Venu] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Canc Imaging Res, Baltimore, MD 21218 USA; [Raman, Venu] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Raman, Venu] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Johns Hopkins University; Johns Hopkins University; Utrecht University; Utrecht University Medical Center	Raman, V (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Div Canc Imaging Res, Baltimore, MD 21218 USA.; Raman, V (corresponding author), Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA.; Raman, V (corresponding author), Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands.	vraman2@jhmi.edu	Vesuna, Farhad/G-3179-2010	Vesuna, Farhad/0000-0002-0356-5096	NCI/NIH [R01CA207208]	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NCI/NIH grant R01CA207208 to VR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarellos ML, 2014, PHARMACOGENET GENOM, V24, P564, DOI 10.1097/FPC.0000000000000086; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2019, QUALITY MANAGEMENT, V11, pS1007; Badwal SPS, 2018, WIRES ENERGY ENVIRON, V7, DOI 10.1002/wene.286; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; BRINKLEY BR, 1980, CANCER RES, V40, P3118; Brown D, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms15759, 10.1038/ncomms14944]; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Dagogo-Jack I, 2016, TRENDS CANCER, V2, P332, DOI 10.1016/j.trecan.2016.06.005; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P438, DOI 10.3322/caac.21583; Fabregat A, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1559-2; Fornasiero EF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06519-0; Genaro-Mattos TC, 2019, ACS CHEM NEUROSCI, V10, P3671, DOI 10.1021/acschemneuro.9b00248; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Herwig R, 2016, NAT PROTOC, V11, P1889, DOI 10.1038/nprot.2016.117; Hu X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10877-8; Jung J, 2018, J NEURO-ONCOL, V137, P295, DOI 10.1007/s11060-017-2717-0; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kerr Candace L, 2019, Genes Cancer, V10, P11, DOI 10.18632/genesandcancer.187; Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Lapek JD, 2017, NAT BIOTECHNOL, V35, P983, DOI 10.1038/nbt.3955; Lindstrom LS, 2012, J CLIN ONCOL, V30, P2601, DOI 10.1200/JCO.2011.37.2482; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Manson QF, 2019, CLIN EXP METASTAS, V36, P29, DOI 10.1007/s10585-018-9950-6; Mathieson T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03106-1; Mimori K, 2018, ANN GASTROENT SURG, V2, P332, DOI 10.1002/ags3.12182; Ning K, 2012, J PROTEOME RES, V11, P2261, DOI 10.1021/pr201052x; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ongaro E, 2018, FUTURE ONCOL, V14, P849, DOI 10.2217/fon-2017-0384; Robertson S, 2019, BREAST CANCER RES TR, V174, P795, DOI 10.1007/s10549-018-05119-2; Ryan CJ, 2017, CELL SYST, V5, P399, DOI 10.1016/j.cels.2017.09.011; Saeed A, 2017, BBA-MOL CELL BIOL L, V1862, P496, DOI 10.1016/j.bbalip.2017.01.007; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schwanhausser B, 2013, NATURE, V495, P126, DOI 10.1038/nature11848; Sousa A, 2019, MOL CELL PROTEOMICS, V18, pS114, DOI 10.1074/mcp.RA118.001280; Tantravedi S, 2019, TRANSL ONCOL, V12, P96, DOI 10.1016/j.tranon.2018.09.002; Tarantino P, 2020, EXPERT OPIN BIOL TH, V20, P1009, DOI 10.1080/14712598.2020.1752176; Testa Ugo, 2020, Med Sci (Basel), V8, DOI 10.3390/medsci8010018; Thangarajah F, 2018, ANTICANCER RES, V38, P6023, DOI 10.21873/anticanres.12952; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Timmer M, 2017, ANTICANCER RES, V37, P4859, DOI 10.21873/anticanres.11894; Tsai TY, 2017, SCI REP-UK, V7, DOI 10.1038/srep41452; Ullah I, 2018, J CLIN INVEST, V128, P1355, DOI 10.1172/JCI96149; Van Mechelen M, 2020, BREAST CANCER RES TR, V181, P115, DOI 10.1007/s10549-020-05597-3; van Voss MRH, 2018, ONCOGENE, V37, P63, DOI 10.1038/onc.2017.308; van Voss MRH, 2018, TRANSL ONCOL, V11, P755, DOI 10.1016/j.tranon.2018.04.001; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang J, 2017, MOL CELL PROTEOMICS, V16, P121, DOI 10.1074/mcp.M116.060301; Wang T, 2019, FRONT MED-PRC, V13, P289, DOI 10.1007/s11684-018-0667-3; Weaver BA, 2014, MOL BIOL CELL, V25, P2677, DOI 10.1091/mbc.E14-04-0916; Winnard PT, 2006, NEOPLASIA, V8, P796, DOI 10.1593/neo.06304; Winnard PT, 2017, ONCOTARGET, V8, P20266, DOI 10.18632/oncotarget.14865; Yamamoto S, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar052; Yuda S, 2019, JPN J CLIN ONCOL, V49, P426, DOI 10.1093/jjco/hyz018; Zhang C, 2018, CHEM SCI, V9, P743, DOI 10.1039/c7sc02905e	58	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242384	10.1371/journal.pone.0242384	http://dx.doi.org/10.1371/journal.pone.0242384			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196681	Green Published, gold			2022-12-26	WOS:000595266800021
J	Wang, YL; Wu, YQ; Chen, J; Guo, XR; Yan, L; Guo, YM; Wang, B; Yuan, JM				Wang, Youli; Wu, Yuqin; Chen, Jing; Guo, Xiaorui; Yan, Lei; Guo, Yuming; Wang, Bo; Yuan, Jianmin			The duration of food withdrawal affects the intestinal structure, nutrients absorption, and utilization in broiler chicken	FASEB JOURNAL			English	Article						&#946; &#8208; hydroxybutyrate; ether extract digestibility; food withdrawal; glutamate oxidation; intestinal morphology	TRUE METABOLIZABLE ENERGY; GROWTH-PERFORMANCE; ACID HOMEOSTASIS; FUEL METABOLISM; TRANSPORTER 1; URIC-ACID; DIGESTIBILITY; PROTEIN; STARVATION; CELLS	Food withdrawal is usually used for accurate feed metabolizable energy (ME) assessment in poultry, but its effects on intestinal structure and the absorption of nutrients are unclear. In this study, broilers were fed ad libitum (CT) or withdrew food for 12 (FH12), 24 (FH24), 36 (FH36), or 48 hours (FH48). We showed that food withdrawal increased the energy assimilation when compared with the CT. Food withdrawal improved the digestibility of ether extract and the level of lipid substances and fatty acid-derived beta-hydroxybutyrate in serum. Compared to the CT, food withdrawal did not influence the digestibility of starch. Due to 12 hours or longer food withdrawal duration increased glutamate oxidation and uric acid excretion, the analyzed digestibility of crude protein was underestimated, although the upregulated amino acid transporter genes. In addition, histological analysis showed that short-term food withdrawal (12 hours) increased intestinal villus height, crypt depth, and proliferative cell, whereas prolonged food withdrawal (more than 24 hours) impaired villus structure due to the decreased cell proliferation. Moreover, proteomics analysis revealed upregulated pathways in birds withdrawn food for 36 hours involved in nutrient absorption and amino acid oxidation. In conclusion, food withdrawal changes nutrient absorption and utilization, especially for amino acid and ether extract, and results in increased ME. Both glutamate oxidation and fatty acid incomplete oxidation are involved in energy supply after refeeding. In contrast to short-term food withdrawal, prolonged food withdrawal impairs the intestinal structure and villus renewal. Our findings deserve attention from nutritionists who are analyzing food digestibility.	[Wang, Youli; Wu, Yuqin; Chen, Jing; Guo, Xiaorui; Yan, Lei; Guo, Yuming; Wang, Bo; Yuan, Jianmin] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing, Peoples R China; [Yan, Lei] Shandong New Hope Liuhe Grp Co Ltd, Qingdao, Peoples R China	China Agricultural University	Wang, B; Yuan, JM (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Beijing 100193, Peoples R China.	wangbo123@cau.edu.cn; yuanjm@cau.edu.cn	Wu, Yuqin/O-1316-2019; Yuan, Jianmin/AAD-6116-2020	Wu, Yuqin/0000-0002-1762-1896; wang, youli/0000-0003-0347-778X	National Natural Science Foundation of China [32072752, 31772620]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	the National Natural Science Foundation of China, Grant/Award Number: 32072752 and 31772620	Abbasi J, 2018, JAMA-J AM MED ASSOC, V319, P215, DOI 10.1001/jama.2017.20639; ALTMANN GG, 1972, AM J ANAT, V133, P391, DOI 10.1002/aja.1001330403; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Bjornvad CR, 2004, J COMP PHYSIOL B, V174, P625, DOI 10.1007/s00360-004-0452-2; Broer S, 2017, BIOCHEM J, V474, P1935, DOI 10.1042/BCJ20160822; Burkholder KM, 2008, POULTRY SCI, V87, P1734, DOI 10.3382/ps.2008-00107; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cancedda FD, 2002, MOL CELL BIOCHEM, V239, P221, DOI 10.1023/A:1020548118241; Caruso G, 2014, FISH PHYSIOL BIOCHEM, V40, P1373, DOI 10.1007/s10695-014-9931-x; Dermadi D, 2017, CANCER RES, V77, P3352, DOI 10.1158/0008-5472.CAN-16-2860; Donsbough AL, 2010, POULTRY SCI, V89, P287, DOI 10.3382/ps.2009-00401; Gilani S, 2018, J ANIM PHYSIOL AN N, V102, pE653, DOI 10.1111/jpn.12808; HEVIA P, 1977, J NUTR, V107, P959, DOI 10.1093/jn/107.6.959; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; Ito J, 2010, AM J PHYSIOL-GASTR L, V298, pG916, DOI 10.1152/ajpgi.00429.2009; Kadim IT, 1997, BRIT POULTRY SCI, V38, P285, DOI 10.1080/00071669708417988; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karunakaran S, 2011, J BIOL CHEM, V286, P31830, DOI 10.1074/jbc.M111.229518; Kerr BJ, 2015, J ANIM SCI, V93, P2183, DOI 10.2527/jas.2014-8633; KROGDAHL A, 1981, POULTRY SCI, V60, P2480, DOI 10.3382/ps.0602480; Krogdahl A, 2005, COMP BIOCHEM PHYS A, V141, P450, DOI 10.1016/j.cbpb.2005.06.002; Li YX, 2018, J PROTEOME RES, V17, P129, DOI 10.1021/acs.jproteome.7b00431; Li YX, 2018, J ANIM SCI, V96, P3804, DOI 10.1093/jas/sky237; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; LONGSTAFF M, 1986, BRIT POULTRY SCI, V27, P435, DOI 10.1080/00071668608416901; Madsen SL, 2011, POULTRY SCI, V90, P2295, DOI 10.3382/ps.2010-01173; McLeod CJ, 2010, CURR BIOL, V20, P2100, DOI 10.1016/j.cub.2010.10.038; Mihaylova MM, 2018, CELL STEM CELL, V22, P769, DOI 10.1016/j.stem.2018.04.001; Moorefield EC, 2017, AGING-US, V9, P1898, DOI 10.18632/aging.101279; Morgan NK, 2014, ANIMAL, V8, P529, DOI 10.1017/S1751731114000068; Mountzouris KC, 2010, POULTRY SCI, V89, P58, DOI 10.3382/ps.2009-00308; Mustafa AF, 2017, POULTRY SCI, V96, P681, DOI 10.3382/ps/pew290; Newman JC, 2017, ANNU REV NUTR, V37, P51, DOI 10.1146/annurev-nutr-071816-064916; Norton M, 2017, CURR OPIN PHARMACOL, V37, P16, DOI 10.1016/j.coph.2017.07.005; PALOU A, 1980, HORM METAB RES, V12, P505, DOI 10.1055/s-2007-999187; Pan XY, 2004, J NUTR, V134, P2211, DOI 10.1093/jn/134.9.2211; Peron A, 2005, BRIT POULTRY SCI, V46, P223, DOI 10.1080/00071660500066142; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Richmond CA, 2015, CELL REP, V13, P2403, DOI 10.1016/j.celrep.2015.11.035; SHIRES A, 1979, POULTRY SCI, V58, P602, DOI 10.3382/ps.0580602; Sibbald I.R., 1989, RECENT DEV POULTRY N, P12; SIBBALD IR, 1976, POULTRY SCI, V55, P303, DOI 10.3382/ps.0550303; SIBBALD IR, 1975, POULTRY SCI, V54, P1990, DOI 10.3382/ps.0541990; Siddiqi S, 2013, BBA-MOL CELL BIOL L, V1831, P1311, DOI 10.1016/j.bbalip.2013.05.001; Song JQ, 2009, JPEN-PARENTER ENTER, V33, P411, DOI 10.1177/0148607108325178; Spanier B, 2018, COMPR PHYSIOL, V8, P843, DOI 10.1002/cphy.c170038; Stoll B, 1998, J NUTR, V128, P606, DOI 10.1093/jn/128.3.606; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Thompson KL, 2006, POULTRY SCI, V85, P1535, DOI 10.1093/ps/85.9.1535; Tome D, 2018, ANN NUTR METAB, V73, P15, DOI 10.1159/000494777; Toney MD, 2014, ARCH BIOCHEM BIOPHYS, V544, P119, DOI 10.1016/j.abb.2013.10.002; van der Schoor SRD, 2002, GASTROENTEROLOGY, V123, P1931, DOI 10.1053/gast.2002.37062; Waheed AA, 1997, LIFE SCI, V61, P2425, DOI 10.1016/S0024-3205(97)00977-6; Wang TY, 2013, EUR J CLIN INVEST, V43, P1203, DOI 10.1111/eci.12161; Wu WC, 2020, FASEB J, V34, P4852, DOI 10.1096/fj.201901994R; Yamauchi K, 1996, BRIT POULTRY SCI, V37, P909, DOI 10.1080/00071669608417922; Zeng LQ, 2012, COMP BIOCHEM PHYS A, V162, P200, DOI 10.1016/j.cbpa.2012.02.022; Zhou M, 2018, INT J CANCER, V143, P921, DOI 10.1002/ijc.31374	58	1	1	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001773R	http://dx.doi.org/10.1096/fj.202001773R		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33190300				2022-12-26	WOS:000592656600001
J	Schindler, M; Blumenthal, A; Moeller, MJ; Endlich, K; Endlich, N				Schindler, Maximilian; Blumenthal, Antje; Moeller, Marcus Johannes; Endlich, Karlhans; Endlich, Nicole			Adriamycin does not damage podocytes of zebrafish larvae	PLOS ONE			English	Article							DOXORUBICIN; NEPHROPATHY; PRONEPHROS; REVEALS; INJURY; MODEL; WT1A	Podocytes are highly specialized epithelial cells that are essential for an intact glomerular filtration barrier in the kidney. Several glomerular diseases like focal segmental glomerulosclerosis (FSGS) are initially due to podocyte injury and loss. Since causative treatments for FSGS are not available until today, drug screening is of great relevance. In order to test a high number of drugs, FSGS needs to be reliably induced in a suitable animal model. The zebrafish larva is an ideal model for kidney research due to the vast amount of offsprings, the rapid development of a simple kidney and a remarkable homology to the mammalian glomerulus. Zebrafish larvae possess a size-selective glomerular filtration barrier at 4 days post fertilization including podocytes with interdigitating foot processes that are connected by a slit membrane. Adriamycin is an anthracycline which is often used in mice and rats to induce a FSGS-like phenotype. In this study, we aimed to induce a similar phenotype to zebrafish larvae by adding adriamycin to the tank water in different concentrations. Surprisingly, zebrafish larvae did not develop glomerular injury and displayed an intact filtration barrier after treatment with adriamycin. This was shown by (immuno-) histology, our filtration assay, in vivo imaging by 2-photon microcopy, RT-(q)PCR as well as transmission electron microscopy. To summarize, adriamycin is unable to induce a podocyte-related damage in zebrafish larvae and therefore major effort must be made to establish FSGS in zebrafish larvae to identify effective drugs by screenings.	[Schindler, Maximilian; Blumenthal, Antje; Endlich, Karlhans; Endlich, Nicole] Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Germany; [Moeller, Marcus Johannes] RWTH Aachen Univ Clin, Dept Nephrol & Clin Immunol, Aachen, Germany	Greifswald Medical School; RWTH Aachen University; RWTH Aachen University Hospital	Endlich, N (corresponding author), Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Germany.	nicole.endlich@uni-greifswald.de		Endlich, Karlhans/0000-0001-6052-6061; Schindler, Maximilian/0000-0001-8549-510X	Federal Ministry of Education and Research (BMBF) [01GM1518B, 01GM1901A]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant of the Federal Ministry of Education and Research (BMBF, grant 01GM1518B, STOP-FSGS) to Nicole Endlich (NE) and (BMBF, grant 01GM1901A, STOP-FSGS) to Marcus Johannes Moeller (MJM). URL: https://www.gesundheitsforschung-bmbf.de/de/stop-fsgs-translationaler-forschungsverbundzur-verbesserung-der-diagnostik-und-therapie-9349.php The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akthar IST, 2019, J BIOCHEM MOL TOXIC, V33, DOI 10.1002/jbt.22235; Bollig F, 2009, DEVELOPMENT, V136, P2883, DOI 10.1242/dev.031773; Bose B, 2014, CLIN J AM SOC NEPHRO, V9, P626, DOI 10.2215/CJN.05810513; Cockwell P, 2020, LANCET, V395, P662, DOI 10.1016/S0140-6736(19)32977-0; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Drummond IA, 2010, METHOD CELL BIOL, V100, P233, DOI 10.1016/B978-0-12-384892-5.00009-8; Endlich N, 2018, J CELL MOL MED, V22, P2656, DOI 10.1111/jcmm.13544; Endlich N, 2014, J AM SOC NEPHROL, V25, P681, DOI 10.1681/ASN.2013020178; Floege J, 2016, LANCET, V387, P2036, DOI 10.1016/S0140-6736(16)00272-5; Fogo AB, 2003, SEMIN NEPHROL, V23, P161, DOI 10.1053/snep.2003.50015; Huang JM, 2013, KIDNEY INT, V83, P1193, DOI 10.1038/ki.2013.6; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Kroeger PT, 2017, DEV BIOL, V428, P148, DOI 10.1016/j.ydbio.2017.05.025; Lazareth H, 2020, CURR OPIN NEPHROL HY, V29, P293, DOI 10.1097/MNH.0000000000000600; Motlagh NSH, 2016, BIOMED OPT EXPRESS, V7, P2400, DOI 10.1364/BOE.7.002400; Muller T, 2011, KIDNEY INT, V80, P1055, DOI 10.1038/ki.2011.256; Pereira WD, 2015, INFLAMM RES, V64, P287, DOI 10.1007/s00011-015-0813-1; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Ponticelli C., 2019, TREATMENT PRIMARY GL; Poureetezadi SJ, 2016, KIDNEY INT, V89, P1204, DOI 10.1016/j.kint.2016.01.031; PPA, 2007, THIS DAY        0303, V16, P30; Rider SA, 2018, ZEBRAFISH, V15, P234, DOI 10.1089/zeb.2017.1527; Siegerist F, 2017, ACTA PHYSIOL, V220, P167, DOI 10.1111/apha.12754; Siegerist F, 2017, SCI REP-UK, V7, DOI 10.1038/srep43655; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Xie J, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-76; Yang JW, 2018, CLIN EXP NEPHROL, V22, P752, DOI 10.1007/s10157-018-1552-8; Zennaro C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098131; Zhang WW, 2015, J MOL CELL BIOL, V7, P489, DOI 10.1093/jmcb/mjv040; Zhang WW, 2018, ACTA BIOCH BIOPH SIN, V50, P1280, DOI 10.1093/abbs/gmy136; Zheng ZY, 2005, P NATL ACAD SCI USA, V102, P2502, DOI 10.1073/pnas.0409786102; Zhou WB, 2012, J AM SOC NEPHROL, V23, P1039, DOI 10.1681/ASN.2011080776	32	0	0	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242436	10.1371/journal.pone.0242436	http://dx.doi.org/10.1371/journal.pone.0242436			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186381	Green Published, gold			2022-12-26	WOS:000593949800040
J	Brant-Zawadzki, M; Fridman, D; Robinson, PA; Zahn, M; Chau, C; German, R; Breit, M; Bock, JR; Hara, J				Brant-Zawadzki, Michael; Fridman, Deborah; Robinson, Philip A.; Zahn, Matthew; Chau, Clayton; German, Randy; Breit, Marcus; Bock, Jason R.; Hara, Junko			SARS-CoV-2 antibody prevalence in health care workers: Preliminary report of a single center study	PLOS ONE			English	Article								Serological surveys have been conducted to establish prevalence for COVID-19 antibodies in various cohorts and communities, reporting a wide range of outcomes. The prevalence of such antibodies among healthcare workers, presumed at higher risk for infection, has been increasingly investigated, more studies are needed to better understand the risks and infection transmission in different healthcare settings. The present study reports on initial sero-surveillance conducted on healthcare workers at a regional hospital system in Orange County, California, during May and June, 2020. Study subjects were recruited from the entire hospital employee workforce and the independent medical staff. Data were collected for job duties and locations, COVID-19 symptoms, a PCR test history, travel record since January 2020, and existence of household contacts with COVID-19. A blood sample was collected from each subject for serum analysis for IgG antibodies to SARS-CoV-2. Of 2,992 tested individuals, a total 2,924 with complete data were included in the analysis. Observed prevalence of 1.06% (31 antibody positive cases), adjusted prevalence of 1.13% for test sensitivity and specificity were identified. Significant group differences between positive vs. negative were observed for age (z = 2.65, p = .008), race (p = .037), presence of fever (p < .001), and loss of smell (p < .001), but not for occupations (p = .710). Possible explanation for this low prevalence includes a relatively low local geographic community prevalence (similar to 4.4%) at the time of testing, the hospital's timely procurement of personal protective equipment, rigorous employee education, patient triage, and treatment protocol development and implementation. In addition, cross-reactive adaptive T cell mediated immunity, as recently described, may possibly play a greater role in healthcare workers than in the general population.	[Brant-Zawadzki, Michael; Fridman, Deborah; Hara, Junko] Hoag Mem Hosp, Hoag Ctr Res & Educ, Newport Beach, CA 92663 USA; [Robinson, Philip A.] Hoag Mem Hosp, Infect Prevent, Newport Beach, CA USA; [Zahn, Matthew; Chau, Clayton] Orange Cty Hlth Care Agcy, Santa Ana, CA USA; [German, Randy] Hoag Mem Hosp, Lab Adm Serv, Newport Beach, CA USA; [Breit, Marcus] Hoag Mem Hosp, Hoag Family Canc Inst, Newport Beach, CA USA; [Bock, Jason R.; Hara, Junko] Med Care Corp, Newport Beach, CA 92663 USA		Hara, J (corresponding author), Hoag Mem Hosp, Hoag Ctr Res & Educ, Newport Beach, CA 92663 USA.; Hara, J (corresponding author), Med Care Corp, Newport Beach, CA 92663 USA.	junko.hara@hoag.org		Bock, Jason/0000-0002-5415-2910; Hara, Junko/0000-0001-7704-4472	Orange County Health Care Agency; Hoag Hospital Foundation; Medical Care Corporation	Orange County Health Care Agency; Hoag Hospital Foundation; Medical Care Corporation	This study was funded by Orange County Health Care Agency and Hoag Hospital Foundation. The funder provided support in the form of salaries for MZ and CC. Medical Care Corporation provided support in the form of salary for JRB and JH. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	[Anonymous], 2020, BRIEFING RESULTS COM; [Anonymous], 2020, REPORT ITALIAN MINIS; Bendavid E, 2020, COVID 19 ANTIBODY SE, DOI [10.1101/2020.04.14.20062463, DOI 10.1101/2020.04.14.20062463]; Garcia-Basteiro AL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17318-x; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Iversen K, 2020, LANCET INFECT DIS, V20, P1401, DOI 10.1016/S1473-3099(20)30589-2; Law SK, 2020, HONG KONG MED J, V26, P264, DOI 10.12809/hkmj208601; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; MEHTA CR, 1986, ACM T MATH SOFTWARE, V12, P154, DOI 10.1145/6497.214326; Moscola J, 2020, JAMA-J AM MED ASSOC, V324, P893, DOI 10.1001/jama.2020.14765; Rosenberg ES, 2020, ANN EPIDEMIOL, V48, P23, DOI 10.1016/j.annepidem.2020.06.004; Sekine T., 2020, CELL, DOI [10.1101/2020.06.29.174888, DOI 10.1016/J.CELL.2020.08.017, 10.1016/j.cell.2020.08.017]; Sood N, 2020, JAMA-J AM MED ASSOC, V323, P2425, DOI 10.1001/jama.2020.8279; StataCorp, 2017, STAT STAT SOFTW REL; Uyoga S, 2021, SCIENCE, V371, P79, DOI 10.1126/science.abe1916	18	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0240006	10.1371/journal.pone.0240006	http://dx.doi.org/10.1371/journal.pone.0240006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180782	Green Published, Green Submitted, gold			2022-12-26	WOS:000593948000072
J	Osorio, EY; Medina-Colorado, AA; Travi, BL; Melby, PC				Osorio, E. Yaneth; Medina-Colorado, Audrie A.; Travi, Bruno L.; Melby, Peter C.			In-situ proliferation contributes to the accumulation of myeloid cells in the spleen during progressive experimental visceral leishmaniasis	PLOS ONE			English	Article							BONE-MARROW; MACROPHAGE PROLIFERATION; MAJOR INFECTION; CANCER; BLOOD; MICE; DIFFERENTIATION; MYELOPOIESIS; GENERATION; REGULATORS	Visceral leishmaniasis (VL) is characterized by expansion of myeloid cells in the liver and spleen, which leads to a severe splenomegaly associated with higher risk of mortality. This increased cellularity is thought to be a consequence of recruitment of cells to the viscera. We studied whether the local proliferation of splenic myeloid cells contributes to increased splenic cellularity. We found that a monocyte-like population of adherent splenic cells from Leishmania donovani-infected hamsters had enhanced replicative capacity ex vivo and in vivo (BrdU incorporation, p<0.0001). In vitro assays demonstrated that proliferation was more pronounced in the proinflammatory M1 environment and that intracellular infection prevented proliferation. Secondary analysis of the published splenic transcriptome in the hamster model of progressive VL revealed a gene expression signature that included division of tumoral cells (Z = 2.0), cell cycle progression (Z = 2.3), hematopoiesis (Z = 2.8), proliferation of stem cells (Z = 2.5) and overexpression of proto-oncogenes. Regulators of myeloid cell proliferation were predicted in-silico (CSF2, TLR4, IFNG, IL-6, IL-4, RTK signaling, and STAT3). The in-silico prediction was confirmed with chemical inhibitors of PI3K/AKT, MAPK and STAT3 which decreased splenic myeloid cell division ex vivo. Hamsters infected with L. donovani treated with a STAT3 inhibitor had reduced in situ splenic myeloid proliferation (p = 0.03) and parasite burden. We conclude that monocyte-like myeloid cells have increased STAT3-dependent proliferation in the spleen of hamsters with visceral leishmaniasis and that inhibition of STAT3 reduces myeloid cell proliferation and parasite burden.	[Osorio, E. Yaneth; Medina-Colorado, Audrie A.; Travi, Bruno L.; Melby, Peter C.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Medina-Colorado, Audrie A.; Melby, Peter C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Travi, Bruno L.; Melby, Peter C.] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA; [Travi, Bruno L.; Melby, Peter C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Melby, Peter C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Osorio, EY (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	ejosorio@utmb.edu		Colorado, Audrie/0000-0002-4917-666X	National Institute of Allergy and Infectious Diseases [T32AI007526, R01AI061624]; University of Texas Medical Branch	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Texas Medical Branch	This work was supported by the National Institute of Allergy and Infectious Diseases Awards T32AI007526, R01AI061624 and institutional funding from the University of Texas Medical Branch.	Abidin BM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006422; Abu-Dayyeh I, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000305; Blanchette J, 1999, EUR J IMMUNOL, V29, P3737, DOI 10.1002/(SICI)1521-4141(199911)29:11&lt;3737::AID-IMMU3737&gt;3.0.CO;2-S; Burotto M, 2014, CANCER-AM CANCER SOC, V120, P3446, DOI 10.1002/cncr.28864; Chappell J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014381; Coterell SEJ, 2000, INFECT IMMUN, V68, P1840, DOI 10.1128/IAI.68.4.1840-1848.2000; Cotterell SEJ, 2000, BLOOD, V95, P1642, DOI 10.1182/blood.V95.5.1642.005k10_1642_1651; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Dorrell C, 2004, MOL CELL BIOL, V24, P6993, DOI 10.1128/MCB.24.16.6993-7002.2004; Fleetwood AJ, 2007, J IMMUNOL, V178, P5245, DOI 10.4049/jimmunol.178.8.5245; Gallina V, 2014, AM J BLOOD RES, V4, P101; GIFAWESEN C, 1989, INFECT IMMUN, V57, P3091, DOI 10.1128/IAI.57.10.3091-3096.1989; Hamilton TA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00554; Iniesta V, 2001, J EXP MED, V193, P777, DOI 10.1084/jem.193.6.777; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kong FP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006165; Kopterides P, 2007, T ROY SOC TROP MED H, V101, P1181, DOI 10.1016/j.trstmh.2007.08.003; Kumar A, 2018, PARASITE IMMUNOL, V40, DOI 10.1111/pim.12586; Lafuse WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059509; McCabe A, 2016, EXP HEMATOL, V44, P213, DOI 10.1016/j.exphem.2016.01.003; Medina-Colorado AA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169496; Melby PC, 2001, J IMMUNOL, V166, P1912, DOI 10.4049/jimmunol.166.3.1912; MIRKOVICH AM, 1986, CLIN EXP IMMUNOL, V64, P1; Mock DJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002635; Monlish DA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00390; Moss ST, 2000, IMMUNOBIOLOGY, V202, P18, DOI 10.1016/S0171-2985(00)80048-0; Osorio EY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002417; Osorio EY, 2013, PLOS PATHOGENS; Osorio Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000962; Pereira WF, 2011, J LEUKOCYTE BIOL, V90, P1191, DOI 10.1189/jlb.1110608; Ruckerl D, 2012, BLOOD, V120, P2307, DOI 10.1182/blood-2012-02-408252; Ruijtenberg S, 2016, CELL CYCLE, V15, P196, DOI 10.1080/15384101.2015.1120925; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Sarkari B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150406; Schepers K, 2015, CELL STEM CELL, V16, P254, DOI 10.1016/j.stem.2015.02.014; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Subramanian A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137976; Swirski FK, 2014, SEMIN IMMUNOPATHOL, V36, P137, DOI 10.1007/s00281-013-0409-1; VERESS B, 1977, IMMUNOLOGY, V33, P605; WILLMAN CL, 1987, P NATL ACAD SCI USA, V84, P4480, DOI 10.1073/pnas.84.13.4480; Xiong AL, 2014, CANCERS, V6, P926, DOI 10.3390/cancers6020926; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818; Zhang X, 2014, STEM CELL RES, V13, P379, DOI 10.1016/j.scr.2014.09.007; Zimmers TA, 2003, HEPATOLOGY, V38, P326, DOI 10.1053/jhep.2003.50318; ZUCKERMAN A, 1975, EXP PARASITOL, V38, P370, DOI 10.1016/0014-4894(75)90123-X	47	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242337	10.1371/journal.pone.0242337	http://dx.doi.org/10.1371/journal.pone.0242337			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180876	gold, Green Published			2022-12-26	WOS:000593948000006
J	Sweeny, K; Rankin, K; Cheng, XR; Hou, LL; Long, FF; Meng, Y; Azer, L; Zhou, RL; Zhang, WW				Sweeny, Kate; Rankin, Kyla; Cheng, Xiaorong; Hou, Lulu; Long, Fangfang; Meng, Yao; Azer, Lilian; Zhou, Renlai; Zhang, Weiwei			Flow in the time of COVID-19: Findings from China	PLOS ONE			English	Article							MINDFULNESS; BENEFITS; WORK; EXPERIENCES; QUARANTINE	In February 2020, the Novel Coronavirus (COVID-19) was raging in Wuhan, China and quickly spreading to the rest of the world. This period was fraught with uncertainty for those in the affected areas. The present investigation examined the role of two potential coping resources during this stressful period of uncertainty: flow and mindfulness. Participants in Wuhan and other major cities affected by COVID-19 (N = 5115) completed an online survey assessing subjective experiences of flow, mindfulness, and well-being. Longer quarantine was associated with poorer well-being; flow and mindfulness were associated with better well-being on some measures. However, flow-but not mindfulness-moderated the link between quarantine length and well-being, such that people who experienced high levels flow showed little or no association between quarantine length and poorer well-being. These findings suggest that experiencing flow (typically by engaging in flow-inducing activities) may be a particularly effective way to protect against potentially deleterious effects of a period of quarantine.	[Sweeny, Kate; Rankin, Kyla; Azer, Lilian; Zhang, Weiwei] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA; [Cheng, Xiaorong] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China; [Hou, Lulu; Long, Fangfang; Meng, Yao; Zhou, Renlai] Nanjing Univ, Dept Psychol, Nanjing, Peoples R China	University of California System; University of California Riverside; Central China Normal University; Nanjing University	Sweeny, K (corresponding author), Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA.; Zhou, RL (corresponding author), Nanjing Univ, Dept Psychol, Nanjing, Peoples R China.	ksweeny@ucr.edu; rlzhou@nju.edu.cn	Zhou, Renlai/ABA-1226-2021	Zhou, Renlai/0000-0001-7035-7097; Sweeny, Kate/0000-0002-6653-422X; Azer, Lilian/0000-0002-7903-6641; Hou, Lulu/0000-0001-7825-9504				[Anonymous], 2014, TURKISH J ZOOL, V38, P1; [Anonymous], 2016, CHINA PHARM BIOTECHN, V11, P313; Asakawa K., 2004, J HAPPINESS STUD, V5, P123, DOI [10.1023/b:johs.0000035915.97836.89, DOI 10.1023/B:JOHS.0000035915.97836.89, 10.1023/B:JOHS.0000035915.97836.89]; Asakawa K, 2010, J HAPPINESS STUD, V11, P205, DOI 10.1007/s10902-008-9132-3; Bassi M, 2014, J HAPPINESS STUD, V15, P829, DOI 10.1007/s10902-013-9451-x; Batchelor S., 1992, AWAKENING W ENCOUNTE; BECK LA, 1992, J LEISURE RES, V24, P93, DOI 10.1080/00222216.1992.11969876; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Brown KW, 2007, PSYCHOL INQ, V18, P211, DOI 10.1080/10478400701598298; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Carleton RN, 2007, J ANXIETY DISORD, V21, P105, DOI 10.1016/j.janxdis.2006.03.014; Chan HL, 2016, J PAC RIM PSYCHOL, V10, DOI 10.1017/prp.2015.4; Coffey KA, 2008, J EVID-BASED INTEGR, V13, P79, DOI 10.1177/1533210108316307; Derogatis LR, 2004, SCL 90 R BRIEF SYMPT; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2009, SOC INDIC RES SER, V39, P1, DOI 10.1007/978-90-481-2354-4_1; Droit-Volet S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236465; Eisenberger R, 2005, J ORGAN BEHAV, V26, P755, DOI 10.1002/job.337; Feldman G, 2007, J PSYCHOPATHOL BEHAV, V29, P177, DOI 10.1007/s10862-006-9035-8; Fullagar CJ, 2009, J OCCUP ORGAN PSYCH, V82, P595, DOI 10.1348/096317908X357903; Garland EL, 2015, MINDFULNESS, V6, P234, DOI 10.1007/s12671-013-0250-6; Hanley AW, 2014, PERS INDIV DIFFER, V66, P146, DOI 10.1016/j.paid.2014.03.014; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Ho HCY, 2017, J CHILD FAM STUD, V26, P2852, DOI 10.1007/s10826-017-0788-3; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Isham A, 2019, ENVIRON BEHAV, V51, P431, DOI 10.1177/0013916518799826; Jackson SA, 1998, J SPORT EXERCISE PSY, V20, P358, DOI 10.1123/jsep.20.4.358; Kabat-Zinn J, 2003, CLIN PSYCHOL-SCI PR, V10, P144, DOI 10.1093/clipsy/bpg016; Keller J, 2011, J POSIT PSYCHOL, V6, P408, DOI 10.1080/17439760.2011.604041; Layous K, 2013, J HAPPINESS STUD, V14, P635, DOI 10.1007/s10902-012-9346-2; Marjanovic Z, 2007, INT J NURS STUD, V44, P991, DOI 10.1016/j.ijnurstu.2006.02.012; Martin JR, 1997, J PSYCHOTHER INTEGR, V7, P291, DOI 10.1023/B:JOPI.0000010885.18025.bc; McCaul KD, WORRY; Mosing MA, 2018, J AFFECT DISORDERS, V226, P6, DOI 10.1016/j.jad.2017.09.017; Nelson SK, 2014, PERS SOC PSYCHOL B, V40, P998, DOI 10.1177/0146167214533389; Rankin K, 2019, STRESS HEALTH, V35, P549, DOI 10.1002/smi.2888; Rankin K, 2019, EMOTION, V19, P818, DOI 10.1037/emo0000479; Reid D, 2011, CAN J OCCUP THER, V78, P50, DOI 10.2182/cjot.2011.78.1.7; Reynolds DL, 2008, EPIDEMIOL INFECT, V136, P997, DOI 10.1017/S0950268807009156; Rogatko TP, 2009, J HAPPINESS STUD, V10, P133, DOI 10.1007/s10902-007-9069-y; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Sedlmeier P, 2012, PSYCHOL BULL, V138, P1139, DOI 10.1037/a0028168; Shapiro SL, 2006, J CLIN PSYCHOL, V62, P373, DOI 10.1002/jclp.20237; Sheldon KM, 2015, SOC PSYCHOL PERS SCI, V6, P276, DOI 10.1177/1948550614555028; Sweeny K, 2017, PERS SOC PSYCHOL B, V43, P1399, DOI 10.1177/0146167217713490; Zumeta L, 2016, AN PSICOL-SPAIN, V32, P717, DOI 10.6018/analesps.32.3.261651	46	16	16	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242043	10.1371/journal.pone.0242043	http://dx.doi.org/10.1371/journal.pone.0242043			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0LY	33175915	Green Published, gold, Green Submitted			2022-12-26	WOS:000593946900057
J	Harbuwono, DS; Tahapary, DL; Tarigan, TJE; Yunir, E				Harbuwono, Dante Saksono; Tahapary, Dicky Levenus; Tarigan, Tri Juli Edi; Yunir, Em			New proposed cut-off of waist circumference for central obesity as risk factor for diabetes mellitus: Evidence from the Indonesian Basic National Health Survey	PLOS ONE			English	Article							HISTORY; SMOKING	Background Waist circumference (WC) measurement is practical to define central obesity. However, WC cut-off point might be differ based on different race or ethnicity. This study aims to analyze the optimal WC cut-off point to identify T2DM risk among Indonesian population. Method We analyzed the secondary data of national based cross-sectional study of the Indonesian Basic National Health Research 2013, comprising 24,660 adults aged >= 18 years who were assessed for fasting plasma glucose (FPG) and oral glucose tolerance test (OGTT). The new proposed cut-off point for WC was calculated using ROC curve analysis and Youden index. The odds ratio of having T2DM was calculated using logistic regression analysis. Results Increased WC was associated with worsening dysglycemia status among men and women (p<0.001). The optimal cut-off point of WC for detecting T2DM from ROC analysis was 76 for men and 80 for women. Based on this WC cut-off point, the odds ratio for having T2DM was 1.64 [95% CI 1.45-1.86, p<0.01] for men and 1.90 [95% CI 1.71-2.11 p<0.01] for women. Conclusion The newly proposed WC cut-off point of 76 for men and 80 women can be used to screen the risk of T2DM among Indonesian population.	[Harbuwono, Dante Saksono; Tahapary, Dicky Levenus; Tarigan, Tri Juli Edi; Yunir, Em] Univ Indonesia, Fac Med, Div Endocrinol, Dept Internal Med,Dr Cipto Mangunkusumo Natl Refe, Depok, Indonesia; [Harbuwono, Dante Saksono; Tahapary, Dicky Levenus] Indonesian Soc Study Obes, Jakarta, Indonesia; [Harbuwono, Dante Saksono; Tahapary, Dicky Levenus; Tarigan, Tri Juli Edi; Yunir, Em] Univ Indonesia, Fac Med, Metab Cardiovasc & Aging Cluster, Indonesian Med Educ & Res Inst, Depok, Indonesia	University of Indonesia; University of Indonesia	Harbuwono, DS (corresponding author), Univ Indonesia, Fac Med, Div Endocrinol, Dept Internal Med,Dr Cipto Mangunkusumo Natl Refe, Depok, Indonesia.; Harbuwono, DS (corresponding author), Indonesian Soc Study Obes, Jakarta, Indonesia.; Harbuwono, DS (corresponding author), Univ Indonesia, Fac Med, Metab Cardiovasc & Aging Cluster, Indonesian Med Educ & Res Inst, Depok, Indonesia.	dante.saksono@ui.ac.id			Ministry of Research and Technology of the Republic of Indonesia [NKB-1556/UN2.R3.1/HKP.05.00/2019]	Ministry of Research and Technology of the Republic of Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	DLT received research grant from Ministry of Research and Technology of the Republic of Indonesia No. NKB-1556/UN2.R3.1/HKP.05.00/2019 URL Funder:https://international.ristekdikti.go.id/The funder did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adi S, 2015, CONSENSUS MANAGEMENT; Aills L, 2008, SURG OBES RELAT DI S, V4, pS73; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Andayani T, 2010, INT J CUR PHARM RES, V2, P32; [Anonymous], 2014, DIABETES RES CLIN PR, V104, P1, DOI 10.1016/j.diabres.2012.10.001; Bennet L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3892-1; Bray GA, 2018, ENDOCR REV, V39, P79, DOI 10.1210/er.2017-00253; Dany F, 2017, FAKTOR RISIKO PREDIA; Elkafrawi NA, 2017, MENOUFIA MED J, V30, P168; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; Feller S, 2010, DTSCH ARZTEBL INT, V107, P470, DOI 10.3238/arztebl.2010.0470; Hara K, 2006, DIABETES CARE; Hastuti J, 2017, ASIA PAC J CLIN NUTR, V26, P650, DOI 10.6133/apjcn.072016.09; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Baena-Diez JM, 2016, DIABETES CARE, V39, P1987, DOI 10.2337/dc16-0614; Nathan DM, 2007, DIABETES CARE; National Institute of Health Research and Development, 2013, RISET KESEHATAN DASA; Pan A, 2015, CIRCULATION, V132, P1795, DOI 10.1161/CIRCULATIONAHA.115.017926; Peytremann-Bridevaux I, 2007, PREV MED, V44, P442, DOI 10.1016/j.ypmed.2006.11.011; Poole C, 2015, ANN EPIDEMIOL, V25, P147, DOI 10.1016/j.annepidem.2014.11.015; Program NCE, 2002, 3 REP EXP PAN DET EV; Siren R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-631; Soelistijo S.A., 2015, KONSENSUS PENGENDALI; Van Dam RM, 2001, DIABETES CARE, V24, P1454, DOI 10.2337/diacare.24.8.1454; Veghari G, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-2; Weisell RC, 2002, ASIA PAC J CLIN NUTR; WHO, 2016, GLOB REP PSOR; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; Williams PT, 2008, OBESITY, V16, P2163, DOI 10.1038/oby.2008.299; World Health Organization, 2006, DEF DIAGN DIAB MELL; Wulansari A, 2016, J GIZI PANGAN; 2019, CHEST S, V155	32	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242417	10.1371/journal.pone.0242417	http://dx.doi.org/10.1371/journal.pone.0242417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206709	gold, Green Published			2022-12-26	WOS:000595265900033
J	Jekauc, D; Nigg, C; Nigg, CR; Reichert, M; Krell-Roesch, J; Oriwol, D; Schmidt, S; Wunsch, K; Woll, A				Jekauc, Darko; Nigg, Carina; Nigg, Claudio R.; Reichert, Markus; Krell-Roesch, Janina; Oriwol, Doris; Schmidt, Steffen; Wunsch, Kathrin; Woll, Alexander			Measurement properties of the German version of the Physical Activity Enjoyment Scale for adults	PLOS ONE			English	Article							MEASUREMENT INVARIANCE; FIT INDEXES; FITNESS; METAANALYSIS; RELIABILITY; EXERCISE; VALIDITY; ANXIETY	The physical activity enjoyment scale (PACES) is a measurement instrument that is commonly used in monitoring and intervention research to assess how much people enjoy being physically active, as this has been related to physical activity adherence. However, while the measurement properties of PACES are well-researched in the English language, there is a gap of research in the German language, especially when looking at adults. Thus, the purpose of this work was to examine reliability, factorial validity, criterion-related validity, and measurement invariance across sex, age groups and time of the PACES for German-speaking adults. Data was obtained from the Motorik-Modul-Study (MoMo) in which 863 adults (53.5% female; mean age = 20.9 years) were examined. To investigate measurement invariance across age groups, data from 2,274 adolescents (50.5% female; mean age = 14.4 years) was obtained additionally. The study provided a nationwide representative sample for Germany. Results showed high internal consistency of PACES in adults (Cronbach's alpha = .94). Confirmatory factor analyses confirmed the invariance of the measure across age groups, time, and sex. Criterion-related validity could be shown as the global factor significantly correlated with overall physical activity, physical activity in sports clubs, and leisure-time physical activity. The analyses of factorial structure indicated a method effect for positively and negatively worded items. Correlated uniqueness, latent method factor and a hybrid model were applied to analyze the method effect and results indicated that the method effect of positively worded items was predictive of physical activity independently of the global factor. Overall, it can be concluded that PACES is reliable, valid and invariant measure of physical activity enjoyment to be used in German-speaking adults. Further studies are warranted to examine the factorial structure of the PACES and the consequences of the method effect.	[Jekauc, Darko; Nigg, Carina; Nigg, Claudio R.; Reichert, Markus; Krell-Roesch, Janina; Oriwol, Doris; Schmidt, Steffen; Wunsch, Kathrin; Woll, Alexander] Karlsruhe Inst Technol, Inst Sports & Sports Sci, Baden, Switzerland; [Reichert, Markus] Heidelberg Univ, Dept Psychiat & Psychotherapy, Cent Inst Mental Hlth, Fac Med, Baden, Switzerland	University of Geneva	Jekauc, D (corresponding author), Karlsruhe Inst Technol, Inst Sports & Sports Sci, Baden, Switzerland.	darko.jekauc@kit.edu	Wunsch, Kathrin/AAL-2850-2021; Nigg, Carina/AAC-2414-2021; Reichert, Markus/AAB-3696-2021	Wunsch, Kathrin/0000-0001-9400-4130; Nigg, Carina/0000-0002-0225-1503; Reichert, Markus/0000-0003-3290-0962	Federal Ministry of Education and Research [01ER1503]; Open Access Publishing Fund of Karlsruhe Institute of Technology; KIT-Publication Fund of the Karlsruhe Institute of Technology;  [20092021]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Open Access Publishing Fund of Karlsruhe Institute of Technology; KIT-Publication Fund of the Karlsruhe Institute of Technology; 	This work was developed within the Motorik-Modul Longitudinal Study (MoMo) (20092021): Physical fitness and physical activity as determinants of health development in children and adolescents. MoMo was funded by the Federal Ministry of Education and Research (funding reference number: 01ER1503) within the research program "long-term studies" in public health research. This article has been funded through the Open Access Publishing Fund of Karlsruhe Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge support by the KIT-Publication Fund of the Karlsruhe Institute of Technology.	[Anonymous], 2007, J Cardiol, V50, P547; [Anonymous], 2007, NUTR BUSINESS J, V12, P1; Arbuckle J, 2017, AMOS USERS GUIDE VER; BAGOZZI RP, 1993, J RES PERS, V27, P49, DOI 10.1006/jrpe.1993.1005; Barrett P, 2007, PERS INDIV DIFFER, V42, P815, DOI 10.1016/j.paid.2006.09.018; Battista J, 2005, CALIFORNIAN J HLTH P, V3, P108, DOI DOI 10.32398/CJHP.V3I4.1785; Bauman A, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-21; Beckett MW, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0007-2; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bollen KA, 1989, STRUCTURAL EQUATIONS; Brand R, 2018, GER J EXERC SPORT RE, V48, P48, DOI [10.1007/s12662-017-0477-9, 10.1007/s12662-017-0450-7]; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Byrne BM, 2004, STRUCT EQU MODELING, V11, P272, DOI 10.1207/s15328007sem1102_8; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Dacey M, 2008, AM J HEALTH BEHAV, V32, P570, DOI 10.5555/ajhb.2008.32.6.570; Devereux-Fitzgerald A, 2016, SOC SCI MED, V158, P14, DOI 10.1016/j.socscimed.2016.04.006; DiStefano C, 2006, STRUCT EQU MODELING, V13, P440, DOI 10.1207/s15328007sem1303_6; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; Ensari I, 2015, DEPRESS ANXIETY, V32, P624, DOI 10.1002/da.22370; Hagberg LA, 2009, SCAND J MED SCI SPOR, V19, P740, DOI 10.1111/j.1600-0838.2008.00844.x; Heesch KC, 2006, HEALTH EDUC RES, V21, P58, DOI 10.1093/her/cyl054; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jekauc D., 2015, PSYCHOLOGY, V06, P48, DOI [10.4236/psych.2015.61005, DOI 10.4236/PSYCH.2015.61005]; Jekauc D, 2012, GER J EXERC SPORT RE, V42, P126, DOI 10.1007/s12662-012-0249-5; Jekauc D, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00121; Jekauc D, 2013, J PUBLIC HEALTH-HEID, V21, P505, DOI 10.1007/s10389-013-0579-2; Jekauc D, 2013, J PEDIATR PSYCHOL, V38, P104, DOI 10.1093/jpepsy/jss088; KENDZIERSKI D, 1991, J SPORT EXERCISE PSY, V13, P50, DOI 10.1123/jsep.13.1.50; Kruk M, 2019, MENT HEALTH PHYS ACT, V16, P38, DOI 10.1016/j.mhpa.2019.03.002; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lance CE, 2002, PSYCHOL METHODS, V7, P228, DOI 10.1037//1082-989X.7.2.228; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lindwall M, 2012, J PERS ASSESS, V94, P196, DOI 10.1080/00223891.2011.645936; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Marques A, 2015, PREV MED, V81, P333, DOI 10.1016/j.ypmed.2015.09.018; Marsh HW, 2010, PSYCHOL ASSESSMENT, V22, P366, DOI 10.1037/a0019225; Mewes N, 2012, STUDY B INT COUNC SP, V63, P74; Moore JB, 2009, J APPL SPORT PSYCHOL, V21, pS116, DOI 10.1080/10413200802593612; Motl RW, 2001, AM J PREV MED, V21, P110, DOI 10.1016/S0749-3797(01)00326-9; Mullen SP, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-103; Nicholls J., 1989, COMPETITIVE ETHOS DE; Paxton RJ, 2008, RES Q EXERCISE SPORT, V79, P423; Peterhans E, 2013, J ADOLESCENT HEALTH, V53, P272, DOI 10.1016/j.jadohealth.2013.02.011; Prinsen CAC, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1555-2; Quilty LC, 2006, STRUCT EQU MODELING, V13, P99, DOI 10.1207/s15328007sem1301_5; Raykov T, 1997, APPL PSYCH MEAS, V21, P173, DOI 10.1177/01466216970212006; Rebar AL, 2015, HEALTH PSYCHOL REV, V9, P366, DOI 10.1080/17437199.2015.1022901; Reiner M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-813; Rhodes RE, 2009, ANN BEHAV MED, V38, P180, DOI 10.1007/s12160-009-9147-y; Roberts GC., 2012, HDB SPORT PSYCHOL, P1; Schwarz N, 2012, PROC INT CONF SOFTW, P1289, DOI 10.1109/ICSE.2012.6227097; Slovic P, 2007, EUR J OPER RES, V177, P1333, DOI 10.1016/j.ejor.2005.04.006; Thorndike EL, 1898, ANIMAL INTELLIGENCE, DOI [10.1126/science.7.181.818, DOI 10.1126/SCIENCE.7.181.818]; Tittlbach S, 2005, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, V48, P891, DOI 10.1007/s00103-005-1106-6; Tittlbach SA, 2017, EUR J SPORT SCI, V17, P1090, DOI 10.1080/17461391.2017.1347963; Vandenberg RJ, 2002, ORGAN RES METHODS, V5, P139, DOI 10.1177/1094428102005002001; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Wagner MO, 2014, INT J EPIDEMIOL, V43, P1410, DOI 10.1093/ije/dyt098; Wienke B, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01296; Williams D.M., 2018, AFFECT DETERMINANTS, P204; Williams DM, 2006, J SPORT EXERCISE PSY, V28, P300, DOI 10.1123/jsep.28.3.300; Williams DM, 2019, DARWINIAN HEDONISM AND THE EPIDEMIC OF UNHEALTHY BEHAVIOR, P1, DOI 10.1017/9781316275047; Woll A, 2011, EUR J PEDIATR, V170, P1129, DOI 10.1007/s00431-010-1391-4; World Health Organization, 2010, Global recommendations on physical activity for health	66	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242069	10.1371/journal.pone.0242069	http://dx.doi.org/10.1371/journal.pone.0242069			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206685	Green Published, gold			2022-12-26	WOS:000595265900028
J	Loda, T; Loffler, T; Erschens, R; Zipfel, S; Herrmann-Werner, A				Loda, Teresa; Loeffler, Tobias; Erschens, Rebecca; Zipfel, Stephan; Herrmann-Werner, Anne			Medical education in times of COVID-19: German students' expectations - A cross-sectional study	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER	Background Since the COVID-19 pandemic has affected the education of medical students, medical faculties have faced the challenge of adapting instruction to digital platforms. Although medical students are willing to support pandemic response efforts, how the crisis will affect their medical training remains uncertain. Thus, in this study, we investigated the teaching- and learning-related stressors and expectations of medical students in Germany during the COVID-19 pandemic. Methods A cross-sectional survey was distributed online to undergraduate medical students at medical faculties in Germany. Students answered questions about COVID-19 and teaching (on a 7-point Likert scale from 0 ("not at all") to 6 ("completely")) and completed mental well-being measurements, including the State-Trait Anxiety Inventory (STAI), the Generalised Anxiety Disorder scale (GAD-7) and the Perceived Health Questionnaire (PHQ-9). Descriptive data analysis, a t-test and Pearson correlations were performed to process the data. Results Medical students felt well-informed about COVID-19 in general (M = 5.64, SD = 1.28) and in the medical context (M = 5.14, SD = 1.34) but significantly less informed about the pandemic in the academic context, M = 2.47, SD = 1.49, t(371) = 31.98, p < .001. Their distress levels were high (STAI: M = 45.12, SD = 4.73) and significantly correlated with the academic context (r(p) = .164, p < .01) but not their private lives. Concerning how they were taught, they most often expected online lectures (91.7%) and live broadcasts (67.2%) and less often expected innovative digital teaching strategies, including serious games (17.3%) and virtual-reality exercises (16.7%). Discussion Medical students seem to be aware of the COVID-19 pandemic and its consequences for academic and healthcare contexts. They also seem to think that their teachers will enhance their digital competencies during the pandemic. Therefore, faculties of medicine need to rapidly and adequately digitalise their approaches to teaching.	[Loda, Teresa; Erschens, Rebecca; Zipfel, Stephan; Herrmann-Werner, Anne] Univ Hosp Tuebingen, Dept Internal Med Psychosomat Med & Psychotherapy, Tubingen, Germany; [Loeffler, Tobias; Zipfel, Stephan] Eberhard Karls Univ Tuebingen, Fac Med, Tubingen, Germany; [Herrmann-Werner, Anne] Univ Tubingen, Fac Med, Competence Ctr Univ Teaching Med, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Herrmann-Werner, A (corresponding author), Univ Hosp Tuebingen, Dept Internal Med Psychosomat Med & Psychotherapy, Tubingen, Germany.; Herrmann-Werner, A (corresponding author), Univ Tubingen, Fac Med, Competence Ctr Univ Teaching Med, Tubingen, Germany.	anne.herrmann-werner@med.uni-tuebingen.de			Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of University of Tuebingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of University of Tuebingen	We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of University of Tuebingen. The authors did not receive any salary from the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H, 2020, LANCET INFECT DIS, V20, P777, DOI 10.1016/S1473-3099(20)30226-7; Bliuc Ana-Maria, 2007, The Internet and Higher Education, V10, P231, DOI 10.1016/j.iheduc.2007.08.001; Erschens R, 2018, MED EDUC ONLINE, V23, DOI 10.1080/10872981.2018.1535738; Erschens R, 2019, MED TEACH, V41, P172, DOI 10.1080/0142159X.2018.1457213; Evans DJR, 2020, ANAT SCI EDUC, V13, P279, DOI 10.1002/ase.1963; Goldberg, 2020, NY TIMES; Huynh R, 2017, ACAD MED, V92, P430, DOI 10.1097/ACM.0000000000001596; IACOBUCCI G, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M1064; Johnson TJ, 2020, APPL SPECTROSC, V74, P851, DOI 10.1177/0003702820930009; Jowsey T, 2020, NURSE EDUC PRACT, V44, DOI 10.1016/j.nepr.2020.102775; Kovaleva A., 2012, KURZSKALA MESSUNG KO; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kvaal K, 2005, INT J GERIATR PSYCH, V20, P629, DOI 10.1002/gps.1330; Liang ZC, 2020, ACAD MED, V95, P1359, DOI 10.1097/ACM.0000000000003441; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; MAHASE E, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M1156; McGarry BJ, 2015, NURS EDUC TODAY, V35, P966, DOI 10.1016/j.nedt.2015.06.009; Miller DG, 2020, ANN INTERN MED, V173, P145, DOI 10.7326/M20-1281; Poh-Sun Goh JS, 2020, VISION USE TECHNOLOG; Sandars J., 2020, MEDEDPUBLISH, V9, P82; Singh Ravi Pratap, 2020, Diabetes Metab Syndr, V14, P661, DOI 10.1016/j.dsx.2020.05.011; Soled D, 2020, ACAD MED, V95, P1384, DOI 10.1097/ACM.0000000000003401; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Taghrir MH, 2020, ARCH IRAN MED, V23, P249, DOI [10.34172/aim.2020.06 Abstract View:, 10.34172/aim.2020.06]; Taylor W, 2020, FORTSCHR PHYS, V68, DOI 10.1002/prop.202000009; Teeman, 2020, THIS IS WHAT WE SIGN; Theoret C, 2020, MED EDUC, V54, P591, DOI 10.1111/medu.14181; Whelan A, 2020, INTERIM GUIDANCE MED; Whelan A., 2020, GUIDANCE MED STUDENT	29	45	46	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241660	10.1371/journal.pone.0241660	http://dx.doi.org/10.1371/journal.pone.0241660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206678	Green Published, gold			2022-12-26	WOS:000595265900039
J	Perez-Fons, L; Ovalle, TM; Maruthi, MN; Colvin, J; Lopez-Lavalle, LAB; Fraser, PD				Perez-Fons, Laura; Ovalle, Tatiana M.; Maruthi, M. N.; Colvin, John; Lopez-Lavalle, Luis Augusto Becerra; Fraser, Paul D.			The metabotyping of an East African cassava diversity panel: A core collection for developing biotic stress tolerance in cassava	PLOS ONE			English	Article							DISEASE; RESISTANCE; GERMPLASM	Cassava will have a vital role to play, if food security is to be achieved in Sub-Saharan Africa, especially Central and East Africa. The whitefly Bemisia tabaci poses a major threat to cassava production by small holder farmers in part due to their role as a vector of cassava mosaic begomoviruses (CMBs) and cassava brown streak ipomoviruses (CBSIs). In the present study untargeted metabolomics has been used as a tool to assess natural variation, similarities and attempts to identify trait differentiators among an East African cassava diversity panel that displayed tolerance/resistance to the effects of Bemisia tabaci infestation. The metabolome captured, was represented by 1529 unique chemical features per accession. Principal component analysis (PCA) identified a 23% variation across the panel, with geographical origin/adaption the most influential classification factors. Separation based on resistance and susceptible traits to Bemisia tabaci could also be observed within the data and was corroborated by genotyping data. Thus the metabolomics pipeline represented an effective metabotyping approach. Agglomerative Hierarchical Clustering Analysis (HCA) of both the metabolomics and genotyping data was performed and revealed a high level of similarity between accessions. Specific differentiating features/metabolites were identified, including those potentially conferring vigour to whitefly tolerance on a constitutive manner. The implications of using these cassava varieties as parental breeding material and the future potential of incorporating more exotic donor material is discussed.	[Perez-Fons, Laura; Fraser, Paul D.] Royal Holloway Univ London, Dept Biol Sci, Egham, Surrey, England; [Ovalle, Tatiana M.; Lopez-Lavalle, Luis Augusto Becerra] Int Ctr Trop Agr CIAT & Biovers Alliance, Cali, Colombia; [Maruthi, M. N.; Colvin, John] Univ Greenwich, Nat Resources Inst, Gillingham, Kent, England	University of London; Royal Holloway University London; University of Greenwich	Fraser, PD (corresponding author), Royal Holloway Univ London, Dept Biol Sci, Egham, Surrey, England.	P.Fraser@rhul.ac.uk	Gowda, Maruthi M. N./A-3507-2008	Gowda, Maruthi M. N./0000-0002-8060-866X	Natural Resources Institute, University of Greenwich; Bill and Melinda Gates Foundation [OPP1058938]	Natural Resources Institute, University of Greenwich; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The present work has been funded by Natural Resources Institute, University of Greenwich, from a grant provided by the Bill and Melinda Gates Foundation (Grant OPP1058938). The funders were involved in the provision of plant material, decision to publish and preparation of the manuscript.	Alicai T, 2007, PLANT DIS, V91, P24, DOI 10.1094/PD-91-0024; Ally HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50259-0; [Anonymous], 2009, How to feed the World in 2050; Aregbesola OZ, 2020, J PEST SCI, V93, P1225, DOI 10.1007/s10340-020-01249-z; Ceballos H, 2016, EUPHYTICA, V210, P79, DOI 10.1007/s10681-016-1701-7; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drapal M, 2019, J AGR FOOD CHEM, V67, P986, DOI 10.1021/acs.jafc.8b04769; Duitama J, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1381; Fernandez O, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1099-1; Floro VO, 2018, J AGR ECON, V69, P518, DOI 10.1111/1477-9552.12247; Fregene M, 2000, THEOR APPL GENET, V100, P678, DOI 10.1007/s001220051339; Gwandu C., 2019, African Crop Science Journal, V27, P213, DOI 10.4314/acsj.v27i2.7; Campo BVH, 2011, FOOD SECUR, V3, P329, DOI 10.1007/s12571-011-0141-4; Hillocks RJ, 2003, INT J PEST MANAGE, V49, P225, DOI 10.1080/0967087031000101061; January C. T., 2019, CIRCULATION, V140, pe125, DOI 10.1161/cir.0000000000000665; Kanju E, 2019, CROP PROT, V120, P58, DOI 10.1016/j.cropro.2019.02.013; Kaweesi T, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0216-x; Kawuki RS, 2016, BREEDING SCI, V66, P560, DOI 10.1270/jsbbs.16005; Legg JP, 2015, ADV VIRUS RES, V91, P85, DOI 10.1016/bs.aivir.2014.10.001; Leiss KA, 2009, PLANT PHYSIOL, V150, P1567, DOI 10.1104/pp.109.138131; Maruthi MN, 2019, PHYSIOL MOL PLANT P, V105, P77, DOI 10.1016/j.pmpp.2018.09.002; Maxmen A, 2019, NATURE, V565, P144, DOI 10.1038/d41586-019-00014-2; Milenovic M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00001; Mukiibi DR, 2019, CROP PROT, V115, P104, DOI 10.1016/j.cropro.2018.09.015; Mwila N., 2017, African Crop Science Journal, V25, P365; Obata T, 2020, PLANT J, V102, P1202, DOI 10.1111/tpj.14693; Omongo CA, 2012, J INTEGR AGR, V11, P327, DOI 10.1016/S2095-3119(12)60017-3; Pena-Venegas C. P., 2014, Diversity, V6, P792, DOI 10.3390/d6040792; Perez-Fons L, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2107-1; Price EJ, 2020, PLANT J, V101, P1258, DOI 10.1111/tpj.14649; Prinsloo G, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1432-y; Ranjan A, 2019, PLANT BIOTECHNOL J, V17, P1567, DOI 10.1111/pbi.13082; Sanchez-Arcos C, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00188; Shahaf N, 2013, RAPID COMMUN MASS SP, V27, P2425, DOI 10.1002/rcm.6705; Sheat S, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00567; Shirima RR, 2020, VIRUS RES, V286, DOI 10.1016/j.virusres.2020.198017; Tumwegamire S, 2018, FOOD SECUR, V10, P351, DOI 10.1007/s12571-018-0779-2; Walker TS, 2015, CROP IMPROVEMENT, ADOPTION, AND IMPACT OF IMPROVED VARIETIES IN FOOD CROPS IN SUB-SAHARAN AFRICA, P1, DOI 10.1079/9781780644011.0000	38	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242245	10.1371/journal.pone.0242245	http://dx.doi.org/10.1371/journal.pone.0242245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206704	Green Accepted, gold, Green Published			2022-12-26	WOS:000595265900071
J	Zhao, YC; Zhu, CQ; Chang, Q; Peng, P; Yang, J; Liu, CM; Liu, Y; Chen, XN; Liu, YG; Cheng, R; Wu, YJ; Wu, XT; Hu, L; Yin, J				Zhao, Yichao; Zhu, Chaoqian; Chang, Qing; Peng, Peng; Yang, Jie; Liu, Chunmei; Liu, Yang; Chen, Xiaonan; Liu, Yuanguang; Cheng, Ran; Wu, Yijie; Wu, Xiaotang; Hu, Liang; Yin, Jun			MiR-424-5p regulates cell cycle and inhibits proliferation of hepatocellular carcinoma cells by targeting E2F7	PLOS ONE			English	Article							LIVER-CANCER; INVASION; MIGRATION; MICRORNAS; MIRNA; P53	Objective This study aims to explore the mechanism of the miR-424-5p/E2F7 axis in hepatocellular carcinoma (HCC) and provide new ideas for targeted therapy of HCC. Methods Bioinformatics analysis was used to identify the target differentially expressed miRNA in HCC and predict its target gene. qRT-PCR was employed to verify the expression of miR-424-5p and E2F7 mRNA in HCC cells. Western blot was performed to detect the effect of miR-424-5p ectopic expression on the protein expression of E2F7. CCK-8 was used to detect proliferative activity of HCC cells and flow cytometry was carried out for analyzing cell cycle distribution. Dual luciferase reporter assay was conducted to verify the direct targeting relationship between miR-424-5p and E2F7. Results We observed that miR-424-5p was down-regulated in HCC cells. CCK-8 showed that overexpression of miR-424-5p inhibited cell proliferation, and flow cytometry showed that miR-424-5p could block cells in G0/G1 phase. E2F7 was up-regulated in HCC cells, and E2F7 overexpression could facilitate the proliferative ability of HCC cells and promote the cell cycle progressing from G0/G1 to S phase. Furthermore, dual-luciferase reporter assay indicated that miR-424-5p could directly down-regulate E2F7 expression. Analysis on cell function demonstrated that miR-424-5p inhibited the proliferation of HCC cells and blocked cell cycle at G0/G1 phase by targeting E2F7. Conclusion Our results proved that E2F7 was a direct target of miR-424-5p, and miR-424-5p could regulate cell cycle and further inhibit the proliferation of HCC cells by targeting E2F7.	[Zhao, Yichao; Zhu, Chaoqian; Peng, Peng; Liu, Chunmei; Liu, Yang; Chen, Xiaonan; Liu, Yuanguang; Cheng, Ran; Wu, Yijie; Yin, Jun] Tangshan Gongren Hosp, Dept Hepatobiliary Surg, Tangshan, Peoples R China; [Chang, Qing] Tangshan Gongren Hosp, Dept Head & Neck Surg, Tangshan, Peoples R China; [Yang, Jie] Tangshan Gongren Hosp, Dept Geriatr, Tangshan, Peoples R China; [Wu, Xiaotang; Hu, Liang] Shanghai Engn Res Ctr Pharmaceut Translat, Shanghai, Peoples R China		Yin, J (corresponding author), Tangshan Gongren Hosp, Dept Hepatobiliary Surg, Tangshan, Peoples R China.	yinjunarmyly@163.com						[Anonymous], 2019, QUALITY MANAGEMENT, V11, pS1007; Borel F, 2012, J HEPATOL, V56, P1371, DOI 10.1016/j.jhep.2011.11.026; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Callegari E, 2015, CELL DEATH DIFFER, V22, P46, DOI 10.1038/cdd.2014.136; Carvajal LA, 2012, GENE DEV, V26, P1533, DOI 10.1101/gad.184911.111; Du HM, 2019, LIFE SCI, V224, P1, DOI 10.1016/j.lfs.2019.03.028; Greene CM, 2013, WORLD J GASTROENTERO, V19, P5212, DOI 10.3748/wjg.v19.i32.5212; Huang Q, 2017, JPN J CLIN ONCOL, V47, P590, DOI 10.1093/jjco/hyw188; Ji ZG, 2018, AM J TRANSL RES, V10, P1784; Jinnin M, 2015, J DERMATOL, V42, P551, DOI 10.1111/1346-8138.12904; Kim NG, 2018, CANCER-AM CANCER SOC, V124, P2588, DOI 10.1002/cncr.31373; Lee D, 2017, J CLIN INVEST, V127, P1856, DOI 10.1172/JCI90253; Li D, 2019, J CELL BIOCHEM, V120, P12290, DOI 10.1002/jcb.28493; Li YJ, 2019, ONCOTARGETS THER, V12, P10441, DOI 10.2147/OTT.S224325; Liang Z, 2017, ONCOTARGET, V8, P47389, DOI 10.18632/oncotarget.17650; Liu JJ, 2018, CELL CYCLE, V17, P309, DOI 10.1080/15384101.2017.1407894; Liu ZC, 2018, INT J MOL MED, V42, P141, DOI 10.3892/ijmm.2018.3637; Ma YB, 2018, CANCER LETT, V430, P201, DOI 10.1016/j.canlet.2018.05.016; Ma YS, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0927-8; McNair C, 2018, J CLIN INVEST, V128, P341, DOI 10.1172/JCI93566; Piao LS, 2019, CANCER BIOTHER RADIO, V34, P196, DOI 10.1089/cbr.2018.2625; Shah R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153691; Wang F, 2016, DIAGN PATHOL, V11, DOI 10.1186/s13000-016-0536-9; Wang S, 2019, J CELL PHYSIOL, V234, P11610, DOI 10.1002/jcp.27818; Wang ZX, 2019, J CELL BIOCHEM, V120, P16416, DOI 10.1002/jcb.28601; Wu JB, 2019, INT J BIOL SCI, V15, P1591, DOI 10.7150/ijbs.34113; WU XW, 1994, P NATL ACAD SCI USA, V91, P3602, DOI 10.1073/pnas.91.9.3602; Yan XL, 2019, ONCOL REP, V41, P1938, DOI 10.3892/or.2018.6930; Yang HQ, 2018, ONCOL LETT, V15, P4097, DOI 10.3892/ol.2018.7879; Yu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091661; Yuzugullu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-90; Zhang X, 2019, ONCOL REP, V41, P1638, DOI 10.3892/or.2018.6948; Zhang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06248	33	13	16	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242179	10.1371/journal.pone.0242179	http://dx.doi.org/10.1371/journal.pone.0242179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201900	gold, Green Published			2022-12-26	WOS:000595003900011
J	Sakamoto, J; Ozawa, H; Nakanishi, H; Fujita, S				Sakamoto, Junichi; Ozawa, Heita; Nakanishi, Hiroki; Fujita, Shin			Oncologic outcomes after resection of para-aortic lymph node metastasis in left-sided colon and rectal cancer	PLOS ONE			English	Article								Aim The optimal surgical management strategy for para-aortic lymph node (PALN) metastasis has not attracted as much attention as surgery for liver or lung metastasis. The purpose of this retrospective study was to evaluate the oncologic outcomes after synchronous resection of PALN metastasis in left-sided colon and rectal cancer. Methods Between January 1986 and August 2016, 29 patients with pathologically positive PALN metastases who underwent curative resection at our hospital were retrospectively reviewed. We examined clinicopathological characteristics, long-term oncologic outcomes, and factors related to favorable prognosis in these patients. Results The 3-year overall survival and recurrence-free survival (RFS) rates were 50.5% and 17.2%, respectively. In total, 6 (20.7%) patients experienced no recurrence in the 3 years after surgery, while postoperative complications were seen in 9 (31.0%) patients. The 3-year RFS rate was significantly better in the pM1a group than in the pM1b/pM1c group (26.3% and 0.0%, respectively, p = 0.032). Conclusion PALN dissection for patients without other organ metastases in left-sided colon or rectal cancer is a good indication as it is for liver and lung metastasis.	[Sakamoto, Junichi; Ozawa, Heita; Nakanishi, Hiroki; Fujita, Shin] Tochigi Canc Ctr, Dept Colorectal Surg, Utsunomiya, Tochigi, Japan	Tochigi Prefectural Cancer Center	Sakamoto, J (corresponding author), Tochigi Canc Ctr, Dept Colorectal Surg, Utsunomiya, Tochigi, Japan.	jsakamoto@tochigi-cc.jp			Tochigi Cancer Center	Tochigi Cancer Center	This study was supported by the Tochigi Cancer Center founded by Tochigi prefecture. All authors listed have contributed sufficiently to this study to be included as authors.	Akiyoshi T, 2015, ANN SURG ONCOL, V22, pS614, DOI 10.1245/s10434-015-4565-5; Bae SU, 2018, CANCER RES TREAT, V50, P712, DOI 10.4143/crt.2017.100; Bae SU, 2016, ANN SURG ONCOL, V23, P1562, DOI 10.1245/s10434-015-5027-9; Choi PW, 2010, J SURG ONCOL, V101, P66, DOI 10.1002/jso.21421; Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002; Fujita S, 2014, INT J COLORECTAL DIS, V29, P1077, DOI 10.1007/s00384-014-1940-9; LEGGERI A, 1994, DIS COLON RECTUM, V37, pS54, DOI 10.1007/BF02048433; Lehnert T, 1999, BRIT J SURG, V86, P241, DOI 10.1046/j.1365-2168.1999.01010.x; Mahmoud N, 2010, DIS COLON RECTUM, V53, P1080, DOI 10.1007/DCR.0b013e3181dcadbc; Nakai N, 2017, INT J COLORECTAL DIS, V32, P999, DOI 10.1007/s00384-017-2806-8; Ogawa S, 2016, ANN SURG ONCOL, V23, P1187, DOI 10.1245/s10434-015-5021-2; Sahara K, 2019, INT J COLORECTAL DIS, V34, P1121, DOI 10.1007/s00384-019-03294-2; Shah SA, 2006, J AM COLL SURGEONS, V202, P468, DOI 10.1016/j.jamcollsurg.2005.11.008; Song SH, 2016, ANN SURG TREAT RES, V90, P29, DOI 10.4174/astr.2016.90.1.29; STEARNS M W Jr, 1959, Dis Colon Rectum, V2, P169; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Wong JSM, 2016, SURG ONCOL, V25, P411, DOI 10.1016/j.suronc.2016.09.008; Yamada K, 2019, DIGEST SURG, V36, P369, DOI 10.1159/000491100	18	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0241815	10.1371/journal.pone.0241815	http://dx.doi.org/10.1371/journal.pone.0241815			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196651	Green Submitted, Green Published, gold			2022-12-26	WOS:000595266800019
J	Aoki, T; Fukuda, K; Tanaka, C; Kamikawa, Y; Tsuji, N; Kasanami, R; Hara, T; Miyazaki, R; Tanaka, H; Asai, H; Yamamoto, N; Oishi, K; Ishii, K				Aoki, Takumi; Fukuda, Kazuhiko; Tanaka, Chiaki; Kamikawa, Yasuko; Tsuji, Nobuhiro; Kasanami, Ryoji; Hara, Taketaka; Miyazaki, Ryo; Tanaka, Hideki; Asai, Hidenori; Yamamoto, Naofumi; Oishi, Kan; Ishii, Kojiro			The relationship between sleep habits, lifestyle factors, and achieving guideline-recommended physical activity levels in ten-to-fourteen-year-old Japanese children: A cross-sectional study	PLOS ONE			English	Article							SCHOOL-AGED CHILDREN; DAYTIME SLEEPINESS; SOCIAL JETLAG; WEIGHT STATUS; DURATION; ADOLESCENTS; CHRONOTYPE; DEPRESSION; VERSION; SCALE	The current focus of meeting the physical activity guidelines for children and young people include preventing conditions such as high blood cholesterol, high blood pressure, metabolic syndrome, obesity, low bone density, depression, and injuries. However, the relationship between sleep habits and meeting physical activity guidelines is still unclear. This study aimed to assess this relationship among fifth- to eighth-grade (ages 10-14) Japanese children. This cross-sectional study included 3,123 children (boys: 1,558, girls: 1,565, mean age: 12.5 +/- 1.2 years). Questionnaires were used to assess parameters such as moderate-to-vigorous physical activity per day, school and weekend night sleep durations, social jetlag, daytime sleepiness, napping, screen time, and breakfast intake. Participants were divided into an achievement and a non-achievement group depending on their physical activity guideline achievement status (i.e., whether they met the children's physical activity guideline of 60 min or more of moderate-to-vigorous physical activity per day). Then, to determine the sleep habits in relation to the children's achievement of guideline-recommended physical activity levels, multivariate logistic regression analyses were conducted. In fifth- and sixth-grade (ages 10-12) boys, an inverse association was observed between physical activity guideline achievement and daytime sleepiness. In seventh- and eighth-grade (ages 12-14) boys, physical activity guideline achievement was inversely associated with social jetlag and skipping breakfast. Additionally, in seventh- and eighth-grade girls, physical activity guideline achievement was inversely associated with inappropriate sleep duration on weekends and screen time. These results suggest that meeting the physical activity guideline is related to favorable sleep habits in Japanese children. However, their relevance may differ by school type and gender.	[Aoki, Takumi; Oishi, Kan] Doshisha Univ, Grad Sch Hlth & Sports Sci, Kyoto, Japan; [Aoki, Takumi] Japan Soc Promot Sci, Tokyo, Japan; [Fukuda, Kazuhiko] Edogawa Univ, Coll Sociol, Chiba, Japan; [Tanaka, Chiaki] JF Oberlin Univ, Coll Hlth & Welf, Tokyo, Japan; [Kamikawa, Yasuko] Toyama Univ, Toyama, Japan; [Tsuji, Nobuhiro] Shiga Univ, Grad Sch Educ, Hikone, Shiga, Japan; [Kasanami, Ryoji] Nara Univ Educ, Fac Educ, Nara, Japan; [Hara, Taketaka] Shimane Univ, Fac Educ, Matsue, Shimane, Japan; [Miyazaki, Ryo] Shimane Univ, Fac Human Sci, Matsue, Shimane, Japan; [Tanaka, Hideki] Hiroshima Int Univ, Fac Psychol, Hiroshima, Japan; [Asai, Hidenori; Yamamoto, Naofumi] Ehime Univ, Fac Collaborat Reg Innovat, Matsuyama, Ehime, Japan; [Ishii, Kojiro] Doshisha Univ, Fac Hlth & Sports Sci, Kyoto, Japan	Doshisha University; Japan Society for the Promotion of Science; University of Toyama; Shiga University; Nara University Education; Shimane University; Shimane University; Ehime University; Doshisha University	Aoki, T (corresponding author), Doshisha Univ, Grad Sch Hlth & Sports Sci, Kyoto, Japan.; Aoki, T (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.	cyhb0001@mail4.doshisha.ac.jp	Tanaka, Chiaki/AGN-2367-2022; Fukuda, Kazuhiko/ABB-3207-2021; Miyazaki, Ryo/GPW-7412-2022	Tanaka, Chiaki/0000-0001-9113-436X; Fukuda, Kazuhiko/0000-0002-0583-5408; Miyazaki, Ryo/0000-0002-1996-709X; Aoki, Takumi/0000-0002-8587-8650; Oishi, Kan/0000-0001-5334-9730	Japan Society for the Promotion of Science [JP18J11552, JP18H01000]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was financially supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/) (JP18J11552 to TA, JP18H01000 to KI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, AUSTR HLTH SURVEY PH; [Anonymous], 2010, ACT CHILD 60 MIN; Barger LK, 2004, AM J PHYSIOL-REG I, V286, pR1077, DOI 10.1152/ajpregu.00397.2003; Bartel KA, 2015, SLEEP MED REV, V21, P72, DOI 10.1016/j.smrv.2014.08.002; Borisenkov MF, 2015, J SLEEP RES, V24, P288, DOI 10.1111/jsr.12266; Brand S, 2010, WORLD J BIOL PSYCHIA, V11, P465, DOI [10.1080/15622970903079820, 10.3109/15622970903079820]; Cave P, 2004, J JPN STUD, V30, P383, DOI 10.1353/jjs.2004.0041; CZEISLER CA, 1981, PHOTOCHEM PHOTOBIOL, V34, P239; de Souza CM, 2014, CHRONOBIOL INT, V31, P199, DOI 10.3109/07420528.2013.838575; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Dollman I, 2007, ACTA PAEDIATR, V96, P1011, DOI 10.1111/j.1651-2227.2007.00278.x; Lopez-Sanchez GF, 2018, MEDICINA-LITHUANIA, V54, DOI 10.3390/medicina54050084; Gradisar M, 2011, SLEEP MED, V12, P110, DOI 10.1016/j.sleep.2010.11.008; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Japan Society of School Health, 2018, SURV SCH CHILDR HLTH; Joint Committee for Japanese reference values the Japanese Society for Pediatric Endocrinology and the Japanese Association for Human Auxology, 2011, J JPN ASS HUM AUXO, V17, P84; Khan MKA, 2015, CAN J PUBLIC HEALTH, V106, pE277, DOI 10.17269/cjph.106.4892; Komada Y, 2016, CHRONOBIOL INT, V33, P1311, DOI 10.1080/07420528.2016.1213739; Lang C, 2016, SLEEP MED REV, V28, P32, DOI 10.1016/j.smrv.2015.07.004; Sanchez GFL, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2033-8; Malone SK, 2016, CHRONOBIOL INT, V33, P1255, DOI 10.1080/07420528.2016.1196697; Metcalf BS, 2015, MED SCI SPORT EXER, V47, P2084, DOI 10.1249/MSS.0000000000000644; Moslein/ Omlor, 2019, FINTECH HDB DIGITALI; Murase N, 2002, J HLTH WELF STAT, V49, P1; Olds TS, 2011, SLEEP, V34, P1299, DOI 10.5665/SLEEP.1266; Oshima Y, 2017, JPN J PHYS FIT SPORT, V66, P427; Paruthi S, 2016, J CLIN SLEEP MED, V12, P1549, DOI 10.5664/jcsm.6288; Pearson N, 2014, OBES REV, V15, P666, DOI 10.1111/obr.12188; Tambalis KD, 2019, NUTR DIET, V76, P328, DOI 10.1111/1747-0080.12522; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Wang LJ, 2017, J SPORT HEALTH SCI, V6, P416, DOI 10.1016/j.jshs.2017.09.001; WEVER RA, 1983, PFLUG ARCH EUR J PHY, V396, P85, DOI 10.1007/BF00584704; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wolfson AR, 1998, CHILD DEV, V69, P875, DOI 10.2307/1132351; Yang CM, 2010, PSYCHIAT CLIN NEUROS, V64, P134, DOI 10.1111/j.1440-1819.2009.02054.x; Zakrzewski-Fruer JK, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6542-6	36	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242517	10.1371/journal.pone.0242517	http://dx.doi.org/10.1371/journal.pone.0242517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0NB	33186410	Green Published, gold			2022-12-26	WOS:000593949800054
J	Kim, JY; Kim, HJ; Jung, CW; Choi, BI; Lee, DH; Park, MJ				Kim, Jeong-Yub; Kim, Hee-Jin; Jung, Chan-Woong; Choi, Byung-Il; Lee, Dae-Hee; Park, Myung-Jin			PARK7 maintains the stemness of glioblastoma stem cells by stabilizing epidermal growth factor receptor variant III	ONCOGENE			English	Article							PARKINSONS-DISEASE; CANCER-CELLS; DJ-1; IDENTIFICATION; EXPRESSION; TARGET; GLIOMA; EGFR; SOX2; ONCOGENE	PARK7 is involved in many key cellular processes, including cell proliferation, transcriptional regulation, cellular differentiation, oxidative stress protection, and mitochondrial function maintenance. Deregulation of PARK7 has been implicated in the pathogenesis of various human diseases, including cancer. Here, we aimed to clarify the effect of PARK7 on stemness and radioresistance of glioblastoma stem cells (GSCs). Serum differentiation and magnetic cell sorting of GSCs revealed that PARK7 was preferentially expressed in GSCs rather than differentiated GSCs. Immunohistochemical staining showed enhanced expression of PARK7 in glioma tissues compared to that in normal brain tissues. shRNA-mediated knockdown of PARK7 inhibited the self-renewal activity of GSCs in vitro, as evidenced by the results of neurosphere formation, limiting dilution, and soft-agar clonogenic assays. In addition, PARK7 knockdown suppressed GSC invasion and enhanced GSC sensitivity to ionizing radiation (IR). PARK7 knockdown suppressed expression of GSC signatures including nestin, epidermal growth factor receptor variant III (EGFRvIII), SOX2, NOTCH1, and OCT4. Contrarily, overexpression of PARK7 in CD133(-) non-GSCs increased self-renewal activities, migration, and IR resistance, and rescued the reduction of GSC factors under shPARK7-transfected and serum-differentiation conditions. Intriguingly, PARK7 acted as a co-chaperone of HSP90 by binding to it, protecting EGFRvIII from proteasomal degradation. Knockdown of PARK7 increased the production of reactive oxygen species, inducing partial apoptosis and enhancing IR sensitivity in GSCs. Finally, PARK7 knockdown increased mouse survival and IR sensitivity in vivo. Based on these data, we propose that PARK7 plays a pivotal role in the maintenance of stemness and therapeutic resistance in GSCs.	[Kim, Jeong-Yub; Kim, Hee-Jin; Jung, Chan-Woong; Park, Myung-Jin] Korea Inst Radiol & Med Sci, Div Radiat Canc Sci, Radiat Therapeut Dev Team, Seoul, South Korea; [Kim, Hee-Jin] Korea Univ, Sch Biomed Sci, Seoul, South Korea; [Jung, Chan-Woong] Korea Univ, Dept Life Sci, Seoul, South Korea; [Choi, Byung-Il] Korea Univ, Coll Med, Guro Hosp, Div Gastroenterol,Dept Internal Med, 148 Gurodong Ro, Seoul, South Korea; [Lee, Dae-Hee] Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Gangwon, South Korea	Korea Institute of Radiological & Medical Sciences; Korea University; Korea University; Korea University; Korea University Medicine (KU Medicine); Kangnung Wonju National University	Park, MJ (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Sci, Radiat Therapeut Dev Team, Seoul, South Korea.; Lee, DH (corresponding author), Gangneung Wonju Natl Univ, Dept Marine Food Sci & Technol, Gangwon, South Korea.	neogene@gwnu.ac.kr; mjpark@kirams.re.kr	Kim, Heejin/HII-8568-2022		Korea Institute of Radiological and Medical Sciences (KIRAMS) - Ministry of Science and ICT (MSIT), Republic of Korea [50531-2019]; Nuclear Research and Development Program of the National Research Foundation of Korea (NRF) - MSIT, Republic of Korea [NRF-2017M2A2A7A02019889]; NRF - MSIT, Republic of Korea [NRF-2019R1A2C2089249]	Korea Institute of Radiological and Medical Sciences (KIRAMS) - Ministry of Science and ICT (MSIT), Republic of Korea(Ministry of Science & ICT (MSIT), Republic of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Nuclear Research and Development Program of the National Research Foundation of Korea (NRF) - MSIT, Republic of Korea(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); NRF - MSIT, Republic of Korea(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This study was supported by a grant of the Korea Institute of Radiological and Medical Sciences (KIRAMS), funded by Ministry of Science and ICT (MSIT), Republic of Korea. (No. 50531-2019), Nuclear Research and Development Program of the National Research Foundation of Korea (NRF) funded by MSIT, Republic of Korea (No. NRF-2017M2A2A7A02019889), and NRF grant funded by MSIT, Republic of Korea (No. NRF-2019R1A2C2089249).	Ahsan A, 2012, NEOPLASIA, V14, P670, DOI 10.1593/neo.12986; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247; Bradley E, 2012, STEM CELLS, V30, P1624, DOI 10.1002/stem.1143; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Cao J, 2017, ADV EXP MED BIOL, V1037, P203, DOI 10.1007/978-981-10-6583-5_13; Cao J, 2015, BIOCHEM PHARMACOL, V93, P241, DOI 10.1016/j.bcp.2014.11.012; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Chen Y, 2012, J CANCER RES CLIN, V138, P1463, DOI 10.1007/s00432-012-1205-3; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Echeverria PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026044; Emlet DR, 2014, CANCER RES, V74, P1238, DOI 10.1158/0008-5472.CAN-13-1407; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gao X, 2011, DRUG TODAY, V47, P215, DOI 10.1358/dot.2011.47.3.1519657; Giaime E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040501; Girotto S, 2014, J BIOL CHEM, V289, P10887, DOI 10.1074/jbc.M113.535112; Hammoud MA, 1996, J NEURO-ONCOL, V27, P65, DOI 10.1007/BF00146086; Im JY, 2012, HUM MOL GENET, V21, P3013, DOI 10.1093/hmg/dds131; Jahani-Asl A, 2016, NAT NEUROSCI, V19, P798, DOI 10.1038/nn.4295; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kawate T, 2017, ADV EXP MED BIOL, V1037, P45, DOI 10.1007/978-981-10-6583-5_4; Kim J, 2015, STEM CELLS DEV, V24, P284, DOI 10.1089/scd.2014.0210; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim Y, 2012, MOL CELL PROTEOMICS, V11, P1870, DOI 10.1074/mcp.M112.017889; Knobbe CB, 2011, J PROTEOME RES, V10, P4388, DOI 10.1021/pr200225c; Kudryavtsev VA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173640; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lavictoire SJ, 2003, J BIOL CHEM, V278, P5292, DOI 10.1074/jbc.M209494200; Le Naour F, 2001, CLIN CANCER RES, V7, P3328; Lee DH, 2018, AUTOPHAGY, V14, P1870, DOI 10.1080/15548627.2018.1491212; Macedo MG, 2003, HUM MOL GENET, V12, P2807, DOI 10.1093/hmg/ddg304; Mellinghoff IK, 2005, NEW ENGL J MED, V353, P2012, DOI 10.1056/NEJMoa051918; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Oh SE, 2017, ADV EXP MED BIOL, V1037, P97, DOI 10.1007/978-981-10-6583-5_8; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Osuka S, 2017, J CLIN INVEST, V127, P415, DOI 10.1172/JCI89587; Parsanejad M, 2014, J NEUROSCI, V34, P8043, DOI 10.1523/JNEUROSCI.1244-13.2014; Raninga PV, 2017, ADV EXP MED BIOL, V1037, P67, DOI 10.1007/978-981-10-6583-5_6; Raninga Prahlad V, 2014, Oncoscience, V1, P95; Ren HG, 2011, J BIOL CHEM, V286, P35308, DOI 10.1074/jbc.M110.207134; Rybak AP, 2013, CELL SIGNAL, V25, P2734, DOI 10.1016/j.cellsig.2013.08.041; Schmitz M, 2007, BRIT J CANCER, V96, P1293, DOI 10.1038/sj.bjc.6603696; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030; Takahashi-Niki K, 2017, ADV EXP MED BIOL, V1037, P89, DOI 10.1007/978-981-10-6583-5_7; Takahashi-Niki K, 2015, J BIOL CHEM, V290, P17838, DOI 10.1074/jbc.M115.666271; Thorne AH, 2016, NEURO-ONCOLOGY, V18, P914, DOI 10.1093/neuonc/nov319; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Wang B, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0065-1; Xu K, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705504; Yin J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002152; Zhang S, 2016, ONCOTARGET, V7, P65758, DOI 10.18632/oncotarget.11613; Zhong HQ, 2015, REDOX BIOL, V4, P193, DOI 10.1016/j.redox.2014.12.011; Zhou L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023936; Zou ZZ, 2017, APOPTOSIS, V22, P1321, DOI 10.1007/s10495-017-1424-9	59	9	10	1	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2021	40	3					508	521		10.1038/s41388-020-01543-1	http://dx.doi.org/10.1038/s41388-020-01543-1		NOV 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PU9SL	33188296				2022-12-26	WOS:000589573800003
J	Domenis, R; Marino, M; Cifu, A; Scardino, G; Curcio, F; Fabris, M				Domenis, Rossana; Marino, Marco; Cifu, Adriana; Scardino, Giulia; Curcio, Francesco; Fabris, Martina			Circulating exosomes express alpha(4)beta(7) integrin and compete with CD4+T cells for the binding to Vedolizumab	PLOS ONE			English	Article							EXTRACELLULAR VESICLES; MAINTENANCE THERAPY; CROHNS-DISEASE; INDUCTION	Vedolizumab (VDZ) is a therapeutic monoclonal antibody approved for the treatment of inflammatory bowel diseases (IBD). VDZ selectively binds to the alpha 4 beta 7 integrin and blocks trafficking of a specific subset of gastrointestinal-homing T-lymphocytes to inflamed tissue. Although VDZ has shown promising results in numerous clinical studies a subgroup of patients do not respond adequately. Mechanistic insights and prognostic biomarkers able to predict which patients might benefit from VDZ therapy are currently lacking. Circulating exosomes were isolated from serum of blood donors and VDZ-treated patients by polymer-based precipitation. The surface expression of alpha 4 beta 7 integrin was evaluated by flow cytometry and the levels of exosome-bound VDZ were investigated by Promonitor-VDZ ELISA kit. The capacity of exosomes to interfere with the adhesion of VDZ-treated CD4+ T cells was assessed by adhesion assay. In this study, we showed that serum exosomes isolated from both blood donor and ulcerative colitis patients express on their surface the VDZ target alpha 4 beta 7 integrin. We observed an increased exosomal sequestration of VDZ in anti-TNF exposed patients compared to anti- TNF alpha naive patients, according to a greater expression of alpha 4 beta 7 integrin on vesicles surface. Circulating exosomes could compete for VDZ binding with CD4+ T cells since we found that the amount of VDZ bound to T cells was impaired in the presence of exosomes. In addition, we demonstrated that exosomes bind VDZ, which consequently becomes unable to block MadCAM-1-mediated adhesion of lymphocytes. Circulating exosomes might contribute to drug sequestration, possibly affecting the therapeutic efficacy of VDZ in IBD patients. Our data suggest that previous biologic therapy may have altered the sequestration capacity of circulating exosomes, thus reducing the efficacy of VDZ in patients who failed anti-TNF agents.	[Domenis, Rossana; Cifu, Adriana; Curcio, Francesco] Univ Udine, Dept Med Area, Udine, Italy; [Marino, Marco; Scardino, Giulia] Azienda Sanitaria Univ Integrata Friuli Centrale, Gastroenterol, Udine, Italy; [Curcio, Francesco; Fabris, Martina] Azienda Sanitaria Univ Integrata Friuli Centrale, Clin Pathol, Udine, Italy	University of Udine	Fabris, M (corresponding author), Azienda Sanitaria Univ Integrata Friuli Centrale, Clin Pathol, Udine, Italy.	martina.fabris@asufc.sanita.fvg.it	Fabris, Martina/AAC-2353-2022	Fabris, Martina/0000-0002-9745-2841; Marino, Marco/0000-0002-3256-3524	Grant Interreg ARTE [J22F170001005]; VivaBioCell S.p.A.	Grant Interreg ARTE; VivaBioCell S.p.A.	This work was supported by Grant Interreg ARTE (J22F170001005) and partially supported by an unrestricted grant from VivaBioCell S.p.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aung T, 2011, P NATL ACAD SCI USA, V108, P15336, DOI 10.1073/pnas.1102855108; Barre A, 2018, ALIMENT PHARM THER, V47, P896, DOI 10.1111/apt.14550; Bian SM, 2017, INFLAMM BOWEL DIS, V23, P2202, DOI 10.1097/MIB.0000000000001255; Carriere J, 2016, INFLAMM BOWEL DIS, V22, P516, DOI 10.1097/MIB.0000000000000635; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Console L, 2019, CLIN CHIM ACTA, V488, P165, DOI 10.1016/j.cca.2018.11.009; de Souza HSP, 2017, CURR OPIN GASTROEN, V33, P222, DOI 10.1097/MOG.0000000000000364; Domenis R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44949-y; Domenis R, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4814987; Engel T, 2018, J CROHNS COLITIS, V12, P245, DOI 10.1093/ecco-jcc/jjx143; Feagan BG, 2013, NEW ENGL J MED, V369, P699, DOI 10.1056/NEJMoa1215734; Gisbert JP, 2020, J CROHNS COLITIS, V14, P694, DOI 10.1093/ecco-jcc/jjz195; Hanzel J, 2019, UNITED EUR GASTROENT, V7, P741, DOI 10.1177/2050640619840211; Leoni G, 2015, J CLIN INVEST, V125, P1215, DOI 10.1172/JCI76693; Mitsuhashi S, 2016, INFLAMM BOWEL DIS, V22, P1587, DOI 10.1097/MIB.0000000000000840; Panes J, 2018, J CROHNS COLITIS, V12, pS633, DOI 10.1093/ecco-jcc/jjy011; Paramsothy S, 2018, MUCOSAL IMMUNOL, V11, P1558, DOI 10.1038/s41385-018-0050-3; Park EJ, 2019, BLOOD ADV, V3, P1, DOI 10.1182/bloodadvances.2018024877; Pellet G, 2019, CLIN GASTROENTEROL H, V17, P494, DOI 10.1016/j.cgh.2018.08.081; Peyrin-Biroulet L, 2019, CLIN GASTROENTEROL H, V17, P838, DOI 10.1016/j.cgh.2018.06.026; S BE, 2018, J CROHNS COLITIS, V12, pS049; Sandborn WJ, 2013, NEW ENGL J MED, V369, P711, DOI 10.1056/NEJMoa1215739; Sands BE, 2014, GASTROENTEROLOGY, V147, P618, DOI 10.1053/j.gastro.2014.05.008; Shmidt E, 2018, INFLAMM BOWEL DIS, V24, P2461, DOI 10.1093/ibd/izy171; Ungar B, 2018, CLIN GASTROENTEROL H, V16, P697, DOI 10.1016/j.cgh.2017.11.050; Ward MG, 2018, THER ADV GASTROENTER, V11, DOI 10.1177/1756284818772786; Wong U, 2017, EXPERT OPIN DRUG MET, V13, P1039, DOI 10.1080/17425255.2017.1377180; Wong WY, 2016, PROTEOMICS, V16, P1131, DOI 10.1002/pmic.201500174; Wyant T, 2016, J CROHNS COLITIS, V10, P1437, DOI 10.1093/ecco-jcc/jjw092; Zhang HT, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01464; Zhang Y, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0282-2; Zheng XW, 2017, PROTEIN CELL, V8, P686, DOI 10.1007/s13238-017-0413-7	32	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242342	10.1371/journal.pone.0242342	http://dx.doi.org/10.1371/journal.pone.0242342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180848	Green Published, gold			2022-12-26	WOS:000593948000009
J	Oetjens, MT; Luo, JZ; Chang, A; Leader, JB; Hartzel, DN; Moore, BS; Strande, NT; Kirchner, HL; Ledbetter, DH; Justice, AE; Carey, DJ; Mirshahi, T				Oetjens, Matthew T.; Luo, Jonathan Z.; Chang, Alexander; Leader, Joseph B.; Hartzel, Dustin N.; Moore, Bryn S.; Strande, Natasha T.; Kirchner, H. Lester; Ledbetter, David H.; Justice, Anne E.; Carey, David J.; Mirshahi, Tooraj			Electronic health record analysis identifies kidney disease as the leading risk factor for hospitalization in confirmed COVID-19 patients	PLOS ONE			English	Article								Background Empirical data on conditions that increase risk of coronavirus disease 2019 (COVID-19) progression are needed to identify high risk individuals. We performed a comprehensive quantitative assessment of pre-existing clinical phenotypes associated with COVID-19-related hospitalization. Methods Phenome-wide association study (PheWAS) of SARS-CoV-2-positive patients from an integrated health system (Geisinger) with system-level outpatient/inpatient COVID-19 testing capacity and retrospective electronic health record (EHR) data to assess pre-COVID-19 pandemic clinical phenotypes associated with hospital admission (hospitalization). Results Of 12,971 individuals tested for SARS-CoV-2 with sufficient pre-COVID-19 pandemic EHR data at Geisinger, 1604 were SARS-CoV-2 positive and 354 required hospitalization. We identified 21 clinical phenotypes in 5 disease categories meeting phenome-wide significance (P<1.60x10(-4)), including: six kidney phenotypes, e.g. end stage renal disease or stage 5 CKD (OR = 11.07, p = 1.96x10(-8)), six cardiovascular phenotypes, e.g. congestive heart failure (OR = 3.8, p = 3.24x10(-5)), five respiratory phenotypes, e.g. chronic airway obstruction (OR = 2.54, p = 3.71x10(-5)), and three metabolic phenotypes, e.g. type 2 diabetes (OR = 1.80, p = 7.51x10(-5)). Additional analyses defining CKD based on estimated glomerular filtration rate, confirmed high risk of hospitalization associated with pre-existing stage 4 CKD (OR 2.90, 95% CI: 1.47, 5.74), stage 5 CKD/dialysis (OR 8.83, 95% CI: 2.76, 28.27), and kidney transplant (OR 14.98, 95% CI: 2.77, 80.8) but not stage 3 CKD (OR 1.03, 95% CI: 0.71, 1.48). Conclusions This study provides quantitative estimates of the contribution of pre-existing clinical phenotypes to COVID-19 hospitalization and highlights kidney disorders as the strongest factors associated with hospitalization in an integrated US healthcare system.	[Oetjens, Matthew T.; Luo, Jonathan Z.; Chang, Alexander; Leader, Joseph B.; Hartzel, Dustin N.; Moore, Bryn S.; Strande, Natasha T.; Kirchner, H. Lester; Ledbetter, David H.; Justice, Anne E.; Carey, David J.; Mirshahi, Tooraj] Geisinger, Danville, PA USA		Carey, DJ; Mirshahi, T (corresponding author), Geisinger, Danville, PA USA.	tmirshahi@geisinger.edu; djcarey@geisinger.edu		Strande, Natasha/0000-0001-5148-9772; Justice, Anne/0000-0002-8903-8712; Luo, Jonathan/0000-0003-2567-1516	NIH-NIGMS (NIH.GOV) [GM111913]	NIH-NIGMS (NIH.GOV)	This work was supported by GM111913 from the NIH-NIGMS (NIH.GOV) to T.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalin E, 2020, NEW ENGL J MED, V382, P2475, DOI 10.1056/NEJMc2011117; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Bush WS, 2016, NAT REV GENET, V17, P129, DOI 10.1038/nrg.2015.36; Caillard S, 2020, KIDNEY INT, V98, P1549, DOI 10.1016/j.kint.2020.08.005; Carey DJ, 2016, GENET MED, V18, P906, DOI 10.1038/gim.2015.187; Carroll RJ, 2014, BIOINFORMATICS, V30, P2375, DOI 10.1093/bioinformatics/btu197; Gandhi RT, 2020, NEW ENGL J MED, V383, P1757, DOI 10.1056/NEJMcp2009249; Griffith Gareth J, 2020, Nat Commun, V11, P5749, DOI 10.1038/s41467-020-19478-2; Hamer M, 2020, P NATL ACAD SCI USA, V117, P21011, DOI 10.1073/pnas.2011086117; Hamer M, 2020, BRAIN BEHAV IMMUN, V87, P184, DOI 10.1016/j.bbi.2020.05.059; Jose RJ, 2020, LANCET RESP MED, V8, pE46, DOI 10.1016/S2213-2600(20)30216-2; Kim L, 2020, CLIN INFECT DIS; Li MY, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00662-x; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Ng JH, 2020, KIDNEY INT; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Saran R, 2019, AM J KIDNEY DIS, V73, pSVII; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	19	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242182	10.1371/journal.pone.0242182	http://dx.doi.org/10.1371/journal.pone.0242182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180868	Green Published, gold			2022-12-26	WOS:000593948000016
J	Ferreira, JC; Khrbtli, AR; Shetler, CL; Mansoor, S; Ali, L; Sensoy, O; Rabeh, WM				Ferreira, Juliana C.; Khrbtli, Abdul-Rahman; Shetler, Cameron L.; Mansoor, Samman; Ali, Liaqat; Sensoy, Ozge; Rabeh, Wael M.			Linker residues regulate the activity and stability of hexokinase 2, a promising anticancer target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL HALVES; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; MAMMALIAN HEXOKINASE; CANCERS; PROTEIN; WARBURG; GLUCOSE; OVEREXPRESSION; MITOCHONDRIA	Hexokinase (HK) catalyzes the first step in glucose metabolism, making it an exciting target for the inhibition of tumor initiation and progression due to their elevated glucose metabolism. The upregulation of hexokinase-2 (HK2) in many cancers and its limited expression in normal tissues make it a particularly attractive target for the selective inhibition of cancer growth and the eradication of tumors with limited side effects. The design of such safe and effective anticancer therapeutics requires the development of HK2-specific inhibitors that will not interfere with other HK isozymes. As HK2 is unique among HKs in having a catalytically active N-terminal domain (NTD), we have focused our attention on this region. We previously found that NTD activity is affected by the size of the linker helix-a13 that connects the N- and C-terminal domains of HK2. Three nonactive site residues (D447, S449, and K451) at the beginning of the linker helix-a13 have been found to regulate the NTD activity of HK2. Mutation of these residues led to increased dynamics, as shown via hydrogen deuterium exchange analysis and molecular dynamic simulations. D447A contributed the most to the enhanced dynamics of the NTD, with reduced calorimetric enthalpy of HK2. Similar residues exist in the C-terminal domain (CTD) but are unnecessary for HK1 and HK2 activity. Thus, we postulate these residues serve as a regulatory site for HK2 and may provide new directions for the design of anticancer therapeutics that reduce the rate of glycolysis in cancer through specific inhibition of HK2.	[Ferreira, Juliana C.; Khrbtli, Abdul-Rahman; Rabeh, Wael M.] New York Univ Abu Dhabi, Sci Div, Abu Dhabi, U Arab Emirates; [Shetler, Cameron L.] New York Univ Shanghai, Dept Chem, Shanghai, Peoples R China; [Mansoor, Samman; Sensoy, Ozge] Istanbul Medipol Univ, Sch Engn & Nat Sci, Istanbul, Turkey; [Ali, Liaqat] New York Univ Abu Dhabi, Core Technol Platforms, Saadiyat Campus, Abu Dhabi, U Arab Emirates; [Sensoy, Ozge] Istanbul Medipol Univ, Regenerat Restorat Med Res Ctr REMER, Istanbul, Turkey; [Sensoy, Ozge] Istanbul Medipol Univ, Res Inst Hlth Sci & Technol SABITA, Istanbul, Turkey	NYU Shanghai; Istanbul Medipol University; Istanbul Medipol University; Istanbul Medipol University	Rabeh, WM (corresponding author), New York Univ Abu Dhabi, Sci Div, Abu Dhabi, U Arab Emirates.	wael.rabeh@nyu.edu		Shetler, Cameron/0000-0001-9825-1892; Mansoor, Samman/0000-0002-3367-7566; rabeh, wael/0000-0001-6071-8581	New York University Abu Dhabi; ADEK (Abu Dhabi Education and Knowledge) Award for Research Excellence [AARE18-130]	New York University Abu Dhabi; ADEK (Abu Dhabi Education and Knowledge) Award for Research Excellence	This work was supported by research funds from New York University Abu Dhabi and the ADEK (Abu Dhabi Education and Knowledge) Award for Research Excellence (AARE18-130).	Ahn KJ, 2009, BMB REP, V42, P350, DOI 10.5483/BMBRep.2009.42.6.350; Aleshin AE, 1998, J MOL BIOL, V282, P345, DOI 10.1006/jmbi.1998.2017; Aleshin AE, 1998, STRUCTURE, V6, P39, DOI 10.1016/S0969-2126(98)00006-9; Anderson M, 2017, ONCOTARGET, V8, P56081, DOI 10.18632/oncotarget.9760; Ardehali H, 1996, J BIOL CHEM, V271, P1849, DOI 10.1074/jbc.271.4.1849; Ardehali H, 1999, J BIOL CHEM, V274, P15986, DOI 10.1074/jbc.274.23.15986; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Chen J, 2014, TUMOR BIOL, V35, P3743, DOI 10.1007/s13277-013-1496-2; Cheong H, 2012, NAT BIOTECHNOL, V30, P671, DOI 10.1038/nbt.2285; DeWaal D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02733-4; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; EVANS DJ, 1985, J CHEM PHYS, V83, P4069, DOI 10.1063/1.449071; FROMM HJ, 1962, J BIOL CHEM, V237, P1661; Garcia SN, 2019, CURR MED CHEM, V26, P7285, DOI 10.2174/0929867326666181213092652; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hayes MG, 2013, DIABETES, V62, P3282, DOI 10.2337/db12-1692; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Jang M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.85; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Kawai S, 2005, J BIOSCI BIOENG, V99, P320, DOI 10.1263/jbb.99.320; Kiss PT, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4807600; Kuettner EB, 2010, J BIOL CHEM, V285, P41019, DOI 10.1074/jbc.M110.185850; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Kuser PR, 2000, J BIOL CHEM, V275, P20814, DOI 10.1074/jbc.M910412199; Li XB, 2015, THORAC CANCER, V6, P17, DOI 10.1111/1759-7714.12148; Lin H, 2016, ACS MED CHEM LETT, V7, P217, DOI 10.1021/acsmedchemlett.5b00214; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Mulichak AM, 1998, NAT STRUCT BIOL, V5, P555, DOI 10.1038/811; Nawaz MH, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171666; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pastorino JG, 2003, CURR MED CHEM, V10, P1535, DOI 10.2174/0929867033457269; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Pedersen PL, 2002, BBA-BIOENERGETICS, V1555, P14, DOI 10.1016/S0005-2728(02)00248-7; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Senisterra GA, 2009, MOL BIOSYST, V5, P217, DOI 10.1039/b814377c; Shi S, 2013, J PHARM SCI-US, V102, P2471, DOI 10.1002/jps.23633; Shulga N, 2014, J BIOL CHEM, V289, P26213, DOI 10.1074/jbc.M114.580175; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Suh DH, 2014, CLIN EXP MED, V14, P345, DOI 10.1007/s10238-013-0250-9; Wang HA, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0280-y; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Zhu K, 2014, PROTEINS, V82, P1646, DOI 10.1002/prot.24551	49	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100071	10.1074/jbc.RA120.015293	http://dx.doi.org/10.1074/jbc.RA120.015293			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33187984	Green Published, gold			2022-12-26	WOS:000672866400052
J	Aguiar, DCF; Pereira, WLA; de Matos, GDB; da Silva, KSM; de Loiola, RDP; Corvelo, TCO				Aguiar, Delia Cristina Figueira; Pereira, Washington Luiz Assuncao; de Matos, Gyselly de Cassia Bastos; Marruaz da Silva, Klena Sarges; de Loiola, Rosane do Socorro Pompeu; Corvelo, Tereza Cristina Oliveira			Tissue expression of antigens of ABH blood groups in species of New World Monkeys (Aotus infulatus, Callithrix jacchus, Sapajus apella and Saimiri sciureus)	PLOS ONE			English	Article							ALPHA-2-FUCOSYL-TRANSFERASE GENES; HISTOLOGICAL DISTRIBUTION; GROUP SUBSTANCES; GASTRIC-MUCOSA; LEWIS; PRIMATES; EVOLUTION; TRACT	ABH antigens are histo-antigens, but were first described on the surface of human erythrocytes. They are found in those cells only in great apes and humans, while in more primitive animals they are found in tissues and body fluids. ABH antigens are mainly distributed in tissues that are in contact with the external environment and may serve as ligands for pathogens in tissues or block their connection. Description of the distribution of these molecules in non-human primate tissues is restricted to a few tissues and species. This paper describes the expression of human A, B and H type antigens in different organs from four species of New World Primates, obtained from the Centro Nacional de Primatas, as well as comparing that expression with what has been described for humans. In this study, although the tissue description of the antigens is similar to the genetic model for humans, some differences in expression between some organs from those species and those of humans were found. The differences occurred mainly in endodermal organs that have secretory functions and are probably under the control of the human-type FUT-2 enzyme. In the mesodermal-origin organs there was a reduction or absence of A and B antigen marking, particularly in the H precursor substance, indicating that those organs are under the control of the human-type FUT-1 enzyme. These findings have demonstrated that there is similar ABH antigen reactivity in tissue distribution between the species, although there are some species-specific cases.	[Aguiar, Delia Cristina Figueira] Fed Univ Para, Inst Biol Sci, Lab Biomol Technol, Ave Augusto Correa, Belem, Para, Brazil; [Pereira, Washington Luiz Assuncao] Rural Fed Univ Amazonia, Pathol Lab, Belem, Para, Brazil; [de Matos, Gyselly de Cassia Bastos] Rural Fed Univ Amazonia, Vet Med Course, Inst Hlth & Anim Prod, Belem, Para, Brazil; [Marruaz da Silva, Klena Sarges] Fundacao Oswaldo Cruz, Inst Sci & Technol Biomodels, Rio De Janeiro, RJ, Brazil; [de Loiola, Rosane do Socorro Pompeu] Para State Hlth Secretary, Epidemiol Div, Belem, Para, Brazil; [Corvelo, Tereza Cristina Oliveira] Fed Univ Para, Inst Biol Sci, Lab Immunogenet, Ave Augusto Correa, Belem, Para, Brazil	Universidade Federal do Para; Universidade Federal de Amazonas; Universidade Federal de Amazonas; Fundacao Oswaldo Cruz; Universidade Federal do Para	Aguiar, DCF (corresponding author), Fed Univ Para, Inst Biol Sci, Lab Biomol Technol, Ave Augusto Correa, Belem, Para, Brazil.	delia@ufpa.br	Corvelo, Tereza/AAE-1872-2021; PEREIRA, WASHINGTON/AAG-9373-2021	Aguiar, Delia Cristina Figueira/0000-0002-9075-9947; Sarges Marruaz Silva, Klena/0000-0002-5996-490X	Federal University of Para (UFPa); Centro Nacional de Primatas (CENP); UFPa	Federal University of Para (UFPa); Centro Nacional de Primatas (CENP); UFPa	This study was supported Federal University of Para (UFPa) and Centro Nacional de Primatas (CENP). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. Gyselly de Cassia Bastos de Matos received a scholarship from UFPa.	Aguiar Délia Cristina Figueira, 2002, Arq. Gastroenterol., V39, P222, DOI 10.1590/S0004-28032002000400004; [Anonymous], 1991, FARMERS WEEKLY, V115; Apoil PA, 2000, MOL BIOL EVOL, V17, P337, DOI 10.1093/oxfordjournals.molbev.a026314; Ayres M, BIOESTATAPLICACOES E; Barreaud JP, 2000, GLYCOBIOLOGY, V10, P611, DOI 10.1093/glycob/10.6.611; Borges BN, 2008, GENET MOL RES, V7, P663, DOI 10.4238/vol7-3gmr452; CLAUSEN H, 1989, VOX SANG, V56, P1, DOI 10.1111/j.1423-0410.1989.tb03040.x; CORDONCARDO C, 1988, CANCER RES, V48, P4113; CORDONCARDO C, 1986, LAB INVEST, V55, P444; Corvelo TCO, 2002, J MED PRIMATOL, V31, P136, DOI 10.1034/j.1600-0684.2002.00035.x; Costache M, 1997, J BIOL CHEM, V272, P29721, DOI 10.1074/jbc.272.47.29721; Dabelsteen E, 2005, J DENT RES, V84, P21, DOI 10.1177/154405910508400103; DAROCHA RM, 1990, REV BRAS GENET, V13, P531; Aguiar DCF, 2011, MEM I OSWALDO CRUZ, V106, P936, DOI 10.1590/S0074-02762011000800007; Fujitani N, 2000, J HISTOCHEM CYTOCHEM, V48, P1649, DOI 10.1177/002215540004801208; ITO N, 1990, HISTOCHEM J, V22, P113, DOI 10.1007/BF01885790; LADEN SA, 1984, J HISTOCHEM CYTOCHEM, V32, P965, DOI 10.1177/32.9.6379041; Landsteiner K, 1925, J EXP MED, V42, P853, DOI 10.1084/jem.42.6.853; Le Pendu J, 2001, APMIS, V109, P9; Martins LC, 2006, WORLD J GASTROENTERO, V12, P1120, DOI 10.3748/wjg.v12.i7.1120; Moor-Jankowski J, 1969, Primates Med, V3, P64; NISHI K, 1992, INT J LEGAL MED, V105, P75, DOI 10.1007/BF02340827; ORIOL R, 1992, APMIS, V100, P28; ORIOL R, 1984, LAB INVEST, V50, P514; ORIOL R, 1986, VOX SANG, V51, P161, DOI 10.1111/j.1423-0410.1986.tb01946.x; Pedal I, 1989, Beitr Gerichtl Med, V47, P153; PERLMAN EJ, 1990, AM J SURG PATHOL, V14, P810, DOI 10.1097/00000478-199009000-00002; RAVN V, 1994, VIRCHOWS ARCH, V424, P411; Ravn V, 2000, APMIS, V108, P1, DOI 10.1034/j.1600-0463.2000.d01-1.x; ROUGER P, 1980, REV FR TRANSFUS IMMU, V23, P553, DOI 10.1016/S0338-4535(80)80159-0; SCHNEIDER H, 1985, REV BRAS GENET, V8, P697; SHIMAMOTO C, 1987, J CLIN INVEST, V80, P1670, DOI 10.1172/JCI113256; Socha WW, 1995, J MED PRIMATOL, V24, P282, DOI 10.1111/j.1600-0684.1995.tb00182.x; SOCHA WW, 1987, TRANSPLANT P, V19, P4448; Socha WW, 1983, BLOOD GROUPS PRIMATE; Stowell CP, 2019, VOX SANG, V114, P426, DOI 10.1111/vox.12787; SZULMAN AE, 1962, J EXP MED, V115, P977, DOI 10.1084/jem.115.5.977; SZULMAN AE, 1960, J EXP MED, V111, P785, DOI 10.1084/jem.111.6.785; TERADA T, 1994, HEPATOLOGY, V20, P388, DOI 10.1002/hep.1840200219; TERAO K, 1988, PRIMATES, V29, P287, DOI 10.1007/BF02381130; Welshinger M, 1996, GYNECOL ONCOL, V62, P106, DOI 10.1006/gyno.1996.0198; YUAN M, 1985, CANCER RES, V45, P4499	42	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241487	10.1371/journal.pone.0241487	http://dx.doi.org/10.1371/journal.pone.0241487			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206689	gold, Green Published			2022-12-26	WOS:000595265900007
J	Dagtekin, D; Sahan, EA; Denk, T; Kose, N; Dalfes, HN				Dagtekin, Dilsad; Sahan, Evrim A.; Denk, Thomas; Kose, Nesibe; Dalfes, H. Nuzhet			Past, present and future distributions of Oriental beech (Fagus orientalis) under climate change projections	PLOS ONE			English	Article							LAST GLACIAL MAXIMUM; BLACK-SEA; SPECIES DISTRIBUTIONS; LATE PLEISTOCENE; PALYNOLOGICAL EVIDENCE; TEMPERATE FORESTS; HOLOCENE HISTORY; CASPIAN SEA; LAKE URMIA; WORLD MAP	Species distribution models can help predicting range shifts under climate change. The aim of this study is to investigate the late Quaternary distribution of Oriental beech (Fagus orientalis) and to project future distribution ranges under different climate change scenarios using a combined palaeobotanical, phylogeographic, and modelling approach. Five species distribution modelling algorithms under the R-package `biomod2`were applied to occurrence data of Fagus orientalis to predict distributions under present, past (Last Glacial Maximum, 21 ka, Mid-Holocene, 6 ka), and future climatic conditions with different scenarios obtained from MIROC-ESM and CCSM4 global climate models. Distribution models were compared to palaeobotanical and phylogeographic evidence. Pollen data indicate northern Turkey and the western Caucasus as refugia for Oriental beech during the Last Glacial Maximum. Although pollen records are missing, molecular data point to Last Glacial Maximum refugia in northern Iran. For the mid-Holocene, pollen data support the presence of beech in the study region. Species distribution models predicted present and Last Glacial Maximum distribution of Fagus orientalis moderately well yet underestimated mid-Holocene ranges. Future projections under various climate scenarios indicate northern Iran and the Caucasus region as major refugia for Oriental beech. Combining palaeobotanical, phylogeographic and modelling approaches is useful when making projections about distributions of plants. Palaeobotanical and molecular evidence reject some of the model projections. Nevertheless, the projected range reduction in the Caucasus region and northern Iran highlights their importance as long-term refugia, possibly related to higher humidity, stronger environmental and climatic heterogeneity and strong vertical zonation of the forest vegetation.	[Dagtekin, Dilsad; Sahan, Evrim A.; Dalfes, H. Nuzhet] Istanbul Tech Univ, Eurasia Inst Earth Sci, Istanbul, Turkey; [Denk, Thomas] Swedish Museum Nat Hist, Dept Paleobiol, Stockholm, Sweden; [Kose, Nesibe] Istanbul Univ Cerrahpasa, Fac Forestry, Dept Forest Bot, Istanbul, Turkey; [Dagtekin, Dilsad] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland	Istanbul Technical University; Swedish Museum of Natural History; Istanbul University - Cerrahpasa; University of Zurich	Dagtekin, D (corresponding author), Istanbul Tech Univ, Eurasia Inst Earth Sci, Istanbul, Turkey.; Dagtekin, D (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Zurich, Switzerland.	dilsad.dagtekin@ieu.uzh.ch	Sahan, Evrim A./AEB-8673-2022; Dalfes, Nüzhet/N-9321-2013; Köse, Nesibe/G-8571-2018; Sahan, Evrim A./AAW-3549-2021	Sahan, Evrim A./0000-0002-6101-0849; Dalfes, Nüzhet/0000-0002-2522-8381; Köse, Nesibe/0000-0001-5766-0526; Dagtekin, Dilsad/0000-0001-8610-0835	Swedish Research Council (VR) [2015-03986]	Swedish Research Council (VR)(Swedish Research Council)	TD acknowledges funding from the Swedish Research Council (VR grant no. 2015-03986).	[Anonymous], TEMP BROADL MIX FOR; [Anonymous], NASA 2020 GLOBAL CLI; [Anonymous], 2009, FAGUS ORIENTALIS EUF; [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47; Arslanov KA, 2007, QUATERN INT, V167, P121, DOI 10.1016/j.quaint.2007.02.013; Atanassova J, 2005, HOLOCENE, V15, P576, DOI 10.1191/0959683605hl832rp; Avc M, 2018, TURKIYENIN DOAL EGZO, P311; Babst F, 2013, GLOBAL ECOL BIOGEOGR, V22, P706, DOI 10.1111/geb.12023; Bartlein PJ, 2011, CLIM DYNAM, V37, P775, DOI 10.1007/s00382-010-0904-1; Garzon MB, 2007, ECOGRAPHY, V30, P120, DOI [10.1111/j.2006.0906-7590.04813.x, 10.1111/j.0906-7590.2007.04813.x]; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; BOTTEMA S, 1986, REV PALAEOBOT PALYNO, V47, P241, DOI 10.1016/0034-6667(86)90039-4; Bozkurt AY, 1997, ORMAN END MUH B S; Bradshaw RHW, 2010, FOREST ECOL MANAG, V259, P2204, DOI 10.1016/j.foreco.2009.11.035; Caudullo G, 2017, DATA BRIEF, V12, P662, DOI 10.1016/j.dib.2017.05.007; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Denk T, 2001, BIOL J LINN SOC, V72, P287, DOI [10.1006/bijl.2000.0502, 10.1111/j.1095-8312.2001.tb01318.x]; Denk Th., 1999, Feddes Repertorium, V110, P381; Denk Th., 1999, Feddes Repertorium, V110, P177; Djamali M, 2008, QUATERNARY RES, V69, P413, DOI 10.1016/j.yqres.2008.03.004; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Dyderski MK, 2018, GLOBAL CHANGE BIOL, V24, P1150, DOI 10.1111/gcb.13925; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fang JY, 2006, J BIOGEOGR, V33, P1804, DOI 10.1111/j.1365-2699.2006.01533.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Filipova-Marinova M, 2016, QUATERN INT, V401, P99, DOI 10.1016/j.quaint.2015.05.009; Filipova-Marinova M, 2013, QUATERN INT, V293, P170, DOI 10.1016/j.quaint.2012.05.002; Giesecke T, 2007, J BIOGEOGR, V34, P118, DOI 10.1111/j.1365-2699.2006.01580.x; Gomory D, 2010, BOT HELV, V120, P63, DOI 10.1007/s00035-010-0068-y; Gomory D, 2007, BOT J LINN SOC, V154, P165, DOI 10.1111/j.1095-8339.2007.00666.x; Gomory D, 2018, ACTA SOC BOT POL, V87, DOI 10.5586/asbp.3582; Guisan A, 2007, ECOL MONOGR, V77, P615, DOI 10.1890/06-1060.1; Haghshenas M, 2016, FOR SCI TECHNOL, V12, P176, DOI 10.1080/21580103.2016.1144542; Hanspach J, 2010, PERSPECT PLANT ECOL, V12, P219, DOI 10.1016/j.ppees.2010.04.002; Harris RMB, 2014, WIRES CLIM CHANGE, V5, P621, DOI 10.1002/wcc.291; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Houle JF, 1997, 1997 SUMMER TECHNOLOGICAL CONFERENCE - 10TH ANNIVERSARY, P89; Kandemir G., 2009, EUFORGEN TECHNICAL G; Kislov AV, 2014, QUATERN INT, V345, P48, DOI 10.1016/j.quaint.2014.05.014; Kose N, 2012, TURK J AGRIC FOR, V36, P501, DOI 10.3906/tar-1109-4; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Kramer K, 2010, FOREST ECOL MANAG, V259, P2213, DOI 10.1016/j.foreco.2009.12.023; Leroy SAG, 2007, QUATERNARY SCI REV, V26, P3359, DOI 10.1016/j.quascirev.2007.09.012; Leroy SAG, 2014, QUATERNARY SCI REV, V101, P91, DOI 10.1016/j.quascirev.2014.07.011; Leroy SAG, 2013, QUATERNARY SCI REV, V78, P77, DOI 10.1016/j.quascirev.2013.07.032; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lisitsyna OV, 2011, REV PALAEOBOT PALYNO, V166, P311, DOI 10.1016/j.revpalbo.2011.06.004; Magri D, 1998, ANN BOT, V56; Magri D, 2008, J BIOGEOGR, V35, P450, DOI 10.1111/j.1365-2699.2007.01803.x; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Maiorano L, 2013, GLOBAL ECOL BIOGEOGR, V22, P302, DOI 10.1111/j.1466-8238.2012.00767.x; Margari V, 2009, QUATERNARY SCI REV, V28, P1317, DOI 10.1016/j.quascirev.2009.01.008; Marret F, 2019, HOLOCENE, V29, P648, DOI 10.1177/0959683618824769; Martin-Benito D, 2018, GLOBAL ECOL BIOGEOGR, V27, P1314, DOI 10.1111/geb.12799; Masson-Delmotte V., GLOBAL WARMING 1 5 C; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; Mayer H., 1986, WALDER TURKEI; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Mudie PJ, 2007, QUATERN INT, V167, P73, DOI 10.1016/j.quaint.2006.11.009; Mudie PJ, 2002, MAR GEOL, V190, P203, DOI 10.1016/S0025-3227(02)00348-1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearman PB, 2008, TRENDS ECOL EVOL, V23, P149, DOI 10.1016/j.tree.2007.11.005; Pearson RG, 2004, ECOGRAPHY, V27, P285, DOI 10.1111/j.0906-7590.2004.03740.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2007, SYNTH AM MUS NAT HIS, V50; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Root TL, 2006, CONSERV BIOL, V20, P706, DOI 10.1111/j.1523-1739.2006.00465.x; Rubel F, 2010, METEOROL Z, V19, P135, DOI 10.1127/0941-2948/2010/0430; Salamon-Albert E, 2016, FORESTS, V7, DOI 10.3390/f7120298; Saltre F, 2013, GLOBAL ECOL BIOGEOGR, V22, P1217, DOI 10.1111/geb.12085; Scheffers BR, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7671; Sekercioglu CH, 2011, BIOL CONSERV, V144, P2752, DOI 10.1016/j.biocon.2011.06.025; Shatilova I., 2011, HIST FLORA VEGETATIO; Shumilovskikh LS, 2016, HOLOCENE, V26, P1676, DOI 10.1177/0959683616646841; Shumilovskikh LS, 2013, QUATERNARY RES, V80, P349, DOI 10.1016/j.yqres.2013.07.005; Shumilovskikh LS, 2012, PALAEOGEOGR PALAEOCL, V337, P177, DOI 10.1016/j.palaeo.2012.04.015; Svenning JC, 2008, J ECOL, V96, P1117, DOI 10.1111/j.1365-2745.2008.01422.x; Tarasov PE, 2000, J BIOGEOGR, V27, P609, DOI 10.1046/j.1365-2699.2000.00429.x; Tarasov PE, 1999, CLIM DYNAM, V15, P227, DOI 10.1007/s003820050278; Tarkhnishvili D, 2012, BIOL J LINN SOC, V105, P231, DOI 10.1111/j.1095-8312.2011.01788.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Ulker ED, 2018, BIOL J LINN SOC, V123, P338, DOI 10.1093/biolinnean/blx154; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; VANZEIST W, 1991, TUEBINGER ATLAS VORD, V18, P1; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wick L, 2003, HOLOCENE, V13, P665, DOI 10.1191/0959683603hl653rp; Willis KJ, 2004, QUATERNARY SCI REV, V23, P2369, DOI 10.1016/j.quascirev.2004.06.002; Woldring H, 2002, PALAEOHISTORIA, P1; Yaltrk F, 1982, STANBUL U ORMAN FA A, V32; 2012, SURG OBES RELAT DIS, V8; 2013, SURG OBES RELAT DIS, V9	96	10	10	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242280	10.1371/journal.pone.0242280	http://dx.doi.org/10.1371/journal.pone.0242280			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201911	Green Published, gold			2022-12-26	WOS:000595003900046
J	Kolin, DA; Kulm, S; Christos, PJ; Elemento, O				Kolin, David A.; Kulm, Scott; Christos, Paul J.; Elemento, Olivier			Clinical, regional, and genetic characteristics of Covid-19 patients from UK Biobank	PLOS ONE			English	Article							RISK; INFLAMMATION	Background Coronavirus disease 2019 (Covid-19) has rapidly infected millions of people worldwide. Recent studies suggest that racial minorities and patients with comorbidities are at higher risk of Covid-19. In this study, we analyzed the effects of clinical, regional, and genetic factors on Covid-19 positive status. Methods The UK Biobank is a longitudinal cohort study that recruited participants from 2006 to 2010 from throughout the United Kingdom. Covid-19 test results were provided to UK Biobank starting on March 16, 2020. The main outcome measure in this study was Covid-19 positive status, determined by the presence of any positive test for a single individual. Clinical risk factors were derived from UK Biobank at baseline, and regional risk factors were imputed using census features local to each participant's home zone. We used robust adjusted Poisson regression with clustering by testing laboratory to estimate relative risk. Blood types were derived using genetic variants rs8176719 and rs8176746, and genomewide tests of association were conducted using logistic-Firth hybrid regression. Results This prospective cohort study included 397,064 UK Biobank participants, of whom 968 tested positive for Covid-19. The unadjusted relative risk of Covid-19 for Black participants was 3.66 (95% CI 2.83-4.74), compared to White participants. Adjusting for Townsend deprivation index alone reduced the relative risk to 2.44 (95% CI 1.86-3.20). Comorbidities that significantly increased Covid-19 risk included chronic obstructive pulmonary disease (adjusted relative risk [ARR] 1.64, 95% CI 1.18-2.27), ischemic heart disease (ARR 1.48, 95% CI 1.16-1.89), and depression (ARR 1.32, 95% CI 1.03-1.70). There was some evidence that angiotensin converting enzyme inhibitors (ARR 1.48, 95% CI 1.13-1.93) were associated with increased risk of Covid-19. Each standard deviation increase in the number of total individuals living in a participant's locality was associated with increased risk of Covid-19 (ARR 1.14, 95% CI 1.08-1.20). Analyses of genetically inferred blood types confirmed that participants with type A blood had increased odds of Covid-19 compared to participants with type O blood (odds ratio [OR] 1.16, 95% CI 1.01-1.33). A meta-analysis of genomewide association studies across ancestry groups did not reveal any significant loci. Study limitations include confounding by indication, bias due to limited information on early Covid-19 test results, and inability to accurately gauge disease severity. Conclusions When assessing the association of Black race with Covid-19, adjusting for deprivation reduced the relative risk of Covid-19 by 33%. In the context of sociological research, these findings suggest that discrimination in the labor market may play a role in the high relative risk of Covid-19 for Black individuals. In this study, we also confirmed the association of blood type A with Covid-19, among other clinical and regional factors.	[Kolin, David A.; Kulm, Scott; Elemento, Olivier] Caryl & Israel Englander Inst Precis Med, Meyer Canc Ctr, Weill Cornell Med, New York, NY 10021 USA; [Kolin, David A.; Kulm, Scott; Elemento, Olivier] Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA; [Christos, Paul J.] Weill Cornell Med, Dept Populat Hlth Sci, New York, NY USA	Cornell University; Cornell University; Cornell University	Kolin, DA (corresponding author), Caryl & Israel Englander Inst Precis Med, Meyer Canc Ctr, Weill Cornell Med, New York, NY 10021 USA.; Kolin, DA (corresponding author), Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA.	dak4001@med.cornell.edu			National Institutes of Health [U24 CA210989, R01 CA194547, P50CA211024, UL1TR002384]; Clinical and Translational Science Center at Weill Cornell Medical College [1-UL1-TR002384-01]; Emerson Research Collective	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Center at Weill Cornell Medical College; Emerson Research Collective	This research was supported by the National Institutes of Health (Grant Numbers: U24 CA210989, R01 CA194547, P50CA211024, UL1TR002384) and by the Emerson Research Collective. Dr. Paul Christos was partially supported by the following grant: Clinical and Translational Science Center at Weill Cornell Medical College (1-UL1-TR002384-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benetti E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242534; Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; Centers for Disease Control and Prevention, 2020, COVID 19 RAC ETHN MI; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chung RYN, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1329; Di Stasio V, 2019, ARE EMPLOYERS BRITAI, P1; Dilthey A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002877; Dyal JW, 2020, MMWR-MORBID MORTAL W, DOI DOI 10.15585/MMWR.MM6918E369; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Ellulu MS, 2017, ARCH MED SCI, V13, P851, DOI 10.5114/aoms.2016.58928; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Fosbol EL, 2020, JAMA-J AM MED ASSOC, V324, P168, DOI 10.1001/jama.2020.11301; Fuentes A, 2019, AM J PHYS ANTHROPOL, V169, P400, DOI 10.1002/ajpa.23882; Goyal P, 2020, NEW ENGL J MED, V382, P2372, DOI 10.1056/NEJMc2010419; Groot HE, 2020, ARTERIOSCL THROM VAS, V40, P830, DOI 10.1161/ATVBAHA.119.313658; Heath AF, 2019, BRIT J SOCIOL, V70, P1774, DOI 10.1111/1468-4446.12676; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Khadjeh S, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0784-4; Khalatbari-Soltani S, 2020, J EPIDEMIOL COMMUN H, V74, P620, DOI 10.1136/jech-2020-214297; Khayat AS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243887; Khunti K, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1548; Knittel C, 2020, WORKING PAPER SERIES; Laurencin CT, 2020, J RACIAL ETHN HEALTH, V7, P398, DOI 10.1007/s40615-020-00756-0; Little P, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1185; Maglo KN, 2016, FRONT GENET, P7, DOI [10.3389/fgene.2016.00007, DOI 10.3389/FGENE.2016.00007]; McNutt LA, 2003, AM J EPIDEMIOL, V157, P940, DOI 10.1093/aje/kwg074; Mehta N, 2020, JAMA CARDIOL, V5, P1020, DOI 10.1001/jamacardio.2020.1855; Niedzwiedz CL, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01640-8; Nomis Official Labor Market Statistics, 2011, NOM OFF LAB MARK STA; Office for National Statistics, 2020, COR COVID 19 REL DEA; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rosner M, 2020, OUR WORLD DATA; Singh AK, 2020, DIABETES METAB SYND, V14, P303, DOI 10.1016/j.dsx.2020.04.004; Tignanelli CJ, 2020, LANCET RESP MED, V8, pE30, DOI 10.1016/S2213-2600(20)30153-3; Tomiyama H, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.005729; Tsalamandris S, 2019, EUR CARDIOL REV, V14, P50, DOI 10.15420/ecr.2018.33.1; Valentino-DeVries J, 2020, NY TIMES; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740; Wang BL, 2020, AGING-US, V12, P6049, DOI 10.18632/aging.103000; Wang JY, 2018, GENE, V678, P226, DOI 10.1016/j.gene.2018.08.027; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548; Zhao J, 2020, CLIN INFECT DIS, DOI 10.1101/2020.03.11.20031096; Zietz Michael, 2020, medRxiv, DOI 10.1101/2020.04.08.20058073	48	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0241264	10.1371/journal.pone.0241264	http://dx.doi.org/10.1371/journal.pone.0241264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ5ZL	33201886	Green Published, gold			2022-12-26	WOS:000595003900025
J	Kuroda, G; Sasaki, S; Matsushita, A; Ohba, K; Sakai, Y; Shinkai, S; Nakamura, HM; Yamagishi, S; Sato, K; Hirahara, N; Oki, Y; Ito, M; Suzuki, T; Suda, T				Kuroda, Go; Sasaki, Shigekazu; Matsushita, Akio; Ohba, Kenji; Sakai, Yuki; Shinkai, Shinsuke; Nakamura, Hiroko Misawa; Yamagishi, Satoru; Sato, Kohji; Hirahara, Naoko; Oki, Yutaka; Ito, Masahiko; Suzuki, Tetsuro; Suda, Takafumi			G ATA2 mediates the negative regulation of the prepro-thyrotropin-releasing hormone gene by liganded T3 receptor beta 2 in the rat hypothalamic paraventricular nucleus	PLOS ONE			English	Article							PITUITARY-THYROID AXIS; TRANSCRIPTIONAL REGULATION; FEEDBACK-REGULATION; RESPONSE ELEMENTS; TRH GENE; EXPRESSION; PROMOTER; CARCINOMA; BINDING; GATA2	Thyroid hormone (T3) inhibits thyrotropin-releasing hormone (TRH) synthesis in the hypothalamic paraventricular nucleus (PVN). Although the T3 receptor (TR) beta 2 is known to mediate the negative regulation of the prepro-TRH gene, its molecular mechanism remains unknown. Our previous studies on the T3-dependent negative regulation of the thyrotropin beta subunit (TSH beta) gene suggest that there is a tethering mechanism, whereby liganded TR beta 2 interferes with the function of the transcription factor, GATA2, a critical activator of the TSH beta gene. Interestingly, the transcription factors Sim1 and Arnt2, the determinants of PVN differentiation in the hypothalamus, are reported to induce expression of TR beta 2 and GATA2 in cultured neuronal cells. Here, we confirmed the expression of the GATA2 protein in the TRH neuron of the rat PVN using immunohistochemistry with an anti-GATA2 antibody. According to an experimental study from transgenic mice, a region of the rat prepro-TRH promoter from nt. -547 to nt. +84 was able to mediate its expression in the PVN. We constructed a chloramphenicol acetyltransferase (CAT) reporter gene containing this promoter sequence (rTRH(547)-CAT) and showed that GATA2 activated the promoter in monkey kidney-derived CV1 cells. Deletion and mutation analyses identified a functional GATA-responsive element (GATA-RE) between nt. -357 and nt. -352. When TR beta 2 was co-expressed, T3 reduced GATA2-dependent promoter activity to approximately 30%. Unexpectedly, T3-dependent negative regulation was maintained after mutation of the reported negative T3-responsive element, site 4. T3 also inhibited the GATA2-dependent transcription enhanced by cAMP agonist, 8-bromo-cAMP. A rat thyroid medullary carcinoma cell line, CA77, is known to express the preproTRH mRNA. Using a chromatin immunoprecipitation assay with this cell line where GATA2 expression plasmid was transfected, we observed the recognition of the GATA-RE by GATA2. We also confirmed GATA2 binding using gel shift assay with the probe for the GATA-RE. In CA77 cells, the activity of rTRH(547)-CAT was potentiated by overexpression of GATA2, and it was inhibited in a T3-dependent manner. These results suggest that GATA2 transactivates the rat prepro-TRH gene and that liganded TR beta 2 interferes with this activation via a tethering mechanism as in the case of the TSH beta gene.	[Kuroda, Go; Sasaki, Shigekazu; Matsushita, Akio; Sakai, Yuki; Shinkai, Shinsuke; Nakamura, Hiroko Misawa; Suda, Takafumi] Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka, Japan; [Ohba, Kenji] Hamamatsu Univ Sch Med, Med Educ Ctr, Hamamatsu, Shizuoka, Japan; [Yamagishi, Satoru; Sato, Kohji] Hamamatsu Univ Sch Med, Dept Organ & Tissue Anat, Hamamatsu, Shizuoka, Japan; [Hirahara, Naoko] Japanese Red Cross Shizuoka Hosp, Dept Internal Med, Div Endocrinol & Metab, Shizuoka, Shizuoka, Japan; [Oki, Yutaka] Hamamatsu Kita Hosp, Dept Internal Med, Hamamatsu, Shizuoka, Japan; [Ito, Masahiko; Suzuki, Tetsuro] Hamamatsu Univ Sch Med, Dept Virol & Parasitol, Hamamatsu, Shizuoka, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Sasaki, S (corresponding author), Hamamatsu Univ Sch Med, Dept Internal Med, Div 2, Hamamatsu, Shizuoka, Japan.	sasakis@hama-med.ac.jp	Ohba, Kenji/AAU-5180-2021	Ohba, Kenji/0000-0001-8538-8742	Ministry of Education, Culture, Sports, Science and Technology of Japan [15K09425]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in Aid for Scientific Research to S.S. from the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 15K09425, URL: https://nrid.nii.ac.jp/ja/nrid/1000020303547/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2001, J CLIN INVEST, V107, P1017, DOI 10.1172/JCI10858; [Anonymous], 2013, BONE MARROW TRANSPL, V48, P452; [Anonymous], 2017, INDIAN J PUBLIC HLTH, V8, P364; Balkan W, 1998, ENDOCRINOLOGY, V139, P252, DOI 10.1210/en.139.1.252; Bresnick EH, 2012, NUCLEIC ACIDS RES, V40, P5819, DOI 10.1093/nar/gks281; Chan IH, 2008, THYROID, V18, P665, DOI 10.1089/thy.2008.0013; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Clifton-Bligh RJ, 1998, MOL ENDOCRINOL, V12, P609, DOI 10.1210/me.12.5.609; Cohen RN, 2012, THRYOID FUNDAMENTAL, P149; Cote-Velez A, 2008, NEUROCHEM RES, V33, P1582, DOI 10.1007/s11064-008-9698-5; Dasen JS, 1999, CELL, V97, P587, DOI 10.1016/S0092-8674(00)80770-9; Decherf S, 2013, MOL CELL ENDOCRINOL, V381, P115, DOI 10.1016/j.mce.2013.07.016; Diaz-Gallardo MY, 2010, NEUROENDOCRINOLOGY, V91, P64, DOI 10.1159/000228833; Fekete C, 2014, ENDOCR REV, V35, P159, DOI 10.1210/er.2013-1087; FENG P, 1994, BIOCHEM BIOPH RES CO, V200, P171, DOI 10.1006/bbrc.1994.1430; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; Goshu E, 2004, MOL ENDOCRINOL, V18, P1251, DOI 10.1210/me.2003-0372; Gothe S, 1999, GENE DEV, V13, P1329, DOI 10.1101/gad.13.10.1329; Guissouma H, 2002, MOL ENDOCRINOL, V16, P1652, DOI 10.1210/me.16.7.1652; Guissouma H, 2000, BIOCHEM CELL BIOL, V78, P155, DOI 10.1139/bcb-78-3-155; Guissouma H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095064; Hadlow NC, 2013, J CLIN ENDOCR METAB, V98, P2936, DOI 10.1210/jc.2012-4223; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Hirahara N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227646; HOLLENBERG AN, 1995, MOL ENDOCRINOL, V9, P540, DOI 10.1210/me.9.5.540; Hollenberg AN, 2008, THYROID, V18, P131, DOI 10.1089/thy.2007.0251; Iwaki H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088610; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Joseph-Bravo P, 2016, REV ENDOCR METAB DIS, V17, P545, DOI 10.1007/s11154-016-9375-y; Kajiya H, 2005, J MOL HISTOL, V36, P265, DOI 10.1007/s10735-005-4710-8; KAKUCSKA I, 1992, ENDOCRINOLOGY, V130, P2845, DOI 10.1210/en.130.5.2845; Kanki Y, 2011, EMBO J, V30, P2582, DOI 10.1038/emboj.2011.173; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Kohno D, 2008, ENDOCRINOLOGY, V149, P1295, DOI 10.1210/en.2007-1276; Langlois MF, 1997, J BIOL CHEM, V272, P24927, DOI 10.1074/jbc.272.40.24927; Larsen PR, 2015, WILLIAMS TXB ENDOCRI, P334; LECHAN RM, 1992, CIBA F SYMP, V168, P144; LEZOUALCH F, 1992, MOL ENDOCRINOL, V6, P1797, DOI 10.1210/me.6.11.1797; Liu CQ, 2003, J BIOL CHEM, V278, P44857, DOI 10.1074/jbc.M304489200; Liu YY, 2008, THYROID, V18, P593, DOI 10.1089/thy.2008.0138; LOPEZ G, 1993, MOL CELL BIOL, V13, P3042, DOI 10.1128/MCB.13.5.3042; Maia AL, 1996, THYROID, V6, P325, DOI 10.1089/thy.1996.6.325; MAIA AL, 1995, ENDOCRINOLOGY, V136, P4842, DOI 10.1210/en.136.11.4842; Martinez-Armenta M, 2015, MOL CELL ENDOCRINOL, V400, P129, DOI 10.1016/j.mce.2014.10.021; Matsunaga H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142400; Matsushita A, 2007, MOL ENDOCRINOL, V21, P865, DOI 10.1210/me.2006-0208; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Misawa H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028916; MUSZYNSKI M, 1983, J BIOL CHEM, V258, P1678; Nagayama K, 2008, J ENDOCRINOL, V199, P113, DOI 10.1677/JOE-08-0128; Nakano K, 2004, BIOCHEM J, V378, P549, DOI 10.1042/BJ20031592; Nillni EA, 2010, FRONT NEUROENDOCRIN, V31, P134, DOI 10.1016/j.yfrne.2010.01.001; Nolan LA, 2004, J ENDOCRINOL, V180, P35, DOI 10.1677/joe.0.1800035; Ogawa Satoshi, 2013, Front Endocrinol (Lausanne), V4, P184, DOI 10.3389/fendo.2013.00184; Ohba K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018667; Okada R, 2004, GEN COMP ENDOCR, V135, P42, DOI 10.1016/j.ygcen.2003.09.001; Penvose A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10264-3; Peter J, 2002, FRONT NEUROENDOCRIN, V23, P342, DOI 10.1016/S0091-3022(02)00005-5; Pietrzak M, 2008, J MOL ENDOCRINOL, V41, P177, DOI 10.1677/JME-08-0010; Sasaki S, 2018, VITAM HORM, V106, P97, DOI 10.1016/bs.vh.2017.06.006; SEVARINO KA, 1989, J BIOL CHEM, V264, P21529; SEVARINO KA, 1988, J BIOL CHEM, V263, P620; Shupnik M A, 2000, Rev Endocr Metab Disord, V1, P35, DOI 10.1023/A:1010008318961; Sugrue ML, 2010, ENDOCRINOLOGY, V151, P793, DOI 10.1210/en.2009-0976; Szarek E, 2010, MOL CELL ENDOCRINOL, V323, P115, DOI 10.1016/j.mce.2010.04.002; TAVIANINI MA, 1989, MOL ENDOCRINOL, V3, P605, DOI 10.1210/mend-3-4-605; TILLMAN JB, 1993, MOL CELL ENDOCRINOL, V95, P101, DOI 10.1016/0303-7207(93)90034-H; Turowska O, 2007, THYROID, V17, P1039, DOI 10.1089/thy.2007.0075; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Uribe RM, 2009, J NEUROENDOCRINOL, V21, P439, DOI 10.1111/j.1365-2826.2009.01861.x; URIBE RM, 1994, PEPTIDES, V15, P435, DOI 10.1016/0196-9781(94)90201-1; Wallis M, 2010, J NEUROENDOCRINOL, V22, P608, DOI 10.1111/j.1365-2826.2010.01996.x; Wilber JF, 1996, TRENDS ENDOCRIN MET, V7, P93, DOI 10.1016/1043-2760(96)00022-7; WONDISFORD FE, 1989, J BIOL CHEM, V264, P14601; Yee SH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213927	75	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242380	10.1371/journal.pone.0242380	http://dx.doi.org/10.1371/journal.pone.0242380			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201916	Green Published, gold			2022-12-26	WOS:000595003900017
J	Ali, NB; Karim, F; Billah, SKM; Hoque, DMDE; Khan, ANS; Hasan, MM; Simi, SM; Arifeen, SEL; Chowdhury, MAK				Ali, Nazia Binte; Karim, Farhana; Billah, S. K. Masum; Hoque, Dewan M. D. Emdadul; Khan, Abdullah Nurus Salam; Hasan, Mohammad Mehedi; Simi, Sonjida Mesket; Arifeen, Shams E. L.; Chowdhury, Mohiuddin Ahsanul Kabir			Are childbirth location and mode of delivery associated with favorable early breastfeeding practices in hard to reach areas of Bangladesh?	PLOS ONE			English	Article							EARLY INITIATION; CESAREAN-SECTION; IMPACT; HEALTH; MORTALITY; PATTERNS; PROGRAM; WOMEN; RISK	Background Early initiation of breastfeeding within one hour of birth (EIBF) and no prelacteal feeding are WHO recommended practices for improving maternal and newborn health outcomes. Globally, EIBF can avert around 22% of newborn death. In recent years, Bangladesh has experienced increasing facility delivery coverage and cesarean section rates. However, the impact of these changes on early breastfeeding initiation in hard to reach areas (HtR) of the country is still poorly understood. Therefore, this study aimed to examine the independent associations between childbirth locations and mode of delivery with favorable early breastfeeding practices in four hard to reach areas of Bangladesh. Method We extracted data from a cross-sectional study conducted in four HtR areas of Bangladesh in 2017. A total of 2768 women, having birth outcomes in the past 12 months of the survey, were interviewed using structured questionnaires. EIBF and no prelacteal feeding were considered as favorable early breastfeeding practices. The categories of childbirth locations were defined by the place of birth (home vs. facility) and the delivery sector (public/NGO vs. private). The mode of delivery was categorized into vaginal delivery and cesarean section. Generalized linear models were used to test the independent associations while adjusting for potential confounders. Results The prevalence of EIBF practices were 69.6%(95% CI:67.8-71.3); 72.2%(95% CI:67.8-71.3) among home births Vs 63.0%(95% CI:59.5%-66.4%) among facility births. Around 73.9% (95% CI:72.3-75.6) mother's in the study areas reported no-prelacteal feeding. Compared to home births, women delivering in the facilities had lower adjusted odds of EIBF (aOR = 0.51; 95%CI:0.35-0.75). Cesarean section was found to be negatively associated with EIBF (aOR = 0.20; 95%CI:0.12-0.35), after adjusting for potential confounders. We could not find any significant associations between the place of birth and mode of delivery with no prelacteal feeding. Discussions This study found that facility births and cesarean deliveries were negatively associated with EIBF. Although the implementation of "Baby-Friendly Hospital Initiatives" could be a potential solution for improving EIBF and no prelacteal feeding practices, the challenges of reduced service availability and accessibility in HtR areas must be considered while devising effective intervention strategies. Future studies can explore potential interventions to promote early breastfeeding for facility births and cesarean deliveries in HtR areas.	[Ali, Nazia Binte; Karim, Farhana; Billah, S. K. Masum; Khan, Abdullah Nurus Salam; Hasan, Mohammad Mehedi; Simi, Sonjida Mesket; Arifeen, Shams E. L.; Chowdhury, Mohiuddin Ahsanul Kabir] Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Maternal & Child Hlth Div, Dhaka, Bangladesh; [Hoque, Dewan M. D. Emdadul] United Nations Populat Fund, Dhaka, Bangladesh; [Khan, Abdullah Nurus Salam; Chowdhury, Mohiuddin Ahsanul Kabir] Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA	International Centre for Diarrhoeal Disease Research (ICDDR); United Nations Population Fund; University of South Carolina System; University of South Carolina Columbia	Ali, NB (corresponding author), Int Ctr Diarrhoeal Dis Res Bangladesh Icddr B, Maternal & Child Hlth Div, Dhaka, Bangladesh.	nazia.ali@icddrb.org	Chowdhury, Mohiuddin Ahsanul Kabir/AAY-9871-2020; Khan, Abdullah Nurus Salam/J-1661-2018; Md. Emdadul Hoque, Dewan/O-3606-2015	Chowdhury, Mohiuddin Ahsanul Kabir/0000-0001-6551-5919; Khan, Abdullah Nurus Salam/0000-0002-8694-4349; Ali, Nazia Binte/0000-0001-5010-9563; Md. Emdadul Hoque, Dewan/0000-0001-8219-9196	Swedish International Development Cooperation Agency (Sida) through icddr,b [GR 01455]	Swedish International Development Cooperation Agency (Sida) through icddr,b	The research study was funded by the Swedish International Development Cooperation Agency (Sida) through icddr,b (Grant number: GR 01455). MAKC received funding for this study. URL of funder website: https://www.sida.se/English/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, J ONCOL PRACT, V13, pe353; [Anonymous], 2020, ZHONGHUA JIE HE HE H, V17, DOI 10.3760/cma.j.issn.1001-0939.2020.0020; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2018, RECOMMENDATIONS INTR; Begum T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220693; Bergamaschi N, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010417; Betran AP, 2018, LANCET, V392, P1358, DOI 10.1016/S0140-6736(18)31927-5; Biswas S, 2012, J MT SCI-ENGL, V9, P147, DOI 10.1007/s11629-012-2028-z; Brodribb W, 2013, PEDIATRICS, V131, P685, DOI 10.1542/peds.2012-2556; Debes AK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S19; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; El Arifeen S, 2013, LANCET, V382, P2012, DOI 10.1016/S0140-6736(13)62149-2; Expert Panel on Gastrointestinal Imaging, 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; GOB, 2011, NAT STRAT WAT SAN HA; Granger K, 2018, BREASTFEED MED, V13, P535, DOI 10.1089/bfm.2018.0125; Haider MR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208623; Hansen K, 2016, LANCET, V387, P416, DOI 10.1016/S0140-6736(16)00012-X; Haque MA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3296-2; Hardin JW, 2012, GEN LINEAR MODELS EX, V3rd; Horii N, 2011, FOOD NUTR BULL, V32, P94, DOI 10.1177/156482651103200203; Hossain J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226923; Islam MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215733; John JR, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2211-0; Karim F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220224; Khan J, 2015, MATERN CHILD HLTH J, V19, P468, DOI 10.1007/s10995-014-1526-8; Legesse M, 2014, INT BREASTFEED J, V9, DOI 10.1186/s13006-014-0025-2; Malik ANJ, 1998, BRIT MED J, V316, P1548, DOI 10.1136/bmj.316.7144.1548; Moinuddin M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189365; Mukora-Mutseyekwa Fadzai, 2019, Matern Health Neonatol Perinatol, V5, P2, DOI 10.1186/s40748-018-0097-x; Mullany LC, 2008, J NUTR, V138, P599, DOI 10.1093/jn/138.3.599; Munn AC, 2016, BREASTFEED MED, V11, P222, DOI 10.1089/bfm.2015.0135; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; NIPORT. & ICF, 2019, BANGL HLTH FAC SURV; Nissen E, 1996, EARLY HUM DEV, V45, P103, DOI 10.1016/0378-3782(96)01725-2; Ogbo FA, 2016, PAEDIATR PERINAT EP, V30, P346, DOI 10.1111/ppe.12293; Patel A, 2013, J HUM LACT, V29, P572, DOI 10.1177/0890334412474718; Perez-Escamilla R, 2016, MATERN CHILD NUTR, V12, P402, DOI 10.1111/mcn.12294; Phukan D, 2018, INT BREASTFEED J, V13, DOI 10.1186/s13006-018-0162-0; Prior E, 2012, AM J CLIN NUTR, V95, P1113, DOI 10.3945/ajcn.111.030254; Raihan MJ, 2020, MATERN CHILD NUTR, V16, DOI 10.1111/mcn.12971; Richards E, 2019, MIDWIFERY, V77, P117, DOI 10.1016/j.midw.2019.07.001; Rocha Semíramis Melani Melo, 2003, Rev. Bras. Enferm., V56, P125, DOI 10.1590/S0034-71672003000200002; Rowe-Murray HJ, 2002, BIRTH-ISS PERINAT C, V29, P124, DOI 10.1046/j.1523-536X.2002.00172.x; Sarker M.H., 2003, INT J RIVER BASIN MA, V1, P61, DOI [10.1080/15715124.2003.9635193, DOI 10.1080/15715124.2003.9635193]; Shaker NZ, 2015, E MEDITERR HEALTH J, V21, P885, DOI 10.26719/2015.21.12.885; Sievers E, 2003, BIOL NEONATE, V83, P246, DOI 10.1159/000069485; Singh K, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020505; Sundaram ME, 2016, INT BREASTFEED J, V11, DOI 10.1186/s13006-016-0090-9; UNICEF W, 2003, GLOB STRAT INF YOUNG; United Nations, 2022, SUSTAIN DEV, DOI DOI 10.1002/SD.2445; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; WHO, 1978, TAN MOD HLTH SERV CO; Word Health Organization, 2018, INF YOUNG CHILD FEED; World Health Organization and the United Nations Children's Fund, 2009, BAB FRIENDL HOSP IN; Yotebieng M, 2015, LANCET GLOB HEALTH, V3, pE546, DOI 10.1016/S2214-109X(15)00012-1	55	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242135	10.1371/journal.pone.0242135	http://dx.doi.org/10.1371/journal.pone.0242135			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186387	gold, Green Published			2022-12-26	WOS:000593949800009
J	Ramirez, GA; Richardson, E; Clark, J; Keshri, J; Drechsler, Y; Berrang, ME; Meinersmann, RJ; Cox, NA; Oakley, BB				Ramirez, Gustavo A.; Richardson, Ella; Clark, Jory; Keshri, Jitendra; Drechsler, Yvonne; Berrang, Mark E.; Meinersmann, Richard J.; Cox, Nelson A.; Oakley, Brian B.			Broiler chickens and early life programming: Microbiome transplant-induced cecal community dynamics and phenotypic effects	PLOS ONE			English	Article							ANTIMICROBIAL GROWTH PROMOTERS; SALMONELLA-TYPHIMURIUM; BACTERIAL COMMUNITY; PERFORMANCE; ALTERNATIVES; MODE; COLONIZATION; ANTIBIOTICS; SUCCESSION; DIVERSITY	The concept of successional trajectories describes how small differences in initial community composition can magnify through time and lead to significant differences in mature communities. For many animals, the types and sources of early-life exposures to microbes have been shown to have significant and long-lasting effects on the community structure and/or function of the microbiome. In modern commercial poultry production, chicks are reared as a single age cohort and do not directly encounter adult birds. This scenario is likely to initiate a trajectory of microbial community development that is significantly different than non-industrial settings where chicks are exposed to a much broader range of environmental and fecal inocula; however, the comparative effects of these two scenarios on microbiome development and function remain largely unknown. In this work, we performed serial transfers of cecal material through multiple generations of birds to first determine if serial transfers exploiting the ceca in vivo, rather than the external environment or artificial incubations, can produce a stable microbial community. Subsequently, we compared microbiome development between chicks receiving this passaged, i.e. host-selected, cecal material orally, versus an environmental inoculum, to test the hypothesis that the first exposure of newly hatched chicks to microbes determines early GI microbiome structure and may have longer-lasting effects on bird health and development. Cecal microbiome dynamics and bird weights were tracked for a two-week period, with half of the birds in each treatment group exposed to a pathogen challenge at 7 days of age. We report that: i) a relatively stable community was derived after a single passage of transplanted cecal material, ii) this cecal inoculum significantly but ephemerally altered community structure relative to the environmental inoculum and PBS controls, and iii) either microbiome transplant administered at day-of-hatch appeared to have some protective effects against pathogen challenge relative to uninoculated controls. Differentially abundant taxa identified across treatment types may inform future studies aimed at identifying strains associated with beneficial phenotypes.	[Ramirez, Gustavo A.; Richardson, Ella; Clark, Jory; Keshri, Jitendra; Drechsler, Yvonne; Oakley, Brian B.] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA; [Ramirez, Gustavo A.] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA; [Berrang, Mark E.; Meinersmann, Richard J.; Cox, Nelson A.] USDA ARS, Natl Poultry Ctr, Athens, GA 30613 USA	Western University of Health Sciences; University of North Carolina; University of North Carolina Chapel Hill; United States Department of Agriculture (USDA)	Oakley, BB (corresponding author), Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA.	boakley@westernu.edu	Oakley, Brian Oakley B/AAG-4015-2019	Oakley, Brian/0000-0003-2098-6439	U.S. Poultry & Egg Association; Western University of Health Sciences College of Veterinary Medicine; Office of the Vice-President for Research and Biotechnology; USDA NIFA grants [1015210, 1011327]	U.S. Poultry & Egg Association; Western University of Health Sciences College of Veterinary Medicine; Office of the Vice-President for Research and Biotechnology; USDA NIFA grants	Support was provided by the U.S. Poultry & Egg Association, the Western University of Health Sciences College of Veterinary Medicine, and the Office of the Vice-President for Research and Biotechnology. Additional funding was provided by USDA NIFA grants (Accession numbers 1015210 and 1011327) to Western University of Health Sciences College of Veterinary Medicine and BBO.	Aidara-Kane A, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-017-0294-9; Allen HK, 2013, TRENDS MICROBIOL, V21, P114, DOI 10.1016/j.tim.2012.11.001; Apajalahti J, 2004, WORLD POULTRY SCI J, V60, P223, DOI 10.1079/WPS200415; Bai SP, 2013, POULTRY SCI, V92, P663, DOI 10.3382/ps.2012-02813; Batte MT, 2007, FOOD POLICY, V32, P145, DOI 10.1016/j.foodpol.2006.05.003; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bortoluzzi C, 2017, POULTRY SCI, V96, P3981, DOI 10.3382/ps/pex218; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Canani RB, 2011, NUTR RES REV, V24, P198, DOI 10.1017/S0954422411000102; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Choi JH, 2014, POULTRY SCI, V93, P1942, DOI 10.3382/ps.2014-03974; Clavijo V, 2018, POULTRY SCI, V97, P1006, DOI 10.3382/ps/pex359; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; CORRIER DE, 1995, POULTRY SCI, V74, P916, DOI 10.3382/ps.0740916; Costa MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171642; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; De Maesschalck C, 2015, APPL ENVIRON MICROB, V81, P5880, DOI 10.1128/AEM.01616-15; Diaz-Sanchez S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216080; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Dunkley KD, 2007, POULTRY SCI, V86, P801, DOI 10.1093/ps/86.5.801; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eeckhaut V, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01416; Faircloth BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042543; FASTIE CL, 1995, ECOLOGY, V76, P1899, DOI 10.2307/1940722; Gadde UD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22004-6; Gaskins HR, 2002, ANIM BIOTECHNOL, V13, P29, DOI 10.1081/ABIO-120005768; LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Liljebjelke KA, 2005, FOODBORNE PATHOG DIS, V2, P90, DOI 10.1089/fpd.2005.2.90; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Malorny B, 2003, APPL ENVIRON MICROB, V69, P290, DOI 10.1128/AEM.69.1.290-296.2003; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mende M, 2009, ITAL J ANIM SCI, P8; Milani C, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00036-17; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; Muller SC, 2018, IEEE T SMART GRID, V9, P14, DOI 10.1109/TSG.2016.2542824; Namkung H, 2011, POULTRY SCI, V90, P2217, DOI 10.3382/ps.2011-01498; Neal-McKinney JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043928; Neu J, 2011, CLIN PERINATOL, V38, P321, DOI 10.1016/j.clp.2011.03.008; Niewold TA, 2007, POULTRY SCI, V86, P605, DOI 10.1093/ps/86.4.605; Oakley BB, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00011; Oakley BB, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0282-8; Oakley BB, 2014, FEMS MICROBIOL LETT, V360, P100, DOI 10.1111/1574-6968.12608; Oakley BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057190; Oakley BB, 2012, FEMS MICROBIOL ECOL, V79, P327, DOI 10.1111/j.1574-6941.2011.01219.x; Oksanen J, 2015, VEGAN COMMUNITY ECOL, V2, P2; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278; RANTALA M, 1973, BRIT POULTRY SCI, V14, P627, DOI 10.1080/00071667308416073; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rubio LA, 2019, POULTRY SCI, V98, P695, DOI 10.3382/ps/pey416; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schokker D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1646-6; Seal BS, 2013, ANIM HEALTH RES REV, V14, P78, DOI 10.1017/S1466252313000030; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; SHAPIRO SK, 1949, J BACTERIOL, V58, P531, DOI 10.1128/JB.58.4.531-544.1949; Siegerstetter SC, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02330-17; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; STAVRIC S, 1985, J FOOD PROTECT, V48, P778, DOI 10.4315/0362-028X-48.9.778; Sunkara LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027225; Szekely AJ, 2014, FEMS MICROBIOL ECOL, V87, P102, DOI 10.1111/1574-6941.12195; Timmerman HM, 2006, POULTRY SCI, V85, P1383, DOI 10.1093/ps/85.8.1383; Torok VA, 2011, APPL ENVIRON MICROB, V77, P5868, DOI 10.1128/AEM.00165-11; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van der Wielen PWJJ, 2000, APPL ENVIRON MICROB, V66, P2536, DOI 10.1128/AEM.66.6.2536-2540.2000; Van Loo E, 2010, J FOOD SCI, V75, pS384, DOI 10.1111/j.1750-3841.2010.01775.x; Wang WC, 2018, J ANIM SCI, V96, P1654, DOI 10.1093/jas/sky092; Yadav S, 2019, J ANIM SCI BIOTECHNO, V10, DOI 10.1186/s40104-018-0310-9; Yarza P, 2010, SYST APPL MICROBIOL, V33, P291, DOI 10.1016/j.syapm.2010.08.001	76	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242108	10.1371/journal.pone.0242108	http://dx.doi.org/10.1371/journal.pone.0242108			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186366	Green Published, Green Submitted, gold			2022-12-26	WOS:000593949800022
J	Bozio, CH; Isenhour, C; McNamara, LA				Bozio, Catherine H.; Isenhour, Cheryl; McNamara, Lucy A.			Characteristics of and meningococcal disease prevention strategies for commercially insured persons receiving eculizumab in the United States	PLOS ONE			English	Article								Introduction Eculizumab is a licensed treatment for several rare, complement-mediated diseases. Eculizumab use is associated with an approximately 2,000-fold increased meningococcal disease risk. In the United States, meningococcal vaccines are recommended for eculizumab recipients but there are no recommendations on use of long-term antibiotic prophylaxis. We describe characteristics of and meningococcal vaccine and antibiotic receipt in U.S. eculizumab recipients to inform meningococcal disease prevention strategies. Methods Persons in the IBM (R) MarketScan (R) Research Databases with >= 1 claim for eculizumab injection during 2007-2017 were included. Indication for eculizumab use, meningococcal vaccine receipt, and antibiotic receipt were assessed using International Classification of Diseases-9/10 diagnosis codes, vaccine administration procedure codes, and antibiotic codes from pharmacy claims, respectively. Results Overall 696 persons met the inclusion criteria. Paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) were the most common indications for eculizumab use (41% and 37%, respectively); 20% had an undetermined indication. From June 2015 through December 2017, 28% (41/148) of continuously-enrolled patients received >= 1 serogroup B vaccine dose. For serogroup ACWY conjugate vaccine, 45% (91/201) of patients received >= 1 dose within five years of their most recent eculizumab dose, as recommended. Of eculizumab recipients with outpatient prescription data, 7% (41/579) received antibiotics for >= 50% of the period of increased risk for meningococcal disease. Conclusion Many eculizumab recipients had an undetermined indication for eculizumab use; few were up-to-date for recommended meningococcal vaccines or were prescribed antibiotics long-term. These findings can inform further investigation of how to best protect this population from meningococcal disease.	[Bozio, Catherine H.; McNamara, Lucy A.] Natl Ctr Immunizat & Resp Dis, Div Bacterial Dis, CDC, Atlanta, GA USA; [Isenhour, Cheryl] Ctr Surveillance, Div Hlth Informat & Surveillance, Epidemiol & Lab Serv, CDC, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Bozio, CH (corresponding author), Natl Ctr Immunizat & Resp Dis, Div Bacterial Dis, CDC, Atlanta, GA USA.	ise7@cdc.gov		Bozio, Catherine/0000-0001-6566-7138				Castaneda-Sanabria J, 2016, EUR J CLIN PHARMACOL, V72, P737, DOI 10.1007/s00228-016-2027-z; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; Crew PE, 2019, CLIN INFECT DIS, V69, P596, DOI 10.1093/cid/ciy958; Crew PE, 2019, J INFECTION, V78, P113, DOI 10.1016/j.jinf.2018.10.015; Food and Drug Administration, 2019, SOL PROD INS; Granoff DM, 2019, HAEMATOLOGICA, V104, pE340, DOI 10.3324/haematol.2018.209692; Haut Conseil de la sante publique, 2017, AV ACT AV REL ANT VA; Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347; Keating GM, 2013, DRUGS, V73, P2053, DOI 10.1007/s40265-013-0147-7; Kelly RJ, 2011, BLOOD, V117, P6786, DOI 10.1182/blood-2011-02-333997; McKeage K, 2019, DRUGS, V79, P347, DOI 10.1007/s40265-019-01068-2; McKeage K, 2011, DRUGS, V71, P2327, DOI 10.2165/11208300-000000000-00000; McNamara LA, 2017, MMWR-MORBID MORTAL W, V66, P734, DOI 10.15585/mmwr.mm6627e1; Noris M, 2009, NEW ENGL J MED, V361, P1676, DOI 10.1056/NEJMra0902814; Parikh SR, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-2452; Parker C, 2005, BLOOD, V106, P3699, DOI 10.1182/blood-2005-04-1717; Patton ME, 2017, MMWR-MORBID MORTAL W, V66, P509, DOI 10.15585/mmwr.mm6619a6; PNH National Service Leeds, 2007, MEN INF EC COMPL INH; Polat M, 2018, HUM VACC IMMUNOTHER, V14, P2802, DOI 10.1080/21645515.2018.1486157; Reher D, 2018, VACCINE, V36, P2507, DOI 10.1016/j.vaccine.2018.03.087; Risitano AM, 2018, AM J HEMATOL, V93, P564, DOI 10.1002/ajh.25016; Schaefer F, 2018, KIDNEY INT, V94, P408, DOI 10.1016/j.kint.2018.02.029; Socie G, 2019, BRIT J HAEMATOL, V185, P297, DOI 10.1111/bjh.15790; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Weitz M, 2011, PEDIATR NEPHROL, V26, P1325, DOI 10.1007/s00467-011-1879-9	25	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241989	10.1371/journal.pone.0241989	http://dx.doi.org/10.1371/journal.pone.0241989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180804	Green Published, gold			2022-12-26	WOS:000593948000055
J	Paganini, J; Nagy, PL; Rouse, N; Gouret, P; Chiaroni, J; Picard, C; Di Cristofaro, J				Paganini, Julien; Nagy, Peter L.; Rouse, Nicholas; Gouret, Philippe; Chiaroni, Jacques; Picard, Chistophe; Di Cristofaro, Julie			Blood group typing from whole-genome sequencing data	PLOS ONE			English	Article							ANTIGENS; PREDICTION; PHENOTYPE; MUTATION; GENES	Many questions can be explored thanks to whole-genome data. The aim of this study was to overcome their main limits, software availability and database accuracy, and estimate the feasibility of red blood cell (RBC) antigen typing from whole-genome sequencing (WGS) data. We analyzed whole-genome data from 79 individuals for HLA-DRB1 and 9 RBC antigens. Whole-genome sequencing data was analyzed with software allowing phasing of variable positions to define alleles or haplotypes and validated for HLA typing from next-generation sequencing data. A dedicated database was set up with 1648 variable positions analyzed in KEL (KEL), ACKR1 (FY), SLC14A1 (JK), ACHE (YT), ART4 (DO), AQP1 (CO), CD44 (IN), SLC4A1 (DI) and ICAM4 (LW). Whole-genome sequencing typing was compared to that previously obtained by amplicon-based monoallelic sequencing and by SNaPshot analysis. Whole-genome sequencing data were also explored for other alleles. Our results showed 93% of concordance for blood group polymorphisms and 91% for HLA-DRB1. Incorrect typing and unresolved results confirm that WGS should be considered reliable with read depths strictly above 15x. Our results supported that RBC antigen typing from WGS is feasible but requires improvements in read depth for SNV polymorphisms typing accuracy. We also showed the potential for WGS in screening donors with rare blood antigens, such as weak JK alleles. The development of WGS analysis in immunogenetics laboratories would offer personalized care in the management of RBC disorders.	[Paganini, Julien; Gouret, Philippe] Xegen, Gemenos, France; [Nagy, Peter L.; Rouse, Nicholas] Columbia Univ, Lab Personalized Genom Med, New York, NY USA; [Chiaroni, Jacques; Picard, Chistophe; Di Cristofaro, Julie] Aix Marseille Univ, CNRS, EFS, Biol Grp Sanguins,ADES, Marseille, France	Columbia University; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; UDICE-French Research Universities; Aix-Marseille Universite	Di Cristofaro, J (corresponding author), Aix Marseille Univ, CNRS, EFS, Biol Grp Sanguins,ADES, Marseille, France.	julie.dicristofaro@efs.sante.fr	Chiaroni, Jacques/ABA-2944-2021	Chiaroni, Jacques/0000-0002-3133-8990; Di Cristofaro, Julie/0000-0001-7867-6455				Abi-Rached L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206512; Agrawal S, 2020, CLIN IMMUNOL, V216, DOI 10.1016/j.clim.2020.108449; Blumenfeld OO, 2004, HUM MUTAT, V23, P8, DOI 10.1002/humu.10296; Brown D, 2004, TISSUE ANTIGENS, V64, P215, DOI 10.1111/j.0001-2815.2004.00290.x; de Knijff P, 2019, FORENSIC SCI INT-GEN, V38, P175, DOI 10.1016/j.fsigen.2018.10.017; Di Cristofaro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076748; Di Cristofaro J, 2010, J MOL DIAGN, V12, P453, DOI 10.2353/jmoldx.2010.090222; Fasano RM, 2016, TRANSFUS MED REV, V30, P197, DOI 10.1016/j.tmrv.2016.05.011; Fuentes-Pardo AP, 2017, MOL ECOL, V26, P5369, DOI 10.1111/mec.14264; Hamilton Janis R, 2015, Immunohematology, V31, P29; Lane WJ, 2018, LANCET HAEMATOL, V5, pE241, DOI 10.1016/S2352-3026(18)30053-X; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lippert C, 2017, P NATL ACAD SCI USA, V114, P10166, DOI 10.1073/pnas.1711125114; Manel S, 2016, MOL ECOL, V25, P170, DOI 10.1111/mec.13468; Matthijs G, 2016, EUR J HUM GENET, V24, P2, DOI 10.1038/ejhg.2015.226; Mazieres S, 2013, TRANSFUSION MED, V23, P167, DOI 10.1111/tme.12038; Nagy PL, 2021, EUR J HUM GENET, V29, P164, DOI 10.1038/s41431-020-0683-z; Olsson ML, 1998, BRIT J HAEMATOL, V103, P1184, DOI 10.1046/j.1365-2141.1998.01083.x; Orzinska A, 2019, TRANSFUSION, V59, P1102, DOI 10.1111/trf.15116; Patnaik SK, 2012, NUCLEIC ACIDS RES, V40, pD1023, DOI 10.1093/nar/gkr958; Paul P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01208; Rebmann V, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/297073; Robinson J, 2020, NUCLEIC ACIDS RES, V48, pD948, DOI 10.1093/nar/gkz950; Vorholt SM, 2020, TRANSFUS MED HEMOTH, V47, P33, DOI 10.1159/000504894; Wester ES, 2011, TRANSFUSION, V51, P380, DOI 10.1111/j.1537-2995.2010.02795.x; Wu PC, 2019, VOX SANG, V114, P268, DOI 10.1111/vox.12759	27	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242168	10.1371/journal.pone.0242168	http://dx.doi.org/10.1371/journal.pone.0242168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180819	Green Published, gold			2022-12-26	WOS:000593948000052
J	Stribling, JB; Leppo, EW				Stribling, James B.; Leppo, Erik W.			Relationship of taxonomic error to frequency of observation	PLOS ONE			English	Article							BIODIVERSITY	Biological nomenclature is the entry point to a wealth of information related to or associated with living entities. When applied accurately and consistently, communication between and among researchers and investigators is enhanced, leading to advancements in understanding and progress in research programs. Based on freshwater benthic macroinvertebrate taxonomic identifications, inter-laboratory comparisons of >900 samples taken from rivers, streams, and lakes across the U.S., including the Great Lakes, provided data on taxon-specific error rates. Using the error rates in combination with frequency of observation (FREQ; as a surrogate for rarity), six uncertainty/frequency classes (UFC) are proposed for approximately 1,000 taxa. The UFC, error rates, FREQ each are potentially useful for additional analyses related to interpreting biological assessment results and/or stressor response relationships, as weighting factors for various aspects of ecological condition or biodiversity analyses and helping set direction for taxonomic research and refining identification tools.	[Stribling, James B.; Leppo, Erik W.] Tetra Tech, Inc Ctr Ecol Sci, Owings Mills, MD 21117 USA		Stribling, JB (corresponding author), Tetra Tech, Inc Ctr Ecol Sci, Owings Mills, MD 21117 USA.	james.stribling@tetratech.com		, Erik/0000-0001-8026-7474; Stribling, James/0000-0002-7327-6919	US Environmental Protection Agency/Office of Water/Office of Wetlands, Oceans, and Watersheds/Assessment and Watershed Protection Division [EP-C-14-016]; Agency's National Aquatic Resources Surveys	US Environmental Protection Agency/Office of Water/Office of Wetlands, Oceans, and Watersheds/Assessment and Watershed Protection Division; Agency's National Aquatic Resources Surveys	Approximately 10% of necessary level of effort in initiating this project was contracted to Tetra Tech, Inc. (JBS) (EP-C-14-016, Work Assignment 4-13) by the US Environmental Protection Agency/Office of Water/Office of Wetlands, Oceans, and Watersheds/Assessment and Watershed Protection Division. The work was in support of the Agency's National Aquatic Resources Surveys: https://www.epa.gov/nationalaquatic-resource-surveys.Additionally, Tetra Tech, Inc., the employer of JBS and EWL, allowed some company resources to be applied to some of the data analyses and manuscript preparation, in particular, computer hardware, software, and network resources, and limited labor hours. The sponsors played no other role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balee W, 1992, J ETHNOBIOL, V13, P144; BERLIN B, 1966, SCIENCE, V154, P273, DOI 10.1126/science.154.3746.273; Blowes SA, 2019, SCIENCE, V366, P339, DOI 10.1126/science.aaw1620; BROWN CH, 1986, CURR ANTHROPOL, V27, P1, DOI 10.1086/203375; Didham RK, 2020, INSECT CONSERV DIVER, V13, P103, DOI 10.1111/icad.12408; Dopheide A, 2020, ELIFE, V9, DOI 10.7554/eLife.52787; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HUNN E, 1982, AM ANTHROPOL, V84, P830, DOI 10.1525/aa.1982.84.4.02a00070; Keith LH, 1991, A PRACTICAL GUIDE; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Lucking Robert, 2020, Megataxa, V1, P73, DOI 10.11646/megataxa.1.1.16; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; Merritt RW., 2019, INTRO AQUATIC INSECT, V5; Nijboer RC, 2004, ARCH HYDROBIOL, V161, P45, DOI 10.1127/0003-9136/2004/0161-0045; Parr CS, 2012, TRENDS ECOL EVOL, V27, P94, DOI 10.1016/j.tree.2011.11.001; Patterson D, 2016, BIODIVERS DATA J, V4, DOI 10.3897/BDJ.4.e8080; Paulsen SG, 2020, RIVERS STREAMS UPGRA; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Rosauer Dan F, 2017, Proc Biol Sci, V284, DOI 10.1098/rspb.2017.0627; SFS-TCP, 2019, TAX CERT PROGR SOC F; Stein ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095525; Stribling JB, 2008, J N AM BENTHOL SOC, V27, P906, DOI 10.1899/07-175.1; The Lancet HIV, 2016, LANCET HIV, V3, pe191; Titley MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189577; Troudet J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09084-6; USEPA, 2012, NAT LAK ASS LAB OP M; USEPA, 2008, EPA841B07010 OFF WAT; Yu J, 2001, J BIOGEOGR, V27, P131	32	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241933	10.1371/journal.pone.0241933	http://dx.doi.org/10.1371/journal.pone.0241933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180842	Green Submitted, Green Published, gold			2022-12-26	WOS:000593948000090
J	Woods, BJ; Gallego-Castillo, S; Talsma, EF; Alvarez, D				Woods, Bo-Jane; Gallego-Castillo, Sonia; Talsma, Elise F.; Alvarez, Daniel			The acceptance of zinc biofortified rice in Latin America: A consumer sensory study and grain quality characterization	PLOS ONE			English	Article							VITAMIN-A STATUS; HIDDEN HUNGER; IRON STATUS; CHILDREN; NUTRITION; MAIZE; ACCUMULATION; CONSUMPTION; PROVITAMIN; CROPS	Zinc deficiency is a major public health problem in vulnerable populations of Latin America and the Caribbean. Biofortification of rice (Oryza sativa L.) with zinc has the potential to alleviate zinc deficiencies. However, as plant breeding processes can alter grain culinary quality and favorable sensory attributes, grain quality and consumer acceptability need to be assessed prior to releasing a variety to the public. A grain quality characterization and a sensory acceptability analysis were carried out with two varieties of zinc biofortified rice and a local control both in Bolivia and Colombia. The aim of this study was to evaluate the physicochemical parameters that are significant in consumer acceptance and to determine the acceptability of zinc biofortified rice by consumers. Results of physicochemical parameters were analyzed using ANOVA. The sensory acceptability was evaluated in 243 adults utilizing a 7-point hedonic scale and a Wilcoxon's signed rank test was used to determine the overall acceptability of the varieties. Biofortified rice variety T2-11 and MAC-18 -control 1- were equally accepted by consumers in Bolivia with no significant differences (p<0.05). The grain quality analysis reported that both presented long and slender rice grains (L>7.5 mm and L/B>3), an intermediate to high amylose content (>25%) and a similar level of chalkiness. In Colombia, the biofortified variety 035 presented a higher score in overall acceptance in comparison to biofortified variety 021 and the local variety CICA4 -control 2-. However, no significant differences were observed (p<0.05). Conversely to the other two varieties, the biofortified variety 035 presented the largest size grain (L/B = 2.97), a lower chalkiness and an amylose content above 25%. This study shows that the grain quality properties of rice have an influence on acceptability and that zinc biofortified rice varieties are accepted by consumers.	[Woods, Bo-Jane; Talsma, Elise F.] Wageningen Univ & Res, Div Human Nutr & Hlth, Wageningen, Netherlands; [Gallego-Castillo, Sonia; Alvarez, Daniel] Alliance Biovers Int, HarvestPlus, Cali, Colombia; [Gallego-Castillo, Sonia; Alvarez, Daniel] Int Ctr Trop Agr CIAT, Cali, Colombia	Wageningen University & Research; Alliance; International Center for Tropical Agriculture - CIAT	Alvarez, D (corresponding author), Alliance Biovers Int, HarvestPlus, Cali, Colombia.; Alvarez, D (corresponding author), Int Ctr Trop Agr CIAT, Cali, Colombia.	d.alvarez@cgiar.org		Alvarez, Daniel/0000-0002-5930-2295; Talsma, Elise/0000-0002-6034-4708				Ackland ML, 2016, ARCH BIOCHEM BIOPHYS, V611, P51, DOI 10.1016/j.abb.2016.06.011; Andersson M. S., 2017, African Journal of Food, Agriculture, Nutrition and Development, V17, P11905, DOI 10.18697/ajfand.78.harvestplus05; Inabangan-Asilo MA, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2384-7; [Anonymous], 2011, ULTRASCHALL MED S2, V32, pE8; Ansari S.A., 2019, INT J ADV AGR SCI TE, V6, P23; Ares G, 2014, FOOD QUAL PREFER, V31, P135, DOI 10.1016/j.foodqual.2013.08.012; Azman Halimi R, 2020, J SCI FOOD AGR, V100, P1495, DOI 10.1002/jsfa.10157; Bailey RL, 2015, ANN NUTR METAB, V66, P22, DOI 10.1159/000371618; Beintema JJS, 2018, FOOD SCI NUTR, V6, P1138, DOI 10.1002/fsn3.632; Bergman CJ, 2019, RICE: CHEMISTRY AND TECHNOLOGY, 4TH EDITION, P273, DOI 10.1016/B978-0-12-811508-4.00009-5; Bouis H., 2012, Reshaping agriculture for nutrition and health: an IFPRI 2020 book, P83; Bouis HE, 2017, GLOB FOOD SECUR-AGR, V12, P49, DOI 10.1016/j.gfs.2017.01.009; Boy E., 2017, African Journal of Food, Agriculture, Nutrition and Development, V17, P11879, DOI 10.18697/ajfand.HarvestPlus03; Brnic M, 2016, J NUTR, V146, P76, DOI 10.3945/jn.115.213421; Calayugan MIC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59184-z; Calingacion M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085106; Carrillo P, 2016, SENSORY TESTS BIOFOR; Cediel G, 2015, FOOD NUTR BULL, V36, pS129, DOI 10.1177/0379572115585781; Cetin I, 2019, ANN NUTR METAB, V74, P269, DOI 10.1159/000499698; Champagne ET, 2010, RICE, V3, P270, DOI 10.1007/s12284-010-9057-4; Cruz N. Dela, 2000, P15; De Bree A., 2009, THESIS; De Groote H, 2014, J SCI FOOD AGR, V94, P3201, DOI 10.1002/jsfa.6672; de Kock HL, 2018, METHODS CONSUMER RES, V2, P373; Delarue Julien, 2014, RAPID SENSORY PROFIL; European Food Safety Authority, 2014, EFSA J, V12, DOI [10.2903/j.efsa.2014.3835, 10.2903/j.efsa.2014.3595, 10.2903/j.efsa.2014.3761]; Executive summary, 2007, FOOD NUTR BULL, V28, pS399; FAO, FAOSTAT FOOD AGR DAT; Finkelstein JL, 2015, J NUTR, V145, P1576, DOI 10.3945/jn.114.208009; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fitzgerald M, 2017, WOODHEAD PUBL FOOD S, P291, DOI 10.1016/B978-0-08-100719-8.00012-7; Garg M, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00012; Gaur N, 2016, PROCEEDINGS ON 2016 2ND INTERNATIONAL CONFERENCE ON NEXT GENERATION COMPUTING TECHNOLOGIES (NGCT), P479, DOI 10.1109/NGCT.2016.7877463; Gibson RS, 2018, NUTR REV, V76, P793, DOI 10.1093/nutrit/nuy028; Gibson RS, 2016, FOOD NUTR BULL, V37, P443, DOI 10.1177/0379572116652252; Godecke T, 2018, GLOB FOOD SECUR-AGR, V17, P21, DOI 10.1016/j.gfs.2018.03.004; Govender L, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071577; Govender L, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061198; Grandy Giuseppe, 2010, Rev. bol. ped., V49, P25; Gupta S, 2020, J HUM NUTR DIET, V33, P624, DOI 10.1111/jhn.12791; Haas JD, 2016, J NUTR, V146, P1586, DOI 10.3945/jn.115.224741; Haddad L, 2016, FOOD SYSTEMS DIETS F; Heck S, 2020, FOOD SECUR, V12, P823, DOI 10.1007/s12571-020-01067-2; Herrington C, 2019, 40 IFPRI; Hotz C, 2012, J NUTR, V142, P1871, DOI 10.3945/jn.111.151829; Hotz C, 2012, BRIT J NUTR, V108, P163, DOI 10.1017/S0007114511005174; Jha AB, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9010073; Johns T, 2007, FOOD POLICY, V32, P1, DOI 10.1016/j.foodpol.2006.03.014; Kennedy G, 2015, DIETARY DIVERSITY BI; King JC, 2016, J NUTR, V146, p858S, DOI 10.3945/jn.115.220079; Knez M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9080825; KONGKIATTIKAJOR.J, 2008, KASETSART J NAT SCI, V42, P111; LATTA M, 1980, J AGR FOOD CHEM, V28, P1313, DOI 10.1021/jf60232a049; Lawless HT, 2010, FOOD SCI TEXT SERIES, P325; Lazarte C., 2014, THESIS LUND U LUND S; Lazarte C. E., 2015, Food and Nutrition Sciences, V6, P399, DOI 10.4236/fns.2015.64041; Liu DY, 2017, NUTRIENTS, V9, DOI 10.3390/nu9050465; Liu KL, 2019, FOOD SCI NUTR, V7, P608, DOI 10.1002/fsn3.884; Lopez de Romana D, 2017, SCALING RICE FORTIFI, P122; Luna SV, 2020, J NUTR, V150, P1093, DOI 10.1093/jn/nxaa016; Majumder S, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9120803; Pinzon-Rondon AM, 2019, BMC NUTR, V5, DOI 10.1186/s40795-019-0305-8; Martinez C., 1989, EVALUACION CALIDAD C; Coelho CMM, 2008, BRAZ ARCH BIOL TECHN, V51, P163, DOI 10.1590/S1516-89132008000100020; Meenakshi JV, 2010, WORLD DEV, V38, P64, DOI 10.1016/j.worlddev.2009.03.014; Mestres C, 2019, RICE CHEM TECHNOLOGY, P400; Ministerio de Salud y Proteccio&PRIME; n Social Repu&PRIME;blica de Colombia (MINSALUD); Departamento Admin- istrativo para la Prosperidad Social; Instituto Colombiano de Bienestar Familiar (ICBF); Instituto Nacio- nal de Salud (INS); Universidad Nacional de Colombia, 2019, ENC NAC SIT NUTR COL; Murray-Kolb LE, 2017, J NUTR, V147, P2109, DOI 10.3945/jn.117.255356; Norhaizan M E Jr, 2009, Malays J Nutr, V15, P213; Noulas C, 2018, J TRACE ELEM MED BIO, V49, P252, DOI 10.1016/j.jtemb.2018.02.009; Pachon H., 2011, PERSPECT NUTR HUM, V13, P135; Palmer AC, 2016, J NUTR, V146, P2551, DOI 10.3945/jn.116.239202; Paltridge NG, 2012, PLANT SOIL, V361, P251, DOI 10.1007/s11104-011-1104-4; Perez-Locas C, 2010, WOODHEAD PUBL FOOD S, P70, DOI 10.1533/9781845699260.1.70; Phattarakul N, 2012, PLANT SOIL, V361, P131, DOI 10.1007/s11104-012-1211-x; Poritosh Roy, 2010, Asian Journal of Food and Agro-Industry, V3, P373; Puldón Padrón Violeta, 2011, Perspect Nut Hum, V13, P123; Rehman A, 2018, PLANT SOIL, V422, P283, DOI 10.1007/s11104-017-3507-3; Reis BZ, 2020, J TRACE ELEM MED BIO, V61, DOI 10.1016/j.jtemb.2020.126537; Ruz M, 2019, FOOD NUTR BULL, V40, P14, DOI 10.1177/0379572119832780; Saltzman A, 2013, GLOB FOOD SECUR-AGR, V2, P9, DOI 10.1016/j.gfs.2012.12.003; Santos MV, 2019, METHODS MOL BIOL, V1892, P99, DOI 10.1007/978-1-4939-8914-0_6; Saravia L, 2018, OBESITY, V26, pS31, DOI 10.1002/oby.22114; Sazawal S, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0391-5; Scott SP, 2018, J NUTR, V148, P1462, DOI 10.1093/jn/nxy113; Sharma P, 2017, FOOD REV INT, V33, P359, DOI 10.1080/87559129.2016.1175009; Stevens R, 2008, FOOD POLICY, V33, P341, DOI 10.1016/j.foodpol.2007.12.003; Swamy BPM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201756; Taboada R, 2010, INFORM TECNICO PROYE; Talsma EF, 2016, P 4 MICR FOR GLOB C; Talsma EF, 2017, NUTR REV, V75, P798, DOI 10.1093/nutrit/nux037; Talsma EF, 2016, AM J CLIN NUTR, V103, P258, DOI 10.3945/ajcn.114.100164; Tananuwong K, 2010, J SCI FOOD AGR, V90, P1590, DOI 10.1002/jsfa.3976; Tong C, 2019, RICE: CHEMISTRY AND TECHNOLOGY, 4TH EDITION, P131, DOI 10.1016/B978-0-12-811508-4.00005-8; Vergara Omaris, 2011, Perspect Nut Hum, V13, P147; Viruez J, 2013, PRODUCCION ARROZ BOL, P40; Wenger MJ, 2019, J NUTR, V149, P687, DOI 10.1093/jn/nxy265; Whiting S. J., 2019, Health Benefits of Pulses, P43, DOI 10.1007/978-3-030-12763-3_4; Yadav N, 2019, BRIT FOOD J, V121, P2967, DOI 10.1108/BFJ-04-2019-0236; Yang RQ, 2018, FOOD SCI TECHNOL RES, V24, P369, DOI 10.3136/fstr.24.369; Yoshioka Y, 2007, CROP SCI, V47, P2113, DOI 10.2135/cropsci2006.10.0631sc; Zaman QU, 2018, ARCH AGRON SOIL SCI, V64, P147, DOI 10.1080/03650340.2017.1338343; Zapata-Caldas E, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-29	104	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242202	10.1371/journal.pone.0242202	http://dx.doi.org/10.1371/journal.pone.0242202			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0LY	33175890	Green Published, gold			2022-12-26	WOS:000593946900064
J	Jackson, GE; Malloch, G; McNamara, L; Little, D				Jackson, Gail E.; Malloch, Gaynor; McNamara, Louise; Little, Damon			Grain aphids (Sitobion avenae) with knockdown resistance (kdr) to insecticide exhibit fitness trade-offs, including increased vulnerability to the natural enemy Aphidius ervi	PLOS ONE			English	Article							PEACH-POTATO APHIDS; MYZUS-PERSICAE; PARASITOIDS; FECUNDITY; SIZE	The development of insecticide-resistance mechanisms in aphids has been associated with inhibitory, pleiotropic fitness costs. Such fitness costs have not yet been examined in the UK's most damaging cereal aphid, Sitobion avenae (grain aphid) (Hemiptera: Aphididae). This study aimed to evaluate the fitness trade-offs of the insecticide-resistant S. avenae clone versus an insecticide-susceptible S. avenae clone. Additionally, the parasitoid, Aphidius ervi (Hymenoptera: Braconidae), was introduced to examine its potential as a biological control agent. This study found that insecticide-resistant clones had significantly lower population growth and individual relative growth rate. Furthermore, insecticide-resistant clones suffered from a significantly greater rate of parasitisation (mummification) compared to their insecticide-susceptible counterparts. The successfulness of the parasitoid as a biological control agent could prevent the spread of the insecticide-resistant genotype. However, for this to be possible, insecticide spraying regimes need to be moderated, and habitat modification and parasitoid manipulation must be considered.	[Jackson, Gail E.; Little, Damon] Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland; [Malloch, Gaynor] James Hutton Inst, Dundee, Scotland; [McNamara, Louise] TEAGASC, Crops Res Ctr, Oak Pk, Carlow, Ireland	University of Edinburgh; James Hutton Institute; Teagasc; United States Department of Energy (DOE); Oak Ridge National Laboratory	Jackson, GE (corresponding author), Univ Edinburgh, Sch GeoSci, Edinburgh, Midlothian, Scotland.	G.Jackson@ed.ac.uk	MCNAMARA, LOUISE/AAV-6502-2021; Jackson, Gail/AAE-7150-2021	Jackson, Gail/0000-0003-4784-7340; Mc Namara, Louise/0000-0003-3751-3486				[Anonymous], 1985, EPISTEME NS, V5-6, P143; Boivin T, 2003, HEREDITY, V90, P107, DOI 10.1038/sj.hdy.6800188; CHAMBERS RJ, 1986, ANN APPL BIOL, V108, P219, DOI 10.1111/j.1744-7348.1986.tb07644.x; Crow J.F., 1957, ANN REV ENTOMOLOGY, V45, P997; DEAN GJ, 1970, ANN APPL BIOL, V66, P485, DOI 10.1111/j.1744-7348.1970.tb04628.x; DeBach P., 1991, BIOL CONTROL NATURAL, V2nd Edn; Desneux N, 2009, OECOLOGIA, V160, P387, DOI 10.1007/s00442-009-1289-x; Dixon AF G, 1998, APHID ECOLOGY; DIXON AFG, 1980, ENTOMOL EXP APPL, V28, P301, DOI 10.1007/BF00366317; DIXON AFG, 1971, B ENTOMOL RES, V6, P97, DOI 10.1017/S0007485300057485; Foster SP, 2003, HEREDITY, V91, P98, DOI 10.1038/sj.hdy.6800285; Foster SP, 2007, ANIM BEHAV, V74, P621, DOI 10.1016/j.anbehav.2006.12.018; Foster SP, 2014, PEST MANAG SCI, V70, P1249, DOI 10.1002/ps.3683; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Harvey JA, 2015, ENTOMOL EXP APPL, V154, P15, DOI 10.1111/eea.12250; Huffaker C.B., 2012, THEORY PRACTICE BIOL; Hunter V, 2009, MOUSEION, V9, P1, DOI 10.1353/mou.2010.0006; Ives AR, 1999, AM NAT, V154, P652, DOI 10.1086/303269; JACKSON GE, 1995, AGR ECOSYST ENVIRON, V54, P187, DOI 10.1016/0167-8809(95)00599-N; Malloch G, 2006, B ENTOMOL RES, V96, P573, DOI 10.1017/BER2006459; Malloch G., 2016, R114R480 AHDB; McKenzie J., 1996, ECOLOGICAL EVOLUTION; NOBLE M. D., 1958, CANADIAN ENT, V90, P760; Pennacchio F, 1999, ARCH INSECT BIOCHEM, V40, P53, DOI 10.1002/(SICI)1520-6327(1999)40:1&lt;53::AID-ARCH6&gt;3.0.CO;2-J; R Core Team, 2021, R LANGUAGE ENV STAT; ROOM PM, 1981, NATURE, V294, P78, DOI 10.1038/294078a0; ROUSH RT, 1987, ANNU REV ENTOMOL, V32, P361, DOI 10.1146/annurev.en.32.010187.002045; Simon JC, 1999, MOL ECOL, V8, P531, DOI 10.1046/j.1365-294x.1999.00583.x; Sloane MA, 2001, GENET RES, V77, P251, DOI 10.1017/S0016672301005018; STARY P, 1988, J APPL ENTOMOL, V105, P74, DOI 10.1111/j.1439-0418.1988.tb00163.x; Stary P., 1988, NATURAL ENEMIES, P171; Thiboldeaux R., 1986, THESIS; VANEMDEN HF, 1969, ENTOMOL EXP APPL, V12, P351, DOI 10.1007/BF00334956; VanEmden HF, 2007, APHIDS AS CROP PESTS, P1; Villagra CA, 2002, ANIM BEHAV, V64, P677, DOI 10.1006/anbe.2002.4015; WATT AD, 1979, ANN APPL BIOL, V91, P147, DOI 10.1111/j.1744-7348.1979.tb06485.x; Wilson ACC, 2004, MOL ECOL NOTES, V4, P104, DOI 10.1046/j.1471-8286.2004.00584.x; WRATTEN SD, 1977, ANN APPL BIOL, V85, P319, DOI 10.1111/j.1744-7348.1977.tb01918.x	38	5	5	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0230541	10.1371/journal.pone.0230541	http://dx.doi.org/10.1371/journal.pone.0230541			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170844	gold, Green Submitted, Green Published			2022-12-26	WOS:000592383400062
J	Tassoulas, LJ; Elias, MH; Wackett, LP				Tassoulas, Lambros J.; Elias, Mikael H.; Wackett, Lawrence P.			Discovery of an ultraspecific triuret hydrolase (TrtA) establishes the triuret biodegradation pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOPHANATE HYDROLASE; CRYSTAL-STRUCTURE; UREA; ENZYME; MECHANISM; PRODUCTS; BIURET	Triuret (carbonyldiurea) is an impurity found in industrial urea fertilizer (<0.1% w/w) that is applied, worldwide, around 300 million pounds each year on agricultural lands. In addition to anthropogenic sources, endogenous triuret has been identified in amoeba and human urine, the latter being diagnostic for hypokalemia. The present study is the first to describe the metabolic breakdown of triuret, which funnels into biuret metabolism. We identified the gene responsible for triuret decomposition (trtA) in bacterial genomes, clustered with biuH, which encodes biuret hydrolase and has close protein sequence homology. TrtA is a member of the isochorismatase-like hydrolase (IHL) protein family, similarly to BiuH, and has a catalytic efficiency (k(cat)/K-M) of 6 x 10(5) M(-1)s(-1), a KM for triuret of 20 mu M, and exquisite substrate specificity. Indeed, TrtA has four orders of magnitude less activity with biuret. Crystal structures of TrtA in apo and holo form were solved and compared with the BiuH structure. The high substrate selectivity was found to be conveyed by second shell residues around each active site. Mutagenesis of residues conserved in TrtA to the alternate consensus found in BiuHs revealed residues critical to triuret hydrolase activity but no single mutant evolved more biuret activity, and likely a combination of mutations is required to interconvert between TrtA, BiuH functions. TrtA-mediated triuret metabolism is relatively rare in recorded genomes (1-2%), but is largely found in plant-associated, nodulating, and endophytic bacteria. This study suggests functions for triuret hydrolase in certain eukaryotic intermediary processes and prokaryotic intermediary or biodegradative metabolism.	[Tassoulas, Lambros J.; Elias, Mikael H.; Wackett, Lawrence P.] Univ Minnesota, Dept Biochem Biophys & Mol Biol, Minneapolis, MN 55455 USA; [Tassoulas, Lambros J.; Elias, Mikael H.; Wackett, Lawrence P.] Univ Minnesota, BioTechnol Inst, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Wackett, LP (corresponding author), Univ Minnesota, Dept Biochem Biophys & Mol Biol, Minneapolis, MN 55455 USA.; Wackett, LP (corresponding author), Univ Minnesota, BioTechnol Inst, St Paul, MN 55108 USA.	wacke003@umn.edu		Wackett, Lawence/0000-0002-3255-1101; Tassoulas, Lambros/0000-0001-6297-0983	DOE Office of Science [DE-AC02 06CH11357]; MnDRIVE Initiative at the University of Minnesota; USDA National Institute of Food and Agriculture, Agricultural and Food Research Initiative Competitive Program, Ecosystem Services and Agro-Ecosystem Management [2019-67019-29403]; National Institutes of Health Biotechnology training grant [5T32GM008347-27]	DOE Office of Science(United States Department of Energy (DOE)); MnDRIVE Initiative at the University of Minnesota; USDA National Institute of Food and Agriculture, Agricultural and Food Research Initiative Competitive Program, Ecosystem Services and Agro-Ecosystem Management; National Institutes of Health Biotechnology training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Ke Shi from the Nanoliter Crystallization Facility at the University of Minnesota for initial crystal screening and beamline use to obtain diffraction data for the TrtA Apo structure. Jack Richman was instrumental in synthesizing 13C-labeled triuret and conducting the NMR experiments. Celine Bergonzi, Sudipta Shaw, and Nathan Hoekstra are acknowledged for their expert advice on X-ray diffraction data collection, processing, and structure solution. Serina Robinson, Anthony Dodge, and Kelly Aukema are indebted to for their consultation on the experimental design and the article. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02 06CH11357. This work was supported by funding from the MnDRIVE Initiative at the University of Minnesota and by the USDA National Institute of Food and Agriculture, Agricultural and Food Research Initiative Competitive Program, Ecosystem Services and Agro-Ecosystem Management, grant no. 2019-67019-29403. LJT was supported by National Institutes of Health Biotechnology training grant (5T32GM008347-27).	Aukema KG, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.01964-19; Bar-Even A, 2011, BIOCHEMISTRY-US, V50, P4402, DOI 10.1021/bi2002289; Cameron SM, 2011, ACS CATAL, V1, P1075, DOI 10.1021/cs200295n; CARLSTRO.D, 1965, ACTA CRYSTALLOGR, V18, P307, DOI 10.1107/S0365110X65000737; Du XL, 2001, BIOCHEMISTRY-US, V40, P14166, DOI 10.1021/bi0115479; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ENGELHARDT M, 1976, CR TRAV LAB CARLSB, V40, P361; Esquirol L, 2018, J BIOL CHEM, V293, P7880, DOI 10.1074/jbc.RA118.001996; Esquirol L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192736; Farbwerke Hoechst A. G., 1969, British Patent, Patent No. [1,230, 473, 1230473]; Gersch C, 2009, NUCLEOS NUCLEOT NUCL, V28, P118, DOI 10.1080/15257770902736400; Glibert PM, 2006, BIOGEOCHEMISTRY, V77, P441, DOI 10.1007/s10533-005-3070-5; Goral Anna M., 2012, Journal of Structural and Functional Genomics, V13, P27, DOI 10.1007/s10969-012-9127-5; GRIFFIN JL, 1961, BIOCHIM BIOPHYS ACTA, V47, P433, DOI 10.1016/0006-3002(61)90538-8; Haworth RC, 1943, J CHEM SOC, P603, DOI 10.1039/jr9430000603; HAYS JT, 1973, J AGR FOOD CHEM, V21, P498, DOI 10.1021/jf60187a031; HOJERUP B, 1973, CR TRAV LAB CARLSB, V39, P169; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim KM, 2009, J CHROMATOGR B, V877, P65, DOI 10.1016/j.jchromb.2008.11.029; Kincaid VA, 2012, BIOCHEMISTRY-US, V51, P545, DOI 10.1021/bi201347n; Lin Y, 2013, BIOCHEMISTRY-US, V52, P690, DOI 10.1021/bi301242m; Lindermayr C, 2015, PLANT PHYSIOL, V167, P1209, DOI 10.1104/pp.15.00293; Izaguirre-Mayoral ML, 2018, PLANT SOIL, V428, P1, DOI 10.1007/s11104-018-3674-x; Ma XF, 2016, PLANT CELL, V28, P1108, DOI 10.1105/tpc.15.00880; MCGRATH ME, 1989, BIOCHEMISTRY-US, V28, P9264, DOI 10.1021/bi00450a005; MURRAY TP, 1985, J LABELLED COMPD RAD, V22, P1251, DOI 10.1002/jlcr.2580221207; OGATA Y, 1965, J ORG CHEM, V30, P1636, DOI 10.1021/jo01016a076; Palii SP, 2010, ARCH BIOCHEM BIOPHYS, V498, P23, DOI 10.1016/j.abb.2010.03.023; Pelissier HC, 2004, PLANT PHYSIOL, V134, P664, DOI 10.1104/pp.103.033365; Robinson SL, 2018, ENVIRON MICROBIOL, V20, P2099, DOI 10.1111/1462-2920.14094; Schmidt E., 1870, Z CHEM, V6, P400; Scholven Chemie Aktiengesellschaft, 1969, British Patent, Patent No. [1,156,028, 196, 1156028196]; Seffernick JL, 2012, J BACTERIOL, V194, P4579, DOI 10.1128/JB.00791-12; Shafee T, 2015, CHEMBIOCHEM, V16, P1866, DOI 10.1002/cbic.201500295; Shapir N, 2005, J BACTERIOL, V187, P3731, DOI 10.1128/JB.187.11.3731-3738.2005; Takagi H, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1491-2; Tassoulas L., 2019, THESIS U MINNESOTA; Tawfik DS, 2020, FEBS J, V287, P1284, DOI 10.1111/febs.15199; Todd CD, 2006, J EXP BOT, V57, P5, DOI 10.1093/jxb/erj013; Venable CS, 1918, J AM CHEM SOC, V40, P1099, DOI 10.1021/ja02240a014; WEATHERBURN MW, 1967, ANAL CHEM, V39, P971, DOI 10.1021/ac60252a045; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	42	1	1	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100055	10.1074/jbc.RA120.015631	http://dx.doi.org/10.1074/jbc.RA120.015631			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33172891	Green Submitted, Green Published, gold			2022-12-26	WOS:000672866400037
J	Thibodeau, S; Yang, WD; Sharma, S; Lytton, J				Thibodeau, Stephanie; Yang, Weidong; Sharma, Sunita; Lytton, Jonathan			Calmodulin binds and modulates K+-dependent Na+/Ca2+-exchanger isoform 4, NCKX4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGER GENE FAMILY; NA+/CA2+ EXCHANGERS; MOLECULAR-CLONING; RETINAL ROD; CA2+ CLEARANCE; IDENTIFICATION; CALCIUM; EXPRESSION; PROTEINS; MEMBER	The family of K+-dependent Na+/Ca2+-exchangers, NCKX, are important mediators of cellular Ca2+ efflux, particularly in neurons associated with sensory transduction. The NCKX family comprises five proteins, NCKX1-5, each being the product of a different SLC24 gene. NCKX4 (SLC24A4) has been found to have a critical role in termination and adaptation of visual and olfactory signals, melanocortin-dependent satiety signaling, and the maturation of dental enamel. To explore mechanisms that might influence the temporal control of NCKX4 activity, a yeast two-hybrid system was used to search for protein interaction partners. We identified calmodulin as a partner for NCKX4 and confirmed the interaction using glutathione-S-transferase fusion pull-down. Calmodulin binding to NCKX4 was demonstrated in extracts from mouse brain and in transfected HEK293 cells. Calmodulin bound in a Ca2+-dependent manner to a motif present in the central cytosolic loop of NCKX4 and was abolished by the double-mutant I328D/F334D. When cotransfected in HEK293 cells, calmodulin bound to NCKX4 under basal conditions and induced a similar to 2.5-fold increase in NCKX4 abundance, but did not influence either cellular location or basal activity. When purinergic stimulation of NCKX4 was examined in these cells, coexpression of wild-type calmodulin, but not a Ca2+ binding-deficient calmodulin mutant, suppressed NCKX4 activation in a time-dependent manner. We propose that Ca2+ binding to calmodulin prepositioned on NCKX4 induces a slow conformational rearrangement that interferes with purinergic stimulation of the exchanger, possibly by obscuring T331, a previously identified potential protein kinase C site.	[Lytton, Jonathan] Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst, Dept Biochem & Mol Biol, Calgary, AB, Canada; Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Calgary	Lytton, J (corresponding author), Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst, Dept Biochem & Mol Biol, Calgary, AB, Canada.	jlytton@ucalgary.ca		Lytton, Jonathan/0000-0003-4770-2512	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by a discovery grant from the Natural Sciences and Engineering Research Council of Canada to J. L.	BAUER PJ, 1992, J PHYSIOL-LONDON, V451, P109, DOI 10.1113/jphysiol.1992.sp019156; Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; Brini M, 2014, CELL MOL LIFE SCI, V71, P2787, DOI 10.1007/s00018-013-1550-7; Bronckers ALJJ, 2017, CALCIFIED TISSUE INT, V100, P80, DOI 10.1007/s00223-016-0197-4; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cai Xinjiang, 2002, Ann N Y Acad Sci, V976, P90; Cali T, 2017, INT REV CEL MOL BIO, V332, P259, DOI 10.1016/bs.ircmb.2017.01.002; Chandrasekera CP, 2003, J BIOL CHEM, V278, P12482, DOI 10.1074/jbc.M212745200; Chou AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138856; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; Gong B, 2016, NEW BIOTECHNOL, V33, P551, DOI 10.1016/j.nbt.2015.11.007; Hassan MT, 2020, CELL CALCIUM, V86, DOI 10.1016/j.ceca.2019.102135; Hu P, 2012, CELLS TISSUES ORGANS, V196, P501, DOI 10.1159/000337493; Jalloul AH, 2020, CELL CALCIUM, V86, DOI 10.1016/j.ceca.2019.102153; Kang K, 2003, BIOCHEMISTRY-US, V42, P4593, DOI 10.1021/bi027276z; Kim MH, 2005, J NEUROSCI, V25, P6057, DOI 10.1523/JNEUROSCI.0454-05.2005; Kraev A, 2001, J BIOL CHEM, V276, P23161, DOI 10.1074/jbc.M102314200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lee JY, 2006, J BIOL CHEM, V281, P39205, DOI 10.1074/jbc.M606287200; Lee SH, 2002, J NEUROSCI, V22, P6891; Li XF, 2002, J BIOL CHEM, V277, P48410, DOI 10.1074/jbc.M210011200; Li XF, 2006, J BIOL CHEM, V281, P6273, DOI 10.1074/jbc.M512137200; Li XF, 2014, J BIOL CHEM, V289, P25445, DOI 10.1074/jbc.M114.564450; LI ZP, 1991, J BIOL CHEM, V266, P1014; Lytton J, 2002, ANN NY ACAD SCI, V976, P382; NICOLL DA, 1990, SCIENCE, V250, P562, DOI 10.1126/science.1700476; Parry DA, 2013, AM J HUM GENET, V92, P307, DOI 10.1016/j.ajhg.2013.01.003; Rogasevskaia TP, 2019, PIGM CELL MELANOMA R, V32, P55, DOI 10.1111/pcmr.12723; SALVATERRA PM, 1980, NEUROCHEM RES, V5, P181, DOI 10.1007/BF00964331; SCHNETKAMP PPM, 1995, CELL CALCIUM, V18, P322, DOI 10.1016/0143-4160(95)90028-4; Sharma S, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2020.165835; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stephan AB, 2012, NAT NEUROSCI, V15, P131, DOI 10.1038/nn.2943; Tian XX, 2013, BIOCHEM J, V455, P367, DOI 10.1042/BJ20130805; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsoi M, 1998, J BIOL CHEM, V273, P4155, DOI 10.1074/jbc.273.7.4155; Vikis HG, 2015, METHODS MOL BIOL, V1278, P353, DOI 10.1007/978-1-4939-2425-7_22; Vinberg F, 2018, PROG RETIN EYE RES, V67, P87, DOI 10.1016/j.preteyeres.2018.06.001; Vinberg F, 2017, ELIFE, V6, DOI 10.7554/eLife.24550; Visser F, 2007, J BIOL CHEM, V282, P4453, DOI 10.1074/jbc.M610582200; Wagemans J, 2015, METHODS MOL BIOL, V1278, P409, DOI 10.1007/978-1-4939-2425-7_27; Yang DM, 2003, CIRC RES, V92, P659, DOI 10.1161/01.RES.0000064566.91495.0C; Yang X, 2013, BIOSCIENCE REP, V33, P939, DOI 10.1042/BSR20130099; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914	46	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100092	10.1074/jbc.RA120.015037	http://dx.doi.org/10.1074/jbc.RA120.015037			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33199372	Green Published, gold			2022-12-26	WOS:000672866400072
J	Galataud, J; Delatte, H; Techer, MA; Simiand, C; Sookar, P; Reynaud, B; Clemencet, J				Galataud, Julien; Delatte, Helene; Techer, Maeva Angelique; Simiand, Christophe; Sookar, Preeaduth; Reynaud, Bernard; Clemencet, Johanna			When European meets African honeybees (Apis mellifera L.) in the tropics: Morphological changes related to genetics in Mauritius Island (South-West Indian Ocean)	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; DEVELOPMENTAL STABILITY; GEOMETRIC MORPHOMETRICS; REPRODUCTIVE ISOLATION; PHENOTYPIC VARIATION; SHAPE VARIATION; HYBRIDIZATION; SIZE; BEE; POPULATIONS	The previous genetic characterization of the honeybee population of Mauritius Island (Indian Ocean) revealed an ongoing process of hybridization between the first established African subspecies Apis mellifera unicolor and recently imported European subspecies (A. m. ligustica, A. m. carnica and A. m. mellifera). This context offers the rare opportunity to explore the influence of hybridization between African and European honeybees on phenotypic traits out of the case largely studied of the Africanized honeybee (hybrid between A. m. scutellata from South Africa and European subspecies). We thus conducted geometric morphometric analyses on forewings of 283 workers genetically characterized at 14 microsatellite loci to evaluate (1) if the morphological variability coincides well with the neutral genetic variability, (2) if hybrids exhibited rather parental, intermediate or transgressive traits, and (3) to test if fluctuating asymmetry (FA) of size and shape, as a measure of developmental stability, was elevated in hybrids (due to genetic stress) and/or European bees (due to unsuitable environment) compared to African bees. A strong concordance was found between morphological variability and neutral genetic variability, especially for wing shape, based on partial least-square analyses (PLS). However, on average, the morphology of hybrids was more similar to the African bees, potentially reflecting the dynamics and direction of introgression. Significant FA for wing size as well as wing shape was detected, suggesting the overall presence of stress during the development of the studied individuals. In contrast, the asymmetry levels do not differ according to the ancestry (African, European or hybrid) of the individuals. Therefore, if ongoing hybridization contributed to increasing the genetic and phenotypic diversity of the populations and influences its adaptive potential, developmental stressors could not be identified and their evolutionary consequences remain uncertain.	[Galataud, Julien; Clemencet, Johanna] Univ La Reunion, UMR PVBMT, St Pierre, La Reunion, France; [Delatte, Helene; Simiand, Christophe] CIRAD, UMR PVBMT, 7 Chemin Irat, St Pierre, La Reunion, France; [Techer, Maeva Angelique] Okinawa Inst Sci & Technol, Okinawa, Japan; [Sookar, Preeaduth] Minist Agro Ind & Food Secur, Agr Serv, Reduit, Mauritius; [Reynaud, Bernard] Univ La Reunion, UMR PVBMT, St Pierre, La Reunion, France	University of La Reunion; CIRAD; Okinawa Institute of Science & Technology Graduate University; University of La Reunion	Galataud, J; Clemencet, J (corresponding author), Univ La Reunion, UMR PVBMT, St Pierre, La Reunion, France.	julien.galataud@univ-reunion.fr; johanna.clemencet@univ-reunion.fr	TECHER, Maeva/X-5315-2019	TECHER, Maeva/0000-0001-5417-5103	CIRAD; Conseil Regional de La Reunion; European Agricultural Fund for Rural Development (EAFRD); doctoral school of La Reunion University	CIRAD; Conseil Regional de La Reunion; European Agricultural Fund for Rural Development (EAFRD); doctoral school of La Reunion University	This study was funded by the CIRAD, the 'Conseil Regional de La Reunion' and the European Agricultural Fund for Rural Development (EAFRD). J Galataud is a recipient of a PhD fellowship from the doctoral school of La Reunion University. The authors acknowledge the Plant Protection Platform 3P, IBISA) where genetic experiments were conducted.	Abaga NOZ, 2011, CHEMOSPHERE, V83, P585, DOI 10.1016/j.chemosphere.2010.12.021; Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Bakker TCM, 2006, J FISH BIOL, V69, P1164, DOI 10.1111/j.1095-8649.2006.01194.x; Banaszak-Cibicka W, 2018, APIDOLOGIE, V49, P297, DOI 10.1007/s13592-017-0554-y; Bancila R, 2010, J ZOOL, V282, P266, DOI 10.1111/j.1469-7998.2010.00736.x; BUCO SM, 1987, APIDOLOGIE, V18, P217, DOI 10.1051/apido:19870301; Chavez AS, 2011, MOL ECOL, V20, P3350, DOI 10.1111/j.1365-294X.2011.05184.x; CLARKE GM, 1993, ENVIRON ENTOMOL, V22, P1362, DOI 10.1093/ee/22.6.1362; Collyer ML, 2013, HYSTRIX, V24, P75, DOI 10.4404/hystrix-24.1-6298; Cornuet J, GENETICS, V128, P393; De la Rua P, 2009, APIDOLOGIE, V40, P263, DOI 10.1051/apido/2009027; Debat V, 2000, P ROY SOC B-BIOL SCI, V267, P423, DOI 10.1098/rspb.2000.1017; ESCOUFIER Y, 1973, BIOMETRICS, V29, P751, DOI 10.2307/2529140; Esnault O, 2019, J APICULT RES, V58, P75, DOI 10.1080/00218839.2018.1517987; Eterovick PC, 2016, BIOL CONSERV, V195, P52, DOI 10.1016/j.biocon.2015.12.036; Evans JD, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.11; Florens F., 2015, INT C TRANSL SCI DRU, P42; Florens FBV, 2012, BIODIVERS CONSERV, V21, P2139, DOI 10.1007/s10531-012-0304-4; Francoy TM, 2012, GENET MOL RES, V11, P3349, DOI 10.4238/2012.September.17.5; Francoy TM, 2009, GENET MOL RES, V8, P709, DOI 10.4238/vol8-2kerr019; Francoy TM, 2008, APIDOLOGIE, V39, P488, DOI 10.1051/apido:2008028; Frey FM, 2014, PLANT SPEC BIOL, V29, P272, DOI 10.1111/1442-1984.12021; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Goto S, 2005, ECOL RES, V20, P733, DOI 10.1007/s11284-005-0090-5; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; HALL HG, 1990, GENETICS, V125, P611; Lezcano AH, 2015, MAR POLLUT BULL, V91, P524, DOI 10.1016/j.marpolbul.2014.09.038; Iguchi K, 2005, FISHERIES SCI, V71, P308, DOI 10.1111/j.1444-2906.2005.00965.x; Jhumun G., 2011, HON MAURIT OIE C REG, P7; Kandemir I, 2011, APIDOLOGIE, V42, P618, DOI 10.1007/s13592-011-0063-3; KERR WE, 1970, EVOLUTION, V24, P145, DOI 10.1111/j.1558-5646.1970.tb01747.x; Klingenberg CP, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00056; Klingenberg CP, 2015, SYMMETRY-BASEL, V7, P843, DOI 10.3390/sym7020843; Klingenberg CP, 2013, HYSTRIX, V24, P15, DOI 10.4404/hystrix-24.1-7691; Klingenberg CP, 2013, SYST BIOL, V62, P591, DOI 10.1093/sysbio/syt025; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 1998, EVOLUTION, V52, P1363, DOI 10.1111/j.1558-5646.1998.tb02018.x; Koeniger N, 2000, APIDOLOGIE, V31, P313, DOI 10.1051/apido:2000125; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lazic MM, 2015, AM NAT, V185, P44, DOI 10.1086/679011; Lazic Stanley E., 2008, BMC Physiology, V8, P1, DOI 10.1186/1472-6793-8-16; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Leonard RJ, 2018, PEERJ, V6, DOI 10.7717/peerj.5940; LOBO JA, 1995, HEREDITY, V75, P133, DOI 10.1038/hdy.1995.116; Lopuch S, 2016, B ENTOMOL RES, V106, P304, DOI 10.1017/S0007485315000784; Maestri R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122412; Marchand HL, 2003, BIOL J LINN SOC, V80, P37, DOI 10.1046/j.1095-8312.2003.00206.x; Meixner M. D., 2013, J APICULT RES, V52, P1, DOI [10.3896/IBRA.1.52.4.05, DOI 10.3896/IBRA.1.52.4.05]; Miguel I, 2011, APIDOLOGIE, V42, P150, DOI 10.1051/apido/2010048; Mikheyev AS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8991; Mikula O, 2010, BIOL J LINN SOC, V101, P13, DOI 10.1111/j.1095-8312.2010.01490.x; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Nawrocka A, 2018, APIDOLOGIE, V49, P172, DOI 10.1007/s13592-017-0538-y; Nazzi F, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002735; Nelson RM, 2017, MOL ECOL, V26, P3603, DOI 10.1111/mec.14122; Nolte Arne W, 2005, Front Zool, V2, P11, DOI 10.1186/1742-9994-2-11; Nunes LA, 2015, REV BIOL TROP, V63, P673, DOI 10.15517/rbt.v63i3.15869; Oleksa A, 2015, APIDOLOGIE, V46, P49, DOI 10.1007/s13592-014-0300-7; Oleksa A, 2013, APIDOLOGIE, V44, P611, DOI 10.1007/s13592-013-0212-y; Palmer, 1994, DEV INSTABILITY ITS, P335, DOI DOI 10.1007/978-94-011-0830-0_; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; Pelabon C, 2008, EVOLUTION, V62, P2855, DOI 10.1111/j.1558-5646.2008.00495.x; Quezada-Euan JJG, 1998, APIDOLOGIE, V29, P555, DOI 10.1051/apido:19980608; Rego C, 2006, EVOLUTION, V60, P746, DOI 10.1111/j.0014-3820.2006.tb01153.x; RINDERER TE, 1987, APIDOLOGIE, V18, P179, DOI 10.1051/apido:19870208; RINDERER TE, 1986, APIDOLOGIE, V17, P33, DOI 10.1051/apido:19860104; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Sanchez-Chardi A, 2013, CHEMOSPHERE, V93, P916, DOI 10.1016/j.chemosphere.2013.05.056; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider SS, 2004, ANNU REV ENTOMOL, V49, P351, DOI 10.1146/annurev.ento.49.061802.123359; Schneider SS, 2003, EVOLUTION, V57, P2350, DOI 10.1111/j.0014-3820.2003.tb00247.x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith DR, 1997, J EVOLUTION BIOL, V10, P551; Soland-Reckeweg G., 2006, THESIS; Solignac M, 2003, MOL ECOL NOTES, V3, P307, DOI 10.1046/j.1471-8286.2003.00436.x; Team RC, 2016, LANG ENV STAT COMP; Techer MA, 2016, INSECT CONSERV DIVER, V9, P13, DOI 10.1111/icad.12138; Techer MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189234; Techer MA, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0520-8; Thevenaz P., 2012, POINT PICKER INTERAC; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Vallejo-Marin M, 2016, NEW PHYTOL, V211, P1170, DOI 10.1111/nph.14004; WAYNE RK, 1986, EVOLUTION, V40, P78, DOI 10.1111/j.1558-5646.1986.tb05719.x; WOODRUFF DS, 1973, SYST ZOOL, V22, P213, DOI 10.2307/2412300; Zayed A, 2008, P NATL ACAD SCI USA, V105, P3421, DOI 10.1073/pnas.0800107105; Zelditch ML, 2012, GEOMETRIC MORPHOMETRICS FOR BIOLOGISTS: A PRIMER, 2ND EDITION, P1	93	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0242053	10.1371/journal.pone.0242053	http://dx.doi.org/10.1371/journal.pone.0242053			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211716	gold, Green Published			2022-12-26	WOS:000603518300031
J	Bai, W; Xu, X; Ji, HX; Liu, J; Ma, H; Xie, HZ; Dong, JJ; Sun, CJ; Shi, YH; Che, KL; Liu, MJ; Guo, YK				Bai, Wei; Xu, Xiao; Ji, Haixia; Liu, Jing; Ma, Heng; Xie, Haizhu; Dong, Jianjun; Sun, Chunjuan; Shi, Yinghong; Che, Kaili; Liu, Meijie; Guo, Yingkun			Evaluation of the anatomical variations of the coronary venous system in patients with coronary artery calcification using 256-slice computed tomography	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; HEART-FAILURE PATIENTS; NONINVASIVE VISUALIZATION; CARDIOMYOPATHY; ANGIOGRAPHY; CALCIUM; DISEASE; VEINS	The factors that determine the anatomical variations of the coronary venous system (CVS) are poorly understood. The objective of this study was to evaluate the anatomical variations of the CVS in patients with coronary artery calcification. 196 patients underwent non-contrast CT and coronary CT angiography using 256-slice CT. All subjects were divided into four groups based on their coronary artery calcium score (CACS): 50 patients with CACS = 0 Agatston unit (AU), 52 patients with CACS = 1-100 AU, 44 patients with CACS = 101-400 AU, and 50 patients with CACS > 400 AU. The presence of the following cardiac veins was evaluated: the coronary sinus (CS), great cardiac vein (GCV), posterior interventricular vein (PIV), posterior vein of the left ventricle (PVLV), left marginal vein (LMV), anterior interventricular vein (AIV), and small cardiac vein (SCV). Vessel diameters were also measured. We found that the CS, GCV, PIV, and AIV were visualized in all patients, whereas the PVLV and LMV were identified in a certain proportion of patients: 98% and 96% in the CACS = 0 AU group, 100% and 78.8% in the CACS = 1-100 AU group, 93.2% and 77.3% in the CACS = 101-400 AU group, and 98% and 78% in the CACS > 400 AU group, respectively. The LMV was less often identified in the last three groups than in the first group (p < 0.05). The frequency of having either one PVLV or LMV was higher in the last three groups than in the first group (p < 0.05). No significant differences in vessel diameters were observed between the groups. It was concluded that patients with coronary artery calcification were less likely to have the LMV, which might hamper the left ventricular lead implantation in cardiac resynchronization therapy.	[Bai, Wei; Xu, Xiao; Ji, Haixia; Liu, Jing; Ma, Heng; Xie, Haizhu; Dong, Jianjun; Sun, Chunjuan; Shi, Yinghong; Che, Kaili] Qingdao Univ, Yantai Yuhuangding Hosp, Yantai, Shandong, Peoples R China; [Bai, Wei; Guo, Yingkun] Sichuan Univ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, West China Univ Hosp 2, Dept Radiol,Minist Educ, Chengdu, Sichuan, Peoples R China; [Ma, Heng; Xie, Haizhu; Liu, Meijie] Binzhou Med Univ, Yantai, Shandong, Peoples R China	Qingdao University; Sichuan University; Binzhou Medical University	Liu, J; Ma, H (corresponding author), Qingdao Univ, Yantai Yuhuangding Hosp, Yantai, Shandong, Peoples R China.; Guo, YK (corresponding author), Sichuan Univ, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, West China Univ Hosp 2, Dept Radiol,Minist Educ, Chengdu, Sichuan, Peoples R China.; Ma, H (corresponding author), Binzhou Med Univ, Yantai, Shandong, Peoples R China.	liujingyhd@126.com; hengma00@163.com; gykpanda@163.com			National Natural Science Foundation of China [81671654]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China No.81671654, awarded to H.M., H.X, C.J., Y.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbara S, 2005, AM J ROENTGENOL, V185, P1001, DOI 10.2214/AJR.04.1382; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Baman TS, 2010, CIRC-ARRHYTHMIA ELEC, V3, P274, DOI 10.1161/CIRCEP.109.910802; Bax JJ, 2005, J AM COLL CARDIOL, V46, P2153, DOI 10.1016/j.jacc.2005.09.019; Benz DC, 2016, ACAD RADIOL, V23, P1008, DOI 10.1016/j.acra.2016.03.015; Boonyasirinant T, 2016, J CARDIOVASC COMPUT, V10, P156, DOI 10.1016/j.jcct.2016.01.015; Chen JJ, 2007, J CARD FAIL, V13, P482, DOI 10.1016/j.cardfail.2007.02.007; Christiaens L, 2008, INT J CARDIOL, V126, P204, DOI 10.1016/j.ijcard.2007.03.128; DEMARCO T, 1988, AM HEART J, V115, P809; Genc B, 2013, DIAGN INTERV RADIOL, V19, P286, DOI 10.5152/dir.2013.012; Giraldi F, 2011, J AM COLL CARDIOL, V58, P483, DOI 10.1016/j.jacc.2011.02.065; Jongbloed MRM, 2005, J AM COLL CARDIOL, V45, P749, DOI 10.1016/j.jacc.2004.11.035; Khan FZ, 2009, EUROPACE, V11, P1491, DOI 10.1093/europace/eup292; Ma H, 2016, INT J CARDIOL, V203, P447, DOI 10.1016/j.ijcard.2015.10.135; Ma H, 2011, INT J CARDIOVAS IMAG, V27, P1003, DOI 10.1007/s10554-010-9757-2; Mao SS, 2005, AM HEART J, V150, P315, DOI 10.1016/j.ahj.2004.09.050; Mlynarska A, 2015, ACTA CARDIOL SIN, V31, P536, DOI 10.6515/ACS20150204B; Mlynarski R, 2014, WORLD J RADIOL, V6, P399, DOI 10.4329/wjr.v6.i7.399; Mlynarski R, 2013, INT J CARDIOVAS IMAG, V29, P885, DOI 10.1007/s10554-012-0139-9; Mlynarski R, 2011, CIRC J, V75, P613, DOI 10.1253/circj.CJ-10-0736; Nikolaidis LA, 2004, EUR J HEART FAIL, V6, P409, DOI 10.1016/j.ejheart.2003.09.013; Randhawa A, 2013, PACE, V36, P94, DOI 10.1111/pace.12026; Roka A, 2017, HEART FAIL CLIN, V13, P79, DOI 10.1016/j.hfc.2016.07.007; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Sun CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104246; Tada H, 2005, CIRC J, V69, P165, DOI 10.1253/circj.69.165; Van de Veire NR, 2006, J AM COLL CARDIOL, V48, P1832, DOI 10.1016/j.jacc.2006.07.042	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242216	10.1371/journal.pone.0242216	http://dx.doi.org/10.1371/journal.pone.0242216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206718	Green Published, gold			2022-12-26	WOS:000595265900003
J	Araujo, JF; Andrioli, A; Pinheiro, RR; Sider, LH; de Sousa, ALM; de Azevedo, DAA; Peixoto, RM; Lima, AMC; Damasceno, EM; Souza, SCR; Teixeira, MFD				Furtado Araujo, Juscilania; Andrioli, Alice; Pinheiro, Raymundo Rizaldo; Sider, Lucia Helena; de Sousa, Ana Lidia Madeira; de Azevedo, Dalva Alana Aragao; Peixoto, Renato Mesquita; Lima, Ana Milena Cesar; Damasceno, Edgar Marques; Souza, Samara Cristina Rocha; Teixeira, Maria Fatima da Silva			Vertical transmissibility of small ruminant lentivirus	PLOS ONE			English	Article							ARTHRITIS-ENCEPHALITIS VIRUS; MAEDI-VISNA-VIRUS; CAPRINE ARTHRITIS; GAG GENE; PROVIRAL DNA; IN-VITRO; GOATS; INFECTION; SHEEP; PCR	This study aimed to evaluate by means of Nested Polymerase Chain Reaction (nPCR), co-cultivation and sequencing, with genetic comparison between strains (mother/newborn), the occurrence of vertical transmission of Small Ruminant Lentiviruses (SRLV) from naturally occurring nannies infected for their offspring. For the detection of SRLV seropositive progenitors, blood was collected from 42 nannies in the final third of gestation in tubes with and without anticoagulant. The diagnostic tests used were Western Blot (WB) and nPCR. During the period of birth, the same blood collection procedure was performed on 73 newborns at zero hours of birth, with the same diagnostic tests. Seventeen blood samples from seven-day-old kids, proven positive for SRLV by nPCR, chosen at random, were subjected to coculture in goat synovial membrane (GSM) cells for 105 days. The pro-viral DNA extracted from the cell supernatant from the coculture was subjected to nPCR. For DNA sequencing from the nPCR products, nine positive samples were chosen at random, four nannies with their respective offspring, also positive. Each sample was performed in triplicate, thus generating 27 nPCR products of which only 19 were suitable for analysis. Among the 42 pregnant goats, in 50% (21/42) pro-viral DNA was detected by nPCR, while in the WB, only 7.14% (3/42) presented antibodies against SRLV. Regarding neonates, of the 73 kids, 34 (46.57%) were positive for the virus, using the nPCR technique, while in the serological test (WB), three positive animals (4.10%) were observed. The coculture of the 17 samples with a positive result in the nPCR was confirmed in viral isolation by amplification of the SRLV pro-viral DNA. When aligned, the pro-viral DNA sequences (nannies and their respective offspring) presented homology in relation to the standard strain CAEV Co. It was concluded that the transmission of SRLV through intrauterine route was potentially the source of infection in the newborn goats.	[Furtado Araujo, Juscilania] Univ Estadual Ceara, Northeast Network Biotechnol, Fortaleza, Ceara, Brazil; [Andrioli, Alice; Pinheiro, Raymundo Rizaldo; Sider, Lucia Helena; Peixoto, Renato Mesquita] Embrapa Goats & Sheep, Sobral, Ceara, Brazil; [de Sousa, Ana Lidia Madeira; de Azevedo, Dalva Alana Aragao] Univ Estadual Ceara, Vet Sci, Fortaleza, Ceara, Brazil; [Peixoto, Renato Mesquita] Natl Council Sci & Technol Dev DCR CNPq FUNCAP, Scholarship Reg Sci Dev, Level C, Brasilia, DF, Brazil; [Lima, Ana Milena Cesar] Univ Fed Piaui, Anim Sci, Teresina, Piaui, Brazil; [Damasceno, Edgar Marques] State Univ Acarau Valley, Zootech, Sobral, Ceara, Brazil; [Souza, Samara Cristina Rocha] State Univ Acarau Valley, Biol Sci, Sobral, Ceara, Brazil; [Teixeira, Maria Fatima da Silva] Univ Estadual Ceara, Fortaleza, Ceara, Brazil	Universidade Estadual do Ceara; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual do Ceara; Universidade Federal do Piaui; Universidade Estadual do Ceara	Araujo, JF (corresponding author), Univ Estadual Ceara, Northeast Network Biotechnol, Fortaleza, Ceara, Brazil.	laninha.araujo@hotmail.com	Peixoto, Renato Mesquita/AAB-4259-2021; Andrioli, Alice/K-6691-2015; PINHEIRO, RAYMUNDO R/R-8186-2017	Peixoto, Renato Mesquita/0000-0003-1338-0949; Andrioli, Alice/0000-0002-6394-8822; PINHEIRO, RAYMUNDO R/0000-0003-3590-6948	Cearense Foundation of Support for Scientific and Technological Development (FUNCAP) [BP3-0139-00328.01.00/2018]; National Council for Scientific and Technological Development (CNPq) [312900/2019-8]; Embrapa Goats and Sheep; AMCL [SEG 02.13.10.003.00.00]; Northeast Network in Biotechnology, State University of Ceara (RENORBIO/UECE)	Cearense Foundation of Support for Scientific and Technological Development (FUNCAP); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Embrapa Goats and Sheep(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)); AMCL; Northeast Network in Biotechnology, State University of Ceara (RENORBIO/UECE)	This study was supported by the Cearense Foundation of Support for Scientific and Technological Development (FUNCAP) in the form of funding (project number BP3-0139-00328.01.00/2018) and scholarship awarded to JFA, the National Council for Scientific and Technological Development (CNPq) in the form of a scholarship awarded to RMP (project number 312900/2019-8), Embrapa Goats and Sheep in the form of a funding awarded to AA, RRP, LHS, ALMdS, DAAdA, and AMCL (project number SEG 02.13.10.003.00.00), and the Northeast Network in Biotechnology, State University of Ceara (RENORBIO/UECE) in the form of funding awarded to MFdST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cavalcante Francisco Roger Aguiar, 2013, Arq. Inst. Biol., V80, P381, DOI 10.1590/S1808-16572013000400002; Alvarez V, 2006, RES VET SCI, V80, P226, DOI 10.1016/j.rvsc.2005.05.008; Alvarez V, 2005, RES VET SCI, V78, P237, DOI 10.1016/j.rvsc.2004.09.006; [Anonymous], 2012, PHYS CHEM CHEM PHYS, V43, P1; [Anonymous], 2017, HIST WORKSHOP J, V84, P1, DOI DOI 10.1016/J.JAS.2017.05.002; de Azevedo DAA, 2019, SMALL RUMINANT RES, V177, P160, DOI 10.1016/j.smallrumres.2019.06.011; de Azevedo DAA, 2019, ACTA SCI VET, V47, DOI 10.22456/1679-9216.92281; Barquero N, 2013, VIRUSES-BASEL, V5, P2614, DOI 10.3390/v5102614; Blacklaws BA, 2004, VET MICROBIOL, V101, P199, DOI 10.1016/j.vetmic.2004.04.006; Blacklaws BA, 2012, COMP IMMUNOL MICROB, V35, P259, DOI 10.1016/j.cimid.2011.12.003; Brock KV, 2003, BIOLOGICALS, V31, P133, DOI 10.1016/S1045-1056(03)00029-0; Cardinaux L, 2013, VET MICROBIOL, V162, P572, DOI 10.1016/j.vetmic.2012.11.017; Colitti B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212585; COURGNAUD V, 1991, AIDS RES HUM RETROV, V7, P337, DOI 10.1089/aid.1991.7.337; Crawford M., 2013, CIENC CULT, V65, DOI [10.21800/S0009-67252013000400012, DOI 10.21800/S0009-67252013000400012]; de Souza TS, 2015, BRAZ J MICROBIOL, V46, P867, DOI 10.1590/S1517-838246320140402; Dias FC, 2010, PESQUI VET BRASIL, V30, P933, DOI 10.1590/S0100-736X2010001100006; Dias RP, 2016, ARQ BRAS MED VET ZOO, V68, P1292, DOI 10.1590/1678-4162-9008; Fieni F, 2003, THERIOGENOLOGY, V59, P1515, DOI 10.1016/S0093-691X(02)01194-9; Gaeta NC, 2016, ACTA SCI VET, V44; Giammarioli M, 2011, VIRUS GENES, V43, P380, DOI 10.1007/s11262-011-0653-1; Mendez ASG, 2020, VIRUS RES, V280, DOI 10.1016/j.virusres.2020.197900; Haeger JD, 2016, THERIOGENOLOGY, V86, P306, DOI 10.1016/j.theriogenology.2016.04.043; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hasegawa MY, 2017, SMALL RUMINANT RES, V149, P23, DOI 10.1016/j.smallrumres.2017.01.010; Hinderer C, 2016, MOL GENET METAB, V119, P124, DOI 10.1016/j.ymgme.2016.06.006; Hotzel I, 2003, J VIROL, V77, P11578, DOI 10.1128/JVI.77.21.11578-11587.2003; Panei CJ, 2017, OPEN VET J, V7, P32, DOI 10.4314/ovj.v7i1.5; Karanikolaou K, 2005, SMALL RUMINANT RES, V58, P181, DOI 10.1016/j.smallrumres.2004.10.001; Kokawa S, 2017, ARCH VIROL, V162, P3007, DOI 10.1007/s00705-017-3447-5; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086083, 10.1371/journal.pone.0109665, 10.1371/journal.pone.0094792]; Lima CCV, 2017, ARQ BRAS MED VET ZOO, V69, P391, DOI 10.1590/1678-4162-8974; Marinho RC, 2018, BRAZ J MICROBIOL, V49, P83, DOI 10.1016/j.bjm.2018.04.013; Martins GR, 2017, BRAZ J MICROBIOL, V48, P125, DOI 10.1016/j.bjm.2016.11.002; Michiels R, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030183; Minguijon E, 2015, VET MICROBIOL, V181, P75, DOI 10.1016/j.vetmic.2015.08.007; Oguma K, 2014, J VET MED SCI, V76, P211, DOI 10.1292/jvms.13-0269; Olech M, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030270; Padiernos RBC, 2015, ARCH VIROL, V160, P969, DOI 10.1007/s00705-015-2359-5; Panneum S, 2017, POL J VET SCI, V20, P347, DOI 10.1515/pjvs-2017-0042; Park JE, 2010, VIRUS GENES, V41, P99, DOI 10.1007/s11262-010-0476-5; PERETZ G, 1993, REV MED VET-TOULOUSE, V144, P93; Pisoni G, 2010, VIROLOGY, V407, P91, DOI 10.1016/j.virol.2010.08.004; Preziuso S, 2003, EUR J HISTOCHEM, V47, P151; Ramirez H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-8; Ravazzolo AP, 2006, VIROLOGY, V350, P116, DOI 10.1016/j.virol.2006.02.014; Rodrigues AS, 2014, ARQ BRAS MED VET ZOO, V66, P417, DOI 10.1590/1678-41626303; SALTARELLI M, 1990, VIROLOGY, V179, P347, DOI 10.1016/0042-6822(90)90303-9; Santry LA, 2013, VIRUS RES, V175, P30, DOI 10.1016/j.virusres.2013.03.019; Sousa ALM, 2018, ARQ BRAS MED VET ZOO, V70, P1459, DOI 10.1590/1678-4162-9556	51	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0239916	10.1371/journal.pone.0239916	http://dx.doi.org/10.1371/journal.pone.0239916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206648	gold, Green Published			2022-12-26	WOS:000595265900080
J	Perry, KE; Taylor, J; Patel, H; Javadi, SS; Mathur, K; Kaytes, A; Concha-Garcia, S; Little, S; Smith, D; Gianella, S; Dube, K				Perry, Kelly E.; Taylor, Jeff; Patel, Hursch; Javadi, Sogol Stephanie; Mathur, Kushagra; Kaytes, Andy; Concha-Garcia, Susanna; Little, Susan; Smith, Davey; Gianella, Sara; Dube, Karine			"[It] is now my responsibility to fulfill that wish:" Clinical and rapid autopsy staff members' experiences and perceptions of HIV reservoir research at the end of life	PLOS ONE			English	Article							ETHICS; CARE; CHALLENGES; PHYSICIANS; ALTRUISM; DONATION; ERA	Introduction Little is known about the effects of HIV reservoir research at the end of life on staff members involved. Staff members' perceptions and experiences were assessed related to their involvement in the Last Gift, a rapid autopsy study at the University of California San Diego enrolling people living with HIV who are terminally ill and have a desire to contribute to HIV cure-related research. Methods Two focus group discussions consisting of clinical (n = 7) and rapid research autopsy (n = 8) staff members were conducted to understand the perspectives of staff members and the impact the Last Gift rapid autopsy study had on them. The total sample consisted of 66.7% females and 33.3% males and was ethnically diverse (66.7% Caucasian, 6.7% African American, 20.0% Asian descent, 6.7% Hispanic descent and American Indian) with a range of experience in the HIV field from 1 year to 30 years. Results Qualitative focus group data revealed five major themes underlying study staff members' multilayered mental and practical involvement: 1) positive perceptions of the Last Gift study, with sub-themes including Last Gift study participants' altruism, fulfillment, and control at the end of life, 2) perceptions of staff members' close involvement in the Last Gift study, with sub-themes related to staff members' cognitive processing, self-actualization and fulfillment, stress management and resilience, coping mechanisms, and gratitude toward Last Gift participants and toward the study itself, 3) considerations for successful and sustainable study implementation, such as ethical awareness and sustained community and patient engagement, 4) collaborative learning and organizational processes and the value of interdependence between staff members, and 5) considerations for potential study scale-up at other clinical research sites. Discussion Understanding staff members' nuanced emotional and procedural experiences is crucial to the Last Gift study's sustainability and will inform similar cure research studies conducted with people living with HIV at the end of life. The study's potential reproducibility depends on a robust research infrastructure with established, interdependent clinical and rapid autopsy teams, continuous community engagement, and an ethical and well-informed engagement process with people living with HIV.	[Perry, Kelly E.; Patel, Hursch; Dube, Karine] UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA; [Taylor, Jeff; Kaytes, Andy] AntiViral Res Ctr Community Advisory Board, San Diego, CA USA; [Taylor, Jeff] HIV Aging Res Project Palm Springs HARP PS, Palm Springs, CA USA; [Javadi, Sogol Stephanie; Mathur, Kushagra; Concha-Garcia, Susanna; Little, Susan; Smith, Davey; Gianella, Sara] Univ Calif San Diego, AntiViral Res Ctr AVRC, San Diego, CA 92103 USA; [Concha-Garcia, Susanna] Univ Calif San Diego, HIV Neurobehav Res Ctr, San Diego, CA 92103 USA; [Little, Susan; Smith, Davey; Gianella, Sara] Univ Calif San Diego, Div Infect Dis & Global Publ Hlth, San Diego, CA 92103 USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Perry, KE (corresponding author), UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.	perryke@email.unc.edu		E. Perry, Kelly/0000-0002-8637-4729; Little, Susan/0000-0002-7645-9737; Gianella, Sara/0000-0002-9927-0849; Patel, Hursch/0000-0002-0725-4922	Department of Veterans Affairs; National Institutes of Health [AI120009, AI131385, AI100665, P30 AI036214, AI134295, HD094646];  [R21MH118120]	Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This work was supported by R21MH118120 to K.D. We also acknowledge support received from the Department of Veterans Affairs and grants from the National Institutes of Health: AI120009, AI131385, AI100665, P30 AI036214, AI134295, and HD094646.	Abt PL, 2013, AM J TRANSPLANT, V13, P1400, DOI 10.1111/ajt.12243; Alsop K, 2016, NAT BIOTECHNOL, V34, P1010, DOI 10.1038/nbt.3674; [Anonymous], 2018, NAT REV GENET, V19, P1, DOI 10.1038/nrg.2017.141; Beaver K., 1999, INT J PALLIAT NURS, V5, P13, DOI [10.12968/ijpn.1999.5.1.9926, DOI 10.12968/IJPN.1999.5.1.9926]; Cresswell J, 2013, QUALITATIVE QUANTITA, V4th; Danielson Michael M, 2018, Ann Intern Med, V169, P349, DOI 10.7326/M18-1719; De Cock KM, 2019, NEW ENGL J MED, V381, P1889, DOI 10.1056/NEJMp1909017; DUBE K, 2015, J VIRUS ERAD, V1, pE14; Dube K, J VIRUS ERAD; Dube K, 2020, AIDS RES HUM RETROV, V36, P1033, DOI [10.1089/aid.2020.0025, 10.1089/AID.2020.0025]; Evans D, 2017, J MED ETHICS, V43, P100, DOI 10.1136/medethics-2015-103120; FDA, 2014, VOICE PATIENT; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Gianella S, 2017, AIDS, V31, P1, DOI 10.1097/QAD.0000000000001300; Gilbertson A, 2019, AIDS RES HUM RETROV, V35, P100, DOI [10.1089/AID.2017.0224, 10.1089/aid.2017.0224]; Goodkin K, 2003, PUTTING FACE HIV INF, pS171; Goodkin K, 2018, NURS CLIN N AM, V53, P123, DOI 10.1016/j.cnur.2017.10.010; Greenberg B, 2000, J URBAN HEALTH, V77, P150, DOI 10.1007/BF02390527; Hold JL, 2017, J ASSOC NURSE AIDS C, V28, P752, DOI 10.1016/j.jana.2017.03.011; Karasz A, 2003, SOC SCI MED, V57, P1609, DOI 10.1016/S0277-9536(03)00013-3; Karnik S, 2016, HEALTHCARE, V4, P1; Lindell KO, 2006, PLOS MED, V3, P953, DOI 10.1371/journal.pmed.0030234; Lo B, 2013, CURR OPIN HIV AIDS, V8, P243, DOI 10.1097/COH.0b013e32835ea1c5; Pentz RD, 2005, NAT MED, V11, P1145, DOI 10.1038/nm1105-1145; Prakash K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199670; Protiere C, 2018, HIV MED, V19, pE56, DOI 10.1111/hiv.12526; Quinn GP, 2013, MED HEALTH CARE PHIL, V16, P857, DOI 10.1007/s11019-013-9480-6; Rosenbaum L, 2020, NEW ENGL J MED, V382, P493, DOI 10.1056/NEJMp2000048; Sandstrom TS, 2019, CLIN INFECT DIS, V69, P1063, DOI 10.1093/cid/ciz068; Seppet E, 2011, BIOGERONTOLOGY, V12, P491, DOI 10.1007/s10522-011-9340-9; Steinhauser AE, 2000, JAMA-J AM MED ASSOC, V284, P2476, DOI 10.1001/jama.284.19.2476; Surman OS, 2005, PSYCHOSOMATICS, V46, P1, DOI 10.1176/appi.psy.46.1.1; Taylor J, 2020, AIDS RES HUM RETROVI; UCSD, 2018, LAST GIFT U CAL SAN; Vasquez JJ, 2019, CLIN INFECT DIS, V69, P1068, DOI 10.1093/cid/ciz070; Wicclair MR, 2008, CAMB Q HEALTHC ETHIC, V17, P87, DOI 10.1017/S0963180108080092	36	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242420	10.1371/journal.pone.0242420	http://dx.doi.org/10.1371/journal.pone.0242420			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206710	Green Published, gold			2022-12-26	WOS:000595265900031
J	Schuitemaker, JHN; Beernink, RHJ; Franx, A; Cremers, TIFH; Koster, MPH				Schuitemaker, Joost H. N.; Beernink, Rik H. J.; Franx, Arie; Cremers, Thomas I. F. H.; Koster, Maria P. H.			First trimester secreted Frizzled-Related Protein 4 and other adipokine serum concentrations in women developing gestational diabetes mellitus	PLOS ONE			English	Article							RISK; BIOMARKERS; ADIPONECTIN; PREDICTION; PREGNANCY; CHEMERIN; PATHOPHYSIOLOGY; METAANALYSIS; PROLACTIN; OBESITY	Background The aim of this study was to evaluate whether soluble frizzled-related protein 4 (sFRP4) concentration in the first trimester of pregnancy is individually, or in combination with Leptin, Chemerin and/or Adiponectin, associated with the development of gestational diabetes (GDM). Methods In a nested case-control study, 50 women with GDM who spontaneously conceived and delivered a live-born infant were matched with a total of 100 uncomplicated singleton control pregnancies based on body mass index (+/- 2 kg/m(2)), gestational age at sampling (exact day) and maternal age (+/- 2 years). In serum samples, obtained between 70-90 days gestational age, sFRP4, Chemerin, Leptin and Adiponectin concentrations were determined by ELISA. Statistical comparisons were performed using univariate and multi-variate logistic regression analysis after logarithmic transformation of the concentrations. Discrimination of the models was assessed by the area under the curve (AUC). Results First trimester sFRP4 concentrations were significantly increased in GDM cases (2.04 vs 1.93 ng/ml; p<0.05), just as Chemerin (3.19 vs 3.15 ng/ml; p<0.05) and Leptin (1.44 vs 1.32 ng/ml; p<0.01). Adiponectin concentrations were significantly decreased (2.83 vs 2.94 ng/ml; p<0.01) in GDM cases. Further analysis only showed a weak, though significant, correlation of sFRP4 with Chemerin (R-2 = 0.124; p<0.001) and Leptin (R-2 = 0.145; p<0.001), and Chemerin with Leptin (R-2 = 0.282; p<0.001) in the control group. In a multivariate logistic regression model of these four markers, only Adiponectin showed to be significantly associated with GDM (odds ratio 0.12, 95%CI 0.02-0.68). The AUC of this model was 0.699 (95%CI 0.605-0.793). Conclusion In the first trimester of pregnancy, a multi-marker model with sFRP4, Leptin, Chemerin and Adiponectin is associated with the development of GDM. Therefore, this panel seems to be an interesting candidate to further evaluate for prediction of GDM in a prospective study.	[Schuitemaker, Joost H. N.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Med Biol, Groningen, Netherlands; [Schuitemaker, Joost H. N.; Beernink, Rik H. J.] IQ Prod BV, Res & Dev, Groningen, Netherlands; [Beernink, Rik H. J.; Cremers, Thomas I. F. H.] Univ Groningen, Dept Analyt Biochem, Groningen Res Inst Pharm, Groningen, Netherlands; [Franx, Arie; Koster, Maria P. H.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Obstet & Gynaecol, Rotterdam, Netherlands	University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC	Beernink, RHJ (corresponding author), IQ Prod BV, Res & Dev, Groningen, Netherlands.; Beernink, RHJ (corresponding author), Univ Groningen, Dept Analyt Biochem, Groningen Res Inst Pharm, Groningen, Netherlands.	r.h.j.beernink@rug.nl	Franx, Arie/AAA-1739-2021	Beernink, Rik/0000-0001-9493-9585	IQ Products BV	IQ Products BV	IQ Products BV provided support in the form of salaries for authors J.H.N.S. and R.H.J.B. but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abell SK, 2019, AUST NZ J OBSTET GYN, V59, P251, DOI 10.1111/ajo.12833; Abell SK, 2015, INT J MOL SCI, V16, P13442, DOI 10.3390/ijms160613442; Ngala RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181613; [Anonymous], 2019, REV ESTUDOS IBEROAME, V45, P76; Baldane S, 2018, BRATISL MED J, V119, P450, DOI 10.4149/BLL_2018_083; Bao W, 2015, METABOLISM, V64, P756, DOI 10.1016/j.metabol.2015.01.013; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bergmann K, 2014, CLIN BIOCHEM, V47, P529, DOI 10.1016/j.clinbiochem.2014.03.007; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Brown J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011970.pub2; Chan TF, 2007, REPROD SCI, V14, P169, DOI 10.1177/1933719106298407; Collares CVA, 2013, MOL BIOL REP, V40, P5351, DOI 10.1007/s11033-013-2635-y; Corcoran SM, 2018, EUR J OBSTET GYN R B, V222, P7, DOI 10.1016/j.ejogrb.2017.12.051; Corlateanu Alexandru, 2017, COPD RES PRACTICE, V3, DOI [DOI 10.1186/S12933-017-0591-X, 10.1186/s40749-017-0025-x, DOI 10.1186/S40749-017-0025-X]; Correa PJ, 2019, J PERINAT MED, V47, P161, DOI 10.1515/jpm-2018-0120; Coustan DR, 2013, CLIN CHEM, V59, P1310, DOI 10.1373/clinchem.2013.203331; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; Evangelista AF, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-28; Farina A, 2017, REPROD SCI, V24, P954, DOI 10.1177/1933719116675057; Fungfuang Wirasak, 2013, Lab Anim Res, V29, P168, DOI 10.5625/lar.2013.29.3.168; Gao Y, 2013, SOL ENERGY, V98, P290, DOI 10.1016/j.solener.2013.10.014; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Grainger S, 2018, WIRES SYST BIOL MED, V10, DOI 10.1002/wsbm.1422; Herder C, 2014, DIABETOLOGIA, V57, P16, DOI 10.1007/s00125-013-3061-3; Hoffmann MM, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/s12933-014-0155-2; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Iliodromiti S, 2016, DIABETOLOGIA, V59, P692, DOI 10.1007/s00125-015-3855-6; Kim C, 2002, DIABETES CARE, V25, P1862, DOI 10.2337/diacare.25.10.1862; Kjos SL, 1999, NEW ENGL J MED, V341, P1749, DOI 10.1056/NEJM199912023412307; Kuc S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063546; Lain KY, 2008, CLIN ENDOCRINOL, V69, P407, DOI 10.1111/j.1365-2265.2008.03198.x; Lamain-de Ruiter M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4338; Lapolla A, 2009, NUTR METAB CARDIOVAS, V19, P674, DOI 10.1016/j.numecd.2009.04.004; Lara-Castro C, 2007, CURR OPIN LIPIDOL, V18, P263, DOI 10.1097/MOL.0b013e32814a645f; Lorenzo-Almoros A, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0935-9; Mahdi T, 2012, CELL METAB, V16, P625, DOI 10.1016/j.cmet.2012.10.009; Mahmoud F, 2005, AM J REPROD IMMUNOL, V53, P21, DOI 10.1111/j.1600-0897.2004.00241.x; Malinauskas T, 2014, CURR OPIN STRUC BIOL, V29, P77, DOI 10.1016/j.sbi.2014.10.003; McKenzie-Sampson S, 2018, ACTA DIABETOL, V55, P315, DOI 10.1007/s00592-017-1099-2; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Nanda S, 2011, PRENATAL DIAG, V31, P135, DOI 10.1002/pd.2636; Nielsen KK, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-41; Oliveira AP, 2015, DIABETES VASC DIS RE, V12, P175, DOI 10.1177/1479164114563302; Oztas E, 2016, J MATERN-FETAL NEO M, V29, P1515, DOI 10.3109/14767058.2015.1052399; Oztekin O, 2007, MED HYPOTHESES, V69, P526, DOI 10.1016/j.mehy.2007.01.054; Pan HT, 2014, PHYSIOL BEHAV, V130, P157, DOI 10.1016/j.physbeh.2014.04.003; Powe CE, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0834-y; Radhika J., 2012, INT J COMPUTER SCI I, V9, P224; Ramos-Roman MA, 2011, HORM METAB RES, V43, P593, DOI 10.1055/s-0031-1284353; Reece EA, 2009, LANCET, V373, P1789, DOI 10.1016/S0140-6736(09)60515-8; Retnakaran R, 2009, CAN MED ASSOC J, V181, P371, DOI 10.1503/cmaj.090569; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Rodgers Julie, 2012, IRISH J FRENCH STUDI, V12, P43; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Shepherd E, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010443.pub3; Steinborn A, 2006, AM J REPROD IMMUNOL, V56, P124, DOI 10.1111/j.1600-0897.2006.00408.x; Surana R, 2014, BBA-REV CANCER, V1845, P53, DOI 10.1016/j.bbcan.2013.11.004; Talasaz ZH, 2018, TAIWAN J OBSTET GYNE, V57, P181, DOI 10.1016/j.tjog.2018.02.003; Taneera J, 2012, CELL METAB, V16, P122, DOI 10.1016/j.cmet.2012.06.006; Thadhani R, 2003, AM J OBSTET GYNECOL, V189, P171, DOI 10.1067/mob.2003.343; Tieu J, 2017, COCHRANE DB SYST REV, V8, DOI DOI 10.1002/14651858.CD007222.PUB4; Tieu J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006674.pub3; van Leeuwen Marsha, 2011, Ned Tijdschr Geneeskd, V155, pA2291; Wang XL, 2020, EXP THER MED, V19, P710, DOI 10.3892/etm.2019.8247; Wolf M, 2003, DIABETES CARE, V26, P819, DOI 10.2337/diacare.26.3.819; Wortelboer EJ, 2010, BJOG-INT J OBSTET GY, V117, P1384, DOI 10.1111/j.1471-0528.2010.02690.x; Yuan XS, 2018, ENDOCR J, V65, P499, DOI 10.1507/endocrj.EJ17-0508; Zhang ZW, 2014, PEPTIDES, V54, P186, DOI 10.1016/j.peptides.2014.01.024	69	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242423	10.1371/journal.pone.0242423	http://dx.doi.org/10.1371/journal.pone.0242423			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206702	Green Published, gold			2022-12-26	WOS:000595265900025
J	Wong, KO; Zaiane, OR; Davis, FG; Yasui, Y				Wong, Kai On; Zaiane, Osmar R.; Davis, Faith G.; Yasui, Yutaka			A machine learning approach to predict ethnicity using personal name and census location in Canada	PLOS ONE			English	Article							CLASSIFICATION; RACE	Background Canada is an ethnically-diverse country, yet its lack of ethnicity information in many large databases impedes effective population research and interventions. Automated ethnicity classification using machine learning has shown potential to address this data gap but its performance in Canada is largely unknown. This study conducted a large-scale machine learning framework to predict ethnicity using a novel set of name and census location features. Methods Using census 1901, the multiclass and binary class classification machine learning pipelines were developed. The 13 ethnic categories examined were Aboriginal (First Nations, Metis, Inuit, and all-combined)), Chinese, English, French, Irish, Italian, Japanese, Russian, Scottish, and others. Machine learning algorithms included regularized logistic regression, C-support vector, and naive Bayes classifiers. Name features consisted of the entire name string, substrings, double-metaphones, and various name-entity patterns, while location features consisted of the entire location string and substrings of province, district, and subdistrict. Predictive performance metrics included sensitivity, specificity, positive predictive value, negative predictive value, F1, Area Under the Curve for Receiver Operating Characteristic curve, and accuracy. Results The census had 4,812,958 unique individuals. For multiclass classification, the highest performance achieved was 76% F1 and 91% accuracy. For binary classifications for Chinese, French, Italian, Japanese, Russian, and others, the F1 ranged 68-95% (median 87%). The lower performance for English, Irish, and Scottish (F1 ranged 63-67%) was likely due to their shared cultural and linguistic heritage. Adding census location features to the name-based models strongly improved the prediction in Aboriginal classification (F1 increased from 50% to 84%). Conclusions The automated machine learning approach using only name and census location features can predict the ethnicity of Canadians with varying performance by specific ethnic categories.	[Wong, Kai On; Davis, Faith G.; Yasui, Yutaka] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Zaiane, Osmar R.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Yasui, Yutaka] St Jude Childrens Res Hosp, Dept Epidemiol & Canc Control, 332 N Lauderdale St, Memphis, TN 38105 USA	University of Alberta; University of Alberta; St Jude Children's Research Hospital	Wong, KO (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	kaion@ualberta.ca	Yasui, Yutaka/E-2564-2015	Yasui, Yutaka/0000-0002-7717-8638; , Kai/0000-0003-2572-0082	Canadian Institutes of Health Research (CIHR) Doctoral Research Award from Government of Canada; University of Alberta; Alberta Machine Intelligence Institute	Canadian Institutes of Health Research (CIHR) Doctoral Research Award from Government of Canada(Canadian Institutes of Health Research (CIHR)); University of Alberta(University of Alberta); Alberta Machine Intelligence Institute	For this research, KW has received financial supports including the Canadian Institutes of Health Research (CIHR) Doctoral Research Award from Government of Canada (https://cihrirsc.gc.ca/e/50513.html), President's Doctoral Prize of Distinction and Queen Elizabeth II Graduate (Doctoral) Scholarships from University of Alberta (https://www.ualberta.ca/graduate-studies), and research funding from Alberta Machine Intelligence Institute (https://www.amii.ca/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2012, CURR ONCOL, V19, pE376, DOI 10.3747/co.19.1177; Ambekar A, 2009, ACM SIGKDD C KNOWL D; Bulatao RA, 2004, UNDERSTANDING RACIAL; CHOI BCK, 1993, AM J EPIDEMIOL, V138, P723, DOI 10.1093/oxfordjournals.aje.a116910; COLDMAN AJ, 1988, J EPIDEMIOL COMMUN H, V42, P390, DOI 10.1136/jech.42.4.390; del Amo J, 2013, CLIN INFECT DIS, V56, P1800, DOI 10.1093/cid/cit111; Fiscella K, 2006, HEALTH SERV RES, V41, P1482, DOI 10.1111/j.1475-6773.2006.00551.x; Fryer RG, 2004, Q J ECON, V119, P767, DOI 10.1162/0033553041502180; Guo XJ, 2008, ICNC 2008: FOURTH INTERNATIONAL CONFERENCE ON NATURAL COMPUTATION, VOL 4, PROCEEDINGS, P192, DOI 10.1109/ICNC.2008.871; Imai K, 2016, POLIT ANAL, V24, P263, DOI 10.1093/pan/mpw001; Indigenous Corporate Training Inc, 2014, IND ACT NAM POL; Kandt J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201774; Kaplan JB, 2003, JAMA-J AM MED ASSOC, V289, P2709, DOI 10.1001/jama.289.20.2709; Karahasan D, 2006, METISSAGE NEW FRANCE; Khan M, 2015, INVISIBLE MINORITIES; Lee  Jongmin, 2017, P 26 INT JOINT C ART; Li YF, 2017, IEEE T KNOWL DATA EN, V29, P1438, DOI 10.1109/TKDE.2017.2681671; Library and Archives Canada, 2016, NEWF LABR 1949 GOV C; Library and Archives Canada, 2018, DISTR SUB DISTR CENS; Library and Archives Canada, 2016, NUN 1999 GOV CAN; Mateos P, 2007, POPUL SPACE PLACE, V13, P243, DOI 10.1002/psp.457; Mateos P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022943; Nestel S, 2012, COLOUR CODED HLTH CA; Norris MJ, 2011, ABORIG POLICY STUD, V1, P13; Pan -Canadian Public Health Inequalities Reporting (HIR) Initiative, 2018, KEY HLTH IN CAN NAT; Patychuk D., 2011, HLTH EQUITY RACIALIZ; Philips L., 2000, C/C++ Users Journal, V18, P38; Poureslami Iraj M, 2007, MedGenMed, V9, P40; Prasad GVR, 2007, KIDNEY INT, V72, P390, DOI 10.1038/sj.ki.5002437; Santos Diego Junior da Silva, 2010, Dental Press J. Orthod., V15, P121; Sood Gaurav, 2018, ARXIV180502109; Statistics Canada, 2011, AB POP CONC; Statistics Canada, 2018, CENS TRACT DET DEF; Treeratpituk P, 2012, P 26 AAAI C ART INT; TRU Libraries, 2020, GEOGR GEOSP TOOLS DA; Tucker D, 2003, SURNAMES FORENAMES C, pxxiii; Walks RA, 2006, CAN GEOGR-GEOGR CAN, V50, P273, DOI 10.1111/j.1541-0064.2006.00142.x; Wang L, 2008, SOC SCI MED, V67, P1410, DOI 10.1016/j.socscimed.2008.06.012; Witherspoon DJ, 2007, GENETICS, V176, P351, DOI 10.1534/genetics.106.067355; 2010, LASER PHOTON REV, V4, pe143	40	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241239	10.1371/journal.pone.0241239	http://dx.doi.org/10.1371/journal.pone.0241239			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206667	Green Published, gold			2022-12-26	WOS:000595265900063
J	Flint, L; Korkegian, A; Parish, T				Flint, Lindsay; Korkegian, Aaron; Parish, Tanya			InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis	PLOS ONE			English	Article								We previously identified a diazaborine series with potential for development as a new tuberculosis drug. This series has activity in vitro and in vivo and targets cell wall biosynthesis via inhibition of InhA. The overall aim of this study was to determine whether InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis. We tested the ability of two molecules of the diazaborine series to kill non-replicating M. tuberculosis in the nutrient starvation model; both molecules were bactericidal, reducing viability by >3 logs in 21 days. Activity showed similar kill rates to other InhA inhibitors (isoniazid and NITD-916). We conclude that inhibition of InhA is bactericidal against nutrient-starved non-replicating M. tuberculosis.	[Flint, Lindsay; Korkegian, Aaron; Parish, Tanya] Infect Dis Res Inst, Seattle, WA 98109 USA; [Parish, Tanya] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA; [Flint, Lindsay] Seattle Childrens Res Inst, Immunotherapy Integrat Hub, Seattle, WA USA; [Korkegian, Aaron] Arzeda, Seattle, WA USA	Seattle Children's Hospital; Seattle Children's Hospital	Parish, T (corresponding author), Infect Dis Res Inst, Seattle, WA 98109 USA.; Parish, T (corresponding author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98101 USA.	tanya.parish@seattlechildrens.org	Parish, Tanya/A-8912-2014	Parish, Tanya/0000-0001-7507-0423	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This research was supported with funding from the Bill & Melinda Gates Foundation. Funding supported LF, AK and TP. https://www.gatesfoundation.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bonnett SA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198059; Early Julie, 2015, Methods Mol Biol, V1285, P269, DOI 10.1007/978-1-4939-2450-9_16; Gold B, 2015, ANTIMICROB AGENTS CH, V59, P6521, DOI 10.1128/AAC.00803-15; Gordon SV, 2018, MICROBIOL-SGM, V164, P437, DOI 10.1099/mic.0.000601; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Mandal S, 2019, MICROBIOL-SGM, V165, P492, DOI 10.1099/mic.0.000760; Manjunatha UH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010597; Robertson GT, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02071-18; WAYNE LG, 1994, ANTIMICROB AGENTS CH, V38, P2054, DOI 10.1128/AAC.38.9.2054; WHO, 2020, GLOB TUB REP 2019; Xia Y, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800025	12	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0239354	10.1371/journal.pone.0239354	http://dx.doi.org/10.1371/journal.pone.0239354			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201882	Green Submitted, gold, Green Published			2022-12-26	WOS:000595003900057
J	Tang, YT; Tao, Y; Wang, L; Yang, LY; Jing, YP; Jiang, XK; Lei, L; Yang, ZL; Wang, X; Peng, MX; Xiao, QL; Ren, J; Zhang, L				Tang, Yuting; Tao, Yao; Wang, Lu; Yang, Liyuan; Jing, Yipei; Jiang, Xueke; Lei, Li; Yang, Zailin; Wang, Xin; Peng, Meixi; Xiao, Qiaoling; Ren, Jun; Zhang, Ling			NPM1 mutant maintains ULK1 protein stability via TRAF6-dependent ubiquitination to promote autophagic cell survival in leukemia	FASEB JOURNAL			English	Article						autophagy; gene mutation; kinase activity; nucleophosmin 1; unc51&#8208; like kinase 1	ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; NUCLEOPHOSMIN; COMPLEX; KINASE; MUTATIONS; DELOCALIZATION; IDENTIFICATION; RESISTANCE; INDUCTION	Nucleophosmin (NPM1) mutations are the most frequent genetic alteration in acute myeloid leukemia (AML) and aberrant cytoplasm-dislocated NPM1 mutant is a distinct biological characterization of this disease. Our group previously reported that NPM1 mutant elevated autophagy activity and autophagy activation contributed to leukemic cell survival. However, the molecular mechanisms by which cytoplasmic NPM1 mutant involving in the autophagy pathway has not been fully elucidated. Here, we showed that Unc-51-like kinase 1 (ULK1) as a core autophagy protein was highly expressed in NPM1-mA positive OCI-AML3 cells and primary NPM1-mutated AML blasts. Meanwhile, we found that NPM1-mA could interact with ULK1 protein and positively regulated ULK1 protein levels. Mechanically, NPM1-mA promoted TRAF6-dependent K63 ubiquitination and further maintained ULK1 stability and kinase activity via miR-146a. In addition, ULK1 high expression-mediated autophagy activation and facilitated to leukemic cell proliferation. Finally, we demonstrated that restoring ULK1 expression, ULK1 inhibitor SBI-0206965 treatment and using shULK1 partially rescued the effect of NPM1-mA on autophagy and cell survival. In conclusion, our findings suggest that NPM1 mutant interacts with ULK1, and thus, maintains its protein stability, which is required for NPM1 mutant-mediated autophagic cell survival. These data extend our understanding of the functions of NPM1 mutant in the regulation of autophagy activation in NPM1-mutated AML.	[Tang, Yuting; Tao, Yao; Yang, Liyuan; Jing, Yipei; Jiang, Xueke; Lei, Li; Peng, Meixi; Xiao, Qiaoling; Ren, Jun; Zhang, Ling] Chongqing Med Univ, Sch Lab Med, Minist Educ, Key Lab Lab Med Diagnost, Chongqing, Peoples R China; [Wang, Lu] Chongqing Med Univ, Univ Town Hosp, Dept Clin Lab, Chongqing, Peoples R China; [Yang, Zailin] Chongqing Med Univ, Dept Clin Lab, Affiliated Hosp 3, Chongqing, Peoples R China; [Wang, Xin] Chongqing Med Univ, Dept Hematol, Affiliated Hosp 1, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Zhang, L (corresponding author), Chongqing Med Univ, Sch Lab Med, 1 Yixueyuan Rd, Chongqing 400016, Peoples R China.	lingzhang@cqmu.edu.cn	Zhang, Ling/AHD-9516-2022	Zhang, Ling/0000-0003-1097-6034	National Natural Science Foundation of China [81873973]; Natural Science Foundation of CQ CSTC [cstc2019jcyj-msxmX0229]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of CQ CSTC(Natural Science Foundation Project of CQ CSTC)	This work was supported by a grant from the National Natural Science Foundation of China (grant no. 81873973), the Natural Science Foundation of CQ CSTC (grant no. cstc2019jcyj-msxmX0229). The authors declare no conflicts of interest.	Altman JK, 2014, CLIN CANCER RES, V20, P2400, DOI 10.1158/1078-0432.CCR-13-3218; Amaravadi RK, 2019, CANCER DISCOV, V9, P1167, DOI 10.1158/2159-8290.CD-19-0292; Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; Auberger P, 2017, BLOOD, V129, P547, DOI 10.1182/blood-2016-07-692707; Bonetti P, 2008, J CELL BIOL, V182, P19, DOI 10.1083/jcb.200711040; Box JK, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0073-9; Brunetti L, 2019, INT J HEMATOL, V110, P150, DOI 10.1007/s12185-018-02578-7; Brunetti L, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a030320; Cagnetta A, 2014, LEUKEMIA RES, V38, P649, DOI 10.1016/j.leukres.2014.03.006; Chan EY, 2009, AUTOPHAGY, V5, P758, DOI 10.4161/auto.8709; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; Duffy A, 2015, CANCER CHEMOTH PHARM, V75, P439, DOI 10.1007/s00280-014-2637-z; Duployez N, 2018, HAEMATOLOGICA, V103, pE575, DOI 10.3324/haematol.2018.190959; Egan DF, 2015, MOL CELL, V59, P285, DOI 10.1016/j.molcel.2015.05.031; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2009, LEUKEMIA, V23, P1731, DOI 10.1038/leu.2009.124; Falini B, 2007, BLOOD, V109, P874, DOI 10.1182/blood-2006-07-012252; Falini B, 2015, BRIT J HAEMATOL, V170, P305, DOI 10.1111/bjh.13409; Federici L, 2013, PROTEIN SCI, V22, P545, DOI 10.1002/pro.2240; Fujita KI, 2011, P NATL ACAD SCI USA, V108, P1427, DOI 10.1073/pnas.1014156108; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Ghani S, 2011, BLOOD, V118, P2275, DOI 10.1182/blood-2011-02-335141; Grummitt Charles G, 2008, J Biol Chem, V283, P23326, DOI 10.1074/jbc.M801706200; Gu XR, 2018, J CLIN INVEST, V128, P4260, DOI 10.1172/JCI97117; Han SH, 2019, AUTOPHAGY, V15, P2076, DOI 10.1080/15548627.2019.1596492; Heath EM, 2017, LEUKEMIA, V31, P798, DOI 10.1038/leu.2017.30; Jang JE, 2017, AUTOPHAGY, V13, P761, DOI 10.1080/15548627.2016.1278328; Jiao H, 2015, CELL DEATH DIFFER, V22, P1812, DOI [10.1038/cdd.2015.34, 10.1038/xyza.2015.34]; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Jung SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3562; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kunchala P, 2018, BLOOD REV, V32, P167, DOI 10.1016/j.blre.2017.11.001; Kuroyanagi H, 1998, GENOMICS, V51, P76, DOI 10.1006/geno.1998.5340; Lebovitz CB, 2015, AUTOPHAGY, V11, P1668, DOI 10.1080/15548627.2015.1067362; Leong SM, 2010, BLOOD, V116, P3286, DOI 10.1182/blood-2009-12-256149; Liang PQ, 2018, NEOPLASMA, V65, P807, DOI 10.4149/neo_2018_171028N691; Lin JH, 2017, NUCLEIC ACIDS RES, V45, P3707, DOI 10.1093/nar/gkw1285; Lin MG, 2016, CURR OPIN CELL BIOL, V39, P61, DOI 10.1016/j.ceb.2016.02.010; Lu J, 2018, EBIOMEDICINE, V34, P85, DOI 10.1016/j.ebiom.2018.07.034; Luo HC, 2018, BLOOD, V132, P837, DOI 10.1182/blood-2017-11-814319; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Ni XH, 2019, EMBO J, V38, DOI 10.15252/embj.201899766; Noguera NI, 2013, LEUKEMIA, V27, P1037, DOI 10.1038/leu.2012.314; Ouyang L, 2018, J MED CHEM, V61, P2776, DOI 10.1021/acs.jmedchem.7b01575; Papinski D, 2016, J MOL BIOL, V428, P1725, DOI 10.1016/j.jmb.2016.03.030; Short NJ, 2018, LANCET, V392, P593, DOI 10.1016/S0140-6736(18)31041-9; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takahashi TS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02345-y; Tang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12033-8; Thayer JA, 2020, AUTOPHAGY, V16, P140, DOI 10.1080/15548627.2019.1598754; Vascotto C, 2014, ONCOGENE, V33, P2876, DOI 10.1038/onc.2013.251; Vassiliou GS, 2011, NAT GENET, V43, P470, DOI 10.1038/ng.796; Wang XW, 2015, J BIOL CHEM, V290, P29086, DOI 10.1074/jbc.M115.664573; Wu WX, 2014, EMBO REP, V15, P566, DOI 10.1002/embr.201438501; Yan J, 1998, BIOCHEM BIOPH RES CO, V246, P222, DOI 10.1006/bbrc.1998.8546; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Zachari M, 2017, ESSAYS BIOCHEM, V61, P585, DOI 10.1042/EBC20170021; Zhang L, 2018, J MED CHEM, V61, P6491, DOI 10.1021/acs.jmedchem.7b01684; Zou Q, 2017, THERANOSTICS, V7, P2289, DOI 10.7150/thno.19439	60	7	7	3	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.201903183RRR	http://dx.doi.org/10.1096/fj.201903183RRR		NOV 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33201521				2022-12-26	WOS:000592662100001
J	Bernau, VM; Barbolla, LJ; McHale, LK; Mercer, KL				Bernau, Vivian M.; Jardon Barbolla, Lev; McHale, Leah K.; Mercer, Kristin L.			Germination response of diverse wild and landrace chile peppers (Capsicum spp.) under drought stress simulated with polyethylene glycol	PLOS ONE			English	Article							SEED-GERMINATION; LOCAL ADAPTATION; CROP ALLELE; GENETICS; ANNUUM; SUNFLOWER; CAPSAICIN; GROWTH; DIFFERENTIATION; DOMESTICATION	Responses to drought within a single species may vary based on plant developmental stage, drought severity, and the avoidance or tolerance mechanisms employed. Early drought stress can restrict emergence and seedling growth. Thus, in areas where water availability is limited, rapid germination leading to early plant establishment may be beneficial. Alternatively, germination without sufficient water to support the seedling may lead to early senescence, so reduced germination under low moisture conditions may be adaptive at the level of the population. We studied the germination response to osmotic stress of diverse chile pepper germplasm collected in southern Mexico from varied ecozones, cultivation systems, and of named landraces. Drought stress was simulated using polyethylene glycol solutions. Overall, survival time analysis revealed delayed germination at the 20% concentration of PEG across all ecozones. The effect was most pronounced in the genotypes from hotter, drier ecozones. Additionally, accessions from wetter and cooler ecozones had the fastest rate of germination. Moreover, accessions of the landraces Costeno Rojo and Tusta germinated more slowly and incompletely if sourced from a drier ecozone than a wetter one, indicating that slower, reduced germination under drought stress may be an adaptive avoidance mechanism. Significant differences were also observed between named landraces, with more domesticated types from intensive cultivation systems nearly always germinating faster than small-fruited backyard- or wild-types, perhaps due to the fact that the smaller-fruited accessions may have undergone less selection. Thus, we conclude that there is evidence of local adaptation to both ecozone of origin and source cultivation system in germination characteristics of diverse chile peppers.	[Bernau, Vivian M.; McHale, Leah K.; Mercer, Kristin L.] Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA; [Jardon Barbolla, Lev] Univ Nacl Autonoma Mexico, Ctr Invest Interdisciplinarias Ciencias & Humanid, Mexico City, DF, Mexico; [Bernau, Vivian M.] ARS, North Cent Reg Plant Intro Stn, USDA, Ames, IA USA; [Bernau, Vivian M.] Iowa State Univ, Dept Agron, Ames, IA USA	University System of Ohio; Ohio State University; Universidad Nacional Autonoma de Mexico; United States Department of Agriculture (USDA); Iowa State University	Mercer, KL (corresponding author), Ohio State Univ, Dept Hort & Crop Sci, Columbus, OH 43210 USA.	mercer.97@osu.edu		Mercer, Kristin/0000-0003-4990-2227; Bernau, Vivian/0000-0002-2393-8101	Seeds: The OARDC Research Enhancement Competitive Grants Program [2016056, 2015100]; Center for Applied Plant Sciences, Ohio State University; Ohio State University [HCS20:09]; U.S. Department of Agriculture, Agriculture Research Service	Seeds: The OARDC Research Enhancement Competitive Grants Program; Center for Applied Plant Sciences, Ohio State University; Ohio State University(Ohio State University); U.S. Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was partially funded by Seeds: The OARDC Research Enhancement Competitive Grants Program (Proposal #2016056) to KLM, LKM, and LJB and (Proposal #2015100) to VMB, KLM, and LKM. (oardc.osu.edu/research-resources/grants-contracts) This research, including the original collection trips, was partially funded by the Center for Applied Plant Sciences, Ohio State University. (caps.osu.edu) Salaries and research support were also provided to LKM and KLM by state and federal funds appropriated to the Ohio Agricultural Research and Development Center, Ohio State University: manuscript no. HCS20:09. (oardc.osu.edu). Further salary support was provided by the U.S. Department of Agriculture, Agriculture Research Service. Mention of tradenames or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. USDA is an equal opportunity provider and employer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghani AH, 2015, GENET RESOUR CROP EV, V62, P275, DOI 10.1007/s10722-014-0152-z; ADLER LS, 1993, FUNCT ECOL, V7, P736, DOI 10.2307/2390196; Aguilar-Melendez A, 2009, AM J BOT, V96, P1190, DOI 10.3732/ajb.0800155; Alexander HM, 2014, AM J BOT, V101, P1176, DOI 10.3732/ajb.1400088; Ancona-Escalante WD, 2013, PLANT CELL TISS ORG, V113, P565, DOI 10.1007/s11240-012-0282-y; [Anonymous], 2015, JMIR MED INFORM, V3, pe22; Barati M, 2015, CROP SCI, V55, P2668, DOI 10.2135/cropsci2015.04.0229; Barchenger DW, 2016, SCI HORTIC-AMSTERDAM, V203, P29, DOI 10.1016/j.scienta.2016.03.009; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Blum A, 2011, FUNCT PLANT BIOL, V38, P753, DOI 10.1071/FP11101; Brazil Ministry of Agriculture and Agrarian Reform, 1992, TOL RUL SEED AN, P229; Casas A, 2007, ANN BOT-LONDON, V100, P1101, DOI 10.1093/aob/mcm126; de Leon N, 2016, CROP SCI, V56, P2081, DOI 10.2135/cropsci2016.07.0002in; DELOUCHE J. C., 1960, Proceedings of the Association of Official Seed Analysts of North America, V50, P124; DEWET JMJ, 1975, B TORREY BOT CLUB, V102, P307, DOI 10.2307/2484756; Djemel A, 2018, EUPHYTICA, V214, DOI 10.1007/s10681-018-2223-2; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; DRACUP JA, 1980, WATER RESOUR RES, V16, P297, DOI 10.1029/WR016i002p00297; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; FUJIWAKE H, 1980, PLANT CELL PHYSIOL, V21, P1023; HAMMER K, 1984, Kulturpflanze, V32, P11; Hernandez-Verdugo S, 2001, PLANT ECOL, V155, P245, DOI 10.1023/A:1013234100003; Iglesias La, 2018, MAYDICA, V62, P12; Kassambara A, 2017, SURVMINER DRAWING SU; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kessler A, 2016, FUNCT ECOL, V30, P1738, DOI 10.1111/1365-2435.12726; Kost MA, 2015, EVOL APPL, V8, P510, DOI 10.1111/eva.12261; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; McNair JN, 2012, SEED SCI RES, V22, P77, DOI 10.1017/S0960258511000547; Mercer K, 2008, EVOL APPL, V1, P489, DOI 10.1111/j.1752-4571.2008.00038.x; Mercer KL, 2019, GENET RESOUR CROP EV, V66, P27, DOI 10.1007/s10722-018-0693-7; Mercer KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109001; Mercer KL, 2011, AM J BOT, V98, P975, DOI 10.3732/ajb.1000408; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Mickky B.M., 2017, EJBAS, V4, P47, DOI DOI 10.1016/J.EJBAS.2016.10.001; Miller A., 2014, TETRAZOLIUM TESTING; Moran E, 2017, NEW PHYTOL, V216, P1034, DOI 10.1111/nph.14774; Murillo-Amador B, 2002, J AGRON CROP SCI, V188, P235, DOI 10.1046/j.1439-037X.2002.00563.x; Ozturk M., 2009, V44, P51; Pace BA, 2015, EVOL APPL, V8, P121, DOI 10.1111/eva.12236; Perales HR, 2005, P NATL ACAD SCI USA, V102, P949, DOI 10.1073/pnas.0408701102; Pickersgill B, 2007, ANN BOT-LONDON, V100, P925, DOI 10.1093/aob/mcm193; Postma FM, 2016, P NATL ACAD SCI USA, V113, P7590, DOI 10.1073/pnas.1606303113; Qu YY, 2008, GENETICA, V133, P187, DOI 10.1007/s10709-007-9199-5; Rao N.K., 2006, MANUAL SEED HANDLING, V8; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Rojas-Arechiga M, 2001, J ARID ENVIRON, V49, P279, DOI 10.1006/jare.2001.0789; de Almeida JAS, 2018, J SEED SCI, V40, P82, DOI 10.1590/2317-1545v40n176667; Taitano N, 2019, EVOL APPL, V12, P78, DOI 10.1111/eva.12651; Tewksbury JJ, 2001, NATURE, V412, P403, DOI 10.1038/35086653; Tewksbury JJ, 2008, ECOLOGY, V89, P107, DOI 10.1890/07-0445.1; Tewksbury JJ, 2006, J CHEM ECOL, V32, P547, DOI 10.1007/s10886-005-9017-4; Thabet SG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206682; Therneau T.M., 2000, MODELING SURVIVAL DA; Tiffin P, 2014, TRENDS ECOL EVOL, V29, P673, DOI 10.1016/j.tree.2014.10.004; van Heerwaarden J, 2010, HEREDITY, V104, P28, DOI 10.1038/hdy.2009.110; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Verhoeven KJF, 2004, EVOLUTION, V58, P270, DOI 10.1111/j.0014-3820.2004.tb01644.x; Wang M, 2018, NAT GENET, V50, P1435, DOI 10.1038/s41588-018-0229-2; Weiss AN, 2013, SEED SCI RES, V23, P241, DOI 10.1017/S0960258513000226; Wu LM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214480; Zhu JJ, 2006, J FOREST RES-JPN, V11, P319, DOI 10.1007/s10310-006-0214-y	64	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0236001	10.1371/journal.pone.0236001	http://dx.doi.org/10.1371/journal.pone.0236001			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196641	gold, Green Submitted, Green Published			2022-12-26	WOS:000595266800044
J	Biondi, S; Mazza, C; Orru, G; Monaro, M; Ferracuti, S; Ricci, E; Di Domenico, A; Roma, P				Biondi, Silvia; Mazza, Cristina; Orru, Graziella; Monaro, Merylin; Ferracuti, Stefano; Ricci, Eleonora; Di Domenico, Alberto; Roma, Paolo			Interrogative suggestibility in the elderly	PLOS ONE			English	Article							MINI-MENTAL-STATE; MEMORY FUNCTIONING QUESTIONNAIRE; GUDJONSSON SUGGESTIBILITY; SELF-ESTEEM; SOCIAL DESIRABILITY; WORRY QUESTIONNAIRE; AGE-DIFFERENCES; OLDER-ADULTS; SCALE; ANXIETY	Interrogative suggestibility (IS) describes the extent to which an individual behavioral response is affected by messages communicated during formal questioning within a closed social interaction. The present study aimed at improving knowledge about IS in the elderly (aged 65 years and older), in particular about its association with both emotive/affective and cognitive variables. The sample (N = 172) was divided into three groups on the basis of age: late adult (aged 55-64, N = 59), young elderly (aged 65-74, N = 63), and elderly (aged 75 and older, N = 50). Cognitive (i.e., Kaufman Brief Intelligence Test-2, Rey Auditory Verbal Learning Test), emotive/affective (i.e., Rosenberg Self-Esteem Scale, Marlowe-Crowne Social Desirability Scale, Penn State Worry Questionnaire) and suggestibility measures (i.e., Gudjonsson Suggestibility Scale-2) were administered. In order to identify differences and associations between groups in IS, cognitive and emotive/affective variables, ANOVAs tests and Pearson's correlations were run. Furthermore, moderation analyses and hierarchical regression were set to determine whether age, cognitive and emotive/affective variables predicted IS components (i.e., Yield and Shift). Finally, machine learning models were developed to highlight the best strategy for classifying elderly subjects with high suggestibility. The results corroborated the significant link between IS and age, showing that elderly participants had the worst performance on all suggestibility indexes. Age was also the most important predictor of both Yield and Shift. Results also confirmed the important role of non-verbal intelligence and memory impairment in explaining IS dimensions, showing that these associations were stronger in young elderly and elderly groups. Implications about interrogative procedures with older adults were discussed.	[Biondi, Silvia; Ferracuti, Stefano; Ricci, Eleonora; Roma, Paolo] Sapienza Univ Rome, Fac Med & Dent, Dept Human Neurosci, Rome, Italy; [Mazza, Cristina] G dAnnunzio Univ Chieti Pescara, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Orru, Graziella] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy; [Monaro, Merylin] Univ Padua, Dept Gen Psychol, Padua, Italy; [Di Domenico, Alberto] G dAnnunzio Univ Chieti Pescara, Dept Psychol Hlth & Terr Sci, Chieti, Italy	Sapienza University Rome; G d'Annunzio University of Chieti-Pescara; University of Pisa; University of Padua; G d'Annunzio University of Chieti-Pescara	Roma, P (corresponding author), Sapienza Univ Rome, Fac Med & Dent, Dept Human Neurosci, Rome, Italy.	paolo.roma@uniroma1.it	Monaro, Merylin/AAM-3066-2021; Di Domenico, Alberto/AIB-7965-2022; Ferracuti, Stefano/K-8437-2012	Monaro, Merylin/0000-0001-5598-691X; Di Domenico, Alberto/0000-0002-9962-2891; Biondi, Silvia/0000-0001-5862-1799; Ricci, Eleonora/0000-0003-0591-3389; Ferracuti, Stefano/0000-0003-1150-1460				Bain S. A., 2000, LEGAL CRIMINOL PSYCH, V5, P123, DOI DOI 10.1348/135532500168029; Balota D. A., 2000, OXFORD HDB MEMORY, P395, DOI DOI 10.1037/A0015086; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bartlett JC, 2007, HDB EYEWITNESS PSYCH, P309; Baxter JS, 2003, PERS INDIV DIFFER, V35, P1285, DOI 10.1016/S0191-8869(02)00349-5; Behar E, 2003, J BEHAV THER EXP PSY, V34, P25, DOI 10.1016/S0005-7916(03)00004-1; Bonifacci P., 2016, KAUFMAN BRIEF INTELL, V2nd; Brown TA, 2003, BEHAV RES THER, V41, P1411, DOI 10.1016/S0005-7967(03)00059-7; Bruck M, 1999, ANNU REV PSYCHOL, V50, P419, DOI 10.1146/annurev.psych.50.1.419; Buddhinath G., 2006, SIMPLE ENHANCEMENT O; Caltagirone C, 1995, ARCH PSICOL NEUROL P, V55, P61; CECI SJ, 1993, PSYCHOL BULL, V113, P403, DOI 10.1037/0033-2909.113.3.403; CLARE ICH, 1994, BRIT J CLIN PSYCHOL, V33, P357, DOI 10.1111/j.2044-8260.1994.tb01132.x; Clark N. K., 1986, SOCIAL BEHAVIOUR, V1, P83; COHEN G, 1989, PSYCHOL AGING, V4, P10, DOI 10.1037/0882-7974.4.1.10; Coin A, 2009, ARCH GERONTOL GERIAT, V49, P35, DOI 10.1016/j.archger.2009.09.010; Corwyn RF, 2000, J RES PERS, V34, P357, DOI 10.1006/jrpe.2000.2291; Costa, 1989, NEO PI NEO FFI MANUA; Costa PT, 2007, REVISED NEO PERSONAL; Coxon P, 1997, APPL COGNITIVE PSYCH, V11, P415, DOI 10.1002/(SICI)1099-0720(199710)11:5<415::AID-ACP469>3.0.CO;2-A; CROOK TH, 1990, PSYCHOL AGING, V5, P48, DOI 10.1037/0882-7974.5.1.48; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Curci A, 2014, MANUALE USO; DANIELSDOTTIR G, 1993, PERS INDIV DIFFER, V14, P499, DOI 10.1016/0191-8869(93)90323-U; Department of Economic and Social Affairs of United Nations, 2019, WORLD POPULATION PRO; Drake K, 2011, PSYCHOL CRIME LAW, V17, P677, DOI 10.1080/10683160903511967; Drake KE, 2008, LEGAL CRIMINOL PSYCH, V13, P299, DOI 10.1348/135532507X209981; DUKALA K, 2013, J GERONTOL B-PSYCHOL, V69, P348; Fastame MC, 2012, CLIN GERONTOLOGIST, V35, P239, DOI 10.1080/07317115.2012.660411; Fastame MC, 2015, QUAL LIFE RES, V24, P241, DOI 10.1007/s11136-014-0750-4; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gignac GE, 2006, APPL COGNITIVE PSYCH, V20, P617, DOI 10.1002/acp.1213; GILEWSKI MJ, 1990, PSYCHOL AGING, V5, P482, DOI 10.1037/0882-7974.5.4.482; GILEWSKI MJ, 1988, PSYCHOPHARMACOL BULL, V24, P665; Gudjonsson G., 2018, PSYCHOL FALSE CONFES, DOI [10.1002/9781119315636, DOI 10.1002/9781119315636]; Gudjonsson G.H., 1997, GUDJONSSON SUGGESTIB; GUDJONSSON GH, 1983, BRIT J PSYCHIAT, V142, P35, DOI 10.1192/bjp.142.1.35; GUDJONSSON GH, 1984, PERS INDIV DIFFER, V5, P425, DOI 10.1016/0191-8869(84)90007-2; Gudjonsson GH, 2003, LEGAL CRIMINOL PSYCH, V8, P241, DOI 10.1348/135532503322363013; GUDJONSSON GH, 1984, PERS INDIV DIFFER, V5, P303, DOI 10.1016/0191-8869(84)90069-2; GUDJONSSON GH, 1987, BRIT J CLIN PSYCHOL, V26, P215, DOI 10.1111/j.2044-8260.1987.tb01348.x; GUDJONSSON GH, 1987, SOC BEHAV, V2, P29; GUDJONSSON GH, 1992, PERS INDIV DIFFER, V13, P479, DOI 10.1016/0191-8869(92)90077-3; GUDJONSSON GH, 1988, BRIT J CLIN PSYCHOL, V27, P159, DOI 10.1111/j.2044-8260.1988.tb00764.x; GUDJONSSON GH, 1984, J FORENSIC SCI SOC, V24, P99, DOI 10.1016/S0015-7368(84)72302-4; GUDJONSSON GH, 1989, PERS INDIV DIFFER, V10, P535, DOI 10.1016/0191-8869(89)90035-4; Gudjonsson GH, 2003, PSYCHOL INTERROGATIO; Gudjonsson GH, 2014, GSS GUDJONSSON SUGGE; Hall M. A., 1999, Proceedings of the Twelfth International Florida AI Research Society Conference, P235; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; Hayes AF, 2018, COMMUN MONOGR, V85, P4, DOI 10.1080/03637751.2017.1352100; Hilgard ER, 1991, HUMAN SUGGESTIBILITY, P37; Holliday RE, 2012, PSYCHOL AGING, V27, P1191, DOI 10.1037/a0022031; Kaufman A. S, 2004, KAUFMAN BRIEF INTELL; Loftus Elizabeth F, 1996, EYEWITNESS TESTIMONY; Luo L, 2008, CAN J PSYCHIAT, V53, P346, DOI 10.1177/070674370805300603; Martino GD, 2018, IEEE T NEUR NET LEAR, V29, P3270, DOI 10.1109/TNNLS.2017.2705694; Mazza C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61636-5; Mazza C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0227113; Mazza C, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00389; McDougall W, 2001, INTRO SOCIAL PSYCHOL, P74; McGroarty A, 2013, LEGAL CRIMINOL PSYCH, V18, P287, DOI 10.1111/j.2044-8333.2012.02046.x; McGroarty A, 2009, PERS INDIV DIFFER, V47, P642, DOI 10.1016/j.paid.2009.05.024; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Mitchell KJ, 2003, APPL COGNITIVE PSYCH, V17, P107, DOI 10.1002/acp.857; Morani S., 1999, PSICOTERAPIA COGNITI, V5, P195; Mueller-Johnson K, 2004, APPL COGNITIVE PSYCH, V18, P1109, DOI 10.1002/acp.1078; Mueller-Johnson K, 2007, BEHAV SCI LAW, V25, P355, DOI 10.1002/bsl.765; Navarin N, 2017, BIOINFORMATICS, V33, P2642, DOI 10.1093/bioinformatics/btx295; Orru G, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02970; Pace G, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01650; Phillips LH, 2006, AGING MENT HEALTH, V10, P250, DOI 10.1080/13607860500310385; Piernik M, 2016, KNOWL INF SYST, V46, P185, DOI 10.1007/s10115-015-0820-0; Polak M, 2016, CURR PSYCHOL, V35, P1, DOI 10.1007/s12144-015-9352-8; Polczyk R, 2004, APPL COGNITIVE PSYCH, V18, P1097, DOI 10.1002/acp.1073; Polczyk R, 2005, PERS INDIV DIFFER, V38, P177, DOI 10.1016/j.paid.2004.03.018; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Prezza M., 1997, BPA APPL PSICOL B, V223, P35; Rey A, 1964, LEXAMEN CLINIQUE PSY; Richardson G, 2004, PERS INDIV DIFFER, V36, P485, DOI 10.1016/S0191-8869(03)00263-0; RICHARDSON G, 1995, J ADOLESCENCE, V18, P211, DOI 10.1006/jado.1995.1014; Ridley AM, 2006, MEMORY, V14, P37, DOI 10.1080/09658210444000494; Ridley AM, 2002, APPL COGNITIVE PSYCH, V16, P547, DOI 10.1002/acp.813; Ridley AM, 2013, SUGGESTIBILITY LEGAL, P85, DOI [10.1002/9781118432907, DOI 10.1002/9781118432907]; Ridley AM, 2013, SUGGESTIBILITY LEGAL; Roma P, 2011, PERS INDIV DIFFER, V51, P488, DOI 10.1016/j.paid.2011.05.003; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; Sarason I.G., 1988, ANXIETY RES, V1, P3, DOI [https://doi.org/10.1080/10615808808248215, DOI 10.1080/10615808808248215]; Sartori, 2016, P5 MED JUSTICE, P330, DOI [10.1007/978-3-319-67092-8_21, DOI 10.1007/978-3-319-67092-8_21]; Sidis B, 1998, PSYCHOL SUGGESTION, P15, DOI [10.1095/biolreprod59.4.807, DOI 10.1095/BIOLREPROD59.4.807]; SIGURDSSON E, 1994, NORD J PSYCHIAT, V48, P443, DOI 10.3109/08039489409078163; SINGH KK, 1992, J ADOLESCENCE, V15, P155, DOI 10.1016/0140-1971(92)90044-6; SINGH KK, 1984, PERS INDIV DIFFER, V5, P203, DOI 10.1016/0191-8869(84)90052-7; SMITH P, 1995, PERS INDIV DIFFER, V19, P517, DOI 10.1016/0191-8869(95)00085-K; Tuijl JP, 2012, INT J GERIATR PSYCH, V27, P755, DOI 10.1002/gps.2776; Tully B., 1984, POLICE INTERVIEWING; WARREN A, 1991, LAW HUMAN BEHAV, V15, P273, DOI 10.1007/BF01061713; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Wells Gary L, 2006, Psychol Sci Public Interest, V7, P45, DOI 10.1111/j.1529-1006.2006.00027.x; Winterling D, 1986, SENILE DEMENTIAS EAR, P482; Wolfradt U, 1998, PERS INDIV DIFFER, V25, P425, DOI 10.1016/S0191-8869(98)00023-3; Yarkoni T, 2017, PERSPECT PSYCHOL SCI, V12, P1100, DOI 10.1177/1745691617693393; Young K, 2003, PERS INDIV DIFFER, V35, P31, DOI 10.1016/S0191-8869(02)00138-1	105	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0241353	10.1371/journal.pone.0241353	http://dx.doi.org/10.1371/journal.pone.0241353			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VP	33196666	gold, Green Published			2022-12-26	WOS:000595266800037
J	Yang, H; Ma, JY; Wan, Z; Wang, Q; Wang, ZB; Zhao, J; Wang, F; Zhang, YL				Yang, Hua; Ma, Jianyu; Wan, Zhen; Wang, Qi; Wang, Zhibo; Zhao, Jie; Wang, Feng; Zhang, Yanli			Characterization of sheep spermatogenesis through single-cell RNA sequencing	FASEB JOURNAL			English	Article						scRNA&#8208; seq; sheep; spermatogenesis; testis	SPERMATOGONIAL STEM-CELLS; SERTOLI-CELLS; TRANSCRIPTOME; SYCP2; GENE	Spermatogenesis is an important biological process in male reproduction. The interaction between male germ cells and somatic cells during spermatogenesis, is necessary for male reproductive activities. This cellular heterogeneity has made it difficult to profile distinct cell types at different stages of development. Here, we present the first comprehensive, unbiased single-cell transcriptomic study of sheep spermatogenesis using 10x genomics single cell sequencing (scRNA-seq). We collected scRNA-seq data from 11 772 cells from the adult sheep testis and identified all known germ cells (including early primary spermatocytes, late primary spermatocytes, round spermatids, elongated spermatids, and sperm), and somatic cells (Sertoli cells and Leydig cells), as well as one somatic cell that unexpectedly contained leukocytes. The functional enrichment analysis indicated that several pathways of cell cycle, gamete generation, protein processing, and mRNA surveillance pathways were significantly enriched in testicular germ cell types, and ribosome pathway was significantly enriched in testicular somatic cell types. Further analysis identified several stage-specific marker genes of sheep germ cells, such as EZH2, SOX18, SCP2, PCNA, and PRKCD. Our research explored for the first time of the changes in the transcription level of various cell types during the process of sheep spermatogenesis, providing new insights for sheep spermatogenesis and spermatogenic cell development.	[Yang, Hua; Ma, Jianyu; Wan, Zhen; Wang, Qi; Wang, Zhibo; Zhao, Jie; Wang, Feng; Zhang, Yanli] Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Livestock Embryo Engn Lab, 1 Weigang, Nanjing 210095, Peoples R China	Nanjing Agricultural University	Zhang, YL (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Jiangsu Livestock Embryo Engn Lab, 1 Weigang, Nanjing 210095, Peoples R China.	zhangyanli@njau.edu.cn	Wang, Zhibo/GSD-3371-2022	Wang, Feng/0000-0002-4965-836X	National Natural Science Foundation of China [31872359]; Youth Talent Project for Animal Science Collage of Nanjing Agricultural University [DKQB201901]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Talent Project for Animal Science Collage of Nanjing Agricultural University	This study was financially supported by the National Natural Science Foundation of China (31872359) and Youth Talent Project for Animal Science Collage of Nanjing Agricultural University (DKQB201901). We sincerely thank all the members of our laboratory for their technical assistance in preparation for the study, especially Dr. Mingtian Deng. And thank the High-Performance Computing Platform of Bioinformatics Center, Nanjing Agricultural University for their data analysis support.	Balaton BP, 2018, HUM MOL GENET, V27, pR242, DOI 10.1093/hmg/ddy148; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bonner RF, 1997, SCIENCE, V278, P1481, DOI 10.1126/science.278.5342.1481; Bryant JM, 2013, JOVE-J VIS EXP, DOI 10.3791/50648; Cardoso-Moreira M, 2019, NATURE, V571, P505, DOI 10.1038/s41586-019-1338-5; Chen HL, 2001, EXP GERONTOL, V36, P1361, DOI 10.1016/S0531-5565(01)00118-8; Chen QY, 2016, SEMIN CELL DEV BIOL, V59, P157, DOI 10.1016/j.semcdb.2016.01.019; Chen XX, 2017, REPRODUCTION, V154, P789, DOI [10.1530/rep-17-0441, 10.1530/REP-17-0441]; Da Ros M, 2019, JOVE-J VIS EXP, DOI 10.3791/60271; Fraune J, 2014, CYTOGENET GENOME RES, V144, P299, DOI 10.1159/000381080; Glazkov M V, 1981, Ontogenez, V12, P470; Green CD, 2018, DEV CELL, V46, P651, DOI 10.1016/j.devcel.2018.07.025; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Guo JT, 2020, CELL STEM CELL, V26, P262, DOI 10.1016/j.stem.2019.12.005; Guo JT, 2018, CELL RES, V28, P1141, DOI 10.1038/s41422-018-0099-2; Hai YA, 2014, SEMIN CELL DEV BIOL, V29, P66, DOI 10.1016/j.semcdb.2014.04.007; Hermann BP, 2018, CELL REP, V25, P1650, DOI 10.1016/j.celrep.2018.10.026; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Hinz S, 2010, WORLD J UROL, V28, P631, DOI 10.1007/s00345-009-0498-6; Liu Y, 2014, CELL DEATH DIS, V5, pe1361; Lukassen S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24725-0; Lukassen S, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.192; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; Mahalingam M, 2018, METHODS MOL BIOL, V1723, P1, DOI 10.1007/978-1-4939-7558-7_1; Rebourcet D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105687; Roumaud P, 2018, MOL CELL BIOCHEM, V447, P175, DOI 10.1007/s11010-018-3302-3; Royo H, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005461; Shah MA, 2018, ANIM REPROD SCI, V193, P182, DOI 10.1016/j.anireprosci.2018.04.067; Sohni A, 2019, CELL REP, V26, P1501, DOI 10.1016/j.celrep.2019.01.045; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Toocheck C, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.132068; UM JY, 1995, J UROLOGY, V154, P1237, DOI 10.1016/S0022-5347(01)67038-1; Verderame M, 2018, CR BIOL, V341, P371, DOI 10.1016/j.crvi.2018.07.002; Walker WH, 2009, STEROIDS, V74, P602, DOI 10.1016/j.steroids.2008.11.017; Wang M, 2018, CELL STEM CELL, V23, P599, DOI 10.1016/j.stem.2018.08.007; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Yang H, 2018, BIOL REPROD, V99, P650, DOI 10.1093/biolre/ioy088; Yu Y, 2018, STEM CELL REP, V11, P1579, DOI 10.1016/j.stemcr.2018.11.013; Zhang QW, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103083; Zhang XN, 2019, MOL CELL, V73, P130, DOI 10.1016/j.molcel.2018.10.020; Zhao WP, 2018, BIOL TRACE ELEM RES, V186, P489, DOI 10.1007/s12011-018-1338-6; Zhou Q, 2015, J CELL MOL MED, V19, P521, DOI 10.1111/jcmm.12407; Zhou R, 2019, CELL MOL LIFE SCI, V76, P2681, DOI 10.1007/s00018-019-03101-9; Zhu ZJ, 2015, ASIAN J ANDROL, V17, P961, DOI 10.4103/1008-682X.159721; Zuo HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164874	45	15	18	6	27	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001035RRR	http://dx.doi.org/10.1096/fj.202001035RRR		NOV 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33197070				2022-12-26	WOS:000592668500001
J	Rafi, MA; Miah, MMZ; Wadood, MA; Hossain, MG				Rafi, Md. Abdur; Miah, M. Morsed Zaman; Wadood, Md. Abdul; Hossain, Md. Golam			Risk factors and etiology of neonatal sepsis after hospital delivery: A case-control study in a tertiary care hospital of Rajshahi, Bangladesh	PLOS ONE			English	Article								Background Sepsis is one of the major causes of neonatal death worldwide as well as in Bangladesh. The objective of the present study was to identify the risk factors and causative organisms of neonatal sepsis after delivery in a tertiary care hospital, Bangladesh. Methods This was a case-control study conducted in the neonatal ward of Rajshahi Medical College Hospital (RMCH), a 1000-bed tertiary hospital situated in Rajshahi, Bangladesh. Neonates diagnosed as neonatal sepsis by clinical and laboratory parameters were included as cases in this study. Admitted neonates unsuspected or undiagnosed for sepsis were considered as controls. Maternal and neonatal information and their laboratory reports were collected and analyzed. Both bivariate and multiple logistic regression models were used to identify the risk factors of neonatal sepsis. Results A total of 91 cases and 193 controls were included in the study. Maternal history of urinary tract infection (UTI) during the third trimester of pregnancy (aOR 2.75, 95% CI: 1.04-7.23, p <0.05), premature birth (aOR 2.77, 95% CI: 1.08-7.13, p <0.05) and APGAR score <7 at five minutes (aOR 2.58, 95% CI: 1.04-6.39, p <0.05) were associated with onset of neonatal sepsis in multiple logistic regression model. All these factors were also associated with developing early-onset neonatal sepsis, while maternal UTI and male sex of neonates were associated with developing late-onset neonatal sepsis. Escherichia coli (40.7%), Staphylococcus aureus (27.5%), and Klebsiella pneumoniae (18.7%) were the commonly isolated organisms causing neonatal sepsis. All these organisms were highly resistant to common antibiotics like amoxicillin, cephalosporins, aminoglycosides and quinolones. Carbapenemase group of drugs along with amikacin, nitrofurantoin and linezolid were the most sensitive drugs. Conclusions Strengthening the existing facility for antenatal screening for early diagnosis and treatment of maternal infection during pregnancy as well as identifying high-risk pregnancy for adequate perinatal management is necessary to prevent neonatal sepsis-related morbidity and mortality. Rational use of antibiotics according to local epidemiology and culture and sensitivity reports may minimize the increasing hazards of antibiotic resistance.	[Rafi, Md. Abdur; Miah, M. Morsed Zaman] Rajshahi Med Coll, Rajshahi, Bangladesh; [Wadood, Md. Abdul] Univ Rajshahi, Med Ctr, Rajshahi, Bangladesh; [Hossain, Md. Golam] Univ Rajshahi, Dept Stat, Hlth Res Grp, Rajshahi, Bangladesh	Rajshahi Medical College; University of Rajshahi; University of Rajshahi	Hossain, MG (corresponding author), Univ Rajshahi, Dept Stat, Hlth Res Grp, Rajshahi, Bangladesh.	hossain95@yahoo.com		RAFI, MD ABDUR/0000-0002-5415-6399				Adatara P, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6153501; Alam MM, 2014, J INFECT DEV COUNTR, V8, P67, DOI 10.3855/jidc.3136; Amare D, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02519; [Anonymous], 2009, SJVFS, V28, pL; [Anonymous], 2014, REG ANESTH PAIN MED; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2013, EC J WATCH, V10, pA1; Bayer A, 1966, ANTIBIOTIC SUSCEPTIB; Begum S, 2012, J BANGLADESH COLL PH, V30, P66; Edmond K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000213; Gebremedhin D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154798; Geyesus T, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0892-y; Goldstein B., 2005, PEDIAT CRIT CARE MED; Haque KN, 2007, J HOSP INFECT, V65, P110, DOI 10.1016/S0195-6701(07)60026-7; Lahariya C, 2010, INDIAN J PEDIATR, V77, P1303, DOI 10.1007/s12098-010-0246-3; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Masanja Pendo P, 2016, J TROP PEDIATRICS, V62, P131, DOI 10.1093/tropej/fmv089; Mitra DK, 2018, J HEALTH POPUL NUTR, V37, DOI 10.1186/s41043-018-0136-2; Muley VA, 2015, J GLOB INFECT DIS, V7, P75, DOI 10.4103/0974-777X.154444; Patel J.B., 2016, PERFORMANCE STANDARD; Pokhrel B, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1176-x; Quddus A R, 2019, Mymensingh Med J, V28, P839; Saqeeb Kazi Nazmus, 2019, Glob Pediatr Health, V6, p2333794X19833730, DOI 10.1177/2333794X19833730; Schelonka RL, 1996, J PEDIATR-US, V129, P275, DOI 10.1016/S0022-3476(96)70254-8; Schrag SJ, 2012, PEDIATR INFECT DIS J, V31, P821, DOI 10.1097/INF.0b013e31825c4b5a; Seale AC, 2014, LANCET INFECT DIS, V14, P731, DOI 10.1016/S1473-3099(14)70804-7; Semuatu S, 2014, INT J RES MED HLTH S, V4; Stefanovic IM, 2011, BIOCHEM MEDICA, V21, P276; Wardlaw T, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-82	31	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242275	10.1371/journal.pone.0242275	http://dx.doi.org/10.1371/journal.pone.0242275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186407	gold, Green Published			2022-12-26	WOS:000593949800034
J	Tolu, LB; Birara, M; Teshome, T; Feyissa, GT				Tolu, Lemi Belay; Birara, Malede; Teshome, Tesfalem; Feyissa, Garumma Tolu			Perinatal outcome of meconium stained amniotic fluid among labouring mothers at teaching referral hospital in urban Ethiopia	PLOS ONE			English	Article							STRATEGY	Objective To determine the perinatal outcome of labouring mothers with meconium-stained amniotic fluid (MSAF) compared with clear amniotic fluid at teaching referral hospital in urban Ethiopia. Methods A prospective cohort study was conducted among labouring mothers with meconium-stained amniotic fluid from July 1 to December 30, 2019. Data was collected with pretested structured questionnaires. A Chi-square test used to check statistical associations between variables. Those variables with a p-value of less than 0.05 were selected for cross-tabulation and binary logistic regression. P-value set at 0.05, and 95% CI was used to determine the significance of the association. Relative risk was used to determine the strength and direction of the association. Result Among 438 participants, there where 75(52.1%) primigravida in a stained fluid group compared to112 (38.5%) of the non-stained fluid group. Labour was induced in 25 (17.4%) of the stained fluid group compared to 25(8.6%) of a non-stained fluid group and has a statistically significant association with meconium staining. The stained fluid group was twice more likely to undergo operative delivery compared with a non-stained fluid group. There were more low Apgar scores at birth (36.8% versus 13.2%), birth asphyxias (9% versus 2.4%), neonatal sepsis (1% versus 5.6%), neonatal death (1% versus 9%), and increased admissions to neonatal intensive care unit (6.2% versus 21.5%) among the meconium-stained group as compared to the non-stained group. Meconium aspiration syndrome was seen in 9(6.3%) of the stained fluid group. Conclusion Meconium-stained amniotic fluid is associated with increased frequency of operative delivery, birth asphyxia, neonatal sepsis, and neonatal intensive care unit admissions compared to clear amniotic fluid.	[Tolu, Lemi Belay; Birara, Malede; Teshome, Tesfalem] St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia; [Feyissa, Garumma Tolu] Jimma Univ, Dept Hlth Behav & Soc, Jimma, Ethiopia	Jimma University	Tolu, LB (corresponding author), St Pauls Hosp, Millennium Med Coll, Addis Ababa, Ethiopia.	lemi.belay@gmail.com	Feyissa, Garumma/AAP-9097-2020	Feyissa, Garumma/0000-0001-6179-0024; Tolu, Lemi Belay/0000-0001-6703-828X				Adda AB, 2017, FACTORS INFLUENCING; Davis PJ, 2001, ARCH DIS CHILD-FETAL, V84, pF1, DOI 10.1136/fn.84.1.F1; Divia A, 2018, STUDY RISK FACTORS P; ELMeneza SA, 2014, MED RES J, V13, P80; Hutton EK, 2014, EARLY HUM DEV, V90, P333, DOI 10.1016/j.earlhumdev.2014.04.005; Kamal PP, 2006, J OBSTET GYN INDIA, V56, P128; Klingner M C, 1999, J Am Board Fam Pract, V12, P450; Kumari R, 2012, J PAK MED ASSOC, V62, P474; Lee J, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.10.009; Monen L, 2014, EARLY HUM DEV, V90, P325, DOI 10.1016/j.earlhumdev.2014.04.003; Mundhra R, 2013, J CLIN DIAGN RES, V7, P2874, DOI 10.7860/JCDR/2013/6509.3781; Naqvi SB, 2011, PAK J SURG, V27, P292; Naveen S, 2006, J OBSTET GYN INDIA, V56, P514; Pop VJ, 2014, EARLY HUM DEV, V90, P341, DOI 10.1016/j.earlhumdev.2014.04.004; Rokade J, 2016, INT J SCI RES PUB, V6, P41, DOI [10.18231/2394-2754.2017.0033, DOI 10.18231/2394-2754.2017.0033]; Saunders K, 2002, TROP DOCT, V32, P7, DOI 10.1177/004947550203200106; Shaikh EM, 2010, J PAK MED ASSOC, V60, P711; Sippola T, 2006, PEDIATR RES, V59, P641, DOI 10.1203/01.pdr.0000214685.31232.6a; Sori D, 2016, GYNECOL OBSTET SUNNY, V6; Wong S F, 2002, J Obstet Gynaecol, V22, P594, DOI 10.1080/0144361021000020333	20	4	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242025	10.1371/journal.pone.0242025	http://dx.doi.org/10.1371/journal.pone.0242025			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186362	gold, Green Published			2022-12-26	WOS:000593949800029
J	Chaklader, MR; Siddik, MAB; Fotedar, R				Chaklader, Md. Reaz; Siddik, Muhammad A. B.; Fotedar, Ravi			Total replacement of fishmeal with poultry by-product meal affected the growth, muscle quality, histological structure, antioxidant capacity and immune response of juvenile barramundi, Lates calcarifer	PLOS ONE			English	Article							ASIAN SEA-BASS; GLUTATHIONE-PEROXIDASE ACTIVITY; HEMATOLOGICAL PARAMETERS; BIOCHEMICAL PARAMETERS; TISSUE COMPOSITION; GENE-EXPRESSION; SOYBEAN-MEAL; DIETS; PROTEIN; PERFORMANCE	The present study investigates if the total replacement of dietary fishmeal (FM) with poultry by-product meal (PBM), supplemented with methionine influences the muscle fatty acids composition, normal gut morphology, histological traits of the liver, muscle, and gill, liver enzymes, immune and antioxidant response, and stress-related gene in juvenile barramundi, Lates calcarifer in relation to growth and feed utilization. Barramundi (3.58 +/- 0.01g) were randomly distributed into six 300 L seawater recirculating tanks (25 fish/tank) and fed two formulated isonitrogenous and isolipidic diets for 6 weeks. The control diet had FM as the sole animal protein source, whereas other test diet had only PBM as an animal protein source. Dietary PBM affected the fish performance and feed utilization. Regarding muscle fatty acid profile, total saturated fatty acids and monounsaturated fatty acids elevated while total PUFA particularly n-3 LC-PUFA and EPA decreased in PBM fed fish than control diet fed fish. Liver, muscle, gill, and intestinal histology showed no obvious alteration in control diet fed fish, however, more lipid droplets and hepatic vacuolization in the liver, necrotic myotome in muscle, hyperplasia in secondary lamellae in gill and short and broken folds in the intestine were observed in PBM fed fish. Similar to light microscopy observation of intestinal morphology, the transmission electron microscopy (TEM) analysis revealed shorter and smaller microvilli in fish fed PBM. Histopathological alterations in the liver of PBM fed fish were further associated with the elevated levels of aspartate aminotransferase (AST) and glutamate dehydrogenase (GLDH) and the significant upregulation of stress-related genes, HSP70 and HSP90. Also, a negative influence on lysozyme activity, and antioxidant enzymatic activities were recorded in fish fed PBM. Overall, it can be concluded that a total substitution of FM protein by methionine supplemented PBM negatively influenced the growth performance, liver health, histological traits of different organs, immune and antioxidant response, and expression of stress-related genes in juvenile barramundi.	[Chaklader, Md. Reaz; Fotedar, Ravi] Curtin Univ, Sch Mol & Life Sci, Bentley, WA, Australia; [Siddik, Muhammad A. B.] Patuakhali Sci & Technol Univ, Fac Fisheries, Dept Fisheries Biol & Genet, Patuakhali, Bangladesh	Curtin University	Chaklader, MR (corresponding author), Curtin Univ, Sch Mol & Life Sci, Bentley, WA, Australia.	mrreaz.chaklader@postgrad.curtin.edu.au	Siddik, Muhammad A.B./ABB-1947-2021	Siddik, Muhammad A.B./0000-0002-3636-1639; Chaklader, Dr Md Reaz/0000-0002-3416-4295	Australian Government [19061054-Curtin]	Australian Government(Australian GovernmentCGIAR)	Support of the trial was obtained from the Research Training Program (RTP) Stipend Scholarship, funded by Australian Government to Md Reaz Chaklader (No. 19061054-Curtin).	Alami-Durante H, 2018, AQUACULTURE, V483, P273, DOI 10.1016/j.aquaculture.2017.10.030; Burgos-Aceves MA, 2016, FISH SHELLFISH IMMUN, V58, P42, DOI 10.1016/j.fsi.2016.09.006; Anderson Brunetti R, 2009, PESQUI VET BRASIL, V29, P303, DOI [10.1590/S0100-736X2009000400005, DOI 10.1590/S0100-736X2009000400005]; AOAC, 1995, OFFICIAL METHODS ANA, V16th; Ayadi F.Y., 2012, J AQUACULT FEED SCI, V4, P1, DOI [10.3923/joafsnu.2012.1.26, DOI 10.3923/JOAFSNU.2012.1.26]; Zapata DB, 2016, AQUAC RES, V47, P1778, DOI 10.1111/are.12636; Barreto-Curiel F, 2016, LAT AM J AQUAT RES, V44, P327, DOI 10.3856/vol44-issue2-fulltext-13; Vo BV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232278; Van Vo B, 2015, AQUACULTURE, V444, P62, DOI 10.1016/j.aquaculture.2015.03.019; Chaklader MR, 2020, FISH SHELLFISH IMMUN, V104, P567, DOI 10.1016/j.fsi.2020.06.014; Chaklader MR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53018-3; Garcia-Perez OD, 2018, LAT AM J AQUAT RES, V46, P37, DOI 10.3856/vol46-issue1-fulltext-5; Dawson MR, 2018, N AM J AQUACULT, V80, P74, DOI 10.1002/naaq.10009; Devi G, 2019, FISH SHELLFISH IMMUN, V89, P687, DOI 10.1016/j.fsi.2019.04.036; Ngo DT, 2015, AQUACULTURE, V435, P442, DOI 10.1016/j.aquaculture.2014.10.031; Emre Y, 2016, AQUAC RES, V47, P2256, DOI 10.1111/are.12677; Galkanda-Arachchige HS, 2019, REV AQUACULT, DOI [10.1111/raq.12367, DOI 10.1111/RAQ.12367]; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Glencross B, 2006, AQUACULT NUTR, V12, P291, DOI 10.1111/j.1365-2095.2006.00410.x; Glencross B, 2011, AQUACULT NUTR, V17, pE722, DOI 10.1111/j.1365-2095.2010.00834.x; Glencross B, 2011, AQUACULT NUTR, V17, pE207, DOI 10.1111/j.1365-2095.2010.00752.x; Glencross B, 2016, AQUACULTURE, V451, P298, DOI 10.1016/j.aquaculture.2015.09.012; Gonzalez-Felix ML, 2016, AQUACULTURE, V454, P217, DOI 10.1016/j.aquaculture.2015.12.021; Gonzalez-Rodriguez A, 2016, AQUAC RES, V47, P1612, DOI 10.1111/are.12622; Gumus E, 2013, TURK J FISH AQUAT SC, V13, P827, DOI 10.4194/1303-2712-v13_5_06; Gunben EM, 2014, SAINS MALAYS, V43, P399; Halliwell B., 2015, Free radicals in biology and medicine; Hardy RW, 2010, AQUAC RES, V41, P770, DOI 10.1111/j.1365-2109.2009.02349.x; Hernandez C, 2014, LAT AM J AQUAT RES, V42, P111, DOI 10.3856/vol42-issue1-fulltext-8; Hoseini SM, 2019, AQUACULTURE, V506, P246, DOI 10.1016/j.aquaculture.2019.03.048; Hu MH, 2008, AQUACULTURE, V275, P260, DOI 10.1016/j.aquaculture.2008.01.005; Huang L, 2015, AQUACULTURE, V438, P33, DOI 10.1016/j.aquaculture.2014.12.029; Pham HD, 2020, ANIM FEED SCI TECH, V267, DOI 10.1016/j.anifeedsci.2020.114556; Huntingford FA, 2014, REV SCI TECH OIE, V33, P233, DOI 10.20506/rst.33.1.2286; Ilham, 2016, AQUACULTURE, V457, P15, DOI 10.1016/j.aquaculture.2016.02.003; Ilham, 2016, FED HIGH SOYBEAN MEA, DOI [10.1007/s12011-016-0708-1, DOI 10.1007/S12011-016-0708-1]; Ilham I, 2017, FISH PHYSIOL BIOCHEM, V43, P775, DOI 10.1007/s10695-016-0331-2; Ilham I, 2018, AQUAC RES, V49, P151, DOI 10.1111/are.13444; Irvin S, 2016, AQUACULT NUTR, V22, P1047, DOI 10.1111/anu.12321; Klinger D, 2012, ANNU REV ENV RESOUR, V37, P247, DOI 10.1146/annurev-environ-021111-161531; Lauriano ER, 2016, FISH SHELLFISH IMMUN, V59, P250, DOI 10.1016/j.fsi.2016.11.003; Lazado CC, 2014, FISH SHELLFISH IMMUN, V39, P78, DOI 10.1016/j.fsi.2014.04.015; Liu JW, 2015, AQUACULTURE, V446, P48, DOI 10.1016/j.aquaculture.2015.04.012; Martinez-Alvarez RM, 2005, REV FISH BIOL FISHER, V15, P75, DOI 10.1007/s11160-005-7846-4; Ming JH, 2012, FISH SHELLFISH IMMUN, V32, P651, DOI 10.1016/j.fsi.2012.01.008; Mohd-Shaharuddin N, 2013, FISH SHELLFISH IMMUN, V34, P762, DOI 10.1016/j.fsi.2012.11.052; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Nengas I, 1999, AQUACULTURE, V179, P13, DOI 10.1016/S0044-8486(99)00148-9; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Nugroho RA, 2014, AQUACULT INT, V22, P585, DOI 10.1007/s10499-013-9682-1; O'Fallon JV, 2007, J ANIM SCI, V85, P1511, DOI 10.2527/jas.2006-491; Panicz R, 2017, AQUAC RES, V48, P5373, DOI 10.1111/are.13351; Poppi DA, 2018, AQUAC RES, V49, P2518, DOI 10.1111/are.13714; RODGER HD, 1991, DIS AQUAT ORGAN, V12, P17, DOI 10.3354/dao012017; Rollo A, 2006, FISH PHYSIOL BIOCHEM, V32, P167, DOI 10.1007/s10695-006-0009-2; Sabbagh M, 2019, AQUACULTURE, V511, DOI 10.1016/j.aquaculture.2019.734220; Sabzi E, 2017, AQUACULTURE, V480, P89, DOI 10.1016/j.aquaculture.2017.08.013; Saraiva A, 2015, AQUACULTURE, V448, P375, DOI 10.1016/j.aquaculture.2015.06.028; Shapawi R, 2007, AQUACULTURE, V273, P118, DOI 10.1016/j.aquaculture.2007.09.014; Siddik MAB, 2020, FISH SHELLFISH IMMUN, V97, P465, DOI 10.1016/j.fsi.2019.12.057; Siddik MAB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215025; Siddik MAB, 2019, FISH SHELLFISH IMMUN, V89, P61, DOI 10.1016/j.fsi.2019.03.042; Siddik MAB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34182-4; Simon CJ, 2019, AQUACULTURE, V498, P305, DOI 10.1016/j.aquaculture.2018.08.069; Sinha AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095319; Spisni E, 1998, J FISH DIS, V21, P177, DOI [10.1111/j.1365-2761.1998.00089.x, 10.1046/j.1365-2761.1998.00089.x]; Subhadra B, 2006, AQUACULTURE, V260, P221, DOI 10.1016/j.aquaculture.2006.06.029; Subhadra B, 2006, AQUACULTURE, V255, P210, DOI 10.1016/j.aquaculture.2005.11.043; SUMIDA S, 1989, INT J BIOCHEM, V21, P835, DOI 10.1016/0020-711X(89)90280-2; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Thiansilakul Y, 2007, FOOD CHEM, V103, P1385, DOI 10.1016/j.foodchem.2006.10.055; Tort Lluis, 2011, P75; Uran PA, 2008, AQUACULT NUTR, V14, P324, DOI 10.1111/j.1365-2095.2007.00534.x; Van Vo B., 2020, AQUAC REP, V18; Van Vo B, AQUACULTURE, V2020, P735741; Wang WN, 2009, COMP BIOCHEM PHYS C, V150, P428, DOI 10.1016/j.cbpc.2009.06.010; WELLS RMG, 1986, COMP BIOCHEM PHYS A, V84, P565, DOI 10.1016/0300-9629(86)90366-X; Williams K, 2001, AQUAC RES, V32, P415, DOI 10.1046/j.1355-557x.2001.00032.x; Williams KC, 2003, AQUACULTURE, V225, P191, DOI 10.1016/S0044-8486(03)00278-3; Williams KC, 2003, AQUAC RES, V34, P23, DOI 10.1046/j.1365-2109.2003.00785.x; Xu HG, 2015, J WORLD AQUACULT SOC, V46, P349, DOI 10.1111/jwas.12205; Ye HQ, 2019, AQUACULTURE, V511, DOI 10.1016/j.aquaculture.2019.734203; Yigit M, 2006, AQUACULT NUTR, V12, P340, DOI 10.1111/j.1365-2095.2006.00409.x; Zheng XC, 2019, FISH SHELLFISH IMMUN, V90, P264, DOI 10.1016/j.fsi.2019.04.296; Zhou QC, 2011, AQUACULTURE, V322, P122, DOI 10.1016/j.aquaculture.2011.09.042; 2014, REG ANESTH PAIN MED, V9; 2019, NEUROLOGIE REHABILIT, V25, P3	88	16	16	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242079	10.1371/journal.pone.0242079	http://dx.doi.org/10.1371/journal.pone.0242079			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180835	Green Published			2022-12-26	WOS:000593948000088
J	Melk, A; Schmidt, BMW; Geyer, S; Epping, J				Melk, Anette; Schmidt, Bernhard M. W.; Geyer, Siegfried; Epping, Jelena			Sex disparities in dialysis initiation, access to waitlist, transplantation and transplant outcome in German patients with renal disease-A population based analysis	PLOS ONE			English	Article							ACCEPTABLE MISMATCH PROGRAM; KIDNEY-TRANSPLANTATION; GRAFT FAILURE; WAITING-LIST; GENDER; ASSOCIATION; AGE; RISK; PROGRESSION; BARRIERS	Background Renal transplantation access and outcome differ between men and women, but no analysis has considered all transition phases and transplant outcome using the same data set. We analyzed sex disparities in all phases of patients' clinical path (progression to dialysis, waitlisting, transplantation, graft failure/death). Methods In a population based approach using health insurance data (2005-2013) we examined patients' risk of changing from one phase to another applying Cox Proportional Hazards model. Results After adjusting for age and comorbidities, women had a 16% lower risk of progression to ESRD (HR/95%-CI: 0.84/0.79-0.88). Access to the waitlist was lowered by 18% in women compared to men (HR/95%-CI: 0.82/0.70-0.96). An age stratified analysis did not reveal differences in any age group. Once waitlisted, the chance to receive a transplant was identical (HR/95%-CI: 0.96/0.81-1.15). The risk of transplant failure/death was identical for both sexes (HR/95%-CI: 0.99/0.73-1.35), but the effect was modified by age: in younger women (18-45 years) the risk was twice as high compared to men (HR/95%-CI: 2.08/1.04-4.14), whereas the risk in elderly women (> 65 years) was only half the risk of men (HR/95%-CI: 0.47/0.24-0.93). Conclusion Sex disparities occurred at different steps in the history of patients with renal disease and affected progression to dialysis, waitlisting and transplantation outcome in a population with equal access to medical treatment.	[Melk, Anette] Hannover Med Sch, Dept Pediat Kidney Liver & Metab Dis, Hannover, Germany; [Schmidt, Bernhard M. W.] Hannover Med Sch, Dept Hypertens & Nephrol, Hannover, Germany; [Geyer, Siegfried; Epping, Jelena] Hannover Med Sch, Dept Med Sociol, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Melk, A (corresponding author), Hannover Med Sch, Dept Pediat Kidney Liver & Metab Dis, Hannover, Germany.	Melk.Anette@mh-hannover.de	Epping, Jelena/AAE-7790-2020		Ministry of Science and Culture of Lower Saxony within the program "Geschlecht-Macht-Wissen"	Ministry of Science and Culture of Lower Saxony within the program "Geschlecht-Macht-Wissen"	This work was supported by a grant of the Ministry of Science and Culture of Lower Saxony within the program "Geschlecht-Macht-Wissen" to B. Schmidt, S. Geyer and A. Melk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; [Anonymous], 2019, ERA EDTA REG ANN REP; Bailey PK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010605; Bloembergen WE, 1997, AM J KIDNEY DIS, V30, P733, DOI 10.1016/S0272-6386(97)90076-7; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Bruck K, 2018, KIDNEY INT, V93, P1432, DOI 10.1016/j.kint.2018.01.008; Claas FHJ, 2004, TRANSPLANTATION, V78, P190, DOI 10.1097/01.tp.0000129260.86766.67; Cleves M., 2010, INTRO SURVIVAL ANAL; Couchoud C, 2012, TRANSPLANTATION, V94, P513, DOI 10.1097/TP.0b013e31825d156a; Dudley CRK, 2009, TRANSPLANTATION, V88, P96, DOI 10.1097/TP.0b013e3181aa901a; Fernandez-Prado R, 2018, CLIN KIDNEY J, V11, P1, DOI 10.1093/ckj/sfx154; Foster BJ, 2011, TRANSPLANTATION, V92, P1237, DOI 10.1097/TP.0b013e31823411d7; Garg PP, 2000, J AM SOC NEPHROL, V11, P958, DOI 10.1681/ASN.V115958; Gill JS, 2014, CLIN J AM SOC NEPHRO, V9, P951, DOI 10.2215/CJN.08310813; Heidt S, 2015, TRANSPL IMMUNOL, V33, P51, DOI 10.1016/j.trim.2015.08.006; HELD PJ, 1988, ARCH INTERN MED, V148, P2594, DOI 10.1001/archinte.148.12.2594; Jackson KR, 2020, TRANSPLANTATION, V104, P1456, DOI 10.1097/TP.0000000000002989; Jaunzeme J, 2013, BUNDESGESUNDHEITSBLA, V56, P447, DOI 10.1007/s00103-012-1626-9; Kabore R, 2017, TRANSPLANTATION, V101, P1327, DOI 10.1097/TP.0000000000001372; Keith DS, 2006, TRANSPLANT INT, V19, P649, DOI 10.1111/j.1432-2277.2006.00333.x; Kim SJ, 2009, J AM SOC NEPHROL, V20, P2025, DOI 10.1681/ASN.2008101110; KJELLSTRAND CM, 1988, ARCH INTERN MED, V148, P1305; Kramer A, 2018, CLIN KIDNEY J, V11, P108, DOI 10.1093/ckj/sfx149; Lepeytre F, 2017, J AM SOC NEPHROL, V28, P3014, DOI 10.1681/ASN.2016121380; McCauley J, 1997, AM J KIDNEY DIS, V30, P739, DOI 10.1016/S0272-6386(97)90077-9; Meier-Kriesche HU, 2001, TRANSPLANTATION, V71, P429, DOI 10.1097/00007890-200102150-00016; Morgan G, 2020, TRANSPLANTATION, V104, P1033, DOI 10.1097/TP.0000000000002915; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; Neugarten J, 2013, ADV CHRONIC KIDNEY D, V20, P390, DOI 10.1053/j.ackd.2013.05.004; Nguyen S, 2011, PEDIATR TRANSPLANT, V15, P376, DOI 10.1111/j.1399-3046.2011.01495.x; O'Hare AM, 2011, ARCH INTERN MED, V171, P1663, DOI 10.1001/archinternmed.2011.436; Oniscu GC, 2003, BRIT MED J, V327, P1261, DOI 10.1136/bmj.327.7426.1261; Purdy A, 1999, J WOMEN HEALTH GEN-B, V8, P631, DOI 10.1089/jwh.1.1999.8.631; Ravanan R, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3451; Salter ML, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0051-y; Salter ML, 2014, CLIN J AM SOC NEPHRO, V9, P1940, DOI 10.2215/CJN.03310414; Salter ML, 2014, J AM GERIATR SOC, V62, P843, DOI 10.1111/jgs.12801; Schaubel DE, 2000, ARCH INTERN MED, V160, P2349, DOI 10.1001/archinte.160.15.2349; Schnee M, GESUNDHEITSMONITOR 2, V2008, P88; Schold JD, 2011, CLIN J AM SOC NEPHRO, V6, P1760, DOI 10.2215/CJN.08620910; Segev DL, 2009, J AM SOC NEPHROL, V20, P621, DOI 10.1681/ASN.2008060591; Silbiger SR, 2011, KIDNEY INT, V79, P382, DOI 10.1038/ki.2010.474; Sood MM, 2014, J AM SOC NEPHROL, V25, P2097, DOI 10.1681/ASN.2013090953; STATISTISCHES BUNDESAMT, 2008, ALL STERB 2016 2018; Tang HY, 2008, CLIN TRANSPLANT, V22, P263, DOI 10.1111/j.1399-0012.2007.00781.x; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Udayaraj U, 2012, TRANSPLANTATION, V93, P610, DOI 10.1097/TP.0b013e318245593f; Wolfe RA, 2000, AM J KIDNEY DIS, V36, P1025, DOI 10.1053/ajkd.2000.19106; Wu DA, 2017, NEPHROL DIAL TRANSPL, V32, P890, DOI 10.1093/ndt/gfx036; Zeier M, 2002, J AM SOC NEPHROL, V13, P2570, DOI 10.1097/01.ASN.0000030078.74889.69; Zhou JY, 2013, CLIN TRANSPLANT, V27, P764, DOI 10.1111/ctr.12191	51	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241556	10.1371/journal.pone.0241556	http://dx.doi.org/10.1371/journal.pone.0241556			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180815	gold, Green Published			2022-12-26	WOS:000593948000096
J	Girondel, C; Levesque, K; Langlois, MJ; Pasquin, S; Saba-El-Leil, MK; Rivard, N; Friesel, R; Servant, MJ; Gauchat, JF; Lesage, S; Meloche, S				Girondel, Charlotte; Levesque, Kim; Langlois, Marie-Josee; Pasquin, Sarah; Saba-El-Leil, Marc K.; Rivard, Nathalie; Friesel, Robert; Servant, Marc J.; Gauchat, Jean-Francois; Lesage, Sylvie; Meloche, Sylvain			Loss of interleukin-17 receptor D promotes chronic inflammation-associated tumorigenesis	ONCOGENE			English	Article							SIMILAR EXPRESSION; COLORECTAL-CANCER; DOWN-REGULATION; IL-17 RECEPTOR; SEF; CELLS; CARCINOGENESIS; INHIBITOR; CYTOKINES; INTERACTS	Interleukin-17 receptor D (IL-17RD), also known as similar expression to Fgf genes (SEF), is proposed to act as a signaling hub that negatively regulates mitogenic signaling pathways, like the ERK1/2 MAP kinase pathway, and innate immune signaling. The expression of IL-17RD is downregulated in certain solid tumors, which has led to the hypothesis that it may exert tumor suppressor functions. However, the role of IL-17RD in tumor biology remains to be studied in vivo. Here, we show that genetic disruption of Il17rd leads to the increased formation of spontaneous tumors in multiple tissues of aging mice. Loss of IL-17RD also promotes tumor development in a model of colitis-associated colorectal cancer, associated with an exacerbated inflammatory response. Colon tumors from IL-17RD-deficient mice are characterized by a strong enrichment in inflammation-related gene signatures, elevated expression of pro-inflammatory tumorigenic cytokines, such as IL-17A and IL-6, and increased STAT3 tyrosine phosphorylation. We further show that RNAi depletion of IL-17RD enhances Toll-like receptor and IL-17A signaling in colon adenocarcinoma cells. No change in the proliferation of normal or tumor intestinal epithelial cells was observed upon genetic inactivation of IL-17RD. Our findings establish IL-17RD as a tumor suppressor in mice and suggest that the protein exerts its function mainly by limiting the extent and duration of inflammation.	[Girondel, Charlotte; Levesque, Kim; Saba-El-Leil, Marc K.; Meloche, Sylvain] Inst Res Immunol & Canc, Montreal, PQ, Canada; [Girondel, Charlotte; Pasquin, Sarah; Gauchat, Jean-Francois; Meloche, Sylvain] Univ Montreal, Dept Pharmacol & Physiol, Fac Med, Montreal, PQ, Canada; [Langlois, Marie-Josee; Rivard, Nathalie] Univ Sherbrooke, Dept Immunol & Cell Biol, Fac Med & Hlth Sci, Sherbrooke, PQ, Canada; [Friesel, Robert] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME USA; [Servant, Marc J.] Univ Montreal, Fac Pharm, Montreal, PQ, Canada; [Lesage, Sylvie] Maisonneuve Rosemont Hosp, Dept Immunol Oncol, Montreal, PQ, Canada; [Lesage, Sylvie] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Meloche, Sylvain] Univ Montreal, Mol Biol Program, Fac Med, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; University of Sherbrooke; Maine Medical Center; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Meloche, S (corresponding author), Inst Res Immunol & Canc, Montreal, PQ, Canada.; Meloche, S (corresponding author), Univ Montreal, Dept Pharmacol & Physiol, Fac Med, Montreal, PQ, Canada.; Meloche, S (corresponding author), Univ Montreal, Mol Biol Program, Fac Med, Montreal, PQ, Canada.	sylvain.meloche@umontreal.ca		Servant, Marc/0000-0003-2014-4127; Lesage, Sylvie/0000-0002-0968-2795	Fonds de recherche Sante Quebec; Cancer Research Society	Fonds de recherche Sante Quebec; Cancer Research Society	We thank C. Kuo and G.R. van den Brink for reagents, J. Hinsinger for histology, L. Gaboury for pathology assistance, P. Melancon for qPCR analysis, J. Huber for RNA-seq, and P. Gendron for help with bioinformatic analyses. CG is recipient of a studentship from the Fonds de recherche Sante Quebec. SM held the Canada Research Chair in Cellular Signaling. Work in the Meloche laboratory was supported by a grant from the Cancer Research Society.	Beringer A, 2016, TRENDS MOL MED, V22, P230, DOI 10.1016/j.molmed.2016.01.001; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Darby S, 2006, ONCOGENE, V25, P4122, DOI 10.1038/sj.onc.1209428; Darby S, 2009, BRIT J CANCER, V101, P1891, DOI 10.1038/sj.bjc.6605379; Duhamel S, 2012, CANCER RES, V72, P626, DOI 10.1158/0008-5472.CAN-11-2126; Fichtner-Feigl S, 2015, TRENDS IMMUNOL, V36, P451, DOI 10.1016/j.it.2015.06.007; Fuchs Y, 2012, DEV CELL, V23, P611, DOI 10.1016/j.devcel.2012.07.013; Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gonneaud A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38195; He Q, 2016, J CELL BIOCHEM, V117, P2346, DOI 10.1002/jcb.25532; He Q, 2014, J BONE MINER RES, V29, P1217, DOI 10.1002/jbmr.2114; Hurtado CG, 2018, GASTROENTEROLOGY, V155, P1706, DOI 10.1053/j.gastro.2018.08.056; Kovalenko D, 2003, J BIOL CHEM, V278, P14087, DOI 10.1074/jbc.C200606200; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Mellett M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7669; Mellett M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2127; Monin L, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028522; Murphy T, 2010, J PATHOL, V220, P452, DOI 10.1002/path.2657; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Parang B, 2016, METHODS MOL BIOL, V1422, P297, DOI 10.1007/978-1-4939-3603-8_26; Pekow J, 2017, CLIN CANCER RES, V23, P5281, DOI 10.1158/1078-0432.CCR-17-0171; Peng DH, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaq1238; Razi S, 2019, CYTOKINE, V116, P7, DOI 10.1016/j.cyto.2018.12.021; Ren YM, 2008, CELL SIGNAL, V20, P518, DOI 10.1016/j.cellsig.2007.11.010; Ren YM, 2006, BIOCHEM BIOPH RES CO, V347, P988, DOI 10.1016/j.bbrc.2006.06.193; Ron D, 2008, INT J BIOCHEM CELL B, V40, P2040, DOI 10.1016/j.biocel.2008.03.013; Rong ZL, 2009, CELL RES, V19, P208, DOI 10.1038/cr.2008.320; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Soulez M, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00527-18; Stidham RW, 2018, CLIN COLON RECT SURG, V31, P168, DOI 10.1055/s-0037-1602237; Su Y, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9657; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Taniguchi K, 2014, SEMIN IMMUNOL, V26, P54, DOI 10.1016/j.smim.2014.01.001; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009; West NR, 2015, NAT REV IMMUNOL, V15, P615, DOI 10.1038/nri3896; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Zisman-Rozen S, 2007, ONCOGENE, V26, P6093, DOI 10.1038/sj.onc.1210424	43	15	15	1	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					452	464		10.1038/s41388-020-01540-4	http://dx.doi.org/10.1038/s41388-020-01540-4		NOV 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33177649				2022-12-26	WOS:000588591500001
J	Muhammad, NAF; Abu Kassim, NF; Ab Majid, AH; Abd Rahman, A; Dieng, H; Avicor, SW				Muhammad, Nor Atikah Farhah; Abu Kassim, Nur Faeza; Ab Majid, Abdul Hafiz; Abd Rahman, Azimah; Dieng, Hamady; Avicor, Silas Wintuma			Biting rhythm and demographic attributes of Aedes albopictus (Skuse) females from different urbanized settings in Penang Island, Malaysia under uncontrolled laboratory conditions	PLOS ONE			English	Article							DIPTERA-CULICIDAE; HOST-SEEKING; AEGYPTI L.; BEHAVIOR; MOSQUITOS; OVIPOSITION; COEXISTENCE; POPULATION; PATTERNS; IDENTIFY	Author summary Aedes mosquito populations associated with human habitation in urban areas do not only have the potential to cause biting nuisance, but also cause significant public health risks through the transmission of dengue virus. The socioeconomic effects of urbanization have been comprehensively studied by socio-ecologists, but the ecological effects and their impact on this vector's biology is not known. The authors found that in Penang Island, the mean number of eggs laid per female of Aedes albopictus was high in the urban area than those in the suburban and rural areas. Survivorship was high for urban populations parallel to fecundity and the apparent biting pattern which peaked at dawn and dusk was noted for all Ae. albopictus strains. The changed environment in the urbanized area where more types of breeding containers and more blood sources produced by condensed human population supported by warm climate may facilitate larval development and enhance vector survivorship and reproductive fitness. These might be the reasons for quick adaptation of Ae. albopictus in urban areas. As higher fecundity and longer adult survival may enhance disease transmission, attention on this species is needed in terms of vector control. Urbanization could potentially modify Aedes albopictus' ecology by changing the dynamics of the species, and affecting their breeding sites due to environmental changes, and thus contribute to dengue outbreaks. Thus, this study was conducted to evaluate the biting rhythm, fecundity and longevity of adult female Ae. albopictus in relation to urbanization strata; urban, suburban and rural areas in Penang Island, Malaysia. The experiments were done in comparison to a laboratory strain. Twenty-four hours biting activity of all the mosquito strains showed a clear bimodal biting activity, with morning and evening twilight peaks. The interaction effect between biting time and mosquito strains was not significant. Meanwhile, differences in fecundity among mosquito strains were statistically significant (F(3,442) = 10.559, P < 0.05) with urban areas having higher mean number of eggs (mean = 107.69, standard error = 3.98) than suburban (mean = 94.48, standard error = 5.18), and rural areas (mean = 72.52, standard error = 3.87). Longevity of adult females were significantly higher (F(3,441) = 31.259, P < 0.05) for mosquito strains from urban areas compared to the other strains. These findings would provide crucial information for the planning of control programs in Malaysia, particularly Penang.	[Muhammad, Nor Atikah Farhah; Abu Kassim, Nur Faeza; Ab Majid, Abdul Hafiz] Univ Sains Malaysia, Sch Biol Sci, Minden, Penang, Malaysia; [Abu Kassim, Nur Faeza] Univ Sains Malaysia, Sch Biol Sci, Vector Control Res Unit, Minden, Penang, Malaysia; [Ab Majid, Abdul Hafiz] Univ Sains Malaysia, Sch Biol Sci, Vector Control Res Unit VCRU, Household & Struct Urban Entomol Lab, Minden, Penang, Malaysia; [Abd Rahman, Azimah] Univ Sains Malaysia, Sch Humanities, Minden, Penang, Malaysia; [Dieng, Hamady] Univ Malaysia Sarawak, Inst Biodivers & Environm Conservat IBEC, Sarawak, Malaysia; [Avicor, Silas Wintuma] Cocoa Res Inst Ghana CRIG, Entomol Div, New Tafo Akim, Eastern Region, Ghana	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia; University of Malaysia Sarawak	Abu Kassim, NF (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Minden, Penang, Malaysia.; Abu Kassim, NF (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Vector Control Res Unit, Minden, Penang, Malaysia.	nurfaeza@usm.my	Abu Kassim, Nur Faeza/K-2323-2013; Ab Majid, Abdul Hafiz/B-6248-2013	Abu Kassim, Nur Faeza/0000-0001-6620-8603; Ab Majid, Abdul Hafiz/0000-0001-5297-8981	Division of Research and Innovation, Universiti Sains Malaysia [304/PBIOLOGI/6313064, 1001/PHUMANITI/811324]	Division of Research and Innovation, Universiti Sains Malaysia	This study were funded by the Short Term Grant (304/PBIOLOGI/6313064) to N.F.A Kassim and the Research University Grant (1001/PHUMANITI/811324) to A.A Rahman awarded by the Division of Research and Innovation, Universiti Sains Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Vector Control Research Unit, Universiti Sains Malaysia and the respective communities for logistical support and sample collection, respectively.	AbuHassan A, 1996, J VECTOR ECOL, V21, P17; Adanan CR., 1991, THESIS; Afrane YA, 2012, ANN NY ACAD SCI, V1269, P204; Afrane YA, 2007, AM J TROP MED HYG, V77, P660, DOI 10.4269/ajtmh.2007.77.660; Ahmad Z., 2009, EUROPEAN J SOCIAL SC, V11, P464; [Anonymous], 2012, WORLD URBANIZATION P; [Anonymous], 2016, CHINA SCI TECHNOLOGY, V10, P2; [Anonymous], 2014, J CLIN DIAGN RES, V8; Bartlett-Healy K, 2012, J MED ENTOMOL, V49, P813, DOI 10.1603/ME11031; Chen CD, 2017, TROP BIOMED, V34, P199; Chen CD, 2014, ASIAN BIOMED, V8, P315, DOI 10.5372/1905-7415.0803.295; COLLESS D H, 1973, Mosquito Systematics, V5, P225; CROVELLO TJ, 1972, EVOLUTION, V26, P185, DOI [10.2307/2407030, 10.1111/j.1558-5646.1972.tb00186.x]; Diallo D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-286; Dieng H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011790; Dociu M., 2012, INT J ACAD RES ACCOU, V2, P47; Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; HIEN D S, 1976, Acta Parasitologica Polonica, V24, P37; Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811; Kawada H, 2005, J MED ENTOMOL, V42, P312, DOI 10.1603/0022-2585(2005)042[0312:CSONBO]2.0.CO;2; Kek R, 2014, J MED ENTOMOL, V51, P880, DOI 10.1603/ME13213; Lenhart AE, 2006, ANN TROP MED PARASIT, V100, pS53, DOI 10.1179/136485906X105516; Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x; Nour El, 1989, GEOJOURNAL, V18, P369; Nur Aida H., 2006, THESIS; O'Neal PA, 2013, J ANIM ECOL, V82, P256, DOI 10.1111/j.1365-2656.2012.02017.x; Paramasivan R., 2015, International Journal of Mosquito Research, V2, P106; Petric D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-187; Rahman GMS, 2012, THESIS; Rattanarithikul Rampa, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P1; Romero-Vivas CME, 2006, ANN TROP MED PARASIT, V100, pS87, DOI 10.1179/136485906X105543; Rozilawati H, 2007, TROP BIOMED, V24, P83; TAYLOR B, 1969, J EXP BIOL, V51, P59; Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100; Wang D, 1999, INT J SOC ECON, V26, P290; Xue RD, 1997, J AM MOSQUITO CONTR, V13, P205; Xue RD, 2010, J MED ENTOMOL, V47, P778, DOI 10.1603/ME09222; Zahouli JBZ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1778-9	39	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241688	10.1371/journal.pone.0241688	http://dx.doi.org/10.1371/journal.pone.0241688			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175896	Green Published, gold, Green Submitted			2022-12-26	WOS:000593946900007
J	Becker, MG; Taylor, T; Kiazyk, S; Cabiles, DR; Meyers, AFA; Sandstrom, PA				Becker, Michael G.; Taylor, Tracy; Kiazyk, Sandra; Cabiles, Dana R.; Meyers, Adrienne F. A.; Sandstrom, Paul A.			Recommendations for sample pooling on the Cepheid GeneXpert(R) system using the Cepheid Xpert(R) Xpress SARS-CoV-2 assay	PLOS ONE			English	Article								The coronavirus disease 2019 (Covid-19) pandemic, caused by SARS-CoV-2, has resulted in a global testing supply shortage. In response, pooled testing has emerged as a promising strategy that can immediately increase testing capacity. In pooled sample testing, multiple samples are combined (or pooled) together and tested as a single unit. If the pool is positive, the individual samples can then be individually tested to identify the positive case(s). Here, we provide support for the adoption of sample pooling with the point-of-care Cepheid Xpert(R) Xpress SARS-CoV-2 molecular assay. Corroborating previous findings, the limit of detection of this assay was comparable to laboratory-developed reverse-transcription quantitative PCR SARS-CoV-2 tests, with observed detection below 100 copies/mL. The Xpert(R) Xpress assay detected SARS-CoV-2 after samples with minimum viral loads of 461 copies/mL were pooled in groups of six. Based on these data, we recommend the adoption of pooled testing with the Xpert(R) Xpress SARS-CoV-2 assay where warranted based on public health needs. The suggested number of samples per pool, or the pooling depth, is unique for each point-of-care testing site and can be determined by the positive test rates. To statistically determine appropriate pooling depth, we have calculated the pooling efficiency for numerous combinations of pool sizes and test rates. This information is included as a supplemental dataset that we encourage public health authorities to use as a guide to make recommendations that will maximize testing capacity and resource conservation.	[Becker, Michael G.; Taylor, Tracy; Kiazyk, Sandra; Cabiles, Dana R.; Meyers, Adrienne F. A.; Sandstrom, Paul A.] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Lab, Natl Microbiol Lab, JC Wilt Infect Dis Res Ctr, Winnipeg, MB, Canada; [Kiazyk, Sandra; Meyers, Adrienne F. A.; Sandstrom, Paul A.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba	Sandstrom, PA (corresponding author), Publ Hlth Agcy Canada, Natl HIV & Retrovirol Lab, Natl Microbiol Lab, JC Wilt Infect Dis Res Ctr, Winnipeg, MB, Canada.; Sandstrom, PA (corresponding author), Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada.	Paul.Sandstrom@Canada.ca						Corman VM, 2020, TRANSFUSION, V60, P1119, DOI 10.1111/trf.15841; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Goethe Universitat, 2020, POOL TEST SARS COV 0; Hanel R., 2020, BOOSTING TEST EFFICI; Hogan CA, 2020, JAMA-J AM MED ASSOC, V323, P1967, DOI 10.1001/jama.2020.5445; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; La Scola B, 2020, EUR J CLIN MICROBIOL, V39, P1059, DOI 10.1007/s10096-020-03913-9; Lieberman JA, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00821-20; Lohse S, 2020, LANCET INFECT DIS, V20, P1231, DOI 10.1016/S1473-3099(20)30362-5; Lui G, 2020, J INFECTION, V81, P324, DOI 10.1016/j.jinf.2020.04.014; Moran A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00772-20; Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4; Rhee C, 2021, CLIN INFECT DIS, V72, P1467, DOI 10.1093/cid/ciaa1249; Shental N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5961; Sinnott-Armstrong N, 2020, EVALUATION GROUP TES, DOI [DOI 10.1101/2020.03.27.20043968, 10.1101/2020.03.27.20043968]; Smithgall MC, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104428; Zhen W, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00783-20; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	18	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0241959	10.1371/journal.pone.0241959	http://dx.doi.org/10.1371/journal.pone.0241959			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166373	Green Submitted, Green Published, gold			2022-12-26	WOS:000592382600017
J	Nagano, T; Iwasaki, T; Onishi, K; Awai, Y; Terachi, A; Kuwaba, S; Asano, S; Katasho, R; Nagai, K; Nakashima, A; Kikkawa, U; Kamada, S				Nagano, Taiki; Iwasaki, Tetsushi; Onishi, Kengo; Awai, Yuto; Terachi, Anju; Kuwaba, Shione; Asano, Shota; Katasho, Ryoko; Nagai, Kiyoko; Nakashima, Akio; Kikkawa, Ushio; Kamada, Shinji			LY6D-induced macropinocytosis as a survival mechanism of senescent cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR SENESCENCE; LIPID RAFTS; PROTEIN; FIBROBLASTS; ACTIVATION; SURFACE	Although senescent cells display various morphological changes including vacuole formation, it is still unclear how these processes are regulated. We have recently identified the gene, lymphocyte antigen 6 complex, locus D (LY6D), to be upregulated specifically in senescent cells. LY6D is a glycosylphosphatidylinositol-anchored cell-surface protein whose function remains unknown. Here, we analyzed the functional relationship between LY6D and the senescence processes. We found that overexpression of LY6D induced vacuole formation and knockdown of LY6D suppressed the senescence-associated vacuole formation. The LY6D-induced vacuoles were derived from macropinocytosis, a distinct form of endocytosis. Furthermore, Src family kinases and Ras were found to be recruited to membrane lipid rafts in an LY6D-dependent manner, and inhibition of their activity impaired the LY6D-induced macropinocytosis. Finally, reduction of senescent-cell survival induced by glutamine deprivation was recovered by albumin supplementation to the culture media in an LY6D-dependent manner. Because macropinocytosis acts as an amino acid supply route, these results suggest that LY6D-mediated macropinocytosis contributes to senescent-cell survival through the incorporation of extracellular nutrients.	[Nagano, Taiki; Iwasaki, Tetsushi; Nagai, Kiyoko; Nakashima, Akio; Kikkawa, Ushio; Kamada, Shinji] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo, Japan; [Iwasaki, Tetsushi; Onishi, Kengo; Terachi, Anju; Asano, Shota; Katasho, Ryoko; Kamada, Shinji] Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo, Japan; [Iwasaki, Tetsushi; Awai, Yuto; Kuwaba, Shione; Kamada, Shinji] Kobe Univ, Fac Sci, Dept Biol, Kobe, Hyogo, Japan; [Nakashima, Akio; Kikkawa, Ushio] Kobe Univ, Grad Sch Agr Sci, Dept Bioresource Sci, Kobe, Hyogo, Japan	Kobe University; Kobe University; Kobe University; Kobe University	Kamada, S (corresponding author), Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo, Japan.; Kamada, S (corresponding author), Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo, Japan.; Kamada, S (corresponding author), Kobe Univ, Fac Sci, Dept Biol, Kobe, Hyogo, Japan.	skamada@kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [25640063, 17K15595, 20K07591, 20K15791]; Uehara Memorial Foundation, Japan; Leave a Nest Co., Ltd., Japan	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Uehara Memorial Foundation, Japan(Uehara Memorial Foundation); Leave a Nest Co., Ltd., Japan	This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 25640063, 17K15595, 20K07591, and 20K15791, The Uehara Memorial Foundation, Japan, and Leave a Nest Grant from Leave a Nest Co., Ltd., Japan.	Babuke T, 2007, EUR J CELL BIOL, V86, P525, DOI 10.1016/j.ejcb.2007.03.003; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Beigneux AP, 2009, J BIOL CHEM, V284, P30240, DOI 10.1074/jbc.M109.046391; Bloomfield G, 2016, J CELL SCI, V129, P2697, DOI 10.1242/jcs.176149; Buckley CM, 2017, FEBS J, V284, P3778, DOI 10.1111/febs.14115; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chen Y, 2006, J CELL BIOL, V175, P169, DOI 10.1083/jcb.200512116; COMINGS DE, 1970, EXP CELL RES, V61, P295, DOI 10.1016/0014-4827(70)90451-9; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fiordalis JJ, 2002, J BIOL CHEM, V277, P10813, DOI 10.1074/jbc.M107684200; Lang MA, 2017, IMMUN INFLAMM DIS, V5, P448, DOI 10.1002/iid3.182; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Leitinger B, 2002, J CELL SCI, V115, P963; LIPETZ J, 1972, J ULTRA MOL STRUCT R, V39, P43, DOI 10.1016/S0022-5320(72)80005-4; Luo LL, 2016, ONCOTARGET, V7, P11165, DOI 10.18632/oncotarget.7163; Masereel B, 2003, EUR J MED CHEM, V38, P547, DOI 10.1016/S0223-5234(03)00100-4; Mettlen M, 2006, TRAFFIC, V7, P589, DOI 10.1111/j.1600-0854.2006.00412.x; Nagano T, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800045; Nagano T, 2017, J CELL SCI, V130, P1413, DOI 10.1242/jcs.196469; Nagano T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31758; Nakano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080411; Overmeyer JH, 2008, MOL CANCER RES, V6, P965, DOI 10.1158/1541-7786.MCR-07-2036; Petranka J, 1996, BLOOD CELL MOL DIS, V22, P281, DOI 10.1006/bcmd.1996.0111; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Saha S, 2016, J LIPID RES, V57, P159, DOI 10.1194/jlr.R062885; Sakakibara K, 2005, J BIOL CHEM, V280, P15029, DOI 10.1074/jbc.M410538200; Salama R, 2014, GENE DEV, V28, P99, DOI 10.1101/gad.235184.113; Santos AL, 2018, CELL MOL LIFE SCI, V75, P1909, DOI 10.1007/s00018-018-2765-4; Sayles PC, 1996, INFECT IMMUN, V64, P3088, DOI 10.1128/IAI.64.8.3088-3092.1996; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P424, DOI 10.1016/S0962-8924(00)89101-1; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3	37	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100049	10.1074/jbc.RA120.013500	http://dx.doi.org/10.1074/jbc.RA120.013500			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33168631	gold, Green Published			2022-12-26	WOS:000672866400032
J	Benetti, E; Giliberti, A; Emiliozzi, A; Valentino, F; Bergantini, L; Fallerini, C; Anedda, F; Amitrano, S; Conticini, E; Tita, R; d'Alessandro, M; Fava, F; Marcantonio, S; Baldassarri, M; Bruttini, M; Mazzei, MA; Montagnani, F; Mandala, M; Bargagli, E; Furini, S; Renieri, A; Mari, F				Benetti, Elisa; Giliberti, Annarita; Emiliozzi, Arianna; Valentino, Floriana; Bergantini, Laura; Fallerini, Chiara; Anedda, Federico; Amitrano, Sara; Conticini, Edoardo; Tita, Rossella; d'Alessandro, Miriana; Fava, Francesca; Marcantonio, Simona; Baldassarri, Margherita; Bruttini, Mirella; Mazzei, Maria Antonietta; Montagnani, Francesca; Mandala, Marco; Bargagli, Elena; Furini, Simone; Renieri, Alessandra; Mari, Francesca		GEN-COVID Multictr Study	Clinical and molecular characterization of COVID-19 hospitalized patients	PLOS ONE			English	Article							IMMUNE-DEFICIENCY; NITRIC-OXIDE; GENE; AUTOPHAGY; VARIANTS; EFFECTOR; VIRUS; CHD7	Clinical and molecular characterization by Whole Exome Sequencing (WES) is reported in 35 COVID-19 patients attending the University Hospital in Siena, Italy, from April 7 to May 7, 2020. Eighty percent of patients required respiratory assistance, half of them being on mechanical ventilation. Fiftyone percent had hepatic involvement and hyposmia was ascertained in 3 patients. Searching for common genes by collapsing methods against 150 WES of controls of the Italian population failed to give straightforward statistically significant results with the exception of two genes. This result is not unexpected since we are facing the most challenging common disorder triggered by environmental factors with a strong underlying heritability (50%). The lesson learned from Autism-Spectrum-Disorders prompted us to re-analyse the cohort treating each patient as an independent case, following a Mendelian-like model. We identified for each patient an average of 2.5 pathogenic mutations involved in virus infection susceptibility and pinpointing to one or more rare disorder(s). To our knowledge, this is the first report on WES and COVID-19. Our results suggest a combined model for COVID-19 susceptibility with a number of common susceptibility genes which represent the favorite background in which additional host private mutations may determine disease progression.	[Benetti, Elisa; Emiliozzi, Arianna; Montagnani, Francesca; Furini, Simone] Univ Siena, Dept Med Biotechnol, Siena, Italy; [Giliberti, Annarita; Valentino, Floriana; Fallerini, Chiara; Fava, Francesca; Baldassarri, Margherita; Bruttini, Mirella; Renieri, Alessandra; Mari, Francesca] Univ Siena, Med Genet, Siena, Italy; [Emiliozzi, Arianna; Montagnani, Francesca] Azienda Osped Univ Senese, Dept Specialized & Internal Med, Trop & Infect Dis Unit, Senese, Italy; [Bergantini, Laura; d'Alessandro, Miriana; Bargagli, Elena] Univ Siena, Dept Internal & Specialist Med, Unit Resp Dis & Lung Transplantat, Siena, Italy; [Anedda, Federico; Marcantonio, Simona] Siena Univ Hosp, Dept Emergency & Urgency Med Surg & Neurosci, Unit Intens Care Med, Siena, Italy; [Amitrano, Sara; Tita, Rossella; Fava, Francesca; Bruttini, Mirella; Renieri, Alessandra; Mari, Francesca] Azienda Osped Univ Senese, Genet Med, Senese, Italy; [Conticini, Edoardo] Univ Siena, Dept Med Surg & Neurosci, Rheumatol Unit, Policlin Scotte, Siena, Italy; [Mazzei, Maria Antonietta] Univ Siena, Azienda Osped Univ Senese, Dept Med Surg & Neuro Sci & Radiol Sci, Unit Diagnost Imaging, Senese, Italy; [Mandala, Marco] Univ Siena, Otolaryngol Unit, Siena, Italy	University of Siena; University of Siena; University of Siena; University Hospital of Siena; University of Siena; University of Siena; University Hospital of Siena; University of Siena; University Hospital of Siena; University of Siena; University of Siena; University Hospital of Siena; University of Siena	Renieri, A (corresponding author), Univ Siena, Med Genet, Siena, Italy.; Renieri, A (corresponding author), Azienda Osped Univ Senese, Genet Med, Senese, Italy.	alessandra.renieri@unisi.it	Benetti, Elisa/AAI-6682-2021; bargagli, elena/CAI-0166-2022; Mandalà, Marco/CAJ-5246-2022; MANTOVANI, STEFANIA/K-4634-2016; Cameli, Paolo/AAN-8345-2020; Montagnani, Francesca/R-3334-2016; d'Alessandro, Miriana/AAA-8803-2020; Furini, Simone/AAU-6456-2020; Di Biagio, Antonio/J-4901-2019; Sanguinetti, Maurizio/A-1453-2019; GIRARDIS, Massimo/K-8974-2016; Renieri, Alessandra/K-5950-2016; Mondelli, Mario/J-5375-2016; Mari, Francesca/E-7737-2012	Benetti, Elisa/0000-0002-0819-604X; MANTOVANI, STEFANIA/0000-0002-5885-2842; Cameli, Paolo/0000-0001-8639-2882; Montagnani, Francesca/0000-0002-2267-1337; d'Alessandro, Miriana/0000-0002-2368-5722; Furini, Simone/0000-0002-1099-8279; Gabrieli, Arianna/0000-0002-2657-8025; Di Biagio, Antonio/0000-0003-1436-5089; Fava, Francesca/0000-0002-4363-2353; Sanguinetti, Maurizio/0000-0002-9780-7059; Palmieri, Maria/0000-0003-3014-1552; Antinori, Andrea/0000-0003-2121-4684; Fallerini, Chiara/0000-0002-7386-3224; Cantarini, Luca/0000-0002-7352-1275; Mencarelli, Maria Antonietta/0000-0001-5131-3718; Anedda, Federico/0000-0002-4240-2345; GIRARDIS, Massimo/0000-0002-2453-0829; Renieri, Alessandra/0000-0002-0846-9220; Conticini, Edoardo/0000-0002-3974-6606; Vergori, Alessandra/0000-0001-6944-0686; Ognibene, Agostino/0000-0001-5287-4250; Mondelli, Mario/0000-0003-1811-3153; Bargagli, Elena/0000-0002-8351-3703; Mari, Francesca/0000-0003-1992-1654	Telethon Network of Genetic Biobanks [GTB18001]	Telethon Network of Genetic Biobanks(Fondazione Telethon)	This study is part of GEN-COVID, https://sites.google.com/dbm.unisi.it/gen-covid the Italian multicenter study aimed to identify the COVID-19 host genetic bases The Genetic and COVID-19 Biobank of Siena, member of BBMRI-IT, of Telethon Network of Genetic Biobanks (project no. GTB18001), of EuroBioBank, and of D-Connect, provided us with specimens. We thank the CINECA consortium for providing computational resources and Network for Italian Genomes NIG http://www.nig.cineca.it.We thank private donors' support to A.R. (Department of Medical Biotechnologies, University of Siena) for the COVID-19 host genetics research project (D.L n.18 of March 17th 2020).	Akerstrom S, 2005, J VIROL, V79, P1966, DOI 10.1128/JVI.79.3.1966-1969.2005; Akerstrom S, 2009, VIROLOGY, V395, P1, DOI 10.1016/j.virol.2009.09.007; Benetti E, 2020, EUR J HUM GENET, V28, P1602, DOI 10.1038/s41431-020-0691-z; Braun E, 2019, CELL REP, V27, P2092, DOI 10.1016/j.celrep.2019.04.063; Cai H, 2020, LANCET RESP MED, V8, pE20, DOI 10.1016/S2213-2600(20)30117-X; Chan CP, 2018, FASEB J, V32, P4380, DOI 10.1096/fj.201701361R; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; d'Alessandro M, 2021, MINERVA MED, V112, P423, DOI 10.23736/S0026-4806.20.06638-0; Dean MM, 2011, IMMUNOLOGY, V132, P296, DOI 10.1111/j.1365-2567.2010.03365.x; Himmelfarb CDR, 2020, J CARDIOVASC NURS, V35, P318, DOI 10.1097/JCN.0000000000000710; Dering C, 2011, GENET EPIDEMIOL, V35, pS12, DOI 10.1002/gepi.20643; Durrant DM, 2016, ACS CHEM NEUROSCI, V7, P464, DOI 10.1021/acschemneuro.6b00043; Ebersole JL, 2019, MOL ORAL MICROBIOL, V34, P14, DOI 10.1111/omi.12251; Finley MJ, 2008, CELL IMMUNOL, V252, P146, DOI 10.1016/j.cellimm.2007.09.008; Gennery AR, 2008, CLIN EXP IMMUNOL, V153, P75, DOI 10.1111/j.1365-2249.2008.03681.x; Giacomelli A, 2020, CLIN INFECT DIS, V71, P889, DOI 10.1093/cid/ciaa330; Guan TX, 2018, J EXP MED, V215, P1153, DOI 10.1084/jem.20171352; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Iwamoto M, 2019, P NATL ACAD SCI USA, V116, P8487, DOI 10.1073/pnas.1811064116; Janssen N, 2012, HUM MUTAT, V33, P1149, DOI 10.1002/humu.22086; Klamer SE, 2018, STEM CELLS DEV, V27, P1494, DOI 10.1089/scd.2018.0124; Klimek Ludger, 2017, Allergo J Int, V26, P16, DOI 10.1007/s40629-016-0006-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Marton J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138222; Miyamoto M, 2017, BIOCHEM BIOPH RES CO, V494, P227, DOI 10.1016/j.bbrc.2017.10.048; Mori I, 2002, J GEN VIROL, V83, P2109, DOI 10.1099/0022-1317-83-9-2109; Nogales A, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040168; Olender T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-414; Oleszkiewicz A, 2019, EUR ARCH OTO-RHINO-L, V276, P719, DOI 10.1007/s00405-018-5248-1; Poplin R., 2017, SCALING ACCURATE GEN, DOI [DOI 10.1101/201178, 10.1101/201178, 10]; Quang D, 2015, BIOINFORMATICS, V31, P761, DOI 10.1093/bioinformatics/btu703; Randall V, 2009, J CLIN INVEST, V119, P3301, DOI 10.1172/JCI37561; Rufini S, 2015, DIGEST LIVER DIS, V47, P744, DOI 10.1016/j.dld.2015.05.012; Salas A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15752-4; Satterstrom FK, 2020, CELL, V180, P568, DOI 10.1016/j.cell.2019.12.036; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Streba LAM, 2014, WORLD J HEPATOL, V6, P137, DOI 10.4254/wjh.v6.i3.137; Tan XJ, 2015, EMBO J, V34, P475, DOI 10.15252/embj.201489425; Teich N, 2005, HUM MUTAT, V25, P343, DOI 10.1002/humu.20148; Theodoropoulos DS, 2003, PEDIATRICS, V111, P711, DOI 10.1542/peds.111.3.711-a; Thio CL, 2005, J VIROL, V79, P9192, DOI 10.1128/JVI.79.14.9192-9196.2005; Tian T, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4482-5; Tong JY, 2020, OTOLARYNG HEAD NECK, V163, P3, DOI 10.1177/0194599820926473; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Waszak SM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000988; Woziwodzka A, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.935; Wu YH, 2008, J INFECT DIS, V197, P812, DOI 10.1086/528377; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zamanian RT, 2020, AM J RESP CRIT CARE, V202, P130, DOI 10.1164/rccm.202004-0937LE; Zhan SQ, 2011, BBA-MOL BASIS DIS, V1812, P565, DOI 10.1016/j.bbadis.2010.11.003; Zhang Y, 2019, ADV CLIN CHEM, V90, P25, DOI 10.1016/bs.acc.2019.01.002; Zhetkenev S, 2019, ASS RS12722 COL5A1 P, V2017, P19008995, DOI [10.1101/19008995, DOI 10.1101/19008995]	55	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242534	10.1371/journal.pone.0242534	http://dx.doi.org/10.1371/journal.pone.0242534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206719	Green Submitted, Green Published, gold			2022-12-26	WOS:000595265900004
J	Chen, R; Wei, QH; Wei, X; Liu, YH; Zhang, XM; Chen, XB; Yin, XP; Xie, T				Chen, Rong; Wei, Qiuhui; Wei, Xin; Liu, Yuheng; Zhang, Xiaomin; Chen, Xiabin; Yin, Xiaopu; Xie, Tian			Stable and efficient immobilization of bi-enzymatic NADPH cofactor recycling system under consecutive microwave irradiation	PLOS ONE			English	Article							COVALENT IMMOBILIZATION; REGENERATION; REDUCTASE	One of the challenges in biocatalysis is the development of stable and efficient bi-enzymatic cascades for bio-redox reactions coupled to the recycling of soluble cofactors. Aldo-keto reductase (LEK) and glucose dehydrogenase (GDH) can be utilized as the NADPH recycling system for economic and efficient biocatalysis of (R)-4-chloro-3-hydroxybutanoate ((R)-CHBE), an important chiral pharmaceutical intermediate. The LEK and GDH was efficiently co-immobilized in mesocellular siliceous foams (MCFs) under microwave irradiation (CoLG-MIA). while they were also co-immobilized by entrapment in calcium alginate without MIA as control (CoLG-CA). The relative activity of CoLG-MIA was increased to 140% compared with that of free LEK. The CoLG-MIA exhibited a wider range of pH and temperature stabilities compared with other preparations. The thermal, storage and batch operational stabilities of microwave-assisted immobilized LEK-GDH were also improved. The NADPH recycling system exhibited the potential as the stable and efficient catalyst for the industrial preparation of (R)-CHBE.	[Chen, Rong; Wei, Qiuhui; Wei, Xin; Liu, Yuheng; Zhang, Xiaomin; Chen, Xiabin; Yin, Xiaopu; Xie, Tian] Hangzhou Normal Univ, Key Lab Elemene Class Anticanc Chinese Med Zhejia, Engn Lab Dev & Applicat Tradit Chinese Med Zhejia, Holist Integrat Pharm Inst,Sch Med, Hangzhou, Peoples R China; [Chen, Rong] Hangzhou Normal Univ, Fac Prevent Med, Hangzhou, Peoples R China; [Chen, Rong] Hangzhou Normal Univ, Coll Med, Hangzhou, Peoples R China	Hangzhou Normal University; Hangzhou Normal University; Hangzhou Normal University	Yin, XP; Xie, T (corresponding author), Hangzhou Normal Univ, Key Lab Elemene Class Anticanc Chinese Med Zhejia, Engn Lab Dev & Applicat Tradit Chinese Med Zhejia, Holist Integrat Pharm Inst,Sch Med, Hangzhou, Peoples R China.	yinxp@hznu.edu.cn; tianxie@hznu.edu.cn		Chen, Rong/0000-0002-0552-7616	Natural Science Foundation of Zhejiang Province [LY21C050004, LQ15C020003, LQ19C020002, LY15B060012]; National Natural Science Foundation of China [21606062, 81803417]; Key projects of National Natural Science Foundation of China [81730108]; start-up research program from HZNU [2018QDL054]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key projects of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); start-up research program from HZNU	This work was supported by the Natural Science Foundation of Zhejiang Province (LY21C050004, LQ15C020003, LQ19C020002 and LY15B060012), National Natural Science Foundation of China (21606062, 81803417), Key projects of National Natural Science Foundation of China (81730108) and the start-up research program from HZNU (2018QDL054).	Basso A, 2020, METHODS MOL BIOL; Bezbradica D, 2009, J CHEM TECHNOL BIOT, V84, P1642, DOI 10.1002/jctb.2222; Bilal M, 2018, INT J BIOL MACROMOL, V108, P893, DOI 10.1016/j.ijbiomac.2017.10.182; Blandino A, 2000, ENZYME MICROB TECH, V27, P319, DOI 10.1016/S0141-0229(00)00204-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen FF, 2012, BIORESOURCE TECHNOL, V115, P158, DOI 10.1016/j.biortech.2011.11.059; Da Ros PCM, 2012, J IND MICROBIOL BIOT, V39, P529, DOI 10.1007/s10295-011-1059-8; de Souza ROMA, 2009, J ORG CHEM, V74, P6157, DOI 10.1021/jo9010443; Du ZQ, 2009, J CHEM ENG JPN, V42, P441, DOI 10.1252/jcej.08we304; Galinada WA, 2007, J CHROMATOGR A, V1163, P157, DOI 10.1016/j.chroma.2007.06.047; Han L, 2018, J IND MICROBIOL BIOT, V45, P111, DOI 10.1007/s10295-018-2002-z; Hollmann F, 2011, GREEN CHEM, V13, P226, DOI 10.1039/c0gc00595a; Hollmann F, 2010, CHEMCATCHEM, V2, P762, DOI 10.1002/cctc.201000069; Kataoka M, 1997, APPL MICROBIOL BIOT, V48, P699, DOI 10.1007/s002530051118; Konsoula Z, 2006, ENZYME MICROB TECH, V39, P690, DOI 10.1016/j.enzmictec.2005.12.002; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Min K, 2014, BIOTECHNOL BIOPROC E, V19, P553, DOI 10.1007/s12257-014-0173-7; Puri M, 1996, ENZYME MICROB TECH, V18, P281, DOI 10.1016/0141-0229(95)00100-X; Rocha-Martin J, 2012, CHEMCATCHEM, V4, P1279, DOI 10.1002/cctc.201200146; Singh RK, 2013, INT J MOL SCI, V14, P1232, DOI 10.3390/ijms14011232; Wang AM, 2008, J BIOSCI BIOENG, V106, P286, DOI 10.1263/jbb.106.286; Wang AM, 2011, BIORESOURCE TECHNOL, V102, P469, DOI 10.1016/j.biortech.2010.08.048; Wang AM, 2009, J BIOSCI BIOENG, V107, P219, DOI 10.1016/j.jbiosc.2008.10.021; Wang QY, 2014, J IND MICROBIOL BIOT, V41, P1609, DOI 10.1007/s10295-014-1502-8; Xu MQ, 2020, INT J BIOL MACROMOL, V144, P1013, DOI 10.1016/j.ijbiomac.2019.09.178; Young DD, 2008, J AM CHEM SOC, V130, P10048, DOI 10.1021/ja802404g	26	3	3	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242564	10.1371/journal.pone.0242564	http://dx.doi.org/10.1371/journal.pone.0242564			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206717	Green Published, gold			2022-12-26	WOS:000595265900073
J	Sakamaki, A; Yokoyama, K; Koyama, K; Morita, S; Abe, H; Kamimura, K; Takamura, M; Terai, S				Sakamaki, Akira; Yokoyama, Kunihiko; Koyama, Kyutaro; Morita, Shinichi; Abe, Hiroyuki; Kamimura, Kenya; Takamura, Masaaki; Terai, Shuji			Obesity and accumulation of subcutaneous adipose tissue are poor prognostic factors in patients with alcoholic liver cirrhosis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; RISK; DISEASE	In alcoholic liver cirrhosis (LC) patients, obesity has become a problem that progresses into liver dysfunction. Herein, we investigated the relationship between the prognosis of steatohepatitis and body weight, along with fat accumulation in patients with alcoholic LC. We conducted a single-center retrospective study, enrolled 104 alcoholic LC patients without hepatocellular carcinoma (HCC) based on histological and clinical evidence, and investigated factors related to poor prognosis using multivariate Cox regression and cluster analyses. Cox regression analysis revealed three independent relevant factors: subcutaneous adipose tissue (SAT) index (median 34.8 cm(2)/m(2), P = 0.009, hazard ratio [HR] 1.017, 95% confidence interval [CI] 1.004-1.030), total bilirubin level (median 1.7 mg/dL, P = 0.003, HR 1.129, 95% CI 1.042-1.223), and prothrombin time value (median 64%, P = 0.007, HR 0.967, 95% CI 0.943-0.991). In the cluster analysis, we categorized the patients into three groups: no adipose tissue accumulation (NAT group), SAT prior accumulation (SAT group), and visceral adipose tissue prior accumulation (VAT group). The results of the three groups revealed that the SAT group displayed a significantly poor prognosis of the Kaplan-Meier curve (67.1 vs 21.2 vs 65.3, P<0.001) of a 5-year survival rate. Propensity score matching analysis of the SAT and VAT groups was performed to adjust the patient's background, but no significant differences were found between them; however, the prognosis was poorer (21.2 vs 66.3, P<0.001), and hemostatic factors were still at a lower level in the SAT group. These findings suggest that SAT accumulation type of obesity is a poor prognostic factor in alcoholic LC patients without HCC, and the hemorrhagic tendency might worsen the poor prognosis in such cases.	[Sakamaki, Akira; Yokoyama, Kunihiko; Koyama, Kyutaro; Morita, Shinichi; Abe, Hiroyuki; Kamimura, Kenya; Takamura, Masaaki; Terai, Shuji] Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan	Niigata University	Sakamaki, A (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Gastroenterol & Hepatol, Niigata, Japan.	saka-a@med.niigata-u.ac.jp						Bell H, 2004, SCAND J GASTROENTERO, V39, P858, DOI 10.1080/00365520410006350; Campollo O, 2019, ANN HEPATOL, V18, P6, DOI 10.5604/01.3001.0012.7854; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cooper DE, 2002, DIABETES CARE, V25, P1425, DOI 10.2337/diacare.25.8.1425; de Lange DW, 2004, ALCOHOL CLIN EXP RES, V28, P1562, DOI 10.1097/01.ALC.0000141808.62230.75; Dunn W, 2006, GASTROENTEROLOGY, V131, P1057, DOI 10.1053/j.gastro.2006.08.020; Dunn W, 2012, AM J GASTROENTEROL, V107, P1668, DOI 10.1038/ajg.2012.285; Ebadi M, 2018, J HEPATOL, V69, P608, DOI 10.1016/j.jhep.2018.04.015; European Association for the Study of the Liver, 2018, J HEPATOL, V69, P154, DOI [10.1016/j.jhep.2018.03.018, DOI 10.1016/j.jhep.2018.03.018]; Ganne-Carrie N, 2018, J HEPATOL, V69, P1274, DOI 10.1016/j.jhep.2018.07.022; Hiuge-Shimizu A, 2012, ANN MED, V44, P82, DOI 10.3109/07853890.2010.526138; HORAK JK, 1982, J CARDIOVASC PHARM, V4, P1037, DOI 10.1097/00005344-198211000-00025; Horie Y, 2013, HEPATOL INT, V7, P280, DOI 10.1007/s12072-012-9347-6; Huang HH, 2008, CLIN NEUROL NEUROSUR, V110, P253, DOI 10.1016/j.clineuro.2007.11.010; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kim MN, 2015, HEPATOLOGY, V61, P1851, DOI 10.1002/hep.27735; Kusminski CM, 2016, NAT REV DRUG DISCOV, V15, P639, DOI 10.1038/nrd.2016.75; Mancebo A, 2013, CLIN GASTROENTEROL H, V11, P95, DOI 10.1016/j.cgh.2012.09.007; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Mirza M S, 2011, ISRN Gastroenterol, V2011, P592404, DOI 10.5402/2011/592404; Mitsiopoulos N, 1998, J APPL PHYSIOL, V85, P115, DOI 10.1152/jappl.1998.85.1.115; Neuman MG, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8030063; Salem Raneem O, 2005, Am J Clin Pathol, V123 Suppl, pS96; Santolaria F, 2000, DRUG ALCOHOL DEPEN, V59, P295, DOI 10.1016/S0376-8716(99)00129-5; Sottier D, 2013, Diagn Interv Imaging, V94, P879, DOI 10.1016/j.diii.2013.04.006; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Styskel B, 2019, CLIN LIVER DIS, V23, P99, DOI 10.1016/j.cld.2018.09.012; Sugiyama C, 2009, WORLD J GASTROENTERO, V15, P4457, DOI 10.3748/wjg.15.4457; Tateishi R, 2019, J GASTROENTEROL, V54, P367, DOI 10.1007/s00535-018-1532-5; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; van Vledder MG, 2012, BRIT J SURG, V99, P550, DOI 10.1002/bjs.7823; Webster DP, 2015, LANCET, V385, P1124, DOI [10.1016/S0140-6736(14)62401-6, 10.1016/S0140-6736(14)61932-2]; Welzel TM, 2013, AM J GASTROENTEROL, V108, P1314, DOI 10.1038/ajg.2013.160; YOKOYAMA A, 1994, ALCOHOL ALCOHOLISM, V29, P181	35	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242582	10.1371/journal.pone.0242582	http://dx.doi.org/10.1371/journal.pone.0242582			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201936	gold, Green Published			2022-12-26	WOS:000595003900015
J	Zacharioudakis, IM; Zervou, FN; Prasad, PJ; Shao, YZ; Basu, A; Inglima, K; Weisenberg, SA; Aguero-Rosenfeld, ME				Zacharioudakis, Ioannis M.; Zervou, Fainareti N.; Prasad, Prithiv J.; Shao, Yongzhao; Basu, Atreyee; Inglima, Kenneth; Weisenberg, Scott A.; Aguero-Rosenfeld, Maria E.			Association of SARS-CoV-2 genomic load trends with clinical status in COVID-19: A retrospective analysis from an academic hospital center in New York City	PLOS ONE			English	Article								The Infectious Diseases Society of America has identified the use of SARS-CoV-2 genomic load for prognostication purposes as a key research question. We designed a retrospective cohort study that included adult patients with COVID-19 pneumonia who had at least 2 positive nasopharyngeal tests at least 24 hours apart to study the correlation between the change in the genomic load of SARS-CoV-2, as reflected by the Cycle threshold (Ct) value of the RT-PCR, with change in clinical status. The Sequential Organ Failure Assessment (SOFA) score was used as a surrogate for patients' clinical status. Among 457 patients with COVID-19 pneumonia between 3/31/2020-4/10/2020, we identified 42 patients who met the inclusion criteria. The median initial SOFA score was 2 (IQR 2-3). 20 out of 42 patients had a lower SOFA score on their subsequent tests. We identified a statistically significant inverse correlation between the change in SOFA score and change in the Ct value with a decrease in SOFA score by 0.05 (SE 0.02; p<0.05) for an increase in Ct values by 1. This correlation was independent of the duration of symptoms. Our findings suggest that an increasing Ct value in sequential tests may be of prognostic value for patients diagnosed with COVID-19 pneumonia.	[Zacharioudakis, Ioannis M.; Zervou, Fainareti N.; Prasad, Prithiv J.; Weisenberg, Scott A.; Aguero-Rosenfeld, Maria E.] NYU Grossman Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY 10016 USA; [Shao, Yongzhao] NYU Grossman Sch Med, Dept Populat Hlth, New York, NY USA; [Basu, Atreyee; Inglima, Kenneth; Aguero-Rosenfeld, Maria E.] NYU Grossman Sch Med, Dept Pathol, New York, NY USA		Zacharioudakis, IM; Zervou, FN (corresponding author), NYU Grossman Sch Med, Dept Med, Div Infect Dis & Immunol, New York, NY 10016 USA.	Ioannis.Zacharioudakis@nyulangone.org; Fainareti.zervou@nyulangone.org	Basu, Atreyee/AAB-5241-2022	Prasad, Prithiv/0000-0003-4142-067X				[Anonymous], OUTL KEY COVID 19 RE; Center for Systems Science and Engineering, 2019, COR COVID 19 GLOB CA; Centers for Disease Control and Prevention, DISC TRANSM BAS PREC; Cheng MP, 2020, ANN INTERN MED, V172, P726, DOI 10.7326/M20-1301; Huang YB, 2020, AM J RESP CRIT CARE, V201, P1435, DOI 10.1164/rccm.202003-0572LE; Ielapi N, 2020, BIOMARK MED, V14, P713, DOI 10.2217/bmm-2020-0201; Ji D, 2020, CLIN INFECT DIS, V71, P1393, DOI 10.1093/cid/ciaa414; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; THOMPSON WA, 1962, ANN MATH STAT, V33, P273, DOI 10.1214/aoms/1177704731; Tom MR, 2020, CLIN INFECT DIS, V71, P2252, DOI 10.1093/cid/ciaa619; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; World Health Organization, 2020, MENT HLTH PSYCH CONS; Xiao AT, 2020, CLIN INFECT DIS, V71, P2249, DOI 10.1093/cid/ciaa460; Zacharioudakis IM, ANN AM THORAC SOC; Zhou B, 2020, CLIN INFECT DIS, V71, P2240, DOI 10.1093/cid/ciaa451; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	17	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242399	10.1371/journal.pone.0242399	http://dx.doi.org/10.1371/journal.pone.0242399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201912	gold, Green Published			2022-12-26	WOS:000595003900036
J	Chen, XW; Wang, L; Su, XM; Luo, SY; Tang, XB; Huang, YG				Chen, Xiuwen; Wang, Li; Su, Xiaomin; Luo, Sen-yuan; Tang, Xianbin; Huang, Yugang			Identification of potential target genes and crucial pathways in small cell lung cancer based on bioinformatic strategy and human samples	PLOS ONE			English	Article							TOPOISOMERASE-II-ALPHA; COMPREHENSIVE ANALYSIS; ROS1 REARRANGEMENTS; GENOMIC INSTABILITY; THERAPEUTIC TARGET; COLORECTAL-CANCER; PROGNOSTIC MARKER; BREAST-CANCER; EXPRESSION; OVEREXPRESSION	Small cell lung cancer (SCLC) is a carcinoma of the lungs with strong invasion, poor prognosis and resistant to multiple chemotherapeutic drugs. It has posed severe challenges for the effective treatment of lung cancer. Therefore, searching for genes related to the development and prognosis of SCLC and uncovering their underlying molecular mechanisms are urgent problems to be resolved. This study is aimed at exploring the potential pathogenic and prognostic crucial genes and key pathways of SCLC via bioinformatic analysis of public datasets. Firstly, 117 SCLC samples and 51 normal lung samples were collected and analyzed from three gene expression datasets. Then, 102 up-regulated and 106 down-regulated differentially expressed genes (DEGs) were observed. And then, functional annotation and pathway enrichment analyzes of DEGs was performed utilizing the FunRich. The protein-protein interaction (PPI) network of the DEGs was constructed through the STRING website, visualized by Cytoscape. Finally, the expression levels of eight hub genes were confirmed in Oncomine database and human samples from SCLC patients. It showed that CDC20, BUB1, TOP2A, RRM2, CCNA2, UBE2C, MAD2L1, and BUB1B were upregulated in SCLC tissues compared to paired adjacent non-cancerous tissues. These suggested that eight hub genes might be viewed as new biomarkers for prognosis of SCLC or to guide individualized medication for the therapy of SCLC.	[Chen, Xiuwen; Wang, Li; Luo, Sen-yuan; Tang, Xianbin; Huang, Yugang] Hubei Univ Med, Taihe Hosp, Dept Pathol, Wuhan, Hubei, Peoples R China; [Su, Xiaomin] Nankai Univ, Sch Med, Dept Immunol, Tianjin, Peoples R China	Hubei University of Medicine; Nankai University	Huang, YG (corresponding author), Hubei Univ Med, Taihe Hosp, Dept Pathol, Wuhan, Hubei, Peoples R China.	huangyg2018@outlook.com	Huang, Yugang/AAC-4266-2021	Huang, Yu-gang/0000-0002-8184-0794	National Natural Science Foundation of China [81600436, 81974088]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (grant number 81600436 and 81974088). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abal M, 2007, GASTROENTEROLOGY, V132, P2448, DOI 10.1053/j.gastro.2007.03.027; [Anonymous], 2019, CANC DISCOV, V10, pOF5; Antonia SJ, 2016, LANCET ONCOL, V17, P883, DOI 10.1016/S1470-2045(16)30098-5; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643; Bargiela-Iparraguirre J, 2014, CELL CYCLE, V13, P3590, DOI 10.4161/15384101.2014.962952; Bergethon K, 2012, J CLIN ONCOL, V30, P863, DOI 10.1200/JCO.2011.35.6345; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Blanchard JM, 2000, BIOCHEM PHARMACOL, V60, P1179, DOI 10.1016/S0006-2952(00)00384-1; Bolanos-Garcia VM, 2011, TRENDS BIOCHEM SCI, V36, P141, DOI 10.1016/j.tibs.2010.08.004; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brcic L, 2019, PATHOLOGY, V51, P481, DOI 10.1016/j.pathol.2019.03.011; Campling BG, 1997, INT J ONCOL, V10, P885; Chang SM, 2017, EUR J MED CHEM, V127, P235, DOI 10.1016/j.ejmech.2016.12.046; Chen SM, 2010, J CANCER RES CLIN, V136, P419, DOI 10.1007/s00432-009-0672-7; Coss A, 2009, CANCER LETT, V276, P228, DOI 10.1016/j.canlet.2008.11.018; Davis AP, 2019, NUCLEIC ACIDS RES, V47, pD948, DOI 10.1093/nar/gky868; Ding Y, 2013, CANCER DISCOV, V3, P198, DOI 10.1158/2159-8290.CD-12-0353; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; FELDHOFF PW, 1994, CANCER RES, V54, P756; Ferone G, 2020, CELL REP, V30, P3837, DOI 10.1016/j.celrep.2020.02.052; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gayyed MF, 2016, TUMOR BIOL, V37, P749, DOI 10.1007/s13277-015-3808-1; Guo JW, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-018-0054-6; Han Z, 2016, J MODERN ONCOLOGY; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haruki N, 2001, CANCER LETT, V162, P201, DOI 10.1016/S0304-3835(00)00675-3; Huang N, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01103; Huang YG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01063; Ieta K, 2007, INT J CANCER, V121, P33, DOI 10.1002/ijc.22605; J L, 2019, J CANC, V10, P4208, DOI [10.7150/jca.33457, DOI 10.7150/JCA.33457]; Janne PA, 2012, J CLIN ONCOL, V30, P878, DOI 10.1200/JCO.2011.39.4197; Jaffrey RG, 2000, CANCER RES, V60, P4349; Jain M, 2013, ENDOCR-RELAT CANCER, V20, P361, DOI 10.1530/ERC-12-0403; Kapanidou M, 2015, TRENDS MOL MED, V21, P364, DOI 10.1016/j.molmed.2015.04.003; Kato T, 2012, J SURG ONCOL, V106, P423, DOI 10.1002/jso.23109; Kato T, 2011, LUNG CANCER, V74, P124, DOI 10.1016/j.lungcan.2011.01.025; Kidokoro T, 2008, ONCOGENE, V27, P1562, DOI 10.1038/sj.onc.1210799; Krishnan R, 1998, GENOMICS, V49, P475, DOI 10.1006/geno.1998.5233; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lee E, 2017, CANCER RES, V77, P5518, DOI 10.1158/0008-5472.CAN-17-0736; Li C, 2018, J CELL PHYSIOL, V233, P6759, DOI 10.1002/jcp.26529; Li F, 2018, MOL CELL, V70, P395, DOI 10.1016/j.molcel.2018.03.032; Li G, 2006, ONCOL REP, V16, P859; Li JF, 2019, FASEB J, V33, P1374, DOI 10.1096/fj.201800667R; Li SS, 2019, BRIEF BIOINFORM, V20, P1420, DOI 10.1093/bib/bby006; Liao Y, 2019, ONCOL LETT, V18, P3723, DOI 10.3892/ol.2019.10685; Liu GL, 2019, J CANCER, V10, P2176, DOI 10.7150/jca.32731; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loussouarn D, 2009, BRIT J CANCER, V101, P166, DOI 10.1038/sj.bjc.6605122; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma TZ, 2017, J COMPUT BIOL, V24, P647, DOI 10.1089/cmb.2017.0056; Mao Y, 2019, MOL MED REP, V20, P2199, DOI 10.3892/mmr.2019.10441; Mazzu YZ, 2019, CLIN CANCER RES, V25, P4480, DOI 10.1158/1078-0432.CCR-18-4046; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Miura Y, 2018, LUNG CANCER, V115, P42, DOI 10.1016/j.lungcan.2017.11.010; Ni MW, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00469; Ni Z, 2018, EXP THER MED, V15, P3273, DOI 10.3892/etm.2018.5833; O'Malley FP, 2009, JNCI-J NATL CANCER I, V101, P644, DOI 10.1093/jnci/djp067; Pathan M, 2017, J EXTRACELL VESICLES, V6, DOI 10.1080/20013078.2017.1321455; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Putluri N, 2014, NEOPLASIA, V16, P390, DOI 10.1016/j.neo.2014.05.007; Qi LN, 2019, J CANCER, V10, P6618, DOI 10.7150/jca.33433; Raaijmakers JA, 2018, CELL REP, V22, P1424, DOI 10.1016/j.celrep.2018.01.034; Rasmussen RD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13398; Reck M, 2016, J CLIN ONCOL, V34, P3740, DOI 10.1200/JCO.2016.67.6601; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Scintu M, 2007, CANCER LETT, V254, P298, DOI 10.1016/j.canlet.2007.03.021; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sos ML, 2012, P NATL ACAD SCI USA, V109, P17034, DOI 10.1073/pnas.1207310109; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Testa U, 2018, CANCERS, V10, DOI 10.3390/cancers10080248; von Pawel J, 2014, J CLIN ONCOL, V32, P4012, DOI 10.1200/JCO.2013.54.5392; Wagner AH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06162-9; Waqar SN, 2017, PHARMACOL THERAPEUT, V180, P16, DOI 10.1016/j.pharmthera.2017.06.002; Wen PS, 2018, MOL MED REP, V18, P1538, DOI 10.3892/mmr.2018.9095; Winther TL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172316; Wu Y, 2018, MED SCI MONITOR, V24, P7541, DOI 10.12659/MSM.909772; Xie D, 2015, J THORAC ONCOL, V10, P1213, DOI 10.1097/JTO.0000000000000585; Xu M, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00498; Yang F, 2016, ONCOTARGET, V7, P75165, DOI 10.18632/oncotarget.12614; Yang YB, 2019, ONCOTARGETS THER, V12, P9927, DOI 10.2147/OTT.S221339; Zhang G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15822; Zhang ZM, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0609-8; Zhou WY, 2016, NAT GENET, V48, P563, DOI 10.1038/ng.3545; 2014, REG ANESTH PAIN MED, V9	88	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242194	10.1371/journal.pone.0242194	http://dx.doi.org/10.1371/journal.pone.0242194			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186389	gold, Green Published			2022-12-26	WOS:000593949800037
J	Florez, LM; Scheper, RWA; Fisher, BM; Sutherland, PW; Templeton, MD; Bowen, JK				Florez, Liz M.; Scheper, Reiny W. A.; Fisher, Brent M.; Sutherland, Paul W.; Templeton, Matthew D.; Bowen, Joanna K.			Reference genes for gene expression analysis in the fungal pathogen Neonectria ditissima and their use demonstrating expression up-regulation of candidate virulence genes	PLOS ONE			English	Article							CANKER NECTRIA-GALLIGENA; REAL-TIME; STAGONOSPORA-NODORUM; HOUSEKEEPING GENES; APPLE CANKER; INFECTION; NORMALIZATION; SELECTION; RNA; VALIDATION	European canker, caused by the necrotrophic fungal phytopathogen Neonectria ditissima, is one of the most damaging apple diseases worldwide. An understanding of the molecular basis of N. ditissima virulence is currently lacking. Identification of genes with an up-regulation of expression during infection, which are therefore probably involved in virulence, is a first step towards this understanding. Reverse transcription quantitative real-time PCR (RT-qPCR) can be used to identify these candidate virulence genes, but relies on the use of reference genes for relative gene expression data normalisation. However, no report that addresses selecting appropriate fungal reference genes for use in the N. ditissima-apple pathosystem has been published to date. In this study, eight N. ditissima genes were selected as candidate RT-qPCR reference genes for gene expression analysis. A subset of the primers (six) designed to amplify regions from these genes were specific for N. ditissima, failing to amplify PCR products with template from other fungal pathogens present in the apple orchard. The efficiency of amplification of these six primer sets was satisfactory, ranging from 81.8 to 107.53%. Analysis of expression stability when a highly pathogenic N. ditissima isolate was cultured under 10 regimes, using the statistical algorithms geNorm, NormFinder and BestKeeper, indicated that actin and myo-inositol-1-phosphate synthase (mips), or their combination, could be utilised as the most suitable reference genes for normalisation of N. ditissima gene expression. As a test case, these reference genes were used to study expression of three candidate virulence genes during a time course of infection. All three, which shared traits with fungal effector genes, had up-regulated expression in planta compared to in vitro with expression peaking between five and six weeks post inoculation (wpi). Thus, these three genes may well be involved in N. ditissima pathogenicity and are priority candidates for further functional characterization.	[Florez, Liz M.; Templeton, Matthew D.; Bowen, Joanna K.] New Zealand Inst Plant & Food Res Ltd, Bioprotect, Auckland, New Zealand; [Florez, Liz M.; Templeton, Matthew D.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Scheper, Reiny W. A.; Fisher, Brent M.] New Zealand Inst Plant & Food Res Ltd, Bioprotect, Havelock North, New Zealand; [Sutherland, Paul W.] New Zealand Inst Plant & Food Res Ltd, Food Innovat, Auckland, New Zealand	New Zealand Institute for Plant & Food Research Ltd; University of Auckland; New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd	Bowen, JK (corresponding author), New Zealand Inst Plant & Food Res Ltd, Bioprotect, Auckland, New Zealand.	Joanna.bowen@plantandfood.co.nz	Templeton, Matthew/J-6966-2017; Scheper, Reiny Wendelke Anna/H-3980-2017	Templeton, Matthew/0000-0003-0192-9041; Scheper, Reiny Wendelke Anna/0000-0002-7320-2530; Bowen, Joanna/0000-0001-9863-1078	New Zealand Institute for Plant and Food Research Limited, Strategic Science Investment Fund [12070]	New Zealand Institute for Plant and Food Research Limited, Strategic Science Investment Fund	LMF, RWAS, BMF, PWS, MDT and JKB all received funding from The New Zealand Institute for Plant and Food Research Limited, Strategic Science Investment Fund, Project number: 12070. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2017, PEDIAT RADIOL S2, V47, pS303; BERESFORD RM, 1988, Z PFLANZENK PFLANZEN, V95, P361; Beresford RM, 2011, PHYTOPATHOLOGY, V101, P135, DOI 10.1094/PHYTO-05-10-0137; Bradshaw RE, 2016, MOL PLANT PATHOL, V17, P210, DOI 10.1111/mpp.12273; Broggini GAL, 2011, FUNGAL GENET BIOL, V48, P166, DOI 10.1016/j.fgb.2010.09.001; Bus VGM, 2019, TREE GENET GENOMES, V15, DOI 10.1007/s11295-019-1332-y; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen C, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.721; Chen C, 2016, BRAZ J MICROBIOL, V47, P259, DOI 10.1016/j.bjm.2015.11.031; Cooke LR, 1999, EUR J PLANT PATHOL, V105, P783, DOI 10.1023/A:1008778900607; Deng CH, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01348-15; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Donahue JL, 2010, PLANT CELL, V22, P888, DOI 10.1105/tpc.109.071779; DUBIN HJ, 1974, PHYTOPATHOLOGY, V64, P1201, DOI 10.1094/Phyto-64-1201; DUBIN HJ, 1975, PHYTOPATHOLOGY, V65, P542, DOI 10.1094/Phyto-65-542; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; Fitzgerald A, 2004, FUNGAL GENET BIOL, V41, P963, DOI 10.1016/j.fgb.2004.06.006; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Ghasemkhani M, 2016, HEREDITAS, V153, DOI 10.1186/s41065-016-0011-3; Gomez-Cortecero A, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01243-15; Gomez-Cortecero A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01365; Hazra Anjan, 2016, Biotechnologia (Poznan), V97, P95, DOI 10.5114/bta.2016.60780; Horberg HM, 2002, EUR J PLANT PATHOL, V108, P73, DOI 10.1023/A:1013936624884; Huang N, 2018, BMC CELL BIOL, V19, DOI 10.1186/s12860-018-0152-5; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones P., 2014, BIOINFORMATICS; Kim HK, 2011, PLANT PATHOLOGY J, V27, P301, DOI 10.5423/PPJ.2011.27.4.301; Kwan YM, 2016, AUSTRALAS PLANT PATH, V45, P261, DOI 10.1007/s13313-016-0417-4; Latorre BA, 2002, CROP PROT, V21, P285, DOI 10.1016/S0261-2194(01)00099-0; Liu ZH, 2006, GENOME, V49, P1265, DOI 10.1139/G06-088; Llanos A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1224-y; Lyu XL, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005435; Majumder AL, 2003, FEBS LETT, V553, P3, DOI 10.1016/S0014-5793(03)00974-8; McCracken AR, 2003, PLANT PATHOL, V52, P553, DOI 10.1046/j.1365-3059.2003.00924.x; Michell RH, 2008, NAT REV MOL CELL BIO, V9, P151, DOI 10.1038/nrm2334; Morales LT, 2017, STAND GENOMIC SCI, V12, DOI 10.1186/s40793-017-0287-6; Oliver RP, 2012, ANNU REV PHYTOPATHOL, V50, P23, DOI 10.1146/annurev-phyto-081211-173019; Oliver RP, 2010, CURR OPIN PLANT BIOL, V13, P415, DOI 10.1016/j.pbi.2010.05.003; Pathan EK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179454; Perdomo H, 2013, MYCOLOGIA, V105, P398, DOI 10.3852/12-137; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plante F, 2002, MYCOL RES, V106, P183, DOI 10.1017/S0953756201005329; Qian J, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6125706; Sasnauskas A., 2006, Agronomy Research, V4, P349; Saville RJ, 2014, REV OUR CURRENT KNOW; Schaffer RJ, 2007, PLANT PHYSIOL, V144, P1899, DOI 10.1104/pp.106.093765; Scheper R. W. A., 2015, New Zealand Plant Protection, V68, P257; Scheper Reiny W. A., 2019, New Zealand Plant Protection, V72, P123, DOI 10.30843/nzpp.2019.72.302; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Scholtz JJ, 2013, PHYSIOL MOL PLANT P, V81, P22, DOI 10.1016/j.pmpp.2012.10.006; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Sperschneider J, 2018, MOL PLANT PATHOL, V19, P2094, DOI 10.1111/mpp.12682; Stergiopoulos I, 2013, FEMS MICROBIOL REV, V37, P67, DOI 10.1111/j.1574-6976.2012.00349.x; Tang LG, 2020, MOL PLANT PATHOL, V21, P686, DOI 10.1111/mpp.12922; Toruno TY, 2016, ANNU REV PHYTOPATHOL, V54, P419, DOI 10.1146/annurev-phyto-080615-100204; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Urban M, 2015, NUCLEIC ACIDS RES, V43, pD645, DOI 10.1093/nar/gku1165; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warzybok A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072887; Wenneker M, 2017, EUR J PLANT PATHOL, V148, P631, DOI 10.1007/s10658-016-1115-3; Ye CQ, 2013, J BIOL CHEM, V288, P24898, DOI 10.1074/jbc.M113.493353; Zhai H, 2016, PLANT BIOTECHNOL J, V14, P592, DOI 10.1111/pbi.12402; Zhang JW, 2019, FUNGAL GENET BIOL, V123, P33, DOI 10.1016/j.fgb.2018.11.005; Zhu WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053901; 2012, SURG OBES RELAT DIS, V8	70	2	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0238157	10.1371/journal.pone.0238157	http://dx.doi.org/10.1371/journal.pone.0238157			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186359	Green Submitted, Green Published, gold			2022-12-26	WOS:000593949800014
J	Mok, J; Park, TS; Kim, S; Kim, D; Choi, CS; Park, J				Mok, Jongsoo; Park, Tae Sub; Kim, Sunhong; Kim, Daehoon; Choi, Cheol Soo; Park, Joonghoon			Prokineticin receptor 1 ameliorates insulin resistance in skeletal muscle	FASEB JOURNAL			English	Article						glucose; insulin resistance; Prokr1; PROK2; skeletal muscle	FREE FATTY-ACID; DEPENDENT ACTIVATION; GLUCOSE-TRANSPORT; IDENTIFICATION; PALMITATE; OBESITY; LIGAND; MEN	Type 2 diabetes mellitus may result from insulin resistance in skeletal muscle. Prokineticin receptor 1 (Prokr1) improves metabolic phenotype in adipose tissue and the cardiovascular system; however, its effects on skeletal muscle have not been investigated. We investigated the Prokr1 signaling pathways and its metabolic function in murine myoblast, satellite cells, and their differentiated myotubes. We measured the expression levels of Prokr1 in the skeletal muscle of mice as well as human skeletal muscle cell-derived myotubes. Prokineticin 2 (PROK2), a ligand of PROKR1, induced calcium mobilization in a dose-dependent manner and altered the mRNA levels of 578 genes in PROKR1-overexpressed HEK293T cells. Functional enrichment of differentially expressed genes revealed that PROKR1 activated Gq-mediated PI3K/AKT and MAPK/ERK signaling pathways in skeletal muscle cells. Prokr1 significantly activated the PI3K/AKT signaling pathway in myotubes derived from C2C12 and satellite cells, regardless of the presence or absence of insulin. Prokr1 also promoted the translocation of glucose transporter 4 (GLUT4) into the plasma membrane. In palmitate-induced insulin-resistant myotubes, Prokr1 enhanced insulin-stimulated AKT phosphorylation, GLUT4 translocation, and glucose uptake. mRNA and protein levels of Prokr1 were significantly decreased in skeletal muscle and white adipose tissue of diet-induced obese mice, and the amount of PROKR1 protein was significantly decreased in human skeletal muscle cell-derived myotubes under insulin resistance conditions. Taken together, these results demonstrate that Prokr1 plays an important role in insulin sensitivity and is a potential therapeutic target to ameliorate insulin resistance in skeletal muscle.	[Mok, Jongsoo; Park, Tae Sub; Park, Joonghoon] Seoul Natl Univ, Grad Sch Int Agr Technol, Dept Int Agr Technol, Seoul, South Korea; [Park, Tae Sub; Park, Joonghoon] Seoul Natl Univ, Inst Green Bio Sci & Technol, Seoul, South Korea; [Kim, Sunhong] Korea Res Inst Biosci & Biotechnol, Dis Target Struct Res Ctr, Cheongwon Gun, South Korea; [Kim, Sunhong] Korea Univ Sci & Technol, KRIBB Sch Biosci, Dept Biomol Sci, Daejeon, South Korea; [Kim, Daehoon] Hyundai Pharm Co, New Drug Discovery Ctr, Pharmacol Res Div, Cheonan Si, South Korea; [Choi, Cheol Soo] Gachon Univ, Sch Med, Lee Gil Ya Canc & Diabet Inst, Korea Mouse Metab Phenotyping Ctr, Seongnam Si, South Korea; [Choi, Cheol Soo] Gachon Univ, Gil Med Ctr, Internal Med, Endocrinol, Seongnam Si, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Gachon University; Gachon University	Park, J (corresponding author), Seoul Natl Univ, Grad Sch Int Agr Technol, Dept Int Agr Technol, Seoul, South Korea.	joonghoon@snu.ac.kr		Park, Joonghoon/0000-0002-3458-2913	Korea Health Industry Development Institute; Ministry of Health and Welfare [KHIDI-HI14C1135]; National Research Foundation [NRF-2018R1D1A1B07048516]	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); National Research Foundation	Korea Health Industry Development Institute; Ministry of Health and Welfare, Grant/Award Number: KHIDI-HI14C1135; National Research Foundation, Grant/Award Number: NRF-2018R1D1A1B07048516	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Balboni G, 2008, J MED CHEM, V51, P7635, DOI 10.1021/jm800854e; Beale KEL, 2013, BRIT J PHARMACOL, V168, P403, DOI 10.1111/j.1476-5381.2012.02191.x; Brown DM, 2012, J MUSCLE RES CELL M, V32, P383, DOI 10.1007/s10974-011-9267-4; Chaly AL, 2016, ELIFE, V5, DOI 10.7554/eLife.12397; Chen JC, 2005, MOL PHARMACOL, V67, P2070, DOI 10.1124/mol.105.011619; Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Dormishian M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000411; Gasser A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121027; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim S, 2017, J AGR FOOD CHEM, V65, P3819, DOI 10.1021/acs.jafc.7b00578; Landau BR, 1996, J CLIN INVEST, V98, P378, DOI 10.1172/JCI118803; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Li JN, 2013, J AM CHEM SOC, V135, P8749, DOI 10.1021/ja404391q; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Lin R, 2002, J BIOL CHEM, V277, P8724, DOI 10.1074/jbc.M110594200; Liu TM, 2013, CELL METAB, V18, P309, DOI 10.1016/j.cmet.2013.08.016; MARIN P, 1994, DIABETES CARE, V17, P382, DOI 10.2337/diacare.17.5.382; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Mittendorfer B, 2009, OBESITY, V17, P1872, DOI 10.1038/oby.2009.224; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; Park JG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40322-1; Pasut A, 2013, JOVE-J VIS EXP, DOI 10.3791/50074; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Rowley WR, 2017, POPUL HEALTH MANAG, V20, P6, DOI 10.1089/pop.2015.0181; Shin E, 2015, SCI REP-UK, V5, DOI 10.1038/srep17784; Soga T, 2002, BBA-GENE STRUCT EXPR, V1579, P173, DOI 10.1016/S0167-4781(02)00546-8; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Subramanian A, 2017, CELL, V171, P1437, DOI 10.1016/j.cell.2017.10.049; Szatkowski C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081175; Tahrani AA, 2016, NAT REV ENDOCRINOL, V12, P566, DOI 10.1038/nrendo.2016.86; Taylor R, 2012, DIABETES, V61, P778, DOI 10.2337/db12-0073; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Wang X, 2010, EXP CLIN ENDOCR DIAB, V118, P657, DOI 10.1055/s-0030-1252069; Wang Y, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-015-0172-5; Wu YL, 2014, INT J MED SCI, V11, P1185, DOI 10.7150/ijms.10001; Yang M, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-104; Yin WQ, 2014, CELL SIGNAL, V26, P1118, DOI 10.1016/j.cellsig.2014.01.031; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zierath JR, 1996, DIABETOLOGIA, V39, P1180, DOI 10.1007/BF02658504	42	5	5	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001641R	http://dx.doi.org/10.1096/fj.202001641R		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33184929	hybrid			2022-12-26	WOS:000590890100001
J	Coradi, PC; Padia, CL; Jaques, LBA; de Souza, GAC; Lima, RE; Muller, A; Teodoro, PE; Steinhaus, JI; Carneiro, LD				Coradi, Paulo Carteri; Padia, Claudir Lari; Jaques, Lanes Beatriz Acosta; de Souza, Guilherme Abreu Coelho; Lima, Roney Eloy; Mueller, Amanda; Teodoro, Paulo Eduardo; Steinhaus, Jonatas Ibage; Carneiro, Leticia de Oliveira			Adaptation of technological packaging for conservation of soybean seeds in storage units as an alternative to modified atmospheres	PLOS ONE			English	Article							PHYSIOLOGICAL QUALITY; SANITARY QUALITY; DRYING KINETICS; CARBON-DIOXIDE; CRAMBE SEEDS; GRAINS; VIGOR; FOOD	This study aimed to evaluate the quality of seeds of RR and RR2 PRO soybean cultivars stored in ambient air with raffia packaging (ANER), ambient air with laminated packaging (ANEL), modified atmosphere with polyethylene packaging (AMEP), refrigerated atmosphere (1 to 3 degrees C) with raffia packaging (ARER), refrigerated atmosphere (1 to 3 degrees C) with laminated packaging (AREL), and modified (-14 PSI) and refrigerated (1 to 3 degrees C) atmosphere with polyethylene packaging (AMREP), over 6 months of storage. Results showed that the seeds of cultivar RR2 were preserved with better physiological quality. Raffia and polyethylene packaging under natural storage conditions, in a refrigerated and modified atmosphere, did not preserve the seed quality over the storage period. The conditions of storage in ambient air with laminated packaging (ANEL) and in a refrigerated atmosphere with laminated packaging (AREL) reduced the environmental effects of temperature and relative humidity, leading to better results of physiological quality of the seeds. Storage time negatively influenced the physiological quality of seeds, except for AREL and ANEL, which maintained the quality close to that of the initial conditions, over the 6 months of storage. The best alternatives for soybean seeds storage over 6 months are the laminated packaging in a natural environment, matching the refrigerated conditions. The technological laminated packaging can be used as a new alternative for conserving soybean seeds in processing and storage units.	[Coradi, Paulo Carteri; de Souza, Guilherme Abreu Coelho; Steinhaus, Jonatas Ibage; Carneiro, Leticia de Oliveira] Univ Fed Santa Maria, Campus Cachoeira Sul, Cachoeira Do Sul, RS, Brazil; [Coradi, Paulo Carteri; Padia, Claudir Lari; Jaques, Lanes Beatriz Acosta; Mueller, Amanda] Univ Fed Santa Maria, Grad Program Agr Engn, Santa Maria, RS, Brazil; [Coradi, Paulo Carteri; Lima, Roney Eloy; Teodoro, Paulo Eduardo] Univ Fed Mato Grosso do Sul, Campus Chapadao Sul, Chapadao Do Sul, MS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM); Universidade Federal de Mato Grosso do Sul	Coradi, PC (corresponding author), Univ Fed Santa Maria, Campus Cachoeira Sul, Cachoeira Do Sul, RS, Brazil.; Coradi, PC (corresponding author), Univ Fed Santa Maria, Grad Program Agr Engn, Santa Maria, RS, Brazil.; Coradi, PC (corresponding author), Univ Fed Mato Grosso do Sul, Campus Chapadao Sul, Chapadao Do Sul, MS, Brazil.	paulo.coradi@ufsm.br	Padia, Claudir/GZL-1426-2022; Coradi, Paulo Carteri/G-8007-2015	TEODORO, PAULO/0000-0002-8236-542X; de Oliveira Carneiro, Leticia/0000-0002-8778-5239; Coradi, Paulo Carteri/0000-0001-9150-2169	CAPES (Coordination for the Improvement of Higher Education Personnel) [001]; CNPq (National Council for Scientific and Technological Development); Federal University of Mato Grosso do Sul (UFMS)	CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Federal University of Mato Grosso do Sul (UFMS)	This study received support, in the form of financial contributions to research projects and scholarships for carrying out the experiments, from the following: CAPES (Coordination for the Improvement of Higher Education Personnel)Financial Code 001; CNPq (National Council for Scientific and Technological Development); and Federal University of Mato Grosso do Sul (UFMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal I, 2020, IND CROP PROD, V155, DOI 10.1016/j.indcrop.2020.112842; ASAE, 1980, PSYCHR DAT AGR ENG Y; Atungulu GG, 2018, DRY TECHNOL, V36, P383, DOI 10.1080/07373937.2017.1335751; Bakhtavar MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207569; Bessa JFV, 2015, REV BRAS ENG AGR AMB, V19, P224, DOI 10.1590/1807-1929/agriambi.v19n3p224-230; Brito RC, 2021, DRY TECHNOL, V39, P820, DOI 10.1080/07373937.2020.1725544; Brody AL, 2002, ACTIVE PACKAGING FOO, p220p, DOI [10.1111/1541-4337.12322, DOI 10.1111/1541-4337.12322]; Camilo Giselli L., 2017, Rev. de Ciências Agrárias, V40, P180, DOI 10.19084/RCA16145; Cao XH, 2017, DRY TECHNOL, V35, P240, DOI 10.1080/07373937.2016.1170698; Cardoso Rafael Brito, 2012, Pesqui. Agropecu. Trop., V42, P272; Carvalho ER, 2016, J SEED SCI, V38, P129, DOI 10.1590/2317-1545v38n2158956; Carvalho ER, 2014, BRAGANTIA, V73, P219, DOI 10.1590/1678-4499.0096; Conceicao GM, 2016, REV BRAS ENG AGR AMB, V20, P1020, DOI 10.1590/1807-1929/agriambi.v20n11p1020-1024; Coradi PC, 2018, REV BRAS ENG AGR AMB, V22, P279, DOI 10.1590/1807-1929/agriambi.v22n4p279-285; Coradi PC, 2019, ACTA SCI-TECHNOL, V41, DOI 10.4025/actascitechnol.v41i1.36949; Coradi PC, 2019, REV CIENC AGRON, V50, P370, DOI 10.5935/1806-6690.20190044; De Jong AR, 2005, FOOD ADDIT CONTAM, V22, P975, DOI 10.1080/02652030500336254; Demito A., 2009, Engenharia na Agricultura, V17, P7; de Oliveira RAD, 2016, IND CROP PROD, V91, P332, DOI 10.1016/j.indcrop.2016.07.039; Ebone LA, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10040545; Ferreira FC, 2017, J SEED SCI, V39, P385, DOI 10.1590/2317-1545v39n4177535; Filho JM, 2013, INFORM ABRATES, V23, P21; Han ZP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092535; Jian F, 2014, J STORED PROD RES, V57, P63, DOI 10.1016/j.jspr.2013.12.002; Juvino ANK, 2014, REV BRAS ENG AGR AMB, V18, P844, DOI 10.1590/1807-1929/agriambi.v18n08p844-850; Keneni YG, 2019, IND CROP PROD, V132, P12, DOI 10.1016/j.indcrop.2019.02.012; Kong F, 2008, J FOOD SCI, V73, pS134, DOI 10.1111/j.1750-3841.2007.00652.x; Sarath KLL, 2016, J SEED SCI, V38, P233, DOI 10.1590/2317-1545v38n3165008; Lima JME, 2014, BRAZILIAN HORTICULTU, V31, P473; Lozano-Isla F, 2018, IND CROP PROD, V118, P214, DOI 10.1016/j.indcrop.2018.03.052; Mbofung GCY, 2013, CROP SCI, V53, P1086, DOI 10.2135/cropsci2012.09.0530; Moncaleano-Escandon J, 2013, IND CROP PROD, V44, P684, DOI 10.1016/j.indcrop.2012.08.035; Moreano TB, 2018, J SEED SCI, V40, P313, DOI 10.1590/2317-1545v40n3198414; Mourad AL, 2016, IND CROP PROD, V80, P6, DOI 10.1016/j.indcrop.2015.10.044; Naldi MC, 2011, APPL SOFT COMPUT, V11, P1938, DOI 10.1016/j.asoc.2010.06.010; Neethirajan S, 2010, BIOSYST ENG, V106, P395, DOI 10.1016/j.biosystemseng.2010.05.002; Neves JMG, 2016, REV BRAS ENG AGR AMB, V20, P1025, DOI 10.1590/1807-1929/agriambi.v20n11p1025-1030; Ozdemir M, 2004, CRIT REV FOOD SCI, V44, P185, DOI 10.1080/10408690490441578; Paraginski RT, 2015, REV BRAS ENG AGR AMB, V19, P358, DOI 10.1590/1807-1929/agriambi.v19n4p358-363; Smaniotto TAD, 2014, REV BRAS ENG AGR AMB, V18, P446, DOI 10.1590/S1415-43662014000400013; Taher HI, 2019, J STORED PROD RES, V82, P1, DOI 10.1016/j.jspr.2019.03.002; Virgolino ZZ, 2016, REV BRAS ENG AGR AMB, V20, P473, DOI 10.1590/1807-1929/agriambi.v20n5p473-480; Wang WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062868; Wijewardana C, 2019, FOOD CHEM, V278, P92, DOI 10.1016/j.foodchem.2018.11.035; Zhang SB, 2014, J STORED PROD RES, V59, P146, DOI 10.1016/j.jspr.2014.07.002; Zucareli C, 2015, REV BRAS ENG AGR AMB, V19, P803, DOI 10.1590/1807-1929/agriambi.v19n8p803-809; Zuchi Jacson, 2013, J. Seed Sci., V35, P353, DOI 10.1590/S2317-15372013000300012; Zuffo Alan Mario, 2017, Pesqui. Agropecu. Trop., V47, P312, DOI 10.1590/1983-40632016v4747576	48	5	5	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241787	10.1371/journal.pone.0241787	http://dx.doi.org/10.1371/journal.pone.0241787			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180797	Green Published, gold			2022-12-26	WOS:000593948000085
J	Costello, MJ; Gilliland, KO; Mohamed, A; Schey, KL; Johnsen, S; Brennan, LA; Kantorow, M				Costello, M. Joseph; Gilliland, Kurt O.; Mohamed, Ashik; Schey, Kevin L.; Johnsen, Sonke; Brennan, Lisa A.; Kantorow, Marc			Novel mitochondrial derived Nuclear Excisosome degrades nuclei during differentiation of prosimian Galago (bush baby) monkey lenses	PLOS ONE			English	Article							FIBER CELL-DIFFERENTIATION; GIANT MITOCHONDRIA; INTERNAL STRUCTURE; AUTOPHAGY	The unique cellular organization and transparent function of the ocular lens depend on the continuous differentiation of immature epithelial cells on the lens anterior surface into mature elongated fiber cells within the lens core. A ubiquitous event during lens differentiation is the complete elimination of organelles required for mature lens fiber cell structure and transparency. Distinct pathways have been identified to mediate the elimination of non-nuclear organelles and nuclei. Recently, we reported the discovery of a unique structure in developing fiber cells of the chick embryo lens, called the Nuclear Excisosome, that is intractably associated with degrading nuclei during lens fiber cell differentiation. In the chick lens, the Nuclear Excisosome is derived from projections of adjacent cells contacting the nuclear envelope during nuclear elimination. Here, we demonstrate that, in contrast to the avian model, Nuclear Excisosomes in a primate model, Galago (bush baby) monkeys, are derived through the recruitment of mitochondria to form unique linear assemblies that define a novel primate Nuclear Excisosome. Four lenses from three monkeys aged 2-5 years were fixed in formalin, followed by paraformaldehyde, then processed for Airyscan confocal microscopy or transmission electron microscopy. For confocal imaging, fluorescent dyes labelled membranes, carbohydrate in the extracellular space, filamentous actin and nuclei. Fiber cells from Galago lenses typically displayed prominent linear structures within the cytoplasm with a distinctive cross-section of four membranes and lengths up to 30 mu m. The outer membranes of these linear structures were observed to attach to the outer nuclear envelope membrane to initiate degradation near the organelle-free zone. The origin of these unique structures was mitochondria in the equatorial epithelium (not from plasma membranes of adjacent cells as in the chick embryo model). Early changes in mitochondria appeared to be the collapse of the cristae and modification of one side of the mitochondrial outer membrane to promote accumulation of protein in a dense cluster. As a mitochondrion surrounded the dense protein cluster, an outer mitochondrial membrane enclosed the protein to form a core and another outer mitochondrial membrane formed the outermost layer. The paired membranes of irregular texture between the inner core membrane and the outer limiting membrane appeared to be derived from modified mitochondrial cristae. Several mitochondria were involved in the formation and maturation of these unique complexes that apparently migrated around the fulcrum into the cytoplasm of nascent fiber cells where they were stabilized until the nuclear degradation was initiated. Thus, unlike in the chick embryo, the Galago lenses degraded nuclear envelopes with a Nuclear Excisosome derived from multiple mitochondria in the epithelium that formed novel linear assemblies in developing fiber cells. These findings suggest that recruitment of distinct structures is required for Nuclear Excisosome formation in different species.	[Costello, M. Joseph; Gilliland, Kurt O.] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA; [Mohamed, Ashik] LV Prasad Eye Inst, Ophthalm Biophys, Hyderabad, Telangana, India; [Schey, Kevin L.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Johnsen, Sonke] Duke Univ, Dept Biol, Durham, NC USA; [Brennan, Lisa A.; Kantorow, Marc] Florida Atlantic Univ, Dept Biomed Sci, Boca Raton, FL USA	University of North Carolina; University of North Carolina Chapel Hill; L. V. Prasad Eye Institute; Vanderbilt University; Duke University; State University System of Florida; Florida Atlantic University	Costello, MJ (corresponding author), Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC 27515 USA.	mjc@med.unc.edu	Core UNC, Hooker Imaging/AAE-1484-2022; Mohamed, Ashik/D-5105-2014	Gilliland, Kurt/0000-0002-9000-2119; Mohamed, Ashik/0000-0001-5520-4930; Costello, Martin/0000-0003-0207-660X; Brennan, Lisa/0000-0003-2265-2387	NIH/NEI [R01EY029708, R01EY008148, P30EY005722, R01EY013462]	NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	MJC: Grant support from NIH/NEI grant number R01EY008148 (MJC) and P30EY005722 (Duke Core Grant). Salary support was provided from this grant and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KOG: Grant support from NIH/NEI grant number R01EY008148. Salary support was provided from this grant and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AM: Grant support from NIH/NEI grant number R01EY008148. No salary support was provided from this grant and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. KLS: Grant support from NIH/NEI grant number R01EY013462 (KLS). Salary support was provided from this grant and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SJ: Grant support from NIH/NEI grant number R01EY008148. No salary support was provided from this grant and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LAB: Grant support from NIH/NEI grant number R01EY029708. Salary support was provided from this grant and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MK: Grant support from NIH/NEI grant number R01EY029708 (MK). Salary support was provided from this grant and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassnett S, 1997, INVEST OPHTH VIS SCI, V38, P1678; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Basu S, 2014, AUTOPHAGY, V10, P1193, DOI 10.4161/auto.28768; Brennan LA, 2018, EXP EYE RES, V174, P173, DOI 10.1016/j.exer.2018.06.003; Chaffee BR, 2014, DEVELOPMENT, V141, P3388, DOI 10.1242/dev.106005; Costello MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160785; Costello MJ, 2013, EXP EYE RES, V116, P411, DOI 10.1016/j.exer.2013.10.015; Costello MJ, 2013, EXP EYE RES, V116, P141, DOI 10.1016/j.exer.2013.08.017; Costello MJ, 2010, EXP EYE RES, V91, P881, DOI 10.1016/j.exer.2010.09.013; Dahm R, 2009, SCIENTIST, V23, P84; DAVIDOWITZ J, 1975, AM J PATHOL, V78, P191; Dudek J, 2013, BBA-MOL CELL RES, V1833, P274, DOI 10.1016/j.bbamcr.2012.05.028; Frey TG, 2000, TRENDS BIOCHEM SCI, V25, P319, DOI 10.1016/S0968-0004(00)01609-1; Frey TG, 2002, BBA-BIOENERGETICS, V1555, P196, DOI 10.1016/S0005-2728(02)00278-5; Gilliland KO, 2001, MOL VIS, V7, P120; Glancy B, 2020, TRENDS MOL MED, V26, P58, DOI 10.1016/j.molmed.2019.09.009; Hiller S, 2010, TRENDS BIOCHEM SCI, V35, P514, DOI 10.1016/j.tibs.2010.03.005; Huff J, 2015, NAT METHODS, V12, DOI 10.1038/nmeth.f.388; Jazek P, 2019, MITOCHONDRION, V49, P245, DOI 10.1016/j.mito.2019.06.007; Kanzaki Y, 2010, CIRCULATION, V121, P831, DOI 10.1161/CIR.0b013e3181d22e2d; Leonard M, 2011, DEV BIOL, V349, P363, DOI 10.1016/j.ydbio.2010.10.009; Maddala R, 2017, INVEST OPHTH VIS SCI, V58, P3445, DOI 10.1167/iovs.17-21539; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Mohamed A, 2013, MOL VIS, V19, P2352; Perkins G, 1997, J STRUCT BIOL, V119, P260, DOI 10.1006/jsbi.1997.3885; Puchades C, 2019, MOL CELL, V75, P1073, DOI 10.1016/j.molcel.2019.06.016; Puchades C, 2017, SCIENCE, V358, P609, DOI 10.1126/science.aao0464; Rabl C., 1899, Z WISS ZOOL, V67, P1; Rowan S, 2017, EXP EYE RES, V156, P72, DOI 10.1016/j.exer.2016.02.011; TANDLER B, 1986, ANN NY ACAD SCI, V488, P65; Vincent AE, 2016, SCI REP-UK, V6, DOI 10.1038/srep30610; Wride MA, 2011, PHILOS T R SOC B, V366, P1219, DOI 10.1098/rstb.2010.0324; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753; Zhou CJ, 2003, EXP EYE RES, V77, P423, DOI 10.1016/S0014-4835(03)00171-4	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241631	10.1371/journal.pone.0241631	http://dx.doi.org/10.1371/journal.pone.0241631			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180800	Green Published, gold			2022-12-26	WOS:000593948000045
J	Ryu, WS; Jeong, SW; Kim, DE				Ryu, Wi-Sun; Jeong, Sang-Wuk; Kim, Dong-Eog			Total small vessel disease burden and functional outcome in patients with ischemic stroke	PLOS ONE			English	Article							CLINICAL-OUTCOMES; LEUKOARAIOSIS; RISK	Background Cerebral small vessel disease (SVD) is comprised of lacunes, cerebral microbleeds (CMBs), white matter hyperintensities (WMHs), and enlarged perivascular space (EPVS). We investigated the cumulative effect of SVD on 3-month functional outcome following ischemic stroke using the total SVD score. Methods The total SVD score of 477 acute ischemic stroke patients with adequate brain MRI was analyzed. We used multivariable ordinal logistic regression analysis to investigate the independent impact of total SVD score on ordinal modified Rankin Scale (mRS) score at 3-month after ischemic stroke. Results Mean age was 66 +/- 14 years, and 61% were men. The distribution of the total SVD score from 0 to 4 was 27%, 24%, 26%, 16%, and 7%, respectively. The proportion of mRS scores 2 or greater was 16% and 47% in total SVD score 0 and 4, respectively. Multivariable ordinal logistic regression analysis results showed that compared with the total SVD score of 0, total SVD scores of 2, 3, and 4 were independently associated with higher mRS scores with adjusted odds ratios (95% confidence intervals) of 1.68 (1.02-2.76), 2.24 (1.25-4.00), and 2.00 (1.02-4.29). Lacunes, CMBs, WMHs but not EPVS were associated with mRS scores at 3 months. However, the impact of each SVD marker on stroke outcome was smaller than that of the total SVD score. Conclusion We found an independent association between total SVD scores and functional outcome at 3 months following ischemic stroke. The total SVD score may be useful for stratification of patients who are at a high-risk of unfavorable outcomes.	[Ryu, Wi-Sun; Jeong, Sang-Wuk; Kim, Dong-Eog] Dongguk Univ Ilsan Hosp, Dept Neurol, Goyang, South Korea; [Ryu, Wi-Sun; Jeong, Sang-Wuk; Kim, Dong-Eog] Korean Brain MRI Data Ctr, Goyang, South Korea	Dongguk University	Ryu, WS (corresponding author), Dongguk Univ Ilsan Hosp, Dept Neurol, Goyang, South Korea.; Ryu, WS (corresponding author), Korean Brain MRI Data Ctr, Goyang, South Korea.	wisunryu@gmail.com			Dongguk University Research Program	Dongguk University Research Program	WSR: This work was supported by the Dongguk University Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, EPIDEMIOL PREV, V39, P224; Arba F, 2017, ACTA NEUROL SCAND, V136, P72, DOI 10.1111/ane.12745; Arba F, 2019, NEUROL SCI, V40, P1227, DOI 10.1007/s10072-019-03824-4; Arba F, 2018, INT J STROKE, V13, P47, DOI 10.1177/1747493016666091; Arba F, 2016, INT J STROKE, V11, P62, DOI 10.1177/1747493015607517; Ay H, 2008, STROKE, V39, P1409, DOI 10.1161/STROKEAHA.107.501932; Brown R, 2018, CARDIOVASC RES, V114, P1462, DOI 10.1093/cvr/cvy113; Charidimou A, 2017, STROKE, V48, P2084, DOI 10.1161/STROKEAHA.116.012992; Charidimou A, 2016, STROKE, V47, P2364, DOI 10.1161/STROKEAHA.116.014096; Choi KH, 2019, STROKE, V50, P127, DOI 10.1161/STROKEAHA.118.023084; Hilal S, 2018, NEUROLOGY, V91, pE832, DOI 10.1212/WNL.0000000000006079; Huo YC, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00808; Inzitari D, 2000, NEUROLOGY, V54, P660, DOI 10.1212/WNL.54.3.660; Jeong HG, 2015, STROKE, V46, P687, DOI 10.1161/STROKEAHA.114.007466; Kim DE, 2019, JAMA NEUROL, V76, P72, DOI 10.1001/jamaneurol.2018.2808; Klarenbeek P, 2013, STROKE, V44, P2995, DOI 10.1161/STROKEAHA.113.002545; Ko Y, 2014, J STROKE, V16, P161, DOI 10.5853/jos.2014.16.3.161; Lau KK, 2017, NEUROLOGY, V88, P2260, DOI 10.1212/WNL.0000000000004042; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Ryu WS, 2019, NEUROLOGY, V93, pE578, DOI 10.1212/WNL.0000000000007896; Ryu WS, 2017, BRAIN, V140, P158, DOI 10.1093/brain/aww259; Ryu WS, 2014, STROKE, V45, P3567, DOI 10.1161/STROKEAHA.114.006662; Sagnier S, 2020, STROKE, V51, P449, DOI 10.1161/STROKEAHA.119.026886; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7	25	7	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242319	10.1371/journal.pone.0242319	http://dx.doi.org/10.1371/journal.pone.0242319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180837	Green Published, gold			2022-12-26	WOS:000593948000054
J	Blair, S; Robertson, S; Duthie, G; Ball, K				Blair, Stephanie; Robertson, Sam; Duthie, Grant; Ball, Kevin			Biomechanics of accurate and inaccurate goal-kicking in Australian football: Group-based analysis	PLOS ONE			English	Article							SUPPORT LEG; SOCCER; PERFORMANCE; KINEMATICS; VELOCITY; ACQUISITION; PATTERNS; IMPACT; TASK	Goal-kicking is an important skill in Australian Football (AF). This study examined whether kinematic differences exist between accurate and inaccurate goal-kicks and determined the relationships between technical factors and accuracy. Eighteen elite to sub-elite AF players performed 15 x 30 m goal-kicks on an AF training ground, with three-dimensional kinematics collected using the Xsens inertial measurement system (Xsens Technologies B.V., Enschede, the Netherlands). A general linear mixed modelling approach and regression-based statistics were employed to quantify differences between accurate and inaccurate goal kicks and the relationships between technical factors and accuracy. Accurate goal-kicks were characterised by a straighter approach line, with less kick-leg joint range of motion (knee and hip), lower linear velocity (centre of mass, foot speed), angular velocity (knee and shank), and less support-leg knee flexion during the kicking phase compared to inaccurate goal-kicks. At the end of the follow through, players produced greater ankle plantarflexion and a straighter-leg line in accurate goal-kicks. Findings in this research indicated that many factors interact with goal-kicking accuracy in AF, ranging from the players' approach line path, their support-leg mechanics, the kick-leg swing motion, to the final position of the kicker during their follow through.	[Blair, Stephanie; Robertson, Sam; Duthie, Grant; Ball, Kevin] Victoria Univ, Inst Hlth & Sport IHES, Melbourne, Vic, Australia; [Blair, Stephanie] English Inst Sport, Manchester, Lancs, England; [Duthie, Grant] Australian Catholic Univ, Sch Exercise Sci, Sydney, NSW, Australia	Victoria University; Australian Catholic University	Blair, S (corresponding author), Victoria Univ, Inst Hlth & Sport IHES, Melbourne, Vic, Australia.; Blair, S (corresponding author), English Inst Sport, Manchester, Lancs, England.	Stephanie.blair@eis2win.co.uk	Duthie, Grant/GSE-5160-2022	Duthie, Grant/0000-0001-5920-0363; Robertson, Samuel/0000-0002-8330-0011				Alcock AM, 2012, J SPORT SCI, V30, P387, DOI 10.1080/02640414.2011.643238; Anderson D, 2018, PERCEPT MOTOR SKILL, V125, P817, DOI 10.1177/0031512518781265; [Anonymous], 2008, IARC PUBL, VIX, P1; [Anonymous], 2016, J GERIATR CARDIOL; Asai T., 2002, SPORTS ENG, V5, P183, DOI DOI 10.1046/J.1460-2687.2002.00108.X; Asami T., 1983, BIOMECHANICS 8 B, P695; Atack AC, 2019, J BIOMECH, V87, P114, DOI 10.1016/j.jbiomech.2019.02.020; Augustus S, 2017, J SPORT SCI, V35, P89, DOI 10.1080/02640414.2016.1156728; Baker J, 1996, BIOMECHANICAL CONSID; Ball K, 2002, J SCI MED SPORT, V5, P48; Ball K, 2018, 36 INT SOC BIOM SPOR; Ball K, 2008, SPORT BIOMECH, V7, P10, DOI 10.1080/14763140701683015; Ball K, 2013, J SCI MED SPORT, V16, P455, DOI 10.1016/j.jsams.2012.10.008; Ball KA, 2011, J SPORT SCI, V29, P1545, DOI 10.1080/02640414.2011.605163; Bates BT, 2004, INNOVATIVE ANAL HUMA, P1; Bernstein N, 1967, COORDINATION REGULAT; Berthouze L, 2004, ADAPT BEHAV, V12, P47, DOI 10.1177/105971230401200104; Bezodis N, 2007, SPORT BIOMECH, V6, P171, DOI 10.1080/14763140701324487; Blair S, 2017, 35 INT SOC BIOM SPOR; Blair S, 2018, 36 INT SOC BIOM SPOR; Blair S, 2019, THESIS; Blair S, 2018, J BIOMECH, V73, P24, DOI 10.1016/j.jbiomech.2018.03.031; Caillou N, 2002, CAN J EXP PSYCHOL, V56, P283, DOI 10.1037/h0087404; Cohen J.E., 1988, STAT POWER ANAL BEHA; D Damayanti D., 2018, BULLWHIP EFFECT SUPP, V1, P1, DOI DOI 10.1080/09593330.2018.1526217; Dichiera A, 2006, J SCI MED SPORT, V9, P292, DOI 10.1016/j.jsams.2006.06.007; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Gheidi N, 2010, AM J APPL SCI, V7, P1334, DOI DOI 10.3844/AJASSP.2010.1334.1340; Hayes GJ, 1970, NUMERICAL APPROXIMAT; Holmes CE, 2008, THESIS; Hosford G, 2007, SCI KICKING, P22; Inoue K, 2014, J SPORT SCI, V32, P1023, DOI 10.1080/02640414.2014.886126; International guidelines for groin hernia management, 2018, REV HISPANOAM HERNIA, V22, P1; Izovska J, 2016, J PHYS ED SPORT, V16, P459, DOI DOI 10.7752/JPES.2016.02070; Jaeger BC, 2017, J APPL STAT, V44, P1086, DOI 10.1080/02664763.2016.1193725; Knudson D, 2001, J SPORT SCI, V19, P839, DOI 10.1080/026404101753113787; Knudson D., 2007, FUNDAMENTALS BIOMECH; Latash ML, 2008, SYNERGY; Lees A, 2010, J SPORT SCI, V28, P805, DOI 10.1080/02640414.2010.481305; Lees A., 2002, SCI FOOTBALL 4, P16; MASSION J, 1991, NATO ADV SCI I D-BEH, V62, P199; Parrington L, 2015, J SPORT SCI, V33, P346, DOI 10.1080/02640414.2014.942685; Peacock J, 2019, J SPORT SCI, V37, P467, DOI 10.1080/02640414.2018.1505408; Peacock J, 2018, HUM MOVEMENT SCI, V61, P99, DOI 10.1016/j.humov.2018.07.009; Peacock JCA, 2017, SPORTS ENG, V20, P221, DOI 10.1007/s12283-017-0237-y; PUTNAM CA, 1991, MED SCI SPORT EXER, V23, P130; Reed ES, 1989, DEV POSTURE GAIT LIF, P3; Roberts TDM, 1995, UNDERSTANDING BALANC; Robertson S, 2016, J SPORT SCI, V34, P637, DOI 10.1080/02640414.2015.1066026; Roetenberg D., 2009, XSENS MOTION TECH BV, V1, P1; Sinclair J, 2017, INT J SPORTS SCI COA, V12, P371, DOI 10.1177/1747954117710515; Sterzing T., 2009, SCI FOOTBALL, VVI, P50; Sterzing T, 2008, EXERC SPORT SCI REV, V36, P91, DOI 10.1097/JES.0b013e318168ece7; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Teixeira LA, 1999, PERCEPT MOTOR SKILL, V88, P785, DOI 10.2466/PMS.88.3.785-789; Tol JL, 2002, AM J SPORT MED, V30, P45, DOI 10.1177/03635465020300012101; VEREIJKEN B, 1992, J MOTOR BEHAV, V24, P133, DOI 10.1080/00222895.1992.9941608; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Woods CT, 2020, SPORTS MED-OPEN, V6, DOI 10.1186/s40798-020-00268-5; Yang JF, 2005, EXP BRAIN RES, V163, P137, DOI 10.1007/s00221-004-2149-x	60	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241969	10.1371/journal.pone.0241969	http://dx.doi.org/10.1371/journal.pone.0241969			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0LY	33175905	Green Accepted, gold, Green Published			2022-12-26	WOS:000593946900030
J	Fernandez-Colorado, CP; Cammayo, PLT; Flores, RA; Nguyen, BT; Kim, WH; Kim, S; Lillehoj, HS; Min, W				Fernandez-Colorado, Cherry P.; Cammayo, Paula Leona T.; Flores, Rochelle A.; Nguyen, Binh T.; Kim, Woo H.; Kim, Suk; Lillehoj, Hyun S.; Min, Wongi			Anti-inflammatory activity of diindolylmethane alleviates Riemerella anatipestifer infection in ducks	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; STAPHYLOCOCCAL-ENTEROTOXIN-B; CELL-CYCLE ARREST; 3,3'-DIINDOLYLMETHANE SUPPRESSES; MOLECULAR-CLONING; GENE-EXPRESSION; DOWN-REGULATION; HOST-DEFENSE; IN-VITRO; T-CELLS	3,3'-Diindolylmethane (DIM) is found in cruciferous vegetables and is used to treat various inflammatory diseases because of its potential anti-inflammatory effects. To investigate effects of DIM in Riemerella anatipestifer-infected ducks which induce upregulation of inflammatory cytokines, ducks were treated orally with DIM at dose of 200 mg/kg/day and infected the following day with R. anatipestifer. Infected and DIM-treated ducks exhibited 14% increased survival rate and significantly decreased bacterial burden compared to infected untreated ducks. Next, the effect on the expression level of inflammatory cytokines (interleukin [IL]-17A, IL-17F, IL-6, IL-1 beta) of both in vitro and in vivo DIM-treated groups was monitored by quantitative reverse-transcription PCR (qRT-PCR). Generally, the expression levels of the cytokines were significantly reduced in DIM-treated splenic lymphocytes stimulated with killed R. anatipestifer compared to stimulated untreated splenic lymphocytes. Similarly, the expression levels of the cytokines were significantly reduced in the spleens and livers of DIM-treated R. anatipestifer-infected ducks compared to infected untreated ducks. This study demonstrated the ameliorative effects of DIM in ducks infected with R. anatipestifer. Thus, DIM can potentially be used to prevent and/or treat R. anatipestifer infection via inhibition of inflammatory cytokine expression.	[Fernandez-Colorado, Cherry P.] Univ Philippines Los Banos, Dept Vet Paraclin Sci, Coll Vet Med, Coll Laguna, Laguna, Philippines; [Fernandez-Colorado, Cherry P.; Cammayo, Paula Leona T.; Flores, Rochelle A.; Nguyen, Binh T.; Kim, Suk; Min, Wongi] Gyeongsang Natl Univ, Coll Vet Med, Jinju, South Korea; [Fernandez-Colorado, Cherry P.; Cammayo, Paula Leona T.; Flores, Rochelle A.; Nguyen, Binh T.; Kim, Suk; Min, Wongi] Gyeongsang Natl Univ, Inst Anim Med, Jinju, South Korea; [Kim, Woo H.; Lillehoj, Hyun S.] ARS, Anim Biosci & Biotechnol Lab, USDA, Beltsville, MD USA	University of the Philippines System; University of the Philippines Los Banos; Gyeongsang National University; Gyeongsang National University; United States Department of Agriculture (USDA)	Min, W (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Jinju, South Korea.; Min, W (corresponding author), Gyeongsang Natl Univ, Inst Anim Med, Jinju, South Korea.	wongimin@gnu.ac.kr		Min, Wongi/0000-0003-2437-7366	Basic Science Research Program through the NRF of Korea - Ministry of Education [2018R1D1A1B07045179]; Korea IPET through Agriculture, Food and Rural Affairs Convergence Technologies Program for Educating Creative Global Leader [MAFRA-7160027]	Basic Science Research Program through the NRF of Korea - Ministry of Education; Korea IPET through Agriculture, Food and Rural Affairs Convergence Technologies Program for Educating Creative Global Leader	This research was supported by the Basic Science Research Program through the NRF of Korea, funded by the Ministry of Education (2018R1D1A1B07045179), and by Korea IPET through Agriculture, Food and Rural Affairs Convergence Technologies Program for Educating Creative Global Leader, funded by MAFRA-7160027.	[Anonymous], 2013, DIS POULTRY; [Anonymous], 2013, POLIT THEORY, V41, p[409, 418]; Bai H, 2017, CELL MOL IMMUNOL, V14, P850, DOI 10.1038/cmi.2016.53; Busbee PB, 2014, TOXICOL APPL PHARM, V274, P7, DOI 10.1016/j.taap.2013.10.022; Cammayo PLT, 2020, DEV COMP IMMUNOL, V106, DOI 10.1016/j.dci.2020.103633; Cha SY, 2015, J WILDLIFE DIS, V51, P341, DOI 10.7589/2014-05-128; Chen I, 1996, BIOCHEM PHARMACOL, V51, P1069, DOI 10.1016/0006-2952(96)00060-3; Cho HJ, 2008, J NUTR, V138, P17, DOI 10.1093/jn/138.1.17; Diaz JAR, 2016, DEV COMP IMMUNOL, V61, P190, DOI 10.1016/j.dci.2016.04.002; Dong L, 2010, BIOCHEM PHARMACOL, V79, P715, DOI 10.1016/j.bcp.2009.10.010; Elliott DM, 2016, J PHARMACOL EXP THER, V357, P177, DOI 10.1124/jpet.115.226563; Fan SJ, 2013, P NATL ACAD SCI USA, V110, P18650, DOI 10.1073/pnas.1308206110; Fernandez CP, 2018, MOL IMMUNOL, V95, P20, DOI 10.1016/j.molimm.2018.01.009; Fernandez CP, 2017, DEV COMP IMMUNOL, V77, P121, DOI 10.1016/j.dci.2017.07.027; Fernandez CP, 2016, DEV COMP IMMUNOL, V63, P36, DOI 10.1016/j.dci.2016.05.009; Flores RA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49516-z; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Han XA, 2012, APPL MICROBIOL BIOT, V93, P1197, DOI 10.1007/s00253-011-3635-2; Hu QH, 2012, VET MICROBIOL, V157, P428, DOI 10.1016/j.vetmic.2012.01.009; Hu QH, 2011, VET MICROBIOL, V150, P278, DOI 10.1016/j.vetmic.2011.01.022; Huang Z, 2013, MOL IMMUNOL, V53, P335, DOI 10.1016/j.molimm.2012.09.007; Ikeda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115198; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Jeon EJ, 2016, J AGR FOOD CHEM, V64, P7702, DOI 10.1021/acs.jafc.6b02604; Jeong J, 2014, VET IMMUNOL IMMUNOP, V162, P154, DOI 10.1016/j.vetimm.2014.09.005; Kim EJ, 2010, MOL CARCINOGEN, V49, P672, DOI 10.1002/mc.20640; Kim HW, 2014, TOXICOL SCI, V137, P158, DOI 10.1093/toxsci/kft240; Kim SM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071155; Kim WH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00560; Kim WH, 2015, VET IMMUNOL IMMUNOP, V164, P194, DOI 10.1016/j.vetimm.2015.02.007; Kim YH, 2009, INFLAMM BOWEL DIS, V15, P1164, DOI 10.1002/ibd.20917; Le HT, 2003, J BIOL CHEM, V278, P21136, DOI 10.1074/jbc.M300588200; Li WX, 2015, ONCOTARGET, V6, P23776, DOI 10.18632/oncotarget.4196; Liu HH, 2012, GENET MOL BIOL, V35, P182, DOI 10.1590/S1415-47572012005000023; LOH H, 1992, AVIAN PATHOL, V21, P453, DOI 10.1080/03079459208418863; Lu L, 2016, FREE RADICAL BIO MED, V99, P463, DOI 10.1016/j.freeradbiomed.2016.09.007; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Maughan MN, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-94; Mondal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051869; Pappu R, 2011, IMMUNOLOGY, V134, P8, DOI 10.1111/j.1365-2567.2011.03465.x; Pathanasophon P, 2002, AVIAN PATHOL, V31, P267, DOI 10.1080/03079450220136576; Rouse M, 2014, J PHARMACOL EXP THER, V350, P341, DOI 10.1124/jpet.114.214742; Rouse M, 2013, BRIT J PHARMACOL, V169, P1305, DOI 10.1111/bph.12205; Roy S, 2014, MED CHEM RES, V23, P1371, DOI 10.1007/s00044-013-0737-7; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Subramaniam S, 2000, CLIN DIAGN LAB IMMUN, V7, P168, DOI 10.1128/CDLI.7.2.168-174.2000; Sung WS, 2007, BIOL PHARM BULL, V30, P1865, DOI 10.1248/bpb.30.1865; Sung WS, 2007, IUBMB LIFE, V59, P408, DOI 10.1080/15216540701422373; Tomar S, 2015, BRIT J PHARMACOL, V172, P2133, DOI 10.1111/bph.13036; Wang XL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109962; Wei LM, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-66; Xue L, 2005, ONCOGENE, V24, P2343, DOI 10.1038/sj.onc.1208434; Xue L, 2008, J NUTR BIOCHEM, V19, P336, DOI 10.1016/j.jnutbio.2007.05.004; Zhai ZP, 2013, VET MICROBIOL, V162, P850, DOI 10.1016/j.vetmic.2012.11.002; Zhang YW, 2014, MICROBIOL IMMUNOL, V58, P456, DOI 10.1111/1348-0421.12169; Zhao XX, 2016, MICROB PATHOGENESIS, V91, P99, DOI 10.1016/j.micpath.2015.12.001; Zhou ZT, 2013, AVIAN PATHOL, V42, P129, DOI 10.1080/03079457.2013.770127; Zou JC, 2015, APPL MICROBIOL BIOT, V99, P10107, DOI 10.1007/s00253-015-6848-y; Zou JC, 2015, VET MICROBIOL, V177, P193, DOI 10.1016/j.vetmic.2015.03.003	59	0	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242198	10.1371/journal.pone.0242198	http://dx.doi.org/10.1371/journal.pone.0242198			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175869	Green Published, gold			2022-12-26	WOS:000593946900038
J	Leal-Gutierrez, JD; Elzo, MA; Carr, C; Mateescu, RG				Leal-Gutierrez, Joel D.; Elzo, Mauricio A.; Carr, Chad; Mateescu, Raluca G.			RNA-seq analysis identifies cytoskeletal structural genes and pathways for meat quality in beef	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; GENOME-WIDE ASSOCIATION; PROSTATE-CANCER; PHOSPHOLAMBAN GENE; IN-VITRO; PROTEIN; MUTATIONS; TRAITS; PARAMETERS; COMPLEX	RNA sequencing (RNA-seq) has allowed for transcriptional profiling of biological systems through the identification of differentially expressed (DE) genes and pathways. A total of 80 steers with extreme phenotypes were selected from the University of Florida multibreed Angus-Brahman herd. The average slaughter age was 12.91 +/- 8.69 months. Tenderness, juiciness and connective tissue assessed by sensory panel, along with marbling, Warner-Bratzler Shear Force (WBSF) and cooking loss, were measured in longissimus dorsi muscle. Total RNA was extracted from muscle and one RNA-seq library per sample was constructed, multiplexed, and sequenced based on protocols by Illumina HiSeq-3000 platform to generate 2x101 bp paired-end reads. The overall read mapping rate using the Btau_4.6.1 reference genome was 63%. A total of 8,799 genes were analyzed using two different methodologies, an expression association and a DE analysis. A gene and exon expression association analysis was carried out using a meat quality index on all 80 samples as a continuous response variable. The expression of 208 genes and 3,280 exons from 1,565 genes was associated with the meat quality index (p-value <= 0.05). A gene and isoform DE evaluation was performed analyzing two groups with extreme WBSF, tenderness and marbling. A total of 676 (adjusted p-value <= 0.05), 70 (adjusted p-value <= 0.1) and 198 (adjusted p-value <= 0.1) genes were DE for WBSF, tenderness and marbling, respectively. A total of 106 isoforms from 98 genes for WBSF, 13 isoforms from 13 genes for tenderness and 43 isoforms from 42 genes for marbling (FDR <= 0.1) were DE. Cytoskeletal and transmembrane anchoring genes and pathways were identified in the expression association, DE and the gene enrichment analyses; these proteins can have a direct effect on meat quality. Cytoskeletal proteins and transmembrane anchoring molecules can influence meat quality by allowing cytoskeletal interaction with myocyte and organelle membranes, contributing to cytoskeletal structure and architecture maintenance postmortem.	[Leal-Gutierrez, Joel D.; Elzo, Mauricio A.; Carr, Chad; Mateescu, Raluca G.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Leal-Gutierrez, JD (corresponding author), Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA.	joelleal@ufl.edu		Leal Gutierrez, Joel David/0000-0002-2811-5390; Mateescu, Raluca/0000-0002-2661-1198	Florida Agricultural Experiment Station Hatch [FLA-ANS-005548]; Florida Cattlemen's Association - Beef Enhancement Fund Award [022962]	Florida Agricultural Experiment Station Hatch; Florida Cattlemen's Association - Beef Enhancement Fund Award	RM; Financial support provided by Florida Agricultural Experiment Station Hatch FLA-ANS-005548 (https://edis.ifas.ufl.edu/topic_faes) and Florida Cattlemen's Association (https://www.floridacattlemen.org/) - Beef Enhancement Fund Award 022962. The funders were not involved in the study design or collection, analysis, or interpretation of the data.	Ahn J, 2013, LIPIDS, V48, P209, DOI 10.1007/s11745-013-3756-8; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Andrews A., 2018, FASTQC; [Anonymous], 2017, LANCET ONCOL, V18, P1, DOI 10.1016/S1470-2045(16)30642-8; [Anonymous], 2011, THER ADV MED ONCOL, V3, pS7; [Anonymous], 2015, PULSE INT, V16, P1; [Anonymous], 2012, REGEN MED S3, V7, pS14; [Anonymous], 1989, JMP VERSION 13; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; [Anonymous], 2013, LANCET ONCOL, V14, pe168; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Azzato EM, 2010, CANCER EPIDEM BIOMAR, V19, P1140, DOI 10.1158/1055-9965.EPI-10-0085; Bandyopadhyay U, 2008, MOL CELL BIOL, V28, P5747, DOI 10.1128/MCB.02070-07; Bang ML, 2006, J CELL BIOL, V173, P905, DOI 10.1083/jcb.200603119; Barcellos KSA, 2013, J BIOL CHEM, V288, P2179, DOI 10.1074/jbc.M112.432716; Basseres DS, 2002, BIOCHEM BIOPH RES CO, V294, P579; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Batrakou DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127712; Belk K., 2015, RES GUIDELINES COOKE, P6; Berryman M, 2004, J BIOL CHEM, V279, P34794, DOI 10.1074/jbc.M402835200; Bhuiyan MSA, 2017, J ANIM SCI, V95, P3359, DOI 10.2527/jas.2017.1493; Biasini Marco, 2014, Nucleic Acids Res, V42, pW252, DOI 10.1093/nar/gku340; Braig S, 2013, ONCOGENE, V32, P837, DOI 10.1038/onc.2012.115; Buurman R, 2016, EUR J MED RES, V21, DOI 10.1186/s40001-016-0217-x; Ceholski DK, 2012, J BIOL CHEM, V287, P26596, DOI 10.1074/jbc.M112.382713; Ceholski DK, 2012, J BIOL CHEM, V287, P16521, DOI 10.1074/jbc.M112.360859; Chen Yunshun, 2016, F1000Res, V5, P1438, DOI 10.12688/f1000research.8987.2; Colin E, 2014, AM J HUM GENET, V95, P637, DOI 10.1016/j.ajhg.2014.10.011; Cuajungco MP, 2014, TRAFFIC, V15, P1247, DOI 10.1111/tra.12205; Cuervo AM, 2000, J CELL SCI, V113, P4441; Draheim KM, 2010, INTEGRAL ROLE ARRDC3, DOI [10.13028/1nh7-nt35.https, DOI 10.13028/1NH7-NT35.HTTPS]; El-Assaad W, 2015, DIABETOLOGIA, V58, P149, DOI 10.1007/s00125-014-3429-z; Elzo MA, 2016, LIVEST SCI, V190, P104, DOI 10.1016/j.livsci.2016.06.011; Elzo MA, 2015, LIVEST SCI, V178, P43, DOI 10.1016/j.livsci.2015.06.015; Elzo MA, 2015, LIVEST SCI, V175, P18, DOI 10.1016/j.livsci.2015.03.002; Fang ZY, 2006, MOL CELL PROTEOMICS, V5, P1437, DOI 10.1074/mcp.M600050-MCP200; Farnier C, 2003, INT J OBESITY, V27, P1178, DOI 10.1038/sj.ijo.0802399; Furukawa T, 2011, SCI REP-UK, V1, DOI 10.1038/srep00161; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Gu Z, 2013, ONCOGENE, V32, P1888, DOI 10.1038/onc.2012.207; Haas BJ, 2010, NAT BIOTECHNOL, V28, P421, DOI 10.1038/nbt0510-421; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Helfer E, 2013, BIOL CELL, V105, P191, DOI 10.1111/boc.201200038; Hu W-X, 2009, BLOOD, V114; Hu WX, 2007, BLOOD, V110, p108B, DOI 10.1182/blood.V110.11.4157.4157; Hubert V, 2016, BIOL OPEN, V5, P1516, DOI 10.1242/bio.018648; Iezaki T, 2016, MOL CELL BIOL, V36, P2451, DOI 10.1128/MCB.01075-15; Jia D, 2010, P NATL ACAD SCI USA, V107, P10442, DOI 10.1073/pnas.0913293107; Johansson MU, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-173; Kelly NJ, 2018, ONCOGENE, V37, P651, DOI 10.1038/onc.2017.372; Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750; Kim A, 2009, CARCINOGENESIS, V30, P927, DOI 10.1093/carcin/bgp072; Korpelainen E., 2014, RNA SEQ DATA ANAL PR; Krem MM, 2010, CELL CYCLE, V9, P670, DOI 10.4161/cc.9.4.10780; Kusakabe M, 2009, BIOCHEM BIOPH RES CO, V390, P1283, DOI 10.1016/j.bbrc.2009.10.137; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leal-Gutierrez JD, 2018, 11 WORLD C GEN APPL; Leal-Gutierrez JD, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.538640; Leal-Gutierrez JD, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5518-3; Leal-Gutierrez JD, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00056; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lin H.W., 2010, J VAC SCI TECHNOL B, V28, pL5; Liu YY, 2014, J BIOL CHEM, V289, P4778, DOI 10.1074/jbc.M113.486290; Long AB, 2013, CELL DEATH DIFFER, V20, P1510, DOI 10.1038/cdd.2013.97; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Ma J, 2016, PATHOLOGY, V48, P691, DOI 10.1016/j.pathol.2016.08.005; Ma T, 2014, CANCER BIOL THER, V15, P643, DOI 10.4161/cbt.28251; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mateescu RG, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00171; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McClure MC, 2012, ANIM GENET, V43, P662, DOI 10.1111/j.1365-2052.2012.02323.x; Medin M, 2007, EUR J HEART FAIL, V9, P37, DOI 10.1016/j.ejheart.2006.04.007; Menetrey J, 2007, EMBO J, V26, P1953, DOI 10.1038/sj.emboj.7601634; Micheli L, 2011, J BIOL CHEM, V286, P5691, DOI 10.1074/jbc.M110.162842; Miliara X, 2015, EMBO REP, V16, P824, DOI 10.15252/embr.201540229; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Patwari P, 2011, CELL METAB, V14, P671, DOI 10.1016/j.cmet.2011.08.011; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; R Core Team, 2021, R LANGUAGE ENV STAT; Ramayo-Caldas Y, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0216-y; Ramo O, 2016, SCI REP-UK, V6, DOI 10.1038/srep35969; Raychowdhury MK, 2004, HUM MOL GENET, V13, P617, DOI 10.1093/hmg/ddh067; Ren GF, 2014, HISTOL HISTOPATHOL, V29, P535, DOI 10.14670/HH-29.10.535; Reyes A, 2013, P NATL ACAD SCI USA, V110, P15377, DOI 10.1073/pnas.1307202110; Riley DG, 2003, J ANIM SCI, V81, P54; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schmiege P, 2017, NATURE, V550, P366, DOI 10.1038/nature24036; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin DH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-240; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; Fonseca LFS, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4323-0; Singh H, 2007, FEBS J, V274, P6306, DOI 10.1111/j.1742-4658.2007.06145.x; Suzuki T, 2006, MOL CELL BIOL, V26, P6149, DOI 10.1128/MCB.00298-06; Teng JP, 2017, ONCOL LETT, V14, P4613, DOI 10.3892/ol.2017.6729; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Uniacke J, 2014, CANCER RES, V74, P1379, DOI 10.1158/0008-5472.CAN-13-2278; Venables WN., 2002, MODERN APPL STAT S, V4; Wang L, 2015, BIOINFORMATICS, V28, P137, DOI [10.1007/978-1-4939-2291-8_8 25577376, DOI 10.1007/978-1-4939-2291-8_8]; Wang P, 2016, SCI REP, V6, P1, DOI DOI 10.1038/s41598-016-0001-8; Wang S, 2016, ELIFE, V5, DOI 10.7554/eLife.14211; Wang WQ, 2009, INT J CANCER, V124, P521, DOI 10.1002/ijc.23961; Wegner B, 2010, AM J PHYSIOL-RENAL, V298, pF1492, DOI 10.1152/ajprenal.00030.2010; Weinstein LS, 2004, ENDOCRINOLOGY, V145, P5459, DOI 10.1210/en.2004-0865; Xu LY, 2015, MOL BIOL EVOL, V32, P711, DOI 10.1093/molbev/msu333; Yong FL, 2014, INT J MOL SCI, V15, P11713, DOI 10.3390/ijms150711713; Zagani R, 2015, ONCOTARGET, V6, P28282, DOI 10.18632/oncotarget.5061; Zalecenia kliniczne dotyczace postepowania u chorych na cukrzyce, 2010, DIABETOLOGIA PRAKTYC, V11, pA38; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang SL, 2018, ONCOL LETT, V16, P3517, DOI 10.3892/ol.2018.9075; Zheng Y, 2017, CURR MOL MED, V17, P221, DOI 10.2174/1566524017666170807144711	115	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0240895	10.1371/journal.pone.0240895	http://dx.doi.org/10.1371/journal.pone.0240895			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175867	gold, Green Submitted, Green Published			2022-12-26	WOS:000593946900045
J	Martin-Delgado, J; Viteri, E; Mula, A; Serpa, P; Pacheco, G; Prada, D; Lourencao, DCD; Baptista, PCP; Ramirez, G; Mira, JJ				Martin-Delgado, Jimmy; Viteri, Eduardo; Mula, Aurora; Serpa, Piedad; Pacheco, Gloria; Prada, Diana; Campos de Andrade Lourencao, Daniela; Campos Pavan Baptista, Patricia; Ramirez, Gustavo; Mira, Jose Joaquin			Availability of personal protective equipment and diagnostic and treatment facilities for healthcare workers involved in COVID-19 care: A cross-sectional study in Brazil, Colombia, and Ecuador	PLOS ONE			English	Article								Many affected counties have had experienced a shortage of personal protective equipment (PPE) during the coronavirus disease (COVID-19) pandemic. We aimed to investigate the needs of healthcare professionals and the technical difficulties faced by them during the initial outbreak. A cross-sectional web-based survey was conducted among the healthcare workforce in the most populous cities from three Latin American countries in April 2020. In total, 1,082 participants were included. Of these, 534 (49.4%), 263 (24.3%), and 114 (10.5%) were physicians, nurses, and other professionals, respectively. At least 70% of participants reported a lack of PPE. The most common shortages were shortages in gown coverall suits (643, 59.4%), N95 masks (600, 55.5%), and face shields (569, 52.6%). Professionals who performed procedures that generated aerosols reported shortages more frequently (p<0.05). Professionals working in the emergency department and primary care units reported more shortages than those working in intensive care units and hospital-based wards (p<0.001). Up to 556 (51.4%) participants reported the lack of sufficient knowledge about using PPE. Professionals working in public institutions felt less prepared, received less training, and had no protocols compared with their peers in working private institutions (p<0.001). Although the study sample corresponded to different hospital centers in different cities from the participating countries, sampling was non-random. Healthcare professionals in Latin America may face more difficulties than those from other countries, with 7 out of 10 professionals reporting that they did not have the necessary resources to care for patients with COVID-19. Technical and logistical difficulties should be addressed in the event of a future outbreak, as they have a negative impact on healthcare workers.	[Martin-Delgado, Jimmy; Mula, Aurora; Mira, Jose Joaquin] Fdn Promot Hlth & Biomed Res, Atenea Res Grp, Sant Joan dAlacant, Spain; [Viteri, Eduardo] Santander Ophthalmol Fdn FOSCAL, Floridablanca, Colombia; [Viteri, Eduardo] CEMEDIP, Guayaquil, Ecuador; [Serpa, Piedad; Pacheco, Gloria; Prada, Diana] Santander Univ, Bucaramanga, Colombia; [Campos de Andrade Lourencao, Daniela; Campos Pavan Baptista, Patricia] Univ Sao Paulo, Sao Paulo, Brazil; [Campos de Andrade Lourencao, Daniela; Campos Pavan Baptista, Patricia] CNPQ Res Grp, Studies Hlth Nursing & Hlth Workers, Sao Paulo, Brazil; [Ramirez, Gustavo] Catholic Univ Santiago Guayaquil, Guayaquil, Ecuador; [Mira, Jose Joaquin] Alicante St Joan Hlth Dept, Alicante, Spain; [Mira, Jose Joaquin] Miguel Hernandez Univ, Elche, Spain; [Martin-Delgado, Jimmy] St Joan Univ Hosp, St Joan, Alacant, Spain	Universidade de Sao Paulo; Universidad Miguel Hernandez de Elche	Martin-Delgado, J (corresponding author), Fdn Promot Hlth & Biomed Res, Atenea Res Grp, Sant Joan dAlacant, Spain.; Martin-Delgado, J (corresponding author), St Joan Univ Hosp, St Joan, Alacant, Spain.	jimmy.martind@umh.es	Martin-Delgado, Jimmy/AAT-1568-2020	Martin-Delgado, Jimmy/0000-0003-4384-9197; Campos de Andrade Lourencao, Daniela/0000-0002-3050-0378; Mula Leal, Aurora/0000-0001-6966-1446	Atenea Research Group of the Foundation for the Promotion of Health and Biomedical Research - FISABIO	Atenea Research Group of the Foundation for the Promotion of Health and Biomedical Research - FISABIO	This study used research funding of the Atenea Research Group of the Foundation for the Promotion of Health and Biomedical Research - FISABIO. It did not receive any other funding from public or private institutions. On the other hand, CEMEDIP did not provided support to this study. CEMEDIP provided in the form of partial-time salaries for author EV. CEMEDIP did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. EV participated in conception and design of the survey. The specific roles of these authors are articulated in the `authors contributions' section.	[Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], FINANCIAL TIMES; Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Cebrian-Cuenca MA, PSYCHOL DISTRESS ASS; Centers for Disease Control and Prevention, 2020, OPT PPE SUPPL; CNN, 2020, CNN; De Groot K, 2018, HEALTH SOC CARE COMM, V26, pE94, DOI 10.1111/hsc.12481; Food and Drug Administration, 2020, FAQS SHORT SURG MASK; Greenberg N, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1211; Instituto Nacional de Estadistica y Censos, 2019, REG EST REC ACT SAL; Mira JJ, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/21692; KAMEROW D, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M1367; Li LX, 2020, INFECT DIS MODEL, V5, P282, DOI 10.1016/j.idm.2020.03.002; Liu M, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2195; Mira J, JMIR PREPR; Nguyen Long H, 2020, Lancet Public Health, V5, pe475, DOI [10.1101/2020.04.29.20084111, 10.1016/S2468-2667(20)30164-X]; Paffenholz P, 2020, EMERG MICROBES INFEC, V9, P1590, DOI 10.1080/22221751.2020.1785951; Peres D, 2020, J HOSP INFECT, V105, P434, DOI 10.1016/j.jhin.2020.05.038; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Seto WH, 2003, LANCET, V361, P1519, DOI 10.1016/S0140-6736(03)13168-6; Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893; Tabah A, 2020, J CRIT CARE, V59, P70, DOI 10.1016/j.jcrc.2020.06.005; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002; WHO, WHO COR DIS COVID 19; World Bank, 2020, REM LEARN DIST ED ON, P1; World Health Organization, 82 WHO; World Health Organization, 2020, PNEUM UNKN CAUS CHIN; Zwaanswijk Marieke, 2014, BMC Res Notes, V7, P756, DOI 10.1186/1756-0500-7-756	30	44	45	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242185	10.1371/journal.pone.0242185	http://dx.doi.org/10.1371/journal.pone.0242185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175877	gold, Green Published			2022-12-26	WOS:000593946900020
J	Morales, N; Bauchet, GJ; Tantikanjana, T; Powell, AF; Ellerbrock, BJ; Tecle, IY; Mueller, LA				Morales, Nicolas; Bauchet, Guillaume J.; Tantikanjana, Titima; Powell, Adrian F.; Ellerbrock, Bryan J.; Tecle, Isaak Y.; Mueller, Lukas A.			High density genotype storage for plant breeding in the Chado schema of Breedbase	PLOS ONE			English	Article							GENOMIC SELECTION	Modern breeding programs routinely use genome-wide information for selecting individuals to advance. The large volumes of genotypic information required present a challenge for data storage and query efficiency. Major use cases require genotyping data to be linked with trait phenotyping data. In contrast to phenotyping data that are often stored in relational database schemas, next-generation genotyping data are traditionally stored in non-relational storage systems due to their extremely large scope. This study presents a novel data model implemented in Breedbase () for uniting relational phenotyping data and non-relational genotyping data within the open-source PostgreSQL database engine. Breedbase is an open-source, web-database designed to manage all of a breeder's informatics needs: management of field experiments, phenotypic and genotypic data collection and storage, and statistical analyses. The genotyping data is stored in a PostgreSQL data-type known as binary JavaScript Object Notation (JSONb), where the JSON structures closely follow the Variant Call Format (VCF) data model. The Breedbase genotyping data model can handle different ploidy levels, structural variants, and any genotype encoded in VCF. JSONb is both compressed and indexed, resulting in a space and time efficient system. Furthermore, file caching maximizes data retrieval performance. Integration of all breeding data within the Chado database schema retains referential integrity that may be lost when genotyping and phenotyping data are stored in separate systems. Benchmarking demonstrates that the system is fast enough for computation of a genomic relationship matrix (GRM) and genome wide association study (GWAS) for datasets involving 1,325 diploid Zea mays, 314 triploid Musa acuminata, and 924 diploid Manihot esculenta samples genotyped with 955,690, 142,119, and 287,952 genotype-by-sequencing (GBS) markers, respectively.	[Morales, Nicolas] Cornell Univ, Plant Breeding & Genet, Ithaca, NY USA; [Morales, Nicolas; Bauchet, Guillaume J.; Tantikanjana, Titima; Powell, Adrian F.; Ellerbrock, Bryan J.; Tecle, Isaak Y.; Mueller, Lukas A.] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA	Cornell University; Cornell University; Boyce Thompson Institute for Plant Research	Mueller, LA (corresponding author), Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA.	lam87@cornell.edu		Morales, Nicolas/0000-0002-3600-0657	Cassava Source to Sink Project (CASS); BMGF; NextGen Cassava Project, Cornell University	Cassava Source to Sink Project (CASS); BMGF; NextGen Cassava Project, Cornell University	LM, Cassava Source to Sink Project (CASS), BMGF, LM, NextGen Cassava Project, Cornell University and BMGF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bombarely A, 2011, NUCLEIC ACIDS RES, V39, pD1149, DOI 10.1093/nar/gkq866; Brian Osborne, 2000, GMOD COMMUNITY; Chen JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157236; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Fernandez-Pozo N, 2015, NUCLEIC ACIDS RES, V43, pD1036, DOI 10.1093/nar/gku1195; Gilmour A. R., 2002, ASREML USER GUIDE RE; Iragaba P, 2020, CROP SCI, V60, P1450, DOI 10.1002/csc2.20152; ISO, 2018, 1907562017 ISO IEC T; Jung S, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar051; McFarland BA, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-4922-8; Menda Naama, 2009, NATURE PRECEDINGS, DOI [10.1038/npre.2009.3134.1, DOI 10.1038/NPRE.2009.3134.1]; Meuwissen T, 2016, ANIM FRONT, V6, P6, DOI 10.2527/af.2016-0002; Mungall CJ, 2007, BIOINFORMATICS, V23, pI337, DOI 10.1093/bioinformatics/btm189; Neil M., 2005, BEGINNING DATABASES; Newell MA, 2014, METHODS MOL BIOL, V1145, P117, DOI 10.1007/978-1-4939-0446-4_10; Nti-Addae Y, 2019, DATABASE-OXFORD, DOI 10.1093/database/baz096; Nyine M, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.10.0090; Postgresql Development Group, 2016, POSTGR 9 6 SERV ADM; Rasheed A, 2017, MOL PLANT, V10, P1047, DOI 10.1016/j.molp.2017.06.008; Selby P, 2019, BIOINFORMATICS, V35, P4147, DOI 10.1093/bioinformatics/btz190; Sempere G, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0131-8; Shrestha R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00326; Tecle IY, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0398-7; Thomson M. J., 2014, PLANT BREEDING BIOTE, DOI [10.1186/1472-6750-14-50, DOI 10.1186/1472-6750-14-50]; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	29	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0240059	10.1371/journal.pone.0240059	http://dx.doi.org/10.1371/journal.pone.0240059			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175872	Green Published, gold			2022-12-26	WOS:000593946900044
J	Mulisa, D; Tolossa, T; Wakuma, B; Etafa, W; Yadesa, G				Mulisa, Diriba; Tolossa, Tadesse; Wakuma, Bizuneh; Etafa, Werku; Yadesa, Girma			Magnitude of first line antiretroviral therapy treatment failure and associated factors among adult patients on ART in South West Shoa, Central Ethiopia	PLOS ONE			English	Article							PREDICTORS	Background First-line antiretroviral treatment failure has become a public health concern in high, low and middle-income countries with high mortality and morbidity In Ethiopia, around 710,000 peoples were living with HIV and 420,000 of them were receiving ART in 2017. Little is known about the magnitude of first-line ART treatment failure and its associated factors in Ethiopia, particularly in the study area. Therefore, this study was aimed to find the magnitude of first-line ART treatment failure and its associated factors among adult patients attending ART clinic at Southwest shoa zone public hospitals. Methods Institutions based cross-sectional study was employed from February 1 to April 2, 2019. An interviewer administered questionnaire was used to collect data from 350 adult patients on ART using a systematic random sampling technique. The collected data were coded and entered into Epidata version 3 and exported to STATA SE version 14 for analysis. Bivariable and multivariable logistic regression was done to identify factors associated with first-line ART treatment failure. At 95% confidence level strength of association was measured using Odds ratio. Variables with a p-value of <= 0.25 in the bivariable analysis were considered as a candidate variable for multivariable analysis. To get the final variables step-wise backward selection procedure was used and those in the final model were selected at a p-value <0.05. Finally, texts, simple frequency tables, and figures were used to present the findings. Results In this study the magnitude of first-line ART treatment failure was 33.42%. Absence of baseline opportunistic infection AOR = 0.362 (95%CI0.178, 0.735), Staying on first-line ART for <5 years AOR = 0.47 (95%CI 0.252, 0.878), Nevirapine containing ART regimen AOR = 3.07 (95%CI 1.677, 5.63), Baseline CD4 count >= 100 cells/mm3 AOR = 0.299 (95%CI 0.152 0.591), absence of opportunistic infections after ART initiation AOR = 0.257 (95%CI 0.142, .467), time taking greater than an one-hour to reach health facility AOR 1.85 (95%CI 1.022 3.367) were significantly associated with first-line ART treatment failure. Conclusion The magnitude of first-line ART treatment failure was high in the study area. Base-line opportunistic infection, duration on first-line ART, NVP based ART, Baseline CD4 count level, OI after ART initiation, and time it takes to reach health facility were independent determinants of first-line ART treatment failure.	[Mulisa, Diriba] Wollega Univ, Inst Hlth Sci, Sch Nursing & Midwifery, Nekemte, Ethiopia; [Tolossa, Tadesse] Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia; [Wakuma, Bizuneh; Etafa, Werku] Wollega Univ, Inst Hlth Sci, Dept Pediat Nursing, Nekemte, Ethiopia; [Yadesa, Girma] Diredawa Univ, Dept Nursing, Coll Hlth Sci, Diredawa, Ethiopia		Mulisa, D (corresponding author), Wollega Univ, Inst Hlth Sci, Sch Nursing & Midwifery, Nekemte, Ethiopia.	diribamilisa@gmail.com	Ebi, Werku Etafa/Q-2742-2019	Ebi, Werku Etafa/0000-0001-9576-8888; Mulisa, Diriba/0000-0002-0453-1998	Debremarkos University	Debremarkos University	We would like to say thank you Debremarkos University for giving us the chance to conduct this research and support us in many ways.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Ahmed M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3924-4; AIDS GiaeoHa, 2018, HIST HIV AIDS OV; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; [Anonymous], 2018, HIST HIV AIDS OVERVI; Assemie MA, 2019, GLOB HEALTH RES POL, V4, DOI 10.1186/s41256-019-0120-4; Ayele G, 2018, BMC IMMUNOL, V19, DOI 10.1186/s12865-018-0278-4; Ayele TA, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0567-7; El-Khatib Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017518; Endalamaw A, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8160-8; Enderis BO, 2019, ETHIOP J HEALTH SCI, V29, P175, DOI 10.4314/ejhs.v29i2.4; Estill J, 2016, LANCET HIV, V3, pE132, DOI 10.1016/S2352-3018(16)00016-3; Gunda DW., 2019, ECON MICROBIOL, V15, P683; Health EFMo, 2017, NAT GUID LIN COMPR H; Health FHAPaCOFMo, 2008, GUID MAN OPP INF ARV; Hong J, 2019, IMMUNE NETW, V19, DOI 10.4110/in.2019.19.e34; Institute Eph, 2017, HIV REV EST PROJ ETH; Jaleta F, 2019, AM J HEAL RES, V7, P71, DOI DOI 10.11648/J.AJHR.20190705.13; Johnston V, 2012, JAIDS-J ACQ IMM DEF, V61, P370, DOI 10.1097/QAI.0b013e318266ee3f; Lenjiso GA, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7078-5; Patrikar Seema, 2017, Med J Armed Forces India, V73, P5, DOI 10.1016/j.mjafi.2016.09.008; The Lancet HIV, 2015, LANCET HIV, V2, pe115; UNAIDS, 2018, STAT EP; UNAIDS, 2018, 90 90 90 TREATM TARG; WHO, 2013, 8 INT C CARDIOLOGY I	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241768	10.1371/journal.pone.0241768	http://dx.doi.org/10.1371/journal.pone.0241768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175902	gold, Green Published			2022-12-26	WOS:000593946900033
J	Wang, HY; Gu, H; Qin, P; Wang, J				Wang, Hongyu; Gu, Hong; Qin, Pan; Wang, Jia			CheXLocNet: Automatic localization of pneumothorax in chest radiographs using deep convolutional neural networks	PLOS ONE			English	Article							SKIP CONNECTIONS; FEATURES; AID	Background Pneumothorax can lead to a life-threatening emergency. The experienced radiologists can offer precise diagnosis according to the chest radiographs. The localization of the pneumothorax lesions will help to quickly diagnose, which will be benefit for the patients in the underdevelopment areas lack of the experienced radiologists. In recent years, with the development of large neural network architectures and medical imaging datasets, deep learning methods have become a methodology of choice for analyzing medical images. The objective of this study was to the construct convolutional neural networks to localize the pneumothorax lesions in chest radiographs. Methods and findings We developed a convolutional neural network, called CheXLocNet, for the segmentation of pneumothorax lesions. The SIIM-ACR Pneumothorax Segmentation dataset was used to train and validate CheXLocNets. The training dataset contained 2079 radiographs with the annotated lesion areas. We trained six CheXLocNets with various hyperparameters. Another 300 annotated radiographs were used to select parameters of these CheXLocNets as the validation set. We determined the optimal parameters by the AP(50) (average precision at the intersection over union (IoU) equal to 0.50), a segmentation evaluation metric used by several well-known competitions. Then CheXLocNets were evaluated by a test set (1082 normal radiographs and 290 disease radiographs), based on the classification metrics: area under the receiver operating characteristic curve (AUC), sensitivity, specificity, and positive predictive value (PPV); segmentation metrics: IoU and Dice score. For the classification, CheXLocNet with best sensitivity produced an AUC of 0.87, sensitivity of 0.78 (95% CI 0.73-0.83), and specificity of 0.78 (95% CI 0.76-0.81). CheXLocNet with best specificity produced an AUC of 0.79, sensitivity of 0.46 (95% CI 0.40-0.52), and specificity of 0.92 (95% CI 0.90-0.94). For the segmentation, CheXLocNet with best sensitivity produced an IoU of 0.69 and Dice score of 0.72. CheXLocNet with best specificity produced an IoU of 0.77 and Dice score of 0.79. We combined them to form an ensemble CheXLocNet. The ensemble CheXLocNet produced an IoU of 0.81 and Dice score of 0.82. Our CheXLocNet succeeded in automatically detecting pneumothorax lesions, without any human guidance. Conclusions In this study, we proposed a deep learning network, called, CheXLocNet, for the automatic segmentation of chest radiographs to detect pneumothorax. Our CheXLocNets generated accurate classification results and high-quality segmentation masks for the pneumothorax at the same time. This technology has the potential to improve healthcare delivery and increase access to chest radiograph expertise for the detection of diseases. Furthermore, the segmentation results can offer comprehensive geometric information of lesions, which can benefit monitoring the sequential development of lesions with high accuracy. Thus, CheXLocNets can be further extended to be a reliable clinical decision support tool. Although we used transfer learning in training CheXLocNet, the parameters of CheXLocNet was still large for the radiograph dataset. Further work is necessary to prune CheXLocNet suitable for the radiograph dataset.	[Wang, Hongyu; Gu, Hong; Qin, Pan] Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Liaoning, Peoples R China; [Wang, Jia] Dalian Med Univ, Dept Surg, Hosp 2, Dalian, Liaoning, Peoples R China	Dalian University of Technology; Dalian Medical University	Qin, P (corresponding author), Dalian Univ Technol, Fac Elect Informat & Elect Engn, Dalian, Liaoning, Peoples R China.; Wang, J (corresponding author), Dalian Med Univ, Dept Surg, Hosp 2, Dalian, Liaoning, Peoples R China.	qp112cn@dlut.edu.cn; wangjia77@hotmail.com		Qin, Pan/0000-0003-0545-3044; Wang, Hongyu/0000-0002-8098-9589	National Natural Science Foundation of China [61633006, 81872247]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (grant number 61633006(PQ received) 81872247(PQ, HW received)), URL http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuar A, 2019, SIIM ACR PNEUMOTHORA; Apostolopoulos ID, 2020, PHYS ENG SCI MED, V43, P635, DOI 10.1007/s13246-020-00865-4; Arriagada R, 2010, J CLIN ONCOL, V28, P35, DOI 10.1200/JCO.2009.23.2272; Ciresan DC, 2013, LECT NOTES COMPUT SC, V8150, P411, DOI 10.1007/978-3-642-40763-5_51; Drozdzal M, 2016, LECT NOTES COMPUT SC, V10008, P179, DOI 10.1007/978-3-319-46976-8_19; Eslami M, 2020, IEEE T MED IMAGING, V39, P2553, DOI 10.1109/TMI.2020.2974159; Everingham M, 2015, INT J COMPUT VISION, V111, P98, DOI 10.1007/s11263-014-0733-5; Girshick R, 2014, P IEEE C COMP VIS PA, DOI [DOI 10.1109/CVPR.2014.81, 10.1109/CVPR.2014.81]; Gu C, 2017, J CANCER, V8, P2097, DOI 10.7150/jca.19454; Gundel Sebastian, 2019, Progress in Pattern Recognition, Image Analysis, Computer Vision, and Applications. 23rd Iberoamerican Congress, CIARP 2018. Proceedings: Lecture Notes in Computer Science (LNCS 11401), P757, DOI 10.1007/978-3-030-13469-3_88; He KM, 2017, IEEE I CONF COMP VIS, P2980, DOI [10.1109/ICCV.2017.322, 10.1109/TPAMI.2018.2844175]; HUBER PJ, 1964, ANN MATH STAT, V35, P73, DOI 10.1214/aoms/1177703732; Hwang EJ, 2019, RADIOLOGY, V293, P573, DOI 10.1148/radiol.2019191225; Kingma DP., 2014, ADAM METHOD STOCHAST; KUNDEL HL, 1990, INVEST RADIOL, V25, P890, DOI 10.1097/00004424-199008000-00004; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Lin Tsung-Yi, 2017, CVPR, DOI DOI 10.1109/CVPR.2017.106; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Lopez-Garnier S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212094; Mzoughi H, 2020, J DIGIT IMAGING, V33, P903, DOI 10.1007/s10278-020-00347-9; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Novikov AA, 2018, IEEE T MED IMAGING, V37, P1865, DOI 10.1109/TMI.2018.2806086; Oh Y, 2020, IEEE T MED IMAGING, V39, P2688, DOI 10.1109/TMI.2020.2993291; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Piantadosi G, 2020, ARTIF INTELL MED, V103, DOI 10.1016/j.artmed.2019.101781; Rajpurkar P, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002686; Raoof S, 2012, CHEST, V141, P545, DOI 10.1378/chest.10-1302; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Salehinejad H, 2019, IEEE T MED IMAGING, V38, P1197, DOI 10.1109/TMI.2018.2881415; Taylor AG, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002697; Vuola AO, 2019, I S BIOMED IMAGING, P208, DOI 10.1109/ISBI.2019.8759574; Welling RD, 2011, J AM COLL RADIOL, V8, P556, DOI 10.1016/j.jacr.2011.01.011; Zhou ZL, 2021, IEEE T BIG DATA, V7, P559, DOI 10.1109/TBDATA.2019.2919570; Zhu J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236621	40	12	12	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242013	10.1371/journal.pone.0242013	http://dx.doi.org/10.1371/journal.pone.0242013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166371	gold, Green Published			2022-12-26	WOS:000592382600014
J	Kerek, EM; Yoon, KH; Luo, SY; Chen, J; Valencia, R; Julien, O; Waskiewicz, AJ; Hubbard, BP				Kerek, Evan M.; Yoon, Kevin H.; Luo, Shu Y.; Chen, Jerry; Valencia, Robert; Julien, Olivier; Waskiewicz, Andrew J.; Hubbard, Basil P.			A conserved acetylation switch enables pharmacological control of tubby-like protein stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR CHARACTERIZATION; MASS-SPECTROMETRY; GENE FAMILY; MOUSE; TULP3; TRAFFICKING; MEMBER; PHOSPHOINOSITIDES; MUTATIONS; SURVIVAL	Tubby-like proteins (TULPs) are characterized by a conserved C-terminal domain that binds phosphoinositides. Collectively, mammalian TULP1-4 proteins play essential roles in intracellular transport, cell differentiation, signaling, and motility. Yet, little is known about how the function of these proteins is regulated in cells. Here, we present the protein-protein interaction network of TULP3, a protein that is responsible for the trafficking of G-protein-coupled receptors to cilia and whose aberrant expression is associated with severe developmental disorders and polycystic kidney disease. We identify several protein interaction nodes linked to TULP3 that include enzymes involved in acetylation and ubiquitination. We show that acetylation of two key lysine residues on TULP3 by p300 increases TULP3 protein abundance and that deacetylation of these sites by HDAC1 decreases protein levels. Furthermore, we show that one of these sites is ubiquitinated in the absence of acetylation and that acetylation inversely correlates with ubiquitination of TULP3. This mechanism is evidently conserved across species and is active in zebrafish during development. Finally, we identify this same regulatory module in TULP1, TULP2, and TULP4 and demonstrate that the stability of these proteins is similarly modulated by an acetylation switch. This study unveils a signaling pathway that links nuclear enzymes to ciliary membrane receptors via TULP3, describes a dynamic mechanism for the regulation of all tubby-like proteins, and explores how to exploit it pharmacologically using drugs.	[Kerek, Evan M.; Chen, Jerry; Valencia, Robert; Hubbard, Basil P.] Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada; [Yoon, Kevin H.; Waskiewicz, Andrew J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Luo, Shu Y.; Julien, Olivier] Univ Alberta, Dept Biochem, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Hubbard, BP (corresponding author), Univ Alberta, Dept Pharmacol, Edmonton, AB, Canada.	bphubbard@ualberta.ca		Hubbard, Basil/0000-0003-4353-9674; Valencia, Robert/0000-0002-9825-7095; Julien, Olivier/0000-0001-7068-7299	Canadian Institutes for Health Research (CIHR) [CIHR-PS-156134]; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 2016-06482]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Project Grant from the Canadian Institutes for Health Research (CIHR) (to B. P. H.) (CIHR-PS-156134) and a Discovery grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) (to A. J. W.) (RGPIN 2016-06482).	Akimov V, 2018, NAT STRUCT MOL BIOL, V25, P631, DOI 10.1038/s41594-018-0084-y; Babu A, 2018, BBA-MOL BASIS DIS, V1864, P1203, DOI 10.1016/j.bbadis.2018.01.029; Badgandi HB, 2017, J CELL BIOL, V216, P743, DOI 10.1083/jcb.201607095; Bahari-Javan S, 2017, P NATL ACAD SCI USA, V114, pE4686, DOI 10.1073/pnas.1613842114; Banerjee P, 1998, NAT GENET, V18, P177, DOI 10.1038/ng0298-177; Bardai FH, 2012, J BIOL CHEM, V287, P35444, DOI 10.1074/jbc.M112.394544; Bateman A, 2009, BIOINFORMATICS, V25, P159, DOI 10.1093/bioinformatics/btn595; Boggon TJ, 1999, SCIENCE, V286, P2119, DOI 10.1126/science.286.5447.2119; Cameron DA, 2009, DEV DYNAM, V238, P1140, DOI 10.1002/dvdy.21926; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Chan HM, 2001, J CELL SCI, V114, P2363; Chen GZ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-24; COLEMAN DL, 1990, J HERED, V81, P424, DOI 10.1093/oxfordjournals.jhered.a111019; Dubiel W, 2018, TRENDS BIOCHEM SCI, V43, P95, DOI 10.1016/j.tibs.2017.11.010; Fauquier L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31102-4; Fouad S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01144; Garcia-Gonzalo FR, 2015, DEV CELL, V34, P400, DOI 10.1016/j.devcel.2015.08.001; Goodman RH, 2000, GENE DEV, V14, P1553; Grossman GH, 2014, ADV EXP MED BIOL, V801, P511, DOI 10.1007/978-1-4614-3209-8_65; Grossman GH, 2009, INVEST OPHTH VIS SCI, V50, P3074, DOI 10.1167/iovs.08-3190; Hagstrom SA, 2001, INVEST OPHTH VIS SCI, V42, P1955; Han J, 2013, CELL CYCLE, V12, P263, DOI 10.4161/cc.23056; Han S, 2019, BIOCHEM BIOPH RES CO, V509, P227, DOI 10.1016/j.bbrc.2018.12.109; Hegarty SV, 2016, NEUROTOX RES, V30, P510, DOI 10.1007/s12640-016-9636-2; Heo JH, 2020, BIOCHEM J, V477, P431, DOI 10.1042/BCJ20190740; Hubbard BP, 2013, CELL CYCLE, V12, P2233, DOI 10.4161/cc.25268; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Hwang SH, 2019, CURR BIOL, V29, P790, DOI 10.1016/j.cub.2019.01.047; Ikeda A, 2002, J CELL SCI, V115, P9; Ikeda A, 2001, HUM MOL GENET, V10, P1325, DOI 10.1093/hmg/10.12.1325; Inagaki A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023155; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kleyn PW, 1996, CELL, V85, P281, DOI 10.1016/S0092-8674(00)81104-6; Legue E, 2019, CURR BIOL, V29, P803, DOI 10.1016/j.cub.2019.01.054; Leus NGJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45047; Li QZ, 2001, GENE, V273, P275, DOI 10.1016/S0378-1119(01)00582-0; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Montgomery DC, 2015, CHEM BIOL, V22, P1030, DOI 10.1016/j.chembiol.2015.06.015; Mukhopadhyay A, 2005, CELL METAB, V2, P35, DOI 10.1016/j.cmet.2005.06.004; Mukhopadhyay S, 2013, CELL, V152, P210, DOI 10.1016/j.cell.2012.12.026; Mukhopadhyay S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-225; Mukhopadhyay S, 2010, GENE DEV, V24, P2180, DOI 10.1101/gad.1966210; Nishina PM, 1998, GENOMICS, V54, P215, DOI 10.1006/geno.1998.5567; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; North MA, 1997, P NATL ACAD SCI USA, V94, P3128, DOI 10.1073/pnas.94.7.3128; OHLEMILLER KK, 1995, NEUROREPORT, V6, P845, DOI 10.1097/00001756-199504190-00005; Romero D, 2019, NAT REV CLIN ONCOL, V16, P465, DOI 10.1038/s41571-019-0224-2; Sachdeva P, 2016, J PEDIATR NEONATAL I, V5, DOI 10.7363/050218; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Sartor ITS, 2014, MOL BIOSYST, V10, P1461, DOI 10.1039/c3mb70590k; Sartor ITS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210762; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang M, 2018, GENE, V642, P16, DOI 10.1016/j.gene.2017.10.077	56	5	6	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100073	10.1074/jbc.RA120.015839	http://dx.doi.org/10.1074/jbc.RA120.015839			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33187986	Green Published, gold			2022-12-26	WOS:000672866400054
J	Schulte, JE; Roggiani, M; Shi, H; Zhu, J; Goulian, M				Schulte, Jane E.; Roggiani, Manuela; Shi, Hui; Zhu, Jun; Goulian, Mark			The phosphohistidine phosphatase SixA dephosphorylates the phosphocarrier NPr	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN HISTIDINE PHOSPHATASE; DIPHOSPHATE KINASE-B; DEPENDENT PHOSPHOTRANSFERASE SYSTEM; ESCHERICHIA-COLI; CHANNEL KCA3.1; PHOSPHORYLATION; PHOSPHOENOLPYRUVATE; POTASSIUM; ENZYME; METABOLISM	Histidine phosphorylation is a posttranslational modification that alters protein function and also serves as an intermediate of phosphoryl transfer. Although phosphohistidine is relatively unstable, enzymatic dephosphorylation of this residue is apparently needed in some contexts, since both prokaryotic and eukaryotic phosphohistidine phosphatases have been reported. Here we identify the mechanism by which a bacterial phosphohistidine phosphatase dephosphorylates the nitrogen-related phosphotransferase system, a broadly conserved bacterial pathway that controls diverse metabolic processes. We show that the phosphatase SixA dephosphorylates the phosphocarrier protein NPr and that the reaction proceeds through phosphoryl transfer from a histidine on NPr to a histidine on SixA. In addition, we show that Escherichia coli lacking SixA are outcompeted by wild-type E. coli in the context of commensal colonization of the mouse intestine. Notably, this colonization defect requires NPr and is distinct from a previously identified in vitro growth defect associated with dysregulation of the nitrogen-related phosphotransferase system. The widespread conservation of SixA, and its coincidence with the phosphotransferase system studied here, suggests that this dephosphorylation mechanism may be conserved in other bacteria.	[Schulte, Jane E.] Univ Penn, Perelman Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA; [Schulte, Jane E.; Roggiani, Manuela; Shi, Hui; Goulian, Mark] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Shi, Hui] Southwest Univ, Coll Food Sci, Chongqing, Peoples R China; [Zhu, Jun] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Goulian, Mark] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Southwest University - China; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Goulian, M (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.; Goulian, M (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	goulian@sas.upenn.edu		Roggiani, Manuela/0000-0002-8564-036X; Zhu, Jun/0000-0001-9182-5224	National Science Foundation Graduate Research Fellowship Program [DGE-1321851]; National Institutes of Health [GM080279, AI125814, AI120489]	National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation Graduate Research Fellowship Program under Grant No. DGE-1321851 (to J. E. S.) and also grants from the National Institutes of Health, GM080279 (to M. G.), AI125814 (to M. G. and J. Z.), and AI120489 (to J. Z.). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and National Science Foundation.	AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; ANDERSON B, 1971, J BIOL CHEM, V246, P7023; Attwood PV, 2007, AMINO ACIDS, V32, P145, DOI 10.1007/s00726-006-0443-6; Attwood PV, 2018, LAB INVEST, V98, P283, DOI 10.1038/labinvest.2017.125; Attwood PV, 2013, BBA-PROTEINS PROTEOM, V1834, P470, DOI 10.1016/j.bbapap.2012.03.001; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bekker M, 2010, J BACTERIOL, V192, P746, DOI 10.1128/JB.01156-09; Bridger W. A., 1974, ENZYMES, P581; Bridger W. A., 1973, PAABS REV, P83; Buljubasic F, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020486; Cai XJ, 2014, MOL BIOL CELL, V25, P1244, DOI 10.1091/mbc.E13-04-0180; CARROLL LJ, 1994, BIOCHEMISTRY-US, V33, P1134, DOI 10.1021/bi00171a012; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Deutscher J, 2014, MICROBIOL MOL BIOL R, V78, P231, DOI 10.1128/MMBR.00001-14; Di L, 2010, J BIOL CHEM, V285, P38765, DOI 10.1074/jbc.M110.168070; Dozot M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012679; Fuhs SR, 2017, CURR OPIN CELL BIOL, V45, P8, DOI 10.1016/j.ceb.2016.12.010; Fuhs SR, 2015, CELL, V162, P198, DOI 10.1016/j.cell.2015.05.046; FUJITAKI JM, 1984, METHOD ENZYMOL, V107, P23; Galinier A, 2017, J MOL BIOL, V429, P773, DOI 10.1016/j.jmb.2017.02.006; GASSNER M, 1977, EUR J BIOCHEM, V75, P287, DOI 10.1111/j.1432-1033.1977.tb11528.x; Gebhardt MJ, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00066-17; Goodwin R, 2015, THESIS U CONNECTICUT; Goodwin RA, 2014, J BACTERIOL, V196, P1901, DOI 10.1128/JB.01489-14; Hakoshima T, 2007, METHOD ENZYMOL, V422, P288, DOI 10.1016/S0076-6879(06)22014-7; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hamada K, 2005, GENES CELLS, V10, P1, DOI 10.1111/j.1365-2443.2005.00817.x; Hardman G, 2019, EMBO J, V38, DOI 10.15252/embj.2018100847; Hindupur SK, 2018, NATURE, V555, P678, DOI 10.1038/nature26140; Hu KY, 2002, RES MICROBIOL, V153, P405, DOI 10.1016/S0923-2508(02)01339-6; HULTQUIST DE, 1966, BIOCHEMISTRY-US, V5, P322, DOI 10.1021/bi00865a041; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jung H, 2019, CHEMBIOCHEM, V20, P623, DOI 10.1002/cbic.201800566; Kee JM, 2012, ACS CHEM BIOL, V7, P44, DOI 10.1021/cb200445w; Klumpp S, 2009, BRAIN RES, V1264, P7, DOI 10.1016/j.brainres.2008.12.052; Krieglstein J, 2008, NEUROCHEM INT, V53, P132, DOI 10.1016/j.neuint.2008.06.012; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lasaro M, 2014, J BACTERIOL, V196, P1723, DOI 10.1128/JB.01296-13; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li X, 2008, AMINO ACIDS, V35, P531, DOI 10.1007/s00726-008-0079-9; Makwana MV, 2018, LAB INVEST, V98, P291, DOI 10.1038/labinvest.2017.126; Matsubara M, 2000, FEBS LETT, V470, P118, DOI 10.1016/S0014-5793(00)01303-X; MATTHEWS HR, 1995, PHARMACOL THERAPEUT, V67, P323, DOI 10.1016/0163-7258(95)00020-8; Maurer A, 2005, BIOCHEM BIOPH RES CO, V334, P1115, DOI 10.1016/j.bbrc.2005.06.200; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Muimo R, 2000, J BIOL CHEM, V275, P36632, DOI 10.1074/jbc.M000829200; Ogino T, 1998, MOL MICROBIOL, V27, P573, DOI 10.1046/j.1365-2958.1998.00703.x; Panda S, 2016, MOL CELL, V63, P457, DOI 10.1016/j.molcel.2016.06.021; Pfluger-Grau K, 2014, FEMS MICROBIOL LETT, V356, P144, DOI 10.1111/1574-6968.12459; Pfluger-Grau K, 2010, TRENDS MICROBIOL, V18, P205, DOI 10.1016/j.tim.2010.02.003; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Potel CM, 2018, NAT METHODS, V15, P187, DOI [10.1038/NMETH.4580, 10.1038/nmeth.4580]; POWELL BS, 1995, J BIOL CHEM, V270, P4822, DOI 10.1074/jbc.270.9.4822; Rabus R, 1999, J BIOL CHEM, V274, P26185, DOI 10.1074/jbc.274.37.26185; Rasband W.S., 1997, IMAGEJ; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Rigden DJ, 2020, METHODS MOL BIOL, V2077, P93, DOI 10.1007/978-1-4939-9884-5_7; Sanchez-Canizares C, 2020, P NATL ACAD SCI USA, V117, P10234, DOI [10.1073/pnas.1917471117, 10.1073/pnas.1917471117/-/DCSupplemental]; SCHNEIDER F, 1978, ANGEW CHEM INT EDIT, V17, P583, DOI 10.1002/anie.197805831; Schulte JE, 2018, MBIO, V9, DOI 10.1128/mBio.01666-18; Schutsky EK, 2017, NUCLEIC ACIDS RES, V45, P7655, DOI 10.1093/nar/gkx345; Sharma R, 2016, J BACTERIOL, V198, P1868, DOI 10.1128/JB.01029-15; Srivastava S, 2008, P NATL ACAD SCI USA, V105, P14442, DOI 10.1073/pnas.0803678105; Srivastava S, 2018, DIABETES, V67, P849, DOI 10.2337/db17-1433; Srivastava S, 2016, ELIFE, V5, DOI 10.7554/eLife.16093; Srivastava S, 2006, MOL CELL, V24, P665, DOI 10.1016/j.molcel.2006.11.012; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Strickland M, 2016, STRUCTURE, V24, P2127, DOI 10.1016/j.str.2016.10.007; WAGNER PD, 1995, J BIOL CHEM, V270, P21758, DOI 10.1074/jbc.270.37.21758; WILLIAMS SP, 1985, BIOCHEMISTRY-US, V24, P5527, DOI 10.1021/bi00341a037; Zhou XB, 2015, ARTERIOSCL THROM VAS, V35, P1852, DOI 10.1161/ATVBAHA.115.305881; Zimmer B, 2008, FEMS MICROBIOL LETT, V286, P96, DOI 10.1111/j.1574-6968.2008.01262.x	74	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100090	10.1074/jbc.RA120.015121	http://dx.doi.org/10.1074/jbc.RA120.015121			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33199374	Green Published, gold			2022-12-26	WOS:000672866400071
J	Brosens, E; Felix, JF; Boerema-de Munck, A; de Jong, EM; Lodder, EM; Swagemakers, S; Buscop-van Kempen, M; de Krijger, RR; Wijnen, RMH; van IJcken, WFJ; van der Spek, P; de Klein, A; Tibboel, D; Rottier, RJ				Brosens, Erwin; Felix, Janine F.; Boerema-de Munck, Anne; de Jong, Elisabeth M.; Lodder, Elisabeth M.; Swagemakers, Sigrid; Buscop-van Kempen, Marjon; de Krijger, Ronald R.; Wijnen, Rene M. H.; van IJcken, Wilfred F. J.; van der Spek, Peter; de Klein, Annelies; Tibboel, Dick; Rottier, Robbert J.			Histological, immunohistochemical and transcriptomic characterization of human tracheoesophageal fistulas	PLOS ONE			English	Article							HORMONAL PREGNANCY TESTS; ANEMIA RELATED SPECTRUM; ENTERIC NERVOUS-SYSTEM; ESOPHAGEAL ATRESIA; SONIC HEDGEHOG; CONGENITAL-ANOMALIES; SMOOTH-MUSCLE; BRANCHING MORPHOGENESIS; VACTERL ASSOCIATION; MOUSE ESOPHAGUS	Esophageal atresia (EA) and tracheoesophageal fistula (TEF) are relatively frequently occurring foregut malformations. EA/TEF is thought to have a strong genetic component. Not much is known regarding the biological processes disturbed or which cell type is affected in patients. This hampers the detection of the responsible culprits (genetic or environmental) for the origin of these congenital anatomical malformations. Therefore, we examined gene expression patterns in the TEF and compared them to the patterns in esophageal, tracheal and lung control samples. We studied tissue organization and key proteins using immunohistochemistry. There were clear differences between TEF and control samples. Based on the number of differentially expressed genes as well as histological characteristics, TEFs were most similar to normal esophagus. The BMP-signaling pathway, actin cytoskeleton and extracellular matrix pathways are downregulated in TEF. Genes involved in smooth muscle contraction are overexpressed in TEF compared to esophagus as well as trachea. These enriched pathways indicate myofibroblast activated fibrosis. TEF represents a specific tissue type with large contributions of intestinal smooth muscle cells and neurons. All major cell types present in esophagus are present-albeit often structurally disorganized-in TEF, indicating that its etiology should not be sought in cell fate specification.	[Brosens, Erwin; de Jong, Elisabeth M.; Lodder, Elisabeth M.; de Klein, Annelies] Erasmus Univ, Dept Clin Genet, Sophia Childrens Hosp, Med Ctr, Rotterdam, Netherlands; [Felix, Janine F.; Boerema-de Munck, Anne; de Jong, Elisabeth M.; Buscop-van Kempen, Marjon; Wijnen, Rene M. H.; Tibboel, Dick; Rottier, Robbert J.] Erasmus Univ, Dept Pediat Surg, Med Ctr, Sophia Childrens Hosp, Rotterdam, Netherlands; [Felix, Janine F.] Erasmus Univ, Dept Pediat, Med Ctr, Sophia Childrens Hosp, Rotterdam, Netherlands; [Felix, Janine F.] Erasmus Univ, Generat R Study Grp, Med Ctr, Sophia Childrens Hosp, Rotterdam, Netherlands; [Boerema-de Munck, Anne; Buscop-van Kempen, Marjon; van IJcken, Wilfred F. J.; Rottier, Robbert J.] Erasmus Univ, Dept Cell Biol, Med Ctr Rotterdam, Rotterdam, Netherlands; [Lodder, Elisabeth M.] Acad Med Ctr, Heart Ctr, Dept Clin & Expt Cardiol, Amsterdam, Netherlands; [Swagemakers, Sigrid; de Krijger, Ronald R.; van der Spek, Peter] Erasmus Univ, Dept Pathol, Med Ctr Rotterdam, Rotterdam, Netherlands; [Swagemakers, Sigrid; van der Spek, Peter] Erasmus Univ, Dept Clin Bioinformat, Med Ctr Rotterdam, Rotterdam, Netherlands; [de Krijger, Ronald R.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center	Brosens, E (corresponding author), Erasmus Univ, Dept Clin Genet, Sophia Childrens Hosp, Med Ctr, Rotterdam, Netherlands.	e.brosens@erasmusmc.nl	Brosens, Erwin/AAP-1913-2020; van ijcken, willem/N-9805-2018	Brosens, Erwin/0000-0001-8235-4010; van ijcken, willem/0000-0002-0421-8301; Rottier, Robbert/0000-0002-9291-4971	Edgar Doncker Foundation; Sophia Foundation for Scientific Research [493, S1309, 436]	Edgar Doncker Foundation; Sophia Foundation for Scientific Research	This work was supported by the Edgar Doncker Foundation [DT; J.F.F.] and the Sophia Foundation for Scientific Research [Grant Numbers 493 [DT; ADK; E.M.de J.], 436 [A.de M.] and S1309 [DT; ADK; E.B.] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira Hokama NA, 1986, PEDIAT SURG INT, V1, P117; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Bachiller D, 2003, DEVELOPMENT, V130, P3567, DOI 10.1242/dev.00581; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Bogs T, 2018, EUR J PEDIATR SURG, V28, P176, DOI 10.1055/s-0036-1597946; Brosens E, 2016, EUR J HUM GENET, V24, P1715, DOI 10.1038/ejhg.2016.86; Brosens E, 2014, EUR J MED GENET, V57, P440, DOI 10.1016/j.ejmg.2014.05.009; BRUNNER HG, 1991, J MED GENET, V28, P389, DOI 10.1136/jmg.28.6.389; Celli J, 2000, AM J HUM GENET, V66, P436, DOI 10.1086/302779; Chambers RC, 2003, AM J PATHOL, V162, P533, DOI 10.1016/S0002-9440(10)63847-3; Choinitzki V, 2013, BIRTH DEFECTS RES A, V97, P786, DOI 10.1002/bdra.23205; Crisera CA, 1999, J PEDIATR SURG, V34, P1322, DOI 10.1016/S0022-3468(99)90003-9; Crisera CA, 1999, J PEDIATR SURG, V34, P204, DOI 10.1016/S0022-3468(99)90258-0; Crisera CA, 2000, J SURG RES, V92, P245, DOI 10.1006/jsre.2000.5850; Crowley AR, 2006, PEDIATR SURG INT, V22, P154, DOI 10.1007/s00383-005-1598-z; CZEIZEL A, 1985, EUR J PEDIATR, V144, P331, DOI 10.1007/BF00441773; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; De Falco F, 2003, AM J MED GENET A, V120A, P222, DOI 10.1002/ajmg.a.10265; del Rosario J F, 1998, Gastroenterologist, V6, P104; DEPAEPE A, 1993, ARCH DIS CHILD, V68, P743, DOI 10.1136/adc.68.6.743; DeWard AD, 2014, CELL REP, V9, P701, DOI 10.1016/j.celrep.2014.09.027; Di Gianantonio E, 2001, TERATOLOGY, V64, P262, DOI 10.1002/tera.1072; Dravis C, 2011, DEV BIOL, V355, P138, DOI 10.1016/j.ydbio.2011.04.020; Dutta HK, 2000, J PEDIATR SURG, V35, P438, DOI 10.1016/S0022-3468(00)90209-4; Felix JF, 2007, EUR J MED GENET, V50, P163, DOI 10.1016/j.ejmg.2006.12.004; Felix JF, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.036; Feng Y, 2016, BIRTH DEFECTS RES A, V106, P840, DOI 10.1002/bdra.23550; Friedland-Little JM, 2011, HUM MOL GENET, V20, P3725, DOI 10.1093/hmg/ddr241; GARBER ED, 1952, P NATL ACAD SCI USA, V38, P876, DOI 10.1073/pnas.38.10.876; Gontan C, 2008, DEV BIOL, V317, P296, DOI 10.1016/j.ydbio.2008.02.035; Gordon CT, 2012, J MED GENET, V49, P737, DOI 10.1136/jmedgenet-2012-101173; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; He LS, 2011, CELL MOL LIFE SCI, V68, P1633, DOI 10.1007/s00018-010-0562-9; Holland PM, 2002, CURR BIOL, V12, P1424, DOI 10.1016/S0960-9822(02)01075-8; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Humbert S, 2000, J CELL SCI, V113, P975; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Ioannides AS, 2002, J PEDIATR SURG, V37, P185, DOI 10.1053/jpsu.2002.30252; Ishii Y, 1998, DEV DYNAM, V213, P464, DOI 10.1002/(SICI)1097-0177(199812)213:4<464::AID-AJA11>3.0.CO;2-Z; Jacobs IJ, 2013, DIS ESOPHAGUS, V26, P356, DOI 10.1111/dote.12055; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Li K, 2007, J PEDIATR SURG, V42, P1433, DOI 10.1016/j.jpedsurg.2007.03.050; Kaltman JR, 2010, J AM COLL CARDIOL, V55, P1262, DOI 10.1016/j.jacc.2009.11.055; Kapoun AM, 2006, MOL PHARMACOL, V70, P518, DOI 10.1124/mol.105.021600; KAUFMAN RL, 1973, LANCET, V1, P1395; Kishimoto K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05189-2; KLUTH D, 1987, J PEDIATR SURG, V22, P389, DOI 10.1016/S0022-3468(87)80254-3; Kluth D, 2003, PEDIAT SURG, V12, P3, DOI DOI 10.1053/SPSU.2003.50003; LAMMER EJ, 1986, JAMA-J AM MED ASSOC, V255, P3128, DOI 10.1001/jama.255.22.3128; Li SR, 2004, SCIENCE, V305, P1619, DOI 10.1126/science.1098674; Li Y, 2008, DEV BIOL, V322, P145, DOI 10.1016/j.ydbio.2008.07.021; Li Y, 2007, DEV DYNAM, V236, P746, DOI 10.1002/dvdy.21075; Lines MA, 2012, AM J HUM GENET, V90, P369, DOI 10.1016/j.ajhg.2011.12.023; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Liu SC, 2000, J CELL SCI, V113, P3563; Mahlapuu M, 2001, DEVELOPMENT, V128, P2397; Malmstrom J, 2004, MOL CELL PROTEOMICS, V3, P466, DOI 10.1074/mcp.M300108-MCP200; Mazzone SB, 2010, AM J PHYSIOL-LUNG C, V298, pL404, DOI 10.1152/ajplung.00166.2009; Merei JM, 2002, PEDIATR SURG INT, V18, P319, DOI 10.1007/s00383-002-0751-1; Michikawa T, 2019, BRIT J NUTR, V121, P100, DOI 10.1017/S0007114518002842; Mill P, 2011, AM J HUM GENET, V88, P508, DOI 10.1016/j.ajhg.2011.03.015; Miller LAD, 2004, DEV DYNAM, V231, P57, DOI 10.1002/dvdy.20105; Millien G, 2008, GENE EXPR PATTERNS, V8, P124, DOI 10.1016/j.modgep.2007.09.003; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Mnayer L, 2006, MOL GENET METAB, V87, P198, DOI 10.1016/j.ymgme.2005.10.014; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Moore KL, 1988, ESSENTIALS HUMAN EMB, P91; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Motoyama J, 1998, NAT GENET, V20, P54, DOI 10.1038/1711; Nagy N, 2017, SEMIN CELL DEV BIOL, V66, P94, DOI 10.1016/j.semcdb.2017.01.006; Nam KT, 2010, J CLIN INVEST, V120, P840, DOI 10.1172/JCI40728; Narchi H, 1999, ARCH DIS CHILD, V80, P207, DOI 10.1136/adc.80.2.207; NORA AH, 1975, ARCH ENVIRON HEALTH, V30, P17, DOI 10.1080/00039896.1975.10666626; NORA JJ, 1973, LANCET, V1, P941; OAKLEY GP, 1973, LANCET, V2, P256; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Perel Y, 1998, ARCH DIS CHILD, V78, P375, DOI 10.1136/adc.78.4.375; Philpott A, 1997, GENE DEV, V11, P1409, DOI 10.1101/gad.11.11.1409; Pinson L, 2004, J MED GENET, V41, P381, DOI 10.1136/jmg.2003.014829; Qi BQ, 2000, DEV GROWTH DIFFER, V42, P145; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Que JW, 2006, DIFFERENTIATION, V74, P422, DOI 10.1111/j.1432-0436.2006.00096.x; RAMIREZ A, 1992, AM J MED GENET, V44, P200, DOI 10.1002/ajmg.1320440216; Rao M, 2018, NAT REV NEUROSCI, V19, P552, DOI 10.1038/s41583-018-0041-0; Rittler M, 1997, AM J MED GENET, V73, P162, DOI 10.1002/(SICI)1096-8628(1997)73:2<162::AID-AJMG10>3.0.CO;2-S; ROBERT E, 1993, REPROD TOXICOL, V7, P405, DOI 10.1016/0890-6238(93)90085-L; Rodriguez P, 2010, DEVELOPMENT, V137, P4171, DOI 10.1242/dev.056077; RYAN GB, 1974, HUM PATHOL, V5, P55, DOI 10.1016/S0046-8177(74)80100-0; Sakiyama J, 2003, DEVELOPMENT, V130, P1225, DOI 10.1242/dev.00345; Schulz AC, 2012, BIRTH DEFECTS RES A, V94, P182, DOI 10.1002/bdra.22879; Sherwood RI, 2009, DEV DYNAM, V238, P29, DOI 10.1002/dvdy.21810; Shu WG, 2007, DEVELOPMENT, V134, P1991, DOI 10.1242/dev.02846; Smigiel R, 2015, DIS ESOPHAGUS, V28, P229, DOI 10.1111/dote.12173; Solomon BD, 2012, AM J MED GENET A, V158A, P3087, DOI 10.1002/ajmg.a.35638; Spilde T, 2003, J PEDIATR SURG, V38, P465, DOI 10.1053/jpsu.2003.50080; Spilde TL, 2002, J PEDIATR SURG, V37, P1065, DOI 10.1053/jpsu.2002.33845; Spilde TL, 2002, ANAT RECORD, V267, P220, DOI 10.1002/ar.10106; Stempien-Otero A, 2016, J MOL CELL CARDIOL, V97, P153, DOI 10.1016/j.yjmcc.2016.05.002; Thomas M, 2009, AM J PATHOL, V174, P380, DOI 10.2353/ajpath.2009.080565; TORFS CP, 1981, AM J EPIDEMIOL, V113, P563, DOI 10.1093/oxfordjournals.aje.a113133; Torfs CP, 1995, TERATOLOGY, V52, P220, DOI 10.1002/tera.1420520408; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Untergasser G, 2005, MECH AGEING DEV, V126, P59, DOI 10.1016/j.mad.2004.09.023; van Beelen NWG, 2014, EUR J PEDIATR SURG, V24, P20, DOI 10.1055/s-0033-1352527; van Bokhoven H, 2005, NAT GENET, V37, P465, DOI 10.1038/ng1546; van de Putte R, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00310; Veenma D, 2012, EUR J HUM GENET, V20, P298, DOI 10.1038/ejhg.2011.194; Villegas SN, 2013, ELIFE, V2, DOI 10.7554/eLife.00806; Villegas SN, 2010, J CELL BIOCHEM, V110, P10, DOI 10.1002/jcb.22536; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wallace AS, 2005, CELL TISSUE RES, V319, P367, DOI 10.1007/s00441-004-1023-2; Williamson KA, 2006, HUM MOL GENET, V15, P1413, DOI 10.1093/hmg/ddl064; Wong-Gibbons DL, 2008, BIRTH DEFECTS RES A, V82, P776, DOI 10.1002/bdra.20529; Xu JQ, 2011, J NEUROCHEM, V116, P192, DOI 10.1111/j.1471-4159.2010.06824.x; Ya J, 1998, CIRC RES, V83, P986, DOI 10.1161/01.RES.83.10.986; YAMADA KM, 1995, CURR OPIN CELL BIOL, V7, P681, DOI 10.1016/0955-0674(95)80110-3; Yu WY, 2005, DEV BIOL, V284, P157, DOI 10.1016/j.ydbio.2005.04.042; ZAWTUN HA, 1982, ACTA ANAT, V114, P1; Zhang R, 2017, BIRTH DEFECTS RES, V109, P1063, DOI 10.1002/bdr2.1042; Zhang Z, 2016, DEV BIOL, V416, P187, DOI 10.1016/j.ydbio.2016.05.025; Zwink N, 2016, DIS ESOPHAGUS, V29, P1032, DOI 10.1111/dote.12431	122	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242167	10.1371/journal.pone.0242167	http://dx.doi.org/10.1371/journal.pone.0242167			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201890	gold, Green Published			2022-12-26	WOS:000595003900052
J	Watanabe, K; Katagiri, S; Takahashi, H; Sasaki, N; Maekawa, S; Komazaki, R; Hatasa, M; Kitajima, Y; Maruyama, Y; Shiba, T; Komatsu, K; Ohsugi, Y; Tanaka, K; Matsuzawa, A; Hirota, T; Tohara, H; Eguchi, Y; Anzai, K; Hattori, A; Iwata, T				Watanabe, Kazuki; Katagiri, Sayaka; Takahashi, Hirokazu; Sasaki, Naoki; Maekawa, Shogo; Komazaki, Rina; Hatasa, Masahiro; Kitajima, Yoichiro; Maruyama, Yusuke; Shiba, Takahiko; Komatsu, Keiji; Ohsugi, Yujin; Tanaka, Kenichi; Matsuzawa, Ayumi; Hirota, Tomomitsu; Tohara, Haruka; Eguchi, Yuichiro; Anzai, Keizo; Hattori, Atsuhiko; Iwata, Takanori			Porphyromonas gingivalis impairs glucose uptake in skeletal muscle associated with altering gut microbiota	FASEB JOURNAL			English	Article						glucose uptake; metabolic syndrome; periodontal disease; Porphyromonas gingivalis; skeletal muscle	NECROSIS-FACTOR-ALPHA; PERIODONTAL-DISEASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; SARCOPENIA; OBESITY	Skeletal muscles have a high metabolic capacity, which play key roles in glucose metabolism. Although periodontal disease increases the risk of metabolic syndrome, the relationship between periodontal bacterial infection and skeletal muscle metabolic dysfunction is unclear. We found that anti-Porphyromonas gingivalis (Pg) antibody titers positively correlated with intramuscular adipose tissue content (IMAC), fasting blood glucose, and HOMA-IR in metabolic syndrome patients. In C57BL/6J mice fed a high-fat diet, recipients of oral Pg (HFPg) had impaired glucose tolerance, insulin resistance, and higher IMAC compared to recipients of saline (HFco). The soleus muscle in HFPg mice exhibited fat infiltration and lower glucose uptake with higher Tnfa expression and lower insulin signaling than in HFco mice. Gene set enrichment analysis showed that TNF alpha signaling via NF kappa B gene set was enriched in the soleus muscle of HFPg mice. Moreover, TNF-alpha also decreased glucose uptake in C2C12 myoblast cells in vitro. Based on 16S rRNA sequencing, Pg administration altered the gut microbiome, particularly by decreasing the abundance of genus Turicibacter. Microbial network of the gut microbiome was dramatically changed by Pg administration. Our findings suggest that infection with Pg is a risk factor for metabolic syndrome and skeletal muscle metabolic dysfunction via gut microbiome alteration.	[Watanabe, Kazuki; Katagiri, Sayaka; Sasaki, Naoki; Maekawa, Shogo; Komazaki, Rina; Hatasa, Masahiro; Shiba, Takahiko; Komatsu, Keiji; Ohsugi, Yujin; Iwata, Takanori] Tokyo Med & Dent Univ TMDU, Grad Sch Med & Dent Sci, Dept Periodontol, Tokyo, Japan; [Takahashi, Hirokazu; Kitajima, Yoichiro; Tanaka, Kenichi; Anzai, Keizo] Saga Univ, Div Endocrinol & Metab, Facil Med, 5-1-1 Nabeshima, Saga 8498501, Japan; [Takahashi, Hirokazu; Eguchi, Yuichiro] Saga Univ, Saga Univ Hosp, Liver Ctr, Saga, Japan; [Kitajima, Yoichiro] Eguchi Hosp, Dept Radiol, Saga, Japan; [Maruyama, Yusuke; Hattori, Atsuhiko] Tokyo Med & Dent Univ TMDU, Dept Biol, Coll Liberal Arts & Sci, Tokyo, Japan; [Matsuzawa, Ayumi] Tokyo Med & Dent Univ TMDU, Med Res Inst, Dept Epigenet, Tokyo, Japan; [Hirota, Tomomitsu] Jikei Univ, Sch Med, Res Ctr Med Sci, Div Mol Genet, Tokyo, Japan; [Tohara, Haruka] Tokyo Med & Dent Univ TMDU, Dysphagia Rehabil, Dept Gerontol & Gerodontol, Grad Sch Med & Dent Sci, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Saga University; Saga University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Jikei University; Tokyo Medical & Dental University (TMDU)	Takahashi, H (corresponding author), Saga Univ, Div Endocrinol & Metab, Facil Med, 5-1-1 Nabeshima, Saga 8498501, Japan.; Katagiri, S (corresponding author), Tokyo Med & Dent Univ, Dept Periodontol, Grad Sch Med & Dent Sci, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	katagiri.peri@tmd.ac.jp; katagiri.peri@tmd.ac.jp	Maekawa, Shogo/GQH-4094-2022; MAEKAWA, SHOGO/AAX-6288-2021	MAEKAWA, SHOGO/0000-0002-6207-7826	MEXT \ Japan Society for the Promotion of Science (JSPS) [JP17K11982, JP18K15754, JP19K24062, JP19K18989, JP19K10221, JP18K11016, JP20J13034, JP20H03863]	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: JP17K11982, JP18K15754, JP19K24062, JP19K18989, JP19K10221, JP18K11016, JP20J13034 and JP20H03863	Amano A, 2004, J PERIODONTAL RES, V39, P136, DOI 10.1111/j.1600-0765.2004.00719.x; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Batsis JA, 2018, NAT REV ENDOCRINOL, V14, P513, DOI 10.1038/s41574-018-0062-9; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Dean DJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE957, DOI 10.1152/ajpendo.1998.275.6.E957; Eke PI, 2015, J PERIODONTOL, V86, P611, DOI 10.1902/jop.2015.140520; Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Frontera WR, 2015, CALCIFIED TISSUE INT, V96, P183, DOI 10.1007/s00223-014-9915-y; Giudice J, 2017, CURR OPIN PHARMACOL, V34, P49, DOI 10.1016/j.coph.2017.05.005; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hua N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182430; Iwata M, 2001, DIABETES, V50, P1083, DOI 10.2337/diabetes.50.5.1083; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Jensen J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00112; Kammoun M, 2014, EUR J HISTOCHEM, V58, P163, DOI 10.4081/ejh.2014.2254; Katagiri S, 2016, DIABETES, V65, P2760, DOI 10.2337/db15-1721; Kim OS, 2018, J PERIODONTAL RES, V53, P362, DOI 10.1111/jre.12521; King GL, 2016, DIABETES, V65, P1462, DOI 10.2337/db16-0152; Kitajima Y, 2018, J GASTROENTEROL, V53, P427, DOI 10.1007/s00535-017-1370-x; Kojima T, 1997, J PERIODONTOL, V68, P618, DOI 10.1902/jop.1997.68.7.618; Komazaki R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14260-9; Kudo C, 2012, J DENT RES, V91, P1190, DOI 10.1177/0022034512461796; Lahiri S, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aan5662; Lamster IB, 2017, INT DENT J, V67, P67, DOI 10.1111/idj.12264; Li YM, 2019, SAUDI J BIOL SCI, V26, P395, DOI 10.1016/j.sjbs.2018.11.008; Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663; Fernandez-Real JM, 2015, DIABETES CARE, V38, P2169, DOI 10.2337/dc14-3082; Martinez-Herrera M, 2017, MED ORAL PATOL ORAL, V22, pE708, DOI 10.4317/medoral.21786; McCracken E, 2018, CLIN DERMATOL, V36, P14, DOI 10.1016/j.clindermatol.2017.09.004; Meyer C, 2002, AM J PHYSIOL-ENDOC M, V282, pE419, DOI 10.1152/ajpendo.00032.2001; Mysak J, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/476068; Nishimura F, 2003, J PERIODONTOL, V74, P97, DOI 10.1902/jop.2003.74.1.97; Page R C, 1998, Ann Periodontol, V3, P108, DOI 10.1902/annals.1998.3.1.108; Pajak B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010234; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Preshaw PM, 2012, DIABETOLOGIA, V55, P21, DOI 10.1007/s00125-011-2342-y; Raza GS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05259-3; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Saito T, 1998, NEW ENGL J MED, V339, P482, DOI 10.1056/NEJM199808133390717; Sasaki N, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02470; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Shadrin IY, 2016, CELL MOL LIFE SCI, V73, P4175, DOI 10.1007/s00018-016-2285-z; Shiba T, 2016, SCI REP-UK, V6, DOI 10.1038/srep30997; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun WL, 2011, INTERNAL MED, V50, P1569, DOI 10.2169/internalmedicine.50.5166; Teramoto T, 2008, J ATHEROSCLER THROMB, V15, P1, DOI 10.5551/jat.E580; Toyoda T, 2011, J BIOL CHEM, V286, P4133, DOI 10.1074/jbc.M110.174938; Udagawa S, 2018, ACTA ODONTOL SCAND, V76, P433, DOI 10.1080/00016357.2018.1426876; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Zhong YD, 2015, MOL NUTR FOOD RES, V59, P2066, DOI 10.1002/mnfr.201500187; Zhu LX, 2013, HEPATOLOGY, V57, P601, DOI 10.1002/hep.26093; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295; Zimowska M, 2017, MUSCLE NERVE, V55, P400, DOI 10.1002/mus.25246; Zoico E, 2004, INT J OBESITY, V28, P234, DOI 10.1038/sj.ijo.0802552	57	13	14	3	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001158R	http://dx.doi.org/10.1096/fj.202001158R		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33197074				2022-12-26	WOS:000592668200001
J	Beck, M; Baranger, M; Moufok-Sadoun, A; Bersuder, E; Hinkel, I; Mellitzer, G; Martin, E; Marisa, L; Duluc, I; de Reynies, A; Gaiddon, C; Freund, JN; Gross, I				Beck, Marine; Baranger, Mathilde; Moufok-Sadoun, Ahlam; Bersuder, Emilie; Hinkel, Isabelle; Mellitzer, Georg; Martin, Elisabeth; Marisa, Laetitia; Duluc, Isabelle; de Reynies, Aurelien; Gaiddon, Christian; Freund, Jean-Noel; Gross, Isabelle			The atypical cadherin MUCDHL antagonizes colon cancer formation and inhibits oncogenic signaling through multiple mechanisms	ONCOGENE			English	Article							MU-PROTOCADHERIN; EXPRESSION; MOUSE; GENE; PATHWAY; GROWTH; MODEL	Cadherins form a large and pleiotropic superfamily of membranous proteins sharing Ca2+-binding repeats. While the importance of classic cadherins such as E- or N-cadherin for tumorigenesis is acknowledged, there is much less information about other cadherins that are merely considered as tissue-specific adhesion molecules. Here, we focused on the atypical cadherin MUCDHL that stood out for its unusual features and unique function in the gut. Analyses of transcriptomic data sets (n > 250) established that MUCDHL mRNA levels are down-regulated in colorectal tumors. Importantly, the decrease of MUCDHL expression is more pronounced in the worst-prognosis subset of tumors and is associated with decreased survival. Molecular characterization of the tumors indicated a negative correlation with proliferation-related processes (e.g., nucleic acid metabolism, DNA replication). Functional genomic studies showed that the loss of MUCDHL enhanced tumor incidence and burden in intestinal tumor-prone mice. Extensive structure/function analyses revealed that the mode of action of MUCDHL goes beyond membrane sequestration of ss-catenin and targets through its extracellular domain key oncogenic signaling pathways (e.g., EGFR, AKT). Beyond MUCDHL, this study illustrates how the loss of a gene critical for the morphological and functional features of mature cells contributes to tumorigenesis by dysregulating oncogenic pathways.	[Beck, Marine; Baranger, Mathilde; Moufok-Sadoun, Ahlam; Bersuder, Emilie; Hinkel, Isabelle; Mellitzer, Georg; Martin, Elisabeth; Duluc, Isabelle; Gaiddon, Christian; Freund, Jean-Noel; Gross, Isabelle] Univ Strasbourg, INSERM, IRFAC, UMR S1113, F-67200 Strasbourg, France; [Marisa, Laetitia; de Reynies, Aurelien] Ligue Natl Canc, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Gross, I (corresponding author), Univ Strasbourg, INSERM, IRFAC, UMR S1113, F-67200 Strasbourg, France.	isabelle.gross@unistra.fr	Georg, Mellitzer/R-4180-2016; Gross, Isabelle/P-9859-2019; Gaiddon, Christian/F-7321-2012; DULUC, Isabelle/AAA-7062-2022; Freund, Jean-Noel/R-4383-2016	Georg, Mellitzer/0000-0003-4467-0789; Gross, Isabelle/0000-0002-2783-8773; Gaiddon, Christian/0000-0003-4315-3851; DULUC, Isabelle/0000-0001-8396-6385; Freund, Jean-Noel/0000-0002-0971-3774	INSERM; Fondation ARC [SFI20101201854]; La Ligue Contre Le Cancer [Haute-Marne 2013, Haut-Rhin 2016]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation ARC; La Ligue Contre Le Cancer(Ligue nationale contre le cancer)	This work was supported by the financial support of INSERM (2013-2019), Fondation ARC (#SFI20101201854), and La Ligue Contre Le Cancer (Haute-Marne 2013, Haut-Rhin 2016); MBe, MBa, EB, AMS, and IH were fellows of the French government (Ministere de l'Enseignement Superieur et de la Recherche). MBe and MBawere also fellows of Fondation ARC, and EB of the FRM.	Balbinot C, 2018, J EXP MED, V215, P911, DOI 10.1084/jem.20170934; Basu Sayon, 2016, F1000Res, V5, DOI 10.12688/f1000research.7579.1; Blasius FM, 2017, ONCOTARGET, V8, P75076, DOI 10.18632/oncotarget.20507; Borowicz S, 2014, JOVE-J VIS EXP, DOI 10.3791/51998; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; CHANTRET I, 1994, J CELL SCI, V107, P213; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; Crawley SW, 2014, CELL, V157, P433, DOI 10.1016/j.cell.2014.01.067; Danielsen SA, 2015, BBA-REV CANCER, V1855, P104, DOI 10.1016/j.bbcan.2014.09.008; Ding X, 2020, IRISH J MED SCI, V189, P439, DOI 10.1007/s11845-019-02092-7; Fichera A, 2007, CANCER RES, V67, P827, DOI 10.1158/0008-5472.CAN-05-3343; Gehart H, 2019, NAT REV GASTRO HEPAT, V16, P19, DOI 10.1038/s41575-018-0081-y; Goldberg M, 2000, J BIOL CHEM, V275, P24622, DOI 10.1074/jbc.M000234200; Goldberg M, 2002, AM J PHYSIOL-RENAL, V283, pF454, DOI 10.1152/ajprenal.00012.2002; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Gul IS, 2017, EXP CELL RES, V358, P3, DOI 10.1016/j.yexcr.2017.03.001; Hinkel I, 2012, GASTROENTEROLOGY, V142, P875, DOI 10.1053/j.gastro.2011.12.037; Hu TH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-236; Hughes LAE, 2017, CURR COLORECT CANC R, V13, P455, DOI 10.1007/s11888-017-0395-0; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee CH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-64; Losi L, 2011, HUM PATHOL, V42, P960, DOI 10.1016/j.humpath.2010.10.009; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Markowitz SD, 2002, CANCER CELL, V1, P233, DOI 10.1016/S1535-6108(02)00053-3; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Mateusz B, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/317093; Mazzolini R, 2012, P NATL ACAD SCI USA, V109, P1530, DOI 10.1073/pnas.1108411109; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Montorsi L, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.163; Moulton DE, 2004, PEDIATR RES, V55, P927, DOI 10.1203/01.PDR.0000125260.46861.32; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Novellasdemunt L, 2015, AM J PHYSIOL-CELL PH, V309, pC511, DOI 10.1152/ajpcell.00117.2015; O'Connell MJ, 2010, J CLIN ONCOL, V28, P3937, DOI 10.1200/JCO.2010.28.9538; Parenti S, 2009, ALIMENT PHARM THER, V31, P108, DOI 10.1111/j.1365-2036.2009.04149.x; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647	40	5	5	1	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2021	40	3					522	535		10.1038/s41388-020-01546-y	http://dx.doi.org/10.1038/s41388-020-01546-y		NOV 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PU9SL	33188295	Green Submitted			2022-12-26	WOS:000589573800002
J	Alvandi, Z; Opas, M				Alvandi, Zahra; Opas, Michal			c-Src kinase inhibits osteogenic differentiation via enhancing STAT1 stability	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; FAMILY KINASES; TRANSCRIPTION FACTOR; BONE-DEVELOPMENT; EXPRESSION; GENE; PHOSPHORYLATION; PROLIFERATION; LOCALIZATION; FIBRONECTIN	The proto-oncogene Src is ubiquitously expressed and is involved in cellular differentiation. However, the role of Src in embryonic stem (ES) cell osteogenic differentiation is largely unknown. Using the small molecule inhibitor PP2, c-Src specific siRNAs, and tet-inducible lentiviral vectors overexpressing active c-Src, we delineated an inhibitory role of c-Src in osteogenic differentiation of mouse embryonic stem cells (mESCs) and mouse MC3T3-E1s preosteoblasts. Active c-Src was shown to restrict the nuclear residency of Runt-related transcription factor 2 (Runx2) and its transcriptional activity with no detectable effect on Runx2 expression level. Furthermore, we showed Signal Transducer and Activator of Transcription 1 (STAT1) was indispensable to the inhibitory role of c-Src on Runx2 nuclear localization. Specifically, higher levels of active c-Src increased STAT1 half-life by inhibiting its proteasomal degradation, thereby increasing the cytoplasmic abundance of STAT1. More abundant cytoplasmic STAT1 bound and anchored Runx2, which restricted its nucleocytoplasmic shuttling and ultimately reduced Runx2 transcriptional activity. Collectively, this study has defined a new mechanism by which c-Src inhibits the transcriptional regulation of osteogenesis from mESCs in vitro.	[Alvandi, Zahra; Opas, Michal] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Alvandi, Zahra] Boston Childrens Hosp, Dept Vasc Biol, Boston, MA 02115 USA; [Alvandi, Zahra] Harvard Med Sch, Dept Surg, Boston, MA 02115 USA	University of Toronto; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Alvandi, Z (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Alvandi, Z (corresponding author), Boston Childrens Hosp, Dept Vasc Biol, Boston, MA 02115 USA.; Alvandi, Z (corresponding author), Harvard Med Sch, Dept Surg, Boston, MA 02115 USA.	Zahra.alvandi@childrens.harvard.edu		Alvandi, Zahra/0000-0003-0097-4713	CIHR [MOP-13055, MOP-106461]	CIHR(Canadian Institutes of Health Research (CIHR))	This work is supported with CIHR MOP-13055 and MOP-106461. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abe T, 2006, J BONE MINER METAB, V24, P283, DOI 10.1007/s00774-006-0685-0; Alvandi Z, 2020, STEM CELL RES, V48, DOI 10.1016/j.scr.2020.101972; Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Blumenthal E, 2017, ADV EXP MED BIOL, V962, P33, DOI 10.1007/978-981-10-3233-2_3; Cartwright P, 2000, CELL MOL LIFE SCI, V57, P1193, DOI 10.1007/PL00000759; Chang YJ, 2004, MOL PHARMACOL, V65, P589, DOI 10.1124/mol.65.3.589; Choi YH, 2015, MOL CELL ENDOCRINOL, V407, P85, DOI 10.1016/j.mce.2015.03.010; Cooley BC, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006927; Crabtree GR, 2001, J BIOL CHEM, V276, P2313, DOI 10.1074/jbc.R000024200; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fujie A, 2015, BIOCHEM BIOPH RES CO, V457, P451, DOI 10.1016/j.bbrc.2015.01.012; Jensen ED, 2010, BIOFACTORS, V36, P25, DOI 10.1002/biof.72; Kim S, 2003, GENE DEV, V17, P1979, DOI 10.1101/gad.1119303; Komori T, 2008, FRONT BIOSCI-LANDMRK, V13, P898, DOI 10.2741/2730; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lee YC, 2010, ONCOGENE, V29, P3196, DOI 10.1038/onc.2010.73; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; McBride Kevin M, 2003, Sci STKE, V2003, pRE13; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Muller S, 2014, ONCOTARGET, V5, P3184; Murrills RJ, 2012, J PHARMACOL EXP THER, V340, P676, DOI 10.1124/jpet.111.185793; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Papp S, 2008, EXP CELL RES, V314, P1313, DOI 10.1016/j.yexcr.2008.01.008; Papp S, 2007, J BIOL CHEM, V282, P16585, DOI 10.1074/jbc.M701011200; Papp S, 2010, AM J PATHOL, V176, P1113, DOI 10.2353/ajpath.2010.090392; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Peruzzi B, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1651; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Roeder E, 2016, BONE, V92, P189, DOI 10.1016/j.bone.2016.09.004; Rutkovskiy A, 2016, MED SCI MONIT BASIC, V22, P95, DOI 10.12659/MSMBR.901142; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Sarkar TR, 2012, MOL CELL BIOL, V32, P320, DOI 10.1128/MCB.05790-11; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Su WCS, 1997, NATURE, V386, P288, DOI 10.1038/386288a0; Tajima K, 2010, J ORTHOP RES, V28, P937, DOI 10.1002/jor.21086; Thouverey C, 2018, BONE, V113, P95, DOI 10.1016/j.bone.2018.05.006; Vandromme M, 1996, TRENDS BIOCHEM SCI, V21, P59, DOI 10.1016/S0968-0004(96)80182-4; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; Xiao LP, 2004, J BIOL CHEM, V279, P27743, DOI 10.1074/jbc.M314323200; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang X, 2014, STEM CELL RES, V13, P379, DOI 10.1016/j.scr.2014.09.007	47	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241646	10.1371/journal.pone.0241646	http://dx.doi.org/10.1371/journal.pone.0241646			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180789	Green Published, gold			2022-12-26	WOS:000593948000005
J	Davidsen, A; Mardal, M; Linnet, K; Dalsgaard, PW				Davidsen, Anders; Mardal, Marie; Linnet, Kristian; Dalsgaard, Petur Weihe			How to perform spectrum-based LC-HR-MS screening for more than 1,000 NPS with HighResNPS consensus fragment ions	PLOS ONE			English	Article							INTER-LABORATORY TRANSFERABILITY; TIME-OF-FLIGHT; PSYCHOACTIVE SUBSTANCES; MASS-SPECTROMETRY; IMMUNOASSAY; INTERINSTRUMENT; REPOSITORY; DRUGS	Introduction The ever-changing market of new psychoactive substances (NPS) poses challenges for laboratories worldwide. Analytical toxicologists are constantly working to keep high-resolution mass spectrometry (HR-MS) screening libraries updated for NPS. This study sought to use the online crowd-sourced HighResNPS database for spectrum comparison screening, thereby broadening its utility to all HR-MS instruments. Method HighResNPS allows formation of a set of consensus fragment ions for a NPS and prioritises among multiple entries of collision-induced fragment ions. A subset of 42 NPS samples was analysed in data-independent acquisition (DIA) and data-dependent acquisition (DDA) modes on two different instruments. HighResNPS-computed spectra were generated with either Absolute (all fragment ions set to 100%) or Fractional (50% intensity reduction of former fragment ion) intensity. The acquired NPS data were analysed using the consensus library with computed ion intensities and evaluated with vendor-neutral screening software. Results Overall, of the 42 samples, 100% were identified, with 88% identified as the top candidate. Three samples had the correct candidate proposed as the second highest ranking NPS. In all three of those samples, the top proposed candidate was a positional isomer or closely related compound. Absolute intensity assignment provided identical scoring between the top two proposed compounds in two samples with DIA. DDA had a slightly higher identification rate in the spectra comparison screening with fractional intensity assignment, but no major differences were observed. Conclusion The fractional intensity assignment was slightly more advantageous than the absolute assignment. It was selective between proposed candidates, showed a high identification rate and had an overall higher fragmentation scoring. The candidates proposed by the HighResNPS library spectra comparison simplify the determination of NPS for researchers and toxicologists. The database provides free monthly updates of consensus spectra, thereby enabling laboratories to stay at the forefront of NPS screening by LC-HR-MS with spectra screening software.	[Davidsen, Anders; Mardal, Marie; Linnet, Kristian; Dalsgaard, Petur Weihe] Univ Copenhagen, Sect Forens Chem, Dept Forens Med, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen	Davidsen, A (corresponding author), Univ Copenhagen, Sect Forens Chem, Dept Forens Med, Fac Hlth & Med Sci, Copenhagen, Denmark.	anders.davidsen@sund.ku.dk		Linnet, Kristian/0000-0001-6974-5535; Mardal, Marie/0000-0002-3203-7305; Davidsen, Anders Bork/0000-0003-0568-0861; Dalsgaard, Petur/0000-0002-8967-7477				Beck O, 2014, DRUG TEST ANAL, V6, P492, DOI 10.1002/dta.1641; Diamanti K, 2019, SCI TOTAL ENVIRON, V685, P1058, DOI 10.1016/j.scitotenv.2019.06.173; EMCDDA, 2018, FENT SYNTH CANN DRIV, DOI [10.2810/006358, DOI 10.2810/006358]; European Monitoring Centre for Drugs and Drug Addiction, EUR DRUG REP, DOI [10.2810/191370, DOI 10.2810/191370]; Gundersen POM, 2020, FORENSIC SCI INT, V311, DOI 10.1016/j.forsciint.2020.110274; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Kronstrand R, 2014, ANAL BIOANAL CHEM, V406, P3599, DOI 10.1007/s00216-013-7574-x; Mardal M, 2019, J ANAL TOXICOL, V43, P520, DOI 10.1093/jat/bkz030; Mollerup CB, 2017, DRUG TEST ANAL, V9, P1052, DOI 10.1002/dta.2120; Oberacher H, 2020, ENVIRON SCI EUR, V32, DOI 10.1186/s12302-020-00314-9; Oberacher H, 2012, J MASS SPECTROM, V47, P263, DOI 10.1002/jms.2961; Oberacher H, 2009, J MASS SPECTROM, V44, P485, DOI 10.1002/jms.1545; Partridge E, 2018, J ANAL TOXICOL, V42, P220, DOI 10.1093/jat/bkx108; Rasmussen NN, 2018, J APPL LAB MED, V2, P535, DOI 10.1373/jalm.2017.024166; Schumacher S, 2016, J IMMUNOL METHODS, V436, P34, DOI 10.1016/j.jim.2016.06.004; Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105; Sundstrom M, 2015, DRUG TEST ANAL, V7, P420, DOI 10.1002/dta.1683; United Nations Office on Drugs and Crime, EARL WARN ADV; Urbas A, 2018, FORENSIC CHEM, V9, P76, DOI 10.1016/j.forc.2018.05.003; von Cupper M, 2020, J ANAL TOXICOL, V44, P1047, DOI 10.1093/jat/bkaa028; Yanini A, 2018, J CHROMATOGR A, V1574, P91, DOI 10.1016/j.chroma.2018.09.006	21	9	9	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242224	10.1371/journal.pone.0242224	http://dx.doi.org/10.1371/journal.pone.0242224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180844	Green Published, gold			2022-12-26	WOS:000593948000021
J	Kajino-Sakamoto, R; Fujishita, T; Taketo, MM; Aoki, M				Kajino-Sakamoto, Rie; Fujishita, Teruaki; Taketo, Makoto Mark; Aoki, Masahiro			Synthetic lethality between MyD88 loss and mutations in Wnt/beta-catenin pathway in intestinal tumor epithelial cells	ONCOGENE			English	Article							TUMORIGENESIS; MICE; APC; ACTIVATION; IMMUNITY	Although the Wnt/beta-catenin pathway plays a central role in the carcinogenesis and maintenance of colorectal cancer (CRC), attempts to target the pathway itself have not been very successful. MyD88, an adaptor protein of the TLR/IL-1 beta signaling, has been implicated in the integrity of the intestines as well as in their tumorigenesis. In this study, we aimed to clarify the mechanisms by which epithelial MyD88 contributes to intestinal tumor formation and to address whether MyD88 can be a therapeutic target of CRC. Conditional knockout of MyD88 in intestinal epithelial cells (IECs) reduced tumor formation in Apc(+/Delta 716) mice, accompanied by decreased proliferation and enhanced apoptosis of tumor epithelial cells. Mechanistically, the MyD88 loss caused inactivation of the JNK-mTORC1, NF-kappa B, and Wnt/beta-catenin pathways in tumor cells. Induction of MyD88 knockout in the intestinal tumor-derived organoids, but not in the normal IEC-derived organoids, induced apoptosis and reduced their growth. Treatment with the MyD88 inhibitor ST2825 also suppressed the growth of the intestinal tumor-derived organoids. Knockdown of MYD88 in human CRC cell lines with mutations in APC or CTNNB1 induced apoptosis and reduced their proliferation as well. These results indicate that MyD88 loss is synthetic lethal with mutational activation of the Wnt/beta-catenin signaling in intestinal tumor epithelial cells. Inhibition of MyD88 signaling can thus be a novel therapeutic strategy for familial adenomatous polyposis (FAP) as well as for colorectal cancer harboring mutations in the Wnt/beta-catenin signaling.	[Kajino-Sakamoto, Rie; Fujishita, Teruaki; Aoki, Masahiro] Aichi Canc Ctr Res Inst, Div Pathophysiol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan; [Taketo, Makoto Mark] Kyoto Univ, Grad Sch Med, Div Expt Therapeut, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan; [Aoki, Masahiro] Nagoya Univ, Dept Canc Physiol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4648550, Japan	Aichi Cancer Center; Kyoto University; Nagoya University	Aoki, M (corresponding author), Aichi Canc Ctr Res Inst, Div Pathophysiol, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.; Aoki, M (corresponding author), Nagoya Univ, Dept Canc Physiol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4648550, Japan.	msaoki@aichi-cc.jp	Aoki, Masahiro/A-5149-2016	Aoki, Masahiro/0000-0003-4316-9490; Fujishita, Teruaki/0000-0002-4397-2438	JSPS [JP18K07254, JP26111001]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by JSPS Grant-in-Aid for Scientific Research (JP18K07254) to RKS and JSPS Grant-in-Aid for Scientific Research on Innovative Areas (JP26111001) to MA.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Colomer C, 2018, BRIT J CANCER, V118, P839, DOI 10.1038/bjc.2017.459; Dhar R, 2009, BIOCHEMISTRY-US, V48, P1474, DOI 10.1021/bi801840s; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fujishita T, 2017, ONCOGENE, V36, P6480, DOI 10.1038/onc.2017.242; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Fujishita T, 2015, CANCER SCI, V106, P692, DOI 10.1111/cas.12670; Fujishita T, 2011, GASTROENTEROLOGY, V140, P1556, DOI 10.1053/j.gastro.2011.02.007; Fujishita T, 2009, CELL CYCLE, V8, P3684, DOI 10.4161/cc.8.22.9946; Holtorf A, 2018, ONCOIMMUNOLOGY, V7, P1, DOI [10.1080/2162402X.2018.1477461, DOI 10.1080/2162402X.2018.1477461]; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Novellasdemunt L, 2015, AM J PHYSIOL-CELL PH, V309, pC511, DOI 10.1152/ajpcell.00117.2015; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Rakoff-Nahoum S, 2007, SCIENCE, V317, P124, DOI 10.1126/science.1140488; Rohwer N, 2019, ONCOGENE, V38, P5670, DOI 10.1038/s41388-019-0816-4; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Scheeren FA, 2014, NAT CELL BIOL, V16, P1238, DOI 10.1038/ncb3058; Scholer-Dahirel A, 2011, P NATL ACAD SCI USA, V108, P17135, DOI 10.1073/pnas.1104182108; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Treon SP, 2012, NEW ENGL J MED, V367, P826, DOI 10.1056/NEJMoa1200710; Vadde R, 2017, CRIT REV ONCOL HEMAT, V113, P22, DOI 10.1016/j.critrevonc.2017.02.025; Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558; Weber ANR, 2018, CANCER IMMUNOL IMMUN, V67, P1797, DOI 10.1007/s00262-018-2242-9; Xue X, 2014, AM J PHYSIOL-GASTR L, V307, pG187, DOI 10.1152/ajpgi.00112.2014; Zundel W, 2000, GENE DEV, V14, P391	39	6	6	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					408	420		10.1038/s41388-020-01541-3	http://dx.doi.org/10.1038/s41388-020-01541-3		NOV 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33177648				2022-12-26	WOS:000588591400001
J	Cho, HM; Gonzalez-Ortiz, G; Melo-Duran, D; Heo, JM; Cordero, G; Bedford, MR; Kim, JC				Cho, Hyun Min; Gonzalez-Ortiz, Gemma; Melo-Duran, Diego; Heo, Jung Min; Cordero, Gustavo; Bedford, Michael R.; Kim, Jae Cheol			Stimbiotic supplementation improved performance and reduced inflammatory response via stimulating fiber fermenting microbiome in weaner pigs housed in a poor sanitary environment and fed an antibiotic-free low zinc oxide diet	PLOS ONE			English	Article							POST-WEANING DIARRHEA; ENTEROTOXIGENIC STRAIN; HEALTH; BUTYRATE; GUT; FERMENTATION; BACTERIUM; ECOLOGY	This study investigated whether the inclusion of a stimbiotic (STB) can improve performance, influence intestinal microbiota and fermentation activity, and reduce pro-inflammatory cytokines in piglets fed a low zinc oxide diet without antimicrobial growth promotors compared to fructo-oligosaccharide (FOS) and mannan-oligosaccharide (MOS) when housed either in good sanitary (GS) or poor sanitary (PS) environments. One hundred forty-four male pigs (28-day-old) were sorted by initial body weight (BW) and allocated to one of six experimental treatments: 1) GS environment without any additive (GS-CTR); 2) GS environment with 0.01% stimbiotic (GS-STB); 3) PS environment (without cleaning and disinfection of a previously populated room) without any additive (PS-CTR); 4) PS environment with 0.01% STB (PS-STB); 5) PS environment with 0.1% MOS (PS-MOS); and 6) PS environment with 0.2% FOS (PS-FOS). Each treatment had six replicates, with four animals each. Three feeding phases, based on corn, wheat, and soybean meal were available ad libitum for the 42-days of the study. Housing piglets under PS conditions negatively influenced performance, increased plasma tumor necrosis factor alpha (TNF-alpha), affected the fecal microbial populations and increased concentrations of branched-chain fatty acids (BCFA) compared to GS. Stimbiotic improved 42-d-BW under PS conditions (P < 0.05) whereas MOS or FOS had no effect. On d35, plasma TNF-alpha was reduced with STB in PS (P < 0.05). The ratio between VFA:BCFA increased (P < 0.05) with STB, MOS or FOS in PS, and under GS condition, STB also increased the ratio. Stimbiotic increased the proportion of Clostridiales Family XIII Incertae Sedis and Clostridiaceae, while MOS and FOS increased Selenomonadaceae, Catabacteriaceae and Fibrobacteraceae. These results indicate that STB shifted the intestinal microbiome to favor fiber fermentation which likely contributed to reduced inflammatory response and improved performance, particularly in piglets reared in PS conditions.	[Cho, Hyun Min; Heo, Jung Min] Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Daejeon, South Korea; [Gonzalez-Ortiz, Gemma; Cordero, Gustavo; Bedford, Michael R.; Kim, Jae Cheol] AB Vista, Marlborough, Wilts, England; [Melo-Duran, Diego] Univ Autonoma Barcelona, Dept Ciencia Anim & Aliments, Serv Nutr & Benestar Anim SNiBA, Bellaterra, Spain	Chungnam National University; Autonomous University of Barcelona	Gonzalez-Ortiz, G (corresponding author), AB Vista, Marlborough, Wilts, England.	Gemma.Gonzalez@abvista.com	Gonzalez, Gemma/AAM-8318-2021; Bedford, Michael/AAV-8204-2020	Bedford, Michael/0000-0002-5308-4290; Gonzalez-Ortiz, Gemma/0000-0003-4181-5524; Kim, Jae Cheol/0000-0001-8215-4051	AB Vista	AB Vista	This study was supported by AB Vista, who supplied the stimbiotic used in this trial. Additionally, AB Vista provided support in the form of salaries for GGO, GC, MB, and JK. The specific roles of these authors are articulated in the `author contributions' section. AB Vista was actively involved in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebiyi AO, 2015, BRIT POULTRY SCI, V56, P239, DOI 10.1080/00071668.2015.1011606; AOAC, 1990, OFFICIAL METHODS ANA; Bautil A, 2019, VALUE OF FIBRE: ENGAGING THE SECOND BRAIN FOR ANIMAL NUTRITION, P199, DOI 10.3920/978-90-8686-893-3_12; Bedford MR, 2019, VALUE OF FIBRE: ENGAGING THE SECOND BRAIN FOR ANIMAL NUTRITION, P373, DOI 10.3920/978-90-8686-893-3_21; Bedford MR, 2018, BRIT POULTRY SCI, V59, P486, DOI 10.1080/00071668.2018.1484074; Bedford MR., 2018, P POULTR SCI ASS 107, V97, P98; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; De Maesschalck C, 2015, APPL ENVIRON MICROB, V81, P5880, DOI 10.1128/AEM.01616-15; Gonzalez-Ortiz G, 2019, VALUE OF FIBRE: ENGAGING THE SECOND BRAIN FOR ANIMAL NUTRITION, P233, DOI 10.3920/978-90-8686-893-3_14; Gonzalez-Ortiz G, 2020, POULTRY SCI, V99, P2068, DOI 10.1016/j.psj.2019.11.051; Hanshew AS, 2013, J MICROBIOL METH, V95, P149, DOI 10.1016/j.mimet.2013.08.007; Heo JM, 2013, J ANIM PHYSIOL AN N, V97, P207, DOI 10.1111/j.1439-0396.2012.01284.x; Heo JM, 2009, J ANIM SCI, V87, P2833, DOI 10.2527/jas.2008-1274; Jain I, 2015, INDIAN J EXP BIOL, V53, P131; Keesing F, 2015, SCIENCE, V349, P235, DOI 10.1126/science.aac7892; Kim JC, 2012, ANIM FEED SCI TECH, V173, P3, DOI 10.1016/j.anifeedsci.2011.12.022; Kim JC, 2011, ANIM FEED SCI TECH, V170, P222, DOI 10.1016/j.anifeedsci.2011.08.012; Kim J. C., 2013, MANIPULATING PIG PRO, VXIV, P62; Knudsen KEB, 2014, POULTRY SCI, V93, P2380, DOI 10.3382/ps.2014-03902; Kruse R, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-32; Liu JB, 2018, ASIAN AUSTRAL J ANIM, V31, P1660, DOI 10.5713/ajas.17.0908; Maharjan P, 2019, POULTRY SCI, V98, P4048, DOI 10.3382/ps/pez079; Manzanilla EG, 2006, J ANIM SCI, V84, P2743, DOI 10.2527/jas.2005-509; Marinho MC, 2007, LIVEST SCI, V108, P236, DOI 10.1016/j.livsci.2007.01.081; Markowiak P, 2018, GUT PATHOG, V10, DOI 10.1186/s13099-018-0250-0; MILLER TL, 1979, J BACTERIOL, V138, P99, DOI 10.1128/JB.138.1.99-104.1979; NRC, 2012, NUTR REW SWIN; Oksanen, PACKAGE VEGAN R PACK; Pan J, 2019, AMB EXPRESS, V9, DOI 10.1186/s13568-019-0858-6; Pastorelli H, 2012, J ANIM SCI, V90, P4866, DOI 10.2527/jas.2012-5309; Pastorelli H, 2012, ANIMAL, V6, P952, DOI 10.1017/S175173111100228X; Paulson NJ, 2019, PACKAGE METAGENOMESE; Pieper R, 2012, J NUTR, V142, P661, DOI 10.3945/jn.111.156190; Pluske J. R., 2001, The weaner pig: nutrition and management. Proceedings of a British Society of Animal Science Occasional Meeting, University of Nottingham, UK, September 2000, P81, DOI 10.1079/9780851995328.0081; Pluske JR, 2018, ANIM NUTR, V4, P187, DOI 10.1016/j.aninu.2017.12.004; Qi M, 2005, J BACTERIOL, V187, P3739, DOI 10.1128/JB.187.11.3739-3751.2005; Ribeiro T, 2018, POULTRY SCI, V97, P4330, DOI 10.3382/ps/pey336; Rozeboom DW, 2005, J ANIM SCI, V83, P2637; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Thanawongnuwech R, 2004, CLIN DIAGN LAB IMMUN, V11, P901, DOI 10.1128/CDLI.11.5.901-908.2004; Touchette KJ, 2002, J ANIM SCI, V80, P494; Van Craeyveld V, 2008, J NUTR, V138, P2348, DOI 10.3945/jn.108.094367; vanGylswyk NO, 1996, INT J SYST BACTERIOL, V46, P559, DOI 10.1099/00207713-46-2-559; Velazquez-Salinas L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01057; Wang SP, 2011, J FOOD AGRIC ENVIRON, V9, P181; Yang JP, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00216	47	14	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0240264	10.1371/journal.pone.0240264	http://dx.doi.org/10.1371/journal.pone.0240264			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170861	Green Published, gold			2022-12-26	WOS:000592383400060
J	Ciccacci, F; Lucaroni, F; Latagliata, R; Morciano, L; Mondlane, E; Balama, M; Tembo, D; Gondwe, J; Orlando, S; Palombi, L; Marazzi, MC				Ciccacci, Fausto; Lucaroni, Francesca; Latagliata, Roberto; Morciano, Laura; Mondlane, Elisa; Balama, Moises; Tembo, Dyna; Gondwe, Jane; Orlando, Stefano; Palombi, Leonardo; Marazzi, Maria Cristina			Hematologic alterations and early mortality in a cohort of HIV positive African patients	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ANEMIA; PATHOPHYSIOLOGY; EPIDEMIOLOGY; TUBERCULOSIS; PATHOGENESIS; DISEASE	Introduction Infection with Human Immunodeficiency Virus (HIV) is highly prevalent worldwide, especially in Sub-Saharan Africa, where anaemia is also widespread. HIV infection is known to be associated with anaemia and various other haematologic alterations, but little data on correlation with immunological and virologic conditions in treatment-naive patients and impact on mortality are available. Our study aims to investigate hematologic features in HIV-infected individuals in Malawi and Mozambique and assesses possible correlations with early morality. Material and methods We conducted a retrospective analysis of baseline data (general details, nutritional status, full blood count and HIV infection progress data) and 12 months follow-up status for HIV+ adult patients in 22 health facilities in Malawi (11 sites) and Mozambique (11 sites) run by DREAM program. Anagraphic details, anthropometric characteristics, full blood count, CD4+ count and Viral Load data were collected from electronical medical records (EMR) for all the HIV-positive, treatment-naive patients starting care in the sites in the period January 2007 -December 2016. Follow-up status after one year since enrolment in care was also considered. All the data extracted from the EMR were included in a dataset and then analysed. Univariate and multivariate analysis were conducted through logistical regression to investigate associations, and survival analysis analysed in a Cox regression model. Results On the whole, 22.657 patients were included; severe and moderate anaemia were observed in 1.174 (8,2%) and 4.703 (21,9%) patients respectively. Gender, nutritional status, CD4+ count, and viral load (VL) were associated with anaemia, leukopenia, and thrombocytopenia. Among 21.166 fully evaluable patients, 8.494 (40,1%) had at least one cytopenia. Any cytopenia was present in 1/3 of patients with normal nutritional status and less advanced HIV infection, and it wouldn't be diagnosed in a basic HIV care setting. During the first year of treatment, 1.725 subjects (7,6% of the entire sample) died. Anaemia, lower Red blood cells and platelets counts correlated with mortality in the first year of care, independently by body mass index, haemoglobin, CD4+ count and VL. Conclusions Notwithstanding anaemia is known to be associated with HIV infection at diagnosis, full blood count is not routinely performed in many African countries. Our results emphasize that including the study of a broader set of parameters in the routine HIV care services in Sub-Saharan Africa would provide significant clinical information able to predict other alterations and poor outcomes.	[Ciccacci, Fausto; Palombi, Leonardo] St Camillus Int Univ Hlth Sci, UniCamillus, Rome, Italy; [Lucaroni, Francesca; Morciano, Laura; Orlando, Stefano; Palombi, Leonardo] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Latagliata, Roberto] Univ Sapienza & Policlin Umberto 1, Dept Translat & Precis Med, Hematol, Rome, Italy; [Mondlane, Elisa] Community St Egidio, DREAM Program, Maputo, Mozambique; [Balama, Moises] Community St Egidio, DREAM Program, Beira, Mozambique; [Tembo, Dyna; Gondwe, Jane] Community St Egidio, DREAM Program, Blantyre, Malawi; [Marazzi, Maria Cristina] LUMSA, Rome, Italy	University of Rome Tor Vergata; Sapienza University Rome; University Hospital Sapienza Rome; Universita LUMSA	Ciccacci, F (corresponding author), St Camillus Int Univ Hlth Sci, UniCamillus, Rome, Italy.	fausto.ciccacci@gmail.com	Orlando, Stefano/AAU-2937-2021; Ciccacci, Fausto/AAF-8625-2020	Orlando, Stefano/0000-0001-9706-4075; Ciccacci, Fausto/0000-0003-0262-707X				[Anonymous], 2015, HARRISONS PRINCIPLES; Bhatta L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-604; Briggs C, 2008, INT J LAB HEMATOL, V30, P105, DOI 10.1111/j.1751-553X.2008.01050.x; Chaparro CM, 2019, ANN NY ACAD SCI, V1450, P15, DOI 10.1111/nyas.14092; Ciccacci F, 2019, AIDS RES HUM RETROV, V35, P1106, DOI [10.1089/aid.2019.0125, 10.1089/AID.2019.0125]; Crum NF, 2006, JAIDS-J ACQ IMM DEF, V41, P194, DOI 10.1097/01.qai.0000179459.31562.16; De Santis GC, 2011, INT J INFECT DIS, V15, pE808, DOI 10.1016/j.ijid.2011.08.001; Eley BS, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-3; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Firnhaber C, 2010, INT J INFECT DIS, V14, pE1088, DOI 10.1016/j.ijid.2010.08.002; Floridia M, 2017, CLIN INFECT DIS, V65, P1878, DOI 10.1093/cid/cix641; Frank TD, 2019, LANCET HIV, V6, pE831, DOI 10.1016/S2352-3018(19)30196-1; Gil-Santana L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37860-5; Goncalves PH, 2016, SEMIN ONCOL, V43, P173, DOI 10.1053/j.seminoncol.2015.09.011; Haas CT, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0583-9; Hella J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195985; Kerkhoff AD, 2014, JAIDS-J ACQ IMM DEF, V66, P33, DOI 10.1097/QAI.0000000000000091; Kreuzer KA, 1997, ANN HEMATOL, V75, P179, DOI 10.1007/s002770050340; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Leone M, 2019, CEPHALALGIA, V39, P1339, DOI 10.1177/0333102419849014; Liotta G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071653; Makubi Abel, 2015, J Int Assoc Provid AIDS Care, V14, P148, DOI 10.1177/2325957413488195; Maner BS., 2019, MEAN CORPUSCULAR VOL; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Musubire AK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209337; O'Brien ME, 2005, JAIDS-J ACQ IMM DEF, V40, P219, DOI 10.1097/01.qai.0000166374.16222.a2; Parinitha SS, 2012, AUSTRALAS MED J, V5, P157, DOI [10.4066/AMJ.20121008, 10.4066/AMJ.2012.100]; Pascutti MF, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00364; Peroni M, 2018, MULTIDISCIPLINARY TE, P33; Redig AJ, 2013, HEMATOL-AM SOC HEMAT, P377, DOI 10.1182/asheducation-2013.1.377; Silverberg MJ, 2007, CURR OPIN ONCOL, V19, P446; SING GK, 1995, BAILLIERE CLIN HAEM, V8, P149, DOI 10.1016/S0950-3536(05)80236-7; Sullivan PS, 1998, BLOOD, V91, P301, DOI 10.1182/blood.V91.1.301.301_301_308; Tamir Z, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211708; UNAIDS, 2019, COUNTR FACTSH MOZ 20, V2018; UNAIDS, 2019, COUNTR FACTSH MAL 20, V2018; WHO, 2011, WHO TECH REP SER, V959, P1; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401; World Health Organization (WHO), 2005, INT WHO CLIN STAG HV	39	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0242068	10.1371/journal.pone.0242068	http://dx.doi.org/10.1371/journal.pone.0242068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170905	Green Published, gold			2022-12-26	WOS:000592383400030
J	Sato, Y; Tominaga, K; Aoki, H; Murayama, M; Oishi, K; Hirooka, H; Yoshida, T; Kumagai, H				Sato, Yoshiaki; Tominaga, Kento; Aoki, Hirotatsu; Murayama, Masayuki; Oishi, Kazato; Hirooka, Hiroyuki; Yoshida, Takashi; Kumagai, Hajime			Calcium salts of long-chain fatty acids from linseed oil decrease methane production by altering the rumen microbiome in vitro	PLOS ONE			English	Article							PALM OIL; RUMINAL BIOHYDROGENATION; SELENOMONAS-RUMINANTIUM; SOYBEAN OIL; GEN-NOV; FERMENTATION; SUPPLEMENTATION; PERFORMANCE; DIETS; DIGESTIBILITY	Calcium salts of long-chain fatty acids (CSFA) from linseed oil have the potential to reduce methane (CH4) production from ruminants; however, there is little information on the effect of supplementary CSFA on rumen microbiome as well as CH4 production. The aim of the present study was to evaluate the effects of supplementary CSFA on ruminal fermentation, digestibility, CH4 production, and rumen microbiome in vitro. We compared five treatments: three CSFA concentrations-0% (CON), 2.25% (FAL) and 4.50% (FAH) on a dry matter (DM) basis-15 mM of fumarate (FUM), and 20 mg/kg DM of monensin (MON). The results showed that the proportions of propionate in FAL, FAH, FUM, and MON were increased, compared with CON (P < 0.05). Although DM and neutral detergent fiber expressed exclusive of residual ash (NDFom) digestibility decreased in FAL and FAH compared to those in CON (P < 0.05), DM digestibility-adjusted CH4 production in FAL and FAH was reduced by 38.2% and 63.0%, respectively, compared with that in CON (P < 0.05). The genera Ruminobacter, Succinivibrio, Succiniclasticum, Streptococcus, Selenomonas.1, and Megasphaera, which are related to propionate production, were increased (P < 0.05), while Methanobrevibacter and protozoa counts, which are associated with CH4 production, were decreased in FAH, compared with CON (P < 0.05). The results suggested that the inclusion of CSFA significantly changed the rumen microbiome, leading to the acceleration of propionate production and the reduction of CH4 production. In conclusion, although further in vivo study is needed to evaluate the reduction effect on rumen CH4 production, CSFA may be a promising candidate for reduction of CH4 emission from ruminants.	[Sato, Yoshiaki; Aoki, Hirotatsu; Oishi, Kazato; Hirooka, Hiroyuki; Kumagai, Hajime] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Anim Husb Resources, Kyoto, Japan; [Tominaga, Kento; Yoshida, Takashi] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Marine Microbiol, Kyoto, Japan; [Murayama, Masayuki] Taiyo Yushi Corp, Project Planning & Dev Dept, Yokohama, Kanagawa, Japan	Kyoto University; Kyoto University	Kumagai, H (corresponding author), Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Lab Anim Husb Resources, Kyoto, Japan.	hkuma@kais.kyoto-u.ac.jp		Tominaga, Kento/0000-0003-4814-5690; Oishi, Kazato/0000-0001-9311-7432; Sato, Yoshiaki/0000-0001-6018-2801	Kyoto University;  [20J15021]	Kyoto University; 	This study was supported by a Grant-inAid for the Japan Society for the Promotion of Science (JSPS) Fellows (20J15021) and a Grant from GAP Fund Program of Kyoto University (2019).	Abubakr A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095713; [Anonymous], 2018, FRONT MICROBIOL, V9, P1; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; Asanuma N, 1999, J DAIRY SCI, V82, P780, DOI 10.3168/jds.S0022-0302(99)75296-3; Bain A, 2016, MEDIA PETERNAK, V39, P180, DOI 10.5398/medpet.2016.39.3.180; Bayat AR, 2017, TRANSL ANIM SCI, V1, P277, DOI 10.2527/tas2017.0032; Beauchemin KA, 2008, AUST J EXP AGR, V48, P21, DOI 10.1071/EA07199; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bensoussan L, 2017, ENVIRON MICROBIOL, V19, P185, DOI 10.1111/1462-2920.13561; Bokulich NA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0470-z; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; CHAO A, 1984, SCAND J STAT, V11, P265; Dai X, 2015, APPL ENVIRON MICROB, V81, P1375, DOI 10.1128/AEM.03682-14; Dohme F, 2001, LETT APPL MICROBIOL, V32, P47, DOI 10.1046/j.1472-765x.2001.00863.x; Eckard RJ, 2010, LIVEST SCI, V130, P47, DOI 10.1016/j.livsci.2010.02.010; Edenhofer O., 2014, CONTRIBUTION WORKING; Eugene M, 2008, CAN J ANIM SCI, V88, P331, DOI 10.4141/CJAS07112; FOTOUHI N, 1992, J ANIM SCI, V70, P3607, DOI 10.2527/1992.70113607x; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Garcia-Martinez R, 2005, BRIT J NUTR, V94, P71, DOI 10.1079/BJN20051455; GRUMMER RR, 1988, J DAIRY SCI, V71, P117, DOI 10.3168/jds.S0022-0302(88)79532-6; Guyader J, 2014, ANIMAL, V8, P1816, DOI 10.1017/S1751731114001852; HARTNELL GF, 1979, J ANIM SCI, V48, P381, DOI 10.2527/jas1979.482381x; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; HINO T, 1993, APPL ENVIRON MICROB, V59, P255, DOI 10.1128/AEM.59.1.255-259.1993; IKWUEGBU OA, 1982, BRIT J NUTR, V48, P365, DOI 10.1079/BJN19820120; Janssen PH, 2008, APPL ENVIRON MICROB, V74, P3619, DOI 10.1128/AEM.02812-07; Janssen PH, 2010, ANIM FEED SCI TECH, V160, P1, DOI 10.1016/j.anifeedsci.2010.07.002; Japan Livestock Industry Association, 2009, STAND TABL FEED COMP; Jenkins TC, 2007, EUR J LIPID SCI TECH, V109, P778, DOI 10.1002/ejlt.200700022; Jeyanathan J, 2014, ANIMAL, V8, P250, DOI 10.1017/S1751731113002085; JOHNSON KA, 1995, J ANIM SCI, V73, P2483; JOYNER AE, 1979, J ANIM SCI, V48, P1065, DOI 10.2527/jas1979.4851065x; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Klieml KE, 2019, ANIMAL, V13, P309, DOI 10.1017/S1751731118001398; Koike S, 2001, FEMS MICROBIOL LETT, V204, P361, DOI 10.1111/j.1574-6968.2001.tb10911.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Leahy SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008926; Li XZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126473; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Machmuller A, 1998, ANIM FEED SCI TECH, V71, P117, DOI 10.1016/S0377-8401(97)00126-0; MACZULAK AE, 1981, APPL ENVIRON MICROB, V42, P856, DOI 10.1128/AEM.42.5.856-862.1981; Maia MRG, 2007, ANTON LEEUW INT J G, V91, P303, DOI 10.1007/s10482-006-9118-2; Manso T, 2006, ANIM FEED SCI TECH, V127, P175, DOI 10.1016/j.anifeedsci.2005.08.013; MAROUNEK M, 1987, J APPL BACTERIOL, V63, P233, DOI 10.1111/j.1365-2672.1987.tb04941.x; Martin C, 2008, J ANIM SCI, V86, P2642, DOI 10.2527/jas.2007-0774; Martin C, 2010, ANIMAL, V4, P351, DOI 10.1017/S1751731109990620; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MCDOUGALL EI, 1948, BIOCHEM J, V43, P99, DOI 10.1042/bj0430099; McNamara S, 2003, ANIM REPROD SCI, V79, P45, DOI 10.1016/S0378-4320(03)00111-8; Mottet, 2013, TACKLING CLIMATE CHA; MULLER M, 1993, J GEN MICROBIOL, V139, P2879, DOI 10.1099/00221287-139-12-2879; Odongo NE, 2007, J DAIRY SCI, V90, P1781, DOI 10.3168/jds.2006-708; OGIMOTO K, 1981, ATLAS RUMEN MICROBIO; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pitta DW, 2010, MICROB ECOL, V59, P511, DOI 10.1007/s00248-009-9609-6; Popova M, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02657-18; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Purushothaman S, 2008, ASIAN AUSTRAL J ANIM, V21, P376, DOI 10.5713/ajas.2008.60505; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Reddy YR, 2003, ANIM FEED SCI TECH, V106, P29, DOI 10.1016/S0377-8401(03)00064-6; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; RUSSELL JB, 1981, APPL ENVIRON MICROB, V41, P1394, DOI 10.1128/AEM.41.6.1394-1399.1981; Russell JB, 2001, SCIENCE, V292, P1119, DOI 10.1126/science.1058830; RUSSELL JB, 1989, APPL ENVIRON MICROB, V55, P1; Sato Y, 2020, LIVEST SCI, V241, DOI 10.1016/j.livsci.2020.104217; Sato Y, 2019, ANIM SCI J, V90, P90, DOI 10.1111/asj.13132; Saunois M, 2016, EARTH SYST SCI DATA, V8, P697, DOI 10.5194/essd-8-697-2016; Sawanon S, 2006, ANIM SCI J, V77, P208, DOI 10.1111/j.1740-0929.2006.00339.x; Sawanon S, 2011, FEMS MICROBIOL LETT, V325, P170, DOI 10.1111/j.1574-6968.2011.02427.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shinkai T, 2012, J DAIRY SCI, V95, P5308, DOI 10.3168/jds.2012-5554; Solden LM, 2017, ISME J, V11, P691, DOI 10.1038/ismej.2016.150; SUTTON JD, 1983, BRIT J NUTR, V49, P419, DOI 10.1079/BJN19830051; SUZUKI Y, 1995, ANIM FEED SCI TECH, V54, P227, DOI 10.1016/0377-8401(95)00769-J; Szumacher-Strabel M, 2004, J ANIM FEED SCI, V13, P215, DOI 10.22358/jafs/73843/2004; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Ueda K, 2003, J DAIRY SCI, V86, P3999, DOI 10.3168/jds.S0022-0302(03)74011-9; Ungerfeld EM, 2007, J ANIM SCI, V85, P2556, DOI 10.2527/jas.2006-674; van Gastelen S, 2017, J DAIRY SCI, V100, P8939, DOI 10.3168/jds.2016-12367; vanGylswyk NO, 1997, INT J SYST BACTERIOL, V47, P155, DOI 10.1099/00207713-47-1-155; VANGYLSWYK NO, 1995, INT J SYST BACTERIOL, V45, P297, DOI 10.1099/00207713-45-2-297; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; VOGELS GD, 1980, APPL ENVIRON MICROB, V40, P608, DOI 10.1128/AEM.40.3.608-612.1980; Wang LJ, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10020223; Weiss WP, 2004, J DAIRY SCI, V87, P1446, DOI 10.3168/jds.S0022-0302(04)73295-6; Whitford M F, 2001, BMC Microbiol, V1, P5, DOI 10.1186/1471-2180-1-5; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; WU Z, 1991, J DAIRY SCI, V74, P3025, DOI 10.3168/jds.S0022-0302(91)78488-9; Yang SL, 2009, ANIMAL, V3, P1562, DOI 10.1017/S1751731109990462; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011	92	5	6	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0242158	10.1371/journal.pone.0242158	http://dx.doi.org/10.1371/journal.pone.0242158			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170886	gold, Green Published			2022-12-26	WOS:000592383400040
J	Ayinuola, YA; Brito-Robinson, T; Ayinuola, O; Beck, JE; Cruz-Topete, D; Lee, SW; Ploplis, VA; Castellino, FJ				Ayinuola, Yetunde A.; Brito-Robinson, Teresa; Ayinuola, Olawole; Beck, Julia E.; Cruz-Topete, Diana; Lee, Shaun W.; Ploplis, Victoria A.; Castellino, Francis J.			Streptococcus co-opts a conformational lock in human plasminogen to facilitate streptokinase cleavage and bacterial virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY BINDING; INDIVIDUAL KRINGLE DOMAINS; OMEGA-AMINO ACIDS; M-PROTEIN; FUNCTIONAL DIFFERENCES; CRYSTAL-STRUCTURE; INTERNAL PEPTIDE; ALPHA-AMINO; BETA-DOMAIN; ACTIVATION	Virulent strains of Streptococcus pyogenes (gram-positive group A Streptococcus pyogenes [GAS]) recruit host single-chain human plasminogen (hPg) to the cell surface-where in the case of Pattern D strains of GAS, hPg binds directly to the cells through a surface receptor, plasminogen-binding group A streptococcal M-protein (PAM). The coinherited Pattern D GAS-secreted streptokinase (SK2b) then accelerates cleavage of hPg at the R-561-V-562 peptide bond, resulting in the disulfide-linked two-chain protease, human plasmin (hPm). hPm localizes on the bacterial surface, assisting bacterial dissemination via proteolysis of host defense proteins. Studies using isolated domains from PAM and hPg revealed that the A-domain of PAM binds to the hPg kringle-2 module (K2(hPg)), but how this relates to the function of the full-length proteins is unclear. Herein, we use intact proteins to show that the lysine-binding site of K2(hPg) is a major determinant of the activation-resistant T-conformation of hPg. The binding of PAM to the lysine-binding site of K2(hPg) relaxes the conformation of hPg, leading to a greatly enhanced activation rate of hPg by SK2b. Domain swapping between hPg and mouse Pg emphasizes the importance of the Pg latent heavy chain (residues 1-561) in PAM binding and shows that while SK2b binds to both hPg and mouse Pg, the activation properties of streptokinase are strictly attributed to the serine protease domain (residues 562-791) of hPg. Overall, these data show that native hPg is locked in an activation-resistant conformation that is relaxed upon its direct binding to PAM, allowing hPm to form and provide GAS cells with a proteolytic surface.	[Ayinuola, Yetunde A.; Brito-Robinson, Teresa; Ayinuola, Olawole; Beck, Julia E.; Cruz-Topete, Diana; Lee, Shaun W.; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; [Beck, Julia E.; Cruz-Topete, Diana; Ploplis, Victoria A.; Castellino, Francis J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Lee, Shaun W.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.; Castellino, FJ (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	fcastell@nd.edu	Ayinuola, Yetunde A./AAE-5943-2019	Castellino, Francis/0000-0003-0317-9539; Ayinuola, Yetunde/0000-0001-7803-8058	National Institutes of Health [HL013423]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grant HL013423 from the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BERGE A, 1993, J BIOL CHEM, V268, P25417; Bessen DE, 1999, J INFECT DIS, V179, P627, DOI 10.1086/314631; Bessen DE., 2016, STREPTOCOCCUS PYOGEN; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; BROCKWAY WJ, 1972, ARCH BIOCHEM BIOPHYS, V151, P194, DOI 10.1016/0003-9861(72)90488-2; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; CASTELLINO FJ, 1984, SEMIN THROMB HEMOST, V10, P18, DOI 10.1055/s-2007-1004404; Chandrahas V, 2015, J BIOL CHEM, V290, P18833, DOI 10.1074/jbc.M115.655365; Chang Y, 1998, BIOCHEMISTRY-US, V37, P3258, DOI 10.1021/bi972284e; CHIBBER BAK, 1985, BIOCHEMISTRY-US, V24, P3429, DOI 10.1021/bi00335a006; Cnudde SE, 2006, BIOCHEMISTRY-US, V45, P11052, DOI 10.1021/bi060914j; Cook SM, 2014, BIOCHEM J, V458, P23, DOI 10.1042/BJ20131305; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Fu QH, 2008, J BIOL CHEM, V283, P1580, DOI 10.1074/jbc.M705063200; Gladysheva IP, 2002, J BIOL CHEM, V277, P26846, DOI 10.1074/jbc.M202999200; Iwaki T, 2008, CYTOTECHNOLOGY, V57, P45, DOI 10.1007/s10616-008-9129-0; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Law RHP, 2013, CURR OPIN STRUC BIOL, V23, P836, DOI 10.1016/j.sbi.2013.10.006; Law RHP, 2012, CELL REP, V1, P185, DOI 10.1016/j.celrep.2012.02.012; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Loof TG, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00128; Lottenberg Richard, 1994, Trends in Microbiology, V2, P20, DOI 10.1016/0966-842X(94)90340-9; MARTI D, 1994, EUR J BIOCHEM, V219, P455, DOI 10.1111/j.1432-1033.1994.tb19959.x; Marti DN, 1997, BIOCHEMISTRY-US, V36, P11591, DOI 10.1021/bi971316v; Mathews II, 1996, BIOCHEMISTRY-US, V35, P2567, DOI 10.1021/bi9521351; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; MCCANCE SG, 1995, BIOCHEMISTRY-US, V34, P9581, DOI 10.1021/bi00029a035; MCCANCE SG, 1994, J BIOL CHEM, V269, P32405; MENHART N, 1995, BIOCHEMISTRY-US, V34, P1482, DOI 10.1021/bi00005a003; Nilsen SL, 1999, PROTEIN EXPRES PURIF, V16, P136, DOI 10.1006/prep.1999.1045; Qiu CJ, 2020, BIOCHEM J, V477, P1613, DOI 10.1042/BCJ20200197; Qiu CJ, 2019, J STRUCT BIOL, V206, P193, DOI 10.1016/j.jsb.2019.03.003; Qiu CJ, 2018, J STRUCT BIOL, V204, P151, DOI 10.1016/j.jsb.2018.07.017; Quek AJH, 2019, J MOL BIOL, V431, P3804, DOI 10.1016/j.jmb.2019.07.003; Rios-Steiner JL, 2001, J MOL BIOL, V308, P705, DOI 10.1006/jmbi.2001.4646; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; SEHL LC, 1990, J BIOL CHEM, V265, P5482; SHI GY, 1988, J BIOL CHEM, V263, P17071; SHI GY, 1990, THROMB RES, V58, P317, DOI 10.1016/0049-3848(90)90101-H; SODETZ JM, 1972, BIOCHEMISTRY-US, V11, P4451, DOI 10.1021/bi00774a005; Sumitomo T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20069; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; TAKADA Y, 1993, THROMB RES, V70, P151, DOI 10.1016/0049-3848(93)90156-I; URANO T, 1991, THROMB RES, V61, P349, DOI 10.1016/0049-3848(91)90648-G; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; VIOLAND BN, 1978, J BIOL CHEM, V253, P5395; VIOLAND BN, 1975, ARCH BIOCHEM BIOPHYS, V170, P300, DOI 10.1016/0003-9861(75)90121-6; Wang M, 2010, J STRUCT BIOL, V169, P349, DOI 10.1016/j.jsb.2009.09.011; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420; WU TP, 1994, BLOOD COAGUL FIBRIN, V5, P157, DOI 10.1097/00001721-199404000-00001; Yuan Y, 2019, J STRUCT BIOL, V208, P18, DOI 10.1016/j.jsb.2019.07.005; Yuan Y, 2017, J BIOL CHEM, V292, P15016, DOI 10.1074/jbc.M117.794198; Zhang Y, 2014, BIOCHEM BIOPH RES CO, V444, P595, DOI 10.1016/j.bbrc.2014.01.109; Zhang YL, 2013, FEBS LETT, V587, P1304, DOI 10.1016/j.febslet.2013.02.033; Zhang YL, 2012, J BIOL CHEM, V287, P42093, DOI 10.1074/jbc.M112.417808	57	2	2	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100099	10.1074/jbc.RA120.016262	http://dx.doi.org/10.1074/jbc.RA120.016262			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33208461	Green Published, gold			2022-12-26	WOS:000672866400079
J	Kellar, GG; Barrow, KA; Rich, LM; Debley, JS; Wight, TN; Ziegler, SF; Reeves, SR				Kellar, Gerald G.; Barrow, Kaitlyn A.; Rich, Lucille M.; Debley, Jason S.; Wight, Thomas N.; Ziegler, Steven F.; Reeves, Stephen R.			Loss of versican and production of hyaluronan in lung epithelial cells are associated with airway inflammation during RSV infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED MURINE MODEL; EXTRACELLULAR-MATRIX; VIRUS-INFECTION; ACCUMULATION; PROTEOGLYCANS; BRONCHIOLITIS; EOSINOPHILS; EXPRESSION; LEUKOCYTES; DISEASE	Airway inflammation is a critical feature of lower respiratory tract infections caused by viruses such as respiratory syncytial virus (RSV). A growing body of literature has demonstrated the importance of extracellular matrix changes such as the accumulation of hyaluronan (HA) and versican in the subepithelial space in promoting airway inflammation; however, whether these factors contribute to airway inflammation during RSV infection remains unknown. To test the hypothesis that RSV infection promotes inflammation via altered HA and versican production, we studied an ex vivo human bronchial epithelial cell (BEC)/human lung fibroblast (HLF) coculture model. RSV infection of BEC/HLF cocultures led to decreased hyaluronidase expression by HLFs, increased accumulation of HA, and enhanced adhesion of U937 cells as would be expected with increased HA. HLF production of versican was not altered following RSV infection; however, BEC production of versican was significantly downregulated following RSV infection. In vivo studies with epithelial-specific versican-deficient mice [SPC-re(+) Vcan(-/-)] demonstrated that RSV infection led to increased HA accumulation compared with control mice, which also coincided with decreased hyaluronidase expression in the lung. SPC-Cre(+) Vcan(-/-) mice demonstrated enhanced recruitment of monocytes and neutrophils in bronchoalveolar lavage fluid and increased neutrophils in the lung compared with SPC-Cre(-) RSV-infected littermates. Taken together, these data demonstrate that altered extracellular matrix accumulation of HAoccurs following RSV infection and may contribute to airway inflammation. In addition, loss of epithelial expression of versican promotes airway inflammation during RSV infection further demonstrating that versican's role in inflammatory regulation is complex and dependent on the microenvironment.	[Kellar, Gerald G.] US Army, Dept Def, Washington, DC 20310 USA; [Kellar, Gerald G.; Wight, Thomas N.; Ziegler, Steven F.] Benaroya Res Inst, Seattle, WA USA; [Kellar, Gerald G.; Ziegler, Steven F.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Barrow, Kaitlyn A.; Rich, Lucille M.; Debley, Jason S.; Reeves, Stephen R.] Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA; [Debley, Jason S.; Reeves, Stephen R.] Univ Washington, Dept Pediat, Div Pulm & Sleep Med, Seattle, WA 98195 USA	United States Department of Defense; Benaroya Research Institute; University of Washington; University of Washington Seattle; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Reeves, SR (corresponding author), Seattle Childrens Res Inst, Ctr Immun & Immunotherapies, Seattle, WA 98101 USA.; Reeves, SR (corresponding author), Univ Washington, Dept Pediat, Div Pulm & Sleep Med, Seattle, WA 98195 USA.	stephen.reeves@seattlechildrens.org			United States Army Long-Term Health Education & Training Program; NIH [K08HL135266, R01 HL128361, U19AI125378]	United States Army Long-Term Health Education & Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the United States Army Long-Term Health Education & Training Program (G. G. K.), NIH grants K08HL135266 (S. R. R.), R01 HL128361 (J. S. D.), and U19AI125378 (S. F. Z., T. N. W., and J. S. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avenoso A, 2020, MINI-REV MED CHEM, V20, P54, DOI 10.2174/1389557519666190906115619; Bartee E, 2009, J VIROL, V83, P498, DOI 10.1128/JVI.01376-08; Bell TJ, 2019, MATRIX BIOL, V80, P14, DOI 10.1016/j.matbio.2018.06.006; Caon I, 2021, J HISTOCHEM CYTOCHEM, V69, P35, DOI 10.1369/0022155420929772; Cattaruzza S, 2002, J BIOL CHEM, V277, P47626, DOI 10.1074/jbc.M206521200; Chang MY, 2014, MATRIX BIOL, V34, P1, DOI 10.1016/j.matbio.2014.01.011; Chang MY, 2012, J BIOL CHEM, V287, P14122, DOI 10.1074/jbc.M111.324988; Cheng G, 2013, GLYCOBIOLOGY, V23, P43, DOI 10.1093/glycob/cws122; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; Evanko SP, 2001, ARCH BIOCHEM BIOPHYS, V394, P29, DOI 10.1006/abbi.2001.2507; Faggian J, 2007, AM J PHYSIOL-REG I, V293, pR784, DOI 10.1152/ajpregu.00801.2006; Funchal GA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124082; Garantziotis S, 2016, AM J PHYSIOL-LUNG C, V310, pL785, DOI 10.1152/ajplung.00168.2015; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hallstrand TS, 2014, CLIN IMMUNOL, V151, P1, DOI 10.1016/j.clim.2013.12.003; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Johnson JE, 2007, MODERN PATHOL, V20, P108, DOI 10.1038/modpathol.3800725; Johnson P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02787; Kai Y, 2007, MED MOL MORPHOL, V40, P128, DOI 10.1007/s00795-007-0370-y; Kang I, 2018, J HISTOCHEM CYTOCHEM, V66, P241, DOI 10.1369/0022155417751880; Kang I, 2017, J BIOL CHEM, V292, P51, DOI 10.1074/jbc.M116.753186; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; Lauer Mark E, 2015, Int J Cell Biol, V2015, P712507, DOI 10.1155/2015/712507; Lennon FE, 2011, AM J PHYSIOL-LUNG C, V301, pL137, DOI 10.1152/ajplung.00071.2010; Liang JR, 2016, ADV DRUG DELIVER REV, V97, P186, DOI 10.1016/j.addr.2015.10.017; Lopez-Guisa JM, 2012, J ALLERGY CLIN IMMUN, V129, P990, DOI 10.1016/j.jaci.2011.11.035; Lozano R, 2013, LANCET, V381, P991, DOI 10.1016/S0140-6736(13)60704-7; Malla N, 2013, FEBS J, V280, P2870, DOI 10.1111/febs.12291; McNamara PS, 2003, ARCH DIS CHILD, V88, P922, DOI 10.1136/adc.88.10.922; Meissner HC, 2016, NEW ENGL J MED, V374, P62, DOI 10.1056/NEJMra1413456; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Morrison PT, 2008, CLIN IMMUNOL, V128, P85, DOI 10.1016/j.clim.2008.03.460; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; OPENSHAW PJM, 1995, SPRINGER SEMIN IMMUN, V17, P187; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potter-Perigo S, 2010, AM J RESP CELL MOL, V43, P109, DOI 10.1165/rcmb.2009-0081OC; Reeves SR, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03159; Reeves SR, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0849-1; Reeves SR, 2016, J HISTOCHEM CYTOCHEM, V64, P364, DOI 10.1369/0022155416642989; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Snyder JM, 2015, J HISTOCHEM CYTOCHEM, V63, P952, DOI 10.1369/0022155415610383; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Tavianatou AG, 2019, FEBS J, V286, P2883, DOI 10.1111/febs.14777; Tighe RM, 2019, MATRIX BIOL, V78-79, P84, DOI 10.1016/j.matbio.2018.01.027; Tregoning JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009381; Trivedi SG, 2007, CELL MOL LIFE SCI, V64, P1269, DOI 10.1007/s00018-007-6527-y; Wight TN, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00512; Wight TN, 2017, CELL IMMUNOL, V312, P1, DOI 10.1016/j.cellimm.2016.12.003; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Yoshino Y, 2018, BIOCHEM BIOPH RES CO, V505, P74, DOI 10.1016/j.bbrc.2018.09.097	52	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100076	10.1074/jbc.RA120.016196	http://dx.doi.org/10.1074/jbc.RA120.016196			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33187989	gold, Green Published			2022-12-26	WOS:000672866400057
J	Schaid, MD; Green, CL; Peter, DC; Gallagher, SJ; Guthery, E; Carbajal, KA; Harrington, JM; Kelly, GM; Reuter, A; Wehner, ML; Brill, AL; Neuman, JC; Lamming, DW; Kimple, ME				Schaid, Michael D.; Green, Cara L.; Peter, Darby C.; Gallagher, Shannon J.; Guthery, Erin; Carbajal, Kathryn A.; Harrington, Jeffrey M.; Kelly, Grant M.; Reuter, Austin; Wehner, Molly L.; Brill, Allison L.; Neuman, Joshua C.; Lamming, Dudley W.; Kimple, Michelle E.			Agonist-independent G alpha(z) activity negatively regulates beta-cell compensation in a diet-induced obesity model of type 2 diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED GLUCOSE-INTOLERANCE; PROSTAGLANDIN-E; INSULIN-SECRETION; CA2+ CHANNELS; EP3; RECEPTOR; MOUSE; DISSOCIATION; DYSFUNCTION; DEFICIENCY	The inhibitory G protein alpha-subunit (G alpha(z)) is an important modulator of beta-cell function. Full-body G alpha(z)-null mice are protected from hyperglycemia and glucose intolerance after long-term high-fat diet (HFD) feeding. In this study, at a time point in the feeding regimen where WT mice are only mildly glucose intolerant, transcriptomics analyses reveal islets from HFD-fed G alpha(z) KO mice have a dramatically altered gene expression pattern as compared with WT HFD-fed mice, with entire gene pathways not only being more strongly upregulated or downregulated versus control-diet fed groups but actually reversed in direction. Genes involved in the "pancreatic secretion" pathway are the most strongly differentially regulated: a finding that correlates with enhanced islet insulin secretion and decreased glucagon secretion at the study end. The protection of G alpha(z)-null mice from HFD-induced diabetes is beta-cell autonomous, as beta cell-specific G alpha(z)-null mice phenocopy the full-body KOs. The glucose-stimulated and incretin-potentiated insulin secretion response of islets from HFD-fed beta cell-specific G alpha(z)-null mice is significantly improved as compared with islets from HFD-fed WT controls, which, along with no impact of G alpha(z) loss or HFD feeding on beta-cell proliferation or surrogates of beta-cell mass, supports a secretion-specific mechanism. G alpha(z) is coupled to the prostaglandin EP3 receptor in pancreatic beta cells. We confirm the EP3. splice variant has both constitutive and agonist-sensitive activity to inhibit cAMP production and downstream beta-cell function, with both activities being dependent on the presence of beta-cell G alpha(z).	[Schaid, Michael D.; Green, Cara L.; Peter, Darby C.; Gallagher, Shannon J.; Guthery, Erin; Carbajal, Kathryn A.; Harrington, Jeffrey M.; Kelly, Grant M.; Reuter, Austin; Wehner, Molly L.; Brill, Allison L.; Neuman, Joshua C.; Lamming, Dudley W.; Kimple, Michelle E.] William S Middleton Mem Vet Adm Med Ctr, Res Serv, Madison, WI 53705 USA; [Schaid, Michael D.; Neuman, Joshua C.; Lamming, Dudley W.; Kimple, Michelle E.] Univ Wisconsin, Interdept Grad Program Nutr Sci, Coll Agr & Life Sci, Madison, WI 53706 USA; [Schaid, Michael D.; Green, Cara L.; Peter, Darby C.; Gallagher, Shannon J.; Guthery, Erin; Carbajal, Kathryn A.; Harrington, Jeffrey M.; Kelly, Grant M.; Reuter, Austin; Wehner, Molly L.; Brill, Allison L.; Lamming, Dudley W.; Kimple, Michelle E.] Univ Wisconsin, Div Endocrinol, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Kimple, Michelle E.] Univ Wisconsin, Dept Cell & Regenerat Biol, Sch Med & Publ Hlth, Madison, WI 53706 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kimple, ME (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Res Serv, Madison, WI 53705 USA.; Kimple, ME (corresponding author), Univ Wisconsin, Interdept Grad Program Nutr Sci, Coll Agr & Life Sci, Madison, WI 53706 USA.; Kimple, ME (corresponding author), Univ Wisconsin, Div Endocrinol, Dept Med, Sch Med & Publ Hlth, Madison, WI 53706 USA.; Kimple, ME (corresponding author), Univ Wisconsin, Dept Cell & Regenerat Biol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	mkimple@medicine.wisc.edu	Lamming, Dudley/O-7191-2015	Lamming, Dudley/0000-0002-0079-4467; Brill, Allison/0000-0002-5046-3578; Green, Cara/0000-0002-2293-9364; Schaid, Michael/0000-0002-3633-5748	United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development (BLRD) Service [I01 BX003700, I01 BX004031]; National Institutes of Health (NIH) [K01 DK080845, R01 DK102598, R01 AG056771]; American Diabetes Association [1-14-BS-115]; University of Wisconsin-Madison Department of Medicine, Graduate School; University of Wisconsin-Madison Institute on Aging (National Institutes of Health) [T32-AG-000213]; Dalio Philanthropies; American Society for Pharmacology and Experimental Therapeutics; American Federation for Aging Research; University of Wisconsin-Madison Office of the Provost	United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development (BLRD) Service; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); University of Wisconsin-Madison Department of Medicine, Graduate School; University of Wisconsin-Madison Institute on Aging (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dalio Philanthropies; American Society for Pharmacology and Experimental Therapeutics; American Federation for Aging Research; University of Wisconsin-Madison Office of the Provost	This work was supported in part by Merit Review Awards I01 BX003700 (to M. E. K.) and I01 BX004031 (to D. W. L.) from the United States (U.S.) Department of Veterans Affairs Biomedical Laboratory Research and Development (BLR&D) Service. This work was also supported in part by National Institutes of Health (NIH) grants K01 DK080845 (to M. E. K.), R01 DK102598 (to M. E. K.), and R01 AG056771 to (D. W. L.); American Diabetes Association Grant 1-14-BS-115 (to M. E. K.); and start-up and pilot project funding from the University of Wisconsin-Madison Department of Medicine, Graduate School, and Office of the Provost (to M. E. K. and D. W. L.). J. C. N. was supported in part by a training grant from the University of Wisconsin-Madison Institute on Aging (National Institutes of Health grant T32-AG-000213). C. L. G. was supported in part by a grant from Dalio Philanthropies. A. L. B. was supported in part by a Summer Undergraduate Research Fellowship from the American Society for Pharmacology and Experimental Therapeutics. This research was conducted while D. W. L. was an AFAR Research Grant recipient from the American Federation for Aging Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the U.S. Department of Veterans Affairs, or the United States Government.	Alejandro EU, 2015, MOL ASPECTS MED, V42, P19, DOI 10.1016/j.mam.2014.12.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boomgaarden I, 2009, PROSTAG LEUKOTR ESS, V80, P185, DOI 10.1016/j.plefa.2009.02.001; Brill AL, 2016, MOL ENDOCRINOL, V30, P543, DOI 10.1210/me.2015-1164; Carboneau BA, 2017, MOL METAB, V6, P548, DOI 10.1016/j.molmet.2017.04.002; Ceddia RP, 2016, ENDOCRINOLOGY, V157, P220, DOI 10.1210/en.2015-1693; Chan PC, 2016, FASEB J, V30, P2282, DOI 10.1096/fj.201500127; Chen LH, 2012, ARTERIOSCL THROM VAS, V32, P3024, DOI 10.1161/ATVBAHA.112.254052; Collins SC, 2010, DIABETES, V59, P1192, DOI 10.2337/db09-0791; Fenske RJ, 2018, EXP BIOL MED, V243, P586, DOI 10.1177/1535370218761662; Fenske RJ, 2017, ENDOCRINOLOGY, V158, P1645, DOI 10.1210/en.2016-1700; Fontaine DA, 2016, DIABETES, V65, P25, DOI 10.2337/db15-0982; Gupta D, 2017, J BIOL CHEM, V292, P12449, DOI [10.1074/jbc.M117.781047, 10.1074/jbc.m117.781047]; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Hogan MF, 2015, J BIOL CHEM, V290, P25997, DOI 10.1074/jbc.M115.679266; Hoppa MB, 2009, CELL METAB, V10, P455, DOI 10.1016/j.cmet.2009.09.011; Hull RL, 2017, J ENDOCRINOL, V233, P53, DOI 10.1530/JOE-16-0377; Ichikawa A, 2010, P JPN ACAD B-PHYS, V86, P848, DOI 10.2183/pjab.86.848; IRIE A, 1993, EUR J BIOCHEM, V217, P313, DOI 10.1111/j.1432-1033.1993.tb18248.x; Kelly P, 2010, J BIOL CHEM, V285, P15777, DOI 10.1074/jbc.M109.069112; Kimple M. E, 1999, G PROTEIN ALPHA Z UC, DOI [10.1038/mp.a000011.01, DOI 10.1038/MP.A000011.01]; Kimple M. E., 2009, HDB CELL SIGNALING, V2nd, P1649; Kimple ME, 2005, J BIOL CHEM, V280, P31708, DOI 10.1074/jbc.M506700200; Kimple ME, 2008, J BIOL CHEM, V283, P4560, DOI 10.1074/jbc.M706481200; Kimple ME, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.40; Kimple ME, 2013, DIABETES, V62, P1904, DOI 10.2337/db12-0769; Kimple ME, 2012, J BIOL CHEM, V287, P20344, DOI 10.1074/jbc.M112.359745; Lu AK, 2015, J CLIN INVEST, V125, P1228, DOI 10.1172/JCI77656; MCRAE JR, 1981, METABOLISM, V30, P1065, DOI 10.1016/0026-0495(81)90049-4; Meece J, 2007, CURR MED RES OPIN, V23, P933, DOI 10.1185/030079906X167336; METZ SA, 1980, PROSTAG LEUKOTR ESS, V4, P247, DOI 10.1016/0161-4630(80)90019-1; Negishi M, 1996, FEBS LETT, V386, P165, DOI 10.1016/0014-5793(96)00354-7; Neuman Joshua C, 2017, Nutr Healthy Aging, V4, P127, DOI 10.3233/NHA-160004; Neuman Joshua C, 2013, J Endocrinol Diabetes Obes, V1; Neuman JC, 2014, JOVE-J VIS EXP, DOI 10.3791/50374; R Core Team, 2021, R LANGUAGE ENV STAT; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; ROBERTSON RP, 1983, ANNU REV MED, V34, P1, DOI 10.1146/annurev.me.34.020183.000245; ROBERTSON RP, 1977, J CLIN INVEST, V60, P747, DOI 10.1172/JCI108827; Schaid MD, 2017, AAPS J, V19, P1276, DOI 10.1208/s12248-017-0097-1; Skugor M, 2017, CLEV CLIN J MED, V84, pS57, DOI 10.3949/ccjm.84.s1.07; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tengholm A, 2017, DIABETES OBES METAB, V19, P42, DOI 10.1111/dom.12993; Truchan NA, 2015, ISLETS, V7, DOI 10.1080/19382014.2015.1076607; Winzell MS, 2007, METABOLISM, V56, P122, DOI 10.1016/j.metabol.2006.09.008; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wisinski JA, 2016, DIABETES, V65, P349, DOI 10.2337/dbi15-0032; Xu H, 2016, J MOL CELL BIOL, V8, P518, DOI 10.1093/jmcb/mjw035; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14	49	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100056	10.1074/jbc.RA120.015585	http://dx.doi.org/10.1074/jbc.RA120.015585			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33172888	gold, Green Published			2022-12-26	WOS:000672866400038
J	Shen, H; Ontiveros, RJ; Owens, MC; Liu, MY; Ghanty, U; Kohli, RM; Liu, KF				Shen, Hui; Ontiveros, Robert Jordan; Owens, Michael C.; Liu, Monica Yun; Ghanty, Uday; Kohli, Rahul M.; Liu, Kathy Fange			TET-mediated 5-methylcytosine oxidation in tRNA promotes translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHYLTRANSFERASE; METHYLATION; DNA; NSUN2; DNMT2; CODON; RECOGNITION; PROTEOME; NUCLEUS; STRESS	Oxidation of 5-methylcytosine (5mC) in DNA by the ten-eleven translocation (TET) family of enzymes is indispensable for gene regulation in mammals. More recently, evidence has emerged to support a biological function for TET-mediated m(5)C oxidation in messenger RNA. Here, we describe a previously uncharacterized role of TET-mediated m(5C) oxidation in transfer RNA (tRNA). We found that the TET-mediated oxidation product 5-hydroxylmethylcytosine (hm5C) is specifically enriched in tRNA inside cells and that the oxidation activity of TET2 on m(5)C in tRNAs can be readily observed in vitro. We further observed that hm(5)C levels in tRNA were significantly decreased in Tet(2) KO mouse embryonic stem cells (mESCs) in comparison with wild-type mESCs. Reciprocally, induced expression of the catalytic domain of TET2 led to an obvious increase in hm(5)C and a decrease in m(5)C in tRNAs relative to uninduced cells. Strikingly, we also show that TET2-mediated m(5)C oxidation in tRNA promotes translation in vitro. These results suggest TET2 may influence translation through impacting tRNA methylation and reveal an unexpected role for TET enzymes in regulating multiple nodes of the central dogma.	[Shen, Hui; Ontiveros, Robert Jordan; Owens, Michael C.; Liu, Monica Yun; Ghanty, Uday; Kohli, Rahul M.; Liu, Kathy Fange] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Ontiveros, Robert Jordan; Owens, Michael C.] Univ Penn, Grad Grp Biochem & Mol Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Liu, Monica Yun; Ghanty, Uday; Kohli, Rahul M.] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Liu, KF (corresponding author), Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA.	liufg@penmeddcine.upenn.edu		Kohli, Rahul/0000-0002-7689-5678; Owens, Michael/0000-0001-9425-106X	National Institutes of Health [R35GM133721, R01-GM118501, T32GM132039, F31GM139325]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (R35GM133721 to K. F. L.; R01-GM118501 to R. M. K.; T32GM132039 to M. C. O.; and F31GM139325 to R. J. O.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbasi-Moheb L, 2012, AM J HUM GENET, V90, P847, DOI 10.1016/j.ajhg.2012.03.021; Arioka Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045031; Blanco S, 2014, EMBO J, V33, P2020, DOI 10.15252/embj.201489282; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chen X, 2019, NAT CELL BIOL, V21, P978, DOI 10.1038/s41556-019-0361-y; Delatte B, 2016, SCIENCE, V351, P282, DOI 10.1126/science.aac5253; DeNizio JE, 2019, BIOCHEMISTRY-US, V58, P411, DOI 10.1021/acs.biochem.8b00912; Haag S, 2016, EMBO J, V35, P2104, DOI 10.15252/embj.201694885; Haag S, 2015, RNA, V21, P1532, DOI 10.1261/rna.051524.115; He CS, 2016, MOL CELL, V64, P416, DOI 10.1016/j.molcel.2016.09.034; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hon GC, 2014, MOL CELL, V56, P286, DOI 10.1016/j.molcel.2014.08.026; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Huber SM, 2017, J AM CHEM SOC, V139, P1766, DOI 10.1021/jacs.6b12180; Hussain S, 2013, MOL CELL BIOL, V33, P1561, DOI 10.1128/MCB.01523-12; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kawarada L, 2017, NUCLEIC ACIDS RES, V45, P7401, DOI 10.1093/nar/gkx354; Khandelia P, 2011, P NATL ACAD SCI USA, V108, P12799, DOI 10.1073/pnas.1103532108; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Liu FG, 2016, CELL, V167, P816, DOI 10.1016/j.cell.2016.09.038; Liu MY, 2016, METHOD ENZYMOL, V573, P365, DOI 10.1016/bs.mie.2015.12.006; Long T, 2016, J BIOL CHEM, V291, P24293, DOI 10.1074/jbc.M116.742569; Motorin Y, 2010, BIOCHEMISTRY-US, V49, P4934, DOI 10.1021/bi100408z; Nakano S, 2016, NAT CHEM BIOL, V12, P546, DOI [10.1038/NCHEMBIO.2099, 10.1038/nchembio.2099]; Nedialkova DD, 2015, CELL, V161, P1606, DOI 10.1016/j.cell.2015.05.022; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Shaheen HH, 2005, P NATL ACAD SCI USA, V102, P11290, DOI 10.1073/pnas.0503836102; Shaheen HH, 2007, P NATL ACAD SCI USA, V104, P8845, DOI 10.1073/pnas.0700765104; Shanmugam R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.10; Shen QC, 2018, NATURE, V554, P123, DOI 10.1038/nature25434; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Sondalle SB, 2019, P NATL ACAD SCI USA, V116, P2561, DOI 10.1073/pnas.1811557116; Song CX, 2013, TRENDS BIOCHEM SCI, V38, P480, DOI 10.1016/j.tibs.2013.07.003; Squires JE, 2010, EPIGENOMICS-UK, V2, P709, DOI [10.2217/epi.10.47, 10.2217/EPI.10.47]; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takano A, 2005, SCIENCE, V309, P140, DOI 10.1126/science.1113346; Takemoto C, 2009, NUCLEIC ACIDS RES, V37, P1616, DOI 10.1093/nar/gkp001; Trixl L, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1510; Trixl L, 2018, CELL MOL LIFE SCI, V75, P1483, DOI 10.1007/s00018-017-2700-0; Tuorto F, 2015, EMBO J, V34, P2350, DOI 10.15252/embj.201591382; Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357; Vare VYP, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010029; Van Haute L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12039; Yang Y, 2019, MOL CELL, V75, P1188, DOI 10.1016/j.molcel.2019.06.033; Zhang Q, 2014, J BIOL CHEM, V289, P5986, DOI 10.1074/jbc.M113.524140	47	17	17	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100087	10.1074/jbc.RA120.014226	http://dx.doi.org/10.1074/jbc.RA120.014226			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33199375	gold, Green Published			2022-12-26	WOS:000672866400068
J	Millesi, F; Weiss, T; Mann, A; Haertinger, M; Semmler, L; Supper, P; Pils, D; Naghilou, A; Radtke, C				Millesi, Flavia; Weiss, Tamara; Mann, Anda; Haertinger, Maximilian; Semmler, Lorenz; Supper, Paul; Pils, Dietmar; Naghilou, Aida; Radtke, Christine			Defining the regenerative effects of native spider silk fibers on primary Schwann cells, sensory neurons, and nerve-associated fibroblasts	FASEB JOURNAL			English	Article						live cell imaging; migration; Nephila edulis; peripheral nerve regeneration; proliferation	PERIPHERAL-NERVE; EXTRACELLULAR-MATRIX; FUNCTIONAL RECOVERY; WALLERIAN DEGENERATION; GUIDANCE CONDUITS; DRAGLINE SILK; INJURY; TISSUE; PROLIFERATION; REPAIR	The search for a suitable material to promote regeneration after long-distance peripheral nerve defects turned the spotlight on spider silk. Nerve conduits enriched with native spider silk fibers as internal guiding structures previously demonstrated a regenerative outcome similar to autologous nerve grafts in animal studies. Nevertheless, spider silk is a natural material with associated limitations for clinical use. A promising alternative is the production of recombinant silk fibers that should mimic the outstanding properties of their native counterpart. However, in vitro data on the regenerative features that native silk fibers provide for cells involved in nerve regeneration are scarce. Thus, there is a lack of reference parameters to evaluate whether recombinant silk fiber candidates will be eligible for nerve repair in vivo. To gain insight into the regenerative effect of native spider silk, our study aims to define the behavioral response of primary Schwann cells (SCs), nerve-associated fibroblasts (FBs), and dorsal root ganglion (DRG) neurons cultured on native dragline silk from the genus Nephila and on laminin coated dishes. The established multi-color immunostaining panels together with confocal microscopy and live cell imaging enabled the analysis of cell identity, morphology, proliferation, and migration on both substrates in detail. Our findings demonstrated that native spider silk rivals laminin coating as it allowed attachment and proliferation and supported the characteristic behavior of all tested cell types. Axonal out-growth of DRG neurons occurred along longitudinally aligned SCs that formed sustained bundled structures resembling Bungner bands present in regenerating nerves. The migration of SCs along the silk fibers achieved the reported distance of regenerating axons of about 1 mm per day, but lacked directionality. Furthermore, rFBs significantly reduced the velocity of rSCs in co-cultures on silk fibers. In summary, this study (a) reveals features recombinant silk must possess and what modifications or combinations could be useful for enhanced nerve repair and (b) provides assays to evaluate the regenerative performance of silk fibers in vitro before being applied as internal guiding structure in nerve conduits in vivo.	[Millesi, Flavia; Weiss, Tamara; Mann, Anda; Haertinger, Maximilian; Semmler, Lorenz; Supper, Paul; Naghilou, Aida; Radtke, Christine] Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Res Lab, Vienna, Austria; [Millesi, Flavia; Weiss, Tamara; Haertinger, Maximilian; Radtke, Christine] Austrian Cluster Tissue Regenerat, Vienna, Austria; [Pils, Dietmar] Med Univ Vienna, Comprehens Canc Ctr Vienna, Dept Surg, Div Gen Surg, Vienna, Austria; [Radtke, Christine] Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Weiss, T (corresponding author), Med Univ Vienna, Dept Surg, Div Plast & Reconstruct Surg, Res Lab, Vienna, Austria.	tamara.weiss@meduniwien.ac.at	Supper, Paul/GYD-4248-2022; Radtke, Christine/B-8491-2018	Supper, Paul/0000-0001-9998-262X; Haertinger, Maximilian/0000-0003-2478-6477; Semmler, Lorenz/0000-0003-4732-5227; Millesi, Flavia/0000-0002-5999-1940; Naghilou, Aida/0000-0002-4351-0620; Weiss, Tamara/0000-0001-7046-3412; Radtke, Christine/0000-0001-6877-5038	Medical University of Vienna; Austrian Science Fund (FWF) [P33613]	Medical University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by institutional funding of the Medical University of Vienna and by the Austrian Science Fund (FWF, P33613).	ABERCROMBIE M, 1970, IN VITRO CELL DEV B, V6, P128; Aigner TB, 2018, ADV MATER, V30, DOI 10.1002/adma.201704636; Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x; Allmeling C, 2006, J CELL MOL MED, V10, P770, DOI 10.1111/j.1582-4934.2006.tb00436.x; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Anderson JM, 2008, SEMIN IMMUNOL, V20, P86, DOI 10.1016/j.smim.2007.11.004; [Anonymous], 2010, OFF J EUR UNION, VL 276, P33; Arslantunali D, 2014, MED DEVICES-EVID RES, V7, P405, DOI 10.2147/MDER.S59124; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; BARONVANEVERCOOREN A, 1986, DEV NEUROSCI-BASEL, V8, P182, DOI 10.1159/000112252; Bini E, 2006, BIOMACROMOLECULES, V7, P3139, DOI 10.1021/bm0607877; Bretz F, 2016, MULTIPLE COMP USING; Brown CN, 2010, ANN ROY COLL SURG, V92, P272, DOI 10.1308/003588410X12664192076296; Cao TT, 2016, MAT SCI ENG C-MATER, V61, P940, DOI 10.1016/j.msec.2015.12.082; Carvalho CR, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00337; Chen MB, 2006, ANN PLAS SURG, V57, P462, DOI 10.1097/01.sap.0000237577.07219.b6; Choe G, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10090997; Ciaramitaro P, 2010, J PERIPHER NERV SYST, V15, P120, DOI 10.1111/j.1529-8027.2010.00260.x; Cunha C, 2011, NANOMED-NANOTECHNOL, V7, P50, DOI 10.1016/j.nano.2010.07.004; Daroff RB, 2016, BRADLEYS NEUROLOGY C, V7th; De Rosa M, 2004, J CELL PHYSIOL, V198, P133, DOI 10.1002/jcp.10397; Di Summa PG, 2018, ANAT REC, V301, P1714, DOI 10.1002/ar.23841; Dinis TM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109770; Dun XP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119168; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; Evans GRD, 2002, BIOMATERIALS, V23, P841, DOI 10.1016/S0142-9612(01)00190-9; Fu SY, 1997, MOL NEUROBIOL, V14, P67, DOI 10.1007/BF02740621; Gaudin R, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3856262; Gomez-Sanchez JA, 2015, J CELL BIOL, V210, P153, DOI 10.1083/jcb.201503019; Grinsell D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/698256; Haertinger M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010163; Herrera J, 2018, J CLIN INVEST, V128, P45, DOI 10.1172/JCI93557; Hoke A, 2010, EXP NEUROL, V223, P1, DOI 10.1016/j.expneurol.2009.12.001; Hoke A, 2006, NAT CLIN PRACT NEURO, V2, P448, DOI 10.1038/ncpneuro0262; Hood B, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E4; Jacobsen MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep45653; Jang SY, 2016, GLIA, V64, P730, DOI 10.1002/glia.22957; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Jessen KR, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00033; Jiang X, 2010, EXP NEUROL, V223, P86, DOI 10.1016/j.expneurol.2009.09.009; Johnson EO, 2005, INJURY, V36, pS24, DOI 10.1016/j.injury.2005.10.012; Kanno H, 2015, REV NEUROSCIENCE, V26, P121, DOI 10.1515/revneuro-2014-0068; Kaplan HM, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-015-5558-4; Kehoe S, 2012, INJURY, V43, P553, DOI 10.1016/j.injury.2010.12.030; Kluge JA, 2008, TRENDS BIOTECHNOL, V26, P244, DOI 10.1016/j.tibtech.2008.02.006; Kuhbier JW, 2011, J BIOMED MATER RES B, V97B, P381, DOI 10.1002/jbm.b.31825; Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032; LALLY KP, 1993, J PEDIATR SURG, V28, P45, DOI 10.1016/S0022-3468(05)80352-5; Leal-Egana A, 2012, J MATER CHEM, V22, P14330, DOI 10.1039/c2jm31174g; Lee H, 2010, P NATL ACAD SCI USA, V107, P3340, DOI 10.1073/pnas.0905437106; Lee SH, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2014.46; Lin YC, 2011, ANN PLAS SURG, V67, P147, DOI 10.1097/SAP.0b013e3182240346; Ling S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00613-5; Lovati AB, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00427; Lundborg G, 1997, J HAND SURG-BRIT EUR, V22B, P299, DOI 10.1016/S0266-7681(97)80390-7; Lundborg G, 2000, J HAND SURG-AM, V25A, P391, DOI 10.1053/jhsu.2000.4165; Madhusudanan P, 2020, J R SOC INTERFACE, V17, DOI 10.1098/rsif.2019.0505; Magaz A, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201800308; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; Mandal BB, 2009, BIOMATERIALS, V30, P2956, DOI 10.1016/j.biomaterials.2009.02.006; MARTINI R, 1988, J CELL BIOL, V106, P1735, DOI 10.1083/jcb.106.5.1735; Millesi H, 2007, ACTA NEUROCHIR SUPPL, V100, P37; MILLESI H, 1972, J BONE JOINT SURG AM, VA 54, P727, DOI 10.2106/00004623-197254040-00004; Millesi H, 2007, ACTA NEUROCHIR SUPPL, V100, P103; Moore AM, 2011, MUSCLE NERVE, V44, P221, DOI 10.1002/mus.22033; Moore Amy M, 2009, Hand (N Y), V4, P180, DOI 10.1007/s11552-008-9158-3; Muheremu A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/237507; Naghilou A, 2020, MAT SCI ENG C-MATER, V116, DOI 10.1016/j.msec.2020.111219; OBREMSKI VJ, 1993, DEV BIOL, V160, P119, DOI 10.1006/dbio.1993.1291; Pabari A, 2011, J CONTROL RELEASE, V156, P2, DOI 10.1016/j.jconrel.2011.07.001; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Pawar K, 2019, ACS APPL BIO MATER, V2, P4872, DOI 10.1021/acsabm.9b00628; Petzold J, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201701427; Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990; Ray WZ, 2010, EXP NEUROL, V223, P77, DOI 10.1016/j.expneurol.2009.03.031; Reimers K, 2015, BIOTECHNOL BIOENG, V112, P2201, DOI 10.1002/bit.25654; Roloff F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/906819; Salehi S, 2020, MOLECULES, V25, DOI 10.3390/molecules25030737; Schafer-Nolte F, 2014, ANN SURG, V259, P781, DOI 10.1097/SLA.0b013e3182917677; Schlosshauer B, 2006, NEUROSURGERY, V59, P740, DOI 10.1227/01.NEU.0000235197.36789.42; Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3; Seddon HJ, 1943, BRAIN, V66, P237, DOI 10.1093/brain/66.4.237; Sinis N, 2005, J NEUROSURG, V103, P1067, DOI 10.3171/jns.2005.103.6.1067; SOONG HK, 1984, OPHTHALMOLOGY, V91, P479; Sosa I, 2005, EXP NEUROL, V195, P7, DOI 10.1016/j.expneurol.2005.04.016; Steins A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145240; Stoll G, 1999, BRAIN PATHOL, V9, P313; Sulaiman OAR, 2009, NEUROSURGERY, V65, pA105, DOI 10.1227/01.NEU.0000358537.30354.63; Sulaiman W, 2013, OCHSNER J, V13, P100; Taylor CA, 2008, AM J PHYS MED REHAB, V87, P381, DOI 10.1097/PHM.0b013e31815e6370; Tokareva O, 2014, ACTA BIOMATER, V10, P1612, DOI 10.1016/j.actbio.2013.08.020; van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299; Vijayavenkataraman S, 2020, ACTA BIOMATER, V106, P54, DOI 10.1016/j.actbio.2020.02.003; Vollrath F, 2000, J Biotechnol, V74, P67; Wang ML, 2019, CONNECT TISSUE RES, V60, P3, DOI 10.1080/03008207.2018.1489381; Webb K, 1998, J BIOMED MATER RES, V41, P422, DOI 10.1002/(SICI)1097-4636(19980905)41:3<422::AID-JBM12>3.0.CO;2-K; Weiss T, 2018, METHODS MOL BIOL, V1739, P67, DOI 10.1007/978-1-4939-7649-2_5; Weiss T, 2016, GLIA, V64, P2133, DOI 10.1002/glia.23045; Widhe M, 2013, BIOMATERIALS, V34, P8223, DOI 10.1016/j.biomaterials.2013.07.058; Wohlrab S, 2012, BIOMATERIALS, V33, P6650, DOI 10.1016/j.biomaterials.2012.05.069; Yang DP, 2008, MOL CELL NEUROSCI, V38, P80, DOI 10.1016/j.mcn.2008.01.017; Yousefi F, 2019, LIFE SCI, V221, P99, DOI 10.1016/j.lfs.2019.01.052; Zhou YZ, 2020, MAT SCI ENG C-MATER, V111, DOI 10.1016/j.msec.2020.110752; Zhu BF, 2015, BIOMACROMOLECULES, V16, P202, DOI 10.1021/bm501403f	104	10	10	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001447R	http://dx.doi.org/10.1096/fj.202001447R		NOV 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33210360	Green Published, hybrid			2022-12-26	WOS:000592745800001
J	Wanandi, SI; Limanto, A; Yunita, E; Syahrani, RA; Louisa, M; Wibowo, AE; Arumsari, S				Wanandi, Septelia Inawati; Limanto, Agus; Yunita, Elvira; Syahrani, Resda Akhra; Louisa, Melva; Wibowo, Agung Eru; Arumsari, Sekar			In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells	PLOS ONE			English	Article							FAST INTERACTION REFINEMENT; MOLECULAR-MECHANISMS; APOPTOSIS; PHOSPHORYLATION; SMAC/DIABLO; ACTIVATION; EXPRESSION; AUTOPHAGY; FIREDOCK	Breast cancer stem cells (BCSCs) express high levels of the anti-apoptotic protein, survivin. This study aimed to discover a natural active compound with anti-cancer properties that targeted survivin in human breast cancer stem cells. From the seven examined compounds, andrographolide was selected as a lead compound through in silico molecular docking with survivin, caspase-9, and caspase-3. We found that the affinity between andrographolide and survivin is higher than that with caspase-9 and caspase-3. Human CD24-/CD44+ BCSCs were treated with andrographolide in vitro for 24 hours. The cytotoxic effect of andrographolide on BCSCs was compared to that on human mesenchymal stem cells (MSCs). The expression of survivin, caspase-9, and caspase-3 mRNA was analyzed using qRT-PCR, while Thr34-phosphorylated survivin and total survivin levels were determined using ELISA and Immunoblotting assay. Annexin-V/PI flow cytometry assays were performed to evaluate the apoptotic activity of andrographolide. Our results demonstrate that the CC50 of andrographolide in BCSCs was 0.32mM, whereas there was no cytotoxic effect in MSCs. Moreover, andrographolide decreased survivin and Thr34-phosphorylated survivin, thus inhibiting survivin activation and increasing survivin mRNA in BCSCs. The apoptotic activity of andrographolide was revealed by the increase of caspase-3 mRNA and protein, as well as the increase in both the early and late phases of apoptosis. In conclusion, andrographolide can be considered an anti-cancer compound that targets BCSCs due to its molecular interactions with survivin, caspase-9, and caspase-3, which induce apoptosis. We suggest that the binding of andrographolide to survivin is a critical aspect of the effect of andrographolide.	[Wanandi, Septelia Inawati] Univ Indonesia, Dept Biochem & Mol Biol, Fac Med, Jakarta, Indonesia; [Wanandi, Septelia Inawati] Univ Indonesia, Ctr Hypoxia & Oxidat Stress Studies, Fac Med, Jakarta, Indonesia; [Wanandi, Septelia Inawati; Syahrani, Resda Akhra; Arumsari, Sekar] Univ Indonesia, Indonesian Med Educ & Res Inst, Fac Med, Mol Biol & Prote Core Facil, Jakarta, Indonesia; [Limanto, Agus; Yunita, Elvira; Syahrani, Resda Akhra] Univ Indonesia, Master Program Biomed Sci, Fac Med, Jakarta, Indonesia; [Louisa, Melva] Univ Indonesia, Dept Pharmacol, Fac Med, Jakarta, Indonesia; [Wibowo, Agung Eru] Agcy Assessment & Applicat Technol BPPT, Lab Dev Ind Agro & Biomed Technol LAPTIAB, Tangerang Selatan, Indonesia	University of Indonesia; University of Indonesia; University of Indonesia; University of Indonesia; University of Indonesia; Agency for the Assessment & Application of Technology (BPPT)	Wanandi, SI (corresponding author), Univ Indonesia, Dept Biochem & Mol Biol, Fac Med, Jakarta, Indonesia.; Wanandi, SI (corresponding author), Univ Indonesia, Ctr Hypoxia & Oxidat Stress Studies, Fac Med, Jakarta, Indonesia.; Wanandi, SI (corresponding author), Univ Indonesia, Indonesian Med Educ & Res Inst, Fac Med, Mol Biol & Prote Core Facil, Jakarta, Indonesia.	septelia.inawati@ui.ac.id		Limanto, Agus/0000-0002-6037-1271; Yunita, Elvira/0000-0002-4290-6527; Wanandi, Septelia Inawati/0000-0002-7963-8853; syahrani, resda akhra/0000-0002-4377-9611	PDUPT Grant from the Ministry of Research, Technology and Higher Education of the Republic of Indonesia [NKB-1564/UN2.R3.1/HKP.05.00/2019]	PDUPT Grant from the Ministry of Research, Technology and Higher Education of the Republic of Indonesia	This work was funded by the PDUPT Grant (NKB-1564/UN2.R3.1/HKP.05.00/2019) from the Ministry of Research, Technology and Higher Education of the Republic of Indonesia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Aspe JR, 2010, ONCOTARGETS THER, V3, P247, DOI 10.2147/OTT.S15293; Bachtiar EW, 2017, J BIOMIM BIOMATER BI, V34, P94, DOI 10.4028/www.scientific.net/JBBBE.34.94; Banerjee M, 2016, J BIOMED SCI, V23, DOI 10.1186/s12929-016-0257-0; Chakraborty D, 2012, EUR J PHARMACOL, V694, P20, DOI 10.1016/j.ejphar.2012.08.001; Chen DS, 2013, BIOORG MED CHEM LETT, V23, P3166, DOI 10.1016/j.bmcl.2013.04.010; Chen X, 2016, J CANCER, V7, P314, DOI 10.7150/jca.13332; Cheung CHA, 2013, ONCOTARGETS THER, V6, P1453, DOI 10.2147/OTT.S33374; Chu YJ, 2011, J MOL CELL BIOL, V3, P260, DOI 10.1093/jmcb/mjq037; Church DN, 2012, CURR ONCOL REP, V14, P120, DOI 10.1007/s11912-012-0215-2; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Dey P, 2019, BREAST CANCER-TARGET, V11, P115, DOI 10.2147/BCTT.S189224; Dey SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058055; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Elfahmi, 2014, J HERB MED, V4, P51, DOI 10.1016/j.hermed.2014.01.002; Groner B, 2014, BIODRUGS, V28, P27, DOI 10.1007/s40259-013-0058-x; Halgren TA, 1996, J COMPUT CHEM, V17, P587, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<587::AID-JCC4>3.0.CO;2-Q; Huang JC, 2015, AM J CANCER RES, V5, P20; Jaiswal PK, 2015, INDIAN J MED RES, V141, P389, DOI 10.4103/0971-5916.159250; Kakarala M, 2010, BREAST CANCER RES TR, V122, P777, DOI 10.1007/s10549-009-0612-x; Koo HJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-27; Kumar D, 2012, EUR J CANCER, V48, P25; Kurose H, 2012, J BIOMED BIOTECH, V2012, P1; Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933; Li YY, 2011, J NUTR BIOCHEM, V22, P799, DOI 10.1016/j.jnutbio.2010.11.001; Li-Weber M, 2015, INT J CANCER, V137, P1791, DOI 10.1002/ijc.29013; Lim SC, 2017, ONCOL LETT, V13, P3837, DOI 10.3892/ol.2017.5923; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Mobahat M, 2014, INT J MOL SCI, V15, P2494, DOI 10.3390/ijms15022494; Palomeras S, 2018, MOLECULES, V23, DOI 10.3390/molecules23092193; Research Collaboratory for Structural Bioinformatics, 1E31 SURV DIM H SAP; Ring A, 2014, STEM CELL REV REP, V10, P512, DOI 10.1007/s12015-014-9515-2; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shi YG, 2004, PROTEIN SCI, V13, P1979, DOI 10.1110/ps.04789804; Sholikhah E.N., 2016, J MED SCI, V48, P226, DOI [10.19106/JMedSci004804201606, DOI 10.19106/JMEDSCI004804201606]; Song ZY, 2003, J BIOL CHEM, V278, P23130, DOI 10.1074/jbc.M300957200; Tan HK, 2016, TOXICOL APPL PHARM, V300, P55, DOI 10.1016/j.taap.2016.03.017; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Velasco-Velazquez MA, 2012, INT J BIOCHEM CELL B, V44, P573, DOI 10.1016/j.biocel.2011.12.020; Wanandi SI, 2017, ANN ONCOL, V28; Wanandi SI, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431x20176538, 10.1590/1414-431X20176538]; Watanapokasin R, 2011, WORLD J GASTROENTERO, V17, P2086, DOI 10.3748/wjg.v17.i16.2086; Wheatley SP, 2004, J BIOL CHEM, V279, P5655, DOI 10.1074/jbc.M311299200; Yang L, 2009, CANCER LETT, V276, P180, DOI 10.1016/j.canlet.2008.11.015	48	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0240020	10.1371/journal.pone.0240020	http://dx.doi.org/10.1371/journal.pone.0240020			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211707	Green Published, gold			2022-12-26	WOS:000603518300007
J	Shoushtarian, M; Alizadehsani, R; Khosravi, A; Acevedo, N; McKay, CM; Nahavandi, S; Fallon, JB				Shoushtarian, Mehrnaz; Alizadehsani, Roohallah; Khosravi, Abbas; Acevedo, Nicola; McKay, Colette M.; Nahavandi, Saeid; Fallon, James B.			Objective measurement of tinnitus using functional near-infrared spectroscopy and machine learning	PLOS ONE			English	Article							LEFT AUDITORY-CORTEX; HEMODYNAMIC-RESPONSES; ACTIVATION; NETWORKS; CONNECTIVITY; TISSUE; FNIRS; TASK	Chronic tinnitus is a debilitating condition which affects 10-20% of adults and can severely impact their quality of life. Currently there is no objective measure of tinnitus that can be used clinically. Clinical assessment of the condition uses subjective feedback from individuals which is not always reliable. We investigated the sensitivity of functional near-infrared spectroscopy (fNIRS) to differentiate individuals with and without tinnitus and to identify fNIRS features associated with subjective ratings of tinnitus severity. We recorded fNIRS signals in the resting state and in response to auditory or visual stimuli from 25 individuals with chronic tinnitus and 21 controls matched for age and hearing loss. Severity of tinnitus was rated using the Tinnitus Handicap Inventory and subjective ratings of tinnitus loudness and annoyance were measured on a visual analogue scale. Following statistical group comparisons, machine learning methods including feature extraction and classification were applied to the fNIRS features to classify patients with tinnitus and controls and differentiate tinnitus at different severity levels. Resting state measures of connectivity between temporal regions and frontal and occipital regions were significantly higher in patients with tinnitus compared to controls. In the tinnitus group, temporal-occipital connectivity showed a significant increase with subject ratings of loudness. Also in this group, both visual and auditory evoked responses were significantly reduced in the visual and auditory regions of interest respectively. Naive Bayes classifiers were able to classify patients with tinnitus from controls with an accuracy of 78.3%. An accuracy of 87.32% was achieved using Neural Networks to differentiate patients with slight/ mild versus moderate/ severe tinnitus. Our findings show the feasibility of using fNIRS and machine learning to develop an objective measure of tinnitus. Such a measure would greatly benefit clinicians and patients by providing a tool to objectively assess new treatments and patients' treatment progress.	[Shoushtarian, Mehrnaz; Acevedo, Nicola; McKay, Colette M.; Fallon, James B.] Bion Inst, East Melbourne, Vic, Australia; [Shoushtarian, Mehrnaz; McKay, Colette M.; Fallon, James B.] Univ Melbourne, Med Bion Dept, Melbourne, Vic, Australia; [Alizadehsani, Roohallah; Khosravi, Abbas; Nahavandi, Saeid] Deakin Univ, Inst Intelligent Syst Res & Innovat IISRI, Melbourne, Vic, Australia; [Fallon, James B.] Univ Melbourne, Dept Otolaryngol, Melbourne, Vic, Australia	Bionics Institute; University of Melbourne; Deakin University; University of Melbourne	Shoushtarian, M (corresponding author), Bion Inst, East Melbourne, Vic, Australia.; Shoushtarian, M (corresponding author), Univ Melbourne, Med Bion Dept, Melbourne, Vic, Australia.	mshoushtarian@bionicsinstitute.org	Acevedo, Nicola/GWZ-1148-2022; Khosravi, Abbas/AAQ-8102-2021; Nahavandi, Saeid/AAE-5536-2022	Alizadehsani, Roohallah/0000-0002-3069-7932; Alizadehsani, Roohallah/0000-0003-0898-5054; Shoushtarian, Mehrnaz/0000-0002-3611-9877; McKay, Colette/0000-0002-1659-9789	Victorian Government through its Operational Infrastructure Support Program - Action on Hearing Loss Flexi Grant	Victorian Government through its Operational Infrastructure Support Program - Action on Hearing Loss Flexi Grant	The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. The project was partly funded by an Action on Hearing Loss Flexi Grant.	Alizadehsani R, 2013, COMPUT METH PROG BIO, V111, P52, DOI 10.1016/j.cmpb.2013.03.004; Amaral AA, 2015, HEARING RES, V326, P15, DOI 10.1016/j.heares.2015.03.006; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2002, THEATRE RECORD, VXXII, P908; [Anonymous], 2009, J APPL SURF SCI, V255, P1; Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; Basura GJ, 2018, LARYNGOSCOPE INVEST, V3, P463, DOI 10.1002/lio2.185; Elgoyhen AB, 2015, NAT REV NEUROSCI, V16, P632, DOI 10.1038/nrn4003; Bzdok D, 2018, NAT METHODS, V15, P232, DOI 10.1038/nmeth.4642; Chen YC, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00022; De Ridder D, 2014, NEUROSCI BIOBEHAV R, V44, P16, DOI 10.1016/j.neubiorev.2013.03.021; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Harms MP, 2003, HUM BRAIN MAPP, V20, P168, DOI 10.1002/hbm.10136; Hu DW, 2015, J NEUROPHYSIOL, V114, P2152, DOI 10.1152/jn.00246.2015; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Husain FT, 2014, HEARING RES, V307, P153, DOI 10.1016/j.heares.2013.07.010; Issa M, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7453149; Lanting CP, 2008, ACTA OTO-LARYNGOL, V128, P415, DOI 10.1080/00016480701793743; Lanting C, 2016, ADV EXP MED BIOL, V894, P175, DOI 10.1007/978-3-319-25474-6_19; Levine RA, 2005, 8 INT TINN SEM PAU F; McMahon CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148828; Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058, DOI 10.1152/jn.2000.83.2.1058; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Perpetuini D, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21010026; Pollonini L, 2016, BIOMED OPT EXPRESS, V7, P5104, DOI 10.1364/BOE.7.005104; Rojas RF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42098-w; Saager RB, 2005, J OPT SOC AM A, V22, P1874, DOI 10.1364/JOSAA.22.001874; Sadaghiani S, 2009, J NEUROSCI, V29, P13410, DOI 10.1523/JNEUROSCI.2592-09.2009; Santosa H, 2018, ALGORITHMS, V11, DOI 10.3390/a11050073; Santosa H, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.5.055002; Schecklmann M, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/894203; Schmidt SA, 2017, NEUROIMAGE-CLIN, V16, P196, DOI 10.1016/j.nicl.2017.07.015; Schmidt SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076488; Scholkmann F, 2014, PHYSIOL MEAS, V35, P717, DOI 10.1088/0967-3334/35/4/717; Shih YYI, 2009, J NEUROSCI, V29, P3036, DOI 10.1523/JNEUROSCI.3447-08.2009; Song JJ, 2012, J NUCL MED, V53, P1550, DOI 10.2967/jnumed.112.102939; The Lancet HIV, 2015, LANCET HIV, V2, pe115; Themelis G, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2710250; Ueyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067778; van der Loo E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007396; Vanneste S, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00031; Wang HT, 2001, CHINESE MED J-PEKING, V114, P848; Weder S, 2018, JARO-J ASSOC RES OTO, V19, P273, DOI 10.1007/s10162-018-0661-0; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007; Wiggins IM, 2016, HEARING RES, V339, P142, DOI 10.1016/j.heares.2016.07.007; Wijeakumar S, 2012, INVEST OPHTH VIS SCI, V53, P2266, DOI 10.1167/iovs.11-8680; Yamamoto T, 2002, PHYS MED BIOL, V47, P1121, DOI 10.1088/0031-9155/47/7/309	51	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241695	10.1371/journal.pone.0241695	http://dx.doi.org/10.1371/journal.pone.0241695			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206675	gold, Green Published			2022-12-26	WOS:000595265900027
J	Dal Corso, L; De Carlo, A; Carluccio, F; Colledani, D; Falco, A				Dal Corso, Laura; De Carlo, Alessandro; Carluccio, Francesca; Colledani, Daiana; Falco, Alessandra			Employee burnout and positive dimensions of well-being: A latent workplace spirituality profile analysis	PLOS ONE			English	Article							WORK-RELATED STRESS; JOB-SATISFACTION; MEDIATING ROLE; ORGANIZATIONAL COMMITMENT; PERSONALITY PROFILES; NEGATIVE AFFECT; HEALTH; LEADERSHIP; ENGAGEMENT; BEHAVIOR	In recent years, a new and promising construct has attracted the attention of organizational research: Workplace spirituality. To investigate the role of workplace spirituality in organizational contexts, two studies were carried out. Study 1 explored the mediation role of workplace spirituality in the relationship between positive supervisor behaviors and employee burnout. Results showed that workplace spirituality strongly contributes to reduce burnout and mediates the effect of supervisor integrity in reducing this threat. Study 2 considered the relationships of workplace spirituality with positive affectivity, resilience, self-efficacy, and work engagement. In particular, workplace spirituality profiles were investigated through latent profile analysis (LPA). Findings showed that workplace spirituality is related to higher positive affectivity, resilience, self-efficacy, and work engagement. In contrast, a workplace spirituality profile characterized by a low-intensity spiritual experience is associated with higher negative feelings. The practical implications of these findings are discussed.	[Dal Corso, Laura; Colledani, Daiana; Falco, Alessandra] Univ Padua, Dept Philosophy Sociol Educ & Appl Psychol, Padua, Italy; [De Carlo, Alessandro] Giustino Fortunato Univ, Benevento, Italy; [Carluccio, Francesca] LUMSA Univ, Dept Human Sci Commun, Training, Psychol, Rome, Italy	University of Padua; Universita Telematica Giustino Fortunato; Universita LUMSA	Dal Corso, L (corresponding author), Univ Padua, Dept Philosophy Sociol Educ & Appl Psychol, Padua, Italy.	dalcorso@unipd.it						Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Albuquerque IF, 2014, J ORGAN CHANGE MANAG, V27, P59, DOI 10.1108/JOCM-11-2012-0186; Almotawa Abdulmohsan, 2020, Advances in Human Factors, Business Management and Leadership. Proceedings of the AHFE 2019 International Conference on Human Factors, Business Management and Society, and the AHFE International Conference on Human Factors in Management and Leadership. Advances in Intelligent Systems and Computing (AISC 961), P435, DOI 10.1007/978-3-030-20154-8_40; [Anonymous], 2013, POLAR GEOPOLITICS NE, V3, P1, DOI DOI 10.4236/NJGC.2013.31001; Arnetz BB, 2013, J MANAG SPIRITUAL RE, V10, P271, DOI 10.1080/14766086.2013.801027; Arokiasamya ARA, 2020, MANAGEMENT SCI LETT, V10, P855, DOI [10.5267/j.msl.2019.10.011, DOI 10.5267/J.MSL.2019.10.011]; Ashmos DP, 2000, J MANAGE INQUIRY, V9, P134, DOI 10.1177/105649260092008; Badrinarayanan V, 2008, J PERS SELL SALES M, V28, P421, DOI 10.2753/PSS0885-3134280406; Bakker A.B., 2008, CAREER DEV INT, V13, P209, DOI [DOI 10.1108/13620430810870476, 10.1108/13620430810870476]; Balducci C, 2010, EUR J PSYCHOL ASSESS, V26, P143, DOI 10.1027/1015-5759/a000020; Barbieri B, 2014, TPM-TEST PSYCHOM MET, V21, P181, DOI 10.4473/TPM21.2.5; Belanger JJ, 2015, J APPL SOC PSYCHOL, V45, P319, DOI 10.1111/jasp.12298; Bell A., 2012, INT J BUSINESS SOCIA, V3, P68; Benevene P, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02069; Bentler P.M., 2005, EQS STRUCTURAL EQUAT; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Birnie EA, 2019, J NURS MANAGE, V27, P1563, DOI 10.1111/jonm.12843; Brown T.A., 2006, CONFIRMATORY FACTOR, Vxiii; Browne M.W., 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Butts D, 1999, J ORGAN CHANGE MANAG, V12, P328, DOI 10.1108/09534819910282162; Carroll S. T., 2013, APA HDB PSYCHOL RELI, V2, P595, DOI [10.1037/14046-031, DOI 10.1037/14046-031]; Celeux G, 1996, J CLASSIF, V13, P195, DOI 10.1007/BF01246098; Chawla V, 2010, J HUM VALUES, V16, P157, DOI 10.1177/097168581001600203; Chirico F., 2016, J HLTH SOC SCI, V1, P11, DOI [10.19204/2016/sprt2, DOI 10.19204/2016/SPRT2]; Chirico F, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02933; Chirico F, 2019, INDIAN J OCCUP ENVIR, V23, P99, DOI 10.4103/ijoem.IJOEM_209_18; Chirico F, 2017, EPIDEMIOL PREV, V41, P294, DOI 10.19191/EP17.5-6.P294.089; Chirico F, 2017, J RELIG HEALTH, V56, P839, DOI 10.1007/s10943-016-0242-7; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Connolly JJ, 2000, PERS INDIV DIFFER, V29, P265, DOI 10.1016/S0191-8869(99)00192-0; Dal Corso L, 2019, TPM-TEST PSYCHOM MET, V26, P561, DOI 10.4473/TPM26.4.5; Dal Corso L, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02361; De Carlo A, 2020, TPM-TEST PSYCHOM MET, V27, P129, DOI 10.4473/TPM27.1.8; De Carlo A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01834; De Carlo NA, 2008, TEST VALUTAZIONE RIS; De Carlo NA, 2016, ETICA MONDO LAVORO R, P69; De Carlo NA, 2016, TPM-TEST PSYCHOM MET, V23, P561, DOI 10.4473/TPM23.4.9; DeVellis RF, 2016, SCALE DEV THEORY APP; Di Sipio A, 2012, TPM-TEST PSYCHOM MET, V19, P81, DOI 10.4473/TPM19.2.2; Donaldson-Feilder E., 2011, PREVENTING STRESS OR, DOI DOI 10.1002/9780470978122; Doolittle BR, 2015, J EDUC EVAL HEALTH P, V12, DOI 10.3352/jeehp.2015.12.41; Doolittle Benjamin R, 2013, J Grad Med Educ, V5, P257, DOI 10.4300/JGME-D-12-00136.1; Duchon D, 2005, LEADERSHIP QUART, V16, P807, DOI 10.1016/j.leaqua.2005.07.008; Falco A, 2013, OCCUP MED-OXFORD, V63, P341, DOI 10.1093/occmed/kqt054; Falco A, 2018, RES NURS HEALTH, V41, P39, DOI 10.1002/nur.21844; Falco A, 2017, TPM-TEST PSYCHOM MET, V24, P583, DOI 10.4473/TPM24.4.8; Falco A, 2013, TPM-TEST PSYCHOM MET, V20, P217, DOI 10.4473/TPM20.3.2; Falco A, 2012, MED LAV, V103, P288; Freedman AM, 2016, WILEY BLACKWELL HDB, DOI DOI 10.1002/9781118326404.CH20; Garcia-Zamor JC, 2003, PUBLIC ADMIN REV, V63, P355, DOI 10.1111/1540-6210.00295; Garg N, 2017, S ASIAN J HUM RE MAN, V4, P191, DOI 10.1177/2322093717736134; Giacalone R. A., 2003, HDB WORKPLACE SPIRIT; Gilbreath B, 2004, WORK STRESS, V18, P255, DOI 10.1080/02678370412331317499; Girardi D, 2015, TPM-TEST PSYCHOM MET, V22, P507, DOI 10.4473/TPM22.4.5; Girardi D, 2011, TPM-TEST PSYCHOM MET, V18, P257, DOI 10.4473/TPM.18.4.5; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; Gupta M, 2014, J BUS ETHICS, V122, P79, DOI 10.1007/s10551-013-1756-5; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hunsaker W., 2019, MANAGEMENT SCI LETT, V9, P1257, DOI [10.5267/j.msl.2019.4.016., DOI 10.5267/J.MSL.2019.4.016]; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; ICD-11, 2018, ICD11 WHO; Ivaldi S, 2019, TPM-TEST PSYCHOM MET, V26, P121, DOI 10.4473/TPM26.1.7; Salvagioni DAJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185781; Jufrizen J., 2019, INT J RES BUSINESS S, V8, P64, DOI [10.20525/ijrbs.v8i1.194, DOI 10.20525/IJRBS.V8I1.194]; Karakas F, 2010, J BUS ETHICS, V94, P89, DOI 10.1007/s10551-009-0251-5; Kaur D, 2013, J CLIN NURS, V22, P3192, DOI 10.1111/jocn.12386; Kazemipour F, 2012, J NURS SCHOLARSHIP, V44, P302, DOI 10.1111/j.1547-5069.2012.01456.x; Kim M, 2019, SPORT MANAG REV, V22, P108, DOI 10.1016/j.smr.2018.04.003; Kinjerski V., 2006, ACAD MANAGEMENT P, V1, pA1; Kinjerski V., 2013, HDB FAITH SPIRITUALI, P383, DOI [10.1007/978-1-4614-5233-1_23, DOI 10.1007/978-1-4614-5233-1_23]; Kinjerski V., 2006, LEADERSHIP ORG DEV J, V27, P280, DOI [10.1108/01437730610666037, DOI 10.1108/01437730610666037]; Kinjerski V, 2008, J GERONTOL NURS, V34, P17, DOI 10.3928/00989134-20081001-03; Kinjerski V, 2006, J MANAG SPIRITUAL RE, V3, P231, DOI 10.1080/14766080609518627; Kinjerski VM, 2004, J ORGAN CHANGE MANAG, V17, P26, DOI 10.1108/09534810410511288; Kinnunen ML, 2012, SCAND J PSYCHOL, V53, P512, DOI 10.1111/j.1467-9450.2012.00969.x; Klein T, 2011, WAYFINDING LIFES CHA, P419; Kolodinsky RW, 2008, J BUS ETHICS, V81, P465, DOI 10.1007/s10551-007-9507-0; Kumar S., 2015, S ASIAN J, V22, P137; Kumar V, 2014, INT REV PSYCHIATR, V26, P344, DOI 10.3109/09540261.2014.924909; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; Lo YT, 2001, BIOMETRIKA, V88, P767, DOI 10.1093/biomet/88.3.767; Luthans F, 2009, J ORGAN BEHAV, V30, P291, DOI 10.1002/job.589; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; McKee MC, 2011, J MANAG SPIRITUAL RE, V8, P233, DOI 10.1080/14766086.2011.599147; Merz EL, 2011, PERS INDIV DIFFER, V51, P915, DOI 10.1016/j.paid.2011.07.022; Miller D., 2013, J RELIG THEOLOGICAL, V12, P29, DOI [10.1080/10477845.2013.800776, DOI 10.1080/10477845.2013.800776]; Milliman J, 2003, J ORGAN CHANGE MANAG, V16, P426, DOI 10.1108/09534810310484172; Moran R, 2017, J MANAG SPIRITUAL RE, V14, P343, DOI 10.1080/14766086.2017.1376287; Muthen B.O., 2012, MPLUS USERS GUIDE, V7th; Nandana Prabhu KP, 2019, PRABANDHAN INDIAN J, V12, P7, DOI 10.17010/pijom/2019/v12i4/143344; Neal, 1997, J MANAGEMENT ED, V21, P121, DOI [10.1177/105256299702100111, DOI 10.1177/105256299702100111]; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; Paloutzian R.F., 2003, HDB WORKPLACE SPIRIT, P123, DOI 10.1146/annurev.psych.54.101601.145024; Parr AD, 2016, HUM PERFORM, V29, P143, DOI 10.1080/08959285.2016.1157596; Rego A, 2008, J ORGAN CHANGE MANAG, V21, P53, DOI 10.1108/09534810810847039; Scaratti G., 2015, BPA APPL PSYCHOL B, V272, P42; Schaufeli WB, 2006, EDUC PSYCHOL MEAS, V66, P701, DOI 10.1177/0013164405282471; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCLOVE SL, 1987, PSYCHOMETRIKA, V52, P333, DOI 10.1007/BF02294360; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; SELTZER J, 1988, ACAD MANAGE J, V31, P439, DOI 10.2307/256559; Shelton CD, 2019, INT J ORGAN ANAL, V28, P399, DOI 10.1108/IJOA-08-2019-1848; Sholikhah Z, 2019, INT J LAW MANAG, V61, P232, DOI 10.1108/IJLMA-04-2018-0081; Skakon J, 2010, WORK STRESS, V24, P107, DOI 10.1080/02678373.2010.495262; Strack Gary, 2002, Front Health Serv Manage, V18, P3; Terracciano A, 2003, EUR J PSYCHOL ASSESS, V19, P131, DOI 10.1027//1015-5759.19.2.131; Testoni I., 2019, J DISABILITY RELIG, V23, P178, DOI [10.1080/23312521.2019.1580174, DOI 10.1080/23312521.2019.1580174]; Treglown L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156279; Tu YD, 2017, J HAPPINESS STUD, V18, P229, DOI 10.1007/s10902-016-9725-1; Ursachi G, 2015, PROC ECON FINANC, V20, P679, DOI 10.1016/S2212-5671(15)00123-9; van Griethuijsen RALF, 2015, RES SCI EDUC, V45, P581, DOI 10.1007/s11165-014-9438-6; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Welbourne JL, 2007, J VOCAT BEHAV, V70, P312, DOI 10.1016/j.jvb.2006.10.006; Yong J, 2011, J CONTIN EDUC NURS, V42, P280, DOI 10.3928/00220124-20101201-04; Youssef CM, 2007, J MANAGE, V33, P774, DOI 10.1177/0149206307305562; Zhang JT, 2015, PERS INDIV DIFFER, V80, P18, DOI 10.1016/j.paid.2015.01.054; Zhang Y, 2019, J NURS MANAGE, V27, P1285, DOI 10.1111/jonm.12810; Zou WC, 2017, EUR J WORK ORGAN PSY, V26, P768, DOI 10.1080/1359432X.2017.1358164	120	8	8	8	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242267	10.1371/journal.pone.0242267	http://dx.doi.org/10.1371/journal.pone.0242267			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ5ZL	33201895	Green Published, gold			2022-12-26	WOS:000595003900023
J	Hansen, MRH; Schlunssen, V; Sandbaek, A				Hansen, Martin Rune Hassan; Schlunssen, Vivi; Sandbaek, Annelli			HemoDownloader: Open source software utility to extract data from HemoCue HbA1c 501 devices in epidemiological studies of diabetes mellitus	PLOS ONE			English	Article								Diabetes mellitus is a serious disease with increasing global prevalence. Point-of-care analysis of glycated hemoglobin A (HbA(1c)) holds promise as a diagnostic test for diabetes mellitus in epidemiological studies in challenging environments with limited access to centralized biochemical labs. The HemoCue HbA1c 501 device can be used for point-of-care determination of HbA(1c), but its usability in epidemiological studies is limited by its inability to export results in digital format. We have developed the open source HemoDownloader software to overcome this limitation of the device. HemoDownloader has an easy-to-use graphical user interface and can export data from HemoCue HbA1c 501 to standard spreadsheet file formats. The program has the potential to improve data collection and management in epidemiological studies of diabetes mellitus.	[Hansen, Martin Rune Hassan; Schlunssen, Vivi] Aarhus Univ, Danish Ramazzini Ctr, Dept Publ Hlth, Res Unit Environm Work & Hlth, Aarhus, Denmark; [Hansen, Martin Rune Hassan; Schlunssen, Vivi] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Sandbaek, Annelli] Aarhus Univ, Dept Publ Hlth, Res Unit Gen Practice, Aarhus, Denmark; [Sandbaek, Annelli] Aarhus Univ, Steno Diabet Ctr Aarhus, Hosp & Cent Denmark Reg, Aarhus, Denmark	Aarhus University; National Research Centre for the Working Environment; Aarhus University; Aarhus University	Hansen, MRH (corresponding author), Aarhus Univ, Danish Ramazzini Ctr, Dept Publ Hlth, Res Unit Environm Work & Hlth, Aarhus, Denmark.; Hansen, MRH (corresponding author), Natl Res Ctr Working Environm, Copenhagen, Denmark.	martinrunehassanhansen@ph.au.dk		Hansen, Martin Rune Hassan/0000-0001-9681-2393; Schlunssen, Vivi/0000-0003-4915-1734	Aarhus University Research Foundation [81231]; National Research Centre for the Working Environment [10322]	Aarhus University Research Foundation; National Research Centre for the Working Environment	This work was supported by grants from Aarhus University Research Foundation (project number 81231, https://auff.au.dk/en/) and the National Research Centre for the Working Environment (project number 10322, https://nfa.dk/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2018, Diabetes Care, V41, pS13, DOI 10.2337/dc18-S002; [Anonymous], 2016, HBA1C 501 AN OP MAN; Cefalu WT, 2019, DIABETES CARE, V42, pS61, DOI 10.2337/dc19-S006; Colagiuri S, 2011, DIABETES RES CLIN PR, V93, P312, DOI 10.1016/j.diabres.2011.06.025; Free Software Foundation, GNU GEN PUBL LIC GPL; Global Burden of Disease Collaborative Network, 2018, GLOB BURD DIS STUD 2; Hansen MRH, 2020, OCCUP ENVIRON MED, V77, P713, DOI 10.1136/oemed-2020-106439; Hansen MRH, 2020, THESIS, DOI [10.5281/zenodo.3775222, DOI 10.5281/ZENODO.3775222]	8	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242087	10.1371/journal.pone.0242087	http://dx.doi.org/10.1371/journal.pone.0242087			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201917	Green Published, gold			2022-12-26	WOS:000595003900043
J	Krewulak, KD; Rosgen, BK; Ely, EW; Stelfox, HT; Fiest, KM				Krewulak, Karla D.; Rosgen, Brianna K.; Ely, E. W.; Stelfox, Henry T.; Fiest, Kirsten M.			The CAM-ICU-7 and ICDSC as measures of delirium severity in critically ill adult patients	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; CONFUSION ASSESSMENT METHOD; MECHANICALLY VENTILATED PATIENTS; SUBSYNDROMAL DELIRIUM; SCREENING CHECKLIST; RISK-FACTORS; CAM-ICU; GUIDELINES; RELIABILITY; AGREEMENT	Background In clinical practice, a dichotomous approach to delirium identification may no longer be relevant when existing delirium screening tools measure a range of scores. The objective of this study was to compare the Confusion Assessment Method for the Intensive Care Unit 7-item (CAM-ICU-7) and the Intensive Care Delirium Screening Checklist (ICDSC) as measures of the spectrum of delirium severity in critically ill adult patients. Methods In this cross-sectional study, 218 patients underwent 641 paired assessments by bedside nurses (ICDSC, as per usual care) and trained research assistants (CAM-ICU-7). Correlation between the CAM-ICU-7 and ICDSC scores was evaluated. Logistic regression was used to explore associations between CAM-ICU-7 or ICDSC score and length of ICU stay and mechanical ventilation (receipt, >= 96 hours). Results Delirium prevalence evaluated by the CAM-ICU-7 and ICDSC were 46.3% (95% CI:39.7-53.0) and 34.4% (95% CI:28.3-41.0). Prevalence of less than clinical threshold symptoms of delirium evaluated by the CAM-ICU-7 (score: 1-2) and ICDSC (score: 1-3) were 30.3% (95%CI:24.5-36.7) and 50.9% (95%CI:44.3-57.6). The CAM-ICU-7 and ICDSC had significant positive correlation (0.58, p<0.001). Agreement between the tools as measures of delirium was moderate (kappa = 0.51) and as measures of less than clinical threshold symptoms of delirium was fair (kappa = 0.21). Less than clinical threshold symptoms of delirium identified by the ICDSC, not CAM-ICU-7, were associated with prolonged length of ICU stay (>= 7 days) in patients <65 years of age [Odds Ratio (OR) 9.2, 95% CI:2.5-34.0] and mechanical ventilation (receipt: OR 2.8, 95% CI:1.3-6.4; >= 96 hours: OR 6.6, 95% CI:1.9-22.9), when compared to patients with no delirium. Conclusions The CAM-ICU-7 and ICDSC are measures of the spectrum of delirium severity that are closely correlated. Less than clinical threshold symptoms of delirium measure by the ICDSC is a better predictor of outcomes, when compared with the CAM-ICU-7.	[Krewulak, Karla D.; Rosgen, Brianna K.; Stelfox, Henry T.; Fiest, Kirsten M.] Univ Calgary, Cumming Sch Med, Dept Crit Care Med, Calgary, AB, Canada; [Rosgen, Brianna K.; Stelfox, Henry T.; Fiest, Kirsten M.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Rosgen, Brianna K.; Stelfox, Henry T.; Fiest, Kirsten M.] Univ Calgary, Cumming Sch Med, OBrien Inst Publ Hlth, Calgary, AB, Canada; [Ely, E. W.] Vanderbilt Univ, Med Ctr, Tennessee Valley Vet Affairs Geriatr Res Educ Cli, Crit Illness Brain Dysfunct & Survivorship CIBS C, Nashville, TN USA; [Stelfox, Henry T.; Fiest, Kirsten M.] Alberta Hlth Serv, Dept Crit Care Med, Calgary, AB, Canada; [Fiest, Kirsten M.] Univ Calgary, Cumming Sch Med, Dept Psychiat, Calgary, AB, Canada; [Fiest, Kirsten M.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; Geriatric Research Education & Clinical Center; Vanderbilt University; Alberta Health Services (AHS); University of Calgary; University of Calgary; University of Calgary	Fiest, KM (corresponding author), Univ Calgary, Cumming Sch Med, Dept Crit Care Med, Calgary, AB, Canada.; Fiest, KM (corresponding author), Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, Calgary, AB, Canada.; Fiest, KM (corresponding author), Univ Calgary, Cumming Sch Med, OBrien Inst Publ Hlth, Calgary, AB, Canada.; Fiest, KM (corresponding author), Alberta Hlth Serv, Dept Crit Care Med, Calgary, AB, Canada.; Fiest, KM (corresponding author), Univ Calgary, Cumming Sch Med, Dept Psychiat, Calgary, AB, Canada.; Fiest, KM (corresponding author), Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Calgary, AB, Canada.	kmfiest@ucalgary.ca	Rosgen, Brianna/GYD-5108-2022	Krewulak, Karla/0000-0003-0300-4122	Medical Services Incorporated Foundation; Canadian Institutes of Health Research; Alberta Health Services; Canadian Frailty Network (Technology Evaluation in the Elderly Network) - Government of Canada through the Networks of Centres of Excellence program	Medical Services Incorporated Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Health Services; Canadian Frailty Network (Technology Evaluation in the Elderly Network) - Government of Canada through the Networks of Centres of Excellence program	This research was supported, in part, by grants from the Medical Services Incorporated Foundation, Canadian Institutes of Health Research, and Alberta Health Services (to Dr. Fiest). This research was funded by the Canadian Frailty Network (Technology Evaluation in the Elderly Network), which is supported by the Government of Canada through the Networks of Centres of Excellence program (to Dr. Fiest). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, CAR CAN ICUS; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Brummel NE, 2017, AM J CRIT CARE, V26, P447, DOI 10.4037/ajcc2017263; Brummel NE, 2014, CRIT CARE MED, V42, P369, DOI 10.1097/CCM.0b013e3182a645bd; Brundin-Mather R, 2018, J CRIT CARE, V47, P295, DOI 10.1016/j.jcrc.2018.07.021; Fagundes JAD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051010; Detroyer E, 2020, BMC NURS, V19, DOI 10.1186/s12912-020-00415-z; Devlin JW, 2018, CRIT CARE MED, V46, P1532, DOI [10.1097/CCM.0000000000003259, 10.1097/CCM.0000000000003299]; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Gignac GE, 2016, PERS INDIV DIFFER, V102, P74, DOI 10.1016/j.paid.2016.06.069; Gusmao-Flores D, 2012, CRIT CARE, V16, DOI 10.1186/cc11407; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; Jones RN, 2019, JAMA INTERN MED, V179, P231, DOI 10.1001/jamainternmed.2018.6975; Khan BA, 2017, CRIT CARE MED, V45, P851, DOI 10.1097/CCM.0000000000002368; Khan BA, 2016, CRIT CARE MED, V44, P1727, DOI 10.1097/CCM.0000000000001813; Krewulak Karla D, 2019, CMAJ Open, V7, pE294, DOI 10.9778/cmajo.20180123; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; MW P, 2001, NUCL ACIDS RES, V29, pe45; Ouimet S, 2007, INTENS CARE MED, V33, P1007, DOI 10.1007/s00134-007-0618-y; Pandharipande P, 2008, J TRAUMA, V65, P34, DOI 10.1097/TA.0b013e31814b2c4d; Plaschke K, 2008, INTENS CARE MED, V34, P431, DOI 10.1007/s00134-007-0920-8; Pulak LM, 2016, J INTENSIVE CARE MED, V31, P14, DOI 10.1177/0885066614538749; Rose L, 2017, RESP CARE, V62, P1324, DOI 10.4187/respcare.05485; Salluh J, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h3129, 10.1136/bmj.h2538]; Schulman-Green D, 2019, QUAL LIFE RES, V28, P2565, DOI 10.1007/s11136-019-02201-0; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; TEASDALE G, 1974, LANCET, V2, P81; Tomasi CD, 2012, J CRIT CARE, V27, P212, DOI 10.1016/j.jcrc.2011.05.015; van Eijk MMJ, 2009, CRIT CARE MED, V37, P1881, DOI 10.1097/CCM.0b013e3181a00118; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Yamada C, 2018, INTENS CRIT CARE NUR, V47, P15, DOI 10.1016/j.iccn.2018.02.010; Zaal IJ, 2015, CRIT CARE MED, V43, P40, DOI 10.1097/CCM.0000000000000625; Zilberberg MD, 2008, CRIT CARE MED, V36, P1451, DOI 10.1097/CCM.0b013e3181691a49	34	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242378	10.1371/journal.pone.0242378	http://dx.doi.org/10.1371/journal.pone.0242378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196655	Green Published, gold			2022-12-26	WOS:000595266800015
J	Shi, ZM; Zhang, JM; Wu, HJ; Yang, J; Hu, ML				Shi, Zimo; Zhang, Jianming; Wu, Haijun; Yang, Jing; Hu, Maolin			Taxonomic diversity pattern and composition of fish species in the upper reaches of Ganjiang River, Jiangxi, China	PLOS ONE			English	Article							WATER PROTECTED AREAS; DISTINCTNESS; BIODIVERSITY; ASSEMBLAGES; HABITAT; CONSERVATION; STREAM; INDEX	Maintaining fish diversity is essential for environmental protection. To characterize the fish composition of the tributaries and mainstream in the upper reaches of the Ganjiang River, we identified seventy-five species of 15 families in 14 sampling sites. These data were analyzed using the inclusion index at the taxonomic level (TINCLi), the importance value index (IVI), the taxonomic diversity indices (Delta(+) and ?(+)), cluster analysis and non-metric multidimensional scaling (nMDS). The results showed that the most common and dominant order was the Cypriniformes, represented most frequently by Hemiculter leucisculus among the sample sites. Most fishes were omnivorous, mountain stream or settled fish that lay sinking or viscid eggs. Most sites showed a trend of more discrete distribution from high latitude to low latitude. According to the taxonomic diversity indices, the fish taxonomic composition in the upper reaches of Ganjiang River is uneven. The Bray-Curtis resemblance matrix and nMDS showed that the habitats of the Ganjiang River were divided into four areas. The results will provide information needed for freshwater fish resource protection in the upper reaches of the Ganjiang River.	[Shi, Zimo; Yang, Jing; Hu, Maolin] Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China; [Zhang, Jianming] Ganzhou Fisheries Res Inst, Ganzhou, Jiangxi, Peoples R China; [Wu, Haijun] Pingxiang Municipal Fisheries, Pingxiang, Jiangxi, Peoples R China; [Hu, Maolin] Nanchang Univ, Minist Educ, Key Lab Poyang Lake Environm & Resource Utilizat, Nanchang, Jiangxi, Peoples R China; [Hu, Maolin] Nanchang Univ, Jiangxi Key Lab Aquat Anim Resource & Utilizat, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University	Hu, ML (corresponding author), Nanchang Univ, Sch Life Sci, Nanchang, Jiangxi, Peoples R China.; Hu, ML (corresponding author), Nanchang Univ, Minist Educ, Key Lab Poyang Lake Environm & Resource Utilizat, Nanchang, Jiangxi, Peoples R China.; Hu, ML (corresponding author), Nanchang Univ, Jiangxi Key Lab Aquat Anim Resource & Utilizat, Nanchang, Jiangxi, Peoples R China.	humaolin@ncu.edu.cn			National Natural Science Foundation of China [31360118, 32060271]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [31360118,32060271]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors alone are responsible for the content and writing of this article.	Abell R, 2007, BIOL CONSERV, V134, P48, DOI 10.1016/j.biocon.2006.08.017; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; [Anonymous], 2018, Obstet Gynecol, V131, pe49, DOI 10.1097/AOG.0000000000002501; [Anonymous], 2008, OPINION, V1, P22; [Anonymous], 2019, MOL MECH STUDY JIAWE, V15; Bevilacqua S, 2012, MAR POLLUT BULL, V64, P1409, DOI 10.1016/j.marpolbul.2012.04.016; Chen YY., 1998, FAUNA SINICA RGANIZA; Chu X.L., 1999, FAUNA SINICA OSTEICH, DOI DOI 10.1007/s11033-010-0107-1; Clarke K.R., 2014, CHANGE MARINE COMMUN, V3; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Clarke KR, 1998, J APPL ECOL, V35, P523, DOI 10.1046/j.1365-2664.1998.3540523.x; Craig CA, 2019, PEERJ, V6, DOI 10.7717/peerj.6144; de Carvalho WD, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0100; Golovanov V. K., 2013, J ICHTHYOLOGY, V53, P252; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Graham NAJ, 2007, ENVIRON BIOL FISH, V78, P57, DOI 10.1007/s10641-006-9077-5; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hu ML, 2015, ENVIRON BIOL FISH, V98, P1201, DOI 10.1007/s10641-014-0342-8; Keith P, 2000, BIOL CONSERV, V92, P265, DOI 10.1016/S0006-3207(99)00041-5; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Leonard DRP, 2006, J ENVIRON MANAGE, V78, P52, DOI 10.1016/j.jenvman.2005.04.008; Li C., 2018, THESIS; Li Chuanqiong, 2018, Hupo Kexue, V30, P139, DOI 10.18307/2018.0114; Li JP, 2013, ECOL INDIC, V34, P94, DOI 10.1016/j.ecolind.2013.04.016; [李娜娜 LI Nana], 2011, [水产学报, Journal of Fisheries of China], V35, P863; Liang Y, 2010, J MT SCI-ENGL, V7, P92, DOI 10.1007/s11629-010-1052-0; Liu B, 2009, JIANGXI SCI, V27, P662; Liu H, 1992, RESOURCES AQUATIC OR; Magoulick DD, 2004, HYDROBIOLOGIA, V527, P209, DOI 10.1023/B:HYDR.0000043302.32382.59; Mouillot D, 2005, HYDROBIOLOGIA, V550, P121, DOI 10.1007/s10750-005-4368-y; Moyle Peter B., 1992, P127; Oberdorff T, 1999, ECOL LETT, V2, P75, DOI 10.1046/j.1461-0248.1999.t01-2-22051.x; Perry D, 2018, CAN J FISH AQUAT SCI, V75, P1723, DOI 10.1139/cjfas-2017-0032; Postel S., 2012, NATURES SERVICES SOC; Qu FY, 2010, BIODIVERSITY SCI, V18, P155; Russell GL, 1995, ATMOS OCEAN, V33, P683, DOI 10.1080/07055900.1995.9649550; Saunders DL, 2002, CONSERV BIOL, V16, P30, DOI 10.1046/j.1523-1739.2002.99562.x; Shan XJ, 2010, ACTA OCEANOL SIN, V29, P70, DOI 10.1007/s13131-010-0024-0; [苏巍 Su Wei], 2013, [中国水产科学, Journal of Fishery Sciences of China], V20, P624; Suski CD, 2007, BIODIVERS CONSERV, V16, P2015, DOI 10.1007/s10531-006-9060-7; Tejerina-Garro FL, 2005, BRAZ ARCH BIOL TECHN, V48, P91, DOI 10.1590/S1516-89132005000100013; THOMAS CD, 1994, CONSERV BIOL, V8, P373, DOI 10.1046/j.1523-1739.1994.08020373.x; Tian JL, 1989, FRESHW FISH, V19, P33; Tian Z, 2016, RES SHANG YOU RIVER; Tu Fei-yun, 2016, Acta Agriculturae Universitatis Jiangxiensis, V38, P975; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Wang P, 2015, J JIANGXI NORMAL U N, P109; Warwick RM, 1995, MAR ECOL PROG SER, V129, P301, DOI 10.3354/meps129301; Whitfield AK, 2002, J FISH BIOL, V61, P229, DOI 10.1006/jfbi.2002.2079; Wu Z. Q., 2011, J HYDROECOLOGY, V32, P142; Xiong W, 2015, REV FISH BIOL FISHER, V25, P651, DOI 10.1007/s11160-015-9396-8; Yan YZ, 2011, ECOL FRESHW FISH, V20, P199, DOI 10.1111/j.1600-0633.2010.00478.x; Yi YJ, 2010, PROCEDIA ENVIRON SCI, V2, P1942, DOI 10.1016/j.proenv.2010.10.207; Yuan L, 2019, ENVIRON POLLUT, V255, DOI 10.1016/j.envpol.2019.113327; Yue P.Q, 2000, FAUNA SINICA OSTEICH; Zeng X., 1990, FISHERY RESOURCES YA; Zhang G, 2019, EUR J IMMUNOL, V49, P52; Zhang QT, 2020, J FISH BIOL, V97, P817, DOI 10.1111/jfb.14437; Zhao Y, 2015, CURRENT STATE FRESHW; Zhong YX, 2005, JIANGXI FISHERY SCI, V101, P15; Zhu R, 2010, THESIS; Zhu S.Q., 1995, SYNOPSIS FRESHWATER; Zou S. Z, 2011, THESIS	64	3	4	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0241762	10.1371/journal.pone.0241762	http://dx.doi.org/10.1371/journal.pone.0241762			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196644	Green Published, gold			2022-12-26	WOS:000595266800016
J	Tsai, TY; Hsu, PF; Lin, CC; Wang, YJ; Ding, YZ; Liou, TL; Wang, YW; Huang, SS; Chan, WL; Lin, SJ; Chen, JW; Leu, HB				Tsai, Tsung-Ying; Hsu, Pai-Feng; Lin, Chung-Chi; Wang, Yuan-Jen; Ding, Yaw-Zon; Liou, Teh-Ling; Wang, Ying-Wen; Huang, Shao-Sung; Chan, Wan-Leong; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang			Factor analysis for the clustering of cardiometabolic risk factors and sedentary behavior, a cross-sectional study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; DOSE-RESPONSE; POPULATION; TIME; ASSOCIATION; COMPONENTS	Background Few studies have reported on the clustering pattern of CVD risk factors, including sedentary behavior, systemic inflammation, and cadiometabolic components in the general population. Objective We aimed to explore the clustering pattern of CVD risk factors using exploratory factor analysis to investigate the underlying relationships between various CVD risk factors. Methods A total of 5606 subjects (3157 male, 51.5 +/- 11.7 y/o) were enrolled, and 14 cardiovascular risk factors were analyzed in an exploratory group (n = 3926) and a validation group (n = 1676), including sedentary behaviors. Results Five factor clusters were identified to explain 69.4% of the total variance, including adiposity (BMI, TG, HDL, UA, and HsCRP; 21.3%), lipids (total cholesterol and LDL-cholesterol; 14.0%), blood pressure (SBP and DBP; 13.3%), glucose (HbA1C, fasting glucose; 12.9%), and sedentary behavior (MET and sitting time; 8.0%). The inflammation biomarker HsCRP was clustered with only adiposity factors and not with other cardiometabolic risk factors, and the clustering pattern was verified in the validation group. Conclusion This study confirmed the clustering structure of cardiometabolic risk factors in the general population, including sedentary behavior. HsCRP was clustered with adiposity factors, while physical inactivity and sedentary behavior were clustered with each other.	[Tsai, Tsung-Ying; Hsu, Pai-Feng; Lin, Chung-Chi; Wang, Yuan-Jen; Ding, Yaw-Zon; Liou, Teh-Ling; Wang, Ying-Wen; Huang, Shao-Sung; Chan, Wan-Leong; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Hsu, Pai-Feng; Huang, Shao-Sung; Chan, Wan-Leong; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang] Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan; [Hsu, Pai-Feng] Natl Yang Ming Univ, Dept Publ Hlth, Taipei, Taiwan; [Hsu, Pai-Feng; Lin, Chung-Chi; Wang, Yuan-Jen; Ding, Yaw-Zon; Liou, Teh-Ling; Wang, Ying-Wen; Huang, Shao-Sung; Chan, Wan-Leong; Lin, Shing-Jong; Chen, Jaw-Wen; Leu, Hsin-Bang] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Lin, Shing-Jong; Leu, Hsin-Bang] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan; [Lin, Shing-Jong; Leu, Hsin-Bang] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan	Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Leu, HB (corresponding author), Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan.; Leu, HB (corresponding author), Taipei Vet Gen Hosp, Healthcare & Management Ctr, Taipei, Taiwan.; Leu, HB (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Leu, HB (corresponding author), Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan.; Leu, HB (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.	hsinbangleu@gmail.com		Hsu, Pai Feng/0000-0003-3234-7941	Research foundation of cardiovascular medicine	Research foundation of cardiovascular medicine	This study is funded by the Research foundation of cardiovascular medicine. The primary recipient of research fund is Dr. Hsin-Bang Leu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AHA NEWS; Boon RM, 2010, BRIT J SPORT MED, V44, P741, DOI 10.1136/bjsm.2008.052167; Brugnara L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160959; Chen SC, 2019, CLIN CHIM ACTA, V488, P1, DOI 10.1016/j.cca.2018.10.028; Chiang CH, 2010, CLIN BIOCHEM, V43, P1399, DOI 10.1016/j.clinbiochem.2010.09.003; Choi KM, 2003, DIABETIC MED, V20, P99, DOI 10.1046/j.1464-5491.2003.00890.x; Christian Allison H, 2009, J Cardiometab Syndr, V4, P12, DOI 10.1111/j.1559-4572.2008.00029.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Ekelund U, 2017, LANCET, V389, P801, DOI 10.1016/S0140-6736(17)30506-8; Esteghamati A, 2010, ENDOCRINE, V38, P206, DOI 10.1007/s12020-010-9374-9; Goodman E, 2005, CIRCULATION, V111, P1970, DOI 10.1161/01.CIR.0000161957.34198.2B; Guthold R, 2008, AM J PREV MED, V34, P486, DOI 10.1016/j.amepre.2008.02.013; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hravnak M, 2016, J CLIN MONIT COMPUT, V30, P875, DOI 10.1007/s10877-015-9788-2; Hwang AC, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003809; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Kelishadi R, 2007, ANN NUTR METAB, V51, P208, DOI 10.1159/000104139; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liou Yiing Mei, 2008, J Nurs Res, V16, P252; Mannuicci E, 2007, NUTR METAB CARDIOVAS, V17, P719, DOI 10.1016/j.numecd.2006.09.003; Maruhashi T, 2018, ATHEROSCLEROSIS, V278, P226, DOI 10.1016/j.atherosclerosis.2018.10.007; Matthews CE, 2019, J AM COLL CARDIOL, V73, P2073, DOI 10.1016/j.jacc.2019.02.030; Meigs JB, 2000, AM J EPIDEMIOL, V152, P908, DOI 10.1093/aje/152.10.908; Nasila Sungwacha John, 2013, BMC Res Notes, V6, P228, DOI 10.1186/1756-0500-6-228; Nicklas JM, 2013, OBESITY, V21, P681, DOI 10.1002/oby.20072; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Pandey A, 2016, JAMA CARDIOL, V1, P575, DOI 10.1001/jamacardio.2016.1567; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0295-3; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Schuna JM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-126; Silfee V, 2017, J HEALTH CARE POOR U, V28, P798, DOI 10.1353/hpu.2017.0075; Stamatakis E, 2019, J AM COLL CARDIOL, V73, P2062, DOI 10.1016/j.jacc.2019.02.031; Stoner L, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007071; The Abu Dhabi Declaration, 2010, J NATL COMPR CANC S3, V8, pS1; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Tsai CH, 2011, ENDOCRINE, V40, P256, DOI 10.1007/s12020-011-9466-1; World Health Organization, 2018, PREV INS PHYS ACT; Wu XF, 2017, INT J EPIDEMIOL, V46, P1744, DOI 10.1093/ije/dyw282; Yang HC, 2019, ACTA CARDIOL SIN, V35, P534, DOI 10.6515/ACS.201909_35(5).20190126A; Young DR, 2016, CIRCULATION, V134, pE262, DOI 10.1161/CIR.0000000000000440; 2002, MORB MORT WEEKLY REP, V51	49	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242365	10.1371/journal.pone.0242365	http://dx.doi.org/10.1371/journal.pone.0242365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196674	Green Published, gold			2022-12-26	WOS:000595266800038
J	Tsumura, T; Kuroda, S; Nishizaki, M; Kikuchi, S; Kakiuchi, Y; Takata, N; Ito, A; Watanabe, M; Kuwada, K; Kagawa, S; Fujiwara, T				Tsumura, Tomoko; Kuroda, Shinji; Nishizaki, Masahiko; Kikuchi, Satoru; Kakiuchi, Yoshihiko; Takata, Nobuo; Ito, Atene; Watanabe, Megumi; Kuwada, Kazuya; Kagawa, Shunsuke; Fujiwara, Toshiyoshi			Short-term and long-term comparisons of laparoscopy-assisted proximal gastrectomy with esophagogastrostomy by the double-flap technique and laparoscopy-assisted total gastrectomy for proximal gastric cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; UPPER 3RD; OUTCOMES	Background Although proximal gastrectomy (PG) is a recognized surgical procedure for early proximal gastric cancer, total gastrectomy (TG) is sometimes selected due to concern about severe gastroesophageal reflux. Esophagogastrostomy by the double-flap technique (DFT) is an anti-reflux reconstruction after PG, and its short-term effectiveness has been reported. However, little is known about the long-term effects on nutritional status and quality of life (QOL). Methods Gastric cancer patients who underwent laparoscopy-assisted PG (LAPG) with DFT or laparoscopy-assisted TG (LATG) between April 2011 and March 2014 were retrospectively analyzed. Body weight (BW), body mass index (BMI), and prognostic nutritional index (PNI) were reviewed to assess nutritional status, and the Postgastrectomy Syndrome Assessment Scale (PGSAS)-45 was used to assess QOL. Results A total of 36 patients (LATG: 17, LAPG: 19) were enrolled. Four of 17 LATG patients (24%) were diagnosed with Stage >= II after surgery, and half received S-1 adjuvant chemotherapy. BW and PNI were better maintained in LAPG than in LATG patients until 1-year follow-up. Seven of 16 LATG patients (44%) were categorized as "underweight (BMI<18.5 kg/m(2))" at 1-year follow-up, compared to three of 18 LAPG patients (17%; p = 0.0836). The PGSAS-45 showed no significant difference in all QOL categories except for decreased BW (p = 0.0132). Multivariate analysis showed that LATG was the only potential risk factor for severe BW loss (odds ratio: 3.03, p = 0.0722). Conclusions LAPG with DFT was superior to LATG in postoperative nutritional maintenance, and can be the first option for early proximal gastric cancer.	[Tsumura, Tomoko; Kuroda, Shinji; Nishizaki, Masahiko; Kikuchi, Satoru; Kakiuchi, Yoshihiko; Takata, Nobuo; Ito, Atene; Watanabe, Megumi; Kuwada, Kazuya; Kagawa, Shunsuke; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama, Japan; [Kuroda, Shinji] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan; [Kikuchi, Satoru; Kagawa, Shunsuke] Okayama Univ Hosp, Minimally Invas Therapy Ctr, Okayama, Japan; [Ito, Atene] Tsuyama Chuo Hosp, Dept Surg, Tsuyama, Japan; [Watanabe, Megumi] Iwakuni Clin Ctr, Dept Surg, Iwakuni, Japan; [Kuwada, Kazuya] Japanese Red Cross Okayama Hosp, Dept Surg Gastroenterol, Okayama, Japan	Okayama University; Okayama University; Okayama University	Kuroda, S (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg Gastroenterol, Okayama, Japan.; Kuroda, S (corresponding author), Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan.	shinkuro@okayama-u.ac.jp	Kagawa, Shunsuke/B-2189-2011	Kuroda, Shinji/0000-0002-4484-1253				Hayami M, 2017, ANN SURG ONCOL, V24, P1635, DOI 10.1245/s10434-017-5782-x; Ichikawa D, 2014, GASTRIC CANCER, V17, P141, DOI 10.1007/s10120-013-0257-7; Isozaki H, 2016, ACTA MED OKAYAMA, V70, P119; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jung DH, 2015, J GASTRIC CANCER, V15, P77, DOI 10.5230/jgc.2015.15.2.77; Kosuga T, 2015, ANN SURG ONCOL, V22, pS929, DOI 10.1245/s10434-015-4590-4; Kuroda S, 2019, ANN GASTROENT SURG, V3, P96, DOI 10.1002/ags3.12216; Kuroda S, 2016, J AM COLL SURGEONS, V223, pE7, DOI 10.1016/j.jamcollsurg.2016.04.041; Lee JH, 2018, GASTRIC CANCER, V21, P913, DOI 10.1007/s10120-018-0818-x; Lundell LR, 1999, GUT, V45, P172, DOI 10.1136/gut.45.2.172; Matsuhashi N, 2015, J GASTROENTEROL, V50, P1173, DOI 10.1007/s00535-015-1073-0; Muraoka A, 2016, WORLD J SURG, V40, P2419, DOI 10.1007/s00268-016-3510-5; Nakada K, 2015, GASTRIC CANCER, V18, P147, DOI 10.1007/s10120-014-0344-4; Nakamura M, 2014, SURGERY, V156, P57, DOI 10.1016/j.surg.2014.02.015; Sugiyama M, 2018, WORLD J SURG, V42, P3270, DOI 10.1007/s00268-018-4625-7; Takiguchi N, 2015, GASTRIC CANCER, V18, P407, DOI 10.1007/s10120-014-0377-8; Ueda Y, 2017, SURG TODAY, V47, P538, DOI 10.1007/s00595-016-1401-x	18	6	9	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242223	10.1371/journal.pone.0242223	http://dx.doi.org/10.1371/journal.pone.0242223			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180871	Green Published, gold			2022-12-26	WOS:000593948000022
J	Jeng, B; Cederberg, KLJ; Lai, B; Sasaki, JE; Bamman, MM; Motl, RW				Jeng, Brenda; Cederberg, Katie L. J.; Lai, Byron; Sasaki, Jeffer E.; Bamman, Marcas M.; Motl, Robert W.			Accelerometer output and its association with energy expenditure in persons with mild-to-moderate Parkinson's disease	PLOS ONE			English	Article							PHYSICAL-ACTIVITY BEHAVIOR; NEUROLOGIC DISORDERS; MULTIPLE-SCLEROSIS; ADULTS; CALIBRATION; REVISION; EXERCISE; QUALITY; WALKING; PEOPLE	Objective This study examined the association between ActiGraph accelerometer output and energy expenditure across different speeds of walking in persons with Parkinson's disease (PD), and further generated cut-points that represent a metric for quantifying time spent in moderate-to-vigorous physical activity (MVPA) among persons with PD. Methods The sample included 30 persons with mild-to-moderate PD (Hoehn and Yahr stages 2-3) and 30 adults without PD matched by sex and age. All participants completed 5 minutes of quiet, seated rest and then underwent three, 6-minute bouts of walking on a treadmill at three different speeds relative to the individual's self-selected pace. Activity counts were measured using an ActiGraph accelerometer worn at the waist level on the least affected side for persons with PD and the dominant side for controls. The rate of oxygen consumption, or energy expenditure, was measured using a portable, open-circuit spirometry system. Results Our results indicated a strong association between activity counts and energy expenditure for persons with PD (R-2 = 0.87) and controls (R-2 = 0.89). However, the significant difference in slopes resulted in a lower cut-point of 1,354 counts center dot min(-1) for persons with PD than the cut-point of 2,010 counts center dot min(-1) for controls. Conclusion Our results support the application of the disease-specific cut-point for quantifying the amount of time spent in MVPA using ActiGraph accelerometers among persons with mild-to-moderate PD. Such an application may provide accurate estimates of MVPA in this population, and better inform future research examining the possible determinants and consequences of physical activity as well as testing of interventions for changing MVPA in PD.	[Jeng, Brenda; Cederberg, Katie L. J.; Lai, Byron; Motl, Robert W.] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL 35294 USA; [Sasaki, Jeffer E.] Univ Fed Triangulo Mineiro, Grad Program Phys Educ, Uberaba, MG, Brazil; [Bamman, Marcas M.; Motl, Robert W.] Univ Alabama Birmingham, Ctr Exercise Med, Birmingham, AL USA; [Bamman, Marcas M.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Bamman, Marcas M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Bamman, Marcas M.] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA; [Bamman, Marcas M.] Birmingham VA Med Ctr, Geriatr Res Educ & Clin Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; Universidade Federal do Triangulo Mineiro; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Jeng, B (corresponding author), Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL 35294 USA.	bjeng@uab.edu		Jeng, Brenda/0000-0002-4522-1523	National Institutes of Health (NIH) National Rehabilitation Research Resource to Enhance Clinical Trials (REACT) [NIH P2CHD086851]; National Multiple Sclerosis Society [MB 0011]; NIH National Heart, Lung, and Blood Institute [NIH T32HL105349]	National Institutes of Health (NIH) National Rehabilitation Research Resource to Enhance Clinical Trials (REACT)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	MM was supported by the National Institutes of Health (NIH) National Rehabilitation Research Resource to Enhance Clinical Trials (REACT, NIH P2CHD086851). https://www.nih.gov/JES was supported by a mentor-based post-doctoral fellowship from the National Multiple Sclerosis Society (MB 0011). https://www.nationalmssociety.org/BJ was supported by the NIH National Heart, Lung, and Blood Institute (NIH T32HL105349). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. https://www.nih.gov/The funders did not play a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adamson BC, 2015, ARCH PHYS MED REHAB, V96, P1329, DOI 10.1016/j.apmr.2015.01.005; American College of Sports Medicine, 2021, ACSMS GUIDELINES EXE; [Anonymous], 2009, OFF J EUR COMMUN L, VL39, P3; Arikan OA, 2016, WASTE MANAGE, V54, P110, DOI 10.1016/j.wasman.2016.04.032; Barnett A, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0380-5; Christiansen CL, 2009, MOVEMENT DISORD, V24, P1481, DOI 10.1002/mds.22621; Cohen J.E., 1988, STAT POWER ANAL BEHA; Del Din S, 2016, MOVEMENT DISORD, V31, P1293, DOI 10.1002/mds.26718; Ellis T, 2013, J NEUROL PHYS THER, V37, P85, DOI 10.1097/NPT.0b013e31829157c0; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Healy GN, 2011, AM J PREV MED, V41, P216, DOI 10.1016/j.amepre.2011.05.005; Lamont RM, 2018, GAIT POSTURE, V63, P104, DOI 10.1016/j.gaitpost.2018.04.034; Marras C, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0058-0; Mehrholz J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007830.pub3; Motl RW, 2012, EXPERT REV NEUROTHER, V12, P1079, DOI [10.1586/ern.12.74, 10.1586/ERN.12.74]; Motl RW, 2009, ARCH PHYS MED REHAB, V90, P1778, DOI 10.1016/j.apmr.2009.03.020; Nero H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135899; Plow MA, 2009, DISABIL REHABIL, V31, P1652, DOI 10.1080/09638280902738375; Pradhan S, 2019, PARKINSONISM RELAT D, V66, P171, DOI 10.1016/j.parkreldis.2019.08.001; Rahman S, 2008, MOVEMENT DISORD, V23, P1428, DOI 10.1002/mds.21667; Sandroff BM, 2014, J NEUROL SCI, V340, P50, DOI 10.1016/j.jns.2014.02.024; Sandroff BM, 2012, J REHABIL RES DEV, V49, P467, DOI 10.1682/JRRD.2011.03.0063; Sasaki JE, 2017, EXPERT REV MED DEVIC, V14, P891, DOI 10.1080/17434440.2017.1386550; Shulman LM, 2008, MOVEMENT DISORD, V23, P790, DOI 10.1002/mds.21879; Speelman AD, 2011, NAT REV NEUROL, V7, P528, DOI 10.1038/nrneurol.2011.107; Suteerawattananon M., 2000, Physiotherapy Theory and Practice, V16, P211, DOI 10.1080/095939800458668; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Trinh L, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.13090; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; van Nimwegen M, 2011, J NEUROL, V258, P2214, DOI 10.1007/s00415-011-6097-7; Wendel N, 2018, PHYS THER, V98, P705, DOI 10.1093/ptj/pzy054	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242136	10.1371/journal.pone.0242136	http://dx.doi.org/10.1371/journal.pone.0242136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175904	gold, Green Published			2022-12-26	WOS:000593946900009
J	Nyamukanza, CC; Sebata, A				Nyamukanza, Casper C.; Sebata, Allan			Effect of leaf type on browse selection by free-ranging goats in a southern African savanna	PLOS ONE			English	Article							DIET SELECTION; SEMIARID SAVANNA; SMALL RUMINANTS; INTAKE RATES; NGUNI GOATS; BEHAVIOR; DESERT; SEASON; FIBER; DIGESTIBILITY	Broad- and fine-leaved woody species respond to seasonal changes from wet to dry season differently. For example, broad-leaved species shed their leaves earlier, while fine-leaved species, especially acacias retain green foliage well into the dry season. These differences are expected to result in variation in selection of broad- and fine-leaved woody species as browse by free-ranging goats. We tested the hypothesis that free-ranging goats select broad-leaved woody species more than fine-leaved species during wet (growth) season and fine-leaved woody species more than broad-leaved species during dry season. In addition, we tested if broad- and fine-leaved woody species had different foliar dry matter digestibility and chemical composition (crude protein, neutral detergent fibre, acid detergent fibre, total phenolics and condensed tannins concentration). Free-ranging goats were observed foraging on broad- and fine-leaved woody species over a two-year period (2014 and 2015) during three seasons: early wet (October/November), late wet (February/March) and dry (May/June). Ivlev's selectivity or Jacob's index (E-i) was calculated for five woody species (two broad-leaved and three fine-leaved) browsed by goats during wet and dry season. Jacob's selectivity index was higher for broad-leaved (Ziziphus mucronata and Searsia (Rhus) tenuinervis) than fine-leaved woody species (Acacia nilotica, Acacia karroo and Dichrostachys cinerea) during wet season. However, the trend was reversed during dry season with fine-leaved species having higher Jacob's selectivity index than broad-leaved species. Leaf dry matter digestibility and chemical composition was similar between broad- and fine-leaved woody species throughout the year. We conclude that goats selected broad-leaved woody species during wet season when browse was plentiful and then switched to fine-leaved species which retained leaves during dry season.	[Nyamukanza, Casper C.] Midlands State Univ, Dept Anim & Wildlife Sci, Gweru, Zimbabwe; [Sebata, Allan] Natl Univ Sci & Technol, Dept Forest Resources & Wildlife Management, Bulawayo, Zimbabwe	National University of Science & Technology - Zimbabwe	Nyamukanza, CC (corresponding author), Midlands State Univ, Dept Anim & Wildlife Sci, Gweru, Zimbabwe.	nyamukanzacc@staff.msu.ac.zw		Nyamukanza, Casper/0000-0002-4411-3731				Agreil C, 2004, SMALL RUMINANT RES, V54, P99, DOI 10.1016/j.smallrumres.2003.10.013; AOAC, 2012, OFFICIAL METHODS ANA; Bakare AG, 2011, LIVEST SCI, V135, P251, DOI 10.1016/j.livsci.2010.07.010; Basha NAD, 2012, SMALL RUMINANT RES, V102, P163, DOI 10.1016/j.smallrumres.2011.08.002; Basha NAD, 2009, S AFR J ANIM SCI, V39, P33; Baumont R, 2000, LIVEST PROD SCI, V64, P15, DOI 10.1016/S0301-6226(00)00172-X; Ben Salem H, 2008, SMALL RUMINANT RES, V77, P174, DOI 10.1016/j.smallrumres.2008.03.008; Casler MD, 2006, ANIM FEED SCI TECH, V125, P151, DOI 10.1016/j.anifeedsci.2005.05.015; Coates-Palgrave K., 2002, TREES SO AFRICA; COOPER SM, 1988, OECOLOGIA, V75, P336, DOI 10.1007/BF00376934; Copani G, 2013, OECOLOGIA, V172, P1041, DOI 10.1007/s00442-012-2551-1; Crowell MM, 2018, J MAMMAL, V99, P565, DOI 10.1093/jmammal/gyy018; Degen AA, 2010, LIVEST SCI, V132, P19, DOI 10.1016/j.livsci.2010.04.016; Dziba LE, 2003, SMALL RUMINANT RES, V47, P17, DOI 10.1016/S0921-4488(02)00235-3; Egea AV, 2014, SMALL RUMINANT RES, V120, P90, DOI 10.1016/j.smallrumres.2014.04.005; FEDELE V, 1993, SMALL RUMINANT RES, V11, P305, DOI 10.1016/0921-4488(93)90002-Y; Fomum SW, 2015, AFR J RANGE FOR SCI, V32, P193, DOI 10.2989/10220119.2014.951072; GOURLAY ID, 1995, J TROP ECOL, V11, P121, DOI 10.1017/S0266467400008488; Iason GR, 1996, PHYSIOL ZOOL, V69, P532, DOI 10.1086/physzool.69.3.30164214; IBM SPSS, 2011, IBM SPSS STAT VERS 2; JACOBS J, 1974, OECOLOGIA, V14, P413, DOI 10.1007/BF00384581; Jansen DAWAM, 2007, SMALL RUMINANT RES, V73, P160, DOI 10.1016/j.smallrumres.2007.01.012; Kababya D, 1998, J AGR SCI-CAMBRIDGE, V131, P221, DOI 10.1017/S0021859698005577; Lovari S, 2007, ITAL J ZOOL, V74, P179, DOI 10.1080/11250000701249777; Lu C. D., 1988, Small Ruminant Research, V1, P205, DOI 10.1016/0921-4488(88)90049-1; Makkar H.P.S., 1996, QUANTIFICATION TANNI, V2 nd; Manousidis T, 2018, LIVEST SCI, V218, P8, DOI 10.1016/j.livsci.2018.10.002; Martz F, 2010, J CHEM ECOL, V36, P1017, DOI 10.1007/s10886-010-9836-9; Mellado M, 2016, RANGELAND J, V38, P331, DOI 10.1071/RJ16002; Min BR, 2003, ANIM FEED SCI TECH, V106, P3, DOI 10.1016/S0377-8401(03)00041-5; Mkhize NR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189626; Mkhize NR, 2014, AFR J RANGE FOR SCI, V31, P209, DOI 10.2989/10220119.2014.901417; Moore KJ, 2001, J RANGE MANAGE, V54, P420, DOI 10.2307/4003113; Mphinyane W. N., 2015, African Journal of Agricultural Research, V10, P2791; National Research Council, 2007, NUTR REQ SMALL RUM S, DOI [10.17226/11654, DOI 10.17226/11654]; NYAMANGARA ME, 1995, J AGR SCI, V124, P455, DOI 10.1017/S002185960007341X; Oddy V.H., 1983, FEED INFORM ANIMAL P, P395; OWENSMITH N, 1982, AM NAT, V119, P151, DOI 10.1086/283902; OWENSMITH N, 1989, J ZOOL, V219, P29, DOI 10.1111/j.1469-7998.1989.tb02563.x; Piluzza G, 2014, GRASS FORAGE SCI, V69, P32, DOI 10.1111/gfs.12053; Raats J. G., 1997, AFR J SCI, V18, P34; Schroeder A, 2019, SMALL RUMINANT RES, V176, P17, DOI 10.1016/j.smallrumres.2019.05.007; Sebata A, 2012, LIVEST SCI, V144, P96, DOI 10.1016/j.livsci.2011.11.001; Sebata A, 2011, ANIM FEED SCI TECH, V170, P122, DOI 10.1016/j.anifeedsci.2011.07.013; Sebata A, 2010, J ARID ENVIRON, V74, P1281, DOI 10.1016/j.jaridenv.2010.05.028; Shackleton CM, 2005, LAND DEGRAD DEV, V16, P273, DOI 10.1002/ldr.652; Silanikove N, 2000, LIVEST PROD SCI, V67, P1, DOI 10.1016/S0301-6226(00)00162-7; Skarpe C, 2007, J ARID ENVIRON, V68, P480, DOI 10.1016/j.jaridenv.2006.06.009; van Wyk AE, 2001, FIELD GUIDE TREES SO; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Ventura-Cordero J, 2018, ANIM PROD SCI, V58, P2314, DOI 10.1071/AN16388	51	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242231	10.1371/journal.pone.0242231	http://dx.doi.org/10.1371/journal.pone.0242231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175912	Green Published, gold			2022-12-26	WOS:000593946900039
J	Frerichs, L; Smith, N; Kuhlberg, JA; Mason, G; Jackson-Diop, D; Stith, D; Corbie-Smith, G; Lich, KH				Frerichs, Leah; Smith, Natalie; Kuhlberg, Jill A.; Mason, Gretchen; Jackson-Diop, Damie; Stith, Doris; Corbie-Smith, Giselle; Lich, Kristen Hassmiller			Novel participatory methods for co-building an agent-based model of physical activity with youth	PLOS ONE			English	Article							SYSTEM DYNAMICS; SCIENCE; SCRIPTS	Public health scholarship has increasingly called for the use of system science approaches to understand complex problems, including the use of participatory engagement to inform the modeling process. Some system science traditions, specifically system dynamics modeling, have an established participatory practice tradition. Yet, there remains limited guidance on engagement strategies using other modeling approaches like agent-based models. Our objective is to describe how we engaged adolescent youth in co-building an agent-based model about physical activity. Specifically, we aim to describe how we communicated technical aspects of agent-based models, the participatory activities we developed, and the resulting visual diagrams that were produced. We implemented six sessions with nine adolescent participants. To make technical aspects more accessible, we used an analogy that linked core components of agent-based models to elements of storytelling. We also implemented novel, facilitated activities that engaged youth in the development, annotation, and review of graphs over time, geographical maps, and state charts. The process was well-received by the participants and helped inform the basic structure of an agent-based model. The resulting visual diagrams created space for deeper discussion among participants about patterns of daily activity, important places for physical activity, and interactions between social and built environments. This work lays a foundation to develop and refine engagement strategies, especially for translating qualitative insights into quantitative model specifications such as 'decision rules'.	[Frerichs, Leah; Smith, Natalie; Kuhlberg, Jill A.; Mason, Gretchen; Lich, Kristen Hassmiller] Univ N Carolina, Dept Hlth Policy & Management, Gillings Sch Publ Hlth, Chapel Hill, NC 27515 USA; [Frerichs, Leah; Corbie-Smith, Giselle] Univ N Carolina, Dept Social Med, Ctr Hlth Equ Res, Chapel Hill, NC 27515 USA; [Smith, Natalie] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27515 USA; [Kuhlberg, Jill A.] Syst Stars LLC, Mason, OH USA; [Stith, Doris] Community Enrichment Org, Tarboro, NC USA; [Corbie-Smith, Giselle] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27515 USA; [Corbie-Smith, Giselle] Univ N Carolina, Dept Social Med & Med, Sch Med, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Frerichs, L (corresponding author), Univ N Carolina, Dept Hlth Policy & Management, Gillings Sch Publ Hlth, Chapel Hill, NC 27515 USA.; Frerichs, L (corresponding author), Univ N Carolina, Dept Social Med, Ctr Hlth Equ Res, Chapel Hill, NC 27515 USA.	leahf@unc.edu		Frerichs, Leah/0000-0002-2507-3789	National Heart Lung and Blood Institute [5K01HL138159]; National Institutes of Health [R01AG047869, K24HL105493]; Carolina Population Center [T32 HD091058, P2C HD050924]	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carolina Population Center	This project was supported by the National Heart Lung and Blood Institute (Grant Number 5K01HL138159; PI Frerichs). It was also supported in part by the National Institutes of Health under award numbers R01AG047869 and K24HL105493. NRS is grateful to the Carolina Population Center for training support (T32 HD091058) and for general support (P2C HD050924). JK and DJD are with System Stars, LLC and an Independent Consultant, respectively. No funding bodies had a role in the design, collection, analysis, interpretation, nor writing of the study. Its contents are the authors' sole responsibility and do not necessarily represent official NIH views. The funders only provided support in the form of salaries for authors and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Andersen DF, 1997, SYST DYNAM REV, V13, P107, DOI 10.1002/(SICI)1099-1727(199722)13:2<107::AID-SDR120>3.3.CO;2-Z; Apostolopoulos Y, 2018, ADDICTION, V113, P363, DOI 10.1111/add.13953; Baker P, 2019, OBES REV, V20, P30, DOI 10.1111/obr.12871; Black LJ, 2012, SYST RES BEHAV SCI, V29, P194, DOI 10.1002/sres.2106; Bousquet F, 2005, COMPANION MODELING M; Bridgewater Khary, 2011, Prog Community Health Partnersh, V5, P67, DOI 10.1353/cpr.2011.0011; Bureau UC, 2019, QUICKFACTS; Calancie L, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170254; Campo PC, 2010, ENVIRON MODELL SOFTW, V25, P1302, DOI 10.1016/j.envsoft.2010.01.005; DeLong TJ, 2011, HARVARD BUSINESS REV; Dianati K, 2019, SCI TOTAL ENVIRON, V660, P1108, DOI 10.1016/j.scitotenv.2018.12.430; EudraLex-The Rules Governing Medicinal Products in the European Union, 2001, EUDRALEX RULES GOVER, V4; Freebairn L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218875; Frerichs L, 2018, HEALTH EDUC BEHAV, V45, P423, DOI 10.1177/1090198117726570; Frerichs L, 2016, PROG COMM HLTH PARTN, V10, P443, DOI 10.1353/cpr.2016.0051; Frerichs L, 2016, AM J PUBLIC HEALTH, V106, P215, DOI 10.2105/AJPH.2015.302944; Gerritsen S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221107; Gittelsohn J, 2015, CURR OBES REP, V4, P174, DOI 10.1007/s13679-015-0147-x; Homa L, 2015, ANN FAM MED, V13, P456, DOI 10.1370/afm.1841; Hovmand PS, 2012, SYST RES BEHAV SCI, V29, P179, DOI 10.1002/sres.2105; Hovmand PS, SCRIPTAPEDIA 4 0 620; Kiraly G, 2019, SYST RES BEHAV SCI, V36, P199, DOI 10.1002/sres.2580; Koh K, 2018, J URBAN HEALTH, V95, P278, DOI 10.1007/s11524-018-0230-1; Kumar P, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0356-2; Langellier BA, 2019, HEALTH PLACE, V60, DOI 10.1016/j.healthplace.2019.102215; Lich KH, 2013, PREV SCI, V14, P279, DOI 10.1007/s11121-012-0285-2; Powell-Wiley TM, 2017, OBESITY, V25, P2149, DOI 10.1002/oby.22040; RICHARDSON GP, 1995, SYST DYNAM REV, V11, P113, DOI 10.1002/sdr.4260110203; Rogers J., CHALLENGING PROCESS; Roux AVD, 2011, AM J PUBLIC HEALTH, V101, P1627, DOI 10.2105/AJPH.2011.300149; Strobel K., 2007, YOUTH ENGAGED LEADER; Trani JF, 2016, CONFL HEALTH, V10, DOI 10.1186/s13031-016-0089-2; van Voorn GAK, 2016, ENVIRON MODELL SOFTW, V83, P224, DOI 10.1016/j.envsoft.2016.06.003; Voinov A, 2010, ENVIRON MODELL SOFTW, V25, P1268, DOI 10.1016/j.envsoft.2010.03.007; Weeks MR, 2017, AM J COMMUN PSYCHOL, V60, P584, DOI 10.1002/ajcp.12204; Williams Faustine, 2018, J Health Dispar Res Pract, V11, P160	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241108	10.1371/journal.pone.0241108	http://dx.doi.org/10.1371/journal.pone.0241108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7KH	33170862	Green Published, gold			2022-12-26	WOS:000592383400068
J	Sohail; Kamran, K; Kemmerling, B; Shutaywi, M; Mashwani, ZUR				Sohail; Kamran, Khalid; Kemmerling, Birgit; Shutaywi, Meshal; Mashwani, Zia ur Rehman			Nano zinc elicited biochemical characterization, nutritional assessment, antioxidant enzymes and fatty acid profiling of rapeseed	PLOS ONE			English	Article							OXIDE NANOPARTICLES; OXIDATIVE STRESS; PLANT-GROWTH; PROLINE; DIOXIDE; EXTRACT; TOMATO; IMPACT; SILVER	The use of nanomaterials in agriculture is a current need and could be helpful in overcoming food security risks. Brassica napus L. is the third most important crop for edible oil, having double low unsaturated fatty acids. In the present study, we investigated the effects of green synthesized Zn NPs on biochemical effects, antioxidant enzymes, nutritional quality parameters and on the fatty acid profile of rapeseed (B. napus). Plant-mediated synthesis of zinc nanoparticles (Zn NPs) was carried out using Mentha arvensis L. leaf extract followed by characterization through ultraviolet-visible spectroscopy (UV-vis), scanning electron microscopy (SEM), transmission electron microscopy (TEM), energy dispersive X-Ray (EDX), and X-Ray diffraction (XRD). NPs exhibited irregular shapes ranging in size from 30-70 nm and EDX analysis confirmed 96.08% of Zn in the sample. The investigated biochemical characterization (protein content, proline content, total soluble sugar (TSS), total flavonoid content (TFC), and total phenolic content (TPC) showed a substantial change on exposure to Zn NPs. A dose-dependent gradual increase was observed in the antioxidant enzymes, superoxide dismutase (SOD), peroxidase (POD), and catalase (CAT). Oil and moisture contents dropped significantly from the control level in the rapeseed (B. napus) varieties. However, different trends in nutritional (Zn, Na+, K+) and fatty acid profiling of B. napus have been noted. This study demonstrates that Zn NPs have the potential to improve the biochemical, nutritional, antioxidant enzymes, and fatty acid profile of B. napus varieties.	[Sohail; Kamran, Khalid; Mashwani, Zia ur Rehman] PMAS Arid Agr Univ, Dept Bot, Rawalpindi, Pakistan; [Sohail; Kemmerling, Birgit] Univ Tubingen, ZMBP Dept Plant Biochem, Tubingen, Germany; [Sohail] Univ Lakki Marwat, Dept Biol Sci, Lakki Marwat, Pakistan; [Shutaywi, Meshal] King Abdulaziz Univ, Coll Sci & Arts, Dept Math, Rabigh, Saudi Arabia	Arid Agriculture University; Eberhard Karls University of Tubingen; King Abdulaziz University	Sohail; Mashwani, ZUR (corresponding author), PMAS Arid Agr Univ, Dept Bot, Rawalpindi, Pakistan.; Sohail (corresponding author), Univ Tubingen, ZMBP Dept Plant Biochem, Tubingen, Germany.; Sohail (corresponding author), Univ Lakki Marwat, Dept Biol Sci, Lakki Marwat, Pakistan.	Sohail.botanist@hotmail.com; zia.botany@gmail.com	Mashwani, Zia-ur-Rehman/N-4498-2015; Shutaywi, Meshal/AAI-3146-2020	Mashwani, Zia-ur-Rehman/0000-0003-4222-7708; Shutaywi, Meshal/0000-0003-1454-2962				AEBI H, 1984, METHOD ENZYMOL, V105, P121; ALLEN S E, 1986, P285; Aminuzzaman M, 2018, B MATER SCI, V41, DOI 10.1007/s12034-018-1568-4; [Anonymous], 2019, A KLEC C, V13, P46; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Balafrej H, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9050562; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Brenna OV, 2004, J AGR FOOD CHEM, V52, P5577, DOI 10.1021/jf0495082; Campbell L, 2015, WORKSH P IRC, DOI [10.3390/plants5020017, DOI 10.3390/PLANTS5020017]; Canola Council of Canada, 2013, CANOLA GROWERS MANUA; Castro MJL, 2013, ENV CHEM SUSTAIN WOR, V3, P287, DOI 10.1007/978-94-007-6836-9_7; Chapman H, 1966, MALEMBO OYERA; Corredor E, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-45; Damodaran S, 2016, U.S. Patent, Patent No. [9,353,300, 9353300]; Daphedar A, 2018, CARYOLOGIA, V71, P93, DOI 10.1080/00087114.2018.1437980; de la Rosa G, 2013, PURE APPL CHEM, V85, P2161, DOI [10.1351/PAC-CON-12-09-05, 10.1351/PAC-CON-12-09-0]; Dobrucka R, 2016, SAUDI J BIOL SCI, V23, P517, DOI 10.1016/j.sjbs.2015.05.016; Drazkiewicz M, 2004, BIOMETALS, V17, P379, DOI 10.1023/B:BIOM.0000029417.18154.22; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; ELLIS RH, 1988, ANN BOT-LONDON, V61, P405, DOI 10.1093/oxfordjournals.aob.a087571; Faber J, 2002, ACTA CRYSTALLOGR B, V58, P325, DOI 10.1107/S0108768102003312; Foong SY, 2020, J HAZARD MATER, V400, DOI 10.1016/j.jhazmat.2020.123006; Fu L, 2011, FOOD CHEM, V129, P345, DOI 10.1016/j.foodchem.2011.04.079; Fu L, 2020, J EXP BOT, V71, P507, DOI 10.1093/jxb/erz314; Gardea-Torresdey JL, 2014, ENVIRON SCI TECHNOL, V48, P2526, DOI 10.1021/es4050665; Ghassemi-Golezani K, 2018, RUSS J PLANT PHYSL+, V65, P229, DOI 10.1134/S1021443718020115; Hamilton PB, 1943, J BIOL CHEM, V150, P231; Heimler D, 2006, FOOD CHEM, V99, P464, DOI 10.1016/j.foodchem.2005.07.057; Hu J, 2012, ENVIRON POLLUT, V162, P216, DOI 10.1016/j.envpol.2011.11.016; Ishwarya R, 2018, J PHOTOCH PHOTOBIO B, V178, P249, DOI 10.1016/j.jphotobiol.2017.11.006; Jamdagni P, 2018, J KING SAUD UNIV SCI, V30, P168, DOI 10.1016/j.jksus.2016.10.002; Kumar U.J., 2017, INT J CURRENT MICROB, V6, P2440, DOI DOI 10.20546/IJCMAS.2017.608.288; Laware S. L., 2014, International Journal of Current Microbiology and Applied Sciences, V3, P874; Lee YC, 2020, INTRO BIONANOTECHNOL, P199, DOI [10.1007/978-981-15-1293-3_11, DOI 10.1007/978-981-15-1293-3_11]; Liu RF, 2014, SCI REP-UK, V4, DOI [10.1038/srep04068, 10.1038/srep05686]; Maity Aniruddha, 2018, Proceedings of the Indian National Science Academy Part B Biological Sciences, V88, P595, DOI 10.1007/s40011-016-0796-x; MARSCHNER H, 1993, DEV PLANT SOIL SCI, V55, P59; Mashwani ZUR, 2016, ADV COLLOID INTERFAC, V234, P132, DOI 10.1016/j.cis.2016.04.008; Mathialagan V, 2020, RES J PHARM TECHNOLO, V13, P2007, DOI [10.5958/0974-360X.2020.00361.3, DOI 10.5958/0974-360X.2020.00361.3]; Meena D.S., 2017, INT J PLANT SOIL SCI, V16, P1, DOI DOI 10.9734/IJPSS/2017/33687; Mehta SK, 1999, NEW PHYTOL, V143, P253, DOI 10.1046/j.1469-8137.1999.00447.x; Mittal AK, 2014, J COLLOID INTERF SCI, V431, P194, DOI 10.1016/j.jcis.2014.06.030; Priester JH, 2012, P NATL ACAD SCI USA, V109, pE2451, DOI 10.1073/pnas.1205431109; Raghav S, 2020, HDB NANOMATERIALS MA, V1, P465, DOI DOI 10.1016/B978-0-12-821381-0.00019-3; Rajakumar G, 2018, BIOPROC BIOSYST ENG, V41, P21, DOI 10.1007/s00449-017-1840-9; Raliya R, 2015, METALLOMICS, V7, P1584, DOI [10.1039/c5mt00168d, 10.1039/C5MT00168D]; Raliya R, 2013, AGR RES, V2, P48, DOI 10.1007/s40003-012-0049-z; Remedios C, 2012, J BOT, DOI [10.1139/b2012-056, DOI 10.1139/B2012-056]; Rizwan M, 2019, CHEMOSPHERE, V214, P269, DOI 10.1016/j.chemosphere.2018.09.120; Roohani N, 2013, J RES MED SCI, V18, P144; Rui MM, 2018, ENVIRON SCI-NANO, V5, P2088, DOI 10.1039/c8en00436f; Rui MM, 2017, ACS SUSTAIN CHEM ENG, V5, P6557, DOI 10.1021/acssuschemeng.7b00736; Shafiq M, 2020, FOODS, V9, DOI 10.3390/foods9020148; Sheteiwy MS, 2016, ENVIRON SCI POLLUT R, V23, P19989, DOI 10.1007/s11356-016-7170-7; Sun DQ, 2016, CHEMOSPHERE, V152, P81, DOI 10.1016/j.chemosphere.2016.02.096; Taheri M., 2015, STEM FELLOWSH J, V1, P17, DOI [10.17975/sfj-2015-011, DOI 10.17975/SFJ-2015-011]; Ullah N, 2015, TOXICOL IND HEALTH, V31, P931, DOI 10.1177/0748233713483205; USDA-ARS, 2017, GERMPL RES INF NETW; Vaknin Y, 2011, IND CROP PROD, V34, P1029, DOI 10.1016/j.indcrop.2011.03.011; Velasco L, 1998, CROP SCI, V38, P1650, DOI 10.2135/cropsci1998.0011183X003800060039x; Venkatachalam P, 2017, PLANT PHYSIOL BIOCH, V110, P118, DOI 10.1016/j.plaphy.2016.09.004; Wang CC, 2010, FOOD CHEM, V120, P184, DOI 10.1016/j.foodchem.2009.10.005; Wang P, 2013, ENVIRON SCI TECHNOL, V47, P13822, DOI 10.1021/es403466p; Yang JH, 2000, FOOD CHEM, V71, P249, DOI 10.1016/S0308-8146(00)00165-5; Zahedi SM, 2020, J SCI FOOD AGR, V100, P25, DOI 10.1002/jsfa.10004; Zargari A, 2004, MED PLANTS, P356	67	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241568	10.1371/journal.pone.0241568	http://dx.doi.org/10.1371/journal.pone.0241568			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170873	Green Published, gold			2022-12-26	WOS:000592383400007
J	Yang, JM; Tavazoie, S				Yang, Jamie; Tavazoie, Saeed			Regulatory and evolutionary adaptation of yeast to acute lethal ethanol stress	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE CELLS; CHRONOLOGICAL LIFE-SPAN; HEAT-SHOCK PROTEINS; DESICCATION TOLERANCE; GENE; SEQUENCE; MEIOSIS; GENOME; GROWTH; TOR	The yeast Saccharomyces cerevisiae has been the subject of many studies aimed at understanding mechanisms of adaptation to environmental stresses. Most of these studies have focused on adaptation to sub-lethal stresses, upon which a stereotypic transcriptional program called the environmental stress response (ESR) is activated. However, the genetic and regulatory factors that underlie the adaptation and survival of yeast cells to stresses that cross the lethality threshold have not been systematically studied. Here, we utilized a combination of gene expression profiling, deletion-library fitness profiling, and experimental evolution to systematically explore adaptation of S. cerevisiae to acute exposure to threshold lethal ethanol concentrations-a stress with important biotechnological implications. We found that yeast cells activate a rapid transcriptional reprogramming process that is likely adaptive in terms of post-stress survival. We also utilized repeated cycles of lethal ethanol exposure to evolve yeast strains with substantially higher ethanol tolerance and survival. Importantly, these strains displayed bulk growth-rates that were indistinguishable from the parental wild-type strain. Remarkably, these hyper-ethanol tolerant strains had reprogrammed their pre-stress gene expression states to match the likely adaptive post-stress response in the wild-type strain. Our studies reveal critical determinants of yeast survival to lethal ethanol stress and highlight potentially general principles that may underlie evolutionary adaptation to lethal stresses in general.	[Yang, Jamie; Tavazoie, Saeed] Columbia Univ, Dept Syst Biol, New York, NY 10027 USA; [Yang, Jamie; Tavazoie, Saeed] Columbia Univ, Dept Biochem & Mol Biol, New York, NY 10027 USA; [Tavazoie, Saeed] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University	Tavazoie, S (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10027 USA.; Tavazoie, S (corresponding author), Columbia Univ, Dept Biochem & Mol Biol, New York, NY 10027 USA.; Tavazoie, S (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	st2744@columbia.edu		Tavazoie, Saeed/0000-0003-2183-4162	NIH [R01-AI077562, R01-HG009065]; NIH MSTP award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH MSTP award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH (R01-AI077562) and NIH (R01-HG009065) to S.T. NIH MSTP award to J.Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript S.T. received salary support base on his effort from both NIH grants.	[Anonymous], 2009, GMS HLTH TECHNOL ASS, V5, pDoc14; [Anonymous], 2009, JARCHSCI, V36, P900; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brachmann CB, 1998, YEAST, V14, P115; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chandler M, 2004, ANN MICROBIOL, V54, P427; Charoenbhakdi S, 2016, APPL ENVIRON MICROB, V82, P3121, DOI 10.1128/AEM.00376-16; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; CHODER M, 1993, MOL CELL BIOL, V13, P6984, DOI 10.1128/MCB.13.11.6984; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cosentino GP, 2000, MOL CELL BIOL, V20, P4604, DOI 10.1128/MCB.20.13.4604-4613.2000; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; DAMORE T, 1990, CRIT REV BIOTECHNOL, V9, P287, DOI 10.3109/07388558909036740; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Erkine AM, 1999, MOL CELL BIOL, V19, P1627; FEARON K, 1988, MOL CELL BIOL, V8, P3636, DOI 10.1128/MCB.8.9.3636; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gasch Audrey P, 2002, Funct Integr Genomics, V2, P181, DOI 10.1007/s10142-002-0058-2; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; GUELIN E, 1994, YEAST, V10, P1389, DOI 10.1002/yea.320101016; Ho YH, 2018, CURR BIOL, V28, P2673, DOI 10.1016/j.cub.2018.06.044; Ho YH, 2015, CURR GENET, V61, P503, DOI 10.1007/s00294-015-0491-0; HOTTIGER T, 1987, FEBS LETT, V220, P113, DOI 10.1016/0014-5793(87)80886-4; Japanese Gastr Canc Assoc, 2021, GASTRIC CANCER, V24, P1, DOI [10.1007/s10120-020-01042-y, 10.1007/s10120-016-0622-4]; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; Kubota S, 2004, BIOSCI BIOTECH BIOCH, V68, P968, DOI 10.1271/bbb.68.968; Kupiec M, 1997, CELL CYCLE CELL BIOL, P3; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LEAO C, 1984, BIOCHIM BIOPHYS ACTA, V774, P43, DOI 10.1016/0005-2736(84)90272-4; Levy SF, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001325; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu C, 2009, MOL BIOL CELL, V20, P891, DOI 10.1091/mbc.E08-08-0852; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; MCEWEN JE, 1993, CURR GENET, V23, P9, DOI 10.1007/BF00336742; MISHRA P, 1989, APPL MICROBIOL BIOT, V30, P294; NASMYTH KA, 1982, ANNU REV GENET, V16, P439, DOI 10.1146/annurev.ge.16.120182.002255; Navarro-Tapia E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00189; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; PIPER PW, 1994, MICROBIOL-SGM, V140, P3031, DOI 10.1099/13500872-140-11-3031; Planta RJ, 1998, YEAST, V14, P471, DOI 10.1002/(SICI)1097-0061(19980330)14:5<471::AID-YEA241>3.0.CO;2-U; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Swan TM, 1999, CAN J MICROBIOL, V45, P472, DOI 10.1139/cjm-45-6-472; Tagkopoulos I, 2008, SCIENCE, V320, P1313, DOI 10.1126/science.1154456; Uffenbeck SR, 2006, BIOCHEM CELL BIOL, V84, P477, DOI 10.1139/O06-079; WAGSTAFF JE, 1982, P NATL ACAD SCI-BIOL, V79, P2986, DOI 10.1073/pnas.79.9.2986; Walker G.M., 1998, YEAST PHYSL BIOTECHN; Welch AZ, 2013, MOL BIOL CELL, V24, P115, DOI 10.1091/mbc.E12-07-0524; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang H, 2006, FEMS YEAST RES, V6, P1254, DOI 10.1111/j.1567-1364.2006.00123.x; Yoshikawa K, 2009, FEMS YEAST RES, V9, P32, DOI 10.1111/j.1567-1364.2008.00456.x; Zakrzewska A, 2011, MOL BIOL CELL, V22, P4435, DOI 10.1091/mbc.E10-08-0721; 2014, KODEX, V4, P11	62	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0239528	10.1371/journal.pone.0239528	http://dx.doi.org/10.1371/journal.pone.0239528			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170850	gold, Green Published			2022-12-26	WOS:000592383400016
J	Sandoval, JE; Reich, NO				Sandoval, Jonathan E.; Reich, Norbert O.			p53 and TDG are dominant in regulating the activity of the human de novo DNA methyltransferase DNMT3A on nucleosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3; METHYLATION; ASSOCIATION; GLYCOSYLASE; BINDING; DOMAIN; SITE; 3A	DNA methylation and histone tail modifications are interrelated mechanisms involved in a wide range of biological processes, and disruption of this crosstalk is linked to diseases such as acute myeloid leukemia. In addition, DNA methyl-transferase 3A (DNMT3A) activity is modulated by several regulatory proteins, including p53 and thymine DNA glycosylase (TDG). However, the relative role of histone tails and regulatory proteins in the simultaneous coordination of DNMT3A activity remains obscure. We observed that DNMT3A binds H3 tails and p53 or TDG at distinct allosteric sites to form DNMT3A-H3 tail-p53 or -TDG multiprotein complexes. Functional characterization of DNMT3A-H3 tail-p53 or -TDG complexes on human-derived synthetic histone H3 tails, mononucleosomes, or polynucleosomes shows p53 and TDG play dominant roles in the modulation of DNMT3A activity. Intriguingly, this dominance occurs even when DNMT3A is actively methylating nucleosome substrates. The activity of histone modifiers is influenced by their ability to sense modifications on histone tails within the same nucleosome or histone tails on neighboring nucleosomes. In contrast, we show here that DNMT3A acts on DNA within a single nucleosome, on nucleosomal DNA within adjacent nucleosomes, and DNA not associated with the DNMT3A-nucleosome complex. Our findings have direct bearing on how the histone code drives changes in DNA methylation and highlight the complex interplay between histone tails, epigenetic enzymes, and modulators of enzymatic activity.	[Sandoval, Jonathan E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Reich, Norbert O.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Reich, NO (corresponding author), Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA.	reich@chem.ucsb.edu		sandoval, jonathan/0000-0003-1986-0804	NSF [1808775]	NSF(National Science Foundation (NSF))	We would like to thank our funders: NSF award number 1808775.	Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Azzaz AM, 2014, J BIOL CHEM, V289, P6850, DOI 10.1074/jbc.M113.512137; Barbosa K, 2019, GENE CHROMOSOME CANC, V58, P875, DOI 10.1002/gcc.22796; Bayraktar G, 2018, NEUROSCIENTIST, V24, P171, DOI 10.1177/1073858417707457; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Biel M, 2005, ANGEW CHEM INT EDIT, V44, P3186, DOI 10.1002/anie.200461346; Camacho OV, 2017, ELIFE, V6, DOI 10.7554/eLife.25293; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chen BF, 2014, EPIGENETICS-US, V9, P669, DOI 10.4161/epi.28324; Danilova N, 2008, MECH DEVELOP, V125, P919, DOI 10.1016/j.mod.2008.09.003; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Feng Y, 2011, J BIOL CHEM, V286, P20323, DOI 10.1074/jbc.M110.207258; Fischle W, 2008, GENE DEV, V22, P3375, DOI 10.1101/gad.1759708; Fuchs SM, 2011, CURR BIOL, V21, P53, DOI 10.1016/j.cub.2010.11.058; Garcia-Gomez A, 2017, NUCLEIC ACIDS RES, V45, P10002, DOI 10.1093/nar/gkx666; Ge YZ, 2004, J BIOL CHEM, V279, P25447, DOI 10.1074/jbc.M312296200; Germanguz I., 2018, F1000RES, V7, P497; Gowher H, 2005, BIOCHEMISTRY-US, V44, P9899, DOI 10.1021/bi047634t; Guo X, 2015, NATURE, V517, P640, DOI 10.1038/nature13899; Hervouet E, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0450-y; Holz-Schietinger C, 2011, J BIOL CHEM, V286, P41479, DOI 10.1074/jbc.M111.284687; Holz-Schietinger C, 2010, J BIOL CHEM, V285, P29091, DOI 10.1074/jbc.M110.142513; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato D, 2017, SCIENCE, V356, P205, DOI 10.1126/science.aak9867; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li BZ, 2011, CELL RES, V21, P1172, DOI 10.1038/cr.2011.92; Li X, 2016, NAT IMMUNOL, V17, P806, DOI 10.1038/ni.3464; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Liao HF, 2012, BIOL CELL, V104, P571, DOI 10.1111/boc.201100109; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luo QY, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020066; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Mungamuri SK, 2012, NAT STRUCT MOL BIOL, V19, P478, DOI 10.1038/nsmb.2271; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Paul TA, 2010, BLOOD, V115, P3098, DOI 10.1182/blood-2009-07-233858; Peterson SN, 2006, J MOL BIOL, V355, P459, DOI 10.1016/j.jmb.2005.11.003; Purdy MM, 2010, ARCH BIOCHEM BIOPHYS, V498, P13, DOI 10.1016/j.abb.2010.03.007; Sandoval JE, 2019, J BIOL CHEM, V294, P18207, DOI 10.1074/jbc.RA119.010827; Sandoval JE, 2019, J BIOL CHEM, V294, P4898, DOI 10.1074/jbc.RA118.006795; Schuermann D, 2016, NUCLEIC ACIDS RES, V44, P2187, DOI 10.1093/nar/gkv1520; Wang YA, 2005, CANCER BIOL THER, V4, P1138, DOI 10.4161/cbt.4.10.2073; Weinberg DN, 2019, NATURE, V573, P281, DOI 10.1038/s41586-019-1534-3; Xu XH, 2016, ACTA BIOCH BIOPH SIN, V48, P82, DOI 10.1093/abbs/gmv083; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147; Zhang ZM, 2018, NATURE, V554, P387, DOI 10.1038/nature25477	50	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100058	10.1074/jbc.RA120.016125	http://dx.doi.org/10.1074/jbc.RA120.016125			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33172892	gold, Green Published			2022-12-26	WOS:000672866400040
J	Granata, V; Fusco, R; Avallone, A; Cassata, A; Palaia, R; Delrio, P; Grassi, R; Tatangelo, F; Grazzini, G; Izzo, F; Petrillo, A				Granata, Vincenza; Fusco, Roberta; Avallone, Antonio; Cassata, Antonino; Palaia, Raffaele; Delrio, Paolo; Grassi, Roberta; Tatangelo, Fabiana; Grazzini, Giulia; Izzo, Francesco; Petrillo, Antonella			Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting	PLOS ONE			English	Article							GD-EOB-DTPA; ACID-ENHANCED MRI; HEPATOCELLULAR-CARCINOMA; DIAGNOSTIC PERFORMANCE; LESION DISCRIMINATION; GADOTERATE MEGLUMINE; HEPATOBILIARY PHASE; HEPATIC METASTASES; COST-EFFECTIVENESS; RECTAL-CANCER	Background MRI is the most reliable imaging modality that allows to assess liver metastases. Our purpose is to compare the per-lesion and per-patient detection rate of gadoxetic acid-(Gd-EOB) enhanced liver MRI and fast MR protocol including Diffusion Weighted Imaging (DWI) and T2-W Fat Suppression sequence in the detection of liver metastasis in pre surgical setting. Methods One hundred and eight patients with pathologically proven liver metastases (756 liver metastases) underwent Gd-EOBMRI were enrolled in this study. Three radiologist independently graded the presence of liver lesions on a five-point confidence scale assessed only abbreviated protocol (DWI and sampling perfection with application-optimized contrasts using different flip angle evolution (SPACE) fat suppressed sequence) and after an interval of more than 2 weeks the conventional study (all acquired sequences). Per-lesion and perpatient detection rate of metastases were calculated. Weighted. values were used to evaluate inter-reader agreement of the confidence scale regarding the presence of the lesion. Results MRI detected 732 liver metastases. All lesions were identified both by conventional study as by abbreviated protocol. In terms of per-lesion detection rate of liver metastasis, all three readers had higher detection rate both with abbreviated protocol and with standard protocol with Gd-EOB (96.8% [732 of 756] vs. 96.5% [730 of 756] for reader 1; 95.8% [725 of 756] vs. 95.2% [720 of 756] for reader 2; 96.5% [730 of 756] vs. 96.5% [730 of 756] for reader 3). Inter-reader agreement of lesions detection rate between the three radiologists was excellent (k range, 0.86-0.98) both for Gd-EOB MRI and for Fast protocol (k range, 0.89-0.99). Conclusion Abbreviated protocol showed the same detection rate than conventional study in detection of liver metastases.	[Granata, Vincenza; Fusco, Roberta; Petrillo, Antonella] Ist Nazl Tumori IRCCS Fdn Pascale, IRCCS Napoli, Div Radiol, Naples, Italy; [Avallone, Antonio; Cassata, Antonino] Ist Nazl Tumori IRCCS Fdn Pascale, IRCCS Napoli, Gastrointestinal Oncol Div, Naples, Italy; [Palaia, Raffaele; Izzo, Francesco] Ist Nazl Tumori IRCCS Fdn Pascale, IRCCS Napoli, Hepatobiliary Surg Oncol Div, Naples, Italy; [Delrio, Paolo] Ist Nazl Tumori IRCCS Fdn Pascale, IRCCS Napoli, Div Gastrointestinal Surg Oncol, Naples, Italy; [Grassi, Roberta] Univ Campania Luigi Vanvitelli, Div Radiol, Naples, Italy; [Tatangelo, Fabiana] Ist Nazl Tumori IRCCS Fdn Pascale, IRCCS Napoli, Div Pathol, Naples, Italy; [Grazzini, Giulia] Azienda Osped Univ Careggi, Div Radiol, Florence, Italy	IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; Universita della Campania Vanvitelli; IRCCS Fondazione Pascale; University of Florence; Azienda Ospedaliero Universitaria Careggi	Fusco, R (corresponding author), Ist Nazl Tumori IRCCS Fdn Pascale, IRCCS Napoli, Div Radiol, Naples, Italy.	robertafusco1985@gmail.com	Grazzini, Giulia/AAW-5224-2021; Fusco, Roberta/I-4062-2018; Avallone, Antonio/K-4662-2016	Fusco, Roberta/0000-0002-0469-9969; Avallone, Antonio/0000-0001-6188-5664; grassi, roberta/0000-0002-4322-8115				Abraham JL, 2008, EUR J RADIOL, V66, P200, DOI 10.1016/j.ejrad.2008.01.026; Besa C, 2017, ABDOM RADIOL, V42, P179, DOI 10.1007/s00261-016-0841-5; Brismar TB, 2009, ACTA RADIOL, V50, P709, DOI 10.1080/02841850903055603; Carr Tara F, 2016, Top Magn Reson Imaging, V25, P265; Chan MV, 2019, EUR RADIOL EXP, V3, DOI 10.1186/s41747-019-0126-1; Chen ZG, 2015, WORLD J GASTROENTERO, V21, P1621, DOI 10.3748/wjg.v21.i5.1621; Cheung HMC, 2019, EUR RADIOL, V29, P1032, DOI 10.1007/s00330-018-5618-5; Colagrande S, 2016, EUR J RADIOL, V85, P1027, DOI 10.1016/j.ejrad.2016.02.011; Dahlstrom N, 2007, ACTA RADIOL, V48, P362, DOI 10.1080/02841850701196922; de Kerviler E, 2016, INVEST RADIOL, V51, P544, DOI 10.1097/RLI.0000000000000276; Eberhardt SC, 2013, ABDOM IMAGING, V38, P647, DOI 10.1007/s00261-012-9941-z; Granata V, 2019, EUR REV MED PHARMACO, V23, P9697, DOI 10.26355/eurrev_201911_19531; Granata V, 2019, INFECT AGENTS CANCER, V14, DOI 10.1186/s13027-019-0264-3; Granata V, 2019, RADIOL ONCOL, V53, P373, DOI 10.2478/raon-2019-0040; Granata V, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-019-1036-7; Granata V, 2019, RADIOL ONCOL, V53, P369, DOI 10.2478/raon-2019-0031; Granata V, 2019, J INT MED RES, V47, P2351, DOI 10.1177/0300060519827168; Granata V, 2018, FUTURE ONCOL, V14, P2189, DOI 10.2217/fon-2018-0080; Granata V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179951; Granata V, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3918292; Granata V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142876; Granata V, 2015, ABDOM IMAGING, V40, P2364, DOI 10.1007/s00261-015-0488-7; Han S, 2018, KOREAN J RADIOL, V19, P568, DOI 10.3348/kjr.2018.19.4.568; Izzo F, 2019, ONCOLOGIST, V24, pE990, DOI 10.1634/theoncologist.2018-0337; Khatri G, 2020, J MAGN RESON IMAGING, V51, P415, DOI 10.1002/jmri.26835; Kim SS, 2020, J MAGN RESON IMAGING, V51, P70, DOI 10.1002/jmri.26768; Kim YK, 2014, MAGN RESON IMAGING, V32, P610, DOI 10.1016/j.mri.2013.12.021; Lee JY, 2018, ABDOM RADIOL, V43, P1627, DOI 10.1007/s00261-017-1339-5; Lee JM, 2016, J MED ECON, V19, P759, DOI 10.3111/13696998.2016.1171230; Low RN, 2007, J MAGN RESON IMAGING, V25, P848, DOI 10.1002/jmri.20864; Mao YT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58855-1; Marks RM, 2015, AM J ROENTGENOL, V204, P527, DOI 10.2214/AJR.14.12986; Marti-Bonmati L, 2017, RADIOLOGIA-MADRID, V59, P469, DOI 10.1016/j.rx.2017.09.007; Milon A, 2020, AM J ROENTGENOL, V214, P282, DOI 10.2214/AJR.19.21924; Mitin T, 2015, J GASTROINTEST ONCOL, V6, P201, DOI 10.3978/j.issn.2078-6891.2014.086; Nishie A, 2017, CLIN THER, V39, P738, DOI 10.1016/j.clinthera.2017.03.006; Runge VM, 2017, INVEST RADIOL, V52, P317, DOI 10.1097/RLI.0000000000000374; Soyer P, 2017, J MAGN RESON IMAGING, V45, P988, DOI 10.1002/jmri.25486; Suh CH, 2018, AM J ROENTGENOL, V210, pW63, DOI 10.2214/AJR.17.18300; Tillman BG, 2018, CLIN RADIOL, V73, P485, DOI 10.1016/j.crad.2017.11.013; Tokuda O, 2004, J MAGN RESON IMAGING, V19, P475, DOI 10.1002/jmri.20031; Tokuda O, 2009, AM J ROENTGENOL, V193, P1607, DOI 10.2214/AJR.09.2675; van Zelst JCM, 2018, INVEST RADIOL, V53, P579, DOI 10.1097/RLI.0000000000000494; Wei CG, 2015, TUMOR BIOL, V36, P983, DOI 10.1007/s13277-014-2663-9; Xiong H, 2016, J COMPUT ASSIST TOMO, V40, P498, DOI 10.1097/RCT.0000000000000377; Zech CJ, 2016, EUR RADIOL, V26, P4121, DOI 10.1007/s00330-016-4271-0	46	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0241431	10.1371/journal.pone.0241431	http://dx.doi.org/10.1371/journal.pone.0241431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211702	gold, Green Published			2022-12-26	WOS:000603518300017
J	Ketema, L; Dememew, ZG; Assefa, D; Gudina, T; Kassa, A; Letta, T; Ayele, B; Tadesse, Y; Tegegn, B; Datiko, DG; Negeri, C; Bedru, A; Klinkenberg, E				Ketema, L.; Dememew, Z. G.; Assefa, D.; Gudina, T.; Kassa, A.; Letta, T.; Ayele, B.; Tadesse, Y.; Tegegn, B.; Datiko, D. G.; Negeri, C.; Bedru, A.; Klinkenberg, E.			Evaluating the integration of tuberculosis screening and contact investigation in tuberculosis clinics in Ethiopia: A mixed method study	PLOS ONE			English	Article							ISONIAZID PREVENTIVE THERAPY; CHILDHOOD TUBERCULOSIS; CHILDREN; BURDEN; DIAGNOSIS; CARE; CHALLENGES; QUALITY; TRIALS	Background Aligned with global childhood tuberculosis (TB) road map, Ethiopia developed its own in 2015. The key strategies outlined in the Ethiopian roadmap are incorporating TB screening in Integrated Maternal, Neonatal and Child Illnesses (IMNCI) clinic for children under five years (U5) and intensifying contact investigations at TB clinic. However, these strategies have never been evaluated. Objective To evaluate the integration of tuberculosis (TB) screening and contact investigation into Integrated Maternal, Neonatal and Child Illnesses (IMNCI) and TB clinics in Addis Ababa, Ethiopia. Methods The study used mixed methods with stepped-wedge design where 30 randomly selected health care facilities were randomized into three groups of 10 during August 2016-November 2017. The integration of TB screening into IMNCI clinic and contact investigation in TB clinic were introduced by a three-day childhood TB training for health providers. An in-depth interview was used to explore the challenges of the interventions and supplemented data on TB screening and contact investigation. Results Overall, 180896 children attended 30 IMNCI clinics and145444 (80.4%) were screened for TB. A total of 688 (0.4%) children had presumptive TB and 47(0.03%) had TB. During the pre-intervention period, 51873 of the 85278 children (60.8%) were screened for TB as compared to 93570 of the 95618 children (97.9%) in the intervention (p< 0.001). This had resulted in 149 (0.30%) and 539 (0.6%) presumptive TB cases in pre-intervention and intervention periods (p<0.001), respectively. Also, nine TB cases (6.0%) in pre-intervention and 38 (7.1%) after intervention were identified (p = 0.72). In TB clinics, 559 under-five (U5) contacts were identified and 419 (80.1%) were screened. In all, 51(9.1%) presumed TB cases and 12 (2.1%) active TB cases were identified from the traced contacts. TB screening was done for 182 of the 275 traced contacts (66.2%) before intervention and for 237 of the 284 of the traced (83.5%) under intervention (p<0.001). Isoniazid prevention therapy (IPT) was initiated for 69 of 163 eligible contacts (42.3%) before intervention and for 159 of 194 eligible children (82.0%) under intervention (p< 0.001). Over 95% of health providers indicated that the integration of TB screening into IMNCI and contact investigation in TB clinic is acceptable and practical. Gastric aspiration to collect sputum using nasogastric tube was reported to be difficult. Conclusions Integrating TB screening into IMNCI clinics and intensifying contact investigation in TB clinics is feasible improving TB screening, presumed TB cases, TB cases, contact screening and IPT coverage during the intervention period. Stool specimen could be non-invasive to address the challenge of sputum collection.	[Ketema, L.; Dememew, Z. G.; Assefa, D.; Datiko, D. G.; Negeri, C.; Bedru, A.] Management Sci Hlth USAID, KNVC TB Fdn, Challenge TB Project, Addis Ababa, Ethiopia; [Gudina, T.; Kassa, A.; Letta, T.; Ayele, B.; Tadesse, Y.] Fed Minist Hlth Ethiopia, Natl TB Program, Addis Ababa, Ethiopia; [Gudina, T.; Kassa, A.; Letta, T.; Ayele, B.; Tadesse, Y.] Child Hlth Unit, Addis Ababa, Ethiopia; [Tegegn, B.] Addis Ababa City Adm, Hlth Bur, Addis Ababa, Ethiopia; [Klinkenberg, E.] KNCV TB Fdn, The Hague, Netherlands; [Klinkenberg, E.] Amsterdam Univ Med Ctr, Locat Acad Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Klinkenberg, E.] Amsterdam Univ Med Ctr, Locat Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	Federal Ministry of Health - Ethiopia (FMOH); KNCV Tuberculosis Foundation	Dememew, ZG (corresponding author), Management Sci Hlth USAID, KNVC TB Fdn, Challenge TB Project, Addis Ababa, Ethiopia.	zgashu@msh.org			American People through the United States Agency for International Development (USAID)	American People through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This study was made possible by the support of the American People through the United States Agency for International Development (USAID). The contents of this article are the sole responsibility of the authors alone and do not necessarily reflect the views of USAID or the United States Government.	Adams LV, 2014, PUBLIC HEALTH ACTION, V4, P233, DOI 10.5588/pha.14.0076; Ade S, 2013, PUBLIC HEALTH ACTION, V3, P15, DOI 10.5588/pha.12.0055; Andriyoko B, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01832-2018; Annabel B., 2019, GLOBAL TUBERCULOSIS; [Anonymous], 2016, NAT GUID PROGR CLIN; Arscott-Mills T, 2017, INT J TUBERC LUNG D, V21, P586, DOI 10.5588/ijtld.16.0668; Assefa Getachew, 2011, Ethiop Med J, V49, P35; Banada PP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151980; Bhargava A, 2014, NATL MED J INDIA, V27, P128; Bhat PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084255; Bosa L, 2017, MEDITERR J HEMATOL I, V9, DOI 10.4084/MJHID.2017.059; Brent AJ, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/865436; Datiko DG, 2017, INT J TUBERC LUNG D, V21, P1002, DOI 10.5588/ijtld.16.0471; Dawit Assefa, 2015, PLOS ONE; Detjen A., 2013, FRAMEWORK INTEGRATIN; Giang DC, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0814-2; Dodd PJ, 2017, LANCET GLOB HEALTH, V5, pE898, DOI [10.1016/S2214-109X(17)30289-9, 10.1016/s2214-109x(17)30289-9]; Fekadu L, 2017, J INFECT DIS, V216, pS696, DOI 10.1093/infdis/jix378; FMOH, 2015, ETH LAUNCH ITS NAC C; Gashu Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160514; Getnet F, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2133-3; Hall C, 2015, TROP MED INT HEALTH, V20, P730, DOI 10.1111/tmi.12479; Hemming K, 2015, STAT MED, V34, P181, DOI 10.1002/sim.6325; Hiruy N, 2018, INT J INFECT DIS, V71, P4, DOI 10.1016/j.ijid.2018.03.011; Islam Z, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4062-9; Jerene D, 2015, INT J TUBERC LUNG D, V19, P898, DOI 10.5588/ijtld.14.0978; Kalu EI, 2013, ANN TROP MED PUBLIC, V6, P608, DOI 10.4103/1755-6783.140218; Kizito S, 2018, INT J TUBERC LUNG D, V22, P1196, DOI 10.5588/ijtld.18.0043; Lo TQ, 2019, INT J TUBERC LUNG D, V23, P315, DOI 10.5588/ijtld.18.0404; MacLean E, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.02057-18, 10.1128/jcm.02057-18]; Malik AA, 2018, INT J TUBERC LUNG D, V22, P851, DOI 10.5588/ijtld.17.0736; Mdege ND, 2011, J CLIN EPIDEMIOL, V64, P936, DOI 10.1016/j.jclinepi.2010.12.003; Mosadeghrad AM, 2013, INT J HEALTH POLICY, V1, P43, DOI 10.15171/ijhpm.2013.07; Murongazvombo AS, 2019, INT J INFECT DIS, V78, P113, DOI 10.1016/j.ijid.2018.10.013; National TBL Program, TB PERF REP; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; Patel LN, 2017, PUBLIC HEALTH ACTION, V7, P110, DOI 10.5588/pha.17.0018; Raizada N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202085; Safdar N, 2010, INT J TUBERC LUNG D, V14, P872; Swaminathan S, 2010, CLIN INFECT DIS, V50, pS184, DOI 10.1086/651490; Tulloch O, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1523-x; Verhagen LM, 2010, PEDIATR INFECT DIS J, V29, pE63, DOI 10.1097/INF.0b013e3181ee23ae; Verkuijl S, 2016, INTEGRATION CHILDHOO; World Health Organization, 2013, ROADM CHILDH TUB ZER, P39; World Health Organization(WHO), 2014, GUID NAT TUB PROGR M, V2nd; World Population Review, 2015, WORLD POPULATION REV	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0241977	10.1371/journal.pone.0241977	http://dx.doi.org/10.1371/journal.pone.0241977			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211710	gold, Green Published			2022-12-26	WOS:000603518300029
J	Lavarenne, J; Gonin, M; Champion, A; Javelle, M; Adam, H; Rouster, J; Conejero, G; Lartaud, M; Verdeil, JL; Laplaze, L; Sallaud, C; Lucas, M; Gantet, P				Lavarenne, Jeremy; Gonin, Mathieu; Champion, Antony; Javelle, Marie; Adam, Helene; Rouster, Jacques; Conejero, Genevieve; Lartaud, Marc; Verdeil, Jean-Luc; Laplaze, Laurent; Sallaud, Christophe; Lucas, Mikael; Gantet, Pascal			Transcriptome profiling of laser-captured crown root primordia reveals new pathways activated during early stages of crown root formation in rice	PLOS ONE			English	Article							AUXIN RESPONSE FACTOR; QUIESCENT CENTER; XYLOGLUCAN ENDOTRANSGLUCOSYLASE/HYDROLASES; ARABIDOPSIS-THALIANA; EXPRESSION PATTERN; GENE-EXPRESSION; GROWTH; INITIATION; ETHYLENE; IDENTIFICATION	Crown roots constitute the main part of the rice root system. Several key genes involved in crown root initiation and development have been identified by functional genomics approaches. Nevertheless, these approaches are impaired by functional redundancy and mutant lethality. To overcome these limitations, organ targeted transcriptome analysis can help to identify genes involved in crown root formation and early development. In this study, we generated an atlas of genes expressed in developing crown root primordia in comparison with adjacent stem cortical tissue at three different developmental stages before emergence, using laser capture microdissection. We identified 3975 genes differentially expressed in crown root primordia. About 30% of them were expressed at the three developmental stages, whereas 10.5%, 19.5% and 12.8% were specifically expressed at the early, intermediate and late stages, respectively. Sorting them by functional ontology highlighted an active transcriptional switch during the process of crown root primordia formation. Cross-analysis with other rice root development-related datasets revealed genes encoding transcription factors, chromatin remodeling factors, peptide growth factors, and cell wall remodeling enzymes that are likely to play a key role during crown root primordia formation. This atlas constitutes an open primary data resource for further studies on the regulation of crown root initiation and development.	[Lavarenne, Jeremy; Gonin, Mathieu; Champion, Antony; Adam, Helene; Laplaze, Laurent; Lucas, Mikael; Gantet, Pascal] Univ Montpellier, IRD, UMR DIADE, Montpellier, France; [Lavarenne, Jeremy; Javelle, Marie; Rouster, Jacques; Sallaud, Christophe] Limagrain Field Seeds Traits & Technol, Grp Limagrain, Ctr Rech, Route Ennezat, Chappes, France; [Conejero, Genevieve; Lartaud, Marc; Verdeil, Jean-Luc] CIRAD, UMR1334 AGAP, PHIV MRI, Montpellier, France; [Conejero, Genevieve; Lartaud, Marc; Verdeil, Jean-Luc] Univ Montpellier, CIRAD, INRA, Montpellier SupAgro, Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier	Gantet, P (corresponding author), Univ Montpellier, IRD, UMR DIADE, Montpellier, France.	pascal.gantet@umontpellier.fr	Laplaze, Laurent/I-5435-2016; adam, helene/GLU-1655-2022	Laplaze, Laurent/0000-0002-6568-6504; LUCAS, Mikael/0000-0001-6286-7759; Lavarenne, Jeremy/0000-0002-1954-4150	CIFRE fellowship from the Association Nationale de la Recherche Technologique, France [2015/0195]; French Agence Nationale de la Recherche (Fondation Agropolis); French Agence Nationale de la Recherche (Program Investissement d'Avenir Labex Agro) [ANR-10LABX-0001-01]; French Agence Nationale de la Recherche (Partenariat de Recherche Collaborative Entreprise MASTEROOT) [ANR-17-CE20-0028-01]; CGIAR Research Program (CRP) on riceagrifood systems (RICE, 2017-2022); seed company Limagrain; French National Research Agency [ANR-10-INBS-04]	CIFRE fellowship from the Association Nationale de la Recherche Technologique, France; French Agence Nationale de la Recherche (Fondation Agropolis)(French National Research Agency (ANR)); French Agence Nationale de la Recherche (Program Investissement d'Avenir Labex Agro)(French National Research Agency (ANR)); French Agence Nationale de la Recherche (Partenariat de Recherche Collaborative Entreprise MASTEROOT)(French National Research Agency (ANR)); CGIAR Research Program (CRP) on riceagrifood systems (RICE, 2017-2022)(CGIAR); seed company Limagrain; French National Research Agency(French National Research Agency (ANR))	In addition to institutional funding, this work is supported by the French Agence Nationale de la Recherche (Fondation Agropolis, Program Investissement d'Avenir Labex Agro no. ANR-10LABX-0001-01, 2016-2018, by the Partenariat de Recherche Collaborative Entreprise MASTEROOT no. ANR-17-CE20-0028-01, 2018-2021) and by the CGIAR Research Program (CRP) on riceagrifood systems (RICE, 2017-2022). J.L. is supported by a CIFRE fellowship (No: 2015/0195) from the Association Nationale de la Recherche Technologique, France, and a financial support from of the seed company Limagrain. Limagrain provided support in the form of salaries for authors J.L., M.J., J.R. and C.S. The specific contribution of these authors are mentioned in the `author contributions' section. The imaging facility MRI, which is part of the UMS BioCampus Montpellier and a member of the national infrastructure France-BioImaging, supported by the French National Research Agency (ANR-10-INBS-04), provided access to biphoton microscopy and Laser Capture Microdissection facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi N, 2014, RICE, V7, DOI 10.1186/s12284-014-0029-y; Aki T, 2009, J PROTEOME RES, V8, P3912, DOI 10.1021/pr900187e; [Anonymous], 2017, J EXP BOT, V68, P3457, DOI [10.1093/jxb/erx208, DOI 10.1093/JXB/ERX208]; Berckmans B, 2011, PLANT CELL, V23, P3671, DOI 10.1105/tpc.111.088377; Blomme J, 2017, PLANT CELL, V29, P1137, DOI 10.1105/tpc.16.00899; Chandler JW, 2018, TRENDS PLANT SCI, V23, P151, DOI 10.1016/j.tplants.2017.09.016; Chung PJ, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4367-1; Collado-Romero M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00356; Coudert Y, 2015, NEW PHYTOL, V206, P243, DOI 10.1111/nph.13196; Coudert Y, 2010, TRENDS PLANT SCI, V15, P219, DOI 10.1016/j.tplants.2010.01.008; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Goh T, 2016, DEVELOPMENT, V143, P3363, DOI 10.1242/dev.135319; Gutjahr C, 2015, P NATL ACAD SCI USA, V112, P6754, DOI 10.1073/pnas.1504142112; Hara Y, 2014, ANN BOT-LONDON, V114, P1309, DOI 10.1093/aob/mct292; Hirose N, 2007, PLANT CELL PHYSIOL, V48, P523, DOI 10.1093/pcp/pcm022; Huang J, 2000, PLANTA, V211, P467, DOI 10.1007/s004250000311; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh J, 2005, PLANT CELL PHYSIOL, V46, P23, DOI 10.1093/pcp/pci501; Jiao YL, 2009, NAT GENET, V41, P258, DOI 10.1038/ng.282; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Kamiya N, 2003, PLANT J, V36, P45, DOI 10.1046/j.1365-313X.2003.01856.x; Kamiya N, 2003, PLANT J, V35, P429, DOI 10.1046/j.1365-313X.2003.01816.x; Kitomi Y., 2018, RICE GENOMICS GENETI, P241; Kitomi Y, 2012, PLANT SCI, V190, P116, DOI 10.1016/j.plantsci.2012.04.005; Kitomi Y, 2011, PLANT J, V67, P472, DOI 10.1111/j.1365-313X.2011.04610.x; Krogan NT, 2016, NEW PHYTOL, V212, P42, DOI 10.1111/nph.14107; Kutschmar A, 2009, NEW PHYTOL, V181, P820, DOI 10.1111/j.1469-8137.2008.02710.x; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lavarenne J, 2019, PLANT J, V100, P954, DOI 10.1111/tpj.14487; Lavenus J, 2015, PLANT CELL, V27, P1368, DOI 10.1105/tpc.114.132993; Li G, 2014, P NATL ACAD SCI USA, V111, P10377, DOI 10.1073/pnas.1401680111; Li P, 2011, ACTA BIOCH BIOPH SIN, V43, P688, DOI 10.1093/abbs/gmr068; Lourenco TF, 2015, PLANT PHYSIOL, V169, P2275, DOI 10.1104/pp.15.01131; Lu XY, 2014, INT PARALL DISTRIB P, DOI 10.1109/IPDPS.2014.90; Ma TL, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-161; Mai CD, 2014, RICE, V7, DOI 10.1186/s12284-014-0030-5; Mantegazza O, 2014, PLANT J, V79, P861, DOI 10.1111/tpj.12585; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; Nakamura A, 2006, PLANT PHYSIOL, V140, P580, DOI 10.1104/pp.105.072330; Neogy A, 2019, PLANT CELL PHYSIOL, V60, P2343, DOI 10.1093/pcp/pcz132; Phung NTP, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0747-y; Ni J, 2014, PLANT BIOLOGY, V16, P1014, DOI 10.1111/plb.12138; Oh JE, 2011, PLANT MOL BIOL, V77, P91, DOI 10.1007/s11103-011-9796-7; Orman-Ligeza B, 2013, TRENDS PLANT SCI, V18, P464, DOI 10.1016/j.tplants.2013.04.010; Parizot B, 2010, PLANT PHYSIOL, V153, P34, DOI 10.1104/pp.109.148676; Peret B, 2009, J EXP BOT, V60, P3637, DOI 10.1093/jxb/erp232; Rebouillat J, 2009, RICE, V2, P15, DOI 10.1007/s12284-008-9016-5; Ryan DP, 2011, CURR OPIN CHEM BIOL, V15, P649, DOI 10.1016/j.cbpa.2011.07.022; Saini S, 2013, PLANT CELL REP, V32, P741, DOI 10.1007/s00299-013-1430-5; Sato Y, 2013, NUCLEIC ACIDS RES, V41, pD1206, DOI 10.1093/nar/gks1125; Sato Y, 2011, NUCLEIC ACIDS RES, V39, pD1141, DOI 10.1093/nar/gkq1085; Sauter M, 2015, J EXP BOT, V66, P5160, DOI 10.1093/jxb/erv071; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Steffens B, 2006, PLANTA, V223, P604, DOI 10.1007/s00425-005-0111-1; Takehisa H, 2012, PLANT J, V69, P126, DOI 10.1111/j.1365-313X.2011.04777.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Usadel B, 2006, BMC BIOINFORMATICS, V8, P1, DOI DOI 10.1186/1471-2105-7-1; Wang HT, 2020, CROP J, V8, P98, DOI 10.1016/j.cj.2019.05.002; Wang YH, 2016, PLANT PHYSIOL BIOCH, V105, P185, DOI 10.1016/j.plaphy.2016.04.022; Xu CX, 2007, MOL GENET GENOMICS, V278, P85, DOI 10.1007/s00438-007-0232-2; Xu J, 2017, PLANT GROWTH REGUL, V82, P175, DOI 10.1007/s10725-017-0249-4; Yao X, 2007, J INTEGR PLANT BIOL, V49, P885, DOI [10.1111/j.1744-7909.2007.00509.x, 10.1111/j.1672-9072.2007.00509.x]; Yokoyama R, 2004, PLANT PHYSIOL, V134, P1088, DOI 10.1104/pp.103.035261; Zhang N, 2014, J PINEAL RES, V56, P39, DOI 10.1111/jpi.12095; Zhao CF, 2012, PLANTA, V236, P1165, DOI 10.1007/s00425-012-1667-1; Zhou WK, 2010, PLANT CELL, V22, P3692, DOI 10.1105/tpc.110.075721	68	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0238736	10.1371/journal.pone.0238736	http://dx.doi.org/10.1371/journal.pone.0238736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211715	gold, Green Published			2022-12-26	WOS:000603518300004
J	Takalloo, Z; Ardakani, ZA; Maroufi, B; Shahangian, SS; Sajedi, RH				Takalloo, Zeinab; Ardakani, Zahra Afshar; Maroufi, Bahman; Shahangian, S. Shirin; Sajedi, Reza H.			Stress-dependent conformational changes of artemin: Effects of heat and oxidant	PLOS ONE			English	Article							CHAPERONE ACTIVITY; HYDROGEN-PEROXIDE; PEPTIDE-BINDING; SHOCK-PROTEIN; CROSS-LINKING; FLUORESCENCE; FERRITIN; EMBRYOS; FRANCISCANA; TRYPTOPHAN	Artemin is an abundant thermostable protein in Artemia embryos and it is considered as a highly efficient molecular chaperone against extreme environmental stress conditions. The conformational dynamics of artemin have been suggested to play a critical role in its biological functions. In this study, we have investigated the conformational and functional changes of artemin under heat and oxidative stresses to identify the relationship between its structure and function. The tertiary and quaternary structures of artemin were evaluated by fluorescence measurements, protein cross-linking analysis, and dynamic light scattering. Based on the structural analysis, artemin showed irreversible substantial conformational lability in responses to heat and oxidant, which was mainly mediated through the hydrophobic interactions and dimerization of the chaperone. In addition, the chaperone-like activity of heated and oxidized artemin was examined using lysozyme refolding assay and the results showed that although both factors, i.e. heat and oxidant, at specific levels improved artemin potency, simultaneous incubation with both stressors significantly triggered the chaperone activation. Moreover, the heat-induced dimerization of artemin was found to be the most critical factor for its activation. It was suggested that oxidation presumably acts through stabilizing the dimer structures of artemin through formation of disulfide bridges between the subunits and strengthens its chaperoning efficacy. Accordingly, it is proposed that artemin probably exists in a monomer-oligomer equilibrium in Artemia cysts and environmental stresses and intracellular portion of protein substrates may shift the equilibrium towards the active dimer forms of the chaperone.	[Takalloo, Zeinab; Ardakani, Zahra Afshar; Sajedi, Reza H.] Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran, Iran; [Maroufi, Bahman] Mah Behin Gene Gostaran Co, Tehran, Iran; [Shahangian, S. Shirin] Univ Guilan, Dept Biol, Fac Sci, Rasht, Iran	Tarbiat Modares University; University of Guilan	Sajedi, RH (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Biochem, Tehran, Iran.	sajedi_r@modares.ac.ir	Shahangian, S. Shirin/ADZ-2819-2022; H. Sajedi, Reza/AAA-8355-2022	Sajedi, Reza/0000-0001-6774-0837				Abatzopoulos TJ, 2006, AQUACULTURE, V254, P442, DOI 10.1016/j.aquaculture.2005.11.007; Abbaspour M., 2007, International Journal of Environmental Studies, V64, P161, DOI 10.1080/00207230701238416; AbdElgawad H, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00276, 10.3389/fpls.2016.00556]; Aieta F, 2012, J NANOPHOTONICS, V6, DOI 10.1117/1.JNP.6.063532; Akhtar MW, 2004, J BIOL CHEM, V279, P55760, DOI 10.1074/jbc.M406333200; Alderson TR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08557-8; Amicale des anciens planteurs d'heveas, 1998, SERNAMBY, V14, P47; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chen T, 2003, EUR J BIOCHEM, V270, P137, DOI 10.1046/j.1432-1033.2003.03373.x; Chen T, 2007, FEBS J, V274, P1093, DOI 10.1111/j.1742-4658.2007.05659.x; Chevallet M, 2006, NAT PROTOC, V1, P1852, DOI 10.1038/nprot.2006.288; Chowdary TK, 2004, BIOCHEM J, V381, P379, DOI 10.1042/BJ20031958; Clegg JS, 2007, BIOL BULL-US, V212, P74, DOI 10.2307/25066582; Clegg JS, 2001, HYDROBIOLOGIA, V466, P221, DOI 10.1023/A:1014580612237; Clegg JS, 2000, CELL TISSUE RES, V301, P433, DOI 10.1007/s004410000249; COWGILL RW, 1967, BIOCHIM BIOPHYS ACTA, V133, P6, DOI 10.1016/0005-2795(67)90034-7; DAS KP, 1995, FEBS LETT, V369, P321, DOI 10.1016/0014-5793(95)00775-5; DEGRAAF J, 1990, EUR J BIOCHEM, V193, P737; Fan HH, 2006, ARCH BIOCHEM BIOPHYS, V447, P34, DOI 10.1016/j.abb.2006.01.012; FLIGIEL SEG, 1984, AM J PATHOL, V115, P418; Fu XM, 2014, ACTA BIOCH BIOPH SIN, V46, P347, DOI 10.1093/abbs/gmt152; Gakamsky A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40375; Ghisaidoobe ABT, 2014, INT J MOL SCI, V15, P22518, DOI 10.3390/ijms151222518; Graumann J, 1993, STRUCT LOND ENGL, V9, P377; Gunther R.T., 1899, GEOGRRAPHY J, V14, P504; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Hu Y, 2011, CELL STRESS CHAPERON, V16, P133, DOI 10.1007/s12192-010-0225-7; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Khoo KK, 2012, AMINO ACIDS, PEPTIDES AND PROTEINS IN ORGANIC CHEMISTRY, VOL 5: ANALYSIS AND FUNCTION OF AMINO ACIDS AND PEPTIDES, P395; Khosravi Z, 2018, CELL J, V19, P569, DOI 10.22074/cellj.2018.4510; Khosrowabadi E, 2018, PREP BIOCHEM BIOTECH, V48, P483, DOI 10.1080/10826068.2018.1466152; King AM, 2014, J EXP BIOL, V217, P1719, DOI 10.1242/jeb.100081; Linderoth NA, 2001, J BIOL CHEM, V276, P11049, DOI 10.1074/jbc.M010059200; Liu L, 2015, FEBS OPEN BIO, V5, P155, DOI 10.1016/j.fob.2015.02.006; Manaffar R, 2011, HYDROBIOLOGIA, V671, P65, DOI 10.1007/s10750-011-0704-6; Marvastizadeh N, 2019, BIOL CHEM, DOI 10.1515/hsz-2020-0446; Mosaddegh B, 2018, CELL STRESS CHAPERON, V23, P685, DOI 10.1007/s12192-018-0880-7; Petersen MTN, 1999, PROTEIN ENG, V12, P535, DOI 10.1093/protein/12.7.535; Rasti B, 2009, BBA-PROTEINS PROTEOM, V1794, P1407, DOI 10.1016/j.bbapap.2009.05.005; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shahangian SS, 2011, PROTEIN J, V30, P549, DOI 10.1007/s10930-011-9359-4; Shirzad F, 2011, INT J BIOL MACROMOL, V49, P311, DOI 10.1016/j.ijbiomac.2011.05.005; Takalloo Z, 2017, INT J BIOL MACROMOL, V95, P618, DOI 10.1016/j.ijbiomac.2016.11.088; Takalloo Z, 2016, ARCH BIOCHEM BIOPHYS, V610, P33, DOI 10.1016/j.abb.2016.09.016; Tan JB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200153; Triantaphyllidis GV, 1998, J BIOGEOGR, V25, P213, DOI 10.1046/j.1365-2699.1998.252190.x; VARTIO T, 1989, J BIOL CHEM, V264, P4471; Wang F, 2002, BIOCHEMISTRY-MOSCOW+, V67, P547, DOI 10.1023/A:1015546211706; Warner AH, 2004, ARCH BIOCHEM BIOPHYS, V424, P189, DOI 10.1016/j.abb.2004.02.022; Wearsch PA, 1998, BIOCHEMISTRY-US, V37, P5709, DOI 10.1021/bi9801006; Wu LZ, 2008, J MOL STRUCT, V882, P101, DOI 10.1016/j.molstruc.2007.09.016	53	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242206	10.1371/journal.pone.0242206	http://dx.doi.org/10.1371/journal.pone.0242206			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196673	Green Submitted, Green Published, gold			2022-12-26	WOS:000595266800027
J	Riordan, C; Jacquet, J; Franks, B				Riordan, Casey; Jacquet, Jennifer; Franks, Becca			Investigating the welfare and conservation implications of alligator wrestling for American Alligators (Alligator mississippiensis)	PLOS ONE			English	Article							TOURISM; WILDLIFE; STRESS; DESTINATIONS; ECOTOURISM; CROCODILE; EDUCATION; REPTILES	Wildlife tourism attractions (WTA) are popular in the United States, but they may be harmful to the individual animals involved and we question whether they provide benefits to environmental conservation. Most research on the welfare and environmental implications of WTAs focuses on charismatic mammals, with few studies investigating these issues for reptiles. Here we examine alligator wrestling, including its impact on animal welfare and environmental conservation. Using a sample of 94 relevant YouTube videos of alligator wrestling in Florida representing 16 different venues, we coded the environmental and behavioral characteristics evident in each video. We then performed a content analysis of wrestlers' narration in a subset of 51 videos to analyze the environmental awareness and educational components of alligator wrestling. Our results show systemic welfare harm: 11 venues housed adult alligators together with conspecifics, 96% of alligator wrestling performances facilitated direct contact in the form of physical restraint by one or more human wrestlers, and as many as 96% of the videos did not show a suitable water or waterside features for captive alligators. Furthermore, 12% of performances showed wrestlers flipping alligators onto their backs while 16% showed wrestlers tying alligators' jaws shut, both of which are known to be acute stressors. Finally, just under half of alligator wrestling commentary (49%) addressed environmental conservation topics, and much of this commentary included contradictory or misleading information that is not likely to benefit alligators in the wild. We argue that alligator wrestling serves no role in promoting positive relationships between humans, animals, and the environment, and instead furthers traditional notions of dominion that undermine welfare and conservation aims.	[Riordan, Casey; Jacquet, Jennifer; Franks, Becca] NYU, Dept Environm Studies, New York, NY 10012 USA	New York University	Franks, B (corresponding author), NYU, Dept Environm Studies, New York, NY 10012 USA.	krf205@nyu.edu			Center from Environmental and Animal Protection (CEAP) at New York University	Center from Environmental and Animal Protection (CEAP) at New York University	CR and BF received an award from the Center from Environmental and Animal Protection (CEAP: https://wp.nyu.edu/ceap/) at New York University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, VID PAUL GAT BOYS FU; [Anonymous], 2005, VID GAT WRESTL GAT O; [Anonymous], 2001, INTENSIVE CARE MED; [Anonymous], 2014, INT J COMP PSYCHOL, DOI DOI 10.46867/IJCP.2014.27.01.03; [Anonymous], 2005, VID GAT GLOB ALL CRO; Arbogast D., 2016, Journal of Tourism and Leisure Studies, V1, P19; Arena Phillip C., 1995, P263; Arena PC, 2014, J AGR ENVIRON ETHIC, V27, P309, DOI 10.1007/s10806-013-9465-8; Ballantyne R, 2011, TOURISM MANAGE, V32, P770, DOI 10.1016/j.tourman.2010.06.012; Ballantyne R, 2009, TOURISM MANAGE, V30, P658, DOI 10.1016/j.tourman.2008.11.003; Basit TN, 2003, EDUC RES-UK, V45, P143, DOI 10.1080/0013188032000133548; Bonnet X, 2002, TRENDS ECOL EVOL, V17, P1, DOI 10.1016/S0169-5347(01)02381-3; Carder G, 2018, ANIMALS-BASEL, V8, DOI 10.3390/ani8110216; Carrier JG, 2005, J ROY ANTHROPOL INST, V11, P315, DOI 10.1111/j.1467-9655.2005.00238.x; Cattelino JR, 2014, NATIVE PATHWAYS AM I, P66; Cohen E, 2019, TOUR CULT COMMUN, V19, P83, DOI 10.3727/109830419X15536971539380; Cohen E, 2013, SOC ANIM, V21, P266, DOI 10.1163/15685306-12341282; Cohen E, 2009, ANATOLIA, V20, P100, DOI 10.1080/13032917.2009.10518898; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; D'Cruze N, 2015, J AGR ENVIRON ETHIC, V28, P57, DOI 10.1007/s10806-014-9519-6; DUFFUS DA, 1990, BIOL CONSERV, V53, P213, DOI 10.1016/0006-3207(90)90087-6; Duffy R, 2014, ANN TOURISM RES, V44, P88, DOI 10.1016/j.annals.2013.09.003; DYLEWSKI L, 2017, SCI NAT-HEIDELBERG, V104, DOI DOI 10.1007/S00114-017-1470-828540595; Elsey R., 2019, ALLIGATOR MISSISSIPP; Everglades Holiday Park, 2020, GET CLOS GAT BOYS AL; Fennell DA, 2013, TOUR RECREAT RES, V38, P325, DOI 10.1080/02508281.2013.11081757; Fennell DA, 2012, TOUR RECREAT RES, V37, P157, DOI [10.1080/02508281.2012.11081700, 10.1080/02508281.2012.11081712]; Florida Fish & Wildlife Conservation Commission (FWC), 2019, STAT NUIS ALL PROGR; Florida Fish & Wildlife Conservation (FWC), 2019, SUMM FLOR NUIS ALL H; Frank AK, 2012, NATIVE AM IDENTITY S, P123; Franklin CE, 2003, J EXP ZOOL PART A, V298A, P86, DOI 10.1002/jez.a.10233; Garrick L. D., 1978, B AM MUS NAT HIST, V160, P153; GARRICK LD, 1977, AM ZOOL, V17, P225; Gatorland, 2020, GAT GLOB CONS EXP RE; George A, 2012, J TRAUMA ACUTE CARE, V72, pE113, DOI 10.1097/TA.0b013e31821e10d8; Green, 2001, POSITIVE EFFECTS WIL; Higginbottom K., 2004, WILDLIFE TOURISM IMP; Higginbottom Karen, 2004, P99; HUGGINS SE, 1969, PHYSIOL ZOOL, V42, P320, DOI 10.1086/physzool.42.3.30155496; Hunter-Jones P., 1998, Tourism and visitor attractions: leisure, culture and commerce., P97; Janovcova M, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9050238; Jones BK, 2015, CULT AGRIC FOOD ENVI, V37, P116, DOI 10.1111/cuag.12058; Karanth KK, 2012, ORYX, V46, P382, DOI 10.1017/S003060531100086X; Kontogeorgopoulos N, 2009, CURR ISSUES TOUR, V12, P429, DOI 10.1080/13683500903042873; Lambert H, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9100821; LANCE VA, 1986, J EXP ZOOL, V239, P241, DOI 10.1002/jez.1402390211; Learmonth MJ, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10050901; Loncaric D, 2019, TOUR S E EUROPE, V5, P405; Louw P, 2006, CURR WRIT, V18, P146, DOI 10.1080/1013929X.2006.9678239; Lovelock B, 2007, CONTEMP GEOGR LEIS T, P1; Luck M, 2003, OCEAN COAST MANAGE, V46, P943, DOI 10.1016/S0964-5691(03)00071-1; Miranda EBP, 2016, TROP CONSERV SCI, V9, P43, DOI 10.1177/194008291600900105; Moorhouse T, 2017, J SUSTAIN TOUR, V25, P505, DOI 10.1080/09669582.2016.1223087; Moorhouse TP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138939; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Nekaris KAI, 2015, FOLIA PRIMATOL, V86, P534, DOI 10.1159/000444231; Nekaris KAI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069215; Orams MB, 1996, AUST GEOGR, V27, P39, DOI 10.1080/00049189608703156; Orams MB, 2000, TOURISM MANAGE, V21, P561, DOI 10.1016/S0261-5177(00)00006-6; Otsuka R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232085; Rita P, 2019, CURR ISSUES TOUR, V22, P2034, DOI 10.1080/13683500.2018.1439902; Russell A. J., 2004, ANTHR TODAY, V20, P1, DOI DOI 10.1111/j.0268-540X.2004.00265.x; Sacasa A., 2017, S FLORIDA SUN SENTIN; Savannah River Ecology Laboratory (SREL), 2012, AM ALL; Shani A., 2008, International Journal of Contemporary Hospitality Management, V20, P679, DOI 10.1108/09596110810892236; Shani A., 2010, DISS ABSTR INT, V70, P4234; Shani A, 2012, TOURISM, V60, P139; Skupien GM, 2017, J HERPETOL, V51, P89, DOI 10.1670/15-163; SMITH EN, 1974, COPEIA, P770, DOI 10.2307/1442691; Smith GD, 2016, HERPETOL CONSERV BIO, V11, P72; Sofronov B., 2018, ANN SPIRU HARET U EC, V18, P109, DOI [10.26458/1838, DOI 10.26458/1838]; The Animal Rescue Site, 2014, FLOR ALL WRESTL IS N; U.S. Fish & Wildlife Service (FWS), 2008, AM ALL; U.S. Travel Association, 2019, US TRAV TOUR OV; van der Meer E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215211; Veiga C, 2017, WORLDW HOSP TOUR THE, V9, P603, DOI 10.1108/WHATT-09-2017-0047; Visit Florida, 2020, EST VIS FLOR Q; Visitor Fun, 2020, VIS OLD ALL FARM; WARWICK C, 1990, APPL ANIM BEHAV SCI, V27, P363, DOI 10.1016/0168-1591(90)90131-V; Weaver DB, 2007, TOURISM MANAGE, V28, P1168, DOI 10.1016/j.tourman.2007.03.004; WEINHEIMER CJ, 1982, J COMP PHYSIOL, V148, P57, DOI 10.1007/BF00688888; West Patsy, 1998, ENDURING SEMINOLES A; Wilkinson PM, 2016, COPEIA, V104, P843, DOI 10.1643/CH-16-430; Woods B., 2000, J TOURISM STUDIES, V11, P25; Zeppel H, 2014, HUM DIMENS WILDL, V13, P280, DOI [10.3727/154427308787716802, DOI 10.3727/154427308787716802]	86	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242106	10.1371/journal.pone.0242106	http://dx.doi.org/10.1371/journal.pone.0242106			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0NB	33186369	Green Published, gold			2022-12-26	WOS:000593949800027
J	Islam, SZ; Othman, ML; Saufi, M; Omar, R; Toudeshki, A; Islam, SZ; Suryawanshi, M; Suryawanshi, M				Islam, Syed Zahurul; Othman, Mohammad Lutfi; Saufi, Muhammad; Omar, Rosli; Toudeshki, Arash; Islam, Syed Zahidul; Suryawanshi, Mahesh; Suryawanshi, Mahesh			Photovoltaic modules evaluation and dry-season energy yield prediction model for NEM in Malaysia	PLOS ONE			English	Article							PERFORMANCE; TEMPERATURE; TECHNOLOGY; GENERATION; CELLS	This study analyzes the performance of two PV modules, amorphous silicon (a-Si) and crystalline silicon (c-Si) and predicts energy yield, which can be seen as facilitation to achieve the target of 35% reduction of greenhouse gases emission by 2030. Malaysia Energy Commission recommends crystalline PV modules for net energy metering (NEM), but the climate regime is a concern for output power and efficiency. Based on rainfall and irradiance data, this study aims to categorize the climate of peninsular Malaysia into rainy and dry seasons; and then the performance of the two modules are evaluated under the dry season. A new mathematical model is developed to predict energy yield and the results are validated through experimental and systematic error analysis. The parameters are collected using a self-developed ZigBeePRO-based wireless system with the rate of 3 samples/min over a period of five days. The results unveil that efficiency is inversely proportional to the irradiance due to negative temperature coefficient for crystalline modules. For this phenomenon, efficiency of c-Si (9.8%) is found always higher than a-Si (3.5%). However, a-Si shows better shadow tolerance compared to c-Si, observed from a lesser decrease rate in efficiency of the former with the increase in irradiance. Due to better spectrum response and temperature coefficient, a-Si shows greater performance on output power efficiency (OPE), performance ratio (PR), and yield factor. From the regression analysis, it is found that the coefficient of determination (R-2) is between 0.7179 and 0.9611. The energy from the proposed model indicates that a-Si yields 15.07% higher kWh than c-Si when luminance for recorded days is 70% medium and 30% high. This study is important to determine the highest percentage of energy yield and to get faster NEM payback period, where as of now, there is no such model to indicate seasonal energy yield in Malaysia.	[Islam, Syed Zahurul; Saufi, Muhammad; Omar, Rosli] Univ Tun Hussein Onn Malaysia UTHM, Fac Elect & Elect Engn, Parit Raja, Johor, Malaysia; [Othman, Mohammad Lutfi] Univ Putra Malaysia, Fac Engn, Dept Elect & Elect Engn Adv Lightning Power & Ene, Serdang, Selangor, Malaysia; [Toudeshki, Arash] Univ Calif Merced, Sch Engn, Merced, CA USA; [Islam, Syed Zahidul] Radiat Solut Inc, Mississauga, ON, Canada	Universiti Putra Malaysia; University of California System; University of California Merced	Islam, SZ (corresponding author), Univ Tun Hussein Onn Malaysia UTHM, Fac Elect & Elect Engn, Parit Raja, Johor, Malaysia.; Othman, ML (corresponding author), Univ Putra Malaysia, Fac Engn, Dept Elect & Elect Engn Adv Lightning Power & Ene, Serdang, Selangor, Malaysia.	zahurul@uthm.edu.my; lutfi@upm.edu.my	Omar, Rosli/AAR-1887-2021; Suryawanshi, Mahesh/U-3525-2019; Toudeshki, Arash/B-3469-2008	Suryawanshi, Mahesh/0000-0003-4711-7655; Toudeshki, Arash/0000-0003-3305-6126; Zahurul Islam, Syed/0000-0003-0069-5423; Omar, Rosli/0000-0001-5079-1515	Universiti Tun Hussein Onn Malaysia (UTHM) [E15501]; Geran Putra Berimpak, University Putra Malaysia (UPM) [9671700]	Universiti Tun Hussein Onn Malaysia (UTHM); Geran Putra Berimpak, University Putra Malaysia (UPM)	Syed Zahurul Islam, Research Management Center, Research Fund E15501, Universiti Tun Hussein Onn Malaysia (UTHM), www.uthm.edu.my.Mohammad Lutfi, 9671700, Geran Putra Berimpak, University Putra Malaysia (UPM), www.upm.edu.my.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Syed Zahidul Islam is an employee of the commercial Canadian company, Radiation Solutions Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Abdullah WSW, 2019, ENERGIES, V12, DOI 10.3390/en12122437; Adamo F, 2011, IEEE T INSTRUM MEAS, V60, P1613, DOI 10.1109/TIM.2011.2105051; Amin N, 2009, RENEW ENERG, V34, P1939, DOI 10.1016/j.renene.2008.12.005; [Anonymous], 2014, FOCUS SURFACTANTS, V5, P5, DOI [10.1016/S1351-4210(14)70123-4, DOI 10.1016/S1351-4210(14)70123-4]; Bashir MA, 2014, INT J PHOTOENERGY, V2014, DOI 10.1155/2014/898414; Bin Sopian K., 2007, INT J ENG TECHNOL, V4, P57; Carr AJ, 2004, SOL ENERGY, V76, P285, DOI 10.1016/j.solener.2003.07.026; Cristofari C, 2006, PROCEEDINGS OF THE SIXTH IASTED INTERNATIONAL CONFERENCE ON MODELLING, SIMULATION, AND OPTIMIZATION, P273; Energy Commision, 2020, PEN MAL EL SUPPL IND; Fraunhofer-Institute for Solar Energy Systems (ISE), 2015, STUD CURR FUT COST P; Gascon David, 2019, LIB WORLD 802 15 4 V; Ghazali M.A., 2012, ENERGY ENV RES, V2, P235, DOI [10.5539/eer.v2n1p235, DOI 10.5539/EER.V2N1P235]; Ghazi S, 2014, RENEW ENERG, V69, P50, DOI 10.1016/j.renene.2014.03.018; Giree N, 2013, REMOTE SENS-BASEL, V5, P1842, DOI 10.3390/rs5041842; Hanifi H, 2018, IEEE J PHOTOVOLT, V8, P1266, DOI 10.1109/JPHOTOV.2018.2841515; Heng SY, 2019, ENERG CONVERS MANAGE, V184, P127, DOI 10.1016/j.enconman.2019.01.059; Humada AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152766; Islam SN, 2016, INT CONF SMART GRID; Jie J, 2007, BUILD ENVIRON, V42, P3529, DOI 10.1016/j.buildenv.2006.10.038; Kardooni R, 2018, RENEW ENERG, V116, P659, DOI 10.1016/j.renene.2017.09.073; Kim GG, 2019, IEEE J PHOTOVOLT, V9, P832, DOI 10.1109/JPHOTOV.2019.2898521; Maghami M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135118; Malaysian Meteorological Department, 2019, MONTHLY WEATHER B; Meneses-Rodriguez D, 2005, SOL ENERGY, V78, P243, DOI 10.1016/j.solener.2004.05.016; Midtgard OM, 2010, RENEW ENERG, V35, P1266, DOI 10.1016/j.renene.2009.12.002; Mustafa NI, 2019, SOL ENERGY, V187, P379, DOI 10.1016/j.solener.2019.05.059; Ng YY, 2018, J ATMOS SOL-TERR PHY, V179, P128, DOI 10.1016/j.jastp.2018.01.004; Othman M. L., 2020, INT J POWER ELECT DR, V11, P667; Park M, 2004, IEEE T ENERGY CONVER, V19, P164, DOI 10.1109/TEC.2003.821837; Pour SH, 2020, ATMOS RES, V233, DOI 10.1016/j.atmosres.2019.104720; Qahtan AM, 2019, CASE STUD THERM ENG, V14, DOI 10.1016/j.csite.2019.100419; Sahraoui M, 2014, INT J SYST ASSUR ENG, V5, P337, DOI 10.1007/s13198-013-0173-6; Salameh T, 2020, ENERGY, V190, DOI 10.1016/j.energy.2019.116475; Sang Y, 2015, ANAL LONG TERM TREND; Shah SFA, 2019, IEEE ACCESS, V7, P161697, DOI 10.1109/ACCESS.2019.2951688; Sharp Solar, 2019, MON PHOT MOD NUS0E3E; Skoplaki E, 2009, SOL ENERGY, V83, P614, DOI 10.1016/j.solener.2008.10.008; Smyth M, 2019, RENEW ENERG, V137, P137, DOI 10.1016/j.renene.2018.04.017; Syafrina AH, 2015, THEOR APPL CLIMATOL, V120, P259, DOI 10.1007/s00704-014-1145-8; Takashima T, 2018, IEEE J PHOTOVOLT, V8, P1761, DOI 10.1109/JPHOTOV.2018.2868017; Touati FA, 2013, INT J GREEN ENERGY, V10, P680, DOI 10.1080/15435075.2012.692134; Vaka M, 2020, J CLEAN PROD, V273, DOI 10.1016/j.jclepro.2020.122834; Velilla E, 2019, SOL ENERG MAT SOL C, V191, P15, DOI 10.1016/j.solmat.2018.10.018; WALRAVEN R, 1978, SOL ENERGY, V20, P393, DOI 10.1016/0038-092X(78)90155-X; Yao W, 2019, ENERG POLICY, P111138; Zahurul S, 2016, RENEW SUST ENERG REV, V53, P978, DOI 10.1016/j.rser.2015.09.020; Zahurul S., 2014, International Journal of Smart Grid and Clean Energy, V3, P241; Zahurul S, 2015, 2015 IEEE INNOVATIVE SMART GRID TECHNOLOGIES - ASIA (ISGT ASIA); Zapata JW, 2015, IEEE J PHOTOVOLT, V5, P1748, DOI 10.1109/JPHOTOV.2015.2478069	49	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241927	10.1371/journal.pone.0241927	http://dx.doi.org/10.1371/journal.pone.0241927			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180779	gold, Green Published			2022-12-26	WOS:000593948000024
J	Moulin, K; Verzhbinsky, IA; Maforo, NG; Perotti, LE; Ennis, DB				Moulin, Kevin; Verzhbinsky, Ilya A.; Maforo, Nyasha G.; Perotti, Luigi E.; Ennis, Daniel B.			Probing cardiomyocyte mobility with multi-phase cardiac diffusion tensor MRI	PLOS ONE			English	Article							IN-VIVO; HUMAN HEART; MAGNETIC-RESONANCE; TIME; REPRODUCIBILITY; TRACTOGRAPHY; FIBER	Purpose Cardiomyocyte organization and performance underlie cardiac function, but the in vivo mobility of these cells during contraction and filling remains difficult to probe. Herein, a novel trigger delay (TD) scout sequence was used to acquire high in-plane resolution (1.6 mm) Spin-Echo (SE) cardiac diffusion tensor imaging (cDTI) at three distinct cardiac phases. The objective was to characterize cardiomyocyte organization and mobility throughout the cardiac cycle in healthy volunteers. Materials and methods Nine healthy volunteers were imaged with cDTI at three distinct cardiac phases (early systole, late systole, and diastasis). The sequence used a free-breathing Spin-Echo (SE) cDTI protocol (b-values = 350s/mm(2), twelve diffusion encoding directions, eight repetitions) to acquire high-resolution images (1.6x1.6x8mm(3)) at 3T in similar to 7 minutes/cardiac phase. Helix Angle (HA), Helix Angle Range (HAR), E2 angle (E2A), Transverse Angle (TA), Mean Diffusivity (MD), diffusion tensor eigenvalues (lambda(1-2-3)), and Fractional Anisotropy (FA) in the left ventricle (LV) were characterized. Results Images from the patient-specific TD scout sequence demonstrated that SE cDTI acquisition was possible at early systole, late systole, and diastasis in 78%, 100% and 67% of the cases, respectively. At the mid-ventricular level, mobility (reported as median [IQR]) was observed in HAR between early systole and late systole (76.9 [72.6, 80.5]degrees vs 96.6 [85.9, 100.3]degrees, p<0.001). E2A also changed significantly between early systole, late systole, and diastasis (27.7 [20.8, 35.1]degrees vs 45.2 [42.1, 49]degrees vs 20.7 [16.6, 26.4]degrees, p<0.001). Conclusion We demonstrate that it is possible to probe cardiomyocyte mobility using multi-phase and high resolution cDTI. In healthy volunteers, aggregate cardiomyocytes re-orient themselves more longitudinally during contraction, while cardiomyocyte sheetlets tilt radially during wall thickening. These observations provide new insights into the three-dimensional mobility of myocardial microstructure during systolic contraction.	[Moulin, Kevin; Verzhbinsky, Ilya A.; Ennis, Daniel B.] Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; [Moulin, Kevin; Verzhbinsky, Ilya A.; Maforo, Nyasha G.] Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90024 USA; [Maforo, Nyasha G.] Univ Calif Los Angeles, Phys & Biol Med IDP, Los Angeles, CA USA; [Perotti, Luigi E.] Univ Cent Florida, Dept Mech & Aerosp Engn, Orlando, FL 32816 USA	Stanford University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; State University System of Florida; University of Central Florida	Moulin, K (corresponding author), Stanford Univ, Dept Radiol, Stanford, CA 94305 USA.; Moulin, K (corresponding author), Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90024 USA.	kevin.moulin.26@gmail.com	Verzhbinsky, Ilya/GYD-5117-2022; Moulin, Kévin/AAC-4626-2022	Moulin, Kévin/0000-0002-9188-6403; Verzhbinsky, Ilya/0000-0002-7890-8559; Ennis, Daniel/0000-0001-7435-1311	NIH/NHLBI [R01-HL131975, R01-HL131823, K25-HL135408]; NSF [DGE 1650604]; AHA [20POST35210644]	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NSF(National Science Foundation (NSF)); AHA(American Heart Association)	This work was supported by NIH/NHLBI R01-HL131975, R01-HL131823, K25-HL135408 grants, by NSF DGE 1650604 grant, and by AHA 20POST35210644 grant. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aliotta E, 2018, MAGN RESON MED, V80, P1074, DOI 10.1002/mrm.27107; Aliotta E, 2017, MAGN RESON MED, V77, P717, DOI 10.1002/mrm.26166; [Anonymous], 2018, IUVA NEWS, V20, P1, DOI DOI 10.1007/S42341-018-00089-0; Axel L, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0089-6; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Chen JJ, 2005, AM J PHYSIOL-HEART C, V289, pH1898, DOI 10.1152/ajpheart.00041.2005; Dou JG, 2002, MAGNET RESON MED, V48, P105, DOI 10.1002/mrm.10188; FEINBERG DA, 1985, RADIOLOGY, V156, P743, DOI 10.1148/radiology.156.3.4023236; Ferreira PF, 2018, MAGN RESON MED, V79, P2205, DOI 10.1002/mrm.26850; Ferreira PF, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0087-8; Ghonim S, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00030; Gorodezky M, 2018, MAGN RESON MED, V80, P648, DOI 10.1002/mrm.27051; Gotschy A, 2019, J CARDIOVASC MAGN R, V21, DOI 10.1186/s12968-019-0563-2; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Kingsley PB, 2006, CONCEPT MAGN RESON A, V28A, P155, DOI 10.1002/cmr.a.20050; Lombaert H, 2012, IEEE T MED IMAGING, V31, P1436, DOI 10.1109/TMI.2012.2192743; Luk A, 2009, J CLIN PATHOL, V62, P219, DOI 10.1136/jcp.2008.060731; McClymont D, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-017-0395-x; Mekkaoui C, 2017, RADIOLOGY, V282, P850, DOI 10.1148/radiol.2016152613; Modesto K, 2014, PROG CARDIOVASC DIS, V57, P111, DOI 10.1016/j.pcad.2014.03.003; Moulin K, 2019, MAGN RESON MED, V81, P1521, DOI 10.1002/mrm.27490; Moulin K, 2016, MAGN RESON MED, V76, P70, DOI 10.1002/mrm.25852; Nielles-Vallespin S, 2017, J AM COLL CARDIOL, V69, P661, DOI 10.1016/j.jacc.2016.11.051; Nielles-Vallespin S, 2013, MAGN RESON MED, V70, P454, DOI 10.1002/mrm.24488; Olivotto I, 2009, NAT REV CARDIOL, V6, P317, DOI 10.1038/nrcardio.2009.9; Omann C, 2019, J CARDIOVASC MAGN R, V21, DOI 10.1186/s12968-019-0547-2; Pashakhanloo F, 2017, J CARDIOVASC MAGN R, V19, DOI 10.1186/s12968-016-0317-3; Rapacchi S, 2011, INVEST RADIOL, V46, P751, DOI 10.1097/RLI.0b013e31822438e8; Stoeck CT, 2016, MAGN RESON MED, V75, P1669, DOI 10.1002/mrm.25784; Stoeck CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107159; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Tseng WI, 1999, MAGNET RESON MED, V42, P393, DOI 10.1002/(SICI)1522-2594(199908)42:2<393::AID-MRM22>3.0.CO;2-F; van Gorkum RJH, 2020, MAGN RESON MED, V84, P2561, DOI 10.1002/mrm.28318; von Deuster C, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.116.005018; von Deuster C, 2016, MAGN RESON MED, V76, P862, DOI 10.1002/mrm.25998; Wei HJ, 2015, IEEE T MED IMAGING, V34, P306, DOI 10.1109/TMI.2014.2356792; Welsh CL, 2015, IEEE T MED IMAGING, V34, P1843, DOI 10.1109/TMI.2015.2411571	37	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241996	10.1371/journal.pone.0241996	http://dx.doi.org/10.1371/journal.pone.0241996			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180823	gold, Green Published			2022-12-26	WOS:000593948000043
J	Goyal, G; Elsbree, N; Fero, M; Hillson, NJ; Linshiz, G				Goyal, Garima; Elsbree, Nick; Fero, Michael; Hillson, Nathan J.; Linshiz, Gregory			Repurposing a microfluidic formulation device for automated DNA construction	PLOS ONE			English	Article							CONTINUOUS-FLOW PCR; PLATFORM	Microfluidic applications have expanded greatly over the past decade. For the most part, however, each microfluidics platform is developed with a specific task in mind, rather than as a general-purpose device with a wide-range of functionality. Here, we show how a microfluidic system, originally developed to investigate protein phase behavior, can be modified and repurposed for another application, namely DNA construction. We added new programable controllers to direct the flow of reagents across the chip. We designed the assembly of a combinatorial Golden Gate DNA library using TeselaGen DESIGN software and used the repurposed microfluidics platform to assemble the designed library from off-chip prepared DNA assembly pieces. Further experiments verified the sequences and function of the on-chip assembled DNA constructs.	[Goyal, Garima; Hillson, Nathan J.; Linshiz, Gregory] DOE Joint BioEnergy Inst, Technol Div, Emeryville, CA 94608 USA; [Goyal, Garima; Hillson, Nathan J.; Linshiz, Gregory] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA; [Elsbree, Nick; Fero, Michael] TeselaGen Biotechnol, San Francisco, CA USA	United States Department of Energy (DOE); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Linshiz, G (corresponding author), DOE Joint BioEnergy Inst, Technol Div, Emeryville, CA 94608 USA.; Linshiz, G (corresponding author), Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Berkeley, CA 94720 USA.	gregory.linshiz@gmail.com			NSF SBIR grant [IIP-1430986]; U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research; NSF SBIR; DOE Joint BioEnergy Institute - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]	NSF SBIR grant(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NSF SBIR(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); DOE Joint BioEnergy Institute - U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE))	The study was supported by NSF SBIR grant IIP-1430986 and the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research. Work conducted at TeselaGen Biotechnology by MF and NE was funded by NSF SBIR. Work conducted at JBEI by GG, NJH, and GL was funded by the DOE Joint BioEnergy Institute (https://www.jbei.org) supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the U.S. Department of Energy. The funding agencies provided support in the form of labor and supplies costs for authors GG, NE, MF, NJH, and GL. The funding agencies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. We declare that this work was done in a collaboration with TeselaGen Biotechnology, which is a commercial entity.	[Anonymous], 2012, NUCLEIC ACIDS RES, V40, pD71; Brower K, 2018, HARDWAREX, V3, P117, DOI 10.1016/j.ohx.2017.10.001; Chen J, 2012, J BIOL ENG, V6, DOI 10.1186/1754-1611-6-1; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Eland LE, 2016, METHOD MICROBIOL, V43, P69, DOI 10.1016/bs.mim.2016.10.002; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2011, METHODS MOL BIOL, V729, P167, DOI 10.1007/978-1-61779-065-2_11; Engler C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005553; Gach PC, 2016, ACS SYNTH BIOL, V5, P426, DOI 10.1021/acssynbio.6b00011; Hansen CL, 2004, P NATL ACAD SCI USA, V101, P14431, DOI 10.1073/pnas.0405847101; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Jiang XR, 2014, TALANTA, V122, P246, DOI 10.1016/j.talanta.2014.01.053; Ko YJ, 2011, SENSOR ACTUAT B-CHEM, V157, P735, DOI 10.1016/j.snb.2011.05.016; Linshiz G, 2016, J BIOL ENG, V10, DOI 10.1186/s13036-016-0024-5; Linshiz G, 2014, ACS SYNTH BIOL, V3, P515, DOI 10.1021/sb4001728; Linshiz G, 2013, ACS SYNTH BIOL, V2, P216, DOI 10.1021/sb300075t; Murphy TW, 2020, ANAL CHEM, V92, P2519, DOI 10.1021/acs.analchem.9b04086; Mutalik VK, 2013, NAT METHODS, V10, P354, DOI [10.1038/NMETH.2404, 10.1038/nmeth.2404]; Nakayama T, 2006, ANAL BIOANAL CHEM, V386, P1327, DOI 10.1007/s00216-006-0688-7; Poust S, 2014, CURR OPIN BIOTECH, V30, P32, DOI 10.1016/j.copbio.2014.04.011; Shih SCC, 2015, ACS SYNTH BIOL, V4, P1151, DOI 10.1021/acssynbio.5b00062; Venken L, 2013, ACM J EMERG TECH COM, V9, DOI 10.1145/2504775; Zhang CS, 2006, BIOTECHNOL ADV, V24, P243, DOI 10.1016/j.biotechadv.2005.10.002; Zhao DD, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0605-5	24	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242157	10.1371/journal.pone.0242157	http://dx.doi.org/10.1371/journal.pone.0242157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175889	gold, Green Submitted, Green Published			2022-12-26	WOS:000593946900049
J	Nead, KT; Mitra, N; Weathers, B; Pyle, L; Emechebe, N; Pucci, DA; Jacobs, LA; Vaughn, DJ; Nathanson, KL; Kanetsky, PA				Nead, Kevin T.; Mitra, Nandita; Weathers, Benita; Pyle, Louisa; Emechebe, Nnadozie; Pucci, Donna A.; Jacobs, Linda A.; Vaughn, David J.; Nathanson, Katherine L.; Kanetsky, Peter A.			Lower abdominal and pelvic radiation and testicular germ cell tumor risk	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; IONIZING-RADIATION; CANCER INCIDENCE; BREAST-CANCER; YOUNG MEN; EXPOSURE	Background Testicular germ cell tumor (TGCT) incidence has increased in recent decades along with the use and dose of diagnostic radiation. Here we examine the association between reported exposure to diagnostic radiation and TGCT risk. Methods We conducted a case-control study of men with and without TGCT recruited from hospital- and population-based settings. Participants reported on exposures to 1) x-ray or CT below the waist and 2) lower GI series or barium enema, which consists of a series of x-rays of the colon. We also derived a combined measure of exposure. We used logistic regression to determine the risk of developing TGCT according to categories of exposures (0, 1-2, or >= 3 exposures) and age at first exposure, adjusting for age, year of birth, race, county, body mass index at diagnosis, family history of TGCT, and personal history of cryptorchidism. Results There were 315 men with TGCT and 931 men without TGCT in our study. Compared to no exposures, risk of TGCT was significantly elevated among those reporting at least three exposures to x-ray or CT (OR >= 3 exposures, 1.78; 95% CI, 1.15-2.76; p = 0.010), lower GI series or barium enema (OR >= 3 exposures, 4.58; 95% CI, 2.39-8.76; p<0.001), and the combined exposure variable (OR >= 3 exposures, 1.59; 95% CI, 1.05-2.42; p = 0.029). The risk of TGCT was elevated for those exposed to diagnostic radiation at age 0-10 years, compared to those first exposed at age 18 years or later, although this association did not reach statistical significance (OR, 2.00; 95% CI, 0.91-4.42; p = 0.086). Conclusions Exposure to diagnostic radiation below the waist may increase TGCT risk. If these results are validated, efforts to reduce diagnostic radiation doses to the testes should be prioritized.	[Nead, Kevin T.] Univ Penn, Perelman Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; [Nead, Kevin T.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Dept Epidemiol, Houston, TX 77030 USA; [Mitra, Nandita] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Weathers, Benita; Pyle, Louisa; Nathanson, Katherine L.] Univ Penn, Dept Med, Perelman Sch Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA; [Pyle, Louisa] Childrens Hosp Philadelphia, Div Human Genet & Metab, Philadelphia, PA 19104 USA; [Emechebe, Nnadozie; Kanetsky, Peter A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL 33612 USA; [Emechebe, Nnadozie] Univ S Florida, Coll Publ Hlth, Dept Epidemiol & Biostat, Tampa, FL 33620 USA; [Pucci, Donna A.; Jacobs, Linda A.; Vaughn, David J.] Univ Penn, Dept Med, Perelman Sch Med, Div Hematol Oncol, Philadelphia, PA 19104 USA; [Jacobs, Linda A.; Vaughn, David J.; Nathanson, Katherine L.] Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Nathanson, KL (corresponding author), Univ Penn, Dept Med, Perelman Sch Med, Div Translat Med & Human Genet, Philadelphia, PA 19104 USA.; Nathanson, KL (corresponding author), Univ Penn, Perelman Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA.	knathans@upenn.edu	Pyle, Louise C/AAR-3513-2021	Pyle, Louise C/0000-0002-8933-9320	National Institutes of Health National Cancer Institute [U01 CA164947, R01 CA114478]; National Institutes of Health CCSG [P30 CA016672]; American Board of Radiology Holman Research Pathway	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health CCSG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Board of Radiology Holman Research Pathway	This research has been supported by grants from the National Institutes of Health National Cancer Institute (www.cancer.gov) grants -U01 CA164947 and R01 CA114478 to K.L.N. and P.A.K. K.T.N was supported, in part, by National Institutes of Health CCSG P30 CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the study participants. K.T.N. was supported through the American Board of Radiology Holman Research Pathway and is currently a CPRIT Scholar in Cancer Research.	Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; BROWN LM, 1987, J EPIDEMIOL COMMUN H, V41, P349, DOI 10.1136/jech.41.4.349; Chesi A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09302-x; Chung CC, 2013, NAT GENET, V45, P680, DOI 10.1038/ng.2634; Clagett B, 2013, AM J EPIDEMIOL, V178, P1638, DOI 10.1093/aje/kwt164; COUGHLIN SS, 1990, J CLIN EPIDEMIOL, V43, P87, DOI 10.1016/0895-4356(90)90060-3; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Doody MM, 2000, SPINE, V25, P2052; Fawcett SL, 2009, BRIT J RADIOL, V82, P363, DOI 10.1259/bjr/86609718; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Goske MJ, 2008, AM J ROENTGENOL, V190, P273, DOI 10.2214/AJR.07.3526; Grobe H, 2009, EUR RADIOL, V19, P1156, DOI 10.1007/s00330-008-1241-1; Hall EJ, 2008, BRIT J RADIOL, V81, P362, DOI 10.1259/bjr/01948454; HOFFMAN DA, 1989, J NATL CANCER I, V81, P1307, DOI 10.1093/jnci/81.17.1307; Howlader N., 2016, SEER CANC STAT REV 1; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Memon A, 2010, ACTA ONCOL, V49, P447, DOI 10.3109/02841861003705778; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Mitchel R. E. J., 2006, Dose-Response, V4, P75, DOI 10.2203/dose-response.04-002.Mitchel; Moller H, 2007, INT J ANDROL, V30, P240; Motzer RJ, 2015, J NATL COMPR CANC NE, V13, P772, DOI 10.6004/jnccn.2015.0092; Noone AM, 2018, SEER CANC STAT REV 1; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Richiardi L, 2007, INT J ANDROL, V30, P230, DOI 10.1111/j.1365-2605.2007.00760.x; Shankar S, 2006, CANCER-AM CANCER SOC, V106, P1169, DOI 10.1002/cncr.21670; THOMPSON DE, 1994, RADIAT RES, V137, pS17, DOI 10.2307/3578892; Vaiserman AM, 2010, DOSE-RESPONSE, V8, P172, DOI 10.2203/dose-response.09-037.Vaiserman; Yousif L, 2010, J RADIOL PROT, V30, P389, DOI 10.1088/0952-4746/30/3/R01; Znaor A, 2014, EUR UROL, V65, P1095, DOI 10.1016/j.eururo.2013.11.004	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0239321	10.1371/journal.pone.0239321	http://dx.doi.org/10.1371/journal.pone.0239321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175879	Green Published, gold			2022-12-26	WOS:000593946900018
J	Luo, C; Franchak, JM				Luo, Chuan; Franchak, John M.			Head and body structure infants' visual experiences during mobile, naturalistic play	PLOS ONE			English	Article							JOINT ATTENTION; EYE-MOVEMENTS; COORDINATION; CHILDREN; MEMORY; VIEW	Infants' visual experiences are important for learning, and may depend on how information is structured in the visual field. This study examined how objects are distributed in 12-month-old infants' field of view in a mobile play setting. Infants wore a mobile eye tracker that recorded their field of view and eye movements while they freely played with toys and a caregiver. We measured how centered and spread object locations were in infants' field of view, and investigated how infant posture, object looking, and object distance affected the centering and spread. We found that far toys were less centered in infants' field of view while infants were prone compared to when sitting or upright. Overall, toys became more centered in view and less spread in location when infants were looking at toys regardless of posture and toy distance. In sum, this study showed that infants' visual experiences are shaped by the physical relation between infants' bodies and the locations of objects in the world. However, infants are able to compensate for postural and environmental constraints by actively moving their head and eyes when choosing to look at an object.	[Luo, Chuan; Franchak, John M.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Franchak, JM (corresponding author), Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA.	john.franchak@ucr.edu		Franchak, John/0000-0002-0751-2864				Adolph K.E., 2015, HDB CHILD PSYCHOL DE, V7th ed., P114, DOI DOI 10.1002/9781118963418.CHILDPSY204; [Anonymous], 2019, R LANG ENV STAT COMP; ASLIN RN, 1975, PERCEPT PSYCHOPHYS, V17, P293, DOI 10.3758/BF03203214; BIGUER B, 1984, EXP BRAIN RES, V55, P462; CASARES Aurelia MARTIN, 2000, ARENAL, V7, P43; Choudhury N, 2000, INFANT CHILD DEV, V9, P127, DOI 10.1002/1522-7219(200009)9:3<127::AID-ICD225>3.0.CO;2-5; Clerkin EM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0055; COLOMBO J, 1989, INTELLIGENCE, V13, P33, DOI 10.1016/0160-2896(89)90004-4; Colombo J, 2001, ANNU REV PSYCHOL, V52, P337, DOI 10.1146/annurev.psych.52.1.337; Dunham DN, 1997, INT J PSYCHOPHYSIOL, V27, P171, DOI 10.1016/S0167-8760(97)00054-8; Einhauser W, 2007, NETWORK-COMP NEURAL, V18, P267, DOI 10.1080/09548980701671094; Einhauser W, 2009, ANN NY ACAD SCI, V1164, P188, DOI 10.1111/j.1749-6632.2008.03714.x; Estigarribia B, 2007, J CHILD LANG, V34, P799, DOI 10.1017/S0305000907008161; Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; Franchak JM, 2016, INT C INF STUD NEW O; Franchak JM, 2015, P ANN M COGN SCI SOC; Franchak JM, 2020, PSYCHOL LEARN MOTIV, V73, P59, DOI 10.1016/bs.plm.2020.07.001; Franchak JM, 2020, CURR OPIN PSYCHOL, V32, P110, DOI 10.1016/j.copsyc.2019.06.035; Franchak JM, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12626; Franchak JM, 2011, CHILD DEV, V82, P1738, DOI 10.1111/j.1467-8624.2011.01670.x; Franchak JM, 2010, VISION RES, V50, P2766, DOI 10.1016/j.visres.2010.09.024; Frank MC, 2013, P ANN M COGN SCI SOC; Ganek H, 2018, J COMMUN DISORD, V72, P77, DOI 10.1016/j.jcomdis.2017.12.005; GIBSON EJ, 1988, ANNU REV PSYCHOL, V39, P1, DOI 10.1146/annurev.ps.39.020188.000245; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Hayhoe MM, 2003, J VISION, V3, P49, DOI 10.1167/3.1.6; Kretch KS, 2014, CHILD DEV, V85, P1503, DOI 10.1111/cdev.12206; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Land MF, 2001, VISION RES, V41, P3559, DOI 10.1016/S0042-6989(01)00102-X; Land MF, 2006, PROG RETIN EYE RES, V25, P296, DOI 10.1016/j.preteyeres.2006.01.002; Lawson KR, 2004, INT J BEHAV DEV, V28, P157, DOI 10.1080/01650250344000361; Luke SG, 2017, BEHAV RES METHODS, V49, P1494, DOI 10.3758/s13428-016-0809-y; Mundy P, 2007, CURR DIR PSYCHOL SCI, V16, P269, DOI 10.1111/j.1467-8721.2007.00518.x; Nakashima R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092284; Oakes LM, 2012, INFANCY, V17, P1, DOI 10.1111/j.1532-7078.2011.00101.x; Pelz J, 2001, EXP BRAIN RES, V139, P266, DOI 10.1007/s002210100745; Ramirez-Esparza N, 2017, CHILD DEV, V88, P1216, DOI 10.1111/cdev.12648; Richmond J, 2009, DEVELOPMENTAL SCI, V12, P549, DOI 10.1111/j.1467-7687.2009.00795.x; Ruff Holly A., 1996, ATTENTION EARLY DEV; Sanchez A, 2018, P ANN M COGN SCI SOC; Satterthwaite FE, 1941, PSYCHOMETRIKA, V6, P309, DOI 10.1007/BF02288586; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Slone LK, 2018, JOVE-J VIS EXP, DOI 10.3791/58496; Smeets JBJ, 1996, EXP BRAIN RES, V109, P434; Smith LB, 2011, DEVELOPMENTAL SCI, V14, P9, DOI 10.1111/j.1467-7687.2009.00947.x; Solman GJF, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160569; Soska KC, 2010, DEV PSYCHOL, V46, P129, DOI 10.1037/a0014618; TOMASELLO M, 1986, CHILD DEV, V57, P1454, DOI 10.2307/1130423; Walle E, 2015, P ANN M COGN SCI SOC; Wass S, 2011, CURR BIOL, V21, P1543, DOI 10.1016/j.cub.2011.08.004; Weisleder A, 2013, PSYCHOL SCI, V24, P2143, DOI 10.1177/0956797613488145; Yamamoto H, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02987; Yoshida H, 2008, INFANCY, V13, P229, DOI 10.1080/15250000802004437; Yu C, 2012, COGNITION, V125, P244, DOI 10.1016/j.cognition.2012.06.016; Yu C, 2009, IEEE T AUTON MENT DE, V1, P141, DOI 10.1109/TAMD.2009.2031513; Yu CC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056667, 10.1371/journal.pone.0054627]; Zukow-Goldring P., 2012, LANG SCI, V34, P559, DOI DOI 10.1016/j.langsci.2012.03.011	57	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0242009	10.1371/journal.pone.0242009	http://dx.doi.org/10.1371/journal.pone.0242009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7KH	33170881	gold, Green Published			2022-12-26	WOS:000592383400052
J	Baksh, KA; Pichugin, D; Prosser, RS; Zamble, DB				Baksh, Karina A.; Pichugin, Dmitry; Prosser, Robert Scott; Zamble, Deborah B.			Allosteric regulation of the nickel-responsive NikR transcription factor from Helicobacter pylori	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; DNA-BINDING; UREASE EXPRESSION; METAL-BINDING; WILD-TYPE; OPERATOR; NI2+; PH; METALLOREGULATION; COORDINATION	Nickel is essential for the survival of the pathogenic bacteria Helicobacter pylori in the fluctuating pH of the human stomach. Due to its inherent toxicity and limited availability, nickel homeostasis is maintained through a network of pathways that are coordinated by the nickel-responsive transcription factor NikR. Nickel binding to H. pylori NikR (HpNikR) induces an allosteric response favoring a conformation that can bind specific DNA motifs, thereby serving to either activate or repress transcription of specific genes involved in nickel homeostasis and acid adaptation. Here, we examine how nickel induces this response using 19F-NMR, which reveals conformational and dynamic changes associated with nickel-activated DNA complex formation. HpNikR adopts an equilibrium between an open state and DNA-binding competent states regardless of nickel binding, but a higher level of dynamics is observed in the absence of metal. Nickel binding shifts the equilibrium toward the binding-competent states and decreases the mobility of the DNA-binding domains. The nickelbound protein is then able to adopt a single conformation upon binding a target DNA promoter. Zinc, which does not promote high-affinity DNA binding, is unable to induce the same allosteric response as nickel. We propose that the allosteric mechanism of nickel-activated DNA binding by HpNikR is driven by conformational selection.	[Baksh, Karina A.; Prosser, Robert Scott; Zamble, Deborah B.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Pichugin, Dmitry; Prosser, Robert Scott; Zamble, Deborah B.] Univ Toronto, Dept Chem, Toronto, ON, Canada	University of Toronto; University of Toronto	Prosser, RS (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.; Prosser, RS (corresponding author), Univ Toronto, Dept Chem, Toronto, ON, Canada.	scott.prosser@utoronto.ca		Pichugin, Dmitry/0000-0003-3730-0931; Prosser, Robert Scott/0000-0001-9351-178X; Baksh, Karina/0000-0001-7706-3251	Canadian Institutes of Health Research [MOP-123483]; Natural Sciences and Engineering Research Council of Canada [418679]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors acknowledge funding from the Canadian Institutes of Health Research (MOP-123483 to D. B. Z) and the Natural Sciences and Engineering Research Council of Canada Discovery grants (project #418679 to R. S. P).	Abraham LO, 2006, J INORG BIOCHEM, V100, P1005, DOI 10.1016/j.jinorgbio.2005.10.014; Ansari S, 2017, HELICOBACTER, V22, DOI 10.1111/hel.12386; Bahlawane C, 2010, NUCLEIC ACIDS RES, V38, P3106, DOI 10.1093/nar/gkp1216; Baksh KA, 2020, J BIOL CHEM, V295, P1673, DOI 10.1074/jbc.REV119.011444; Bauerfeind P, 1997, GUT, V40, P25, DOI 10.1136/gut.40.1.25; Benanti EL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.196055; Benini S, 2011, DALTON T, V40, P7831, DOI 10.1039/c1dt11107h; Benoit SL, 2008, ANN NY ACAD SCI, V1125, P242, DOI 10.1196/annals.1419.014; Capdevila DA, 2018, ELIFE, V7, DOI 10.7554/eLife.37268; Capdevila DA, 2018, J AM CHEM SOC, V140, P9108, DOI 10.1021/jacs.8b02129; Capdevila DA, 2017, ESSAYS BIOCHEM, V61, P177, DOI 10.1042/EBC20160076; Capdevila DA, 2017, P NATL ACAD SCI USA, V114, P4424, DOI 10.1073/pnas.1620665114; Chivers PT, 2005, J MOL BIOL, V348, P597, DOI 10.1016/j.jmb.2005.03.017; Chivers PT, 2000, J BIOL CHEM, V275, P19735, DOI 10.1074/jbc.M002232200; Cioni P, 2002, BIOPHYS J, V82, P3246, DOI 10.1016/S0006-3495(02)75666-X; Contreras M, 2003, MOL MICROBIOL, V49, P947, DOI 10.1046/j.1365-2958.2003.03621.x; de Reuse H, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00094; Delany I, 2005, J BACTERIOL, V187, P7703, DOI 10.1128/JB.187.22.7703-7715.2005; Dian C, 2006, J MOL BIOL, V361, P715, DOI 10.1016/j.jmb.2006.06.058; Dosanjh NS, 2006, CURR OPIN CHEM BIOL, V10, P123, DOI 10.1016/j.cbpa.2006.02.011; Dosanjh NS, 2007, BIOCHEMISTRY-US, V46, P2520, DOI 10.1021/bi062092w; Dosanjh NS, 2009, BIOCHEMISTRY-US, V48, P527, DOI 10.1021/bi801481j; Evans SE, 2012, DALTON T, V41, P7946, DOI 10.1039/c2dt30504f; Fabini E, 2016, ANAL BIOANAL CHEM, V408, P7971, DOI 10.1007/s00216-016-9894-0; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GERIG JT, 1994, PROG NUCL MAG RES SP, V26, P293, DOI 10.1016/0079-6565(94)80009-X; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; Guerra AJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P210, DOI 10.1016/j.abb.2011.11.021; Higgins K. A., 2013, ENCY INORGANIC BIOIN, P1; HOPFER SM, 1989, ANN CLIN LAB SCI, V19, P161; Jones MD, 2015, METALLOMICS, V7, P662, DOI 10.1039/c4mt00210e; Jones M. D., 2013, ENCY INORGANIC BIOIN, P1; Kim TH, 2013, J AM CHEM SOC, V135, P9465, DOI 10.1021/ja404305k; Kitevski-LeBlanc JL, 2012, PROG NUCL MAG RES SP, V62, P1, DOI 10.1016/j.pnmrs.2011.06.003; Kitevski-LeBlanc JL, 2009, J BIOMOL NMR, V45, P255, DOI 10.1007/s10858-009-9359-2; Krecisz S, 2012, BIOCHEMISTRY-US, V51, P7873, DOI 10.1021/bi300510z; Lakowicz J. R., 2006, PRINCIPLES FLUORESCE, V3rd, P353; Ma Z, 2009, CHEM REV, V109, P4644, DOI 10.1021/cr900077w; Macomber L, 2011, METALLOMICS, V3, P1153, DOI 10.1039/c1mt00063b; MARSHALL BJ, 1984, LANCET, V1, P1311; Mazzei L, 2015, J BIOL INORG CHEM, V20, P1021, DOI 10.1007/s00775-015-1284-0; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Muller C, 2011, NUCLEIC ACIDS RES, V39, P7564, DOI 10.1093/nar/gkr460; Musiani F, 2015, METALLOMICS, V7, P1305, DOI 10.1039/c5mt00072f; Musiani F, 2010, J CHEM THEORY COMPUT, V6, P3503, DOI 10.1021/ct900635z; Olson JW, 2002, SCIENCE, V298, P1788, DOI 10.1126/science.1077123; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Paul NK, 2020, PROTEIN EXPRES PURIF, V167, DOI 10.1016/j.pep.2019.105541; Phillips CM, 2008, BIOCHEMISTRY-US, V47, P1938, DOI 10.1021/bi702006h; Phillips CM, 2010, BIOCHEMISTRY-US, V49, P7830, DOI 10.1021/bi100923j; QUIGLEY EMM, 1987, GASTROENTEROLOGY, V92, P1876, DOI 10.1016/0016-5085(87)90619-6; Reyes-Caballero H, 2011, BIOPHYS CHEM, V156, P103, DOI 10.1016/j.bpc.2011.03.010; RULE GS, 1987, BIOCHEMISTRY-US, V26, P549, DOI 10.1021/bi00376a029; Rulisek L, 1998, J INORG BIOCHEM, V71, P115, DOI 10.1016/S0162-0134(98)10042-9; Schreiter ER, 2003, NAT STRUCT BIOL, V10, P794, DOI 10.1038/nsb985; Schreiter ER, 2006, P NATL ACAD SCI USA, V103, P13676, DOI 10.1073/pnas.0606247103; Sibony M, 2012, CURR OPIN GASTROEN, V28, P30, DOI 10.1097/MOG.0b013e32834dda51; Sjostrom JE, 1996, J MED MICROBIOL, V44, P425; Stingl K, 2002, J BACTERIOL, V184, P3053, DOI 10.1128/JB.184.11.3053-3060.2002; Stoof J, 2010, BIOMETALS, V23, P145, DOI 10.1007/s10534-009-9275-7; SUNDERMAN FW, 1993, SCAND J WORK ENV HEA, V19, P34; Sydor AM, 2013, METAL IONS LIFE SCI, V12, P375, DOI 10.1007/978-94-007-5561-1_11; Tataurov AV, 2008, BIOPHYS CHEM, V133, P66, DOI 10.1016/j.bpc.2007.12.004; van Vliet AHM, 2002, INFECT IMMUN, V70, P2846, DOI 10.1128/IAI.70.6.2846-2852.2002; van Vliet AHM, 2001, INFECT IMMUN, V69, P4891, DOI 10.1128/IAI.69.8.4891-4897.2001; Vannini A, 2017, SCI REP-UK, V7, DOI 10.1038/srep45458; Wang F, 2014, CANCER LETT, V345, P196, DOI 10.1016/j.canlet.2013.08.016; Wang SC, 2004, BIOCHEMISTRY-US, V43, P10018, DOI 10.1021/bi049405c; West AL, 2012, P NATL ACAD SCI USA, V109, P5633, DOI 10.1073/pnas.1120283109; West AL, 2010, J AM CHEM SOC, V132, P14447, DOI 10.1021/ja104118r; Zambelli B, 2008, J MOL BIOL, V383, P1129, DOI 10.1016/j.jmb.2008.08.066; Zambelli B, 2007, CHEM COMMUN, P3649, DOI 10.1039/b706025d	72	2	3	4	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100069	10.1074/jbc.RA120.015459	http://dx.doi.org/10.1074/jbc.RA120.015459			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33199369	Green Published, gold			2022-12-26	WOS:000672866400050
J	Wangeline, MA; Hampton, RY				Wangeline, Margaret A.; Hampton, Randolph Y.			An autonomous, but INSIG-modulated, role for the sterol sensing domain in mallostery-regulated ERAD of yeast HMG-CoA reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; PROTEIN-QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; 3-HYDROXY-3-METHYLGLUTARYL-COA REDUCTASE; MEMBRANE-PROTEIN; CHOLESTEROL-SYNTHESIS; MEDIATED DEGRADATION; UBIQUITIN LIGASES; SCAP PROTEIN; BINDING	HMG-CoA reductase (HMGR) undergoes feedback-regulated degradation as part of sterol pathway control. Degradation of the yeast HMGR isozyme Hmg2 is controlled by the sterol pathway intermediate GGPP, which causes misfolding of Hmg2, leading to degradation by the HRD pathway; we call this process mallostery. We evaluated the role of the Hmg2 sterol sensing domain (SSD) in mallostery, as well as the involvement of the highly conserved INSIG proteins. We show that the Hmg2 SSD is critical for regulated degradation of Hmg2 and required for mallosteric misfolding of GGPP as studied by in vitro limited proteolysis. The Hmg2 SSD functions independently of conserved yeast INSIG proteins, but its function was modulated by INSIG, thus imposing a second layer of control on Hmg2 regulation. Mutant analyses indicated that SSD-mediated mallostery occurred prior to and independent of HRD-dependent ubiquitination. GGPP-dependent misfolding was still extant but occurred at a much slower rate in the absence of a functional SSD, indicating that the SSD facilitates a physiologically useful rate of GGPP response and implying that the SSD is not a binding site for GGPP. Nonfunctional SSD mutants allowed us to test the importance of Hmg2 quaternary structure in mallostery: a nonresponsive Hmg2 SSD mutant strongly suppressed regulation of a coexpressed, normal Hmg2. Finally, we have found that GGPP-regulated misfolding occurred in detergent-solubilized Hmg2, a feature that will allow next-level analysis of the mechanism of this novel tactic of ligand-regulated misfolding.	[Wangeline, Margaret A.; Hampton, Randolph Y.] UCSD, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), UCSD, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	rhampton@ucsd.edu			National Institutes of Health [5 R37 DK051996]; CMG Training Program [5T32GM007240]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CMG Training Program	This work was supported by National Institutes of Health grant 5 R37 DK051996 to 24 (R. Y. H. PI) and the CMG Training Program 5T32GM007240 (M. A. W. Trainee). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; BETZ JL, 1988, GENE, V67, P147, DOI 10.1016/0378-1119(88)90392-7; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Davies JP, 2000, J BIOL CHEM, V275, P24367, DOI 10.1074/jbc.M002184200; Davies JP, 2000, GENOMICS, V65, P137, DOI 10.1006/geno.2000.6151; EISENSTEIN E, 1992, J BIOL CHEM, V267, P22148; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Foresti O, 2013, ELIFE, V2, DOI 10.7554/eLife.00953; Fuhrer F, 2006, MOL MICROBIOL, V59, P1025, DOI 10.1111/j.1365-2958.2005.04994.x; Gao YS, 2017, J BIOL CHEM, V292, P8729, DOI 10.1074/jbc.M117.783894; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gardner RG, 1999, J BIOL CHEM, V274, P31671, DOI 10.1074/jbc.274.44.31671; Gardner RG, 2001, J BIOL CHEM, V276, P8681, DOI 10.1074/jbc.M007888200; Garza RM, 2009, J BIOL CHEM, V284, P35368, DOI 10.1074/jbc.M109.023994; Gong X, 2016, CELL, V165, P1467, DOI 10.1016/j.cell.2016.05.022; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hausmann G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000146; Hughes AL, 2008, J LIPID RES, V49, P2001, DOI 10.1194/jlr.M800207-JLR200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Li XC, 2016, P NATL ACAD SCI USA, V113, P8212, DOI 10.1073/pnas.1607795113; Marsh A, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9365; Mehnert M, 2010, BIOESSAYS, V32, P905, DOI 10.1002/bies.201000046; Mehrtash AB, 2019, SEMIN CELL DEV BIOL, V93, P111, DOI 10.1016/j.semcdb.2018.09.013; Menzies SA, 2018, ELIFE, V7, DOI [10.7554/eLife.40009.001, 10.7554/eLife.40009]; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Motamed M, 2011, J BIOL CHEM, V286, P18002, DOI 10.1074/jbc.M111.238311; Needham PG, 2013, BBA-MOL CELL RES, V1833, P2447, DOI 10.1016/j.bbamcr.2013.03.018; Nikaido H, 2009, BBA-PROTEINS PROTEOM, V1794, P769, DOI 10.1016/j.bbapap.2008.10.004; Nowaczyk MJM, 2012, AM J MED GENET C, V160C, P250, DOI 10.1002/ajmg.c.31343; Ohgane K, 2013, CHEM BIOL, V20, P391, DOI 10.1016/j.chembiol.2013.02.009; Osborne T. F., 2009, GENE DEV, V446, P669; Osborne TF, 1998, CURR OPIN LIPIDOL, V9, P137, DOI 10.1097/00041433-199804000-00010; Prabhu AV, 2016, PROG LIPID RES, V64, P138, DOI 10.1016/j.plipres.2016.09.003; Prabhu AV, 2016, J BIOL CHEM, V291, P8363, DOI 10.1074/jbc.M115.699546; Pu J, 2015, CARDIOL CLIN, V33, P325, DOI 10.1016/j.ccl.2015.01.005; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Raychaudhuri S, 2012, CURR OPIN CELL BIOL, V24, P502, DOI 10.1016/j.ceb.2012.05.006; Roberg-Larsen H, 2014, BIOCHEM BIOPH RES CO, V446, P669, DOI 10.1016/j.bbrc.2014.01.087; Schultz ML, 2016, BRAIN RES, V1649, P181, DOI 10.1016/j.brainres.2016.03.035; Schumacher MM, 2015, ELIFE, V4, DOI [10.7554/eLife.05560, 10.7554/eLife.04490]; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Sharpe LJ, 2014, TRENDS BIOCHEM SCI, V39, P527, DOI 10.1016/j.tibs.2014.08.008; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Shearer AG, 2005, EMBO J, V24, P149, DOI 10.1038/sj.emboj.7600498; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Stevenson J, 2014, BIOCHEM J, V461, P435, DOI 10.1042/BJ20131404; Theesfeld CL, 2013, J BIOL CHEM, V288, P8519, DOI 10.1074/jbc.M112.404517; Theesfeld CL, 2011, J BIOL CHEM, V286, P26298, DOI 10.1074/jbc.M111.244798; Vanier MT, 2015, J INHERIT METAB DIS, V38, P187, DOI 10.1007/s10545-014-9794-4; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Wang LJ, 2012, BBA-MOL CELL BIOL L, V1821, P964, DOI 10.1016/j.bbalip.2012.03.004; Wangeline MA, 2018, J BIOL CHEM, V293, P14937, DOI 10.1074/jbc.RA118.001808; Wangeline MA, 2017, ANNU REV CELL DEV BI, V33, P467, DOI 10.1146/annurev-cellbio-111315-125036; Wassif CA, 1998, AM J HUM GENET, V63, P55, DOI 10.1086/301936; WOJCIKIEWICZ RJH, 1994, J BIOL CHEM, V269, P7963; Yabe D, 2002, P NATL ACAD SCI USA, V99, P16672, DOI 10.1073/pnas.262669399; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zhang YX, 2018, CELL, V175, P1352, DOI 10.1016/j.cell.2018.10.026; Zhong Y, 2014, GENET MOL RES, V13, P7318, DOI 10.4238/2014.February.13.11	71	3	3	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100063	10.1074/jbc.RA120.015910	http://dx.doi.org/10.1074/jbc.RA120.015910			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33184059	Green Published, Green Submitted, gold			2022-12-26	WOS:000672866400044
J	Wang, Y; Xie, GM; Li, M; Du, J; Wang, M				Wang, Yan; Xie, Guangmei; Li, Min; Du, Juan; Wang, Min			COPB2 gene silencing inhibits colorectal cancer cell proliferation and induces apoptosis via the JNK/c-Jun signaling pathway	PLOS ONE			English	Article							COLON-CANCER; COATOMER; MOTIFS; HETEROGENEITY; RECOGNITION; MUTATIONS; THERAPY; CYCLE	Objectives Colorectal cancer (CRC) is one of the most common malignant human tumors. It is associated with high morbidity and mortality rates. In recent years, tumor gene therapy has emerged as a promising new approach for colorectal cancer therapy. Herein, we identify and analyze the role of COPB2 (coatomer protein complex, subunit beta 2) in proliferation and apoptosis of CRC cells. Methods To investigate the role of COPB2 in the proliferation and apoptosis of CRC cells, a shCOPB2 vector and a shCtrl vector were constructed for transfection into RKO and HCT116 cells. Cells proliferation was subsequently measured via cell counting kit-8 (CCK8) assay and Celigo cell counting assay. Apoptosis was measured via flow cytometry. The activity level of Caspase 3/7 was measured. Finally, the level of several JNK/c-Jun apoptosis pathway-related proteins were measured to characterize the mechanism of apoptosis. Results Our results showed that the proliferation rate was decreased and the apoptosis rate was increased in shCOPB2-treated RKO and HCT116 cells compared to those in controls. After the silencing of COPB2, JNK/c-Jun signal pathway activation was increased, the expression levels of apoptosis pathway-related proteins, such as Bad, p53 and Caspase 3, were also increased. Conclusion COPB2 gene silencing can inhibit RKO and HCT116 cells proliferation and induce apoptosis via the JNK/c-Jun signaling pathway.	[Wang, Yan; Du, Juan] Gansu Prov Hosp, Lanzhou, Gansu, Peoples R China; [Wang, Yan; Li, Min; Wang, Min] Lanzhou Univ, Inst Pathol, Sch Basic Med Sci, Lanzhou, Gansu, Peoples R China; [Xie, Guangmei] Gansu Prov Matern & Child Care Hosp, Lanzhou, Gansu, Peoples R China	Lanzhou University	Wang, Y (corresponding author), Gansu Prov Hosp, Lanzhou, Gansu, Peoples R China.; Wang, Y (corresponding author), Lanzhou Univ, Inst Pathol, Sch Basic Med Sci, Lanzhou, Gansu, Peoples R China.	wangyanimmunity@126.com	min, Li/GQQ-2169-2022					Amer Magid H, 2014, Mol Cell Ther, V2, P27, DOI 10.1186/2052-8426-2-27; An CX, 2019, INT J ONCOL, V54, P1195, DOI 10.3892/ijo.2019.4717; Baena R, 2015, MATURITAS, V80, P258, DOI 10.1016/j.maturitas.2014.12.017; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Bhandari A, 2019, J CELL MOL MED, V23, P5235, DOI 10.1111/jcmm.14398; BOYD D, 1988, CANCER RES, V48, P3112; BRATTAIN MG, 1984, CANCER METAST REV, V3, P177, DOI 10.1007/BF00048384; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Chen RK, 2016, TUMOR BIOL, V37, P15065, DOI 10.1007/s13277-016-5402-6; Chen Z, 2018, BIOL CHEM, V399, P265, DOI 10.1515/hsz-2017-0222; Dekker E, 2019, LANCET, V394, P1467, DOI 10.1016/S0140-6736(19)32319-0; DiStasio A, 2017, HUM MOL GENET, V26, P4836, DOI 10.1093/hmg/ddx362; Dodonova SO, 2015, SCIENCE, V349, P195, DOI 10.1126/science.aab1121; Durai R, 2008, J GASTROINTEST LIVER, V17, P59; Ferrantini M, 2008, TUMORI, V94, P182; Heinimann K, 2018, THER UMSCH, V75, P601, DOI 10.1024/0040-5930/a001046; Jackson LP, 2012, DEV CELL, V23, P1255, DOI 10.1016/j.devcel.2012.10.017; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia D, 2018, AGING-US, V10, P592, DOI 10.18632/aging.101415; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Kobiela J, 2018, CRIT REV ONCOL HEMAT, V129, P91, DOI 10.1016/j.critrevonc.2018.06.005; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Krishna S, 2011, BIOCHEM J, V435, P545, DOI 10.1042/BJ20101996; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; Li XL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040437; Liu JN, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0691-x; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Mi YY, 2018, BIOCHEM BIOPH RES CO, V495, P473, DOI 10.1016/j.bbrc.2017.11.040; Mi YY, 2016, ARCH MED RES, V47, P411, DOI 10.1016/j.arcmed.2016.09.005; Pan YL, 2014, BIOSENS BIOELECTRON, V52, P62, DOI 10.1016/j.bios.2013.07.057; SCHROY PC, 1995, CANCER, V76, P201, DOI 10.1002/1097-0142(19950715)76:2<201::AID-CNCR2820760207>3.0.CO;2-T; Shin A, 2013, WORLD J GASTROENTERO, V19, P979, DOI 10.3748/wjg.v19.i7.979; Shtutman M, 2011, P NATL ACAD SCI USA, V108, P12449, DOI 10.1073/pnas.1103842108; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; SMITH ML, 1995, ONCOGENE, V10, P1053; Styers ML, 2008, AM J PHYSIOL-CELL PH, V294, pC1485, DOI 10.1152/ajpcell.00010.2008; Suckling RJ, 2015, P NATL ACAD SCI USA, V112, P14242, DOI 10.1073/pnas.1506186112; SUN LZ, 1994, EXP CELL RES, V214, P215, DOI 10.1006/excr.1994.1251; [孙学军 Sun Xuejun], 2016, [西安交通大学学报. 医学版, Journal of Xi'an Jiaotong University. Medical Sciences], V37, P613; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Voutsadakis IA, 2000, ACTA ONCOL, V39, P151, DOI 10.1080/028418600430707; Wang SL, 2016, PROTEIN CELL, V7, P586, DOI 10.1007/s13238-016-0296-z; Wang Y, 2018, EXP THER MED, V15, P777, DOI 10.3892/etm.2017.5506; Wirth T, 2013, GENE, V525, P162, DOI 10.1016/j.gene.2013.03.137; Yuan SJ, 2013, STRUCTURE, V21, P501, DOI 10.1016/j.str.2013.02.024; Zheng S., 2016, J PRACTICAL ONCOL, V31, P2; Zhou Y, 2020, CNS NEUROSCI THER, V26, P309, DOI 10.1111/cns.13254; Zuckerman DS, 2008, CANCER-AM CANCER SOC, V112, P1879, DOI 10.1002/cncr.23409	48	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0240106	10.1371/journal.pone.0240106	http://dx.doi.org/10.1371/journal.pone.0240106			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211699	Green Published, gold			2022-12-26	WOS:000603518300008
J	Bonanno, AM; Graham, TL; Wilson, LN; Ross, JD				Bonanno, Alicia M.; Graham, Todd L.; Wilson, Lauren N.; Ross, James D.			Novel use of XSTAT 30 for mitigation of lethal non-compressible torso hemorrhage in swine	PLOS ONE			English	Article							ENDOVASCULAR BALLOON OCCLUSION; AORTA; MODEL	Background Management of Non-Compressible Torso Hemorrhage (NCTH) consists primarily of aortic occlusion which has significant adverse outcomes, including ischemia-reperfusion injury, in prolonged field care paradigms. One promising avenue for treatment is through use of RevMedx XSTAT 30 (TM) (an FDA approved sponge-based dressing utilized for extremity wounds). We hypothesized that XSTAT 30 (TM) would effectively mitigate NCTH during a prolonged pre-hospital period with correctable metabolic and physiologic derangements. Methods and findings Twenty-four male swine (53 +/- 2kg) were anesthetized, underwent line placement, and splenectomy. Animals then underwent laparoscopic transection of 70% of the left lobe of the liver with hemorrhage for a period of 10min. They were randomized into three groups: No intevention (CON), XSTAT 30 (TM)-Free Pellets (FP), and XSTAT 30 (TM)-Bagged Pellets (BP). Animals were observed for a pre-hospital period of 180min. At 180min, animals underwent damage control surgery (DCS), balanced blood product resuscitation and removal of pellets followed by an ICU period of 5 hours. Postoperative fluoroscopy was performed to identify remaining pellets or bags. Baseline physiologic and injury characteristics were similar. Survival rates were significantly higher in FP and BP (p<0.01) vs CON. DCS was significantly longer in FP in comparison to BP (p = 0.001). Two animals in the FP group had pellets discovered on fluoroscopy following DCS. There was no significant difference in blood product or pressor requirements between groups. End-ICU lactates trended to baseline in both FP and BP groups. Conclusions While these results are promising, further study will be required to better understand the role for XSTAT in the management of NCTH.	[Bonanno, Alicia M.] Oregon Hlth & Sci Univ, Dept Surg, Portland, OR 97201 USA; [Graham, Todd L.; Wilson, Lauren N.; Ross, James D.] Oregon Hlth & Sci Univ, Div Trauma & Acute Care Surg, Portland, OR 97201 USA; [Ross, James D.] Oregon Hlth & Sci Univ, Charles T Dotter Dept Intervent Radiol, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Ross, JD (corresponding author), Oregon Hlth & Sci Univ, Div Trauma & Acute Care Surg, Portland, OR 97201 USA.; Ross, JD (corresponding author), Oregon Hlth & Sci Univ, Charles T Dotter Dept Intervent Radiol, Portland, OR 97201 USA.	rosja@ohsu.edu		Bonanno, Alicia/0000-0002-7300-2475; Graham, Todd/0000-0002-2255-6603	Military Health Research Foundation [SC-15-03, PO 0006]	Military Health Research Foundation	This work was supported by Military Health Research Foundation, Award Number: Contract SC-15-03, PO 0006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; [Anonymous], 2017, AM J TRANSPLANT, V17, P1, DOI DOI 10.1093/jisesa/iew097; Davidson AJ, 2018, J TRAUMA ACUTE CARE, V84, P192, DOI 10.1097/TA.0000000000001711; Davis JS, 2014, J TRAUMA ACUTE CARE, V77, P213, DOI 10.1097/TA.0000000000000292; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Karakose O, 2016, MED SCI MONITOR, V22, DOI 10.12659/MSM.897109; Kragh JF, 2015, AM J EMERG MED, V33, P974, DOI 10.1016/j.ajem.2015.03.048; Kuckelman J, 2019, J TRAUMA ACUTE CARE, V87, P9, DOI 10.1097/TA.0000000000002307; Markov NP, 2013, SURGERY, V153, P848, DOI 10.1016/j.surg.2012.12.001; Montgomery HR, J SPEC OPER MED PEER, V17, P154; Morrison JJ, 2014, J SURG RES, V191, P423, DOI 10.1016/j.jss.2014.04.012; Morrison JJ, 2014, SHOCK, V41, P388, DOI 10.1097/SHK.0000000000000136; Morrison JJ, 2014, SHOCK, V41, P130, DOI 10.1097/SHK.0000000000000085; Rago AP, 2014, J TRAUMA ACUTE CARE, V77, pS127, DOI 10.1097/TA.0000000000000380; Rall JM, 2013, J TRAUMA ACUTE CARE, V75, pS150, DOI 10.1097/TA.0b013e318299d909; Ross JD, 2014, J TRAUMA ACUTE CARE, V77, pS77, DOI 10.1097/TA.0000000000000385; Van PY, 2017, CURR OPIN CRIT CARE, V23, P498, DOI 10.1097/MCC.0000000000000455	17	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241906	10.1371/journal.pone.0241906	http://dx.doi.org/10.1371/journal.pone.0241906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206692	gold, Green Published			2022-12-26	WOS:000595265900079
J	Madlala, HP; Myer, L; Malaba, TR; Newell, ML				Madlala, Hlengiwe P.; Myer, Landon; Malaba, Thokozile R.; Newell, Marie-Louise			Neurodevelopment of HIV-exposed uninfected children in Cape Town, South Africa	PLOS ONE			English	Article							STAGES QUESTIONNAIRES; SOCIOECONOMIC-STATUS; BRAIN-DEVELOPMENT; PRETERM BIRTH; AGES; TERM; AFFORDANCES; PROGRAMS; VALIDITY; OUTCOMES	Background Evidence shows that antiretroviral (ART) exposure is associated with neurodevelopmental delays in human immunodeficiency virus (HIV)-exposed uninfected (HEU) children. However, there are few insights into modifiable maternal and child factors that may play a role in improving neurodevelopment in HEU children. We used a parent-centric neurodevelopment tool, Ages & Stages Questionnaire (ASQ) to examined neurodevelopment in HEU children at 12-24 months of age, and associations with maternal and child factors. Methods 505 HIV-infected women (initiated ART pre- or during pregnancy) with live singleton births attending primary health care were enrolled; 355 of their HEU children were assessed for neurodevelopment (gross motor, fine motor, communication, problem solving and personal-social domains) at 12-24 months using age-specific ASQ administered by a trained fieldworker. Associations with maternal and child factors were examined using logistic regression models. Results Among mothers (median age 30 years, IQR, 26-34), 52% initiated ART during pregnancy; the median CD4 count was 436 cells/mu l (IQR, 305-604). Most delayed neurodevelopment in HEU children was in gross (9%) and fine motor (5%) functions. In adjusted models, maternal socio-economic status (aOR 0.42, 95% CI 0.24-0.76) was associated with reduced odds of delayed gross-fine motor neurodevelopment. Maternal age >= 35 years (aOR 0.22, 95% CI 0.05-0.89) and maternal body mass index (BMI) <18.5 (aOR 6.76, 95% CI 1.06-43.13) were associated with delayed communication-problem-solving-personal-social neurodevelopment. There were no differences in odds for either domain by maternal ART initiation timing. Conclusions Delayed neurodevelopment was detected in both gross and fine motor functions in this cohort of HEU children, with strong maternal predictors that may be explored as potentially modifiable factors associated with neurodevelopment at one to two years of age.	[Madlala, Hlengiwe P.; Myer, Landon; Malaba, Thokozile R.] Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, Western Cape, South Africa; [Madlala, Hlengiwe P.; Myer, Landon; Malaba, Thokozile R.] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Cape Town, Western Cape, South Africa; [Newell, Marie-Louise] Univ Southampton, Sch Human Dev & Hlth, Fac Med, Southampton, Hants, England; [Newell, Marie-Louise] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa	University of Cape Town; University of Cape Town; University of Southampton; University of Witwatersrand	Madlala, HP (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Epidemiol & Biostat, Cape Town, Western Cape, South Africa.; Madlala, HP (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Cape Town, Western Cape, South Africa.	hlengiwe.madlala@uct.ac.za		Malaba, Thokozile/0000-0003-0938-5587; Madlala, Hlengiwe/0000-0001-7759-3498	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R01HD080385]	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health	The research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R01HD080385 (Recipient: M-L.N). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. https://www.nichd.nih.gov.	Abubakar A, 2008, EARLY HUM DEV, V84, P613, DOI 10.1016/j.earlhumdev.2008.02.003; Alcaide ML, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz351; [Anonymous], 2016, THAIL IS 1 COUNTR AS; [Anonymous], 2010, NEW YORK TIMES 1007, VZ, P1; Arcangeli T, 2012, ULTRASOUND OBST GYN, V40, P267, DOI 10.1002/uog.11112; Asbjornsdottir KH, 2016, J HUM LACT, V32, pNP61, DOI 10.1177/0890334415607854; Bardin C, 2004, SEMIN PERINATOL, V28, P288, DOI 10.1053/j.semperi.2004.08.006; Blencowe H, 2013, PEDIATR RES, V74, P17, DOI 10.1038/pr.2013.204; Boivin MJ, 2019, LANCET HIV, V6, pE518, DOI 10.1016/S2352-3018(19)30083-9; Boivin M, 2016, CURR HIV-AIDS REP, V13, P318, DOI 10.1007/s11904-016-0342-8; Bonnier C, 2008, ACTA PAEDIATR, V97, P853, DOI 10.1111/j.1651-2227.2008.00834.x; Bork KA, 2014, AM J CLIN NUTR, V100, P1559, DOI 10.3945/ajcn.113.082149; Cacola P, 2011, PEDIATR INT, V53, P820, DOI 10.1111/j.1442-200X.2011.03386.x; Cassidy AR, 2019, PEDIATR INFECT DIS J, V38, P828, DOI 10.1097/INF.0000000000002332; Chandna J, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-001718; Chaudhury S, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0988; City of Cape Town, 2011, CIT CAP TOWN 2011 CE, P1; Colvin M, 2004, BRIT MED J, V329, P1390, DOI 10.1136/bmj.329.7479.1390; Crowell CS, 2018, OPEN FORUM INFECT DI; de Bie HMA, 2010, HORM RES PAEDIAT, V73, P6, DOI 10.1159/000271911; Donald KA, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002920; Freitas TCB, 2013, BRAZ J PHYS THER, V17, P319, DOI 10.1590/S1413-35552013005000096; Gadama LA, 2014, THESIS U CAPE TOWN, P1; Heckman JJ, 2007, REV AGR ECON, V29, P446, DOI 10.1111/j.1467-9353.2007.00359.x; Hsiao C, 2017, CHILD CARE HLTH DEV, V43, P59, DOI 10.1111/cch.12413; le Roux SM, 2018, AIDS, V32, P1781, DOI 10.1097/QAD.0000000000001872; Lu CL, 2016, LANCET GLOB HEALTH, V4, pE916, DOI [10.1016/S2214-109X(16)30266-2, 10.1016/s2214-109x(16)30266-2]; Malaba TR, 2020, COHORT PROFILE PREMA; McHenry MS, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2888; Mofenson LM, 2018, LANCET GLOB HEALTH, V6, pE716, DOI 10.1016/S2214-109X(18)30272-9; Myer L, 2008, SOC SCI MED, V66, P1828, DOI 10.1016/j.socscimed.2008.01.025; Ntozini R, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25456; Nuss EE, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2019.100082; Piccolo LD, 2016, PSICOL-REFLEX CRIT, V29, DOI 10.1186/s41155-016-0016-x; Playford CJ, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0698-4; Prado EL, 2014, NUTR REV, V72, P267, DOI 10.1111/nure.12102; Rice ML, 2013, PEDIATR INFECT DIS J, V32, pE406, DOI 10.1097/INF.0b013e31829b80ee; Rochat TJ, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002044; Santos S, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1189-1; Schonhaut L, 2013, PEDIATRICS, V131, pE1468, DOI 10.1542/peds.2012-3313; Singh A, 2017, B MED HOSP INFANT M, V74, P5, DOI 10.1016/j.bmhimx.2016.07.008; Springer PE, 2018, TROP MED INT HEALTH, V23, P69, DOI 10.1111/tmi.13006; Struyf T, 2020, EUR J PAEDIATR NEURO, V25, P157, DOI 10.1016/j.ejpn.2019.11.004; Suggate S, 2017, EARLY CHILD DEV CARE, V187, P1297, DOI 10.1080/03004430.2016.1167047; Twogood T., 1999, HLTH CHILDCARE AM NE, P1; UNICEF, 2017, 1 1000 DAYS CRIT WIN; Van Dyke RB, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00199; van Heerden A, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0802-3; Veldhuizen S, 2015, ACAD PEDIATR, V15, P231, DOI 10.1016/j.acap.2014.08.002; Visser M, 2016, AFR J DISABIL, V5, DOI [10.4102/ajod.v5il.265, 10.4102/ajod.v5i1.265]; Wedderburn C, 2019, LANCET CHILD ADOLESC, V3, P803, DOI 10.1016/S2352-4642(19)30250-0; Woodward BJ, 2011, J PERINATOL, V31, P641, DOI 10.1038/jp.2011.1; Yoshikawa H, 1995, FUTURE CHILD, V5, P51, DOI 10.2307/1602367; Yue A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221675	54	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242244	10.1371/journal.pone.0242244	http://dx.doi.org/10.1371/journal.pone.0242244			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206724	Green Published, gold			2022-12-26	WOS:000595265900075
J	Touma, BR; Kondolf, GM; Walls, S				Rios Touma, Blanca; Kondolf, G. Mathias; Walls, Scott			Impacts of sediment derived from erosion of partially-constructed road on aquatic organisms in a tropical river: The Rio San Juan, Nicaragua and Costa Rica	PLOS ONE			English	Article							BENTHIC MACROINVERTEBRATES; INSECT COMMUNITIES; FINE SEDIMENT; STREAMS; SURFACE; DEFORESTATION; SILTATION; RATES	Throughout the humid tropics, increased land disturbance and concomitant road construction increases erosion and sediment delivery to rivers. Building road networks in developing countries is commonly a priority for international development funding based on anticipated socio-economic benefits. Yet the resulting erosion from roads, which recent studies have shown result in at least ten-fold increases in erosion rates, is not fully accounted for. While effects of road-derived sediment on aquatic ecosystems have been documented in temperate climates, little has been published on the effects of road-induced sediment on aquatic ecosystems in developing countries of the tropics. We studied periphyton biomass and macroinvertebrate communities on the deltas of Rio San Juan tributaries, comparing north-bank tributaries draining undisturbed rain forest with south-bank tributaries receiving runoff from a partially-built road experiencing rapid erosion. Periphyton biomass, richness and abundance of macroinvertebrates overall, and richness and abundance of Ephemeroptera, Plecoptera and Trichoptera were higher on the north-bank tributary deltas than the south-bank tributary deltas. These findings were consistent with prior studies in temperate climates showing detrimental effects of road-derived fine sediment on aquatic organisms. A Non-Metric Multidimensional Scaling (NMDS) analysis showed the impacted community on the south-bank deltas was influenced by poorly-sorted substrate with greater proportions of fine sediment and higher water temperatures.	[Rios Touma, Blanca] Univ Calif Berkeley, Ctr Environm Design Res, Berkeley, CA 94720 USA; [Rios Touma, Blanca] Univ Las Amer, Fac Ingn & Ciencias Aplicadas, FICA Grp Invest Biodiversidad Medio Ambiente & Sa, Quito, Ecuador; [Kondolf, G. Mathias; Walls, Scott] Univ Calif Berkeley, Dept Landscape Architecture & Environm Planning, Berkeley, CA 94720 USA; [Kondolf, G. Mathias] Univ Lyon, Coll Lyon, Inst Etud Avancees, Lyon, France	University of California System; University of California Berkeley; Universidad de Las Americas - Ecuador; University of California System; University of California Berkeley	Kondolf, GM (corresponding author), Univ Calif Berkeley, Dept Landscape Architecture & Environm Planning, Berkeley, CA 94720 USA.; Kondolf, GM (corresponding author), Univ Lyon, Coll Lyon, Inst Etud Avancees, Lyon, France.	kondolf@berkeley.edu	Rios-Touma, Blanca/AAR-9631-2020	Rios-Touma, Blanca/0000-0002-3921-0908; Kondolf, G.Mathias/0000-0001-5639-9995	Embassy of Nicaragua in the Hague, Netherlands; Beatrix Farrand Fund of the Department of Landscape Architecture and Environmental Planning of the University of California Berkeley; Collegium de Lyon - Institut des Etudes Avancees de l'Universite de Lyon; EURIAS Fellowship Programme; European Commission (Marie-Sklodowska-Curie Actions - COFUND Programme - FP7)	Embassy of Nicaragua in the Hague, Netherlands; Beatrix Farrand Fund of the Department of Landscape Architecture and Environmental Planning of the University of California Berkeley; Collegium de Lyon - Institut des Etudes Avancees de l'Universite de Lyon; EURIAS Fellowship Programme; European Commission (Marie-Sklodowska-Curie Actions - COFUND Programme - FP7)(European Commission)	Field work for data collection by BRT, GMK, and SPW was supported by the Embassy of Nicaragua in the Hague, Netherlands. Manuscript preparation for BRT, GMK, and SPW was supported by the Beatrix Farrand Fund of the Department of Landscape Architecture and Environmental Planning of the University of California Berkeley, and manuscript preparation for GMK was also supported by the Collegium de Lyon - Institut des Etudes Avancees de l'Universite de Lyon, the EURIAS Fellowship Programme and the European Commission (Marie-Sklodowska-Curie Actions - COFUND Programme - FP7) (no grant numbers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Public Health Association (APHA), 2005, STANDARD METHODS EXA; [Anonymous], 2014, THESIS; [Anonymous], 2012, NUMERICAL ECOLOGY DE, DOI DOI 10.1016/B978-0-444-53868-0.50016-2; Association of Federated Engineers and Architects of Costa Rica (CFIA), 2012, DRDINSP02992012 CFIA; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonada N, 2006, ANNU REV ENTOMOL, V51, P495, DOI 10.1146/annurev.ento.51.110104.151124; BROOKES A, 1986, BIOL CONSERV, V38, P351, DOI 10.1016/0006-3207(86)90060-1; Bussing WA, 1998, PECES AGUAS CONTINEN, V2nd; Carter J. L, 2013, ANAL APPROACHES USED; Centro Cientifico Tropical, 2015, FOLL UP MON STUD ROU; Chang FH, 2014, ENVIRON MONIT ASSESS, V186, P2135, DOI 10.1007/s10661-013-3523-6; CLINE LD, 1982, HYDROBIOLOGIA, V96, P149, DOI 10.1007/BF02185430; Flotemersch J. E, 2006, 600R06127 EPA US EPA; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Fossati O, 2001, ARCH HYDROBIOL, V151, P33; Gotelli NJ, 2013, ECOSIMR 1 00; GRAHAM AA, 1990, HYDROBIOLOGIA, V199, P107, DOI 10.1007/BF00005603; Hauer F. Richard, 2007, P435, DOI 10.1016/B978-012332908-0.50028-0; Henley W. F., 2000, Reviews in Fisheries Science, V8, P125, DOI 10.1080/10641260091129198; Hewawasam T, 2003, GEOLOGY, V31, P597, DOI 10.1130/0091-7613(2003)031<0597:IOHONE>2.0.CO;2; Inman D.L., 1952, SEPM J SEDIMENT RES, V22, P125, DOI [DOI 10.1306/D42694DB-2B26-11D7-8648000102C1865D, 10.1306/D42694DB-2B26-11D7-8648000102C1865D]; Kleinn C, 2002, ENVIRON MONIT ASSESS, V73, P17, DOI 10.1023/A:1012659129083; Kondolf G.M, 2016, TOOLS FLUVIAL GEOMOR, P278, DOI DOI 10.1002/9781118648551.CH13; Kondolf GM, 1997, J AM WATER RESOUR AS, V33, P79, DOI 10.1111/j.1752-1688.1997.tb04084.x; Laboratorio Nacional de Materiales y Modelos Estructurales (LANAMME), 2012, REP REC TRIP ROUT 18, P52; LEMLY AD, 1982, HYDROBIOLOGIA, V87, P229, DOI 10.1007/BF00007232; LEWIS K, 1973, Freshwater Biology, V3, P391, DOI 10.1111/j.1365-2427.1973.tb00930.x; LEWIS K, 1973, Freshwater Biology, V3, P251, DOI 10.1111/j.1365-2427.1973.tb00920.x; Liu SL, 2008, ECOL ENG, V34, P91, DOI 10.1016/j.ecoleng.2008.07.006; Lorion CM, 2009, FRESHWATER BIOL, V54, P165, DOI 10.1111/j.1365-2427.2008.02092.x; Organization of American States (OAS), 1996, TRANSB DIAGN AN INCL; Otto GH, 1939, J SEDIMENT PETROL, V9, P62; PECKARSKY BL, 1985, CAN J ZOOL, V63, P1519, DOI 10.1139/z85-226; QUINN JM, 1992, HYDROBIOLOGIA, V248, P235, DOI 10.1007/BF00006150; Resh VH, 2008, ENVIRON MONIT ASSESS, V138, P131, DOI 10.1007/s10661-007-9749-4; RICHARDS C, 1994, GREAT BASIN NAT, V54, P106; SADER SA, 1988, BIOTROPICA, V20, P11, DOI 10.2307/2388421; Sanchez-Azofeifa G, 2001, BIOTROPICA, V33, P378, DOI 10.1111/j.1744-7429.2001.tb00192.x; Sidle RC, 2006, FOREST ECOL MANAG, V224, P199, DOI 10.1016/j.foreco.2005.12.019; Sidle RC, 2012, NAT GEOSCI, V5, P437, DOI 10.1038/ngeo1512; Sidle RC, 2011, NAT HAZARDS, V57, P313, DOI 10.1007/s11069-010-9614-6; Spellerberg IF, 1998, GLOBAL ECOL BIOGEOGR, V7, P317, DOI 10.1046/j.1466-822x.1998.00308.x; Steinman A, 2006, METHODS STREAM ECOLO, P257; VANNIEUWENHUYSE EE, 1986, WATER RESOUR BULL, V22, P91; Wood PJ, 1997, ENVIRON MANAGE, V21, P203, DOI 10.1007/s002679900019	45	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242356	10.1371/journal.pone.0242356	http://dx.doi.org/10.1371/journal.pone.0242356			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201898	Green Published, gold			2022-12-26	WOS:000595003900034
J	Stachowski, TR; Snell, ME; Snell, EH				Stachowski, Timothy R.; Snell, Mary E.; Snell, Edward H.			SAXS studies of X-ray induced disulfide bond damage: Engineering high-resolution insight from a low-resolution technique	PLOS ONE			English	Article							SMALL-ANGLE SCATTERING; QUANTIFYING RADIATION-DAMAGE; N-ACETYLGLUCOSAMINIDASE-H; ROOM-TEMPERATURE; BIOLOGICAL MACROMOLECULES; PROTEINS; CRYSTALLOGRAPHY; LYSOZYME; BIOMOLECULES; ASSEMBLIES	A significant problem in biological X-ray crystallography is the radiation chemistry caused by the incident X-ray beam. This produces both global and site-specific damage. Site specific damage can misdirect the biological interpretation of the structural models produced. Cryo-cooling crystals has been successful in mitigating damage but not eliminating it altogether; however, cryo-cooling can be difficult in some cases and has also been shown to limit functionally relevant protein conformations. The doses used for X-ray crystallography are typically in the kilo-gray to mega-gray range. While disulfide bonds are among the most significantly affected species in proteins in the crystalline state at both cryogenic and higher temperatures, there is limited information on their response to low X-ray doses in solution, the details of which might inform biomedical applications of X-rays. In this work we engineered a protein that dimerizes through a susceptible disulfide bond to relate the radiation damage processes seen in cryo-cooled crystals to those closer to physiologic conditions. This approach enables a low-resolution technique, small angle X-ray scattering (SAXS), to detect and monitor a residue specific process. A dose dependent fragmentation of the engineered protein was seen that can be explained by a dimer to monomer transition through disulfide bond cleavage. This supports the crystallographically derived mechanism and demonstrates that results obtained crystallographically can be usefully extrapolated to physiologic conditions. Fragmentation was influenced by pH and the conformation of the dimer, providing information on mechanism and pointing to future routes for investigation and potential mitigation. The novel engineered protein approach to generate a large-scale change through a site-specific interaction represents a promising tool for advancing radiation damage studies under solution conditions.	[Stachowski, Timothy R.; Snell, Mary E.; Snell, Edward H.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Stachowski, Timothy R.] Roswell Pk Comprehens Canc Ctr, Dept Cell Stress Biol, Buffalo, NY USA; [Snell, Edward H.] SUNY Buffalo, Dept Mat Design & Innovat, Buffalo, NY 14214 USA; [Stachowski, Timothy R.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; St Jude Children's Research Hospital	Snell, EH (corresponding author), Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA.; Snell, EH (corresponding author), SUNY Buffalo, Dept Mat Design & Innovat, Buffalo, NY 14214 USA.	esnell@hwi.buffalo.edu	; Snell, Edward/G-2055-2018	Stachowski, Timothy/0000-0002-6097-4857; Snell, Edward/0000-0001-8714-3191	Louis Sklarow Charitable Trust; National Science Foundation [1231306]; DOE Office of Biological and Environmental Research; National Institute of Health [P30 GM124169, S10OD018483]; companies of the Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute	Louis Sklarow Charitable Trust; National Science Foundation(National Science Foundation (NSF)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); companies of the Industrial Macromolecular Crystallography Association; Hauptman-Woodward Medical Research Institute	EHS acknowledges support from the Louis Sklarow Charitable Trust, and National Science Foundation Grant no. 1231306. This work was based in part upon research conducted at the Advanced Light Source (ALS), a national user facility operated by Lawrence Berkeley National Laboratory on behalf the Department of Energy, Office of Basic Energy Sciences through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by DOE Office of Biological and Environmental Research. Additional support comes from the National Institute of Health project ALS-ENABLE (P30 GM124169) and a High-End Instrumentation Grant S10OD018483. This research also used resources at the Industrial Macromolecular Crystallography Association Collaborative Access Team (IMCA-CAT) beamline 17-ID, supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2012, J CHEMINFORMATICS, V4, P17; ARMSTRONG DA, 1964, CAN J CHEM, V42, P2631, DOI 10.1139/v64-389; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Barker AI, 2009, J SYNCHROTRON RADIAT, V16, P205, DOI 10.1107/S0909049509003343; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Brooks-Bartlett JC, 2017, J SYNCHROTRON RADIAT, V24, P63, DOI 10.1107/S1600577516015083; Brosey CA, 2019, CURR OPIN STRUC BIOL, V58, P197, DOI 10.1016/j.sbi.2019.04.004; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark GNI, 2010, P NATL ACAD SCI USA, V107, P14003, DOI 10.1073/pnas.1006599107; Cremers CM, 2013, J BIOL CHEM, V288, P26489, DOI 10.1074/jbc.R113.462929; de la Mora E, 2020, P NATL ACAD SCI USA, V117, P4142, DOI 10.1073/pnas.1821522117; Durand D, 2010, J STRUCT BIOL, V169, P45, DOI 10.1016/j.jsb.2009.08.009; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fischetti RF, 2003, J SYNCHROTRON RADIAT, V10, P398, DOI 10.1107/S0909049503016583; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Fraser JS, 2011, P NATL ACAD SCI USA, V108, P16247, DOI 10.1073/pnas.1111325108; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; FRAUENFELDER H, 1987, BIOCHEMISTRY-US, V26, P254, DOI 10.1021/bi00375a035; Freeze Hudson H, 2010, Curr Protoc Mol Biol, VChapter 17, DOI [10.1002/0471140864.ps1204s62, 10.1002/0471142735.im0815s83, 10.1002/0471142727.mb1713as89]; Garman EF, 2017, RAD DAMAGE MACROMOLE, P467, DOI 10.1007/978-1-4939-7000-1_20; Gerstel M, 2015, J SYNCHROTRON RADIAT, V22, P201, DOI 10.1107/S1600577515002131; Gotthard G, 2019, IUCRJ, V6, P665, DOI 10.1107/S205225251900616X; Grant TD, 2018, NAT METHODS, V15, P191, DOI [10.1038/NMETH.4581, 10.1038/nmeth.4581]; Hajizadeh NR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25355-2; Hopkins JB, 2016, J APPL CRYSTALLOGR, V49, P880, DOI 10.1107/S1600576716005136; Juers DH, 2001, J MOL BIOL, V311, P851, DOI 10.1006/jmbi.2001.4891; Kapp GT, 2012, P NATL ACAD SCI USA, V109, P5277, DOI 10.1073/pnas.1114487109; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; KONIG S, 1992, BIOCHEMISTRY-US, V31, P8726; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuwamoto S, 2004, J SYNCHROTRON RADIAT, V11, P462, DOI 10.1107/S0909049504019272; Lerner AM, 2018, ACS SYNTH BIOL, V7, P2898, DOI 10.1021/acssynbio.8b00368; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; MATSUMURA M, 1989, P NATL ACAD SCI USA, V86, P6562, DOI 10.1073/pnas.86.17.6562; Okamoto S, 2003, J APPL CRYSTALLOGR, V36, P982, DOI 10.1107/S0021889803008483; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powell HR, 1999, ACTA CRYSTALLOGR D, V55, P1690, DOI 10.1107/S0907444999009506; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Putnam CD, 2016, J APPL CRYSTALLOGR, V49, P1412, DOI 10.1107/S1600576716010906; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rao V, 1999, PROTEIN SCI, V8, P2338; RAO VH, 1995, STRUCTURE, V3, P449, DOI 10.1016/S0969-2126(01)00178-2; Ravelli RBG, 2000, STRUCTURE, V8, P315, DOI 10.1016/S0969-2126(00)00109-X; Remesh SG, 2018, STRUCTURE, V26, P1007, DOI 10.1016/j.str.2018.03.017; RODGERS DW, 1994, STRUCTURE, V2, P1135, DOI 10.1016/S0969-2126(94)00116-2; Russi S, 2017, J SYNCHROTRON RADIAT, V24, P73, DOI 10.1107/S1600577516017343; Sauter A, 2016, J PHYS CHEM B, V120, P5564, DOI 10.1021/acs.jpcb.6b03559; SINGH A, 1983, PROG BIOPHYS MOL BIO, V39, P69, DOI 10.1016/0079-6107(83)90014-7; Southworth-Davies RJ, 2007, STRUCTURE, V15, P1531, DOI 10.1016/j.str.2007.10.013; Stachowski T, 2019, J SYNCHROTRON RADIAT, V26, P967, DOI 10.1107/S1600577519005113; Sutton KA, 2013, ACTA CRYSTALLOGR D, V69, P2381, DOI 10.1107/S0907444913022117; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Symons MCR, 1999, PROG REACT KINET MEC, V24, P139; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tian XS, 2015, IUCRJ, V2, P9, DOI 10.1107/S205225251402209X; Trewhella J, 2017, ACTA CRYSTALLOGR D, V73, P710, DOI 10.1107/S2059798317011597; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Wang F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120458; Weik M, 2001, ACTA CRYSTALLOGR D, V57, P566, DOI 10.1107/S0907444901001196; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Yumerefendi H, 2016, NAT CHEM BIOL, V12, P399, DOI 10.1038/nchembio.2068	73	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0239702	10.1371/journal.pone.0239702	http://dx.doi.org/10.1371/journal.pone.0239702			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201877	Green Published, gold, Green Submitted			2022-12-26	WOS:000595003900040
J	Singh, KB; Hahm, ER; Kim, SH; Wendell, SG; Singh, SV				Singh, Krishna B.; Hahm, Eun-Ryeong; Kim, Su-Hyeong; Wendell, Stacy G.; Singh, Shivendra V.			A novel metabolic function of Myc in regulation of fatty acid synthesis in prostate cancer	ONCOGENE			English	Article							C-MYC; CHROMOSOMAL-ANOMALIES; GENE; EXPRESSION; SYNTHASE; AMPLIFICATION; CARCINOMA; OVEREXPRESSION; ADENOCARCINOMA; ONCOGENE	A subset of human prostate cancer exhibits increased de novo synthesis of fatty acids, but the molecular driver(s) of this metabolic abnormality remains obscure. This study demonstrates a novel metabolic function of c-Myc (Myc) in regulation of fatty acid synthesis. The role of Myc in regulation of fatty acid synthesis was investigated by: (a) interrogation of the prostate cancer The Cancer Genome Atlas (TCGA) dataset, (b) chromatin immunoprecipitation, and (c) determination of the expression of fatty acid synthesis enzymes and targeted metabolomics using a mouse model and human specimens. The expression of MYC was positively associated with that of key fatty acid synthesis genes including ACLY, ACC1, and FASN in prostate cancer TCGA dataset. Chromatin immunoprecipitation revealed Myc occupancy at the promoters of ACLY, ACC1, and FASN. Prostate-specific overexpression of Myc in Hi-Myc transgenic mice resulted in overexpression of ACLY, ACC1, and FASN proteins in neoplastic lesions and increased circulating levels of total free fatty acids. Targeted metabolomics confirmed increased circulating levels of individual fatty acids in the plasma of Hi-Myc mice and human subjects when compared to corresponding controls. Immunohistochemistry also revealed a positive and statistically significant association in expression of Myc with that of ACC1 in human prostate adenocarcinoma specimens. We propose that Myc-regulated fatty acid synthesis is a valid target for therapy and/or prevention of prostate cancer.	[Singh, Krishna B.; Hahm, Eun-Ryeong; Kim, Su-Hyeong; Wendell, Stacy G.; Singh, Shivendra V.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Singh, Shivendra V.] Univ Pittsburgh, Sch Med, UPMC Hillman Canc Ctr, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Singh, SV (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA.; Singh, SV (corresponding author), Univ Pittsburgh, Sch Med, UPMC Hillman Canc Ctr, Pittsburgh, PA 15213 USA.	singhs@upmc.edu	Singh, Krishna Beer/AAT-9496-2021	/0000-0002-4052-4373	National Cancer Institute [P30 CA047904]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute grant R01 CA225716 (to S.V.S.). This study used the Animal Facility and the Tissue and Research Pathology Facility partly supported by the National Cancer Institute grant P30 CA047904. The funders had no role in the design of the study, data collection, analysis or interpretation of the data, manuscript preparation or decision to submit the manuscript for publication.	BUTTYAN R, 1987, PROSTATE, V11, P327, DOI 10.1002/pros.2990110405; Chavarro JE, 2013, AM J EPIDEMIOL, V178, P1246, DOI 10.1093/aje/kwt136; Chen HW, 2012, PROSTATE CANCER P D, V15, P260, DOI 10.1038/pcan.2012.15; Edwards J, 2003, CLIN CANCER RES, V9, P5271; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; FOX SB, 1993, J UROLOGY, V150, P490, DOI 10.1016/S0022-5347(17)35533-7; Gao LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063563; Gao YJ, 2014, CANCER LETT, V349, P15, DOI 10.1016/j.canlet.2014.03.015; Gouw AM, 2019, CELL METAB, V30, P556, DOI 10.1016/j.cmet.2019.07.012; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Jenkins RB, 1997, CANCER RES, V57, P524; Li XN, 2011, ANAL CHEM, V83, P3192, DOI 10.1021/ac103093w; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Miyoshi Y, 2000, PROSTATE, V43, P225, DOI 10.1002/(SICI)1097-0045(20000515)43:3<225::AID-PROS9>3.0.CO;2-7; NAG A, 1989, PROSTATE, V15, P115, DOI 10.1002/pros.2990150205; Priolo C, 2014, CANCER RES, V74, P7198, DOI 10.1158/0008-5472.CAN-14-1490; Rossi S, 2003, MOL CANCER RES, V1, P707; Rubin MA, 2011, J CLIN ONCOL, V29, P3659, DOI 10.1200/JCO.2011.35.1916; Schmidt LJ, 2013, CURR DRUG TARGETS, V14, P401; Scott KEN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029761; Shah US, 2006, HUM PATHOL, V37, P401, DOI 10.1016/j.humpath.2005.11.022; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh KB, 2019, CARCINOGENESIS, V40, P1545, DOI 10.1093/carcin/bgz155; Singh KB, 2019, MOL CANCER THER, V18, P1800, DOI 10.1158/1535-7163.MCT-19-0046; Singh KB, 2018, CARCINOGENESIS, V39, P826, DOI 10.1093/carcin/bgy051; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Suburu J, 2012, PROSTAG OTH LIPID M, V98, P1, DOI 10.1016/j.prostaglandins.2012.03.003; Sun JS, 2007, PROSTATE, V67, P692, DOI 10.1002/pros.20543; Swinnen JV, 1996, ENDOCRINOLOGY, V137, P4468, DOI 10.1210/en.137.10.4468; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Vyas AR, 2016, J CELL BIOCHEM, V117, P2482, DOI 10.1002/jcb.25541; Wang SI, 1998, CLIN CANCER RES, V4, P811; WARBURG O, 1956, SCIENCE, V124, P269; Wu XY, 2014, AM J CLIN EXP UROL, V2, P111; Zeng W, 2015, INT J CLIN EXP PATHO, V8, P1878; Zhang Q, 2019, ONCOL LETT, V18, P4237, DOI 10.3892/ol.2019.10765	42	10	10	3	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2021	40	3					592	602		10.1038/s41388-020-01553-z	http://dx.doi.org/10.1038/s41388-020-01553-z		NOV 2020	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PU9SL	33199826	Green Accepted			2022-12-26	WOS:000590042900002
J	Voronin, A; Weiel, M; Schug, A				Voronin, Arthur; Weiel, Marie; Schug, Alexander			Including residual contact information into replica-exchange MD simulations significantly enriches native-like conformations	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; DIRECT-COUPLING ANALYSIS; FORCE-FIELD; POTENTIALS; ENERGETICS; SCATTERING; SEQUENCE; SIGNALS; GROMACS; CHARMM	Proteins are complex biomolecules which perform critical tasks in living organisms. Knowledge of a protein's structure is essential for understanding its physiological function in detail. Despite the incredible progress in experimental techniques, protein structure determination is still expensive, time-consuming, and arduous. That is why computer simulations are often used to complement or interpret experimental data. Here, we explore how in silico protein structure determination based on replica-exchange molecular dynamics (REMD) can benefit from including contact information derived from theoretical and experimental sources, such as direct coupling analysis or NMR spectroscopy. To reflect the influence from erroneous and noisy data we probe how false-positive contacts influence the simulated ensemble. Specifically, we integrate varying numbers of randomly selected native and non-native contacts and explore how such a bias can guide simulations towards the native state. We investigate the number of contacts needed for a significant enrichment of native-like conformations and show the capabilities and limitations of this method. Adhering to a threshold of approximately 75% true-positive contacts within a simulation, we obtain an ensemble with native-like conformations of high quality. We find that contact-guided REMD is capable of delivering physically reasonable models of a protein's structure.	[Voronin, Arthur; Weiel, Marie] Karlsruhe Inst Technol, Steinbuch Ctr Comp, Eggenstein Leopoldshafen, Germany; [Voronin, Arthur; Weiel, Marie] Karlsruhe Inst Technol, Dept Phys, Karlsruhe, Germany; [Schug, Alexander] Julich Supercomp Ctr, Inst Adv Simulat, Julich, Germany; [Schug, Alexander] Univ Duisburg Essen, Fac Biol, Duisburg, Germany	Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Duisburg Essen	Schug, A (corresponding author), Julich Supercomp Ctr, Inst Adv Simulat, Julich, Germany.; Schug, A (corresponding author), Univ Duisburg Essen, Fac Biol, Duisburg, Germany.	al.schug@fz-juelich.de		Schug, Alexander/0000-0002-0534-502X; Voronin, Arthur/0000-0002-5804-5151	Helmholtz Association Initiative and Networking Fund [ZT-I-0003]; Ministry of Science, Research and the Arts Baden-Wurttemberg; Federal Ministry of Education and Research	Helmholtz Association Initiative and Networking Fund; Ministry of Science, Research and the Arts Baden-Wurttemberg; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work is supported by the Helmholtz Association Initiative and Networking Fund under project number ZT-I-0003. The computing time on the ForHLR II cluster was funded by the Ministry of Science, Research and the Arts Baden-Wurttemberg and by the Federal Ministry of Education and Research.	Abraham M., 2016, GROMACS REFERENCE MA; AlQuraishi M, 2019, CELL SYST, V8, P292, DOI 10.1016/j.cels.2019.03.006; Alzheimer's Association, 2014, Alzheimers Dement, V10, pe47; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bernardi RC, 2015, BBA-GEN SUBJECTS, V1850, P872, DOI 10.1016/j.bbagen.2014.10.019; Bjelkmar P, 2010, J CHEM THEORY COMPUT, V6, P459, DOI 10.1021/ct900549r; Bjorling A, 2015, J CHEM THEORY COMPUT, V11, P780, DOI 10.1021/ct5009735; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Chen PC, 2015, BIOPHYS J, V108, P2573, DOI 10.1016/j.bpj.2015.03.062; De Leonardis E, 2015, NUCLEIC ACIDS RES, V43, P10444, DOI 10.1093/nar/gkv932; Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j; Freddolino PL, 2009, BIOPHYS J, V97, P2338, DOI 10.1016/j.bpj.2009.08.012; Gan HH, 2002, BIOPHYS J, V83, P2781, DOI 10.1016/S0006-3495(02)75287-9; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; GUZZO AV, 1965, BIOPHYS J, V5, P809, DOI 10.1016/S0006-3495(65)86753-4; Halabis A, 2012, J PHYS CHEM B, V116, P6898, DOI 10.1021/jp212630y; Hansmann UHE, 1997, CHEM PHYS LETT, V281, P140, DOI 10.1016/S0009-2614(97)01198-6; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kufareva Irina, 2012, Methods Mol Biol, V857, P231, DOI 10.1007/978-1-61779-588-6_10; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lee H, 2019, PROCEEDINGS OF 2019 IEEE/ACM THIRD WORKSHOP ON DEEP LEARNING ON SUPERCOMPUTERS (DLS), P12, DOI 10.1109/DLS49591.2019.00007; Lei HX, 2007, P NATL ACAD SCI USA, V104, P4925, DOI 10.1073/pnas.0608432104; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; McKnight CJ, 1997, NAT STRUCT BIOL, V4, P180, DOI 10.1038/nsb0397-180; Modi V, 2016, PROTEINS, V84, P200, DOI 10.1002/prot.25049; Morcos F, 2013, P NATL ACAD SCI USA, V110, P20533, DOI 10.1073/pnas.1315625110; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798; Okabe T, 2001, CHEM PHYS LETT, V335, P435, DOI 10.1016/S0009-2614(01)00055-0; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Paschek D, 2008, P NATL ACAD SCI USA, V105, P17754, DOI 10.1073/pnas.0804775105; Patriksson A, 2008, PHYS CHEM CHEM PHYS, V10, P2073, DOI 10.1039/b716554d; Qiu LL, 2002, J AM CHEM SOC, V124, P12952, DOI 10.1021/ja0279141; Raval A, 2016, PROTEIN SCI, V25, P19, DOI 10.1002/pro.2770; Reinartz I, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5010434; Robertson MJ, 2015, J CHEM THEORY COMPUT, V11, P3499, DOI 10.1021/acs.jctc.5b00356; Sanbonmatsu KY, 2002, PROTEINS, V46, P225, DOI 10.1002/prot.1167; Schug A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.158102; Schug A, 2009, P NATL ACAD SCI USA, V106, P22124, DOI 10.1073/pnas.0912100106; Senior AW, 2020, NATURE, V577, P706, DOI 10.1038/s41586-019-1923-7; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Sheu SY, 2003, P NATL ACAD SCI USA, V100, P12683, DOI 10.1073/pnas.2133366100; Shevchuk R, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005800; Sindhikara D, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2816560; Smith MD, 2015, J CHEM INF MODEL, V55, P2587, DOI 10.1021/acs.jcim.5b00308; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Uguzzoni G, 2017, P NATL ACAD SCI USA, V114, pE2662, DOI 10.1073/pnas.1615068114; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang ZY, 2010, IEEE INT C BIOINFORM, P109, DOI 10.1109/BIBM.2010.5706547; Weiel M, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006900; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zerihun MB, 2020, BIOINFORMATICS, V36, P2264, DOI 10.1093/bioinformatics/btz892; Zhao F, 2010, J COMPUT BIOL, V17, P783, DOI 10.1089/cmb.2009.0235	58	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242072	10.1371/journal.pone.0242072	http://dx.doi.org/10.1371/journal.pone.0242072			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196676	Green Published, gold			2022-12-26	WOS:000595266800006
J	Bergelt, M; Yuan, VF; O'Brien, R; Middleton, LE; dos Santos, WM				Bergelt, Maximilian; Fung Yuan, Vanessa; O'Brien, Richard; Middleton, Laura E.; Martins dos Santos, Wellington			Moderate aerobic exercise, but not anticipation of exercise, improves cognitive control	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; EXECUTIVE FUNCTIONS; WORKING-MEMORY; OLDER-ADULTS; AROUSAL; PERFORMANCE; METAANALYSIS; TASK; IMPAIRMENT; CORTISOL	Background Evidence suggests a single bout of exercise can improve cognitive control. However, many studies only include assessments after exercise. It is unclear whether exercise changes as a result, or in anticipation, of exercise. Objective To examine changes in cognitive control due to moderate aerobic exercise, and anticipation of such exercise. Methods Thirty-one young healthy adults (mean age 22 years; 55% women) completed three conditions (randomized order): 1) exercise (participants anticipated and completed exercise); 2) anticipation (participants anticipated exercise but completed rest); and 3) rest (participants anticipated and completed rest). Cognitive control was assessed with a modified Flanker task at three timepoints: (1) early (20 min pre-intervention, pre-reveal in anticipation session); (2) pre-intervention (after reveal); and (3) post-intervention. An accuracy-weighted response time (RTLISAS) was the primary outcome, analyzed with a linear mixed effects modeling approach. Results There was an interaction between condition and time (p = 0.003) and between session and time (p = 0.015). RTLISAS was better post-exercise than post-rest and post-deception, but was similar across conditions at other timepoints. RTLISAS improved across time in session 1 and session 2, but did not improve over time in session 3. There were also main effects of condition (p = 0.024), session (p = 0.005), time (p<0.001), and congruency (p<0.001). Conclusions Cognitive control improved after moderate aerobic exercise, but not in anticipation of exercise. Improvements on a Flanker task were also observed across sessions and time, indicative of a learning effect that should be considered in study design and analyses.	[Bergelt, Maximilian; Fung Yuan, Vanessa; O'Brien, Richard; Middleton, Laura E.] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada; [Fung Yuan, Vanessa] Brock Univ, Dept Kinesiol, St Catharines, ON, Canada; [Martins dos Santos, Wellington] Univ Estadual Campinas, Dept Phys Educ, Campinas, SP, Brazil	University of Waterloo; Brock University; Universidade Estadual de Campinas	Middleton, LE (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada.	laura.middleton@uwaterloo.ca	Middleton, Laura/ABG-8940-2021	Santos, Welligton/0000-0002-4955-8764; Bergelt, Maximilian/0000-0003-2910-5108				Angevaren M, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005381.pub3, 10.1002/14651858.CD005381.pub2]; BarbergerGateau P, 1997, DISABIL REHABIL, V19, P175, DOI 10.3109/09638289709166525; Basso Julia C, 2017, Brain Plast, V2, P127, DOI 10.3233/BPL-160040; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; Budde H, 2012, ARCH MED RES, V43, P125, DOI 10.1016/j.arcmed.2012.02.005; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; COOPER CJ, 1973, ERGONOMICS, V16, P601, DOI 10.1080/00140137308924551; Coull JT, 1998, PROG NEUROBIOL, V55, P343, DOI 10.1016/S0301-0082(98)00011-2; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Du Z, 2018, CLIN INTERV AGING, V13, P1593, DOI 10.2147/CIA.S169565; Eriksen BA, 1974, PERCEPT PSYCHOPHYS, DOI [10.3758/bf03213946, DOI 10.3758/BF03213946]; Etnier JL, 2009, J SPORT EXERCISE PSY, V31, P469, DOI 10.1123/jsep.31.4.469; Gomez-Pinilla F, 2013, COMPR PHYSIOL, V3, P403, DOI 10.1002/cphy.c110063; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Hillman CH, 2006, HEALTH PSYCHOL, V25, P678, DOI 10.1037/0278-6133.25.6.678; Hirsch P, 2018, ADV COGN PSYCHOL, V14, P62, DOI 10.5709/acp-0239-y; Joyce J, 2014, MED SCI SPORT EXER, V46, P630, DOI 10.1249/MSS.0b013e3182a77980; Joyce J, 2009, BRAIN COGNITION, V71, P14, DOI 10.1016/j.bandc.2009.03.004; Kamijo K, 2004, CLIN NEUROPHYSIOL, V115, P2693, DOI 10.1016/j.clinph.2004.06.016; Kamijo K, 2007, INT J PSYCHOPHYSIOL, V65, P114, DOI 10.1016/j.ijpsycho.2007.04.001; Kopp B, 2020, PSYCHOL RES-PSYCH FO, V84, P1112, DOI 10.1007/s00426-018-1113-5; Kramer AF, 2006, J APPL PHYSIOL, V101, P1237, DOI 10.1152/japplphysiol.00500.2006; Kuper K, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00184; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; LaBar KS, 1998, PSYCHOL SCI, DOI [10.1111/1467-9280.00083, DOI 10.1111/1467-9280.00083]; Lambourne K, 2010, MED SCI SPORT EXER, V42, P1396, DOI 10.1249/MSS.0b013e3181cbee11; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lehle C, 2008, PSYCHON B REV, V15, P814, DOI 10.3758/PBR.15.4.814; Lenth RV., 2021, EMMEANS ESTIMATED MA; Loprinzi PD, 2015, MAYO CLIN PROC, V90, P450, DOI 10.1016/j.mayocp.2014.12.023; MANTYSAARI MJ, 1988, PSYCHOPHYSIOLOGY, V25, P179, DOI 10.1111/j.1469-8986.1988.tb00983.x; MASON JW, 1973, PSYCHOSOM MED, V35, P406, DOI 10.1097/00006842-197309000-00004; Mather M, 2006, J COGNITIVE NEUROSCI, V18, P614, DOI 10.1162/jocn.2006.18.4.614; McMorris T, 2009, INT J PSYCHOPHYSIOL, V73, P334, DOI 10.1016/j.ijpsycho.2009.05.004; Meng XF, 2020, AGING CLIN EXP RES, V32, P7, DOI 10.1007/s40520-019-01159-w; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; Northey JM, 2018, BRIT J SPORT MED, V52, P154, DOI 10.1136/bjsports-2016-096587; Okumiya K, 1996, J AM GERIATR SOC, V44, P569, DOI 10.1111/j.1532-5415.1996.tb01444.x; PAR-Q+ and ePARmed-X+, 2013, PAR Q EPARMED X; Parkin C, 1997, HUM PSYCHOPHARM CLIN, DOI DOI 10.1002/(SICI)1099-1077(199701/02)12:1<LESSTHAN>65::AID-HUP838<GREATERTHAN>3.0.CO;2-W; R Core Team, 2021, R LANGUAGE ENV STAT; Riediger M, 2014, PSYCHOL AGING, V29, P103, DOI 10.1037/a0035766; Schuch S, 2018, J EXP PSYCHOL LEARN, V44, P1487, DOI 10.1037/xlm0000530; Sharot T, 2004, COGN AFFECT BEHAV NE, V4, P294, DOI 10.3758/CABN.4.3.294; Shields GS, 2015, PSYCHONEUROENDOCRINO, V58, P91, DOI 10.1016/j.psyneuen.2015.04.017; Skosnik PD, 2000, INT J PSYCHOPHYSIOL, V36, P59, DOI 10.1016/S0167-8760(99)00100-2; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Strohle A, 2015, AM J GERIAT PSYCHIAT, V23, P1234, DOI 10.1016/j.jagp.2015.07.007; TOBIN MJ, 1986, J APPL PHYSIOL, V60, P1306, DOI 10.1152/jappl.1986.60.4.1306; Tomaszewski S, 2009, CLIN NEUROPSYCHOL, V23, P446, DOI 10.1080/13854040802360558; Tumati S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154450; Vandierendonck Andre, 2018, J Cogn, V1, P8, DOI 10.5334/joc.6; Vandierendonck A, 2017, BEHAV RES METHODS, V49, P653, DOI 10.3758/s13428-016-0721-5; Wendt M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00682; Weuve J, 2004, JAMA-J AM MED ASSOC, V292, P1454, DOI 10.1001/jama.292.12.1454; Winter B, 2007, NEUROBIOL LEARN MEM, V87, P597, DOI 10.1016/j.nlm.2006.11.003; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00595; Wu CX, 2019, J AM GERIATR SOC, V67, P749, DOI 10.1111/jgs.15714; Zheng GH, 2016, BRIT J SPORT MED, V50, P1443, DOI 10.1136/bjsports-2015-095699; Zou LY, 2019, ARCH PHYS MED REHAB, V100, P1556, DOI 10.1016/j.apmr.2019.03.009	67	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242270	10.1371/journal.pone.0242270	http://dx.doi.org/10.1371/journal.pone.0242270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0NB	33186396	gold, Green Published			2022-12-26	WOS:000593949800038
J	Shiramizu, V; Docherty, C; DeBruine, LM; Jones, BC				Shiramizu, Victor; Docherty, Ciaran; DeBruine, Lisa M.; Jones, Benedict C.			Sexual orientation predicts men's preferences for sexually dimorphic face-shape characteristics: A replication study	PLOS ONE			English	Article								Many researchers have proposed that straight men prefer women's faces displaying feminine shape characteristics at least partly because mating with such women will produce healthier offspring. Although a prediction of this adaptation-for-mate-choice hypothesis is that straight men will show stronger preferences for feminized versus masculinized versions of women's faces than will gay men, only one previous study has directly tested this prediction. Here we directly replicated that study by comparing 623 gay and 3163 straight men's preferences for feminized versus masculinized versions of faces. Consistent with the adaptation-for-mate-choice hypothesis of straight men's femininity preferences, we found that straight men showed significantly stronger preferences for feminized female faces than did gay men. Consistent with previous research suggesting that gay men place a premium on masculinity in potential romantic partners, we also found that gay men showed significantly stronger preferences for masculinized versions of male faces than did straight men. Together, these findings indicate the sexual orientation contributes to individual differences in men's face preferences.	[Shiramizu, Victor; Docherty, Ciaran; DeBruine, Lisa M.; Jones, Benedict C.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	University of Glasgow	Shiramizu, V (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland.	victor.shiramizu@glasgow.ac.uk	DeBruine, Lisa M/A-6990-2008; Shiramizu, Victor/GPP-0919-2022; Jones, Benedict/A-7850-2008	DeBruine, Lisa M/0000-0002-7523-5539; Jones, Benedict/0000-0001-7777-0220	European Research Council (ERC) [KINSHIP - 647910]	European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was funded by a European Research Council (ERC) grant (KINSHIP - 647910) awarded to LMD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey JM, 1997, J PERS SOC PSYCHOL, V73, P960, DOI 10.1037/0022-3514.73.5.960; Barr DJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00328; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Cai ZY, 2019, EVOL HUM BEHAV, V40, P156, DOI 10.1016/j.evolhumbehav.2018.10.002; Glassenberg AN, 2010, ARCH SEX BEHAV, V39, P1289, DOI 10.1007/s10508-009-9559-6; Jones AL, 2019, SYMMETRY-BASEL, V11, DOI 10.3390/sym11020279; Jones BC, 2018, PSYCHOL SCI, V29, P996, DOI 10.1177/0956797618760197; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Little AC, 2011, PHILOS T R SOC B, V366, P1638, DOI 10.1098/rstb.2010.0404; Marcinkowska UM, 2017, J GERONTOL B-PSYCHOL, V72, P180, DOI 10.1093/geronb/gbv077; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; R Core Team, 2021, R LANGUAGE ENV STAT; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; 2012, BIOPRESERV BIOBANK, V10	18	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242262	10.1371/journal.pone.0242262	http://dx.doi.org/10.1371/journal.pone.0242262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0NB	33186368	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000593949800019
J	Wei, ZP; Du, QY; Li, PF; Liu, HC; Xia, MH; Chen, YF; Bi, GY; Tang, ZH; Cheng, X; Lu, YM; He, R; Laurence, A; Wang, J; Huang, L; Li, HB; Yang, XP				Wei, Zhengping; Du, Qiuyang; Li, Pingfei; Liu, Huicheng; Xia, Minghui; Chen, Yufei; Bi, Guoyu; Tang, Zhao-Hui; Cheng, Xiang; Lu, Youming; He, Ran; Laurence, Arian; Wang, Jing; Huang, Liu; Li, Huabin; Yang, Xiang-Ping			Death-associated protein kinase 1 (DAPK1) controls CD8(+) T cell activation, trafficking, and antitumor activity	FASEB JOURNAL			English	Article						Akt; CD8(+) T cells; DAPK1; mTORC1; trafficking	CHEMOKINE RECEPTOR; L-SELECTIN; MIGRATION; MTOR; CCR7; SIGNALS	Appropriate migration of cytotoxic T effector cells into the tumors is crucial for their antitumor function. Despite the controversial role of PI3K-Akt in CD8(+) T cell mTORC1 activation, a link between Akt-mTORC1 signaling and CD8(+) trafficking has been demonstrated. We have recently discovered that TCR-induced calcineurin activates DAPK1, which interacts with TSC2 via its death domain and phosphorylates TSC2 via its kinase domain to mediate mTORC1 activation in CD8(+) T cells. However, whether DAPK1 regulates CD8(+) trafficking into tumors remains unclear. Here, using pharmacological inhibitor and genetic approaches, we found that like rapamycin, inhibition of DAPK1 activity led to enhanced expression of the homing receptors CD62L and CCR7. Deletion of either kinase domain or death domain in the T cell compartment reduced the T cell activation and maintained the expression of CD62L and CCR7. DAPK1-DD-deficient mice were more susceptible to tumor growth and deficiency of DAPK1 activity significantly reduced the migratory ability of CD8(+) into the tumors. These data revealed a crucial role of DAPK1-mTORC1 in mediating CD8(+) trafficking and antitumor function.	[Wei, Zhengping; Du, Qiuyang; Li, Pingfei; Liu, Huicheng; Xia, Minghui; Chen, Yufei; Bi, Guoyu; He, Ran; Wang, Jing; Yang, Xiang-Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Immunol, Wuhan, Peoples R China; [Li, Pingfei] Hubei Univ Med, Dept Immunol, Shiyan, Peoples R China; [Tang, Zhao-Hui] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Surg, Wuhan, Peoples R China; [Cheng, Xiang] HUST, Union Hosp, Tongji Med Coll, Inst Cardiol,Lab Cardiovasc Immunol, Wuhan, Peoples R China; [Lu, Youming] Huazhong Univ Sci & Technol, Inst Brain Res, Wuhan, Peoples R China; [Lu, Youming] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Basic Med, Dept Physiol, Wuhan, Peoples R China; [Laurence, Arian] UCL, Hosp NHS Trust, Dept Haematol, London, England; [Huang, Liu] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Oncol, Wuhan, Peoples R China; [Li, Huabin] Fudan Univ, Affiliated Eye Ear Nose & Throat Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China	Huazhong University of Science & Technology; Hubei University of Medicine; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; University of London; University College London; Huazhong University of Science & Technology; Fudan University	Li, HB (corresponding author), Fudan Univ, Affiliated Eye Ear Nose & Throat Hosp, Dept Otolaryngol Head & Neck Surg, Shanghai, Peoples R China.; Yang, XP (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Sch, Dept Immunol, Wuhan 430030, Peoples R China.	allergyli@163.com; yangxp@hust.edu.cn	Wu, Jing/GZK-5063-2022; Wang, Jin/GYA-2019-2022; wang, jing/GVT-8700-2022	Yang, Xiang-Ping/0000-0001-9003-1772	National Natural Science Foundation of China (NSFC) [81671539, 31870892, 81725004, 81602104]; Ministry of Science and Technology [81725004, 81602104, 2019YFC1316203]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81671539, 31870892, 81725004 and 81602104; Ministry of Science and Technology, Grant/Award Number: 2019YFC1316203, 81725004 and 81602104	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bachmann MF, 2006, NAT REV IMMUNOL, V6, P159, DOI 10.1038/nri1776; Bai AL, 2007, J IMMUNOL, V178, P7632, DOI 10.4049/jimmunol.178.12.7632; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Chou TF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11904; Chuang YT, 2008, J IMMUNOL, V180, P3238, DOI 10.4049/jimmunol.180.5.3238; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Galkina E, 2007, EUR J IMMUNOL, V37, P1243, DOI 10.1002/eji.200636481; Gaud G, 2018, NAT REV IMMUNOL, V18, P485, DOI 10.1038/s41577-018-0020-8; Harty JT, 2000, ANNU REV IMMUNOL, V18, P275, DOI 10.1146/annurev.immunol.18.1.275; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Hirata T, 2002, J IMMUNOL, V169, P4307, DOI 10.4049/jimmunol.169.8.4307; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Krummel MF, 2016, NAT REV IMMUNOL, V16, P193, DOI 10.1038/nri.2015.16; Li QS, 2011, IMMUNITY, V34, P541, DOI 10.1016/j.immuni.2011.04.006; Macintyre AN, 2011, IMMUNITY, V34, P224, DOI 10.1016/j.immuni.2011.01.012; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Pei L, 2015, CEREB CORTEX, V25, P4559, DOI 10.1093/cercor/bhv096; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Shu S, 2016, J NEUROSCI, V36, P10843, DOI 10.1523/JNEUROSCI.2258-16.2016; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; Wei ZP, 2021, CELL MOL IMMUNOL, V18, P138, DOI 10.1038/s41423-019-0293-2; Weigelin B, 2011, IMMUNOL LETT, V138, P19, DOI 10.1016/j.imlet.2011.02.016; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zou WP, 2018, CELL MOL IMMUNOL, V15, P419, DOI 10.1038/s41423-018-0011-5	33	3	3	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.201903067RR	http://dx.doi.org/10.1096/fj.201903067RR		NOV 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33184932				2022-12-26	WOS:000590889200001
J	Asada, R; Senmatsu, S; Montpetit, B; Hirota, K				Asada, Ryuta; Senmatsu, Satoshi; Montpetit, Ben; Hirota, Kouji			Topoisomerase activity is linked to altered nucleosome positioning and transcriptional regulation in the fission yeast fbp1 gene	PLOS ONE			English	Article							LONG NONCODING RNAS; DNA TOPOISOMERASES; CHROMATIN; STRESS; REPLICATION; MUTANTS; SINGLE; RECRUITMENT; EXPRESSION; PROMOTERS	Chromatin structure, including nucleosome positioning, has a fundamental role in transcriptional regulation through influencing protein-DNA interactions. DNA topology is known to influence chromatin structure, and in doing so, can also alter transcription. However, detailed mechanism(s) linking transcriptional regulation events to chromatin structure that is regulated by changes in DNA topology remain to be well defined. Here we demonstrate that nucleosome positioning and transcriptional output from the fission yeast fbp1 and prp3 genes are altered by excess topoisomerase activity. Given that lncRNAs (long noncoding RNAs) are transcribed from the fbp1 upstream region and are important for fbp1 gene expression, we hypothesized that local changes in DNA topological state caused by topoisomerase activity could alter lncRNA and fbp1 transcription. In support of this, we found that topoisomerase overexpression caused destabilization of positioned nucleosomes within the fbp1 promoter region, which was accompanied by aberrant fbp1 transcription. Similarly, the direct recruitment of topoisomerase, but not a catalytically inactive form, to the promoter region of fbp1 caused local changes in nucleosome positioning that was also accompanied by altered fbp1 transcription. These data indicate that changes in DNA topological state induced by topoisomerase activity could lead to altered fbp1 transcription through modulating nucleosome positioning.	[Asada, Ryuta; Senmatsu, Satoshi; Hirota, Kouji] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Hachioji, Tokyo, Japan; [Asada, Ryuta; Montpetit, Ben] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA	Tokyo Metropolitan University; University of California System; University of California Davis	Hirota, K (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Hachioji, Tokyo, Japan.	khirota@tmu.ac.jp		Montpetit, Ben/0000-0002-8317-983X; Hirota, Kouji/0000-0003-1676-979X; Asada, Ryuta/0000-0001-8360-6355	JSPS KAKENHI from Japan Society for the Promotion of Science [JP16H01314, JP16H02957, JP16J02252]; Yamada Science Foundation; Takeda Science Foundation	JSPS KAKENHI from Japan Society for the Promotion of Science; Yamada Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by the JSPS KAKENHI: Grants-in-Aid for Scientific Research on Innovative Areas (JP16H01314), Grant-in-Aid for Scientific Research (B)(JP16H02957) and Grant-in-Aid for Challenging Exploratory Research (JP16H02957) to KH and Grant-in-Aid for JSPS Research Fellow (JP16J02252) to RA all from Japan Society for the Promotion of Science. This work was also supported by the Yamada Science Foundation and the Takeda Science Foundation to KH.	Adachi A, 2017, GENES GENET SYST, V92, P267, DOI 10.1266/ggs.17-00018; ALMOUZNI G, 1988, EMBO J, V7, P4355, DOI 10.1002/j.1460-2075.1988.tb03334.x; Asada R, 2017, NUCLEIC ACIDS RES, V45, P9361, DOI 10.1093/nar/gkx555; Asada R, 2015, MOL CELL BIOL, V35, P847, DOI 10.1128/MCB.00924-14; Durand-Dubief M, 2010, EMBO J, V29, P2126, DOI 10.1038/emboj.2010.109; Galipon J, 2013, GENES CELLS, V18, P353, DOI 10.1111/gtc.12042; Garinther WI, 1997, MOL CELL BIOL, V17, P3520, DOI 10.1128/MCB.17.7.3520; GARTENBERG MR, 1992, P NATL ACAD SCI USA, V89, P11461, DOI 10.1073/pnas.89.23.11461; Gavin I, 2001, MOL CELL, V7, P97, DOI 10.1016/S1097-2765(01)00158-7; Gibb EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025915; Gonzalez S, 2016, GENOME RES, V26, P1532, DOI 10.1101/gr.207241.116; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Gupta P, 2009, BIOPHYS J, V97, P3150, DOI 10.1016/j.bpj.2009.09.032; Hirota K, 2004, NUCLEIC ACIDS RES, V32, P855, DOI 10.1093/nar/gkh251; Hirota K, 2003, GENETICS, V165, P505; Hirota K, 2003, MOL BIOL CELL, V14, P3617, DOI 10.1091/mbc.E02-10-0665; Hirota K, 2001, GENES CELLS, V6, P201, DOI 10.1046/j.1365-2443.2001.00415.x; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Hirota K, 2006, EUKARYOT CELL, V5, P1980, DOI 10.1128/EC.00272-06; HOFFMAN CS, 1990, GENETICS, V124, P807; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; Joshi RS, 2010, EMBO J, V29, P740, DOI 10.1038/emboj.2009.391; Kaur H, 2015, MOL CELL, V57, P583, DOI 10.1016/j.molcel.2015.01.020; Kent NA, 2001, GENE DEV, V15, P619, DOI 10.1101/gad.190301; Koster DA, 2010, CELL, V142, P519, DOI 10.1016/j.cell.2010.08.001; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LIU LF, 1987, P NATL ACAD SCI USA, V84, P7024, DOI 10.1073/pnas.84.20.7024; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Nakazawa N, 2015, GENES CELLS, V20, P481, DOI 10.1111/gtc.12239; Neely LA, 2000, MOL CELL BIOL, V20, P6426, DOI 10.1128/MCB.20.17.6426-6434.2000; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Norman-Axelsson U, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003371; Pecina A, 2002, CELL, V111, P173, DOI 10.1016/S0092-8674(02)01002-4; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; POTASHKIN J, 1989, EMBO J, V8, P551, DOI 10.1002/j.1460-2075.1989.tb03409.x; Sanso M, 2011, NUCLEIC ACIDS RES, V39, P6369, DOI 10.1093/nar/gkr255; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Steger DJ, 2003, SCIENCE, V299, P114, DOI 10.1126/science.1078062; TAKEDA T, 1987, P NATL ACAD SCI USA, V84, P3580, DOI 10.1073/pnas.84.11.3580; Takemata N, 2016, NUCLEIC ACIDS RES, V44, P5174, DOI 10.1093/nar/gkw142; Teves SS, 2014, NAT STRUCT MOL BIOL, V21, P88, DOI 10.1038/nsmb.2723; UEMURA T, 1984, EMBO J, V3, P1737, DOI 10.1002/j.1460-2075.1984.tb02040.x; UEMURA T, 1986, EMBO J, V5, P2355, DOI 10.1002/j.1460-2075.1986.tb04504.x; Umeda M, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00194-18; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Win TZ, 2004, J CELL SCI, V117, P4769, DOI 10.1242/jcs.01351; Yamashita A, 1998, CELL, V95, P115, DOI 10.1016/S0092-8674(00)81787-0; 2012, SURG OBES RELAT DIS, V8	52	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242348	10.1371/journal.pone.0242348	http://dx.doi.org/10.1371/journal.pone.0242348			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180846	gold, Green Published			2022-12-26	WOS:000593948000018
J	Heizmann, B; Le Gras, S; Simand, C; Marchal, P; Chan, SS; Kastner, P				Heizmann, Beate; Le Gras, Stephanie; Simand, Celestine; Marchal, Patricia; Chan, Susan; Kastner, Philippe			Ikaros antagonizes DNA binding by STAT5 in pre-B cells	PLOS ONE			English	Article							LYMPHOBLASTIC-LEUKEMIA; IDENTIFICATION; ACTIVATION; REPRESSION; NETWORKS; IKZF1	The IKZF1 gene, which encodes the Ikaros transcription factor, is frequently deleted or mutated in patients with B-cell precursor acute lymphoblastic leukemias that express oncogenes, like BCR-ABL, which activate the JAK-STAT5 pathway. Ikaros functionally antagonizes the transcriptional programs downstream of IL-7/STAT5 during B cell development, as well as STAT5 activity in leukemic cells. However, the mechanisms by which Ikaros interferes with STAT5 function is unknown. We studied the genomic distribution of Ikaros and STAT5 on chromatin in a murine pre-B cell line, and found that both proteins colocalize on >60% of STAT5 target regions. Strikingly, Ikaros activity leads to widespread loss of STAT5 binding at most of its genomic targets within two hours of Ikaros induction, suggesting a direct mechanism. Ikaros did not alter the level of total or phosphorylated STAT5 proteins, nor did it associate with STAT5. Using sequences from the Cish, Socs2 and Bcl6 genes that Ikaros and STAT5 target, we show that both proteins bind overlapping sequences at GGAA motifs. Our results demonstrate that Ikaros antagonizes STAT5 DNA binding, in part by competing for common target sequences. Our study has implications for understanding the functions of Ikaros and STAT5 in B cell development and transformation.	[Heizmann, Beate; Le Gras, Stephanie; Simand, Celestine; Marchal, Patricia; Chan, Susan; Kastner, Philippe] Inst Genet Biol Mol & Cellulaire IGBMC, Illkirch Graffenstaden, France; [Heizmann, Beate; Le Gras, Stephanie; Simand, Celestine; Marchal, Patricia; Chan, Susan; Kastner, Philippe] Inst Natl Sante & Rech Med INSERM, U1258, Illkirch Graffenstaden, France; [Heizmann, Beate; Le Gras, Stephanie; Simand, Celestine; Marchal, Patricia; Chan, Susan; Kastner, Philippe] Ctr Natl Rech Sci CNRS, UMR7104, Illkirch Graffenstaden, France; [Heizmann, Beate; Le Gras, Stephanie; Simand, Celestine; Marchal, Patricia; Chan, Susan; Kastner, Philippe] Univ Strasbourg, Illkirch Graffenstaden, France; [Simand, Celestine] Inst Cancerol Strasbourg Europe ICANS, Serv Hematol, Strasbourg, France; [Kastner, Philippe] Univ Strasbourg, Fac Med, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Heizmann, B; Chan, SS; Kastner, P (corresponding author), Inst Genet Biol Mol & Cellulaire IGBMC, Illkirch Graffenstaden, France.; Heizmann, B; Chan, SS; Kastner, P (corresponding author), Inst Natl Sante & Rech Med INSERM, U1258, Illkirch Graffenstaden, France.; Heizmann, B; Chan, SS; Kastner, P (corresponding author), Ctr Natl Rech Sci CNRS, UMR7104, Illkirch Graffenstaden, France.; Heizmann, B; Chan, SS; Kastner, P (corresponding author), Univ Strasbourg, Illkirch Graffenstaden, France.; Kastner, P (corresponding author), Univ Strasbourg, Fac Med, Strasbourg, France.	heizmann@igbmc.fr; scpk@igbmc.fr		Heizmann, Beate/0000-0002-4236-2937; Le Gras, Stephanie/0000-0001-6293-6507	Fondation ARC; Fondation de France; Institut National du Cancer [2015-114]; Ligue Nationale Contre le Cancer (equipe labellisee); French State fund [ANR-10-LABX-0030-INRT, ANR-10-IDEX-0002-02]; Ligue Nationale Contre le Cancer	Fondation ARC; Fondation de France(Fondation de France); Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale Contre le Cancer (equipe labellisee)(Ligue nationale contre le cancer); French State fund; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported by grants from Fondation ARC (https://www.fondation-arc.org) (to BH), Fondation de France (https://www.fondationdefrance.org) (to SC), Institut National du Cancer (https://www.e-cancer.fr) (#2015-114, to PK), Ligue Nationale Contre le Cancer (https://www.ligue-cancer.net) (equipe labellisee, to SC) and by the grant ANR-10-LABX-0030-INRT, a French State fund managed by the Agence Nationale de la Recherche (https://anr.fr) under the framework program Investissements d'Avenir ANR-10-IDEX-0002-02. BH was supported by a postdoctoral fellowship from the Fondation de France (https://www.fondationdefrance.org), and CS by a predoctoral fellowship from the Ligue Nationale Contre le Cancer (https://www.liguecancer.net).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, CORSALUD; [Anonymous], 2017, ECONOMICS-KIEL, V6, P1, DOI 10.1057/s11369-017-0051-3; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Basham B, 2008, NUCLEIC ACIDS RES, V36, P3802, DOI 10.1093/nar/gkn271; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Dovat S, 2017, NAT IMMUNOL, V18, P597, DOI 10.1038/ni.3747; Fistonich C, 2018, J EXP MED, V215, P2586, DOI 10.1084/jem.20180778; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; Harvey RC, 2010, BLOOD, V115, P5312, DOI 10.1182/blood-2009-09-245944; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heizmann B, 2013, J EXP MED, V210, P2823, DOI 10.1084/jem.20131735; Iacobucci I, 2017, J CLIN ONCOL, V35, P975, DOI 10.1200/JCO.2016.70.7836; Johnson K, 2008, IMMUNITY, V28, P335, DOI 10.1016/j.immuni.2007.12.019; Joshi I, 2014, NAT IMMUNOL, V15, P294, DOI 10.1038/ni.2821; Katerndahl CDS, 2017, NAT IMMUNOL, V18, P694, DOI 10.1038/ni.3716; Kleinmann E, 2008, MOL CELL BIOL, V28, P7465, DOI 10.1128/MCB.00715-08; Langmead B, 2011, CURR PROTOC BIOINFOR, P1, DOI 10.1002/0471250953.bi1107s32; Liang Z, 2017, ELIFE, V6, DOI DOI 10.7554/eLife.22767; Mandal M, 2011, NAT IMMUNOL, V12, P1212, DOI 10.1038/ni.2136; Marke R, 2018, HAEMATOLOGICA, V103, P565, DOI 10.3324/haematol.2017.185603; McDonald PW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10285; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Nahar R, 2011, BLOOD, V118, P4174, DOI 10.1182/blood-2011-01-331181; Olsson L, 2015, BRIT J HAEMATOL, V169, P479, DOI 10.1111/bjh.13342; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Powell MD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01299; Schwickert TA, 2014, NAT IMMUNOL, V15, P283, DOI 10.1038/ni.2828; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Stanulla M, 2020, BLOOD, V135, P252, DOI 10.1182/blood.2019000813; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Verdier F, 1998, MOL CELL BIOL, V18, P5852, DOI 10.1128/MCB.18.10.5852; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LJ, 2010, BMC BIOINFORMATICS, P11, DOI 10.1186/1471-2105-11-11	37	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242211	10.1371/journal.pone.0242211	http://dx.doi.org/10.1371/journal.pone.0242211			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180866	Green Published, gold			2022-12-26	WOS:000593948000008
J	Phillips, R; Friberg, M; Cronqvist, ML; Jonson, CO; Prytz, E				Phillips, Rachel; Friberg, Marc; Lantz Cronqvist, Mattias; Jonson, Carl-Oscar; Prytz, Erik			Visual estimates of blood loss by medical laypeople: Effects of blood loss volume, victim gender, and perspective	PLOS ONE			English	Article							BYSTANDER TRAUMA CARE; STUDENT MIDWIVES; LEVEL; AID	A severe hemorrhage can result in death within minutes, before professional first responders have time to arrive. Thus, intervention by bystanders, who may lack medical training, may be necessary to save a victim's life in situations with bleeding injuries. Proper intervention requires that bystanders accurately assess the severity of the injury and respond appropriately. As many bystanders lack tools and training, they are limited in terms of the information they can use in their evaluative process. In hemorrhage situations, visible blood loss may serve as a dominant cue to action. Therefore, understanding how medically untrained bystanders (i.e., laypeople) perceive hemorrhage is important. The purpose of the current study was to investigate the ability of laypeople to visually assess blood loss and to examine factors that may impact accuracy and the classification of injury severity. A total of 125 laypeople watched 78 short videos each of individuals experiencing a hemorrhage. Victim gender, volume of blood lost, and camera perspective were systematically manipulated in the videos. The results revealed that laypeople overestimated small volumes of blood loss (from 50 to 200 ml), and underestimated larger volumes (from 400 to 1900 ml). Larger volumes of blood loss were associated with larger estimation errors. Further, blood loss was underestimated more for female victims than male victims and their hemorrhages were less likely to be classified as life-threatening. These results have implications for training and intervention design.	[Phillips, Rachel] Old Dominion Univ, Dept Psychol, Norfolk, VA 23529 USA; [Friberg, Marc; Lantz Cronqvist, Mattias; Prytz, Erik] Linkoping Univ, Dept Comp & Informat Sci, Linkoping, Sweden; [Friberg, Marc; Jonson, Carl-Oscar; Prytz, Erik] Linkoping Univ, Dept Biomed & Clin Sci, Ctr Disaster Med & Traumatol, Linkoping, Sweden	Old Dominion University; Linkoping University; Linkoping University	Phillips, R (corresponding author), Old Dominion Univ, Dept Psychol, Norfolk, VA 23529 USA.; Prytz, E (corresponding author), Linkoping Univ, Dept Comp & Informat Sci, Linkoping, Sweden.; Prytz, E (corresponding author), Linkoping Univ, Dept Biomed & Clin Sci, Ctr Disaster Med & Traumatol, Linkoping, Sweden.	rphil019@odu.edu; erik.prytz@liu.se	Jonson, Carl-Oscar/C-8491-2015	Jonson, Carl-Oscar/0000-0003-1383-375X	Swedish Civil Contingencies Agency [2018-12395 MSB]	Swedish Civil Contingencies Agency	This study was partially funded by the Swedish Civil Contingencies Agency grant 2018-12395 MSB. EP and CJ received the award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins Ashleigh R, 2014, AANA J, V82, P300; [Anonymous], 2016, SENSORS, V16, pC1, DOI 10.1109/JSEN.2016.2517933; Ashburn JC, 2012, WEST J EMERG MED, V13, P376, DOI 10.5811/westjem.2011.9.6669; Bakke HK, 2015, ACTA ANAESTH SCAND, V59, P1187, DOI 10.1111/aas.12561; Beer HL, 2005, J LARYNGOL OTOL, V119, P16, DOI 10.1258/0022215053222752; Berry DC, 2014, ATHL TRAIN ED J, V9, P142; Birkinshaw R, 1998, PREHOSPITAL IMMEDIAT, V2, P197; Budair B, 2017, J ORTHOP, V14, P81, DOI 10.1016/j.jor.2016.10.019; De La Pena Silva AJ, 2014, REV COLOMB ANESTESIO, V42, P247; Expert Panel on Neurologic Imaging, 2017, J AM COLL RADIOL, V14, pS550; Faul M, 2016, PREHOSP EMERG CARE, V20, P317, DOI 10.3109/10903127.2015.1088605; Fiala SE, 1999, J APPL SOC PSYCHOL, V29, P2164, DOI 10.1111/j.1559-1816.1999.tb02300.x; Frank M, 2010, J TRAUMA, V69, P1191, DOI 10.1097/TA.0b013e3181c452e7; Glover Pauline, 2003, Aust J Midwifery, V16, P21, DOI 10.1016/S1031-170X(03)80005-3; Goolsby C, 2018, J AM COLL SURGEONS, V227, P502, DOI 10.1016/j.jamcollsurg.2018.08.692; Hancock A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0653-6; Henry S, 2018, ATLS ADV TRAUMA LIFE, P42; Jacobs LM, 2017, J AM COLL SURGEONS, V224, P1084, DOI 10.1016/j.jamcollsurg.2017.02.013; Johnson KL, 2005, PSYCHOL SCI, V16, P890, DOI 10.1111/j.1467-9280.2005.01633.x; Kolb K S, 1999, CRNA, V10, P170; Koval KJ, 2006, J BONE JOINT SURG AM, V88A, P2124, DOI 10.2106/JBJS.F.00245; Lakstein D, 2003, J TRAUMA, V54, pS221, DOI 10.1097/01.TA.0000047227.33395.49; Merlin MA, 2009, AM J EMERG MED, V27, P1085, DOI 10.1016/j.ajem.2008.07.039; Natrella M, 2018, J MATERN-FETAL NEO M, V31, P106, DOI 10.1080/14767058.2016.1274302; O Neill ML., 2011, J SPEC OPER MED, V11, P30; Oliver GJ, 2017, INJURY, V48, P985, DOI 10.1016/j.injury.2017.02.026; Parayre I, 2015, INT J NURS STUD, V52, P1798, DOI 10.1016/j.ijnurstu.2015.06.015; Pelinka LE, 2004, RESUSCITATION, V61, P289, DOI 10.1016/j.resuscitation.2004.01.012; Phillips R, P HUM FACTORS ERGON; Pranal M, 2018, MIDWIFERY, V59, P17, DOI 10.1016/j.midw.2017.12.017; Prytz EG, 2018, HUM FACTORS, V60, P1219, DOI 10.1177/0018720818788142; Ram GG, 2014, CHIN J TRAUMATOL, V17, P225, DOI 10.3760/cma.j.issn.1008-1275.2014.04.008; Razvi K, 1996, AUST NZ J OBSTET GYN, V36, P152, DOI 10.1111/j.1479-828X.1996.tb03273.x; Rothermel LD, 2016, SURGERY, V160, P946, DOI 10.1016/j.surg.2016.06.006; SALMINEN S, 1992, J SOC PSYCHOL, V132, P131, DOI 10.1080/00224545.1992.9924697; Schorn MN, 2010, J MIDWIFERY WOM HEAL, V55, P20, DOI 10.1016/j.jmwh.2009.02.014; Tall Gary, 2003, Emerg Med (Fremantle), V15, P318, DOI 10.1046/j.1442-2026.2003.00469.x; Thierbach AR, 2004, RESUSCITATION, V60, P271, DOI 10.1016/j.resuscitation.2003.11.008; Tjardes T, 2018, MIL MED, V183, pE207, DOI 10.1093/milmed/usx016; Yoong W, 2010, ARCH GYNECOL OBSTET, V281, P207, DOI 10.1007/s00404-009-1099-8; Zuckerwise LC, 2014, OBSTET GYNECOL, V123, P982, DOI 10.1097/AOG.0000000000000233	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242096	10.1371/journal.pone.0242096	http://dx.doi.org/10.1371/journal.pone.0242096			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0MJ	33180812	Green Published, gold			2022-12-26	WOS:000593948000058
J	Saleh, D; Abdelbaset, M; Hassan, A; Sharaf, O; Mahmoud, S; Hegazy, R				Saleh, Dalia; Abdelbaset, Marawan; Hassan, Azza; Sharaf, Ola; Mahmoud, Sawsan; Hegazy, Rehab			Omega-3 fatty acids ameliorate doxorubicin-induced cardiorenal toxicity: In-vivo regulation of oxidative stress, apoptosis and renal Nox4, and in-vitro preservation of the cytotoxic efficacy	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; INDUCED CARDIOTOXICITY; ANTHRACYCLINE ANTIBIOTICS; DIETARY OMEGA-3; NADPH OXIDASES; RATS ROLE; NRF2; INFLAMMATION; METABOLISM; EXPRESSION	This study examines the protective effects of omega-3 fatty acids (OMG), a frequently used nutritional therapy in cancer patients, against doxorubicin (DOX)-induced acute cardiorenal toxicity in rats, and evaluates the cytotoxic activity of DOX when used with OMG against breast cancer cell line. Five groups of rats were treated for 4 consecutive weeks with vehicle (groups I & II), or OMG (25, 50 or 100 mg/kg/day, po; groups III, IV & V, respectively). After twenty-four hours, the last four groups were injected with DOX (200 mg/kg, ip). In DOX-treated rats, the altered ECG, serum cardiac and renal function biomarkers, and histopathological features indicated the induction of cardiorenal toxicity. Increased oxidative and apoptotic markers in both organs was observed, with elevated renal contents of NADPH-oxidase-4 (Nox4) and renin. OMG pretreatment improved those DOX-induced impairments in a dose-dependent manner, and showed antioxidant and antiapoptotic effects with regulation of renal Nox4 expression. The in-vitro study showed preservation of the cytotoxic activity of DOX on MCF7 cell line in the presence of OMG. The data suggests OMG for protection against acute DOX-induced cardiorenal damage without affecting the latter antitumor activity. It proposes regulation of oxidative stress, Nox4 activity and apoptosis as contributing protective mechanisms.	[Saleh, Dalia; Abdelbaset, Marawan; Sharaf, Ola; Mahmoud, Sawsan; Hegazy, Rehab] Natl Res Ctr, Dept Pharmacol, Med Div, Giza, Egypt; [Hassan, Azza] Cairo Univ, Fac Vet Med, Dept Pathol, Giza, Giza, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Cairo University	Hegazy, R (corresponding author), Natl Res Ctr, Dept Pharmacol, Med Div, Giza, Egypt.	rehab_hegazy@hotmail.com	Abd Elbaset, Marawan/M-8214-2019	Abd Elbaset, Marawan/0000-0002-0861-6251; Mahmoud, Sawasn/0000-0003-2172-0763; Hegazy, Rehab/0000-0002-2586-2104				Adkins Y, 2010, J NUTR BIOCHEM, V21, P781, DOI 10.1016/j.jnutbio.2009.12.004; Avramovic N, 2012, HIPPOKRATIA, V16, P241; BARTLES JR, 1979, J BIOL CHEM, V254, P3156; Brewer AC, 2011, FREE RADICAL BIO MED, V51, P205, DOI 10.1016/j.freeradbiomed.2011.04.022; BRISTOW MR, 1980, J CARDIOVASC PHARM, V2, P487, DOI 10.1097/00005344-198009000-00002; Brown SA, 1998, J LAB CLIN MED, V131, P447, DOI 10.1016/S0022-2143(98)90146-9; Cappetta D, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1521020; Churchman AT, 2009, J CELL MOL MED, V13, P2282, DOI 10.1111/j.1582-4934.2009.00874.x; D'Eliseo D, 2016, J CLIN MED, V5, DOI 10.3390/jcm5020015; de Batlle J, 2012, J NUTR BIOCHEM, V23, P817, DOI 10.1016/j.jnutbio.2011.04.005; de Carvalho PB, 2016, CELL PHYSIOL BIOCHEM, V40, P431, DOI 10.1159/000452558; Desnoyers M, 2018, MAR DRUGS, V16, DOI 10.3390/md16070234; Deten A, 2002, CARDIOVASC RES, V55, P329, DOI 10.1016/S0008-6363(02)00413-3; Dimitrow PP, 2009, MINI-REV MED CHEM, V9, P1030, DOI 10.2174/138955709788922638; DOROSHOW JH, 1983, CANCER RES, V43, P460; Drimal J, 2006, NEUROENDOCRINOL LETT, V27, P176; Ebrahimi M, 2009, ACTA CARDIOL, V64, P321, DOI 10.2143/AC.64.3.2038016; El-Ashmawy NE, 2018, BIOMED PHARMACOTHER, V99, P504, DOI 10.1016/j.biopha.2018.01.036; Elsherbiny NM, 2014, CHEM-BIOL INTERACT, V223, P102, DOI 10.1016/j.cbi.2014.09.015; Fadillioglu E, 2004, J APPL TOXICOL, V24, P47, DOI 10.1002/jat.945; FAWCETT JK, 1960, J CLIN PATHOL, V13, P156, DOI 10.1136/jcp.13.2.156; Freitas RDS, 2019, NUTRIENTS, V11, DOI 10.3390/nu11050945; Gelsomino G, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-137; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Giri SN, 2004, CANCER CHEMOTH PHARM, V53, P141, DOI 10.1007/s00280-003-0703-z; Goyal V, 2016, CAN J CARDIOL, V32, P1513, DOI 10.1016/j.cjca.2016.06.002; Gu Zhennan, 2015, Curr Pharmacol Rep, V1, P283; Guo JC, 2008, J AM SOC NEPHROL, V19, P961, DOI 10.1681/ASN.2007101109; Hajianfar H, 2013, INT J PREVENTIVE MED, V4, pS234; Hajrasouliha AR, 2004, EUR J PHARMACOL, V499, P307, DOI 10.1016/j.ejphar.2004.07.099; Hassan IR, 2009, J IMMUNOL, V182, P3223, DOI 10.4049/jimmunol.0802064; Hijazi MA, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/5269074; Injac R, 2008, TECHNOL CANCER RES T, V7, P497, DOI 10.1177/153303460800700611; Injac R, 2008, PHARMACOL REP, V60, P742; Jagetia GC, 2005, PHYTOTHER RES, V19, P772, DOI 10.1002/ptr.1713; JENSEN RA, 1984, J CARDIOVASC PHARM, V6, P186; KALYANARAMAN B, 1980, BIOCHIM BIOPHYS ACTA, V630, P119, DOI 10.1016/0304-4165(80)90142-7; Khan S, 2002, J LIPID RES, V43, P979; Kim K, 2016, TOXICOL PATHOL, V44, P1072, DOI 10.1177/0192623316668276; KITADA M, 1994, BIOCHEM PHARMACOL, V48, P93; Laviano A, 2013, CURR OPIN CLIN NUTR, V16, P156, DOI 10.1097/MCO.0b013e32835d2d99; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Licata S, 2000, CHEM RES TOXICOL, V13, P414, DOI 10.1021/tx000013q; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Mizutani H, 2005, LIFE SCI, V76, P1439, DOI 10.1016/j.lfs.2004.05.040; Mukhopadhyay S, 2020, CANCER RES, V80, P1630, DOI 10.1158/0008-5472.CAN-19-1363; Mustafa HN, 2017, TISSUE CELL, V49, P410, DOI 10.1016/j.tice.2017.03.007; Nagai K, 2018, PHARMACOLOGY, V101, P219, DOI 10.1159/000486625; Niazi ZR, 2017, HYPERTENS RES, V40, P966, DOI 10.1038/hr.2017.72; Oscarsson J, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0541-3; Panjrath GS, 2007, J AM COLL CARDIOL, V49, P2457, DOI 10.1016/j.jacc.2007.02.060; Patel N, 2010, TOXICOL APPL PHARM, V245, P143, DOI 10.1016/j.taap.2010.02.002; Rajaram RD, 2019, NEPHROL DIAL TRANSPL, V34, P567, DOI 10.1093/ndt/gfy161; Reagan WJ, 2013, TOXICOL PATHOL, V41, P1146, DOI 10.1177/0192623313482056; Renu K, 2018, EUR J PHARMACOL, V818, P241, DOI 10.1016/j.ejphar.2017.10.043; Roca-Alonso L, 2012, CARDIOLOGY, V122, P253, DOI 10.1159/000339858; Ruan Y, 2015, CELL PHYSIOL BIOCHEM, V35, P1116, DOI 10.1159/000373937; Ryoo IG, 2016, BIOMOL THER, V24, P482, DOI 10.4062/biomolther.2016.145; Saleem Mohamed T S, 2014, Ther Adv Cardiovasc Dis, V8, P4, DOI 10.1177/1753944713516532; Saleh DO, 2019, EUR J PHARMACOL, V855, P40, DOI 10.1016/j.ejphar.2019.04.043; Sedeek M, 2013, J AM SOC NEPHROL, V24, P1512, DOI 10.1681/ASN.2012111112; Shen JM, 2018, NEUROL RES, V40, P499, DOI 10.1080/01616412.2018.1451290; Sindhu ER, 2016, J ENVIRON PATHOL TOX, V35, P236, DOI 10.1615/JEnvironPatholToxicolOncol.2016014010; Singh SK, 2008, ANN MED, V40, P110, DOI 10.1080/07853890701749225; Sinha RA, 2009, INT J DEV NEUROSCI, V27, P377, DOI 10.1016/j.ijdevneu.2009.02.003; SMITH IK, 1975, POSTGRAD MED J, V51, P506, DOI 10.1136/pgmj.51.598.506; Sun Z, 2016, EXP THER MED, V12, P1879, DOI 10.3892/etm.2016.3518; Swanson D, 2012, ADV NUTR, V3, P1, DOI 10.3945/an.111.000893; Szalay CI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127090; SZASZ G, 1979, J CLIN CHEM CLIN BIO, V17, P683; Takemura G, 2007, PROG CARDIOVASC DIS, V49, P330, DOI 10.1016/j.pcad.2006.10.002; Tang J, 2019, HYPERTENSION, V74, P83, DOI 10.1161/HYPERTENSIONAHA.119.12873; Thorn CF, 2011, PHARMACOGENET GENOM, V21, P440, DOI 10.1097/FPC.0b013e32833ffb56; Tulubas F, 2015, TOXICOL IND HEALTH, V31, P638, DOI 10.1177/0748233713483203; Uygur R, 2014, HUM EXP TOXICOL, V33, P435, DOI 10.1177/0960327113493304; Wellington D, 2013, J AM ASSOC LAB ANIM, V52, P481; Wenningmann N, 2019, MOL PHARMACOL, V96, P219, DOI 10.1124/mol.119.115725; Xu F, 2019, CYTOGENET GENOME RES, V158, P17, DOI 10.1159/000500290; Yang Q, 2018, FREE RADICAL BIO MED, V124, P466, DOI 10.1016/j.freeradbiomed.2018.06.042; Zhang QL, 2019, BIOMED PHARMACOTHER, V109, P71, DOI 10.1016/j.biopha.2018.07.037; Zhang YW, 2009, ARCH IMMUNOL THER EX, V57, P435, DOI 10.1007/s00005-009-0051-8	82	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242175	10.1371/journal.pone.0242175	http://dx.doi.org/10.1371/journal.pone.0242175			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180794	gold, Green Published			2022-12-26	WOS:000593948000002
J	D'Onofrio, V; Donders, E; Vanden Abeele, ME; Dubois, J; Cartuyvels, R; Achten, R; Lammens, M; Dendooven, A; Driessen, A; Augsburg, L; Vanrusselt, J; Cox, J				D'Onofrio, Valentino; Donders, Elena; Vanden Abeele, Marie-Elena; Dubois, Jasperina; Cartuyvels, Reinoud; Achten, Ruth; Lammens, Martin; Dendooven, Amelie; Driessen, Ann; Augsburg, Lukasz; Vanrusselt, Jan; Cox, Janneke			The clinical value of minimal invasive autopsy in COVID-19 patients	PLOS ONE			English	Article							ILL ICU PATIENTS	Background Minimally invasive autopsy (MIA) is a validated and safe method to establish the cause of death (COD), mainly in low-resource settings. However, the additional clinical value of MIA in Coronavirus disease (COVID-19) patients in a high-resource setting is unknown. The objective was to assess if and how MIA changed clinical COD and contributing diagnoses in deceased COVID-19 patients. Methods and findings A prospective observational cohort from April to May 2020 in a 981-bed teaching hospital in the epicenter of the COVID-19 pandemic in Belgium was established. Patients who died with either PCR-confirmed or radiologically confirmed COVID-19 infection were consecutively included. MIA consisted of whole-body CT and CT-guided Tru-Cut (R) biopsies. Diagnostic modalities were clinical chart review, radiology, microbiology, and histopathology which were assessed by two independent experts per modality. MIA COD and contributing diagnoses were established during a multi-disciplinary meeting. Clinical COD (CCOD) and contributing diagnosis were abstracted from the discharge letter. The main outcomes were alterations in CCOD and contributing diagnoses after MIA, and the contribution of each diagnostic modality. We included 18 patients, of which 7 after intensive care unit hospitalization. MIA led to an alteration in 15/18 (83%) patients. The CCOD was altered in 5/18 (28%) patients. MIA found a new COD (1/5), a more specific COD (1/5), a less certain COD (1/5), or a contributing diagnosis to be the COD (2/5). Contributing diagnoses were altered in 14/18 (78%) patients: 9 new diagnoses, 5 diagnoses dismissed, 3 made more specific, and 2 made less certain. Overall, histopathology contributed in 14/15 (93%) patients with alterations, radiology and microbiology each in 6/15 (40%), and clinical review in 3/15 (20%). Histopathology was deemed the most important modality in 10 patients, radiology in two patients, and microbiology in one patient. Conclusion MIA, especially histological examination, can add valuable new clinical information regarding the cause of death in COVID-19 patients, even in a high-resource setting with wide access to premortem diagnostic modalities. MIA may provide important clinical insights and should be applied in the current ongoing pandemic.	[D'Onofrio, Valentino; Cox, Janneke] Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium; [D'Onofrio, Valentino; Donders, Elena; Cox, Janneke] Jessa Hosp, Dept Infect Dis & Immun, Hasselt, Belgium; [Vanden Abeele, Marie-Elena] Jessa Hosp, Dept Geriatr, Hasselt, Belgium; [Dubois, Jasperina] Jessa Hosp, Intens Care & Anesthesiol, Hasselt, Belgium; [Cartuyvels, Reinoud] Jessa Hosp, Clin Lab, Hasselt, Belgium; [Achten, Ruth] Jessa Hosp, Dept Pathol, Hasselt, Belgium; [Achten, Ruth; Lammens, Martin; Dendooven, Amelie; Driessen, Ann] Antwerp Univ Hosp, Dept Pathol, Edegem, Belgium; [Lammens, Martin; Dendooven, Amelie; Driessen, Ann] Univ Antwerp, CORE, Antwerp, Belgium; [Dendooven, Amelie] Univ Hosp Ghent, Dept Pathol, Ghent, Belgium; [Augsburg, Lukasz; Vanrusselt, Jan] Jessa Hosp, Dept Radiol, Hasselt, Belgium	Hasselt University; University of Antwerp; University of Antwerp; Ghent University; Ghent University Hospital	Cox, J (corresponding author), Hasselt Univ, Fac Med & Life Sci, Hasselt, Belgium.; Cox, J (corresponding author), Jessa Hosp, Dept Infect Dis & Immun, Hasselt, Belgium.	janneke.cox@jessazh.be	Lammens, Martin/H-1503-2011; Dendooven, Amélie/AAC-1192-2021; Driessen, Ann/D-3768-2017; Lammens, Martin/AAI-9343-2021	Lammens, Martin/0000-0002-3881-6692; Driessen, Ann/0000-0003-4148-610X; Dendooven, Amelie/0000-0002-9900-7952; Donders, Elena/0000-0002-8466-7755; D'Onofrio, Valentino/0000-0003-3828-0442	Research Foundation Flanders (FWO) [G0G2620N]; foundation Limburg Sterk Merk (LSM); Hasselt University; Jessa Hospital; Ziekenhuis Oost-Limburg	Research Foundation Flanders (FWO)(FWO); foundation Limburg Sterk Merk (LSM); Hasselt University; Jessa Hospital; Ziekenhuis Oost-Limburg	This study/Janneke Cox has received funding from the Research Foundation Flanders (FWO) (G0G2620N). FWO.be. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study is part of the Limburg Clinical Research Center (LCRC) UHasselt-ZOL-Jessa, supported by the foundation Limburg Sterk Merk (LSM), Hasselt University, Ziekenhuis Oost-Limburg and Jessa Hospital.	Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823; Blokker BM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178200; Carsana L., LANCET INFECT DIS; Castillo P, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002171; Control ECfD, 2020, CAS DEF COR DIS 2019; Hanley B, 2020, J CLIN PATHOL, V73, P239, DOI 10.1136/jclinpath-2020-206522; Klok FA, 2020, THROMB RES, V191, P148, DOI 10.1016/j.thromres.2020.04.041; Langford BJ, CLIN MICROBIOLOGY IN; Lansbury L, 2020, J INFECTION, V81, P266, DOI 10.1016/j.jinf.2020.05.046; Rawson TM, 2020, CLIN INFECT DIS, V71, P2459, DOI 10.1093/cid/ciaa530; Sciensano, CHRON CAS DEF DOC; Stessel B, 2020, THROMB RES, V194, P209, DOI 10.1016/j.thromres.2020.07.038; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V2, P1, DOI DOI 10.5194/GCHRON-2-1-2020; The Royal College of Pathologists, AUT PRACT REL POSS C; Vincent JL, 2020, LANCET RESP MED, V8, P430, DOI 10.1016/S2213-2600(20)30165-X; World Health O, 2020, WHO 2019 NCOV SURV C; Yaacoub S, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002650	17	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242300	10.1371/journal.pone.0242300	http://dx.doi.org/10.1371/journal.pone.0242300			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175911	Green Published, gold			2022-12-26	WOS:000593946900026
J	Noh, GT; Kwon, J; Kim, J; Park, M; Choi, D; Cho, KA; Woo, SY; Oh, BY; Lee, KY; Lee, RA				Noh, Gyoung Tae; Kwon, Jiyun; Kim, Jungwoo; Park, Minhwa; Choi, Da-Won; Cho, Kyung-Ah; Woo, So-Youn; Oh, Bo-Young; Lee, Kang Young; Lee, Ryung-Ah			Verification of the role of exosomal microRNA in colorectal tumorigenesis using human colorectal cancer cell lines	PLOS ONE			English	Article							COLON-CANCER; TUMOR-GROWTH; LUNG-CANCER; FIBROBLASTS; PROGRESSION; MICROENVIRONMENT; METASTASIS; EXPRESSION; INVASION; MARKERS	Exosomes are a group of small membranous vesicles that are shed into the extracellular environment by tumoral or non-tumoral cells and contribute to cellular communication by delivering micro RNAs (miRNAs). In this study, we aimed to evaluate the role of exosomal miRNAs from colorectal cancer cell lines in tumorigenesis, by affecting cancer-associated fibroblasts (CAFs), which are vital constituents of the tumor microenvironment. To analyze the effect of exosomal miRNA on the tumor microenvironment, migration of the monocytic cell line THP-1 was evaluated via Transwell migration assay using CAFs isolated from colon cancer patients. The migration assay was performed with CAFs +/- CCL7-blocking antibody and CAFs that were treated with exosomes isolated from colon cancer cell lines. To identify the associated exosomal miRNAs, miRNA sequencing and quantitative reverse transcription polymerase chain reaction were performed. The migration assay revealed that THP-1 migration was decreased in CCL7-blocking antibody-expressing and exosome-treated CAFs. Colon cancer cell lines contained miRNA let-7d in secreted exosomes targeting the chemokine CCL7. Exosomes from colorectal cancer cell lines affected CCL7 secretion from CAFs, possibly via the miRNA let-7d, and interfered with the migration of CCR2+ monocytic THP-1 cells in vitro.	[Noh, Gyoung Tae; Lee, Kang Young] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Kwon, Jiyun; Kim, Jungwoo; Park, Minhwa; Choi, Da-Won; Cho, Kyung-Ah; Woo, So-Youn] Ewha Womans Univ, Coll Med, Dept Microbiol, Seoul, South Korea; [Oh, Bo-Young] Hallym Univ, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Ryung-Ah] Ewha Womans Univ, Dept Surg, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Ewha Womans University; Hallym University; Ewha Womans University	Lee, RA (corresponding author), Ewha Womans Univ, Dept Surg, Coll Med, Seoul, South Korea.	ralee@ewha.ac.kr		Kim, Jungwoo/0000-0001-8877-6556				Alexander J, 2016, CURR OPIN CELL BIOL, V42, P80, DOI 10.1016/j.ceb.2016.05.002; Bai YP, 2015, CANCER SCI, V106, P1278, DOI 10.1111/cas.12745; Bhome R, 2018, CANCER LETT, V420, P228, DOI 10.1016/j.canlet.2018.02.002; Bhome R, 2017, AGING-US, V9, P2666, DOI 10.18632/aging.101355; Bigagli E, 2016, CANCER BIOL THER, V17, P1062, DOI 10.1080/15384047.2016.1219815; Calon A, 2014, SEMIN CANCER BIOL, V25, P15, DOI 10.1016/j.semcancer.2013.12.008; Chen WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095240; Chiba M, 2012, ONCOL REP, V28, P1551, DOI 10.3892/or.2012.1967; Cho YB, 2012, ONCOL REP, V28, P689, DOI 10.3892/or.2012.1815; Chronicle of Higher Education, 2010, CHRON HIGHER EDUC, V17, pA3; Cirri P, 2012, CANCER METAST REV, V31, P195, DOI 10.1007/s10555-011-9340-x; Cooks T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03224-w; Crenshaw B.J., 2018, NANOMEDICINES INTECH; Dai GY, 2018, B CANCER, V105, P336, DOI 10.1016/j.bulcan.2017.12.009; de Vries Nienke A, 2006, Expert Rev Neurother, V6, P1199, DOI 10.1586/14737175.6.8.1199; De Wever O, 2004, FASEB J, V18, P1016, DOI 10.1096/fj.03-1110fje; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Hashemian SM, 2020, MOL THER-NUCL ACIDS, V21, P51, DOI 10.1016/j.omtn.2020.05.012; Hessvik NP, 2018, CELL MOL LIFE SCI, V75, P193, DOI 10.1007/s00018-017-2595-9; Jiang XL, 2017, PEERJ, V5, DOI 10.7717/peerj.4196; Jung DW, 2010, INT J CANCER, V127, P332, DOI 10.1002/ijc.25060; Kahlert C, 2013, J MOL MED, V91, P431, DOI 10.1007/s00109-013-1020-6; Kikuchi Y, 2008, J HISTOCHEM CYTOCHEM, V56, P753, DOI 10.1369/jhc.2008.951061; Klemm F, 2015, TRENDS CELL BIOL, V25, P198, DOI 10.1016/j.tcb.2014.11.006; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Lan JQ, 2019, CANCER RES, V79, P146, DOI 10.1158/0008-5472.CAN-18-0014; Lee J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174126; Lee JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084256; Lee YS, 2016, ONCOTARGET, V7, P36842, DOI 10.18632/oncotarget.9209; Li HD, 2018, BRIT J CANCER, V119, P744, DOI 10.1038/s41416-018-0254-z; Li J, 2017, J CELL MOL MED, V21, P838, DOI 10.1111/jcmm.12941; Mao L, 2018, CANCER GENE THER, V25, P248, DOI 10.1038/s41417-018-0032-3; Marley AR, 2016, INT J MOL EPIDEMIOL, V7, P105; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; McKenzie AJ, 2016, CELL REP, V15, P978, DOI 10.1016/j.celrep.2016.03.085; Medioni J, 2007, ANN ONCOL, V18, P1282, DOI 10.1093/annonc/mdm275; Mizoguchi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209750; Mohammadi S, 2020, IUBMB LIFE, V72, P724, DOI 10.1002/iub.2182; Naeli P, 2020, CRIT REV ONCOL HEMAT, V145, DOI 10.1016/j.critrevonc.2019.102854; Nahand JS, 2020, EPIGENOMICS-UK, V12, P353, DOI 10.2217/epi-2019-0192; Ostman A, 2009, CURR OPIN GENET DEV, V19, P67, DOI 10.1016/j.gde.2009.01.003; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Patel GK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41800-2; Pourhanifeh MH, 2020, IUBMB LIFE, V72, P314, DOI 10.1002/iub.2211; Pourhanifeh MH, 2020, PHARMACOL RES, V161, DOI 10.1016/j.phrs.2020.105133; Pyrzynska K, 2019, SEP PURIF REV, V48, P65, DOI 10.1080/15422119.2018.1430589; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Safiri S, 2019, LANCET GASTROENTEROL, V4, P913, DOI 10.1016/S2468-1253(19)30345-0; Savardashtaki A, 2019, EPIGENOMICS-UK, V11, P1627, DOI 10.2217/epi-2019-0110; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Sha M, 2018, CANCER MED-US, V7, P4665, DOI 10.1002/cam4.1704; Shi YF, 2017, NAT REV DRUG DISCOV, V16, P35, DOI 10.1038/nrd.2016.193; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Taddei ML, 2013, CANCER LETT, V341, P80, DOI 10.1016/j.canlet.2013.01.042; Teng Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14448; Tommelein J, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00063; Tricarico Christopher, 2017, Small GTPases, V8, P220, DOI 10.1080/21541248.2016.1215283; Tsukamoto M, 2017, ONCOLOGY-BASEL, V92, P360, DOI 10.1159/000463387; Umezu T, 2013, ONCOGENE, V32, P2747, DOI 10.1038/onc.2012.295; Valencia K, 2014, MOL ONCOL, V8, P689, DOI 10.1016/j.molonc.2014.01.012; Wei CM, 2018, BIOMARK MED, V12, P1185, DOI 10.2217/bmm-2017-0440; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; World Tourism Organization-UNWTO, 2022, UNWTO WORLD TOUR BAR, V17, P1, DOI [DOI 10.18111/WTOBAROMETERENG, 10.18111/wtobarometereng.2022.20.1.4, DOI 10.18111/WTOBAROMETERENG.2022.20.1.4]; Wyler L, 2014, BRIT J CANCER, V110, P686, DOI 10.1038/bjc.2013.755; Yan SS, 2018, J CELL PHYSIOL, V233, P6660, DOI 10.1002/jcp.26316; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yang H, 2016, CLIN CHEM LAB MED, V54, P1871, DOI 10.1515/cclm-2016-0029; Yoshii S, 2019, CANCER SCI, V110, P2396, DOI 10.1111/cas.14084; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zeng ZC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07810-w; Zhang Z, 2018, BIOMED PHARMACOTHER, V106, P1135, DOI 10.1016/j.biopha.2018.07.042; Zhao BT, 2014, CANCER LETT, V342, P43, DOI 10.1016/j.canlet.2013.08.030; 2018, EUR UROL SUPPL, V17	77	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242057	10.1371/journal.pone.0242057	http://dx.doi.org/10.1371/journal.pone.0242057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175885	Green Published, gold			2022-12-26	WOS:000593946900014
J	de Oliveira, TCT; Monteiro, AB; Faria, LD				Oliveira, Tamires Camila Talamonte de; Monteiro, Angelo Barbosa; Faria, Lucas Del Bianco			Can multitrophic interactions shape morphometry, allometry, and fluctuating asymmetry of seed-feeding insects?	PLOS ONE			English	Article							BODY-SIZE; FOOD-WEB; DEVELOPMENTAL STABILITY; MORPHOLOGICAL TRAITS; STATIC ALLOMETRY; BEETLE; FITNESS; HOST; COMPETITION; DIMORPHISM	Body size is commonly associated with biological features such as reproductive capacity, competition, and resource acquisition. Many studies have tried to understand how these isolated factors can affect the body pattern of individuals. However, little is known about how interactions among species in multitrophic communities determine the body shape of individuals exploiting the same resource. Here, we evaluate the effect of fruit infestation, parasitism rate, and seed biomass on size, allometric and asymmetric patterns of morphological structures of insects that exploit the same resource. To test it, we measured 750 individuals associated with the plant Senegalia tenuifolia (Fabaceae), previously collected over three consecutive years. Negative allometry was maintained for all species, suggesting that with increasing body size the body structure did not grow proportionally. Despite this, some variations in allometric slopes suggest that interactions in a multitrophic food web can shape the development of these species. Also, we observed a higher confidence interval at higher categories of infestation and parasitism rate, suggesting a great variability in the allometric scaling. We did not observe fluctuating asymmetry for any category or species, but we found some changes in morphological structures, depending on the variables tested. These findings show that both allometry and morphological trait measurements are the most indicated in studies focused on interactions and morphometry. Finally, we show that, except for the fluctuating asymmetry, each species and morphological structure respond differently to interactions, even if the individuals play the same functional role within the food web.	[Oliveira, Tamires Camila Talamonte de; Monteiro, Angelo Barbosa] Univ Fed Lavras, Grad Program Appl Ecol, Lavras, Brazil; [Faria, Lucas Del Bianco] Univ Fed Lavras, Inst Nat Sci, Dept Ecol & Conservat, Lavras, Brazil	Universidade Federal de Lavras; Universidade Federal de Lavras	de Oliveira, TCT (corresponding author), Univ Fed Lavras, Grad Program Appl Ecol, Lavras, Brazil.	tamires_talamonte@hotmail.com	Del Bianco Faria, Lucas/I-1832-2013	Del Bianco Faria, Lucas/0000-0002-7230-800X; Talamonte, Tamires/0000-0002-7626-7970	Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES); National Council for Scientific and Technological Development (CNPq) [141129/2018-2, 306196/2018-2]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	TCTO thanks the Brazilian Coordination for the Improvement of Higher Education Personnel (CAPES) and the National Council for Scientific and Technological Development (CNPq) (141129/2018-2) for financial support. LDBF thanks CAPES, CNPq (306196/2018-2), and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarillo-Suarez AR, 2006, OECOLOGIA, V150, P247, DOI 10.1007/s00442-006-0516-y; Amarillo-Suarez AR, 2011, ECOL EVOL, V1, P1, DOI 10.1002/ece3.1; [Anonymous], 2020, J CLIN ENDOCRINOL ME, V105, pe32; [Anonymous], 2001, J APPL MICROBIOL, V30, p1S; Arambourou H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048844; Arnqvist G, 1998, GENET RES, V71, P193, DOI 10.1017/S0016672398003279; Bacher S, 1997, J INSECT PHYSIOL, V43, P945, DOI 10.1016/S0022-1910(97)00058-9; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beasley DE, 2013, ECOL INDIC, V30, P218, DOI 10.1016/j.ecolind.2013.02.024; Bennett DM, 1998, J ANIM ECOL, V67, P580, DOI 10.1046/j.1365-2656.1998.00218.x; Bjorksten TA, 2000, TRENDS ECOL EVOL, V15, P163, DOI 10.1016/S0169-5347(99)01788-7; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; Campbell R.C., 1970, J ROYAL STAT SOC, V133, P102, DOI [10.2307/2343822, DOI 10.2307/2343822]; Canto A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44761-8; Cariveau DP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151482; Chmielewska D., 2011, FOOD SECURITY POLICY; Colgoni A, 2006, ENTOMOL SCI, V9, P171, DOI 10.1111/j.1479-8298.2006.00164.x; Cornelissen T, 2004, GLOBAL CHANGE BIOL, V10, P27, DOI 10.1111/j.1365-2486.2003.00712.x; David P, 1998, P ROY SOC B-BIOL SCI, V265, P2211, DOI 10.1098/rspb.1998.0561; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; Djemai I, 2000, AM NAT, V156, P257, DOI 10.1086/303388; Ecotoxicology Sommer C., 1996, AMBIO, V25, P374; Emlen DJ, 2003, INTEGR COMP BIOL, V43, P617, DOI 10.1093/icb/43.5.617; EMLEN DJ, 1994, P ROY SOC B-BIOL SCI, V256, P131, DOI 10.1098/rspb.1994.0060; Emlen DJ, 2000, ANNU REV ENTOMOL, V45, P661, DOI 10.1146/annurev.ento.45.1.661; Fox CW, 2003, FUNCT ECOL, V17, P619, DOI 10.1046/j.1365-2435.2003.00781.x; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Haga EB, 2016, ECOL EVOL, V6, P6892, DOI 10.1002/ece3.2364; Hunt J, 1997, BEHAV ECOL SOCIOBIOL, V41, P109, DOI 10.1007/s002650050370; Ings TC, 2009, J ANIM ECOL, V78, P253, DOI 10.1111/j.1365-2656.2008.01460.x; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Kanegae Alexandre P., 2003, Neotrop. entomol., V32, P37, DOI 10.1590/S1519-566X2003000100005; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; KOEHN RK, 1989, BIOL J LINN SOC, V37, P157, DOI 10.1111/j.1095-8312.1989.tb02100.x; Kozlov MV, 1996, J APPL ECOL, V33, P1489, DOI 10.2307/2404787; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; LEARY RF, 1989, TRENDS ECOL EVOL, V4, P214, DOI 10.1016/0169-5347(89)90077-3; Lerner IM, 1954, GENETIC HOMEOSTASIS; Leung B, 1996, ECOSCIENCE, V3, P400, DOI 10.1080/11956860.1996.11682357; MACEDO M V D, 1989, Journal of the New York Entomological Society, V97, P358; Maia LF, 2017, NEOTROP ENTOMOL, V46, P36, DOI 10.1007/s13744-016-0436-4; Maia LF, 2018, STUD NEOTROP FAUNA E, V53, P132, DOI 10.1080/01650521.2018.1428042; MEYHOFER R, 1994, PHYSIOL ENTOMOL, V19, P349, DOI 10.1111/j.1365-3032.1994.tb01062.x; Miner AL, 2000, J INSECT PHYSIOL, V46, P251, DOI 10.1016/S0022-1910(99)00177-8; Moller AP, 1997, AM NAT, V149, P916, DOI 10.1086/286030; MOLLER AP, 1995, J ANIM ECOL, V64, P697, DOI 10.2307/5849; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; Nijhout HF, 1996, AM NAT, V148, P40, DOI 10.1086/285910; Oliveira TCT, 2020, ECOL ENTOMOL, V45, P538, DOI [10.1111/een.12825, DOI 10.1111/EEN.12825]; Palmer A. Richard, 2003, P279; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Queiroz L. P. de, 2009, LEGUMINOSAS CAATINGA; Quicke D. L. J., 1997, PARASITIC WASPS; Reimchen TE, 1997, CAN J ZOOL, V75, P2084, DOI 10.1139/z97-843; Rettig JE, 1997, OIKOS, V80, P123, DOI 10.2307/3546523; Sagarra LA, 2001, B ENTOMOL RES, V91, P363, DOI 10.1079/BER2001121; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; Shingleton AW, 2008, P ROY SOC B-BIOL SCI, V275, P1875, DOI 10.1098/rspb.2008.0227; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Shingleton AW, 2009, P ROY SOC B-BIOL SCI, V276, P2625, DOI 10.1098/rspb.2008.1796; Shingleton AW., 2010, NAT ED KNOWL, V3, P2; SILVA EF, 2007, R BRAS BIOCI, V5, P948; Silva JA, 2017, REV BRAS ENTOMOL, V61, P243, DOI 10.1016/j.rbe.2017.04.003; SOUTHGATE BJ, 1979, ANNU REV ENTOMOL, V24, P449, DOI 10.1146/annurev.en.24.010179.002313; Souza D, 2018, ENTOMOL EXP APPL, V166, P298, DOI 10.1111/eea.12665; Thornhill R, 1998, BEHAV ECOL, V9, P546, DOI 10.1093/beheco/9.6.546; Tobler A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010723; Tuller J, 2015, REV BIOL TROP, V63, P1149, DOI 10.15517/rbt.v63i4.16855; Valkama J, 2001, J APPL ECOL, V38, P665, DOI 10.1046/j.1365-2664.2001.00628.x; van Dongen S, 1999, J EVOLUTION BIOL, V12, P94, DOI 10.1046/j.1420-9101.1999.00012.x; Venkataramana PB, 2016, EUPHYTICA, V207, P135, DOI 10.1007/s10681-015-1551-8; Weller B, 2004, BASIC APPL ECOL, V5, P193, DOI 10.1078/1439-1791-00220; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Zaldivar-Riveron A, 2018, CAN ENTOMOL, V150, P279, DOI 10.4039/tce.2018.1; Zaugg I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055317	76	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241913	10.1371/journal.pone.0241913	http://dx.doi.org/10.1371/journal.pone.0241913			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175854	gold, Green Published			2022-12-26	WOS:000593946900016
J	Valdovinos, EM; Niedzwiecki, MJ; Guo, JN; Hsia, REY				Valdovinos, Erica M.; Niedzwiecki, Matthew J.; Guo, Joanna; Hsia, Renee Y.			The association of Medicaid expansion and racial/ethnic inequities in access, treatment, and outcomes for patients with acute myocardial infarction	PLOS ONE			English	Article							AFFORDABLE CARE ACT; PERCUTANEOUS CORONARY INTERVENTION; RACIAL DISPARITIES; COMMUNITY UNINSURANCE; AMBULANCE DIVERSION; ETHNIC DISPARITIES; HIGHER MORTALITY; REVASCULARIZATION; RACE; BENEFICIARIES	Introduction After having an acute myocardial infarction (AMI), racial and ethnic minorities have less access to care, decreased rates of invasive treatments such as percutaneous coronary intervention (PCI), and worse outcomes compared with white patients. The objective of this study was to determine whether the Affordable Care Act's expansion of Medicaid eligibility was associated with changes in racial disparities in access, treatments, and outcomes after AMI. Methods Quasi-experimental, difference-in-differences-in-differences analysis of non-Hispanic white and minority patients with acute myocardial infarction in California and Florida from 2010-2015, using linear regression models to estimate the difference-in-differences. This population-based sample included all Medicaid and uninsured patients ages 18-64 hospitalized with acute myocardial infarction in California, which expanded Medicaid through the Affordable Care Act beginning as early as July 2011 in certain counties, and Florida, which did not expand Medicaid. The main outcomes included rates of admission to hospitals capable of performing PCI, rates of transfer for patients who first presented to hospitals that did not perform PCI, rates of PCI during hospitalization and rates of early (within 48 hours of admission) PCI, rates of readmission to the hospital within 30 days, and rates of in-hospital mortality. Results A total of 55,991 hospital admissions met inclusion criteria, 32,540 of which were in California and 23,451 were in Florida. Among patients with AMI who initially presented to a non-PCI hospital, the likelihood of being transferred increased by 12 percentage points (95% CI 2 to 21) for minority patients relative to white patients after the Medicaid expansion. The likelihood of undergoing PCI increased by 3 percentage points (95% CI 0 to 5) for minority patients relative to white patients after the Medicaid expansion. We did not find an association between the Medicaid expansion and racial disparities in overall likelihood of admission to a PCI hospital, hospital readmissions, or in-hospital mortality. Conclusions The Medicaid expansion was associated with a decrease in racial disparities in transfers and rates of PCI after AMI. We did not find an association between the Medicaid expansion and admission to a PCI hospital, readmissions, and in-hospital mortality. Additional factors outside of insurance coverage likely continue to contribute to disparities in outcomes after AMI. These findings are crucial for policy makers seeking to reduce racial disparities in access, treatment and outcomes in AMI.	[Valdovinos, Erica M.] Adventist Hlth Ukiah Valley, Dept Emergency Med, Ukiah, CA 95482 USA; [Niedzwiecki, Matthew J.] Univ Calif San Francisco, Math Policy Res, San Francisco, CA 94143 USA; [Niedzwiecki, Matthew J.; Guo, Joanna; Hsia, Renee Y.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Niedzwiecki, Matthew J.; Hsia, Renee Y.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	Mathematica; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Valdovinos, EM (corresponding author), Adventist Hlth Ukiah Valley, Dept Emergency Med, Ukiah, CA 95482 USA.	ericavaldovinos@gmail.com			NIH NHLBI [R01HL134182, R01HL114822]; Emergency Medicine Foundation Resident Research Grant	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Emergency Medicine Foundation Resident Research Grant	SOURCES OF FUNDING This study was supported in part by NIH NHLBI R01HL134182 and R01HL114822 (RYH), and the Emergency Medicine Foundation Resident Research Grant 2017 - 2018 (EMV). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The contents of the article are solely the responsibility of the authors and do not necessarily represent the official views of the funders.	Alderman MH, 2000, CIRCULATION, V101, P1109, DOI 10.1161/01.CIR.101.10.1109; [Anonymous], 2018, MEDICAID CALIFORNIA; [Anonymous], 2011, QPEDIA THERMAL M AUG, V5, P14; [Anonymous], 2020, OFFICE STATEWIDE HLT; [Anonymous], 2018, DIFFERENCE DIFFERENC; Artiga S FJ, 2018, HLTH COVERAGE RACE E; Bertoni AG, 2005, J NATL MED ASSOC, V97, P317; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Breathett K, 2017, JACC-HEART FAIL, V5, P136, DOI 10.1016/j.jchf.2016.10.013; Brown AF, 2019, AM J PUBLIC HEALTH, V109, pS72, DOI [10.2105/AJPH.2018.304844, 10.2105/ajph.2018.304844]; Buchmueller TC, 2016, AM J PUBLIC HEALTH, V106, P1416, DOI 10.2105/AJPH.2016.303155; Bucholz EM, 2015, CIRCULATION, V132, P1338, DOI 10.1161/CIRCULATIONAHA.115.017009; Chen J, 2010, ARCH INTERN MED, V170, P433, DOI 10.1001/archinternmed.2009.538; Cooke CR, 2011, MED CARE, V49, P662, DOI 10.1097/MLR.0b013e31821d98b2; Cram P, 2009, J NATL MED ASSOC, V101, P1132, DOI 10.1016/S0027-9684(15)31109-3; Ding JZ, 2003, AM HEART J, V146, P459, DOI 10.1016/S0002-8703(03)00228-X; Escarce JJ, 2014, MED CARE, V52, P626, DOI 10.1097/MLR.0000000000000145; Gibson T, 2016, 201602 AG HEALTHC RE; Graham GN, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.4240; Gresenz CR, 2011, MED CARE, V49, pE14, DOI 10.1097/MLR.0b013e31822dc7f4; Gurwitz JH, 2002, AM J MED, V112, P528, DOI 10.1016/S0002-9343(02)01072-0; Guzman LA, 2012, J AM COLL CARDIOL, V59, P630, DOI 10.1016/j.jacc.2011.10.882; Hanmer J, 2014, ANN INTERN MED, V160, P81, DOI 10.7326/M12-1977; Hannan EL, 2016, CAN J CARDIOL, V32, DOI 10.1016/j.cjca.2016.01.012; Hannan EL, 2013, J INTERV CARDIOL, V26, P470, DOI 10.1111/joic.12059; Hayes SL RP, 2017, REDUCING RACIAL ETHN; Hsia RY, 2017, HEALTH AFFAIR, V36, P1070, DOI 10.1377/hlthaff.2016.0925; Iwashyna TJ, 2010, CIRC-CARDIOVASC QUAL, V3, P468, DOI 10.1161/CIRCOUTCOMES.110.957993; Joynt K, 2011, JAMA-J AM MED ASSOC, V305, P675; Kaiser Family Foundation, 2018, COV GAP UN POOR AD S; Kaiser Family Foundation, UN RAT NON RAC ETHN; Kressin NR, 2001, ANN INTERN MED, V135, P352, DOI 10.7326/0003-4819-135-5-200109040-00012; Labarere J, 2007, ARCH INTERN MED, V167, P913, DOI 10.1001/archinte.167.9.913; Lipton BJ, 2019, MED CARE RES REV, V76, P32, DOI 10.1177/1077558717706575; Loehrer AP, 2018, JAMA SURG, V153, DOI 10.1001/jamasurg.2017.5568; Loehrer AP, 2016, ANN SURG, V263, P705, DOI 10.1097/SLA.0000000000001310; Loehrer AP, 2015, ANN SURG, V262, P139, DOI 10.1097/SLA.0000000000000970; Loehrer AP, 2013, JAMA SURG, V148, P1116, DOI 10.1001/jamasurg.2013.2750; McKenna RM, 2017, MED CARE, V55, P654, DOI 10.1097/MLR.0000000000000726; Moore BJ, 2017, ICD 10 CM DIAGNOSIS; Napan S, 2010, J INVASIVE CARDIOL, V22, P168; Niedzwiecki MJ, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008152; Philbin EF, 2001, AM J PUBLIC HEALTH, V91, P1082, DOI 10.2105/AJPH.91.7.1082; Popescu I, 2007, JAMA-J AM MED ASSOC, V297, P2489, DOI 10.1001/jama.297.22.2489; Popescu I, 2011, CIRCULATION, V123, P2710, DOI 10.1161/CIRCULATIONAHA.110.973628; Shen YC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010263; Shen YC, 2011, JAMA-J AM MED ASSOC, V305, P2440, DOI 10.1001/jama.2011.811; Singh JA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0190-6; Sommers BD, 2016, JAMA INTERN MED, V176, P1501, DOI 10.1001/jamainternmed.2016.4419; Sommers BD, 2016, HEALTH SERV RES, V51, P825, DOI 10.1111/1475-6773.12397; Vaccarino V, 2005, NEW ENGL J MED, V353, P671, DOI 10.1056/NEJMsa032214; Wadhera RK, 2019, JAMA CARDIOL, V4, P120, DOI 10.1001/jamacardio.2018.4577; Zogg CK, 2019, J AM COLL SURGEONS, V228, P29, DOI 10.1016/j.jamcollsurg.2018.09.022	53	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241785	10.1371/journal.pone.0241785	http://dx.doi.org/10.1371/journal.pone.0241785			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0LY	33175899	gold, Green Published			2022-12-26	WOS:000593946900047
J	Afzal, S; Sattar, MA; Johns, EJ; Eseyin, OA				Afzal, Sheryar; Sattar, Munavvar Abdul; Johns, Edward James; Eseyin, Olorunfemi A.			Renoprotective and haemodynamic effects of adiponectin and peroxisome proliferator-activated receptor agonist, pioglitazone, in renal vasculature of diabetic Spontaneously hypertensive rats	PLOS ONE			English	Article							FATTY-ACID OXIDATION; PPAR-GAMMA AGONIST; ANGIOTENSIN-II; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; METABOLIC PARAMETERS; ENDOTHELIAL FUNCTION; WISTAR-KYOTO; LOSARTAN	Pioglitazone, a therapeutic drug for diabetes, possesses full PPAR-gamma agonist activity and increase circulating adiponectin plasma concentration. Plasma adiponectin concentration decreases in hypertensive patients with renal dysfunctions. Present study investigated the reno-protective, altered excretory functions and renal haemodynamic responses to adrenergic agonists and ANG II following separate and combined therapy with pioglitazone in diabetic model of hypertensive rats. Pioglitazone was given orally [10mg/kg/day] for 28 days and adiponectin intraperitoneally [2.5 mu g/kg/day] for last 7 days. Groups of SHR received either pioglitazone or adiponectin in combination. A group of Wistar Kyoto rats [WKY] served as normotensive controls, whereas streptozotocin administered SHRs served as diabetic hypertensive rats. Metabolic data and plasma samples were taken on day 0, 8, 21 and 28. In acute studies, the renal vasoconstrictor actions of Angiotensin II [ANGII], noradrenaline [NA], phenylephrine [PE] and methoxamine [ME] were determined. Diabetic SHRs control had a higher basal mean arterial blood pressure than the WKY, lower RCBP and plasma adiponectin, higher creatinine clearance and urinary sodium excretion compared to WKY [all P<0.05] which were normalized by the individual drug treatments and to greater degree following combined treatment. Responses to intra-renal administration of NA, PE, ME and ANGII were larger in diabetic SHR than WKY and SHRs [P<0.05]. Adiponectin significantly blunted responses to NA, PE, ME and ANG II in diabetic treated SHRs by 40%, whereas the pioglitazone combined therapy with adiponectin further attenuated the responses to adrenergic agonists by 65%. [all P <0.05]. These findings suggest that adiponectin possesses renoprotective effects and improves renal haemodynamics through adiponectin receptors and PPAR-gamma in diabetic SHRs, suggesting that synergism exists between adiponectin and pioglitazone. A cross-talk relationship also supposed to exists between adiponectin receptors, PPAR-gamma and alpha adrenoceptors in renal vasculature of diabetic SHRs.	[Afzal, Sheryar; Sattar, Munavvar Abdul; Eseyin, Olorunfemi A.] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia; [Afzal, Sheryar; Sattar, Munavvar Abdul] MAHSA Univ, Fac Pharm, Selangor, Malaysia; [Johns, Edward James] Univ Uyo, Fac Pharm, Uyo, Akwa & Ibom Sta, Nigeria; [Eseyin, Olorunfemi A.] Univ Coll Cork, Dept Physiol, Cork, Ireland	Universiti Sains Malaysia; Mahsa University; University of Uyo; University College Cork	Afzal, S (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia.; Afzal, S (corresponding author), MAHSA Univ, Fac Pharm, Selangor, Malaysia.	samalik77@hotmail.com	AFZAL, SHERYAR/ABA-6051-2021; Stefanadis, Christodoulos/ABH-2232-2020; ESEYIN, OLORUNFEMI ABRAHAM/F-7783-2010; ESEYIN, OLORUNFEMI/HDO-1588-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; ESEYIN, OLORUNFEMI ABRAHAM/0000-0002-8232-7634; afzal, sheryar/0000-0001-8387-7550	Universiti Sains Malaysia [1001/PFARMASI/815078]; Institute of PostGraduate Studies (IPS), Universiti Sains Malaysia (USM), Penang, Malaysia	Universiti Sains Malaysia(Universiti Sains Malaysia); Institute of PostGraduate Studies (IPS), Universiti Sains Malaysia (USM), Penang, Malaysia	This study was funded by: the Universiti Sains Malaysia, Research grant #1001/PFARMASI/815078. Sheryar Afzal is a recipient of USM Fellowship from the Institute of PostGraduate Studies (IPS), Universiti Sains Malaysia (USM), Penang, Malaysia. No additional external funding was received for this study.	Abdulla MH, 2009, ACTA PHYSIOL, V195, P397, DOI 10.1111/j.1748-1716.2008.01895.x; Abdulla MH, 2009, EUR J PHARMACOL, V612, P69, DOI 10.1016/j.ejphar.2009.03.064; Adamczak M, 2003, AM J HYPERTENS, V16, P72, DOI 10.1016/S0895-7061(02)03197-7; Afzal S, 2016, J PHYSIOL BIOCHEM, V72, P593, DOI 10.1007/s13105-016-0497-1; ALEXANDER WD, 1977, POSTGRAD MED J, V53, P117, DOI 10.1136/pgmj.53.617.117; ANDERSON EA, 1991, J CLIN INVEST, V87, P2246, DOI 10.1172/JCI115260; Armando I, 2001, ENDOCRINOLOGY, V142, P3880, DOI 10.1210/en.142.9.3880; Armenia A, 2004, BRIT J PHARMACOL, V142, P719, DOI 10.1038/sj.bjp.0705842; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chen H, 2003, J BIOL CHEM, V278, P45021, DOI 10.1074/jbc.M307878200; Clasen R, 2005, HYPERTENSION, V46, P137, DOI 10.1161/01.HYP.0000168046.19884.6a; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; Cowley AW, 1996, JAMA-J AM MED ASSOC, V275, P1581, DOI 10.1001/jama.275.20.1581; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Desvergne B, 2004, MOL ENDOCRINOL, V18, P1321, DOI 10.1210/me.2004-0088; El-Mas MM, 2011, BIOCHEM PHARMACOL, V81, P526, DOI 10.1016/j.bcp.2010.11.013; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Frystyk J, 2005, DIABETOLOGIA, V48, P1911, DOI 10.1007/s00125-005-1850-z; Giacchetti G, 2005, TRENDS ENDOCRIN MET, V16, P120, DOI 10.1016/j.tem.2005.02.003; Guo ZX, 2007, METABOLISM, V56, P1363, DOI 10.1016/j.metabol.2007.05.005; Guthrie Richard A, 2004, Crit Care Nurs Q, V27, P113; Havel PJ, 2000, DIABETES, V49, P244, DOI 10.2337/diabetes.49.2.244; Hirose H, 2002, METABOLISM, V51, P314, DOI 10.1053/meta.2002.30506; Imagawa A, 2002, DIABETES CARE, V25, P1665, DOI 10.2337/diacare.25.9.1665; Jiang XW, 2011, J ORTHOP RES, V29, P1081, DOI 10.1002/jor.21355; Kadowaki T, 2003, EXP BIOL MED, V228, P1111, DOI 10.1177/153537020322801003; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kaizu K, 1995, J DIABETES COMPLICAT, V9, P224, DOI 10.1016/1056-8727(95)80007-2; Khan MAH, 2009, KIDNEY BLOOD PRESS R, V32, P349, DOI 10.1159/000249149; Kong X, 2014, J RENIN-ANGIO-ALDO S, V15, P259, DOI 10.1177/1470320313489061; Kusminski CM, 2007, DIABETOLOGIA, V50, P634, DOI 10.1007/s00125-006-0577-9; Kuti M, 2007, INT J DIABETES METAB, V15, P82; Lee S, 2006, NEPHROL DIAL TRANSPL, V21, P2096, DOI 10.1093/ndt/gfl194; Majithiya JB, 2005, CARDIOVASC RES, V66, P150, DOI 10.1016/j.cardiores.2004.12.025; Mallamaci F, 2002, J NEPHROL, V15, P507; Montilla P, 2005, J BIOCHEM MOL BIOL, V38, P539, DOI 10.5483/BMBRep.2005.38.5.539; Ohga S, 2007, AM J PHYSIOL-RENAL, V292, pF1141, DOI 10.1152/ajprenal.00288.2005; Ouedraogo R, 2006, DIABETES, V55, P1840, DOI 10.2337/db05-1174; Peredo HA, 2008, CLIN EXP HYPERTENS, V30, P159, DOI 10.1080/10641960801946889; Ramesh B, 2006, J MED FOOD, V9, P562, DOI 10.1089/jmf.2006.9.562; Sarafidis PA, 2006, AM J HYPERTENS, V19, P646, DOI 10.1016/j.amjhyper.2005.12.017; Siasos G, 2012, CURR MED CHEM, V19, P1193, DOI 10.2174/092986712799320583; Sowers JR, 2001, HYPERTENSION, V37, P1053, DOI 10.1161/01.HYP.37.4.1053; Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125; Takatori S, 2013, CURR PROTEIN PEPT SC, V14, P275, DOI 10.2174/13892037113149990047; Tanida M, 2007, EXP BIOL MED, V232, P390; Thule PM, 2006, AM J PHYSIOL-ENDOC M, V290, pE114, DOI 10.1152/ajpendo.00134.2005; Vidotti DB, 2004, AM J PHYSIOL-RENAL, V286, pF1039, DOI 10.1152/ajprenal.00371.2003; Vrbjar N, 2004, ACTA DIABETOL, V41, P172, DOI 10.1007/s00592-004-0162-y; Wang ZV, 2008, HYPERTENSION, V51, P8, DOI 10.1161/HYPERTENSIONAHA.107.099424; Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341; WONG KK, 1993, BIOCHEM MOL BIOL INT, V30, P1035; Wong WT, 2011, CELL METAB, V14, P104, DOI 10.1016/j.cmet.2011.05.009; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yin XX, 2005, ACTA PHARMACOL SIN, V26, P721, DOI 10.1111/j.1745-7254.2005.00111.x; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zanchetti A, 1999, J CARDIOVASC PHARM, V33, pS1, DOI 10.1097/00005344-199900001-00001; Zanchi A, 2006, AM J PHYSIOL-ENDOC M, V291, pE1228, DOI 10.1152/ajpendo.00171.2006	59	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0229803	10.1371/journal.pone.0229803	http://dx.doi.org/10.1371/journal.pone.0229803			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170841	Green Submitted, gold, Green Published			2022-12-26	WOS:000592383400051
J	Benedict, MQ; Bascunan, P; Hunt, CM; Aviles, EI; Rotenberry, RD; Dotson, EM				Benedict, Mark Q.; Bascunan, Priscila; Hunt, Catherine M.; Aviles, Erica, I; Rotenberry, Rachel D.; Dotson, Ellen M.			Trials of the Automated Particle Counter for laboratory rearing of mosquito larvae	PLOS ONE			English	Article							ARABIENSIS DIPTERA-CULICIDAE; DIET	As a means of obtaining reproducible and accurate numbers of larvae for laboratory rearing, we tested a large-particle flow-cytometer type device called the 'Automated Particle Counter' (APC). The APC is a gravity-fed, self-contained unit that detects changes in light intensity caused by larvae passing the detector in a water stream and controls dispensing by stopping the flow when the desired number has been reached. We determined the accuracy (number dispensed compared to the target value) and precision (distribution of number dispensed) of dispensing at a variety of counting sensitivity thresholds and larva throughput rates (larvae per second) using < 1-day old Anopheles gambiae and Aedes aegypti larvae. All measures were made using an APC algorithm called the 'Smoothed Z-Score' which allows the user to define how many standard deviations (Z scores) from the baseline light intensity a particle's absorbance must exceed to register a count. We dispensed a target number of 100 An. gambiae larvae using Z scores from 2.5-8 and observed no difference among them in the numbers dispensed for scores from 2.5-6, however, scores of 7 and 8 under-counted (over-dispensed) larvae. Using a Z score <= 6, we determined the effect of throughput rate on the accuracy of the device to dispense An. gambiae larvae. For rates <= 98 larvae per second, the accuracy of dispensing a target of 100 larvae was - 2.29% +/- 0.72 (95% CI of the mean) with a mode of 99 (49 of 348 samples). When using a Z score of 3.5 and rates <= 100 larvae per second, the accuracy of dispensing a target of 100 Ae. aegypti was - 2.43% +/- 1.26 (95% CI of the mean) with a mode of 100 (6 of 42 samples). No effect on survival was observed on the number of An. gambiae first stage larvae that reached adulthood as a function of dispensing.	[Benedict, Mark Q.; Bascunan, Priscila; Hunt, Catherine M.; Aviles, Erica, I; Rotenberry, Rachel D.; Dotson, Ellen M.] Ctr Dis Control & Prevent CDC, Div Parasit Dis & Malaria, Entomol Branch, Atlanta, GA 30341 USA	Centers for Disease Control & Prevention - USA	Benedict, MQ (corresponding author), Ctr Dis Control & Prevent CDC, Div Parasit Dis & Malaria, Entomol Branch, Atlanta, GA 30341 USA.	mbenedict@cdc.gov		Benedict, Mark/0000-0001-5494-0522; Bascunan, Priscila/0000-0003-3132-9776	Bill & Melinda Gates Foundation; Open Philanthropy Project Fund, an advised fund of Silicon Valley Community Foundation; Foundation for the Centers for Disease Control and Prevention	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Open Philanthropy Project Fund, an advised fund of Silicon Valley Community Foundation; Foundation for the Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	MQB, PB, CMH, RDR and EIA are paid employees of Target Malaria, a project that receives core funding from the Bill & Melinda Gates Foundation and from the Open Philanthropy Project Fund, an advised fund of Silicon Valley Community Foundation to the Target Malaria project. The funds for this study were awarded to the Foundation for the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis or decision to publish.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Armbruster P, 2002, J MED ENTOMOL, V39, P699, DOI 10.1603/0022-2585-39.4.699; DAME DA, 1978, MOSQ NEWS, V38, P68; Damiens D, 2012, J MED ENTOMOL, V49, P1001, DOI 10.1603/ME11289; Gerberg EJ, 1979, AM MOSQ CONTROL ASS, V5, P7; Gilles JRL, 2011, J MED ENTOMOL, V48, P296, DOI 10.1603/ME09209; Gopinath T., 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2; Jahan N, 2012, J BANGLADESH ELECT, V12, P63; Kulma K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058322; Maiga H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1119-7; Mamica ., 2018, EC ENV STUD, V18, P265, DOI [10.25167/ees.2018.45.15, DOI 10.25167/EES.2018.45.15]; Marois E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-302; Mei TT, 2018, STRAITS TIMES; RUTLEDGE LC, 1976, MOSQ NEWS, V36, P537; Shapiro LLM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0298; Vantaux A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1514-5; Zaiontz C., REAL STAT USING EXCE	17	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241492	10.1371/journal.pone.0241492	http://dx.doi.org/10.1371/journal.pone.0241492			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170865	Green Published, gold			2022-12-26	WOS:000592383400025
J	Choi, HS; Baek, YS				Choi, Ho Seon; Baek, Yoon Su			Effects of the degree of freedom and assistance characteristics of powered ankle-foot orthoses on gait stability	PLOS ONE			English	Article							DYNAMIC STABILITY; ELDERLY-WOMEN; EXOSKELETON; BALANCE; PRESSURE; FALLS; RISK; PREDICTORS; STRENGTH; SYSTEMS	We studied the use of powered ankle-foot orthoses (PAFOs) and walking stability of the wearers, focusing on the ankle joint, which is known to play a critical role in gait stability. Recognizing that the subtalar joint is an important modulator of walking stability, we conducted the walking experiment on a treadmill by applying varying assistance techniques to the 2-degree-of-freedom (DOF) PAFO, which has the subtalar joint as the rotating axis, and the commonly used 1-DOF PAFO. The participants were 8 healthy men (mean +/- SD: height, 174.8 +/- 7.1 cm; weight, 69.8 +/- 6.5 kg; and age, 29.1 +/- 4.8 years) with no history of gait abnormality. Center of pressure (COP) was measured with an in-shoe pressure sensor, and stability was estimated on the basis of the angular acceleration measured with the inertial measurement unit attached to the trunk. The experimental results of the 2-DOF PAFO, with or without assistance, showed a significantly higher stability than those of the 1-DOF PAFO (up to 23.78%, p<0.0326). With the 1-DOF PAFO, the stability deteriorated with the increase in the degree of assistance provided. With the 2-DOF PAFO, this tendency was not observed. Thus, the importance of the subtalar joint was proven using PAFOs. The mean position analysis of the COP during the stance phase confirmed that the COP highly correlated with stability (Pearson correlation coefficient: -0.6607). Thus, we conclude that only the 2-DOF PAFO can maintain walking stability, regardless of the assistance characteristics, by preserving the COP in the medial position through eversion. Awareness regarding the role of the subtalar joint is necessary during the manufacture or use of PAFOs, as lack of awareness could lead to the degradation of the wearer's gait stability, regardless of effective assistance, and deteriorate the fundamental functionality of PAFO.	[Choi, Ho Seon; Baek, Yoon Su] Yonsei Univ, Sch Mech Engn, Seoul, South Korea	Yonsei University	Baek, YS (corresponding author), Yonsei Univ, Sch Mech Engn, Seoul, South Korea.	ysbaek@yonsei.ac.kr			National Research Foundation of Korea (NRF) - Korea Government (MSIP) [NRF2017M1A3A3A02016507]	National Research Foundation of Korea (NRF) - Korea Government (MSIP)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This study is based on work supported by a grant that Y.S.B received from the National Research Foundation of Korea (NRF) funded by the Korea Government (MSIP) (No. NRF2017M1A3A3A02016507)(www.nrf.re.kr).The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. And there was no additional external funding received for this study.	Anam K, 2012, PROCEDIA ENGINEER, V41, P988, DOI 10.1016/j.proeng.2012.07.273; [Anonymous], 2017, EUR GERIATR MED, V8, pS98; Asbeck AT, 2015, INT J ROBOT RES, V34, P744, DOI 10.1177/0278364914562476; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bergland A, 2004, INJURY PREV, V10, P308, DOI 10.1136/ip.2003.004721; Bergland A, 2003, AGING CLIN EXP RES, V15, P43; Biswas A, 2008, J BIOMECH, V41, P1574, DOI 10.1016/j.jbiomech.2008.02.009; Bok SK, 2013, ANN REHABIL MED-ARM, V37, P10, DOI 10.5535/arm.2013.37.1.10; Choi HS, 2019, P 2019 IEEE 16 INT C; Choi J, 2017, IEEE ROBOT AUTOM MAG, V24, P75, DOI 10.1109/MRA.2017.2752285; Esquenazi A, 2012, AM J PHYS MED REHAB, V91, P911, DOI 10.1097/PHM.0b013e318269d9a3; Farris RJ, 2011, IEEE T NEUR SYS REH, V19, P652, DOI 10.1109/TNSRE.2011.2163083; Galle S, 2017, GAIT POSTURE, V52, P183, DOI 10.1016/j.gaitpost.2016.11.040; Galle S, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0235-0; Gordon KE, 2006, J BIOMECH, V39, P1832, DOI 10.1016/j.jbiomech.2005.05.018; Grimmer M, 2019, J BIOMECH, V83, P76, DOI 10.1016/j.jbiomech.2018.11.023; Hof AL, 2010, J EXP BIOL, V213, P2655, DOI 10.1242/jeb.042572; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Hoogvliet P, 1997, GAIT POSTURE, V6, P39, DOI 10.1016/S0966-6362(96)01096-X; Hoogvliet P, 1997, THESIS; Howcroft J, 2016, J BIOMECH, V49, P992, DOI 10.1016/j.jbiomech.2016.01.015; Isman RE, 1969, B PROSTHETICS RES, P97; Kang HG, 2009, GAIT POSTURE, V30, P260, DOI 10.1016/j.gaitpost.2009.05.003; Kao PC, 2010, J BIOMECH, V43, P203, DOI 10.1016/j.jbiomech.2009.09.030; Kawamoto H, 2003, P 2003 IEEE INT C SY; Kim M, 2020, J BIOMECH ENG-T ASME, V142, DOI 10.1115/1.4046881; Koller JR, 2017, INT C REHAB ROBOT, P294, DOI 10.1109/ICORR.2017.8009262; Koller JR, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0086-5; Lee SJ, 2016, IEEE INT CONF ROBOT, P3509, DOI 10.1109/ICRA.2016.7487531; LeVeau BF, 2011, BIOMECHANICS OF HUMAN MOTION: BASICS AND BEYOND FOR THE HEALTH PROFESSIONS, P1; Lin WH, 2009, J SCI MED SPORT, V12, P42, DOI 10.1016/j.jsams.2007.10.001; Liu J, 2006, GAIT POSTURE, V23, P480, DOI 10.1016/j.gaitpost.2005.06.011; Liu J, 2012, SAF HEALTH WORK, V3, P192, DOI 10.5491/SHAW.2012.3.3.192; Lunenburger L, 2005, INT C REHAB ROBOT, P345; Madureira MM, 2007, OSTEOPOROSIS INT, V18, P419, DOI 10.1007/s00198-006-0252-5; MAKI BE, 1993, MED BIOL ENG COMPUT, V31, P355, DOI 10.1007/BF02446688; Malcolm P, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0267-5; Malcolm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056137; MATSUSAKA N, 1986, ACTA ORTHOP SCAND, V57, P555, DOI 10.3109/17453678609014793; Mizelle C, 2006, GAIT POSTURE, V24, P356, DOI 10.1016/j.gaitpost.2005.11.003; Moltedo M, 2018, J NEUROENG REHABIL, V15, DOI 10.1186/s12984-018-0424-5; Mukaka MM, 2012, MALAWI MED J, V24, P69; Piirtola M, 2006, GERONTOLOGY, V52, P1, DOI 10.1159/000089820; PRINCE F, 1994, GAIT POSTURE, V2, P19, DOI 10.1016/0966-6362(94)90013-2; Qiu H, 2015, INT J IND ERGONOM, V47, P37, DOI 10.1016/j.ergon.2015.02.004; Rodrigues O., 1840, J MATH PURE APPL, V5, P380; Scrucca L, 2016, R J, V8, P289; Seimetz Christina, 2012, Biomed Sci Instrum, V48, P386; Silsupadol P, 2009, GAIT POSTURE, V29, P634, DOI 10.1016/j.gaitpost.2009.01.006; van Diest M, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-101; Whitney SL, 2011, GAIT POSTURE, V33, P594, DOI 10.1016/j.gaitpost.2011.01.015; Willems T, 2002, J ATHL TRAINING, V37, P487; Witte KA, 2015, IEEE INT CONF ROBOT, P1223, DOI 10.1109/ICRA.2015.7139347; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Yang CJ, 2008, P I MECH ENG C-J MEC, V222, P1599, DOI 10.1243/09544062JMES936; Yim-Chiplis P K, 2000, Biol Res Nurs, V1, P321; Zhang JJ, 2017, SCIENCE, V356, P1280, DOI 10.1126/science.aal5054; Zoss AB, 2006, IEEE-ASME T MECH, V11, P128, DOI 10.1109/TMECH.2006.871087; 박설, 2011, [The Journal of Korean Society of Physical Therapy, 대한물리치료학회지], V23, P1	60	10	10	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0242000	10.1371/journal.pone.0242000	http://dx.doi.org/10.1371/journal.pone.0242000			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170866	Green Published, gold			2022-12-26	WOS:000592383400046
J	Diaz-Garcia, JM; Lopez-Barrera, F; Pineda, E; Toledo-Aceves, T; Andresen, E				Manuel Diaz-Garcia, Juan; Lopez-Barrera, Fabiola; Pineda, Eduardo; Toledo-Aceves, Tarin; Andresen, Ellen			Comparing the success of active and passive restoration in a tropical cloud forest landscape: A multi-taxa fauna approach	PLOS ONE			English	Article							ECOLOGICAL FUNCTIONS; ECOSYSTEM SERVICES; MAMMAL DIVERSITY; RECOVERY; INDICATORS; BIRD; EXTRAPOLATION; REGENERATION; RAREFACTION; AMPHIBIANS	Tropical forest restoration initiatives are becoming more frequent worldwide in an effort to mitigate biodiversity loss and ecosystems degradation. However, there is little consensus on whether an active or a passive restoration strategy is more successful for recovering biodiversity because few studies make adequate comparisons. Furthermore, studies on animal responses to restoration are scarce compared to those on plants, and those that assess faunal recovery often focus on a single taxon, limiting the generalization of results. We assessed the success of active (native mixed-species plantations) and passive (natural regeneration) tropical cloud forest restoration strategies based on the responses of three animal taxa: amphibians, ants, and dung beetles. We compared community attributes of these three taxa in a 23-year-old active restoration forest, a 23-year-old passive restoration forest, a cattle pasture, and a mature forest, with emphasis on forest-specialist species. We also evaluated the relationship between faunal recovery and environmental variables. For all taxa, we found that recovery of species richness and composition were similar in active and passive restoration sites. However, recovery of forest specialists was enhanced through active restoration. For both forests under restoration, similarity in species composition of all faunal groups was 60-70% with respect to the reference ecosystem due to a replacement of generalist species by forest-specialist species. The recovery of faunal communities was mainly associated with canopy and leaf litter covers. We recommend implementing active restoration using mixed plantations of native tree species and, whenever possible, selecting sites close to mature forest to accelerate the recovery of tropical cloud forest biodiversity. As active restoration is more expensive than passive restoration, both strategies might be used in a complementary manner at the landscape level to compensate for high implementation costs.	[Manuel Diaz-Garcia, Juan; Lopez-Barrera, Fabiola; Toledo-Aceves, Tarin] Inst Ecol AC, Red Ecol Func, Xalapa, Veracruz, Mexico; [Manuel Diaz-Garcia, Juan; Pineda, Eduardo] Inst Ecol AC, Red Biol & Conservac Vertebrados, Xalapa, Veracruz, Mexico; [Andresen, Ellen] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Morelia, Michoacan, Mexico	Instituto de Ecologia - Mexico; Instituto de Ecologia - Mexico; Universidad Nacional Autonoma de Mexico	Diaz-Garcia, JM; Lopez-Barrera, F (corresponding author), Inst Ecol AC, Red Ecol Func, Xalapa, Veracruz, Mexico.; Diaz-Garcia, JM (corresponding author), Inst Ecol AC, Red Biol & Conservac Vertebrados, Xalapa, Veracruz, Mexico.	juan.diazgarcia@gmail.com; fabiola.lopez@inecol.mx	Andresen, Ellen/AFM-7145-2022; Pineda, Eduardo/N-5254-2014; Lopez-Barrera, Fabiola/Q-6271-2018; Toledo-Aceves, Tarin/K-8718-2017	Andresen, Ellen/0000-0001-8957-4454; Pineda, Eduardo/0000-0002-1997-9576; Lopez-Barrera, Fabiola/0000-0002-6092-6230; Toledo-Aceves, Tarin/0000-0001-6069-468X	Secretaria de Educacio n Publica-Consejo Nacional de Ciencia y Tecnologia (SEP-CONACYT) [CB2014-238831-B]; CONACYT [486768]	Secretaria de Educacio n Publica-Consejo Nacional de Ciencia y Tecnologia (SEP-CONACYT); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study is part of the fundamental science project "Atributos funcionales de especies arboreas y los escenarios para la restauracion del paisaje de bosque mesofilo de montana en el Centro de Veracruz" funded by the Secretaria de Educacio n Publica-Consejo Nacional de Ciencia y Tecnologia (SEP-CONACYT), numbers CB2014-238831-B. This article was written to comply with the requirements of the Programa de Estudios del Posgrado of the Instituto de Ecologia A. C. for the doctoral studies of JMDG (CONACYT Scholarship No. 486768). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Charry O, 2019, OIKOS, V128, P1065, DOI 10.1111/oik.06252; Aguilar-Dorantes K, 2014, INVAS PLANT SCI MANA, V7, P580, DOI 10.1614/IPSM-D-13-00062.1; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; [Anonymous], **NON-TRADITIONAL**; Audino LD, 2014, BIOL CONSERV, V169, P248, DOI 10.1016/j.biocon.2013.11.023; Bestelmeyer Brandon T., 2000, P122; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Catterall CP, 2018, ECOL MANAG RESTOR, V19, P54, DOI 10.1111/emr.12306; Catterall CP, 2012, BIOL CONSERV, V146, P53, DOI 10.1016/j.biocon.2011.10.033; Chao A, 2015, METHODS ECOL EVOL, V6, P873, DOI 10.1111/2041-210X.12349; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Chazdon RL, 2016, BIOTROPICA, V48, P716, DOI 10.1111/btp.12381; Clewell A. F., 2013, ECOLOGICAL RESTORATI, DOI DOI 10.5822/978-1-59726-323-8; Cole RJ, 2016, ECOL EVOL, V6, P5158, DOI 10.1002/ece3.2220; Comision Nacional para el conocimiento y uso de la Biodiversidad, 2010, BOSQUE MESOFILO MONT, V1st; Cortes-Gomez AM, 2015, Univ. Sci., V20, P229, DOI 10.11144/Javeriana.SC20-2.efna; Crouzeilles R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701345; Crump M.L., 1994, MEASURING MONITORING, P84, DOI DOI 10.1007/S10682-018-9929-4; Del Toro I, 2012, MYRMECOL NEWS, V17, P133; Delabie J.H.C., 2003, P181; Derhe MA, 2018, RESTOR ECOL, V26, P778, DOI 10.1111/rec.12582; Devictor V, 2010, J APPL ECOL, V47, P15, DOI 10.1111/j.1365-2664.2009.01744.x; Diaz-Garcia JM, 2020, BIOL CONSERV, V242, DOI 10.1016/j.biocon.2019.108400; Diaz-Garcia JM, 2017, BIODIVERS CONSERV, V26, P2569, DOI 10.1007/s10531-017-1372-2; Fagan ME, 2020, CONSERV LETT, V13, DOI 10.1111/conl.12700; Fife D.A., 2014, INTRO FIFER PACKAGE; Fisher MC, 2020, NAT REV MICROBIOL, V18, P332, DOI 10.1038/s41579-020-0335-x; Fraser LH, 2015, RESTOR ECOL, V23, P503, DOI 10.1111/rec.12225; Gann GD, 2019, RESTOR ECOL, V27, pS3, DOI 10.1111/rec.13035; Gardner CJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12539-1; Gilman AC, 2016, BIOTROPICA, V48, P798, DOI 10.1111/btp.12361; Gossner MM, 2013, FOREST ECOL MANAG, V302, P404, DOI 10.1016/j.foreco.2013.03.039; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hernandez-Ordonez O, 2015, BIOTROPICA, V47, P377, DOI 10.1111/btp.12207; Holl KD, 2011, FOREST ECOL MANAG, V261, P1558, DOI 10.1016/j.foreco.2010.07.004; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Kanowski J, 2005, REFORESTATION TROPIC, P183; Korhonen L, 2006, SILVA FENN, V40, P577, DOI 10.14214/sf.315; Lanping L, 2017, J APPL ECOL, V55, P986, DOI [10.1111/1365-2664.12976, DOI 10.1111/1365-2664.12976]; Lawes MJ, 2017, ECOL EVOL, V7, P8442, DOI 10.1002/ece3.2992; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; Meli P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171368; Morrison EB, 2011, RESTOR ECOL, V19, P170, DOI 10.1111/j.1526-100X.2010.00725.x; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Oksanen J, 2016, COMMUNITY ECOLOGY PA; R Development Core Team, 2017, R LANG ENV STAT COMP; Ramirez, 2015, MONITOREO PROCESOS R; Rolo V, 2017, RESTOR ECOL, V25, P788, DOI 10.1111/rec.12501; Shoo LP, 2016, CONSERV BIOL, V30, P121, DOI 10.1111/cobi.12606; Smith GC, 2015, RESTOR ECOL, V23, P787, DOI 10.1111/rec.12269; Suganuma MS, 2014, COMMUNITY ECOL, V15, P27, DOI [10.1556/COMEC.15.2014.1.3, 10.1556/ComEc.15.2014.1.3]; Thompson ME, 2018, COPEIA, V106, P10, DOI 10.1643/CH-17-654; Trujillo-Miranda AL, 2018, ECOL ENG, V117, P50, DOI 10.1016/j.ecoleng.2018.03.011; UN, 2019, DEC EC REST; van Klink R, 2020, SCIENCE, V368, P417, DOI 10.1126/science.aax9931; Venables WN, 2010, MODERN APPL STAT, V4; Warnes G., 2018, GMODELS VARIOUS R PR; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wortley L, 2013, RESTOR ECOL, V21, P537, DOI 10.1111/rec.12028; WWF, 2018, LIV PLAN REP AIM HIG; Zahawi RA, 2014, RESTOR ECOL, V22, P284, DOI 10.1111/rec.12098	61	13	14	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0242020	10.1371/journal.pone.0242020	http://dx.doi.org/10.1371/journal.pone.0242020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170890	gold, Green Published			2022-12-26	WOS:000592383400024
J	Bonnewell, JP; Farrow, L; Dicks, KV; Cox, GM; Stout, JE				Bonnewell, John P.; Farrow, Laura; Dicks, Kristen, V; Cox, Gary M.; Stout, Jason E.			Geographic analysis of latent tuberculosis screening: A health system approach	PLOS ONE			English	Article							UNITED-STATES; INFECTION; ACCESS; GUIDELINES; ADULTS; BORN; CARE	Background Novel approaches are required to better focus latent tuberculosis infection (LTBI) efforts in low-prevalence regions. Geographic information systems, used within large health systems, may provide one such approach. Methods A retrospective, cross-sectional design was used to integrate US Census and Duke Health System data between January 1, 2010 and October 31, 2017 and examine the relationships between LTBI screening and population tuberculosis risk (assessed using the surrogate measure of proportion of persons born in tuberculosis-endemic regions) by census tract. Results The median proportion of Duke patients screened per census tract was 0.01 (range 0-0.1, interquartile range 0.01-0.03). The proportion of Duke patients screened within a census tract significantly but weakly correlated with the population risk. Furthermore, patients residing in census tracts with higher population tuberculosis risk were more likely to be screened with TST than with an IGRA (p<0.001). Conclusion The weak correlation between patient proportion screened for LTBI and our surrogate marker of population tuberculosis risk suggests that LTBI screening efforts should be better targeted. This type of geography-based analysis may serve as an easily obtainable benchmark for LTBI screening in health systems with low tuberculosis prevalence.	[Bonnewell, John P.; Farrow, Laura; Dicks, Kristen, V; Cox, Gary M.; Stout, Jason E.] Duke Univ, Dept Med, Med Ctr, Div Infect Dis, Durham, NC 27710 USA	Duke University	Stout, JE (corresponding author), Duke Univ, Dept Med, Med Ctr, Div Infect Dis, Durham, NC 27710 USA.	jason.stout@duke.edu		Bonnewell, John/0000-0002-2886-4885; Stout, Jason/0000-0002-6698-8176				[Anonymous], 2018, BCG IMM COV EST WHO; [Anonymous], 2018, TUBERCULOSIS CASES N; [Anonymous], 2018, NUMBER REPORTED TUBE; [Anonymous], 2019, QUANTIFERON TB GOLD; Butler DC, 2013, HEALTH SERV RES, V48, P539, DOI 10.1111/j.1475-6773.2012.01449.x; Flavin L, 2018, INT J HEALTH SERV, V48, P601, DOI 10.1177/0020731418791963; Goodell AJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214532; Goswami ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046029; Horvath MM, 2011, J BIOMED INFORM, V44, P266, DOI 10.1016/j.jbi.2010.11.008; Katrak S, 2019, CLIN INFECT DIS, V69, P2109, DOI 10.1093/cid/ciz192; Lebrun LA, 2010, HEALTH SERV RES, V45, P1693, DOI 10.1111/j.1475-6773.2010.01163.x; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, pE1, DOI 10.1093/cid/ciw694; Linas BP, 2011, AM J RESP CRIT CARE, V184, P590, DOI 10.1164/rccm.201101-0181OC; LoBue PA, 2017, LANCET INFECT DIS, V17, pE327, DOI 10.1016/S1473-3099(17)30248-7; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Menzies NA, 2018, AM J EPIDEMIOL, V187, P2011, DOI 10.1093/aje/kwy094; Moonan PK, 2006, AM J RESP CRIT CARE, V174, P599, DOI 10.1164/rccm.200512-1977OC; Moonan Patrick K, 2004, Int J Health Geogr, V3, P23, DOI 10.1186/1476-072X-3-23; Moonan PK, 2012, EMERG INFECT DIS, V18, P458, DOI 10.3201/eid1803.111107; Mullins J, 2018, INT J TUBERC LUNG D, V22, P165, DOI 10.5588/ijtld.17.0223; Onozuka D, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-26; R Core Team, 2021, R LANGUAGE ENV STAT; Robert Graham Center, 2015, 2015 SDI CENS TRACT, pDC2015; Ronald LA, 2019, CLIN INFECT DIS, V69, P2101, DOI 10.1093/cid/ciz188; Talwar A, 2019, MMWR-MORBID MORTAL W, V68, P257, DOI 10.15585/mmwr.mm6811a2; Tasillo A, 2017, JAMA INTERN MED, V177, P1755, DOI 10.1001/jamainternmed.2017.3941; US Census Bureau, 2016, 2012 2016 ACS 5 YEAR	27	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242055	10.1371/journal.pone.0242055	http://dx.doi.org/10.1371/journal.pone.0242055			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166372	Green Published, gold			2022-12-26	WOS:000592382600002
J	Hammond, EN; Brys, N; Kates, A; Musuuza, JS; Haleem, A; Bentz, ML; Safdar, N				Hammond, Eric N.; Brys, Nicole; Kates, Ashley; Musuuza, Jackson S.; Haleem, Ambar; Bentz, Michael L.; Safdar, Nasia			Nasal povidone-iodine implementation for preventing surgical site infections: Perspectives of surgical nurses	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; MUPIROCIN; HEALTH; PREVALENCE; PROTOCOL	Introduction Preoperative nasal decolonization of surgical patients with nasal povidone-iodine (PI) has potential to eliminate pathogenic organisms responsible for surgical site infections. However, data on implementation of PI for quality improvement in clinical practice is limited. The purpose of this study was to evaluate the implementation feasibility, fidelity and acceptability of intranasal PI solution application by surgical nurses using the Integrated Promoting Action on Research Implementation in Health Services (i-PARIHS) conceptual framework. Materials and methods Using the i-PARIHS framework to frame questions and guide interview content areas, we conducted 15 semi-structured interviews of pre- and post-operative care nurses in two facilities. We analyzed the data using deductive content analysis to evaluate nurses' experience and perceptions on preoperative intranasal PI solution decolonization implementation. Open coding was used to analyze the data to ensure all relevant information was captured. Results Each facility adopted a different quality improvement implementation strategy. The mode of facilitation, training, and educational materials provided to the nurses varied by facility. Barriers identified included lack of effective communication, insufficient information and lack of systematic implementation protocol. Action taken to mitigate some of the barriers included a collaboration between the study team and nurses to develop a systematic written protocol. The training assisted nurses to systematically follow the implementation protocol smoothly to ensure PI administration compliance, and to meet the goal of the facilities. Nurses' observations and feedback showed that PI did not cause any adverse effects on patients. Conclusions We found that PI implementation was feasible and acceptable by nurses and could be extended to other facilities. However further studies are required to ensure standardization of PI application.	[Hammond, Eric N.] Univ Wisconsin, Inst Clin & Translat Res, Madison, WI USA; [Hammond, Eric N.; Kates, Ashley; Musuuza, Jackson S.; Haleem, Ambar; Safdar, Nasia] Univ Wisconsin, Dept Med, Div Infect Dis, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Brys, Nicole] Univ Wisconsin, Waisman Ctr, Madison, WI USA; [Kates, Ashley; Musuuza, Jackson S.; Safdar, Nasia] William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA; [Bentz, Michael L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Surg, Div Plast & Reconstruct Surg, Madison, WI USA; [Bentz, Michael L.] Univ Wisconsin, Dept Urol, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Safdar, N (corresponding author), Univ Wisconsin, Dept Med, Div Infect Dis, Sch Med & Publ Hlth, Madison, WI 53706 USA.; Safdar, N (corresponding author), William S Middleton Mem Vet Adm Med Ctr, Madison, WI 53705 USA.	ns2@medicine.wisc.edu			NLM NIH HHS [T15 LM007359] Funding Source: Medline	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Bebko SP, 2015, JAMA SURG, V150, P390, DOI 10.1001/jamasurg.2014.3480; Chaturvedi P, 2014, N AM J MED SCI, V6, P403, DOI 10.4103/1947-2714.139293; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Harvey G, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0398-2; Hill RLR, 2000, J HOSP INFECT, V45, P198, DOI 10.1053/jhin.2000.0733; Hogue JS, 2010, J CLIN MICROBIOL, V48, P2599, DOI 10.1128/JCM.02118-09; Junka A, 2014, INT WOUND J, V11, P730, DOI 10.1111/iwj.12057; Kotecha J, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0298-6; Kuehnert MJ, 2006, J INFECT DIS, V193, P172, DOI 10.1086/499632; Leonard P, 2017, SUPPORT CARE CANCER, V25, P7, DOI 10.1007/s00520-017-3635-6; Maslow J, 2014, ORTHOPEDICS, V37, pE576, DOI 10.3928/01477447-20140528-59; MCLURE AR, 1992, J HOSP INFECT, V21, P291, DOI 10.1016/0195-6701(92)90139-D; Norouzinia Roohangiz, 2015, Glob J Health Sci, V8, P65, DOI 10.5539/gjhs.v8n6p65; Peng HM, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20176736, 10.1590/1414-431x20176736]; Perencevich EN, 2003, EMERG INFECT DIS, V9, P196; Persch AC, 2013, AM J OCCUP THER, V67, P146, DOI 10.5014/ajot.2013.006213; Phillips M, 2014, INFECT CONT HOSP EP, V35, P826, DOI 10.1086/676872; Powell BJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0209-1; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Taran S., 2011, MCGILL J MED MJM, V13; The Centers for Disease Control and Prevention, CDC SURG SIT INF SSI; Urias DS, 2018, EUR J TRAUMA EMERG S, V44, P787, DOI 10.1007/s00068-017-0896-1; Weiner BJ, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0635-3; World Health Organization, GLOB GUID PREV SURG; Zhan LX, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00277	25	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0242217	10.1371/journal.pone.0242217	http://dx.doi.org/10.1371/journal.pone.0242217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211722	Green Published, gold			2022-12-26	WOS:000603518300043
J	Iqbal, MF; Liu, MC; Iram, A; Feng, YL				Iqbal, Mazher Farid; Liu, Ming-Chao; Iram, Aafia; Feng, Yu-Long			Effects of the invasive plant Xanthium strumarium on diversity of native plant species: A competitive analysis approach in North and Northeast China	PLOS ONE			English	Article							POTHWAR REGION; L.; IMPACT; REAL	Xanthium strumarium is native to North America and now has become one of the invasive alien species (IAS) in China. In order to detect the effects of the invader on biodiversity and evaluate its suitable habitats and ecological distribution, we investigated the abundance, relative abundance, diversity indices, and the number of the invasive and native plants in paired invaded and non-invaded quadrats in four locations in North and Northeast China. We also analyzed the effects of monthly mean maximum and minimum temperatures, relative humidity (%), and precipitations (mm). Strong positive significant (P < 0.01) correlation and maximum interspecific competition (41%) were found in Huailai between invaded and non-invaded quadrats. Shannon's Diversity Index showed that non-invaded plots had significantly (P < 0.05) more diversified species than invaded ones. The significant (P < 0.05) Margalef's Richness Index was found in Huailai and Zhangjiakou in non-invaded recorded heterogeneous nature of plant communities. Similarly, significant (P < 0.05) species richness found in Huailai and Zhangjiakou in non-invaded quadrats compared to invaded ones. Maximum evenness of Setaria feberi (0.47, 0.37), Seteria viridis (0.43) found in Fushun and Zhangjiakou recorded more stable in a community compared to other localities. Evenness showed positive relationship of Shannon Entropy within different plant species. The higher dissimilarity in plant communities found in Huailai (87.06%) followed by Yangyuan (44.43%), Zhangjiakou (40.13%) and Fushun (29.02%). The significant (P < 0.01) value of global statistics R (0.943/94.3%) showed high species diversity recorded in Huailai followed by Zhangjiakou recorded by non-metric multidimensional scaling and analysis of similarity between invaded and non-invaded plots. At the end it was concluded that the diversity indices reduced significantly (P < 0.05) in invaded quadrats indicated that native plant species become less diverse due to X. strumarium invasion. The degrees of X. strumarium invasion affected on species richness resulted to reduce diversity indices significantly in invaded quadrats.	[Iqbal, Mazher Farid; Liu, Ming-Chao; Feng, Yu-Long] Shenyang Agr Univ, Coll Biosci & Biotechnol, Liaoning Key Lab Biol Invas & Global Changes, Shenyang, Liaoning, Peoples R China; [Iram, Aafia] Govt Punjab Educ Dept, Gujranwala, Punjab, Pakistan	Shenyang Agricultural University	Feng, YL (corresponding author), Shenyang Agr Univ, Coll Biosci & Biotechnol, Liaoning Key Lab Biol Invas & Global Changes, Shenyang, Liaoning, Peoples R China.	fyl@syau.edu.cn	Feng, Yulong/B-7416-2012	Iqbal, Mazher/0000-0003-0662-4634	National Key RAMP;D Program of China [2017YFC1200101]; National Natural Science Foundation of China [31670545, 31971557]	National Key RAMP;D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We are thankful to the support of National Key R&D Program of China (2017YFC1200101), the National Natural Science Foundation of China (31670545, and 31971557). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2006, BIOL INVASIONS, V8, P1523, DOI 10.1007/s10530-005-5844-z; [Anonymous], 2010, BIOL NYSSANA; Arifa Zereen, 2014, Journal of Biodiversity and Environmental Sciences (JBES), V5, P230; Berhanu L, 2015, BASIC RES J AGR SCI, V4, P271; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Clarke K. R., 2001, CHANGES MARINE COMMU; Clarke K.R., 2014, CHANGE MARINE COMMUN; Dekker J, 2011, EVOL ECOL; Dekker J, 2018, EEW; Ehrenfeld JG, 2010, ANNU REV ECOL EVOL S, V41, P59, DOI 10.1146/annurev-ecolsys-102209-144650; Genovesi P., 2004, EUROPEAN STRATEGY IN; Harrison SK, 2003, WEED SCI, V51, P955, DOI 10.1614/P2002-110; Hussain Z, 2014, TURK J AGRIC FOR, V38, P39, DOI 10.3906/tar-1210-53; Iqbal MF, 2019, APPL ECOL ENV RES, V17, P13383, DOI 10.15666/aeer/1706_1338313394; Iqbal MF, 2020, BMC CHEM, V14, DOI 10.1186/s13065-020-00699-x; Kara B, 2012, J FOOD AGRIC ENVIRON, V10, P919; Khan MA, 2010, PAK J BOT, V42, P1529; Lemma B, 2015, BASIC RES J AGR SCI, V4, P271; Levine Jonathan M, 2009, Nature, V461, P254, DOI 10.1038/nature08251; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Mahajan M., 2017, INT J MULTIDISCIP RE, V3, P1; Maszura C. M., 2018, International Journal of Agronomy, V2018, P1046214; Murugesan Muthulakshmi, 2020, International Journal of Entomology Research, V5, P103; Nel JL, 2004, S AFR J SCI, V100, P53; Osunkoya OO, 2017, PLANT SOIL, V420, P177, DOI 10.1007/s11104-017-3375-x; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Powell KI, 2013, SCIENCE, V339, P316, DOI 10.1126/science.1226817; Qureshi H, 2019, ANN BOT-COENOL PLANT, V9, P73, DOI 10.13133/2239-3129/14411; Qureshi H, 2018, APPL ECOL ENV RES, V16, P5799, DOI 10.15666/aeer/1605_57995813; Rai PK., 2013, PLANT INVASION ECOLO; Rai PK., 2015, ENV SKEP CRIT, V4, P36, DOI DOI 10.0000/ISSN-2224-4263-ENVIR0NSC-2015-V4-0003; Reshi Z., 2009, INT J ECOLOGY ENV SC, V35, P91; Sartorato I, 1996, CROP PROT, V15, P63, DOI 10.1016/0261-2194(95)00114-X; Seifu A, 2017, INT J, V1; Si CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085490; Simberloff D, 2011, BIOL INVASIONS, V13, P1255, DOI 10.1007/s10530-011-9956-3; Sujay Y.H., 2010, Karnataka Journal of Agricultural Sciences, V23, P26; Tadesse Nigussie Seboka, 2017, Journal of Coastal Life Medicine, V5, P350, DOI [10.12980/jclm.5.2017J7-26, 10.12980/jclm.5.2017j7-26]; Valery L, 2008, BIOL INVASIONS, V10, P1345, DOI 10.1007/s10530-007-9209-7; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; Zhao YZ, 2020, PLANT SOIL, V452, P19, DOI 10.1007/s11104-020-04520-5	41	8	8	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0228476	10.1371/journal.pone.0228476	http://dx.doi.org/10.1371/journal.pone.0228476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211690	Green Published, gold			2022-12-26	WOS:000603518300001
J	Pewowaruk, R; Rutkowski, D; Hernando, D; Kumapayi, BB; Bushman, W; Roldan-Alzate, A				Pewowaruk, Ryan; Rutkowski, David; Hernando, Diego; Kumapayi, Bunmi B.; Bushman, Wade; Roldan-Alzate, Alejandro			A pilot study of bladder voiding with real-time MRI and computational fluid dynamics	PLOS ONE			English	Article							UNDERACTIVE BLADDER; DETRUSOR UNDERACTIVITY; WALL THICKNESS; BLOOD-FLOW; EPIDEMIOLOGY	Lower urinary track symptoms (LUTS) affect many older adults. Multi-channel urodynamic studies provide information about bladder pressure and urinary flow but offer little insight into changes in bladder anatomy and detrusor muscle function. Here we present a novel method for real time MRI during bladder voiding. This was performed in a small cohort of healthy men and men with benign prostatic hyperplasia and lower urinary tract symptoms (BPH/LUTS) to demonstrate proof of principle; The MRI urodynamic protocol was successfully implemented, and bladder wall displacement and urine flow dynamics were calculated. Displacement analysis on healthy controls showed the greatest bladder wall displacement in the dome of the bladder while men with BPH/LUTS exhibited decreased and asymmetric bladder wall motion. Computational fluid dynamics of voiding showed men with BPH/LUTS had larger recirculation regions in the bladder. This study demonstrates the feasibility of performing MRI voiding studies and their potential to provide new insight into lower urinary tract function in health and disease.	[Pewowaruk, Ryan; Roldan-Alzate, Alejandro] Univ Wisconsin, Biomed Engn, Madison, WI 53705 USA; [Rutkowski, David] Univ Wisconsin, Cardiovasc Res Ctr, Madison, WI USA; [Rutkowski, David; Hernando, Diego; Roldan-Alzate, Alejandro] Univ Wisconsin, Radiol, Madison, WI USA; [Hernando, Diego] Univ Wisconsin, Med Phys, Madison, WI USA; [Kumapayi, Bunmi B.; Bushman, Wade] Univ Wisconsin, Urol, Madison, WI USA; [Roldan-Alzate, Alejandro] Univ Wisconsin, Mech Engn, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Roldan-Alzate, A (corresponding author), Univ Wisconsin, Biomed Engn, Madison, WI 53705 USA.; Roldan-Alzate, A (corresponding author), Univ Wisconsin, Radiol, Madison, WI USA.; Roldan-Alzate, A (corresponding author), Univ Wisconsin, Mech Engn, Madison, WI USA.	roldan@wisc.edu		Pewowaruk, Ryan/0000-0003-1190-7196; Roldan-Alzate, Alejandro/0000-0003-4149-4038	National Institutes for Health [K12DK100022, T32 HL 007936]; GE Healthcare	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GE Healthcare(General ElectricGE Healthcare)	This work was supported by the National Institutes for Health (nih.gov) grants K12DK100022 (AR, DH, WB) and T32 HL 007936 (RP, DR). The authors also wish to acknowledge support from GE Healthcare who provides research support to the University of Wisconsin. CONVERGE licenses were provided by a partnership between Convergent Science Inc. and the University of Wisconsin -Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldamanhori R, 2017, CURR OPIN UROL, V27, P293, DOI 10.1097/MOU.0000000000000381; Atesci YZ, 2011, TURK KLIN TIP BILIM, V31, P1186, DOI 10.5336/medsci.2010-21420; Baillargeon B, 2014, EUR J MECH A-SOLID, V48, P38, DOI 10.1016/j.euromechsol.2014.04.001; Bosch R, 2019, NEUROUROL URODYNAM, V38, pS56, DOI 10.1002/nau.24076; Bushman W, 2009, UROL CLIN N AM, V36, P403, DOI 10.1016/j.ucl.2009.07.003; Busse R., 2007, 3D FSE REDUCES SCAN; Chuang YC, 2015, CLIN GERIATR MED, V31, P523, DOI 10.1016/j.cger.2015.06.002; Fananapazir G, 2018, ABDOM RADIOL, V43, P2442, DOI 10.1007/s00261-018-1463-x; Guneyli S, 2017, J MAGN RESON IMAGING, V45, P917, DOI 10.1002/jmri.25418; Guzel O, 2015, UROLOGY, V86, P439, DOI 10.1016/j.urology.2015.06.023; Hartigan SM, 2019, NEUROUROL URODYNAM, V38, P2070, DOI 10.1002/nau.24147; Hocaoglu Y, 2012, BJU INT, V109, P234, DOI 10.1111/j.1464-410X.2011.10255.x; Hou P, 2007, J MAGN RESON IMAGING, V25, P160, DOI 10.1002/jmri.20813; Jin QH, 2010, FRONT MECH ENG, V5, P336, DOI 10.1007/s11465-010-0027-8; Lai CQ, 2016, BIOMECH MODEL MECHAN, V15, P1159, DOI 10.1007/s10237-015-0750-5; Marom G, 2015, ARCH COMPUT METHOD E, V22, P595, DOI 10.1007/s11831-014-9133-9; Marsden AL, 2015, CURR OPIN PEDIATR, V27, P587, DOI 10.1097/MOP.0000000000000269; Mirone V, 2007, EUR UROL, V51, P57, DOI 10.1016/j.eururo.2006.07.050; Moller T., 1997, J GRAPH TOOL, V2, P21, DOI [DOI 10.1080/10867651.1997.10487468, 10.1080/10867651.1997.10487468]; Osman NI, 2014, EUR UROL, V65, P389, DOI 10.1016/j.eururo.2013.10.015; Peskin C. S., 1977, Journal of Computational Physics, V25, P220, DOI 10.1016/0021-9991(77)90100-0; PESKIN CS, 1972, J COMPUT PHYS, V10, P252, DOI 10.1016/0021-9991(72)90065-4; Taylor CA, 2009, ANNU REV BIOMED ENG, V11, P109, DOI 10.1146/annurev.bioeng.10.061807.160521; Taylor CA, 2010, ANN BIOMED ENG, V38, P1188, DOI 10.1007/s10439-010-9901-0; Thiele H, 2001, J MAGN RESON IMAGING, V14, P362, DOI 10.1002/jmri.1195; Vasudevan V, 2017, BIOMECH MODEL MECHAN, V16, P1503, DOI 10.1007/s10237-017-0902-x; Wasserman NF, 2015, AM J ROENTGENOL, V205, P564, DOI 10.2214/AJR.14.13602; Wei JT, 2005, J UROLOGY, V173, P1256, DOI 10.1097/01.ju.0000155709.37840.fe; Zheng JM, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0081-y	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0238404	10.1371/journal.pone.0238404	http://dx.doi.org/10.1371/journal.pone.0238404			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211706	Green Published, gold			2022-12-26	WOS:000603518300003
J	Nteveros, A; Kyprianou, M; Artemiadis, A; Charalampous, A; Christoforaki, K; Cheilidis, S; Germanos, O; Bargiotas, P; Chatzittofis, A; Zis, P				Nteveros, Antonios; Kyprianou, Marios; Artemiadis, Artemios; Charalampous, Antrianthi; Christoforaki, Kallistheni; Cheilidis, Stephanos; Germanos, Orestis; Bargiotas, Panagiotis; Chatzittofis, Andreas; Zis, Panagiotis			Burnout among medical students in Cyprus: A cross-sectional study	PLOS ONE			English	Article							SLEEP; DEPRESSION; STRESS; LIFE; PREVALENCE; RESIDENTS; PATTERNS; BEHAVIOR; HEALTH	Objectives The primary aim was to estimate the burnout prevalence among all medical students at the Medical School of the University of Cyprus. Secondary aims were to ascertain the predictors of burnout and its relationship with lifestyle habits, sleep quality and mental health. Background Burnout in the healthcare sector has drawn significant scientific attention over the last few years. Recent research underscored the large burden of profession-related burnout among medical students. Materials and methods An anonymous questionnaire was administered to all 189 eligible candidates. This included demographic and lifestyle characteristics. Sleep quality was assessed via the Pittsburg Sleep Quality Index, mental health was assessed via the mental health (MH) domain of the 36-item Short Form Health Survey (SF-36) and burnout with the Maslach Burnout Inventory-Student Survey (MBI-SS). Results Overall response rate was 96.3%. The burnout prevalence was 18.1%. There was a significant linear effect of between the year of studies and the burnout frequency [F(1) = 5.09, p = 0.024], implying that with increasing academic year there were more students with burnout, especially after the 4th year of education which signifies the beginning of clinical education. Students with burnout were more likely to have poor sleep quality (90.9% vs. 60.8%, odds ratio 4.33, p = 0.023) and worse mental health (MH score 40.2 +/- 17.7 vs 62.9 +/- 20.3, p<0.001). Alcohol consumers had more symptoms of cynicism and less feelings of efficacy than non-alcohol consumers. Moreover, less feelings of efficacy were significantly associated with more alcohol consumption among alcohol consumers. Conclusions Burnout is prevalent in medical students and increases significantly during the clinical years. Students with burnout have worse sleep and mental health and might use alcohol as a coping mechanism. Implementing prevention strategies of burnout may be beneficial.	[Nteveros, Antonios; Kyprianou, Marios; Artemiadis, Artemios; Charalampous, Antrianthi; Christoforaki, Kallistheni; Cheilidis, Stephanos; Germanos, Orestis; Bargiotas, Panagiotis; Chatzittofis, Andreas; Zis, Panagiotis] Univ Cyprus, Sch Med, Nicosia, Cyprus	University of Cyprus	Zis, P (corresponding author), Univ Cyprus, Sch Med, Nicosia, Cyprus.	takiszis@gmail.com	Chatzittofis, Andreas/CAH-2502-2022; Germanos, Orestis/GLU-1712-2022; Zis, Panagiotis/AAH-8027-2021	Chatzittofis, Andreas/0000-0002-6635-9564; Zis, Panagiotis/0000-0001-8567-3092; Artemiadis, Artemios/0000-0001-9435-9644; Germanos, Orestis/0000-0002-6795-1260; Nteveros, Antonios/0000-0001-5266-5504; Hilides, Stefanos/0000-0003-3401-1835				Anagnostopoulos F, 2015, J CLIN PSYCHOL MED S, V22, P90, DOI 10.1007/s10880-014-9415-2; [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645; [Anonymous], 2015, STAHLBAU, V85, pA11; Backovic DV, 2012, PSYCHIAT DANUB, V24, P175; Boehm MA, 2016, J AM COLL HEALTH, V64, P565, DOI 10.1080/07448481.2016.1205073; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cecil J, 2014, MED EDUC ONLINE, V19, DOI 10.3402/meo.v19.25209; Chang E, 2012, ACAD PSYCHIATR, V36, P177, DOI 10.1176/appi.ap.11040079; Dyrbye L, 2016, MED EDUC, V50, P132, DOI 10.1111/medu.12927; Dyrbye LN, 2011, MED TEACH, V33, P756, DOI 10.3109/0142159X.2011.577468; Dyrbye LN, 2010, JAMA-J AM MED ASSOC, V304, P1173, DOI 10.1001/jama.2010.1318; Dyrbye LN, 2006, ACAD MED, V81, P374, DOI 10.1097/00001888-200604000-00010; Erschens R, 2018, MED EDUC ONLINE, V23, DOI 10.1080/10872981.2018.1535738; Erschens R, 2019, MED TEACH, V41, P172, DOI 10.1080/0142159X.2018.1457213; Fares J, 2016, J EPIDEMIOL GLOB HEA, V6, P177, DOI 10.1016/j.jegh.2015.10.003; Fitzpatrick O, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023297; Grandner Michael A, 2006, Sleep Biol Rhythms, V4, P129, DOI 10.1111/j.1479-8425.2006.00207.x; Gyorffy Z, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0690-5; Hays R D, 1993, Health Econ, V2, P217, DOI 10.1002/hec.4730020305; Jackson ER, 2016, ACAD MED, V91, P1251, DOI 10.1097/ACM.0000000000001138; Kumar S, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030037; Liu HC, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010326; Pagnin D, 2014, ACAD PSYCHIATR, V38, P438, DOI 10.1007/s40596-014-0093-z; Pagnin D, 2013, MED TEACH, V35, P388, DOI 10.3109/0142159X.2013.769673; Paro HBMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094133; Popa-Velea O, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060560; Prins JT, 2007, MED EDUC, V41, P788, DOI 10.1111/j.1365-2923.2007.02797.x; Prinz Patrick, 2012, GMS Z Med Ausbild, V29, pDoc10, DOI 10.3205/zma000780; Ripp J, 2011, ACAD MED, V86, P1304, DOI 10.1097/ACM.0b013e31822c1236; Santen SA, 2010, SOUTH MED J, V103, P758, DOI 10.1097/SMJ.0b013e3181e6d6d4; Schaufeli WB, 2002, J CROSS CULT PSYCHOL, V33, P464, DOI 10.1177/0022022102033005003; Scholz M, 2015, PSYCHOTHER PSYCH MED, V65, P93, DOI 10.1055/s-0034-1375630; Schutte N, 2000, J OCCUP ORGAN PSYCH, V73, P53, DOI 10.1348/096317900166877; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; The Society for Cardiovascular Angiography and Interventions, 2016, CATHETER CARDIOVASC, V87, pS1; Voltmer E, 2010, MED TEACH, V32, pE422, DOI 10.3109/0142159X.2010.496008; Wolf MR, 2017, ACAD PSYCHIATR, V41, P174, DOI 10.1007/s40596-016-0526-y; World Health Organization, 2019, BURN OUT OCC PHEN IN; Worly B, 2019, PSYCHOL HEALTH MED, V24, P429, DOI 10.1080/13548506.2018.1529329; Zis Panagiotis, 2014, ScientificWorldJournal, V2014, P673279, DOI 10.1155/2014/673279	40	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241335	10.1371/journal.pone.0241335	http://dx.doi.org/10.1371/journal.pone.0241335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206654	Green Published, gold			2022-12-26	WOS:000595265900023
J	Cortez, FD; Gebhart, D; Robinson, PV; Seftel, D; Pourmandi, N; Owyoung, J; Bertozzi, CR; Wilson, DM; Maahs, DM; Buckingham, BA; Mills, JR; Roforth, MM; Pittock, SJ; McKeon, A; Page, K; Wolf, WA; Sanda, S; Speake, C; Greenbaum, CJ; Tsai, CT				Cortez, Felipe de Jesus; Gebhart, David; Robinson, Peter V.; Seftel, David; Pourmandi, Narges; Owyoung, Jordan; Bertozzi, Carolyn R.; Wilson, Darrell M.; Maahs, David M.; Buckingham, Bruce A.; Mills, John R.; Roforth, Matthew M.; Pittock, Sean J.; McKeon, Andrew; Page, Kara; Wolf, Wendy A.; Sanda, Srinath; Speake, Cate; Greenbaum, Carla J.; Tsai, Cheng-ting			Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR	PLOS ONE			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GAD65 AUTOANTIBODIES; ANTIBODY DETECTION; ASSAY; GAD(65); RISK; IA-2; STATEMENT; DIAGNOSIS; INSULIN	Islet autoantibodies are predominantly measured by radioassay to facilitate risk assessment and diagnosis of type 1 diabetes. However, the reliance on radioactive components, large sample volumes and limited throughput renders radioassay testing costly and challenging. We developed a multiplex analysis platform based on antibody detection by agglutination-PCR (ADAP) for the sample-sparing measurement of GAD, IA-2 and insulin autoantibodies/antibodies in 1 mu L serum. The assay was developed and validated in 7 distinct cohorts (n = 858) with the majority of the cohorts blinded prior to analysis. Measurements from the ADAP assay were compared to radioassay to determine correlation, concordance, agreement, clinical sensitivity and specificity. The average overall agreement between ADAP and radioassay was above 91%. The average clinical sensitivity and specificity were 96% and 97%. In the IASP 2018 workshop, ADAP achieved the highest sensitivity of all assays tested at 95% specificity (AS95) rating for GAD and IA-2 autoantibodies and top-tier performance for insulin autoantibodies. Furthermore, ADAP correctly identified 95% high-risk individuals with two or more autoantibodies by radioassay amongst 39 relatives of T1D patients tested. In conclusion, the new ADAP assay can reliably detect the three cardinal islet autoantibodies/antibodies in 1 mu L serum with high sensitivity. This novel assay may improve pediatric testing compliance and facilitate easier community-wide screening for islet autoantibodies.	[Cortez, Felipe de Jesus; Gebhart, David; Robinson, Peter V.; Seftel, David; Pourmandi, Narges; Owyoung, Jordan; Tsai, Cheng-ting] Enable Biosci Inc, San Francisco, CA 94080 USA; [Bertozzi, Carolyn R.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Bertozzi, Carolyn R.; Wilson, Darrell M.; Maahs, David M.; Buckingham, Bruce A.] Stanford Diabet Res Ctr, Stanford, CA USA; [Wilson, Darrell M.; Maahs, David M.; Buckingham, Bruce A.] Stanford Univ, Dept Pediat, Sch Med, Div Pediat Endocrinol & Diabet, Stanford, CA 94305 USA; [Mills, John R.; Roforth, Matthew M.; Pittock, Sean J.; McKeon, Andrew] Mayo Clin, Coll Med, Dept Lab Med Pathol, Rochester, MN USA; [Mills, John R.; Roforth, Matthew M.; Pittock, Sean J.; McKeon, Andrew] Mayo Clin, Coll Med, Dept Neurol, Rochester, MN USA; [Page, Kara; Wolf, Wendy A.] T1D Exchange, Boston, MA USA; [Sanda, Srinath] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Speake, Cate; Greenbaum, Carla J.] Benaroya Res Inst, Diabet Clin Res Program, Seattle, WA USA	Stanford University; Stanford University; Mayo Clinic; Mayo Clinic; University of California System; University of California San Francisco; Benaroya Research Institute	Tsai, CT (corresponding author), Enable Biosci Inc, San Francisco, CA 94080 USA.	jasontsai@enablebiosciences.com	McKeon, Andrew/AAY-9214-2021	Maahs, David/0000-0002-4602-7909; Buckingham, Bruce/0000-0003-4581-4887	National Institutes of Health (NIH) [R43DK111005, R44DK111005]; T1D Exchange Diabetes Innovation Challenge Award Enable Biosciences; NIH [5 U01 DK061042]; National Center for Advancing Translational Science Clinical and Translational Science Award [UL1TR001085]; JDRF [2-SRA2018-535]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); T1D Exchange Diabetes Innovation Challenge Award Enable Biosciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Science Clinical and Translational Science Award; JDRF(Juvenile Diabetes Research Foundation)	This work was supported by grants from National Institutes of Health (NIH) R43DK111005, R44DK111005 and T1D Exchange Diabetes Innovation Challenge Award Enable Biosciences. The funder provided support in the form of salaries for authors FJC, DG, PVR, DS, NP, JO and CTT as employees of Enable Biosciences, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. DMW, DMM, BAB was supported by NIH 5 U01 DK061042 Stanford TrialNet, National Center for Advancing Translational Science Clinical and Translational Science Award UL1TR001085 and JDRF 2-SRA2018-535. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. Part of this study were presented in abstract form at the 70th America Association Clinical Chemistry Annual Scientific Meeting, Chicago, Illinois, July 29 -Aug 2 2018. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach P, 2009, DIABETOLOGIA, V52, P1881, DOI 10.1007/s00125-009-1438-0; Amoroso M, 2016, CLIN CHIM ACTA, V462, P60, DOI 10.1016/j.cca.2016.08.013; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Bonifacio E, 2010, J CLIN ENDOCR METAB, V95, P3360, DOI 10.1210/jc.2010-0293; Brooking H, 2003, CLIN CHIM ACTA, V331, P55, DOI 10.1016/S0009-8981(03)00088-3; Chen S, 2005, CLIN CHIM ACTA, V357, P74, DOI 10.1016/j.cccn.2005.02.006; Chiang JL, 2014, DIABETES CARE, V37, P2034, DOI 10.2337/dc14-1140; FEINSTEIN AR, 1956, ANN INTERN MED, V44, P899, DOI 10.7326/0003-4819-44-5-899; Gao XY, 2019, ENDOCR CONNECT, V8, P1493, DOI 10.1530/EC-19-0379; Gu Y, 2019, EBIOMEDICINE, V47, P365, DOI 10.1016/j.ebiom.2019.08.036; Herold KC, 2019, NEW ENGL J MED, V381, P603, DOI 10.1056/NEJMoa1902226; Insel RA, 2015, DIABETES CARE, V38, P1964, DOI 10.2337/dc15-1419; Lampasona V, 2019, CLIN CHEM, V65, P1141, DOI 10.1373/clinchem.2019.304196; Miao DM, 2013, DIABETES, V62, P4174, DOI 10.2337/db13-0534; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Perchard R, 2015, ARCH DIS CHILD, V100, P348, DOI 10.1136/archdischild-2014-306542; PETERSEN JS, 1994, DIABETES, V43, P459, DOI 10.2337/diabetes.43.3.459; Raab J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011144; Sysi-Aho M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002257; Tsai CT, 2018, P NATL ACAD SCI USA, V115, P1250, DOI 10.1073/pnas.1711004115; Tsai CT, 2016, ACS CENTRAL SCI, V2, P139, DOI 10.1021/acscentsci.5b00340; Walikonis JE, 1998, MAYO CLIN PROC, V73, P1161, DOI 10.4065/73.12.1161; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Yu LP, 2013, DIABETES CARE, V36, P2266, DOI 10.2337/dc12-2245; Yu LP, 2012, DIABETES CARE, V35, P1213, DOI 10.2337/dc11-2081; Yu LP, 2012, DIABETES, V61, P179, DOI 10.2337/db11-0670; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; Zhang B, 2014, NAT MED, V20, P948, DOI 10.1038/nm.3619; Zhao ZY, 2016, J IMMUNOL METHODS, V430, P28, DOI 10.1016/j.jim.2016.01.011; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285	31	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242049	10.1371/journal.pone.0242049	http://dx.doi.org/10.1371/journal.pone.0242049			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186361	Green Published, gold			2022-12-26	WOS:000593949800050
J	Harnie, J; Cattagni, T; Cornu, C; McNair, P; Jubeau, M				Harnie, Jonathan; Cattagni, Thomas; Cornu, Christophe; McNair, Peter; Jubeau, Marc			Acute effect of tendon vibration applied during isometric contraction at two knee angles on maximal knee extension force production	PLOS ONE			English	Article							NEUROMUSCULAR ELECTRICAL-STIMULATION; MUSCLE LENGTH; VOLUNTARY CONTRACTION; SUPRASPINAL FACTORS; MOTOR-PERFORMANCE; PROLONGED MUSCLE; ACTIVATION; FATIGUE; RESPONSES; TORQUE	The aim of the current study was to investigate the effect of a single session of prolonged tendon vibration combined with low submaximal isometric contraction on maximal motor performance. Thirty-two young sedentary adults were assigned into two groups that differed based on the knee angle tested: 90 degrees or 150 degrees (180 degrees = full knee extension). Participants performed two fatigue-inducing exercise protocols: one with three 10 min submaximal (10% of maximal voluntary contraction) knee extensor contractions and patellar tendon vibration (80 Hz) another with submaximal knee extensor contractions only. Before and after each fatigue protocol, maximal voluntary isometric contractions (MVC), voluntary activation level (assessed by the twitch interpolation technique), peak-to-peak amplitude of maximum compound action potentials of vastus medialis and vastus lateralis (assessed by electromyography with the use of electrical nerve stimulation), peak twitch amplitude and peak doublet force were measured. The knee extensor fatigue was significantly (P<0.05) greater in the 90 degrees knee angle group (-20.6% MVC force, P<0.05) than the 150 degrees knee angle group (-8.3% MVC force, P = 0.062). Both peripheral and central alterations could explain the reduction in MVC force at 90 degrees knee angle. However, tendon vibration added to isometric contraction did not exacerbate the reduction in MVC force. These results clearly demonstrate that acute infrapatellar tendon vibration using a commercial apparatus operating at optimal conditions (i.e. contracted and stretched muscle) does not appear to induce knee extensor neuromuscular fatigue in young sedentary subjects.	[Harnie, Jonathan; Cattagni, Thomas; Cornu, Christophe; Jubeau, Marc] Univ Nantes, Lab Motric, Interact, Performance EA 4334,Fac Sport Sci, Nantes, France; [McNair, Peter] Auckland Univ Technol, Hlth & Rehabil Res Inst, Fac Hlth & Environm Sci, Auckland, New Zealand	Nantes Universite; Auckland University of Technology	Jubeau, M (corresponding author), Univ Nantes, Lab Motric, Interact, Performance EA 4334,Fac Sport Sci, Nantes, France.	marc.jubeau@univ-nantes.fr			Region des Pays de la Loire, France [2013-12915]	Region des Pays de la Loire, France(French National Research Agency (ANR)Region Pays de la Loire)	The research was supported by a grant (no 2013-12915) from the Region des Pays de la Loire, France, for the project "Longevite, Mobilite, Autonomie" (LMA), http://www.paysdelaloire.fr.	Allen DG, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00463; ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; [Anonymous], 2017, HEART LUNG CIRC, V26, pe125; Balnave CD, 1996, J PHYSIOL-LONDON, V492, P705, DOI 10.1113/jphysiol.1996.sp021339; Bampouras TM, 2006, MUSCLE NERVE, V34, P740, DOI 10.1002/mus.20610; Becker R, 2001, MUSCLE NERVE, V24, P667, DOI 10.1002/mus.1053; BIGLANDRITCHIE B, 1986, J APPL PHYSIOL, V61, P421, DOI 10.1152/jappl.1986.61.2.421; Bojsen-Moller J, 2011, SCAND J MED SCI SPOR, V21, pE48, DOI 10.1111/j.1600-0838.2010.01148.x; Boyas S., 2011, Annals of Physical and Rehabilitation Medicine, V54, P88, DOI 10.1016/j.rehab.2011.01.001; Brunetti O, 2006, KNEE SURG SPORT TR A, V14, P1180, DOI 10.1007/s00167-006-0101-2; Brunetti O, 2015, J SPORT MED PHYS FIT, V55, P118; BURKE D, 1976, J PHYSIOL-LONDON, V261, P673, DOI 10.1113/jphysiol.1976.sp011580; Cattagni T, 2018, J ELECTROMYOGR KINES, V38, P111, DOI 10.1016/j.jelekin.2017.11.013; Chen XF, 2016, J BIOMECH, V49, P2989, DOI 10.1016/j.jbiomech.2016.07.013; Duchateau J, 2002, J PHYSIOL-LONDON, V541, P959, DOI 10.1113/jphysiol.2002.016790; Ekblom MMN, 2011, MED SCI SPORT EXER, V43, P1933, DOI 10.1249/MSS.0b013e318217d720; Enoka RM, 2008, J PHYSIOL-LONDON, V586, P11, DOI 10.1113/jphysiol.2007.139477; Fallon JB, 2007, MUSCLE NERVE, V36, P21, DOI 10.1002/mus.20796; Farabet A, 2016, EUR J APPL PHYSIOL, V116, P1197, DOI 10.1007/s00421-016-3378-y; Fattorini L, 2006, EUR J APPL PHYSIOL, V98, P79, DOI 10.1007/s00421-006-0250-5; Filippi GM, 2009, ARCH PHYS MED REHAB, V90, P2019, DOI 10.1016/j.apmr.2009.08.139; FITCH S, 1985, J PHYSIOL-LONDON, V362, P205, DOI 10.1113/jphysiol.1985.sp015671; Fry A, 2014, EUR J APPL PHYSIOL, V114, P1757, DOI 10.1007/s00421-014-2904-z; FUGLEVAND AJ, 1993, J PHYSIOL-LONDON, V460, P549, DOI 10.1113/jphysiol.1993.sp019486; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; Gondin J, 2006, J NEUROPHYSIOL, V95, P3328, DOI 10.1152/jn.01002.2005; Herda TJ, 2009, SCAND J MED SCI SPOR, V19, P703, DOI 10.1111/j.1600-0838.2008.00787.x; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hisaeda HO, 2001, EUR J APPL PHYSIOL, V86, P17, DOI 10.1007/s004210100497; Hucteau E, 2020, EUR J APPL PHYSIOL, V120, P513, DOI 10.1007/s00421-019-04299-z; Jackson SW, 2003, EUR J APPL PHYSIOL, V88, P380, DOI 10.1007/s00421-002-0701-6; JAMI L, 1992, PHYSIOL REV, V72, P623, DOI 10.1152/physrev.1992.72.3.623; Kent-Braun JA, 1999, EUR J APPL PHYSIOL O, V80, P57, DOI 10.1007/s004210050558; Kluka V, 2015, MED SCI SPORT EXER, V47, P718, DOI 10.1249/MSS.0000000000000463; Konishi Y, 2009, J SPORT SCI MED, V8, P548; Kooistra RD, 2005, J APPL PHYSIOL, V98, P810, DOI 10.1152/japplphysiol.00712.2004; Kouzaki M, 2000, J APPL PHYSIOL, V89, P1420, DOI 10.1152/jappl.2000.89.4.1420; MATTHEWS PB, 1964, PHYSIOL REV, V44, P219, DOI 10.1152/physrev.1964.44.2.219; MATTHEWS PB, 1962, Q J EXP PHYSIOL CMS, V47, P324, DOI 10.1113/expphysiol.1962.sp001616; Nakajima T, 2009, EXP BRAIN RES, V192, P211, DOI 10.1007/s00221-008-1571-x; NG AV, 1994, J APPL PHYSIOL, V76, P2561, DOI 10.1152/jappl.1994.76.6.2561; Pageaux B, 2013, MED SCI SPORT EXER, V45, P2254, DOI 10.1249/MSS.0b013e31829b504a; Place N, 2005, J APPL PHYSIOL, V98, P429, DOI 10.1152/japplphysiol.00664.2004; Place N, 2007, MUSCLE NERVE, V35, P486, DOI 10.1002/mus.20714; Rice DA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3467; ROLL JP, 1989, EXP BRAIN RES, V76, P213; Rozand V, 2015, INT J SPORTS MED, V36, P35, DOI 10.1055/s-0034-1375614; Saito A, 2016, EXP BRAIN RES, V234, P209, DOI 10.1007/s00221-015-4447-x; Shinohara M, 2005, J APPL PHYSIOL, V99, P1835, DOI 10.1152/japplphysiol.00312.2005; Souron R, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00519; Strojnik V, 1998, J APPL PHYSIOL, V84, P344, DOI 10.1152/jappl.1998.84.1.344; Ushiyama J, 2005, J APPL PHYSIOL, V98, P1427, DOI 10.1152/japplphysiol.00613.2004; VALLBO AB, 1974, ACTA PHYSIOL SCAND, V90, P319, DOI 10.1111/j.1748-1716.1974.tb05594.x; VISSER JJ, 1990, EUR J APPL PHYSIOL O, V61, P453, DOI 10.1007/BF00236067; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Xu JF, 2018, J SPORT HEALTH SCI, V7, P245, DOI 10.1016/j.jshs.2016.07.001; Yoshitake Y, 2004, J APPL PHYSIOL, V97, P2090, DOI 10.1152/japplphysiol.00560.2004	58	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242324	10.1371/journal.pone.0242324	http://dx.doi.org/10.1371/journal.pone.0242324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186411	Green Published, gold			2022-12-26	WOS:000593949800049
J	Hu, WX; Wu, RR; Gao, CY; Liu, F; Zeng, ZR; Zhu, QF; Chen, JY; Cheng, S; Yu, KX; Qian, Y; Zhao, J; Zhong, SH; Li, QJ; Wang, LH; Liu, XB; Wang, JA				Hu, Wangxing; Wu, Rongrong; Gao, Chenyang; Liu, Feng; Zeng, Zhiru; Zhu, Qifeng; Chen, Jinyong; Cheng, Si; Yu, Kaixiang; Qian, Yi; Zhao, Jing; Zhong, Shuhan; Li, Qingju; Wang, Lihan; Liu, Xianbao; Wang, Jian'an			Knockdown of estrogen-related receptor alpha inhibits valve interstitial cell calcification in vitro by regulating heme oxygenase 1	FASEB JOURNAL			English	Article						calcification; CAVD; ERR&#945; Hmox1; valve interstitial cells	ERR-ALPHA; OSTEOBLAST DIFFERENTIATION; TRANSCRIPTIONAL CONTROL; VASCULAR CALCIFICATION; AORTIC-STENOSIS; UP-REGULATION; METABOLISM; EXPRESSION; DISEASE; MECHANISMS	Calcific aortic valve disease (CAVD) is the most common valvular heart disease in adults. The cellular mechanisms of CAVD are still unknown, but accumulating evidence has revealed that osteogenic differentiation of human valve interstitial cells (hVICs) plays an important role in CAVD. Thus, we aimed to investigate the function of estrogen-related receptor alpha (ERR alpha) in the osteogenic differentiation of hVICs. We found that the level of ERR alpha was significantly increased in CAVD samples compared to normal controls. In addition, ERR alpha was significantly upregulated during hVIC osteogenic differentiation in vitro. Gain- and loss-of-function experiments were performed to identify the function of ERR alpha in hVIC calcification in vitro. Inhibition of endogenous ERR alpha attenuated hVIC calcification, whereas overexpression of ERR alpha in hVICs promoted this process. RNA sequencing results suggested that heme oxygenase-1 (Hmox1) was a downstream target of ERR alpha, which was further confirmed by western blotting. Additionally, we also found that downregulation of Hmox1 by shHmox1 efficiently reversed the inhibition of calcification induced by ERR alpha shRNA in hVICs. ChIP-qPCR and luciferase assays indicated that Hmox1 was negatively regulated by ERR alpha. We found that overexpression of Hmox1 or its substrates significantly inhibited hVIC calcification in vitro. In conclusion, we found that knockdown of ERR alpha can inhibit hVIC calcification through upregulating Hmox1 and that ERR alpha and Hmox1 are potential targets for the treatment of CAVD.	[Hu, Wangxing; Wu, Rongrong; Gao, Chenyang; Liu, Feng; Zeng, Zhiru; Zhu, Qifeng; Chen, Jinyong; Cheng, Si; Yu, Kaixiang; Qian, Yi; Zhao, Jing; Zhong, Shuhan; Li, Qingju; Wang, Lihan; Liu, Xianbao; Wang, Jian'an] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou, Peoples R China; [Hu, Wangxing; Wu, Rongrong; Gao, Chenyang; Liu, Feng; Zeng, Zhiru; Zhu, Qifeng; Chen, Jinyong; Cheng, Si; Yu, Kaixiang; Qian, Yi; Zhao, Jing; Zhong, Shuhan; Li, Qingju; Wang, Lihan; Liu, Xianbao; Wang, Jian'an] Key Lab Cardiovasc Dis Zhejiang Prov, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University	Liu, XB; Wang, JA (corresponding author), Key Lab Cardiovasc Dis Zhejiang Prov, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China.	liuxb@zju.edu.cn; wangjianan111@zju.edu.cn			National Natural Science Foundation of China (NSFC) [81870292, 81622006, 81670261, 81570233, 81770252, 81960083]; National Key R&D Program of China [2019YFA0110400, 2016YFC1301204, 2017YFA0103700]; Key R&D Projects of Zhejiang Province [2015C03028, 2018C03014]; Fundamental Research Funds for the Central Universities [2019XZZX005-4-03]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Key R&D Projects of Zhejiang Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870292, 81622006, 81670261, 81570233, 81770252 and 81960083; National Key R&D Program of China, Grant/Award Number: 2019YFA0110400, 2016YFC1301204 and 2017YFA0103700; The Key R&D Projects of Zhejiang Province, Grant/Award Number: 2015C03028 and 2018C03014; Fundamental Research Funds for the Central Universities, Grant/Award Number: 2019XZZX005-4-03	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Alushi B, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00685; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Audet-Walsh E, 2016, CELL REP, V14, P920, DOI 10.1016/j.celrep.2015.12.086; Bolisetty S, 2017, AM J KIDNEY DIS, V69, P531, DOI 10.1053/j.ajkd.2016.10.037; Bonnelye E, 2005, J CLIN ENDOCR METAB, V90, P3115, DOI 10.1210/jc.2004-2168; Bonnelye E, 1997, MECH DEVELOP, V65, P71, DOI 10.1016/S0925-4773(97)00059-2; Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971; Bruderer M, 2014, EUR CELLS MATER, V28, P269, DOI 10.22203/eCM.v028a19; Caira FC, 2006, J AM COLL CARDIOL, V47, P1707, DOI 10.1016/j.jacc.2006.02.040; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; De Bosscher K, 2020, NAT REV ENDOCRINOL, V16, P363, DOI 10.1038/s41574-020-0349-5; Di Pietro C, 2000, FRONT PHARMACOL, V11; Durante W, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9090829; Eichner LJ, 2011, MITOCHONDRION, V11, P544, DOI 10.1016/j.mito.2011.03.121; Evans RM, 2005, MOL ENDOCRINOL, V19, P1429, DOI 10.1210/me.2005-0046; Gaillard S, 2007, MOL ENDOCRINOL, V21, P62, DOI 10.1210/me.2006-0179; Gallet M, 2010, TRENDS ENDOCRIN MET, V21, P637, DOI 10.1016/j.tem.2010.06.008; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Hou YC, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072466; Huang T, 2000, STEM CELLS, V35, P411; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Kado DM, 2000, J BONE MINER RES, V15, P1974, DOI 10.1359/jbmr.2000.15.10.1974; Lin TH, 2010, J CELL PHYSIOL, V222, P757, DOI 10.1002/jcp.22008; Liu AC, 2007, AM J PATHOL, V171, P1407, DOI 10.2353/ajpath.2007.070251; Meng XZ, 2008, AM J PHYSIOL-CELL PH, V294, pC29, DOI 10.1152/ajpcell.00137.2007; MESSIER RH, 1994, J SURG RES, V57, P1, DOI 10.1006/jsre.1994.1102; Mullican SE, 2013, J MOL ENDOCRINOL, V51, pT115, DOI 10.1530/JME-13-0212; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Rajalin AM, 2010, BIOCHEM BIOPH RES CO, V396, P477, DOI 10.1016/j.bbrc.2010.04.120; Rajamannan NM, 2011, CIRCULATION, V124, P1783, DOI 10.1161/CIRCULATIONAHA.110.006767; Ranhotra HS, 2018, J RECEPT SIG TRANSD, V38, P95, DOI 10.1080/10799893.2018.1456552; Rutkovskiy A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006339; Rutkovskiy A, 2016, MED SCI MONIT BASIC, V22, P95, DOI 10.12659/MSMBR.901142; Sallam T, 2019, CURR OPIN LIPIDOL, V30, P357, DOI 10.1097/MOL.0000000000000632; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shen J, 2018, CIRC RES, V122, P1395, DOI 10.1161/CIRCRESAHA.117.312418; Small A, 2017, ARTERIOSCL THROM VAS, V37, P623, DOI 10.1161/ATVBAHA.116.308615; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; TENHUNEN R, 1970, J LAB CLIN MED, V75, P410; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Wang LJ, 1998, AM J PATHOL, V152, P711; Wang T, 2015, MOL CELL BIOL, V35, P1281, DOI 10.1128/MCB.01156-14; Weiss RM, 2006, CIRCULATION, V114, P2065, DOI 10.1161/CIRCULATIONAHA.106.634139; Wiesel P, 2000, CIRCULATION, V102, P3015, DOI 10.1161/01.cir.102.24.3015; Wu BR, 2017, ANNU REV PHYSIOL, V79, P21, DOI 10.1146/annurev-physiol-022516-034001; Xia H, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00206; Yang F, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0579-9; Yutzey KE, 2014, ARTERIOSCL THROM VAS, V34, P2387, DOI 10.1161/ATVBAHA.114.302523; Zarjou A, 2009, J AM SOC NEPHROL, V20, P1254, DOI 10.1681/ASN.2008070788	52	3	3	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001588RR	http://dx.doi.org/10.1096/fj.202001588RR		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33184978				2022-12-26	WOS:000590889600001
J	Chen, CC; Lim, CY; Lee, PJ; Hsu, AL; Ching, TT				Chen, Chia-Chang; Lim, Chiao Yin; Lee, Pin-Jung; Hsu, Ao-Lin; Ching, Tsui-Ting			S-adenosyl methionine synthetase SAMS-5 mediates dietary restriction-induced longevity in Caenorhabditis elegans	PLOS ONE			English	Article							LIFE-SPAN; CALORIC RESTRICTION; ADENOSYLMETHIONINE; GENES; EXPRESSION; POLYAMINES; DISEASE	S-adenosyl methionine synthetase (SAMS) catalyzes the biosynthesis of S-adenosyl methionine (SAM), which serves as a universal methyl group donor for numerous biochemical reactions. Previous studies have clearly demonstrated that SAMS-1, a C. elegans homolog of mammalian SAMS, is critical for dietary restriction (DR)-induced longevity in Caenorhabditis elegans. In addition to SAMS-1, three other SAMS paralogs have been identified in C. elegans. However, their roles in longevity regulation have never been explored. Here, we show that depletion of sams-5, but not sams-3 or sams-4, can extend lifespan in worms. However, the phenotypes and expression pattern of sams-5 are distinct from sams-1, suggesting that these two SAMSs might regulate DR-induced longevity via different mechanisms. Through the genetic epistasis analysis, we have identified that sams-5 is required for DR-induced longevity in a pha-4/FOXA dependent manner.	[Chen, Chia-Chang; Lee, Pin-Jung; Ching, Tsui-Ting] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan; [Lim, Chiao Yin; Hsu, Ao-Lin] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan; [Lim, Chiao Yin] Natl Yang Ming Univ, Taiwan Int Grad Program Mol Med, Taipei, Taiwan; [Lim, Chiao Yin] Acad Sinica, Taipei, Taiwan; [Hsu, Ao-Lin] China Med Univ, Res Ctr Hlth Aging, Taichung, Taiwan; [Hsu, Ao-Lin] Univ Michigan, Dept Internal Med, Div Geriatr & Palliat Med, Ann Arbor, MI 48109 USA	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; China Medical University Taiwan; University of Michigan System; University of Michigan	Ching, TT (corresponding author), Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei, Taiwan.	ttching@ym.edu.tw	Hsu, Ao-Lin Allen/AAX-1856-2020	Ching, Tsui-Ting/0000-0001-7650-1766; Hsu, Ao-Lin/0000-0002-2864-3134	Minister of Science and Technology, Taiwan [NSC 103-2311-B-010-007, MOST 106-2311-B-010-005, MOST 108-2628B-010-002]; National Health Research Institute, Taiwan [NHRIEX103-1034NI]	Minister of Science and Technology, Taiwan; National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan)	The authors received funding from the Minister of Science and Technology, Taiwan with the grants NSC 103-2311-B-010-007 and MOST 106-2311-B-010-005 to T.C. and MOST 108-2628B-010-002 to A.H.. T.C. was also funded by National Health Research Institute, Taiwan (NHRIEX103-1034NI). Some strains were provided by the Caenorhabditis Genetics Center (CGC). Taiwan C. elegans Core Facility (CECF) provided technical support. The funders had no role in study design, data collection and analysis to publish, or preparation of the manuscript.	Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Chapman T, 1996, NATURE, V381, P189, DOI 10.1038/381189a0; Chiang PK, 1996, FASEB J, V10, P471, DOI 10.1096/fasebj.10.4.8647346; Ching TT, 2010, AGING CELL, V9, P545, DOI 10.1111/j.1474-9726.2010.00580.x; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; FINKELSTEIN JD, 1990, J NUTR BIOCHEM, V1, P228, DOI 10.1016/0955-2863(90)90070-2; Gil B, 1996, HEPATOLOGY, V24, P876; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Hsin H, 1999, NATURE, V399, P362, DOI 10.1038/20694; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Janne J, 2004, EUR J BIOCHEM, V271, P877, DOI 10.1111/j.1432-1033.2004.04009.x; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kotb M, 1997, TRENDS GENET, V13, P51, DOI 10.1016/S0168-9525(97)01013-5; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Li Y, 2011, J BIOCHEM, V149, P529, DOI 10.1093/jb/mvr025; Lu SC, 2012, PHYSIOL REV, V92, P1515, DOI 10.1152/physrev.00047.2011; Masoro EJ, 2000, EXP GERONTOL, V35, P299, DOI 10.1016/S0531-5565(00)00084-X; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Nakano S, 2010, DEVELOPMENT, V137, P4017, DOI 10.1242/dev.058834; ORENTREICH N, 1993, J NUTR, V123, P269; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; PEGG AE, 1986, BIOCHEM J, V234, P249, DOI 10.1042/bj2340249; Richie JP, 2004, NUTRITION, V20, P800, DOI 10.1016/j.nut.2004.05.009; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Tamiya H, 2013, J RECEPT SIG TRANSD, V33, P56, DOI 10.3109/10799893.2012.756896; WAINFAN E, 1989, CANCER RES, V49, P4094; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Zimmerman JA, 2003, EXP GERONTOL, V38, P47, DOI 10.1016/S0531-5565(02)00149-3	31	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241455	10.1371/journal.pone.0241455	http://dx.doi.org/10.1371/journal.pone.0241455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175851	gold, Green Published			2022-12-26	WOS:000593946900024
J	Hara, H; Maemura, S; Fujiwara, T; Takeda, N; Ishii, S; Yagi, H; Suzuki, T; Harada, M; Toko, H; Kanaya, T; Ijichi, H; Moses, HL; Takimoto, E; Morita, H; Akazawa, H; Komuro, I				Hara, Hironori; Maemura, Sonoko; Fujiwara, Takayuki; Takeda, Norifumi; Ishii, Satoshi; Yagi, Hiroki; Suzuki, Takaaki; Harada, Mutsuo; Toko, Haruhiro; Kanaya, Tsubasa; Ijichi, Hideaki; Moses, Harold L.; Takimoto, Eiki; Morita, Hiroyuki; Akazawa, Hiroshi; Komuro, Issei			Inhibition of transforming growth factor-beta signaling in myeloid cells ameliorates aortic aneurysmal formation in Marfan syndrome	PLOS ONE			English	Article							MOUSE MODEL; CONTRIBUTES; PROGRESSION	Increased transforming growth factor-beta (TGF-beta) signaling contributes to the pathophysiology of aortic aneurysm in Marfan syndrome (MFS). Recent reports indicate that a small but significant number of inflammatory cells are infiltrated into the aortic media and adventitia in MFS. However, little is known about the contribution of myeloid cells to aortic aneurysmal formation. In this study, we ablated the TGF-beta type II receptor gene Tgfbr2 in myeloid cells of Fbn1(C1039G/+) MFS mice (Fbn1(C1039G/+);LysM-Cre/+;Tgfbr2(fl/fl) mice, hereinafter called Fbn1(C1039G/+);Tgfbr2(MyeKO)) and evaluated macrophage infiltration and TGF-beta signaling in the aorta. Aneurysmal formation with fragmentation and disarray of medial elastic fibers observed in MFS mice was significantly ameliorated in Fbn1(C1039G/+);Tgfbr2(MyeKO) mice. In the aorta of Fbn1(C1039G/+);Tgfbr2(MyeKO) mice, both canonical and noncanonical TGF-beta signals were attenuated and the number of infiltrated F4/80-positive macrophages was significantly reduced. In vitro, TGF-beta enhanced the migration capacity of RAW264.7 macrophages. These findings suggest that TGF-beta signaling in myeloid cells promotes aortic aneurysmal formation and its inhibition might be a novel therapeutic target in MFS.	[Hara, Hironori; Maemura, Sonoko; Fujiwara, Takayuki; Takeda, Norifumi; Ishii, Satoshi; Yagi, Hiroki; Suzuki, Takaaki; Harada, Mutsuo; Toko, Haruhiro; Kanaya, Tsubasa; Takimoto, Eiki; Morita, Hiroyuki; Akazawa, Hiroshi; Komuro, Issei] Univ Tokyo Hosp, Dept Cardiovasc Med, Bunkyo Ku, Tokyo, Japan; [Toko, Haruhiro] Univ Tokyo Hosp, Dept Adv Translat Res & Med Management Pulm Hyper, Bunkyo Ku, Tokyo, Japan; [Ijichi, Hideaki] Univ Tokyo Hosp, Dept Gastroenterol, Bunkyo Ku, Tokyo, Japan; [Moses, Harold L.] Vanderbilt Univ, Vanderbilt Ingram Comprehens Canc Ctr, 221 Kirkland Hall, Nashville, TN 37235 USA	University of Tokyo; University of Tokyo; University of Tokyo; Vanderbilt University	Takeda, N (corresponding author), Univ Tokyo Hosp, Dept Cardiovasc Med, Bunkyo Ku, Tokyo, Japan.	notakeda-tky@umin.ac.jp	Yagi, Hiroki/GMX-4161-2022; IJICHI, Hideaki/AGZ-2874-2022; Takimoto, Eiki/AAC-5100-2021; Ijichi, Hideaki/AAE-6692-2022	Yagi, Hiroki/0000-0001-6615-6196; IJICHI, Hideaki/0000-0002-2379-7986; Ijichi, Hideaki/0000-0002-2379-7986; Akazawa, Hiroshi/0000-0002-3574-9607; Fujiwara, Takayuki/0000-0002-8719-3997	JSPS KAKENHI [19K08484]; Mochida Memorial Foundation for Medical and Pharmaceutical Research	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mochida Memorial Foundation for Medical and Pharmaceutical Research	This work was supported by JSPS KAKENHI Grant Number 19K08484 and Mochida Memorial Foundation for Medical and Pharmaceutical Research (NT). https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-19K08484/http://www.mochida.co.jp/zaidan/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Jeff Z, 2019, Circ Rep, V1, P199, DOI 10.1253/circrep.CR-18-0012; Chung SJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123563; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cook JR, 2015, ARTERIOSCL THROM VAS, V35, P911, DOI 10.1161/ATVBAHA.114.305150; Derrett-Smith EC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2986; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Emrich F, 2019, J CELL MOL MED, V23, P7000, DOI 10.1111/jcmm.14587; Fujiwara T, 2018, EUR J HUM GENET, V26, P1151, DOI 10.1038/s41431-018-0127-1; Gong DP, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-31; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hara H, 2018, JACC-BASIC TRANSL SC, V3, P639, DOI 10.1016/j.jacbts.2018.07.005; Hara H, 2017, HUM GENOME VAR, V4, DOI 10.1038/hgv.2017.10; He RM, 2008, J THORAC CARDIOV SUR, V136, P922, DOI 10.1016/j.jtcvs.2007.12.063; Hollander MC, 2017, CIRC RES, V121, P1360, DOI 10.1161/CIRCRESAHA.116.310349; Holm TM, 2011, SCIENCE, V332, P358, DOI 10.1126/science.1192149; Ju XX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000476; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; Li JY, 2013, CARCINOGENESIS, V34, P2099, DOI 10.1093/carcin/bgt172; Li JY, 2019, ARTERIOSCL THROM VAS, V39, P446, DOI 10.1161/ATVBAHA.118.312023; Li W, 2014, J CLIN INVEST, V124, P755, DOI 10.1172/JCI69942; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Munjal C, 2014, DIS MODEL MECH, V7, P987, DOI 10.1242/dmm.015255; Novitskiy SV, 2012, J LEUKOCYTE BIOL, V92, P641, DOI 10.1189/jlb.1211639; Pang YL, 2013, CANCER DISCOV, V3, P936, DOI 10.1158/2159-8290.CD-12-0527; Radonic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032963; Takahashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072558; Takeda N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072125; Takeda N, 2018, CIRC-GENOM PRECIS ME, V11, DOI 10.1161/CIRCGEN.117.002058; Takeda N, 2016, INT HEART J, V57, P271, DOI 10.1536/ihj.16-094; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Ueta M, 2019, MOL MED REP, V20, P4331, DOI 10.3892/mmr.2019.10662; Wang YY, 2016, THROMB RES, V140, P51, DOI 10.1016/j.thromres.2016.02.012; Zhang F, 2016, ONCOTARGET, V7, P52294, DOI 10.18632/oncotarget.10561	34	1	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0239908	10.1371/journal.pone.0239908	http://dx.doi.org/10.1371/journal.pone.0239908			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175881	Green Published, gold			2022-12-26	WOS:000593946900050
J	Khan, SMS; Qurieshi, MA; Haq, I; Majid, S; Bhat, AA; Nabi, S; Ganai, NA; Zahoor, N; Nisar, A; Chowdri, IN; Qazi, TB; Kousar, R; Lone, AA; Sabah, I; Nabi, S; Sumji, IA; Kawoosa, MF; Ayoub, S				Khan, S. Muhammad Salim; Qurieshi, Mariya Amin; Haq, Inaamul; Majid, Sabhiya; Bhat, Arif Akbar; Nabi, Sahila; Ganai, Nisar Ahmad; Zahoor, Nazia; Nisar, Auqfeen; Chowdri, Iqra Nisar; Qazi, Tanzeela Bashir; Kousar, Rafiya; Lone, Abdul Aziz; Sabah, Iram; Nabi, Shahroz; Sumji, Ishtiyaq Ahmad; Kawoosa, Misbah Ferooz; Ayoub, Shifana			Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross-sectional study	PLOS ONE			English	Article								Background Prevalence of IgG antibodies against SARS-CoV-2 infection provides essential information for deciding disease prevention and mitigation measures. We estimate the seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar. Methods 2906 persons >18 years of age selected from hospital visitors across District Srinagar participated in the study. We tested samples for the presence of SARS-CoV-2 specific IgG antibodies using a chemiluminescent microparticle immunoassay-based serologic test. Results Age- and gender-standardized seroprevalence was 3.6% (95% CI 2.9% to 4.3%). Age 30-69 years, a recent history of symptoms of an influenza-like-illness, and a history of being placed under quarantine were significantly related to higher odds of the presence of SARS-CoV-2 specific IgG antibodies. The estimated number of SARS-CoV-2 infections during the two weeks preceding the study, adjusted for test performance, was 32602 with an estimated (median) infection-to-known-case ratio of 46 (95% CI 36 to 57). Conclusions The seroprevalence of SARS-CoV-2 specific IgG antibodies is low in the District. A large proportion of the population is still susceptible to the infection. A sizeable number of infections remain undetected, and a substantial proportion of people with symptoms compatible with COVID-19 are not tested.	[Khan, S. Muhammad Salim; Qurieshi, Mariya Amin; Haq, Inaamul; Nabi, Sahila; Ganai, Nisar Ahmad; Zahoor, Nazia; Nisar, Auqfeen; Chowdri, Iqra Nisar; Qazi, Tanzeela Bashir; Kousar, Rafiya; Lone, Abdul Aziz; Sabah, Iram; Nabi, Shahroz; Sumji, Ishtiyaq Ahmad; Kawoosa, Misbah Ferooz; Ayoub, Shifana] Govt Med Coll Srinagar, Dept Community Med, Srinagar, India; [Majid, Sabhiya; Bhat, Arif Akbar] Govt Med Coll Srinagar, Dept Biochem, Srinagar, India		Haq, I (corresponding author), Govt Med Coll Srinagar, Dept Community Med, Srinagar, India.	haqinaam@yahoo.co.in	Majid, Sabhiya/AAG-6506-2021; Khan, S. Muhammad Salim/AAP-7668-2021; Haq, Inaamul/M-9181-2015	Khan, S. Muhammad Salim/0000-0002-1494-688X; Haq, Inaamul/0000-0001-8559-8010	District Disaster Management Authority, Srinagar	District Disaster Management Authority, Srinagar	This work was supported by primarily Institutional funding with support from the District Disaster Management Authority, Srinagar.; We are grateful to Prof. Samia Rashid, Principal, Government Medical College, Srinagar; Shahid Choudhary, District Commissioner, Srinagar; the Department of Biochemistry, Government Medical College, Srinagar; Directorate of Health Services, Kashmir; Chief Medical Officer, Srinagar; all Block Medical Officers and Zonal Medical Officers of District Srinagar; all healthcare workers, and interns involved in this study. We thank the study participants for understanding the importance of this study and giving their time and consent for participation.	Abbott Core Laboratory, SARS COV 2 IMM; [Anonymous], 2020, NOVEL CORONAVIRUS 20; [Anonymous], TRIBUNE INDIA; [Anonymous], 2020, CORONAVIRUS DIS 2019; [Anonymous], 2020, SER PREV STUD COND; [Anonymous], 2020, CORONAVIRUS DIS COVI; Bryan A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00941-20; Bundschuh C, 2020, CLIN CHIM ACTA, V509, P79, DOI 10.1016/j.cca.2020.05.047; Census of India Website, 2020, OFF REG GEN CENS COM; Fugitive Literacies Collective, 2020, ENGLISH ED, V52, pN3; Gao Z, 2020, J MICROBIOL IMMUNOL, DOI [10.1016/j.jmii.2020.05.001, DOI 10.1016/J.JMII.2020.05.00132425996]; Havers FP, 2020, JAMA INTERN MED, DOI [10.1001/jamainternmed.2020.4130, DOI 10.1001/JAMAINTERNMED.2020.413032692365]; Hou HY, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1136; Iwata K., 2020, ESTIMATION SEROPREVA, DOI [10.1101/2020.04.26.20079822, DOI 10.1101/2020.04.26.20079822]; Kontou PI, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10050319; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P17513, DOI 10.1073/pnas.2008373117; Nuccetelli M, 2020, CELL DEATH DISCOV, P6, DOI [10.1038/s41420-020-0240-0, DOI 10.1038/S41420-020-0240-032123582]; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Pawelec G, 2020, IMMUN AGEING, V17, DOI 10.1186/s12979-020-00180-2; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Sempos CT, 2020, AM J EPIDEMIOL, DOI [10.1093/aje/kwaa174, DOI 10.1093/AJE/KWAA17432803245]; Shakiba M., 2020, SEROPREVALENCE COVID, V27, P636, DOI [10.3201/eid2702.201960, 10.1101/2020.04.26.20079244]; Snoeck CJ, 2020, PREVALENCE SARS COV, DOI 10.1101/2020.05.11.20092916; Sood N, 2020, JAMA-J AM MED ASSOC, V323, P2425, DOI 10.1001/jama.2020.8279; Stringhini S, 2020, LANCET, V396, P313, DOI 10.1016/S0140-6736(20)31304-0; Xie JJ, 2020, J MED VIROL, V92, P2004, DOI 10.1002/jmv.25930; Zeng FF, 2020, J MED VIROL, V92, P2050, DOI 10.1002/jmv.25989	27	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0239303	10.1371/journal.pone.0239303	http://dx.doi.org/10.1371/journal.pone.0239303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175878	gold, Green Published, Green Submitted			2022-12-26	WOS:000593946900053
J	Agabu, A; Baughman, AL; Fischer-Walker, C; de Klerk, M; Mutenda, N; Rusberg, F; Diergaardt, D; Pentikainen, N; Sawadogo, S; Agolory, S; Dinh, TH				Agabu, Andrew; Baughman, Andrew L.; Fischer-Walker, Christa; de Klerk, Michael; Mutenda, Nicholus; Rusberg, Francina; Diergaardt, Dorothea; Pentikainen, Ndumbu; Sawadogo, Souleymane; Agolory, Simon; Thu-Ha Dinh			National-level effectiveness of ART to prevent early mother to child transmission of HIV in Namibia	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; POPULATION; DELIVERY	Background Namibia introduced the prevention of mother to child HIV transmission (MTCT) program in 2002 and lifelong antiretroviral therapy (ART) for pregnant women (option B-plus) in 2013. We sought to quantify MTCT measured at 4-12 weeks post-delivery. Methods During Aug 2014-Feb 2015, we recruited a nationally representative sample of 1040 pairs of mother and infant aged 4-12 weeks at routine immunizations in 60 public health clinics using two stage sampling approach. Of these, 864 HIV exposed infants had DNA-PCR HIV test results available. We defined an HIV exposed infant if born to an HIV-positive mother with documented status or diagnosed at enrollment using rapid HIV tests. Dried Blood Spots samples from HIV exposed infants were tested for HIV. Interview data and laboratory results were collected on smartphones and uploaded to a central database. We measured MTCT prevalence at 4-12 weeks post-delivery and evaluated associations between infant HIV infection and maternal and infant characteristics including maternal treatment and infant prophylaxis. All statistical analyses accounted for the survey design. Results Based on the 864 HIV exposed infants with test results available, nationally weighted early MTCT measured at 4-12 weeks post-delivery was 1.74% (95% confidence interval (CI): 1.00%-3.01%). Overall, 62% of mothers started ART pre-conception, 33.6% during pregnancy, 1.2% post-delivery and 3.2% never received ART. Mothers who started ART before pregnancy and during pregnancy had low MTCT prevalence, 0.78% (95% CI: 0.31%-1.96%) and 0.98% (95% CI: 0.33%-2.91%), respectively. MTCT rose to 4.13% (95% CI: 0.54%-25.68%) when the mother started ART after delivery and to 11.62% (95% CI: 4.07%-28.96%) when she never received ART. The lowest MTCT of 0.76% (95% CI: 0.36% - 1.61%) was achieved when mother received ART and ARV prophylaxis within 72hrs for infant and highest 22.32% (95%CI: 2.78% -74.25%) when neither mother nor infant received ARVs. After adjusting for mother's age, maternal ART (Prevalence Ratio (PR) = 0.10, 95% CI: 0.03-0.29) and infant ARV prophylaxis (PR = 0.32, 95% CI: 0.10-0.998) remained strong predictors of HIV transmission. Conclusion As of 2015, Namibia achieved MTCT of 1.74%, measured at 4-12 weeks post-delivery. Women already on ART pre-conception had the lowest prevalence of MTCT emphasizing the importance of early HIV diagnosis and treatment initiation before pregnancy. Studies are needed to measure MTCT and maternal HIV seroconversion during breastfeeding.	[Agabu, Andrew; Baughman, Andrew L.; Fischer-Walker, Christa; de Klerk, Michael; Sawadogo, Souleymane; Agolory, Simon] US Ctr Dis Control & Prevent, Windhoek, Namibia; [Mutenda, Nicholus; Rusberg, Francina; Diergaardt, Dorothea] Namibia Minist Hlth & Social Serv, Windhoek, Namibia; [Pentikainen, Ndumbu] Namibia Inst Pathol, Windhoek, Namibia; [Thu-Ha Dinh] US Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Agabu, A (corresponding author), US Ctr Dis Control & Prevent, Windhoek, Namibia.	andrewagabu@ymail.com	Agolory, Simon/AIF-4664-2022	Agolory, Simon/0000-0001-5023-5754	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [PS001468-05]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research has been supported in part by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of the cooperative agreement award #PS001468-05. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies.	Barr BAT, 2018, LANCET HIV, V5, pE688, DOI 10.1016/S2352-3018(18)30316-3; Bertolli J, 1996, J INFECT DIS, V174, P722, DOI 10.1093/infdis/174.4.722; Chasela CS, 2010, NEW ENGL J MED, V362, P2271, DOI 10.1056/NEJMoa0911486; Colvin M, 2007, B WORLD HEALTH ORGAN, V85, P466, DOI 10.2471/BLT.06.033639; Forbes JC, 2012, AIDS, V26, P757, DOI 10.1097/QAD.0b013e328350995c; Galli L, 2005, JAIDS-J ACQ IMM DEF, V40, P479, DOI 10.1097/01.qai.0000164247.49098.0e; Goga AE, 2015, J EPIDEMIOL COMMUN H, V69, P240, DOI 10.1136/jech-2014-204535; HIV/AIDS J.U.N.P.o, 2013, HIV REL EST PROJ NAM; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Lash, 2008, MODERN EPIDEMIOLOGY, P345; Ministry of Health and Social Service, 2017, NAT GUID PREV MOTH C, V3rd; Ministry of Health and Social Services, 2012, PREV MOTH CHILD TRAN, V2012; Ministry of Health and Social Services, 2016, NAT HIV SENT SURV RE; Ministry of Health and Social Services, 2013, NAT HIV SENT SURV; Ministry of Health and Social Services, 2013, NAT STRAT ACT PLAN E; Ministry of Health and Social Services, 2016, NAT GUID ANT THER; Namibia Ministry of Health and Social Services, 2016, SURV REP 2016 NAT HI; Namibia Statistics Agency, 2014, CENS POP PROJ 2011 2, P2013; Tchendjou P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010411; Dinh TH, 2018, CLIN INFECT DIS, V66, P576, DOI 10.1093/cid/cix820; Tovo PA, 1996, J ACQ IMMUN DEF SYND, V11, P88, DOI 10.1097/00042560-199601010-00012; UNAIDS, 2016, UNAIDS REP GLOB AIDS; World Health Organization, 2013, CONGUID UANT DRU	23	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0233341	10.1371/journal.pone.0233341	http://dx.doi.org/10.1371/journal.pone.0233341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170840	Green Published, gold			2022-12-26	WOS:000592383400020
J	Ingerslew, KS; Finke, DL				Ingerslew, Kathryn S.; Finke, Deborah L.			Non-consumptive effects stabilize herbivore control over multiple generations	PLOS ONE			English	Article							PARASITOID-HOST; PREDATION RISK; PEA APHID; FORAGING BEHAVIOR; TROPHIC CASCADES; LIFE-HISTORY; SCALING-UP; PREY; HYMENOPTERA; BIODIVERSITY	Understanding the factors that influence predator-prey dynamics requires an investigation of oscillations in predator and prey population sizes over time. However, empirical studies are often performed over one or fewer predator generations. This is particularly true for studies addressing the non-consumptive effects of predators on prey. In a previous study that lasted less than one predator generation, we demonstrated that two species of parasitoid wasps additively suppressed aphid populations through a combination of consumptive and non-consumptive effects. However, the non-consumptive effects of one wasp reduced the reproductive success of the other, suggesting that a longer-term experiment may have revealed antagonism between the wasps. The goal of our current study is to evaluate multi-generation consumptive and non-consumptive interactions between pea aphids (Acyrthosiphon pisum) and the wasps Aphidius ervi and Aphidius colemani. Aphidius ervi is a common natural enemy of pea aphids. Aphidius colemani is a non-consumptive enemy that does not consume pea aphids, but negatively affects pea aphid performance through behavioral disturbance. Large field cages were installed to monitor aphid abundance in response to the presence and absence of both species of wasp over four weeks (two parasitoid generations). We found that the non-consumptive enemy A. colemani initially controlled the pea aphid population, but control in the absence of parasitism was not sustainable over the long term. Aphidius ervi suppressed pea aphids through a combination of consumptive and non-consumptive effects. This suppression was more effective than that of A. colemani, but aphid abundance fluctuated over time. Suppression by A. ervi and A. colemani together was complementary, leading to the most effective and stable control of pea aphids. Therefore, promoting a diverse natural enemy community that contributes to pest control through consumptive and non-consumptive interactions may enhance the stability of herbivore population suppression over time.	[Ingerslew, Kathryn S.; Finke, Deborah L.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Finke, DL (corresponding author), Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA.	FinkeD@Missouri.edu		Finke, Deborah/0000-0001-8291-1964	Agriculture and Food Research Initiative of the United States Department of Agriculture National Institute of Food and Agriculture [200902083, 2016-67011-25100]; University of Missouri Research Board	Agriculture and Food Research Initiative of the United States Department of Agriculture National Institute of Food and Agriculture; University of Missouri Research Board	This project was supported by the Agriculture and Food Research Initiative of the United States Department of Agriculture National Institute of Food and Agriculture grants #200902083 and #2016-67011-25100 (https://nifa.usda.gov/program/agriculture-and-food-researchinitiative-afri, DLF and KSI) and the University of Missouri Research Board (https://research.missouri.edu/internal/board, DLF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, REG ANESTH PAIN MED; Beresford AL, 2010, FRESHWATER BIOL, V55, P514, DOI 10.1111/j.1365-2427.2009.02366.x; Bilodeau E, 2013, EVOL ECOL, V27, P165, DOI 10.1007/s10682-012-9577-z; BLACKMAN R.L., 1984, ORIENT INSECTS; Briggs CJ, 2004, THEOR POPUL BIOL, V65, P299, DOI 10.1016/j.tpb.2003.11.001; Buchanan AL, 2017, OIKOS, V126, P1233, DOI 10.1111/oik.04384; Du YJ, 1998, J CHEM ECOL, V24, P1355, DOI 10.1023/A:1021278816970; Fill A, 2012, ECOL ENTOMOL, V37, P43, DOI 10.1111/j.1365-2311.2011.01333.x; HASSELL MP, 1969, NATURE, V223, P1133, DOI 10.1038/2231133a0; HASSELL MP, 1973, J ANIM ECOL, V42, P693, DOI 10.2307/3133; Hawlena D, 2011, FUNCT ECOL, V25, P279, DOI 10.1111/j.1365-2435.2010.01767.x; Hermann SL, 2017, CURR OPIN INSECT SCI, V20, P54, DOI 10.1016/j.cois.2017.03.010; Huston MA, 1999, ECOLOGY, V80, P1088, DOI 10.2307/177044; Ingerslew KS, 2017, ENVIRON ENTOMOL, V46, P75, DOI 10.1093/ee/nvw151; Ingerslew KS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197230; Jensen K, 2020, ECOL ENTOMOL, V45, P901, DOI 10.1111/een.12860; Jones EI, 2011, BEHAV ECOL SOCIOBIOL, V65, P1505, DOI 10.1007/s00265-011-1160-z; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; MACKAUER M, 1993, OECOLOGIA, V94, P339, DOI 10.1007/BF00317107; Mackauer M., 1971, BIOL CONTROL PROGRAM, V4, P3; Malone MA, 2020, OIKOS, V129, P787, DOI 10.1111/oik.06948; Mondor EB, 2000, ENTOMOL EXP APPL, V97, P75, DOI 10.1023/A:1004065423227; MURDOCH WW, 1987, AM NAT, V129, P263, DOI 10.1086/284634; Nelson EH, 2004, ECOLOGY, V85, P1853, DOI 10.1890/03-3109; Nelson EH, 2007, OECOLOGIA, V151, P22, DOI 10.1007/s00442-006-0573-2; Nicholson AJ, 1935, P ZOOLOGICAL SOC LON; Peacor SD, 2013, OECOLOGIA, V171, P1, DOI 10.1007/s00442-012-2394-9; Peacor SD, 2012, P ROY SOC B-BIOL SCI, V279, P122, DOI 10.1098/rspb.2011.0606; Peckarsky BL, 2008, ECOLOGY, V89, P2416, DOI 10.1890/07-1131.1; Peckarsky BL, 2002, ECOLOGY, V83, P612, DOI 10.2307/3071867; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; Rypstra AL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0948; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Schmitz OJ, 2005, OECOLOGIA, V145, P225, DOI 10.1007/s00442-005-0063-y; Schmitz OJ, 2004, ECOL LETT, V7, P153, DOI 10.1111/j.1461-0248.2003.00560.x; Schworer U, 2001, BIOL CONTROL, V21, P111, DOI 10.1006/bcon.2001.0931; Seiter M, 2015, SCI REP-UK, V5, DOI 10.1038/srep15046; SEQUEIRA R, 1992, ECOLOGY, V73, P183, DOI 10.2307/1938730; Sheriff MJ, 2014, OECOLOGIA, V176, P607, DOI 10.1007/s00442-014-3105-5; Sheriff MJ, 2011, OECOLOGIA, V166, P593, DOI 10.1007/s00442-011-1907-2; Snyder WE, 2003, ECOLOGY, V84, P91, DOI 10.1890/0012-9658(2003)084[0091:IBSAGN]2.0.CO;2; Snyder WE, 2006, ECOL LETT, V9, P789, DOI 10.1111/j.1461-0248.2006.00922.x; STARY P, 1975, ACTA ENTOMOL BOHEMOS, V72, P156; Thaler JS, 2008, ENTOMOL EXP APPL, V128, P34, DOI 10.1111/j.1570-7458.2008.00737.x; Tigreros N, 2019, ECOL ENTOMOL, V44, P738, DOI 10.1111/een.12752; Tylianakis JM, 2006, ECOLOGY, V87, P3047, DOI 10.1890/0012-9658(2006)87[3047:DEFASO]2.0.CO;2; van Veen FJF, 2005, ECOLOGY, V86, P3182, DOI 10.1890/04-1590; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Xiong XF, 2015, BIOCONTROL, V60, P827, DOI 10.1007/s10526-015-9689-9; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zamani AA, 2007, ENVIRON ENTOMOL, V36, P263, DOI 10.1603/0046-225X-36.2.263	52	8	8	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241870	10.1371/journal.pone.0241870	http://dx.doi.org/10.1371/journal.pone.0241870			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170896	gold, Green Published			2022-12-26	WOS:000592383400061
J	Laamarti, M; Alouane, T; Kartti, S; Chemao-Elfihri, MW; Hakmi, M; Essabbar, A; Laamarti, M; Hlali, H; Bendani, H; Boumajdi, N; Benhrif, O; Allam, L; El Hafidi, N; El Jaoudi, R; Allali, I; Marchoudi, N; Fekkak, J; Benrahma, H; Nejjari, C; Amzazi, S; Belyamani, L; Ibrahimi, A				Laamarti, Meriem; Alouane, Tarek; Kartti, Souad; Chemao-Elfihri, M. W.; Hakmi, Mohammed; Essabbar, Abdelomunim; Laamarti, Mohamed; Hlali, Haitam; Bendani, Houda; Boumajdi, Nassma; Benhrif, Oussama; Allam, Loubna; El Hafidi, Naima; El Jaoudi, Rachid; Allali, Imane; Marchoudi, Nabila; Fekkak, Jamal; Benrahma, Houda; Nejjari, Chakib; Amzazi, Saaid; Belyamani, Lahcen; Ibrahimi, Azeddine			Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations	PLOS ONE			English	Article							AMINO-ACID SITES; CORONAVIRUS; IDENTIFICATION	In late December 2019, an emerging viral infection COVID-19 was identified in Wuhan, China, and became a global pandemic. Characterization of the genetic variants of SARS-CoV-2 is crucial in following and evaluating it spread across countries. In this study, we collected and analyzed 3,067 SARS-CoV-2 genomes isolated from 55 countries during the first three months after the onset of this virus. Using comparative genomics analysis, we traced the profiles of the whole-genome mutations and compared the frequency of each mutation in the studied population. The accumulation of mutations during the epidemic period with their geographic locations was also monitored. The results showed 782 variants sites, of which 512 (65.47%) had a non-synonymous effect. Frequencies of mutated alleles revealed the presence of 68 recurrent mutations, including ten hotspot non-synonymous mutations with a prevalence higher than 0.10 in this population and distributed in six SARS-CoV-2 genes. The distribution of these recurrent mutations on the world map revealed that certain genotypes are specific to geographic locations. We also identified co-occurring mutations resulting in the presence of several haplotypes. Moreover, evolution over time has shown a mechanism of mutation co-accumulation which might affect the severity and spread of the SARS-CoV-2. The phylogentic analysis identified two major Clades C1 and C2 harboring mutations L3606F and G614D, respectively and both emerging for the first time in China. On the other hand, analysis of the selective pressure revealed the presence of negatively selected residues that could be taken into considerations as therapeutic targets. We have also created an inclusive unified database () that lists all of the genetic variants of the SARS-CoV-2 genomes found in this study with phylogeographic analysis around the world.	[Laamarti, Meriem; Alouane, Tarek; Kartti, Souad; Chemao-Elfihri, M. W.; Hakmi, Mohammed; Essabbar, Abdelomunim; Laamarti, Mohamed; Hlali, Haitam; Bendani, Houda; Boumajdi, Nassma; Benhrif, Oussama; Allam, Loubna; El Hafidi, Naima; El Jaoudi, Rachid; Ibrahimi, Azeddine] Mohammed Vth Univ, Bioinova Res Ctr, Rabat Med & Pharm Sch, Med Biotechnol Lab MedBiotech, Rabat, Morocco; [Allali, Imane; Amzazi, Saaid] Mohammed V Univ, Fac Sci, Dept Biol, Lab Human Pathol Biol, Rabat, Morocco; [Allali, Imane; Amzazi, Saaid] Mohammed V Univ, Fac Med & Pharm, Genom Ctr Human Pathol, Rabat, Morocco; [Marchoudi, Nabila; Fekkak, Jamal] Anoual Lab Radioimmuno Anal, Casablanca, Morocco; [Benrahma, Houda] Mohammed VI Univ Hlth Sci UM6SS, Fac Med, Casablanca, Morocco; [Nejjari, Chakib] Mohammed VI Univ Hlth Sci UM6SS, Int Sch Publ Hlth, Casablanca, Morocco; [Belyamani, Lahcen] Mohammed Vth Univ, Mil Hosp Mohammed, Rabat Med & Pharm Sch, Emergency Dept, Rabat, Morocco	Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed V University in Rabat; Mohammed First University of Oujda; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; Mohammed First University of Oujda; Mohammed VI University of Health Sciences (UM6SS); Mohammed VI University of Health Sciences (UM6SS); Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat	Ibrahimi, A (corresponding author), Mohammed Vth Univ, Bioinova Res Ctr, Rabat Med & Pharm Sch, Med Biotechnol Lab MedBiotech, Rabat, Morocco.	a.ibrahimi@um5s.net.ma	Essabbar, Abdelmounim/AAT-7354-2021; ESSABBAR, Abdelmounim/AFO-6147-2022; Hakmi, Mohammed/AAR-8576-2021	Hakmi, Mohammed/0000-0002-1548-3792; KARTTI, SOUAD/0000-0003-4350-9926; Benrahma, Houda/0000-0002-7523-2581; BENDANI, HOUDA/0000-0002-8955-3327; Ibrahimi, Azeddine/0000-0003-3226-3836; CHEMAO-ELFIHRI, Mohammed Walid/0000-0002-8624-5839	Moroccan Ministry of Higher Education and Scientific Research; Moroccan Cancer Research Institute of the Lalla Salma foundation	Moroccan Ministry of Higher Education and Scientific Research; Moroccan Cancer Research Institute of the Lalla Salma foundation	This work was carried out under a National Funding from the Moroccan Ministry of Higher Education and Scientific Research for Covid Research and for the PPR-1 program to AI. This work was also supported by a grant to AI from the Moroccan Cancer Research Institute of the Lalla Salma foundation. EnsSup-covid-07, IRC, PPR119, IRC-509, Azeddine Ibrahimi.	Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Angeletti S, 2020, J MED VIROL, V92, P584, DOI 10.1002/jmv.25719; Angelini MM, 2013, MBIO, V4, DOI 10.1128/mBio.00524-13; [Anonymous], 2020, LANCET MICROBE, V1, pe99, DOI [10.1016/S2666-5247(20)30054-9, DOI 10.1016/S2666-5247(20)30054-9]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Denison MR, 2011, RNA BIOL, V8, P270, DOI 10.4161/rna.8.2.15013; Fauquet C.M., 2000, VIRUS TAXONOMY CLASS, P835; Fehr AR, 2016, MBIO, V7, DOI 10.1128/mBio.01721-16; Hagemeijer MC, 2014, VIROLOGY, V458, P125, DOI 10.1016/j.virol.2014.04.027; Harcourt BH, 2004, J VIROL, V78, P13600, DOI 10.1128/JVI.78.24.13600-13612.2004; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Khailany RA, 2020, GENE REP, V19, DOI 10.1016/j.genrep.2020.100682; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kusov Y, 2015, VIROLOGY, V484, P313, DOI 10.1016/j.virol.2015.06.016; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757; Mazumder R, 2007, VIRUS GENES, V35, P175, DOI 10.1007/s11262-007-0103-2; Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Neuman BW, 2016, ANTIVIR RES, V135, P97, DOI 10.1016/j.antiviral.2016.10.005; Ou J., 2020, RBD MUTATIONS CIRCUL, DOI [10.1101/2020.03.15.991844, DOI 10.1101/2020.03.15.991844]; Pachetti M, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02344-6; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Stern A, 2017, CELL, V169, P35, DOI 10.1016/j.cell.2017.03.013; Su YCF, 2020, DISCOVERY 382 NT DEL; Subissi L, 2014, ANTIVIR RES, V101, P122, DOI 10.1016/j.antiviral.2013.11.006; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, 2020, CHINA CDC WEEKLY, V2, P1, DOI DOI 10.5194/GCHRON-2-1-2020; Wen F, 2020, J INFECTION, V80, P679, DOI 10.1016/j.jinf.2020.02.027; World Health Organization (WHO), 2020, 102 WHO; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762	39	45	45	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0240345	10.1371/journal.pone.0240345	http://dx.doi.org/10.1371/journal.pone.0240345			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170902	Green Published, gold, Green Submitted			2022-12-26	WOS:000592383400055
J	Gani, LU; Saripalli, KR; Fernandes, K; Leong, SF; Tsai, KT; Tan, PT; Chong, LR; King, TFJ				Gani, Linsey U.; Saripalli, Kundan R.; Fernandes, Karen; Leong, Suet F.; Tsai, Koh T.; Tan, Pei T.; Chong, Le R.; King, Thomas F. J.			Bone mineral density and trabecular bone score in elderly type 2 diabetes Southeast Asian patients with severe osteoporotic hip fractures	PLOS ONE			English	Article							RISK PREDICTION; WOMEN; TBS; MEN; MELLITUS; OLDER; BMD; METAANALYSIS; NEPHROPATHY; ASSOCIATION	Introduction Studies show trabecular bone score (TBS) may provide information regarding bone quality independent of bone mineral density (BMD) in type 2 diabetes (DM2) patients. We analyzed our Southeast Asian severe osteoporotic hip fracture patients to study these differences. Methods We conducted a retrospective cross-sectional analysis of subjects admitted to Changi General Hospital, Singapore with severe osteoporotic hip fractures from 2014-2017 who had BMD performed. Electronic records were reviewed and subjects were classified as having diabetes according to the WHO 2019 criteria. DM2 patients were classified according to their HbA1c into well controlled (HbA1c < 7%) and poorly controlled (HbA1c. 7%) DM2. Results Elderly patients with hip fractures present with average femur neck T scores at the osteoporotic range, however those with DM2 had higher BMD and TBS values compared to non DM2 patients. These differences were statistically significant in elderly women-poorly controlled elderly DM2 women with hip fracture had the highest total hip T-score (-2.57 +/- 0.86) vs (-2.76 +/- 0.96) in well controlled DM2 and (-3.09 +/- 1.01) in non DM2 women with hip fracture, p < 0.001. In contrast, TBS scores were lower in poorly controlled DM2 women with hip fracture compared to well controlled DM2 women with hip fracture (1.22 +/- 0.11) vs (1.24 +/- 0.09), but these were still significantly higher compared to non DM2 women with hip fracture (1.19 +/- 0.10), p < 0.001. In elderly men with hip fractures, univariate analysis showed no statistically significant differences in TBS or hip or LS BMD between those with poorly controlled DM2, well controlled DM2 and non DM2. The differences in TBS and BMD remained significant in all DM2 women with hip fractures even after adjustments for potential confounders. Differences in TBS and BMD in poorly controlled DM2 men with hip fractures only became significant after accounting for potential confounders. However, upon inclusion of LS BMD into the multivariate model these differences were attenuated and remained significant only between elderly women with well controlled DM2 and non DM2 women with hip fractures. Conclusions Elderly patients with DM2 and severe osteoporosis present with hip fractures at a higher BMD and TBS values compared to non DM2 patients. These differences were significant after adjustment for confounders in all DM2 women and poorly controlled DM2 men with hip fractures, TBS differences were attenuated with the inclusion LS BMD. Further studies are needed to ascertain differences in BMD and TBS in older Southeast Asian DM2 patients with variable glycemic control and severe osteoporosis.	[Gani, Linsey U.; Saripalli, Kundan R.; King, Thomas F. J.] Changi Gen Hosp, Dept Endocrinol, Singapore, Singapore; [Fernandes, Karen; Leong, Suet F.; Tsai, Koh T.; Chong, Le R.] Changi Gen Hosp, Dept Radiol, Singapore, Singapore; [Tan, Pei T.] Changi Gen Hosp, Clin Trials & Res Unit, Singapore, Singapore	Changi General Hospital; Changi General Hospital; Changi General Hospital	Gani, LU (corresponding author), Changi Gen Hosp, Dept Endocrinol, Singapore, Singapore.	Linsey.u.gani@singhealth.com.sg	Fernandes, Karen/AHA-8650-2022; King, Thomas/F-8482-2015	King, Thomas/0000-0002-0383-3433				Bonds DE, 2006, J CLIN ENDOCR METAB, V91, P3404, DOI 10.1210/jc.2006-0614; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Compston J, 2018, J INTERN MED, V283, P140, DOI 10.1111/joim.12725; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; de Liefde II, 2005, OSTEOPOROSIS INT, V16, P1713, DOI 10.1007/s00198-005-1909-1; de Waard EAC, 2016, OSTEOPOROSIS INT, V27, P3207, DOI 10.1007/s00198-016-3645-0; Dufour R, 2013, OSTEOPOROSIS INT, V24, P2837, DOI 10.1007/s00198-013-2384-8; Evans AL, 2015, J BONE MINER RES, V30, P920, DOI 10.1002/jbmr.2407; Hanley DA, 2003, J BONE MINER RES, V18, P784, DOI 10.1359/jbmr.2003.18.4.784; Harvey NC, 2015, BONE, V78, P216, DOI 10.1016/j.bone.2015.05.016; Ho-Pham LT, 2019, DIABETES RES CLIN PR, V155, DOI 10.1016/j.diabres.2019.107790; Iki M, 2017, BONE, V105, P18, DOI 10.1016/j.bone.2017.08.007; Jain RK, 2017, J CLIN DENSITOM, V20, P172, DOI 10.1016/j.jocd.2016.04.003; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Janghorbani M, 2006, DIABETES CARE, V29, P1573, DOI 10.2337/dc06-0440; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Kim JH, 2015, J CLIN ENDOCR METAB, V100, P475, DOI 10.1210/jc.2014-2047; Kim SM, 2012, BONE, V50, P1343, DOI 10.1016/j.bone.2012.02.633; KRAKAUER JC, 1995, DIABETES, V44, P775, DOI 10.2337/diabetes.44.7.775; Langsetmo L, 2016, J BONE MINER RES, V31, P1820, DOI 10.1002/jbmr.2867; Lee MK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11906-6; Lee WJ, 2014, INVEST OPHTH VIS SCI, V55, P6547, DOI 10.1167/iovs.14-15001; Leslie WD, 2013, J CLIN DENSITOM, V16, P374, DOI 10.1016/j.jocd.2013.01.006; Leslie WD, 2013, J CLIN ENDOCR METAB, V98, P602, DOI 10.1210/jc.2012-3118; Looker AC, 2016, BONE, V82, P9, DOI 10.1016/j.bone.2014.12.008; Martineau P, 2018, BONE, V113, P161, DOI 10.1016/j.bone.2018.05.026; McCloskey EV, 2016, J BONE MINER RES, V31, P940, DOI 10.1002/jbmr.2734; Melton LJ, 2008, J CLIN ENDOCR METAB, V93, P4804, DOI 10.1210/jc.2008-0639; Phan TP, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2013-000012; Rianon N, 2018, J CLIN DENSITOM, V21, P355, DOI 10.1016/j.jocd.2018.02.004; Ruppert K, 2018, OSTEOPOROSIS INT, V29, P347, DOI 10.1007/s00198-017-4276-9; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schacter GI, 2017, OSTEOPOROSIS INT, V28, P3199, DOI 10.1007/s00198-017-4166-1; Silva BC, 2015, J CLIN DENSITOM, V18, P309, DOI 10.1016/j.jocd.2015.06.008; Sritara C, 2016, J CLIN DENSITOM, V19, P494, DOI 10.1016/j.jocd.2015.05.068; Starup-Linde J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009686; Tatangelo G, 2019, J BONE MINER RES, V34, P616, DOI 10.1002/jbmr.3640; Thrailkill KM, 2005, AM J PHYSIOL-ENDOC M, V289, pE735, DOI 10.1152/ajpendo.00159.2005; World Health Organization, 2019, CLASS DIAB MELL 2019	40	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0241616	10.1371/journal.pone.0241616	http://dx.doi.org/10.1371/journal.pone.0241616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211723	gold, Green Published			2022-12-26	WOS:000603518300020
J	Russo, TA; Banuth, AMM; Nader, HB; Dreyfuss, JL				Russo, T. A.; Banuth, A. M. M.; Nader, H. B.; Dreyfuss, J. L.			Altered shear stress on endothelial cells leads to remodeling of extracellular matrix and induction of angiogenesis	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; TISSUE FACTOR; RESPONSES; FIBRONECTIN; ATHEROSCLEROSIS; EXPRESSION; SECRETION; MIGRATION; GROWTH; ROLES	Endothelial cells (ECs) are subjected to physical forces such as shear stress (SS) induced by blood flow that leads to significant changes in morphology, physiology and gene expression. The abnormal mechanical forces applied in the cardiovascular system can influence the development of conditions and diseases such as thrombosis, hypertension and atherosclerosis. This study investigated the expression of glycosaminoglycans (GAGs), proteoglycans and extracellular matrix molecules in ECs exposed to normal and altered SS. ECs were exposed to SS of 12 dyn/cm(2) (artery physiological condition) and 4 dyn/cm(2) (artery pathological condition). Subsequently, ECs were subjected to immunofluorescence, qPCR, GAG biosynthesis analyses and cell-based assays. SS induced changes in ECs morphology. There were other pathological consequences of altered SS, including inhibited adhesion, stimulation of migration and capillary-like tube formation, as well as increases of GAG synthesis. We observed higher expression of syndecan-4, perlecan, decorin, fibronectin and collagen III alpha 1 and growth factors, including VEGF-A and TGF beta-1. ECs exposed to SS displayed extracellular matrix remodeling as well as expression of cell-matrix and cell-cell interaction molecules. This study contributes to the understanding of how vascular biology is affected by mechanical forces and how these molecules can be affected in cardiovascular diseases.	[Russo, T. A.; Banuth, A. M. M.; Nader, H. B.; Dreyfuss, J. L.] Univ Fed Sao Paulo, Escola Paulista Med, Carl Peter von Dietrich Lab, Mol Biol Div,Dept Biochem, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP)	Dreyfuss, JL (corresponding author), Univ Fed Sao Paulo, Escola Paulista Med, Carl Peter von Dietrich Lab, Mol Biol Div,Dept Biochem, Sao Paulo, Brazil.	jdreyfuss@unifesp.br	Nader, Helena Bonciani/D-9253-2012	Amaral Russo, Thatiane/0000-0002-9446-6930; NADER, HELENA/0000-0002-7569-2166	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/10156-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	HBN and JLDR - Grant number: 2014/10156-0. - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). - http://www.fapesp.br/-The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; BUONASSISI V, 1983, BIOCHIM BIOPHYS ACTA, V760, P1, DOI 10.1016/0304-4165(83)90118-6; BUONASSISI V, 1973, EXP CELL RES, V76, P363, DOI 10.1016/0014-4827(73)90388-1; BUONASSISI V, 1976, P NATL ACAD SCI USA, V73, P1612, DOI 10.1073/pnas.73.5.1612; Carneiro BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116001; Cavalheiro RP, 2017, MATRIX BIOL, V63, P23, DOI 10.1016/j.matbio.2016.12.006; Chang AH, 2017, GENE DEV, V31, P1308, DOI 10.1101/gad.301549.117; Chiu JJ, 2009, ANN MED, V41, P19, DOI 10.1080/07853890802186921; COLBURN P, 1987, BIOCHEM BIOPH RES CO, V147, P920, DOI 10.1016/S0006-291X(87)80158-4; COLBURN P, 1991, J CELL PHYSIOL, V148, P320, DOI 10.1002/jcp.1041480219; COLBURN P, 1988, IN VITRO CELL DEV B, V24, P1133; COLBURN P, 1978, SCIENCE, V201, P817, DOI 10.1126/science.684408; COLBURN P, 1982, BIOCHEM BIOPH RES CO, V104, P220, DOI 10.1016/0006-291X(82)91962-3; Cullen JP, 2002, ARTERIOSCL THROM VAS, V22, P1610, DOI 10.1161/01.ATV.0000034470.37007.58; Cunningham KS, 2005, LAB INVEST, V85, P9, DOI 10.1038/labinvest.3700215; Mesquita APD, 2017, APOPTOSIS, V22, P1116, DOI 10.1007/s10495-017-1392-0; DIETRICH CP, 1974, BIOCHIM BIOPHYS ACTA, V343, P34, DOI 10.1016/0304-4165(74)90237-2; DIETRICH CP, 1976, ANAL BIOCHEM, V70, P645, DOI 10.1016/0003-2697(76)90496-6; Ding SF, 2010, AM J PHYSIOL-HEART C, V298, pH2121, DOI 10.1152/ajpheart.00308.2009; Dreyfuss JL, 2010, J THROMB HAEMOST, V8, P1828, DOI 10.1111/j.1538-7836.2010.03916.x; Estrada R, 2011, IEEE ENG MED BIO, P186, DOI 10.1109/IEMBS.2011.6089925; Farnoodian M, 2018, J OPHTHAL VIS RES, V13, P470, DOI 10.4103/jovr.jovr_67_18; Feaver RE, 2010, CIRC RES, V106, P1703, DOI 10.1161/CIRCRESAHA.109.216283; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V281, pL529, DOI 10.1152/ajplung.2001.281.3.L529; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Iozzo RV, 2009, MOL CELLS, V27, P503, DOI 10.1007/s10059-009-0069-0; JAQUES LB, 1968, CAN J PHYSIOL PHARM, V46, P351, DOI 10.1139/y68-055; KAMIYA A, 1984, B MATH BIOL, V46, P127, DOI 10.1016/S0092-8240(84)80038-5; Katsumi A, 2005, J BIOL CHEM, V280, P16546, DOI 10.1074/jbc.C400455200; Kim M, 2012, J BIOL CHEM, V287, P40722, DOI 10.1074/jbc.M112.381509; Kojima T, 2001, THROMB HAEMOSTASIS, V85, P793; Koo A, 2013, AM J PHYSIOL-CELL PH, V304, pC137, DOI 10.1152/ajpcell.00187.2012; Kwak BR, 2002, ARTERIOSCL THROM VAS, V22, P225, DOI 10.1161/hq0102.104125; LAHAV J, 1981, J SUPRAMOL STR CELL, V17, P299, DOI 10.1002/jsscb.380170402; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahmoud MM, 2016, CIRC RES, V119, P450, DOI 10.1161/CIRCRESAHA.116.308870; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Moon JJ, 2005, J CELL PHYSIOL, V203, P166, DOI 10.1002/jcp.20220; NADER HB, 1987, P NATL ACAD SCI USA, V84, P3565, DOI 10.1073/pnas.84.11.3565; NADER HB, 1991, SEMIN THROMB HEMOST, V17, P47; Neill T, 2012, AM J PATHOL, V181, P380, DOI 10.1016/j.ajpath.2012.04.029; Prado CM, 2008, OPEN CARDIOVASC MED, V2, P41, DOI 10.2174/1874192400802010041; Rocha HAO, 2005, J BIOL CHEM, V280, P41278, DOI 10.1074/jbc.M501124200; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; Russo TA, 2018, LIFE SCI, V213, P214, DOI 10.1016/j.lfs.2018.10.030; Sato Y, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0012674, 10.1371/journal.pone.0015119, 10.1371/journal.pone.0013109]; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shyu KG, 2009, CLIN SCI, V116, P377, DOI 10.1042/CS20080163; Tran-Lundmark K, 2008, CIRC RES, V103, P43, DOI 10.1161/CIRCRESAHA.108.172833; Veiga SS, 2001, THROMB RES, V102, P229, DOI 10.1016/S0049-3848(01)00254-7; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Wentzel JJ, 2012, CARDIOVASC RES, V96, P234, DOI 10.1093/cvr/cvs217; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Yousif LF, 2013, CELL ADHES MIGR, V7, P101, DOI 10.4161/cam.22680	55	15	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0241040	10.1371/journal.pone.0241040	http://dx.doi.org/10.1371/journal.pone.0241040			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211705	Green Published, gold			2022-12-26	WOS:000603518300013
J	Sacco, V; Rauch, B; Gar, C; Haschka, S; Potzel, AL; Kern-Matschilles, S; Banning, F; Benz, I; Meisel, M; Seissler, J; Lechner, A				Sacco, Vanessa; Rauch, Barbara; Gar, Christina; Haschka, Stefanie; Potzel, Anne L.; Kern-Matschilles, Stefanie; Banning, Friederike; Benz, Irina; Meisel, Mandy; Seissler, Jochen; Lechner, Andreas			Overweight/obesity as the potentially most important lifestyle factor associated with signs of pneumonia in COVID-19	PLOS ONE			English	Article								Objective The occurrence of pneumonia separates severe cases of COVID-19 from the majority of cases with mild disease. However, the factors determining whether or not pneumonia develops remain to be fully uncovered. We therefore explored the associations of several lifestyle factors with signs of pneumonia in COVID-19. Methods Between May and July 2020, we conducted an online survey of 201 adults in Germany who had recently gone through COVID-19, predominantly as outpatients. Of these, 165 had a PCR-based diagnosis and 36 had a retrospective diagnosis by antibody testing. The survey covered demographic information, eight lifestyle factors, comorbidities and medication use. We defined the main outcome as the presence vs. the absence of signs of pneumonia, represented by dyspnea, the requirement for oxygen therapy or intubation. Results Signs of pneumonia occurred in 39 of the 165 individuals with a PCR-based diagnosis of COVID-19 (23.6%). Among the lifestyle factors examined, only overweight/obesity was associated with signs of pneumonia (odds ratio 2.68 (1.29-5.59) p = 0.008). The observed association remained significant after multivariate adjustment, with BMI as a metric variable, and also after including the antibody-positive individuals into the analysis. Conclusions This exploratory study finds an association of overweight/obesity with signs of pneumonia in COVID-19. This finding suggests that a signal proportional to body fat mass, such as the hormone leptin, impairs the body's ability to clear SARS-CoV-2 before pneumonia develops. This hypothesis concurs with previous work and should be investigated further to possibly reduce the proportion of severe cases of COVID-19.	[Sacco, Vanessa; Rauch, Barbara; Gar, Christina; Haschka, Stefanie; Potzel, Anne L.; Kern-Matschilles, Stefanie; Banning, Friederike; Benz, Irina; Meisel, Mandy; Seissler, Jochen; Lechner, Andreas] LMU Klinikum, Med Klin & Poliklin 4, Diabet Res Grp, Munich, Germany; [Sacco, Vanessa; Rauch, Barbara; Gar, Christina; Haschka, Stefanie; Potzel, Anne L.; Kern-Matschilles, Stefanie; Banning, Friederike; Benz, Irina; Meisel, Mandy; Seissler, Jochen; Lechner, Andreas] Helmholtz Zentrum Munchen, Clin Cooperat Grp Type 2 Diabet, Neuherberg, Germany; [Sacco, Vanessa; Rauch, Barbara; Gar, Christina; Haschka, Stefanie; Potzel, Anne L.; Kern-Matschilles, Stefanie; Banning, Friederike; Benz, Irina; Meisel, Mandy; Seissler, Jochen; Lechner, Andreas] German Ctr Diabet Res DZD, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Sacco, V; Seissler, J; Lechner, A (corresponding author), LMU Klinikum, Med Klin & Poliklin 4, Diabet Res Grp, Munich, Germany.; Sacco, V; Seissler, J; Lechner, A (corresponding author), Helmholtz Zentrum Munchen, Clin Cooperat Grp Type 2 Diabet, Neuherberg, Germany.; Sacco, V; Seissler, J; Lechner, A (corresponding author), German Ctr Diabet Res DZD, Neuherberg, Germany.	vanessa.sacco@med.uni-muenchen.de; jochen.seissler@med.uni-muenchen.de; andreas.lechner@med.uni-muenchen.de		Haschka, Stefanie Julia/0000-0002-1347-5553; Gar, Christina/0000-0002-4218-6945	LMU Klinikum; Helmholtz Zentrum Munchen; German Center for Diabetes Research	LMU Klinikum; Helmholtz Zentrum Munchen(Helmholtz Association); German Center for Diabetes Research	This work was funded by LMU Klinikum, Helmholtz Zentrum Munchen, and the German Center for Diabetes Research (all to AL). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Davison G, 2016, AM J LIFESTYLE MED, V10, P152, DOI 10.1177/1559827614557773; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; McArthur L, 2020, AM J TROP MED HYG, V103, P625, DOI 10.4269/ajtmh.20-0564; Neidich SD, 2017, INT J OBESITY, V41, P1324, DOI 10.1038/ijo.2017.131; Nieman DC, 2019, J SPORT HEALTH SCI, V8, P201, DOI 10.1016/j.jshs.2018.09.009; Teran-Cabanillas E, 2017, INFLAMMATION, V40, P58, DOI 10.1007/s10753-016-0452-x; Wang X, 2020, CLIN MICROBIOL INFEC, V26, P1063, DOI 10.1016/j.cmi.2020.03.032; Weyh C, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030622; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	9	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0237799	10.1371/journal.pone.0237799	http://dx.doi.org/10.1371/journal.pone.0237799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206653	Green Published, Green Submitted, gold			2022-12-26	WOS:000595265900035
J	Song, YF; Wang, MF; Tong, H; Tan, Y; Hu, X; Wang, K; Wan, XP				Song, Yunfeng; Wang, Mengfei; Tong, Huan; Tan, Yuan; Hu, Xiang; Wang, Kai; Wan, Xiaoping			Plasma exosomes from endometrial cancer patients contain LGALS3BP to promote endometrial cancer progression	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SIGNALING PATHWAY; BINDING-PROTEIN; TUMOR-GROWTH; EXPRESSION; SUPERFAMILY; BIOMARKER; VESICLES; MEMBER; CELLS	Endometrial cancer (EC) is a common gynaecological cancer worldwide. Exosomes, secreted by living cells and detected in various body fluids, can exchange information between organs and compartments to affect cellular functions, such as proliferation, apoptosis, migration and angiogenesis. We hypothesise that plasma exosomal contents are altered during cancer progression and promote cancer growth and angiogenesis by delivering biomolecules to cancer and vascular endothelial cells. In this study, circulating exosomes derived from EC patients and age-matched healthy people were acquired by commercial kits. Cell counting kit-8, Transwell and Matrigel tube formation assays showed that circulating exosomes from EC patients promote EC cell growth and human umbilical vein endothelial cell (HUVEC) angiogenesis. Next, proteomic analysis and ELISA revealed that plasma exosomal lectin galactoside-binding soluble 3 binding protein (LGALS3BP) increased during EC progression. Moreover, to explore the function of exosomal LGALS3BP, we acquired exosomes containing high levels of LGALS3BP by overexpressing LGALS3BP in human embryonic kidney 293 cells, and we demonstrated that highly contained exosomal LGALS3BP contributed to EC cell proliferation and migration and HUVEC functions via the activation of the PI3K/AKT/VEGFA signalling pathway both in vitro and in vivo. Finally, high LGALS3BP expression was observed in human EC tissue, which indicated a poor prognosis. In addition, immunohistochemical analysis of human EC tissues revealed that LGALS3BP expression was correlated with VEGFA expression and blood vessel density. Hence, we proposed that plasma exosomes containing LGALS3BP contributed to EC growth and angiogenesis during EC progression, which also provided a novel perspective on EC diagnosis and prognosis.	[Song, Yunfeng; Wang, Mengfei; Tong, Huan; Tan, Yuan; Hu, Xiang; Wan, Xiaoping] Tongji Univ, Shanghai Matern & Infant Hosp 1, Dept Gynaecol, Sch Med, Shanghai, Peoples R China; [Wang, Kai] Tongji Univ, Shanghai Matern & Infant Hosp 1, Clin & Translat Res Ctr, Sch Med, Shanghai, Peoples R China	Tongji University; Tongji University	Wan, XP (corresponding author), Tongji Univ, Shanghai Matern & Infant Hosp 1, Dept Gynaecol, Sch Med, Shanghai, Peoples R China.; Wang, K (corresponding author), Tongji Univ, Shanghai Matern & Infant Hosp 1, Clin & Translat Res Ctr, Sch Med, Shanghai, Peoples R China.	kaiwangcn@yahoo.com; wanxiaoping@tongji.edu.cn		wan, xiaoping/0000-0001-6079-631X; wang, kai/0000-0003-2298-4816; Song, yunfeng/0000-0002-7373-3198	Shanghai Science and Technology Commission Innovation Plan [17411951600]; National Natural Science Foundation of China [81672574, 81972438]; Shanghai Key Clinical Specialty Programme [2017ZZ02015]	Shanghai Science and Technology Commission Innovation Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Clinical Specialty Programme	This work was supported by Shanghai Science and Technology Commission Innovation Plan (No. 17411951600), the National Natural Science Foundation of China (Nos. 81672574 and 81972438) and Shanghai Key Clinical Specialty Programme (No. 2017ZZ02015).	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bhagirath D, 2018, CANCER RES, V78, P1833, DOI 10.1158/0008-5472.CAN-17-2069; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chatterjee S, 2013, J CLIN INVEST, V123, P1732, DOI 10.1172/JCI65385; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; IACOBELLI S, 1986, CANCER RES, V46, P3005; Jiang Y, 2019, BRAIN RES, V1722, DOI 10.1016/j.brainres.2019.146331; Jiang ZY, 2002, J BIOL CHEM, V277, P509, DOI 10.1074/jbc.M108280200; KOTHS K, 1993, J BIOL CHEM, V268, P14245; Ludwig AK, 2012, INT J BIOCHEM CELL B, V44, P11, DOI 10.1016/j.biocel.2011.10.005; Mariscal J, 2019, J PROTEOME RES, V18, P1043, DOI 10.1021/acs.jproteome.8b00750; Matei I, 2017, CELL, V170, P223, DOI 10.1016/j.cell.2017.06.047; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Ozaki Y, 2004, ONCOL REP, V12, P1071; Pan C, 2018, MOL ONCOL, V12, P1935, DOI 10.1002/1878-0261.12371; Peng S, 2014, HEPATOLOGY, V60, P1264, DOI 10.1002/hep.27236; Piccolo E, 2013, J MOL MED, V91, P83, DOI 10.1007/s00109-012-0936-6; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Pramanik KC, 2013, CARCINOGENESIS, V34, P2061, DOI 10.1093/carcin/bgt154; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Stampolidis P, 2015, ONCOGENE, V34, P39, DOI 10.1038/onc.2013.548; Teng Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14448; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Wahlgren J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks463; Wang JJ, 2018, CANCER BIOMARK, V21, P805, DOI 10.3233/CBM-170738; Wang M, 2018, CLIN TRANSL ONCOL, V20, P906, DOI 10.1007/s12094-017-1805-0; Weiderpass E, 2015, INT J EPIDEMIOL, V44, P3; Wen XL, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0170-6; Zhang XX, 2019, CELL SIGNAL, V63, DOI 10.1016/j.cellsig.2019.109359; Zhong H, 2000, CANCER RES, V60, P1541; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273	35	25	25	3	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2021	40	3					633	646		10.1038/s41388-020-01555-x	http://dx.doi.org/10.1038/s41388-020-01555-x		NOV 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PU9SL	33208911				2022-12-26	WOS:000590925500002
J	Tan, SH; Zhang, JW; Lin, Y; Liu, H; Yang, ML; Ge, WY				Tan Shihan; Zhang Jianwei; Lin Yi; Liu Hong; Yang Menglong; Ge Wenyi			Adaptive volumetric light and atmospheric scattering	PLOS ONE			English	Article								An adaptive sampling-based atmospheric scattering and volumetric light framework for flight simulator (FS) is proposed to enhance the immersion and realism in real-time. The framework comprises epipolar sampling (ES), visible factor culling (VFC), interactive participating media density estimating (IPMDE). The main process of proposed architecture is as follows: the scene is divided into two levels according to the distance from the camera. In the high-level pipeline, the layer close to the camera, more samples, and smaller sampling step size is used to improve image quality. Further, the IPMDE method is designed to enhance realism by achieving interactivity with the participating media and multiple light sources. Further optimization is performed by the lookup table and 3D volumetric textures, by which we can compute the density of participating media and the scattering coefficient in parallel. In the low-level pipeline, when the samples are far away from the camera, its influence on the final output is also reduced, which results in fewer samples and a bigger sampling step size. The improved ES method further reduces the number of samples involved in ray marching using the features of epipolar geometry. It then generates global light effects and shadows of distant terrain. The VFC method uses an acceleration structure to quickly find the lit segments which eliminate samples blocked by obstacles. The experimental results demonstrate our architecture achieves a better sense of reality in real-time and is very suitable for FS.	[Tan Shihan; Zhang Jianwei; Lin Yi; Liu Hong; Yang Menglong; Ge Wenyi] Sichuan Univ, Natl Key Lab Fundamental Sci Synthet Vis, Chengdu, Sichuan, Peoples R China	Sichuan University	Tan, SH (corresponding author), Sichuan Univ, Natl Key Lab Fundamental Sci Synthet Vis, Chengdu, Sichuan, Peoples R China.	530916232@qq.com						[艾祖亮 Ai Zuliang], 2014, [图学学报, Journal of Graphics], V35, P181; Ali HH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178415; Ali HH, 2017, MULTIMED TOOLS APPL, V76, P2591, DOI 10.1007/s11042-016-3254-0; Ament M, VISUALIZATION COMPUT, V20, P2437; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Baran I, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1866158.1866200; Billeter M, 2010, ACM SIGGR EUR C HIGH; Brown SA, 2017, REAL TIME PANORAMA M; Bruneton E, 2010, COMPUT GRAPH FORUM, V27, P1079; Cerezo E, 2005, SURVEY PARTICIPATING; Chen J, 2016, RENDERING IMAGES VOL; Chen Jiawen, 2011, INTERACTIVE 3D GRAPH, P39; Chen S, 2006, ADV VISUAL COMPUTING; Dobashi Y, 2000, INTERACTIVE RENDERIN; Engelhardt T, 2010, ACM SIGGR S INT 3D G; Feng YK, 2012, COMPUTER ENG, V38; Feng Yu-kang, 2012, Computer Engineering, V38, P218, DOI 10.3969/j.issn.1000-3428.2012.19.056; Green Simon, GPU GEMS2, P409; Huang B, 2008, 2008 INTERNATIONAL CONFERENCE ON AUDIO, LANGUAGE AND IMAGE PROCESSING, VOLS 1 AND 2, PROCEEDINGS, P1250, DOI 10.1109/ICALIP.2008.4590228; Imagire T, VISUAL COMPUTER, V23, P935; Jackel D, 1997, COMPUT GRAPH FORUM, V16, P201, DOI 10.1111/1467-8659.00180; Ju M, 2017, NEUROCOMPUTING, V260; Kai L, 2014, VISION MODELING VISU; Kallweit S, 2017, ACM T GRAPHIC, V36, DOI 10.1145/3130800.3130880; Kaneda K., 1991, Visual Computer, V7, P247, DOI 10.1007/BF01905690; KLASSEN RV, 1987, ACM T GRAPHIC, V6, P215, DOI 10.1145/35068.35071; Levoy M, IEEE COMPUTER GRAPHI, V8, P37; Li S, 2007, COMP AID DES COMP GR; Lin HY, IET IMAGE PROCESSING, V7, P762; Lipus B, VISUAL COMPUTER, V21, P83; Max NL, 1986, ACM SIGGRAPH COMPUTE, V20, DOI 10.1145/15886.15899; Nishita T, 1993, C COMP GRAPH INT TEC; Nowrouzezahrai D, ACM T GRAPHICS, V30; Pegoraro V, 2010, COMPUT GRAPH FORUM, V29, P1365, DOI 10.1111/j.1467-8659.2010.01732.x; Sloan P., 2017, ACM T GRAPHY, V21, P527; Tevs A, 2008, I3D 2008: SYMPOSIUM ON INTERACTIVE 3D GRAPHICS AND GAMES, PROCEEDINGS, P183; Tomasi C., 1998, INT C COMP VIS; Wang DL, 2014, INT C INF SCI; Whitted Turner, ACM SIGGRAPH COMPUTE, V13, P14; Williams A, J GRAPHICS GPU GAME, V10, P49; Wyman C., 2013, P 5 HIGH PERF GRAPH, P45, DOI DOI 10.1145/2492045.2492050; Wyman Chris, 2011, P ACM SIGGRAPH S HIG, P33	42	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242265	10.1371/journal.pone.0242265	http://dx.doi.org/10.1371/journal.pone.0242265			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206695	Green Published, gold			2022-12-26	WOS:000595265900016
J	Lijster, T; Aberg, C				Lijster, Tim; Aberg, Christoffer			Asymmetry of nanoparticle inheritance upon cell division: Effect on the coefficient of variation	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; QUANTUM DOTS; TRACKING; MODELS; DELIVERY; IMPACT	Several previous studies have shown that when a cell that has taken up nanoparticles divides, the nanoparticles are inherited by the two daughter cells in an asymmetrical fashion, with one daughter cell receiving more nanoparticles than the other. This interesting observation is typically demonstrated either indirectly using mathematical modelling of high-throughput experimental data or more directly by imaging individual cells as they divide. Here we suggest that measurements of the coefficient of variation (standard deviation over mean) of the number of nanoparticles per cell over the cell population is another means of assessing the degree of asymmetry. Using simulations of an evolving cell population, we show that the coefficient of variation is sensitive to the degree of asymmetry and note its characteristic evolution in time. As the coefficient of variation is readily measurable using high-throughput techniques, this should allow a more rapid experimental assessment of the degree of asymmetry.	[Lijster, Tim; Aberg, Christoffer] Univ Groningen, Groningen Res Inst Pharm, Groningen, Netherlands	University of Groningen	Aberg, C (corresponding author), Univ Groningen, Groningen Res Inst Pharm, Groningen, Netherlands.	christoffer.aberg@rug.nl	Åberg, Christoffer/N-8812-2015	Åberg, Christoffer/0000-0002-6886-7239				Aberg C, 2017, NAT NANOTECHNOL, V12, P600, DOI 10.1038/nnano.2017.139; Beentjes CHL, 2020, PHYS REV E, V101, DOI 10.1103/PhysRevE.101.032403; Berg CA, 2013, AM SCI, V101, P3; Bergeland T, 2001, CURR BIOL, V11, P644, DOI 10.1016/S0960-9822(01)00177-4; Bjornmalm M, 2017, ACS NANO, V11, P9594, DOI 10.1021/acsnano.7b04855; Bogart LK, 2014, ACS NANO, V8, P3107, DOI 10.1021/nn500962q; Bourquin J, 2019, ACS NANO, V13, P7759, DOI 10.1021/acsnano.9b01604; Brown MR, 2010, CYTOM PART A, V77A, P925, DOI 10.1002/cyto.a.20936; Cadart C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05393-0; Cao ZX, 2020, P NATL ACAD SCI USA, V117, P4682, DOI 10.1073/pnas.1910888117; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Couvreur P, 2013, ADV DRUG DELIVER REV, V65, P21, DOI 10.1016/j.addr.2012.04.010; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Errington RJ, 2010, CELL CYCLE, V9, P121, DOI 10.4161/cc.9.1.10246; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; Himmelreich U, 2009, METHODS, V48, P112, DOI 10.1016/j.ymeth.2009.03.020; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Kim JA, 2013, ACS NANO, V7, P7483, DOI 10.1021/nn403126e; Kim JA, 2012, NAT NANOTECHNOL, V7, P62, DOI [10.1038/nnano.2011.191, 10.1038/NNANO.2011.191]; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Rees P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10112-4; Rees P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-31; Salvati A, 2018, NANOIMPACT, V9, P42, DOI 10.1016/j.impact.2017.10.004; Skinner SO, 2016, ELIFE, V5, DOI 10.7554/eLife.12175; Soenen SJ, 2012, BIOMATERIALS, V33, P4882, DOI 10.1016/j.biomaterials.2012.03.042; Soltani M, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004972; Steel GG, 1977, GROWTH KINETICS OF T; Summers HD, 2013, ACS NANO, V7, P6129, DOI 10.1021/nn4019619; Summers HD, 2011, NAT NANOTECHNOL, V6, P170, DOI [10.1038/nnano.2010.277, 10.1038/NNANO.2010.277]; TYSON JJ, 1985, J MATH BIOL, V22, P61, DOI 10.1007/BF00276546; Valsami-Jones E, 2015, SCIENCE, V350, P388, DOI 10.1126/science.aad0768; Van de Walle A, 2019, P NATL ACAD SCI USA, V116, P4044, DOI 10.1073/pnas.1816792116; Walczak P, 2007, MAGN RESON MED, V58, P261, DOI 10.1002/mrm.21280; Wang X, 2016, P NATL ACAD SCI USA, V113, P7177, DOI 10.1073/pnas.1606091113; Wegner KD, 2015, CHEM SOC REV, V44, P4792, DOI 10.1039/c4cs00532e; Wolfram J, 2019, NANO TODAY, V25, P85, DOI 10.1016/j.nantod.2019.02.005; Xiong RH, 2016, NANO LETT, V16, P5975, DOI 10.1021/acs.nanolett.6b01411; Yan Y, 2013, ACS NANO, V7, P5558, DOI 10.1021/nn401800u; Yates CA, 2017, B MATH BIOL, V79, P2905, DOI 10.1007/s11538-017-0356-4	41	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242547	10.1371/journal.pone.0242547	http://dx.doi.org/10.1371/journal.pone.0242547			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201918	gold, Green Published			2022-12-26	WOS:000595003900019
J	Varela, R; Rodriguez-Diaz, L; deCastro, M				Varela, R.; Rodriguez-Diaz, L.; deCastro, M.			Persistent heat waves projected for Middle East and North Africa by the end of the 21st century	PLOS ONE			English	Article							CLIMATE-CHANGE PROJECTIONS; FUTURE CLIMATE; MORTALITY RISK; CORDEX; TEMPERATURE; PRECIPITATION; ADAPTATION; RESOURCES; HEATWAVES; HEALTH	The duration and intensity of future heat waves are analyzed for 53 cities in the Middle East and the North Africa (MENA) region for the 21(st) century under two different scenarios (RCP4.5 and RCP8.5). A consistent approach is carried out using data from 13 Regional models within the framework of the Coordinated Regional Climate Downscaling Experiment (CORDEX). By the end of the century, 80% of the most populated MENA cities are expected to be at least 50% of the days under heat wave conditions during the warm season. In addition, the mean and maximum intensity of the heat waves will also increase. Changes in the duration and intensity of heat waves have shown to be negatively correlated. Therefore, the vulnerability of the MENA cities to future heat waves was determined using a cumulative index (CI) that takes into account both duration and intensity. This CI indicates that Middle East and the eastern part of Africa will suffer the most unfavorable temperature conditions in the future. Assuming no intervention trough adaptation/mitigation strategies, these results, together with the particular properties of the MENA region, such as aridity or lack of precipitation, make it likely that the area will be affected by disease or famine.	[Varela, R.; Rodriguez-Diaz, L.; deCastro, M.] Univ Vigo, Environm Phys Lab EphysLab, CIM UVIGO, Orense, Spain	Universidade de Vigo; CIM UVIGO	Varela, R (corresponding author), Univ Vigo, Environm Phys Lab EphysLab, CIM UVIGO, Orense, Spain.	ruvarela@uvigo.es	Varela, Ruben/AAB-7411-2022; deCastro, Maite/R-6739-2019	deCastro, Maite/0000-0001-6443-3620; Varela, Ruben/0000-0001-9676-2349; Rodriguez-Diaz, Laura/0000-0003-2857-077X	European Regional Development Fund (FEDER) under the project "Prevencion de Riesgos de Inundaciones y Sequias en la Cuenca Internacional del Mino- Limia" Interreg-Poctep 2014- 2020 (EU. INTERREG-POCTEP 2014-2020) [0034RISC_ML_6_E]; Xunta de Galicia [ED431C 2017/64-GRC]	European Regional Development Fund (FEDER) under the project "Prevencion de Riesgos de Inundaciones y Sequias en la Cuenca Internacional del Mino- Limia" Interreg-Poctep 2014- 2020 (EU. INTERREG-POCTEP 2014-2020); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was partially supported by the European Regional Development Fund (FEDER) under the project "Prevencion de Riesgos de Inundaciones y Sequias en la Cuenca Internacional del Mino- Limia" Interreg-Poctep 2014- 2020 (EU. INTERREG-POCTEP 2014-2020, 0034RISC_ML_6_E) and by Xunta de Galicia under the project ED431C 2017/64-GRC (Grupos de Referencia Competitiva). Both projects were awarded to R.V., L.R-D and M.dC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Adeniyi MO, 2019, EARTH SYST ENVIRON, V3, P189, DOI 10.1007/s41748-019-00103-2; Ahmadalipour A, 2019, CLIMATIC CHANGE, V152, P569, DOI 10.1007/s10584-018-2348-2; Ahmadalipour A, 2018, ENVIRON INT, V117, P215, DOI 10.1016/j.envint.2018.05.014; Al Adaileh H, 2019, EARTH SYST ENVIRON, V3, P445, DOI 10.1007/s41748-019-00118-9; Altieri MA, 2017, CLIMATIC CHANGE, V140, P33, DOI 10.1007/s10584-013-0909-y; Anderson GB, 2018, CLIMATIC CHANGE, V146, P455, DOI 10.1007/s10584-016-1779-x; [Anonymous], 2016, CLIN REP, V9, P1, DOI DOI 10.3823/1909; Araro K., 2019, EARTH SYS ENV, P1; Awdeh A., 2019, INT J EMERG MARKET; Bobb JF, 2014, ENVIRON HEALTH PERSP, V122, P811, DOI 10.1289/ehp.1307392; Bucchignani E, 2018, ADV CLIM CHANG RES, V9, P66, DOI 10.1016/j.accre.2018.01.004; Christensen O.B., 2014, CORDEX ARCH DESIGN; Coffel ED, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaa00e; Costoya X, 2019, ENERGY, V178, P356, DOI 10.1016/j.energy.2019.04.121; Coumou D, 2013, CLIMATIC CHANGE, V118, P771, DOI 10.1007/s10584-012-0668-1; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Dahou K, 2012, OECD J, V2, P7, DOI [10.1787/gen_papers-2010-5k9btsvgg5d, DOI 10.1787/GEN_PAPERS-2010-5K9BTSVGG5D]; deCastro M, 2011, CLIM RES, V48, P333, DOI 10.3354/cr00988; Dosio A, 2017, CLIM DYNAM, V49, P493, DOI 10.1007/s00382-016-3355-5; Dosio A, 2016, CLIM DYNAM, V46, P1599, DOI 10.1007/s00382-015-2664-4; El-Zeiny AM, 2019, EARTH SYST ENVIRON, V3, P507, DOI 10.1007/s41748-019-00112-1; Evans JP, 2009, CLIMATIC CHANGE, V92, P417, DOI 10.1007/s10584-008-9438-5; Feng S, 2014, GLOBAL PLANET CHANGE, V112, P41, DOI 10.1016/j.gloplacha.2013.11.002; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Fragaszy SR, 2020, B AM METEOROL SOC, V101, pE1148, DOI 10.1175/BAMS-D-18-0084.1; Frolicher TL, 2018, NATURE, V560, P360, DOI 10.1038/s41586-018-0383-9; Garland RM, 2015, INT J ENV RES PUB HE, V12, P12577, DOI 10.3390/ijerph121012577; Gibbons JD, 2011, NONPARAMETRIC STAT I, P977, DOI [10.1007/978-3-642-04898-2_420, DOI 10.1007/978-3-642-04898-2_420]; Giugni M., 2015, URBAN VULNERABILITY, P37, DOI DOI 10.1007/978-3-319-03982-4_2; Guerreiro SB, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aaaad3; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hobday AJ, 2016, PROG OCEANOGR, V141, P227, DOI 10.1016/j.pocean.2015.12.014; Hondula DM, 2015, CURR CLIM CHANGE REP, V1, P144, DOI 10.1007/s40641-015-0016-4; Hotez PJ, 2018, ADV PARASIT, V100, P29, DOI 10.1016/bs.apar.2018.03.002; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Islam M. N., 2018, BANGLADESH 1 CLIMATE; Jacob D, 2014, REG ENVIRON CHANGE, V14, P563, DOI 10.1007/s10113-013-0499-2; Jones B, 2015, NAT CLIM CHANGE, V5, P652, DOI [10.1038/NCLIMATE2631, 10.1038/nclimate2631]; Koletsis I, 2016, RENEW SUST ENERG REV, V60, P234, DOI 10.1016/j.rser.2016.01.080; Lelieveld J, 2016, CLIMATIC CHANGE, V137, P245, DOI 10.1007/s10584-016-1665-6; Lelieveld J, 2014, REG ENVIRON CHANGE, V14, P1937, DOI 10.1007/s10113-013-0444-4; Lwasa S, 2018, CURR OPIN ENV SUST, V30, P52, DOI 10.1016/j.cosust.2018.02.012; Mazdiyasni O, 2015, P NATL ACAD SCI USA, V112, P11484, DOI 10.1073/pnas.1422945112; McMichael AJ, 2011, J INTERN MED, V270, P401, DOI 10.1111/j.1365-2796.2011.02415.x; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Michelozzi P, 2007, EPIDEMIOLOGY, V18, pS130; Mitchell D, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/7/074006; Ncube M, 2014, AFR DEV REV, V26, P435, DOI 10.1111/1467-8268.12103; Niang I, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1199; Nimeus-Malmstrom E, 2008, BREAST CANC RES, V10, pR34; Nissan H, 2017, J APPL METEOROL CLIM, V56, P2653, DOI 10.1175/JAMC-D-17-0035.1; Ozturk T, 2018, ATMOS RES, V206, P87, DOI 10.1016/j.atmosres.2018.02.009; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Pal JS, 2016, NAT CLIM CHANGE, V6, P197, DOI [10.1038/NCLIMATE2833, 10.1038/nclimate2833]; Parente J, 2018, SCI TOTAL ENVIRON, V631-632, P534, DOI 10.1016/j.scitotenv.2018.03.044; Patricola CM, 2010, CLIM DYNAM, V35, P193, DOI 10.1007/s00382-009-0623-7; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Perkins SE, 2013, J CLIMATE, V26, P4500, DOI 10.1175/JCLI-D-12-00383.1; Pinto I, 2016, CLIMATIC CHANGE, V135, P655, DOI 10.1007/s10584-015-1573-1; Raftery AE, 2017, NAT CLIM CHANGE, V7, P637, DOI [10.1038/nclimate3352, 10.1038/NCLIMATE3352]; Ritchie H., 2018, URBANIZATION; Rohat G, 2019, EARTHS FUTURE, V7, P528, DOI 10.1029/2018EF001020; Roy M., 2016, URBAN POVERTY CLIMAT; Russo S, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014727; Russo S, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/5/054016; Russo S, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/124003; Russo S, 2014, J GEOPHYS RES-ATMOS, V119, P12500, DOI 10.1002/2014JD022098; Stern N, 2008, AM ECON REV, V98, P1, DOI 10.1257/aer.98.2.1; Tanarhte M, 2015, CLIM RES, V63, P99, DOI 10.3354/cr01285; Tavakol A, 2020, ATMOS RES, V239, DOI 10.1016/j.atmosres.2020.104907; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Vautard R, 2013, CLIM DYNAM, V41, P2555, DOI 10.1007/s00382-013-1714-z; Vizy EK, 2012, J CLIMATE, V25, P5748, DOI 10.1175/JCLI-D-11-00693.1; Wang PY, 2019, CLIM DYNAM, V53, P957, DOI 10.1007/s00382-019-04621-7; Wilson R. H., 2016, URBAN RESILIENCE CLI, V208	75	10	10	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242477	10.1371/journal.pone.0242477	http://dx.doi.org/10.1371/journal.pone.0242477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201909	gold, Green Published			2022-12-26	WOS:000595003900033
J	Woodin, G; Winter, B; Perlman, M; Littlemore, J; Matlock, T				Woodin, Greg; Winter, Bodo; Perlman, Marcus; Littlemore, Jeannette; Matlock, Teenie			'Tiny numbers' are actually tiny: Evidence from gestures in the TV News Archive	PLOS ONE			English	Article							R PACKAGE; MAGNITUDE; METAPHOR; SPACE; GRIP; TIME	We report a large-scale, quantitative investigation of manual gestures that speakers perform when speaking metaphorically about numerical quantities. We used the TV News Archive-an online database of over 2 million English language news broadcasts-to examine 681 videos in which 584 speakers used the phrase 'tiny number', 'small number', 'large number', or 'huge number', which metaphorically frame numerical quantity in terms of physical size. We found that the gestures speakers used reflect a number of different strategies to express the metaphoric size of quantities. When referring to greater versus lesser quantities, speakers were far more likely to gesture (1) with an open versus closed hand configuration, (2) with an outward versus inward movement, and (3) with a wider distance between the gesturing hands. These patterns were often more pronounced for the phrases containing more extreme adjectives ('tiny/huge number'). However, we did not find that speakers performed two-handed versus one-handed gestures. Nor did we find that speakers performed right-handed versus left-handed gestures, when referring to greater versus lesser quantities. Overall, this work supports the claim that metaphoric thought is involved in the production of verbal metaphors that describe numerical magnitudes. It demonstrates that size-based numerical associations observed in previous lab experiments are active in real-life communication outside the lab.	[Woodin, Greg; Winter, Bodo; Perlman, Marcus; Littlemore, Jeannette] Univ Birmingham, English Language & Linguist, Birmingham, W Midlands, England; [Matlock, Teenie] Univ Calif, Cognit & Informat Sci, Merced, CA USA	University of Birmingham; University of California System; University of California Merced	Woodin, G (corresponding author), Univ Birmingham, English Language & Linguist, Birmingham, W Midlands, England.	gawoodin@gmail.com	Littlemore, Jeannette/K-6977-2018; Winter, Bodo/K-6975-2018; Perlman, Marcus/K-6972-2018	Littlemore, Jeannette/0000-0003-4670-0275; Winter, Bodo/0000-0001-6036-6774; Woodin, Greg/0000-0001-7992-4991; Perlman, Marcus/0000-0002-1269-3882	ESRC [2067243] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Andres M, 2004, NEUROREPORT, V15, P2773; [Anonymous], 2016, EUR UROL, V70, pe136; [Anonymous], 2013, BIS DAS MAGAZIN BIBL, V6, P85; Badets A, 2007, EXP BRAIN RES, V180, P525, DOI 10.1007/s00221-007-0870-y; BLACKBURN MJ, 1993, MATER DESIGN, V14, P19, DOI 10.1016/0261-3069(93)90041-S; Borstell C, 2020, SIGN LANG LINGUIST, V23, P112, DOI 10.1075/sll.00046.bor; Borstell C, 2016, LINGUIST INVESTIG, V39, P391, DOI 10.1075/li.39.2.10bor; Bouissac P, 2008, METAPHOR AND GESTURE, P277; Burkner PC, 2018, R J, V10, P395; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Calbris G., 1990, SEMIOTICS FRENCH GES; Cao Z., 2018, ARXIV181208008CS; Cao Z., 2016, ARXIV161108050CS; Casasanto D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011805; Casasanto D, 2010, COGNITION, V115, P179, DOI 10.1016/j.cognition.2009.11.002; Catak EN, 2018, Q J EXP PSYCHOL, V71, P2615, DOI 10.1177/1747021817750110; Chui KW, 2018, GESTURE, V17, P176, DOI 10.1075/gest.00015.chu; Cienki A, 1998, DISCOURSE AND COGNITION: BRIDGING THE GAP, P189; Cienki A, 2008, CAMB HANDB PSYCHOL, P483; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cooperrider K, 2018, FRONT COMMUN, V3, P23, DOI [10.3389/fcomm.2018.00023, DOI 10.3389/FCOMM.2018.00023]; Cooperrider K, 2014, J PRAGMATICS, V71, P1, DOI 10.1016/j.pragma.2014.07.003; Daar M, 2008, CORTEX, V44, P400, DOI 10.1016/j.cortex.2007.12.003; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Gamer M., 2019, R PACKAGE VERSION, P1; Gibbs Raymond W., 1994, POETICS MIND FIGURAT; Hassemer J., 2016, THEORY GESTURE FORM; Hassemer J, 2018, COGNITIVE SCI, V42, P3034, DOI 10.1111/cogs.12680; Hassemer J, 2016, GESTURE, V15, P404, DOI 10.1075/gest.15.3.07has; HENIK A, 1982, MEM COGNITION, V10, P389, DOI 10.3758/BF03202431; Hinnell J, 2018, COGN LINGUIST, V29, P773, DOI 10.1515/cog-2017-0009; Holyoak KJ, 2018, PSYCHOL BULL, V144, P641, DOI 10.1037/bul0000145; Hurewitz F, 2006, P NATL ACAD SCI USA, V103, P19599, DOI 10.1073/pnas.0609485103; Kendon A., 2004, GESTURE VISIBLE ACTI, DOI DOI 10.1017/CBO9780511807572; Kovecses Z., 2002, METAPHOR PRACTICAL I; Lakoff G, 1980, METAPHORS WE LIVE BY, DOI [10.1086/292206, DOI 10.1086/292206]; Landau MJ, 2010, PSYCHOL BULL, V136, P1045, DOI 10.1037/a0020970; Lempert M, 2011, GESTURE, V11, P241, DOI 10.1075/gest.11.3.01lem; Lindemann O, 2007, J EXP PSYCHOL HUMAN, V33, P1400, DOI 10.1037/0096-1523.33.6.1400; M?ller C., 2008, METAPHORS DEAD ALIVE; M?ller C., 1998, REDEBEGLEITENDE GEST; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; McNeill D., 2000, LANGUAGE GESTURE, DOI [10.1017/CBO9780511620850, DOI 10.1017/CB09780511620850]; McNeill D., 1992, HAND MIND WHAT GESTU; McNeill David, 2005, GESTURE THOUGHT, DOI [10.7208/chicago/9780226514642.001.0001, DOI 10.7208/CHICAGO/9780226514642.001.0001]; Mesirov JP, 2010, SCIENCE, V327, P415, DOI 10.1126/science.1179653; Mills KJ, 2014, NEUROPSYCHOLOGIA, V58, P99, DOI 10.1016/j.neuropsychologia.2014.04.001; Muller C., 2004, SEMANTICS PRAGMATICS, P233; Murphy GL, 1996, COGNITION, V60, P173, DOI 10.1016/0010-0277(96)00711-1; Murphy GL, 1997, COGNITION, V62, P99, DOI 10.1016/S0010-0277(96)00725-1; Ooms J, 2014, ARXIV14032805CSSTAT; Ostling R, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00725; Canovas CP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233892; Parrill F, 2013, COGN LINGUIST, V24, P135, DOI 10.1515/cog-2013-0005; Pouw W, 2020, BEHAV RES METHODS, V52, P723, DOI 10.3758/s13428-019-01271-9; R Core Team, 2021, R LANGUAGE ENV STAT; Rstudio T, 2020, RSTUDIO INT DEV R; Sowa T., 2006, UNDERSTANDING COVERB; Steen Francis, 2013, LANGUAGE CREATIVE MI, P255; Walker E, 2016, COGNITIVE SCI, V40, P481, DOI 10.1111/cogs.12254; Winter B, 2017, METAPHOR: EMBODIED COGNITION AND DISCOURSE, P99; Winter B, 2015, NEUROSCI BIOBEHAV R, V57, P209, DOI 10.1016/j.neubiorev.2015.09.005; Winter B, 2015, CORTEX, V64, P209, DOI 10.1016/j.cortex.2014.10.015; Winter B, 2013, GESTURE, V13, P377, DOI 10.1075/gest.13.3.06win; Wood G., 2008, PSYCHOL SCI Q, V50, P489	65	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242142	10.1371/journal.pone.0242142	http://dx.doi.org/10.1371/journal.pone.0242142			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ5ZL	33201907	Green Published, gold			2022-12-26	WOS:000595003900016
J	Wu, Q; Hao, Q; Li, HY; Wang, B; Wang, PN; Jin, XF; Yu, P; Gao, GF; Chang, YZ				Wu, Qiong; Hao, Qian; Li, Haiyan; Wang, Bo; Wang, Peina; Jin, Xiaofang; Yu, Peng; Gao, Guofen; Chang, Yan-Zhong			Brain iron deficiency and affected contextual fear memory in mice with conditional Ferroportin1 ablation in the brain	FASEB JOURNAL			English	Article						brain iron homeostasis; contextual fear; ferroportin1; Nestin&#8208; cre	MITOCHONDRIAL FERRITIN; CELLULAR IRON; HOMEOSTASIS; METABOLISM; EXPRESSION; TRANSPORTER; MACROPHAGES; KIDNEY	Fear memory is a pivotal biological function by which organisms can predict possible danger to avoid or reduce harm. However, dysregulation of fear memory processing may lead to pathological fear or anxiety and produce serious clinical symptoms, such as post-traumatic stress disorder (PTSD). Iron deficiency (ID) is reported to inhibit the initiation of fear memory. In our study, we found that ferroportin1 (FPN1), the only known cellular iron export protein in mammals, and ablation in neurons and astrocytes caused iron deficiency in the cortex and hippocampus. However, little is known about its role in the development of fear memory. Moreover, direct evidence of the role of FPN1, or the related molecular mechanisms of such a role, in balancing brain iron homeostasis, especially in neuronal cells, is lacking. Herein, we deleted Fpn1 in mouse neurons, using Nestin-cre transgenic mice, and explored the impact on neuronal iron recycling and brain iron homeostasis in the cortex and hippocampus. We investigated the response of the mice to contextual fear and found that formation of fear memory was impeded after neuronal FPN1 depletion. We also found that FPN1 ablation in neurons and astrocytes caused an atypical expression of iron metabolism-related proteins in these two regions: decreased expression of DMT1, Ft-H, and Ft-L, and increased TfR1 expression. In addition, the decreased FPN1 in brain microvascular endothelial cells (BMVECs) also shed light on the cause of the decreased iron delivery to the brain through the blood-brain barrier (BBB). Our research highlights the major role played by FPN1 in brain iron homeostasis and identifies a potential target for the treatment of PTSD.	[Wu, Qiong; Hao, Qian; Li, Haiyan; Wang, Bo; Wang, Peina; Jin, Xiaofang; Yu, Peng; Gao, Guofen; Chang, Yan-Zhong] Hebei Normal Univ, Coll Life Sci, Lab Mol Iron Metab, 20 Nanerhuan Eastern Rd, Shijiazhuang 050024, Hebei, Peoples R China; [Wu, Qiong] Hebei Univ Chinese Med, Coll Basic Med, Shijiazhuang, Hebei, Peoples R China; [Wu, Qiong] Hebei Key Lab Chinese Med Res Cardiocerebrovasc D, Shijiazhuang, Hebei, Peoples R China	Hebei Normal University; Hebei University of Chinese Medicine	Chang, YZ (corresponding author), Hebei Normal Univ, Coll Life Sci, Lab Mol Iron Metab, 20 Nanerhuan Eastern Rd, Shijiazhuang 050024, Hebei, Peoples R China.	yzchang@hebtu.edu.cn	YU, Peng/GRJ-4129-2022; Chang, Yan-Zhong/AAB-5676-2020	Chang, Yan-Zhong/0000-0002-6386-9649	National Natural Science Foundation of China (NSFC) [31520103908, 31471035]; Natural Science Foundation of Hebei Province (Hebei Provincial Natural Science Foundation) [H2019423032]; Bureau of Science and Technology of Hebei Province (Hebei Province Science and Technology Bureau) [18962401D]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hebei Province (Hebei Provincial Natural Science Foundation); Bureau of Science and Technology of Hebei Province (Hebei Province Science and Technology Bureau)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31520103908 and 31471035; Natural Science Foundation of Hebei Province (Hebei Provincial Natural Science Foundation), Grant/Award Number: H2019423032; Bureau of Science and Technology of Hebei Province (Hebei Province Science and Technology Bureau), Grant/Award Number: 18962401D	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Aguirre P, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-3; Bastian TW, 2016, DEV NEUROSCI-BASEL, V38, P264, DOI 10.1159/000448514; Batista-Nascimento L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/128647; Ben Menachem-Zidon O, 2011, BRAIN BEHAV IMMUN, V25, P1008, DOI 10.1016/j.bbi.2010.11.007; Bradbury MWB, 1997, J NEUROCHEM, V69, P443; Burdo JR, 2001, J NEUROSCI RES, V66, P1198, DOI 10.1002/jnr.1256.abs; Carlson ES, 2009, J NUTR, V139, P672, DOI 10.3945/jn.108.096354; DAHLSTRAND J, 1995, DEV BRAIN RES, V84, P109, DOI 10.1016/0165-3806(94)00162-S; De Domenico I, 2005, P NATL ACAD SCI USA, V102, P8955, DOI 10.1073/pnas.0503804102; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Dubois NC, 2006, GENESIS, V44, P355, DOI 10.1002/dvg.20226; Furigo IC, 2018, BRAIN STRUCT FUNCT, V223, P2229, DOI 10.1007/s00429-018-1627-z; Ganz T, 2005, CELL METAB, V1, P155, DOI 10.1016/j.cmet.2005.02.005; Gao GF, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00019; Gewirtz JC, 2008, BRAIN RES, V1237, P195, DOI 10.1016/j.brainres.2008.08.079; Giusti SA, 2014, J PSYCHIATR RES, V55, P87, DOI 10.1016/j.jpsychires.2014.04.002; Hasan MT, 2019, NEURON, V103, P133, DOI 10.1016/j.neuron.2019.04.029; Heffron DS, 2009, AM J PATHOL, V175, P2586, DOI 10.2353/ajpath.2009.090130; Huckleberry KA, 2018, NEUROPSYCHOPHARMACOL, V43, P2487, DOI 10.1038/s41386-018-0109-6; Jiang RW, 2015, J NUTR, V145, P1003, DOI 10.3945/jn.114.207316; Ke Y, 2007, PROG NEUROBIOL, V83, P149, DOI 10.1016/j.pneurobio.2007.07.009; Knutson MD, 2019, FREE RADICAL BIO MED, V133, P101, DOI 10.1016/j.freeradbiomed.2018.10.413; Lakhal-Littleton S, 2015, P NATL ACAD SCI USA, V112, P3164, DOI 10.1073/pnas.1422373112; Li X, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071518; Li YP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0740-2; Liao ZH, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00396; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Mayr R, 2010, J HEPATOL, V53, P941, DOI 10.1016/j.jhep.2010.05.016; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mobbs D, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00055; Mok H, 2004, DEVELOPMENT, V131, P1859, DOI 10.1242/dev.01081; Moos T, 1996, J COMP NEUROL, V375, P675, DOI 10.1002/(SICI)1096-9861(19961125)375:4<675::AID-CNE8>3.0.CO;2-Z; Morales AV, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00096; Mouri A, 2010, HIPPOCAMPUS, V20, P293, DOI 10.1002/hipo.20625; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Pietrangelo A, 2004, BLOOD CELL MOL DIS, V32, P131, DOI 10.1016/j.bcmd.2003.08.003; Qian ZM, 2019, BIOL REV, V94, P1672, DOI 10.1111/brv.12521; Ramey G, 2010, HAEMATOL-HEMATOL J, V95, P501, DOI 10.3324/haematol.2009.014399; Rozeske RR, 2015, GENES BRAIN BEHAV, V14, P22, DOI 10.1111/gbb.12181; Saur L, 2016, NEUROCHEM RES, V41, P892, DOI 10.1007/s11064-015-1770-3; Scott GA, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00407; Sengupta A, 2019, NEURON, V103, P489, DOI 10.1016/j.neuron.2019.05.029; Soler-Cedeno O, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0354-18.2019; Texel SJ, 2012, J NEUROCHEM, V120, P125, DOI 10.1111/j.1471-4159.2011.07554.x; Wang L, 2019, J CELL PHYSIOL, V234, P7600, DOI 10.1002/jcp.27522; Wang SM, 2010, CELL MOL LIFE SCI, V67, P123, DOI 10.1007/s00018-009-0167-3; Wang XQ, 2018, AM J PHYSIOL-RENAL, V315, pF1042, DOI 10.1152/ajprenal.00072.2018; Wenger MJ, 2019, J NUTR, V149, P687, DOI 10.1093/jn/nxy265; Wiese C, 2004, CELL MOL LIFE SCI, V61, P2510, DOI 10.1007/s00018-004-4144-6; Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066; Wu Q, 2019, ANTIOXID REDOX SIGN, V30, P198, DOI 10.1089/ars.2017.7063; Wu WY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.372; You LH, 2015, NEUROSCIENCE, V284, P234, DOI 10.1016/j.neuroscience.2014.09.071; You LH, 2016, BRAIN RES, V1642, P33, DOI 10.1016/j.brainres.2016.03.023; Zhang RR, 2013, CELL STEM CELL, V13, P237, DOI 10.1016/j.stem.2013.05.006; Zhang ZZ, 2012, HEPATOLOGY, V56, P961, DOI 10.1002/hep.25746; Zhang ZZ, 2011, BLOOD, V118, P1912, DOI 10.1182/blood-2011-01-330324; Zohn IE, 2007, BLOOD, V109, P4174, DOI 10.1182/blood-2007-01-066068	63	4	4	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202000167RR	http://dx.doi.org/10.1096/fj.202000167RR		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33200454				2022-12-26	WOS:000592669300001
J	Huang, BS; Gan, L; Chen, DJ; Zhang, YC; Zhang, YJ; Liu, XL; Chen, S; Wei, ZS; Tong, LQ; Song, ZJ; Zhang, XH; Cai, DT; Zhang, CF; He, YC				Huang, Baosheng; Gan, Lu; Chen, Dongjie; Zhang, Yachun; Zhang, Yujie; Liu, Xiangli; Chen, Si; Wei, Zhisong; Tong, Liqi; Song, Zhaojian; Zhang, Xianhua; Cai, Detian; Zhang, Changfeng; He, Yuchi			Integration of small RNA, degradome and proteome sequencing in Oryza sativa reveals a delayed senescence network in tetraploid rice seed	PLOS ONE			English	Article							NAC TRANSCRIPTION FACTOR; IDENTIFICATION; GERMINATION; EXPRESSION; METABOLISM; MECHANISMS; STABILITY; OXIDATION; OXIDASE; GENES	Seed of rice is an important strategic resource for ensuring the security of China's staple food. Seed deterioration as a result of senescence is a major problem during seed storage, which can cause major economic losses. Screening among accessions in rice germplasm resources for traits such as slow senescence and increased seed longevity during storage is, therefore, of great significance. However, studies on delayed senescence in rice have been based mostly on diploid rice seed to date. Despite better tolerance have been verified by the artificial aging treatment for polyploid rice seed, the delayed senescence properties and delayed senescence related regulatory mechanisms of polyploid rice seed are rarely reported, due to the lack of polyploid rice materials with high seed set. High-throughput sequencing was applied to systematically investigate variations in small RNAs, the degradome, and the proteome between tetraploid and diploid rice seeds. Degradome sequencing analysis of microRNAs showed that expression of miR-164d, which regulates genes encoding antioxidant enzymes, was changed significantly, resulting in decreased miRNA-mediated cleavage of target genes in tetraploid rice. Comparisons of the expression levels of small RNAs (sRNAs) in the tetraploid and diploid libraries revealed that 12 sRNAs changed significantly, consistent with the findings from degradome sequencing. Furthermore, proteomics also showed that antioxidant enzymes were up-regulated in tetraploid rice seeds, relative to diploids.	[Huang, Baosheng; Gan, Lu; Zhang, Yachun; Zhang, Yujie; Liu, Xiangli; Chen, Si; Wei, Zhisong; Tong, Liqi; Song, Zhaojian; Zhang, Xianhua; Cai, Detian; He, Yuchi] Hubei Univ, Sch Life Sci, State Key Lab Biocatalysis & Enzyme Engn, Wuhan, Peoples R China; [Chen, Dongjie; Zhang, Changfeng] Shandong Prov Key Lab Storage & Transportat Techn, Jinan, Peoples R China; [Song, Zhaojian; Zhang, Xianhua; Cai, Detian; He, Yuchi] Wuhan Polyploid Biol Technol Co Ltd, Wuhan, Peoples R China	Hubei University	He, YC (corresponding author), Hubei Univ, Sch Life Sci, State Key Lab Biocatalysis & Enzyme Engn, Wuhan, Peoples R China.; Zhang, CF (corresponding author), Shandong Prov Key Lab Storage & Transportat Techn, Jinan, Peoples R China.; He, YC (corresponding author), Wuhan Polyploid Biol Technol Co Ltd, Wuhan, Peoples R China.	zcf202@163.com; hyc@hubu.edu.cn			Chinese National Natural Science Foundation [31960068, 31270356, 31271690, 31571639]; 2017 Hubei Science and Technology Department Innovation Team [2017CFA023]; Wuhan Yellow Crane Talents (science) Foundation; Wuhan Polyploid Biology Technology Co. Ltd	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 2017 Hubei Science and Technology Department Innovation Team; Wuhan Yellow Crane Talents (science) Foundation; Wuhan Polyploid Biology Technology Co. Ltd	This project was supported by the Chinese National Natural Science Foundation (Grant Nos.31960068, 31270356, 31271690, and 31571639), 2017 Hubei Science and Technology Department Innovation Team (2017CFA023), 2016 Wuhan Yellow Crane Talents (science) Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Wuhan Polyploid Biology Technology Co. Ltd provided support for this study in the form of salaries for ZS, XZ, DC, and YH. The specific roles of these authors are articulated in the "author contributions" section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaron J B, 2015, ROLES MECH DNA REPAI; Afrikanova Tatiana, 2013, PLoS One, V8, pe54166, DOI 10.1371/journal.pone.0054166; [Anonymous], 2016, AM J INFECT CONTROL, V44, P1, DOI 10.1016/j.ajic.2015.11.014; [Anonymous], 2012, KIDNEY INT, V2, ps1; Bazin J, 2011, PLANT CELL, V23, P2196, DOI 10.1105/tpc.111.086694; Bewley JD., 2012, PHYSL BIOCH SEEDS RE, V2; Burklew CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034783; Chandra J, 2018, PHYSIOL MOL BIOL PLA, V24, P75, DOI 10.1007/s12298-017-0487-y; Chen CL, 2003, NUCLEIC ACIDS RES, V31, P2601, DOI 10.1093/nar/gkg373; Chen XL, 2018, PLANT PHYSIOL BIOCH, V130, P455, DOI 10.1016/j.plaphy.2018.07.022; Chen X, 2015, PLANT J, V82, P302, DOI 10.1111/tpj.12819; Chen ZJ, 2010, TRENDS PLANT SCI, V15, P57, DOI 10.1016/j.tplants.2009.12.003; Datta R, 2015, PLANT PHYSIOL, V169, P2963, DOI 10.1104/pp.15.01543; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Dong XY, 2017, J INTEGR AGR, V16, P1084, DOI 10.1016/S2095-3119(16)61579-4; editorial Journal, 2014, NETW SECUR, V7, P1; Fleming MB, 2017, J EXP BOT, V68, P2219, DOI 10.1093/jxb/erx100; Fu LW, 2020, PLANT PHYSIOL, V182, P1613, DOI 10.1104/pp.19.01214; He YC, 2010, PLANTA, V232, P1219, DOI 10.1007/s00425-010-1249-z; Jiali Z, 2018, MOL PLANT BREEDING; Jiang AiMing, 2013, Australian Journal of Crop Science, V7, P1814; Ko KW, 2008, BIOSCI BIOTECH BIOCH, V72, P3285, DOI 10.1271/bbb.80427; Koltover Vitaly K, 2017, Curr Aging Sci, V10, P12; Kranner I, 2011, ENVIRON EXP BOT, V72, P93, DOI 10.1016/j.envexpbot.2010.05.005; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Li J, 2017, RUSS J PLANT PHYSL+, V64, P251, DOI 10.1134/S102144371702008X; Li LS, 2018, 22ND INTERNATIONAL CONFERENCE ON OPTICAL NETWORK DESIGN AND MODELING (ONDM 2018), P172; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Liu JZ, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1707-0; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mao CJ, 2017, PLANT PHYSIOL, V174, P1747, DOI 10.1104/pp.17.00542; Minibayeva F, 2015, PHYTOCHEMISTRY, V112, P122, DOI 10.1016/j.phytochem.2014.06.008; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nayar NM, 2014, ORIGINS AND PHYLOGENY OF RICES, P1; Oenel A, 2017, PLANT CELL PHYSIOL, V58, P925, DOI 10.1093/pcp/pcx036; Rajjou L, 2012, ANNU REV PLANT BIOL, V63, P507, DOI 10.1146/annurev-arplant-042811-105550; Scarpino SV, 2014, AM NAT, V184, P456, DOI 10.1086/677752; Sharma SN, 2018, PLANT PHYSIOL BIOCH, V124, P40, DOI 10.1016/j.plaphy.2017.12.036; Song MJ, 2020, PLANT CELL, V32, P1434, DOI 10.1105/tpc.19.00832; Tomonobu T, 2014, J EXPT BOT, P1369; Troyjack C., 2018, American Journal of Plant Sciences, V9, P83, DOI 10.4236/ajps.2018.91008; Wang WQ, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00172; Wang XM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57518-5; Wang YQ, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0364-7; Wang Y, 2015, PLANT J, V81, P438, DOI 10.1111/tpj.12737; Waterworth WM, 2016, P NATL ACAD SCI USA, V113, P9647, DOI 10.1073/pnas.1608829113; Wen DX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23909-y; Wu JH, 2009, J INTEGR PLANT BIOL, V51, P638, DOI 10.1111/j.1744-7909.2009.00841.x; Xu XueZhong, 2018, Acta Agronomica Sinica, V44, P24; Yidong QI, 2019, CURRENT BIOTECHNOLOG; Yujie F, J EXPT BOT, P2119; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhan J, 2014, PLANT PHYSIOL BIOCH, V75, P105, DOI 10.1016/j.plaphy.2013.12.010; Zhang GY, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-018-1340-4; Zhao MingHui, 2006, Acta Agronomica Sinica, V32, P1472; Zhiyou K, 2010, J CHINESE CEREALS OI, P24; Zhou Y, 2020, J INTEGR PLANT BIOL, V62, P470, DOI 10.1111/jipb.12792; [朱艳乔 Zhu Yanqiao], 2016, [草业科学, Pratacultural Science], V33, P290	58	6	7	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242260	10.1371/journal.pone.0242260	http://dx.doi.org/10.1371/journal.pone.0242260			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186373	Green Published, gold			2022-12-26	WOS:000593949800021
J	West, J; Harris, TJC				West, Junior J.; Harris, Tony J. C.			The Arf-GEF Steppke promotes F-actin accumulation, cell protrusions and tissue sealing during Drosophila dorsal closure	PLOS ONE			English	Article							WAVE REGULATORY COMPLEX; DOWNSTREAM ACTIVATION; SHEET MORPHOGENESIS; ADHERENS JUNCTIONS; G-PROTEINS; MIGRATION; DYNAMICS; CYTOSKELETON; FAMILY; ROLES	Cytohesin Arf-GEFs promote actin polymerization and protrusions of cultured cells, whereas the Drosophila cytohesin, Steppke, antagonizes actomyosin networks in several developmental contexts. To reconcile these findings, we analyzed epidermal leading edge actin networks during Drosophila embryo dorsal closure. Here, Steppke is required for F-actin of the actomyosin cable and for actin-based protrusions. steppke mutant defects in the leading edge actin networks are associated with improper sealing of the dorsal midline, but are distinguishable from effects of myosin mis-regulation. Steppke localizes to leading edge cell-cell junctions with accumulations of the F-actin regulator Enabled emanating from either side. Enabled requires Steppke for full leading edge recruitment, and genetic interaction shows the proteins cooperate for dorsal closure. Inversely, Steppke over-expression induces ectopic, actin-rich, lamellar cell protrusions, an effect dependent on the Arf-GEF activity and PH domain of Steppke, but independent of Steppke recruitment to myosin-rich AJs via its coiled-coil domain. Thus, Steppke promotes actin polymerization and cell protrusions, effects that occur in conjunction with Steppke's previously reported regulation of myosin contractility during dorsal closure.	[West, Junior J.; Harris, Tony J. C.] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada	University of Toronto	Harris, TJC (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON, Canada.	tony.harris@utoronto.ca			Canadian Institutes of Health Research (CIHR) [82829]; Ontario Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship)	Work supported by a Canadian Institutes of Health Research (CIHR) operating grant (82829) to T.H. J.W. was supported by an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CIHR website: https://cihr-irsc.gc.ca/Ontario Graduate Scholarship website: https://osap.gov.on.ca/OSAPPortal/en/A-ZListofAid/PRDR019245.html.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Agarwal P, 2019, TRENDS CELL BIOL, V29, P150, DOI 10.1016/j.tcb.2018.09.006; Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Bahri S, 2010, DEVELOPMENT, V137, P2023, DOI 10.1242/dev.045088; Blanchard GB, 2010, DEVELOPMENT, V137, P2743, DOI 10.1242/dev.045872; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Casalou Cristina, 2016, Small GTPases, V7, P270; Chugh P, 2018, J CELL SCI, V131, DOI 10.1242/jcs.186254; Cohen LA, 2007, MOL BIOL CELL, V18, P2244, DOI 10.1091/mbc.E06-11-0998; Collins C, 2015, CURR OPIN CELL BIOL, V36, P62, DOI 10.1016/j.ceb.2015.07.004; Del Signore SJ, 2018, DEV CELL, V44, P471, DOI 10.1016/j.devcel.2017.12.025; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Czerniak ND, 2016, CURR BIOL, V26, P1895, DOI 10.1016/j.cub.2016.05.027; Ducuing A, 2016, NAT CELL BIOL, V18, P1149, DOI 10.1038/ncb3421; Edwards M, 2014, NAT REV MOL CELL BIO, V15, P677, DOI 10.1038/nrm3869; Efimova N, 2018, J CELL BIOL, V217, P1827, DOI 10.1083/jcb.201708103; Gates J, 2007, DEVELOPMENT, V134, P2027, DOI 10.1242/dev.02849; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Grosshans J, 2005, DEVELOPMENT, V132, P1009, DOI 10.1242/dev.01669; Hernandez-Deviez DJ, 2004, MOL BIOL CELL, V15, P111, DOI 10.1091/mbc.E03-06-0410; Humphreys D, 2012, J CELL SCI, V125, P5630, DOI 10.1242/jcs.108092; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Jegou A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2888; Kiehart DP, 2017, ANNU REV CELL DEV BI, V33, P169, DOI 10.1146/annurev-cellbio-111315-125357; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kim YS, 2002, DEV BIOL, V249, P367, DOI 10.1006/dbio.2002.0768; Koronakis V, 2011, P NATL ACAD SCI USA, V108, P14449, DOI 10.1073/pnas.1107666108; Kozlov MM, 2004, J CELL BIOL, V167, P1011, DOI 10.1083/jcb.200410017; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Krugmann S, 2001, CURR BIOL, V11, P1645, DOI 10.1016/S0960-9822(01)00506-1; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Lee DM, 2015, GENETICS, V200, P863, DOI 10.1534/genetics.115.176867; Lee DM, 2013, CURR BIOL, V23, P2110, DOI 10.1016/j.cub.2013.08.058; Leerberg JM, 2014, CURR BIOL, V24, P1689, DOI 10.1016/j.cub.2014.06.028; Li JXH, 2020, P NATL ACAD SCI USA, V117, P432, DOI 10.1073/pnas.1908654117; Liu JS, 2015, MOL BIOL CELL, V26, P711, DOI 10.1091/mbc.E14-11-1554; Manning LA, 2019, MOL BIOL CELL, V30, P1938, DOI 10.1091/mbc.E19-04-0209; Martin P, 2004, DEVELOPMENT, V131, P3021, DOI 10.1242/dev.01253; Muralidharan-Chari V, 2009, CANCER RES, V69, P2201, DOI 10.1158/0008-5472.CAN-08-1301; Myers KR, 2008, TRENDS CELL BIOL, V18, P184, DOI 10.1016/j.tcb.2008.02.002; Nowotarski SH, 2014, MOL BIOL CELL, V25, P3147, DOI 10.1091/mbc.E14-05-0951; Park JA, 2016, J CELL SCI, V129, P3375, DOI 10.1242/jcs.187922; Pickering K, 2013, DEVELOPMENT, V140, P800, DOI 10.1242/dev.089557; Pollard TD, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018226; Rafiq NBM, 2017, J CELL BIOL, V216, P181, DOI 10.1083/jcb.201605104; Rauskolb C, 2019, J CELL SCI, V132, DOI 10.1242/jcs.224063; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Schock F, 2002, DEV BIOL, V248, P29, DOI 10.1006/dbio.2002.0698; Spracklen AJ, 2014, DEV BIOL, V393, P209, DOI 10.1016/j.ydbio.2014.06.022; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Toret CP, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.157495; West JJ, 2017, CURR BIOL, V27, P2260, DOI 10.1016/j.cub.2017.06.038; White DT, 2010, MOL BIOL CELL, V21, P562, DOI 10.1091/mbc.E09-03-0217; Winkelman JD, 2014, P NATL ACAD SCI USA, V111, P4121, DOI 10.1073/pnas.1322093111; Woolner S, 2005, DEV BIOL, V282, P163, DOI 10.1016/j.ydbio.2005.03.005; Zeledon C, 2019, CELL REP, V28, P3238, DOI 10.1016/j.celrep.2019.08.044; Zheng SY, 2019, MOL BIOL CELL, V30, P3090, DOI 10.1091/mbc.E19-10-0566; Zulueta-Coarasa T, 2017, MECH DEVELOP, V144, P43, DOI 10.1016/j.mod.2016.11.004	60	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0239357	10.1371/journal.pone.0239357	http://dx.doi.org/10.1371/journal.pone.0239357			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186390	Green Submitted, Green Published, gold			2022-12-26	WOS:000593949800056
J	Tanaka, H; Murata, K; Hashimoto, W; Kawai, S				Tanaka, Hideki; Murata, Kousaku; Hashimoto, Wataru; Kawai, Shigeyuki			Hsp104-dependent ability to assimilate mannitol and sorbitol conferred by a truncated Cyc8 with a C-terminal polyglutamine in Saccharomyces cerevisiae	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSION; GENERAL REPRESSOR; SUGAR ALCOHOLS; YEAST; COREPRESSOR; HSP104; TUP1; DEHYDROGENASE; INHERITANCE; METABOLISM	Tup1-Cyc8 (also known as Tup1-Ssn6) is a general transcriptional corepressor. D-Mannitol (mannitol) and D-sorbitol (sorbitol) are the major polyols in nature. Budding yeast Saccharomyces cerevisiae is unable to assimilate mannitol or sorbitol, but acquires the ability to assimilate mannitol due to a spontaneous mutation in TUP1 or CYC8. In this study, we found that spontaneous mutation of TUP1 or CYC8 also permitted assimilation of sorbitol. Some spontaneous nonsense mutations of CYC8 produced a truncated Cyc8 with a C-terminal polyglutamine. The effects were guanidine hydrochloride-sensitive and were dependent on Hsp104, but were complemented by introduction of CYC8, ruling out involvement of a prion. Assimilation of mannitol and sorbitol conferred by other mutations of TUP1 or CYC8 was guanidine hydrochloride-tolerant. It is physiologically reasonable that S. cerevisiae carries this mechanism to acquire the ability to assimilate major polyols in nature.	[Tanaka, Hideki; Hashimoto, Wataru] Kyoto Univ, Grad Sch Agr, Lab Basic & Appl Mol Biotechnol, Div Food Sci & Biotechnol, Uji, Kyoto, Japan; [Murata, Kousaku] Setsunan Univ, Fac Sci & Engn, Dept Life Sci, Ikeda Nakamachi, Neyagawa, Osaka, Japan; [Kawai, Shigeyuki] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Lab Environm Biotechnol, Nonoichi, Ishikawa, Japan	Kyoto University; Setsunan University; Ishikawa Prefecture University	Kawai, S (corresponding author), Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Lab Environm Biotechnol, Nonoichi, Ishikawa, Japan.	kawais@ishikawa-pu.ac.jp		Kawai, Shigeyuki/0000-0002-3640-9540	Shorai Foundation for Science And Technology; Asahi Group foundation [19K05796]	Shorai Foundation for Science And Technology; Asahi Group foundation	Research Grant-in-Aid (to S.K.) from the 41th Iwatani Naoji Foundation Iwatani Scientific Technology (http://www.iwatani-foundation.or.jp/) Research Grant-in-Aid in 2015 (to S.K.) from Shorai Foundation for Science And Technology (https://www.harima.co.jp/en/shorai-foundation/) Research Grant-in-Aid in 2015 (to S.K.) from Asahi Group foundation (http://www.asahigroup-foundation.com/academic/) Grant-in-Aid for Scientific Research (C) (19K05796) (to S.K.) (https://www.jsps.go.jp/english/e-grants/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; BARNETT JA, 1968, J GEN MICROBIOL, V52, P131, DOI 10.1099/00221287-52-1-131; Bieleski RL, 1982, SUGAR ALCOHOLS; Carrico PM, 1998, GENETICS, V148, P637; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chujo M, 2015, APPL ENVIRON MICROB, V81, P9, DOI 10.1128/AEM.02906-14; Enquist-Newman M, 2014, NATURE, V505, P239, DOI 10.1038/nature12771; FOX TD, 1991, METHOD ENZYMOL, V194, P149; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Jia Y, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0478-5; Jordan P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23502; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kawai S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020145; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; Kimura Y, 2001, GENES CELLS, V6, P887, DOI 10.1046/j.1365-2443.2001.00472.x; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; LEWIS DH, 1967, NEW PHYTOL, V66, P143, DOI 10.1111/j.1469-8137.1967.tb05997.x; LOESCHER WH, 1987, PHYSIOL PLANTARUM, V70, P553, DOI 10.1111/j.1399-3054.1987.tb02857.x; Malave TM, 2006, BIOCHEM CELL BIOL, V84, P437, DOI 10.1139/O06-073; Ota A, 2013, J BIOSCI BIOENG, V116, P327, DOI 10.1016/j.jbiosc.2013.03.018; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Perfect JR, 1996, J BACTERIOL, V178, P5257, DOI 10.1128/jb.178.17.5257-5262.1996; QUAIN DE, 1987, J GEN MICROBIOL, V133, P1675; Romanova NV, 2009, PROTEIN PEPTIDE LETT, V16, P598, DOI 10.2174/092986609788490078; SARTHY AV, 1994, GENE, V140, P121, DOI 10.1016/0378-1119(94)90741-2; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SIKORSKI RS, 1989, GENETICS, V122, P19; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016; Varanasi US, 1996, MOL CELL BIOL, V16, P6707	33	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242054	10.1371/journal.pone.0242054	http://dx.doi.org/10.1371/journal.pone.0242054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175887	Green Published, gold			2022-12-26	WOS:000593946900002
J	Wang, Y; Jin, C; Wu, CC; Zhao, HF; Liang, T; Liu, Z; Jian, ZJ; Li, RQ; Wang, ZK; Li, F; Zhou, J; Cai, SB; Liu, Y; Li, H; Liang, YK; Tian, C; Yang, J				Wang, Yan; Jin, Chao; Wu, Carol C.; Zhao, Huifang; Liang, Ting; Liu, Zhe; Jian, Zhijie; Li, Runqing; Wang, Zekun; Li, Fen; Zhou, Jie; Cai, Shubo; Liu, Yang; Li, Hao; Liang, Yukun; Tian, Cong; Yang, Jian			Organizing pneumonia of COVID-19: Time-dependent evolution and outcome in CT findings	PLOS ONE			English	Article								Background As a pandemic, a most-common pattern resembled organizing pneumonia (OP) has been identified by CT findings in novel coronavirus disease (COVID-19). We aimed to delineate the evolution of CT findings and outcome in OP of COVID-19. Materials and methods 106 COVID-19 patients with OP based on CT findings were retrospectively included and categorized into non-severe (mild/common) and severe (severe/critical) groups. CT features including lobar distribution, presence of ground glass opacities (GGO), consolidation, linear opacities and total severity CT score were evaluated at three time intervals from symptom-onset to CT scan (day 0-7, day 8-14, day > 14). Discharge or adverse outcome (admission to ICU or death), and pulmonary sequelae (complete absorption or lesion residuals) on CT after discharge were analyzed based on the CT features at different time interval. Results 79 (74.5%) patients were non-severe and 103 (97.2%) were discharged at median day 25 (range, day 8-50) after symptom-onset. Of 67 patients with revisit CT at 2-4 weeks after discharge, 20 (29.9%) had complete absorption of lesions at median day 38 (range, day 30-53) after symptom-onset. Significant differences between complete absorption and residuals groups were found in percentages of consolidation (1.5% vs. 13.8%, P = 0.010), number of involved lobe > 3 (40.0% vs. 72.5%, P = 0.030), CT score > 4 (20.0% vs. 65.0%, P = 0.010) at day 8-14. Conclusion Most OP cases had good prognosis. Approximately one-third of cases had complete absorption of lesions during 1-2 months after symptom-onset while those with increased frequency of consolidation, number of involved lobe > 3, and CT score > 4 at week 2 after symptom-onset may indicate lesion residuals on CT.	[Wang, Yan; Jin, Chao; Zhao, Huifang; Liang, Ting; Liu, Zhe; Jian, Zhijie; Li, Runqing; Tian, Cong; Yang, Jian] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian, Peoples R China; [Wu, Carol C.] Univ Texas MD Anderson Canc Ctr, Dept Thorac Imaging, Houston, TX 77030 USA; [Wang, Zekun; Li, Fen] Eighth Hosp Xian, Dept Radiol, Xian, Peoples R China; [Zhou, Jie; Cai, Shubo] Xian Chest Hosp, Dept Radiol, Xian, Peoples R China; [Liu, Yang] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Cardiol, Xian, Peoples R China; [Li, Hao] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Crit Care Med, Xian, Peoples R China; [Liang, Yukun] Ankang Ctr Hosp, Dept Radiol, Ankang, Peoples R China	Xi'an Jiaotong University; University of Texas System; UTMD Anderson Cancer Center; Xi'an Jiaotong University; Xi'an Jiaotong University	Yang, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Radiol, Xian, Peoples R China.	yj1118@mail.xjtu.edu.cn	Li, Hao/GPS-9834-2022; Li, Run-Qing/ABH-2730-2021					[Anonymous], 2005, DISCOVERY NEW FRONTI, V6, P5; [Anonymous], 2020, J THORAC ONCOL, V13, pS322, DOI 10.1016/j.jtho.2018.08.241; Antonio GE, 2003, RADIOLOGY, V228, P810, DOI 10.1148/radiol.2283030726; Chan KS, 2003, RESPIROLOGY, V8, pS36, DOI 10.1046/j.1440-1843.2003.00522.x; Chen J, 2020, J INFECTION, V80, pE1, DOI 10.1016/j.jinf.2020.03.004; Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1148/radiol.2020200230, 10.1007/s00330-019-06574-1]; Clyne B, 1999, J EMERG MED, V17, P1019, DOI 10.1016/S0736-4679(99)00135-3; Cordier JF, 2006, EUR RESPIR J, V28, P422, DOI 10.1183/09031936.06.00013505; Das Karuna M, 2017, Indian J Radiol Imaging, V27, P342, DOI 10.4103/ijri.IJRI_469_16; Drakopanagiotakis F, 2011, CHEST, V139, P893, DOI 10.1378/chest.10-0883; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jenne CN, 2018, CELL TISSUE RES, V371, P395, DOI 10.1007/s00441-018-2802-5; Kang H, 2012, J COMPUT ASSIST TOMO, V36, P285, DOI 10.1097/RCT.0b013e31825588e6; Kanne Jeffrey P, 2020, Radiology, V296, pE113, DOI 10.1148/radiol.2020200527; Kligerman SJ, 2013, RADIOGRAPHICS, V33, P1951, DOI 10.1148/rg.337130057; National Health Commission of the People's Republic of China, DIAGN TREATM PNEUM C; Park WB, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e169; Roberton BJ, 2011, EUR RADIOL, V21, P2244, DOI 10.1007/s00330-011-2191-6; Salem S, 2020, GLOB MID EAST, P1, DOI [10.2214/AJR.20.23034, 10.1017/9781108868969, 10.2214/AJR.20.23034S.]; Shi HS, 2020, LANCET INFECT DIS, V20, P425, DOI 10.1016/S1473-3099(20)30086-4; Simpson Scott, 2020, Radiol Cardiothorac Imaging, V2, pe200152, DOI [10.1097/RTI.0000000000000524, 10.1148/ryct.2020200152]; Wang Yuhui, 2020, Radiology, V296, pE55, DOI 10.1148/radiol.2020200843; WHO, 2020, COR DIS COVID 19 PAN; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; You JJ, 2020, J INFECTION, V81, pE150, DOI 10.1016/j.jinf.2020.06.003; Zhao YM, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100463; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zu ZY, 2020, RADIOLOGY, V296, pE15, DOI 10.1148/radiol.2020200490	29	19	19	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0240347	10.1371/journal.pone.0240347	http://dx.doi.org/10.1371/journal.pone.0240347			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175876	gold, Green Submitted, Green Published			2022-12-26	WOS:000593946900059
J	Chen, HY; Lu, SN; Hung, CH; Wang, JH; Chen, CH; Yen, YH; Kuo, YH; Kee, KM				Chen, Hsin-Yeh; Lu, Sheng-Nan; Hung, Chao-Hung; Wang, Jing-Houng; Chen, Chien-Hung; Yen, Yi-Hao; Kuo, Yuan-Hung; Kee, Kwong-Ming			Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation	PLOS ONE			English	Article							ALBUMIN-BILIRUBIN GRADE; ASPARTATE-AMINOTRANSFERASE; ALBI GRADE; RESECTION; FIBROSIS; RISK; PROGNOSIS; SURVIVAL; THERAPY; DISEASE	Background Intrahepatic distant recurrence (IDR) is a significant problem for patients who have undergone radiofrequency ablation (RFA) for hepatocellular carcinoma (HCC). The objective of the study was to investigate risk factors and to predict outcomes of recurrent IDR within Milan criteria after complete RFA for primary early-stage HCC. Method This retrospective study reviewed 449 patients with intrahepatic distant recurrent HCC after complete RFA for early-stage HCC. After excluding 100 patients who were beyond Milan criteria, with incomplete lab data, or had follow-up less than three months, a total of 349 patient cases were compiled and their baseline characteristics, further treatment modalities after tumor recurrence and survival were analyzed. Results After a median follow-up of 36.2 months, 92 patients had expired. The majority of patients were male (59.9%) with a median age of 64.3 years (range:38-88). The cumulative 5-year overall survival (OS) rates after treatment for recurrent HCC was 67.2%. On multivariate analysis, end-stage renal disease(Hazard ratio (H.R.) = 2.33, p = 0.021), m-ALBI grade 2a (H.R. = 2.86, p = 0.003) and m-ALBI grades 2b or 3 (H.R. = 2.30, p = 0.009), APRI greater than 1 (H.R. = 1.92, p = 0.036) and 2(nd) recurrence occurring within 1 year (H.R. = 2.69, p<0.001) were significantly associated with worse survival. The cumulative 5-year 2(nd) recurrence rate was 87.4%. On multivariate analysis, male gender (H.R. = 1.47, p = 0.01), age greater than 65 years (H.R. = 1.72, p<0.001), an alpha fetoprotein level greater than 20ng/ml (H.R. = 1.41, p = 0.016), surgical treatment for recurrent HCC (H.R. = 0.25, p = 0.007), tumor number greater than 1 (H.R. = 1.35, p = 0.046), and IDR developing within 2 years (H.R. = 1.67, p = 0.001) were prognostic factors for 2(nd) recurrence. Conclusion Our study suggested that presence of end-stage renal disease, m-ALBI grades 2 and 3, APRI >1 and time to 2(nd) HCC recurrence were all associated with overall survival while the 2(nd) HCC recurrence was associated with male gender, age >= 65 years, alpha-fetoprotein level >20 ng/mL, non-surgical therapy, time to IDR, and tumor number> 1.	[Chen, Hsin-Yeh; Lu, Sheng-Nan; Hung, Chao-Hung; Wang, Jing-Houng; Chen, Chien-Hung; Yen, Yi-Hao; Kuo, Yuan-Hung; Kee, Kwong-Ming] Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Hsin-Yeh; Lu, Sheng-Nan; Hung, Chao-Hung; Wang, Jing-Houng; Chen, Chien-Hung; Yen, Yi-Hao; Kuo, Yuan-Hung; Kee, Kwong-Ming] Chang Gung Univ, Div Hepatogastroenterol, Dept Internal Med, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Kee, KM (corresponding author), Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Dept Internal Med, Kaohsiung, Taiwan.; Kee, KM (corresponding author), Chang Gung Univ, Div Hepatogastroenterol, Dept Internal Med, Coll Med, Kaohsiung, Taiwan.	kee.kkm@gmail.com						Ahmed M, 2014, RADIOLOGY, V273, P241, DOI 10.1148/radiol.14132958; Alins J, 2012, COMPUT NETW, V56, P412, DOI 10.1016/j.comnet.2011.09.005; Allaire M, 2019, DIGEST LIVER DIS, V51, P86, DOI 10.1016/j.dld.2018.07.014; [Anonymous], 2018, CAUS DEATH TAIW 2018; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Chan ACY, 2013, LIVER TRANSPLANT, V19, P411, DOI 10.1002/lt.23605; Chan AWH, 2018, J HEPATOL, V69, P1284, DOI 10.1016/j.jhep.2018.08.027; Chen XX, 2015, J SURG RES, V195, P166, DOI 10.1016/j.jss.2015.01.042; Cho JY, 2016, CLIN MOL HEPATOL, V22, P477, DOI 10.3350/cmh.2016.0048; Choi SI, 2017, J GASTROEN HEPATOL, V32, P651, DOI 10.1111/jgh.13532; Chung HA, 2016, SAUDI J GASTROENTERO, V22, P57, DOI 10.4103/1319-3767.173760; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Faber W, 2011, J GASTROEN HEPATOL, V26, P1189, DOI 10.1111/j.1440-1746.2011.06721.x; Fukuhara T, 2015, EUR J RADIOL, V84, P1540, DOI 10.1016/j.ejrad.2015.04.020; Hann HW, 2015, J GASTROEN HEPATOL, V30, P131, DOI 10.1111/jgh.12664; He W, 2018, CLIN GASTROENTEROL H, V16, P756, DOI 10.1016/j.cgh.2017.12.002; Hiraoka A, 2019, LIVER CANCER, V8, P312, DOI 10.1159/000494844; Hiraoka A, 2019, LIVER CANCER, V8, P121, DOI 10.1159/000488778; Hiraoka A, 2017, LIVER CANCER, V6, P325, DOI 10.1159/000479984; Ikemoto T, 2017, HEPATOL RES, V47, P23, DOI 10.1111/hepr.12705; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kang TW, 2017, CLIN MOL HEPATOL, V23, P95, DOI 10.3350/cmh.2017.0006; Kao WY, 2017, RADIOLOGY, V285, P670, DOI 10.1148/radiol.2017162382; Kao WY, 2011, EUR J GASTROEN HEPAT, V23, P528, DOI 10.1097/MEG.0b013e328346d529; Lee CH, 2017, ONCOTARGET, V8, P73154, DOI 10.18632/oncotarget.17127; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Marrero JA, 2019, CLIN LIVER DIS, V13, P1; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; N'Kontchou G, 2009, HEPATOLOGY, V50, P1475, DOI 10.1002/hep.23181; Nishikawa H, 2012, ANTICANCER RES, V32, P5059; Okuwaki Y, 2009, AM J GASTROENTEROL, V104, P2747, DOI 10.1038/ajg.2009.414; Paik N, 2018, LIVER INT, V38, P68, DOI 10.1111/liv.13489; Pinato DJ, 2017, J HEPATOL, V66, P338, DOI 10.1016/j.jhep.2016.09.008; Rossi S, 2011, HEPATOLOGY, V53, P136, DOI 10.1002/hep.23965; Sato M, 2017, J GASTROEN HEPATOL, V32, P1873, DOI 10.1111/jgh.13780; Shiha G, 2009, HEPATOL INT, V3, P323, DOI 10.1007/s12072-008-9114-x; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263; Vitale A, 2017, J HEPATOL, V66, P412, DOI 10.1016/j.jhep.2016.09.012; Xu XF, 2019, JAMA SURG, V154, P209, DOI 10.1001/jamasurg.2018.4334; Yamashita S, 2015, SURGERY, V157, P463, DOI 10.1016/j.surg.2014.10.019; Zhang CM, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/2046825	43	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0242113	10.1371/journal.pone.0242113	http://dx.doi.org/10.1371/journal.pone.0242113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170894	gold, Green Published			2022-12-26	WOS:000592383400041
J	Dooley, EE; Gabriel, KP; Kohl, HW; Durand, CP; Hoelscher, DM; Byrd-Williams, CE				Dooley, Erin E.; Gabriel, Kelley Pettee; Kohl, Harold W., III; Durand, Casey P.; Hoelscher, Deanna M.; Byrd-Williams, Courtney E.			Adiposity, cardiovascular, and health-related quality of life indicators and the reallocation of waking movement behaviors in preschool children with overweight and obesity: An isotemporal data analysis	PLOS ONE			English	Article							BODY-MASS INDEX; PHYSICAL-ACTIVITY INTENSITY; FOR-DISEASE-CONTROL; BLOOD-PRESSURE; SEDENTARY TIME; UNITED-STATES; CHILDHOOD OBESITY; PREVENTION; PREVALENCE; ADOLESCENTS	Background Isotemporal substitution evaluates hypothetical time replacement scenarios of physical movement on health, with few studies conducted among ethnically diverse preschool-aged populations. This study examines the reallocation of waking movement behaviors on adiposity, cardiovascular, and quality of life indicators among low-income, majority Hispanic preschool-aged youth (2-5 years) with overweight. Methods Participants wore an ActiGraph monitor (waist) and completed adiposity, cardiovascular, and health-related quality of life health assessments. Covariates included age, sex, ethnicity, and socioeconomic status. The isotemporal substitution approach was employed to address study aims. Results Complete data were available for 131 preschoolers. For boys, reallocating 5 minutes of stationary time with light intensity, moderate to vigorous intensity, or total physical activity showed a relation with beneficial reductions in adiposity indicators; for girls, these relations were statistically null. For boys and girls, reallocating 5 minutes of stationary time [-2.2 (95% CI: -3.7, -0.7) mmHg], light intensity [-2.1 (95% CI: -3.7, -0.7) mmHg], or moderate intensity activity [-2.7 (95% CI: -5.0, -0.4) mmHg] to vigorous intensity activity was related to favorable systolic blood pressure. Reallocating 5 minutes of stationary time to moderate to vigorous intensity activity [0.6 (95% CI: -1.0, -0.1) mmHg] or total physical activity [-0.2 (95% CI: -0.3, -0.01) mmHg] was related to lowered systolic blood pressure. Reallocating 5 minutes of stationary time to moderate to vigorous intensity activity [0.6 (95% CI: -1.1, -0.02) bpm] was related to lowered resting heart rate. No significant results for quality of life were found. Conclusion Reallocation of time from stationary time to other movement behaviors is associated with several favorable adiposity and cardiovascular health outcomes among preschool children with overweight and obesity.	[Dooley, Erin E.] NCI, Risk Factor Assessment Branch, Epidemiol & Genom Res Program, Rockville, MD 20850 USA; [Dooley, Erin E.; Gabriel, Kelley Pettee; Kohl, Harold W., III; Hoelscher, Deanna M.; Byrd-Williams, Courtney E.] Univ Texas Hlth Sci Ctr UTHlth, Sch Publ Hlth Austin, Michael & Susan Ctr Hlth Living, Austin, TX 77030 USA; [Gabriel, Kelley Pettee] Univ Alabama Birmingham, Sch Publ Hlth, Dept Epidemiol, Birmingham, AL 35294 USA; [Kohl, Harold W., III] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA; [Durand, Casey P.] Univ Texas Hlth Sci Ctr Houston UTHlth, Hlth Promot & Behav Sci, Sch Publ Hlth, Houston, TX USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Dooley, EE (corresponding author), NCI, Risk Factor Assessment Branch, Epidemiol & Genom Res Program, Rockville, MD 20850 USA.; Dooley, EE (corresponding author), Univ Texas Hlth Sci Ctr UTHlth, Sch Publ Hlth Austin, Michael & Susan Ctr Hlth Living, Austin, TX 77030 USA.	erin.dooley2@nih.gov	Dooley, Erin/ABH-4906-2020	Dooley, Erin/0000-0001-9881-5053; Hoelscher, Deanna/0000-0002-0910-5031	Centers for Disease Control and Prevention [RFA-DP-11-007]; USDA/ARS [58-6250-0-008]; Michael & Susan Dell Foundation	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USDA/ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Michael & Susan Dell Foundation	This research was supported by cooperative agreement RFA-DP-11-007 from the Centers for Disease Control and Prevention and with federal funds from the USDA/ARS under Cooperative Agreement No. 58-6250-0-008 (PI: DMH). Additional support was provided by the Michael & Susan Dell Foundation for resources provided at the Michael & Susan Center for Healthy Living at the University of Texas Health Science Center in Houston (UTHealth) School of Public Health in Austin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker ME, 2000, PAEDIATR PERINAT EP, V14, P179, DOI 10.1046/j.1365-3016.2000.00250.x; Biddle GJH, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162885; Bingham DD, 2016, J SPORT SCI, V34, P2005, DOI 10.1080/02640414.2016.1149605; Britto PR, 2017, LANCET, V389, P91, DOI 10.1016/S0140-6736(16)31390-3; Butte NF, 2014, MED SCI SPORT EXER, V46, P1216, DOI 10.1249/MSS.0000000000000209; Cain KL, 2013, J PHYS ACT HEALTH, V10, P437, DOI 10.1123/jpah.10.3.437; Carson V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4852-0; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Collings PJ, 2017, MED SCI SPORT EXER, V49, P930, DOI 10.1249/MSS.0000000000001180; Collings PJ, 2013, AM J CLIN NUTR, V97, P1020, DOI 10.3945/ajcn.112.045088; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; de Onis M, 2010, AM J CLIN NUTR, V92, P1257, DOI 10.3945/ajcn.2010.29786; Esliger DW, 2005, J PHYS ACTIVITY HLTH, V3, P366, DOI DOI 10.1186/1479-5868-8-62; Flegal KM, 2009, AM J CLIN NUTR, V90, P1314, DOI 10.3945/ajcn.2009.28335; Flynn JT, 2017, PEDIATRICS, V140, DOI [10.1542/peds.2018-1739, 10.1542/peds.2017-1904]; Gabriel KP, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-53; Garcia-Hermoso A, 2017, OBES REV, V18, P1088, DOI 10.1111/obr.12552; Gopinath B, 2011, ANN EPIDEMIOL, V21, P351, DOI 10.1016/j.annepidem.2011.02.002; Grgic J, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0691-3; H-r L, 2016, SPINE, V41, pE116, DOI 10.1097/BRS.0000000000001139; He Q, 2000, HYPERTENSION, V36, P165, DOI 10.1161/01.HYP.36.2.165; Hinkley T, 2012, MED SCI SPORT EXER, V44, P2436, DOI 10.1249/MSS.0b013e3182661478; Hoelscher DM, 2015, CHILD OBES, V11, P71, DOI 10.1089/chi.2014.0084; Irving BA, 2008, MED SCI SPORT EXER, V40, P1863, DOI 10.1249/MSS.0b013e3181801d40; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P3, DOI 10.3109/17477160903067601; Kuhl ES, 2012, J PEDIATR PSYCHOL, V37, P1148, DOI 10.1093/jpepsy/jss090; Kuzik N, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4851-1; LeBlanc AG, 2012, APPL PHYSIOL NUTR ME, V37, P753, DOI [10.1139/h2012-063, 10.1139/H2012-063]; Leeger-Aschmann CS, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6837-7; Leppanen M, 2017, MED SCI SPORTS EXERC, P49; Leppanen MH, 2016, INT J OBESITY, V40, P1126, DOI 10.1038/ijo.2016.54; Macdonald-Wallis C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188618; Mekary RA, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16050797; Mekary RA, 2009, AM J EPIDEMIOL, V170, P519, DOI 10.1093/aje/kwp163; Mendoza JA, 2014, J PHYS ACT HEALTH, V11, P195, DOI 10.1123/jpah.2012-0018; Metallinos-Katsaras ES, 2007, OBESITY, V15, P686, DOI 10.1038/oby.2007.571; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Okely AD, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4867-6; Pereira-da-Silva L, 2016, J PEDIAT-BRAZIL, V92, P421, DOI 10.1016/j.jped.2015.11.003; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Raiber L, 2019, APPL PHYSIOL NUTR ME, V44, P407, DOI 10.1139/apnm-2017-0643; Raitakari OT, 2003, JAMA-J AM MED ASSOC, V290, P2277, DOI 10.1001/jama.290.17.2277; Rich C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067206; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD; Stuart B, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.6; Taylor RW, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0753-6; Timmons BW, 2012, APPL PHYSIOL NUTR ME, V37, P773, DOI [10.1139/h2012-070, 10.1139/H2012-070]; TREMBLAY A, 1994, METABOLISM, V43, P814, DOI 10.1016/0026-0495(94)90259-3; Tremblay A, 2006, CAN J PHYSIOL PHARM, V84, P149, DOI 10.1139/Y05-132; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; U.S. Department of Health and Human Services, 2018, 2018 PHYS ACTIVITY G; Vale S, 2015, J PEDIATR-US, V167, P98, DOI 10.1016/j.jpeds.2015.04.031; van Sluijs EMF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074934; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Wake M, 2008, ARCH DIS CHILD, V93, P502, DOI 10.1136/adc.2007.128116; WHO, 2020, GUID PHYS ACT SED BE; Wijndaele K, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0858-6	60	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0242088	10.1371/journal.pone.0242088	http://dx.doi.org/10.1371/journal.pone.0242088			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170898	Green Published, gold			2022-12-26	WOS:000592383400047
J	Hailu, NA; Tolessa, T; Gufue, ZH; Tsegay, EW; Tekola, KB				Hailu, Nigus Alemu; Tolessa, Tesfaye; Gufue, Zenawi Hagos; Tsegay, Etsay Weldekidan; Tekola, Kidanemaryam Berhe			The magnitude of anemia and associated factors among adult diabetic patients in Tertiary Teaching Hospital, Northern Ethiopia, 2019, cross-sectional study	PLOS ONE			English	Article							MELLITUS; DISEASE; TYPE-1	Background Patients with Diabetic Mellitus are at higher risk of different complications. Many previous studies show that anemia among diabetic patients is poorly diagnosed. Objective This study aimed to assess the magnitude and associated factors of anemia among adult diabetes patients having regular follow up at the diabetic clinic of Ayder Comprehensive Specialized Hospital, Tigray, 2018/19. Methods This study was conducted the Diabetic clinic of Ayder comprehensive specialized hospital, Tigray regional state, Northern Ethiopia from January to March 2019. A systematic random sampling technique was used to select study participants. About 5 ml of venous blood was collected by experienced laboratory technologists under a complete aseptic technique. Two ml of the venous blood was used for hemoglobin determination. And three ml of the venous blood was used without any anticoagulant for creatinine determination. The association of variables was assessed using bivariate and multivariable analysis in the logistic regression model with p-value, odds ratio, and 95% CI in the SPSS version 24 software. Results From a total of 262 diabetes patients, forty-seven (17.9%) were found to be anemic (6.7% males and 11.5% females). Among the related factors, residency (Adjusted Odds Ratio, 7.69, 95% CI, 2.060, 28.69, p = 0.002,), age of the patients (Adjusted Odds Ratio, 4.007, 95%CI, 1.53-10.51, p = 0.005,) and sex (Adjusted Odds Ratio, 3.434, 95% CI, 1.582, 7.458, p = 0.042,) were significantly associated with anemia. Conclusion According to this study, the magnitude of anemia is high among diabetic patients. Occupation of the participants, residency, HIV status, being female, and age was significantly associated with anemia.	[Hailu, Nigus Alemu] Adigrat Univ, Coll Med & Hlth Sci, Biomed Sci Dept, Adigrat, Ethiopia; [Tolessa, Tesfaye] Addis Ababa Univ, Coll Hlth Sci, Med Physiol Dept, Addis Ababa, Ethiopia; [Gufue, Zenawi Hagos] Adigrat Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Adigrat, Ethiopia; [Tsegay, Etsay Weldekidan] Adigrat Univ, Coll Med & Hlth Sci, Pharm Dept, Adigrat, Ethiopia; [Tekola, Kidanemaryam Berhe] Mekelle Univ, Coll Hlth Sci, Nutr Dept, Mekelle, Ethiopia	Addis Ababa University; Mekelle University	Hailu, NA (corresponding author), Adigrat Univ, Coll Med & Hlth Sci, Biomed Sci Dept, Adigrat, Ethiopia.	Nigusalemu2@gmail.com	Hagos Gufue, Zenawi/GPW-8105-2022	Hagos Gufue, Zenawi/0000-0002-2236-5524	Addis Ababa University	Addis Ababa University	The corresponding author gets fund from Addis Ababa University (internal organization) but the funder had no role in study design, data collection, analysis and decision to publish or preparation of the manuscript.	Adejumo B. I., 2012, Health, V4, P304, DOI 10.4236/health.2012.46050; Alemu F., 2015, J DIAB METAB, V6, P1; Aljohani AH, 2017, EGYPT J HOSP MED, V70, P526; [Anonymous], 2013, NAT NEUROSCI, V16, P1, DOI 10.1038/nn0113-1; Antwi-Bafour Samuel, 2016, J Med Case Rep, V10, P110, DOI 10.1186/s13256-016-0889-4; Barbieri J, 2015, ANEMIA, V2015, DOI 10.1155/2015/354737; Biadgo B, 2016, DIABET METAB SYND OB, V9, P91, DOI 10.2147/DMSO.S97563; Chan M., 2016, GLOBAL REPORT DIABET, P1; Chen CXR, 2013, HONG KONG MED J, V19, P214, DOI 10.12809/hkmj133814; Craig KJ, 2005, DIABETES CARE, V28, P1118, DOI 10.2337/diacare.28.5.1118; Ellinger Vivian C.M., 2006, Arq Bras Endocrinol Metab, V50, P114, DOI 10.1590/S0004-27302006000100016; Grossman C, 2014, DIABETES-METAB RES, V30, P291, DOI 10.1002/dmrr.2491; Mekelle University, 2018, AYD COMPR SPEC HOSP; NCCN Clinical Practice, 2018, ACUTE MYELOID LEUKEM, VV2, pMS28; Ohta M, 2010, DIABETIC MED, V27, P1017, DOI 10.1111/j.1464-5491.2010.03049.x; OP026, 2016, J CROHNS COLITIS, V10, pS21; Punthakee Z, 2018, CAN J DIABETES, V42, pS10, DOI 10.1016/j.jcjd.2017.10.003; Ritz E, 2005, NEPHROL DIAL TRANSPL, V20, P21, DOI 10.1093/ndt/gfh1093; Roglic G., 2016, GLOBAL REPORT DIABET; Stoltzfus RJ., 1999, GUIDELINES USE IRON; Thomas MC, 2006, DIABETIC MED, V23, P502, DOI 10.1111/j.1464-5491.2006.01829.x; Thomas MC, 2004, J CLIN ENDOCR METAB, V89, P4359, DOI 10.1210/jc.2004-0678; World Health Organization, 2011, SER FERR CONC ASS IR; Yoon H, 2018, CLIN EXP HYPERTENS, V40, P650, DOI 10.1080/10641963.2017.1416123; Zarychanski R, 2008, CAN MED ASSOC J, V179, P333, DOI 10.1503/cmaj.071131	25	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0240678	10.1371/journal.pone.0240678	http://dx.doi.org/10.1371/journal.pone.0240678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170882	gold, Green Published			2022-12-26	WOS:000592383400006
J	Georgiev, GA; Gh, MS; Romano, J; Teixeira, KLD; Struble, C; Ryan, DS; Sia, RK; Kitt, JP; Harris, JM; Hsu, KL; Libby, A; Odrich, MG; Suarez, T; McKown, RL; Laurie, GW				Georgiev, Georgi A.; Gh, Mohammad Sharifian; Romano, Jeff; Teixeira, Karina L. Dias; Struble, Craig; Ryan, Denise S.; Sia, Rose K.; Kitt, Jay P.; Harris, Joel M.; Hsu, Ku-Lung; Libby, Adam; Odrich, Marc G.; Suarez, Tatiana; McKown, Robert L.; Laurie, Gordon W.			Lacritin proteoforms prevent tear film collapse and maintain epithelial homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACTANT PROTEIN-B; PULMONARY SURFACTANT; DRY EYE; PROTEOMIC ANALYSIS; TRANSGLUTAMINASE 2; OCULAR SURFACE; MUTATION; MEMBRANE; BINDING; DIFFERENTIATION	Lipids in complex, protein-enriched films at air/liquid interfaces reduce surface tension. In the absence of this benefit, the light refracting and immunoprotective tear film on eyes would collapse. Premature collapse, coupled with chronic inflammation compromising visual acuity, is a hallmark of dry eye disease affecting 7 to 10% of individuals worldwide. Although collapse seems independent of mutation (unlike newborn lung alveoli), selective proteome and possible lipidome changes have been noted. These include elevated tissue transglutaminase and consequent inactivation through C-terminal cross-linking of the tear mitogen lacritin, leading to significant loss of lacritin monomer. Lacritin monomer restores homeostasis via autophagy and mitochondrial fusion and promotes basal tearing. Here, we discover that lacritin monomer C-terminal processing, inclusive of cysteine, serine, and metalloproteinase activity, generates cationic amphipathic a-helical proteoforms. Such proteoforms (using synthetic peptide surrogates) act like alveolar surfactant proteins to rapidly bind and stabilize the tear lipid layer. Immunodepletion of C- but not N-terminal proteoforms nor intact lacritin, from normal human tears promotes loss of stability akin to human dry eye tears. Stability of these and dry eye tears is rescuable with C- but not N-terminal proteoforms. Repeated topical application in rabbits reveals a proteoform turnover time of 7 to 33 h with gradual loss from human tear lipid that retains bioactivity without further processing. Thus, the processed C-terminus of lacritin that is deficient or absent in dry eye tears appears to play a key role in preventing tear film collapse and as a natural slow release mechanism that restores epithelial homeostasis.	[Georgiev, Georgi A.] Univ Lisbon, Inst Bioengn & Biosci, Inst Super Tecn, Lisbon, Portugal; [Gh, Mohammad Sharifian; Romano, Jeff; Teixeira, Karina L. Dias; Laurie, Gordon W.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22901 USA; [Hsu, Ku-Lung; Libby, Adam] Univ Virginia, Dept Chem, Charlottesville, VA USA; [Odrich, Marc G.; Laurie, Gordon W.] Univ Virginia, Dept Ophthalmol, Charlottesville, VA 22901 USA; [Laurie, Gordon W.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22901 USA; [Struble, Craig] Covance Labs Inc, Drug Metab, Madison, WI USA; [Ryan, Denise S.; Sia, Rose K.] Warfighter Refract Eye Surg Program & Res Ctr Ft, Ft Belvoir, VA USA; [Kitt, Jay P.; Harris, Joel M.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA; [Suarez, Tatiana] FAES FARMA, Dept Res Dev & Innovat, Bizkaia, Spain; [McKown, Robert L.] James Madison Univ, Dept Integrated Sci & Technol, Harrisonburg, VA 22807 USA	Universidade de Lisboa; Instituto Superior Tecnico; University of Virginia; University of Virginia; University of Virginia; University of Virginia; Covance; Utah System of Higher Education; University of Utah; James Madison University	Laurie, GW (corresponding author), Univ Virginia, Dept Cell Biol, Charlottesville, VA 22901 USA.; Laurie, GW (corresponding author), Univ Virginia, Dept Ophthalmol, Charlottesville, VA 22901 USA.; Laurie, GW (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22901 USA.	glaurie@virginia.edu	Dias Teixeira, Karina/J-4918-2017; Hsu, Ku-Lung/J-2885-2014	Dias Teixeira, Karina/0000-0002-6115-6768; Laurie, Gordon/0000-0002-5311-2650; Hsu, Ku-Lung/0000-0001-5620-3972; Sharifian Gh., Mohammad/0000-0003-3867-1611; Georgiev, Georgi/0000-0002-7774-9314	European Union [839315]; NIH [RO1 EY0024327, R01 EY026171]; NSF [CHE-1904424]; National Institute of Dental and Craniofacial Research [N01 DE-32636]; National Eye Institute; Office for Research in Women's Health; 2016 ARVO Collaborative Research Grant	European Union(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Office for Research in Women's Health; 2016 ARVO Collaborative Research Grant	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 839315 (G. A. G.); and a 2016 ARVO Collaborative Research Grant (G. A. G.). It was also supported by NIH RO1 EY0024327 and R01 EY026171 (G. W. L.); an unrestricted gift from TearSolutions Inc (G. W. L.); and NSF CHE-1904424 (J. M. H.). Secondary Sjogren's Syndrome tear samples were kindly provided by the Sjogren's International Collaborative Clinical Alliance [SICCA], funded under contract N01 DE-32636 by the National Institute of Dental and Craniofacial Research, with funding support from the National Eye Institute and Office for Research in Women's Health. The content is soley the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, nor the official policy or position of Belvoir Hospital, the Defense Health Agency, Department of Defense, or the US Government. Discussion of any commercial products within this presentation does not create or imply any Federal/DoD endorsement.	Abreau K, 2016, OCUL SURF, V14, P64, DOI 10.1016/j.jtos.2015.09.001; Aragona P, 2015, OPHTHALMOLOGY, V122, P62, DOI 10.1016/j.ophtha.2014.07.048; Azkargorta M, 2015, J PROTEOME RES, V14, P2649, DOI 10.1021/acs.jproteome.5b00179; Baechle D, 2006, J BIOL CHEM, V281, P5406, DOI 10.1074/jbc.M504670200; Balas L, 2016, ORG BIOMOL CHEM, V14, P9012, DOI 10.1039/c6ob01597b; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; BANGHAM AD, 1979, BIOCHIM BIOPHYS ACTA, V573, P552, DOI 10.1016/0005-2760(79)90229-7; Bland HC, 2019, LANGMUIR, V35, P3545, DOI 10.1021/acs.langmuir.8b04182; Braide-Moncoeur O, 2016, CURR OPIN CHEM BIOL, V32, P22, DOI 10.1016/j.cbpa.2016.02.012; Bridges TE, 2006, ANAL CHEM, V78, P2121, DOI 10.1021/ac052056n; Brockman H, 1999, CURR OPIN STRUC BIOL, V9, P438, DOI 10.1016/S0959-440X(99)80061-X; Brooks BP, 2005, CLIN GENET, V68, P215, DOI 10.1111/j.1399-0004.2005.00482.x; Brown Rhoderick E., 2007, V398, P41, DOI 10.1007/978-1-59745-513-8_5; Butovich IA, 2012, INVEST OPHTH VIS SCI, V53, P6881, DOI 10.1167/iovs.12-10516; Cabre EJ, 2012, BBA-BIOMEMBRANES, V1818, P1717, DOI 10.1016/j.bbamem.2012.03.008; Eftimov P, 2017, EUR BIOPHYS J BIOPHY, V46, P129, DOI 10.1007/s00249-016-1146-x; Enns GM, 2014, GENET MED, V16, P751, DOI 10.1038/gim.2014.22; FARRELL PM, 1975, AM REV RESPIR DIS, V111, P657; Fujii A, 2013, INVEST OPHTH VIS SCI, V54, P2533, DOI 10.1167/iovs.12-10394; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gasymov OK, 1998, BBA-PROTEIN STRUCT M, V1386, P145, DOI 10.1016/S0167-4838(98)00092-2; Georgiev GA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246132; Georgiev GA, 2014, SOFT MATTER, V10, P5579, DOI 10.1039/c4sm00758a; Gericke A, 1997, BIOPHYS J, V73, P492, DOI 10.1016/S0006-3495(97)78087-1; Goto E, 2003, ARCH OPHTHALMOL-CHIC, V121, P173; Gouveia SM, 2005, BBA-PROTEINS PROTEOM, V1753, P155, DOI 10.1016/j.bbapap.2005.08.023; Hadj-Rabia S, 2018, GENET MED, V20, P190, DOI 10.1038/gim.2017.71; Hermans E, 2015, SOFT MATTER, V11, P8048, DOI 10.1039/c5sm01603g; Holder-Espinasse M, 2007, EUR J HUM GENET, V15, P1115, DOI 10.1038/sj.ejhg.5201888; HOLLY FJ, 1973, EXP EYE RES, V15, P515, DOI 10.1016/0014-4835(73)90064-X; HONIG D, 1991, J PHYS CHEM-US, V95, P4590, DOI 10.1021/j100165a003; Karnati R, 2013, EXP EYE RES, V117, P39, DOI 10.1016/j.exer.2013.05.020; Kitt JP, 2015, ANAL CHEM, V87, P5340, DOI 10.1021/acs.analchem.5b00634; Koehler K, 2017, J MED GENET, V54, P176, DOI 10.1136/jmedgenet-2016-104108; Korzeniewski C, 2019, ANAL CHEM, V91, P1049, DOI 10.1021/acs.analchem.8b04390; Lam SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024339; LOGLIO G, 1981, COLLOID POLYM SCI, V259, P1221, DOI 10.1007/BF01525018; Ma PS, 2006, J CELL BIOL, V174, P1097, DOI 10.1083/jcb.200511134; Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5; MATTER ML, 1994, J CELL BIOL, V124, P1083, DOI 10.1083/jcb.124.6.1083; McKown RL, 2014, J BIOL CHEM, V289, P22172, DOI 10.1074/jbc.M114.570143; McNamara NA, 2016, INVEST OPHTH VIS SCI, V57, P5237, DOI 10.1167/iovs.16-19309; Miano F, 2005, COLLOID SURFACE B, V44, P49, DOI 10.1016/j.colsurfb.2005.05.011; Millar TJ, 2015, EXP EYE RES, V137, P125, DOI 10.1016/j.exer.2015.05.002; Millar TJ, 2009, INVEST OPHTH VIS SCI, V50, P140, DOI 10.1167/iovs.08-2097; Millar TJ, 2006, CORNEA, V25, P91, DOI 10.1097/01.ico.0000164779.87795.3c; Milunsky JM, 2006, CLIN GENET, V69, P349, DOI 10.1111/j.1399-0004.2006.00597.x; Miyamoto M, 2020, ELIFE, V9, DOI 10.7554/eLife.53582; Mochizuki H, 2009, BRIT J OPHTHALMOL, V93, P1535, DOI 10.1136/bjo.2008.156828; Mudgil P, 2006, COLLOID SURFACE B, V48, P128, DOI 10.1016/j.colsurfb.2006.01.017; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Nogee LM, 2001, NEW ENGL J MED, V344, P573, DOI 10.1056/NEJM200102223440805; Palaniappan CK, 2013, INVEST OPHTH VIS SCI, V54, P2571, DOI 10.1167/iovs.12-11084; Piggot TJ, 2012, J CHEM THEORY COMPUT, V8, P4593, DOI 10.1021/ct3003157; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; Sakimoto T, 2015, BRIT J OPHTHALMOL, V99, P26, DOI 10.1136/bjophthalmol-2014-305039; Samudre S, 2011, INVEST OPHTH VIS SCI, V52, P6265, DOI 10.1167/iovs.10-6220; Sanghi S, 2001, J MOL BIOL, V310, P127, DOI 10.1006/jmbi.2001.4748; SHARMA A, 1985, J COLLOID INTERF SCI, V106, P12, DOI 10.1016/0021-9797(85)90375-3; Sim SY, 2019, PROTEOM CLIN APPL, V13, DOI 10.1002/prca.201900028; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050300; Soria J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17536-2; Stapleton F, 2017, OCUL SURF, V15, P334, DOI 10.1016/j.jtos.2017.05.003; Svitova TF, 2010, OPTOMETRY VISION SCI, V87, P10, DOI 10.1097/OPX.0b013e3181c07908; Tang XF, 2017, J CLIN INVEST, V127, P4314, DOI 10.1172/JCI94152; TIFFANY JM, 1991, INT OPHTHALMOL, V15, P371, DOI 10.1007/BF00137947; Tragoulias ST, 2005, CORNEA, V24, P189, DOI 10.1097/01.ico.0000138837.52694.37; Tsai PS, 2006, BRIT J OPHTHALMOL, V90, P372, DOI 10.1136/bjo.2005.080846; Tutt R, 2000, INVEST OPHTH VIS SCI, V41, P4117; Ueno T, 2004, J BIOL CHEM, V279, P16178, DOI 10.1074/jbc.M312029200; Velez VF, 2013, INVEST OPHTH VIS SCI, V54, P2123, DOI 10.1167/iovs.12-11488; Vijmasi T, 2014, INVEST OPHTH VIS SCI, V55, P5401, DOI 10.1167/iovs.14-13924; Wang JH, 2006, J CELL BIOL, V174, P689, DOI 10.1083/jcb.200605140; Wang N, 2013, J BIOL CHEM, V288, P18146, DOI 10.1074/jbc.M112.436584; Wang W, 2015, J CONTROL RELEASE, V199, P156, DOI 10.1016/j.jconrel.2014.11.016; Wang W, 2014, J MATER CHEM B, V2, P8131, DOI 10.1039/c4tb00979g; Waring AJ, 2005, J PEPT RES, V66, P364, DOI 10.1111/j.1399-3011.2005.00300.x; Whitsett JA, 2014, NEONATOLOGY, V105, P337, DOI 10.1159/000360649; Willcox MDP, 2017, OCUL SURF, V15, P366, DOI 10.1016/j.jtos.2017.03.006; Witsch TJ, 2014, EUR RESPIR J, V44, P109, DOI 10.1183/09031936.00075713; Wu J, 2005, MOL CELL PROTEOMICS, V4, P1251, DOI 10.1074/mcp.M500041-MCP200; Zhang GA, 2010, METHODS MOL BIOL, V673, P211, DOI 10.1007/978-1-60761-842-3_13; Zhang LL, 2016, INT J BIOL SCI, V12, P1114, DOI 10.7150/ijbs.13774; Zhang YH, 2013, J BIOL CHEM, V288, P12090, DOI 10.1074/jbc.M112.422717	84	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100070	10.1074/jbc.RA120.015833	http://dx.doi.org/10.1074/jbc.RA120.015833			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33187980	gold, Green Published			2022-12-26	WOS:000672866400051
J	Jain, N; Janning, P; Neumann, H				Jain, Neha; Janning, Petra; Neumann, Heinz			14-3-3 Protein Bmh1 triggers short-range compaction of mitotic chromosomes by recruiting sirtuin deacetylase Hst2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3; IN-VIVO; CONDENSIN; COMPLEX; YEAST; PHOSPHORYLATION; HETEROCHROMATIN; EXPRESSION; INTERACTS; ANAPHASE	During mitosis, chromosomes are compacted in length by more than 100-fold into rod-shaped forms. In yeast, this process depends on the presence of a centromere, which promotes condensation in cis by recruiting mitotic kinases such as Aurora B kinase. This licensing mechanism enables the cell to discriminate chromosomal from noncentromeric DNA and to prohibit the propagation of the latter. Aurora B kinase elicits a cascade of events starting with phosphorylation of histone H3 serine 10 (H3S10ph), which signals the recruitment of lysine deacetylase Hst2 and the removal of lysine 16 acetylation in histone 4. The unmasked histone 4 tails interact with the acidic patch of neighboring nucleosomes to drive short-range compaction of chromatin, but the mechanistic details surrounding the Hst2 activity remain unclear. Using in vitro and in vivo assays, we demonstrate that the interaction of Hst2 with H3S10ph is mediated by the yeast 14-3-3 protein Bmh1. As a homodimer, Bmh1 binds simultaneously to H3S10ph and the phosphorylated C-terminus of Hst2. Our pull-down experiments with extracts of synchronized cells show that the Hst2-Bmh1 interaction is cell cycle dependent, peaking in the M phase. Furthermore, we show that phosphorylation of C-terminal residues of Hst2, introduced by genetic code expansion, stimulates its deacetylase activity. Hence, the data presented here identify Bmh1 as a key player in the mechanism of licensing of chromosome compaction in mitosis.	[Jain, Neha; Neumann, Heinz] Max Planck Inst Mol Physiol, Dept Struct Biochem, Dortmund, Germany; [Janning, Petra] Max Planck Inst Mol Physiol, Dept Chem Biol, Dortmund, Germany; [Neumann, Heinz] Univ Appl Sci Darmstadt, Dept Chem Engn & Biotechnol, Darmstadt, Germany	Max Planck Society; Max Planck Society; Hochschule Darmstadt	Neumann, H (corresponding author), Max Planck Inst Mol Physiol, Dept Struct Biochem, Dortmund, Germany.; Neumann, H (corresponding author), Univ Appl Sci Darmstadt, Dept Chem Engn & Biotechnol, Darmstadt, Germany.	heinz.neumann@h-da.de	Neumann, Heinz/ABC-7323-2021; Neumann, Heinz/F-7875-2014	Neumann, Heinz/0000-0001-9657-1913	German Research Foundation (DFG) [NE1589/5-1, NE1589/6-1]; Human Frontier Science Program (HFSP) [RPG0031/2017]; Max Planck Institute of Molecular Physiology	German Research Foundation (DFG)(German Research Foundation (DFG)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Max Planck Institute of Molecular Physiology(Max Planck Society)	This project was supported by the German Research Foundation (DFG) [Grants NE1589/5-1 and NE1589/6-1], the Human Frontier Science Program (HFSP, RPG0031/2017), and the Max Planck Institute of Molecular Physiology to H. N.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Antonin W, 2016, CURR OPIN CELL BIOL, V40, P15, DOI 10.1016/j.ceb.2016.01.013; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Cuijpers SAG, 2018, TRENDS BIOCHEM SCI, V43, P251, DOI 10.1016/j.tibs.2018.02.004; Fan XL, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143518; Ganji M, 2018, SCIENCE, V360, P102, DOI 10.1126/science.aar7831; Gardino AK, 2011, SEMIN CELL DEV BIOL, V22, P688, DOI 10.1016/j.semcdb.2011.09.008; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goloborodko A, 2016, BIOPHYS J, V110, P2162, DOI 10.1016/j.bpj.2016.02.041; Healy S, 2011, DISCOV MED, V11, P349; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Houlard M, 2015, NAT CELL BIOL, V17, P771, DOI 10.1038/ncb3167; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hyrien Olivier, 2016, F1000Res, V5, DOI 10.12688/f1000research.9008.1; Jin YH, 2008, BIOCHEM BIOPH RES CO, V368, P690, DOI 10.1016/j.bbrc.2008.01.114; Kakiuchi K, 2007, BIOCHEMISTRY-US, V46, P7781, DOI 10.1021/bi700501t; Kruitwagen T, 2018, CELL, V175, P780, DOI 10.1016/j.cell.2018.09.012; Kruitwagen T, 2015, ELIFE, V4, DOI 10.7554/eLife.10396; Kschonsak M, 2017, CELL, V171, P588, DOI 10.1016/j.cell.2017.09.008; Kschonsak M, 2015, BIOESSAYS, V37, P755, DOI 10.1002/bies.201500020; Langdon EM, 2018, SCIENCE, V360, P922, DOI 10.1126/science.aar7432; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Mora-Bermudez F, 2007, NAT CELL BIOL, V9, P822, DOI 10.1038/ncb1606; Naini SM, 2015, MOL CELL BIOL, V35, P3768, DOI 10.1128/MCB.00184-15; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Oliveira RA, 2005, MOL CELL BIOL, V25, P8971, DOI 10.1128/MCB.25.20.8971-8984.2005; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Pereira JM, 2018, CELL REP, V23, P1124, DOI 10.1016/j.celrep.2018.03.116; Ribeiro SA, 2009, MOL BIOL CELL, V20, P2371, DOI 10.1091/mbc.E08-11-1127; Rogerson DT, 2015, NAT CHEM BIOL, V11, P496, DOI [10.1038/nchembio.1823, 10.1038/NCHEMBIO.1823]; Spinck M, 2018, BIOCHEMISTRY-US, V57, P3552, DOI 10.1021/acs.biochem.8b00483; Terakawa T, 2017, SCIENCE, V358, P672, DOI 10.1126/science.aan6516; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Vincenz C, 1996, J BIOL CHEM, V271, P20029, DOI 10.1074/jbc.271.33.20029; Walter W, 2008, MOL CELL BIOL, V28, P2840, DOI 10.1128/MCB.01457-07; Wang Y, 2006, MECH AGEING DEV, V127, P741, DOI 10.1016/j.mad.2006.05.005; Wilkins BJ, 2014, SCIENCE, V343, P77, DOI 10.1126/science.1244508; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978; Zhiteneva A, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170076	44	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100078	10.1074/jbc.AC120.014758	http://dx.doi.org/10.1074/jbc.AC120.014758			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33187982	Green Submitted, gold, Green Published			2022-12-26	WOS:000672866400059
J	Ruggiero, MJ; Malhotra, S; Fenton, AW; Swint-Kruse, L; Karanicolas, J; Hagenbuch, B				Ruggiero, Melissa J.; Malhotra, Shipra; Fenton, Aron W.; Swint-Kruse, Liskin; Karanicolas, John; Hagenbuch, Bruno			A clinically relevant polymorphism in the Na+/taurocholate cotransporting polypeptide (NTCP) occurs at a rheostat position	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; DESIGN; SLC10	Conventionally, most amino acid substitutions at "important" protein positions are expected to abolish function. However, in several soluble-globular proteins, we identified a class of nonconserved positions for which various substitutions produced progressive functional changes; we consider these evolutionary "rheostats". Here, we report a strong rheostat position in the integral membrane protein, Na+/taurocholate (TCA) cotransporting polypeptide, at the site of a pharmacologically relevant polymorphism (S267F). Functional studies were performed for all 20 substitutions (S267X) with three substrates (TCA, estrone-3-sulfate, and rosuvastatin). The S267X set showed strong rheostatic effects on overall transport, and individual substitutions showed varied effects on transport kinetics (K-m and V-max) and substrate specificity. To assess protein stability, we measured surface expression and used the Rosetta software (https://www.rosettacommons.org) suite to model structure and stability changes of S267X. Although buried near the substrate-binding site, S267X substitutions were easily accommodated in the Na+/TCA cotransporting polypeptide structure model. Across the modest range of changes, calculated stabilities correlated with surface-expression differences, but neither parameter correlated with altered transport. Thus, substitutions at rheostat position 267 had wide-ranging effects on the phenotype of this integral membrane protein. We further propose that polymorphic positions in other proteins might be locations of rheostat positions.	[Ruggiero, Melissa J.; Hagenbuch, Bruno] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA; [Malhotra, Shipra; Karanicolas, John] Fox Chase Canc Ctr, Program Mol Therapeut, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Malhotra, Shipra] Univ Kansas, Ctr Computat Biol, Lawrence, KS 66045 USA; [Fenton, Aron W.; Swint-Kruse, Liskin] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA	University of Kansas; University of Kansas Medical Center; Fox Chase Cancer Center; University of Kansas; University of Kansas; University of Kansas Medical Center	Hagenbuch, B (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66103 USA.	bhagenbuch@kumc.edu	Hagenbuch, Bruno/M-5294-2016	Hagenbuch, Bruno/0000-0002-2938-8630; Malhotra, Shipra/0000-0002-2234-191X; Swint-Kruse, Liskin/0000-0002-5925-9741	W.M. Keck Foundation; National Institutes of Health [P30 CA006927, R01 GM077336, GM118589, P20 GM103549, P30 GM118247]	W.M. Keck Foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by a grant from the W.M. Keck Foundation and by National Institutes of Health grants P30 CA006927, R01 GM077336, GM118589, P20 GM103549, and P30 GM118247. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Appelman MD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170419; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boxberger KH, 2018, BIOCHEM PHARMACOL, V156, P371, DOI 10.1016/j.bcp.2018.08.028; Campitelli P, 2021, MOL BIOL EVOL, V38, P201, DOI 10.1093/molbev/msaa202; Conway P, 2014, PROTEIN SCI, V23, P47, DOI 10.1002/pro.2389; Creighton T. E., 1993, PROTEINS STRUCTURES; da Silva TC, 2013, MOL ASPECTS MED, V34, P252, DOI 10.1016/j.mam.2012.07.004; Deng M, 2016, EXP THER MED, V12, P3294, DOI 10.3892/etm.2016.3752; Doring B, 2012, CURR TOP MEMBR, V70, P105, DOI 10.1016/B978-0-12-394316-3.00004-1; Dong C, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017305; Fenton AW, 2020, MED CHEM RES, V29, P1133, DOI 10.1007/s00044-020-02582-9; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Gray VE, 2012, BIOINFORMATICS, V28, P2093, DOI 10.1093/bioinformatics/bts336; Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z; Ho RH, 2004, J BIOL CHEM, V279, P7213, DOI 10.1074/jbc.M305782200; Ho RH, 2006, GASTROENTEROLOGY, V130, P1793, DOI 10.1053/j.gastro.2006.02.034; Hodges AM, 2018, HUM MUTAT, V39, P1814, DOI 10.1002/humu.23616; Hu NJ, 2011, NATURE, V478, P408, DOI 10.1038/nature10450; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Liu RH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07012-2; Mazin PV, 2010, ALGORITHM MOL BIOL, V5, DOI 10.1186/1748-7188-5-29; Meinhardt S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083502; Miller M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41329; Miller M, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz818; Modi T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123808; Nivon LG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059004; Pan W, 2011, XENOBIOTICA, V41, P501, DOI 10.3109/00498254.2011.555567; Roscoe BP, 2013, J MOL BIOL, V425, P1363, DOI 10.1016/j.jmb.2013.01.032; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Tungtur S, 2019, PROTEIN SCI, V28, P1806, DOI 10.1002/pro.3695; Tyka MD, 2011, J MOL BIOL, V405, P607, DOI 10.1016/j.jmb.2010.11.008; Wu T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53464-z; Ye K, 2008, BIOINFORMATICS, V24, P908, DOI 10.1093/bioinformatics/btn057; Zhao W, 2015, TOXICOL SCI, V146, P363, DOI 10.1093/toxsci/kfv102; Zhou XM, 2014, NATURE, V505, P569, DOI 10.1038/nature12811	41	10	10	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100047	10.1074/jbc.RA120.014889	http://dx.doi.org/10.1074/jbc.RA120.014889			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33168628	Green Published, gold, Green Submitted			2022-12-26	WOS:000672866400030
J	Dong, H; Wu, C; Luo, CG; Wei, MH; Qu, SC; Wang, SH				Dong, Hui; Wu, Chao; Luo, Changguo; Wei, Menghan; Qu, Shenchun; Wang, Sanhong			Overexpression of MdCPK1a gene, a calcium dependent protein kinase in apple, increase tobacco cold tolerance via scavenging ROS accumulation	PLOS ONE			English	Article							GENOME-WIDE IDENTIFICATION; SALT-STRESS; EXPRESSION ANALYSIS; DROUGHT TOLERANCE; OXIDATIVE STRESS; OVER-EXPRESSION; ABIOTIC STRESS; CELL-DEATH; RICE; CDPK	Calcium-dependent protein kinases (CDPKs) are important calcium receptors, which play a crucial part in the process of sensing and decoding intracellular calcium signals during plant development and adaptation to various environmental stresses. In this study, a CDPK gene MdCPK1a, was isolated from apple (Malusxdomestica) which contains 1701bp nucleotide and encodes a protein of 566 amino acid residues, and contains the conserved domain of CDPKs. The transient expression and western blot experiment showed that MdCPK1a protein was localized in the nucleus and cell plasma membrane. Ectopic expression of MdCPK1a in Nicotiana benthamiana increased the resistance of the tobacco plants to salt and cold stresses. The mechanism of MdCPK1a regulating cold resistance was further investigated. The overexpressed MdCPK1a tobacco plants had higher survival rates and longer root length than wild type (WT) plants under cold stress, and the electrolyte leakages (EL), the content of malondialdehyde (MDA) and reactive oxygen species (ROS) were lower, and accordingly, antioxidant enzyme activities, such as superoxide dismutase (SOD), peroxidase (POD) and catalase (CAT) were higher, suggesting the transgenic plants suffered less chilling injury than WT plants. Moreover, the transcript levels of ROS-scavenging and stress-related genes were higher in the transgenic plants than those in WT plants whether under normal conditions or cold stress. The above results suggest that the improvement of cold tolerance in MdCPK1a-overexpressed plants was due to scavenging ROS accumulation and modulating the expression of stress-related genes.	[Dong, Hui; Wu, Chao; Wei, Menghan; Qu, Shenchun; Wang, Sanhong] Nanjing Agr Univ, Coll Hort, Nanjing, Peoples R China; [Luo, Changguo] Guizhou Acad Agr Sci, Guizhou Fruit Inst, Guiyang, Peoples R China	Nanjing Agricultural University; Guizhou Academy of Agricultural Sciences	Wang, SH (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Peoples R China.	wsh3xg@hotmail.com	Wang, sanhong/CAG-9117-2022		National Natural Science Foundation of China [31872076, 31560551]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31872076, 31560551). There was no additional external funding received for this study.	Abbasi F, 2004, PLANT MOL BIOL, V55, P541, DOI 10.1007/s11103-004-1178-y; Allwood EG, 2001, FEBS LETT, V499, P97, DOI 10.1016/S0014-5793(01)02528-5; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Asano T, 2012, PLANT J, V69, P26, DOI 10.1111/j.1365-313X.2011.04766.x; Berberich T, 1997, MOL GEN GENET, V254, P275, DOI 10.1007/s004380050416; Boudsocq M, 2013, TRENDS PLANT SCI, V18, P30, DOI 10.1016/j.tplants.2012.08.008; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Bundo M, 2016, PLANT BIOTECHNOL J, V14, P1357, DOI 10.1111/pbi.12500; Campo S, 2014, PLANT PHYSIOL, V165, P688, DOI 10.1104/pp.113.230268; Almadanim MC, 2018, BBA-MOL CELL RES, V1865, P231, DOI 10.1016/j.bbamcr.2017.10.010; Almadanim MC, 2017, PLANT CELL ENVIRON, V40, P1197, DOI 10.1111/pce.12916; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chen JH, 2013, BIOCHEM BIOPH RES CO, V441, P630, DOI 10.1016/j.bbrc.2013.10.103; Cheng SH, 2001, FEBS LETT, V503, P185, DOI 10.1016/S0014-5793(01)02732-6; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Coca M, 2010, PLANT J, V63, P526, DOI 10.1111/j.1365-313X.2010.04255.x; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; Dubiella U, 2013, P NATL ACAD SCI USA, V110, P8744, DOI 10.1073/pnas.1221294110; Dubrovina AS, 2015, J PLANT PHYSIOL, V185, P1, DOI 10.1016/j.jplph.2015.05.020; Gallois P, 1995, Methods Mol Biol, V49, P39; Gao AL, 2014, CHINESE SCI BULL, V59, P1113, DOI 10.1007/s11434-013-0062-z; Harmon AC, 2001, NEW PHYTOL, V151, P175, DOI 10.1046/j.1469-8137.2001.00171.x; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; He SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18829-2; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Ho SL, 2013, PLANT MOL BIOL, V81, P347, DOI 10.1007/s11103-012-0006-z; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Klimecka M, 2007, ACTA BIOCHIM POL, V54, P219, DOI 10.18388/abp.2007_3242; Knight H, 2000, INT REV CYTOL, V195, P269; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Komatsu S, 2007, MOL GENET GENOMICS, V277, P713, DOI 10.1007/s00438-007-0220-6; Kong XP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-433; Leshem Y, 2007, PLANT J, V51, P185, DOI 10.1111/j.1365-313X.2007.03134.x; Liese A, 2013, BBA-MOL CELL RES, V1833, P1582, DOI 10.1016/j.bbamcr.2012.10.024; Liu JH, 2006, J EXP BOT, V57, P2589, DOI 10.1093/jxb/erl018; Liu Y, 2018, J INTEGR PLANT BIOL, V60, P173, DOI 10.1111/jipb.12614; Ma PD, 2013, APPL BIOCHEM BIOTECH, V169, P2111, DOI 10.1007/s12010-013-0125-2; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Martin ML, 2001, PLANT PHYSIOL, V125, P1442, DOI 10.1104/pp.125.3.1442; Matschi S, 2013, PLANT J, V73, P883, DOI 10.1111/tpj.12090; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Monaghan J, 2014, CELL HOST MICROBE, V16, P605, DOI 10.1016/j.chom.2014.10.007; Myers C, 2009, PLANT J, V59, P528, DOI 10.1111/j.1365-313X.2009.03894.x; Pan ZC, 2014, SCI REP-UK, V4, DOI 10.1038/srep07331; PAOLETTI F, 1986, ANAL BIOCHEM, V154, P536, DOI 10.1016/0003-2697(86)90026-6; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Schulz P, 2013, PLANT PHYSIOL, V163, P523, DOI 10.1104/pp.113.222539; Sebastia CH, 2004, ARCH BIOCHEM BIOPHYS, V428, P81, DOI 10.1016/j.abb.2004.04.025; Seybold H, 2014, NEW PHYTOL, V204, P782, DOI 10.1111/nph.13031; Sheludko YV, 2007, BIOTECHNOL BIOENG, V96, P608, DOI 10.1002/bit.21075; Shen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep22439; Simeunovic A, 2016, J EXP BOT, V67, P3855, DOI 10.1093/jxb/erw157; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Valmonte GR, 2014, PLANT CELL PHYSIOL, V55, P551, DOI 10.1093/pcp/pct200; Vivek PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076392; Wan BL, 2007, FEBS LETT, V581, P1179, DOI 10.1016/j.febslet.2007.02.030; Wang WH, 2018, GENE, V651, P49, DOI 10.1016/j.gene.2018.02.006; Weckwerth P, 2015, PLANT CELL ENVIRON, V38, P544, DOI 10.1111/pce.12414; Wei MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155590; Wei SY, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-133; Wernimont AK, 2010, NAT STRUCT MOL BIOL, V17, P596, DOI 10.1038/nsmb.1795; Wu LJ, 2008, PLANT PHYSIOL, V148, P1953, DOI 10.1104/pp.108.126813; Xie YT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20628; Xing YD, 2018, PLANT CELL PHYSIOL, V59, P2512, DOI 10.1093/pcp/pcy169; Xu XW, 2015, MOL GENET GENOMICS, V290, P1403, DOI 10.1007/s00438-015-1002-1; Yu TF, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00651; Zuo R, 2013, MOL BIOL REP, V40, P2645, DOI 10.1007/s11033-012-2351-z	77	16	17	12	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0242139	10.1371/journal.pone.0242139	http://dx.doi.org/10.1371/journal.pone.0242139			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211731	Green Published, gold			2022-12-26	WOS:000603518300038
J	Born, DP; Lomax, I; Romann, M				Born, Dennis-Peter; Lomax, Ishbel; Romann, Michael			Variation in competition performance, number of races, and age: Long-term athlete development in elite female swimmers	PLOS ONE			English	Article							DELIBERATE PRACTICE; SPORT; VARIABILITY; SECONDS	While talent development and the contributing factors to success are hardly discussed among the experts in the field, the aim of the study was to investigate annual variation in competition performance (AVCP), number of races per year, and age, as potential success factors for international swimming competitions. Data from 40'277 long-course races, performed by all individual female starters (n = 253) at the 2018 European Swimming Championships (2018EC) for all 10 years prior to these championships, were analyzed. Relationships between 2018EC ranking and potential success factors, i.e., AVCP, number of races per year, and age, were determined using Pearson's correlation coefficient and multiple linear regression analysis. While AVCP was not related to ranking, higher ranked swimmers at the 2018EC swam more races during each of the ten years prior to the championships (P < 0.001). Additionally, older athletes were more successful (r = -0.42, P < 0.001). The regression model explained highly significant proportions (P < 0.001) and 43%, 34%, 35%, 49% of total variance in the 2018EC ranking for 50m, 100m, 200m, and 400m races, respectively. As number of races per year (beta = -0.29 --0.40) had a significant effect on ranking of 50-400m races, and age (beta = -0.40 --0.61) showed a significant effect on ranking over all race distances, number of races per year and age may serve as success factors for international swimming competitions. The larger number of races swum by higher ranked female swimmers may have aided long-term athlete development regarding technical, physiological, and mental skill acquisitions. As older athletes were more successful, female swimmers under the age of peak performance, who did not reach semi-finals or finals, may increase their chances of success in following championships with increased experience.	[Born, Dennis-Peter; Romann, Michael] Swiss Fed Inst Sport Magglingen, Dept Elite Sport, Magglingen, Switzerland; [Born, Dennis-Peter] Swiss Swimming Federat, Bern, Switzerland; [Lomax, Ishbel] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	University of Exeter	Born, DP (corresponding author), Swiss Fed Inst Sport Magglingen, Dept Elite Sport, Magglingen, Switzerland.; Born, DP (corresponding author), Swiss Swimming Federat, Bern, Switzerland.	dennis.born@swiss-aquatics.ch	Romann, Michael/H-3571-2019	Romann, Michael/0000-0003-4139-2955; Born, Dennis-Peter/0000-0002-1058-4367				Abbott S, 2020, J SPORT SCI, V38, P1077, DOI 10.1080/02640414.2020.1741956; Allen SV, 2015, SPORTS MED, V45, P1431, DOI 10.1007/s40279-015-0354-3; Allen SV, 2014, EUR J SPORT SCI, V14, P643, DOI 10.1080/17461391.2014.893020; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2017, LANCET GLOBAL HLTH, V5, pe428; Barbosa AC, 2019, INT J SPORTS SCI COA, V14, P393, DOI 10.1177/1747954119828885; Burns L, 2019, BRIT J SPORT MED, V53, P818, DOI 10.1136/bjsports-2018-099217; Calleja-Gonzalez J, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00194; Carrasco L, 2007, J SPORT MED PHYS FIT, V47, P239; Clephas C, 2019, GER J EXERC SPORT RE, V49, P20, DOI 10.1007/s12662-018-0563-7; Cohen J, 1988, STAT POWER ANAL BEHA, DOI 10.1234/12345678; Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Global Cohort Collaboration, 2019, LANCET, V6, pe105; Costa MJ, 2010, J SPORT SCI MED, V9, P411; Costello JT, 2014, EUR J SPORT SCI, V14, P847, DOI 10.1080/17461391.2014.911354; Cote J, 2009, INT J SPORT EXERC PS, V7, P7, DOI 10.1080/1612197X.2009.9671889; Dweck C. S., 2009, OLYMPIC COACH, V21, P4; Dweck CS, 2019, PERSPECT PSYCHOL SCI, V14, P481, DOI 10.1177/1745691618804166; Elmenshawy AR, 2015, AGE, V37, DOI 10.1007/s11357-015-9795-8; Ericsson KA, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02396; Ericsson KA, 2013, BRIT J SPORT MED, V47, P533, DOI 10.1136/bjsports-2012-091767; ERICSSON KA, 1993, PSYCHOL REV, V100, P363, DOI 10.1037/0033-295X.100.3.363; Feeley BT, 2016, AM J SPORT MED, V44, P234, DOI 10.1177/0363546515576899; Field A., 2013, DISCOVERING STAT USI; FINA, 2020, SWIMM FAC RUL LAUS; Gould D., 2004, ENCY APPL PSYCHOL C, P441, DOI [10.1016/B0-12-657410-3/00408-6, DOI 10.1016/B0-12-657410-3/00408-6]; Gullich A, 2014, EUR J SPORT SCI, V14, pS383, DOI 10.1080/17461391.2012.706320; Hellard P, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00363; Hopkins W, 2020, SCALE MAGNITUDE EFFE; Johnston K, 2018, SPORTS MED, V48, P97, DOI 10.1007/s40279-017-0803-2; Knechtle B, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103651; Knechtle R, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-538; Konig S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-652; Malina RM, 2015, BRIT J SPORT MED, V49, P852, DOI 10.1136/bjsports-2015-094623; Meggs J, 2016, INT J SPORTS MED, V37, P169, DOI 10.1055/s-0035-1559773; Moesch K, 2011, SCAND J MED SCI SPOR, V21, pE282, DOI 10.1111/j.1600-0838.2010.01280.x; Mujika I, 2019, INT J SPORT PHYSIOL, V14, P1013, DOI 10.1123/ijspp.2019-0514; Nugent FJ, 2017, J HUM KINET, V57, P147, DOI 10.1515/hukin-2017-0056; Pfeiffer M, 2012, HUM MOVEMENT SCI, V31, P344, DOI 10.1016/j.humov.2010.11.004; Pollock S, 2019, J SPORT SCI MED, V18, P577; Post AK, 2020, SCAND J MED SCI SPOR, V30, P564, DOI 10.1111/sms.13599; Pyne DB, 2004, J SPORT SCI, V22, P613, DOI 10.1080/02640410310001655822; Ribeiro J, 2017, J SPORT SCI, V35, P1614, DOI 10.1080/02640414.2016.1227079; Sandbakk O, 2018, INT J SPORT PHYSIOL, V13, P2, DOI 10.1123/ijspp.2017-0196; Sarkar M, 2015, J SCI MED SPORT, V18, P475, DOI 10.1016/j.jsams.2014.06.010; Stewart AM, 2000, MED SCI SPORT EXER, V32, P997; Trewin CB, 2004, J SPORT SCI, V22, P339, DOI 10.1080/02640410310001641610; Tucker R, 2012, BRIT J SPORT MED, V46, P555, DOI 10.1136/bjsports-2011-090548; Yustres I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218601; Zamparo P, 2020, EUR J APPL PHYSIOL, V120, P41, DOI 10.1007/s00421-019-04270-y; Zaryski Calvin, 2005, Curr Sports Med Rep, V4, P165	50	4	4	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242442	10.1371/journal.pone.0242442	http://dx.doi.org/10.1371/journal.pone.0242442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206722	Green Published, gold			2022-12-26	WOS:000595265900076
J	Han, AN; Purwin, TJ; Bechtel, N; Liao, C; Chua, V; Seifert, E; Sato, T; Schug, ZT; Speicher, DW; Harbour, JW; Aplin, AE				Han, Anna; Purwin, Timothy J.; Bechtel, Nelisa; Liao, Connie; Chua, Vivian; Seifert, Erin; Sato, Takami; Schug, Zachary T.; Speicher, David W.; William Harbour, J.; Aplin, Andrew E.			BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors	ONCOGENE			English	Article							TARGETING CANCER METABOLISM; FATTY-ACID OXIDATION; CELL-METABOLISM; GENE; EXPRESSION; PROTEIN; ASSOCIATION; GLYCOLYSIS; REGULATOR; SUBTYPES	Cancer cell metabolism is a targetable vulnerability; however, a precise understanding of metabolic heterogeneity is required. Inactivating mutations in BRCA1-associated protein 1 (BAP1) are associated with metastasis in uveal melanoma (UM), the deadliest adult eye cancer. BAP1 functions in UM remain unclear. UM patient sample analysis divided BAP1 mutant UM tumors into two subgroups based on oxidative phosphorylation (OXPHOS) gene expression suggesting metabolic heterogeneity. Consistent with patient data, transcriptomic analysis of BAP1 mutant UM cell lines also showed OXPHOShigh or OXPHOSlow subgroups. Integrated RNA sequencing, metabolomics, and molecular analyses showed that OXPHOS(high)BAP1 mutant UM cells utilize glycolytic and nucleotide biosynthesis pathways, whereas OXPHOS(low)BAP1 mutant UM cells employ fatty acid oxidation. Furthermore, the two subgroups responded to different classes of metabolic suppressors. Our findings indicate that targeting cancer metabolism is a promising therapeutic option for BAP1 mutant UM; however, tailored approaches may be required due to metabolic heterogeneities.	[Han, Anna; Purwin, Timothy J.; Bechtel, Nelisa; Liao, Connie; Chua, Vivian; Aplin, Andrew E.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Seifert, Erin] Thomas Jefferson Univ, Dept Pathol, Philadelphia, PA 19107 USA; [Sato, Takami] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA; [Sato, Takami; Aplin, Andrew E.] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Schug, Zachary T.; Speicher, David W.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, 3601 Spruce St, Philadelphia, PA 19104 USA; [Speicher, David W.] Wistar Inst Anat & Biol, Prote & Metab Facil, 3601 Spruce St, Philadelphia, PA 19104 USA; [William Harbour, J.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33101 USA; [William Harbour, J.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33101 USA; [William Harbour, J.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33101 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; The Wistar Institute; The Wistar Institute; Bascom Palmer Eye Institute; University of Miami; University of Miami; University of Miami	Aplin, AE (corresponding author), Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA.; Aplin, AE (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	Andrew.Aplin@Jefferson.edu		Purwin, Timothy/0000-0002-7053-8039; Schug, Zachary/0000-0003-4197-8227; Han, Anna/0000-0001-8180-6214	Melanoma Research Alliance team science award [559058]; National Institutes of Health (NIH)/National Cancer Institute (NCI) [R01 CA196278, R01 CA253977, P50CA174523]; National Cancer Center; American Association for Cancer Research (AACR)/Ocular Melanoma Foundation; NCI [P01 CA114046];  [P30CA010815];  [S10OD023586]	Melanoma Research Alliance team science award; National Institutes of Health (NIH)/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Center; American Association for Cancer Research (AACR)/Ocular Melanoma Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; 	We thank Dr. Sergio Roman-Roman (Uveal Melanoma Translational Group, Department of Translational Research, Institute Curie, PSL Research University, Paris, France) for cell lines. We thank Dr. Michele Carbone (University of Hawaii Cancer Center, Honolulu, HI, USA) for BAP1 cDNA. This work was supported by a Melanoma Research Alliance team science award (#559058) to AEA and JWH. Further support was from National Institutes of Health (NIH)/National Cancer Institute (NCI), R01 CA196278 and R01 CA253977 to AEA, P50CA174523 to DWS and fellowships from the National Cancer Center and American Association for Cancer Research (AACR)/Ocular Melanoma Foundation (OMF) awarded to AH and VC. This work was also supported by grant from NCI P01 CA114046. The Wistar Proteomics and Metabolomics Facility was supported by P30CA010815 and S10OD023586.	Amirouchene-Angelozzi N, 2014, MOL ONCOL, V8, P1508, DOI 10.1016/j.molonc.2014.06.004; Baughman JM, 2016, CELL REP, V16, P583, DOI 10.1016/j.celrep.2016.05.096; Bononi A, 2017, CELL DEATH DIFFER, V24, P1694, DOI 10.1038/cdd.2017.95; Camarda R, 2016, NAT MED, V22, P427, DOI 10.1038/nm.4055; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Cheng HY, 2017, MOL CANCER THER, V16, P516, DOI 10.1158/1535-7163.MCT-16-0552; Chua V, 2018, CURR OPIN ONCOL, V30, P134, DOI 10.1097/CCO.0000000000000425; Daemen A, 2015, P NATL ACAD SCI USA, V112, pE4410, DOI 10.1073/pnas.1501605112; Dai FY, 2017, P NATL ACAD SCI USA, V114, P3192, DOI 10.1073/pnas.1619588114; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; Desler Claus, 2012, J Aging Res, V2012, P192503, DOI 10.1155/2012/192503; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gaude E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13041; Goodwin J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15503; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hebert L, 2017, ONCOTARGET, V8, P72513, DOI 10.18632/oncotarget.19872; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Izawa T, 2015, CELL REP, V11, P1625, DOI 10.1016/j.celrep.2015.05.019; JAGER MJ, 2020, NAT REV DIS PRIMERS, V6, P1, DOI DOI 10.1038/s41572-019-0135-7; Johansson PA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16276-8; Jones NP, 2012, DRUG DISCOV TODAY, V17, P232, DOI 10.1016/j.drudis.2011.12.017; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kalirai H, 2014, BRIT J CANCER, V111, P1373, DOI 10.1038/bjc.2014.417; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlsson J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15606-0; Klebe S, 2015, BIOMARK RES, V3, DOI 10.1186/s40364-015-0040-5; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Lehuede C, 2016, CANCER RES, V76, P5201, DOI 10.1158/0008-5472.CAN-16-0266; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liem Minh Phan, 2014, Cancer Biology Medicine, V11, P1, DOI 10.7497/j.issn.2095-3941.2014.01.001; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luke JJ, 2015, PIGM CELL MELANOMA R, V28, P135, DOI 10.1111/pcmr.12304; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Ma JF, 2013, EXPERT REV PROTEOMIC, V10, P365, DOI 10.1586/14789450.2013.820536; Matatall KA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-371; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Molina JR, 2018, NAT MED, V24, P1036, DOI 10.1038/s41591-018-0052-4; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Pacella I, 2018, P NATL ACAD SCI USA, V115, pE6546, DOI 10.1073/pnas.1720113115; Peng XX, 2018, CELL REP, V23, P255, DOI 10.1016/j.celrep.2018.03.077; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Postow MA, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.9074; Rai K, 2016, CLIN GENET, V89, P285, DOI 10.1111/cge.12630; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Seedor RS, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.9592; SHIELDS JA, 1991, SURV OPHTHALMOL, V36, P161, DOI 10.1016/0039-6257(91)90001-V; Singh Arun D, 2005, Ophthalmol Clin North Am, V18, P75, DOI 10.1016/j.ohc.2004.07.002; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van Essen TH, 2014, BRIT J OPHTHALMOL, V98, P1738, DOI 10.1136/bjophthalmol-2014-305047; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Vivas-Garcia Y, 2020, MOL CELL, V77, P120, DOI 10.1016/j.molcel.2019.10.014; Wang A, 2016, J CLIN PATHOL, V69, P750, DOI 10.1136/jclinpath-2016-203866; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10; Yu LL, 2017, CANCER RES, V77, P1564, DOI 10.1158/0008-5472.CAN-16-2074	62	19	19	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2021	40	3					618	632		10.1038/s41388-020-01554-y	http://dx.doi.org/10.1038/s41388-020-01554-y		NOV 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PU9SL	33208912	Green Accepted			2022-12-26	WOS:000590925500001
J	Leni, Z; Cassagnes, LE; Daellenbach, KR; El Haddad, I; Vlachou, A; Uzu, G; Prevot, ASH; Jaffrezo, JL; Baumlin, N; Salathe, M; Baltensperger, U; Dommen, J; Geiser, M				Leni, Zaira; Cassagnes, Laure Estelle; Daellenbach, Kaspar R.; El Haddad, Imad; Vlachou, Athanasia; Uzu, Gaelle; Prevot, Andre S. H.; Jaffrezo, Jean-Luc; Baumlin, Nathalie; Salathe, Matthias; Baltensperger, Urs; Dommen, Josef; Geiser, Marianne			Oxidative stress-induced inflammation in susceptible airways by anthropogenic aerosol	PLOS ONE			English	Article							SOURCE APPORTIONMENT; AIR-POLLUTION; MASS; PM10; PARTICLES; IDENTIFICATION; ASTHMA	Ambient air pollution is one of the leading five health risks worldwide. One of the most harmful air pollutants is particulate matter (PM), which has different physical characteristics (particle size and number, surface area and morphology) and a highly complex and variable chemical composition. Our goal was first to comparatively assess the effects of exposure to PM regarding cytotoxicity, release of pro-inflammatory mediators and gene expression in human bronchial epithelia (HBE) reflecting normal and compromised health status. Second, we aimed at evaluating the impact of various PM components from anthropogenic and biogenic sources on the cellular responses. Air-liquid interface (ALI) cultures of fully differentiated HBE derived from normal and cystic fibrosis (CF) donor lungs were exposed at the apical cell surface to water-soluble PM filter extracts for 4 h. The particle dose deposited on cells was 0.9-2.5 and 8.8-25.4 mu g per cm(2) of cell culture area for low and high PM doses, respectively. Both normal and CF HBE show a clear dose-response relationship with increasing cytotoxicity at higher PM concentrations. The concurrently enhanced release of pro-inflammatory mediators at higher PM exposure levels links cytotoxicity to inflammatory processes. Further, the PM exposure deregulates genes involved in oxidative stress and inflammatory pathways leading to an imbalance of the antioxidant system. Moreover, we identify compromised defense against PM in CF epithelia promoting exacerbation and aggravation of disease. We also demonstrate that the adverse health outcome induced by PM exposure in normal and particularly in susceptible bronchial epithelia is magnified by anthropogenic PM components. Thus, including health-relevant PM components in regulatory guidelines will result in substantial human health benefits and improve protection of the vulnerable population.	[Leni, Zaira; Geiser, Marianne] Univ Bern, Inst Anat, Bern, Switzerland; [Cassagnes, Laure Estelle; Daellenbach, Kaspar R.; El Haddad, Imad; Vlachou, Athanasia; Prevot, Andre S. H.; Baltensperger, Urs; Dommen, Josef] Paul Scherrer Inst, Lab Atmospher Chem, Villigen, Switzerland; [Uzu, Gaelle; Jaffrezo, Jean-Luc] Univ Grenoble Alpes, CNRS, IRD, INP,IGE, Grenoble, France; [Baumlin, Nathalie; Salathe, Matthias] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66103 USA	University of Bern; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut de Recherche pour le Developpement (IRD); University of Kansas; University of Kansas Medical Center	Geiser, M (corresponding author), Univ Bern, Inst Anat, Bern, Switzerland.; Dommen, J (corresponding author), Paul Scherrer Inst, Lab Atmospher Chem, Villigen, Switzerland.	marianne.geiser@ana.unibe.ch; josef.dommen@psi.ch	Dällenbach, Kaspar Rudolf/ABB-4630-2020; Prevot, Andre S. H./C-6677-2008; Daellenbach, Kaspar/AAY-4521-2020; Haddad, Imad El/B-8073-2011; Cassagnes, Laure-Estelle/M-5046-2016; UZU, Gaelle/L-9005-2017	Dällenbach, Kaspar Rudolf/0000-0003-1246-6396; Prevot, Andre S. H./0000-0002-9243-8194; Haddad, Imad El/0000-0002-2461-7238; Cassagnes, Laure-Estelle/0000-0002-5858-1827; UZU, Gaelle/0000-0002-7720-0233	Swiss National Science Foundation (SNSF) [CR32I3_166325]; SNSF mobility grant [P2EZP2_181599]; National Institutes of Health (NIH) [NIH R01-HL139365, NIH R01-HL-133240]; "Investissements d'avenir"program [ANR-15-IDEX-02]; LABEX OSUG@2020 [ANR-10-LABX-56]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SNSF mobility grant; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Investissements d'avenir"program(French National Research Agency (ANR)); LABEX OSUG@2020	This study was supported by the Swiss National Science Foundation (SNSF) grant CR32I3_166325. K.R.D. acknowledges support by the SNSF mobility grant P2EZP2_181599. M.S. and N.B. acknowledge funding by the National Institutes of Health (NIH) grants NIH R01-HL139365 and NIH R01-HL-133240. G.U. and J.-L.J. acknowledge support by the "Investissements d'avenir"program (ANR-15-IDEX-02) and LABEX OSUG@2020(ANR-10-LABX-56).	[Anonymous], 2018, NEW ENGL J MED, V379, P2429, DOI [DOI 10.1056/NEJMOA1804492, 10.1056/NEJMoa1804492]; [Anonymous], 2005, PART FIBRE TOXICOL, V2, P8; [Anonymous], 2008, PUBLIC CULTURE, V20, P75; [Anonymous], 2007, ZESZYTY NAUKOWE WALB, V1, P174; Barmpadimos I, 2011, ATMOS CHEM PHYS, V11, P1813, DOI 10.5194/acp-11-1813-2011; Bates JT, 2019, ENVIRON SCI TECHNOL, V53, P4003, DOI 10.1021/acs.est.8b03430; Bates JT, 2015, ENVIRON SCI TECHNOL, V49, P13605, DOI 10.1021/acs.est.5b02967; Birch ME, 1996, AEROSOL SCI TECH, V25, P221, DOI 10.1080/02786829608965393; Calas A, 2018, ATMOS CHEM PHYS, V18, P7863, DOI 10.5194/acp-18-7863-2018; Calas A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11979-3; Canonaco F, 2013, ATMOS MEAS TECH, V6, P3649, DOI 10.5194/amt-6-3649-2013; Cassee FR, 2013, INHAL TOXICOL, V25, P802, DOI 10.3109/08958378.2013.850127; Daellenbach KR, 2016, ATMOS MEAS TECH, V9, P23, DOI 10.5194/amt-9-23-2016; Daellenbach KR, 2019, ATMOS CHEM PHYS, V19, P5973, DOI 10.5194/acp-19-5973-2019; Daellenbach KR, 2017, ATMOS CHEM PHYS, V17, P13265, DOI 10.5194/acp-17-13265-2017; Delfino RJ, 2013, J EXPO SCI ENV EPID, V23, P466, DOI 10.1038/jes.2013.25; Delfino RJ, 2005, ENVIRON HEALTH PERSP, V113, P934, DOI 10.1289/ehp.7938; European Environment Agency, 2018, EEA Report, DOI 10.2800/777411; Expert Panel on Women's I, 2018, J AM COLL RADIOL, V15, pS365; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Goss CH, 2004, AM J RESP CRIT CARE, V169, P816, DOI 10.1164/rccm.200306-779OC; Jaffrezo JL, 1998, ATMOS ENVIRON, V32, P2705, DOI 10.1016/S1352-2310(98)00026-0; Kim MD, 2019, AM J RESP CRIT CARE; Krapf M, 2017, ENVIRON SCI-PROC IMP, V19, P538, DOI [10.1039/c6em00586a, 10.1039/C6EM00586A]; Kunzi L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11801; Lelieveld J, 2017, FARADAY DISCUSS, V200, P693, DOI 10.1039/c7fd90032e; Li N, 2003, CLIN IMMUNOL, V109, P250, DOI 10.1016/j.clim.2003.08.006; McDonald JD, 2012, INHAL TOXICOL, V24, P689, DOI 10.3109/08958378.2012.712164; Miller FJ, 2016, J AEROSOL SCI, V99, P14, DOI 10.1016/j.jaerosci.2016.01.018; Morakinyo OM, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060592; Naili M. B., 2010, ARAB J CHEM, V3, P79; Paatero P, 1999, J COMPUT GRAPH STAT, V8, P854, DOI 10.2307/1390831; Peters-Hall JR, 2015, AM J RESP CELL MOL, V53, P22, DOI 10.1165/rcmb.2014-0256RC; Pillai DK, 2014, AM J RESP CELL MOL, V50, P292, DOI 10.1165/rcmb.2013-0188OC; Piot C, 2012, ATMOS MEAS TECH, V5, P141, DOI 10.5194/amt-5-141-2012; Ruckerl R, 2011, INHAL TOXICOL, V23, P555, DOI 10.3109/08958378.2011.593587; Sacks JD, 2011, ENVIRON HEALTH PERSP, V119, P446, DOI 10.1289/ehp.1002255; SS V et al. on behalf of the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, 2020, CIRCULATION, V2020, pe1; Torseth K, 2012, ATMOS CHEM PHYS, V12, P5447, DOI 10.5194/acp-12-5447-2012; Usemann J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20736-z; Van Den Heuvel R, 2016, ENVIRON RES, V149, P48, DOI 10.1016/j.envres.2016.04.029; van der Kamp J, 2015, ENVIRON SCI TECHNOL, V49, P2929, DOI 10.1021/es5054607; Verma V, 2012, ENVIRON SCI TECHNOL, V46, P11384, DOI 10.1021/es302484r; Vlachou A, 2018, ATMOS CHEM PHYS, V18, P6187, DOI 10.5194/acp-18-6187-2018; Waked A, 2014, ATMOS CHEM PHYS, V14, P3325, DOI 10.5194/acp-14-3325-2014; Wilder Gary, 2009, PUBLIC CULTURE, V21; Xiao GG, 2003, J BIOL CHEM, V278, P50781, DOI 10.1074/jbc.M306423200; Zheng YX, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8a32	49	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0233425	10.1371/journal.pone.0233425	http://dx.doi.org/10.1371/journal.pone.0233425			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206642	gold, Green Published			2022-12-26	WOS:000595265900011
J	Yoshikawa, K; Ishida, M; Yanai, H; Tsuta, K; Sekimoto, M; Sugie, T				Yoshikawa, Katsuhiro; Ishida, Mitsuaki; Yanai, Hirotsugu; Tsuta, Koji; Sekimoto, Mitsugu; Sugie, Tomoharu			Adipophilin expression is an independent marker for poor prognosis of patients with triple-negative breast cancer: An immunohistochemical study	PLOS ONE			English	Article							RECURRENCE; FEATURES; PROTEIN; RISK	Adipophilin is a lipid droplet-associated protein whose expression can act as a prognostic marker for specific cancers. Using immunohistochemical staining and tissue microarrays, we assayed the expression of adipophilin in 61 patients with triple-negative breast cancer (TNBC) who underwent surgery from January 2006-December 2018. Relapse-free survival (RFS) and its risk factors were analyzed based on adipophilin expression. Fourteen (23.0%) patients expressed adipophilin. As compared to the adipophilin-negative TNBC patients, adipophilin-positive patients exhibited poor RFS (p = 0.032). Among the TNBC patients with a high Ki-67 labeling index, patients negative for adipophilin exhibited better RFS than patients positive for adipophilin (p = 0.032). Moreover, among patients who did not undergo adjuvant chemotherapy, patients negative for adipophilin expression exhibited better RFS than adipophilin-positive patients (p = 0.080). Multivariate analysis showed that adipophilin expression correlated with a high rate of relapse (hazard ratio, 4.89; 95% confidence interval, 1.04-23.0; p = 0.044). Taken together, these results indicate that adipophilin is a novel marker for the poor prognosis of patients with TNBC.	[Yoshikawa, Katsuhiro; Ishida, Mitsuaki; Tsuta, Koji] Kansai Med Univ, Dept Pathol & Clin Lab, Osaka, Japan; [Yoshikawa, Katsuhiro; Yanai, Hirotsugu; Sekimoto, Mitsugu; Sugie, Tomoharu] Kansai Med Univ, Dept Surg, Osaka, Japan	Kansai Medical University; Kansai Medical University	Ishida, M (corresponding author), Kansai Med Univ, Dept Pathol & Clin Lab, Osaka, Japan.	ishidamt@hirakata.kmu.ac.jp						Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Ambrosio MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044315; Baenke F, 2013, DIS MODEL MECH, V6, P1353, DOI 10.1242/dmm.011338; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dowsett M, 2010, J CLIN ONCOL, V28, P1829, DOI 10.1200/JCO.2009.24.4798; Elston C W, 2002, Histopathology, V41, P154; Fujimoto M, 2017, J CUTAN PATHOL, V44, P228, DOI 10.1111/cup.12868; Fujimoto M, 2017, HISTOPATHOLOGY, V70, P232, DOI 10.1111/his.13048; Hashimoto Y, 2019, PANCREATOLOGY, V19, P443, DOI 10.1016/j.pan.2019.03.001; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Kaplan HG, 2009, BREAST J, V15, P454, DOI 10.1111/j.1524-4741.2009.00789.x; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Koizume S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091430; Kuniyoshi S, 2019, PATHOL INT, V69, P463, DOI 10.1111/pin.12831; Matsubara J, 2011, CANCER EPIDEM BIOMAR, V20, P2195, DOI 10.1158/1055-9965.EPI-11-0400; Nalwoga H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146823; Pucer A, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-111; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Saarikoski ST, 2002, FEBS LETT, V530, P186, DOI 10.1016/S0014-5793(02)03475-0; Sztalryd C, 2014, BIOCHIMIE, V96, P96, DOI 10.1016/j.biochi.2013.08.026; Toi M, 2010, CANCER-AM CANCER SOC, V116, P3112, DOI 10.1002/cncr.25206; Wu Q, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01068; Xiang L, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-32; Yao M, 2007, CLIN CANCER RES, V13, P152, DOI 10.1158/1078-0432.CCR-06-1877	26	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242563	10.1371/journal.pone.0242563	http://dx.doi.org/10.1371/journal.pone.0242563			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201923	gold, Green Published			2022-12-26	WOS:000595003900053
J	May, Z; Alam, MK; Mahmud, MS; Rahman, NAA				May, Zazilah; Alam, M. K.; Mahmud, Muhammad Shazwan; Rahman, Noor A'in A.			Unsupervised bivariate data clustering for damage assessment of carbon fiber composite laminates	PLOS ONE			English	Article							ACOUSTIC-EMISSION; CLASSIFICATION; TENSILE	Damage assessment is a key element in structural health monitoring of various industrial applications to understand well and predict the response of the material. The big uncertainty in carbon fiber composite materials response is because of variability in the initiation and propagation of damage. Developing advanced tools to design with composite materials, methods for characterizing several damage modes during operation are required. While there is a significant amount of work on the analysis of acoustic emission (AE) from different composite materials and many loading cases, this research focuses on applying an unsupervised clustering method for separating AE data into several groups with distinct evolution. In this paper, we develop an adaptive sampling and unsupervised bivariate data clustering techniques to characterize the several damage initiations of a composite structure in different lay-ups. An adaptive sampling technique pre-processes the AE features and eliminates redundant AE data samples. The reduction of unnecessary AE data depends on the requirements of the proposed bivariate data clustering technique. The bivariate data clustering technique groups the AE data (dependent variable) with respect to the mechanical data (independent variable) to assess the damage of the composite structure. Tensile experiments on carbon fiber reinforced composite laminates (CFRP) in different orientations are carried out to collect mechanical and AE data and demonstrate the damage modes. Based on the mechanical stress-strain data, the results show the dominant damage regions in different lay-ups of specimens and the definition of the different states of damage. In addition, the states of the damage are observed using Scanning Electron Microscope (SEM) analysis. Based on the AE data, the results show that the strong linear correlation between AE and mechanical energy, and the classification of various modes of damage in all lay-ups of specimens forming clusters of AE energy with respect to the mechanical energy. Furthermore, the validation of the cluster-based characterization and improvement of the sensitivity of the damage modes classification are observed by the combined knowledge of AE and mechanical energy and time-frequency spectrum analysis.	[May, Zazilah; Alam, M. K.; Rahman, Noor A'in A.] Univ Teknol PETRONAS, Elect & Elect Engn Dept, Seri Iskandar, Perak, Malaysia; [Mahmud, Muhammad Shazwan] Univ Teknol PETRONAS, Dept Mech Engn, Seri Iskandar, Perak, Malaysia	Universiti Teknologi Petronas; Universiti Teknologi Petronas	Alam, MK (corresponding author), Univ Teknol PETRONAS, Elect & Elect Engn Dept, Seri Iskandar, Perak, Malaysia.	md.khorshed_g03456@utp.edu.my		Alam, Md Khorshed/0000-0002-9625-2688	Yayasan Universiti Teknologi PETRONAS-Fundamental Research Grant (YUTP-FRG) [015LCO-187]	Yayasan Universiti Teknologi PETRONAS-Fundamental Research Grant (YUTP-FRG)	This research was funded by Yayasan Universiti Teknologi PETRONAS-Fundamental Research Grant (YUTP-FRG) 2020 under Grant number 015LCO-187.	Alam MK, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20041011; [Anonymous], 2019, CIRCULATION, V2019; Cai J, 2012, COMPOS THEIR APP AUG, P36; Crivelli D, 2015, COMPOS PART B-ENG, V74, P1, DOI 10.1016/j.compositesb.2014.12.032; Ghimire R, 2011, ASME 2011 INT MECH E, P273; Gutkin R, 2011, MECH SYST SIGNAL PR, V25, P1393, DOI 10.1016/j.ymssp.2010.11.014; Huang Y, 2009, STRUCT HEALTH MONIT, V8, P493, DOI 10.1177/1475921709340979; Kalteremidou KA, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8112021; Khamedi R, 2020, COMPOS INTERFACE, V27, P111, DOI 10.1080/09276440.2019.1601939; Masmoudi S, 2016, APPL ACOUST, V108, P50, DOI 10.1016/j.apacoust.2015.10.024; McCrory JP, 2015, COMPOS PART B-ENG, V68, P424, DOI 10.1016/j.compositesb.2014.08.046; Mohammadi R, 2015, J REINF PLAST COMP, V34, P868, DOI 10.1177/0731684415583166; Munoz V, 2016, COMPOS PART B-ENG, V85, P68, DOI 10.1016/j.compositesb.2015.09.011; Notario B, 2016, MATER LETT, V168, P76, DOI 10.1016/j.matlet.2016.01.037; Roundi W, 2018, APPL ACOUST, V132, P124, DOI 10.1016/j.apacoust.2017.11.017; Saeedifar M, 2020, COMPOS PART B-ENG, V195, DOI 10.1016/j.compositesb.2020.108039; Sawan HA, 2015, COMPOS SCI TECHNOL, V107, P89, DOI 10.1016/j.compscitech.2014.12.003; Vinogradov A, 2016, MATER LETT, V183, P417, DOI 10.1016/j.matlet.2016.07.063; Wang WZ, 2014, J AEROSPACE ENG, V27, P308, DOI 10.1061/(ASCE)AS.1943-5525.0000243; Xu Y, 2011, MATER LETT, V65, P3609, DOI 10.1016/j.matlet.2011.08.012; Zhu D, 2018, PROCESSES, V6, DOI 10.3390/pr6080101	21	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242022	10.1371/journal.pone.0242022	http://dx.doi.org/10.1371/journal.pone.0242022			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186372	Green Published, gold			2022-12-26	WOS:000593949800016
J	Tilley, A; Lopes, JD; Wilkinson, SP				Tilley, Alexander; Dos Reis Lopes, Joctan; Wilkinson, Shaun P.			PeskAAS: A near-real-time, open-source monitoring and analytics system for small-scale fisheries	PLOS ONE			English	Article							CATCH	Small-scale fisheries are responsible for landing half of the world's fish catch, yet there are very sparse data on these fishing activities and associated fisheries production in time and space. Fisheries-dependent data underpin scientific guidance of management and conservation of fisheries systems, but it is inherently difficult to generate robust and comprehensive data for small-scale fisheries, particularly given their dispersed and diverse nature. In tackling this challenge, we use open source software components including the Shiny R package to build PeskAAS; an adaptable and scalable digital application that enables the collation, classification, analysis and visualisation of small-scale fisheries catch and effort data. We piloted and refined this system in Timor-Leste; a small island developing nation. The features that make PeskAAS fit for purpose are that it is: (i) fully open-source and free to use (ii) component-based, flexible and able to integrate vessel tracking data with catch records; (iii) able to perform spatial and temporal filtering of fishing productivity by fishing method and habitat; (iv) integrated with species-specific length-weight parameters from FishBase; (v) controlled through a click-button dashboard, that was co-designed with fisheries scientists and government managers, that enables easy to read data summaries and interpretation of context-specific fisheries data. With limited training and code adaptation, the PeskAAS workflow has been used as a framework on which to build and adapt systematic, standardised data collection for small-scale fisheries in other contexts. Automated analytics of these data can provide fishers, managers and researchers with insights into a fisher's experience of fishing efforts, fisheries status, catch rates, economic efficiency and geographic preferences and limits that can potentially guide management and livelihood investments.	[Tilley, Alexander; Dos Reis Lopes, Joctan] WorldFish, Bayan Lepas, Penang, Malaysia; [Wilkinson, Shaun P.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Wilkinson, Shaun P.] Wilderlab, Wellington, New Zealand	CGIAR; Worldfish; Victoria University Wellington	Tilley, A (corresponding author), WorldFish, Bayan Lepas, Penang, Malaysia.	alex.tilley@gmail.com		Wilkinson, Shaun/0000-0002-7332-7931; Dos Reis Lopes, Joctan/0000-0002-4437-1044; Tilley, Alexander/0000-0002-6363-0945	Royal Norwegian Embassy in Jakarta	Royal Norwegian Embassy in Jakarta	This work was undertaken as part of the CGIAR Research Program on Fish Agri-Food Systems (FISH) led by WorldFish, and the CGIAR Big Data Platform Inspire Challenge 2018 led by CIAT and IFPRI. These programs are supported by contributors to the CGIAR Trust Fund. PeskAAS was established under the Fisheries Sector Support Program funded by the Royal Norwegian Embassy in Jakarta. The funders provided support in the form of salary for authors [A.T.] and field costs, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Wilderlab is a recent, unassociated affiliation for S.P.W. and did not contribute funding towards the study. The specific roles of these authors are articulated in the `author contributions' section.	Apgar JM, 2017, ECOL SOC, V22, DOI [10.5751/ES-08929-220109, 10.5751/es-08929-220109]; Boettiger C, 2012, J FISH BIOL, V81, P2030, DOI 10.1111/j.1095-8649.2012.03464.x; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Donnelly M, 2018, IMPLEMENTING ICTS IN; Dowling N.A., 2016, ASSESSING MANAGING D, P59, DOI 10.4027/amdlfs.2016.03; FAO, 2007, SER POL BRIEFS DEV I; FAO and WorldFish, 2020, HDB FISH STAK; FAO ITU, 2017, E AGR ACT; Flannery W, 2018, MAR POLICY, V88, P32, DOI 10.1016/j.marpol.2017.11.001; Food Agriculture Organization of the United Nations (FAO-UN)., 2006, FAO FISH AQ ASFIS LI; Food and Agriculture Organization (FAO), 2018, STAT WORLD FISH AQ 2; Food and Agriculture Organization of the United Nations, 2018, VOL GUID SEC SUST SM; FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS, 2014, VOL GUID RESP GOV TE; Garcia SM, 2013, AIRES MARINES PROTEG; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Hicks CC, 2019, NATURE, V574, P95, DOI 10.1038/s41586-019-1592-6; James M, 2018, MAR POLICY, V91, P113, DOI 10.1016/j.marpol.2018.02.012; Jeffers VF, 2019, MAR POLICY, V99, P267, DOI 10.1016/j.marpol.2018.10.040; Kelleher K., 2012, HIDDEN HARVEST GLOBA; Kolding J, 2014, GOVERNANCE OF MARINE FISHERIES AND BIODIVERSITY CONSERVATION: INTERACTION AND COEVOLUTION, P317; Kolding J., 2011, Forum for Development Studies, V38, P267, DOI 10.1080/08039410.2011.577798; Lopez-Angarita J, 2019, FISHERIES AQUACULTUR; Mallalieu KI, 2007, DIGITAL POVERTY LATI, P119, DOI 10.3362/9781780441115.006; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; Mildenberger TK, 2017, METHODS ECOL EVOL, V8, P1520, DOI 10.1111/2041-210X.12791; Mills DJ, 2011, SMALL-SCALE FISHERIES MANAGEMENT: FRAMEWORKS AND APPROACHES FOR THE DEVELOPING WORLD, P1, DOI 10.1079/9781845936075.0001; Petrik M, 2018, 177 SAIIA; Stacey Natasha, 2017, FAO Fisheries and Aquaculture Technical Paper, V603, P113; Tilley A, 2021, AMBIO, V50, P113, DOI 10.1007/s13280-020-01335-7; Tilley A, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00487; Tilley A, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00392	31	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0234760	10.1371/journal.pone.0234760	http://dx.doi.org/10.1371/journal.pone.0234760			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186386	Green Published, gold, Green Submitted			2022-12-26	WOS:000593949800032
J	Feng, LN; Dong, KH; Zhang, XX; Ma, B; Chen, L; Yang, QQ; Chen, QL; Wen, XY; Jin, QL				Feng, Lina; Dong, Kaihui; Zhang, Xiaoxue; Ma, Bo; Chen, Lin; Yang, Qianqian; Chen, Qingling; Wen, Xiaoyu; Jin, Qinglong			Clinical significance of IgG antimitochondrial M2 antibody levels in primary biliary cholangitis: A single center study from China	PLOS ONE			English	Article							CIRRHOSIS; ANTI-M2; DIAGNOSIS; FEATURES; DISEASE	Background and objective The relationship between antimitochondrial antibody (AMA) levels and the severity or prognosis of primary biliary cholangitis (PBC) is unclear. This study explored the clinical significance of serum IgG antimitochondrial M2 antibody (IgG-M2) levels. Methods From 2008 to 2017, a retrospective analysis was conducted with PBC patients who had available quantitative values of serum IgG-M2 levels obtained with ELISA based on triple expression hybrid clones. The patients were divided into two groups based on high and low concentrations of IgG-M2. Baseline parameters, the incidence of adverse events, and prognosis were compared. Results Among the 530 PBC patients, the levels of albumin, cholinesterase, hemoglobin, fibrinogen and triglycerides and the red blood cell count were significantly lower in the high-concentration group than in the low-concentration group (n = 263, 49.6%). The red cell distribution width (RDW) and levels of serum immunoglobulin (Ig) G, IgM and IgA were significantly higher in the high-concentration group than in the low-concentration group. Spearman's correlation analysis suggested that the correlation between the above baseline indicators and IgG-M2 levels was statistically significant but weak (r < 0.2, P < 0.05). In total, 203 patients were followed up, of whom 87 (42.9%) were in the high-concentration group. During the median follow-up period of 52 months (range: 28-75), 121 (59.6%) experienced hepatic decompensation, and 37 (18.2%) died or underwent liver transplantation. There was no significant difference in the incidence of complications or survival (log-rank test: P = 0.079) between the two groups. One year after ursodeoxycholic acid (UDCA) treatment, the two groups had similar responses. In addition, the levels of IgG-M2 did not fluctuate significantly during treatment. Conclusion IgG-M2 levels were not related to the disease severity, prognosis or efficacy of UDCA. The levels of IgG-M2 did not change significantly during treatment.	[Feng, Lina; Zhang, Xiaoxue; Ma, Bo; Chen, Lin; Yang, Qianqian; Chen, Qingling; Wen, Xiaoyu; Jin, Qinglong] First Hosp Jilin Univ, Dept Hepatol, Changchun, Peoples R China; [Dong, Kaihui] Yantaishan Hosp, Dept Gastroenterol, Yantai, Shandong, Peoples R China	Jilin University	Jin, QL (corresponding author), First Hosp Jilin Univ, Dept Hepatol, Changchun, Peoples R China.	Jinql2016@163.com			Jilin Provincial Department of Finance [JLSCZD2019-027]	Jilin Provincial Department of Finance	This work is funded by Jilin Provincial Department of Finance (JLSCZD2019-027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano AM, 2017, IMMUNOL RES, V65, P299, DOI 10.1007/s12026-016-8838-2; [Anonymous], 2003, TRAINING STRATEGIES, V17, P17; [Anonymous], 2017, KARLOVACKI TJEDNIK, V64, P7; Benson Gordon D, 2004, Clin Dev Immunol, V11, P129, DOI 10.1080/10446670410001722113; Bizzaro N, 2012, CLIN REV ALLERG IMMU, V42, P288, DOI 10.1007/s12016-010-8234-y; Carbone M, 2016, HEPATOLOGY, V63, P930, DOI 10.1002/hep.28017; Carey EJ, 2015, LANCET, V386, P1565, DOI 10.1016/S0140-6736(15)00154-3; Chen S, 2019, J GASTROEN HEPATOL, V34, P1236, DOI 10.1111/jgh.14521; CHRISTENSEN E, 1980, GASTROENTEROLOGY, V78, P236; Flisiak R, 2005, WORLD J GASTROENTERO, V11, P5706, DOI 10.3748/wjg.v11.i36.5706; Gabeta S, 2007, J CLIN IMMUNOL, V27, P378, DOI 10.1007/s10875-007-9092-0; GERSHWIN ME, 1987, J IMMUNOL, V138, P3525; Invernizzi P, 1997, HEPATOLOGY, V25, P1090, DOI 10.1002/hep.510250507; Joshi S, 2002, AM J GASTROENTEROL, V97, P999; Juliusson G, 2016, SCAND J GASTROENTERO, V51, P745, DOI 10.3109/00365521.2015.1132337; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; KITAMI N, 1995, INTERNAL MED, V34, P496, DOI 10.2169/internalmedicine.34.496; Leung PSC, 2016, EXPERT REV MOL DIAGN, V16, P697, DOI 10.1586/14737159.2016.1164038; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Liu B, 2008, LIVER INT, V28, P233, DOI 10.1111/j.1478-3231.2007.01651.x; Lleo A, 2017, HEPATOL INT, V11, P485, DOI 10.1007/s12072-017-9830-1; Ludwig J, 2000, BEST PRACT RES CL GA, V14, P601, DOI 10.1053/bega.2000.0106; Mendes F, 2008, GASTROENTEROL CLIN N, V37, P479, DOI 10.1016/j.gtc.2008.02.006; Nakajima M, 1999, J GASTROENTEROL, V34, P607, DOI 10.1007/s005350050380; Nishio A, 2002, SEMIN LIVER DIS, V22, P291, DOI 10.1055/s-2002-34506; ROLL J, 1983, NEW ENGL J MED, V308, P1, DOI 10.1056/NEJM198301063080101; Sakauchi F, 2006, J EPIDEMIOL, V16, P30, DOI 10.2188/jea.16.30; Trivedi PJ, 2015, NAT REV GASTRO HEPAT, V12, P678, DOI 10.1038/nrgastro.2015.187; VanNorstrand MD, 1997, HEPATOLOGY, V25, P6, DOI 10.1053/jhep.1997.v25.pm0008985257; Zhao DT, 2011, DIGEST DIS SCI, V56, P2750, DOI 10.1007/s10620-011-1661-7	30	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242164	10.1371/journal.pone.0242164	http://dx.doi.org/10.1371/journal.pone.0242164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180817	Green Published			2022-12-26	WOS:000593948000034
J	Tekele, SG; Teklu, DS; Tullu, KD; Birru, SK; Legese, MH				Tekele, Saba Gebremichael; Teklu, Dejenie Shiferaw; Tullu, Kassu Desta; Birru, Samuel Kinde; Legese, Melese Hailu			Extended-spectrum Beta-lactamase and AmpC beta-lactamases producing gram negative bacilli isolated from clinical specimens at International Clinical Laboratories, Addis Ababa, Ethiopia	PLOS ONE			English	Article							ESCHERICHIA-COLI; E. COLI; ENTEROBACTERIACEAE; PREVALENCE; RESISTANCE; HOSPITALS; BACTERIA	Background Extended spectrum Beta-lactamases (ESBLs) and AmpC beta-lactamases (AmpC) are the common enzymes produced by gram negative bacilli, which are their main mechanisms of resistance to all generations of cephalosporins. Hence, this study aimed to determine the magnitude of ESBLs and AmpC producing gram negative bacilli (GNB) isolated from clinical specimens at International clinical Laboratories in Addis Ababa, Ethiopia. Methods A cross sectional study was conducted from January to May 2018. From different clinical specimens, 338 GNB were isolated and characterized. Bacterial species identification, antimicrobial susceptibility testing and screening for ESBLs and AmpC production were performed using Phoenix automated system (BD phoenix(100)). ESBLs production was confirmed using a combination disc method. All Cefoxitin resistant and confirmed ESBLs producing GNB were confirmed for AmpC beta-lactamases production by AmpC confirmatory Neo-Sensitabs discs (ROSCO tablet). Data were analyzed using SPSS version 20 software. Results E. coli 66.0% (224/338) followed by K. pneumoniae 12.1% (41/338) were GNB most frequently isolated. The overall magnitude of ESBLs producing GNB was 38.8% (131/338) and the extent of AmpC beta-lactamase producing GNB was 2.4% (8/338). Majority of ESBLs and AmpC beta-lactamases producing GNB were isolated from urine specimens 47.5% (116/338). Ampicillin (75.4%), amoxicillin with clavulanic acid (64.0%) and sulfamethoxazole-trimethoprim (55.6%) were most the antibiotics to which resistance was most commonly found. The multidrug resistance (MDR) level of GNB was 74.0% (250/338). Of ESBLs and AmpC beta-lactamases producing GNB, 99.3% were MDR (p < 0.05). Conclusion The high magnitude of ESBLs and AmpC beta-lactamases producing GNB calls the needs of strong intervention to minimize further occurrence and spread of such GNB. More importantly, the MDR level was high which suggests continuous monitoring & reviewing of antimicrobial policy in hospitals and the country at large.	[Tekele, Saba Gebremichael] Wollo Univ, Dept Med Lab Sci, Coll Hlth Sci, Dessie, Ethiopia; [Teklu, Dejenie Shiferaw] Ethiopian Publ Hlth Inst, Dept Bacteriol & Mycol, Addis Ababa, Ethiopia; [Tullu, Kassu Desta; Birru, Samuel Kinde; Legese, Melese Hailu] Addis Ababa Univ, Dept Med Lab Sci, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University	Tekele, SG (corresponding author), Wollo Univ, Dept Med Lab Sci, Coll Hlth Sci, Dessie, Ethiopia.	sabagmichael2@gmail.com	Gebremichael, Saba/AAJ-5693-2021; Birru, Samuel kinde/AAO-1769-2021	Legese, Melese Hailu/0000-0002-3868-2401; Gebremichael, Saba/0000-0001-8529-6194	Addis Ababa University	Addis Ababa University	The International Clinical Laboratories and Addis Ababa University covered the cost of Antibiotics disks, culture media and other supplies.	Abera B., 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/JOURNAL.PONE.0166519; Andrew B, 2017, INT J MICROBIOL, V2017, DOI 10.1155/2017/3183076; [Anonymous], 2016, NATL MUSEUM AFRICAN, V2, P5; [Anonymous], 2017, BD PHOENIX 100 MANUA; [Anonymous], 2017, ROSCO AMPC INSERT KI; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Bush K, 2011, ANNU REV MICROBIOL, V65, P455, DOI 10.1146/annurev-micro-090110-102911; Doddaiah V., 2014, AM J LIFE SCI, V2, P76, DOI DOI 10.11648/J.AJLS.20140202.17; Eshetie S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0054-7; EUCAST, 2018, EUR COMM ANT SUSC TE, P1; Farrokhnazar E, 2016, INT J MED RES HEALTH, V5, P83; Fernando MMPSC, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2250-y; Fisher MA, 2009, J MED MICROBIOL, V58, P774, DOI 10.1099/jmm.0.006171-0; Gazouli M, 1998, J ANTIMICROB CHEMOTH, V42, P419, DOI 10.1093/jac/42.4.419; Ghadiri H, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/890797; Godebo G, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-17; Gomara M, 2018, ENFERM INFEC MICR CL, V36, P296, DOI 10.1016/j.eimc.2017.07.006; Grover Naveen, 2013, Med J Armed Forces India, V69, P4, DOI 10.1016/j.mjafi.2012.02.001; GUPTA S, 2017, INT J CURRENT MICROB, V6, P2620, DOI DOI 10.20546/IJCMAS.2017.609.323; Ibrahim Y, 2017, ETHIOP J HEALTH SCI, V27, P3, DOI 10.4314/ejhs.v27i1.2; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Kateregga JN, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0013-1; Kibret M, 2011, AFR HEALTH SCI, V11, pS40; Lamichhane B, 2014, ASIAN J PHARM CLIN R, V7, P30; Lautenbach E, 2001, CLIN INFECT DIS, V32, P1162, DOI 10.1086/319757; Lee JH, 2011, MED RES REV; Leski TA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1495-1; Mansouri S, 2010, IRAN J MED SCI, V35, P101; Moges F, 2002, East Afr Med J, V79, P415; Mulisa G, 2016, J EMERG INFECT DIS, V1, P1; Mulu Wondemagegn, 2017, BMC Res Notes, V10, P8, DOI 10.1186/s13104-016-2328-4; Mushi MF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/303104; Nepal K, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0236-7; Obeng-Nkrumah N, 2013, AM J TROP MED HYG, V89, P960, DOI 10.4269/ajtmh.12-0642; Ogefere HO, 2016, TROP J PHARM RES, V15, P1947, DOI 10.4314/tjpr.v15i9.20; Oo KZ, 2018, INT J SCI ENG TECHNO, V7, P2278; Parveen RM, 2010, BRAZ J MICROBIOL, V41, P596, DOI 10.1590/S1517-83822010000300009; Pasteran F, 2009, J CLIN MICROBIOL, V47, P1631, DOI 10.1128/JCM.00130-09; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Peter-Getzlaff S, 2011, J CLIN MICROBIOL, V49, P2924, DOI 10.1128/JCM.00091-11; Philippon A, 2002, ANTIMICROB AGENTS CH, V46, P1, DOI 10.1128/AAC.46.1.1-11.2002; RAP JLFSR, 2018, REV LATINOAM ENFERMA, V26, pe3100; Rawat D, 2010, J GLOB INFECT DIS, V2, P263, DOI 10.4103/0974-777X.68531; Sanguinetti M, 2003, J CLIN MICROBIOL, V41, P1463, DOI 10.1128/JCM.41.4.1463-1468.2003; Seid J, 2005, ACTA TROP, V95, P143, DOI 10.1016/j.actatropica.2005.05.009; Shahandeh Z, 2015, INT J HLTH SYST DIS, P2; Shashwati Nema, 2014, J Nat Sci Biol Med, V5, P30, DOI 10.4103/0976-9668.127280; Shivana V., 2017, INDIAN J MICROBIOL R, V4, P64, DOI 10.18231/2394-5478.2017.0013; Singhal S, 2005, Indian J Med Microbiol, V23, P120; Spanu T, 2002, ANTIMICROB AGENTS CH, V46, P196, DOI 10.1128/AAC.46.1.196-202.2002; Teklu DS, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0488-4; Tewari R., 2018, INT J RES MED SCI, V6, P1308, DOI 10.18203/2320-6012.ijrms20181288; Thakur S., 2013, Research Journal of Pharmaceutical, Biological and Chemical Sciences, V4, P1615; Yadav KK, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0085-0; Yilmaz NO, 2013, INDIAN J MED MICROBI, V31, P53, DOI 10.4103/0255-0857.108723; Yusuf I, 2017, AFR J CLN EXPER MICR, V14, P109; Yusuf I, 2013, INT J S TECHNOL, V3, P220	57	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241984	10.1371/journal.pone.0241984	http://dx.doi.org/10.1371/journal.pone.0241984			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180785	Green Submitted, Green Published, gold			2022-12-26	WOS:000593948000028
J	Wang, YF; Ao, YJ; Yang, Q; Liu, Y; Ouyang, YJ; Jing, XJ; Pang, YJ; Cui, Q; Chen, HF				Wang, Yifeng; Ao, Yujia; Yang, Qi; Liu, Yang; Ouyang, Yujie; Jing, Xiujuan; Pang, Yajing; Cui, Qian; Chen, Huafu			Spatial variability of low frequency brain signal differentiates brain states	PLOS ONE			English	Article							NEURAL VARIABILITY; BOLD VARIABILITY; FMRI; COMPLEXITY; NETWORK	Temporal variability of the neural signal has been demonstrated to be closely related to healthy brain function. Meanwhile, the evolving brain functions are supported by dynamic relationships among brain regions. We hypothesized that the spatial variability of brain signal might provide important information about brain function. Here we used the spatial sample entropy (SSE) to investigate the spatial variability of neuroimaging signal during a steady-state presented face detection task. Lower SSE was found during task state than during resting state, associating with more repetitive functional interactions between brain regions. The standard deviation (SD) of SSE during the task was negatively related to the SD of reaction time, suggesting that the spatial pattern of neural activity is reorganized according to particular cognitive function and supporting the previous theory that greater variability is associated with better task performance. These results were replicated with reordered data, implying the reliability of SSE in measuring the spatial organization of neural activity. Overall, the present study extends the research scope of brain signal variability from the temporal dimension to the spatial dimension, improving our understanding of the spatiotemporal characteristics of brain activities and the theory of brain signal variability.	[Wang, Yifeng; Ao, Yujia; Liu, Yang; Ouyang, Yujie] Sichuan Normal Univ, Inst Brain & Psychol Sci, Chengdu, Peoples R China; [Yang, Qi; Pang, Yajing; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, MOE Key Lab Neuroinformat, Clin Hosp,Chengdu Brain Sci Inst, Chengdu, Peoples R China; [Jing, Xiujuan] Southwestern Univ Finance & Econ, Tianfu Coll, Chengdu, Peoples R China; [Cui, Qian] Univ Elect Sci & Technol China, Sch Publ Affairs & Adm, Chengdu, Peoples R China	Sichuan Normal University; University of Electronic Science & Technology of China; Southwestern University of Finance & Economics - China; University of Electronic Science & Technology of China	Wang, YF (corresponding author), Sichuan Normal Univ, Inst Brain & Psychol Sci, Chengdu, Peoples R China.; Chen, HF (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, MOE Key Lab Neuroinformat, Clin Hosp,Chengdu Brain Sci Inst, Chengdu, Peoples R China.	wyf@sicnu.edu.cn; chenhf@uestc.edu.cn		Wang, Yifeng/0000-0002-0743-9986	Natural Science Foundation of China [31600930, 61533006, U1808204, 81771919]; Sichuan Science and Technology Program [2018TJPT0016]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Science and Technology Program	The study was funded by the Natural Science Foundation of China (31600930(YW), 61533006(HC), U1808204(HC), and 81771919 (QC)) and Sichuan Science and Technology Program (2018TJPT0016(HC)).	[Anonymous], 2015, ALZHEIMERS DEMENTI S, V11, pP121; Binder JR, 2012, NEUROIMAGE, V62, P1086, DOI 10.1016/j.neuroimage.2011.09.026; Boylan MA, 2020, CEREBRAL CORTEX, P1, DOI 10.1093/cercor/bhz066; Centers for Disease Control Prevention, 2010, MMWR RECOMM REP, V59, P1, DOI DOI 10.1123/TSP.6.2.111; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Courtiol J, 2016, J NEUROSCI METH, V273, P175, DOI 10.1016/j.jneumeth.2016.09.004; de la Torre-Luque A, 2016, NEUROSCI BIOBEHAV R, V68, P410, DOI 10.1016/j.neubiorev.2016.05.023; Deco G, 2016, TRENDS NEUROSCI, V39, P125, DOI 10.1016/j.tins.2016.01.001; DeSalvo MN, 2014, BRAIN BEHAV, V4, P877, DOI 10.1002/brb3.286; Di X, 2019, CEREB CORTEX, V29, P1572, DOI 10.1093/cercor/bhy055; Dinstein I, 2015, TRENDS COGN SCI, V19, P322, DOI 10.1016/j.tics.2015.04.005; Fan LZ, 2016, CEREB CORTEX, V26, P3508, DOI 10.1093/cercor/bhw157; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Gao JB, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00064; Gao XQ, 2018, BRAIN STRUCT FUNCT, V223, P2433, DOI 10.1007/s00429-018-1630-4; Garrett DD, 2014, CEREB CORTEX, V24, P2931, DOI 10.1093/cercor/bht150; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Garrett DD, 2013, CEREB CORTEX, V23, P684, DOI 10.1093/cercor/bhs055; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Grady CL, 2018, NEUROIMAGE, V169, P510, DOI 10.1016/j.neuroimage.2017.12.031; Grandy TH, 2016, SCI REP-UK, V6, DOI 10.1038/srep23073; Guitart-Masip M, 2016, CEREB CORTEX, V26, P2074, DOI 10.1093/cercor/bhv029; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Lewis LD, 2016, P NATL ACAD SCI USA, V113, pE6679, DOI 10.1073/pnas.1608117113; Li LY, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00084; Lu FM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15046-9; McDonough IM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00409; Newell KM, 2003, J EXP PSYCHOL HUMAN, V29, P379, DOI 10.1037/0096-1523.29.2.379; Nichols ALA, 2017, SCIENCE, V356, DOI 10.1126/science.aam6851; Nogueira R, 2018, TRENDS NEUROSCI, V41, P170, DOI 10.1016/j.tins.2018.02.003; Padmanathan K, 2018, J IND INF INTEGR, V10, P39, DOI 10.1016/j.jii.2018.01.003; Perdikis D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002198; Ponce-Alvarez A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004445; Raichle ME, 2015, ANNU REV NEUROSCI, V38, P433, DOI 10.1146/annurev-neuro-071013-014030; Sokunbi MO, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00069; Takahashi T, 2013, PROG NEURO-PSYCHOPH, V45, P258, DOI 10.1016/j.pnpbp.2012.05.001; Thavabalasingam S, 2018, NEUROIMAGE, V178, P136, DOI 10.1016/j.neuroimage.2018.05.036; Vaillancourt DE, 2002, NEUROBIOL AGING, V23, P1, DOI 10.1016/S0197-4580(01)00247-0; Wang YF, 2016, HUM BRAIN MAPP, V37, P381, DOI 10.1002/hbm.23037; Wang YF, 2015, J COGNITIVE NEUROSCI, V27, P2406, DOI 10.1162/jocn_a_00864; Wang YF, 2014, SCI REP-UK, V4, DOI 10.1038/srep07376; Wang YF, 2019, NEUROSCIENCE, V422, P172, DOI 10.1016/j.neuroscience.2019.10.024; Wang YF, 2019, J AFFECT DISORDERS, V246, P387, DOI 10.1016/j.jad.2018.12.107; Wang YF, 2018, HUM BRAIN MAPP, V39, P2121, DOI 10.1002/hbm.23992; Wang YF, 2018, NEUROIMAGE, V165, P112, DOI 10.1016/j.neuroimage.2017.10.004; Wang YF, 2016, ADV COGN NEURODYN, P305, DOI 10.1007/978-981-10-0207-6_42; [夏涛 Xia Tao], 2018, [科学通报, Chinese Science Bulletin], V63, P241; Xue G, 2010, SCIENCE, V330, P97, DOI 10.1126/science.1193125; Yang AC, 2013, NEUROBIOL AGING, V34, P428, DOI 10.1016/j.neurobiolaging.2012.05.004; Zhang H, 2015, BRAIN RES, V1629, P104, DOI 10.1016/j.brainres.2015.10.023; Zhang J, 2016, BRAIN, V139, P2307, DOI 10.1093/brain/aww143; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	54	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242330	10.1371/journal.pone.0242330	http://dx.doi.org/10.1371/journal.pone.0242330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0MJ	33180843	Green Published, gold			2022-12-26	WOS:000593948000001
J	Bajaj, R; Tripathi, R; Sridhar, TS; Korlimarla, A; Choudhury, KD; Suryavanshi, M; Mehta, A; Doval, DC				Bajaj, Rajat; Tripathi, Rupal; Sridhar, T. S.; Korlimarla, Aruna; Choudhury, Kumardeep Dutta; Suryavanshi, Moushumi; Mehta, Anurag; Doval, Dinesh Chandra			Prognostic role of microRNA 182 and microRNA 18a in locally advanced triple negative breast cancer	PLOS ONE			English	Article							OPERATING CHARACTERISTIC ROC; MOLECULAR SUBTYPES; TUMOR RESPONSE; UP-REGULATION; MIR-182; EXPRESSION; CHEMOTHERAPY; CARBOPLATIN; DOCETAXEL	Background The study assessed the epigenetic regulation and the role of microRNA (miR) expression in locally advanced triple negative breast cancers (TNBC) and comparison with the clinico-pathological variables and survival. Methods Fifty patients of locally advanced TNBC during the period 2011-2013 were included. Expression level of test microRNA (miR-182 and miR-18a) was determined using Taqman quantitative Real time polymerase chain reaction (qRT-PCR) from formalin fixed paraffin embedded biopsy blocks. Clinical and demographic information and survival data was retrieved from the Hospital medical records. Results An improved clinical complete response (cCR) was observed in patients with age >= 45 years (80%), premenopausal status (70%), tumor size < 6 cms (80%), nodal status N0-N1 (95%) and grade II-III tumor (80%). A statistically significant correlation was observed on comparison of cCR with menopausal status (p-value 0.020), T category (p-value 0.018) and the clinical nodal status (p-value 0.003). pCR also correlated with clinical nodal status (p-value 0.008). Epigenetically, miR-18a under expression (< 8.84) was most commonly associated with tumor size < 6 cms (76.7%), clinical nodal status N0-N1 (90%), cCR (60%) and pCR (53.3%). A similar trend was observed with miR-182. Statistical significance was observed with T category (p-values 0.003 and 0.004), clinical nodal status (p-values 0.001 and 0.001), clinical response (p-values 0.002 and 0.002) and pathological response (p-values 0.007 and 0.006) with respect to miR-18a and miR-182, respectively. Also, the menopausal status significantly correlated with the miR-182 expression (p-value 0.009). miR-182 overexpression (>= 6.32) was not observed in any of the postmenopausal patients. A univariate cox proportional hazard regression model also showed statistical interactions (p-values <0.004). Conclusion miR-182 and miR-18a overexpression correlates with worse clinical and pathological tumor characteristics in locally advanced TNBC and hence could be used to predict the outcomes and prognosis in these patients.	[Bajaj, Rajat; Choudhury, Kumardeep Dutta] Fortis Hosp, Int Oncol Serv, Dept Med Oncol, Noida, UP, India; [Tripathi, Rupal] Rajiv Gandhi Canc Inst & Res Ctr, Dept Res, Delhi, India; [Sridhar, T. S.; Korlimarla, Aruna] St Johns Res Inst, Dept Mol Med, Bengaluru, Karnataka, India; [Suryavanshi, Moushumi] Rajiv Gandhi Canc Inst & Res Ctr, Dept Mol Diagnost & Cell Biol, New Delhi, India; [Mehta, Anurag] Rajiv Gandhi Canc Inst & Res Ctr, Dept Pathol, Delhi, India; [Doval, Dinesh Chandra] Rajiv Gandhi Canc Inst & Res Ctr, Dept Med Oncol, Delhi, India	St. John's National Academy of Health Sciences; St. John's Research Institute	Doval, DC (corresponding author), Rajiv Gandhi Canc Inst & Res Ctr, Dept Med Oncol, Delhi, India.	dcdoval@gmail.com		Doval, Dinesh Chandra/0000-0002-6191-563X				[Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Bajpai J, 2012, INDIAN J CANCER, V49, P57, DOI 10.4103/0019-509X.98920; Barton VN, 2015, MOL CANCER THER, V14, P769, DOI 10.1158/1535-7163.MCT-14-0926; Bear HD, 2003, J CLIN ONCOL, V21, P4165, DOI 10.1200/JCO.2003.12.005; Cai Yimei, 2009, Genomics Proteomics & Bioinformatics, V7, P147, DOI 10.1016/S1672-0229(08)60044-3; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Chang HR, 2010, CANCER-AM CANCER SOC, V116, P4227, DOI 10.1002/cncr.25309; Chiang CH, 2013, BBA-GEN SUBJECTS, V1830, P3067, DOI 10.1016/j.bbagen.2013.01.009; Choi M, 2017, J PATHOL TRANSL MED, V51, P69, DOI 10.4132/jptm.2016.10.05; Chou HH, 2019, BIOMED J, V42, P66, DOI 10.1016/j.bj.2018.10.007; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Ding L, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121492; Doval Dinesh Chandra, 2015, Asian Pac J Cancer Prev, V16, P4959; Du LQ, 2012, EXPERT OPIN BIOL TH, V12, P1221, DOI 10.1517/14712598.2012.697149; Dvinge H, 2013, NATURE, V497, P378, DOI 10.1038/nature12108; Fasching PA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-486; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Hirata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055502; Iwamoto T, 2010, GENOME MED, V2, DOI 10.1186/gm202; Jansson MD, 2012, MOL ONCOL, V6, P590, DOI 10.1016/j.molonc.2012.09.006; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kitajima K, 2018, NAGOYA J MED SCI, V80, P183, DOI 10.18999/nagjms.80.2.183; Kolacinska A, 2014, MOL BIOL REP, V41, P2851, DOI 10.1007/s11033-014-3140-7; Korlimarla A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153113; Kulkarni P, 2018, MOL CANCER RES, V16, P1750, DOI 10.1158/1541-7786.MCR-17-0762; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li P, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0473-z; Liu HL, 2013, TUMOR BIOL, V34, P1713, DOI 10.1007/s13277-013-0708-0; Lu C, 2018, ONCOL LETT, V16, P3150, DOI 10.3892/ol.2018.9032; Luengo-Gil G, 2019, CELL ONCOL, V42, P627, DOI 10.1007/s13402-019-00450-2; Mathe A, 2015, INT J MOL SCI, V16, P28347, DOI 10.3390/ijms161226090; McFarland DC, 2016, J ONCOL, V2016, DOI 10.1155/2016/4324863; Medimegh I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111877; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Nair N, 2018, INDIAN J CANCER, V55, P16, DOI 10.4103/ijc.IJC_484_17; Ngoma T, 2006, ANN ONCOL, V17, P9, DOI [10.1093/annonc.mdl983, 10.1093/annonc/mdl982]; Perilli L, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5982-9; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Schwartz LH, 2016, EUR J CANCER, V62, P132, DOI 10.1016/j.ejca.2016.03.081; Segura MF, 2009, P NATL ACAD SCI USA, V106, P1814, DOI 10.1073/pnas.0808263106; Serpico D, 2014, CANCER TREAT REV, V40, P595, DOI 10.1016/j.ctrv.2013.11.002; Sha LY, 2016, EUR REV MED PHARMACO, V20, P2201; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Tang T, 2013, GYNECOL ONCOL, V129, P199, DOI 10.1016/j.ygyno.2012.12.043; von Minckwitz G, 2014, LANCET ONCOL, V15, P747, DOI 10.1016/S1470-2045(14)70160-3; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Wang RX, 2016, SCI REPORTS, P6, DOI [10.1038/s41598-016-0015-2, DOI 10.1038/S41598-016-0015-2]; Weiss HL, 2003, DIS MARKERS, V19, P273; Zhang KY, 2014, INT J ONCOL, V45, P950, DOI 10.3892/ijo.2014.2487; Zhu HL, 2014, BIOCHEM BIOPH RES CO, V450, P857, DOI 10.1016/j.bbrc.2014.06.073; 2015, J BUSINESS EC STAT, V33, P13	54	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242190	10.1371/journal.pone.0242190	http://dx.doi.org/10.1371/journal.pone.0242190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175907	Green Published, gold			2022-12-26	WOS:000593946900052
J	Jung, S; Park, J; Ko, KS				Jung, Soohan; Park, Jaehee; Ko, Kwang Suk			Lipopolysaccharide-induced innate immune responses are exacerbated by Prohibitin 1 deficiency and mitigated by S-adenosylmethionine in murine macrophages	PLOS ONE			English	Article							INFLAMMATION; CYTOKINES; RECEPTOR; ROLES	Prohibitin 1 (Phb1) is a pleiotropic protein with multiple functions in mammalian cells including cell cycle regulation and mitochondrial protein stabilization. It has been proposed as a potential therapeutic target for a variety of diseases including inflammatory diseases. In this study, we investigated the potential immune-modulatory functions of Phb1 and anti-inflammatory properties of S-adenosylmethionine (SAMe) using macrophages, which play a major role in the innate immune system. The results showed that expressions of Phb1 mRNA and protein were reduced in lipopolysaccharide (LPS)-stimulated RAW 264.7 cells (p0.05). Phb1 knockdown further ameliorated the mRNA expression of pro- and anti-inflammatory cytokines such as TNF-alpha, IL-1 alpha, IL-1 beta, IL-6, and IL10 in LPS-stimulated RAW 264.7 cells. SAMe significantly attenuated LPS-induced inflammatory responses such as IL-1 beta, IL-10, Nos2, and NO production in the presence of siPhb1. Luciferase reporter assay was conducted to determine the mechanisms underlying the effects of Phb1 and SAMe on the immune system. The luciferase activity of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) was significantly increased in LPS-treated RAW 264.7 cells. In addition, the luciferase reporter assay showed increased NF-kappa B activation in Phb1 knockdown RAW 264.7 cells (p0.1) and SAMe treatment attenuated the NF-kappa B luciferase activity in Phb1 knockdown RAW 264.7 cells. Based on the results, we concluded that Phb1 possibly modulates the inflammatory response whereas SAMe has an anti-inflammatory effect on Phb1 knockdown macrophage cells. Furthermore, Phb1 expression level has potential properties of affecting on innate immune system by modulating the NF-kappa B signaling pathway.	[Jung, Soohan] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Park, Jaehee; Ko, Kwang Suk] Ewha Womans Univ, Dept Nutr Sci & Food Management, Coll Sci & Ind Convergence, Seoul, South Korea	Seoul National University (SNU); Ewha Womans University	Ko, KS (corresponding author), Ewha Womans Univ, Dept Nutr Sci & Food Management, Coll Sci & Ind Convergence, Seoul, South Korea.	kko@ewha.ac.kr		Ko, Kwang Suk/0000-0002-0515-5904	National Research Foundation of Korea [2016R1D1A1B04935653, 2020R1A2C1102451]	National Research Foundation of Korea(National Research Foundation of Korea)	The National Research Foundation of Korea provided support for this study in the form of grants awarded to KK (2016R1D1A1B04935653, 2020R1A2C1102451).	AGOMELATINE (Valdoxan/ Thymanax), 2013, DRUG SAFETY UPDATE, V6, pA1; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gobejishvili L, 2011, J PHARMACOL EXP THER, V337, P433, DOI 10.1124/jpet.110.174268; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; Hoebe K, 2004, NAT IMMUNOL, V5, P971, DOI 10.1038/ni1004-971; Hsieh SY, 2006, PROTEOMICS, V6, P5322, DOI 10.1002/pmic.200500541; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Lee Seo Yeon, 2016, J Cancer Prev, V21, P152, DOI 10.15430/JCP.2016.21.3.152; Li PZ, 2014, HEPATOL INT, V8, P275, DOI 10.1007/s12072-014-9528-6; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Lucas CR, 2013, J IMMUNOL, V190, P723, DOI 10.4049/jimmunol.1201646; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; Mato JM, 2002, FASEB J, V16, P15, DOI 10.1096/fj.01-0401rev; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Moon MK, 2010, EXP MOL MED, V42, P345, DOI 10.3858/emm.2010.42.5.036; Najm WI, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-6; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Parkin J, 2001, LANCET, V357, P1777, DOI 10.1016/S0140-6736(00)04904-7; Pfalzer AC, 2014, PHYSIOL GENOMICS, V46, P617, DOI 10.1152/physiolgenomics.00056.2014; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Ross JA, 2008, J BIOL CHEM, V283, P4699, DOI 10.1074/jbc.M708232200; Sanchez-Quiles V, 2012, J PROTEOMICS, V75, P5783, DOI 10.1016/j.jprot.2012.08.009; Scheller J, 2011, BBA-MOL CELL RES, V1813, P878, DOI 10.1016/j.bbamcr.2011.01.034; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Theiss AL, 2011, INFLAMM BOWEL DIS, V17, P1163, DOI 10.1002/ibd.21469; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e	33	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241224	10.1371/journal.pone.0241224	http://dx.doi.org/10.1371/journal.pone.0241224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175859	Green Published, gold			2022-12-26	WOS:000593946900046
J	Song, JN; Merrill, RA; Usachev, AY; Strack, S				Song, Jianing; Merrill, Ronald A.; Usachev, Andrew Y.; Strack, Stefan			The X-linked intellectual disability gene product and E3 ubiquitin ligase KLHL15 degrades doublecortin proteins to constrain neuronal dendritogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE-ASSOCIATED PROTEIN; PHOSPHATASE 2A; REGULATORY SUBUNITS; KINASE; UBIQUITYLATION; PHOSPHORYLATION; ORGANIZATION; CROSSROADS; RECOGNIZES; EXPRESSION	Proper brain development and function requires finely controlled mechanisms for protein turnover, and disruption of genes involved in proteostasis is a common cause of neuro-developmental disorders. Kelch-like 15 (KLHL15) is a substrate adaptor for cullin3-containing E3 ubiquitin ligases, and KLHL15 gene mutations were recently described as a cause of severe X-linked intellectual disability. Here, we used a bio-informatics approach to identify a family of neuronal microtubule-associated proteins as KLHL15 substrates, which are themselves critical for early brain development. We biochemically validated doublecortin (DCX), also an X-linked disease protein, and doublecortin-like kinase 1 and 2 as bona fide KLHL15 interactors and mapped KLHL15 interaction regions to their tandem DCX domains. Shared with two previously identified KLHL15 substrates, a FRY tripeptide at the C-terminal edge of the second DCX domain is necessary for KLHL15-mediated ubiquitination of DCX and doublecortin-like kinase 1 and 2 and subsequent proteasomal degradation. Conversely, silencing endogenous KLHL15 markedly stabilizes these DCX domain-containing proteins and prolongs their half-life. Functionally, overexpression of KLHL15 in the presence of WT DCX reduces dendritic complexity of cultured hippocampal neurons, whereas neurons expressing FRY-mutant DCX are resistant to KLHL15. Collectively, our findings highlight the critical importance of the E3 ubiquitin ligase adaptor KLHL15 in proteostasis of neuronal microtubule-associated proteins and identify a regulatory network important for development of the mammalian nervous system.	[Strack, Stefan] Univ Iowa, Dept Neurosci & Pharmacol, Iowa City, IA 52242 USA; Univ Iowa, Iowa Neurosci Inst, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Strack, S (corresponding author), Univ Iowa, Dept Neurosci & Pharmacol, Iowa City, IA 52242 USA.	stefan-strack@uiowa.edu		Merrill, Ronald/0000-0002-5276-4163; Song, Jianing/0000-0002-1847-5544; Strack, Stefan/0000-0002-6175-7280; Usachev, Andrew/0000-0002-3686-1051	National Institutes of Health [DK116624, MH115673, MH113352]; Jordan's Guardian Angels; Roy J. Carver Charitable Trust; Iowa Neuroscience Institute; Genomics Division of the University of Iowa Carver College of Medicine	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jordan's Guardian Angels; Roy J. Carver Charitable Trust; Iowa Neuroscience Institute; Genomics Division of the University of Iowa Carver College of Medicine	This work was supported by National Institutes of Health grants DK116624, MH115673, MH113352 (to S. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Additional support to S. S. was provided by Jordan's Guardian Angels, the Roy J. Carver Charitable Trust, and Iowa Neuroscience Institute. We also acknowledge support by the Genomics Division of the University of Iowa Carver College of Medicine.	Bechstedt S, 2014, CURR BIOL, V24, P2366, DOI 10.1016/j.cub.2014.08.039; Bechstedt S, 2012, DEV CELL, V23, P181, DOI 10.1016/j.devcel.2012.05.006; Bidinosti M, 2016, SCIENCE, V351, P1199, DOI 10.1126/science.aad5487; Brandt N, 2008, FASEB J, V22, P2521, DOI 10.1096/fj.07-096115; Cheon S, 2019, NEUROBIOL LEARN MEM, V165, DOI 10.1016/j.nlm.2018.01.012; Cohen D, 2008, DEV NEUROSCI-BASEL, V30, P187, DOI 10.1159/000109862; Coquelle FM, 2006, CELL CYCLE, V5, P976, DOI 10.4161/cc.5.9.2715; Cornell B, 2016, HUM MOL GENET, V25, P4405, DOI 10.1093/hmg/ddw270; Couillard-Despres S, 2006, EUR J NEUROSCI, V24, P1535, DOI 10.1111/j.1460-9568.2006.05039.x; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Deuel TAS, 2006, NEURON, V49, P41, DOI 10.1016/j.neuron.2005.10.038; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Dijkmans Thomas Frederik, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P32; Edelman AM, 2005, J BIOL CHEM, V280, P8531, DOI 10.1074/jbc.M411027200; Ferretti LP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12628; Fourniol F, 2013, METHOD CELL BIOL, V115, P27, DOI 10.1016/B978-0-12-407757-7.00003-7; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Friocourt G, 2005, MOL CELL NEUROSCI, V28, P153, DOI 10.1016/j.mcn.2004.09.005; Friocourt G, 2003, CEREB CORTEX, V13, P620, DOI 10.1093/cercor/13.6.620; Fukunaga K, 2000, J NEUROCHEM, V74, P807, DOI 10.1046/j.1471-4159.2000.740807.x; Fung SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025194; Ge XY, 2015, HUM MOL GENET, V24, P599, DOI 10.1093/hmg/ddu473; George AJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00029; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Groen EJN, 2015, TRENDS MOL MED, V21, P622, DOI 10.1016/j.molmed.2015.08.003; Gupta VA, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-11; Hegde AN, 2007, TRENDS NEUROSCI, V30, P587, DOI 10.1016/j.tins.2007.08.005; Hehr U., 1993, GENEREVIEWS R; Hu H, 2016, MOL PSYCHIATR, V21, P133, DOI 10.1038/mp.2014.193; Ibeawuchi SRC, 2015, J BIOL CHEM, V290, P19208, DOI 10.1074/jbc.M115.645358; Karaca E, 2015, NEURON, V88, P499, DOI 10.1016/j.neuron.2015.09.048; Kerjan G, 2009, P NATL ACAD SCI USA, V106, P6766, DOI 10.1073/pnas.0812687106; Koizumi H, 2006, NEURON, V49, P55, DOI 10.1016/j.neuron.2005.10.040; Koizumi H, 2006, NAT NEUROSCI, V9, P779, DOI 10.1038/nn1704; Layfield R, 2003, AGEING RES REV, V2, P343, DOI 10.1016/S1568-1637(03)00025-4; Lin PT, 2000, J NEUROSCI, V20, P9152; Louros SR, 2016, J NEUROCHEM, V139, P1081, DOI 10.1111/jnc.13723; Lydeard JR, 2013, EMBO REP, V14, P1050, DOI 10.1038/embor.2013.173; Martens E, 2004, J MOL BIOL, V336, P971, DOI 10.1016/j.jmb.2003.12.047; MCCRIGHT B, 1995, J BIOL CHEM, V270, P26123, DOI 10.1074/jbc.270.44.26123; Meloche J, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.992; Merrill RA, 2019, J BIOL CHEM, V294, P16164, DOI 10.1074/jbc.RA119.010596; Mignon-Ravix C, 2014, AM J MED GENET A, V164, P1991, DOI 10.1002/ajmg.a.36602; Moores CA, 2004, MOL CELL, V14, P833, DOI 10.1016/j.molcel.2004.06.009; Oberg EA, 2012, J BIOL CHEM, V287, P43378, DOI 10.1074/jbc.M112.420281; Ohmae S, 2006, J BIOL CHEM, V281, P20427, DOI 10.1074/jbc.M513212200; Rape M, 2018, NEUROCHEM, V19, P59; Rape M, 2018, NAT REV MOL CELL BIO, V19, P59, DOI 10.1038/nrm.2017.83; Reiner O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-188; Reiner O, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/393975; Saraf A, 2007, J BIOL CHEM, V282, P573, DOI 10.1074/jbc.M607407200; Schumann M, 2016, J NEURODEV DISORD, V8, DOI 10.1186/s11689-016-9144-y; Shi XX, 2019, PHARMACOL RES, V148, DOI 10.1016/j.phrs.2019.104404; Shin E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2443; Shu TZ, 2006, NEURON, V49, P25, DOI 10.1016/j.neuron.2005.10.039; Smith M, 2002, CYTOGENET GENOME RES, V98, P233, DOI 10.1159/000071040; Tanaka T, 2004, NEURON, V41, P215, DOI 10.1016/S0896-6273(03)00852-3; Tanaka T, 2006, CEREB CORTEX, V16, pI69, DOI 10.1093/cercor/bhk005; Tint I, 2009, J NEUROSCI, V29, P10995, DOI 10.1523/JNEUROSCI.3399-09.2009; Upadhyay A, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00151; Upadhyay A, 2015, AGEING RES REV, V24, P138, DOI 10.1016/j.arr.2015.07.009; Van Kanegan MJ, 2009, MOL CELL BIOL, V29, P662, DOI 10.1128/MCB.01242-08; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Yamada T, 2013, TRENDS NEUROSCI, V36, P218, DOI 10.1016/j.tins.2012.12.004; Yap CC, 2016, J BIOL CHEM, V291, P26613, DOI 10.1074/jbc.M116.760777; Yoshihara S, 2014, CELL REP, V8, P843, DOI 10.1016/j.celrep.2014.06.056; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922	68	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100082	10.1074/jbc.RA120.016210	http://dx.doi.org/10.1074/jbc.RA120.016210			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33199366	gold, Green Published, Green Submitted			2022-12-26	WOS:000672866400063
J	Lim, K; Molostvov, G; Lubczanska, M; Fletcher, S; Bland, R; Hiemstra, TF; Zehnder, D				Lim, Kenneth; Molostvov, Guerman; Lubczanska, Maria; Fletcher, Simon; Bland, Rosemary; Hiemstra, Thomas F.; Zehnder, Daniel			Impaired arterial vitamin D signaling occurs in the development of vascular calcification	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SMOOTH-MUSCLE-CELLS; D-RECEPTOR ACTIVATORS; 25-HYDROXYVITAMIN D-3-1-ALPHA-HYDROXYLASE; MATRIX-METALLOPROTEINASES; EXPRESSION; D-3; 1-ALPHA-HYDROXYLASE; HEMODIALYSIS; PARICALCITOL	Conflicting data exists as to whether vitamin D receptor agonists (VDRa) are protective of arterial calcification. Confounding this, is the inherent physiological differences between human and animal experimental models and our current fragmented understanding of arterial vitamin D metabolism, their alterations in disease states and responses to VDRa's. Herein, the study aims to address these problems by leveraging frontiers in human arterial organ culture models. Human arteries were collected from a total of 24 patients (healthy controls, n = 12; end-stage CKD, n = 12). Cross-sectional and interventional studies were performed using arterial organ cultures treated with normal and calcifying (containing 5mmol/L CaCl2 and 5mmol/L beta-glycerophosphate) medium, ex vivo. To assess the role of VDRa therapy, arteries were treated with either calcitriol or paricalcitol. We found that human arteries express a functionally active vitamin D system, including the VDR, 1 alpha-hydroxylase and 24-hydroxylase (24-OHase) components and these were dysregulated in CKD arteries. VDRa therapy increased VDR expression in healthy arteries (p< 0.01) but not in CKD arteries. Arterial 1 alpha-OHase (p< 0.05) and 24-OHase mRNA and protein expression were modulated differentially in healthy and CKD arteries by VDRa therapy. VDRa exposure suppressed Runx2 and MMP-9 expression in CKD arteries, however only paricalcitol suppressed MMP-2. VDRa exposure did not modulate arterial calcification in all organ culture models. However, VDRa reduced expression of senescence associated beta-galactosidase (SA beta G) staining in human aortic-smooth muscle cells under calcifying conditions, in vitro. In conclusion, maladaptation of arterial vitamin D signaling components occurs in CKD. VDRa exposure can exert vasculo-protective effects and seems critical for the regulation of arterial health in CKD.	[Lim, Kenneth] Indiana Univ Sch Med, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA; [Molostvov, Guerman] Univ Birmingham, Coll Med & Dent Sci, Inst Canc & Genom Sci, Birmingham, W Midlands, England; [Lubczanska, Maria; Bland, Rosemary] Univ Warwick, Div Biomed Sci, Coventry, W Midlands, England; [Fletcher, Simon] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Nephrol, Coventry, W Midlands, England; [Hiemstra, Thomas F.] Univ Cambridge, Cambridge Clin Trials Unit, Cambridge, England; [Hiemstra, Thomas F.] Univ Cambridge, Sch Clin Med, Cambridge, England; [Zehnder, Daniel] North Cumbria Integrated Care Univ Hosp NHS Trust, Dept Nephrol, Carlisle, England; [Zehnder, Daniel] North Cumbria Integrated Care Univ Hosp NHS Trust, Dept Acute Med, Carlisle, England	Indiana University System; Indiana University Bloomington; University of Birmingham; University of Warwick; University of Warwick; University of Cambridge; University of Cambridge	Lim, K (corresponding author), Indiana Univ Sch Med, Dept Med, Div Nephrol, Indianapolis, IN 46202 USA.	kjlim@iu.edu			Abbott Laboratories; NIH [K23 DK115683-01]; National Institute for Health Research NIHR HTA [14/49/127, 16/167/120, 17/83/06]	Abbott Laboratories(Abbott Laboratories); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research NIHR HTA	This work was supported by an unrestricted research grant from Abbott Laboratories (DZ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the `author contributions' section. K. L. received an NIH (K23 DK115683-01) award. T.F. H receives funding from the National Institute for Health Research NIHR HTA 14/49/127, 16/167/120 and 17/83/06.	Agarwal R, 2005, KIDNEY INT, V68, P2823, DOI 10.1111/j.1523-1755.2005.00755.x; AHMED KY, 1978, LANCET, V1, P629; Andrade J, 2008, CLIN J AM SOC NEPHRO, V3, P1800, DOI 10.2215/CJN.00900208; Becker LE, 2011, AM J PHYSIOL-RENAL, V300, pF772, DOI 10.1152/ajprenal.00042.2010; Bland R, 1999, ENDOCRINOLOGY, V140, P2027, DOI 10.1210/en.140.5.2027; Bosse Y, 2007, PHYSIOL GENOMICS, V29, P161, DOI 10.1152/physiolgenomics.00134.2006; Chen NX, 2011, AM J NEPHROL, V34, P211, DOI 10.1159/000330175; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; Cozzolino M, 2010, EUR J HEART FAIL, V12, P1031, DOI 10.1093/eurjhf/hfq112; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Finch JL, 2001, J AM SOC NEPHROL, V12, P1468, DOI 10.1681/ASN.V1271468; Hiemstra TF, 2019, J CLIN ENDOCR METAB, V104, P4033, DOI 10.1210/jc.2019-00194; Jones G, 2007, SEMIN DIALYSIS, V20, P316, DOI 10.1111/j.1525-139X.2007.00302.x; Jones G, 2008, J BONE MINER RES, V23, P771, DOI 10.1359/JBMR.071209; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Kumar V, 2017, J AM SOC NEPHROL, V28, P3100, DOI 10.1681/ASN.2017010003; LAMBERT PW, 1982, J CLIN INVEST, V69, P722, DOI 10.1172/JCI110501; Lim K, 2018, SEMIN NEPHROL, V38, P251, DOI 10.1016/j.semnephrol.2018.02.005; Lim K, 2012, CIRCULATION, V125, P2243, DOI 10.1161/CIRCULATIONAHA.111.053405; Luo XH, 2003, ENDOCR RES, V29, P353, DOI 10.1081/ERC-120025042; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Mathew S, 2008, J AM SOC NEPHROL, V19, P1509, DOI 10.1681/ASN.2007080902; Mizobuchi M, 2007, KIDNEY INT, V72, P709, DOI 10.1038/sj.ki.5002406; Moe SM, 2008, J AM SOC NEPHROL, V19, P213, DOI 10.1681/ASN.2007080854; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Peiskerova M, 2009, KIDNEY BLOOD PRESS R, V32, P276, DOI 10.1159/000243050; Reynolds JL, 2004, J AM SOC NEPHROL, V15, P2857, DOI 10.1097/01.ASN.0000141960.01035.28; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Schmidt N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035316; Scragg R, 2017, JAMA CARDIOL, V2, P608, DOI 10.1001/jamacardio.2017.0175; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Sikora E, 2011, AGEING RES REV, V10, P146, DOI 10.1016/j.arr.2010.10.002; Somjen D, 2005, CIRCULATION, V111, P1666, DOI 10.1161/01.CIR.0000160353.27927.70; Stenvinkel P, 2013, AM J KIDNEY DIS, V62, P339, DOI 10.1053/j.ajkd.2012.11.051; Teng M, 2003, NEW ENGL J MED, V349, P446, DOI 10.1056/NEJMoa022536; Tentori F, 2006, KIDNEY INT, V70, P1858, DOI 10.1038/sj.ki.5001868; Thadhani R, 2012, JAMA-J AM MED ASSOC, V307, P674, DOI 10.1001/jama.2012.120; WEISHAAR RE, 1990, AM J PHYSIOL, V258, pE134, DOI 10.1152/ajpendo.1990.258.1.E134; WEISHAAR RE, 1987, J CLIN INVEST, V79, P1706, DOI 10.1172/JCI113010; Zehnder D, 1999, J AM SOC NEPHROL, V10, P2465; Zehnder D, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133621; Zehnder D, 2002, AM J PATHOL, V161, P105, DOI 10.1016/S0002-9440(10)64162-4	42	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0241976	10.1371/journal.pone.0241976	http://dx.doi.org/10.1371/journal.pone.0241976			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211721	gold, Green Published			2022-12-26	WOS:000603518300028
J	Grohova, A; Danova, K; Adkins, I; Sumnik, Z; Petruzelkova, L; Obermannova, B; Kolouskova, S; Spisek, R; Palova-Jelinkova, L				Grohova, Anna; Danova, Klara; Adkins, Irena; Sumnik, Zdenek; Petruzelkova, Lenka; Obermannova, Barbora; Kolouskova, Stanislava; Spisek, Radek; Palova-Jelinkova, Lenka			Myeloid-derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms	PLOS ONE			English	Article							TH17 CELLS; EXPRESSION; DIFFERENTIATION; IL-17; ACCUMULATION; LYMPHOCYTES; INDUCTION; TOLERANCE; PSORIASIS; FREQUENCY	Myeloid-derived suppressor cells (MDSC) represent a heterogeneous group of immature myeloid cells with immunoregulatory function in cancer and autoimmune diseases. In humans, two subsets of MDSC were determined based on the characteristic surface markers, monocytic MDSC (M-MDSC) and granulocytic MDSC (G-MDSC). Expansion of MDSC has been reported in some murine models and patients with autoimmune diseases and their immune-suppressive properties were characterized. However, the exact role of MDSC in the pathogenesis of autoimmune diseases is more complex and/or controversial. In type 1 diabetes mellitus (T1D), the increased frequency of MDSC was found in the blood of T1D patients but their suppressor capacity was diminished. In our study, we assessed the role of M-MDSC in the pathogenesis of T1D and showed for the first time the increased frequency of M-MDSC not only in the blood of T1D patients but also in their at-risk relatives compared to healthy donors. T1D patients with inadequate long term metabolic control showed an elevation of M-MDSC compared to patients with better disease control. Furthermore, we described the positive correlation between the percentage of M-MDSC and Th17 cells and IFN-gamma producing T cells in T1D patients and their at-risk relatives. Finally, we found that the ability of M-MDSC to suppress autologous T cells is efficient only at the high MDSC: T cells ratio and dependent on cell-cell-contact and TGF-beta production. Our data show that the engagement of MDSC in the pathogenesis of T1D is evident, yet not entirely explored and more experiments are required to clarify whether MDSC are beneficial or harmful in T1D.	[Grohova, Anna; Danova, Klara; Adkins, Irena; Spisek, Radek; Palova-Jelinkova, Lenka] Charles Univ Prague, Fac Med 2, Dept Immunol, Prague, Czech Republic; [Grohova, Anna; Danova, Klara; Adkins, Irena; Sumnik, Zdenek; Petruzelkova, Lenka; Obermannova, Barbora; Kolouskova, Stanislava; Spisek, Radek; Palova-Jelinkova, Lenka] Motol Univ Hosp, Prague, Czech Republic; [Danova, Klara; Adkins, Irena; Spisek, Radek; Palova-Jelinkova, Lenka] SOTIO As, Prague, Czech Republic; [Sumnik, Zdenek; Petruzelkova, Lenka; Obermannova, Barbora; Kolouskova, Stanislava] Charles Univ Prague, Fac Med 2, Dept Pediat, Prague, Czech Republic	Charles University Prague; Motol University Hospital; Charles University Prague	Grohova, A (corresponding author), Charles Univ Prague, Fac Med 2, Dept Immunol, Prague, Czech Republic.; Grohova, A (corresponding author), Motol Univ Hosp, Prague, Czech Republic.	anna.grohova@gmail.com			Ministry of Health, Czech Republic [00064203]	Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government)	Lenka Palova Jelinkova, Klara Danova, Irena Adkins, and Radek Spisek are employees of Sotio a.s., Prague, Czech Republic. The funder provided support in the form of salaries for authors (LPJ, KD, IA, RS) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. The other co-authors declare that the research was conducted in the absence of any commercial or financial relationship that could be construed as a potential conflict of interest. This study was supported by the project of the Ministry of Health, Czech Republic, for conceptual development of the research institution 00064203 (University Hospital Motol, Prague, Czech Republic).	Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS126, DOI 10.2337/dc18-S012; [Anonymous], 2014, 24TH INFORMATIONAL S, V34, P10; [Anonymous], 2015, BMJ, V2015, ph1887; Baker PR, 2011, CURR DIABETES REP, V11, P445, DOI 10.1007/s11892-011-0212-0; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bauswein M, 2018, IMMUNOL LETT, V202, P31, DOI 10.1016/j.imlet.2018.07.010; Bian Z, 2018, EUR J IMMUNOL, V48, P1046, DOI 10.1002/eji.201747355; Bonifacio E, 2015, DIABETES CARE, V38, P989, DOI 10.2337/dc15-0101; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Bronte V, 2009, J IMMUNOTHER, V32, P1, DOI 10.1097/CJI.0b013e3181837276; Brudecki L, 2012, INFECT IMMUN, V80, P2026, DOI 10.1128/IAI.00239-12; CAMPBELL IL, 1991, J CLIN INVEST, V87, P739, DOI 10.1172/JCI115055; Cao LY, 2016, J INVEST DERMATOL, V136, P1801, DOI 10.1016/j.jid.2016.02.816; Cassetta L, 2019, CANCER IMMUNOL IMMUN, V68, P687, DOI 10.1007/s00262-019-02302-2; Cinek O, 2001, Pediatr Diabetes, V2, P98, DOI 10.1034/j.1399-5448.2001.002003098.x; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Cripps JG, 2010, HEPATOLOGY, V52, P1350, DOI 10.1002/hep.23841; Crook KR, 2015, J LEUKOCYTE BIOL, V97, P573, DOI 10.1189/jlb.4A0314-139R; Damuzzo V, 2015, CYTOM PART B-CLIN CY, V88, P77, DOI [10.1002/cyto.b.21206, 10.1002/cytob.21206]; Danova K, 2017, J IMMUNOL, V198, P729, DOI 10.4049/jimmunol.1600676; Dilek N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00208; Dogan Y, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/59206; Dorhoi A, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01895; Ersek B, 2012, J IMMUNOL, V189, P1602, DOI 10.4049/jimmunol.1102365; Fatima N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161548; Fu WX, 2012, NAT IMMUNOL, V13, P361, DOI 10.1038/ni.2233; Fujii W, 2013, J IMMUNOL, V191, P1073, DOI 10.4049/jimmunol.1203535; Fujimura T, 2012, ONCOIMMUNOLOGY, V1, P1433, DOI 10.4161/onci.21176; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Gabrilovich DI, 2017, CANCER IMMUNOL RES, V5, P3, DOI 10.1158/2326-6066.CIR-16-0297; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Grohova A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00079; Guo CQ, 2016, ANN RHEUM DIS, V75, P278, DOI 10.1136/annrheumdis-2014-205508; Haile LA, 2008, GASTROENTEROLOGY, V135, P871, DOI 10.1053/j.gastro.2008.06.032; He DG, 2010, J IMMUNOL, V184, P2281, DOI 10.4049/jimmunol.0902574; Hu CY, 2012, J IMMUNOL, V188, P294, DOI 10.4049/jimmunol.1101590; Huang B, 2006, CANCER RES, V66, P1123, DOI 10.1158/0008-5472.CAN-05-1299; Huang M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02243; Ilkovitch D, 2016, MOL MED REP, V14, P3935, DOI 10.3892/mmr.2016.5685; Ioannou M, 2012, J IMMUNOL, V188, P1136, DOI 10.4049/jimmunol.1101816; Ji JJ, 2016, CLIN SCI, V130, P1453, DOI 10.1042/CS20160311; Jiao Z, 2013, SCAND J RHEUMATOL, V42, P85, DOI 10.3109/03009742.2012.716450; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kim J, 2013, ANN LAB MED, V33, P52, DOI 10.3343/alm.2013.33.1.52; Kumar P, 2014, CELL SIGNAL, V26, P528, DOI 10.1016/j.cellsig.2013.11.031; Kumar V, 2016, TRENDS IMMUNOL, V37, P208, DOI 10.1016/j.it.2016.01.004; Kuriya G, 2013, DIABETOLOGIA, V56, P1773, DOI 10.1007/s00125-013-2935-8; Kurko J, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-281; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lelis FJN, 2017, IMMUNOL LETT, V188, P108, DOI 10.1016/j.imlet.2017.07.003; Li M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02849; Lindau D, 2013, IMMUNOLOGY, V138, P105, DOI 10.1111/imm.12036; Lu H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-80; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Mandruzzato S, 2016, CANCER IMMUNOL IMMUN, V65, P161, DOI 10.1007/s00262-015-1782-5; Mantovani A, 2010, EUR J IMMUNOL, V40, P3317, DOI 10.1002/eji.201041170; Marhaba R, 2007, J IMMUNOL, V179, P5071, DOI 10.4049/jimmunol.179.8.5071; Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005; Medina E, 2018, J INNATE IMMUN, V10, P407, DOI 10.1159/000489830; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Novitskiy SV, 2011, CANCER DISCOV, V1, P430, DOI 10.1158/2159-8290.CD-11-0100; Obermajer N, 2013, J EXP MED, V210, P1433, DOI 10.1084/jem.20121277; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Ozkan B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051468; Paluskievicz CM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02453; Park MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21856-2; Qiao YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176157; Reinert-Hartwall L, 2015, J IMMUNOL, V194, P68, DOI 10.4049/jimmunol.1401653; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rodriguez PC, 2002, J BIOL CHEM, V277, P21123, DOI 10.1074/jbc.M110675200; Roep BO, 2014, NAT REV ENDOCRINOL, V10, P229, DOI 10.1038/nrendo.2014.2; Sacchi A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01271; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Stechova K, 2007, DIABETES-METAB RES, V23, P462, DOI 10.1002/dmrr.718; Wen L, 2016, ONCOTARGET, V7, P35490, DOI 10.18632/oncotarget.8204; Whitfield-Larry F, 2014, CLIN IMMUNOL, V153, P156, DOI 10.1016/j.clim.2014.04.006; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Xi QH, 2015, IMMUNOL INVEST, V44, P279, DOI 10.3109/08820139.2014.999937; Yi HF, 2012, J IMMUNOL, V189, P4295, DOI 10.4049/jimmunol.1200086; Yin BJ, 2010, J IMMUNOL, V185, P5828, DOI 10.4049/jimmunol.0903636; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505; Zhang H, 2015, CLIN IMMUNOL, V157, P175, DOI 10.1016/j.clim.2015.02.001; Zhang L, 2014, INFLAMMATION, V37, P670, DOI 10.1007/s10753-013-9783-z; Zhao XQ, 2012, J CLIN INVEST, V122, P4094, DOI 10.1172/JCI64115; Zhao Y, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1004983	85	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242092	10.1371/journal.pone.0242092	http://dx.doi.org/10.1371/journal.pone.0242092			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206686	Green Published, gold			2022-12-26	WOS:000595265900014
J	Gureev, AP; Syromyatnikov, MY; Ignatyeva, DA; Valuyskikh, VV; Solodskikh, SA; Panevina, AV; Gryaznova, MV; Kokina, AV; Popov, VN				Gureev, Artem P.; Syromyatnikov, Mikhail Yu.; Ignatyeva, Daria A.; Valuyskikh, Valeria V.; Solodskikh, Sergey A.; Panevina, Anna V.; Gryaznova, Maria V.; Kokina, Anastasia V.; Popov, Vasily N.			Effect of long-term methylene blue treatment on the composition of mouse gut microbiome and its relationship with the cognitive abilities of mice	PLOS ONE			English	Article							COLON-CANCER; MEMORY; COLITIS; ASSOCIATION; DYSBIOSIS; BACTERIA; DISEASE; DYE	In recent years, methylene blue (MB) has attracted considerable interest as a potential drug for the treatment of methemoglobinemia and neurodegenerative diseases. MB is active against microorganisms from various taxonomic groups. However, no studies have yet been conducted on the effect of MB on the intestinal microbiome of model animals. The aim of this work was to study the effect of different concentrations of MB on the mouse gut microbiome and its relationship with the cognitive abilities of mice. We showed that a low MB concentration (15 mg/kg/day) did not cause significant changes in the microbiome composition. The Bacteroidetes/Firmicutes ratio decreased relative to the control on the 2(nd) and 3(rd) weeks. A slight decrease in the levels Actinobacteria was detected on the 3(rd) week of the experiment. Changes in the content of Delta, Gamma, and Epsilonproteobacteria have been also observed. We did not find significant alterations in the composition of intestinal microbiome, which could be an indication of the development of dysbiosis or other gut dysfunction. At the same time, a high concentration of MB (50 mg/kg/day) led to pronounced changes, primarily an increase in the levels of Delta, Gamma and Epsilonproteobacteria. Over 4 weeks of therapy, the treatment with high MB concentration has led to an increase in the median content of Proteobacteria to 7.49% vs. 1.61% in the control group. Finally, we found that MB at a concentration of 15 mg/kg/day improved the cognitive abilities of mice, while negative correlation between the content of Deferribacteres and cognitive parameters was revealed. Our data expand the understanding of the relationship between MB, cognitive abilities, and gut microbiome in respect to the antibacterial properties of MB.	[Gureev, Artem P.; Syromyatnikov, Mikhail Yu.; Ignatyeva, Daria A.; Valuyskikh, Valeria V.; Solodskikh, Sergey A.; Panevina, Anna V.; Gryaznova, Maria V.; Kokina, Anastasia V.; Popov, Vasily N.] Voronezh State Univ, Dept Genet Cytol & Bioengn, Voronezh, Russia; [Syromyatnikov, Mikhail Yu.; Solodskikh, Sergey A.; Panevina, Anna V.; Gryaznova, Maria V.; Kokina, Anastasia V.; Popov, Vasily N.] Voronezh State Univ Engn Technol, Lab Metagen & Food Biotechnol, Voronezh, Russia; [Syromyatnikov, Mikhail Yu.] All Russian Vet Res Inst Pathol, Lab Innovat Recombinant Prote, Pharmacol & Therapy, Voronezh, Russia	Voronezh State University; Voronezh State University of Engineering Technologies	Syromyatnikov, MY (corresponding author), Voronezh State Univ, Dept Genet Cytol & Bioengn, Voronezh, Russia.; Syromyatnikov, MY (corresponding author), Voronezh State Univ Engn Technol, Lab Metagen & Food Biotechnol, Voronezh, Russia.; Syromyatnikov, MY (corresponding author), All Russian Vet Res Inst Pathol, Lab Innovat Recombinant Prote, Pharmacol & Therapy, Voronezh, Russia.	syromyatnikov@bio.vsu.ru	Gryaznova, Mariya/AAU-6618-2021; Popov, Vasily/J-9175-2013; Gureev, Artem P/O-5128-2017	Popov, Vasily/0000-0003-1294-8686; Gureev, Artem P/0000-0003-3562-5329; Syromyatnikov, Mikhail/0000-0001-9028-0613; Gryaznova, Mariya/0000-0003-2076-3868	Russian Federation [MK-3173.2019.11]; RF Ministry of Science and Higher Education [075-03-2020-088, 075001X39782002]	Russian Federation(Russian Federation); RF Ministry of Science and Higher Education	This work was supported by the grant of the President of the Russian Federation for young scientists (Project MK-3173.2019.11) to M.Yu.S. and A.P.G.; by RF Ministry of Science and Higher Education in the framework of the national project "Science" (Agreement 075-03-2020-088, Unique number of the register of State tasks 075001X39782002) to V.N.P.	[Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; Ash SR, 2006, ASAIO J, V52, p17A; Atamna H, 2010, J ALZHEIMERS DIS, V20, pS439, DOI 10.3233/JAD-2010-100414; BALDI F, 1979, ENDOSCOPY, V11, P179, DOI 10.1055/s-0028-1098348; Becker C, 2005, GUT, V54, P950, DOI 10.1136/gut.2004.061283; Benga L, 2018, VET MICROBIOL, V217, P121, DOI 10.1016/j.vetmic.2018.03.011; Berry D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01408; Bessissow T, 2013, EXPERT REV GASTROENT, V7, P57, DOI [10.1586/EGH.12.65, 10.1586/egh.12.65]; Bruchey Aleksandra K, 2008, Am J Pharmacol Toxicol, V3, P72; Callaway NL, 2002, NEUROSCI LETT, V332, P83, DOI 10.1016/S0304-3940(02)00827-3; Chan EP, 2012, AM J GASTROENTEROL, V107, P633, DOI 10.1038/ajg.2011.462; Coleman MD, 1996, DRUG SAFETY, V14, P394, DOI 10.2165/00002018-199614060-00005; Mendez DAC, 2018, LASER MED SCI, V33, P479, DOI 10.1007/s10103-017-2379-3; Danilova NA, 2019, TERAPEVT ARKH, V91, P13, DOI 10.26442/00403660.2019.04.000211; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Dinc S, 2015, INT SURG, V100, P1364, DOI 10.9738/INTSURG-D-15-00118.1; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Sayed NS, 2019, ARCH TOXICOL, V93, P2927, DOI 10.1007/s00204-019-02548-w; Eroglu L, 1997, PHARMACOL RES, V36, P381, DOI 10.1006/phrs.1997.0245; GIBSON M, 1993, CLIN INFECT DIS, V16, pS411, DOI 10.1093/clinids/16.Supplement_4.S411; Gureev AP, 2016, NEUROSCI RES, V113, P19, DOI 10.1016/j.neures.2016.07.006; Huang TC, 2019, PHOTODIAGN PHOTODYN, V25, P7, DOI 10.1016/j.pdpdt.2018.11.008; Jeon WJ, 2015, J VET SCI, V16, P475, DOI 10.4142/jvs.2015.16.4.475; Kiesslich R, 2003, GASTROENTEROLOGY, V124, P880, DOI 10.1053/gast.2003.50146; Liang S, 2018, FRONT INTEGR NEUROSC, V12, DOI 10.3389/fnint.2018.00033; Loy A, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00171-16; Lu G, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1045-3; Maharshak N, 2013, GUT MICROBES, V4, P316, DOI 10.4161/gmic.25486; Manderino L, 2017, J INT NEUROPSYCH SOC, V23, P700, DOI 10.1017/S1355617717000492; MANSOURI A, 1993, AM J HEMATOL, V42, P7, DOI 10.1002/ajh.2830420104; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Piccirillo C, 2009, J MATER CHEM, V19, P6167, DOI 10.1039/b905495b; Riha PD, 2005, EUR J PHARMACOL, V511, P151, DOI 10.1016/j.ejphar.2005.02.001; Rojas JC, 2012, PROG NEUROBIOL, V96, P32, DOI 10.1016/j.pneurobio.2011.10.007; Sanguinetti E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48090-8; Sauer K, 2009, J ANTIMICROB CHEMOTH, V63, P937, DOI 10.1093/jac/dkp060; Schirmer RH, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.12.012; Schirmer RH, 2003, REDOX REP, V8, P272, DOI 10.1179/135100003225002899; Sevik P, 2008, ACTA CHIMICA SLOVACA, V1, P238; Shen J, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01133; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Sinev Iu V, 1981, Klin Med (Mosk), V59, P38; Slots J, 2012, PERIODONTOL 2000, V60, P110, DOI 10.1111/j.1600-0757.2011.00429.x; Sonobe T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131340; Sorrentino D, 2017, WORLD J GASTROENTERO, V23, P6747, DOI 10.3748/wjg.v23.i37.6747; Stack C, 2014, HUM MOL GENET, V23, P3716, DOI 10.1093/hmg/ddu080; Techo S, 2019, INT J SYST EVOL MICR, V69, P2506, DOI 10.1099/ijsem.0.003524; Trollor JN, 2012, AGE, V34, P1295, DOI 10.1007/s11357-011-9301-x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Wrubel KM, 2007, PHARMACOL BIOCHEM BE, V86, P712, DOI 10.1016/j.pbb.2007.02.018; Yang SM, 2019, PHOTOCHEM PHOTOBIOL, V95, P833, DOI 10.1111/php.13056; Yang YW, 2015, APPL ENVIRON MICROB, V81, P6749, DOI 10.1128/AEM.01906-15; Yu LCH, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0483-8; Zheng F, 2020, NEUROCHEM RES, V45, P956, DOI 10.1007/s11064-020-02976-6	56	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241784	10.1371/journal.pone.0241784	http://dx.doi.org/10.1371/journal.pone.0241784			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206681	gold, Green Published			2022-12-26	WOS:000595265900045
J	Al Fadhli, AH; Jamal, WY; Rotimi, VO				Al Fadhli, Amani H.; Jamal, Wafaa Y.; Rotimi, Vincent O.			Prevalence of carbapenem-resistant Enterobacteriaceae and emergence of high rectal colonization rates of bla(OXA-181)-positive isolates in patients admitted to two major hospital intensive care units in Kuwait	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; FECAL CARRIAGE; INTESTINAL CARRIAGE; ESCHERICHIA-COLI; RISK-FACTORS; 1ST REPORT; OXA-181; OXA-48; INFECTIONS	Background Fecal colonization by carbapenem-resistant Enterobacteriaceae (CRE) can be the main reservoir for transmission of these resistant organisms especially in the Intensive Care Units (ICUs). Aim This study was conducted to evaluate the rate of rectal carriage and molecular characterization of CRE in patients hospitalized in the ICUs of 2 major hospitals (Adan and Mubarak Al Kabeer Hospitals) in Kuwait. Materials and methods Rectal swabs were collected from all patients at admission, 48 h after admission and once weekly from April 2017- March 2018. Initial CRE screening was carried out on MacConkey agar on which meropenem disc 10 mu g was placed. Identification of isolates was by API 20E. Susceptibility testing was performed using the E-test method. Polymerase chain reaction (PCR) was used to detect the carbapenemase-encoding genes. Clonal relationship was investigated by pulsed-field electrophoresis (PFGE). Genes of bla(OXA-181) and bla(NDM-5)-carrying plasmids were detected in some strains. Results A total of 590 patients were recruited into the study. Of these, 58 were positive for CRE, giving a prevalence of 9.8%; 25/320 (7.8%) in Adan and 33/270 (12.2%) in Mubarak Al Kabeer Hospitals. All isolates were resistant to multiple antibiotics. Resistance rates to colistin and tigecycline were 17% and 83%, respectively. Single genes of bla(OXA-181) were detected in isolates from 38 (65.5%) out of 58 patients and in 5 patients colonized by bla(OXA-48)-positive CRE. A combination of 2 genes was detected in 12 isolates; 5 bla(KPC-2) and bla(OXA-181), 4 bla(VIM-1) and bla(OXA-181), and 3 bla(NDM-5) and bla(OXA-181). PFGE showed an overall level of similarity of 38%. Southern hybridization studies localized the bla(OXA-181) and bla(NDM-5) genes to a large plasmid of 200kb in 3 K. pneumoniae isolates and a small plasmid of 80kb in 2 E. coli isolates, respectively. Conclusion The prevalence of CRE colonization in the 2 hospital ICUs was relatively high and the emergence of bla(OXA-181)-mediated CRE is a cause for concern as there is the possibility of rapid horizontal spread among hospital patients in Kuwait. Active surveillance of CRE in the ICUs is highly recommended to stem its spread.	[Al Fadhli, Amani H.; Jamal, Wafaa Y.; Rotimi, Vincent O.] Kuwait Univ, Fac Med, Dept Microbiol, Kuwait, Kuwait	Kuwait University	Jamal, WY (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Kuwait, Kuwait.	wjamal@hsc.edu.kw		Jamal, Wafaa/0000-0001-7301-0144	Kuwait University [YM07/17]	Kuwait University	This work was supported by Kuwait University, Research Grant no. YM07/17. The funder had no rule in study design, data collection and analysis, decision to publish or preparing of the manuscript.	Ghany MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201613; Balm MND, 2013, CLIN MICROBIOL INFEC, V19, pE421, DOI 10.1111/1469-0691.12247; Baraniak A, 2016, J ANTIMICROB CHEMOTH, V71, P85, DOI 10.1093/jac/dkv282; Ben-David D, 2011, INFECT CONT HOSP EP, V32, P845, DOI 10.1086/661279; Ben-David D, 2010, INFECT CONT HOSP EP, V31, P620, DOI 10.1086/652528; Bitar I, 2018, J GLOB ANTIMICROB RE, V12, P113, DOI 10.1016/j.jgar.2018.01.002; Bogaerts P, 2009, J ANTIMICROB CHEMOTH, V63, P1073, DOI 10.1093/jac/dkp046; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; Cho SY, 2015, EMERG INFECT DIS, V21, P1088, DOI 10.3201/eid2106.150048; CLSI, 2018, CLSI PUBL; Decraene V, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.01689-18, 10.1128/aac.01689-18]; Dortet L, 2012, CLIN MICROBIOL INFEC, V18, pE144, DOI 10.1111/j.1469-0691.2012.03796.x; EUCAST, BREAKP TABL INT MICS; Gamal D, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.24; Giani T, 2012, J HOSP INFECT, V81, P119, DOI 10.1016/j.jhin.2012.04.004; Gijon D, 2012, J CLIN MICROBIOL, V50, P1558, DOI 10.1128/JCM.00020-12; Girlich D, 2014, CLIN MICROBIOL INFEC, V20, P350, DOI 10.1111/1469-0691.12325; Hall JM, 2014, J MED MICROBIOL, V63, P1087, DOI 10.1099/jmm.0.076760-0; Jaiswal SR, 2018, MEDITERR J HEMATOL I, V10, DOI 10.4084/MJHID.2018.025; Jamal W, 2012, INT J ANTIMICROB AG, V39, P183, DOI 10.1016/j.ijantimicag.2011.10.002; Jamal W, 2013, J MED MICROBIOL, V62, P1239, DOI 10.1099/jmm.0.059915-0; Jamal WY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152638; Jamal WY, 2015, MICROB DRUG RESIST, V21, P329, DOI 10.1089/mdr.2014.0123; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kim J, 2014, ANN LAB MED, V34, P20, DOI 10.3343/alm.2014.34.1.20; Lerner A, 2013, J CLIN MICROBIOL, V51, P177, DOI 10.1128/JCM.01992-12; Meyer E, 2010, CRIT CARE, V14, DOI 10.1186/cc9062; Ng E, 2012, ANN ACAD MED SINGAP, V41, P189; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poirel L, 2012, J ANTIMICROB CHEMOTH, V67, P1597, DOI 10.1093/jac/dks121; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Potron A, 2011, ANTIMICROB AGENTS CH, V55, P4896, DOI 10.1128/AAC.00481-11; Rojas LJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00454-17; Solgi H, 2017, EUR J CLIN MICROBIOL, V36, P2127, DOI 10.1007/s10096-017-3035-3; Sonnevend A, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00418-17, 10.1128/aac.00418-17]; Swaminathan M, 2013, INFECT CONT HOSP EP, V34, P809, DOI 10.1086/671270; Tanner WD, 2016, ANTIMICROB AGENTS CH, V60, P712, DOI 10.1128/AAC.01904-15; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Toleman MA, 2003, J ANTIMICROB CHEMOTH, V52, P583, DOI 10.1093/jac/dkg410; Viale P, 2015, CLIN MICROBIOL INFEC, V21, P242, DOI 10.1016/j.cmi.2014.10.020; Viau R, 2016, CLIN MICROBIOL REV, V29, P1, DOI 10.1128/CMR.00108-14; Vidal-Navarro L, 2010, J ANTIMICROB CHEMOTH, V65, P2455, DOI 10.1093/jac/dkq333; Yamamoto N, 2017, J HOSP INFECT, V97, P212, DOI 10.1016/j.jhin.2017.07.015; Yamamoto N, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2312-1; Zhao ZC, 2014, AM J INFECT CONTROL, V42, pE61, DOI 10.1016/j.ajic.2014.01.024	46	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0241971	10.1371/journal.pone.0241971	http://dx.doi.org/10.1371/journal.pone.0241971			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201906	gold, Green Published			2022-12-26	WOS:000595003900021
J	Bogliotti, C; Aksen, H; Isel, F				Bogliotti, Caroline; Aksen, Hatice; Isel, Frederic			Language experience in LSF development: Behavioral evidence from a sentence repetition task	PLOS ONE			English	Article							AMERICAN SIGN-LANGUAGE; WORKING-MEMORY; 2ND-LANGUAGE ACQUISITION; NONWORD REPETITION; DEAF SIGNERS; IMPAIRMENT; AGE; CHILDREN; IMPACT; 1ST	In psycholinguistics and clinical linguistics, the Sentence Repetition Task (SRT) is known to be a valuable tool to screen general language abilities in both spoken and signed languages. This task enables users to reliably and quickly assess linguistic abilities at different levels of linguistic analysis such as phonology, morphology, lexicon, and syntax. To evaluate sign language proficiency in deaf children using French Sign Language (LSF), we designed a new SRT comprising 20 LSF sentences. The task was administered to a cohort of 62 children- 34 native signers (6;09-12 years) and 28 non-native signers (6;08-12;08 years)-in order to study their general linguistic development as a function of age of sign language acquisition (AOA) and chronological age (CA). Previously, a group of 10 adult native signers was also evaluated with this task. As expected, our results showed a significant effect of AOA, indicating that the native signers repeated more signs and were more accurate than non-native signers. A similar pattern of results was found for CA. Furthermore, native signers made fewer phonological errors (i.e., handshape, movement, and location) than non-native signers. Finally, as shown in previous sign language studies, handshape and movement proved to be the most difficult parameters to master regardless of AOA and CA. Taken together, our findings support the assumption that AOA is a crucial factor in the development of phonological skills regardless of language modality (spoken vs. signed). This study thus constitutes a first step toward a theoretical description of the developmental trajectory in LSF, a hitherto understudied language.	[Bogliotti, Caroline; Isel, Frederic] CNRS, Lab MODYCO, Nanterre, France; [Bogliotti, Caroline; Isel, Frederic] Paris Nanterre Univ, Nanterre, France; [Aksen, Hatice] CNRS, Lab Struct Formelles Langage, Paris, France; [Aksen, Hatice] St Denis Univ, Paris, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Bogliotti, C (corresponding author), CNRS, Lab MODYCO, Nanterre, France.; Bogliotti, C (corresponding author), Paris Nanterre Univ, Nanterre, France.	caroline.bogliotti@parisnanterre.fr		Bogliotti, Caroline/0000-0003-1413-1135	Education, Audiovisual and Culture Executive Agency - EACEA [543264-LLP-1-2013-1-ITKA2-KA2MP]; EVASIGNE Project (Paris Lumiere University Fund)	Education, Audiovisual and Culture Executive Agency - EACEA; EVASIGNE Project (Paris Lumiere University Fund)	This research was partially supported by the Education, Audiovisual and Culture Executive Agency -EACEA (543264-LLP-1-2013-1-ITKA2-KA2MP "SignMET" -Principal Investigator: Pasquale Rinaldi). Sign Language coders were paid by the EVASIGNE Project (Paris Lumiere University Funding) (PI: Caroline Bogliotti & Marion Blondel). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Acheson DJ, 2009, J MEM LANG, V60, P329, DOI 10.1016/j.jml.2008.12.002; Acheson DJ, 2009, PSYCHOL BULL, V135, P50, DOI 10.1037/a0014411; Adams AM, 2000, INT J LANG COMM DIS, V35, P95; Alloway TP, 2005, EUR J COGN PSYCHOL, V17, P207, DOI 10.1080/09541440440000005; Anderson Diane, 2002, J Deaf Stud Deaf Educ, V7, P83, DOI 10.1093/deafed/7.2.83; Anderson Diane., 2006, ADV SIGN LANGUAGE DE, P135, DOI [https://doi.org/10.1093/acprof:oso/9780195180947.003.0006, DOI 10.1093/ACPROF:OSO/9780195180947.003.0006]; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Berk S. B., 2003, THESIS; Bishop DVM, 2009, CHILD DEV, V80, P593, DOI 10.1111/j.1467-8624.2009.01281.x; Bishop DVM, 1996, J CHILD PSYCHOL PSYC, V37, P391, DOI 10.1111/j.1469-7610.1996.tb01420.x; Bley-Vroman R., 1994, RES METHODOLOGY 2 LA, P245; Blondel M, 2008, LEADING RES SIGN LAN, P275; BONVILLIAN JD, 1983, CHILD DEV, V54, P1435, DOI 10.1111/j.1467-8624.1983.tb00059.x; Boutla M, 2004, NAT NEUROSCI, V7, P997, DOI 10.1038/nn1298; Boyes Braem P., 1990, GESTURE LANGUAGE HEA, P107, DOI [DOI 10.1007/978-3-642-74859-2_10, 10.1007/978-3-642-74859-2_10]; Brentari D, 1998, MODEL SIGN LANGUAGE; Caselli NK, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00428; Cheek A, 2001, LANGUAGE, V77, P292, DOI 10.1353/lan.2001.0072; Chen Pichler D, 2009, LANGUAGE DEV LIFESPA, P217; Chen-Pichler Deborah, 2012, HDB LINGUISTICS COMM, P647; Chiat S., 2013, ISSUES ASSESSMENT BI, P56; Conlin KE, 2000, LANGUAGE ACQUISITION BY EYE, P51; Conti-Ramsden G, 2001, J CHILD PSYCHOL PSYC, V42, P741, DOI 10.1111/1469-7610.00770; Corina DP, 2016, GESTURE, V15, P291, DOI 10.1075/gest.15.3.01cor; Corina DP, 2003, J COGNITIVE NEUROSCI, V15, P718, DOI 10.1162/jocn.2003.15.5.718; Cormier K, 2012, ANN M GERM LING SOC; Cormier K, 2012, COGNITION, V124, P50, DOI 10.1016/j.cognition.2012.04.003; Courtin C, 2000, J Deaf Stud Deaf Educ, V5, P266, DOI 10.1093/deafed/5.3.266; Courtin C., 2010, LANG INTERACT ACQUIS, V1, P129, DOI [10.1075/lia.1.1.08cou, DOI 10.1075/LIA.1.1.08COU, DOI 10.1075/LIA.1.1.08C0U]; Devescovi A, 2007, INT J LANG COMM DIS, V42, P187, DOI 10.1080/13682820601030686; Emmorey K, 2002, NEUROIMAGE, V17, P812, DOI 10.1006/nimg.2002.1187; Emmorey Karen., 2013, PERSPECTIVES CLASSIF; Fenson Larry, 1994, Monographs of the Society for Research in Child Development, V59, P1; Gathercole S. E., 1993, WORKING MEMORY LANGU; Guy-Guyenet E, 2018, 8 C INT SOC GEST STU; Haug T, 2016, GUIDELINES SIGN LANG; Haug T, 2008, J DEAF STUD DEAF EDU, V13, P138, DOI 10.1093/deafed/enm027; HULST H. van der, 1993, PHONOLOGY, V10, P209, DOI [10.1017/S095267570000004X, DOI 10.1017/S095267570000004X]; Jacob S., 2007, THESIS; Klem M, 2015, DEVELOPMENTAL SCI, V18, P146, DOI 10.1111/desc.12202; Komeili M, 2013, CLIN LINGUIST PHONET, V27, P152, DOI 10.3109/02699206.2012.751625; Liddell Scott, 1989, SIGN LANG STUD, V64, P195, DOI DOI 10.1353/SLS.1989.0027; Limousin F., 2011, THESIS, V8; Lu J, 2016, J CHILD LANG, V43, P537, DOI 10.1017/S0305000915000835; MacSweeney M, 2006, HUM BRAIN MAPP, V27, P63, DOI 10.1002/hbm.20167; MacSweeney M, 2008, NEUROIMAGE, V40, P1369, DOI 10.1016/j.neuroimage.2007.12.047; Mann W, 2010, LANG LEARN DEV, V6, P60, DOI 10.1080/15475440903245951; Marentette PF, 2000, LANGUAGE ACQUISITION BY EYE, P71; Marshall C, 2015, LANG LEARN DEV, V11, P237, DOI 10.1080/15475441.2014.917557; Mayberry R.I., 2006, ENCYCLOP LANG LINGUI, V11, P739; Mayberry RI, 2007, APPL PSYCHOLINGUIST, V28, P537, DOI 10.1017/S0142716407070294; Mayberry RI, 2003, BRAIN LANG, V87, P369, DOI 10.1016/S0093-934X(03)00137-8; MAYBERRY RI, 1989, MEM COGNITION, V17, P740, DOI 10.3758/BF03202635; McIntire M.L., 1977, SIGN LANG STUD, V1016, P247, DOI [10.1353/sls.1977.0019, DOI 10.1353/SLS.1977.0019]; Meier RP, 2008, LANG LEARN DEV, V4, P63, DOI 10.1080/15475440701377618; MEIER RP, 1995, LANGUAGE, GESTURE, AND SPACE, P391; Miller C, 2000, RECH LINGUISTIQUES V, P101; Millet Agn?s., 2019, GRAMMAIRE DESCRIPTIV; Mitchell Ross E, 2004, J Deaf Stud Deaf Educ, V9, P133, DOI 10.1093/deafed/enh017; Morford J. P., 2000, RECHERCHES LINGUISTI, V29, P121; Morford JP, 2000, LANGUAGE ACQUISITION BY EYE, P111; Morgan G, 2007, INT J LANG COMM DIS, V42, P97, DOI 10.1080/13682820600783178; Morgan G, 2007, APPL PSYCHOLINGUIST, V28, P3, DOI 10.1017/S0142716407070014; Morgan G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01217; Naiman N., 1974, WORKING PAPERS BILIN; NATALICIO DS, 1977, BILINGUAL REV, V4, P107; Neville HJ, 1998, P NATL ACAD SCI USA, V95, P922, DOI 10.1073/pnas.95.3.922; Newman AJ, 2002, NAT NEUROSCI, V5, P76, DOI 10.1038/nn775; Newport E.L., 1985, CROSS LINGUISTIC STU, VVol. 1, P881; Niederberger N., 2001, TELSF TEST LANGUE SI; Niederberger N., 2005, ENFANCE, V4, P285; Ortega G., 2010, LANG INTERACT ACQUIS, V1, P67, DOI DOI 10.1075/LIA.1.1.05ORT; Paludneviiene Raylene., 2008, SIGN LANGUAGES SPINN, P160; PETITTO LA, 1987, COGNITION, V27, P1, DOI 10.1016/0010-0277(87)90034-5; Polisenska K, 2015, INT J LANG COMM DIS, V50, P106, DOI 10.1111/1460-6984.12126; Puissant-Schontz L, 2018, SIGN LANG ACQ ASS C; Ramirez NF, 2016, CEREB CORTEX, V26, P1015, DOI 10.1093/cercor/bhu273; Ramirez NF, 2013, J CHILD LANG, V40, P391, DOI 10.1017/S0305000911000535; Redmond SM, 2011, J SPEECH LANG HEAR R, V54, P99, DOI 10.1044/1092-4388(2010/10-0010); Riches NG, 2010, INT J LANG COMM DIS, V45, P47, DOI 10.3109/13682820802647676; Rinaldi P, 2018, J DEAF STUD DEAF EDU, V23, P408, DOI 10.1093/deafed/eny021; Sandler W, 2006, SIGN LANGUAGE AND LINGUISTIC UNIVERSALS, P1, DOI 10.2277/ 0521483956; Schein JD, 1997, HOME STRANGERS EXPLO; Schick B., 2006, ADV SIGN LANGUAGE DE; Siedlecki T, 1997, APPL PSYCHOLINGUIST, V18, P17, DOI 10.1017/S0142716400009851; Singleton JL, 2004, COGNITIVE PSYCHOL, V49, P370, DOI 10.1016/j.cogpsych.2004.05.001; Slobin D, 1971, LANGUAGE TRAINING EA, P170; Stokoe WC, 2005, J DEAF STUD DEAF EDU, V10, P3, DOI 10.1093/deafed/eni001; STOKOE WC, 1980, ANNU REV ANTHROPOL, V9, P365, DOI 10.1146/annurev.an.09.100180.002053; Supalla T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00859; Sutton-Spence R, 2004, HDB APPL LINGUISTICS, P165; Tomasello M., 2005, CONSTRUCTING LANGUAG; Van der Kooij E., 2002, PHONOLOGICAL CATEGOR; VARGO ME, 1984, J CLIN PSYCHOL, V40, P1525, DOI 10.1002/1097-4679(198411)40:6<1525::AID-JCLP2270400644>3.0.CO;2-B; Weismer SE, 2000, J SPEECH LANG HEAR R, V43, P865, DOI 10.1044/jslhr.4304.865; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Woolfe T, 2010, J CHILD PSYCHOL PSYC, V51, P322, DOI 10.1111/j.1469-7610.2009.02151.x	97	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0236729	10.1371/journal.pone.0236729	http://dx.doi.org/10.1371/journal.pone.0236729			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ5ZL	33201887	Green Published, gold			2022-12-26	WOS:000595003900054
J	Chen, TY; Ren, YM; Wang, CH; Huang, BW; Lan, ZG; Liu, WK; Ju, Y; Hui, XH; Zhang, YK				Chen, Tengyun; Ren, Yanming; Wang, Chenghong; Huang, Bowen; Lan, Zhigang; Liu, Wenke; Ju, Yan; Hui, Xuhui; Zhang, Yuekang			Risk factors for hydrocephalus following fourth ventricle tumor surgery: A retrospective analysis of 121 patients	PLOS ONE			English	Article							POSTERIOR-FOSSA-TUMORS; ENDOSCOPIC 3RD VENTRICULOSTOMY; PERSISTENT HYDROCEPHALUS; MANAGEMENT; CHILDREN; REQUIREMENT; SECONDARY; SCORE; NEED	Background and aim Most patients who present with a fourth ventricle tumor have concurrent hydrocephalus, and some demonstrate persistent hydrocephalus after tumor resection. There is still no consensus on the management of hydrocephalus in patients with fourth ventricle tumor after surgery. The purpose of this study was to identify the factors that predispose to postoperative hydrocephalus and the need for a postoperative cerebrospinal fluid (CSF) diversion procedure. Materials and methods We performed a retrospective analysis of patients who underwent surgery of the fourth ventricle tumor between January 2013 and December 2018 at the Department of Neurosurgery in West China Hospital of Sichuan University. The characteristics of patients and the tumor location, tumor size, tumor histology, and preventive external ventricular drainage (EVD) that were potentially correlated with CSF circulation were evaluated in univariate and multivariate analysis. Results A total of 121 patients were enrolled in our study; 16 (12.9%) patients underwent postoperative CSF drainage. Univariate analysis revealed that superior extension (p = 0.004), preoperative hydrocephalus (p<0.001), and subtotal resection (p<0.001) were significantly associated with postoperative hydrocephalus. Multivariate analysis revealed that superior extension (p = 0.013; OR = 44.761; 95% CI 2.235-896.310) and subtotal resection (p = 0.005; OR = 0.087; 95% CI 0.016-0.473) were independent risk factors for postoperative hydrocephalus after resection of fourth ventricle tumor. Conclusion Superior tumor extension (into the aqueduct) and failed total resection of tumor were identified as independent risk factors for postoperative hydrocephalus in patients with fourth ventricle tumor.	[Chen, Tengyun; Ren, Yanming; Wang, Chenghong; Huang, Bowen; Lan, Zhigang; Liu, Wenke; Ju, Yan; Hui, Xuhui; Zhang, Yuekang] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China	Sichuan University	Zhang, YK (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China.	2012zykyx@sina.cn	Lan, Zhigang/HGA-7245-2022		Program of Chengdu Science and Technology Bureau [2019-YF05-00392-SN]	Program of Chengdu Science and Technology Bureau	This work was supported by Program of Chengdu Science and Technology Bureau in the form of a grant awarded to YZ (2019-YF05-00392-SN). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, LABANIMAL EUROPE, V15, P4; Bateman GA, 2016, J NEUROSURG-PEDIATR, V18, P21, DOI 10.3171/2016.1.PEDS15676; Beale N, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-13; Bhatia R, 2009, PEDIATR NEUROSURG, V45, P186, DOI 10.1159/000222668; Bognar L, 2003, CHILD NERV SYST, V19, P332, DOI 10.1007/s00381-003-0745-x; CULLEY DJ, 1994, NEUROSURGERY, V34, P402, DOI 10.1227/00006123-199403000-00003; Di Vincenzo J, 2014, J NEUROL SURG PART A, V75, P20, DOI 10.1055/s-0032-1328953; Ferguson SD, 2018, J NEUROSURG, V128, P339, DOI 10.3171/2016.11.JNS161167; Gnanalingham KK, 2003, PEDIATR NEUROSURG, V39, P246, DOI 10.1159/000072869; Gopalakrishnan CV, 2012, PEDIATR NEUROSURG, V48, P93, DOI 10.1159/000343009; Hosainey SAM, 2014, J NEUROSURG-PEDIATR, V14, P604, DOI 10.3171/2014.8.PEDS13585; Kulkarni AV, 2010, J NEUROSURG-PEDIATR, V6, P310, DOI 10.3171/2010.8.PEDS103; Kulkarni AV, 2009, J PEDIATR-US, V155, P254, DOI 10.1016/j.jpeds.2009.02.048; Kumar V, 1996, BRIT J NEUROSURG, V10, P467, DOI 10.1080/02688699647096; Le Fournier L, 2017, CHILD NERV SYST, V33, P1473, DOI 10.1007/s00381-017-3447-5; Lescher S, 2014, NEUROSURG FOCUS, V37, DOI 10.3171/2014.9.FOCUS14479; Lin CT, 2015, CHILD NERV SYST, V31, P1781, DOI 10.1007/s00381-015-2781-8; Marx S, 2018, ACTA NEUROCHIR, V160, P1063, DOI 10.1007/s00701-018-3496-x; McLaurin R L, 1983, Clin Neurosurg, V30, P286; Mei XD, 2019, CHIN J NAT MEDICINES, V17, P59, DOI 10.1016/S1875-5364(19)30010-X; Morelli D, 2005, J NEUROSURG, V103, P247, DOI 10.3171/ped.2005.103.3.0247; Mussi ACM, 2000, J NEUROSURG, V92, P812, DOI 10.3171/jns.2000.92.5.0812; Ostrom QT, 2019, NEURO-ONCOLOGY, V21, pV1, DOI 10.1093/neuonc/noz150; PAPO I, 1982, NEUROSURGERY, V10, P13, DOI 10.1227/00006123-198201000-00002; RAIMONDI AJ, 1981, J NEUROSURG, V55, P174, DOI 10.3171/jns.1981.55.2.0174; Rhoton AL, 2000, NEUROSURGERY, V47, pS7, DOI 10.1097/00006123-200009001-00007; Sainte-Rose C, 2001, J NEUROSURG, V95, P791, DOI 10.3171/jns.2001.95.5.0791; SCHMID UD, 1986, J NEUROSURG, V65, P649, DOI 10.3171/jns.1986.65.5.0649; Tamburrini G, 2008, CHILD NERV SYST, V24, P593, DOI 10.1007/s00381-008-0585-9; Won SY, 2020, NEUROSURG REV, V43, P1143, DOI 10.1007/s10143-019-01139-8; Won SY, 2020, J NEUROSURG, V132, P296, DOI 10.3171/2018.8.JNS181005; Yanamadala V, 2013, NEUROSURGERY, V72, P9, DOI 10.1227/NEU.0b013e3182744b67	32	5	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0241853	10.1371/journal.pone.0241853	http://dx.doi.org/10.1371/journal.pone.0241853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201889	Green Published, gold			2022-12-26	WOS:000595003900020
J	Li, LN; Liu, Y; Zhang, HC; Wu, T; Dai, Y; Wang, WH				Li, Luo-Na; Liu, Yun; Zhang, Hong-Chen; Wu, Ting; Dai, Yun; Wang, Wei-Hong			Helicobacter pylori infection reduces TAMs infiltration in a mouse model of AOM/DSS induced colitis-associated cancer	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ULCERATIVE-COLITIS; COLORECTAL-CANCER; RISK; INFLAMMATION	Inflammatory bowel disease (IBD) increases the risk of colitis-associated cancer (CAC). Evidences suggest that Helicobacter pylori (H. pylori) infection is associated with a low risk of IBD and protects against experimental colitis in mouse models. However, the effect of H. pylori infection in CAC remains unclear. We previously reported that H. pylori infection increased M2 macrophages in dextran sodium sulfate (DSS)-induced chronic colitis. Tumor-associated macrophages (TAMs) play a pivotal role in colon cancer. Therefore, we established a H. pylori-infected CAC mouse model induced by azoxymethane and DSS to explore the effect of H. pylori infection on TAMs in CAC. Here, we demonstrated that H. pylori infection attenuated the development of CAC by decreasing tumor multiplicity, tumor size, tumor grade and colitis scores. Moreover, H. pylori infection reduced the infiltration of TAMs, particularly M2-like TAMs in CAC tumors, accompanied with the down-regulated pro-inflammatory and pro-tumorigenic factors TNF-alpha, IL-1 beta, IL-6 and IL-23 in tumors of CAC mice. Our study suggests that H. pylori infection can reduce TAMs infiltration and regulate cytokines expression in CAC.	[Li, Luo-Na; Liu, Yun; Zhang, Hong-Chen; Wu, Ting; Dai, Yun; Wang, Wei-Hong] Peking Univ First Hosp, Dept Gastroenterol, Beijing, Peoples R China		Wang, WH (corresponding author), Peking Univ First Hosp, Dept Gastroenterol, Beijing, Peoples R China.	wangweihong2581@163.com		Wang, Wei Hong/0000-0003-4740-7388	Natural Science Foundation of Beijing Municipality [7182165]	Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation)	This work was supported by the Natural Science Foundation of Beijing Municipality (7182165). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2014, SEBARC, V12, P105; Canavan C, 2006, ALIMENT PHARM THER, V23, P1097, DOI 10.1111/j.1365-2036.2006.02854.x; Chanmee T, 2014, CANCERS, V6, P1670, DOI 10.3390/cancers6031670; Chen YN, 2020, EUR J PHARMACOL, V877, DOI 10.1016/j.ejphar.2020.173090; Choi DS., 2020, CLIN TRANSL GASTROEN, V11, pe00127, DOI DOI 10.14309/CTG.0000000000000127; Dai Y, 2014, MOL CANCER THER, V13, P1206, DOI 10.1158/1535-7163.MCT-13-0378; Dehnel N, 2017, CURR OPIN PHARMACOL, V35, P12, DOI 10.1016/j.coph.2017.04.007; Deryugina EI, 2015, MATRIX BIOL, V44-46, P94, DOI 10.1016/j.matbio.2015.04.004; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Li H, 2020, CANCER BIOL THER, V21, P178, DOI 10.1080/15384047.2019.1679555; Li X, 2019, INFLAMMATION, V42, P1611, DOI 10.1007/s10753-019-01022-0; Lin KD, 2019, CLIN GASTROENTEROL H, V17, P1991, DOI 10.1016/j.cgh.2018.12.014; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Ngambenjawong C, 2017, ADV DRUG DELIVER REV, V114, P206, DOI 10.1016/j.addr.2017.04.010; Ostuni R, 2015, TRENDS IMMUNOL, V36, P229, DOI 10.1016/j.it.2015.02.004; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Szebeni GJ, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9294018; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Wang W, 2015, MOL MED REP, V11, P2397, DOI 10.3892/mmr.2014.3018; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Wu T, 2016, ONCOTARGET, V7, P19548, DOI 10.18632/oncotarget.6969; Wu YZ, 2017, ONCOTARGET, V8, P73810, DOI 10.18632/oncotarget.17962; Yang L, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0430-2; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zhang HC, 2018, INFLAMM BOWEL DIS, V24, P1481, DOI 10.1093/ibd/izy107; Zhang Y, 2012, AM J EPIDEMIOL, V175, P441, DOI 10.1093/aje/kwr331	27	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0241840	10.1371/journal.pone.0241840	http://dx.doi.org/10.1371/journal.pone.0241840			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201893	gold, Green Published			2022-12-26	WOS:000595003900009
J	Ogunrinu, OJ; Norman, KN; Vinasco, J; Levent, G; Lawhon, SD; Fajt, VR; Volkova, VV; Gaire, T; Poole, TL; Genovese, KJ; Wittum, TE; Scott, HM				Ogunrinu, Olanrewaju J.; Norman, Keri N.; Vinasco, Javier; Levent, Gizem; Lawhon, Sara D.; Fajt, Virginia R.; Volkova, Victoria V.; Gaire, Tara; Poole, Toni L.; Genovese, Kenneth J.; Wittum, Thomas E.; Scott, H. Morgan			Can the use of older-generation beta-lactam antibiotics in livestock production over-select for beta-lactamases of greatest consequence for human medicine? An in vitro experimental model	PLOS ONE			English	Article							CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI; DIAUXIC GROWTH; ACINETOBACTER-BAUMANNII; RESISTANCE; KLEBSIELLA; BACTERIA; SEQUENCE; EMERGENCE; CHICKEN	Though carbapenems are not licensed for use in food animals in the U.S., carbapenem resistance among Enterobacteriaceae has been identified in farm animals and their environments. The objective of our study was to determine the extent to which older-generation beta-lactam antibiotics approved for use in food animals in the U.S. might differentially select for resistance to antibiotics of critical importance to human health, such as carbapenems. Escherichia coli (E. coli) strains from humans, food animals, or the environment bearing a single beta-lactamase gene (n = 20 each) for bla(TEM-1), bla(CMY-2), and bla(CTX-M-*) or else bla(KPC/IMP/NDM) (due to limited availability, often in combination with other bla genes), were identified, along with 20 E. coli strains lacking any known beta-lactamase genes. Baseline estimates of intrinsic bacterial fitness were derived from the population growth curves. Effects of ampicillin (32 mu g/mL), ceftriaxone (4 mu g/mL) and meropenem (4 mu g/mL) on each strain and resistance-group also were assessed. Further, in vitro batch cultures were prepared by mixing equal concentrations of 10 representative E. coli strains (two from each resistance gene group), and each mixture was incubated at 37 degrees C for 24 hours in non-antibiotic cation-adjusted Mueller-Hinton II (CAMH-2) broth, ampicillin + CAMH-2 broth (at 2, 4, 8, 16, and 32 mu g/mL) and ceftiofur + CAMH-2 broth (at 0.5, 1, 2, 4, and 8 mu g/mL). Relative and absolute abundance of resistance-groups were estimated phenotypically. Line plots of the raw data were generated, and non-linear Gompertz models and multilevel mixed-effect linear regression models were fitted to the data. The observed strain growth rate distributions were significantly different across the groups. AmpC strains (i.e., bla(CMY-2)) had distinctly less robust (p < 0.05) growth in ceftriaxone (4 mu g/mL) compared to extended-spectrum beta-lactamase (ESBL) producers harboring bla(CTX-M-*)variants. With increasing beta-lactam antibiotic concentrations, relative proportions of ESBLs and CREs were over-represented in the mixed bacterial communities; importantly, this was more pronounced with ceftiofur than with ampicillin. These results indicate that aminopenicillins and extended-spectrum cephalosporins would be expected to propagate carbapenemase-producing Enterobacteriaceae in food animals if and when Enterobacteriaceae from human health care settings enter the food animal environment.	[Ogunrinu, Olanrewaju J.; Vinasco, Javier; Levent, Gizem; Lawhon, Sara D.; Scott, H. Morgan] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Norman, Keri N.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA; [Fajt, Virginia R.] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA; [Volkova, Victoria V.; Gaire, Tara] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Poole, Toni L.; Genovese, Kenneth J.] USDA, Southern Plains Agr Res Ctr, College Stn, TX USA; [Wittum, Thomas E.] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Kansas State University; United States Department of Agriculture (USDA); University System of Ohio; Ohio State University	Scott, HM (corresponding author), Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX 77843 USA.	hmscott@cvm.tamu.edu	Lawhon, Sara D./G-5147-2011; Fajt, Virginia/AAN-8785-2020	Lawhon, Sara D./0000-0001-9154-8909; Fajt, Virginia/0000-0003-0697-7149; Wittum, Thomas/0000-0002-9216-1308; Poole, Toni/0000-0003-0882-0209; Levent, Gizem/0000-0001-9207-9999; Gaire, Tara/0000-0003-1805-8051	USDA-NIFA-AFRI [2016-68003-24607]; University Libraries	USDA-NIFA-AFRI(United States Department of Agriculture (USDA)); University Libraries	Some of the data presented in this publication were funded through a grant by USDA-NIFA-AFRI (2016-68003-24607) entitled "Voluntary compliance in antimicrobial stewardship programs: a critical factor for effective intervention". The findings or conclusions expressed in this publication are those of the publishing authors and do not necessarily represent those of the United States Department of Agriculture. The open access publishing fees for this article have been covered by the Texas A&M University Open Access to Knowledge Fund (OAKFund), supported by the University Libraries.	Aarestrup F, 2012, NATURE, V486, P465, DOI 10.1038/486465a; Abraham EP, 1940, NATURE, V146, P837, DOI 10.1038/146837a0; ADUSEOPOKU J, 1988, FEMS MICROBIOL LETT, V50, P45; Al Bayssari C, 2015, J ANTIMICROB CHEMOTH, V70, P950, DOI 10.1093/jac/dku469; Alexander TW, 2010, INT J FOOD MICROBIOL, V137, P40, DOI 10.1016/j.ijfoodmicro.2009.11.008; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Andersson DI, 1999, CURR OPIN MICROBIOL, V2, P489, DOI 10.1016/S1369-5274(99)00005-3; [Anonymous], 2019, CDC FDA ANT RES IS B; [Anonymous], 2019, MED EXTR US ANT; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Baty F, 2004, INT J FOOD MICROBIOL, V91, P261, DOI 10.1016/j.ijfoodmicro.2003.07.002; BIRCH LC, 1957, AM NAT, V91, P5, DOI 10.1086/281957; BUSH K, 1995, ANTIMICROB AGENTS CH, V39, P1211, DOI 10.1128/AAC.39.6.1211; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Bush K, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025247; Bush K, 2011, ANNU REV MICROBIOL, V65, P455, DOI 10.1146/annurev-micro-090110-102911; Carattoli A, 2017, EUROSURVEILLANCE, V22, P18, DOI 10.2807/1560-7917.ES.2017.22.31.30589; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; CASE TJ, 1974, P NATL ACAD SCI USA, V71, P3073, DOI 10.1073/pnas.71.8.3073; Castanheira M, 2011, ANTIMICROB AGENTS CH, V55, P1274, DOI 10.1128/AAC.01497-10; Centers for Disease Control and Prevention, TRACK CRE US; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Chalmers G, 2018, GENES-BASEL, V9, DOI 10.3390/genes9100504; CLSI, 2017, PERFORMANCE STANDARD; Cornforth DM, 2013, NAT REV MICROBIOL, V11, P285, DOI 10.1038/nrmicro2977; Cox G, 2013, INT J MED MICROBIOL, V303, P287, DOI 10.1016/j.ijmm.2013.02.009; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; El-Shaboury SR, 2007, J PHARMACEUT BIOMED, V45, P1, DOI 10.1016/j.jpba.2007.06.002; Fischer J, 2013, 23 EUR C CLIN MICR I; Fischer J, 2013, J ANTIMICROB CHEMOTH, V68, P478, DOI 10.1093/jac/dks393; Fischer J, 2012, J ANTIMICROB CHEMOTH, V67, P1793, DOI 10.1093/jac/dks108; Fujikawa H, 2004, FOOD MICROBIOL, V21, P501, DOI 10.1016/j.fm.2004.01.007; GEORGE SE, 1985, J BACTERIOL, V164, P866, DOI 10.1128/JB.164.2.866-871.1985; Gillespie SH, 2010, ANTIBIOTIC RESISTANC, DOI [10.1038/nprot.2009.205, DOI 10.1038/NPROT.2009.20520134428]; Gnedenko B. V., 1954, LIMIT DISTRIBUTIONS; Hall BG, 2005, J ANTIMICROB CHEMOTH, V55, P1050, DOI 10.1093/jac/dki130; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Johnson JR, 2006, J INFECT DIS, V194, P71, DOI 10.1086/504921; Kim YA, 2012, CLIN INFECT DIS, V55, P224, DOI 10.1093/cid/cis387; Kugelberg E, 2005, J ANTIMICROB CHEMOTH, V55, P22, DOI 10.1093/jac/dkh505; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; LEE IH, 1974, APPL MICROBIOL, V28, P831, DOI 10.1128/AEM.28.5.831-835.1974; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Levin BR, 2000, GENETICS, V154, P985; LEVY SB, 1976, NATURE, V260, P40, DOI 10.1038/260040a0; LIVERMORE DM, 1995, CLIN MICROBIOL REV, V8, P557, DOI 10.1128/CMR.8.4.557; Logan LK, 2017, J INFECT DIS, V215, pS28, DOI 10.1093/infdis/jiw282; Mathys DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218650; McCuddin Z, 2006, VET MICROBIOL, V114, P275, DOI 10.1016/j.vetmic.2005.12.004; McEwen SA, 2002, CLIN INFECT DIS, V34, pS93, DOI 10.1086/340246; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; Mollenkopf DF, 2018, FOODBORNE PATHOG DIS, V15, P372, DOI 10.1089/fpd.2017.2355; Mollenkopf DF, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01298-16; Morrison D. F., 1976, MULTIVARIATE STAT ME; Naas T, 2011, ANTIMICROB AGENTS CH, V55, P4933, DOI 10.1128/AAC.00719-11; National Antimicrobial Resistance Monitoring System, 2016, INT LAB MAN, VThird; National Center for Biotechnology Information (NCBI), SEQ READ ARCH; NEGRI MC, 1994, ANTIMICROB AGENTS CH, V38, P122, DOI 10.1128/AAC.38.1.122; NIGHTINGALE CH, 1975, J PHARM SCI-US, V64, P1899, DOI 10.1002/jps.2600641202; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; OIE, 2007, OIE LIST ANT VET IMP, V9; ONeill J., 2014, REV ANTIMICROB RESIS; Page MI, 2012, CHEM BETA LACTAMS; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Peechakara BV, 2020, AMPICILLIN; Poirel L, 2004, ANTIMICROB AGENTS CH, V48, P15, DOI 10.1128/AAC.48.1.15-22.2004; Poirel L, 2012, EMERG INFECT DIS, V18, P523, DOI 10.3201/eid1803.111330; Price LB, 2007, ENVIRON HEALTH PERSP, V115, P1738, DOI 10.1289/ehp.10191; SANDERS CC, 1992, CLIN INFECT DIS, V15, P824, DOI 10.1093/clind/15.5.824; Sorensen TL, 2001, NEW ENGL J MED, V345, P1161, DOI 10.1056/NEJMoa010692; TACKET CO, 1985, JAMA-J AM MED ASSOC, V253, P2058, DOI 10.1001/jama.253.14.2058; Taylor EA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220068; Temkin E, 2014, ANN NY ACAD SCI, V1323, P22, DOI 10.1111/nyas.12537; Tjorve KMC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178691; U.S. Food and Drug Administration, ROCH ROC CEFTR SOD; USHIJIMA T, 1991, J MED MICROBIOL, V35, P111, DOI 10.1099/00222615-35-2-111; Walther-Rasmussen J, 2004, CAN J MICROBIOL, V50, P137, DOI 10.1139/W03-111; Wang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037152; Webb HE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147363; WHO, WHO GLOB ACT PLAN AN; WHO, 2017, INT SURV ANT RES FOO; Wilke MS, 2005, CURR OPIN MICROBIOL, V8, P525, DOI 10.1016/j.mib.2005.08.016; Woodford N, 2014, J ANTIMICROB CHEMOTH, V69, P287, DOI 10.1093/jac/dkt392; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yandrapalli N, 2020, MICROMACHINES-BASEL, V11, DOI 10.3390/mi11030285; Zankari E, 2013, J ANTIMICROB CHEMOTH, V68, P771, DOI 10.1093/jac/dks496; Zerbino Daniel R, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1105s31; Zhang WJ, 2013, J ANTIMICROB CHEMOTH, V68, P1681, DOI 10.1093/jac/dkt066	89	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242195	10.1371/journal.pone.0242195	http://dx.doi.org/10.1371/journal.pone.0242195			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196662	gold, Green Published			2022-12-26	WOS:000595266800005
J	Okada, M; Kozaki, I; Honda, H				Okada, Masayoshi; Kozaki, Ikkou; Honda, Hiroyuki			Antidepressive effect of an inward rectifier K+ channel blocker peptide, tertiapin-RQ	PLOS ONE			English	Article							UNION-OF-PHARMACOLOGY; MOLECULAR RELATIONSHIPS; DIFFERENTIAL EXPRESSION; NOMENCLATURE; DEPRESSION; INHIBITION; BEHAVIORS; NUCLEUS; ANXIETY	Renal outer medullary K+ channel, ROMK (Kir1.1, kcnj1) is expressed in the kidney and brain, but its role in the central nervous system remains unknown. Recent studies suggested an involvement of the ROMK channel in mental diseases. Tertiapin (TPN) is a European honey bee venom peptide and is reported to selectively block the ROMK channel. Here, we have chemically synthesized a series of mutated TPN peptides, including TPN-I8R and -M13Q (TPN-RQ), reported previously, and examined their blocking activity on the ROMK channel. Among 71 peptides tested, TPN-RQ was found to block the ROMK channel most effectively. Whole-cell patch-clamp recordings showed the essential roles of two disulfide bonds and the circular structure for the blockade activity. To examine the central role, we injected TPN-RQ intracerebroventricularly and examined the effects on depression- and anxiety-like behaviors in mice. TPN-RQ showed an antidepressive effect in tail-suspension and forced swim tests. The injection of TPN-RQ also enhanced the anxiety-like behavior in the elevated plus-maze and light/dark box tests and impaired spontaneous motor activities in balance beam and wheel running tests. Administration of TPM-RQ suppressed the anti-c-Fos immunoreactivity in the lateral septum, without affecting immunoreactivity in antidepressant-related nuclei, e.g. the dorsal raphe nucleus and locus coeruleus. TPN-RQ may exert its antidepressive effects through a different mechanism from current drugs.	[Okada, Masayoshi] Kurashiki Univ Sci & Arts, Coll Life Sci, Dept Med Life Sci, Kurashiki, Okayama, Japan; [Kozaki, Ikkou; Honda, Hiroyuki] Nagoya Univ, Dept Biomol Engn, Grad Schoosl Engn, Nagoya, Japan	Nagoya University	Okada, M (corresponding author), Kurashiki Univ Sci & Arts, Coll Life Sci, Dept Med Life Sci, Kurashiki, Okayama, Japan.	mokada-tky@umin.ac.jp	Okada, Masayoshi/ABE-9020-2020	Okada, Masayoshi/0000-0001-8515-7143	KAKENHI form JSPS [18K06830, 25460323]; Wesco Scientific Promotion Foundation; Ryobi Memorial Foundation	KAKENHI form JSPS; Wesco Scientific Promotion Foundation; Ryobi Memorial Foundation	M.O. was supported by the KAKENHI (18K06830, 25460323) form JSPS, Wesco Scientific Promotion Foundation, and Ryobi Memorial Foundation. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Amin N, 2013, EUR J HUM GENET, V21, P876, DOI 10.1038/ejhg.2012.263; Anonymous, 2014, Journal of Cetacean Research and Management, V15, P1; Anthony TE, 2014, CELL, V156, P522, DOI 10.1016/j.cell.2013.12.040; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Bhave G, 2011, MOL PHARMACOL, V79, P42, DOI 10.1124/mol.110.066928; BODNOFF SR, 1989, PSYCHOPHARMACOLOGY, V97, P277, DOI 10.1007/BF00442264; Chee MJS, 2015, J NEUROSCI, V35, P3644, DOI 10.1523/JNEUROSCI.4187-14.2015; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Cryan JF, 2002, TRENDS PHARM SCI; DiBernardo A, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1920-7; Djillani A, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00643; Doupnik CA, 2017, NEUROPHARMACOLOGY, V127, P161, DOI 10.1016/j.neuropharm.2017.07.011; Friedman A, 2016, NATURE, DOI [10.1038/ncomms11671, DOI 10.1038/NC0MMS11671]; Gilbert HF, 1997, PROTEIN DISULFIDE IS; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; Hilder TA, 2013, BIOCHEMISTRY-US, V52, P967, DOI 10.1021/bi301498x; Hille B., ION CHANNELS EXCITAB; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14294, DOI 10.1021/bi991206j; Joseph A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201092; KENNA S, 1994, MOL BRAIN RES, V24, P353, DOI 10.1016/0169-328X(94)90150-3; Kim S, 2018, NEUROPHARMACOLOGY, V130, P10, DOI 10.1016/j.neuropharm.2017.11.041; Kozaki I, 2020, J BIOSCI BIOENG, V129, P613, DOI 10.1016/j.jbiosc.2019.11.012; Kozaki I, 2017, J BIOSCI BIOENG, V124, P209, DOI 10.1016/j.jbiosc.2017.03.013; Kubo Y, 2005, PHARMACOL REV, V57, P509, DOI 10.1124/pr.57.4.11; Lira A, 2003, BIOL PSYCHIAT, V54, P960, DOI 10.1016/S0006-3223(03)00696-6; Llamosas N, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyv051; Lozano AM, 2015, SCI AM, V312, P68, DOI 10.1038/scientificamerican0215-68; Model organisms, 2005, ASC MOUS ADV MOD HUM, DOI [10.1038/nrd1825, DOI 10.1038/NRD1825]; Mongeau R, 2003, J NEUROSCI, V23, P3855; Nollet M., 2013, CURR PROTOC PHARM; Okada M, 2015, BMC NEUROSCI, P16, DOI [10.1186/s12868-015-0156-4, DOI 10.1186/S12868-015-0156-4]; Okada M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215391; Ozdemir O, 2014, J NEUROPSYCH CLIN N, V26, pE6, DOI 10.1176/appi.neuropsych.13060129; Palucha-Poniewiera A, 2020, BEHAV PHARMACOL, V31, P574, DOI 10.1097/FBP.0000000000000564; Ramu Y, 2008, P NATL ACAD SCI USA, V105, P10774, DOI 10.1073/pnas.0802850105; Ressler KJ, 2008, TARGETING ABNORMAL N; Ridout KK, ACUTE PSYCHOSIS 2 PA, DOI [10.1089/cap.2015.0138, DOI 10.1089/CAP.2015.0138]; Sheehan TP, 2004, BRAIN RES REV, V46, P71, DOI 10.1016/j.brainresrev.2004.04.009; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Smolin B, 2012, INT J NEUROPSYCHOPH, V15, P869, DOI 10.1017/S1461145711001428; Stamp J, 1999, MULTIPLE IMMEDIATEEA; Strauss KA, POPULATION BASED STU, DOI [10.1093/hmg/ddu335, DOI 10.1093/HMG/DDU335]; Wang DY, 2007, NEUROPSYCHOPHARMACOL, V32, P1261, DOI 10.1038/sj.npp.1301256; Wei AD, 2005, PHARMACOL REV, V57, P463, DOI 10.1124/pr.57.4.9; Welling PA, 2016, ANNU REV PHYSIOL, V78, P415, DOI 10.1146/annurev-physiol-021115-105423; Welling PA, 2009, AM J PHYSIOL-RENAL, V297, pF849, DOI 10.1152/ajprenal.00181.2009	50	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0233815	10.1371/journal.pone.0233815	http://dx.doi.org/10.1371/journal.pone.0233815			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186384	gold, Green Published			2022-12-26	WOS:000593949800006
J	Lee, Y; Lee, SH; Lim, SM; Baek, SH; Ha, IH				Lee, Yura; Lee, Sook-Hyun; Lim, Sung Min; Baek, Seung Ho; Ha, In-Hyuk			Mental health and quality of life of patients with osteoarthritis pain: The sixth Korea National Health and Nutrition Examination Survey (2013-2015)	PLOS ONE			English	Article							KNEE OSTEOARTHRITIS; OLDER-ADULTS; HIP; DEPRESSION; ANXIETY; IMPACT; RISK	Objectives This study aims to investigate the association between mental health and quality of life of osteoarthritis (OA) patients according to the site of pain. Design Retrospective cross-sectional study Participants Data of 22,948 participants of the sixth Korea National Health and Nutrition Examination Survey conducted from 2013-2015 were used. Outcome measures Participants were asked if they had OA pain in the hip joint, knee joint, and lower back (yes/no) and whether they experienced anxiety or depression. The EQ-5D questionnaire was used to determine the quality of life of patients with hip, knee, and lower back OA. Multiple logistic regression analysis was performed after adjusting. Results A total of 5,401 patients reported pain in the hip joint, knee joint, or lower back. The analysis showed significant relations between pain sites, mental health, and quality of life. First, more female patients with OA experienced stress and depression than males. Second, for males with OA, stress was reported in the order of: lower back > hip > knee, while pain and depression was reported in the order of: lower back > knee > hip (p < 0.05). For females with OA, stress was reported in the order of: knee > lower back > hip, while depression was reported in the order of: knee > lower back > hip. Third, considering quality of life, for males, hip joint pain had the greatest impact on quality of life and for females, knee joint pain had the largest impact (p < 0.001). Conclusions For patients with OA, the effect on the mental health and quality of life differed according to sex and sites of pain. Therefore, this study confirms that pain sites, sex, mental health, and quality of life are independent risk factors when determining OA pain.	[Lee, Yura] Jaseng Hosp Korean Med, Seoul, South Korea; [Lee, Sook-Hyun] Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea; [Lim, Sung Min; Ha, In-Hyuk] Korea Natl Rehabil Res Inst, Dept Clin Res Rehabil, Seoul, South Korea; [Baek, Seung Ho] Dongguk Univ, Dept Korean Med, Seoul, South Korea	Dongguk University	Ha, IH (corresponding author), Korea Natl Rehabil Res Inst, Dept Clin Res Rehabil, Seoul, South Korea.	hanihata@gmail.com	Lee, Sook Hyun/GSN-3995-2022	Lee, Sook Hyun/0000-0002-9465-3621; HA, IN-HYUK/0000-0002-5020-6723	Jaseng Medical Foundation, Republic of Korea	Jaseng Medical Foundation, Republic of Korea	This research was funded by the Jaseng Medical Foundation, Republic of Korea.	Al-Ahaideb A., 2013, SAUDI J SPORTS MED, V13, P10, DOI [10.4103/1319-6308.112207, DOI 10.4103/1319-6308.112207]; [Anonymous], 2017, CONTAGION J VIOLENCE, V24, P138; [Anonymous], 2015, JHEP, V09, P175, DOI DOI 10.1017/dmp.2015.4; Bair MJ, 2008, PSYCHOSOM MED, V70, P890, DOI 10.1097/PSY.0b013e318185c510; Bruce Travis O, 2008, Curr Psychiatry Rep, V10, P258, DOI 10.1007/s11920-008-0042-1; Christmas C, 2002, COMMON IS HIP PAIN O, V51, P346; Clohisy JC, 2013, AM J SPORT MED, V41, P1348, DOI 10.1177/0363546513488861; Creamer P, 2000, RHEUMATOLOGY, V39, P490, DOI 10.1093/rheumatology/39.5.490; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; EJKIOPF, 2011, IMP AG ELD HLTH CAR; Hawker GA, 2008, OSTEOARTHR CARTILAGE, V16, P415, DOI 10.1016/j.joca.2007.12.017; Health MO, 2013, KCFDC PREV KOR HLTH; HopmanRock M, 1997, QUAL LIFE RES, V6, P67; Huang HC, 2003, PUBLIC HEALTH NURS, V20, P399, DOI 10.1046/j.1525-1446.2003.20508.x; Hurley MV, 2003, EXERC SPORT SCI REV, V31, P138, DOI 10.1097/00003677-200307000-00007; Hyejin Park，, 2012, [KOREAN JOURNAL OF HEALTH EDUCATION AND PROMOTION, 보건교육건강증진학회지], V29, P23; Jakobsson U, 2006, J GERONTOL NURS, V32, P51, DOI 10.3928/00989134-20060801-08; Jinks C, 2002, PAIN, V100, P55, DOI 10.1016/S0304-3959(02)00239-7; Juhakoski R, 2009, RHEUMATOLOGY, V48, P83, DOI 10.1093/rheumatology/ken427; 주영주, 2012, [The Journal of Muscle and Joint Health, 근관절건강학회지], V19, P161, DOI 10.5953/JMJH.2012.19.2.161; Kim Minju, 2014, [The Journal of Muscle and Joint Health, 근관절건강학회지], V21, P195, DOI 10.5953/JMJH.2014.21.3.195; Lee E-J, 2016, KOREAN J FAMILY PRAC, V6, P111; Lee Eunkyeong, 2011, IMPACT AGING ELDERLY; Lee Jae Ho, 2004, Korean Journal of Family Medicine, V25, P380; 전형준, 2010, Anesthesia and Pain Medicine, V5, P201; Lim Nan-Young, 2010, [The Journal of Muscle and Joint Health, 근관절건강학회지], V17, P203; Noble RE, 2005, METABOLISM, V54, P49, DOI 10.1016/j.metabol.2005.01.014; Price MD, 2009, MENOPAUSE, V16, P624, DOI 10.1097/gme.0b013e3181a5c9e6; Riddle DL, 2011, OSTEOARTHR CARTILAGE, V19, P1095, DOI 10.1016/j.joca.2011.06.003; Salaffi F, 2005, AGING CLIN EXP RES, V17, P255; Son Jungtae, 2014, [Journal of the Korea Gerontological Society, 한국노년학], V34, P23; Stubbs B, 2016, AGE AGEING, V45, P228, DOI 10.1093/ageing/afw001; Vennu V, 2014, CLIN INTERV AGING, V9, P793, DOI 10.2147/CIA.S62207; Yang S. J., 2011, J NURSING SCI, V23, P23; 전은영, 2015, [Journal of the Korean Data And Information Science Sociaty, 한국데이터정보과학회지], V26, P1453, DOI 10.7465/jkdi.2015.26.6.1453; 김혜정, 2014, [Journal of Korea Entertainment Industry Association, 한국엔터테인먼트산업학회논문지], V8, P223; 김숙영, 2011, [The Korean Journal of Rehabilitation Nursing, 재활간호학회지], V14, P111; 이윤정, 2011, [Journal of the Korea Gerontological Society, 한국노년학], V31, P211	38	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242077	10.1371/journal.pone.0242077	http://dx.doi.org/10.1371/journal.pone.0242077			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0MJ	33180888	Green Published, gold			2022-12-26	WOS:000593948000083
J	Mohapatra, S; Nath, P; Chatterjee, M; Das, N; Kalita, D; Roy, P; Satapathi, S				Mohapatra, Sovesh; Nath, Prathul; Chatterjee, Manisha; Das, Neeladrisingha; Kalita, Deepjyoti; Roy, Partha; Satapathi, Soumitra			Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking	PLOS ONE			English	Article								Background The outbreak of the novel coronavirus disease COVID-19, caused by the SARS-CoV-2 virus has spread rapidly around the globe during the past 3 months. As the virus infected cases and mortality rate of this disease is increasing exponentially, scientists and researchers all over the world are relentlessly working to understand this new virus along with possible treatment regimens by discovering active therapeutic agents and vaccines. So, there is an urgent requirement of new and effective medications that can treat the disease caused by SARS-CoV-2. Methods and findings We perform the study of drugs that are already available in the market and being used for other diseases to accelerate clinical recovery, in other words repurposing of existing drugs. The vast complexity in drug design and protocols regarding clinical trials often prohibit developing various new drug combinations for this epidemic disease in a limited time. Recently, remarkable improvements in computational power coupled with advancements in Machine Learning (ML) technology have been utilized to revolutionize the drug development process. Consequently, a detailed study using ML for the repurposing of therapeutic agents is urgently required. Here, we report the ML model based on the Naive Bayes algorithm, which has an accuracy of around 73% to predict the drugs that could be used for the treatment of COVID-19. Our study predicts around ten FDA approved commercial drugs that can be used for repurposing. Among all, we found that 3 of the drugs fulfils the criterions well among which the antiretroviral drug Amprenavir (DrugBank ID-DB00701) would probably be the most effective drug based on the selected criterions. Conclusions Our study can help clinical scientists in being more selective in identifying and testing the therapeutic agents for COVID-19 treatment. The ML based approach for drug discovery as reported here can be a futuristic smart drug designing strategy for community applications.	[Mohapatra, Sovesh; Nath, Prathul; Satapathi, Soumitra] Indian Inst Technol, Dept Phys, Haridwar, Uttarakhand, India; [Chatterjee, Manisha] Subharti Med Coll, Dept Pharmacol, Meerut, Uttar Pradesh, India; [Das, Neeladrisingha; Roy, Partha] Indian Inst Technol, Dept Biotechnol, Roorkee, Uttarakhand, India; [Kalita, Deepjyoti] All India Inst Med Sci, Dept Microbiol, Rishikesh, Uttarakhand, India; [Satapathi, Soumitra] Indian Inst Technol, Ctr Nanotechnol, Roorkee, Uttarakhand, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; All India Institute of Medical Sciences (AIIMS) Rishikesh; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	Satapathi, S (corresponding author), Indian Inst Technol, Dept Phys, Haridwar, Uttarakhand, India.; Chatterjee, M (corresponding author), Subharti Med Coll, Dept Pharmacol, Meerut, Uttar Pradesh, India.; Satapathi, S (corresponding author), Indian Inst Technol, Ctr Nanotechnol, Roorkee, Uttarakhand, India.	ssphf.fph@iitr.ac.in; manishachaterjee1988@gmail.com	Das, Neeladrisingha/GSI-6798-2022; DAS, NEELADRISINGHA/ABD-4830-2021; Satapathi, Soumitra/Q-9035-2019	DAS, NEELADRISINGHA/0000-0001-5394-0432; Satapathi, Soumitra/0000-0001-9218-3796; Nath, Prathul/0000-0001-5976-4812; Mohapatra, Sovesh/0000-0002-5371-7596	Ministry of Information Science and Technology, Government of India	Ministry of Information Science and Technology, Government of India	Ministry of Information Science and Technology, Government of India.	[Anonymous], 2013, EUR J MED CHEM; [Anonymous], 2020, BIORXIV, DOI 10.1101/2020.04.04.020925; Armstrong GL, 2019, NEW ENGL J MED, V381, P2569, DOI 10.1056/NEJMsr1813907; Arshad U., MEDRXIV, DOI [10.1101/2020.04.16.20068379, DOI 10.1101/2020.04.16.20068379]; Beck BR, 2020, COMPUT STRUCT BIOTEC, V18, P784, DOI 10.1016/j.csbj.2020.03.025; Browne MW, 2000, J MATH PSYCHOL, V44, P108, DOI 10.1006/jmps.1999.1279; Carlos WG, 2020, AM J RESP CRIT CARE, V201, pP7, DOI 10.1164/rccm.2014P7; Cheng TJ, 2012, AAPS J, V14, P133, DOI 10.1208/s12248-012-9322-0; Colson P, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105932; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Ekins S, 2020, DRUG DISCOV TODAY, V25, P928, DOI 10.1016/j.drudis.2020.03.019; Ezat Ahmed A., 2019, VirusDisease, V30, P207, DOI 10.1007/s13337-019-00516-7; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Hop P, 2018, MOL PHARMACEUT, V15, P4371, DOI 10.1021/acs.molpharmaceut.7b01144; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang R, 2020, LANCET INFECT DIS, V20, P534, DOI 10.1016/S1473-3099(20)30147-X; Liu GS, 2019, BIOMED ENVIRON SCI, V32, P438, DOI 10.3967/bes2019.058; Lowe R, 2010, MOL PHARMACEUT, V7, P1708, DOI 10.1021/mp100103e; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Markland W, 2000, ANTIMICROB AGENTS CH, V44, P859, DOI 10.1128/AAC.44.4.859-866.2000; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Masnadi-Shirazi H, 2011, IEEE T PATTERN ANAL, V33, P294, DOI 10.1109/TPAMI.2010.71; Melville JL, 2009, COMB CHEM HIGH T SCR, V12, P332, DOI 10.2174/138620709788167980; MITCHELL T, 1989, ANNU REV COMPUT SCI, V4, P417; Ng A., 2012, MACH LEARN, DOI [10.1111/j.1466-8238.2009.00506.x, DOI 10.1111/J.1466-8238.2009.00506.X]; Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757; Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126; Ross K.A., 2009, ENCYCL DATABASE SYST, P532, DOI [DOI 10.1007/978-0-387-39940-9_565, 10.1007/978-0-387-39940-9]; Schierz AC, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-21; Sen P, 2008, DATA MIN KNOWL DISC, V17, P136, DOI 10.1007/s10618-008-0090-5; She J, 2020, CLIN TRANSL MED, V9, DOI 10.1186/s40169-020-00271-z; Sun YM, 2007, PATTERN RECOGN, V40, P3358, DOI 10.1016/j.patcog.2007.04.009; Tang B, 2020, INFECT DIS MODEL, V5, P248, DOI 10.1016/j.idm.2020.02.001; Thai-Nghe N., 2010, 2010 INT JOINT C NEU, P1, DOI DOI 10.1109/IJCNN.2010.5596486; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Wang JL, 2014, IEEE T KNOWL DATA EN, V26, P2425, DOI 10.1109/TKDE.2013.157; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Yang PL, 2011, CURR OPIN VIROL, V1, P607, DOI 10.1016/j.coviro.2011.10.019; Zhou P, 2020, DISCOVERY NOVEL CORO, DOI [10.1038/s41586-020-2012-7, 10.1101/2020.01.22.914952, DOI 10.1101/2020.01.22.914952]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	46	29	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241543	10.1371/journal.pone.0241543	http://dx.doi.org/10.1371/journal.pone.0241543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180803	Green Submitted, Green Published, gold			2022-12-26	WOS:000593948000086
J	Moser, A; Carlander, M; Wieser, S; Hammig, O; Puhan, MA; Hoglinger, M				Moser, Andre; Carlander, Maria; Wieser, Simon; Hammig, Oliver; Puhan, Milo A.; Hoglinger, Marc			The COVID-19 Social Monitor longitudinal online panel: Real-time monitoring of social and public health consequences of the COVID-19 emergency in Switzerland	PLOS ONE			English	Article								Background The COVID-19 pandemic challenges societies in unknown ways, and individuals experience a substantial change in their daily lives and activities. Our study aims to describe these changes using population-based self-reported data about social and health behavior in a random sample of the Swiss population during the COVID-19 pandemic. The aim of the present article is two-fold: First, we want to describe the study methodology. Second, we want to report participant characteristics and study findings of the first survey wave to provide some baseline results for our study. Methods Our study design is a longitudinal online panel of a random sample of the Swiss population. We measure outcome indicators covering general well-being, physical and mental health, social support, healthcare use and working state over multiple survey waves. Results From 8,174 contacted individuals, 2,026 individuals participated in the first survey wave which corresponds to a response rate of 24.8%. Most survey participants reported a good to very good general life satisfaction (93.3%). 41.4% of the participants reported a worsened quality of life compared to before the COVID-19 emergency and 9.8% feelings of loneliness. Discussion The COVID-19 Social Monitor is a population-based online survey which informs the public, health authorities, and the scientific community about relevant aspects and potential changes in social and health behavior during the COVID-19 emergency and beyond. Future research will follow up on the described study population focusing on COVID-19 relevant topics such as subgroup differences in the impact of the pandemic on well-being and quality of life or different dynamics of perceived psychological distress.	[Moser, Andre; Hammig, Oliver; Puhan, Milo A.] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Carlander, Maria; Wieser, Simon; Hoglinger, Marc] Zurich Univ Appl Sci, Winterthur Inst Hlth Econ, Winterthur, Switzerland	University of Zurich; Zurich University of Applied Sciences	Moser, A (corresponding author), Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland.	andre.moser@uzh.ch	Puhan, Milo/ABE-6298-2020; Wieser, Simon/AAC-1589-2022	Puhan, Milo/0000-0003-4721-1879; Carlander, Maria/0000-0001-8827-0133; Hoglinger, Marc/0000-0003-2743-2199; Moser, Andre/0000-0001-7178-6539				Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Dell NA, 2020, J GERONTOL SOC WORK, V63, P659, DOI 10.1080/01634372.2020.1765064; Downes M, 2018, AM J EPIDEMIOL, V187, P1780, DOI 10.1093/aje/kwy070; Elran-Barak R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17155403; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Gelman A, 2007, STAT SCI, V22, P153, DOI 10.1214/088342306000000691; Kawohl W, 2020, LANCET PSYCHIAT, V7, P389, DOI 10.1016/S2215-0366(20)30141-3; Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009; Palmer K, 2020, AGING CLIN EXP RES, V32, P1189, DOI 10.1007/s40520-020-01601-4; R Team Core, 2020, R LANG ENV STAT COMP; Sher L, 2020, QJM-INT J MED, V113, P707, DOI 10.1093/qjmed/hcaa202; Tillmann R, 2018, SOCIAL DYNAMICS SWIS, DOI [10.1007/978-3-319-89557-4, DOI 10.1007/978-3-319-89557-4]; Vasileios N, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20284; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Ward H., 2020, PERCEPTIONS BEHAV RE, DOI 10.1101/2020.04.01.20050039; Wasserman D, 2020, WORLD PSYCHIATRY, V19, P294, DOI 10.1002/wps.20801; Wu B, 2020, GLOB HEALTH RES POL, V5, DOI 10.1186/s41256-020-00154-3	17	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242129	10.1371/journal.pone.0242129	http://dx.doi.org/10.1371/journal.pone.0242129			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175906	gold, Green Published			2022-12-26	WOS:000593946900060
J	Hortobagyi, D; Grossmann, T; Tschernitz, M; Grill, M; Kirsch, A; Gerstenberger, C; Gugatschka, M				Hortobagyi, David; Grossmann, Tanja; Tschernitz, Magdalena; Grill, Magdalena; Kirsch, Andrijana; Gerstenberger, Claus; Gugatschka, Markus			In vitro mechanical vibration down-regulates pro-inflammatory and pro-fibrotic signaling in human vocal fold fibroblasts	PLOS ONE			English	Article							BETA TGF-BETA; GROWTH-FACTOR; GENE-EXPRESSION; VOICE REST; PHONATION; FIBROSIS; TIME; FIBRONECTIN; VALIDATION; BIOREACTOR	Introduction Voice rest following phonotrauma or phonosurgery has a considerable clinical impact, but clinical recommendations are inconsistent due to inconclusive data. As biopsies of the vocal folds (VF) for molecular biology studies in humans are unethical, we established a new in vitro model to explore the effects of vibration on human vocal fold fibroblasts (hVFF) in an inflammatory and normal state, which is based on previously published models. Methods By using a phonomimetic bioreactor we were able to apply predefined vibrational stress patterns on hVFF cultured under inflammatory or normal conditions. Inflammatory and profibrotic stimuli were induced by interleukin (IL)1 beta and transforming growth factor (TGF)beta 1, respectively. Mechanical stimulation was applied four hours daily, over a period of 72 hours. Outcome measurements comprised assessment of extracellular matrix (ECM)-related components, angiogenic factors, and inflammatory and fibrogenic markers on gene expression and protein levels. Results Under inflammatory conditions, the inflammatory cytokine IL11, as well as the myofibroblast marker alpha smooth muscle actin (alpha-SMA) were significantly reduced when additional vibration was applied. The desirable anti-fibrotic ECM component hyaluronic acid was increased following cytokine treatment, but was not diminished following vibration. Conclusion Our experiments revealed the effect of vibrational stress on hVFF in an inflammatory state. Elevated levels of certain pro-inflammatory/pro-fibrotic factors could be mitigated by additional vibrational excitation in an in vitro setting. These findings corroborate clinical studies which recommend early voice activation following an acute event.	[Hortobagyi, David; Grossmann, Tanja; Tschernitz, Magdalena; Grill, Magdalena; Kirsch, Andrijana; Gerstenberger, Claus; Gugatschka, Markus] Med Univ Graz, Div Phoniatr, Graz, Austria	Medical University of Graz	Hortobagyi, D (corresponding author), Med Univ Graz, Div Phoniatr, Graz, Austria.	david.hortobagyi@medunigraz.at	Grill, Magdalena/J-2614-2013	Grill, Magdalena/0000-0002-4733-5815; Grossmann, Tanja/0000-0001-5219-2428; Kirsch, Andrijana/0000-0002-6623-0234; Hortobagyi, David/0000-0001-8132-0855				Abbott KV, 2012, J VOICE, V26, DOI 10.1016/j.jvoice.2012.03.008; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Becirovic M, 2019, ABSOLUTE RELATIVE VO, DOI [10.1055/s-0039-1686602, DOI 10.1055/S-0039-1686602]; Berse B, 1999, CLIN EXP IMMUNOL, V115, P176; Branco A, 2016, LARYNGOSCOPE, V126, pE110, DOI 10.1002/lary.25581; Branski RC, 2005, J VOICE, V19, P283, DOI 10.1016/j.jvoice.2004.04.003; Branski RC, 2007, J VOICE, V21, P651, DOI 10.1016/j.jvoice.2006.06.005; Branski RC, 2010, LARYNGOSCOPE, V120, P1826, DOI 10.1002/lary.21017; Chan A, 2013, J ACOUST SOC AM, V133, P1667, DOI 10.1121/1.4789937; Chen HY, 2020, EXP MOL MED, V52, P130, DOI 10.1038/s12276-019-0371-7; Cheuy VA, 2017, J ARTHROPLASTY, V32, P2604, DOI 10.1016/j.arth.2017.02.005; Cho SH, 2000, ANN OTO RHINOL LARYN, V109, P658; Dhaliwal SS, 2020, LARYNGOSCOPE, V130, P1750, DOI 10.1002/lary.28287; Dheda K, 2004, BIOTECHNIQUES, V37, P112, DOI 10.2144/04371RR03; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Farran AJE, 2013, J TISSUE ENG REGEN M, V7, P213, DOI 10.1002/term.514; Foote AG, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5682-5; Gaston Joel, 2013, Biomatter, V3, DOI 10.4161/biom.23799; Gaston J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030965; Graupp M, 2018, EUR ARCH OTO-RHINO-L, V275, P1211, DOI 10.1007/s00405-018-4922-7; Graupp M, 2015, LARYNGOSCOPE, V125, pE203, DOI 10.1002/lary.25103; Grossmann T, 2021, LARYNGOSCOPE, V131, pE547, DOI 10.1002/lary.28855; Guerra ML, 2015, CLIN REHABIL, V29, P844, DOI 10.1177/0269215514558641; Gugatschka M, 2019, MOL CELL PROTEOMICS, V18, P1511, DOI 10.1074/mcp.RA119.001272; Hansen JK, 2006, J VOICE, V20, P110, DOI 10.1016/j.jvoice.2004.12.005; Hirschi SD, 2002, J VOICE, V16, P310, DOI 10.1016/S0892-1997(02)00102-9; Ishikawa K, 2010, J VOICE, V24, P379, DOI 10.1016/j.jvoice.2008.10.011; Jette ME, 2013, LARYNGOSCOPE, V123, P738, DOI 10.1002/lary.23681; Joshi A, 2018, LARYNGOSCOPE, V128, P1170, DOI 10.1002/lary.26979; Judd LM, 2009, J PATHOL, V217, P552, DOI 10.1002/path.2479; Kaneko M, 2017, CURR OPIN OTOLARYNGO, V25, P459, DOI 10.1097/MOO.0000000000000407; Kaneko M, 2017, J VOICE, V31, P97, DOI 10.1016/j.jvoice.2016.02.009; Karbiener M, 2017, J PROTEOMICS, V155, P11, DOI 10.1016/j.jprot.2017.01.010; Kido S, 2009, BONE, V45, P1125, DOI 10.1016/j.bone.2009.07.087; Kim D, 2018, LARYNGOSCOPE, V128, pE258, DOI 10.1002/lary.27113; King SN, 2013, CYTOKINE, V61, P228, DOI 10.1016/j.cyto.2012.09.023; Kirsch A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213788; Kishimoto Y, 2019, MOL THER-NUCL ACIDS, V16, P616, DOI 10.1016/j.omtn.2019.04.014; Kishimoto Y, 2016, LAB INVEST, V96, P807, DOI 10.1038/labinvest.2016.43; Kojima T, 2014, LARYNGOSCOPE, V124, P2770, DOI 10.1002/lary.24827; Krishna P, 2010, LARYNGOSCOPE, V120, P2247, DOI 10.1002/lary.21087; Latifi N, 2016, TISSUE ENG PART C-ME, V22, P823, DOI 10.1089/ten.tec.2016.0053; Lenselink EA, 2015, INT WOUND J, V12, P313, DOI 10.1111/iwj.12109; Li-Jessen NYK, 2017, LARYNGOSCOPE, V127, pE193, DOI 10.1002/lary.26333; Lichtman MK, 2016, WOUND REPAIR REGEN, V24, P215, DOI 10.1111/wrr.12398; Lim XH, 2008, ANN OTO RHINOL LARYN, V117, P227, DOI 10.1177/000348940811700311; Lim XH, 2006, ANN OTO RHINOL LARYN, V115, P921, DOI 10.1177/000348940611501212; Ling CY, 2010, WOUND REPAIR REGEN, V18, P89, DOI 10.1111/j.1524-475X.2009.00550.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ng B, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw1237; Ogawa M, 2018, AURIS NASUS LARYNX, V45, P661, DOI 10.1016/j.anl.2017.08.003; Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011; Rihkanen H, 2019, EUR ARCH OTO-RHINO-L, V276, P483, DOI 10.1007/s00405-019-05283-1; Rousseau B, 2008, OTOLARYNG HEAD NECK, V138, P62, DOI 10.1016/j.otohns.2007.10.024; Rousseau B, 2017, CELLS TISSUES ORGANS, V204, P93, DOI 10.1159/000472251; Schafer S, 2017, NATURE, V552, P110, DOI 10.1038/nature24676; Shi ZD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012196; Tang SS, 2017, J VOICE, V31, P520, DOI 10.1016/j.jvoice.2017.01.008; Tang SS, 2017, J VOICE, V31, DOI 10.1016/j.jvoice.2015.12.005; Tateya I, 2016, CLIN EXP OTORHINOLAR, V9, P56, DOI 10.21053/ceo.2016.9.1.56; Tateya I, 2015, J VOICE, V29, P133, DOI 10.1016/j.jvoice.2014.07.021; Titze IR, 2007, J ACOUST SOC AM, V121, P469, DOI 10.1121/1.2390676; Titze IR, 2004, J BIOMECH, V37, P1521, DOI 10.1016/j.jbiomech.2004.01.007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verdolini K, 2003, ANN OTO RHINOL LARYN, V112, P1021, DOI 10.1177/000348940311201205; Wang XT, 2010, BIOMATERIALS, V31, P2542, DOI 10.1016/j.biomaterials.2009.12.018; Welham NV, 2008, ANN OTO RHINOL LARYN, V117, P145, DOI 10.1177/000348940811700213; White A, 2019, CURR OPIN OTOLARYNGO, V27, P185, DOI 10.1097/MOO.0000000000000536; Whitling S, 2018, LOGOP PHONIATR VOCO, V43, P143, DOI 10.1080/14015439.2018.1504985; Xiao L, 2012, FRONT BIOSCI-LANDMRK, V17, P2667, DOI 10.2741/4077; Yakkanti RR, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.02.02; Zhang HY, 2015, J VOICE, V29, DOI 10.1016/j.jvoice.2014.06.001; Zhang X, 2015, ONCOTARGET, V6	73	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0241901	10.1371/journal.pone.0241901	http://dx.doi.org/10.1371/journal.pone.0241901			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211714	Green Published, gold			2022-12-26	WOS:000603518300026
J	Imbir, KK; Pastwa, M; Jankowska, M; Kosman, M; Modzelewska, A; Wielgopolan, A				Imbir, Kamil K.; Pastwa, Maciej; Jankowska, Marta; Kosman, Marcin; Modzelewska, Aleksandra; Wielgopolan, Adrianna			Valence and arousal of words in visual and conceptual interference control efficiency	PLOS ONE			English	Article							COGNITIVE CONTROL; EXECUTIVE FUNCTIONS; EMOTIONAL WORDS; STROOP; CONFLICT; FLANKER; ATTENTION; RESPONSES; ERP; INHIBITION	Cognitive control efficiency is susceptible to the emotional state of an individual. The aim of the current experiment was to search for the role of valence and arousal of emotion-laden words in a performance efficiency of a modified emotional Stroop task (EST) combined with the flanker task. Both paradigms allow for the measurement of the interference control, but interference appears on different stages of stimulus processing. In the flanker task, the interference is perceptual, while in EST, it is based on the emotional meaning of stimuli. We expected to find the effects of emotionality of words, that is, arousal and valence levels, for interference measured with EST. In a series of two experiments, the results confirmed that a high arousal level enlarges the reaction latencies to the EST. We also identified interaction between valence and arousal in shaping reaction latencies. We found the flanker congruency effect. We did not find interactions between emotional factors and flanker congruency. This suggests that interference measured with the EST and flanker task are in fact different from one another, and while using the modified EST combined with the flanker task, the word-meaning effects do not interfere with pure perceptual interferences.	[Imbir, Kamil K.; Pastwa, Maciej; Jankowska, Marta; Modzelewska, Aleksandra; Wielgopolan, Adrianna] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Kosman, Marcin] Fac Polish Studies, Inst Appl Polish Studies, Warsaw, Poland	University of Warsaw; University of Warsaw	Imbir, KK (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	kimbir@psych.uw.edu.pl		Imbir, Kamil/0000-0002-3630-5602; Modzelewska, Aleksandra/0000-0002-9690-9512; Kosman, Marcin/0000-0003-1811-9723	National Science Center [2017/25/B/HS6/00198]	National Science Center(National Science Centre, Poland)	KI, 2017/25/B/HS6/00198, National Science Center, https://www.ncn.gov.pl/, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashley V, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-14; Ben-Haim MS, 2016, JOVE-J VIS EXP, DOI 10.3791/53720; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Bruyneel L, 2013, PSYCHOL RES-PSYCH FO, V77, P320, DOI 10.1007/s00426-012-0432-1; Bugg JM, 2008, MEM COGNITION, V36, P1484, DOI 10.3758/MC.36.8.1484; Chajut E, 2010, J EXP PSYCHOL LEARN, V36, P1567, DOI 10.1037/a0020710; Cohen N, 2016, COGNITION EMOTION, V30, P325, DOI 10.1080/02699931.2014.1000830; Cohen N, 2012, EMOTION, V12, P970, DOI 10.1037/a0026890; Costanzi Marco, 2019, Front Psychol, V10, P2587, DOI 10.3389/fpsyg.2019.02587; Demanet J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00336; Ding JF, 2016, COGN AFFECT BEHAV NE, V16, P433, DOI 10.3758/s13415-016-0403-x; Dresler T, 2009, PSYCHOL RES-PSYCH FO, V73, P364, DOI 10.1007/s00426-008-0154-6; Epstein S., 2003, HDB PSYCHOL, V5, P159, DOI DOI 10.1002/0471264385.WEI0507; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V26, P195, DOI 10.3758/BF03199869; Fackrell K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080141; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fenske MJ, 2003, EMOTION, V3, P327, DOI 10.1037/1528-3542.3.4.327; Feroz FS, 2017, BRAIN TOPOGR, V30, P30, DOI 10.1007/s10548-016-0521-3; Finkenzeller T, 2019, J SPORT EXERCISE PSY, V41, P206, DOI 10.1123/jsep.2018-0239; Finucane AM, 2010, J ATTEN DISORD, V13, P629, DOI 10.1177/1087054709334514; Gable PA, 2012, BIOL PSYCHOL, V90, P150, DOI 10.1016/j.biopsycho.2012.02.006; Gratton G, 2018, PSYCHOPHYSIOLOGY, V55, DOI 10.1111/psyp.13016; Horstmann G, 2006, PSYCHON B REV, V13, P1067, DOI 10.3758/BF03213927; Imbir K.K., 2013, POLISH PSYCHOL B, V44, P137, DOI [https://doi.org/10.2478/ppb-2013-0016, DOI 10.2478/PPB-2013-0016, 10.2478/ppb-2013-0016]; Imbir KK, 2018, CURR PSYCHOL, V37, P716, DOI 10.1007/s12144-016-9553-9; Imbir KK, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00880; Imbir KK, 2017, CURR PSYCHOL, V36, P157, DOI 10.1007/s12144-015-9396-9; Imbir KK, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01081; Imbir KK, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00075; Jefferies LN, 2008, PSYCHOL SCI, V19, P290, DOI 10.1111/j.1467-9280.2008.02082.x; Kanske P, 2012, BIOL PSYCHOL, V91, P88, DOI 10.1016/j.biopsycho.2012.04.007; Kanske P, 2011, BEHAV BRAIN RES, V219, P382, DOI 10.1016/j.bbr.2011.01.043; Kanske P, 2011, BIOL PSYCHOL, V87, P122, DOI 10.1016/j.biopsycho.2011.02.018; Kanske P, 2011, HUM BRAIN MAPP, V32, P198, DOI 10.1002/hbm.21012; Kuhbandner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029287; Kuppens P, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00380; Lang PJ, 1997, A8 CTR RES PSYCH U F; Lang PJ, 1993, LOOKING PICTURES AFF; Levy-Drori S, 2006, AM J PSYCHOL, V119, P45, DOI 10.2307/20445318; Li Q, 2014, J NEUROSCI, V34, P4382, DOI 10.1523/JNEUROSCI.1820-13.2014; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; MARKELALERENC J, 2004, COGNITIVE BRAIN RES, V18, P278, DOI DOI 10.1016/J.C0GBRAINRES.2003.10.013; Mather M, 2008, J MEM LANG, V58, P449, DOI 10.1016/j.jml.2007.01.004; Melcher T, 2012, ACTA PSYCHOL, V139, P507, DOI 10.1016/j.actpsy.2012.01.012; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Monsell S, 2001, MEM COGNITION, V29, P137, DOI 10.3758/BF03195748; Moors A, 2013, BEHAV RES METHODS, V45, P169, DOI 10.3758/s13428-012-0243-8; Nealis LJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147275; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Osgood C.E., 1957, MEASUREMENT MEANING; Pratto F., 1994, CONSCIOUSNESS AUTOMA, P115; Rowe G, 2007, P NATL ACAD SCI USA, V104, P383, DOI 10.1073/pnas.0605198104; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Russell JA, 1999, CORE AFFECT PROTOTYP, P76; Schimmack U, 2005, EMOTION, V5, P55, DOI 10.1037/1528-3542.5.1.55; Sharma D, 2001, BRIT J PSYCHOL, V92, P471, DOI 10.1348/000712601162293; Straub E, 2020, COGNITION EMOTION, V34, P807, DOI 10.1080/02699931.2019.1666799; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tillman CM, 2011, PSYCHOPHYSIOLOGY, V48, P1405, DOI 10.1111/j.1469-8986.2011.01203.x; van Hooff JC, 2008, INT J PSYCHOPHYSIOL, V67, P23, DOI 10.1016/j.ijpsycho.2007.09.002; van Steenbergen H, 2014, MOTIV EMOTION, V38, P444, DOI 10.1007/s11031-013-9380-3; van Steenbergen H, 2010, PSYCHOL SCI, V21, P1629, DOI 10.1177/0956797610385951; Vanlessen N, 2013, COGN AFFECT BEHAV NE, V13, P60, DOI 10.3758/s13415-012-0130-x; Verbruggen F, 2004, ACTA PSYCHOL, V116, P21, DOI 10.1016/j.actpsy.2003.12.011; West WC, 2000, J COGNITIVE NEUROSCI, V12, P1024, DOI 10.1162/08989290051137558; Zeng QH, 2017, COGNITION EMOTION, V31, P1083, DOI 10.1080/02699931.2016.1189882; Zetsche U, 2011, J BEHAV THER EXP PSY, V42, P65, DOI 10.1016/j.jbtep.2010.06.001	70	3	3	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0241694	10.1371/journal.pone.0241694	http://dx.doi.org/10.1371/journal.pone.0241694			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM0RU	33211720	gold, Green Published			2022-12-26	WOS:000603518300021
J	O'Connor, EB; Munoz-Wolf, N; Leon, G; Lavelle, EC; Mills, KHG; Walsh, PT; Porterid, RK				O'Connor, Emma B.; Munoz-Wolf, Natalia; Leon, Gemma; Lavelle, Ed C.; Mills, Kingston H. G.; Walsh, Patrick T.; Porterid, Richard K.			UCP3 reciprocally controls CD4+Th17 and Treg cell differentiation	PLOS ONE			English	Article							MITOCHONDRIAL UNCOUPLING PROTEIN-3; FATTY-ACID OXIDATION; SKELETAL-MUSCLE; CHOLERA-TOXIN; EXPRESSION; INTERLEUKIN-2; IL-2; INDUCTION; IMMUNITY; HOMOLOG	Uncoupling proteins (UCPs) are members of the mitochondrial anion carrier superfamily that can mediate the transfer of protons into the mitochondrial matrix from the intermembrane space. We have previously reported UCP3 expression in thymocytes, mitochondria of total splenocytes and splenic lymphocytes. Here, we demonstrate that Ucp3 is expressed in peripheral naive CD4(+) T cells at the mRNA level before being markedly downregulated following activation. Non-polarized, activated T cells (Th0 cells) from Ucp3(-/-) mice produced significantly more IL-2, had increased expression of CD25 and CD69 and were more proliferative than Ucp3(+/+) Th0 cells. The altered IL-2 expression observed between T cells from Ucp3(+/+) and Ucp3(-/-) mice may be a factor in determining differentiation into Th17 or induced regulatory (iTreg) cells. When compared to Ucp3(+/+), CD4(+) T cells from Ucp3(-/-) mice had increased FoxP3 expression under iTreg conditions. Conversely, Ucp3(-/-) CD4(+) T cells produced a significantly lower concentration of IL-17A under Th17 cell-inducing conditions in vitro. These effects were mirrored in antigen-specific T cells from mice immunized with KLH and CT. Interestingly, the altered responses of Ucp3(-/-) T cells were partially reversed upon neutralisation of IL-2. Together, these data indicate that UCP3 acts to restrict the activation of naive T cells, acting as a rheostat to dampen signals following TCR and CD28 co-receptor ligation, thereby limiting early activation responses. The observation that Ucp3 ablation alters the Th17:Treg cell balance in vivo as well as in vitro suggests that UCP3 is a potential target for the treatment of Th17 cell-mediated autoimmune diseases.	[O'Connor, Emma B.; Munoz-Wolf, Natalia; Lavelle, Ed C.; Mills, Kingston H. G.; Porterid, Richard K.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland; [Leon, Gemma; Walsh, Patrick T.] Trinity Coll Dublin, Sch Med, Dept Clin Med, Dublin 2, Ireland; [Leon, Gemma; Walsh, Patrick T.] Our Ladys Childrens Hosp, Natl Childrens Res Ctr, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; National Children's Research Centre (NCRC); Our Ladys Children Hospital Crumlin; Trinity College Dublin	Porterid, RK (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland.	rkporter@tcd.ie	Muñoz-Wolf, Natalia/AAQ-1677-2021; Porter, Richard/HGF-0546-2022; Mills, Kingston H/F-5684-2013	Muñoz-Wolf, Natalia/0000-0002-5173-4026; Mills, Kingston H/0000-0003-3646-8222; Leon, Gemma/0000-0002-3903-9389; Walsh, Patrick/0000-0002-0130-8766; Porter, Richard/0000-0001-9854-5161	John Scott Fellowship; School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland	John Scott Fellowship; School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland	This work was funded only by the John Scott Fellowship to EO'C, RKP and PTW from the School of Medicine, Trinity Biomedical Sciences Institute, Trinity College Dublin, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo L, 2017, ELIFE, V6, DOI 10.7554/eLife.21330; Azzu V, 2010, BIOCHEM J, V426, P13, DOI 10.1042/BJ20091321; Boss O, 1998, EUR J ENDOCRINOL, V139, P1, DOI 10.1530/eje.0.1390001; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Carroll AM, 2004, BBA-PROTEINS PROTEOM, V1700, P145, DOI 10.1016/j.bbapap.2004.05.008; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; Cunningham O, 2003, BBA-BIOENERGETICS, V1604, P170, DOI 10.1016/S0005-2728(03)00057-4; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gimeno RE, 1997, DIABETES, V46, P900, DOI 10.2337/diabetes.46.5.900; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; Gregori S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00030; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; Hilse KE, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00747; Hilse KE, 2016, BBA-BIOENERGETICS, V1857, P72, DOI 10.1016/j.bbabio.2015.10.011; Himms-Hagen J, 2001, EXP BIOL MED, V226, P78, DOI 10.1177/153537020122600204; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kang JO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157015; Kang Y, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004651, 10.1371/journal.pone.0004275]; Kelly OM, 2012, MITOCHONDRION, V12, P110, DOI 10.1016/j.mito.2011.03.011; Kelly OM, 2011, BBA-BIOENERGETICS, V1807, P1064, DOI 10.1016/j.bbabio.2011.06.002; Krauss S, 2005, NAT REV MOL CELL BIO, V6, P248, DOI 10.1038/nrm1592; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lavelle EC, 2003, J IMMUNOL, V171, P2384, DOI 10.4049/jimmunol.171.5.2384; Lavelle EC, 2004, J LEUKOCYTE BIOL, V75, P756, DOI 10.1189/jlb.1103534; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; Mills Kingston H. G., 1996, P197; Nedergaard J, 2001, BBA-BIOENERGETICS, V1504, P82, DOI 10.1016/S0005-2728(00)00247-4; Pecqueur C, 2008, FASEB J, V22, P9, DOI 10.1096/fj.07-8945com; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Russell SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047748; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schrauwen P, 2006, PROG LIPID RES, V45, P17, DOI 10.1016/j.plipres.2005.11.001; Stockinger B, 2007, IMMUNITY, V26, P278, DOI 10.1016/j.immuni.2007.03.001; Tsai HC, 2015, CRIT REV IMMUNOL, V35, P135, DOI 10.1615/CritRevImmunol.2015012295; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Yarosz EL, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e14; Yu XX, 2000, FASEB J, V14, P1611, DOI 10.1096/fj.14.11.1611	42	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0239713	10.1371/journal.pone.0239713	http://dx.doi.org/10.1371/journal.pone.0239713			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211703	Green Published, gold			2022-12-26	WOS:000603518300006
J							COVID 19 APHP Univ INRIA INSERM	Early indicators of intensive care unit bed requirement during the COVID-19 epidemic: A retrospective study in Ile-de-France region, France	PLOS ONE			English	Article							SEVERITY	The aim of our retrospective study was to evaluate the earliest COVID19-related signal to anticipate requirements of intensive care unit (ICU) beds. Although the number of ICU beds is crucial during the COVID-19 epidemic, there is no recognized early indicator to anticipate it. In the Ile-de-France region, from February 20 to May 5, 2020, emergency medical service (EMS) calls and the response provided (ambulances) together the percentage of positive reverse transcriptase polymerase chain reaction (RT-PCR) tests, general practitioner (GP) and emergency department (ED) visits, and hospital admissions of COVID-19 patients were recorded daily and compared to the number of ICU patients. Correlation curve analysis was performed to determine the best correlation coefficient, depending on the number of days the indicator has been shifted. Primary endpoint was the number of ICU patients. EMS calls, percentage of positive RT-PCR tests, ambulances used, ED and GP visits of COVID-19 patients were strongly associated (R-2 ranging between 0.79 to 0.99, all P<0.001) with COVID-19 ICU patients with an anticipation delay of 23, 15, 14, 13, and 12 days respectively. Hospitalization did not anticipate ICU bed requirement. A qualitative analysis of the onset of the second wave period of the epidemic (August 1 to September 15, 2020) in the same region provided similar results. The daily number of COVID19-related telephone calls received by the EMS and corresponding dispatch ambulances, and the proportion of positive RT-PCR tests were the earliest indicators of the number of COVID19 patients requiring ICU care during the epidemic crisis, rapidly followed by ED and GP visits. This information may help health authorities to anticipate a future epidemic, including a second wave of COVID19, or decide additional social measures.										Ayyoubzadeh SM, 2020, JMIR PUBLIC HLTH SUR, V6, P192, DOI 10.2196/18828; Boelle PY, 2020, EUROSURVEILLANCE, V25, P14, DOI 10.2807/1560-7917.ES.2020.25.14.2000326; Cauchemez S, 2006, AM J EPIDEMIOL, V164, P591, DOI 10.1093/aje/kwj274; Cooperation operationnelle Risque Epidemiologique et Biologique (COREB), REP PRENDR CHARG PAT; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6; Gaubert S, UNDERSTANDING MONITO; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang C, 2020, RADIOLOGY, V395, P497, DOI DOI 10.1148/radiol.2020200463; Institute of Social and Preventive Medicine, LIV EV COVID 19 2020; Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1; Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5; Kim H, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002714; Lapostolle F, 2005, PRESSE MED, V34, P199, DOI 10.1016/S0755-4982(05)88247-8; Lapostolle F, 2020, EUR J EMERG MED, V27, P274, DOI 10.1097/MEJ.0000000000000723; Leung K, 2020, LANCET, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7; Li CL, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.10.2000199; Li RR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.8297; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P9122, DOI 10.1073/pnas.2004064117; Oranger M, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01692-2020; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Phua J, 2020, LANCET RESP MED, V8, P506, DOI 10.1016/S2213-2600(20)30161-2; Qin L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072365; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.7681]; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; Shim E, 2020, INT J INFECT DIS, V93, P339, DOI 10.1016/j.ijid.2020.03.031; Tuite AR, 2020, CAN MED ASSOC J, V192, pE497, DOI 10.1503/cmaj.200476; WHO, RESP COMM SPREAD COV; Wong LE, 2020, NEJM CATALYST INNOV, DOI DOI 10.1056/CAT.20.0193; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	31	12	12	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241406	10.1371/journal.pone.0241406	http://dx.doi.org/10.1371/journal.pone.0241406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206660	Green Published, Green Submitted, gold			2022-12-26	WOS:000595265900032
J	Odwe, G; Ndwiga, C; Okondo, C; Sripad, P; Abuya, T; Warren, CE				Odwe, George; Ndwiga, Charity; Okondo, Chantalle; Sripad, Pooja; Abuya, Timothy; Warren, Charlotte E.			Exploring communities' perceptions of the etiology of illnesses in newborns and young infants 0-59 days old in 4 counties in Kenya	PLOS ONE			English	Article							CARE-SEEKING; CHILDHOOD ILLNESSES; HEALTH; MALARIA	Background Understanding communities' beliefs about the causes of illnesses in sick young infants (SYIs) is key to strengthening interventions and improving newborn health outcomes. This study explored communities' perception of the etiology of illnesses in SYIs 0-59 days old in four counties in Kenya. Methods We used an exploratory qualitative study design. Data were collected between August and September 2018 and involved 23 in-depth interviews with female caregivers aged 15-24years; 25 focus group discussions with female caregivers aged 15-18 years, 19-24 years and 25-45 years; and 7 focus group discussions with fathers aged 18-34 years and 35 or more years. Participants were purposely sampled, only those with SYIs 0-59 days old were eligible to participate. Data were analyzed using inductive thematic analysis framework approach. Results Female caregivers and fathers attributed illnesses in SYIs 0-59 days old to natural (biomedical) and supernatural causes which sometimes co-existed. There were commonalities in perceived natural causes of illness in SYIs across sites, age groups and gender. Perceived natural causes of illness in SYIs include unfavorable environmental and hygiene conditions, poor maternal and child nutrition, and healthcare practices. Perceived supernatural causes of illness in SYIs such as 'evil eyes' were common across the four counties while others were geographically unique such as the belief that owls cause illnesses. Conclusion Communities' understanding of the etiology of illnesses in SYIs in the study settings overlapped between natural and supernatural causes. There is need for child health programmes to take into consideration communities' beliefs and practices regarding disease and health to improve newborn health outcomes.	[Odwe, George; Ndwiga, Charity; Okondo, Chantalle; Abuya, Timothy] Populat Council, Nairobi, Kenya; [Sripad, Pooja; Warren, Charlotte E.] Populat Council, Washington, DC USA	Population Council	Odwe, G (corresponding author), Populat Council, Nairobi, Kenya.	godwe@popcouncil.org			American people through the United States Agency for International Development (USAID) [AID-OAA-A-17-00031]	American people through the United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The project that generated data used in this study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) under the terms of AID-OAA-A-17-00031. The contents of this manuscript are the sole responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.	Abbey M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3513-z; Abubakar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071998; [Anonymous], 2019, LANCET GLOB HEALTH; [Anonymous], 2020, BMC PEDIATR, V20, P1, DOI DOI 10.1016/J.CLAE.2020.04.011; Applegate JA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231490; Aruldas K, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0121-1; Awasthi S, 2006, B WORLD HEALTH ORGAN, V84, P819, DOI 10.2471/BLT.05.029207; Bakare AA, 2020, PEDIATR PULM, V55, pS104, DOI 10.1002/ppul.24620; Bakari A, 2021, J BIOSOC SCI, V53, P497, DOI 10.1017/S0021932020000322; Bell AJ, 2020, J BIOSOC SCI, V52, P159, DOI 10.1017/S0021932019000312; Chibwana AI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-219; Cunnama L, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1911-7; DH News Services, 2017, DECCAN HERALD, V70, p3A; Dumbaugh M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-269; Hill Z, 2003, TROP MED INT HEALTH, V8, P668, DOI 10.1046/j.1365-3156.2003.01058.x; Hooft A, 2020, AM J TROP MED HYG, V103, P501, DOI 10.4269/ajtmh.19-0897; Kahissay MH, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4052-y; Kenya National Bureau of Statistics, 2015, KENYA DEMOGRAPHIC HL; Kenya National Bureau of Statistics, 2019, 2019 KEN POP HOUS CE, VI; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Munguti KJ, 1998, E AFR MED J, V75, P687; Murdock GP., 1980, THEORIES ILLNESS WOR; MWENESI HA, 1995, J BIOSOC SCI, V27, P235, DOI 10.1017/S0021932000022720; National AIDS and STI Control Programme (NASCOP) & Kenya Medical Research Institute (KEMRI), 2015, GUIDELINES CONDUCTIN; Okuga M, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0125-x; Patton M. Q., 1990, QUALITATIVE EVALUATI; Simieneh MM, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3897-4; Smith Joanna, 2011, Nurse Res, V18, P52; Taffa N, 2005, TROP MED INT HEALTH, V10, P240, DOI 10.1111/j.1365-3156.2004.01381.x; Tareke KG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227542; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wanjohi M, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-016-0092-7; Warren C, 2010, ETHIOP J HEALTH DEV, V24, P100; Workneh T, 2018, J ETHNOBIOL ETHNOMED, V14, DOI 10.1186/s13002-018-0214-y	35	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0240852	10.1371/journal.pone.0240852	http://dx.doi.org/10.1371/journal.pone.0240852			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ5ZL	33201913	gold, Green Published			2022-12-26	WOS:000595003900031
J	Smallhorn-West, P; Gordon, S; Stone, K; Ceccarelli, D; Malimali, S; Halafihi, T; Wyatt, M; Bridge, T; Pressey, R; Jones, G				Smallhorn-West, Patrick; Gordon, Sophie; Stone, Karen; Ceccarelli, Daniela; Malimali, Siola'a; Halafihi, Tu'ikolongahau; Wyatt, Mathew; Bridge, Tom; Pressey, Robert; Jones, Geoffrey			Biophysical and anthropogenic influences on the status of Tonga's coral reefs and reef fish fishery	PLOS ONE			English	Article							HABITAT; CONSERVATION; DISTURBANCE; SIZE	Despite increasing threats to Tonga's coral reefs from stressors that are both local (e.g. overfishing and pollution) and global (e.g. climate change), there is yet to be a systematic assessment of the status of the country's coral reef ecosystem and reef fish fishery stocks. Here, we provide a national ecological assessment of Tonga's coral reefs and reef fish fishery using ecological survey data from 375 sites throughout Tonga's three main island groups (Ha'apai, Tongatapu and Vava'u), represented by seven key metrics of reef health and fish resource status. Boosted regression tree analysis was used to assess and describe the relative importance of 11 socio-environmental variables associated with these key metrics of reef condition. Mean live coral cover across Tonga was 18%, and showed a strong increase from north to south correlated with declining sea surface temperature, as well as with increasing distance from each provincial capital. Tongatapu, the southernmost island group, had 2.5 times greater coral cover than the northernmost group, Vava'u (24.9% and 10.4% respectively). Reef fish species richness and density were comparable throughout Tongatapu and the middle island group, Ha'apai (similar to 35 species/transect and similar to 2500 fish/km(2)), but were significantly lower in Vava'u (similar to 24 species/transect and similar to 1700 fish/km(2)). Spatial patterns in the reef fish assemblage were primarily influenced by habitat-associated variables (slope, structural complexity, and hard coral cover). The biomass of target reef fish was greatest in Ha'apai (similar to 820 kg/ha) and lowest in Vava'u (similar to 340 kg/ha), and was negatively associated with higher human influence and fishing activity. Overall mean reef fish biomass values suggest that Tonga's reef fish fishery can be classified as moderately to heavily exploited, with 64% of sites having less than 500 kg/ha. This study provides critical baseline ecological information for Tonga's coral reefs that will: (1) facilitate ongoing management and research; and (2) enable accurate reporting on conservation targets locally and internationally.	[Smallhorn-West, Patrick; Jones, Geoffrey] James Cook Univ, Coll Sci & Engn, Marine Biol & Aquaculture, Townsville, Qld, Australia; [Smallhorn-West, Patrick; Ceccarelli, Daniela; Bridge, Tom; Pressey, Robert; Jones, Geoffrey] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia; [Smallhorn-West, Patrick] WorldFish, Jalan Batu Maung, Bayan Lepas, Penang, Malaysia; [Gordon, Sophie] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Sippy Downs, Qld, Australia; [Stone, Karen] Vavau Environm Protect Assoc VEPA, Neiafu, Vavau, Tonga; [Malimali, Siola'a; Halafihi, Tu'ikolongahau] Minist Fisheries, Nukualofa, Tongatapu, Tonga; [Wyatt, Mathew] Australian Inst Marine Sci, Cape Cleveland, Qld, Australia; [Bridge, Tom] Queensland Museum Network Townsville, Museum Trop Queensland, Biodivers & Geosci Program, Townsville, Qld, Australia	James Cook University; James Cook University; CGIAR; Worldfish; University of the Sunshine Coast; Australian Institute of Marine Science	Smallhorn-West, P (corresponding author), James Cook Univ, Coll Sci & Engn, Marine Biol & Aquaculture, Townsville, Qld, Australia.; Smallhorn-West, P (corresponding author), James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld, Australia.; Smallhorn-West, P (corresponding author), WorldFish, Jalan Batu Maung, Bayan Lepas, Penang, Malaysia.	patricksmallhornwest@jcu.edu.au	Ceccarelli, Daniela/AGO-7628-2022	Gordon, Sophie/0000-0003-1775-7221; Smallhorn-West, patrick/0000-0001-6782-3704	Australian Research Council; DECRA Fellowship [DE180100746]; National Geographic Society [CP-137ER-17]	Australian Research Council(Australian Research Council); DECRA Fellowship; National Geographic Society(National Geographic Society)	PSW, TCLB, RLP and GPJ acknowledge support from the Australian Research Council, including DECRA Fellowship DE180100746 to TCLB. PSW acknowledges support from from the National Geographic Society CP-137ER-17. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2013, ENV MONIT ASSESS; Aholahi H, 2017, STATUS FANGAUTA LAGO; Alvarez-Filip L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03486; [Anonymous], 2014, REV TONGAS NATL BIOD; [Anonymous], 2018, DTSCH ARZTEBL, V115, pA; [Anonymous], 2016, TONG SD TONG NAT POP; [Anonymous], 2015, RAP BIOD ASS VAV ARC, P358; [Anonymous], 2016, EVIDENCE, V8, pe1000; Beijbom O., 2015, AUTOMATED ANNOTATION; Beijbom O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130312; Bellwood DR, 2019, BIOL CONSERV, V236, P604, DOI 10.1016/j.biocon.2019.05.056; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bruckner A, 2014, GLOBAL REEF EXPEDITI; Bruno JF, 2019, ANNU REV MAR SCI, V11, P307, DOI 10.1146/annurev-marine-010318-095300; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Buckley R, 2017, VAVAU CORAL REEF SUR; Buston PM, 2011, J ANIM ECOL, V80, P528, DOI 10.1111/j.1365-2656.2011.01803.x; Ceccarelli D, 2016, VAVAU SMA PROJECT BA; Ceccarelli DM, 2020, ECOL APPL, V30, DOI 10.1002/eap.2008; Ceccarelli DM, 2018, MAR ECOL PROG SER, V588, P85, DOI 10.3354/meps12444; Chapman MR, 1999, MAR ECOL PROG SER, V181, P81, DOI 10.3354/meps181081; Chin A, 2011, STATUS CORAL REEFS P; Cinner JE, 2016, NATURE, V535, P416, DOI 10.1038/nature18607; Darling ES, 2019, NAT ECOL EVOL, V3, P1341, DOI 10.1038/s41559-019-0953-8; Darling ES, 2019, NAT ECOL EVOL; Dulvy NK, 2004, CAN J FISH AQUAT SCI, V61, P466, DOI 10.1139/F03-169; Dustan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057386; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2017, BOOSTED REGRESSION T, DOI [10.1111/brv.12359, DOI 10.1111/BRV.12359]; Fabricius K, 2001, CORAL REEFS, V19, P303, DOI 10.1007/s003380000120; Friedman K, 2008, TONGA COUNTRY REPORT; Gillett R., 2017, REV SPECIAL MANAGEME; Graham N, 2013, IMPORTANCE STRUCTURA, P315; Gurney G. G., 2017, GLOBAL SOCIAL ECOLOG; Harborne AR, 2012, ENVIRON BIOL FISH, V94, P431, DOI 10.1007/s10641-011-9956-2; Harborne AR, 2016, NATURE CONSERVANCY; Hastie T., 2009, SPRINGER SCI BUSINES; Holthus P, 1996, S PACIFIC REG ENV PR; Hughes TP, 2019, NATURE, V568, P387, DOI 10.1038/s41586-019-1081-y; Hughes TP, 2017, NATURE, V546, P82, DOI 10.1038/nature22901; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Jones GP, 1998, AUST J ECOL, V23, P287, DOI 10.1111/j.1442-9993.1998.tb00733.x; Jouffray JB, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2544; Knudby A, 2010, ECOL MODEL, V221, P503, DOI 10.1016/j.ecolmodel.2009.11.008; Kronen M, 2004, FISH RES, V70, P121, DOI 10.1016/j.fishres.2004.05.013; Kulbicki M, 2005, CYBIUM, V29, P235; Lovell E, 2000, INT OCEAN I S PACIFI, P26; MacNeil MA, 2015, NATURE, V520, P341, DOI 10.1038/nature14358; Malimali S, 2013, SOCIOECONOMIC ECOLOG; Mayfield AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185857; McClanahan TR, 2015, CONSERV BIOL, V29, P409, DOI 10.1111/cobi.12430; McClanahan TR, 2019, MAR ECOL PROG SER, V612, P167, DOI 10.3354/meps12874; McClanahan TR, 2018, FISH FISH, V19, P471, DOI 10.1111/faf.12268; McClanahan TR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154585; Mellin C, 2009, MAR POLLUT BULL, V58, P11, DOI 10.1016/j.marpolbul.2008.10.010; Morrison TH, 2019, SAVE REEFS RESCUE AL, DOI [10.1038/d41586-019-02737-8, DOI 10.1038/D41586-019-02737-8]; Pakoa K, 2008, STATUS TROCHUS TROCH; Pittman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020583; Purkis S, 2020, GLOBAL REEF EXPEDITI; R-Core-Team, 2017, R PROJ; Randall JE, 2003, CHECKLIST SHORE EPIP; Richardson L. L, 2010, THESIS; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Smallhorn-West P, CONSERV LETT; Smallhorn-West P., 2020, KINGDOM TONGA SPECIA, DOI [10.1038/s41559-019-0953-8, DOI 10.1038/S41559-019-0953-8]; Smallhorn-West PF, 2020, CORAL REEFS, V39, P529, DOI 10.1007/s00338-019-01868-8; Smallhorn-West PF, 2020, CONSERV LETT, V13, DOI 10.1111/conl.12742; Stone K., 2017, VAVAU OCEAN INITIATI; Stone K, 2019, 2 EDI WORLD SEAS ENV, P661; Vercelloni J, 2020, GLOBAL CHANGE BIOL, V26, P2785, DOI 10.1111/gcb.15059; Vieux C, 2005, CORAL REEF SURVEYS V; Vieux C, 2005, CENTURY CHANGE CORAL; Visconti P, 2013, CONSERV BIOL, V27, P1000, DOI 10.1111/cobi.12095; Wedding LM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189792	74	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0241146	10.1371/journal.pone.0241146	http://dx.doi.org/10.1371/journal.pone.0241146			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201891	Green Accepted, Green Published, gold			2022-12-26	WOS:000595003900032
J	Zaky, A; Beck, AW; Bae, S; Sturdivant, A; Liwo, A; Zdenek, N; McAnally, N; Ahmad, S; Meers, B; Robbin, M; Pittet, JF; Tolwani, A; Berkowitz, D				Zaky, Ahmed; Beck, Adam W.; Bae, Sejong; Sturdivant, Adam; Liwo, Amandiy; Zdenek, Novak; McAnally, Nicole; Ahmad, Shama; Meers, Brad; Robbin, Michelle; Pittet, J. F.; Tolwani, Ashita; Berkowitz, Dan			The bio-sonographic index. A novel modality for early detection of acute kidney injury after complex vascular surgery. A protocol for an exploratory prospective study	PLOS ONE			English	Article							SHEAR-WAVE ELASTOGRAPHY; ANEURYSM REPAIR; OUTCOMES; DIAGNOSIS; BREAST	Objective Acute kidney injury (AKI) is a common complication of complex aortic surgery with high mortality, morbidity and health care expense. The current definition of AKI does not allow for structural characterization of the kidneys and utilizes functional indices with substantial limitations leading to delayed diagnosis and ineffective interventions. The aim of this study is to develop a method of early detection of structural renal abnormalities that can precede and predict the occurrence of AKI in this population. We propose a novel combined index of ultrasonography (shear wave elastography), biomarkers of renal stress (urinary insulin growth factor binding protein-7, IGFBP-7 and inhibitor of tissue metalloproteinase-2, TIMP-2) and renal injury markers (urinary neutrophil gelatinase-associated lipocalin -NGAL)- the bio-sonographic index (BSI). Methods A prospective observational study at a tertiary referral center will be performed enrolling 80 patients undergoing elective open and endovascular repair of the visceral aorta. The BSI will be evaluated at baseline, and at 6 and 24 hours after the procedure. The primary outcome is the occurrence of AKI according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria. Each patient will be his/her own control. A reference group of 15 healthy volunteers who are not undergoing interventions will be enrolled to test the feasibility of and to refine the novel SWE protocol. The BSI will be tested for its predictability of the occurrence of AKI. Comparisons will be made between individual and combined components of the BSI and traditional markers used in the KDIGO definition; serum creatinine and urine output in terms of baseline status of the kidney. Correlations will be made between the BSI and conventional indices of AKI and exploratory analyses will be conducted to identify individual disease patterns using the BSI. Discussion We hypothesize that the BSI will be a sensitive index of early structural abnormalities that precede and predict the occurrence of AKI as defined by KDIGO in complex vascular surgery.	[Zaky, Ahmed; Sturdivant, Adam; Liwo, Amandiy; Ahmad, Shama; Meers, Brad; Pittet, J. F.; Berkowitz, Dan] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL 35294 USA; [Beck, Adam W.; Zdenek, Novak; McAnally, Nicole] Univ Alabama Birmingham, Dept Surg, Div Vasc Surg & Endovasc Therapy, Birmingham, AL 35294 USA; [Bae, Sejong] Univ Alabama Birmingham, Dept Med, Div Prevent Med, Birmingham, AL 35294 USA; [Robbin, Michelle] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA; [Tolwani, Ashita] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Zaky, A (corresponding author), Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL 35294 USA.	azaky@uabmc.edu	Meers, Brad/ABF-7219-2020; ahmad, shama/GNH-1803-2022; Robbin, Michelle/AAL-6369-2021	Meers, Brad/0000-0002-8207-6046; ahmad, shama/0000-0003-1049-5054; Liwo, Amandiy/0000-0003-1906-5392; F. Zaky, Ahmed/0000-0002-0548-6906; bae, sejong/0000-0001-9982-3223	University of Alabama At Birmingham Surgery Engineering Collaborative Grant Funds 2019 [3122053.000.213122053.311850000.0000]	University of Alabama At Birmingham Surgery Engineering Collaborative Grant Funds 2019	This work was supported by the University of Alabama At Birmingham Surgery Engineering Collaborative Grant Funds 2019. 'Internal funding'. 3122053.000.213122053.311850000.0000 to AZ/ AB The funders had and will not play any role in the study design, data collection, and analysis, decision to publish, or the preparation of the manuscript.	Ammar A, 2016, ANAESTHESIA, V71, P1308, DOI 10.1111/anae.13564; [Anonymous], 2007, CIRCULATION, V116, pe148; Antonello M, 2013, J VASC SURG, V58, P886, DOI 10.1016/j.jvs.2013.02.249; Bihorac A, 2014, AM J RESP CRIT CARE, V189, P932, DOI 10.1164/rccm.201401-0077OC; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Cuartero M, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0317-y; Early H, 2017, J ULTRAS MED, V36, P1771, DOI 10.1002/jum.14217; Eilenberg W, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0579-6; Engelman DT, 2020, J THORAC CARDIOV SUR, V160, P1235, DOI 10.1016/j.jtcvs.2019.10.034; Hobson C, 2018, J VASC SURG, V68, P916, DOI 10.1016/j.jvs.2018.05.017; Huber M, 2016, JAMA SURG, V151, P441, DOI 10.1001/jamasurg.2015.4526; Kashani K, 2013, CRIT CARE, V17, DOI 10.1186/cc12503; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Krzeminska E, 2016, J CLIN LAB ANAL, V30, P956, DOI 10.1002/jcla.21962; Lee JT, 2014, J VASC SURG, V60, P563, DOI 10.1016/j.jvs.2014.03.239; Liang NL, 2019, CURR PHARM DESIGN, V25, P4686, DOI 10.2174/1381612825666191129095829; Lupsor-Platon M, 2016, J GASTROINTEST LIVER, V25, P525, DOI 10.15403/jgld.2014.1121.254.lup; Martin-Gonzalez T, 2015, EUR J VASC ENDOVASC, V50, P420, DOI 10.1016/j.ejvs.2015.04.011; Marwick TH, 2015, J NUCL MED, V56, p31S, DOI 10.2967/jnumed.114.150433; McNally MM, 2015, J VASC SURG, V61, P309, DOI 10.1016/j.jvs.2014.07.097; Meersch M, 2017, INTENS CARE MED, V43, P1551, DOI 10.1007/s00134-016-4670-3; Meersch M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093460; O'Donnell TFX, 2020, ANN SURG, V271, P969, DOI 10.1097/SLA.0000000000003094; Palevsky PM, 2013, AM J KIDNEY DIS, V61, P649, DOI 10.1053/j.ajkd.2013.02.349; Pearce BJ, 2017, J CARDIOVASC SURG, V58, P861, DOI 10.23736/S0021-9509.17.10103-5; Peride I, 2016, MED ULTRASON, V18, P362, DOI 10.11152/mu.2013.2066.183.per; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sandhu RS, 2018, J MED ULTRASOUND, V26, P81, DOI 10.4103/JMU.JMU_9_17; Saratzis A, 2015, EUR J VASC ENDOVASC, V49, P534, DOI 10.1016/j.ejvs.2015.01.002; Scali ST, 2018, J VASC SURG, V67, P409, DOI 10.1016/j.jvs.2017.05.136; Siew ED, 2011, J AM SOC NEPHROL, V22, P810, DOI 10.1681/ASN.2010080796; Singbartl K, 2012, KIDNEY INT, V81, P819, DOI 10.1038/ki.2011.339; Youk JH, 2017, ULTRASONOGRAPHY, V36, P300, DOI 10.14366/usg.17024; Zheng XY, 2020, KOREAN J RADIOL, V21, P172, DOI 10.3348/kjr.2019.0453	35	1	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0241782	10.1371/journal.pone.0241782	http://dx.doi.org/10.1371/journal.pone.0241782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201924	Green Published, gold			2022-12-26	WOS:000595003900037
J	Chen, Y; Liu, H; Chen, M; Sun, HY; Wu, YN				Chen, Yan; Liu, Hong; Chen, Min; Sun, He-Yang; Wu, Yong-Ning			The human health burden of non-typhoidal Salmonella enterica and Vibrio parahaemolyticus foodborne gastroenteritis in Shanghai, east China	PLOS ONE			English	Article							INFECTIOUS INTESTINAL DISEASE; UNITED-STATES; ILLNESS; COMMUNITY; FOOD; CAMPYLOBACTER; SURVEILLANCE; PATHOGENS; OUTBREAKS; PROVINCE	Information on the burden of disease due to foodborne pathogens in China is quite limited. To understand the incidence of foodborne gastroenteritis due to non-typhoidal Salmonella enterica and Vibrio parahaemolyticus, population survey and sentinel hospital surveillance were conducted during July 2010 to June 2011 in Shanghai, east China, and a model for calculating disease burden was established. The multiplier for gastroenteritis caused by these pathogens was estimated at 59 [95% confidence interval (CI) 30-102]. Annual incidence per 100,000 population in Shanghai was estimated as 48 (95% CI 24-83) and 183 (95% CI 93-317) cases for foodborne non-typhoidal salmonellosis and V. parahaemolyticus gastroenteritis, respectively, illustrating that bacterial gastroenteritis due to these two pathogens poses a substantial health burden. There is a significant difference between our simulated incidence and the data actually reported for foodborne diseases, indicating significant underreporting and underdiagnosis of non-typhoidal S. enterica and V. parahaemolyticus gastroenteritis in the surveillance area. The present research demonstrates basic situation of the health burden caused by major foodborne pathogens in the surveillance area. Enhanced laboratory-based sentinel hospital surveillance is one of the effective ways to monitor food safety in east China.	[Chen, Yan; Sun, He-Yang; Wu, Yong-Ning] Chinese Acad Med Sci, China Natl Ctr Food Safety Risk Assessment, Res Unit, NHC Key Lab Food Safety Risk Assessment, Beijing, Peoples R China; [Liu, Hong; Chen, Min] Shanghai Municipal Ctr Dis Control & Prevent, Shanghai, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Shanghai Center for Disease Control & Prevention	Chen, Y (corresponding author), Chinese Acad Med Sci, China Natl Ctr Food Safety Risk Assessment, Res Unit, NHC Key Lab Food Safety Risk Assessment, Beijing, Peoples R China.	chenyan@cfsa.net.cn	Wu, Yongning/F-5818-2019; Chen, Yan/AGL-5103-2022	Wu, Yongning/0000-0001-6430-1302; Chen, Yan/0000-0001-7120-9571	National Natural Science Foundation of China [81673175]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by grant from the National Natural Science Foundation of China (No. 81673175).	Adak GK, 2002, GUT, V51, P832, DOI 10.1136/gut.51.6.832; Bi Y, 2010, CLIN THER, V32, P973, DOI 10.1016/j.clinthera.2010.05.002; Chen Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-456; de Wit MAS, 2001, AM J EPIDEMIOL, V154, P666, DOI 10.1093/aje/154.7.666; Dewey-Mattia Daniel, 2016, MMWR Morb Mortal Wkly Rep, V63, P79, DOI 10.15585/mmwr.mm6355a8; Ebel ED, 2016, EMERG INFECT DIS, V22, P1193, DOI 10.3201/eid2207.150833; Flint JA, 2005, CLIN INFECT DIS, V41, P698, DOI 10.1086/432064; Gargouri N, 2009, FOODBORNE PATHOG DIS, V6, P481, DOI 10.1089/fpd.2008.0192; Hald T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145839; Hall G, 2005, EMERG INFECT DIS, V11, P1257, DOI 10.3201/eid1108.041367; Hall G, 2008, EMERG INFECT DIS, V14, P1601, DOI 10.3201/eid1410.071042; Huang X, 2016, EMERG INFECT DIS, V22, P726, DOI 10.3201/eid2204.151372; Kubota K, 2011, J FOOD PROTECT, V74, P1592, DOI 10.4315/0362-028X.JFP-10-387; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mao X., 2011, CHIN J DIS CONTROL P, V15, P622; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Ministry of Health of the People's Republic of China, 1999, MAN FOOD POIS INC; Ministry of Health of the People's Republic of China Standardization Administration of the People's Republic of China., 2008, 478972008 GBT MIN HL; Ministry of Health of the People's Republic of China Standardization Administration of the People's Republic of China., 2008, 478942008 GBT MIN HL; National Bureau of Statistics of China, 2012, CHINA STAT PRESS; O'Brien SJ, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011119; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Thomas M Kate, 2006, Can J Infect Dis Med Microbiol, V17, P229; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Vose D., 2000, RISK ANAL QUANTITATI; Wheeler JG, 1999, BMJ-BRIT MED J, V318, P1046, DOI 10.1136/bmj.318.7190.1046; Wu YN, 2018, FOOD CONTROL, V90, P429, DOI 10.1016/j.foodcont.2018.03.009; Wu YN, 2018, FOOD CONTROL, V84, P382, DOI 10.1016/j.foodcont.2017.08.010; Wu YN, 2014, FOOD CONTROL, V46, P197, DOI 10.1016/j.foodcont.2014.05.023	31	4	4	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242156	10.1371/journal.pone.0242156	http://dx.doi.org/10.1371/journal.pone.0242156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186379	Green Published, gold			2022-12-26	WOS:000593949800046
J	Henzi, A; Senatore, A; Lakkaraju, AKK; Scheckel, C; Muhle, J; Reimann, R; Sorce, S; Schertler, G; Toyka, KV; Aguzzi, A				Henzi, Anna; Senatore, Assunta; Lakkaraju, Asvin K. K.; Scheckel, Claudia; Muehle, Jonas; Reimann, Regina; Sorce, Silvia; Schertler, Gebhard; Toyka, Klaus V.; Aguzzi, Adriano			Soluble dimeric prion protein ligand activates Adgrg6 receptor but does not rescue early signs of demyelination in PrP-deficient mice	PLOS ONE			English	Article							COUPLED RECEPTOR; SCHWANN-CELLS; FUSION PROTEINS; GENE; IMMUNOGENICITY; POLYNEUROPATHY; DEGENERATION; MYELINATION; MAINTENANCE; GPR126	The adhesion G-protein coupled receptor Adgrg6 (formerly Gpr126) is instrumental in the development, maintenance and repair of peripheral nervous system myelin. The prion protein (PrP) is a potent activator of Adgrg6 and could be used as a potential therapeutic agent in treating peripheral demyelinating and dysmyelinating diseases. We designed a dimeric Fc-fusion protein comprising the myelinotrophic domain of PrP (FT(2)Fc), which activated Adgrg6 in vitro and exhibited favorable pharmacokinetic properties for in vivo treatment of peripheral neuropathies. While chronic FT(2)Fc treatment elicited specific transcriptomic changes in the sciatic nerves of PrP knockout mice, no amelioration of the early molecular signs demyelination was detected. Instead, RNA sequencing of sciatic nerves revealed downregulation of cytoskeletal and sarcomere genes, akin to the gene expression changes seen in myopathic skeletal muscle of PrP overexpressing mice. These results call for caution when devising myelinotrophic therapies based on PrP-derived Adgrg6 ligands. While our treatment approach was not successful, Adgrg6 remains an attractive therapeutic target to be addressed in other disease models or by using different biologically active Adgrg6 ligands.	[Henzi, Anna; Senatore, Assunta; Lakkaraju, Asvin K. K.; Scheckel, Claudia; Reimann, Regina; Sorce, Silvia; Aguzzi, Adriano] Univ Zurich, Inst Neuropathol, Zurich, Switzerland; [Muehle, Jonas; Schertler, Gebhard] Paul Scherrer Inst, Dept Biol & Chem, Villigen, Switzerland; [Toyka, Klaus V.] Univ Wurzburg, Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany	University of Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Wurzburg	Aguzzi, A (corresponding author), Univ Zurich, Inst Neuropathol, Zurich, Switzerland.	adriano.aguzzi@usz.ch	Reimann, Regina Rose/A-1195-2016	Reimann, Regina Rose/0000-0002-6396-4195; Muhle, Jonas/0000-0002-7759-3620; Henzi, Anna/0000-0002-5712-7059	Swiss National Foundation [323530_171140]; European Research Council; Nomis Foundation; SystemsX.ch; Synapsis Foundation; University of Wurzburg; Swiss National Foundation Sinergia grant [CRSII5 183563]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); Nomis Foundation; SystemsX.ch; Synapsis Foundation; University of Wurzburg; Swiss National Foundation Sinergia grant	AH is the recipient of an MD PhD fellowship from Swiss National Foundation (project number 323530_171140). AA is the recipient of an Advanced Grant of the European Research Council, the Nomis Foundation and SystemsX.ch. AS and AKKL are recipients of grants from the Synapsis Foundation. KVT is the recipient of a senior professorship research grant by the University of Wurzburg. AA and GS are the recipients of the Swiss National Foundation Sinergia grant CRSII5 183563. Swiss National Foundation: http://www.snf.ch/en/funding/Pages/default.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2019, CIRCULATION, V2019; Arthur-Farraj PJ, 2017, CELL REP, V20, P2719, DOI 10.1016/j.celrep.2017.08.064; Baiardi S, 2019, J NEUROL NEUROSUR PS, V90, P424, DOI 10.1136/jnnp-2018-319221; Boerboom A, 2016, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00038; Bradley EC, 2019, ANN NY ACAD SCI, V1456, P44, DOI 10.1111/nyas.14233; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Carr MJ, 2019, CELL STEM CELL, V24, P240, DOI 10.1016/j.stem.2018.10.024; Cervellini I, 2018, J NEUROSCI, V38, P679, DOI 10.1523/JNEUROSCI.2255-17.2017; Chirmule N, 2012, AAPS J, V14, P296, DOI 10.1208/s12248-012-9340-y; Collins AM, 2016, IMMUNOL CELL BIOL, V94, P949, DOI 10.1038/icb.2016.65; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; Czajkowsky DM, 2012, EMBO MOL MED, V4, P1015, DOI 10.1002/emmm.201201379; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Diamantopoulou E, 2019, ELIFE, V8, DOI 10.7554/eLife.44889; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ferre S, 2014, PHARMACOL REV, V66, P413, DOI 10.1124/pr.113.008052; Figlia G, 2017, ELIFE, V6, DOI 10.7554/eLife.29241; Franco R, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00076; Gerber D, 2019, ELIFE, V8, DOI 10.7554/eLife.42404; Hatakeyama M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1104-8; Huang SH, 2007, P NATL ACAD SCI USA, V104, P6800, DOI 10.1073/pnas.0608885104; Hubner H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12298; Jablonka-Shariff A, 2020, GLIA, V68, P1182, DOI 10.1002/glia.23769; JESSEN KR, 1991, ANN NY ACAD SCI, V633, P78; Koop O, 2005, NEUROMUSCULAR DISORD, V15, P549, DOI 10.1016/j.nmd.2005.06.007; Kuffer A, 2016, NATURE, V536, P464, DOI 10.1038/nature19312; Lammermann T, 2019, IMMUNOL REV, V289, P205, DOI 10.1111/imr.12752; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu CJ, 2014, FEBS LETT, V588, P4831, DOI 10.1016/j.febslet.2014.11.018; Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; Mogha A, 2016, J NEUROSCI, V36, P12351, DOI 10.1523/JNEUROSCI.3854-15.2016; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Monje PV, 2010, J BIOL CHEM, V285, P31024, DOI 10.1074/jbc.M110.116970; Monje PV, 2006, GLIA, V53, P649, DOI 10.1002/glia.20330; Monk KR, 2011, DEVELOPMENT, V138, P2673, DOI 10.1242/dev.062224; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; Musa G, 2019, ANN NY ACAD SCI, V1456, P96, DOI 10.1111/nyas.14135; NEUFELD MY, 1992, MUSCLE NERVE, V15, P1234, DOI 10.1002/mus.880151103; Nishida N, 1999, LAB INVEST, V79, P689; Nuvolone M, 2016, J EXP MED, V213, P313, DOI 10.1084/jem.20151610; Piazza M, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1134; Pupo AS, 2016, PHARMACOL RES, V112, P49, DOI 10.1016/j.phrs.2016.01.031; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Salomon B, 2001, J EXP MED, V194, P677, DOI 10.1084/jem.194.5.677; Salzer JL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020529; SEITZ RJ, 1985, ACTA NEUROPATHOL, V68, P15, DOI 10.1007/BF00688950; Senatore A, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012739; Skedsmo FS, 2020, FASEB J, V34, P2359, DOI 10.1096/fj.201902588R; Sorce S, 2020, BIORXIV; Strohl WR, 2015, BIODRUGS, V29, P215, DOI 10.1007/s40259-015-0133-6; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Wozniak-Knopp G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030083; Wulf MA, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0375-5; Zhou L, 2013, AAPS J, V15, P30, DOI 10.1208/s12248-012-9408-8; Zielasek J, 1996, MUSCLE NERVE, V19, P946, DOI 10.1002/(SICI)1097-4598(199608)19:8<946::AID-MUS2>3.0.CO;2-8	57	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242137	10.1371/journal.pone.0242137	http://dx.doi.org/10.1371/journal.pone.0242137			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180885	Green Published, gold			2022-12-26	WOS:000593948000059
J	Lu, PX; Li, X; Lu, L; Zhang, Y				Lu, Peixin; Li, Xin; Lu, Long; Zhang, Yue			The psychological states of people after Wuhan eased the lockdown	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; HEALTH-CARE WORKERS; GENERALIZED ANXIETY DISORDER; MENTAL-HEALTH; IMPACT; OUTBREAK; TORONTO; STRESS; CHINA; RISK	It has been two months since Wuhan eased the lockdown and the people of Wuhan have been under great pressure during COVID-19. The psychological status among healthcare workers and residents were barely know due to the lack of research after Wuhan eased of the lockdown. The purpose of this study was to assess people's mental health and the changes after Wuhan eased the lockdown. A cross-sectional online study among citizens in Wuhan was conducted. Among 1417 participants, 387(27.0%) were frontline healthcare workers and 1035(73.0%) were residents from the general public. Their COVID-19 psychological status was evaluated using Patient Health Questionnaire-9(PHQ-9), Generalized Anxiety Disorder 7-item (GAD-7), and the PTSD Checklist-Civilian Version (PCL-C). Results show that 16.1%,22.3% and 17.2% healthcare workers and 21.2%, 16.7% and 17.2% general public had symptoms of depression, anxiety and PTSD ranging from moderate to severe. Anxiety levels were not significantly different between healthcare workers and the general public. The decreased income and the frequent social media exposure are the risk factors for general public. Compared to the early COVID-19 epidemic period, the proportion of anxiety and depression among both the general public and health workers decreased after Wuhan eased the lockdown. Our finding can be used to help the government of Wuhan to develop psychological interventions to improve the mental health of the population and work as a reference of public health guidelines for other cities with severe COVID-19 outbreak.	[Lu, Peixin; Li, Xin; Lu, Long] Wuhan Univ, Sch Informat Management, Wuhan, Hubei, Peoples R China; [Zhang, Yue] Huazhong Univ Sci & Technol, Wuhan Forth Hosp, Tongji Med Coll, Med Records Stat Div,Puai Hosp, Wuhan, Hubei, Peoples R China	Wuhan University; Huazhong University of Science & Technology	Lu, L (corresponding author), Wuhan Univ, Sch Informat Management, Wuhan, Hubei, Peoples R China.; Zhang, Y (corresponding author), Huazhong Univ Sci & Technol, Wuhan Forth Hosp, Tongji Med Coll, Med Records Stat Div,Puai Hosp, Wuhan, Hubei, Peoples R China.	lulong@whu.edu.cn; zywhsdsyy@126.com		Li, Xin/0000-0002-8169-6059	National Natural Science Foundation of China [61772375, 18ZDA325]; Hubei Provincial Natural Science Foundation of China [2019CFA025]; National Key R&D Program of China [2019YFC010167]; Independent Research Project of School of Information Management Wuhan University [413100032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Independent Research Project of School of Information Management Wuhan University	This research was funded by National Natural Science Foundation of China [No. 61772375, 18ZDA325]; Hubei Provincial Natural Science Foundation of China [No. 2019CFA025]; National Key R&D Program of China (2019YFC010167); and Independent Research Project of School of Information Management Wuhan University(No: 413100032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrykowski MA, 1998, J CONSULT CLIN PSYCH, V66, P586, DOI 10.1037/0022-006X.66.3.586; Chan AOM, 2004, OCCUP MED-OXFORD, V54, P190, DOI 10.1093/occmed/kqh027; Chen NH, 2007, INFECT CONT HOSP EP, V28, P75, DOI 10.1086/508824; Chong MY, 2004, BRIT J PSYCHIAT, V185, P127, DOI 10.1192/bjp.185.2.127; de Girolamo G, 2020, JAMA PSYCHIAT, V77, P974, DOI 10.1001/jamapsychiatry.2020.1276; Durodie B, 2019, LANCET PSYCHIAT, V6, P61, DOI 10.1016/S2215-0366(18)30335-3; Gao JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231924; Kang LJ, 2020, LANCET PSYCHIAT, V7, pE14, DOI 10.1016/S2215-0366(20)30047-X; Kang S, 2020, PSYCHOL RESPONSES BE, V2507, P1; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lancee WJ, 2008, PSYCHIAT SERV, V59, P91, DOI 10.1176/ps.2008.59.1.91; Lee AM, 2007, CAN J PSYCHIAT, V52, P233, DOI 10.1177/070674370705200405; Li LY, 2003, JAMA-J AM MED ASSOC, V290, P2662, DOI 10.1001/jama.290.20.2662; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lin CY, 2007, EMERG MED J, V24, P12, DOI 10.1136/emj.2006.035089; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Marshall RD, 2007, AM PSYCHOL, V62, P304, DOI 10.1037/0003-066X.62.4.304; Maunder R, 2004, PHILOS T R SOC B, V359, P1117, DOI 10.1098/rstb.2004.1483; Maunder RG, 2006, EMERG INFECT DIS, V12, P1924; McAlonan GM, 2007, CAN J PSYCHIAT, V52, P241, DOI 10.1177/070674370705200406; Neria Y, 2011, JAMA-J AM MED ASSOC, V306, P1374, DOI 10.1001/jama.2011.1358; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Nwachukwu I, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176366; Organization WH, 2020, M INT HLTH REG EM CO; Organization WH, 2020, MENT HLTHPSYCH CONS; Ozamiz-Etxebarria N, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01491; Phua DH, 2005, ACAD EMERG MED, V12, P322, DOI 10.1197/j.aem.2004.11.015; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Rutter LA, 2017, J PSYCHOPATHOL BEHAV, V39, P140, DOI 10.1007/s10862-016-9571-9; Shih FJ, 2007, APPL NURS RES, V20, P171, DOI 10.1016/j.apnr.2006.08.007; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Styra R, 2008, J PSYCHOSOM RES, V64, P177, DOI 10.1016/j.jpsychores.2007.07.015; Tan BYQ, 2020, ANN INTERN MED, V173, P317, DOI 10.7326/M20-1083; Taylor S, 2020, FEM PSYCHOL, V30, P63, DOI 10.1177/0959353519864390; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wu P, 2009, CAN J PSYCHIAT, V54, P302, DOI 10.1177/070674370905400504; Yang Y., 2020, LANCET PSYCHIAT; Yu XN, 2012, COMPR PSYCHIAT, V53, P95, DOI 10.1016/j.comppsych.2010.11.002; Zhang YL, 2013, ASIA-PAC PSYCHIAT, V5, P268, DOI 10.1111/appy.12103	40	12	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241173	10.1371/journal.pone.0241173	http://dx.doi.org/10.1371/journal.pone.0241173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0MJ	33180783	Green Published, gold			2022-12-26	WOS:000593948000070
J	Sergiel, A; Barja, I; Navarro-Castilla, A; Zwijacz-Kozica, T; Selva, N				Sergiel, Agnieszka; Barja, Isabel; Navarro-Castilla, Alvaro; Zwijacz-Kozica, Tomasz; Selva, Nuria			Losing seasonal patterns in a hibernating omnivore? Diet quality proxies and faecal cortisol metabolites in brown bears in areas with and without artificial feeding	PLOS ONE			English	Article							PHYSIOLOGICAL STRESS-RESPONSE; URSUS-ARCTOS; TOURIST PRESSURE; FOOD-HABITS; BIESZCZADY MOUNTAINS; NATIONAL-PARK; NITROGEN; GLUCOCORTICOIDS; INDEX; POPULATION	Bears are omnivores particularly well-adapted to variations in the nutritional composition, quality and availability of food resources. Artificial feeding practices have been shown to strongly influence diet composition and seasonality, as well as to cause alterations in wintering and movement in brown bears (Ursus arctos). In this study, we investigated seasonal differences (hypophagia vs hyperphagia) in food quality of two brown bear subpopulations in the Polish Carpathians using faecal nitrogen (FN) and carbon (FC) estimates. The subpopulations inhabit areas that differ in artificial feeding practices: no artificial feeding occurs in the western subpopulation (Tatra Mountains), while artificial food targeted to ungulates is provided and used year-round in the eastern subpopulation (Bieszczady Mountains). We also compared these results with faecal cortisol metabolites (FCM) to explore how FN and FC correlate with the hypothalamic-pituitary-adrenal axis activity and if the seasonal patterns are apparent. We found that in Tatra Mts bears fed on significantly higher quality diet, as shown by FN and FC values, and had significantly higher FC levels in hyperphagia, when they accumulate fat reserves for wintering. The pattern in FCM levels for Tatra subpopulation followed the changes in energy intake during the seasons of hypo- and hyperphagia, while in Bieszczady Mts, the area with intensive feeding, no seasonal patterns could be observed. Artificial feeding practices may disrupt nutrient phenology and seasonality, relative to subpopulations with natural diets. We showed that the availability of human-provided foods may alter not only the overall dietary quality, but also hormonal patterns linked to seasonal nutritional requirements. Combining FN, FC and FCM proved to be a useful tool for reconstructing diet quality and related physiological patterns.	[Sergiel, Agnieszka; Selva, Nuria] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland; [Barja, Isabel; Navarro-Castilla, Alvaro] Univ Autonoma Madrid, Dept Biol, Madrid, Spain; [Barja, Isabel] Univ Autonoma Madrid, Ctr Invest Biodiversidad & Cambio Global CIBC UAM, Madrid, Spain; [Zwijacz-Kozica, Tomasz] Tatra Natl Pk, Zakopane, Poland	Polish Academy of Sciences; Autonomous University of Madrid; Autonomous University of Madrid	Sergiel, A (corresponding author), Polish Acad Sci, Inst Nat Conservat, Krakow, Poland.	sergiel@iop.krakow.pl	Selva, Nuria/J-6970-2013; Navarro-Castilla, Álvaro/M-7315-2018	Selva, Nuria/0000-0003-3389-201X; Navarro-Castilla, Álvaro/0000-0003-0928-3978; Sergiel, Agnieszka/0000-0002-3455-4218	Polish Ministry of Science and Higher Education [NN304294037]; Polish-Norwegian Research Program [POL-NOR/198352/85/2013]; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant through National Science Centre in Poland [665778, 2016/23/P/NZ9/03951];  [CCG10-UAM/AMB-5325]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Polish-Norwegian Research Program; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant through National Science Centre in Poland; 	The research leading to these results has received funding from the Polish Ministry of Science and Higher Education (project NN304294037; NS), Polish-Norwegian Research Program operated by the National Center for Research and Development in Poland under the Norwegian Financial Mechanism 2009-2014 in the frame of Project Contract No. POL-NOR/198352/85/2013 (GLOBE; NS, AS). AS and NS were partly supported by funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 665778 through National Science Centre in Poland, within the frames of project no. 2016/23/P/NZ9/03951 (BearHealth). Financial support for the hormonal analysis came from project CCG10-UAM/AMB-5325 (IB, ANC). The extraction and quantification of physiological stress were conducted in the Etho-Physiology Laboratory, Universidad Auto ' noma de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; [Anonymous], 2017, LANCET GLOBAL HLTH, V5, pe428; Baldwin RA, 2009, CAN J ZOOL, V87, P1000, DOI 10.1139/Z09-088; Barja I, 2007, J STEROID BIOCHEM, V104, P136, DOI 10.1016/j.jsbmb.2007.03.008; Bergstrom BJ, 2013, J MAMMAL, V94, P436, DOI 10.1644/12-MAMM-A-146.1; Bojarska K, 2014, THESIS; Bojarska K, 2019, GLOB ECOL CONSERV, V17, DOI 10.1016/j.gecco.2019.e00523; Bojarska K, 2012, MAMMAL REV, V42, P120, DOI 10.1111/j.1365-2907.2011.00192.x; BRODY AJ, 1988, CAN J ZOOL, V66, P1482, DOI 10.1139/z88-215; Bryan HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080537; Clauss M, 2010, ZOO BIOL, V29, P687, DOI 10.1002/zoo.20302; Codron D, 2006, AM J PHYS ANTHROPOL, V129, P204, DOI 10.1002/ajpa.20253; Codron D, 2007, J ANIM ECOL, V76, P526, DOI 10.1111/j.1365-2656.2007.01222.x; Coogan SCP, 2018, ECOL EVOL, V8, P2365, DOI 10.1002/ece3.3867; Coogan SCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097968; Costello CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153702; Council of Europe, 2018, TPVS20187 COUNC EUR, P7; Creech TG, 2016, J ARID ENVIRON, V127, P160, DOI 10.1016/j.jaridenv.2015.11.011; Dahle B, 1998, WILDLIFE BIOL, V4, P147, DOI 10.2981/wlb.1998.017; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; Dallman MF, 2004, ENDOCRINOLOGY, V145, P2633, DOI 10.1210/en.2004-0037; Deacy W, 2016, ECOLOGY, V97, P1091, DOI 10.1890/15-1060.1; Deschner T, 2012, RAPID COMMUN MASS SP, V26, P69, DOI 10.1002/rcm.5312; Elfstrom M, 2014, BIOL CONSERV, V178, P128, DOI 10.1016/j.biocon.2014.08.003; Elfstrom M, 2013, WILDLIFE BIOL, V19, P317, DOI 10.2981/12-121; Erlenbach JA, 2014, J MAMMAL, V95, P160, DOI 10.1644/13-MAMM-A-161; Fernandez N, 2012, BIOL CONSERV, V153, P134, DOI 10.1016/j.biocon.2012.04.013; Flezar U, 2019, EUR J WILDLIFE RES, V65, DOI 10.1007/s10344-018-1237-3; FRACKOWIAK W, 1992, ACTA THERIOL, V37, P339; Galvez-Ceron A, 2015, ECOL INDIC, V52, P161, DOI 10.1016/j.ecolind.2014.11.020; Gende SM, 2001, OECOLOGIA, V127, P372, DOI 10.1007/s004420000590; Gil-Jimenez E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125190; Gula R, 2004, WILDLIFE BIOL, V10, P17, DOI 10.2981/wlb.2004.005; Hertel AG, 2018, OIKOS, V127, P197, DOI 10.1111/oik.04515; Janova E, 2015, EUR J WILDLIFE RES, V61, P57, DOI 10.1007/s10344-014-0873-5; Jaworski A., 2002, Journal of Forest Science (Prague), V48, P185; Kamler J, 2003, FOLIA ZOOL, V52, P31; Kavcic I, 2015, WILDLIFE BIOL, V21, P1, DOI 10.2981/wlb.00013; Kershaw JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21889; Konopinski Maciej K., 2018, Chronmy Przyrode Ojczysta, V74, P410; Kozloski GV, 2014, J ANIM PHYSIOL AN N, V98, P659, DOI 10.1111/jpn.12118; Krofel M, 2017, J ZOOL, V302, P8, DOI 10.1111/jzo.12421; LANDERS JL, 1979, J WILDLIFE MANAGE, V43, P143, DOI 10.2307/3800645; Leslie DM, 2008, J WILDLIFE MANAGE, V72, P1420, DOI 10.2193/2007-404; Lopez-Alfaro C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128088; Lopez-Alfaro C, 2013, ECOL MODEL, V270, P1, DOI 10.1016/j.ecolmode1.2013.09.002; Matsuda I, 2018, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00246; MATTSON DJ, 1991, CAN J ZOOL, V69, P1619, DOI 10.1139/z91-226; Mesa-Cruz JB, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou039; <monospace>R</monospace>Development Core Team, 2019, R LANG ENV STAT COMP; Monteith KB, 2014, J MAMMAL, V95, P301, DOI 10.1644/12-MAMM-A-306.1; Mowat G, 2006, CAN J ZOOL, V84, P473, DOI 10.1139/z06-016; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Murray MH, 2016, BIOL CONSERV, V204, P163, DOI 10.1016/j.biocon.2016.10.034; Naves J, 2006, J MAMMAL, V87, P899, DOI 10.1644/05-MAMM-A-318R2.1; Oro D, 2013, ECOL LETT, V16, P1501, DOI 10.1111/ele.12187; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; PATTERSO.RK, 1973, ANAL CHEM, V45, P605, DOI 10.1021/ac60325a050; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; PELLA E, 1973, MIKROCHIM ACTA, P697; Pineiro A, 2012, WILDLIFE RES, V39, P532, DOI 10.1071/WR10218; Prdki R., 2018, ROCZNIKI BIESZCZADZK, V26, P249; Reeder DM, 2004, GEN COMP ENDOCR, V136, P260, DOI 10.1016/j.ygcen.2003.12.020; Rehnus M, 2014, J APPL ECOL, V51, P6, DOI 10.1111/1365-2664.12174; Rigano KS, 2017, J COMP PHYSIOL B, V187, P649, DOI 10.1007/s00360-016-1050-9; Robbins CT, 2007, OIKOS, V116, P1675, DOI 10.1111/j.0030-1299.2007.16140.x; Romero LM, 2017, HBK STRESS SER, V2, P421, DOI 10.1016/B978-0-12-802175-0.00042-5; Romero LM, 2008, AM J PHYSIOL-REG I, V294, pR614, DOI 10.1152/ajpregu.00752.2007; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Selva N, 2011, MANAGEMENT PLAN BROW; Selva N, 2017, BASIC APPL ECOL, V24, P68, DOI 10.1016/j.baae.2017.09.007; Selva N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090740; Selva N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051267; Skuban M, 2016, EUR J WILDLIFE RES, V62, P353, DOI 10.1007/s10344-016-1009-x; Stephens PA, 2005, J APPL ECOL, V42, P4, DOI 10.1111/j.1365-2664.2005.01002.x; Stetz J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055967; Steyaert SMJG, 2012, WILDLIFE BIOL, V18, P431, DOI 10.2981/12-036; Stofik J, 2016, POL J ECOL, V64, P277, DOI 10.3161/15052249PJE2016.64.2.011; Stofik J, 2013, FOLIA ZOOL, V62, P222; STRACK AM, 1995, AM J PHYSIOL-REG I, V268, pR142, DOI 10.1152/ajpregu.1995.268.1.R142; Strandin T, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0088; STUDIER EH, 1994, J MAMMAL, V75, P674, DOI 10.2307/1382515; Szott ID, 2020, WILDLIFE RES, V47, P34, DOI 10.1071/WR19045; Thiel D, 2008, J APPL ECOL, V45, P845, DOI 10.1111/j.1365-2664.2008.01465.x; Ueno M, 2007, ACTA THERIOL, V52, P119, DOI 10.1007/BF03194207; Verheyden H, 2011, WILDLIFE BIOL, V17, P166, DOI 10.2981/10-111; von der Ohe CG, 2004, PHYSIOL BIOCHEM ZOOL, V77, P313, DOI 10.1086/378139; Wasser SK, 2000, GEN COMP ENDOCR, V120, P260, DOI 10.1006/gcen.2000.7557; WASSER SK, 1993, J REPROD FERTIL, V97, P569, DOI 10.1530/jrf.0.0970569; WILBER JP, 1991, ECOL MODEL, V53, P109, DOI 10.1016/0304-3800(91)90144-P; Xu AC, 2006, URSUS, V17, P132; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016; Ziolkowska E, 2016, LANDSCAPE ECOL, V31, P1863, DOI 10.1007/s10980-016-0368-8; Zwijacz-Kozica T, 2017, POL J ECOL, V65, P415, DOI [10.3161/15052249PJE2017.65.4.010, 10.3161/15052249pje2017.65.4.010]; Zwijacz-Kozica T, 2013, ACTA THERIOL, V58, P215, DOI 10.1007/s13364-012-0108-7	95	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242341	10.1371/journal.pone.0242341	http://dx.doi.org/10.1371/journal.pone.0242341			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180870	Green Published, gold			2022-12-26	WOS:000593948000013
J	Terzyan, SS; Nguyen, LT; Burgett, AWG; Heroux, A; Smith, CA; You, Y; Hanigan, MH				Terzyan, Simon S.; Nguyen, Luong T.; Burgett, Anthony W. G.; Heroux, Annie; Smith, Clyde A.; You, Youngjae; Hanigan, Marie H.			Crystal structures of glutathione- and inhibitor-bound human GGT1: critical interactions within the cysteinylglycine binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYL-TRANSPEPTIDASE; ACTIVE-SITE; SUBSTRATE-SPECIFICITY; EXPRESSION; MECHANISM; GGSTOP; POTENT; IDENTIFICATION; TRANSFERASE; PROTECTS	Overexpression of.-glutamyl transpeptidase (GGT1) has been implicated in an array of human diseases including asthma, reperfusion injury, and cancer. Inhibitors are needed for therapy, but development of potent, specific inhibitors of GGT1 has been hampered by a lack of structural information regarding substrate binding and cleavage. To enhance our understanding of the molecular mechanism of substrate cleavage, we have solved the crystal structures of human GGT1 (hGGT1) with glutathione (a substrate) and a phosphate-glutathione analog (an irreversible inhibitor) bound in the active site. These are the first structures of any eukaryotic GGT with the cysteinylglycine region of the substrate-binding site occupied. These structures and the structure of apo-hGGT reveal movement of amino acid residues within the active site as the substrate binds. Asn-401 and Thr-381 each form hydrogen bonds with two atoms of GSH spanning the gamma glutamyl bond. Three different atoms of hGGT1 interact with the carboxyl oxygen of the cysteine of GSH. Interactions between the enzyme and substrate change as the substrate moves deeper into the active site cleft. The substrate reorients and a new hydrogen bond is formed between the substrate and the oxyanion hole. Thr-381 is locked into a single conformation as an acyl bond forms between the substrate and the enzyme. These data provide insight on a molecular level into the substrate specificity of hGGT1 and provide an explanation for seemingly disparate observations regarding the enzymatic activity of hGGT1 mutants. This knowledge will aid in the design of clinically useful hGGT1 inhibitors.	[Terzyan, Simon S.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Lab Biomol Struct & Funct, Oklahoma City, OK 73019 USA; [Nguyen, Luong T.; You, Youngjae] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY USA; [Burgett, Anthony W. G.] Univ Oklahoma, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Oklahoma City, OK 73190 USA; [Heroux, Annie] Brookhaven Natl Lab, Energy Sci Directorate, Photon Sci Div, Upton, NY 11973 USA; [Smith, Clyde A.] Stanford Univ, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA USA; [Hanigan, Marie H.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73019 USA; [Heroux, Annie] Elettra Sincrotrone Trieste SCpA, Basovizza, TS, Italy	University of Oklahoma System; University of Oklahoma Health Sciences Center; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Oklahoma System; University of Oklahoma Health Sciences Center; United States Department of Energy (DOE); Brookhaven National Laboratory; Stanford University; University of Oklahoma System; University of Oklahoma Health Sciences Center; Elettra Sincrotrone Trieste	Hanigan, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73019 USA.	marie-hanigan@ouhsc.edu		Terzyan, Simon/0000-0002-2967-5306; heroux, annie/0000-0001-5713-0525; HANIGAN, MARIE/0000-0002-7646-9871	National Institute of General Medical Sciences of the National Institutes of Health (NIH) [R01GM125952]; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health [P20GM103640]; University of Oklahoma Biomolecular Structure Core; DOE Office of Science [DE-SC0012704, DE-AC02, 98CH10886]; National Center for Research Resources of the National Institutes of Health [P41GM103473, P41GM111244]; Department of Energy (BES); National Institutes of Health (NCRR); NCRR, National Institutes of Health [5 P41 RR001209]; US Department of Energy, Office of Biological and Environmental Research; US Department of Energy, Office of Basic Energy Sciences; Department of Energy (BER); National Institutes of Health (BTP); National Institutes of Health (NIGMS)	National Institute of General Medical Sciences of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health(General Electric); University of Oklahoma Biomolecular Structure Core; DOE Office of Science(United States Department of Energy (DOE)); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Energy (BES)(United States Department of Energy (DOE)); National Institutes of Health (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy (BER)(United States Department of Energy (DOE)); National Institutes of Health (BTP); National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by: National Institute of General Medical Sciences of the National Institutes of Health (NIH); Grant Number R01GM125952 (M. H. H.). Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103640 which supported, in part, this project and The University of Oklahoma Biomolecular Structure Core. This research used resources of the Synchrotron at Brookhaven National Laboratory, a US Department of Energy (DOE), Office of Science User Facility operated for the DOE Office of Science by Brookhaven National Laboratory under Contracts DE-SC0012704, DE-AC02 to 98CH10886 and funded by the National Center for Research Resources of the National Institutes of Health Grant P41GM103473 and P41GM111244. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy (BES, BER) and by the National Institutes of Health (NCRR, BTP, NIGMS). The project described was also supported by Grant Number 5 P41 RR001209 from the NCRR, a component of the National Institutes of Health. US Department of Energy, Offices of Biological and Environmental Research and of Basic Energy Sciences grants.	Alt J, 2015, ANAL BIOCHEM, V474, P28, DOI 10.1016/j.ab.2015.01.001; Chikhi N, 1999, COMP BIOCHEM PHYS B, V122, P367, DOI 10.1016/S0305-0491(99)00013-9; Cooper A.J.L., 2018, COMPREHENSIVE TOXICO, P363, DOI [10.1016/B978-0-12-801238-3.01973-5, DOI 10.1016/B978-0-12-801238-3.01973-5]; Emdin M, 2005, CIRCULATION, V112, P2078, DOI 10.1161/CIRCULATIONAHA.105.571919; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Han L, 2007, BIOCHEMISTRY-US, V46, P1432, DOI 10.1021/bi061890j; HANIGAN MH, 1994, CANCER RES, V54, P5925; Hanigan MH, 1999, CARCINOGENESIS, V20, P553, DOI 10.1093/carcin/20.4.553; Hanigan MH, 1998, CHEM-BIOL INTERACT, V112, P333, DOI 10.1016/S0009-2797(97)00170-1; HANIGAN MH, 1995, CARCINOGENESIS, V16, P181, DOI 10.1093/carcin/16.2.181; Hanigan MH, 2001, AM J PATHOL, V159, P1889, DOI 10.1016/S0002-9440(10)63035-0; Hanna PE, 2019, CRIT REV TOXICOL, V49, P819, DOI 10.1080/10408444.2019.1692191; HEISTERKAMP N, 1991, P NATL ACAD SCI USA, V88, P6303, DOI 10.1073/pnas.88.14.6303; Heisterkamp N, 2008, HUM GENET, V123, P321, DOI 10.1007/s00439-008-0487-7; Hu X, 2012, BIOCHEMISTRY-US, V51, P1199, DOI 10.1021/bi200987b; IKEDA Y, 1993, J BIOL CHEM, V268, P3980; IKEDA Y, 1995, J BIOL CHEM, V270, P12471, DOI 10.1074/jbc.270.21.12471; IKEDA Y, 1995, J BIOL CHEM, V270, P22223, DOI 10.1074/jbc.270.38.22223; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamiyama A, 2016, BIOORGAN MED CHEM, V24, P5340, DOI 10.1016/j.bmc.2016.08.050; Lherbet C, 2004, BIOORG MED CHEM LETT, V14, P3451, DOI 10.1016/j.bmcl.2004.04.072; Lherbet C, 2004, ORG BIOMOL CHEM, V2, P238, DOI 10.1039/b310767a; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakajima M, 2014, BIOORGAN MED CHEM, V22, P1176, DOI 10.1016/j.bmc.2013.12.034; Olver IN, 1998, J CLIN NEUROSCI, V5, P46, DOI 10.1016/S0967-5868(98)90201-6; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; SUZUKI H, 1986, J BACTERIOL, V168, P1325, DOI 10.1128/jb.168.3.1325-1331.1986; Tamura K, 2016, AM J PHYSIOL-GASTR L, V311, pG305, DOI 10.1152/ajpgi.00439.2015; Terzyan SS, 2017, PROTEIN SCI, V26, P1196, DOI 10.1002/pro.3172; Terzyan SS, 2015, J BIOL CHEM, V290, P17576, DOI 10.1074/jbc.M115.659680; Tuzova M, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00179; Watanabe B, 2017, BIOORG MED CHEM LETT, V27, P4920, DOI 10.1016/j.bmcl.2017.09.017; West MB, 2013, J BIOL CHEM, V288, P31902, DOI 10.1074/jbc.M113.498139; Wickham S, 2013, BIOCHEM J, V450, P547, DOI 10.1042/BJ20121435; Wickham S, 2011, ANAL BIOCHEM, V414, P208, DOI 10.1016/j.ab.2011.03.026; Yamamoto S, 2011, J PHARMACOL EXP THER, V339, P945, DOI 10.1124/jpet.111.183004	38	3	3	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100066	10.1074/jbc.RA120.016265	http://dx.doi.org/10.1074/jbc.RA120.016265			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33187988	Green Published, gold			2022-12-26	WOS:000672866400047
J	Salles, TCG; Cerrato, SG; Santana, TF; Medeiros, EA				Salles, Thais Cristina Garbelini; Cerrato, Santiago Grau; Santana, Tatiana Fiscina; Medeiros, Eduardo Alexandrino			Factors associated with successful completion of outpatient parenteral antibiotic therapy in an area with a high prevalence of multidrug-resistant bacteria: 30-day hospital admission and mortality rates	PLOS ONE			English	Article							ANTIMICROBIAL THERAPY; OPAT; SAFETY; MANAGEMENT; EFFICACY; OUTCOMES; COHORT; HOME	Objectives To identify factors associated with hospital admission and mortality within the first 30 days after enrolment in an outpatient parenteral antimicrobial therapy (OPAT) program, also analysing adequacy of the treatment regimen and clinical outcomes. Patients and methods This was a retrospective cohort study conducted between October 2016 and June 2017 in the state of Sao Paulo, Brazil. Variables related to hospital admission and mortality were subjected to bivariate analysis, and those with a PResults We evaluated 276 patients, of whom 80.5% were >= 60 years of age and 69.9% had more than one comorbidity. Of the patients evaluated, 41.3% had pneumonia and 35.1% had a urinary tract infection. The most common etiological agent, isolated in 18 (31.6%) cases, was Klebsiella pneumoniae, and 13 (72,2%) strains were carbapenem resistant. The OPAT was in accordance with the culture results in 76.6% of the cases and with the institutional protocols in 76.4%. The majority (64.5%) of the patients were not admitted, and a cure or clinical improvement was achieved in 78.6%. Multivariate analysis showed that, within the first 30 days after enrolment, the absence of a physician office visit was a predictor of hospital admission (P<0.001) and mortality (P = 0.006). Conclusions This study demonstrated the viability of OPAT in elderly patients with pulmonary or urinary tract infections in an area with a high prevalence of multidrug-resistant bacteria and that a post-discharge physician office visit is protective against hospital admission and mortality.	[Salles, Thais Cristina Garbelini; Medeiros, Eduardo Alexandrino] Univ Fed Sao Paulo, Paulista Sch Med, Dept Internal Med, Div Infect Dis, Sao Paulo, SP, Brazil; [Salles, Thais Cristina Garbelini] Hosp Santa Helena, Santo Andre, SP, Brazil; [Cerrato, Santiago Grau] Autonomous Univ Barcelona, Campus UAB, Barcelona, Spain; [Santana, Tatiana Fiscina] UnitedHlth Grp, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Autonomous University of Barcelona	Salles, TCG (corresponding author), Univ Fed Sao Paulo, Paulista Sch Med, Dept Internal Med, Div Infect Dis, Sao Paulo, SP, Brazil.; Salles, TCG (corresponding author), Hosp Santa Helena, Santo Andre, SP, Brazil.	thais.salles@yahoo.com.br	Medeiros, Eduardo Alexandrino/B-9825-2012	Medeiros, Eduardo Alexandrino/0000-0002-6205-259X; Salles, Thais/0000-0002-5146-234X	Hospital Epidemiology Research Group of the Federal University of Sao Paulo; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)	Hospital Epidemiology Research Group of the Federal University of Sao Paulo; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Hospital Epidemiology Research Group of the Federal University of Sao Paulo, registered with the Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, National Council for Scientific and Technological Development). The company United Health Group provided support in the form of salaries for authors T.C.G.S. and E.A.M, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2018, U TORONTO LAW J S1, V68, P1, DOI DOI 10.1007/S11881-018-0158-X; Barr DA, 2012, INT J ANTIMICROB AG, V39, P407, DOI 10.1016/j.ijantimicag.2012.01.016; Chapman ALN, 2019, J ANTIMICROB CHEMOTH, V74, P3125, DOI 10.1093/jac/dkz343; DHOORE W, 1993, METHOD INFORM MED, V32, P382; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Lopardo G, 2001, CHEMOTHERAPY, V47, P24, DOI 10.1159/000048565; MacKenzie M, 2014, INT J ANTIMICROB AG, V43, P7, DOI 10.1016/j.ijantimicag.2013.09.006; Matthews PC, 2007, J ANTIMICROB CHEMOTH, V60, P356, DOI 10.1093/jac/dkm210; Mazzariol A, 2017, J CHEMOTHERAPY, V29, P2, DOI [10.1080/1120009x.2017.1380395, 10.1080/1120009X.2017.1380395]; Messina JA, 2016, INFECT CONT HOSP EP, V37, P281, DOI 10.1017/ice.2015.298; Nathwani D, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-476; Oliveira PR, 2017, BRAZ J INFECT DIS, V21, P648, DOI 10.1016/j.bjid.2017.06.006; Oliveira PR, 2016, BRAZ J INFECT DIS, V20, P272, DOI 10.1016/j.bjid.2016.03.005; Ortiz-Alvarez A, 2019, INFECT DRUG RESIST, V12, P111, DOI 10.2147/IDR.S173468; Palms DL, 2019, CLIN INFECT DIS, Vii, pciz150; Pena A, 2013, REV CHIL INFECTOL, V30, P426, DOI 10.4067/S0716-10182013000400012; Perez-Lopez J, 2008, INT J CLIN PRACT, V62, P1188, DOI 10.1111/j.1742-1241.2008.01747.x; Psaltikidis EM, 2019, EXPERT REV PHARM OUT, V19, P341, DOI 10.1080/14737167.2019.1541404; Ramos-Castaneda JA, 2018, J INFECTION, V76, P438, DOI 10.1016/j.jinf.2018.02.007; RUCKER RW, 1974, PEDIATRICS, V54, P358; Saini E, 2019, CLIN INFECT DIS, pciz073; Seetoh T, 2013, INT J ANTIMICROB AG, V41, P569, DOI 10.1016/j.ijantimicag.2013.01.015; van Duin D, 2017, VIRULENCE, V8, P460, DOI 10.1080/21505594.2016.1222343; World Health Organization, 1992, INT STAT CLASS DIS R	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241595	10.1371/journal.pone.0241595	http://dx.doi.org/10.1371/journal.pone.0241595			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206669	gold, Green Published			2022-12-26	WOS:000595265900077
J	Younes, ST; Herrington, B				Younes, Subhi Talal; Herrington, Betty			In silico analysis identifies a putative cell-of-origin for BRAF fusion-positive cerebellar pilocytic astrocytoma	PLOS ONE			English	Article							CHILDHOOD; MEDULLOBLASTOMA; EXPRESSION; LEUKEMIA; TRANSLOCATIONS; LANDSCAPE; BIRTH	Childhood cancers are increasingly recognized as disorders of cellular development. This study sought to identify the cellular and developmental origins of cerebellar pilocytic astrocytoma, the most common brain tumor of childhood. Using publicly available gene expression data from pilocytic astrocytoma tumors and controlling for driver mutation, a set of developmental-related genes which were overexpressed in cerebellar pilocytic astrocytoma was identified. These genes were then mapped onto several developmental atlases in order to identify normal cells with similar gene expression patterns and the developmental trajectory of those cells was interrogated. Eight known neuro-developmental genes were identified as being expressed in cerebellar pilocytic astrocytoma. Mapping those genes or their orthologs onto mouse neuro-developmental atlases identified overlap in their expression within the ventricular zone of the cerebellar anlage. Further analysis with a single cell RNA-sequencing atlas of the developing mouse cerebellum defined this overlap as occurring in ventricular zone progenitor cells at the division point between GABA-ergic neuronal and glial lineages, a developmental trajectory which closely mirrors that previously described to occur within pilocytic astrocytoma cells. Furthermore, ventricular zone progenitor cells and their progeny exhibited evidence of MAPK pathway activation, the paradigmatic oncogenic cascade known to be active in cerebellar pilocytic astrocytoma. Gene expression from developing human brain atlases recapitulated the same anatomic localizations and developmental trajectories as those found in mice. Taken together, these data suggest this population of ventricular zone progenitor cells as the cell-of-origin for BRAF fusion-positive cerebellar pilocytic astrocytoma.	[Younes, Subhi Talal] Univ Mississippi, Med Ctr, MD PhD Program, Jackson, MS 39216 USA; [Younes, Subhi Talal] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA; [Herrington, Betty] Univ Mississippi, Med Ctr, Div Pediat Hematol Oncol, Dept Pediat, Jackson, MS 39216 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Younes, ST (corresponding author), Univ Mississippi, Med Ctr, MD PhD Program, Jackson, MS 39216 USA.; Younes, ST (corresponding author), Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA.	styounes@icloud.com		Younes, Subhi Talal/0000-0003-4320-0355	NIH [P20GM104357, U54GM115428]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors received funding for open access fees from the following: NIH grants P20GM104357 (University of Mississippi Medical Center COBRE) and U54GM115428 (Mississippi Center for Clinical and Translational Research).; Thanks to Kurt Showmaker, Ph.D. for careful review of the statistical and bioinformatic methodology used. The authors would like to thank the following persons for reviewing the manuscript and providing helpful feedback: Michael J. Ryan, Ph.D.; Cynthia Karlson, Ph.D.; and Jason Engel, Ph.D. Dr. Younes issues a special thanks to his wife, Hannah Younes, for her patience, kindness, helpful comments, and steadfast support.	Alexa A., 2019, GENE SET ENRICHMENT; Anastas JN, 2019, CANCER CELL, V36, P528, DOI 10.1016/j.ccell.2019.09.005; Antonelli Manila, 2018, Oncotarget, V9, P13807, DOI 10.18632/oncotarget.24480; Armstrong GT, 2011, NEURO-ONCOLOGY, V13, P223, DOI 10.1093/neuonc/noq178; Baker SJ, 2016, GLIA, V64, P879, DOI 10.1002/glia.22945; CARLSON M, 2016, HGU133PLUS2 DB AFFYM; Carter RA, 2018, CURR BIOL, V28, P2910, DOI 10.1016/j.cub.2018.07.062; Cin H, 2011, ACTA NEUROPATHOL, V121, P763, DOI 10.1007/s00401-011-0817-z; Filbin M, 2019, NAT MED, V25, P367, DOI 10.1038/s41591-019-0383-9; Gale KB, 1997, P NATL ACAD SCI USA, V94, P13950, DOI 10.1073/pnas.94.25.13950; Gentleman R., 2019, R PACKAGE; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Grobner SN, 2018, NATURE, V555, P321, DOI 10.1038/nature25480; Hjalgrim LL, 2002, BRIT J CANCER, V87, P994, DOI 10.1038/sj.bjc.6600601; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Jeyapalan JN, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0323-6; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Jones DTW, 2012, CELL MOL LIFE SCI, V69, P1799, DOI 10.1007/s00018-011-0898-9; Kanton S, 2019, NATURE, V574, P418, DOI 10.1038/s41586-019-1654-9; Kaul A, 2012, GENE DEV, V26, P2561, DOI 10.1101/gad.200907.112; Krijthe J., 2015, RTSNE T DISTRUBTED S; Lambert SR, 2013, ACTA NEUROPATHOL, V126, P291, DOI 10.1007/s00401-013-1124-7; Lawson ARJ, 2010, ACTA NEUROPATHOL, V120, P271, DOI 10.1007/s00401-010-0693-y; Lin CY, 2016, NATURE, V530, P57, DOI 10.1038/nature16546; Lucas A., 2019, **DATA OBJECT**; Maaten L van der, 2014, J MACH LEARN RES; Martinez S, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00018; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Monje M, 2011, P NATL ACAD SCI USA, V108, P4453, DOI 10.1073/pnas.1101657108; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Packer RJ, 2008, J CHILD NEUROL, V23, P1122, DOI 10.1177/0883073808320758; Ramaswamy V, 2016, ACTA NEUROPATHOL, V131, P821, DOI 10.1007/s00401-016-1569-6; Reitman ZJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11493-2; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Selt F, 2017, ONCOTARGET, V8, P11460, DOI 10.18632/oncotarget.14004; Sharma MK, 2007, CANCER RES, V67, P890, DOI 10.1158/0008-5472.CAN-06-0973; Tian YJ, 2011, J MOL DIAGN, V13, P669, DOI 10.1016/j.jmoldx.2011.07.002; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vladoiu MC, 2019, NATURE, V572, P67, DOI 10.1038/s41586-019-1158-7; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Wiemels JL, 1999, LANCET, V354, P1499, DOI 10.1016/S0140-6736(99)09403-9; Wiemels JL, 2002, BLOOD, V99, P3801, DOI 10.1182/blood.V99.10.3801; Zakrzewski K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1810-z; Zhang JH, 2013, NAT GENET, V45, P602, DOI 10.1038/ng.2611	52	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242521	10.1371/journal.pone.0242521	http://dx.doi.org/10.1371/journal.pone.0242521			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206716	Green Published, gold			2022-12-26	WOS:000595265900070
J	Cromar, KR; Ghazipura, M; Gladson, LA; Perlmutt, L				Cromar, Kevin R.; Ghazipura, Marya; Gladson, Laura A.; Perlmutt, Lars			Evaluating the US Air Quality Index as a risk communication tool: Comparing associations of index values with respiratory morbidity among adults in California	PLOS ONE			English	Article							SHORT-TERM EXPOSURE; HEALTH INDEX; POLLUTION; ASTHMA	Background The Air Quality Index (AQI) in the United States is widely used to communicate daily air quality information to the public. While use of the AQI has led to reported changes in individual behaviors, such behavior modifications will only mitigate adverse health effects if AQI values are indicative of public health risks. Few studies have assessed the capability of the AQI to accurately predict respiratory morbidity risks. Methods and findings In three major regions of California, Poisson generalized linear models were used to assess seasonal associations between 1,373,165 respiratory emergency department visits and short-term exposure to multiple metrics between 2012-2014, including: daily concentrations of NO2, O-3, and PM2.5; the daily reported AQI; and a newly constructed health-based air quality index. AQI values were positively associated (average risk ratio = 1.03, 95% CI 1.02-1.04) during the cooler months of the year (November-February) in all three regions when the AQI was very highly correlated with PM2.5 (R-2 >= 0.89). During the warm season (March-October) in the San Joaquin Valley region, neither AQI values nor the individual underlying air pollutants were associated with respiratory morbidity. Additionally, AQI values were not positively associated with respiratory morbidity in the Southern California region during the warm season, despite strong associations of the individual underlying air pollutants with respiratory morbidity; in contrast, health-based index values were observed to be significantly associated with respiratory morbidity as part of an applied policy analysis in this region, with a combined risk ratio of 1.02 (95% CI: 1.01-1.03). Conclusions In regions where individual air pollutants are associated with respiratory morbidity, and during seasons with relatively simple air mixtures, the AQI can effectively serve as a risk communication tool for respiratory health risks. However, the predictive ability of the AQI and any other index is contingent upon the monitored values being representative of actual population exposures. Other approaches, such as health-based indices, may be needed in order to effectively communicate health risks of air pollution in regions and seasons with more complex air mixtures.	[Cromar, Kevin R.; Gladson, Laura A.; Perlmutt, Lars] NYU, Marron Inst Urban Management, New York, NY 10003 USA; [Cromar, Kevin R.; Ghazipura, Marya] NYU, Sch Med, New York, NY 10003 USA	New York University; New York University	Cromar, KR (corresponding author), NYU, Marron Inst Urban Management, New York, NY 10003 USA.; Cromar, KR (corresponding author), NYU, Sch Med, New York, NY 10003 USA.	kevin.cromar@nyu.edu		Cromar, Kevin/0000-0002-7745-2780; Ghazipura, Marya/0000-0003-4328-6822	Marron Institute or Urban Management	Marron Institute or Urban Management	This study was funded by the Marron Institute or Urban Management; funding organization had no role in the study design, data collection/analysis, decision to publish or preparation of the manuscript.	American Thoracic Society, 2018, AM THOR SOC CLIN PRA; Balluz L, 2007, PUBLIC HEALTH REP, V122, P626, DOI 10.1177/003335490712200510; Borbet TC, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5418-5; Cairncross EK, 2007, ATMOS ENVIRON, V41, P8442, DOI 10.1016/j.atmosenv.2007.07.003; Carlsten C, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.02056-2019; Chen H., 2013, REV AIR QUALITY INDE; Chen RJ, 2013, ENVIRON INT, V51, P168, DOI 10.1016/j.envint.2012.11.008; Cheng WL, 2007, SCI TOTAL ENVIRON, V382, P191, DOI 10.1016/j.scitotenv.2007.04.036; Cromar KR, 2019, ANN AM THORAC SOC, V16, P1207, DOI 10.1513/AnnalsATS.201906-477ST; Cromar KR, 2018, ANN AM THORACIC SOC; Fang X, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011487; Glatting G, 2007, MED PHYS, V34, P4285, DOI 10.1118/1.2794176; Kyrkilis G, 2007, ENVIRON INT, V33, P670, DOI 10.1016/j.envint.2007.01.010; Letz AG, 2005, ALLERGY ASTHMA PROC, V26, P463; Li X, 2017, ENVIRON POLLUT, V220, P487, DOI 10.1016/j.envpol.2016.09.091; McDermott M, 2006, J ASTHMA, V43, P235, DOI 10.1080/02770900600567114; Neidell M, 2010, J EPIDEMIOL COMMUN H, V64, P921, DOI 10.1136/jech.2008.081489; Perlmutt LD, 2019, ATMOS ENVIRON, V202, P1, DOI 10.1016/j.atmosenv.2019.01.011; Perlmutt LD, 2019, J ENVIRON HEALTH, V81, P8; Pratt GC, 2015, INT J ENV RES PUB HE, V12, P5355, DOI 10.3390/ijerph120505355; Rice MB, 2013, AM J RESP CRIT CARE, V188, P1351, DOI 10.1164/rccm.201308-1414OC; Robichaud A, 2016, AIR QUAL ATMOS HLTH, V9, P743, DOI 10.1007/s11869-015-0385-9; Ruggieri M, 2012, SCI TOTAL ENVIRON, V420, P263, DOI 10.1016/j.scitotenv.2011.09.019; Sicard P, 2011, ATMOS ENVIRON, V45, P1145, DOI 10.1016/j.atmosenv.2010.12.052; Stieb DM, 2008, J AIR WASTE MANAGE, V58, P435, DOI 10.3155/1047-3289.58.3.435; Stieb DM, 2005, J TOXICOL ENV HEAL A, V68, P1275, DOI 10.1080/15287390590936120; To T, 2013, ENVIRON HEALTH PERSP, V121, P46, DOI 10.1289/ehp.1104816; U.S. EPA, 2017, PART POLL YOUR PAT H; United States Environmental Protection Agency [US EPA], 2017, AIR DAT AIR QUAL DAT; US Census Bureau, 2020, SMALL AR INC POV EST; US Environmental Protection Agency, 2017, AIR QUAL NAT SUMM; Wang L, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121196; Ward ALS, 2016, ENVIRON RESOUR ECON, V65, P487, DOI 10.1007/s10640-015-9915-z; Wells EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050526; Wen XJ, 2009, J COMMUN HEALTH, V34, P40, DOI 10.1007/s10900-008-9126-4; Wong TW, 2013, ATMOS ENVIRON, V76, P52, DOI 10.1016/j.atmosenv.2012.06.071; Yang L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-165	37	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242031	10.1371/journal.pone.0242031	http://dx.doi.org/10.1371/journal.pone.0242031			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201930	gold, Green Published			2022-12-26	WOS:000595003900027
J	Konishi, H; Miyauchi, K; Onishi, A; Suzuki, S; Fuchimoto, D; Shitara, J; Endo, H; Wada, H; Doi, S; Naito, R; Ogita, M; Dohi, T; Kasai, T; Daida, H				Konishi, Hirokazu; Miyauchi, Katsumi; Onishi, Akira; Suzuki, Shunichi; Fuchimoto, Daiichiro; Shitara, Jun; Endo, Hirohisa; Wada, Hideki; Doi, Shinichiro; Naito, Ryo; Ogita, Manabu; Dohi, Tomotaka; Kasai, Takatoshi; Daida, Hiroyuki			Effect of pemafibrate (K-877), a novel selective peroxisome proliferator-activated receptor alpha modular (SPPARM alpha), in atherosclerosis model using low density lipoprotein receptor knock-out swine with balloon injury	PLOS ONE			English	Article							PPAR-ALPHA; DOUBLE-BLIND; FENOFIBRATE; COMBINATION; EXPRESSION; EFFICACY; THERAPY	Background Peroxisome proliferator-activated receptor alpha (PPAR alpha) is a nuclear receptor that has key roles of lipid metabolism and inflammation. The PPAR alpha may affects the initiation and progression of atherosclerosis by reducing inflammatory responses. Pemafibrate (K-877) is a novel selective PPAR alpha modulator (SPPARM alpha), which was designed to possess higher PPAR alpha potency and selectivity than existing PPAR alpha agonists. The aim of this study is to evaluate the effect of pemafibrate on vascular response in coronary atherosclerosis model using low density lipoprotein receptor knock-out (LDLR-KO) pigs with balloon injury. Methods and results Ten LDLR-KO pigs were randomly allocated to two groups [pemafibrate (n = 5) and control (n = 5)] and fed with a diet containing 2.0% cholesterol and 20% lard throughout the study. Balloon injury was created in 40 coronary segments two weeks after starting the oral administration of pemafibrate or placebo. Necropsy was conducted 8 weeks later. Coronary artery sections were reviewed to evaluate lesion progression and the mRNA expression levels for C-Jun, NF kappa B, CCL2, CCR7, CD163 and MMP9 determined using real-time RT-PCR. LDL cholesterol at baseline was about 700 mg/dL. The mean ratio of macrophages to plaque area was significantly lower in pemafibrate group compared with control one (7.63 +/- 1.16 vs 14.04 +/- 4.51, P = 0.02) whereas no differences were observed in intimal area between groups. The mRNA levels of C-Jun, NF kappa B and MMP9 were significantly decreased in pemafibrate group. Conclusions Pemafibrate was associated with inhibition of inflammatory responses in coronary artery atherosclerosis model using LDLR-KO swine with balloon injury.	[Konishi, Hirokazu; Miyauchi, Katsumi; Shitara, Jun; Endo, Hirohisa; Wada, Hideki; Doi, Shinichiro; Naito, Ryo; Ogita, Manabu; Dohi, Tomotaka; Kasai, Takatoshi; Daida, Hiroyuki] Juntendo Univ, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan; [Onishi, Akira] Nihon Univ, Coll Bioresource Sci, Dept Anim Sci & Resources, Lab Anim Reprod, Fujisawa, Kanagawa, Japan; [Suzuki, Shunichi; Fuchimoto, Daiichiro] Natl Agr & Food Res Org NARO, Div Anim Sci, Inst Agrobiol Sci, Ibaraki, Japan	Juntendo University; Nihon University; National Agriculture & Food Research Organization - Japan	Miyauchi, K (corresponding author), Juntendo Univ, Dept Cardiovasc Med, Grad Sch Med, Tokyo, Japan.	ktmmy@juntendo.ac.jp	Dohi, Tomotaka/ABH-3047-2021	Dohi, Tomotaka/0000-0002-6646-468X				Arai H, 2017, ATHEROSCLEROSIS, V261, P144, DOI 10.1016/j.atherosclerosis.2017.03.032; CATAPANO AL, 2016, ATHEROSCLEROSIS, V253, P281, DOI [DOI 10.1016/J.ATHER0SCLER0SIS.2016.08.018, 10.1093/eurheartj/ehw272]; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Fruchart JC, 2001, PHARMACOL RES, V44, P345, DOI 10.1006/phrs.2001.0871; Fruchart JC, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0864-7; Fruchart JC, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0602-y; Fruchart JC, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-82; Gervois P, 2004, J BIOL CHEM, V279, P16154, DOI 10.1074/jbc.M400346200; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Granada JF, 2009, EUROINTERVENTION, V5, P140, DOI 10.4244/EIJV5I1A22; Hennuyer N, 2016, ATHEROSCLEROSIS, V249, P200, DOI 10.1016/j.atherosclerosis.2016.03.003; Ishibashi S, 2016, ATHEROSCLEROSIS, V249, P36, DOI 10.1016/j.atherosclerosis.2016.02.029; Kasai T, 2006, ATHEROSCLEROSIS, V188, P274, DOI 10.1016/j.atherosclerosis.2005.10.047; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Kikuchi K, 2002, BIOL REPROD, V66, P1033, DOI 10.1095/biolreprod66.4.1033; Li YX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002779; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Marx N, 1999, CIRCULATION, V99, P3125, DOI 10.1161/01.CIR.99.24.3125; Ogita M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163055; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Shu H, 2000, BIOCHEM BIOPH RES CO, V267, P345, DOI 10.1006/bbrc.1999.1968; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Yamashita S, 2018, J CLIN LIPIDOL, V12, P1267, DOI 10.1016/j.jacl.2018.06.010; Yamazaki Y, 2007, BIOORG MED CHEM LETT, V17, P4689, DOI 10.1016/j.bmcl.2007.05.066	25	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0241195	10.1371/journal.pone.0241195	http://dx.doi.org/10.1371/journal.pone.0241195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201888	Green Published, gold			2022-12-26	WOS:000595003900044
J	Park, SO; Chang, H; Imanishi, N				Park, Seong Oh; Chang, Hak; Imanishi, Nobuaki			Differences of the midline-crossing venous drainage pattern in supraumbilical and infraumbilical regions: Angiographic study using fresh cadavers	PLOS ONE			English	Article							INFERIOR EPIGASTRIC PERFORATOR; FLAP BREAST RECONSTRUCTION; DIEP FLAP; SYSTEM; SUPERDRAINAGE; CONGESTION; VEINS; SIEV	Current clinical and anatomical studies show that the venous problem associated with the deep inferior epigastric perforator flap results from poor midline-crossing. We examined the venous anatomy of the infraumbilical midline area and the dynamic venous flow of the deep inferior epigastric perforator flap in nine fresh cadavers. All nine abdominal specimens were harvested between the subcostal margin and the groin crease. Two specimens were used to analyze the abdominal venous anatomy, one of which was divided into two hemi-abdominal specimens. The remaining seven specimens were harvested as deep inferior epigastric perforator flaps with one major paraumbilical perforator. Venous cannulation and serial angiographic agent injection were performed in several conditions. Each specimen was radiographed using a soft X-ray system. For additional information, computed tomography (CT) angiography-visualized superficial inferior epigastric veins (SIEVs) and the supraumbilical branch were analyzed. We noted that the venous drainage between the bilateral SIEVs was easier to configure in the supraumbilical area than in the infraumbilical area. Only one to two short polygonal venous networks connect the bilateral superficial inferior epigastric veins in the supraumbilical area; however, long and multiple polygonal venous networks connect the bilateral superficial inferior epigastric veins in the infraumbilical area, which could be a predisposing factor for venous congestion. The mean distance from the umbilicus upper border to evident supraumbilical midline crossover was 18.39 +/- 4.03 mm (range: 10.10-28.49) in CT angiograms. In cadaver specimens, the mean distance was 10.87 +/- 4.85 mm (range: 4.6-18.9). Supraumbilical midline crossover was more favorable than infraumbilical midline crossover in venous flow.	[Park, Seong Oh] Hanyang Univ, Dept Plast & Reconstruct Surg, Coll Med, Med Ctr, Seoul, South Korea; [Chang, Hak] Seoul Natl Univ, Coll Med, Dept Plast & Reconstruct Surg, Seoul, South Korea; [Imanishi, Nobuaki] Keio Univ, Dept Anat, Coll Med, Tokyo, Japan	Hanyang University; Seoul National University (SNU); Keio University	Chang, H (corresponding author), Seoul Natl Univ, Coll Med, Dept Plast & Reconstruct Surg, Seoul, South Korea.	hchang@snu.ac.kr			Hanyang University [HY-2020]	Hanyang University	This work was supported by the research fund of Hanyang University(HY-2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayestaray B, 2016, ANN PLAS SURG, V76, P78, DOI 10.1097/SAP.0000000000000581; Blondeel PN, 2000, PLAST RECONSTR SURG, V106, P1295, DOI 10.1097/00006534-200011000-00009; Boutros SG, 2013, PLAST RECONSTR SURG, V131, P671, DOI 10.1097/PRS.0b013e31828189e6; Chang H, 2019, JOVE-J VIS EXP, DOI 10.3791/57732; Enajat M, 2010, MICROSURG, V30, P185, DOI 10.1002/micr.20712; Eom JS, 2016, PLAST RECONSTR SURG, V137, p7E, DOI 10.1097/PRS.0000000000001867; Gravvanis A, 2014, MICROSURG, V34, P169, DOI 10.1002/micr.22193; Imanishi N, 2003, BRIT J PLAST SURG, V56, P552, DOI 10.1016/S0007-1226(03)00207-8; Kwon SS, 2009, SCAND J PLAST RECONS, V43, P312, DOI 10.1080/02844310902955821; Lee KT, 2017, MICROSURG, V37, P75, DOI 10.1002/micr.22420; Lee KT, 2016, PLAST RECONSTR SURG, V137, p771E, DOI 10.1097/PRS.0000000000002045; Lie KH, 2014, PLAST RECONSTR SURG, V133, p790E, DOI 10.1097/PRS.0000000000000228; Lie KH, 2013, PLAST RECONSTR SURG, V132, P1401, DOI 10.1097/01.prs.0000434402.06564.bd; Rothenberger J, 2013, J PLAST RECONSTR AES, V66, P67, DOI 10.1016/j.bjps.2012.08.020; Rozen WM, 2009, PLAST RECONSTR SURG, V124, P848, DOI 10.1097/PRS.0b013e3181b037a2; Schaverien M, 2008, PLAST RECONSTR SURG, V121, P1909, DOI 10.1097/PRS.0b013e31817151f8; Wechselberger G, 2001, PLAST RECONSTR SURG, V108, P162, DOI 10.1097/00006534-200107000-00026; Xin Q, 2012, J RECONSTR MICROSURG, V28, P313, DOI 10.1055/s-0032-1311688	18	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242214	10.1371/journal.pone.0242214	http://dx.doi.org/10.1371/journal.pone.0242214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196658	Green Published, gold			2022-12-26	WOS:000595266800013
J	Guo, Y; Wang, QJ; Zhang, KH; Yao, CY; Huang, J; Li, Q; Liu, ZY; Zhang, Y; Shan, CH; Liu, P; Wang, MZ; An, L; Tian, JH; Wu, ZH				Guo, Yao; Wang, Qiang-Jun; Zhang, Ke-Hao; Yao, Chun-Yan; Huang, Jie; Li, Qin; Liu, Zhong-Ying; Zhang, Yu; Shan, Chun-Hua; Liu, Peng; Wang, Mei-Zhi; An, Lei; Tian, Jian-Hui; Wu, Zhong-Hong			Night-restricted feeding improves locomotor activity rhythm and modulates nutrient utilization to accelerate growth in rabbits	FASEB JOURNAL			English	Article						adolescent obesity; circadian rhythm; core body temperature; muscle growth; night&#8208; restricted feeding	MUSCLE INSULIN SENSITIVITY; BODY-TEMPERATURE RHYTHMS; CIRCADIAN CLOCK; SKELETAL-MUSCLE; THYROID-HORMONE; ENERGY-METABOLISM; US CHILDREN; OBESITY; TIME; GENE	An unfavorable lifestyle disrupts the circadian rhythm, leading to metabolic dysfunction in adult humans and animals. Increasing evidence suggests that night-restricted feeding (NRF) can effectively prevent ectopic fat deposition caused by circadian rhythm disruption, and reduce the risk of metabolic diseases. However, previous studies have mainly focused on the prevention of obesity in adults by regulating dietary patterns, whereas limited attention has been paid to the effect of NRF on metabolism during growth and development. Here, we used weaning rabbits as models and found that NRF increased body weight gain without increasing feed intake, and promoted insulin-mediated protein synthesis through the mTOR/S6K pathway and muscle formation by upregulating MYOG. NRF improved the circadian clock, promoted PDH-regulated glycolysis and CPT1B-regulated fatty-acid beta-oxidation, and reduced fat content in the serum and muscles. In addition, NRF-induced body temperature oscillation might be partly responsible for the improvement in the circadian clock and insulin sensitivity. Time-restricted feeding could be used as a nondrug intervention to prevent obesity and accelerate growth in adolescents.	[Guo, Yao; Wang, Qiang-Jun; Zhang, Ke-Hao; Yao, Chun-Yan; Huang, Jie; Li, Qin; Liu, Zhong-Ying; Zhang, Yu; Shan, Chun-Hua; Liu, Peng; Wang, Mei-Zhi; Wu, Zhong-Hong] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, 2 Yuanmingyuan West, Beijing 100193, Peoples R China; [An, Lei; Tian, Jian-Hui] China Agr Univ, Coll Anim Sci & Technol, Natl Engn Lab Anim Breeding, Beijing, Peoples R China	China Agricultural University; China Agricultural University	Wu, ZH (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, 2 Yuanmingyuan West, Beijing 100193, Peoples R China.	wuzhh@cau.edu.cn	An, Lei/GQB-0039-2022	Guo, Yao/0000-0002-4691-5623	National Key Reseach and Development Program of China [2016YFD0500506]; Earmarked fund for China Agriculture Research System for Rabbits [CARS-43-D-1]	National Key Reseach and Development Program of China; Earmarked fund for China Agriculture Research System for Rabbits	National Key Reseach and Development Program of China, Grant/Award Number: 2016YFD0500506; Earmarked fund for China Agriculture Research System for Rabbits, Grant/Award Number: CARS-43-D-1	Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Benham CD, 2003, CELL CALCIUM, V33, P479, DOI 10.1016/S0143-4160(03)00063-0; BIANCO AC, 1988, J BIOL CHEM, V263, P18168; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Burgoine T, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0713-1; Chahal H, 2013, PEDIATR OBES, V8, P42, DOI 10.1111/j.2047-6310.2012.00085.x; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chung H, 2016, METABOLISM, V65, P1743, DOI 10.1016/j.metabol.2016.09.006; COMTE B, 1990, METABOLISM, V39, P259, DOI 10.1016/0026-0495(90)90044-D; Denzer C, 2007, INT J OBESITY, V31, P1509, DOI 10.1038/sj.ijo.0803691; Diop SB, 2015, TRENDS ENDOCRIN MET, V26, P618, DOI 10.1016/j.tem.2015.09.009; Dungan CM, 2016, LIPIDS, V51, P905, DOI 10.1007/s11745-016-4168-3; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Fernandez-Twinn DS, 2006, PHYSIOL BEHAV, V88, P234, DOI 10.1016/j.physbeh.2006.05.039; Francisco V, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00640; Gidenne T, 2012, ANIMAL, V6, P1407, DOI 10.1017/S1751731112000389; Guerrot D, 2011, J CLIN ENDOCR METAB, V96, pE929, DOI 10.1210/jc.2010-2337; Hatori M, 2012, CELL METAB, V15, P848, DOI 10.1016/j.cmet.2012.04.019; Himes JH, 2006, MOL CELL ENDOCRINOL, V254, P13, DOI 10.1016/j.mce.2006.04.013; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Ihara T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23115-w; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jackson-Hayes L, 2003, J BIOL CHEM, V278, P7964, DOI 10.1074/jbc.M211062200; James FO, 2007, SLEEP, V30, P1427, DOI 10.1093/sleep/30.11.1427; JILGE B, 1995, PHYSIOL BEHAV, V58, P131, DOI 10.1016/0031-9384(95)00006-5; Kim TW, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/591729; Kimani-Murage EW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-158; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee J, 2011, ISLETS, V3, P381, DOI 10.4161/isl.3.6.18157; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu J, 2016, ENDOCRINOLOGY, V157, P2259, DOI 10.1210/en.2015-2027; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lubrano C, 2015, ENDOCRINE, V49, P503, DOI 10.1007/s12020-015-0530-0; Mandal S, 2010, J CELL BIOL, V188, P473, DOI 10.1083/jcb.200912024; Murakami K, 2016, BRIT J NUTR, V115, P1819, DOI 10.1017/S0007114516000854; Neufeld-Cohen A, 2016, P NATL ACAD SCI USA, V113, pE1673, DOI 10.1073/pnas.1519650113; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Paruthi S, 2016, J CLIN SLEEP MED, V12, P785, DOI 10.5664/jcsm.5866; Pifferi F, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/187301; Prendergast BJ, 2015, J BIOL RHYTHM, V30, P543, DOI 10.1177/0748730415609450; Qian JY, 2018, DIABETES OBES METAB, V20, P2481, DOI 10.1111/dom.13391; Ravussin E, 2019, OBESITY, V27, P1244, DOI 10.1002/oby.22518; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Reznick J, 2013, BBA-MOL BASIS DIS, V1832, P228, DOI 10.1016/j.bbadis.2012.08.010; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Salgado-Delgado RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060052; Satoh Y, 2006, AM J PHYSIOL-REG I, V290, pR1276, DOI 10.1152/ajpregu.00775.2005; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Scheer FAJL, 2005, NEUROSCIENCE, V132, P465, DOI 10.1016/j.neuroscience.2004.12.012; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Simonides WS, 1996, J BIOL CHEM, V271, P32048, DOI 10.1074/jbc.271.50.32048; Simonides WS, 2001, BIOSCIENCE REP, V21, P139, DOI 10.1023/A:1013692023449; Smaldone A, 2007, PEDIATRICS, V119, pS29, DOI 10.1542/peds.2006-2089F; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sunderram J, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-79; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wang XL, 2009, PUBLIC HEALTH NUTR, V12, P1991, DOI 10.1017/S1368980009990796; Wang XL, 2018, J INT MED RES, V46, P3765, DOI 10.1177/0300060518779305; Yasumoto Y, 2016, METABOLISM, V65, P714, DOI 10.1016/j.metabol.2016.02.003; Yoda T, 2000, AM J PHYSIOL-REG I, V278, pR134, DOI 10.1152/ajpregu.2000.278.1.R134; Zhang EE, 2010, NAT MED, V16, P1152, DOI 10.1038/nm.2214; Zhang PP, 2015, BIOCHEM BIOPH RES CO, V463, P102, DOI 10.1016/j.bbrc.2015.05.032; Zhu MF, 2017, ONCOTARGET, V8, P101720, DOI 10.18632/oncotarget.21591	66	1	3	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001265RR	http://dx.doi.org/10.1096/fj.202001265RR		NOV 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33184921				2022-12-26	WOS:000590890200001
J	Keledjian, K; Tsymbalyuk, O; Semick, S; Moyer, M; Negoita, S; Kim, K; Ivanova, S; Gerzanich, V; Simard, JM				Keledjian, Kaspar; Tsymbalyuk, Orest; Semick, Stephen; Moyer, Mitchell; Negoita, Serban; Kim, Kevin; Ivanova, Svetlana; Gerzanich, Volodymyr; Simard, J. Marc			The peroxisome proliferator-activated receptor gamma (PPAR gamma) agonist, rosiglitazone, ameliorates neurofunctional and neuroinflammatory abnormalities in a rat model of Gulf War Illness	PLOS ONE			English	Article							TAIL SUSPENSION TEST; AL-ESKAN-DISEASE; PROTEIN 18 KDA; COGNITIVE IMPAIRMENT; MOUSE MODEL; CYCLOPENTENONE PROSTAGLANDINS; ANTIDEPRESSANT ACTIVITY; PYRIDOSTIGMINE BROMIDE; CORTICOSTERONE PRIMES; GENE-EXPRESSION	Background Gulf War (GW) Illness (GWI) is a debilitating condition with a complex constellation of immune, endocrine and neurological symptoms, including cognitive impairment, anxiety and depression. We studied a novel model of GWI based on 3 known common GW exposures (GWE): (i) intranasal lipopolysaccharide, to which personnel were exposed during desert sand storms; (ii) pyridostigmine bromide, used as prophylaxis against chemical warfare; and (iii) chronic unpredictable stress, an inescapable element of war. We used this model to evaluate prophylactic treatment with the PPAR gamma agonist, rosiglitazone (ROSI). Methods Rats were subjected to the three GWE for 33 days. In series 1 and 2, male and female GWE-rats were compared to naive rats. In series 3, male rats with GWE were randomly assigned to prophylactic treatment with ROSI (GWE-ROSI) or vehicle. After the 33-day exposures, three neurofunctional domains were evaluated: cognition (novel object recognition), anxiety-like behaviors (elevated plus maze, open field) and depression-like behaviors (coat state, sucrose preference, splash test, tail suspension and forced swim). Brains were analyzed for astrocytic and microglial activation and neuroinflammation (GFAP, Iba1, tumor necrosis factor and translocator protein). Neurofunctional data from rats with similar exposures were pooled into 3 groups: naive, GWE and GWE-ROSI. Results Compared to naive rats, GWE-rats showed significant abnormalities in the three neurofunctional domains, along with significant neuroinflammation in amygdala and hippocampus. There were no differences between males and females with GWE. GWE-ROSI rats showed significant attenuation of neuroinflammation and of some of the neurofunctional abnormalities. Conclusion This novel GWI model recapitulates critical neurofunctional abnormalities reported by Veterans with GWI. Concurrent prophylactic treatment with ROSI was beneficial in this model.	[Keledjian, Kaspar; Tsymbalyuk, Orest; Semick, Stephen; Moyer, Mitchell; Negoita, Serban; Kim, Kevin; Ivanova, Svetlana; Gerzanich, Volodymyr; Simard, J. Marc] Univ Maryland, Dept Neurosurg, Sch Med, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Dept Pathol, Sch Med, Baltimore, MD 21201 USA; [Simard, J. Marc] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Simard, J. Marc] Vet Affairs Maryland Hlth Care Syst, Neurosurg Serv, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Simard, JM (corresponding author), Univ Maryland, Dept Neurosurg, Sch Med, Baltimore, MD 21201 USA.; Simard, JM (corresponding author), Univ Maryland, Dept Pathol, Sch Med, Baltimore, MD 21201 USA.; Simard, JM (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.; Simard, JM (corresponding author), Vet Affairs Maryland Hlth Care Syst, Neurosurg Serv, Baltimore, MD 21201 USA.	msimard@som.umaryland.edu		Moyer, Mitchell/0000-0002-7504-1435	Department of Veterans Affairs [I01 BX002889]; Department of Defense [SCI170199]; National Heart, Lung and Blood Institute [R01HL082517]; NINDS [R01NS060801, R01NS102589, R01NS105633]	Department of Veterans Affairs(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant (I01 BX002889) to JMS from the Department of Veterans Affairs. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study. JMS is also supported by grants from the Department of Defense (SCI170199), the National Heart, Lung and Blood Institute (R01HL082517) and the NINDS (R01NS060801; R01NS102589; R01NS105633).	Abdullah L, 2016, TOXICOLOGY, V372, P22, DOI 10.1016/j.tox.2016.10.012; Abdullah L, 2011, NEUROMOL MED, V13, P275, DOI 10.1007/s12017-011-8160-z; Abou-Donia MB, 2017, NEUROTOXICOL TERATOL, V61, P36, DOI 10.1016/j.ntt.2017.03.002; Alshelh Z, 2020, BRAIN BEHAV IMMUN, V87, P498, DOI 10.1016/j.bbi.2020.01.020; Amantea D, 2016, CURR OPIN PHARMACOL, V26, P124, DOI 10.1016/j.coph.2015.11.006; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2018, PARLIAMENTS ESTATES, V38, P121; [Anonymous], 2012, DIABETES CARE S1, V35, pS12; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bierer LM, 2015, PSYCHONEUROENDOCRINO, V51, P567, DOI 10.1016/j.psyneuen.2014.11.007; BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147; Bruinsmann FA, 2019, MOLECULES, V24, DOI 10.3390/molecules24234312; Cai W, 2018, PROG NEUROBIOL, V163, P27, DOI 10.1016/j.pneurobio.2017.10.002; Carpenter JM, 2020, NEUROTOXICOLOGY, V77, P40, DOI 10.1016/j.neuro.2019.12.012; Carreras I, 2018, BRAIN RES, V1681, P34, DOI 10.1016/j.brainres.2017.12.030; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Christova P, 2017, EXP BRAIN RES, V235, P2777, DOI 10.1007/s00221-017-5010-8; Commons KG, 2017, ACS CHEM NEUROSCI, V8, P955, DOI 10.1021/acschemneuro.7b00042; Cowley TR, 2012, NEUROBIOL AGING, V33, P162, DOI 10.1016/j.neurobiolaging.2010.02.002; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Foyet HSH, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-2012-9; Gill M, 2018, NEUROREPORT, V29, P134, DOI 10.1097/WNR.0000000000000944; Golomb BA, 2008, P NATL ACAD SCI USA, V105, P4295, DOI 10.1073/pnas.0711986105; Graves J. C., 2008, GULF WAR ILLNESS HLT; Gray GC, 2004, AM J PREV MED, V26, P443, DOI 10.1016/j.amepre.2004.02.006; Guilarte TR, 2019, PHARMACOL THERAPEUT, V194, P44, DOI 10.1016/j.pharmthera.2018.09.003; Hattiangady B, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00078; He M, 2013, TOXICOL APPL PHARM, V272, P647, DOI 10.1016/j.taap.2013.07.010; Heaton KJ, 2007, NEUROTOXICOLOGY, V28, P761, DOI 10.1016/j.neuro.2007.03.006; Isingrini E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010404; Joshi U, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31242-7; Kant GJ, 2001, PHARMACOL BIOCHEM BE, V70, P209, DOI 10.1016/S0091-3057(01)00596-2; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kerr KJ, 2015, REV ENVIRON HEALTH, V30, P273, DOI 10.1515/reveh-2015-0032; Khan MA, 2019, CURR NEUROPHARMACOL, V17, P232, DOI 10.2174/1570159X16666180828100002; Kim ST, 2011, AM J RHINOL ALLERGY, V25, P303, DOI 10.2500/ajra.2011.25.3627; King LA, 2007, AGING MENT HEALTH, V11, P175, DOI 10.1080/13607860600844424; Kodali M, 2018, BRAIN BEHAV IMMUN, V69, P499, DOI 10.1016/j.bbi.2018.01.009; Koo BB, 2018, BRAIN BEHAV IMMUN, V67, P42, DOI 10.1016/j.bbi.2017.08.003; Korenyi-Both AL, 2000, MIL MED, V165, P321, DOI 10.1093/milmed/165.5.321; KorenyiBoth AL, 1997, MIL MED, V162, P1; Kushwaha R, 2019, J NEUROCHEM, V149, P679, DOI 10.1111/jnc.14610; Ladich ER, 2002, MIL MED, V167, P864, DOI 10.1093/milmed/167.10.864; Lamproglou I, 2009, BEHAV BRAIN RES, V197, P301, DOI 10.1016/j.bbr.2008.08.031; Lavisse S, 2012, J NEUROSCI, V32, P10809, DOI 10.1523/JNEUROSCI.1487-12.2012; Lee S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30875-y; Locker AR, 2017, J NEUROCHEM, V142, P444, DOI 10.1111/jnc.14071; Macht VA, 2019, BRAIN BEHAV IMMUN, V80, P384, DOI 10.1016/j.bbi.2019.04.015; Macht VA, 2018, PSYCHONEUROENDOCRINO, V96, P195, DOI 10.1016/j.psyneuen.2018.07.015; Madhu LN, 2019, BRAIN BEHAV IMMUN, V81, P430, DOI 10.1016/j.bbi.2019.06.040; Mao QQ, 2009, PROG NEURO-PSYCHOPH, V33, P1211, DOI 10.1016/j.pnpbp.2009.07.002; McFadden LM, 2011, PHYSIOL BEHAV, V102, P266, DOI 10.1016/j.physbeh.2010.10.022; McManus RM, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0241-2; Megahed T, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00447; Miller JV, 2018, TOXICOL SCI, V165, P302, DOI 10.1093/toxsci/kfy130; Minshall D, 2014, J R Nav Med Serv, V100, P252; O'Callaghan JP, 2015, J NEUROCHEM, V133, P708, DOI 10.1111/jnc.13088; O'Donovan A, 2015, PSYCHONEUROENDOCRINO, V51, P557, DOI 10.1016/j.psyneuen.2014.11.010; Odegard TN, 2013, NEUROCASE, V19, P316, DOI 10.1080/13554794.2012.667126; Ojo JO, 2014, NEUROPATHOLOGY, V34, P109, DOI 10.1111/neup.12061; Ortmann CF, 2016, NEUROTOX RES, V29, P469, DOI 10.1007/s12640-016-9596-6; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Parihar VK, 2013, NEUROPSYCHOPHARMACOL, V38, P2348, DOI 10.1038/npp.2013.158; Park EJ, 2003, J BIOL CHEM, V278, P14747, DOI 10.1074/jbc.M210819200; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Petrova TV, 1999, P NATL ACAD SCI USA, V96, P4668, DOI 10.1073/pnas.96.8.4668; Phillips KF, 2016, NEUROTOXICOLOGY, V52, P127, DOI 10.1016/j.neuro.2015.11.014; Pierce LM, 2016, NEUROTOXICOLOGY, V55, P20, DOI 10.1016/j.neuro.2016.05.007; Rayhan RU, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058493, 10.1371/journal.pone.0063903]; Repine JE, 2016, J ENVIRON SCI HEAL B, V51, P366, DOI 10.1080/03601234.2016.1142318; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Roberts JC, 2009, EXP NEUROL, V216, P459, DOI 10.1016/j.expneurol.2009.01.002; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Sapolsky RM, 1998, NATURE, V393, P308, DOI 10.1038/30606; Seth RK, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100968; Shetty AK, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101389; Shetty GA, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00182; Stedenfeld KA, 2011, PHYSIOL BEHAV, V103, P210, DOI 10.1016/j.physbeh.2011.02.001; Steele L, 2012, ENVIRON HEALTH PERSP, V120, P112, DOI 10.1289/ehp.1003399; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Stokum JA, 2017, BEHAV BRAIN RES, V333, P43, DOI 10.1016/j.bbr.2017.06.038; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Sullivan K, 2018, NEUROTOXICOL TERATOL, V65, P1, DOI 10.1016/j.ntt.2017.11.002; Tonelli LH, 2008, NEUROPSYCHOPHARMACOL, V33, P1038, DOI 10.1038/sj.npp.1301488; Toomey R, 2009, J INT NEUROPSYCH SOC, V15, P717, DOI 10.1017/S1355617709990294; Treitler L, 2015, ARCH MUSIKWISS, V72, P1; Tufano M, 2020, MOLECULES, V25, DOI 10.3390/molecules25051062; van Haaren F, 2001, PHARMACOL BIOCHEM BE, V69, P23, DOI 10.1016/S0091-3057(01)00504-4; Wady L, 2004, J EXPO ANAL ENV EPID, V14, P293, DOI 10.1038/sj.jea.7500324; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Weiler BA, 2018, AM J IND MED, V61, P793, DOI 10.1002/ajim.22893; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Xu GM, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00032; Young DA, 2018, NEUROBIOL LEARN MEM, V155, P189, DOI 10.1016/j.nlm.2018.08.006; Zakirova Z, 2016, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00071; Zakirova Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119579; Zhou DD, 2020, J MOL NEUROSCI, V70, P542, DOI 10.1007/s12031-019-01454-1	100	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242427	10.1371/journal.pone.0242427	http://dx.doi.org/10.1371/journal.pone.0242427			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186383	Green Published, gold			2022-12-26	WOS:000593949800023
J	Becker, F; Conrad, ND; Eser, RA; Helfmann, L; Schutt, B; Schutte, C; Zonker, J				Becker, Fabian; Djurdjevac Conrad, Natasa; Eser, Raphael A.; Helfmann, Luzie; Schuett, Brigitta; Schuette, Christof; Zonker, Johannes			The furnace and the goat-A spatio-temporal model of the fuelwood requirement for iron metallurgy on Elba Island, 4th century BCE to 2nd century ce	PLOS ONE			English	Article							SOUTHERN TUSCANY; LAND-USE; DEFORESTATION; UNCERTAINTY; VEGETATION; IMPACT; SCARCITY; ECOLOGY; CRISIS; VALLEY	Scholars frequently cite fuel scarcity after deforestation as a reason for the abandonment of most of the Roman iron smelting sites on Elba Island (Tuscan Archipelago, Italy) in the 1st century bce. Whereas the archaeological record clearly indicates the decrease in smelting activities, evidence confirming the 'deforestation narrative' is ambiguous. Therefore, we employed a stochastic, spatio-temporal model of the wood required and consumed for iron smelting on Elba Island in order to assess the availability of fuelwood on the island. We used Monte Carlo simulations to cope with the limited knowledge available on the past conditions on Elba Island and the related uncertainties in the input parameters. The model includes both, wood required for the furnaces and to supply the workforce employed in smelting. Although subject to high uncertainties, the outcomes of our model clearly indicate that it is unlikely that all woodlands on the island were cleared in the 1st century bce. A lack of fuel seems only likely if a relatively ineffective production process is assumed. Therefore, we propose taking a closer look at other reasons for the abandonment of smelting sites, e.g. the occupation of new Roman provinces with important iron ore deposits; or a resource-saving strategy in Italia. Additionally, we propose to read the development of the 'deforestation narrative' originating from the 18th/19th century in its historical context.	[Becker, Fabian; Schuett, Brigitta] Free Univ Berlin, Inst Geog Sci, Dept Earth Sci, Phys Geog, Berlin, Germany; [Djurdjevac Conrad, Natasa; Helfmann, Luzie; Schuette, Christof; Zonker, Johannes] Zuse Inst Berlin, Math Life & Mat Sci, Berlin, Germany; [Eser, Raphael A.] Humboldt Univ, Class Archaeol Winckelmann Inst, Fac Humanities & Social Sci, Berlin, Germany; [Helfmann, Luzie; Schuette, Christof; Zonker, Johannes] Free Univ Berlin, Math Inst, Biocomp Grp, Dept Math & Comp Sci, Berlin, Germany	Free University of Berlin; Zuse Institute Berlin; Humboldt University of Berlin; Free University of Berlin	Becker, F (corresponding author), Free Univ Berlin, Inst Geog Sci, Dept Earth Sci, Phys Geog, Berlin, Germany.	fabian.becker@fu-berlin.de	Becker, Fabian/AAV-3555-2021	Zonker, Johannes/0000-0001-5415-3684; Djurdjevac Conrad, Natasa/0000-0001-8422-4930; Becker, Fabian/0000-0001-6981-7164	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy [EXC 2046/1, 390685689, EXC 264, 39235742]; Open Access Publication Fund of the Freie Universitat Berlin	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy(German Research Foundation (DFG)); Open Access Publication Fund of the Freie Universitat Berlin	The authors are grateful to the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) for funding under Germany's Excellence Strategy: "The Berlin Mathematics Research Center MATH+" (EXC 2046/1, 390685689; https://gepris.dfg.de/gepris/projekt/390685689) and "Topoi. The Formation and Transformation of Space and Knowledge in Ancient Civilizations"(EXC 264; https://gepris.dfg.de/gepris/projekt/39235742).We acknowledge support by the Open Access Publication Fund of the Freie Universitat Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamoli R, 2013, MELOA PREISTORIA STO; Allen HD, 2001, ECOGEOGRAPHY SERIES; Andreau J., 1990, RN, V32, P85; [Anonymous], 1993, CLEFT PALATE CRANI S, V30, pS1; [Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; [Anonymous], 2005, CENTHINI STORY JAVAN; [Anonymous], 2012, GASTROINTEST ENDOSC, V76, P8; [Anonymous], 2014, NEUROSURG FOCUS, V36, pA1; [Anonymous], 1983, UNCERTAINTY FORECAST, DOI DOI 10.1007/978-3-642-82054-0_11; [Anonymous], 2016, CANC DISCOV; Aranguren B, 1995, MAT COSTRUZIONE PROD, P159; Arnaldi I., MEMORIA POMONTE; Bachmann H.G., 1982, IDENTIFICATION SLAGS; Bailis R, 2009, BIOMASS BIOENERG, V33, P1491, DOI 10.1016/j.biombioe.2009.07.001; Bayon G, 2012, SCIENCE, V335, P1219, DOI 10.1126/science.1215400; Bebermeier W, SOCIOECOLOGICAL ASPE; Becker F, BERLINER ARCHAOLOGIS, P1; Becker F, 2019, GEOARCHAEOLOGY, V34, P336, DOI 10.1002/gea.21726; Benvenuti M, 2016, J ARCHAEOL SCI, V70, P1, DOI 10.1016/j.jas.2016.04.008; Benvenuti M, 2013, ARCHAEOMETRY, V55, P479, DOI 10.1111/j.1475-4754.2012.00692.x; Benvenuti M, 2003, CERAMIC SOC, P1; Benvenuti M., 2000, HIST METALLURGY, V34, P67; Bevan A, 2013, ARCHAEOMETRY, V55, P312, DOI 10.1111/j.1475-4754.2012.00674.x; Blasi C, 2014, PLANT BIOSYST, V148, P1255, DOI 10.1080/11263504.2014.985756; Blasi C, 2017, ENVIRON SCI POLICY, V78, P173, DOI 10.1016/j.envsci.2017.09.002; Bowman D, 2014, ESTUAR COAST SHELF S, V138, P37, DOI 10.1016/j.ecss.2013.12.005; Brambilla G., 2003, ARGOMENTI ARCHEOLOGI, V1; Brown WA, 2015, J ARCHAEOL SCI, V53, P133, DOI 10.1016/j.jas.2014.10.013; Brumlich M., 2018, BERLINER ARCHAOLOGIS, P15; Buchwald VF, 2005, HIST FILOSOFISKE SKR, V29; Burg MB, 2016, INTERD CONTRIB ARCH, P1, DOI 10.1007/978-3-319-27833-9_1; Cambi F, 2018, RASSEGNA ARCHEOLOGIC, V26, P147; Campbell N, 1869, NAPOLEON FONTAINEBLE; Camporeale G, 1989, MINERIA METALURGIA A, V1, P205; Carta A, 2018, APPL GEOGR, V98, P78, DOI 10.1016/j.apgeog.2018.07.010; Castellani C., 1972, TAVOLE STEREOMETRICH, V2; Castellani C., 1970, TAVOLE STEREOMETRICH, V1; Chiarantini L, 2018, J ARCHAEOL SCI-REP, V19, P11, DOI 10.1016/j.jasrep.2018.02.005; Chiarantini L, 2009, J ARCHAEOL SCI, V36, P1626, DOI 10.1016/j.jas.2009.03.026; Chiarantini L, 2007, P 2 INT C ARCH EUR A, P221; Chiarantini L, 2013, BIBLIOTHECA ARCHAEOL, P203; Cipriani LE, 2011, J COASTAL RES, P1774; Cleere H.F., 1981, THESIS; Clist B, 2018, P NATL ACAD SCI USA, V115, pE4733, DOI 10.1073/pnas.1805247115; Coretti A., 2017, ETRUSCOLOGY, P445; Coria C, 2014, BIO WEB CONF, V3, DOI 10.1051/bioconf/20140304001; Corretti A, 2014, EARLY IRON EUROPE ED, P181; Corretti A., 1991, ALLINSEGNA GIGLIO; Corretti A, 2001, MEDITERR ARCHAEOL AR, P127; Corretti A., 2016, STUDIA ERUDITA I EDI, P215; Corretti A., 1988, GEOARCHEOLOGIA, P7; Corretti A., 2011, ARCHEOMETALLURGIA CO, P229; Corretti A, 2018, 18 C MON UN INT SCI, P1; CORRETTI A., 2004, MAT POPULONIA, V3, P269; Corretti A., 2009, MAT COSTRUZIONE PROD, P133; Costagliola P, 2008, APPL GEOCHEM, V23, P1241, DOI 10.1016/j.apgeochem.2008.01.005; Crema ER, 2012, J ARCHAEOL METHOD TH, V19, P440, DOI 10.1007/s10816-011-9122-3; Crew P., 2013, THE WORLD OF IRON, P473; Crew P, 1991, J HIST METAL SOC, V25, P109; Cyffka B, 2006, NATO SCI PEACE SECUR, V7, P85, DOI 10.1007/1-4020-4493-3_7; Daems D, 2018, 24 EAA ANN M BARC 5, V2, P877; Dal Corso M, 2019, HOLOCENE, V29, P1622, DOI 10.1177/0959683619857229; Davies O., 1935, ROMAN MINES EUROPE; Davis DK, 2004, CULT GEOGR, V11, P359, DOI 10.1191/1474474004eu313oa; Di Pasquale G, 2014, HOLOCENE, V24, P1491, DOI 10.1177/0959683614544063; Donati L, 2006, STUDI ETRUSCHI, V72, P253; Duenkel I, 2003, NEUES JAHRB GEOL P-A, V230, P391, DOI 10.1127/njgpa/230/2003/391; Dunkel I., 2002, THESIS; Durand A, 2010, RENCONTRES INT HIST, P323; Eichhorn B, 2013, BRIT ARCHAEOLOGICAL, P57; Eichhorn B., 2013, THE WORLD OF IRON, P435; Eser RA, P 19 INT C CLA UNPUB; Eser RA., 2020, THESIS; Evans C, 2018, PAST PRESENT, P41, DOI 10.1093/pastj/gtx055; Fairhead J, 1998, REFRAMING DEFORESTAT, P121; FIRMATI M., 2006, ATT SUOL SPEC ARCH U, V3, P301; Fischer-Kowalski M, 2005, ADV HUMAN ECOLOGY, P113; Fischer-Kowalski M, 1998, SOZIOLOGIE NATUR THE, P145, DOI 10.1007/978-3-663-11442-0_7; FischerKowalski M, 1997, SOC NATUR RESOUR, V10, P61, DOI 10.1080/08941929709381009; Flinn M. W., 1959, ANN SCI, V15, P109, DOI [10.1080/00033795900200108, DOI 10.1080/00033795900200108]; Florsch N, 2011, J ARCHAEOL SCI, V38, P438, DOI 10.1016/j.jas.2010.09.027; Food and Agriculture Organization of the United Nations, 1983, FAO FORESTRY PAPER; Forbes RJ, 1964, METALLURGY ANTIQUITY; Freise F, 1907, Z BERG HUTTEN SALINE, V55, P199; Frisch W, 2008, SAMMLUNG GEOLOGISCHE, V98; Garcin Y, 2018, P NATL ACAD SCI USA, V115, pE6674, DOI 10.1073/pnas.1808481115; Garcin Y, 2018, P NATL ACAD SCI USA, V115, P3261, DOI 10.1073/pnas.1715336115; Garnier A, 2018, GEOMORPHOLOGIE, V24, P257, DOI 10.4000/geomorphologie.12446; Giovannelli M, 1771, BREVE RELAZIONE ISOL; Girbal B., 2013, HMS OCCASIONAL PUBLI, V7, P83; GORDON RB, 1993, TECHNOL CULT, V34, P243, DOI 10.2307/3106536; GOUCHER CL, 1981, J AFR HIST, V22, P179, DOI 10.1017/S0021853700019393; Greene Kevin, 1986, ARCHAEOLOGY ROMAN EC; Grove AT., 2003, NATURE MEDITERRANEAN; HAMMERSLEY G, 1973, ECON HIST REV, V26, P593; Harris WV, 2013, COLUMBIA STUD CLASS, V38, P1; Harrison F.A., 1931, MINING MAG, V45, P137; Haumann S., 2018, WAS HEIT KRITIKALITA, P97; Haupt T, 1888, BERG HUTTENMANNISCHE, V47; Healy JF, 1978, ASPECTS GREEK ROMAN; Horne L., 1982, EXPEDITION, V25, P6; Horrocks M, 2017, PALYNOLOGY, V41, P339, DOI 10.1080/01916122.2016.1204566; Hughes J. D., 1982, Journal of Forest History, V26, P60, DOI 10.2307/4004530; Hughes JD, 2011, J HIST BIOL, V44, P43, DOI 10.1007/s10739-010-9247-3; Hughes JD, 1983, J FIELD ARCHAEOL, V10, P435; Hughes JD, 2014, ANCIENT SOC HIST; Hughes RE, 2018, LAND-BASEL, V7, DOI 10.3390/land7010009; Humphris J, 2018, J FIELD ARCHAEOL, V43, P399, DOI 10.1080/00934690.2018.1479085; Humphris J, 2016, J ARCHAEOL SCI, V70, P132, DOI 10.1016/j.jas.2016.04.022; Iles L, 2019, SCI TECHNOL ARCHAEOL, V5, P179, DOI 10.1080/20548923.2020.1718366; Iles L, 2016, J ARCHAEOL METHOD TH, V23, P1219, DOI 10.1007/s10816-015-9266-7; Janssen E, 2017, J ARCHAEOL SCI-REP, V11, P592, DOI 10.1016/j.jasrep.2016.12.029; Joosten I, 1998, J GEOCHEM EXPLOR, V62, P129, DOI 10.1016/S0375-6742(97)00043-5; Kennedy WM, 2017, ETOPOI J ANCIENT STU, V6, P64; Lambardi S., 1791, MEMORIE ANTICHE MODE; Lang J, 2017, MATER MANUF PROCESS, V32, P857, DOI 10.1080/10426914.2017.1279326; Lauffer S., 1979, FORSCHUNGEN ANTIKEN, V11; Lee S., 2002, HIST METALL, V36, P122; Lohri CR, 2016, RENEW SUST ENERG REV, V59, P1514, DOI 10.1016/j.rser.2016.01.088; Lupo KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132632; Maggiani A, 1981, ETRURIA MINERARIA, P173; Maley J, 2012, SCIENCE, V337, DOI [10.1126/science.1221747, 10.1126/science.1221820]; Malhi Y, 2018, P NATL ACAD SCI USA, V115, P3202, DOI 10.1073/pnas.1802172115; Manca R, 2014, P SGI SIMP C SEPT 10, P265; Manca R, 2018, RASSEGNA ARCHEOLOGIA, V226, P253; Mazzei-Karl U., 1990, CARBONAIA ROBERTO; MEIGGS R., 1982, TREES TIMBER ANCIENT; Mellini V, 1879, B PALETNOLOGIA ITALI, V5, P84; Metz O, 2015, MINING ARCHAEOLOGY P, P8; Meurer M., 1986, Rangelands: a resource under siege. Proceedings of the 2nd International Rangeland Congress, Adelaide, Australia, 13-18 May 1984., P134; Mighall T, 2017, J ARCHAEOL SCI-REP, V11, P613, DOI 10.1016/j.jasrep.2016.12.021; Mighall T.M., 1997, P PREHIST SOC, V63, P199; Milanesi C, 2016, CR BIOL, V339, P487, DOI 10.1016/j.crvi.2016.09.003; Monaco G, 1965, POCKET LIB STUDIES A; Monaco G., 1961, ARCH MAT ARCH STORIC; Nenninger M, 2001, ROMER WALD; Nihlen J., 1960, TEKNIKOCH INDUSTRIHI; Nihlen J., 1958, FYND ALDRE JARNTILLV; Nikulka F., 1995, EXPT ARCHAOLOGIE S D, P255; Ninci G, 1815, STORIA ISOLA ELBA; Olson SD, 2012, ENCY ANCIENT HIST, P1440, DOI 10.1002/9781444338386.wbeah06064; Orton David, 2017, Open Quaternary, V3, DOI 10.5334/oq.29; Pagliantini L., 2014, THESIS; Paysen A., 2011, THESIS; Peacock David, 1991, AMPHORAE ROMAN EC IN; Penna A. N., 2014, HUMAN FOOTPRINT GLOB; Piccinini A, 1938, MINIERE FERRO ELBA T, P5; Pistolesi C., 2013, FERRO AUTARCHICO USO; Pleiner R., 2000, ARCHEOLOGICKY USTAV; Pluymers K, 2016, WILLIAM MARY QUART, V73, P389, DOI 10.5309/willmaryquar.73.3.0389; Pococke R., 1745, DESCRIPTION E SOME 2, VII; Poggiali F, 2017, QUATERN INT, V458, P134, DOI 10.1016/j.quaint.2017.06.028; Prins C, 2011, IGOVERNMENT, P83; Pucci G., 1985, ATLANTE FORME CERAMI, P365; Qin D., 2014, CLIM CHANG 2013 PHYS, P5; Raab A, 2019, QUATERN INT, V511, P153, DOI 10.1016/j.quaint.2017.07.022; Radkau J., 1986, VSWG VIERTELJAHRSCHR, V73, P37; Radt S, 2003, STRABONS GEOGRAPHIKA, V2; Rehder J.E., 2000, MASTERY USES FIRE AN; Rull V, 2010, EARTH-SCI REV, V99, P50, DOI 10.1016/j.earscirev.2010.02.003; Rull V, 2015, QUATERNARY SCI REV, V126, P219, DOI 10.1016/j.quascirev.2015.09.008; Sabbadini R., 1919, RENDICONTI I LOMBARD, V52, P835; Sadori L, 2010, PLANT BIOSYST, V144, P940, DOI 10.1080/11263504.2010.491982; Sands R., 2013, Forestry in a global context, P1, DOI 10.1079/9781780641560.0001; Saredo Parodi N, 2013, POPULONIA INFERNO PA; Sashi Sivramkrishna, 2013, Economic and Political Weekly, V48, P39; Schenk W., 2006, Schweizerische Zeitschrift fur Forstwesen, V157, P377, DOI 10.3188/szf.2006.0377; Schenkel Y, 1997, BIOTECHNOLOGIE AGRON; Schmidt M, 2016, FOR ECOSYST, V3, DOI 10.1186/s40663-016-0067-6; Schweighardt E., 1841, THESIS; Senn M, 2010, ARCHAEOMETRY, V52, P131, DOI 10.1111/j.1475-4754.2009.00461.x; Shaw I., 1998, SOCIAL APPROACHES IN, P242; Shepherd R, 1993, ELSEVIER APPL SCI; Sherwood AN., 2003, GREEK ROMAN TECHNOLO; Simonin Voir par exemple Louis, 1858, ANN MINES RECUEIL ME, V14, P557; Sperl G, 1981, P 12 CONV STUD ETR I, P29; Steinmueller WE, 2013, RES POLICY, V42, P1739, DOI 10.1016/j.respol.2013.08.010; Strabo, 1923, STRABO GEOGRAPHY, V50; Straka T. J., 2014, ADV HIST STUDIES, V3, P104, DOI [DOI 10.4236/AHS.2014.32010, 10.4236/ahs.2014.32010]; Swinburne H, 1814, MONTHLY MAGAZINE BRI, V37, P428; Symposium, 1995, POPSAHAK YONGU, V16, P3; Tanelli G, 2001, OFIOLITI, V26, P239; Tanelli G., 1985, ETRURIA MINERARIA EL, P37; Thiebaut de Berneaud A., 1814, VOYAGE ISLE ELBA NOT; Thommes P., 1998, THESIS ALBERT LUDWIG; Veal R., 2013, ANCIENT MEDITERRANEA, P37, DOI DOI 10.1163/9789004254053_004; Veal R, 2019, FUEL FIRE ANCIENT RO, P1, DOI 10.17863/CAM.46326; Veal R, 2017, ECONOMIE INEGALITE R, V63, P317, DOI DOI 10.17863/CAM.13218; Veal R., 2017, EC INTEGRATION ROMAN, P388; Veal RJ., 2012, INT ROMAN C SERIES S, P19; Visser RM, 2010, TRAC 2009, P11; Von Carlowitz Hans Carl, 1713, SYLVICULTURA OECONOM; Voss O, 1988, 1 IRON MEDITERRANEAN, P91; Wallner M., 2013, STUD KULTURGESCH OBE, V37, P209; Wardenga U, 2006, MITT OSTERR GEOGR G, V148, P9; Wertime T. A., 1983, J FIELD ARCHAEOL, V10, P445, DOI [10.2307/529467, DOI 10.2307/529467]; Williams D, 2014, ARCHAEOLOGICAL DATA; Williams M, 2000, J HIST GEOGR, V26, P28, DOI 10.1006/jhge.1999.0189; Williams M, 2010, DEFORESTING EARTH PR; Wiman IMG, 2001, OPUSCULA ROMANA ANN, V25/26, P109; Wiman IMB, 2013, ROUTLEDGE WORLDS, P11; Zecchini M., 2001, STUDI TESTI ACCADEMI; 2018, CURR OPIN TOXICOL, V10	203	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241133	10.1371/journal.pone.0241133	http://dx.doi.org/10.1371/journal.pone.0241133			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0MJ	33180813	Green Published, gold			2022-12-26	WOS:000593948000023
J	Boussier, J; Levi, L; Weger-Lucarelli, J; Poirier, EZ; Vignuzzi, M; Albert, ML				Boussier, Jeremy; Levi, Laura; Weger-Lucarelli, James; Poirier, Enzo Z.; Vignuzzi, Marco; Albert, Matthew L.			Chikungunya virus superinfection exclusion is mediated by a block in viral replication and does not rely on non-structural protein 2	PLOS ONE			English	Article							CELL-SURFACE CD4; MESSENGER-RNA; CROSS-PROTECTION; INFECTION; INTERFERENCE; MECHANISMS; EXPRESSION; STRAINS; KINASE; NEF	Superinfection exclusion (SIE) is a process by which a virally infected cell is protected from subsequent infection by the same or a closely related virus. By preventing cell coinfection, SIE favors preservation of genome integrity of a viral strain and limits its recombination potential with other viral genomes, thereby impacting viral evolution. Although described in virtually all viral families, the precise step(s) impacted by SIE during the viral life cycle have not been systematically explored. Here, we describe for the first time SIE triggered by chikungunya virus (CHIKV), an alphavirus of public health importance. Using single-cell technologies, we demonstrate that CHIKV excludes subsequent infection with: CHIKV; Sindbis virus, a related alphavirus; and influenza A, an unrelated RNA virus. We further demonstrate that SIE does not depend on the action of type I interferon, nor does it rely on host cell transcription. Moreover, exclusion is not mediated by the action of a single CHIKV protein; in particular, we observed no role for non-structural protein 2 (nsP2), making CHIKV unique among characterized alphaviruses. By stepping through the viral life cycle, we show that CHIKV exclusion occurs at the level of replication, but does not directly influence virus binding, nor viral structural protein translation. In sum, we characterized co-infection during CHIKV replication, which likely influences the rate of viral diversification and evolution.	[Boussier, Jeremy; Albert, Matthew L.] Inst Pasteur, Immubiol Dendrit Cells Unit, Paris, France; [Boussier, Jeremy] Inst Pasteur, Inserm U1223, Paris, France; [Boussier, Jeremy] Univ Paris Diderot, Ecole Doctorale Frontieres Vivant, Paris, France; [Levi, Laura; Weger-Lucarelli, James; Poirier, Enzo Z.; Vignuzzi, Marco] Inst Pasteur, Viral Populat & Pathogenesis Unit, Paris, France; [Weger-Lucarelli, James] Virginia Tech, Dept Biomed Sci & Pathobiol, VA MD Reg Coll Vet Med, Blacksburg, VA USA; [Poirier, Enzo Z.] Francis Crick Inst, Immunobiol Lab, London, England; [Albert, Matthew L.] Insitro, San Francisco, CA 94080 USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Virginia Polytechnic Institute & State University; Francis Crick Institute	Albert, ML (corresponding author), Inst Pasteur, Immubiol Dendrit Cells Unit, Paris, France.; Albert, ML (corresponding author), Insitro, San Francisco, CA 94080 USA.	albertm@insitro.com		Boussier, Jay/0000-0002-2249-377X; Weger-Lucarelli, James/0000-0002-9483-1694; Poirier, Enzo/0000-0001-9795-2144	DARPA [HR0011-17-2-0023]; Ecole normale superieure; ecole doctorale Frontieres du vivant -programme Bettencourt; Agence nationale de la recherche; DARPA INTERCEPT program	DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Ecole normale superieure; ecole doctorale Frontieres du vivant -programme Bettencourt; Agence nationale de la recherche(French National Research Agency (ANR)); DARPA INTERCEPT program	This work was funded by the Agence nationale de la recherche, the DARPA INTERCEPT program managed by Jim Gimlett and Bradley Ringeisen, and administered through DARPA Cooperative Agreement #HR0011-17-2-0023 to M. V. (the content of the information does not necessarily reflect the position or the policy of the US government, and no official endorsement should be inferred). J.B. was supported by a grant from the Ecole normale superieure and by the ecole doctorale Frontieres du vivant -programme Bettencourt. Insitro provided support in the form of salaries for M.L.A. The specific roles of these authors are articulated in the author contributions' section. None of the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RH, 1985, J VIROL, V54, P351, DOI 10.1128/JVI.54.2.351-357.1985; Akhrymuk I, 2012, J VIROL, V86, P7180, DOI 10.1128/JVI.00541-12; Balistreri G, 2014, CELL HOST MICROBE, V16, P403, DOI 10.1016/j.chom.2014.08.007; BRATT MA, 1968, VIROLOGY, V35, P395, DOI 10.1016/0042-6822(68)90218-3; CHRISTEN L, 1990, VIROLOGY, V174, P35, DOI 10.1016/0042-6822(90)90051-R; Coffey LL, 2011, P NATL ACAD SCI USA, V108, P16038, DOI 10.1073/pnas.1111650108; CONDREAY LD, 1986, J VIROL, V58, P81, DOI 10.1128/JVI.58.1.81-86.1986; Cortes MJ, 2002, J BIOL CHEM, V277, P1770, DOI 10.1074/jbc.M109807200; Ehrengruber MU, 2007, J NEUROVIROL, V13, P353, DOI 10.1080/13550280701393204; Folimonova SY, 2012, J VIROL, V86, P5554, DOI 10.1128/JVI.00310-12; Folimonova SY, 2010, J VIROL, V84, P1314, DOI 10.1128/JVI.02075-09; Fros JJ, 2015, J GEN VIROL, V96, P580, DOI 10.1099/vir.0.071845-0; Garcia-Nafria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27459; HOXIE JA, 1986, SCIENCE, V234, P1123, DOI 10.1126/science.3095925; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; JOHNSTON RE, 1974, J VIROL, V14, P1076, DOI 10.1128/JVI.14.5.1076-1082.1974; Joubert PE, 2012, J EXP MED, V209, P1029, DOI 10.1084/jem.20110996; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Lee YM, 2005, J VIROL, V79, P3231, DOI 10.1128/JVI.79.6.3231-3242.2005; Levesque K, 2003, J BIOL CHEM, V278, P28346, DOI 10.1074/jbc.M300327200; Matthews REF, 2002, MATTHEWS PLANT VIROL, P1; Nanduri S, 1998, EMBO J, V17, P5458, DOI 10.1093/emboj/17.18.5458; Posten H. O., 1984, ROBUSTNESS STAT METH, P92, DOI [10.1007/ 978-94-009-6528-7_23, DOI 10.1007/978-94-009-6528-7_23]; RIEDEL B, 1979, J VIROL, V29, P51, DOI 10.1128/JVI.29.1.51-60.1979; Roberts GC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15269-w; ROBERTS WK, 1976, NATURE, V264, P477, DOI 10.1038/264477a0; Ronen K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003593; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12; SALMON P, 1988, J EXP MED, V168, P1953, DOI 10.1084/jem.168.6.1953; Schaller T, 2007, J VIROL, V81, P4591, DOI 10.1128/JVI.02144-06; Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; SHIRAKO Y, 1994, J VIROL, V68, P1874, DOI 10.1128/JVI.68.3.1874-1885.1994; Singh IR, 1997, VIROLOGY, V231, P59, DOI 10.1006/viro.1997.8492; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; Stapleford KA, 2014, CELL HOST MICROBE, V15, P706, DOI 10.1016/j.chom.2014.05.008; Walters KA, 2004, J VIROL, V78, P7925, DOI 10.1128/JVI.78.15.7925-7937.2004; Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006; WEN F, 1991, J GEN VIROL, V72, P791, DOI 10.1099/0022-1317-72-4-791; WHITAKERDOWLING P, 1983, VIROLOGY, V131, P137, DOI 10.1016/0042-6822(83)90540-8; White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10; Wildurn S, 2006, J VIROL, V80, P8047, DOI 10.1128/JVI.00252-06; Zhang XF, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00040; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	47	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241592	10.1371/journal.pone.0241592	http://dx.doi.org/10.1371/journal.pone.0241592			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180795	Green Published, gold			2022-12-26	WOS:000593948000035
J	Cui, PY; Chen, Y; Waili, N; Li, YX; Ma, CL; Li, Y				Cui, PinYu; Chen, Yuan; Waili, Nuremaguli; Li, YaXing; Ma, CuiLing; Li, Ying			Associations of serum C-peptide and insulin-like growth factor binding proteins-3 with breast cancer deaths	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; CIRCULATING INSULIN; FACTOR (IGF)-I; FACTOR-I; RISK; CELLS; HYPERCHOLESTEROLEMIA; CHOLESTEROL; PATHWAYS; MUTATION	C-peptide is usually considered as a marker of insulin secretion and has no physiological function. This study aimed to assess the association between serum C-peptide level as independent risk factor and breast cancer and explored the possible underlying mechanisms. This was a population-based cohort study. All the data was collected according to a standard protocol. The C-peptide and insulin-like growth factor binding proteins-3(IGFBP-3) concentrations were measured in blood. The breast cancer deaths were confirmed by National Death Index records. Cox proportional hazard regression analysis was conducted to determine the hazard ratio of serum C-peptide level for breast cancer deaths. Analysis of covariance was used to assess the association between serum C-peptide and IGFBP-3 level, and the linear trend was tested by using a linear model. A total of 8,373 women 17 years of age or older were included in the study, and 57 breast cancer deaths were observed over the study period. The result of survival analysis showed that breast cancer deaths increased with increasing levels of serum C-peptide. The hazard ratio was 1.69 (95% confidence interval, 1.17-2.45). The levels of circulating IGFBP-3 were positively associated with changes in serum C-peptide levels and showed a strong linear trend in the covariance analysis. Serum C-peptide level was associated with increased risk of breast cancer death. Our results suggest that the increased risk of breast cancer death can be via a pathway that serum C-peptide level positive associated with the change in serum IGFBP-3 level.	[Cui, PinYu; Chen, Yuan; Waili, Nuremaguli; Li, YaXing; Ma, CuiLing; Li, Ying] Zhejiang Univ, Sch Med, Dept Publ Hlth, Hangzhou, Peoples R China	Zhejiang University	Li, Y (corresponding author), Zhejiang Univ, Sch Med, Dept Publ Hlth, Hangzhou, Peoples R China.	ying_li@zju.edu.cn			Public Welfare Technology Applied Research Projects in Zhejiang Province [LGF19H260012]	Public Welfare Technology Applied Research Projects in Zhejiang Province	This work was supported by Public Welfare Technology Applied Research Projects in Zhejiang Province (LGF19H260012).	Ahern TP, 2013, CANCER EPIDEM BIOMAR, V22, P1786, DOI 10.1158/1055-9965.EPI-13-0375; Ahluwalia M, 2002, DIABETES OBES METAB, V4, P376, DOI 10.1046/j.1463-1326.2002.00230.x; Al-Rasheed NM, 2004, J BIOL CHEM, V279, P49747, DOI 10.1074/jbc.M408268200; Arnold M, 2015, EUR J CANCER, V51, P1164, DOI 10.1016/j.ejca.2013.09.002; Author, 2013, CMAJ, V185, pE57, DOI 10.1503/cmaj.112017; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Bronsveld HK, 2017, PRIM CARE DIABETES, V11, P373, DOI 10.1016/j.pcd.2017.02.001; Chenevix-Trench G, 2006, CANCER RES, V66, P2019, DOI 10.1158/0008-5472.CAN-05-3546; Danilo C, 2012, CURR OPIN PHARMACOL, V12, P677, DOI 10.1016/j.coph.2012.07.009; Diorio C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2093; Eliassen AH, 2007, CANCER EPIDEM BIOMAR, V16, P161, DOI 10.1158/1055-9965.EPI-06-0693; Evans DG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-155; Fuentes E, 2013, MOL MED REP, V8, P1611, DOI 10.3892/mmr.2013.1714; Howe LR, 2013, CLIN CANCER RES, V19, P6074, DOI 10.1158/1078-0432.CCR-12-2603; Kawachi S, 2005, ARTERIOSCL THROM VAS, V25, P617, DOI 10.1161/01.ATV.0000154486.03017.35; King MC, 2002, SCIENCE, V298, P2342, DOI 10.1126/science.1080373; Krajcik RA, 2002, CANCER EPIDEM BIOMAR, V11, P1566; Kucharska-Newton AM, 2008, ANN EPIDEMIOL, V18, P671, DOI 10.1016/j.annepidem.2008.06.006; Li Y, 2014, J STROKE CEREBROVASC, V23, pE163, DOI 10.1016/j.jstrokecerebrovasdis.2013.09.013; Maas P, 2016, JAMA ONCOL, V2, P1295, DOI 10.1001/jamaoncol.2016.1025; Martin JL, 2014, MOL CANCER THER, V13, P316, DOI 10.1158/1535-7163.MCT-13-0367; Marx N, 2013, DIABETES CARE, V36, P708, DOI 10.2337/dc12-1211; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Patel N, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003152; Probst-Hensch NM, 2010, CLIN CANCER RES, V16, P1025, DOI 10.1158/1078-0432.CCR-09-0957; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Ren JY, 2010, MOL CELL BIOCHEM, V342, P171, DOI 10.1007/s11010-010-0481-y; Renehan AG, 2006, ENDOCR-RELAT CANCER, V13, P273, DOI 10.1677/erc.1.01219; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Renehan Andrew G., 2008, Archives of Physiology and Biochemistry, V114, P71, DOI [10.1080/13813450801954303, 10.1080/13813450801954303 ]; Schernhammer ES, 2005, CANCER EPIDEM BIOMAR, V14, P699, DOI 10.1158/1055-9965.EPI-04-0561; Schmid MC, 2003, INT J CANCER, V103, P577, DOI 10.1002/ijc.10874; Sheen-Chen SM, 2009, ANTICANCER RES, V29, P1131; Subbarayan V, 2005, NEOPLASIA, V7, P280, DOI 10.1593/neo.04457; Suzuki T, 2006, ENDOCR-RELAT CANCER, V13, P233, DOI 10.1677/erc.1.01075; Tryggvadottir L, 2006, JNCI-J NATL CANCER I, V98, P116, DOI 10.1093/jnci/djj012; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Yu H, 1998, INT J CANCER, V79, P624, DOI 10.1002/(SICI)1097-0215(19981218)79:6<624::AID-IJC12>3.0.CO;2-9; Yu H, 2002, CANCER EPIDEM BIOMAR, V11, P705; Yu HJ, 2019, CELL, V179, P1276, DOI 10.1016/j.cell.2019.10.034; Zhong Z, 2005, DIABETOLOGIA, V48, P187, DOI 10.1007/s00125-004-1602-5	42	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242310	10.1371/journal.pone.0242310	http://dx.doi.org/10.1371/journal.pone.0242310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180852	Green Published, gold			2022-12-26	WOS:000593948000031
J	Morrison, CS; Paskaleva, EE; Rios, MA; Beusse, TR; Blair, EM; Lin, LQ; Hu, JR; Gorby, AH; Dodds, DR; Armiger, WB; Dordick, JS; Koffas, MAG				Morrison, Clifford S.; Paskaleva, Elena E.; Rios, Marvin A.; Beusse, Thomas R.; Blair, Elaina M.; Lin, Lucy Q.; Hu, James R.; Gorby, Aidan H.; Dodds, David R.; Armiger, William B.; Dordick, Jonathan S.; Koffas, Mattheos A. G.			Improved soluble expression and use of recombinant human renalase	PLOS ONE			English	Article							NICOTINAMIDE ADENINE-DINUCLEOTIDE; LACTATE-DEHYDROGENASE INHIBITOR; ELECTROCHEMICAL REGENERATION; ESCHERICHIA-COLI; NADH; MONOOXYGENASE; REDUCTION; BIOCATALYSIS; PURIFICATION; STRATEGIES	Electrochemical bioreactor systems have enjoyed significant attention in the past few decades, particularly because of their applications to biobatteries, artificial photosynthetic systems, and microbial electrosynthesis. A key opportunity with electrochemical bioreactors is the ability to employ cofactor regeneration strategies critical in oxidative and reductive enzymatic and cell-based biotransformations. Electrochemical cofactor regeneration presents several advantages over other current cofactor regeneration systems, such as chemoenzymatic multi-enzyme reactions, because there is no need for a sacrificial substrate and a recycling enzyme. Additionally, process monitoring is simpler and downstream processing is less costly. However, the direct electrochemical reduction of NAD(P)(+) on a cathode may produce adventitious side products, including isomers of NAD(P)H that can act as potent competitive inhibitors to NAD(P)H-requiring enzymes such as dehydrogenases. To overcome this limitation, we examined how nature addresses the adventitious formation of isomers of NAD(P)H. Specifically, renalases are enzymes that catalyze the oxidation of 1,2- and 1,6-NAD(P)H to NAD(P)(+), yielding an effective recycling of unproductive NAD(P)H isomers. We designed several mutants of recombinant human renalase isoform 1 (rhRen1), expressed them in E. coli BL21(DE3) to enhance protein solubility, and evaluated the activity profiles of the renalase variants against NAD(P)H isomers. The potential for rhRen1 to be employed in engineering applications was then assessed in view of the enzyme's stability upon immobilization. Finally, comparative modeling was performed to assess the underlying reasons for the enhanced solubility and activity of the mutant enzymes.	[Morrison, Clifford S.; Rios, Marvin A.; Beusse, Thomas R.; Lin, Lucy Q.; Dordick, Jonathan S.; Koffas, Mattheos A. G.] Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Paskaleva, Elena E.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA; [Blair, Elaina M.] Brigham Young Univ, Dept Chem Engn, Provo, UT 84602 USA; [Hu, James R.; Gorby, Aidan H.; Dordick, Jonathan S.; Koffas, Mattheos A. G.] Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA; [Dodds, David R.; Armiger, William B.] BiochemInsights, Malvern, PA USA; [Dordick, Jonathan S.] Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Brigham Young University; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Dordick, JS; Koffas, MAG (corresponding author), Rensselaer Polytech Inst, Dept Chem & Biol Engn, Troy, NY 12180 USA.; Dordick, JS; Koffas, MAG (corresponding author), Rensselaer Polytech Inst, Dept Biol Sci, Troy, NY 12180 USA.; Dordick, JS (corresponding author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.	dordick@rpi.edu; koffam@rpi.edu		Morrison, Clifford Steven/0000-0001-7057-2926; Gorby, Aidan/0000-0003-3063-324X; Beusse, Thomas/0000-0002-8276-0016; Koffas, Mattheos/0000-0002-1405-0565; Rios, Marvin/0000-0002-1758-3340	BioChemInsights, Inc., Malvern, PA; Rensselaer Polytechnic Institute [J71742]; National Science Foundation Graduate Research Fellowship Program [DGE-1247271]	BioChemInsights, Inc., Malvern, PA; Rensselaer Polytechnic Institute; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This work was supported by BioChemInsights, Inc., Malvern, PA through a Sponsored Research Agreement with Rensselaer Polytechnic Institute [J71742]; and the National Science Foundation Graduate Research Fellowship Program [grant number DGE-1247271]. BioChemInsights, Inc. provided support in the form of money for covering experimental costs and supply purchases, and also had an additional role in the decision to publish and in the preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ali I, 2012, CHEM ENG J, V188, P173, DOI 10.1016/j.cej.2012.02.005; Ali I, 2011, ELECTROCHEM COMMUN, V13, P562, DOI 10.1016/j.elecom.2011.03.010; Azem A, 2004, J MOL CATAL A-CHEM, V219, P283, DOI 10.1016/j.molcata.2004.04.041; Baik SH, 1999, BIOTECHNOL TECH, V13, P1, DOI 10.1023/A:1008865212773; Beaupre BA, 2015, BIOCHEMISTRY-US, V54, P795, DOI 10.1021/bi5013436; Beaupre BA, 2013, J AM CHEM SOC, V135, P13980, DOI 10.1021/ja407384h; BIELLMANN JF, 1979, BIOCHEMISTRY-US, V18, P1212, DOI 10.1021/bi00574a015; Blank LM, 2010, ANTIOXID REDOX SIGN, V13, P349, DOI 10.1089/ars.2009.2931; BRESNAHAN WT, 1981, BIOCHIM BIOPHYS ACTA, V678, P151, DOI 10.1016/0304-4165(81)90200-2; CHAKRAVERTY K, 1964, BIOCHEM BIOPH RES CO, V15, P262, DOI 10.1016/0006-291X(64)90157-3; CHENAULT HK, 1987, APPL BIOCHEM BIOTECH, V14, P147, DOI 10.1007/BF02798431; DALZIEL K, 1963, J BIOL CHEM, V238, P1538; Desir GV, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002634; GODTFREDSEN SE, 1978, CARLSBERG RES COMMUN, V43, P171, DOI 10.1007/BF02914239; Goldenzweig A, 2016, MOL CELL, V63, P337, DOI 10.1016/j.molcel.2016.06.012; Hoag MR, 2015, BIOCHEMISTRY-US, V54, P3791, DOI 10.1021/acs.biochem.5b00451; Hollmann F, 2006, TRENDS BIOTECHNOL, V24, P163, DOI 10.1016/j.tibtech.2006.02.003; JAEGFELDT H, 1981, BIOELECTROCH BIOENER, V8, P355, DOI 10.1016/0302-4598(81)80018-9; Kang HS, 2007, BIOTECHNOL LETT, V29, P1277, DOI 10.1007/s10529-007-9385-7; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; LEE LG, 1985, J AM CHEM SOC, V107, P6999, DOI 10.1021/ja00310a043; Long YT, 1997, J ELECTROANAL CHEM, V440, P239, DOI 10.1016/S0022-0728(97)00390-2; Madje K, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-7; McClay K, 2000, APPL ENVIRON MICROB, V66, P1877, DOI 10.1128/AEM.66.5.1877-1882.2000; Moran GR, 2016, BBA-PROTEINS PROTEOM, V1864, P177, DOI 10.1016/j.bbapap.2015.04.010; Morrison C, 2018, ADV APPL MICROBIOL, V105, P51, DOI 10.1016/bs.aambs.2018.07.001; Morrison CS, 2018, BIOTECHNOL ADV, V36, P120, DOI 10.1016/j.biotechadv.2017.10.003; Morrison CS, 2019, United States patent application, Patent No. [US 16/084,579, 16084579]; Pandini V, 2010, PROTEIN EXPRES PURIF, V72, P244, DOI 10.1016/j.pep.2010.03.008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pryor KD, 1997, PROTEIN EXPRES PURIF, V10, P309, DOI 10.1006/prep.1997.0759; SCHMAKEL CO, 1975, J AM CHEM SOC, V97, P5083, DOI 10.1021/ja00851a010; Shin IH, 2004, J MICROBIOL BIOTECHN, V14, P540; Ullah N, 2015, MATER CHEM PHYS, V149, P413, DOI 10.1016/j.matchemphys.2014.10.038; Urlacher VB, 2006, TRENDS BIOTECHNOL, V24, P324, DOI 10.1016/j.tibtech.2006.05.002; WENZ I, 1976, J CHROMATOGR, V120, P187, DOI 10.1016/S0021-9673(01)99011-9; Wichmann R, 2005, ADV BIOCHEM ENG BIOT, V92, P225, DOI 10.1007/b98911; WILLIAMS JN, 1952, J BIOL CHEM, V195, P629; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Zambianchi F, 2002, BIOTECHNOL BIOENG, V78, P489, DOI 10.1002/bit.10207	40	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242109	10.1371/journal.pone.0242109	http://dx.doi.org/10.1371/journal.pone.0242109			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180865	gold, Green Published			2022-12-26	WOS:000593948000089
J	Tang, DCC				Tang, De-chu Christopher			Paradoxical modulation of influenza by intranasal administration of non-replicating adenovirus particles	PLOS ONE			English	Article							INFLAMMATION	Respiratory mucosal infection by airborne microbes is a common event that occurs every day. We report here that intranasal administration of non-replicating adenovirus (Ad) particles to mice could either confer rapid protection against influenza virus (IFV) challenge independent of adaptive immunity, or exacerbate influenza by triggering rapid death. The life-or-death outcome hinges on the time interval between Ad administration and IFV challenge in conjunction with specific mouse/IFV strains. Intranasal instillation of Ad particles 1-47 days prior to IFV challenge conferred rapid protection against influenza in Balb/c mice whereas exposure to Ad 39 days prior to challenge with a specific IFV strain or 1 day post-challenge with that IFV strain induced rapid death in C57BL/6 mice. Notably, consecutive administrations of Ad prior to IFV challenge conferred a synergy in triggering a potent anti-influenza state; even a detrimental Ad exposure 39 days before challenge with the deadly IFV strain was reversed to a beneficial one by subsequent Ad boosts. Results revealed an intricate relationship between infection and innate immunity that is a linchpin around which effects revolve from protective immunity to collateral damage. It is urgent to repeat the experiments with an expanded scope for characterizing the status that defines susceptibility or resistance to IFV infection and subsequently reveal the underlying mechanisms. Whether broad heterologous protective effects induced by AdE and adaptive immunity elicited by vaccination could confer synergy during mitigation of a pandemic remains to be seen.	[Tang, De-chu Christopher] Univ North Texas Hlth Sci Ctr, Commercializat Program, VaxDome Inc, Ft Worth, TX 76107 USA		Tang, DCC (corresponding author), Univ North Texas Hlth Sci Ctr, Commercializat Program, VaxDome Inc, Ft Worth, TX 76107 USA.	dechutang@vaxdome.com		Tang, De-chu/0000-0003-3813-9238	International Vaccine Institute (IVI; Seoul, South Korea); UNTHSC (Fort Worth, Texas, USA); Flu Lab and Center for Open Science (FL-COS); Korean National Brain Pool Program (KBP)	International Vaccine Institute (IVI; Seoul, South Korea); UNTHSC (Fort Worth, Texas, USA); Flu Lab and Center for Open Science (FL-COS); Korean National Brain Pool Program (KBP)	The animal studies (Fig 1) were supported by International Vaccine Institute (IVI; Seoul, South Korea) in conjunction with the Korean National Brain Pool Program (KBP). The proposed studies will be supported by UNTHSC (Fort Worth, Texas, USA) and a grant from Flu Lab and Center for Open Science (FL-COS). The funders have provided support in the form of salaries (KBP and IVI), laboratory space (IVI and UNTHSC), equipment and supplies (IVI, UNTHSC, FL-COS), as well as core and animal facilities (IVI and UNTHSC), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appledorn DM, 2011, CLIN VACCINE IMMUNOL, V18, P150, DOI 10.1128/CVI.00341-10; Huang CM, 2003, J INVEST DERMATOL, V121, P51, DOI 10.1046/j.1523-1747.2003.12327.x; Kollmann TR, 2020, SCIENCE, V368, P612, DOI 10.1126/science.aaz9447; Kumar RK, 2003, J PHARMACOL EXP THER, V307, P349, DOI 10.1124/jpet.103.053819; Li ZF, 2019, NEUROSCI LETT, V705, P39, DOI 10.1016/j.neulet.2019.04.035; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Seo SU, 2010, J VIROL, V84, P12713, DOI 10.1128/JVI.01675-10; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043; Zhang JF, 2011, EXPERT REV VACCINES, V10, P1539, DOI [10.1586/ERV.11.141, 10.1586/erv.11.141]; Zhang JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022605	11	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241266	10.1371/journal.pone.0241266	http://dx.doi.org/10.1371/journal.pone.0241266			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180828	Green Published, gold			2022-12-26	WOS:000593948000087
J	Kazimbaya, KM; Chisenga, CC; Simuyandi, M; Phiri, CM; Laban, NM; Bosomprah, S; Permar, SR; Munsaka, S; Chilengi, R				Kazimbaya, Katayi Mwila; Chisenga, Caroline C.; Simuyandi, Michelo; Phiri, Cynthia Mubanga; Laban, Natasha Makabilo; Bosomprah, Samuel; Permar, Sallie R.; Munsaka, Sody; Chilengi, Roma			In-vitro inhibitory effect of maternal breastmilk components on rotavirus vaccine replication and association with infant seroconversion to live oral rotavirus vaccine	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SERUM IGG; IMMUNOGENICITY; LACTOFERRIN; PROTECTION; ANTIBODIES; EFFICACY; RESPONSES; PROTEINS; CHILDREN	Background Despite contributing to a significant reduction in rotavirus associated diarrhoea in highly burdened low- and middle-income countries, live attenuated, oral rotavirus vaccines have lower immunogenicity and efficacy in these settings in comparison to more developed countries. Breastmilk has been implicated among factors contributing to this lowered oral vaccine efficacy. We conducted in-vitro experiments to investigate the inhibitory effects of maternal antibody and other non-antibody components in breastmilk on rotavirus vaccine strain (Rotarix) multiplication in MA104 cell culture system and assessed associations with in-vivo vaccine seroconversion in vaccinated infants. Methods Breastmilk samples were collected from mothers before routine rotavirus vaccination of their infant at 6 weeks of age. For each sample, whole breastmilk, purified IgA, purified IgG and IgG and IgA depleted breastmilk samples were prepared as exposure preparations. A 96 well microtitre plate was set up for each sample including a control in which only MA104 cells were grown as well as a virus control with MA104 cells and virus only. The outcome of interest was 50% inhibition dilution of each of the exposure preparations calculated as the titer at which 50% of virus dilution was achieved. Samples from 30 women were tested and correlated to vaccine seroconversion status of the infant. HIV status was also correlated to antiviral breastmilk proteins. Results The mean 50% inhibitory dilution titer when whole breastmilk was added to virus infected MA104 cells was 14.3 (95% CI: 7.1, 22.7). Incubation with purified IgG resulted in a mean 50% inhibitory dilution of 5 (95%CI -1.6, 11.6). Incubating with purified IgA resulted in a mean 50% inhibitory dilution of 6.5 (95% CI -0.7, 13.7) and IgG and IgA depleted breastmilk did not yield any inhibition with a titer of 1.06 (95%CI 0.9, 1.2). Higher milk IgA levels contributed to a failure of infants to seroconvert. HIV was also not associated with any antiviral breastmilk proteins. Discussion and conclusion Whole breastmilk and breastmilk purified IgG and IgA fractions showed inhibitory activity against the rotavirus vaccine Rotarix (TM) whilst IgA and IgG depleted breastmilk with non-antibody breastmilk fraction failed to show any inhibition activity in-vitro. These findings suggest that IgA and IgG may have functional inhibitory properties and indicates a possible mechanism of how mothers in rotavirus endemic areas with high titres of IgA and IgG may inhibit viral multiplication in the infant gut and would potentially contribute to the failure of their infants to serocovert. There was not association of HIV with either lactoferrin, lactadherin or tenascin-C concentrations.	[Kazimbaya, Katayi Mwila; Chisenga, Caroline C.; Simuyandi, Michelo; Phiri, Cynthia Mubanga; Laban, Natasha Makabilo; Bosomprah, Samuel; Chilengi, Roma] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Kazimbaya, Katayi Mwila; Munsaka, Sody] Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia; [Bosomprah, Samuel] Univ Ghana, Sch Publ Hlth, Dept Biostat, Legon, Ghana; [Permar, Sallie R.] Duke Univ, Human Vaccine Inst, Dept Pediat, Durham, NC USA	University of Zambia; University of Ghana; Duke University	Kazimbaya, KM (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.; Kazimbaya, KM (corresponding author), Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia.	Katayi.Kazimbaya@cidrz.org	Simuyandi, Michelo/I-5598-2018; Munsaka, Sody/AAD-9186-2022	Simuyandi, Michelo/0000-0002-7348-2835; Mwila Kazimbaya, Katayi/0000-0002-8482-4693; Chilengi, Roma/0000-0003-0221-9527	Fogarty International Center of the National Institutes of Health [D43 TW009744]; National Institutes for Health (NIH), USA, through an R01 grant [1R01AI099601]; Zambia National Science and Technology Council [NSTC/101/5/10]	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes for Health (NIH), USA, through an R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zambia National Science and Technology Council(National Science and Technology Council (NSTC) Zambia)	This work was supported by the Fogarty International Center of the National Institutes of Health under Award Number D43 TW009744 (KMK beneficiary). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The primary study was funded by the National Institutes for Health (NIH), USA, through an R01 grant 1R01AI099601 (RC). Non-immunological components of breastmilk study was funded by the Zambia National Science and Technology Council NSTC/101/5/10.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Adlerova L, 2008, LACTOFERRIN REV, V2008, P457; Andreas NJ, 2015, EARLY HUM DEV, V91, P629, DOI 10.1016/j.earlhumdev.2015.08.013; [Anonymous], **NON-TRADITIONAL**; Armah G, 2016, CLIN INFECT DIS, V62, pS200, DOI 10.1093/cid/ciw014; Arnold Michelle, 2009, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15c03s15; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Becker-Dreps S, 2015, PEDIATR INFECT DIS J, V34, P115, DOI 10.1097/INF.0000000000000481; Chilengi R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150100; Correia JB, 2010, J INFECT DIS, V201, P363, DOI 10.1086/649843; Feng NG, 2002, J CLIN INVEST, V109, P1203, DOI 10.1172/JCI200214397; Fouda GG, 2013, P NATL ACAD SCI USA, V110, P18220, DOI 10.1073/pnas.1307336110; Glass RI, 1991, ADV EXPT MED BIOL, P249, DOI DOI 10.1007/978-1-4615-3838-7_33; Goldsmith SJ, 1983, J FOOD PROT; Groome MJ, 2017, LANCET INFECT DIS, V17, P843, DOI [10.1016/S1473-3099(17)30242-6, 10.1016/s1473-3099(17)30242-6]; Groome MJ, 2014, B WORLD HEALTH ORGAN, V92, P238, DOI 10.2471/BLT.13.128066; HARMSEN MC, 1995, J INFECT DIS, V172, P380, DOI 10.1093/infdis/172.2.380; Jiang BM, 2002, CLIN INFECT DIS, V34, P1351, DOI 10.1086/340103; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Leshem E, 2014, LANCET INFECT DIS, V14, P847, DOI 10.1016/S1473-3099(14)70832-1; Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827; Mansour RG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155261; Martin CR, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050279; Moon SS, 2016, CLIN INFECT DIS, V62, P157, DOI 10.1093/cid/civ828; Moon SS, 2013, PEDIATR INFECT DIS J, V32, P863, DOI 10.1097/INF.0b013e318290646d; Moon SS, 2010, PEDIATR INFECT DIS J, V29, P919, DOI 10.1097/INF.0b013e3181e232ea; Mwila K, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00405-16; Mwila-Kazimbaya K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189351; Newburg DS, 1998, LANCET, V351, P1160, DOI 10.1016/S0140-6736(97)10322-1; PICHICHERO ME, 1990, J INFECT DIS, V162, P753, DOI 10.1093/infdis/162.3.753; Puddu P, 1998, INT J BIOCHEM CELL B, V30, P1055, DOI 10.1016/S1357-2725(98)00066-1; Rennels MB, 1996, J INFECT DIS, V174, pS107, DOI 10.1093/infdis/174.Supplement_1.S107; ROBBINS JB, 1995, J INFECT DIS, V171, P1387, DOI 10.1093/infdis/171.6.1387; Rongsen-Chandola T, 2014, VACCINE, V32, pA134, DOI 10.1016/j.vaccine.2014.04.078; Ruggeri FM, 1998, J VIROL, V72, P2708, DOI 10.1128/JVI.72.4.2708-2714.1998; SANCHEZ L, 1992, ARCH DIS CHILD, V67, P657, DOI 10.1136/adc.67.5.657; Superti F, 1997, MED MICROBIOL IMMUN, V186, P83, DOI 10.1007/s004300050049; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Trang NV, 2014, HUM VACC IMMUNOTHER, V10, P3681, DOI 10.4161/21645515.2014.980204; Troeger C, 2018, JAMA PEDIATR, V172, P958, DOI 10.1001/jamapediatrics.2018.1960; Vesikari T, 2004, PEDIATR INFECT DIS J, V23, P937, DOI 10.1097/01.inf.0000141722.10130.50; Vesikari T, 2012, PEDIATR INFECT DIS J, V31, P509, DOI 10.1097/INF.0b013e3182489cac; Wakabayashi H, 2014, J INFECT CHEMOTHER, V20, P666, DOI 10.1016/j.jiac.2014.08.003; Xu J, 2005, CLIN DIAGN LAB IMMUN, V12, P273, DOI 10.1128/CDLI.12.2.273-279.2005; YOLKEN RH, 1992, J CLIN INVEST, V90, P1984, DOI 10.1172/JCI116078; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	46	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0240714	10.1371/journal.pone.0240714	http://dx.doi.org/10.1371/journal.pone.0240714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170860	Green Published, gold			2022-12-26	WOS:000592383400032
J	Kim, JK; Crimmins, EM				Kim, Jung Ki; Crimmins, Eileen M.			How does age affect personal and social reactions to COVID-19: Results from the national Understanding America Study	PLOS ONE			English	Article							BEHAVIORS; RATES	The COVID-19 pandemic has had tremendous impact on Americans' lives including their personal and social behaviors. While people of all ages are affected in some way by the pandemic, older persons have been far more likely to suffer the most severe health consequences. For this reason, how people have responded to mitigating behaviors to COVID-19 may differ by age. Using a nationally representative sample from the longitudinal data of the Understanding America Study (UAS), we examined differentials in behavioral responses to COVID-19 by age and how they changed over the first three months of the pandemic. Behavioral responses and changes in behavior over time differed by age, type of behaviors and time reference. At the beginning of the pandemic (March, 2020), older and younger people were similar in their likelihood of engaging in preventive personal behaviors when controlling for other influences. As the pandemic progressed, however, older people adopted mitigating personal behavioral changes more than younger people, such that about 1-2 months after the pandemic started, older people were more likely to comply with suggested behaviors and regulations including practicing better hygiene, quarantining, and social distancing. One month into the pandemic, older people were less likely than younger people to engage in two of four risky behaviors. The change in risky behavior over time did not differ by age; but both younger and older people were more likely to engage in risky behaviors after two months. Being female, a member of a racial/ethnic minority group, higher socioeconomic status, having more COVID-19 cases in one's state of residence, a higher perceived risk for infection and dying, and a more left-leaning political orientation were related to adopting more pandemic mitigating behaviors.	[Kim, Jung Ki; Crimmins, Eileen M.] Univ Southern Calif, Davis Sch Gerontol, Los Angeles, CA 90007 USA	University of Southern California	Kim, JK (corresponding author), Univ Southern Calif, Davis Sch Gerontol, Los Angeles, CA 90007 USA.	jungk@usc.edu		Kim, Jung Ki/0000-0002-4842-0579	National Institute on Aging [NIA P30 AG17265, U01AG054580]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	EMC NIA P30 AG17265 National Institute on Aging https://www.nia.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper relies on data from survey(s) administered by the Understanding America Study, which is maintained by the Center for Economic and Social Research (CESR) at the University of Southern California. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of USC or UAS. The collection of the UAS COVID-19 tracking data is supported in part by the Bill & Melinda Gates Foundation and by grant U01AG054580 from the National Institute on Aging.	Alattar L., 2018, SOC SECUR B, V78, P13; Allcott H, 2020, J PUBLIC ECON, V191, DOI 10.1016/j.jpubeco.2020.104254; [Anonymous], 2006, PLOS MED, V3, pe252; [Anonymous], 2020, EVALUATING COVID 19; [Anonymous], WEEKL UPD SEL DEM GE; Ash E., 2020, EFFECT FOX NEWS HLTH, DOI [10.2139/ssrn.3636762, DOI 10.2139/SSRN.3636762]; ASPE, POV GUID; Balkhy HH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-42; Baum MA, 2011, J HEALTH POLIT POLIC, V36, P1021, DOI 10.1215/03616878-1460569; Bults M, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-2, 10.1186/1471-2458-11-165]; Callaghan D, 2005, J COMMUN HEALTH NURS, V22, P169, DOI 10.1207/s15327655jchn2203_4; CDC, DAIL LIF COP; Crimmins E, 2020, PUBLIC POLICY AGING; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; El Ansari W, 2011, CENT EUR J PUBL HEAL, V19, P197, DOI 10.21101/cejph.a3684; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; GitHub, COVID 19 STAT TREND; Hutchins SS, 2009, AM J PUBLIC HEALTH, V99, pS261, DOI 10.2105/AJPH.2009.161505; Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296; Lin YL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-128; Sadique MZ, 2007, EMERG INFECT DIS, V13, P1307, DOI 10.3201/eid1309.070372; Simonov A., 2020, NBER WORKING PAPER S, V27237; Small GW, 2013, INT PSYCHOGERIATR, V25, P981, DOI 10.1017/S1041610213000082; Spiegelhalter D, WHAT ARE RISKS COVID; Understanding America Study, 2020, METH SEL CROSST RES; Understanding America Study Recruitment Protoco, UND AM STUD RECR PRO; Wu Z, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI [10.1001/jama.2020.2648, DOI 10.1001/JAMA.2020.2648]; Zhao E, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003323	28	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241950	10.1371/journal.pone.0241950	http://dx.doi.org/10.1371/journal.pone.0241950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7KH	33170903	Green Published, gold			2022-12-26	WOS:000592383400059
J	Kraus, FB; Medenwald, D; Ludwig-Kraus, B				Kraus, Frank Bernhard; Medenwald, Daniel; Ludwig-Kraus, Beatrice			Do extreme summers increase blood vitamin D (25-hydroxyvitamin D) levels?	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; SEASONAL-VARIATIONS; CLIMATE-CHANGE; HEALTH; EXPOSURE; SUNLIGHT; LATITUDE; AGE; UVR	Climate change is expected to increase the frequency of extreme weather events, such as extended heat waves and droughts in the northern hemisphere. Besides affecting ecosystems worldwide, these changes in climate patterns will also affect the environmental health of human populations. While the medical community is mostly concerned with the negative impact of climate change, there might also be some beneficial effects. In this study we used laboratory data from a large university clinic in Germany (n = 13 406), to test for any detectable impact of two extreme summers on Vitamin-D [25(OH)D] plasma concentrations over a six year period (2014-2019). For the two years with extreme summers (2018 and 2019) the 25(OH)D plasma concentrations were significantly higher than in the previous four years (p < 0.001). A time series analysis (autoregressive term, AR, phi = 0.84, with an AR of one indicating a persistent effect) showed that 25(OH)D concentrations rise by 0.04 nmol/l (95% CI: 0.04-0.05 nmol/l) per hour of sunshine. The incidence of vitamin D deficiency was generally high (60% for 2014-2017) but dropped by 10% in 2018 and 2019. As such, the summers of 2018 and 2019, which are among the hottest and driest in Germany since the start of modern climate recordings, had a measurable positive effect on 25(OH)D plasma levels of the examined population. Given that 25(OH)D deficiency is widespread in higher latitudes, this implies that while mostly considered negative, climate change might also confer some health benefits with regard to vitamin D related medical conditions.	[Kraus, Frank Bernhard; Ludwig-Kraus, Beatrice] Univ Hosp Halle, Cent Lab, Halle, Germany; [Medenwald, Daniel] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Germany; [Medenwald, Daniel] Univ Hosp Halle Saale, Dept Radiat Oncol, Halle, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Kraus, FB (corresponding author), Univ Hosp Halle, Cent Lab, Halle, Germany.	bernhard.kraus@zoologie.uni-halle.de	Ludwig-Kraus, Beatrice/D-2390-2013; Kraus, Bernhard/B-8172-2011	Kraus, Bernhard/0000-0003-4354-9952	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	Financial support for publishing was granted by the funding program Open Access Publishing of the German Research Foundation (DFG).	ADAMS JS, 1982, NEW ENGL J MED, V306, P722, DOI 10.1056/NEJM198203253061206; [Anonymous], 2014, LANCET DIABETES ENDO, V2, P1, DOI 10.1016/S2213-8587(13)70164-5; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Box G, 1976, SERIES TIME SERIES A; Bundesorztekammer, 2014, DTSCH ARZTEBL, V111, pA1583; Challet D, 2009, ECONOMICS-KIEL, V3; CLSI, 2013, CLSI DOCUMENT EP09 A, V3rd; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Craviari T, 2008, J HEALTH POPUL NUTR, V26, P112; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; Diffey BL, 2010, BRIT J DERMATOL, V162, P1342, DOI 10.1111/j.1365-2133.2010.09697.x; DWD Climate Data Center (CDC), ZEITR FUER GEB FUER; Elder CJ, 2014, LANCET, V383, P1665, DOI 10.1016/S0140-6736(13)61650-5; Engelsen O, 2010, NUTRIENTS, V2, P482, DOI 10.3390/nu2050482; Feelisch M, 2010, EUR HEART J, V31, P1041, DOI 10.1093/eurheartj/ehq069; Haines A, 2019, NEW ENGL J MED, V380, P263, DOI 10.1056/NEJMra1807873; Harrison SR, 2020, CALCIFIED TISSUE INT, V106, P58, DOI 10.1007/s00223-019-00577-2; Hayes CE., 2018, VITAMIN MULTIPLE SCL, V2, P989; Heidari B, 2012, CASP J INTERN MED, V3, P535; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Kimlin MG, 2007, J PHOTOCH PHOTOBIO B, V86, P234, DOI 10.1016/j.jphotobiol.2006.10.004; Klingberg E, 2015, ENDOCRINE, V49, P800, DOI 10.1007/s12020-015-0548-3; Kull M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-22; Lai JKC, 2012, INTERN MED J, V42, P43, DOI 10.1111/j.1445-5994.2011.02471.x; Leary PF, 2017, J AM OSTEOPATH ASSOC, V117, P433, DOI 10.7556/jaoa.2017.089; Lips P, 2007, J BONE MINER RES, V22, P1668, DOI 10.1359/JBMR.070716; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Marcinowska-Suchowierska E, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00550; McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3; Paterson D, 1926, Arch Dis Child, V1, P36; Ponsonby A, 2005, PHOTOCHEM PHOTOBIOL, V81, P1267, DOI 10.1562/2005-02-15-IR-441; R Core Team, 2021, R LANGUAGE ENV STAT; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Rummukainen M, 2012, WIRES CLIM CHANGE, V3, P115, DOI 10.1002/wcc.160; Souberbielle JC, 2006, JOINT BONE SPINE, V73, P249, DOI 10.1016/j.jbspin.2006.01.003; Souberbielle JC, 2010, AUTOIMMUN REV, V9, P709, DOI 10.1016/j.autrev.2010.06.009; T/l/lyan K., 1996, DIASPORA, V5, P3, DOI [10.1353/dsp.1996.0000, DOI 10.1353/DSP.1996.0000]; Thieden E, 2009, PHOTOCHEM PHOTOBIOL, V85, P1480, DOI 10.1111/j.1751-1097.2009.00612.x; Thomas P, 2012, GLOBAL CHANGE BIOL, V18, P2392, DOI 10.1111/j.1365-2486.2012.02706.x; Vieth R, 2011, BEST PRACT RES CL EN, V25, P681, DOI 10.1016/j.beem.2011.06.009; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; WEBB AR, 1988, J CLIN ENDOCR METAB, V67, P373, DOI 10.1210/jcem-67-2-373; Williamson CE, 2014, NAT CLIM CHANGE, V4, P434, DOI [10.1038/nclimate2225, 10.1038/NCLIMATE2225]	46	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0242230	10.1371/journal.pone.0242230	http://dx.doi.org/10.1371/journal.pone.0242230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170904	gold, Green Published			2022-12-26	WOS:000592383400036
J	Kungu, W; Khasakhala, A; Agwanda, A				Kungu, Wambui; Khasakhala, Anne; Agwanda, Alfred			Use of long-acting reversible contraception among adolescents and young women in Kenya	PLOS ONE			English	Article							RAPID REPEAT PREGNANCY; INTERVENTIONS	The Kenya Demographic and Health Survey (KDHS 2014) revealed changing patterns in the contraceptive use of young women aged 15-24, shifting from injectable methods to implants. Long-acting reversible contraception (LARC) is user friendly, long-term, and more effective than other modern methods. It could be a game-changer in dealing with unintended pregnancies and herald a new chapter in the reproductive health and rights of young women. This study determined the factors associated with LARC use among adolescent girls and young women to expand the evidence of its potential as the most effective method of reducing unwanted pregnancies among the cohort. This study analysed secondary data from KDHS 2014 using binary logistic regression. The findings showed a rise in LARC use (18%), with identified predictors of reduced odds being aged 15-19 [OR = 0.735, 95% CI = 0.549-0.984], residence (rural) [OR = 0.674, CI = 0.525-0.865], religion (Protestant/other Christian) [OR = 0.377, CI = 0.168-0.842], married, [OR = 0.746, CI = 0.592-0.940], and region (high contraception) [OR = 0.773, CI = 0.626-0.955], while the number of living children showed increased odds for 1-2 children [OR = 17.624, CI = 9.482-32.756] and 3+ children [OR = 23.531, CI = 11.751-47.119]. This study established the rising popularity of LARC and identified factors that can be addressed to promote it. Its increased uptake could help Kenya achieve the International Conference on Population and Development 25's first and second commitments on teenage pregnancies and maternal and new-born health, thus promoting the health, wellbeing, educational goals, and rights of this critical cohort. This study can guide the accelerated efforts needed in Kenya's march towards the five zeros of unmet need for contraception, teenage pregnancies, unsafe abortions, preventable maternal deaths, and preventable neonatal/infant deaths.	[Kungu, Wambui; Khasakhala, Anne; Agwanda, Alfred] Univ Nairobi, Populat Studies & Res Inst, Nairobi, Kenya	University of Nairobi	Kungu, W (corresponding author), Univ Nairobi, Populat Studies & Res Inst, Nairobi, Kenya.	buikungu@yahoo.com	Kungu, Wambui/ABC-5612-2021	Kungu, Wambui/0000-0003-4441-7927				Achwoka D, 2018, CONTRACEPTION, V97, P227, DOI 10.1016/j.contraception.2017.10.001; Adedini SA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217574; American College of Obstetricians and Gynaecologists, 2018, OBSTET GYNECOL, V20, P8; [Anonymous], 2019, NAIR SUMM ICPD25; Askew I, 2019, KENYAS FERTILITY TRA; Baldwin MK, 2013, J ADOLESCENT HEALTH, V52, pS47, DOI 10.1016/j.jadohealth.2012.10.278; Chandra-Mouli V, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-1; Cooper CM, 2017, MATERN CHILD HLTH J, V21, P1880, DOI 10.1007/s10995-017-2341-9; Darroch JE, 2018, ADDING IT COSTS BENE; Dempsey AR, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.02.014; Duvall S, 2014, GLOB HEALTH-SCI PRAC, V2, P72, DOI 10.9745/GHSP-D-13-00116; Glinski A, 2014, UNDERSTANDING ADOLES, DOI DOI 10.1017/CBO9781107415324.004; Hubacher D, 2012, CONTRACEPTION, V86, P511, DOI 10.1016/j.contraception.2012.04.013; Jacobstein R, 2018, GLOB HEALTH-SCI PRAC, V6, P17, DOI 10.9745/GHSP-D-17-00396; Kavanaugh ML, 2013, J PEDIATR ADOL GYNEC, V26, P86, DOI 10.1016/j.jpag.2012.10.006; Kenya National Bureau of Statistics, 2019, KEN POP HOUS CENS, VIII; Kenya National Bureau of Statistics Ministry of Health National AIDS Control Council Kenya Medical Research Institute, 2015, KEN DEM HLTH SURV 20; Keyonzo N, 2015, REPROD HEALTH MATTER, V23, P103, DOI 10.1016/j.rhm.2015.06.010; Kimani M., 2013, African Population Studies, V27, P43; Kungu W, F1000 RES; Larsson C., 2014, African Population Studies, V28, P1022; Li ZH, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2019.21437; Magadi MA, 2003, STUD FAMILY PLANN, V34, P149, DOI 10.1111/j.1728-4465.2003.00149.x; Ministry of Health Kenya, 2012, NAT FAM PLANN COST I; Ministry of Health Kenya, 2015, NATL ADOLESCENT SEXU; Ministry of Health Kenya, 2017, NAT FAM PLANN COST I; Monitoring Performance and Accountability, 2018, ADOLESCENTS YOUNG AD; Monitoring Performance and Accountability, 2017, ADOLESCENT HLTH BRIE; Norton M, 2017, GLOB HEALTH-SCI PRAC, V5, P547, DOI 10.9745/GHSP-D-17-00131; Coll CDN, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0686-9; Ochako R, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0314-6; Ochako R, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1483-1; Ontiri S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16091543; Planning Family, 2015, GLOBAL CONSENSUS STA; Population Services International, 2015, WOM HLTH PROJ BEST P; Sedgh G, 2015, J ADOLESCENT HEALTH, V56, P223, DOI 10.1016/j.jadohealth.2014.09.007; Shoupe D, 2016, CONTRACEP REPROD MED, V1, DOI 10.1186/s40834-016-0011-8; Solo J, 2019, GLOB HEALTH-SCI PRAC, V7, P371, DOI 10.9745/GHSP-D-19-00130; Temple-Smith M, 2017, AUST FAM PHYSICIAN, V46, P710; Tsui AO, 2017, POPUL DEV REV, V43, P166, DOI 10.1111/padr.12051; WHO, 2015, WHO REC ASS HIV TEST; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855; Yinger N, 2016, M NEED FULF PROM YOU, DOI [10.1093/jmt/thw010, DOI 10.1093/JMT/THW010]	44	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241506	10.1371/journal.pone.0241506	http://dx.doi.org/10.1371/journal.pone.0241506			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170851	Green Published, gold			2022-12-26	WOS:000592383400064
J	Diouf, B; Dia, I; Sene, NM; Ndiaye, E; Diallo, M; Diallo, D				Diouf, Babacar; Dia, Ibrahima; Sene, Ndeye Marie; Ndiaye, El Hadji; Diallo, Mawlouth; Diallo, Diawo			Morphology and taxonomic status of Aedes aegypti populations across Senegal	PLOS ONE			English	Article							YELLOW-FEVER; DIPTERA; TRANSMISSION; EVOLUTION; FORMOSUS; DENGUE; AREA	Aedes aegypti is the primary vector of dengue, Zika, yellow fever and chikungunya viruses to humans. In Africa, two subspecies, Ae. aegypti aegypti (Aaa) and Ae. aegypti formosus (Aaf) have been described. Until very recently, it was considered that the two forms were sympatric in East Africa and that only Aaf was present in Central and West Africa. However, recent data suggests that Aaa was also common in Senegal without any clear evidence of genetic differences with Aaf. This study was carried out in different Ae. aegypti populations from Senegal to better clarify their taxonomic status. The larvae, pupae and eggs were collected between July and September 2018 and reared individually to adult stage. For each population, F-1 progeny from eggs laid by a single female F-0 were reared as sibling samples. The number of pale scales on the first abdominal tergite (T-1) and the basal part of the second tergite (T-2) were counted. Individuals with no pale scale on T-1 were classified as Aaf while those with at least one pale scale on this tergite were classified as Aaa. The morphological variations within families of Aaf were studied across 4 generations. In total, 2400 individuals constituting 240 families were identified, of which 42.5% were heterogeneous (families with both forms). Multivariate statistical analysis of variance including T-1 and T-2 data together showed that populations were significantly different from each other. Statistical analysis of T-1 alone showed a similarity between populations from the southeast while variations were observed within northwest population. The analysis of family composition across generations showed the presence of Aaa and Aaf forms in each generation. The classification of Ae. aegypti into two subspecies is invalid in Senegal. Populations exhibit morphological polymorphism at the intra-family level that could have biological and epidemiological impacts.	[Diouf, Babacar; Dia, Ibrahima; Sene, Ndeye Marie; Ndiaye, El Hadji; Diallo, Mawlouth; Diallo, Diawo] Inst Pasteur, Pole Zool Med, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar	Diouf, B (corresponding author), Inst Pasteur, Pole Zool Med, Dakar, Senegal.	Babacar.DIOUF2@pasteur.sn			 [H2020INFRAIA-2016-2017 (INFRAVEC2)]		This study was supported fully by H2020INFRAIA-2016-2017 (INFRAVEC2) funds. There was no additional external funding received for this study.	Ahmed QA, 2017, TROP DOCT, V47, P92, DOI 10.1177/0049475517699726; [Anonymous], 2021, LANG ENV STAT COMP; [Anonymous], 2017, WHO AFRO OUTBR OTH E; Bernhardt SA, 2009, INSECT MOL BIOL, V18, P557, DOI 10.1111/j.1365-2583.2009.00895.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brooke BD, 2000, MED VET ENTOMOL, V14, P190, DOI 10.1046/j.1365-2915.2000.00222.x; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Diallo Diawo, 2017, BMC Res Notes, V10, P524, DOI 10.1186/s13104-017-2854-8; Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442; Diallo D, 2014, AM J TROP MED HYG, V90, P1003, DOI 10.4269/ajtmh.13-0404; Diallo M., 2018, EMERGENCES CHIKUNGUN, P87; Diallo M, 2008, T ROY SOC TROP MED H, V102, P493, DOI 10.1016/j.trstmh.2008.02.010; Futami K, 2020, J MED ENTOMOL, V57, P772, DOI 10.1093/jme/tjz233; Gerberg E. J., 1994, MANUAL MOSQUITO REAR; Higa Yukiko, 2015, Tropical Medicine and Health, V43, P107, DOI 10.2149/tmh.2014-29; HILL. G. F., 1921, Annals of Tropical Medicine and Parasitology, V15, P91; Huang YM, 2004, ZOOTAXA, P1; Huber K, 2008, AM J TROP MED HYG, V79, P218, DOI 10.4269/ajtmh.2008.79.218; JUPP P G, 1991, Mosquito Systematics, V23, P182; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kropelin S, 2008, SCIENCE, V320, P765, DOI 10.1126/science.1154913; MACHADOA, 1972, ANN ENTOMOL SOC AM, V65, P542, DOI 10.1093/aesa/65.3.542; Main BJ, 2016, ANOPHELES ARABIENSIS, P044701; Manoukis NC, 2008, P NATL ACAD SCI USA, V105, P2940, DOI 10.1073/pnas.0709806105; Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392; MATTINGLY P. F., 1958, ANN TROP MED AND PARASITOL, V52, P5; MCCLELLAND G. A. H., 1960, ANN TROP MED AND PARASITOL, V54, P305; MCCLELLAND GA, 1974, T ROY ENT SOC LONDON, V126, P239, DOI 10.1111/j.1365-2311.1974.tb00853.x; MOORE DF, 1979, J MED ENTOMOL, V16, P223, DOI 10.1093/jmedent/16.3.223; MUNSTERMANN LE, 1979, J HERED, V70, P291, DOI 10.1093/oxfordjournals.jhered.a109261; Paupy C, 2010, INFECT GENET EVOL, V10, P473, DOI 10.1016/j.meegid.2010.03.001; PETRARCA V, 1992, AM J TROP MED HYG, V46, P229, DOI 10.4269/ajtmh.1992.46.229; Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395; Powers A.M., 2018, EMERGENCE CHIKUNGUNY, P215, DOI [10.1016/B978-0-12-811865-8.00007%E2%80%936, DOI 10.1016/B978-0-12-811865-8.00007%E2%80%936, DOI 10.1016/B978-0-12-811865-8.00007-6]; Riehle MM, 2017, ELIFE, V6, DOI [10.7554/eLife.25813, 10.7554/elife.25813]; Sanford MR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-225; SEVERSON DW, 1993, J HERED, V84, P241, DOI 10.1093/oxfordjournals.jhered.a111333; TABACHNICK WJ, 1979, EVOLUTION, V33, P287, DOI [10.1111/j.1558-5646.1979.tb04682.x, 10.2307/2407619]; WALLER RA, 1969, J AM STAT ASSOC, V64, P1484, DOI 10.2307/2286085; WALLIS GP, 1983, GENET RES, V41, P241, DOI 10.1017/S0016672300021315; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; Wilder-Smith A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax008; World Health Organization (WHO), 2019, YELLOW FEVER; World Tourism Organization-UNWTO, 2022, UNWTO WORLD TOUR BAR, V17, P1, DOI [DOI 10.18111/WTOBAROMETERENG, 10.18111/wtobarometereng.2022.20.1.4, DOI 10.18111/WTOBAROMETERENG.2022.20.1.4]	46	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242576	10.1371/journal.pone.0242576	http://dx.doi.org/10.1371/journal.pone.0242576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206725	gold, Green Published			2022-12-26	WOS:000595265900006
J	Hickey, P; Barnett-Young, A; Patel, AD; Race, E				Hickey, Paige; Barnett-Young, Annie; Patel, Aniruddh D.; Race, Elizabeth			Environmental rhythms orchestrate neural activity at multiple stages of processing during memory encoding: Evidence from event-related potentials	PLOS ONE			English	Article							TEMPORAL STRUCTURE; NEURONAL OSCILLATIONS; CORTICAL ENTRAINMENT; ORIENTING ATTENTION; DIVIDED ATTENTION; FREQUENCY; TIME; EXPECTATIONS; MODULATION; FLUCTUATIONS	Accumulating evidence suggests that rhythmic temporal structures in the environment influence memory formation. For example, stimuli that appear in synchrony with the beat of background, environmental rhythms are better remembered than stimuli that appear out-of-synchrony with the beat. This rhythmic modulation of memory has been linked to entrained neural oscillations which are proposed to act as a mechanism of selective attention that prioritize processing of events that coincide with the beat. However, it is currently unclear whether rhythm influences memory formation by influencing early (sensory) or late (post-perceptual) processing of stimuli. The current study used stimulus-locked event-related potentials (ERPs) to investigate the locus of stimulus processing at which rhythm temporal cues operate in the service of memory formation. Participants viewed a series of visual objects that either appeared in-synchrony or out-of-synchrony with the beat of background music and made a semantic classification (living/non-living) for each object. Participants' memory for the objects was then tested (in silence). The timing of stimulus presentation during encoding (in-synchrony or out-of-synchrony with the background beat) influenced later ERPs associated with post-perceptual selection and orienting attention in time rather than earlier ERPs associated with sensory processing. The magnitude of post-perceptual ERPs also differed according to whether or not participants demonstrated a mnemonic benefit for in-synchrony compared to out-of-synchrony stimuli, and was related to the magnitude of the rhythmic modulation of memory performance across participants. These results support two prominent theories in the field, the Dynamic Attending Theory and the Oscillation Selection Hypothesis, which propose that neural responses to rhythm act as a core mechanism of selective attention that optimize processing at specific moments in time. Furthermore, they reveal that in addition to acting as a mechanism of early attentional selection, rhythm influences later, post-perceptual cognitive processes as events are transformed into memory.	[Hickey, Paige; Barnett-Young, Annie; Patel, Aniruddh D.; Race, Elizabeth] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Patel, Aniruddh D.] Canadian Inst Adv Res CIFAR, Program Brain Mind & Consciousness, Toronto, ON, Canada	Tufts University; Canadian Institute for Advanced Research (CIFAR)	Hickey, P (corresponding author), Tufts Univ, Dept Psychol, Medford, MA 02155 USA.	Paige.hickey@tufts.edu			GRAMMY Museum	GRAMMY Museum	This research was funded in part by a grant from the GRAMMY Museum: https://grammymuseum.org/national-reach/nationalprograms/grants/(PH, AP, ER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Dunabeitia JA, 2018, Q J EXP PSYCHOL, V71, P808, DOI 10.1080/17470218.2017.1310261; [Anonymous], 2017, J Prosthet Dent, V117, pe1, DOI 10.1016/j.prosdent.2016.12.001; Assaneo MF, 2019, NAT NEUROSCI, V22, P627, DOI 10.1038/s41593-019-0353-z; Auksztulewicz R, 2019, J NEUROSCI, V39, P9806, DOI 10.1523/JNEUROSCI.0925-19.2019; Bouwer FL, 2020, J COGNITIVE NEUROSCI, V32, P1221, DOI 10.1162/jocn_a_01529; Burke JF, 2014, NEUROIMAGE, V85, P834, DOI 10.1016/j.neuroimage.2013.06.067; Calderone DJ, 2014, TRENDS COGN SCI, V18, P300, DOI 10.1016/j.tics.2014.02.005; Clouter A, 2017, CURR BIOL, V27, P3143, DOI 10.1016/j.cub.2017.09.001; Correa A, 2006, BRAIN RES, V1076, P116, DOI 10.1016/j.brainres.2005.11.074; Correa A, 2005, PSYCHON B REV, V12, P328, DOI 10.3758/BF03196380; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; Daltrozzo J, 2012, BRAIN SCI, V2, P267, DOI 10.3390/brainsci2030267; Doelling KB, 2019, P NATL ACAD SCI USA, V116, P10113, DOI 10.1073/pnas.1816414116; Doelling KB, 2015, P NATL ACAD SCI USA, V112, pE6233, DOI 10.1073/pnas.1508431112; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; Driver J, 2000, NAT REV NEUROSCI, V1, P147, DOI 10.1038/35039083; Escoffier N, 2015, NEUROIMAGE, V111, P267, DOI 10.1016/j.neuroimage.2015.02.024; FABIANI M, 1990, ELECTROEN CLIN NEURO, V75, P22, DOI 10.1016/0013-4694(90)90149-E; Frey JN, 2015, BRAIN RES, V1626, P183, DOI 10.1016/j.brainres.2015.02.017; Friederici AD, 1996, J EXP PSYCHOL LEARN, V22, P1219, DOI 10.1037//0278-7393.22.5.1219; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Griffin IC, 2002, NEUROPSYCHOLOGIA, V40, P2325, DOI 10.1016/S0028-3932(02)00087-8; Guo CY, 2004, NEUROSCI LETT, V356, P79, DOI 10.1016/j.neulet.2003.09.049; Helfrich RF, 2019, CURR OPIN PSYCHOL, V29, P82, DOI 10.1016/j.copsyc.2018.12.016; Henry MJ, 2014, P NATL ACAD SCI USA, V111, P14935, DOI 10.1073/pnas.1408741111; Herrmann B, 2016, NEUROIMAGE, V124, P487, DOI 10.1016/j.neuroimage.2015.09.019; Hickey P, 2020, NEUROIMAGE, V213, DOI 10.1016/j.neuroimage.2020.116693; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hillyard SA, 2016, NEUROPSYCHOLOGIA, V83, P170, DOI 10.1016/j.neuropsychologia.2015.06.003; Holtje G, 2019, NEUROPSYCHOLOGIA, V131, P285, DOI 10.1016/j.neuropsychologia.2019.05.013; Honing H, 2014, ADV EXP MED BIOL, V829, P305, DOI 10.1007/978-1-4939-1782-2_16; Hopfinger JB LS, 2004, COGNITIVE NEUROSCIEN; Johndro H, 2019, ACTA PSYCHOL, V200, DOI 10.1016/j.actpsy.2019.102923; Jones A, 2019, J COGNITIVE NEUROSCI, V31, P1549, DOI 10.1162/jocn_a_01431; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; Jones MR., 2019, TIME WILL TELL THEOR, DOI DOI 10.1093/OSO/9780190618216.001.0001; Kamp SM, 2019, NEUROBIOL LEARN MEM, V157, P128, DOI 10.1016/j.nlm.2018.12.006; Kashiwase Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070922; Koster M, 2019, NEUROIMAGE, V188, P181, DOI 10.1016/j.neuroimage.2018.12.002; Krol M, 2015, Q J EXP PSYCHOL, V68, P1723, DOI 10.1080/17470218.2014.996166; KUTAS M, 1977, SCIENCE, V197, P792, DOI 10.1126/science.887923; Lakatos P, 2008, SCIENCE, V320, P110, DOI 10.1126/science.1154735; Lakatos P, 2019, CURR BIOL, V29, pR890, DOI 10.1016/j.cub.2019.07.075; Lange K, 2006, J COGNITIVE NEUROSCI, V18, P715, DOI 10.1162/jocn.2006.18.5.715; Lange K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00263; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Luck SJ, 2000, TRENDS COGN SCI, V4, P432, DOI 10.1016/S1364-6613(00)01545-X; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Mathewson KE, 2012, J COGNITIVE NEUROSCI, V24, P2321, DOI 10.1162/jocn_a_00288; Miniussi C, 1999, BRAIN, V122, P1507, DOI 10.1093/brain/122.8.1507; Naveh-Benjamin M, 2003, MEM COGNITION, V31, P1021, DOI 10.3758/BF03196123; Nobre AC, 2018, NAT REV NEUROSCI, V19, P34, DOI 10.1038/nrn.2017.141; Nozaradan S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20612; Nozaradan S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0393; Otten LJ, 2007, J COGNITIVE NEUROSCI, V19, P1776, DOI 10.1162/jocn.2007.19.11.1776; Otten LJ, 2010, J COGNITIVE NEUROSCI, V22, P1212, DOI 10.1162/jocn.2009.21298; Otten LJ, 2006, NAT NEUROSCI, V9, P489, DOI 10.1038/nn1663; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; PALLER KA, 1987, ELECTROEN CLIN NEURO, V67, P360, DOI 10.1016/0013-4694(87)90124-6; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Richter FR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167396; Rimmele J, 2011, J COGNITIVE NEUROSCI, V23, P1136, DOI 10.1162/jocn.2010.21437; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; Rolke B, 2016, PSYCHOPHYSIOLOGY, V53, P1690, DOI 10.1111/psyp.12734; Schroeder CE, 2009, TRENDS NEUROSCI, V32, P9, DOI 10.1016/j.tins.2008.09.012; Schwartze M, 2011, BIOL PSYCHOL, V87, P146, DOI 10.1016/j.biopsycho.2011.02.021; Stormer VS, 2009, P NATL ACAD SCI USA, V106, P22456, DOI 10.1073/pnas.0907573106; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Thavabalasingam S, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.02062; Thut G, 2012, CURR BIOL, V22, pR658, DOI 10.1016/j.cub.2012.06.061; Tierney A, 2015, J COGNITIVE NEUROSCI, V27, P400, DOI 10.1162/jocn_a_00704; Tierney A, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00014; Wang DY, 2018, J NEUROSCI, V38, P6299, DOI 10.1523/JNEUROSCI.0349-18.2018	74	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0234668	10.1371/journal.pone.0234668	http://dx.doi.org/10.1371/journal.pone.0234668			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206657	Green Published, Green Submitted, gold			2022-12-26	WOS:000595265900081
J	Azegami, T; Nishimura, T; Murai-Takeda, A; Yamada-Goto, N; Sato, Y; Mori, M				Azegami, Tatsuhiko; Nishimura, Tomoyasu; Murai-Takeda, Ayano; Yamada-Goto, Nobuko; Sato, Yasunori; Mori, Masaaki			The distributions of hematologic and biochemical values in healthy high-school adolescents in Japan	PLOS ONE			English	Article							PEDIATRIC REFERENCE INTERVALS; SERUM URIC-ACID; CHILDREN; ADULT; WEIGHT; BIRTH	Laboratory tests of adolescents are often interpreted by using reference intervals derived from adults, even though these populations differ in their physical and physiologic characteristics and disease susceptibility. Therefore, to examine the distribution of laboratory values specific for adolescents, we analyzed hematologic and biochemical measurements obtained from 12,023 healthy Japanese adolescents (ages 15 through 18 years; male, 9165; female, 2858) during 2009 through 2018. Distributions were shown as medians with 95% (2.5th and 97.5th percentiles) of values and were compared with those from previous studies that examined similar Asian populations. There were some differences between hematologic parameters, serum creatinine and uric acid concentration, and lipid levels of Japanese adults and adolescents. In comparison with other Asian populations, the distributions of serum uric acid and high-density-lipoprotein cholesterol in the present study were slightly higher than those in the other studies. Although further research is need, the distributions of hematologic and biochemical tests in adolescents may have the potential to facilitate the early identification and management of disease in this population.	[Azegami, Tatsuhiko; Nishimura, Tomoyasu; Murai-Takeda, Ayano; Yamada-Goto, Nobuko; Mori, Masaaki] Keio Univ, Hlth Ctr, Yokohama, Kanagawa, Japan; [Sato, Yasunori] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan	Keio University; Keio University	Azegami, T (corresponding author), Keio Univ, Hlth Ctr, Yokohama, Kanagawa, Japan.	t.azegami-1114@z2.keio.jp	SATO, Yasunori/AGK-2994-2022	Azegami, Tatsuhiko/0000-0002-4809-5788; Sato, Yasunori/0000-0002-7189-5126				Adeli K, 2017, CRIT REV CL LAB SCI, V54, P358, DOI 10.1080/10408363.2017.1379945; Adeli K, 2017, CLIN BIOCHEM, V50, P925, DOI 10.1016/j.clinbiochem.2017.06.006; Adeli K, 2015, CLIN CHEM, V61, P1049, DOI 10.1373/clinchem.2015.240515; [Anonymous], 2016, B WORLD HEALTH ORGAN, V94, P484, DOI [10.2471/BLT.16.179381, DOI 10.2471/BLT.16.179381]; Bandesh K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213255; Bogner B, 2019, CLIN CHEM LAB MED, V57, P891, DOI 10.1515/cclm-2018-0715; Jaime-Perez JC, 2019, HEMATOL TRANSF CELL, V41, P57, DOI 10.1016/j.htct.2018.05.010; Centers for Disease Control and Prevention, 2017, CLIN GROWTH CHARTS; Cho SM, 2014, CLIN BIOCHEM, V47, P268, DOI 10.1016/j.clinbiochem.2014.09.010; Drion I, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-133; Fadrowski JJ, 2011, CLIN J AM SOC NEPHRO, V6, P1427, DOI 10.2215/CJN.06460710; Giuliano I, 2011, NUTR METAB CARDIOVAS, V21, P33, DOI 10.1016/j.numecd.2009.08.002; Ichihara K, 2016, ANN CLIN BIOCHEM, V53, P347, DOI 10.1177/0004563215608875; Isojima T, 2016, CLIN PEDIATR ENDOCRI, V25, P71, DOI 10.1297/cpe.25.71; Kelishadi R, 2016, WORLD J PEDIATR, V12, P335, DOI 10.1007/s12519-015-0065-8; Kubota M, 2019, J NUTR METAB, V2019, DOI 10.1155/2019/3480718; Kuwahara E, 2017, PEDIATR RES, V81, P293, DOI 10.1038/pr.2016.213; Li Y, 2018, CLIN BIOCHEM, V53, P72, DOI 10.1016/j.clinbiochem.2018.01.019; Marwaha RK, 2011, CLIN BIOCHEM, V44, P760, DOI 10.1016/j.clinbiochem.2011.05.011; Odhiambo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123140; Rhone ET, 2017, PEDIATR INT, V59, P948, DOI 10.1111/ped.13328; Ridefelt P, 2018, SCAND J CLIN LAB INV, V78, P365, DOI 10.1080/00365513.2018.1474493; Shaw JLV, 2014, CLIN BIOCHEM, V47, P166, DOI 10.1016/j.clinbiochem.2013.11.008; Tanaka T., 2008, J JPN PEDIAT SOC, V112, P1117; Tinggaard J, 2014, ACTA PAEDIATR, V103, P214, DOI 10.1111/apa.12468; Yoon JM, 2014, PEDIATR GASTROENTERO, V17, P85, DOI 10.5223/pghn.2014.17.2.85; Zeh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021040	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242272	10.1371/journal.pone.0242272	http://dx.doi.org/10.1371/journal.pone.0242272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201901	Green Published, gold			2022-12-26	WOS:000595003900028
J	Jin, L; Wei, D; Yin, DW; Zhou, BK; Ding, JL; Wang, W; Zhang, JM; Qiu, SJ; Zhang, CJ; Li, Y; An, ZZ; Gu, JL; Wang, L				Jin, Liang; Wei, Dan; Yin, Dawei; Zhou, Baoku; Ding, JianLi; Wang, Wei; Zhang, Jiuming; Qiu, Shaojun; Zhang, Chengjun; Li, Yan; An, Zhizhuang; Gu, Jialin; Wang, Lei			Investigations of the effect of the amount of biochar on soil porosity and aggregation and crop yields on fertilized black soil in northern China	PLOS ONE			English	Article							5-YEAR FIELD TRIAL; ORGANIC-MATTER; CARBON; MAIZE	The combination of chemical fertilizer and biochar is regarded as a useful soil supplement for improving the properties of soil and crop yields, and this study describes how the biochar of maize straw can be used to improve the quality of the degraded black soil. This has been achieved by examining the effects of combining different amounts of biochar with chemical fertilizer on the porosities and aggregate formation of soil and exploring how these changes positively impact on crop yields. A field trial design combining different amounts of maize straw biochar [0 (NPK), 15.75 (BC1), 31.5 (BC2), and 47.25 t ha(-1) (BC3)] with a chemical fertilizer (NPK) has been used to investigate changes in the formation of soil aggregate, clay content, soil organic carbon (SOC), and crop yields in Chinese black soil over a three year period from 2013 to 2015. The results of this study show that the addition of fertilizer and biochar in 2013 to black soil results in an increased soybean and maize yields from 2013 to 2015 for all the treatments, with BC1/BC2 affording improved crop yields in 2015, while BC3 gave a lower soybean yield in 2015. Total porosities and pore volumes were increased for BC1 and BC2 treatments but relatively decreased for BC3, which could be attributed to increased soil capillary caused by the presence of higher numbers of fine soil particles. The addition of biochar had a positive influence on the numbers and mean weight diameters (MWD) of soil macroaggregates (>0.25 mm) that were present, with the ratio of SOC to TN in soil macroaggregates found to be greater than in the microaggregates. The most significant amount of carbon present in macroaggregates (>2 mm and 0.25-2 mm) was observed when BC2 was applied as a soil additive. Increasing the levels of maze straw biochar to 47.25 t ha(-1) led to an increase in the total organic carbon of soil, however, the overall amount of macroaggregates and MWD were decreased, which is possibly due to localized changes in microbial habitat. The supplementation of biochar increased in the amount of aromatic C present (most significant effect observed for BC2), with the ratio of aliphatic C to aromatic C found to be enhanced due to a relative reduction in the aliphatic C content with >2 mm particle fraction. These changes in organic carbon content and soil stability were analyzed using univariate quadratic equations to explain the relationship between the type of functional groups (polysaccharide C, aliphatic C, aromatic C, aliphatic C/aromatic C) present in the soil aggregates and their MWDs, which were found to vary significantly. Overall, the results of this study indicate that the use of controlled amounts of maize-straw biochar in black soil is beneficial for improving crop yields and levels of soil aggregation, however, the use of excessive amounts of biochar results in unfavorable aggregate formation which negatively impacts the yields of crop growth. The data produced suggest that aromatic C content can be used as a single independent variable to characterize the stability of soil aggregate when biochar/fertilizer mixtures are used as soil additives to boost growth yields. Analysis of soil and crop performance in black soil revealed that the application of maize-straw biochar at a rate of 15.75 and 31.5 t ha(-1) had positive effects on crop yields, soil aggregation and accumulation of aromatic C in the aggregate fractions when a soybean-maize rotation system was followed over three years.	[Jin, Liang; Wei, Dan; Ding, JianLi; Zhang, Chengjun; An, Zhizhuang; Gu, Jialin; Wang, Lei] Beijing Acad Agr & Forestry Sci, Plant Nutr & Resources Inst, Beijing, Peoples R China; [Jin, Liang; Zhou, Baoku; Wang, Wei; Zhang, Jiuming] Heilongjiang Acad Agr & Sci, Soil Fertilizer & Environm Resource Inst, Key Lab Soil Environm & Plant Nutr Heilongjiang P, Harbin, Peoples R China; [Yin, Dawei] Heilongjiang Bayi Agr Univ, Coll Agr Sci & Technol, Daqing, Heilongjiang, Peoples R China; [Qiu, Shaojun] Chinese Acad Agr Sci, Minist Agr & Rural Affairs, Key Lab Plant Nutr & Fertilizers, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [Li, Yan] Northeast Agr Univ, Coll Resources & Environm, Harbin, Peoples R China	Beijing Academy of Agriculture & Forestry; Heilongjiang Academy of Agricultural Sciences; Heilongjiang Bayi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Wei, D (corresponding author), Beijing Acad Agr & Forestry Sci, Plant Nutr & Resources Inst, Beijing, Peoples R China.	wd2087@163.com	Qiu, Shaojun/AGO-2672-2022; Zhang, Cheng/GRS-8698-2022		National Key R&D Program of China [2018YFD0201000, 2017YFD0200803]; national Natural Science Foundation of China [41977095, 31901479, 41771284]; Heilongjiang Natural Science Foundation [ZD2017008]; Beijing Academy of Agricultural and Forestry Sciences Science and Technology Innovation Capacity Building Project [KJCX20190408]	National Key R&D Program of China; national Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Natural Science Foundation(Natural Science Foundation of Heilongjiang Province); Beijing Academy of Agricultural and Forestry Sciences Science and Technology Innovation Capacity Building Project	National Key R&D Program of China (2018YFD0201000;2017YFD0200803), national Natural Science Foundation of China (41977095; 31901479; 41771284). Heilongjiang Natural Science Foundation (No. ZD2017008), Beijing Academy of Agricultural and Forestry Sciences Science and Technology Innovation Capacity Building Project(KJCX20190408. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Z, 2018, ARAB J GEOSCI, V11, DOI 10.1007/s12517-018-3790-1; Anyanwu IN, 2018, ECOTOX ENVIRON SAFE, V153, P116, DOI 10.1016/j.ecoenv.2018.02.005; Belcheva M, 2018, ICON NEWS, V77, P32; Bronick CJ, 2005, GEODERMA, V124, P3, DOI 10.1016/j.geoderma.2004.03.005; Busscher WJ, 2010, SOIL SCI, V175, P10, DOI 10.1097/SS.0b013e3181cb7f46; Chang RX, 2019, J ENVIRON MANAGE, V233, P283, DOI 10.1016/j.jenvman.2018.12.021; Chibuike Ezepue G.U., 2019, ADV AGR SCI, V7, P59; Dong XL, 2017, CATENA, V159, P136, DOI 10.1016/j.catena.2017.08.008; Haider G, 2017, AGR ECOSYST ENVIRON, V237, P80, DOI 10.1016/j.agee.2016.12.019; Huang R, 2018, AGR ECOSYST ENVIRON, V265, P576, DOI 10.1016/j.agee.2018.07.013; Hunter B., 2017, Journal of Agricultural Extension and Rural Development, V9, P1, DOI 10.5897/jaerd2016.0787; Jeffery S, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa67bd; Jin ZW, 2019, FIELD CROP RES, V232, P77, DOI 10.1016/j.fcr.2018.12.013; Kim H, 2019, ATMOS ENVIRON, V200, P158, DOI 10.1016/j.atmosenv.2018.11.062; Laghari M, 2015, CATENA, V135, P313, DOI 10.1016/j.catena.2015.08.013; Lal R, 2015, CURR OPIN ENV SUST, V15, P79, DOI 10.1016/j.cosust.2015.09.002; Li H., 2017, RES AGR MECH, V39, P256; [梁尧 Liang Yao], 2016, [植物营养与肥料学报, Journal of Plant Nutrition and Fertitizer], V22, P1586; Liu Y, 2018, ECOL ENG, V122, P295, DOI 10.1016/j.ecoleng.2018.08.018; Ma TT, 2019, APPL CLAY SCI, V172, P85, DOI 10.1016/j.clay.2019.02.011; Madari BE, 2017, GEODERMA, V305, P100, DOI 10.1016/j.geoderma.2017.05.029; Meng Jun, 2011, Journal of Shenyang Agricultural University, V42, P387; Nakamura R, 2020, J PLANT RES, V133, P271, DOI 10.1007/s10265-019-01162-2; Niu YH, 2017, ATMOS ENVIRON, V170, P58, DOI 10.1016/j.atmosenv.2017.09.050; Oladele SO, 2019, GEODERMA, V336, P1, DOI 10.1016/j.geoderma.2018.08.025; Oren A, 2018, GEODERMA, V319, P204, DOI 10.1016/j.geoderma.2018.01.007; Rabbi SMF, 2015, SOIL TILL RES, V146, P193, DOI 10.1016/j.still.2014.10.008; Rao ZX, 2018, ENVIRON POLLUT, V239, P198, DOI 10.1016/j.envpol.2018.04.024; Sistani KR, 2019, ENVIRONMENTS, V6, DOI 10.3390/environments6050055; Six J, 2002, AGRONOMIE, V22, P755, DOI 10.1051/agro:2002043; Six J, 2000, SOIL SCI SOC AM J, V64, P1042, DOI 10.2136/sssaj2000.6431042x; Sun DQ, 2017, J GEOGR SCI, V27, P943, DOI 10.1007/s11442-017-1414-4; Sun HJ, 2019, PLANT SOIL ENVIRON, V65, P83, DOI [10.17221/525/2018-PSE, 10.17221/525/2018-pse]; [王金武 Wang Jinwu], 2017, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V48, P1; Wang Na, 2019, Huanjing Kexue, V40, P2375, DOI 10.13227/j.hjkx.201809204; Wang YC, 2019, SCI TOTAL ENVIRON, V685, P741, DOI 10.1016/j.scitotenv.2019.06.244; Wu YZ, 2017, HABITAT INT, V69, P126, DOI 10.1016/j.habitatint.2017.09.002; Yang P., 1993, CHINESE SCI BULL, V38, P1896; Yoo G, 2011, ECOL ENG, V37, P487, DOI 10.1016/j.ecoleng.2010.12.016; Zeeshan M, 2020, J CLEAN PROD, V255, DOI 10.1016/j.jclepro.2020.120318; Zhu QH, 2015, INT AGROPHYS, V29, P257, DOI 10.1515/intag-2015-0023; Zong YT, 2018, ENVIRON SCI POLLUT R, V25, P25726, DOI 10.1007/s11356-017-9509-0	42	8	8	11	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0238883	10.1371/journal.pone.0238883	http://dx.doi.org/10.1371/journal.pone.0238883			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201879	gold, Green Published			2022-12-26	WOS:000595003900024
J	Ethier, I; Cho, Y; Hawley, C; Pascoe, EM; Viecelli, AK; Campbell, SB; van Eps, C; Isbel, NM; Cooper, BA; Harris, DC; Pollock, CA; Wong, MG; Johnson, DW				Ethier, Isabelle; Cho, Yeoungjee; Hawley, Carmel; Pascoe, Elaine M.; Viecelli, Andrea K.; Campbell, Scott B.; van Eps, Carolyn; Isbel, Nicole M.; Cooper, Bruce A.; Harris, David C.; Pollock, Carol A.; Wong, Muh Geot; Johnson, David W.			Rate of decline in residual kidney function pre and post peritoneal dialysis initiation: A post hoc analysis of the IDEAL study	PLOS ONE			English	Article							RENAL-FUNCTION; RELATIVE CONTRIBUTION; PREDICTORS; ADEQUACY; PRESERVATION; CLEARANCE; NUTRITION; SURVIVAL; START	Background Residual kidney function (RKF) is associated with improved survival and quality of life in dialysis patients. Previous studies have suggested that initiation of peritoneal dialysis (PD) may slow RKF decline compared to the pre-dialysis period. We sought to evaluate the association between PD initiation and RKF decline in the Initiating Dialysis Early And Late (IDEAL) trial. Methods In this post hoc analysis of the IDEAL randomized controlled trial, PD participants were included if results from 24-hour urine collections had been recorded within 30 days of dialysis initiation, and at least one value pre- and one value post-dialysis commencement were available. The primary outcome was slope of RKF decline, calculated as mean of urinary creatinine and urea clearances. Secondary outcomes included slope of urine volume decline and time from PD initiation to anuria. Results The study included 151 participants (79 early start, 72 late start). The slope of RKF decline was slower after PD initiation (-2.69 +/- 0.18mL/min/1.73m(2)/yr) compared to before PD (-4.09 +/- 0.33mL/min/1.73m(2)/yr; change in slope +1.19 mL/min/1.73m(2)/yr, 95%CI 0.48-1.90, p<0.001). In contrast, urine volume decline was faster after PD commencement (-0.74 +/- 0.05 L/yr) compared to beforehand (-0.57 +/- 0.06L/yr; change in slope -0.18L/yr, 95%CI -0.34--0.01, p = 0.04). No differences were observed between the early- and late-start groups with respect to RKF decline, urine volume decline or time to anuria. Conclusions Initiation of PD was associated with a slower decline of RKF compared to the pre-dialysis period.	[Ethier, Isabelle] Ctr Hosp Univ Montreal, Div Nephrol, Montreal, PQ, Canada; [Ethier, Isabelle; Cho, Yeoungjee; Hawley, Carmel; Viecelli, Andrea K.; Campbell, Scott B.; van Eps, Carolyn; Isbel, Nicole M.; Johnson, David W.] Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia; [Cho, Yeoungjee; Hawley, Carmel; Pascoe, Elaine M.; Viecelli, Andrea K.; Johnson, David W.] Univ Queensland, Australasian Kidney Trials Network, Brisbane, Qld, Australia; [Hawley, Carmel; Johnson, David W.] Translat Res Inst, Brisbane, Qld, Australia; [Hawley, Carmel; Pascoe, Elaine M.; Campbell, Scott B.; van Eps, Carolyn; Isbel, Nicole M.; Johnson, David W.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Cooper, Bruce A.; Pollock, Carol A.; Wong, Muh Geot] Royal North Shore Hosp, Dept Renal Med, St Leonards, NSW, Australia; [Harris, David C.] Westmead Inst Med Res, Ctr Transplantat & Renal Res, Sydney, NSW, Australia; [Harris, David C.; Pollock, Carol A.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Wong, Muh Geot] George Inst Global Hlth, Newtown, Tas, Australia	Universite de Montreal; University of Queensland; University of Queensland; Royal North Shore Hospital; University of Sydney; Westmead Institute for Medical Research; University of Sydney; George Institute for Global Health; University of Sydney	Ethier, I (corresponding author), Ctr Hosp Univ Montreal, Div Nephrol, Montreal, PQ, Canada.; Ethier, I (corresponding author), Princess Alexandra Hosp, Dept Nephrol, Brisbane, Qld, Australia.	isabelle.ethier@umontreal.ca	; Johnson, David/F-2897-2011	Ethier, Isabelle/0000-0003-4909-0417; Johnson, David/0000-0001-5491-3460	National Health and Medical Research Council of Australia [211146, 465095]; Australian Health Ministers Advisory Council [PDR 2001/10]; Royal Australasian College of Physicians/Australian and New Zealand Society of Nephrology (Don and Lorraine Jacquot Fellowship); National Heart Foundation (Australia); National Heart Foundation (New Zealand); Baxter Healthcare; Health Funding Authority New Zealand (Te Mana Putea Hauora O Aotearoa); International Society for Peritoneal Dialysis; Amgen Australia; Janssen-Cilag; Centre Hospitalier de l'Universite de Montreal; Fondation du CHUM; NHMRC; Jacquot Research Establishment Fellowship Award; Princess Alexandra Research Foundation; Diabetes Australian Research Trust Millennium Grant; Australian National Health and Medical Research Council Practitioner Fellowship	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Health Ministers Advisory Council; Royal Australasian College of Physicians/Australian and New Zealand Society of Nephrology (Don and Lorraine Jacquot Fellowship); National Heart Foundation (Australia)(National Heart Foundation of Australia); National Heart Foundation (New Zealand); Baxter Healthcare; Health Funding Authority New Zealand (Te Mana Putea Hauora O Aotearoa); International Society for Peritoneal Dialysis; Amgen Australia(Amgen); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Centre Hospitalier de l'Universite de Montreal; Fondation du CHUM; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Jacquot Research Establishment Fellowship Award; Princess Alexandra Research Foundation; Diabetes Australian Research Trust Millennium Grant; Australian National Health and Medical Research Council Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	The IDEAL study was supported by grants from the National Health and Medical Research Council of Australia (211146 and 465095), the Australian Health Ministers Advisory Council (PDR 2001/10), the Royal Australasian College of Physicians/Australian and New Zealand Society of Nephrology (Don and Lorraine Jacquot Fellowship), the National Heart Foundation (Australia), and the National Heart Foundation (New Zealand), and by unrestricted grants from Baxter Healthcare, Health Funding Authority New Zealand (Te Mana Putea Hauora O Aotearoa), the International Society for Peritoneal Dialysis, Amgen Australia, and Janssen-Cilag. IE is supported by a fellowship grant from the Centre Hospitalier de l'Universite de Montreal and the Fondation du CHUM. YC is supported by an Early career fellowship grant from the NHMRC. AV received grant support from the Jacquot Research Establishment Fellowship Award and the Princess Alexandra Research Foundation. MGW is supported by Diabetes Australian Research Trust Millennium Grant. DJ is supported by an Australian National Health and Medical Research Council Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Berlanga JR, 2002, PERITON DIALYSIS INT, V22, P239; Churchill DN, 1996, J AM SOC NEPHROL, V7, P198; Cooper BA, 2004, PERITON DIALYSIS INT, V24, P176; Cooper BA, 2010, NEW ENGL J MED, V363, P609, DOI 10.1056/NEJMoa1000552; de Jager DJ, 2013, NEPHROL DIAL TRANSPL, V28, P698, DOI 10.1093/ndt/gfs578; DUBOIS D, 1989, NUTRITION, V5, P303; He L, 2016, PERITON DIALYSIS INT, V36, P334, DOI 10.3747/pdi.2016.00024; Janmaat CJ, 2018, CLIN EPIDEMIOL, V10, P613, DOI 10.2147/CLEP.S153367; Jansen MAM, 2002, KIDNEY INT, V62, P1046, DOI 10.1046/j.1523-1755.2002.00505.x; Johnson DW, 2012, J AM SOC NEPHROL, V23, P1097, DOI 10.1681/ASN.2011121201; Johnson DW, 2003, PERITON DIALYSIS INT, V23, P276; Lang SM, 2001, PERITON DIALYSIS INT, V21, P52; Liao CT, 2008, PERITON DIALYSIS INT, V28, pS191; Lysaght M J, 1991, ASAIO Trans, V37, P598; Medcalf JF, 2001, KIDNEY INT, V59, P1128, DOI 10.1046/j.1523-1755.2001.0590031128.x; Moist LM, 2000, J AM SOC NEPHROL, V11, P556, DOI 10.1681/ASN.V113556; Perl J, 2009, AM J KIDNEY DIS, V53, P1068, DOI 10.1053/j.ajkd.2009.02.012; Phisitkul S, 2010, KIDNEY INT, V77, P617, DOI 10.1038/ki.2009.519; Singhal MK, 2000, PERITON DIALYSIS INT, V20, P429; Termorshuizen F, 2004, J AM SOC NEPHROL, V15, P1061, DOI 10.1097/01.ASN.0000117976.29592.93; Termorshuizen F, 2003, AM J KIDNEY DIS, V41, P1293, DOI 10.1016/S0272-6386(03)00362-7; UCLA: Statistical Consulting Group, CAN I RUN PIEC REGR; Ueda Atsushi, 2017, Adv Perit Dial, V33, P18	25	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242254	10.1371/journal.pone.0242254	http://dx.doi.org/10.1371/journal.pone.0242254			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196667	gold, Green Published			2022-12-26	WOS:000595266800002
J	Pham, TQ; Robinson, K; Xu, L; Pavlova, MN; Skapek, SX; Chen, EY				Pham, Thao Q.; Robinson, Kristin; Xu, Lin; Pavlova, Maria N.; Skapek, Stephen X.; Chen, Eleanor Y.			HDAC6 promotes growth, migration/invasion, and self-renewal of rhabdomyosarcoma	ONCOGENE			English	Article							CANCER STEM-CELLS; DIFFERENTIATION; DEACETYLATION; METASTASIS; DYNAMICS; REVEALS; PATHWAY; COMPLEX; STATE; RAC1	Rhabdomyosarcoma (RMS) is a devastating pediatric sarcoma. The survival outcomes remain poor for patients with relapsed or metastatic disease. Effective targeted therapy is lacking due to our limited knowledge of the underlying cellular and molecular mechanisms leading to disease progression. In this study, we used functional assays in vitro and in vivo (zebrafish and xenograft mouse models) to demonstrate the crucial role of HDAC6, a cytoplasmic histone deacetylase, in driving RMS tumor growth, self-renewal, and migration/invasion. Treatment with HDAC6-selective inhibitors recapitulates the HDAC6 loss-of-function phenotypes. HDAC6 regulates cytoskeletal dynamics to promote tumor cell migration and invasion. RAC1, a Rho family GTPase, is an essential mediator of HDAC6 function, and is necessary and sufficient for RMS cell migration and invasion. High expression of RAC1 correlates with poor clinical prognosis in RMS patients. Targeting the HDAC6-RAC1 axis represents a promising therapeutic option for improving survival outcomes of RMS patients.	[Pham, Thao Q.; Robinson, Kristin; Pavlova, Maria N.; Chen, Eleanor Y.] Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA; [Xu, Lin; Skapek, Stephen X.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Xu, Lin] Univ Texas Southwestern Med Ctr Dallas, Quantitat Biomed Res Ctr, Dept Populat & Data Sci, Dallas, TX 75390 USA	University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, EY (corresponding author), Univ Washington, Dept Lab Med & Pathol, Seattle, WA 98195 USA.	eleanor2@uw.edu		Chen, Eleanor/0000-0003-4372-7560	NIH [R01 CA196882]; Children's Cancer Fund; Rally Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Cancer Fund; Rally Foundation	The authors want to thank Terra Vleeshouwer-Neumann and Amy Chen for technical assistance with some experiments. EYC is supported by NIH R01 CA196882. Lin Xu is supported by Children's Cancer Fund and Rally Foundation.	BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Chen DM, 2017, CELL STEM CELL, V20, P621, DOI 10.1016/j.stem.2017.02.003; Chen EY, 2014, P NATL ACAD SCI USA, V111, P5349, DOI 10.1073/pnas.1317731111; Chen EY, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003727; Dogterom M, 2019, NAT REV MOL CELL BIO, V20, P38, DOI 10.1038/s41580-018-0067-1; Du FY, 2019, WORLD J STEM CELLS, V11, P398, DOI 10.4252/wjsc.v11.i7.398; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Goto N, 2019, P NATL ACAD SCI USA, V116, P12996, DOI 10.1073/pnas.1900251116; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Hayes MN, 2018, CELL STEM CELL, V22, P414, DOI 10.1016/j.stem.2018.02.002; Hosoyama T, 2011, CLIN CANCER RES, V17, P2757, DOI 10.1158/1078-0432.CCR-10-3445; Hu S, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0339; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ignatius MS, 2018, ELIFE, V7, DOI 10.7554/eLife.37202; Ignatius MS, 2012, CANCER CELL, V21, P680, DOI 10.1016/j.ccr.2012.03.043; Jankowski K, 2003, CANCER RES, V63, P7926; Kamai T, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-164; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kozyreva VK, 2014, MOL CANCER RES, V12, P681, DOI 10.1158/1541-7786.MCR-13-0654; Kreso A, 2014, CELL STEM CELL, V14, P275, DOI 10.1016/j.stem.2014.02.006; Langenau DM, 2007, GENE DEV, V21, P1382, DOI 10.1101/gad.1545007; Lof-Ohlin ZM, 2017, NAT CELL BIOL, V19, P1313, DOI 10.1038/ncb3628; Marampon F, 2017, CANCER LETT, V397, P1, DOI 10.1016/j.canlet.2017.03.028; Miekus K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.199; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Phelps MP, 2016, P NATL ACAD SCI USA, V113, P15090, DOI 10.1073/pnas.1610270114; Saygin C, 2019, CELL STEM CELL, V24, P25, DOI 10.1016/j.stem.2018.11.017; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Tran ADA, 2007, J CELL SCI, V120, P1469, DOI 10.1242/jcs.03431; Vleeshouwer-Neumann T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144320; Walter D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019506; Wu JY, 2018, J BIOL CHEM, V293, P1976, DOI 10.1074/jbc.M117.795955; Wu LF, 2011, FEBS LETT, V585, P1322, DOI 10.1016/j.febslet.2011.03.067; Xu L, 2018, CELL REP, V24, P238, DOI 10.1016/j.celrep.2018.06.006; Yang MH, 2013, MOL CANCER RES, V11, P1072, DOI 10.1158/1541-7786.MCR-13-0040-T; Yang W, 2018, CANCER LETT, V415, P164, DOI 10.1016/j.canlet.2017.12.005; Yin ZS, 2018, ONCOL LETT, V16, P7082, DOI 10.3892/ol.2018.9504; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhuang XQ, 2017, NAT CELL BIOL, V19, P1274, DOI 10.1038/ncb3613	40	10	10	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2021	40	3					578	591		10.1038/s41388-020-01550-2	http://dx.doi.org/10.1038/s41388-020-01550-2		NOV 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PU9SL	33199827	Green Accepted			2022-12-26	WOS:000590042900003
J	Rovini, A; Heslop, K; Hunt, EG; Morris, ME; Fang, DN; Gooz, M; Gerencser, AA; Maldonado, EN				Rovini, Amandine; Heslop, Kareem; Hunt, Elizabeth G.; Morris, Morgan E.; Fang, Diana; Gooz, Monika; Gerencser, Akos A.; Maldonado, Eduardo N.			Quantitative analysis of mitochondrial membrane potential heterogeneity in unsynchronized and synchronized cancer cells	FASEB JOURNAL			English	Article						cancer; cell cycle; fibroblasts; HepG2 cells; heterogeneity; mitochondria; mitochondrial membrane potential; plasma membrane potential; TMRM	GLUTAMATE EXCITOTOXICITY; RESPIRATORY IMPAIRMENT; METABOLISM; DYSFUNCTION; APOPTOSIS; STATE	Mitochondrial membrane potential (Delta psi m) is a global indicator of mitochondrial function. Previous reports on heterogeneity of Delta psi m were qualitative or semiquantitative. Here, we quantified intercellular differences in Delta psi m in unsynchronized human cancer cells, cells synchronized in G1, S, and G2, and human fibroblasts. We assessed Delta psi m using a two-pronged microscopy approach to measure relative fluorescence of tetramethylrhodamine methyl ester (TMRM) and absolute values of Delta psi m. We showed that Delta psi m is more heterogeneous in cancer cells compared to fibroblasts, and it is maintained throughout the cell cycle. The effect of chemical inhibition of the respiratory chain and ATP synthesis differed between basal, low and high Delta psi m cells. Overall, our results showed that intercellular heterogeneity of Delta psi m is mainly modulated by intramitochondrial factors, it is independent of the Delta psi m indicator and it is not correlated with intercellular heterogeneity of plasma membrane potential or the phases of the cell cycle.	[Rovini, Amandine; Heslop, Kareem; Hunt, Elizabeth G.; Morris, Morgan E.; Fang, Diana; Gooz, Monika; Maldonado, Eduardo N.] Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA; [Gerencser, Akos A.] Buck Inst Res Aging & Image Analyst Software, Novato, CA USA; [Maldonado, Eduardo N.] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Maldonado, EN (corresponding author), Med Univ South Carolina, Dept Drug Discovery & Biomed Sci, Charleston, SC 29425 USA.	maldona@musc.edu	Maldonado, Eduardo/AAN-3907-2020	Rovini, Amandine/0000-0003-0483-9092; Maldonado, Eduardo/0000-0002-5285-3027; Heslop, Kareem/0000-0002-2618-2530	US National Institutes of Health (NIH) National Cancer Institute (NCI) [RO1 CA184456]; NIH National Institute of General Medical Sciences [P20 GM103542]; NCI [R01CA184456-02]; South Carolina COBRE in Oxidants, Redox Balance, and Stress Signaling (NIH National Institute of General Medical Sciences) [P20 GM103542]	US National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); South Carolina COBRE in Oxidants, Redox Balance, and Stress Signaling (NIH National Institute of General Medical Sciences)	This work was supported, in part, by the US National Institutes of Health (NIH) National Cancer Institute (NCI) Grant RO1 CA184456 and NIH National Institute of General Medical Sciences Grant P20 GM103542 [10] to ENM, and an NCI Administrative Supplement (R01CA184456-02) to MEM. The Cell and Molecular Imaging Shared Resource and the Medical University of South Carolina (MUSC) is supported, in part, by the South Carolina COBRE in Oxidants, Redox Balance, and Stress Signaling (NIH National Institute of General Medical Sciences Grant P20 GM103542)	Begum HM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47593-8; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; Cannino G, 2018, METABOLIC PLASTICITY, V8, DOI 10.3389/fonc.2018.00333; Chakrabarti L, 2019, J IMMUNOL METHODS, V464, P31, DOI 10.1016/j.jim.2018.10.007; Christie CF, 2019, FASEB J, V33, P8186, DOI 10.1096/fj.201802723R; Collins TJ, 2002, EMBO J, V21, P1616, DOI 10.1093/emboj/21.7.1616; Connolly NMC, 2018, CELL DEATH DIFFER, V25, P542, DOI 10.1038/s41418-017-0020-4; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503; EPPS DE, 1994, CHEM PHYS LIPIDS, V69, P137, DOI 10.1016/0009-3084(94)90035-3; Fang D, 2018, ADV CANCER RES, V138, P41, DOI 10.1016/bs.acr.2018.02.002; Gan Z, 2011, AM J PHYSIOL-LUNG C, V300, pL762, DOI 10.1152/ajplung.00334.2010; Gerencser AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159199; Gerencser AA, 2012, J PHYSIOL-LONDON, V590, P2845, DOI 10.1113/jphysiol.2012.228387; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heerdt BG, 2005, CANCER RES, V65, P9861, DOI 10.1158/0008-5472.CAN-05-2444; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heslop KA, 2020, BIOCHEM PHARMACOL, V171, DOI 10.1016/j.bcp.2019.113728; HOEK JB, 1980, J BIOL CHEM, V255, P1458; Jeon JH, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.129; Kalucka J, 2015, CELL CYCLE, V14, P3379, DOI 10.1080/15384101.2015.1090068; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Kumagai A, 2016, STEM CELL TRANSL MED, V5, P275, DOI 10.5966/sctm.2015-0145; Kuznetsov AV, 2009, INT J MOL SCI, V10, P1911, DOI 10.3390/ijms10041911; Lee S, 2007, BIOCHEM BIOPH RES CO, V357, P111, DOI 10.1016/j.bbrc.2007.03.091; Maher MP, 2007, J BIOMOL SCREEN, V12, P656, DOI 10.1177/1087057107302113; Maldonado EN, 2013, J BIOL CHEM, V288, P11920, DOI 10.1074/jbc.M112.433847; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; MARTIN J, 1991, J BIOL CHEM, V266, P18051; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Mathur A, 2000, CARDIOVASC RES, V46, P126, DOI 10.1016/S0008-6363(00)00002-X; Milani L, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0732; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Mizutani S, 2009, CANCER SCI, V100, P1680, DOI 10.1111/j.1349-7006.2009.01238.x; Neagu M, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00348; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Salvioli S, 2000, CYTOMETRY, V40, P189, DOI 10.1002/1097-0320(20000701)40:3<189::AID-CYTO3>3.0.CO;2-6; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; Schieke SM, 2008, CELL CYCLE, V7, P1782, DOI 10.4161/cc.7.12.6067; Seth S, 2019, CELL REP, V26, P1518, DOI 10.1016/j.celrep.2019.01.048; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Sukumar M, 2016, CELL METAB, V23, P63, DOI 10.1016/j.cmet.2015.11.002; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Ward MW, 2000, J NEUROSCI, V20, P7208; WEINHOUSE S, 1976, Z KREBSFORSCH KLIN O, V87, P115; WEINHOUSE S, 1956, SCIENCE, V124, P267, DOI 10.1126/science.124.3215.267; Wolf DM, 2019, EMBO J, V38, DOI 10.15252/embj.2018101056; Woods DC, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/7068567; Yousif LF, 2009, CHEMBIOCHEM, V10, P1939, DOI 10.1002/cbic.200900185; Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009	55	6	6	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001693R	http://dx.doi.org/10.1096/fj.202001693R		NOV 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33196122	Green Accepted			2022-12-26	WOS:000592668800001
J	Sominsky, L; Dangel, T; Malik, S; De Luca, SN; Singewald, N; Spencer, SJ				Sominsky, Luba; Dangel, Tamara; Malik, Sajida; De Luca, Simone N.; Singewald, Nicolas; Spencer, Sarah J.			Microglial ablation in rats disrupts the circadian system	FASEB JOURNAL			English	Article						circadian rhythms; clock genes; hippocampus; microglia; temperature	ENDOTOXIN; CLOCK	Microglia, the key neuroimmune cells of the central nervous system, are best known for their function in defending an individual from pathogens and injury. Recent findings, including our own, suggest microglia also have several immune-independent roles, including in regulating satiety, promoting memory, and modifying pain responses. Many of these microglia-associated functions are affected by circadian rhythmicity, thus, varying substantially depending upon the time of day. To gain further insight into this link, we used a Cx3cr1-Dtr transgenic Wistar rat model to acutely deplete microglia and examined if this could lead to a disruption in diurnal temperature, metabolism, and activity measures. We also examined if differences in the physiological rhythms corresponded with changes in the expression of key circadian rhythm-regulating genes and proteins. Our data show that in the absence of microglia there is a pronounced disruption of diurnal rhythms in several domains consistent with a shift toward the inactive phase, in conjunction with changes in circadian rhythm-regulating genes and proteins. These data suggest microglia are involved in the regulation of circadian rhythms and indicate an exciting potential to manipulate these cells to improve disrupted circadian rhythms such as with shift-work or jet-lag.	[Sominsky, Luba; Dangel, Tamara; Malik, Sajida; De Luca, Simone N.; Spencer, Sarah J.] RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia; [Dangel, Tamara; Singewald, Nicolas] Univ Innsbruck, Inst Pharm, Dept Pharmacol & Toxicol, Innsbruck, Austria; [Dangel, Tamara; Singewald, Nicolas] Univ Innsbruck, CMBI, Innsbruck, Austria; [Spencer, Sarah J.] RMIT Univ, ARC Ctr Excellence Nanoscale Biophoton, Melbourne, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); University of Innsbruck; University of Innsbruck; Royal Melbourne Institute of Technology (RMIT)	Spencer, SJ (corresponding author), RMIT Univ, Sch Hlth & Biomed Sci, Melbourne, Vic, Australia.	Sarah.Spencer@rmit.edu.au		De Luca, Simone/0000-0001-9001-4024; Spencer, Sarah/0000-0001-8832-4824; Sominsky, Luba/0000-0002-0674-8824	Department of Health \ National Health and Medical Research Council (NHMRC) [APP1128646]; RMIT University (RMIT); Innsbruck University; Austrian Science Fund FWF [I 3875-B26]	Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); RMIT University (RMIT); Innsbruck University; Austrian Science Fund FWF(Austrian Science Fund (FWF))	Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: APP1128646; RMIT University (RMIT); Innsbruck University; Austrian Science Fund FWF, Grant/Award Number: I 3875-B26	Barrientos RM, 2010, AGING DIS, V1, P212; Bray MS, 2013, INT J OBESITY, V37, P843, DOI 10.1038/ijo.2012.137; Cermakian N, 2014, ARCH IMMUNOL THER EX, V62, P303, DOI 10.1007/s00005-014-0286-x; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Choudhury ME, 2020, GLIA, V68, P44, DOI 10.1002/glia.23698; Dantzer R, 2001, ANN NY ACAD SCI, V933, P222; De Luca SN, 2020, J NEUROENDOCRINOL, V32, DOI 10.1111/jne.12838; De Luca SN, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1729-4; De Luca SN, 2019, BRAIN BEHAV IMMUN, V77, P77, DOI 10.1016/j.bbi.2018.12.008; De Luca SN, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0578-7; Early JO, 2018, P NATL ACAD SCI USA, V115, pE8460, DOI 10.1073/pnas.1800431115; Fonken LK, 2016, NEUROBIOL AGING, V47, P102, DOI 10.1016/j.neurobiolaging.2016.07.019; Fonken LK, 2015, BRAIN BEHAV IMMUN, V45, P171, DOI 10.1016/j.bbi.2014.11.009; Gaudet AD, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0328-18.2018; Grace PM, 2018, EXP NEUROL, V304, P125, DOI 10.1016/j.expneurol.2018.03.005; Grace PM, 2016, P NATL ACAD SCI USA, V113, pE3441, DOI 10.1073/pnas.1602070113; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Harbour VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103309; Hayashi M, 2007, BIOL PHARM BULL, V30, P621, DOI 10.1248/bpb.30.621; Hayashi Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02744; Lananna BV, 2018, CELL REP, V25, P1, DOI 10.1016/j.celrep.2018.09.015; Lusk G, 1924, J Physiol, V59, P213; Marpegan L, 2009, CHRONOBIOL INT, V26, P1430, DOI 10.3109/07420520903408358; Martinez-Tapia RJ, 2020, CELL MOL NEUROBIOL, V40, P301, DOI 10.1007/s10571-019-00736-x; Milanova IV, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00424; Mosser EA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48914-7; Okamoto-Uchida Y, 2019, CURR GENOMICS, V20, P332, DOI 10.2174/1389202919666191014094349; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Seillet C, 2020, NAT IMMUNOL, V21, P168, DOI 10.1038/s41590-019-0567-y; Smith BL, 2020, BRAIN BEHAV IMMUN, V84, P80, DOI 10.1016/j.bbi.2019.11.010; Takahashi JS, 2015, DIABETES OBES METAB, V17, P6, DOI 10.1111/dom.12514; Takayama F, 2016, SCI REP-UK, V6, DOI 10.1038/srep30006; Tuan LH, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104517; Vichaya EG, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01832-2; Wang C, 2020, SCIENCE, V367, P688, DOI 10.1126/science.aaz2288; Wang DQ, 2019, BEHAV BRAIN RES, V363, P61, DOI 10.1016/j.bbr.2019.01.035; Weil ZM, 2009, NEUROBIOL DIS, V36, P352, DOI 10.1016/j.nbd.2009.07.032; Whitt JP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10837; Wilton DK, 2019, ANNU REV NEUROSCI, V42, P107, DOI 10.1146/annurev-neuro-070918-050306; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406	41	16	17	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001555RR	http://dx.doi.org/10.1096/fj.202001555RR		NOV 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33200466				2022-12-26	WOS:000592669700001
J	Wang, XG; Song, YQ; Chen, W; Ding, N; Liu, WP; Xie, Y; Wang, YN; Zhu, J; Zeng, CQ				Wang, Xiaogan; Song, Yuqin; Chen, Wei; Ding, Ning; Liu, Weiping; Xie, Yan; Wang, Yinan; Zhu, Jun; Zeng, Changqing			Germline variants of DNA repair genes in early onset mantle cell lymphoma	ONCOGENE			English	Article							NON-HODGKINS-LYMPHOMA; MICROSATELLITE INSTABILITY; MOLECULAR PATHOGENESIS; CANCER; EXPRESSION; ASSOCIATION; DEFICIENCY; SIGNATURES; ALIGNMENT; PATIENT	Although somatic mutations of DNA repair genes are frequent in mantle cell lymphoma (MCL), our understanding of their germline defects is limited. In a Chinese family with maternal Lynch syndrome and paternal B cell non-Hodgkin lymphoma, one sibling developed both Lynch syndrome and MCL. Lynch syndrome is caused by heterozygous mutations in mismatch repair (MMR) genes. To understand the genetic predispositions in the family, we performed exome sequencing and analyses of affected individuals and their tumor samples. A novel germline indel, MLH1 Gly101fsX1, was identified as the cause of Lynch syndrome, and unstable microsatellite loci and mutational signatures as evidence of defective MMR were revealed in the MCL sample. Furthermore, we included additional 15 MCL patients with early onset, and found by exome sequencing that 11 patients carried heterozygous germline variants of 20 DNA repair genes, including MSH2 in MMR. In the MCL with MSH2 Arg359fsX16, unstable microsatellite loci and defective MMR signatures were also found. In addition, five patients also had heterozygous germline variants of genes involved in B cell functions. Thus, our study found germline variants of genes in single-strand break repair, double-strand break repair, and Fanconi anemia pathway in early onset MCL; and for the first time we identified germline defects of MMR in two MCLs.	[Wang, Xiaogan; Song, Yuqin; Ding, Ning; Liu, Weiping; Xie, Yan; Zhu, Jun] Peking Univ Canc Hosp & Inst, Minist Educ, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China; [Wang, Xiaogan; Chen, Wei; Zeng, Changqing] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genom & Precis Med, Beijing, Peoples R China; [Chen, Wei; Zeng, Changqing] China Natl Ctr Bioinformat, Beijing, Peoples R China; [Wang, Yinan] Hebei Tangshan Peoples Hosp, Tangshan, Hebei, Peoples R China; [Zeng, Changqing] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhu, J (corresponding author), Peking Univ Canc Hosp & Inst, Minist Educ, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res, Beijing, Peoples R China.; Zeng, CQ (corresponding author), Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genom & Precis Med, Beijing, Peoples R China.; Zeng, CQ (corresponding author), China Natl Ctr Bioinformat, Beijing, Peoples R China.; Zeng, CQ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	zhu-jun2017@outlook.com; czeng@big.ac.cn			Key Research Program of the Chinese Academy of Sciences [KJZD-EWL06-2]; National Natural Science Foundation of China [81972807, 81670187, 81470368]; National High Technology Research and Development Program (863 Program) of China [2012AA022502]; Beijing Natural Science Foundation [7202025]; China Postdoctoral Science Foundation [2013M541009]	Key Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program (863 Program) of China(National High Technology Research and Development Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants from the Key Research Program of the Chinese Academy of Sciences (KJZD-EWL06-2) (CZ), the National Natural Science Foundation of China (81972807, 81670187 and 81470368) (YS and JZ), the National High Technology Research and Development Program (863 Program) of China (2012AA022502) (CZ), the Beijing Natural Science Foundation (7202025) (YS), and the China Postdoctoral Science Foundation (2013M541009) (XW). We thank Sheng Li for the help in the interview of relatives of the family and collection of their samples. We are grateful to Yunfei Shi for pathological review. Further thanks are due to Wen Zheng, Ningjing Lin, Meifeng Tu, Xiaopei Wang, Lingyan Ping, Zhitao Ying, Lijuan Deng, Chen Zhang, Tingting Du, Meng Wu, Xin Len, and Feier Feng for their help in collection of clinical information. We are grateful to Caixia Guo for advice and help in revision.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Blokzijl F, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0539-0; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheah CY, 2016, J CLIN ONCOL, V34, P1256, DOI 10.1200/JCO.2015.63.5904; Cheah CY, 2015, J CLIN PATHOL, V68, P755, DOI 10.1136/jclinpath-2015-203039; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Cuceu C, 2018, CANCERS, V10, DOI 10.3390/cancers10070233; de Miranda NFCC, 2013, J EXP MED, V210, P1729, DOI 10.1084/jem.20122842; Degroote A, 2013, LEUKEMIA LYMPHOMA, V54, P812, DOI 10.3109/10428194.2012.723211; Dreyling M, 2017, ANN ONCOL, V28, P62, DOI [10.1093/annonc/mdx223, 10.1093/annonc/mdx289]; Du ZL, 2019, GENOM PROTEOM BIOINF, V17, P229, DOI 10.1016/j.gpb.2019.07.002; Elenitoba-Johnson KSJ, 2018, ANNU REV PATHOL-MECH, V13, P193, DOI 10.1146/annurev-pathol-020117-043803; Ferrari Vittorio, 1999, Recenti Progressi in Medicina, V90, P81; Hirano K, 2002, DIS COLON RECTUM, V45, P273, DOI 10.1007/s10350-004-6161-9; Huet S, 2018, NAT REV CANCER, V18, P224, DOI 10.1038/nrc.2017.127; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kotoula V, 2002, LEUKEMIA LYMPHOMA, V43, P393, DOI 10.1080/10428190290006215; Kratz CP, 2008, LEUKEMIA, V22, P1078, DOI 10.1038/sj.leu.2405008; Krueger S, 2008, EUR J HUM GENET, V16, P62, DOI 10.1038/sj.ejhg.5201923; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lindsley AW, 2016, J ALLERGY CLIN IMMUN, V137, P179, DOI 10.1016/j.jaci.2015.06.002; Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878; Moffitt AB, 2017, J CLIN ONCOL, V35, P955, DOI 10.1200/JCO.2016.71.7603; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ortega-Molina A, 2015, NAT MED, V21, P1199, DOI 10.1038/nm.3943; Perez-Galan P, 2011, BLOOD, V117, P26, DOI 10.1182/blood-2010-04-189977; Pineda M, 2008, GENE CHROMOSOME CANC, V47, P326, DOI 10.1002/gcc.20536; Puente XS, 2018, BLOOD, V131, P2283, DOI 10.1182/blood-2017-10-764373; Rao RC, 2015, NAT REV CANCER, V15, P334, DOI 10.1038/nrc3929; Renkonen E, 2003, J CLIN ONCOL, V21, P3629, DOI 10.1200/JCO.2003.03.181; Ripperger T, 2016, EUR J MED GENET, V59, P133, DOI 10.1016/j.ejmg.2015.12.014; Ripperger T, 2010, HAEMATOL-HEMATOL J, V95, P841, DOI 10.3324/haematol.2009.015503; Rosty C, 2000, MODERN PATHOL, V13, P586, DOI 10.1038/modpathol.3880100; Salipante SJ, 2014, CLIN CHEM, V60, P1192, DOI 10.1373/clinchem.2014.223677; Sanz-Vaque L, 2001, HAEMATOLOGICA, V86, P181; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Smedby Karin E., 2014, Journal of the National Cancer Institute Monographs, P76, DOI 10.1093/jncimonographs/lgu007; Sud A, 2019, BLOOD, V132, P960, DOI 10.1182/blood.2019001362; Supek F, 2015, NATURE, V521, P81, DOI 10.1038/nature14173; Taylor J, 2017, BLOOD, V130, P410, DOI 10.1182/blood-2017-02-734541; Teruya-Feldstein J, 2002, LEUKEMIA LYMPHOMA, V43, P1619, DOI 10.1080/1042819021000002956; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Tian T, 2020, LAB INVEST, V100, P1397, DOI 10.1002/cam4.2870; Vogt N, 2017, LEUKEMIA LYMPHOMA, V58, P1530, DOI 10.1080/10428194.2016.1248965; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940	51	5	5	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2021	40	3					551	563		10.1038/s41388-020-01542-2	http://dx.doi.org/10.1038/s41388-020-01542-2		NOV 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PU9SL	33191405				2022-12-26	WOS:000589571100001
J	Kengne-Nde, C; Anoubissi, JD; Loni-Ekali, G; Nguefeu-Nkenfou, C; Moussa, Y; Messeh, A; Fokam, J; Zeh-Meka, A; Snayeul-Wawo, D; Tseuko, D; Ngo-Nemb, M; Kob, D; Billong, SC; Bonono, L; Elat, JB				Kengne-Nde, Cyprien; de Dieu Anoubissi, Jean; Loni-Ekali, Gabriel; Nguefeu-Nkenfou, Celine; Moussa, Yasmine; Messeh, Arlette; Fokam, Joseph; Zeh-Meka, Albert; Snayeul-Wawo, Denis; Tseuko, Dorine; Ngo-Nemb, Marinette; Kob, David; Billong, Serge-Clotaire; Bonono, Leonard; Elat, Jean-Bosco			Highlighting a population-based re-emergence of Syphilis infection and assessing associated risk factors among pregnant women in Cameroon: Evidence from the 2009, 2012 and 2017 national sentinel surveillance surveys of HIV and syphilis	PLOS ONE			English	Article							HEPATITIS-B; BLOOD-DONORS; C VIRUSES; PREVALENCE; SEROPREVALENCE; REGION; TRENDS	Background Syphilis and HIV can be transmitted from pregnant women to their children and they remain a public health problem in Africa. Our study aimed to determine the trends of seroprevalence of HIV/syphilis co-infection and syphilis infection overtime through the national surveillance system in Cameroon and to explore associated risk factors. Methods We conducted cross-sectional studies of HIV and syphilis, targeting each year 7000 first antenatal care (ANC-1) attendees at the same sites during the 2009, 2012 and 2017 sentinel surveillance surveys. Pregnant women were enrolled at their ANC-1, sociodemographic and clinical information were collected. HIV and Syphilis test were performed by serial algorithm as per the national guidelines. Trends were assessed for HIV, syphilis and HIV/syphilis by estimating seroprevalence from cross-sectional studies. Associated risk factors were explored using multinomial logistic regression with 4 outcomes: HIV/syphilis co-infection, HIV infection only, syphilis infection only and no infection. Results Overall, 6 632, 6 521 and 6 859 pregnant women were enrolled in 2009, 2012 and 2017 respectively. In 2017, a total of 3 901 pregnant women enrolled were tested for syphilis. Almost half of them (47.9%) were living in urban area and were aged less than 25 years (44.7%). While HIV epidemic was on a decline (from 7.6% (95% CI: 6.99-8.28) in 2009 to 5.7% (95% CI: 4.93-6.4) in 2017), a huge significant increase of syphilis prevalence was observed (from 0.6% (95% CI:0.40-0.80) in 2009 to 5.7% (95% CI:4.93-6.40) in 2017). Pregnant women residing in rural areas were more likely to be infected with syphilis than those living in the urban area (aOR = 1.8 [95% CI: 1.3-2.4]). Unmarried pregnant women were three time more likely to be infected by HIV/Syphilis Co-infection than married, cohabiting, widow or divorced pregnant women (aOR = 2.8 [95% CI: 1.3-2.4]). Furthermore; living in Northern region was associated with a lower risk of being infected with HIV (aOR = 0.6 [95% CI: 0.5-0.9]) and Syphilis infection (aOR = 0.6 [95% CI: 0.4-0.9]). Conclusion The epidemiological dynamics of syphilis suggests a growing burden of syphilis infection in the general population of Cameroon. Our findings support the fact that while emphasizing strategies to fight HIV, huge efforts should also be made for strategies to prevent and fight syphilis infection especially among HIV positive women, in rural area, and southern regions.	[Kengne-Nde, Cyprien; de Dieu Anoubissi, Jean; Loni-Ekali, Gabriel; Moussa, Yasmine; Messeh, Arlette; Zeh-Meka, Albert; Snayeul-Wawo, Denis; Ngo-Nemb, Marinette; Billong, Serge-Clotaire; Bonono, Leonard; Elat, Jean-Bosco] Natl AIDS Control Comm, Cent Tech Grp, Yaounde, Cameroon; [Nguefeu-Nkenfou, Celine; Fokam, Joseph] Chantal BIYA Int Reference Ctr CBIRC Res HIV AIDS, Yaounde, Cameroon; [Nguefeu-Nkenfou, Celine] Univ Yaounde I, Higher Teachers Training Coll, Yaounde, Cameroon; [Fokam, Joseph; Billong, Serge-Clotaire] Univ Yaounde I, Fac Med & Biomed Sci FMBS, Yaounde, Cameroon; [Fokam, Joseph; Billong, Serge-Clotaire; Elat, Jean-Bosco] Natl AIDS Control Comm, Natl HIV Drug Resistance Surveillance & Prevent W, Yaounde, Cameroon; [Tseuko, Dorine] Natl Lab Publ Hlth, Yaounde, Cameroon; [Kob, David] USAID, Yaounde, Cameroon	University of Yaounde I; University of Yaounde I; United States Agency for International Development (USAID)	Kengne-Nde, C (corresponding author), Natl AIDS Control Comm, Cent Tech Grp, Yaounde, Cameroon.	cyprien.kengne@cnls.cm	NDE, Cyprien KENGNE/AAM-7309-2020; de dieu anoubissi, jean/AAO-8093-2020	NDE, Cyprien KENGNE/0000-0002-8338-2221; de dieu anoubissi, jean/0000-0002-1332-0906	Global Fund to fight AIDS, tuberculosis and malaria [CMR_H_MOH_FM281019]	Global Fund to fight AIDS, tuberculosis and malaria	This study was funded by the Global Fund to fight AIDS, tuberculosis and malaria CMR_H_MOH_FM281019 (https://www.theglobalfund.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankouane F, 2016, TRANSFUS CLIN BIOL, V23, P72, DOI 10.1016/j.tracli.2015.11.008; [Anonymous], 2016, THE TOTAL AUDIENCE R; [Anonymous], 2020, START FREE STAY FREE; Anoubissi JD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208963; BHIVA/ BASHH, 2019, HIV MED S2, V20, ps2; Blocker ME, 2000, SEX TRANSM DIS, V27, P53, DOI 10.1097/00007435-200001000-00011; Chimoyi LA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-555; Chow EPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022768; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Gamba EP, 2013, MED SANTE TROP, V23, P421, DOI 10.1684/mst.2013.0256; Signorini DJHP, 2007, REV SOC BRAS MED TRO, V40, P282, DOI 10.1590/S0037-86822007000300006; Kumogola Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-553; Kuznik A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001545; Makasa M, 2012, SEX TRANSM DIS, V39, P173, DOI 10.1097/OLQ.0b013e31823b23a4; Melku M, 2015, HIV AIDS-RES PALLIAT, V7, P175, DOI 10.2147/HIV.S81481; Mohamed BA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/971203; Mutagoma M, 2017, INT J STD AIDS, V28, P45, DOI 10.1177/0956462415624058; N. A. C. C. Ministry of health, 2017, FIN REP SENT SURV SU; Noubiap JJN, 2013, INT J INFECT DIS, V17, pE832, DOI 10.1016/j.ijid.2012.12.007; Nurse-Findlay S, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002473; Quest Diagnostics Incorporated Quest Diagnostics, 2000, QUEST DIAGN INC QUES; Reda S, 2018, INT J GYNECOL OBSTET, V142, P143, DOI 10.1002/ijgo.12507; Simon V, 2006, LANCET, V368, P489, DOI 10.1016/S0140-6736(06)69157-5; WHO, WHO GUID SYPH SCREEN; WHO, INV CAS EL MOTH CHIL; WHO UNAIDS CDC, GUID COND HIV SENT S; Yeganeh N, 2015, PEDIATR INFECT DIS J, V34, pE52, DOI 10.1097/INF.0000000000000578; Zoufaly A, 2012, INT J STD AIDS, V23, P435, DOI 10.1258/ijsa.2011.011279	28	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0241999	10.1371/journal.pone.0241999	http://dx.doi.org/10.1371/journal.pone.0241999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186360	gold, Green Published			2022-12-26	WOS:000593949800013
J	Mo, PQ				Mo, Pin-Qiang			Internal rolling method for particle shape evaluation and reconstruction	PLOS ONE			English	Article							SURFACE-ROUGHNESS; GENERATION; ROUNDNESS	A concise and robust method for 2D particle shape evaluation and reconstruction is proposed using the concept of the internal rolling of covering discs within the outline of a particle. By downscaling the covering disc size for capturing multiscale features, the calculation of the Euclidean distance can effectively yield three indices for sphericity, roundness and roughness. The geometric-based evaluations of particle morphology are dimensionless and precisely distinguishable between shapes after calibration and validation against constructed particles and natural sands. A sphericity-roundness diagram is provided to visualize the particle shape characterization, and a probabilistic density surface in the sphericity-roundness diagram is then proposed to statistically represent the distributions of the particle shapes. The concept of internal rolling is also utilized for particle shape reconstruction using a limited number of balls to replicate the indices of sphericity, roundness and roundness characteristic curve. The probabilistic density surface is duplicated for statistical particle shape reconstruction, which provides an effective approach for numerical investigations of the relationships between particle shapes and mechanical behavior. The effect of image quality on 2D shape evaluation is also examined by using a minimum area per particle, and the proposed method is intuitively extendable to 3D measurements using rolling covering spheres.	[Mo, Pin-Qiang] China Univ Min & Technol, Sch Mech & Civil Engn, State Key Lab GeoMech & Deep Underground Engn, Xuzhou, Jiangsu, Peoples R China	China University of Mining & Technology	Mo, PQ (corresponding author), China Univ Min & Technol, Sch Mech & Civil Engn, State Key Lab GeoMech & Deep Underground Engn, Xuzhou, Jiangsu, Peoples R China.	pinqiang.mo@cumt.edu.cn	Mo, Pin-Qiang/AAT-7462-2020	Mo, Pin-Qiang/0000-0002-1469-4838	National Natural Science Foundation of China [51908546]; Natural Science Foundation of Jiangsu Province [BK20170279]; China Postdoctoral Science Foundation [2020T130699]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	MO: National Natural Science Foundation of China (Grant No. 51908546) http://www.nsfc.gov.cn/english/site_1/index.html MO: Natural Science Foundation of Jiangsu Province (Grant No. BK20170279) http://kxjst.jiangsu.gov.cn/MO: China Postdoctoral Science Foundation (no. 2020T130699) http://chinapostdoctor.org.cn/WebSite/program/Default.aspx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alshibli KA, 2004, J COMPUT CIVIL ENG, V18, P36, DOI 10.1061/(ASCE)0887-3801(2004)18:1(36); Alshibli KA, 2018, J GEOTECH GEOENVIRON, V144, DOI 10.1061/(ASCE)GT.1943-5606.0001841; Alshibli KA, 2015, J MATER CIVIL ENG, V27, DOI 10.1061/(ASCE)MT.1943-5533.0001246; Altuhafi F, 2013, J GEOTECH GEOENVIRON, V139, P1290, DOI 10.1061/(ASCE)GT.1943-5606.0000855; Bareither CA, 2008, J GEOTECH GEOENVIRON, V134, P1476, DOI 10.1061/(ASCE)1090-0241(2008)134:10(1476); BARRETT PJ, 1980, SEDIMENTOLOGY, V27, P291, DOI 10.1111/j.1365-3091.1980.tb01179.x; Blott SJ, 2008, SEDIMENTOLOGY, V55, P31, DOI 10.1111/j.1365-3091.2007.00892.x; Cavarretta I., 2009, THESIS; Cho GC, 2006, J GEOTECH GEOENVIRON, V132, P591, DOI 10.1061/(ASCE)1090-0241(2006)132:5(591); Das N., 2007, MODELING 3 DIMENSION; DeJong JT, 2009, J GEOTECH GEOENVIRON, V135, P449, DOI 10.1061/(ASCE)1090-0241(2009)135:3(449); Ferellec J, 2010, GEOTECHNIQUE, V60, P227, DOI 10.1680/geot.9.T.015; Gong J, 2019, COMPUT GEOTECH, V106, P161, DOI 10.1016/j.compgeo.2018.10.021; Guo YL, 2020, TRANSP GEOTECH, V23, DOI 10.1016/j.trgeo.2020.100341; Hryciw RD, 2016, J GEOTECH GEOENVIRON, V142, DOI 10.1061/(ASCE)GT.1943-5606.0001485; Katagiri J, 2015, J AEROSPACE ENG, V28, DOI 10.1061/(ASCE)AS.1943-5525.0000421; Kawamoto R, 2016, J MECH PHYS SOLIDS, V91, P1, DOI 10.1016/j.jmps.2016.02.021; Krumbein W. C., 1941, J SEDIMENT RES, V11, P64, DOI [10.1306/d42690f3-2b26-11d7-8648000102c1865d, 10.1306/D42690F3-2B26-11D7-8648000102C1865D, DOI 10.1306/D42690F3-2B26-11D7-8648000102C1865D]; Krumbein W.C., 1963, STRATIGRAPHY SEDIMEN; Lai ZS, 2017, GRANUL MATTER, V19, DOI 10.1007/s10035-017-0754-1; Lee YG, 1998, NEUROCOMPUTING, V20, P115, DOI 10.1016/S0925-2312(97)00095-7; McKay D. S., 1991, LUNAR SOURCEBOOK, P285, DOI DOI 10.1006/ICAR.1999.6165; Mollon G, 2012, GRANUL MATTER, V14, P621, DOI 10.1007/s10035-012-0356-x; Powers M., 1953, SEPM J SEDIMENT RES, V23, P117, DOI DOI 10.1306/D4269567-2B26-11D7-8648000102C1865D; Rickman D, 2016, POWDER TECHNOL, V291, P466, DOI 10.1016/j.powtec.2015.10.044; Riley NA., 1941, SEPM J SEDIMENT RES, DOI [10.1306/d426910c-2b26-11d7-8648000102c1865d, DOI 10.1306/D426910C-2B26-11D7-8648000102C1865D, 10.1306/D426910C-2B26-11D7-8648000102C1865D]; Santamarina JC, 2004, PROC 3 DAY C ADV GEO, P604; Shi C, 2015, GRANUL MATTER, V17, P377, DOI 10.1007/s10035-015-0557-1; Smith ML, 1999, IMAGE VISION COMPUT, V17, P1009, DOI 10.1016/S0262-8856(99)00003-7; Stock SR, 2008, INT MATER REV, V53, P129, DOI 10.1179/174328008X277803; Su D, 2020, ACTA GEOTECH, V15, P1533, DOI 10.1007/s11440-019-00845-3; Sukumaran B, 2001, GEOTECHNIQUE, V51, P619, DOI 10.1680/geot.51.7.619.51393; Sun Q, 2019, COMPUT GEOTECH, V114, DOI 10.1016/j.compgeo.2019.103110; Vangla P, 2018, GRANUL MATTER, V20, DOI 10.1007/s10035-017-0776-8; Wadell H, 1932, J GEOL, V40, P443, DOI 10.1086/623964; WALTON WH, 1948, NATURE, V162, P329, DOI 10.1038/162329b0; Wang X, 2019, COMPUT GEOTECH, V114, DOI 10.1016/j.compgeo.2019.103131; Zheng J, 2015, GEOTECHNIQUE, V65, P494, DOI 10.1680/geot.14.P.192; Zheng JX, 2016, J COMPUT CIVIL ENG, V30, DOI 10.1061/(ASCE)CP.1943-5487.0000578; Zhou B, 2017, INT J NUMER ANAL MET, V41, P93, DOI 10.1002/nag.2548	40	1	1	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242162	10.1371/journal.pone.0242162	http://dx.doi.org/10.1371/journal.pone.0242162			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180861	Green Published, gold			2022-12-26	WOS:000593948000038
J	Nazzal, Z; Khader, S; Zawyani, H; Abdallah, M; Sawalmeh, O; Hamdan, Z				Nazzal, Zaher; Khader, Shahd; Zawyani, Hiba; Abdallah, Mazen; Sawalmeh, Osama; Hamdan, Zakaria			Bone mineral density in Palestinian patients with end-stage renal disease and the related clinical and biochemical factors: Cross-sectional study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; RISK-FACTORS; CLASSIFICATION; PREDICTORS; DIALYSIS; CKD	Introduction End-Stage Renal Disease (ESRD) is the ultimate result of chronic kidney disease (CKD). In Palestine, the prevalence of ESRD was 240.3 PMP which is comparable with the nearby countries. Accelerated bone loss among ESRD patients is attributed to abnormal bone turn over that leads to osteoporosis and osteopenia. The risk of fractures is increased four-fold in men and women on hemodialysis, which explains the importance of assessing the bone mineral density among these population. The goals of this study were to find the prevalence of osteoporosis in ESRD patients as determined by bone mineral density (BMD) at different sites and to determine whether BMD correlates with many other clinical parameters. Methods A cross-sectional study of 194 ESRD patients were recruited from the dialysis unit in An-Najah National University Hospital, Nablus, Palestine. The patients were on regular hemodialysis or peritoneal dialysis. BMD was measured at the lumbar spine and the hip using the dual-energy X-Ray absorptiometry (DEXA) and the value is expressed as T-score. The data were analyzed using SPSS, version 26. The relationship between BMD and the clinical and biochemical parameters among the ESRD patients was assessed. Results We found that 42.8% of ESRD patient had osteoporosis and 40.2% had osteopenia. There were significantly higher proportions of osteoporosis and osteopenia among patients >60 years of age (p<0.005). Patients with osteoporosis and osteopenia had significantly higher serum levels of PTH (792.9 and 469.7) (p<0.05). BMD decreases as the duration of dialysis (39.0 months Vs. 56.8 months), (p<0.05). We found no significant difference between patients on hemodialysis or peritoneal dialysis. Conclusion This study showed that Palestinian patients with ESRD have low BMD at the hip and spine. The observed high serum level of PTH was associated with low BMD. Those patients should be closely monitored especially those with more than one risk factor. Moreover, more attention should be paid for these category of patients to decrease the incidence of falling down and the resulting fractures that might lead to mortality and morbidity.	[Nazzal, Zaher] An Najah Natl Univ, Family & Community Med Dept, Fac Med & Hlth Sci, Nablus, Palestine; [Khader, Shahd; Zawyani, Hiba] An Najah Natl Univ, Med Dept, Fac Med & Hlth Sci, Nablus, Palestine; [Abdallah, Mazen] An Najah Natl Univ, An Najah Natl Univ Hosp, Orthoped Surg Dept, Nablus, Palestine; [Sawalmeh, Osama] An Najah Natl Univ, An Najah Natl Univ Hosp, Internal Med Dept, Nablus, Palestine; [Hamdan, Zakaria] An Najah Natl Univ, An Najah Natl Univ Hosp, Nephrol Dept, Nablus, Palestine	An Najah National University; An Najah National University; An Najah National University; An Najah National University; An Najah National University	Hamdan, Z (corresponding author), An Najah Natl Univ, An Najah Natl Univ Hosp, Nephrol Dept, Nablus, Palestine.	z.hamdan@najah.edu	Nazzal, Zaher Ahmad/AAW-3875-2020	Nazzal, Zaher Ahmad/0000-0002-2655-6109; Sawalmeh, Osama/0000-0002-5733-2589; Abdalla, Mazen/0000-0002-9837-1875	Nursing Team at the Dialysis Department at NNUH	Nursing Team at the Dialysis Department at NNUH	We are grateful to the Nursing Team at the Dialysis Department at NNUH for supporting the work on this project. A big thank you to all the patients involved in this research as they showed a great deal of cooperation. Special thanks to the team at Al-Rahma Clinic in Nablus for their excellent assistance in obtaining a DEXA scan for patients during the month we were there.	Ambrus C, 2011, INT UROL NEPHROL, V43, P191, DOI 10.1007/s11255-009-9702-2; [Anonymous], 2002, AM J KIDNEY DIS S, V39, pS46; Atsumi K, 1999, AM J KIDNEY DIS, V33, P287, DOI 10.1016/S0272-6386(99)70302-1; Binici DN, 2010, RENAL FAILURE, V32, P469, DOI 10.3109/08860221003675260; Boland M, 2009, PAED CHILD HEALT-CAN, V14, P395, DOI 10.1093/pch/14.6.395; Elder G, 2002, J BONE MINER RES, V17, P2094, DOI 10.1359/jbmr.2002.17.12.2094; Genant HK, 1999, OSTEOPOROSIS INT, V10, P259, DOI 10.1007/s001980050224; Gupta R, 2010, MED PRIN PRACT, V20, P156, DOI 10.1159/000319775; Huang GS, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-60; ISCD, 2015, 015 ISCD OFFICIAL PO, P015; Kazama JJ, 2018, THER APHER DIAL, V22, P229, DOI 10.1111/1744-9987.12678; Ketteler M, 2017, KIDNEY INT, V92, P26, DOI 10.1016/j.kint.2017.04.006; Khader Mohammed I, 2013, Saudi J Kidney Dis Transpl, V24, P832; Lai M-N, 2002, ACTA NEUROL-NAPLES, V16, P25; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; M K., 2018, SCH J ENG TECH, V6, P58, DOI [10.21276/sjet.2018.6.2.3, DOI 10.21276/SJET.2018.6.2.3]; Malekmakan L, 2018, IRAN J KIDNEY DIS, V12, P195; Malluche HH, 2014, CLIN J AM SOC NEPHRO, V9, P1254, DOI 10.2215/CJN.09470913; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Mirfakhraee Sasan, 2012, Arch Osteoporos, V7, P283; Nybo M, 2013, BIOCHEM MEDICA, V23, P342; Orlic L, 2010, RENAL FAILURE, V32, P300, DOI 10.3109/08860221003611661; Raisz LG, 2005, NEW ENGL J MED, V353, P164, DOI 10.1056/NEJMcp042092; Sawalmeh O, 2018, INT J NEPHROL RENOV, V11, P25, DOI 10.2147/IJNRD.S149877; Slouma M, 2020, ADV RHEUMATOL, V60, DOI 10.1186/s42358-020-0118-0; Thomas R, 2008, PRIMARY CARE, V35, P329, DOI 10.1016/j.pop.2008.01.008; United States Renal Data System, 2018, USRDS ANN DATA REPOR; Yucel AE, 2004, RENAL FAILURE, V26, P159, DOI 10.1081/JDI-120038501; Yuen NK., 2016, PERM J, V20, P15, DOI [10.7812/TPP/15-127, DOI 10.7812/TPP/15-127]; Zayour D, 2004, TRANSPL P, V36, P1297, DOI 10.1016/j.transproceed.2004.05.069	31	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241201	10.1371/journal.pone.0241201	http://dx.doi.org/10.1371/journal.pone.0241201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180791	Green Published, gold			2022-12-26	WOS:000593948000061
J	Mao, HW; Shi, Y; Liu, Y; Wei, LQ; Li, YJ; Long, YH				Mao, Hongwei; Shi, Yan; Liu, Yue; Wei, Linqiang; Li, Yijie; Long, Yanhua			Short-time speaker verification with different speaking style utterances	PLOS ONE			English	Article							FEATURES; FUSION	In recent years, great progress has been made in the technical aspects of automatic speaker verification (ASV). However, the promotion of ASV technology is still a very challenging issue, because most technologies are still very sensitive to new, unknown and spoofing conditions. Most previous studies focused on extracting target speaker information from natural speech. This paper aims to design a new ASV corpus with multi-speaking styles and investigate the ASV robustness to these different speaking styles. We first release this corpus in the Zenodo website for public research, in which each speaker has several text-dependent and text-independent singing, humming and normal reading speech utterances. Then, we investigate the speaker discrimination of each speaking style in the feature space. Furthermore, the intra and inter-speaker variabilities in each different speaking style and cross-speaking styles are investigated in both text-dependent and text-independent ASV tasks. Conventional Gaussian Mixture Model (GMM), and the state-of-the-art x-vector are used to build ASV systems. Experimental results show that the voiceprint information in humming and singing speech are more distinguishable than that in normal reading speech for conventional ASV systems. Furthermore, we find that combing the three speaking styles can significantly improve the x-vector based ASV system, even when only limited gains are obtained by conventional GMM-based systems.	[Mao, Hongwei; Shi, Yan; Liu, Yue; Wei, Linqiang; Long, Yanhua] Shanghai Normal Univ, SHNU Unisound Joint Lab Nat Human Comp Interact, Shanghai, Peoples R China; [Li, Yijie] Unisound AI Technol Co Ltd, Beijing, Peoples R China	Shanghai Normal University	Long, YH (corresponding author), Shanghai Normal Univ, SHNU Unisound Joint Lab Nat Human Comp Interact, Shanghai, Peoples R China.	yanhua@shnu.edu.cn		LONG, YANHUA/0000-0003-0924-408X	National Natural Science Foundation of China [61701306, 62071302]; Unisound AI Technology Co., Ltd.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Unisound AI Technology Co., Ltd.	This work was funded by the Project 61701306 and 62071302 supported by National Natural Science Foundation of China. The funder provided support in the form of salaries for authors L. Wei, Y. Liu, Y. Shi, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Unisound AI Technology Co., Ltd. provided support in the form of a salary for author Y. Li. The specific roles of these authors are articulated in the `author contributions' section.	Bu H, 2017, 2017 20TH CONFERENCE OF THE ORIENTAL CHAPTER OF THE INTERNATIONAL COORDINATING COMMITTEE ON SPEECH DATABASES AND SPEECH I/O SYSTEMS AND ASSESSMENT (O-COCOSDA), P58, DOI 10.1109/ICSDA.2017.8384449; Chen NX, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P185; Das RK, 2018, IETE TECH REV, V35, P599, DOI 10.1080/02564602.2017.1357507; Dehak N, 2011, IEEE T AUDIO SPEECH, V19, P788, DOI 10.1109/TASL.2010.2064307; Du J., 2018, ARXIV180810583; Ferrer L, 2018, P INTERSPEECH, P1116; Garcia-Romero D, 2019, INTERSPEECH, P1493, DOI 10.21437/Interspeech.2019-2205; Hasan T, 2013, IEEE T AUDIO SPEECH, V21, P842, DOI 10.1109/TASL.2012.2226161; Heigold G, 2016, INT CONF ACOUST SPEE, P5115, DOI 10.1109/ICASSP.2016.7472652; Jin M, 2009, INT CONF ACOUST SPEE, P1453, DOI 10.1109/ICASSP.2009.4959868; Kanagasundaram A, 2019, INTERSPEECH, P2943, DOI 10.21437/Interspeech.2019-1891; Kanervisto A, 2017, INT CONF ACOUST SPEE, P5360, DOI 10.1109/ICASSP.2017.7953180; Kenny P, 2008, IEEE T AUDIO SPEECH, V16, P980, DOI 10.1109/TASL.2008.925147; Kinnunen T, 2010, SPEECH COMMUN, V52, P12, DOI 10.1016/j.specom.2009.08.009; Kumar K, 2011, INT CONF ACOUST SPEE, P4784; KYTTA J, 1970, ACTA OTO-LARYNGOL, P95; Larcher A, 2013, INTERSPEECH, P2767; Li XG, 2015, 16TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION (INTERSPEECH 2015), VOLS 1-5, P1086; Meng Z, 2019, INT CONF ACOUST SPEE, P6216, DOI 10.1109/ICASSP.2019.8682488; Muckenhirn H, 2018, P INTERSPEECH, P82; Nandwana MK, 2019, INT CONF ACOUST SPEE, P6001, DOI 10.1109/ICASSP.2019.8683881; Nidadavolu P, 2018, INTERSPEECH, P1111; Park SJ, 2017, INTERSPEECH, P1522, DOI 10.21437/Interspeech.2017-157; Park SJ, 2018, J ACOUST SOC AM, V144, P375, DOI 10.1121/1.5045323; Patil H.A., 2010, AC SPEECH SIGN PROC, P4526; Patil HA, 2012, INT CONF ASIAN LANG, P149, DOI 10.1109/IALP.2012.58; Patil HA, 2008, LECT NOTES ARTIF INT, V5246, P461, DOI 10.1007/978-3-540-87391-4_59; Povey D., 2011, IEEE 2011 AUT SPEECH, P4; Prince SJD, 2007, IEEE I CONF COMP VIS, P1751; Reynolds DA, 2000, DIGIT SIGNAL PROCESS, V10, P19, DOI 10.1006/dspr.1999.0361; Sarria-Paja M, 2018, SPEECH COMMUN, V102, P78, DOI 10.1016/j.specom.2018.07.005; Sarria-Paja M, 2017, COMPUT SPEECH LANG, V45, P437, DOI 10.1016/j.csl.2017.04.004; Shi Y, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9132636; Shriberg E, 2008, INTERSPEECH 2008: 9TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2008, VOLS 1-5, P609; Snyder D, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P5329; Suzuki N, 2003, SPEECH COMMUN, V40, P559, DOI 10.1016/S0167-6393(02)00180-2; TITZE IR, 1989, J ACOUST SOC AM, V85, P1699, DOI 10.1121/1.397959; Todisco M, 2019, INTERSPEECH, P1008, DOI 10.21437/Interspeech.2019-2249; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Variani Ehsan, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P4052, DOI 10.1109/ICASSP.2014.6854363; Wu W, 2006, INTERSPEECH 2006 AND 9TH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, VOLS 1-5, P2102; Yun Lei, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P1695, DOI 10.1109/ICASSP.2014.6853887	42	0	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241809	10.1371/journal.pone.0241809	http://dx.doi.org/10.1371/journal.pone.0241809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175898	gold, Green Published			2022-12-26	WOS:000593946900036
J	Gezahegn, LK; Argaw, E; Assefa, B; Geberesilassie, A; Hagazi, M				Gezahegn, Liwam Kidane; Argaw, Ermias; Assefa, Belete; Geberesilassie, Azeb; Hagazi, Mengistu			Magnitude, outcome, and associated factors of anti-tuberculosis drug-induced hepatitis among tuberculosis patients in a tertiary hospital in North Ethiopia: A cross-sectional study	PLOS ONE			English	Article							RISK-FACTORS; INDUCED HEPATOTOXICITY; PYRAZINAMIDE; RIFAMPICIN; TOXICITY; THERAPY	Background Short-course chemotherapy comprising isoniazid, rifampicin, ethambutol, and pyrazinamide has proved to be highly effective in the treatment of tuberculosis (TB). However, the most common adverse effect of this regimen leading to interruption of therapy is hepatotoxicity. There is a paucity of evidence in Tigray region on anti-tuberculosis drug-induced hepatitis. Therefore, this study aims to determine the magnitude, outcomes, and associated factors of drug-induced hepatitis in Ayder specialized comprehensive hospital tuberculosis clinic. Methods An institution-based cross-sectional study was done on 188 cases of patients who took anti-tuberculosis drugs from August 4, 2015 to June 30, 2018 in tuberculosis clinic, Ayder Comprehensive Specialized Hospital, Northern Ethiopia. Data on socio-demography, clinical characteristics and magnitude of the incidence and outcome of anti-tuberculosis drugs-induced hepatitis were collected using structured checklist from patients' records using census method. Then, we entered and analyzed the data using statistical packages for social sciences (SPSS) statistical software version 21. Descriptive statistics were done in tables, counts, proportions, median and range. Bivariate and multivariable regression analyses were done to identify factors that are associated with drug-induced hepatitis. Confidence interval was taken at 95% and p-value of less than 0.05 was used to denote significance. Results We approached a total of 226 patients' records, and we collected data from188 records (83.2%response rate). Anti-tuberculosis drug-induced hepatitis was found in 26 (13.8%) of the patients, of which 3 (11.54%) have died. Using multivariable logistic regression analyses, preexisting liver disease (AOR: 42.01, 95% CI: 4.22-417.49), taking other hepatotoxic drugs (AOR: 23.66, 95% CI: 1.77-314.79), and having lower serum albumin (AOR: 10.55, 95% CI: 2.57-43.32) were found to be significantly associated with the development of anti-tuberculosis drug-induced hepatitis. Conclusion and recommendation The incidence of anti-tuberculosis drug-induced hepatitis was high. Patients with low baseline serum albumin, taking other hepatotoxic drugs and having preexisting liver disease should be followed with serial liver enzymes after initiation of anti-tuberculosis medications. These patients should be followed with frequent measurement of liver enzymes to assess for the development of drug-induced hepatitis.	[Gezahegn, Liwam Kidane; Argaw, Ermias] Mekelle Univ, Coll Hlth Sci, Sch Med, Mekelle, Ethiopia; [Assefa, Belete; Geberesilassie, Azeb; Hagazi, Mengistu] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia	Mekelle University; Mekelle University	Gezahegn, LK (corresponding author), Mekelle Univ, Coll Hlth Sci, Sch Med, Mekelle, Ethiopia.	liwamey147@gmail.com		Gezahegn, Liwam/0000-0002-1378-0670				Abera W, 2016, INT J MYCOBACT, V5, P14, DOI 10.1016/j.ijmyco.2015.10.002; Ali AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064622; Anand A C, 2006, Med J Armed Forces India, V62, P45, DOI 10.1016/S0377-1237(06)80155-3; [Anonymous], 1990, J HEPATOL, V11, P272, DOI [10.1016/0168-8278(90)90124-A, DOI 10.1016/0168-8278(90)90124-A]; [Anonymous], 2016, FEDERAL DEMOCRATIC R; [Anonymous], 2015, HARRISONS PRINCIPLES; Brewer TF, 2004, J EPIDEMIOL COMMUN H, V58, P822, DOI 10.1136/jech.2003.008664; BRITISH THORACIC AND TUBERCULOSIS ASSOCIATION, 1975, Lancet, P119; COMBS DL, 1990, ANN INTERN MED, V112, P397, DOI 10.7326/0003-4819-76-3-112-6-397; DASH LA, 1980, AM REV RESPIR DIS, V121, P1039; Devarbhavi H, 2013, J GASTROEN HEPATOL, V28, P161, DOI 10.1111/j.1440-1746.2012.07279.x; Echresh A, 2014, SEMICOND SCI TECH, V29, DOI 10.1088/0268-1242/29/11/115009; Fauzi A R M, 2004, Med J Malaysia, V59, P72; Freidman LS, 2012, UPTODATE 21 6 TESTS; Gaude Gajanan S, 2015, J Family Med Prim Care, V4, P238, DOI 10.4103/2249-4863.154661; Ghasemi BR, 2011, GOVARESH, V16, P134; Kebede A, 2011, 1 ETHIOPIAN NATL POP; Khalili H, 2009, DARU, V17, P163; Makhlouf HA, 2008, HEPATOL INT, V2, P353, DOI 10.1007/s12072-008-9085-y; Mandel GL, 2010, MANDELL DOUGLAS BENN; Marzuki OA, 2008, SINGAP MED J, V49, P688; Mekonnen T, 2002, J ETHIOPIA MED PRACT, V4, P32; Pande JN, 1996, THORAX, V51, P132, DOI 10.1136/thx.51.2.132; PARTHASARATHY R, 1986, TUBERCLE, V67, P99, DOI 10.1016/0041-3879(86)90003-6; Quyen T, 2008, MANAGEMENT COMMON SI; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Schaberg T, 1996, EUR RESPIR J, V9, P2026, DOI 10.1183/09031936.96.09102026; Shakya R, 2006, KATHMANDU U J SCI EN, V2, P1; Shang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021836; Sharma SK, 2002, AM J RESP CRIT CARE, V166, P916, DOI 10.1164/rccm.2108091; de Lima MDS, 2012, CAD SAUDE PUBLICA, V28, P698, DOI 10.1590/S0102-311X2012000400009; SINGH J, 1995, POSTGRAD MED J, V71, P359, DOI 10.1136/pgmj.71.836.359; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; TURKTAS H, 1994, TUBERCLE LUNG DIS, V75, P58, DOI 10.1016/0962-8479(94)90104-X; Ungo JR, 1998, AM J RESP CRIT CARE, V157, P1871, DOI 10.1164/ajrccm.157.6.9711039; Variane F, TUBERCULOSIS PRACTIC	36	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241346	10.1371/journal.pone.0241346	http://dx.doi.org/10.1371/journal.pone.0241346			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170847	Green Published, gold			2022-12-26	WOS:000592383400039
J	Song, H; Huang, YP; Gu, BQ				Song, Hui; Huang, Yunping; Gu, Binquan			QTL-Seq identifies quantitative trait loci of relative electrical conductivity associated with heat tolerance in bottle gourd (Lagenaria siceraria)	PLOS ONE			English	Article							AP-3 ADAPTER COMPLEX; DROUGHT TOLERANCE; FREEZING-INJURY; POD SET; GENOME; PROTEIN; PLANT; STRESS; GENES; WHEAT	Heat is a major abiotic stress that seriously affects watermelon (Citrullus lanatus) production. However, its effects may be mitigated through grafting watermelon to heat tolerant bottle gourd (Lagenaria siceraria) rootstocks. Understanding the genetic basis of heat tolerance and development of reliable DNA markers to indirectly select for the trait are necessary in breeding for new varieties with heat tolerance. The objectives of this study were to investigate the inheritance of heat tolerance and identify molecular markers associated with heat tolerance in bottle gourd. A segregating F-2 population was developed from a cross between two heat tolerant and sensitive inbred lines. The population was phenotyped for relative electrical conductivity (REC) upon high temperature treatment which was used as an indicator for heat tolerance. QTL-seq was performed to identify regions associated with heat tolerance. We found that REC-based heat tolerance in this population exhibited recessive inheritance. Seven heat-tolerant quantitative trait loci (qHT1.1, qHT2.1, qHT2.2, qHT5.1, qHT6.1, qHT7.1, and qHT8.1) were identified with qHT2.1 being a promising major-effect QTL. In the qHT2.1 region, we identified three non-synonymous SNPs that were potentially associated with heat tolerance. These SNPs were located in the genes that may play roles in pollen sterility, intracellular transport, and signal recognition. Association of the three SNPs with heat tolerance was verified in segregating F-2 populations, which could be candidate markers for marker assisted selection for heat tolerance in bottle gourd. The qHT2.1 region is an important finding that may be used for fine mapping and discovery of novel genes associated with heat tolerance in bottle gourd.	[Song, Hui; Huang, Yunping; Gu, Binquan] Ningbo Acad Agr Sci, Key Lab Cucurbit Vegetable Breeding, Ningbo, Zhejiang, Peoples R China		Song, H (corresponding author), Ningbo Acad Agr Sci, Key Lab Cucurbit Vegetable Breeding, Ningbo, Zhejiang, Peoples R China.	975281674@qq.com		Song, Hui/0000-0001-8672-113X	National Natural Science Foundation of China; Special Fund for Agro-Scientific Research in the Public Interest	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest	Funding for this research comes from the National Natural Science Foundation of China and Special Fund for Agro-Scientific Research in the Public Interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELIOVICH H, 1993, MOL CELL BIOL, V13, P7766, DOI 10.1128/MCB.13.12.7766; Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; [Anonymous], 2015, GEO J GENDER L, V16, P41; Arvin MJ, 2008, J AGRIC SCI TECHNOL, V10, P33; Asthir B, 2015, J PLANT INTERACT, V10, P202, DOI 10.1080/17429145.2015.1067726; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barakat MN, 2011, AUST J CROP SCI, V5, P104; Bassham Diane C, 2008, Arabidopsis Book, V6, pe0116, DOI 10.1199/tab.0116; Berry S., 2018, J IMMUNOTHER CANCER, V6, P115, DOI [DOI 10.1186/S40425-018-0423-X, 10.1186/s40425-018-0423-x]; BOUWKAMP JC, 1982, J HERED, V73, P385, DOI 10.1093/oxfordjournals.jhered.a109680; Branham SE, 2017, THEOR APPL GENET, V130, P529, DOI 10.1007/s00122-016-2832-x; BRINEN GH, 1979, J AM SOC HORTIC SCI, V104, P724; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Davies Julia M., 2014, Plants-Basel, V3, P128, DOI 10.3390/plants3010128; Davis AR, 2008, CRIT REV PLANT SCI, V27, P50, DOI 10.1080/07352680802053940; Donlin MJ, 1995, PLANT CELL, V7, P1989, DOI 10.1105/tpc.7.12.1989; Du YL, 2016, NAT CHEM BIOL, V12, P194, DOI [10.1038/NCHEMBIO.2009, 10.1038/nchembio.2009]; ElBasyoni I, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9091606; Fan LS, 2013, DEVELOPMENT, V140, P3826, DOI 10.1242/dev.095711; Farnham MW, 2011, HORTSCIENCE, V46, P858, DOI 10.21273/HORTSCI.46.6.858; Fedoroff NV, 2010, SCIENCE, V327, P833, DOI 10.1126/science.1186834; Feng QN, 2018, PLANT PHYSIOL, V177, P216, DOI 10.1104/pp.17.01722; Feraru E, 2010, PLANT CELL, V22, P2812, DOI 10.1105/tpc.110.075424; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gilliham M, 2017, PLANT J, V90, P898, DOI 10.1111/tpj.13456; Gul IS, 2017, CELL MOL LIFE SCI, V74, P525, DOI 10.1007/s00018-016-2319-6; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; He AL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020469; Hirayama T, 2010, PLANT J, V61, P1041, DOI 10.1111/j.1365-313X.2010.04124.x; HOLZMAN LB, 1994, J BIOL CHEM, V269, P30808; Hruba P, 2005, PLANTA, V220, P931, DOI 10.1007/s00425-004-1409-0; Huang N, 2018, GENE, V678, P207, DOI 10.1016/j.gene.2018.08.043; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Idanheimo N, 2014, BIOCHEM BIOPH RES CO, V445, P457, DOI 10.1016/j.bbrc.2014.02.013; Jha UC, 2014, PLANT BREEDING, V133, P679, DOI 10.1111/pbr.12217; Jin XQ, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1660-y; Julien Cusin, 2015, REV FRANCAISE GESTIO, V1, P13; Kaminski KP, 2016, POTATO RES, V59, P81, DOI 10.1007/s11540-015-9314-4; Kaya H, 2001, CELL, V104, P131, DOI 10.1016/S0092-8674(01)00197-0; Kraus B, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-21; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; Laohavisit A, 2010, PLANT PHYSIOL, V152, P1824, DOI 10.1104/pp.109.145458; Lee JungMyung, 2003, Horticultural Reviews, V28, P61, DOI 10.1002/9780470650851.ch2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XM, 2015, NAT GENET, V47, P827, DOI 10.1038/ng.3305; Lichocka M, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1405-3; Liu N, 2016, MOL GENET GENOMICS, V291, P621, DOI 10.1007/s00438-015-1132-5; Liu S, 2020, OIL CROP SCI, DOI [10.1016/j.ocsci.2020.05.003, DOI 10.1016/J.OCSCI.2020.05.003]; Livaja M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-628; Lu HF, 2014, THEOR APPL GENET, V127, P1491, DOI 10.1007/s00122-014-2313-z; MARFO KO, 1992, CROP SCI, V32, P912, DOI 10.2135/cropsci1992.0011183X003200040015x; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; Mashilo J, 2017, ACTA AGR SCAND B-S P, V67, P43, DOI 10.1080/09064710.2016.1215518; Mondal S, 2015, EUPHYTICA, V201, P123, DOI 10.1007/s10681-014-1193-2; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Paliwal R, 2012, THEOR APPL GENET, V125, P561, DOI 10.1007/s00122-012-1853-3; Pandey MK, 2017, PLANT BIOTECHNOL J, V15, P927, DOI 10.1111/pbi.12686; Park M, 2013, P NATL ACAD SCI USA, V110, P10318, DOI 10.1073/pnas.1300460110; Parsiegla G, 2012, BIOCHEMISTRY-US, V51, P10250, DOI 10.1021/bi300873f; Paul PJ, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082166; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Rashkova S, 2002, P NATL ACAD SCI USA, V99, P3621, DOI 10.1073/pnas.032071999; SAADALLA MM, 1990, CROP SCI, V30, P1243, DOI 10.2135/cropsci1990.0011183X003000060017x; Samadia D. K., 2002, Indian Journal of Horticulture, V59, P167; Schaefer H, 2009, P ROY SOC B-BIOL SCI, V276, P843, DOI 10.1098/rspb.2008.1447; Shanmugavadivel PS, 2017, RICE, V10, DOI 10.1186/s12284-017-0167-0; Simpson F, 1996, J CELL BIOL, V133, P749, DOI 10.1083/jcb.133.4.749; Singh D, 2017, CROP SCI, V57, P3059, DOI 10.2135/cropsci2017.05.0284; Singh VK, 2016, PLANT BIOTECHNOL J, V14, P2110, DOI 10.1111/pbi.12567; Soldi S, 2015, CLIN EXP GASTROENTER, V8, P309, DOI 10.2147/CEG.S89999; Staub JE, 2005, PLANT BREEDING, V124, P44, DOI 10.1111/j.1439-0523.2004.01061.x; Su AY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122651; Sui YiHu, 2014, Journal of Nanjing Agricultural University, V37, P46; SULC RM, 1991, CROP SCI, V31, P430, DOI 10.2135/cropsci1991.0011183X003100020041x; Sun CX, 2009, ACTA AGR JIANGXI, V21, P33; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Talukder SK, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0097-4; Tian SW, 2018, PLANT CELL REP, V37, P1353, DOI 10.1007/s00299-018-2299-0; Umate P, 2010, PLANT MOL BIOL, V73, P449, DOI 10.1007/s11103-010-9632-5; Umezawa T, 2004, P NATL ACAD SCI USA, V101, P17306, DOI 10.1073/pnas.0407758101; von Karsa L, 2013, ENDOSCOPY, V45, P51, DOI 10.1055/s-0032-1325997; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; Wang CG, 2006, EUPHYTICA, V151, P111, DOI 10.1007/s10681-005-9049-4; Wang YH, 2014, Chinese Patent, Patent No. 2012100939951; Wang Y, 2015, AUTOPHAGY, V11, P2033, DOI 10.1080/15548627.2015.1098798; Win KT, 2017, THEOR APPL GENET, V130, P199, DOI 10.1007/s00122-016-2806-z; Wu S, 2017, PLANT J, V92, P963, DOI 10.1111/tpj.13722; Wu XY, 2017, HORTIC PLANT J, V3, P13, DOI 10.1016/j.hpj.2017.01.011; Xiao WF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177641; Xu P, 2014, PLANT J, V77, P430, DOI 10.1111/tpj.12370; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-467; Yabuta S, 2010, PLANT CELL PHYSIOL, V51, P866, DOI 10.1093/pcp/pcq060; Yang YJ, 2013, J PLANT PHYSIOL, V170, P653, DOI 10.1016/j.jplph.2012.12.013; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433; Zhou WJ, 1998, PLANT GROWTH REGUL, V26, P41, DOI 10.1023/A:1006004921265; Zhu JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102407; Zuryn S, 2010, GENETICS, V186, P427, DOI 10.1534/genetics.110.119230; Zwiewka M, 2011, CELL RES, V21, P1711, DOI 10.1038/cr.2011.99	99	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0227663	10.1371/journal.pone.0227663	http://dx.doi.org/10.1371/journal.pone.0227663			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170849	gold, Green Submitted, Green Published			2022-12-26	WOS:000592383400058
J	Holbrook, R; Higuera, L; Wherry, K; Phay, D; Hsieh, YC; Lin, KH; Liu, YB				Holbrook, Reece; Higuera, Lucas; Wherry, Kael; Phay, Dave; Hsieh, Yu-Cheng; Lin, Kuo-Hung; Liu, Yen-Bin			Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial	PLOS ONE			English	Article							SUDDEN CARDIAC DEATH; PROPHYLACTIC IMPLANTATION; HEART-FAILURE; TASK-FORCE; ASSOCIATION; AMIODARONE; GUIDELINES; RATES; TIME	Objective Implantable cardiac defibrillators (ICDs) for primary prevention (PP) of sudden cardiac arrest (SCA) are well-established but underutilized globally. The Improve SCA study has identified a cohort of patients called 1.5 primary prevention (1.5PP) based on PP patients with the presence of certain risk factors. We evaluated the cost-effectiveness of ICD therapy compared to no ICD among the PP population and the subset of 1.5PP patients in Taiwan. Methods A Markov model was run over a lifetime time horizon from the Taiwan payer perspective. Mortality and utility estimates were obtained from the literature (PP) and the IMPROVE SCA trial (1.5PP). Cost inputs were obtained from the Taiwan National Health Insurance Administration (NHIA), Ministry of Health and Welfare. We used a willingness-to-pay (WTP) threshold of NT$2,100,000, as established through standard WTP research methods and in alignment with World Health Organization recommendations. Results The total discounted costs for ICD therapy and no ICD therapy were NT$1,664,259 and NT $646,396 respectively for PP, while they were NT$2,410,603 and NT$905,881 respectively for 1.5PP. Total discounted QALYs for ICD therapy and no ICD therapy were 6.48 and 4.98 respectively for PP, while they were 10.78 and 7.71 respectively for 1.5PP. The incremental cost effectiveness ratio was NT$708,711 for PP and NT$441,153 for 1.5PP, therefore ICD therapy should be considered cost effective for PP and highly cost effective for 1.5PP. Conclusions ICD therapy compared to no ICD therapy is cost-effective in the whole PP population and highly cost-effective in the subset 1.5PP population in Taiwan.	[Holbrook, Reece; Higuera, Lucas; Wherry, Kael; Phay, Dave] Medtron Plc, Dublin, Ireland; [Hsieh, Yu-Cheng] Taichung Vet Gen Hosp, Dept Cardiol, Taichung, Taiwan; [Hsieh, Yu-Cheng] Natl Yan Ming Univ, Sch Med, Taichung, Taiwan; [Lin, Kuo-Hung] China Med Ctr Univ Hosp, Dept Cardiol, Taichung, Taiwan; [Liu, Yen-Bin] Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan	Taichung Veterans General Hospital; National Taiwan University; National Taiwan University Hospital	Liu, YB (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan.	yenbin@ntu.edu.tw		LIU, YEN-BIN/0000-0003-0623-9146				Al-Khatib SM, 2013, JAMA-J AM MED ASSOC, V309, P55, DOI 10.1001/jama.2012.157182; Auricchio A, 2015, HEART RHYTHM, V12, P926, DOI 10.1016/j.hrthm.2015.01.017; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bundgaard JS, 2019, EUROPACE, V21, P900, DOI 10.1093/europace/euz018; Chia YMF, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.003651; Cowie MR, 2009, EUROPACE, V11, P716, DOI 10.1093/europace/eup068; Eby EL, 2020, J MED ECON, V23, P698, DOI 10.1080/13696998.2020.1751649; Epstein AE, 2008, CIRCULATION, V117, P2820, DOI 10.1161/CIRCUALTIONAHA.108.189741; Gasparini M, 2013, JAMA-J AM MED ASSOC, V309, P1903, DOI 10.1001/jama.2013.4598; Ghani A, 2014, NETH HEART J, V22, P286, DOI 10.1007/s12471-014-0556-6; Hammill SC, 2010, HEART RHYTHM, V7, P1340, DOI 10.1016/j.hrthm.2010.07.015; Hussein Ayman A, 2016, JACC Clin Electrophysiol, V2, P498, DOI 10.1016/j.jacep.2016.01.019; Lee HY, 2013, J FORMOS MED ASSOC, V112, P699, DOI 10.1016/j.jfma.2012.12.015; Lee JH, 2019, KOREAN CIRC J, V49, P841, DOI 10.4070/kcj.2018.0444; Li HG, 1998, AM J CARDIOL, V81, P1203, DOI 10.1016/S0002-9149(98)00090-3; Mark DB, 2006, CIRCULATION, V114, P135, DOI 10.1161/CIRCULATIONAHA.105.581884; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2012, NEW ENGL J MED, V367, P2275, DOI 10.1056/NEJMoa1211107; Poole JE, 2010, CIRCULATION, V122, P1553, DOI 10.1161/CIRCULATIONAHA.110.976076; Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316; Providencia R, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002418; Saeed M, 2014, J CARDIOVASC ELECTR, V25, P52, DOI 10.1111/jce.12273; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Satake H, 2015, CIRC J, V79, P381, DOI 10.1253/circj.CJ-14-0925; Schrage B, 2019, CIRCULATION, V140, P1530, DOI 10.1161/CIRCULATIONAHA.119.043012; Sears SF, 2018, HEART RHYTHM, V15, P734, DOI 10.1016/j.hrthm.2017.12.026; Shiroiwa T, 2010, HEALTH ECON, V19, P422, DOI 10.1002/hec.1481; Thijssen J, 2014, PACE, V37, P25, DOI 10.1111/pace.12238; Zhang S, 2020, HEART RHYTHM, V17, P468, DOI 10.1016/j.hrthm.2019.09.023; Zhang S, 2015, EUROPACE, V17, P1720, DOI 10.1093/europace/euv103	30	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0241697	10.1371/journal.pone.0241697	http://dx.doi.org/10.1371/journal.pone.0241697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211698	Green Published, gold			2022-12-26	WOS:000603518300022
J	Kamiya, H; Yasuga, H; Miki, N				Kamiya, Haruka; Yasuga, Hiroki; Miki, Norihisa			Ion concentration measurement using synthetic microfluidic papers	PLOS ONE			English	Article							TEAR GLUCOSE	Non-invasive diagnosis on biological liquid samples, such as urine, sweat, saliva, and tears, may allow patients to evaluate their health by themselves. To obtain accurate diagnostic results, target liquid must be precisely sampled. Conventionally, urine sampling using filter paper can be given as an example sampling, but differences in the paper structure can cause variations in sampling volume. This paper describes precise liquid sampling using synthetic microfluidic papers, which are composed of obliquely combined micropillars. Sampling volume accuracy was investigated using different designs and collection methods to determine the optimal design and sample collecting method. The optimized protocol was followed to accurately measure potassium concentration using synthetic microfluidic paper and a commercially available densitometer, which verified the usefulness of the synthetic microfluidic papers for precision sampling.	[Kamiya, Haruka; Yasuga, Hiroki; Miki, Norihisa] Keio Univ, Sch Integrated Design Engn, Yokohama, Kanagawa, Japan; [Yasuga, Hiroki] Waseda Univ, Waseda Res Inst Sci & Engn, Shinjuku Ku, Tokyo, Japan; [Yasuga, Hiroki] Ochanomizu Univ, Fac Core Res, Tokyo, Japan	Keio University; Waseda University; Ochanomizu University	Miki, N (corresponding author), Keio Univ, Sch Integrated Design Engn, Yokohama, Kanagawa, Japan.	miki@mech.keio.ac.jp	Yasuga, Hiroki/AGZ-6419-2022	Yasuga, Hiroki/0000-0003-2040-9017	Keio University Ishii-Ishibashi Fund for Education and Research Development; AMED [JP20lm0203130h0001]; JSPS KAKENHI [JP19K23498, 20J00716]	Keio University Ishii-Ishibashi Fund for Education and Research Development; AMED; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by Keio University Ishii-Ishibashi Fund for Education and Research Development and AMED under Grant Number JP20lm0203130h0001 to Norihisa Miki; and by Grant-in-Aid for Research Activity Start-up and for JSPS Fellows (JSPS KAKENHI Grant number JP19K23498 and 20J00716) to Hiroki Yasuga.	Amado LA, 2006, MEM I OSWALDO CRUZ, V101, P149, DOI 10.1590/S0074-02762006000200006; Briggs AL, 2004, SELF MONITORING BLOO, DOI [10.1177/0897190003261306, DOI 10.1177/0897190003261306]; Carlborg CF, 2011, LAB CHIP, V11, P3136, DOI 10.1039/c1lc20388f; CHARD T, 1992, HUM REPROD, V7, P701, DOI 10.1093/oxfordjournals.humrep.a137722; Chu MX, 2011, TALANTA, V83, P960, DOI 10.1016/j.talanta.2010.10.055; Farandos NM, 2015, ADV HEALTHC MATER, V4, P792, DOI 10.1002/adhm.201400504; Freiser H., 1978, ION SELECTIVE ELECTR; Gao W, 2016, NATURE, V529, P509, DOI 10.1038/nature16521; GASSET AR, 1968, AM J OPHTHALMOL, V65, P414, DOI 10.1016/0002-9394(68)93093-6; Hansson J, 2016, LAB CHIP, V16, P298, DOI 10.1039/c5lc01318f; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; HORIBA Instruments Incorporation, 2018, LAQUA WAT POCK WAT Q; Jonsson C, 2008, LAB CHIP, V8, P1191, DOI 10.1039/b800297e; Kamiya H, 2018, Annu Int Conf IEEE Eng Med Biol Soc, V2018, P3837, DOI 10.1109/EMBC.2018.8513267; Kanno Y, 2012, CONTRIB NEPHROL, V177, P178, DOI 10.1159/000337052; Lane JD, 2006, CURR EYE RES, V31, P895, DOI 10.1080/02713680600976552; LINDSTROM T, 1976, J COLLOID INTERF SCI, V55, P305, DOI 10.1016/0021-9797(76)90038-2; Luppa PB, 2011, TRAC-TREND ANAL CHEM, V30, P887, DOI 10.1016/j.trac.2011.01.019; Martinez AW, 2008, ANAL CHEM, V80, P3699, DOI 10.1021/ac800112r; Martinez AW, 2007, ANGEW CHEM INT EDIT, V46, P1318, DOI 10.1002/anie.200603817; Simerville JA, 2005, URINALYSIS COMPREHEN; To N, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00070; Yasui T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701133; Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h; Zimmermann M, 2007, LAB CHIP, V7, P119, DOI 10.1039/b609813d	25	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0242188	10.1371/journal.pone.0242188	http://dx.doi.org/10.1371/journal.pone.0242188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211718	Green Published, gold			2022-12-26	WOS:000603518300041
J	Liu, JH; Li, H; Luo, M; Liu, JY; Wu, LZ; Lin, XF; Li, RJ; Wang, ZH; Zhong, HY; Zheng, WL; Zhou, Y; Jiang, DX; Tan, X; Zhou, ZG; Peng, HL; Zhang, GS				Liu, Jiheng; Li, Heng; Luo, Ming; Liu, Jiyang; Wu, Lingzhen; Lin, Xianfeng; Li, Ruijuan; Wang, Zhihua; Zhong, Haiying; Zheng, Wenli; Zhou, Yan; Jiang, Dixuan; Tan, Xin; Zhou, Zhiguo; Peng, Hongling; Zhang, Guangsen			Lymphopenia predicted illness severity and recovery in patients with COVID-19: A single-center, retrospective study	PLOS ONE			English	Article							SARS; CORONAVIRUS; OUTBREAK; PNEUMONIA; RECEPTOR; OUTCOMES	The outbreak of SARS-CoV-2 began in December 2019 and rapidly became a pandemic. The present study investigated the significance of lymphopenia on disease severity. A total of 115 patients with confirmed COVID-19 from a tertiary hospital in Changsha, China, were enrolled. Clinical, laboratory, treatment and outcome data were gathered and compared between patients with and without lymphopenia. The median age was 42 years (1-75). Fifty-four patients (47.0%) of the 115 patients had lymphopenia on admission. More patients in the lymphopenia group had hypertension (30.8% vs. 10.0%, P = 0.006) and coronary heart disease (3.6% vs. 0%, P = 0.029) than in the nonlymphopenia group, and more patients with leukopenia (48.1% vs 14.8%, P<0.001) and eosinopenia (92.6% vs 54.1%, P<0.001) were observed. Lymphopenia was also correlated with severity grades of pneumonia (P<0.001) and C-reactive protein (CRP) level (P = 0.0014). Lymphopenia was associated with a prolonged duration of hospitalization (17.0 days vs. 14.0 days, P = 0.002). Lymphocyte recovery appeared the earliest, prior to CRP and chest radiographs, in severe cases, which suggests its predictive value for disease improvement. Our results demonstrated the clinical significance of lymphopenia for predicting the severity of and recovery from COVID-19, which emphasizes the need to dynamically monitor lymphocyte count.	[Liu, Jiheng] First Hosp Changsha, Dept Hematol & Oncol, Changsha, Hunan, Peoples R China; [Li, Heng; Wu, Lingzhen; Lin, Xianfeng; Li, Ruijuan; Wang, Zhihua; Zhong, Haiying; Zheng, Wenli; Peng, Hongling; Zhang, Guangsen] Cent South Univ, Xiangya Hosp 2, Dept Hematol, Changsha, Hunan, Peoples R China; [Li, Heng; Wu, Lingzhen; Lin, Xianfeng; Li, Ruijuan; Wang, Zhihua; Zhong, Haiying; Zheng, Wenli; Peng, Hongling; Zhang, Guangsen] Cent South Univ, Inst Mol Hematol, Changsha, Hunan, Peoples R China; [Li, Heng; Peng, Hongling; Zhang, Guangsen] Hunan Key Lab Tumor Models & Individualized Med, Changsha, Hunan, Peoples R China; [Luo, Ming] Cent South Univ, Xiangya Hosp 2, Dept Gen Surg, Changsha, Hunan, Peoples R China; [Liu, Jiyang] First Hosp Changsha, Changsha, Hunan, Peoples R China; [Zhou, Yan] First Hosp Changsha, Dept Emergency, Changsha, Hunan, Peoples R China; [Jiang, Dixuan; Zhou, Zhiguo] First Hosp Changsha, Dept Resp Med, Changsha, Hunan, Peoples R China; [Tan, Xin; Zhou, Zhiguo] First Hosp Changsha, Dept Pediat, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University	Peng, HL (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Hematol, Changsha, Hunan, Peoples R China.; Peng, HL (corresponding author), Cent South Univ, Inst Mol Hematol, Changsha, Hunan, Peoples R China.; Peng, HL (corresponding author), Hunan Key Lab Tumor Models & Individualized Med, Changsha, Hunan, Peoples R China.; Zhou, ZG (corresponding author), First Hosp Changsha, Dept Resp Med, Changsha, Hunan, Peoples R China.	zhouzhiguo1217@163.com; penghongling@csu.edu.cn		Li, Heng/0000-0002-3633-6679	National Natural Science Foundation of China [81800198, 81670160]; Innovative Major Emergency Project Funding against the New Coronavirus Pneumonia in Hunan Province [2020SK3014, 2020SK3045]; Scientific Research Project of Hunan Provincial Health Commission [20200216]; Natural Science Foundation of Hunan Province [2019JJ50863]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative Major Emergency Project Funding against the New Coronavirus Pneumonia in Hunan Province; Scientific Research Project of Hunan Provincial Health Commission; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	This research was supported in part by the National Natural Science Foundation of China in the form of grants awarded to LH (81800198) and PH (81670160), the Innovative Major Emergency Project Funding against the New Coronavirus Pneumonia in Hunan Province in the form of grants awarded to LJ (2020SK3014) and TX (2020SK3045), Scientific Research Project of Hunan Provincial Health Commission in the form of a grant awarded to LJ (20200216), and the Natural Science Foundation of Hunan Province in the form of a grant (2019JJ50863).	Ahmed AE, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2712-2; [Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; Arabi YM, 2014, ANN INTERN MED, V160, P389, DOI 10.7326/M13-2486; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Chafekar A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020093; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen RF, 2006, MICROBES INFECT, V8, P122, DOI 10.1016/j.micinf.2005.06.007; CUPPS TR, 1982, IMMUNOL REV, V65, P133, DOI 10.1111/j.1600-065X.1982.tb00431.x; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; He ZP, 2005, INT J INFECT DIS, V9, P323, DOI 10.1016/j.ijid.2004.07.014; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Imai Y, 2010, CIRC J, V74, P405, DOI 10.1253/circj.CJ-10-0045; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu Chun-Yu, 2005, J Chin Med Assoc, V68, P110, DOI 10.1016/S1726-4901(09)70231-X; Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744; Liu YX, 2020, SCI CHINA LIFE SCI, V63, P364, DOI 10.1007/s11427-020-1643-8; National Health Commission of the People's Republic of China, 2020, CHIN MAN GUID COVID; O'Donnell DR, 2002, PEDIATR PULM, V34, P128, DOI 10.1002/ppul.10140; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343; Thompson BT, 2003, CRIT CARE MED, V31, pS253, DOI 10.1097/01.CCM.0000057900.19201.55; Xie XZ, 2020, RADIOLOGY, V296, pE41, DOI 10.1148/radiol.2020200343; Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5; Yang YL, 2017, SCI REP-UK, V7, DOI 10.1038/srep39883; Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zumla A, 2015, LANCET, V386, P995, DOI 10.1016/S0140-6736(15)60454-8	28	31	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241659	10.1371/journal.pone.0241659	http://dx.doi.org/10.1371/journal.pone.0241659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206680	Green Published, gold			2022-12-26	WOS:000595265900053
J	Munoz-Moreno, R; Chaves-Montero, A; Morilla-Luchena, A; Vazquez-Aguado, O				Munoz-Moreno, Rocio; Chaves-Montero, Alfonso; Morilla-Luchena, Aleix; Vazquez-Aguado, Octavio			COVID-19 and social services in Spain	PLOS ONE			English	Article								During the state of alarm declared in Spain by COVID-19 due to the pandemic, the country's authorities declared Social Services and their workers to be essential, considering that the activity of these professionals with the vulnerable population was crucial and that services should continue to be provided to guarantee the well-being of users in this exceptionally serious situation. This article analyzes the impact that the COVID-19 and the state of alarm has had on Spanish social service professionals. An ad hoc questionnaire was used, administered on-line, individually, voluntarily and anonymously to 560 professionals working in social services, both in the public and private sectors, based throughout Spain. This questionnaire has five different parts: socio-demographic profiling, impact that the health crisis has had on the practice of professional functions, degree of knowledge of the measures imposed to guarantee the protection and safety of professionals and users, impact that it has had on the professional and personal development of social services professionals and, the fifth and last part, degree of adaptation of the measures aimed at the care of the vulnerable population. These results are discussed based on the situation in which professionals working in this sector find themselves in the face of the changes they are experiencing in the development of their work, and we are able to determine the profile of the workers who have felt most affected by the situation, with the consequent and foreseeable mental and emotional affectation that this implies. These professionals tend to value more negatively the set of measures developed to mitigate the impact of COVID-19 on Spanish social services.	[Munoz-Moreno, Rocio; Chaves-Montero, Alfonso; Morilla-Luchena, Aleix; Vazquez-Aguado, Octavio] Univ Huelva, Dept Sociol Social Work & Publ Hlth, Huelva, Spain	Universidad de Huelva	Morilla-Luchena, A (corresponding author), Univ Huelva, Dept Sociol Social Work & Publ Hlth, Huelva, Spain.	aleix.morilla@dstso.uhu.es	MORENO, ROCÍO MUÑOZ/AAG-2028-2020; Chaves-Montero, Alfonso/I-3500-2017; Vázquez-Aguado, Octavio/D-3110-2013; Morilla-Luchena, Aleix/A-3340-2019	MORENO, ROCÍO MUÑOZ/0000-0002-0597-8003; Chaves-Montero, Alfonso/0000-0001-5861-3414; Vázquez-Aguado, Octavio/0000-0002-7636-2724; Morilla-Luchena, Aleix/0000-0003-2283-7736				Abiru N, 2020, DIABETOL INT, V11, P1, DOI 10.1007/s13340-019-00415-8; Allyson M, 2020, COVID 19 WHY WE NEED, V369, P1, DOI [10.1136/bmj.m14 65, DOI 10.1136/BMJ.M1465]; [Anonymous], 2000, PHYS REV FOCUS, V6, P15; Bacon AM, 2020, BRIT J HEALTH PSYCH, V25, P839, DOI 10.1111/bjhp.12423; Barrera Algarin E., 2015, COMUNITANIA REV INT, V9, P51, DOI [10.5944/comunitania.9.2, DOI 10.5944/C0MUNITANIA.9.2]; Cosic K, 2020, PSYCHIAT DANUB, V32, P25, DOI 10.24869/psyd.2020.25; Couper MP, 2008, PUBLIC OPIN QUART, V72, P831, DOI 10.1093/poq/nfn066; Dosil M, 2020, REV PSIQUIATR SALUD, P1, DOI [10.1016/j.rpsm.2019.10.001, DOI 10.1016/J.RPSM.2019.10.001]; Fernandes MA, 2020, REV CUID, V11, DOI 10.15649/cuidarte.1222; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Li SJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062032; Roberton T, 2020, LANCET GLOB HEALTH, DOI [10.1016/52214-109X(20)30229-1, DOI 10.1016/52214-109X(20)30229-1]; Rodriguez-Jaume Maria-Jose, 2014, EMPIRIA REV METODOLO, V29, P155, DOI [10.5944/empiria.29.2014.12944, DOI 10.5944/EMPIRIA.29.2014.12944]; Sun LC, 2020, IEEE C EVOL COMPUTAT; Wang ZC, 2020, NAT MED, V26, P458, DOI 10.1038/s41591-020-0823-6	16	10	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241538	10.1371/journal.pone.0241538	http://dx.doi.org/10.1371/journal.pone.0241538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206665	gold, Green Published			2022-12-26	WOS:000595265900054
J	Zawedde-Muyanja, S; Musaazi, J; Manabe, YC; Katamba, A; Nankabirwa, JI; Castelnuovo, B; Cattamanchi, A				Zawedde-Muyanja, Stella; Musaazi, Joseph; Manabe, Yukari C.; Katamba, Achilles; Nankabirwa, Joaniter I.; Castelnuovo, Barbara; Cattamanchi, Adithya			Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda	PLOS ONE			English	Article							TUBERCULOSIS TREATMENT; TIME; CARE	Introduction Tuberculosis (TB) mortality estimates derived only from cohorts of patients initiated on TB treatment do not consider outcomes of patients with pretreatment loss to follow-up (LFU). We aimed to assess the effect of pretreatment LFU on TB-associated mortality in the six months following TB diagnosis at public health facilities in Uganda. Methods At ten public health facilities, we retrospectively reviewed treatment data for all patients with a positive Xpert(R)MTB/RIF test result from January to June 2018. Pretreatment LFU was defined as not initiating TB treatment within two weeks of a positive test. We traced patients with pretreatment LFU to ascertain their vital status. We performed Kaplan Meier survival analysis to compare the cumulative incidence of mortality, six months after diagnosis among patients who did and did not experience pretreatment LFU. We also determined the health facility level estimates of TB associated mortality before and after incorporating deaths prior to treatment initiation among patients who experienced pretreatment LFU. Results Of 510 patients with positive test, 100 (19.6%) experienced pretreatment LFU. Of these, we ascertained the vital status of 49 patients. In the six months following TB diagnosis, mortality was higher among patients who experienced pretreatment LFU 48.1/1000py vs 22.9/1000py. Hazard ratio [HR] 3.18, 95% confidence interval [CI] (1.61-6.30). After incorporating deaths prior to treatment initation among patients who experienced pretreatment LFU, health facility level estimates of TB associated mortality increased from 8.4% (95% CI 6.1%-11.6%) to 10.2% (95% CI 7.7%-13.4%). Conclusion Patients with confirmed TB who experience pretreatment LFU have high mortality within the first six months. Efforts should be made to prioritise linkage to treatment for this group of patients. Deaths that occur prior to treatment initation should be included when reporting TB mortality in order to more accurately reflect the health impact of TB.	[Zawedde-Muyanja, Stella; Musaazi, Joseph; Manabe, Yukari C.; Castelnuovo, Barbara] Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda; [Manabe, Yukari C.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Katamba, Achilles; Nankabirwa, Joaniter I.] Makerere Univ, Coll Hlth Sci, Sch Med, Dept Med, Kampala, Uganda; [Cattamanchi, Adithya] Univ Calif San Francisco, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Cattamanchi, Adithya] Univ Calif San Francisco, Ctr TB, San Francisco, CA 94143 USA	Makerere University; Johns Hopkins University; Makerere University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Zawedde-Muyanja, S (corresponding author), Makerere Univ, Infect Dis Inst, Coll Hlth Sci, Kampala, Uganda.	szawedde@idi.co.ug		Zawedde-Muyanja, Stella/0000-0002-8823-7082	Fogarty International Center, National Institutes for Health [D43TW009771]; Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [DEL-15-006]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107752/Z/15/Z]; UK government	Fogarty International Center, National Institutes for Health; Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government	The authors received funding from the following sources during the drafting of this manuscript: SZM and YCM received support from the Fogarty International Center, National Institutes for Health: Grant #D43TW009771 "HIV Coinfections in Uganda: TB, Cryptococcus and Viral Hepatitis". SZM received support through the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a DELTAS Africa Initiative [grant #DEL-15-006]. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [grant #107752/Z/15/Z] and the UK government. We particularly thank the NTLP and the health facilities where we worked for providing the data analyzed for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, CRIT CARE, V13, pR190; [Anonymous], 2019, JMIR PUBLIC HLTH SUR, V4, pe53, DOI 10.2196/publichealth.9932; Botha E, 2008, INT J TUBERC LUNG D, V12, P820; Bui TQ, 2019, C54 TUBERCULOSIS EPI, pA5162; Davis JL, 2011, AM J RESP CRIT CARE, V184, P362, DOI 10.1164/rccm.201012-1984OC; Dodd PJ, 2018, GTBR2018 ONLINE TECH; Kim HJ, 2005, WATER SCI TECHNOL, V52, P153, DOI 10.2166/wst.2005.0511; Loveday M, 2019, SAMJ S AFR MED J, V109, P728, DOI [10.7196/SAMJ.2019.v109i10.14073, 10.7196/samj.2019.v109i10.14073]; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; Manabe YC, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv030; Mugauri H, 2018, INT J INFECT DIS, V76, P6, DOI 10.1016/j.ijid.2018.07.012; Musaazi J, 2019, INT J TUBERC LUNG D, V23, P514, DOI 10.5588/ijtld.18.0306; Negin J, 2015, INT J INFECT DIS, V32, P135, DOI 10.1016/j.ijid.2014.11.018; Shete PB, 2015, INT J TUBERC LUNG D, V19, P912, DOI 10.5588/ijtld.14.0166; Squire SB, 2005, INT J TUBERC LUNG D, V9, P25; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Straetemans M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020755; Tenforde MW, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002723; The Republic of Uganda, 2015, UG NAT TUB PREV SURV; Thomas BE, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3039-3; Uganda Ministry of Health, 2019, DIR IND COSTS DUE TU; Uganda Ministry of Health, 2017, UG POP BAS HIV IMP A, P62; WHO, 2019, GLOB TUB REP; WHO, 2015, END TB STRATEGY; Zawedde-Muyanja S, 2018, INT J TUBERC LUNG D, V22, P1475, DOI 10.5588/ijtld.17.0460	25	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241611	10.1371/journal.pone.0241611	http://dx.doi.org/10.1371/journal.pone.0241611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206650	Green Published, gold			2022-12-26	WOS:000595265900022
J	Borkowski, K; Newman, JW; Aghaeepour, N; Mayo, JA; Blazenovic, I; Fiehn, O; Stevenson, DK; Shaw, GM; Carmichael, SL				Borkowski, Kamil; Newman, John W.; Aghaeepour, Nima; Mayo, Jonathan A.; Blazenovic, Ivana; Fiehn, Oliver; Stevenson, David K.; Shaw, Gary M.; Carmichael, Suzan L.			Mid-gestation serum lipidomic profile associations with spontaneous preterm birth are influenced by body mass index	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; INFLAMMATION; OBESITY; PLASMA; IDENTIFICATION; OXYLIPINS; ACIDS; RISK; F-2-ISOPROSTANES; SUPPLEMENTATION	Spontaneous preterm birth (sPTB) is a major cause of infant morbidity and mortality. While metabolic changes leading to preterm birth are unknown, several factors including dyslipidemia and inflammation have been implicated and paradoxically both low (<18.5 kg/m(2)) and high (>30 kg/m(2)) body mass indices (BMIs) are risk factors for this condition. The objective of the study was to identify BMI-associated metabolic perturbations and potential mid-gestation serum biomarkers of preterm birth in a cohort of underweight, normal weight and obese women experiencing either sPTB or full-term deliveries (n = 102; n = 17/group). For this purpose, we combined untargeted metabolomics and lipidomics with targeted metabolic profiling of major regulators of inflammation and metabolism, including oxylipins, endocannabinoids, bile acids and ceramides. Women who were obese and had sPTB showed elevated oxidative stress and dyslipidemia characterized by elevated serum free fatty acids. Women who were underweight-associated sPTB also showed evidence of dyslipidemia characterized by elevated phospholipids, unsaturated triglycerides, sphingomyelins, cholesteryl esters and long-chain acylcarnitines. In normal weight women experiencing sPTB, the relative abundance of 14(15)-epoxyeicosatrienoic acid and 14,15-dihydroxyeicosatrienoic acids to other regioisomers were altered at mid-pregnancy. This phenomenon is not yet associated with any biological process, but may be linked to estrogen metabolism. These changes were differentially modulated across BMI groups. In conclusion, using metabolomics we observed distinct BMI-dependent metabolic manifestations among women who had sPTB. These observations suggest the potential to predict sPTB mid-gestation using a new set of metabolomic markers and BMI stratification. This study opens the door to further investigate the role of cytochrome P450/epoxide hydrolase metabolism in sPTB.	[Borkowski, Kamil; Newman, John W.; Blazenovic, Ivana; Fiehn, Oliver] Univ Calif Davis, West Coast Metabol Ctr, Genome Ctr, Davis, CA 95616 USA; [Newman, John W.] ARS, USDA, Western Human Nutr Res Ctr, Davis, CA USA; [Newman, John W.] Univ Calif Davis, Dept Nutr, Davis, CA USA; [Aghaeepour, Nima] Stanford Univ, Sch Med, Dept Anesthesiol Pain & Perioperat Med, Stanford, CA USA; [Aghaeepour, Nima; Mayo, Jonathan A.; Stevenson, David K.; Shaw, Gary M.; Carmichael, Suzan L.] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA USA; [Aghaeepour, Nima] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA USA	University of California System; University of California Davis; United States Department of Agriculture (USDA); University of California System; University of California Davis; Stanford University; Stanford University; Stanford University	Borkowski, K (corresponding author), Univ Calif Davis, West Coast Metabol Ctr, Genome Ctr, Davis, CA 95616 USA.	kborkowski@ucdavis.edu		Shaw, Gary/0000-0001-7438-4914; Borkowski, Kamil/0000-0003-3637-3450	March of Dimes Foundation Prematurity Research Center at Stanford University School of Medicine [22-FY18-808]; Hess Research Fund award HAESD at Stanford University; Lucile Packard Foundation for Children's Health; Stanford Child Health Research Institute, the National Institutes of Health [UL1-TR001085]; NIH West Coast Metabolomics Center NIH [U24 DK097154]; USDA [2032-51530-022-00D, 2032-51530-025-00D]	March of Dimes Foundation Prematurity Research Center at Stanford University School of Medicine; Hess Research Fund award HAESD at Stanford University; Lucile Packard Foundation for Children's Health; Stanford Child Health Research Institute, the National Institutes of Health; NIH West Coast Metabolomics Center NIH; USDA(United States Department of Agriculture (USDA))	This research was supported by the March of Dimes Foundation Prematurity Research Center at Stanford University School of Medicine project 22-FY18-808 (GMS, DKS); the Hess Research Fund award HAESD at Stanford University (DKS); the Lucile Packard Foundation for Children's Health; the Stanford Child Health Research Institute, the National Institutes of Health project UL1-TR001085 (SLC, GMS, DKS); and the NIH West Coast Metabolomics Center NIH U24 DK097154 (OF, JWN) as a 2015 Pilot Project (SLC). Additional support was provided by USDA Projects 2032-51530-022-00D and 2032-51530-025-00D (JWN). The USDA is an equal opportunity employer and provider.	Agrawal K, 2017, J LIPID RES, V58, P188, DOI 10.1194/jlr.M071738; [Anonymous], 2007, RADIOGRAPHY S1, V13, pe1; [Anonymous], 2019, CANC DISCOV, V9, pOF3, DOI 10. 1158/2159-8290. CD-NB2018-158; [Anonymous], 2019, CANC DISCOV, V10, pOF5; [Anonymous], 2015, J CROHNS COLITIS S1, V9, pS15; Aung MT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53448-z; Bachkangi P, 2019, EUR J OBSTET GYN R B, V243, P1, DOI 10.1016/j.ejogrb.2019.09.029; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Borkowski K, 2019, J NUTR BIOCHEM, V68, P51, DOI 10.1016/j.jnutbio.2019.03.004; Boyle AK, 2017, J REPROD IMMUNOL, V119, P62, DOI 10.1016/j.jri.2016.11.008; Cajka T, 2017, ANAL CHEM, V89, P12360, DOI 10.1021/acs.analchem.7b03404; Cajka T, 2017, METHODS MOL BIOL, V1609, P149, DOI 10.1007/978-1-4939-6996-8_14; Cappelletti M, 2016, J LEUKOCYTE BIOL, V99, P67, DOI 10.1189/jlb.3MR0615-272RR; Chen IJ, 2018, FREE RADICAL BIO MED, V115, P113, DOI 10.1016/j.freeradbiomed.2017.11.016; Chou WL, 2007, J BIOL CHEM, V282, P18162, DOI 10.1074/jbc.M702289200; Christmas Peter, 2015, Adv Pharmacol, V74, P163, DOI 10.1016/bs.apha.2015.03.005; Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154; Deressa AT, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1957-0; Di Renzo GC, 2018, BEST PRACT RES CL OB, V52, P13, DOI 10.1016/j.bpobgyn.2018.01.022; Dobierzewska A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175118; Edin ML, 2018, J BIOL CHEM, V293, P3281, DOI 10.1074/jbc.RA117.000298; Enooku K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47216-2; Feingold KR, 2020, ENDOTEXT INTERNET; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Gabbs M, 2015, ADV NUTR, V6, P513, DOI 10.3945/an.114.007732; Gil AM, 2018, REPROD SCI, V25, P967, DOI 10.1177/1933719118756748; Gilman-Sachs A, 2018, J REPROD IMMUNOL, V129, P53, DOI 10.1016/j.jri.2018.06.029; Grapov D, 2019, AM J PHYSIOL-ENDOC M, V317, pE999, DOI 10.1152/ajpendo.00091.2019; Grapov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048852; Headen I, 2017, OBES REV, V18, P350, DOI 10.1111/obr.12486; Helmo FR, 2018, J MATERN-FETAL NEO M, V31, P1227, DOI 10.1080/14767058.2017.1311318; Jelliffe-Pawlowski LL, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.02.019; Jiang SY, 2017, TAIWAN J OBSTET GYNE, V56, P9, DOI 10.1016/j.tjog.2016.07.012; Kahraman S, 2005, J RENAL NUTR, V15, P377, DOI 10.1053/j.jrn.2005.07.004; Karakas SE, 2016, BBA CLIN, V5, P179, DOI 10.1016/j.bbacli.2016.04.003; Kaviarasan S, 2009, J CLIN BIOCHEM NUTR, V45, P1, DOI 10.3164/jcbn.08-266; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Koch E, 2020, TALANTA, V217, DOI 10.1016/j.talanta.2020.121074; Kosa JL, 2011, MATERN CHILD HLTH J, V15, P772, DOI 10.1007/s10995-010-0633-4; La Frano MR, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-018-1450-9; La Frano MR, 2017, NUTR RES, V46, P11, DOI 10.1016/j.nutres.2017.07.006; Lee JW, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040508; Liston A, 2016, TRENDS IMMUNOL, V37, P637, DOI 10.1016/j.it.2016.08.002; Mallat Z, 1999, J CLIN INVEST, V103, P421, DOI 10.1172/JCI3985; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mazaleuskaya LL, 2018, J LIPID RES, V59, P564, DOI 10.1194/jlr.D081414; MAZOR M, 1994, AM J OBSTET GYNECOL, V171, P231, DOI 10.1016/0002-9378(94)90474-X; Menon R, 2008, ACTA OBSTET GYN SCAN, V87, P590, DOI 10.1080/00016340802005126; Menon R, 2011, OBSTET GYNECOL, V118, P121, DOI 10.1097/AOG.0b013e3182204eaa; Midtbo LK, 2015, J NUTR BIOCHEM, V26, P585, DOI 10.1016/j.jnutbio.2014.12.005; Mihalik SJ, 2010, OBESITY, V18, P1695, DOI 10.1038/oby.2009.510; Mosha KS, 2008, J CELL PHYSIOL, V215, P771, DOI 10.1002/jcp.21356; Newman JW, 2004, ENDOCRINOLOGY, V145, P5097, DOI 10.1210/en.2004-0710; Newson J, 2017, CELL REP, V20, P3162, DOI 10.1016/j.celrep.2017.08.098; Ovadia C, 2019, LANCET, V393, P899, DOI 10.1016/S0140-6736(18)31877-4; Pandey M, 2017, INDIAN J MED RES, V146, P316, DOI 10.4103/ijmr.IJMR_1624_14; Pedersen TL, 2018, METHODS MOL BIOL, V1730, P175, DOI 10.1007/978-1-4939-7592-1_13; Peiris HN, 2017, PLACENTA, V54, P95, DOI 10.1016/j.placenta.2016.12.013; Phaniendra A, 2015, INDIAN J CLIN BIOCHE, V30, P11, DOI 10.1007/s12291-014-0446-0; Picklo MJ, 2015, FREE RADICAL BIO MED, V89, P182, DOI 10.1016/j.freeradbiomed.2015.07.152; Raba G, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/8073476; Rajamani A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45005-5; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Sander AL, 2013, J SURG RES, V182, P362, DOI 10.1016/j.jss.2012.10.034; Schymanski EL, 2014, ENVIRON SCI TECHNOL, V48, P2097, DOI 10.1021/es5002105; Shaw GM, 2014, PAEDIATR PERINAT EP, V28, P302, DOI 10.1111/ppe.12125; Shearer GC, 2018, PROSTAG LEUKOTR ESS, V128, P1, DOI 10.1016/j.plefa.2017.10.006; Smedes F, 1999, ANALYST, V124, P1711, DOI 10.1039/a905904k; Smith CJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209579; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Sundrani D, 2017, IUBMB LIFE, V69, P985, DOI 10.1002/iub.1687; Sundrani D, 2013, REPRODUCTION, V145, P401, DOI 10.1530/REP-12-0520; Tomkin GH, 2016, J TRANSL INTERN MED, V4, P73, DOI 10.1515/jtim-2016-0018; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Vadillo-Ortega F, 2005, BJOG-INT J OBSTET GY, V112, P19, DOI 10.1111/j.1471-0528.2005.00579.x; Velez DR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003283; Vinturache A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015258; Wallenstein MB, 2016, J MATERN-FETAL NEO M, V29, P3317, DOI 10.3109/14767058.2015.1124083; Watrous JD, 2019, CELL CHEM BIOL, V26, P433, DOI 10.1016/j.chembiol.2018.11.015; Wei SQ, 2010, OBSTET GYNECOL, V116, P393, DOI 10.1097/AOG.0b013e3181e6dbc0; Weiss A, 2007, FRONT BIOSCI-LANDMRK, V12, P649, DOI 10.2741/2089; Willenberg I, 2016, INFLAMM RES, V65, P133, DOI 10.1007/s00011-015-0897-7	84	9	9	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0239115	10.1371/journal.pone.0239115	http://dx.doi.org/10.1371/journal.pone.0239115			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201881	gold, Green Published			2022-12-26	WOS:000595003900058
J	Daniels, S; Hepworth, J; Moore-Colyer, M				Daniels, Simon; Hepworth, Jacob; Moore-Colyer, Meriel			The haybiome: Characterising the viable bacterial community profile of four different hays for horses following different pre-feeding regimens	PLOS ONE			English	Article							HYGIENIC QUALITY; SOAKING; FORAGES; DUST	Respirable dust in conserved forages can pose problems with equid respiratory health, thus soaking (W) and high temperature steaming (HTS) are employed to reduce the levels in hay. The aim of this study was to characterize the viable bacterial community profile of four hays from two different locations in UK following pre-feeding wetting regimens. Hypothesis: (1) Viable microbial community profile of hays will not differ between different pre-feeding regimens. (2) Hay type and location will not influence microbial community profile. Replicates of each of the four hays were subjected to dry (D), HTS conducted in a HG600, W by submergence in 45 L tap water, 16 degrees C for 12 hours. From each post-treated hay, 100 g samples were chopped and half (n = 36) treated with Propidium monoazide dye, the remaining half untreated. Bacterial DNA were extracted for profiling the V4-V5 region of 16S rRNA gene from all 72 samples, then sequenced on the Illumina MiSeq platform. Bioinformatics were conducted using QIIME pipeline (v1.9.1). Linear discriminate analysis effect size (LEfSe) was used to identify differences in operational taxonomic units and predicted metabolic pathways between hays and regimens. HTS reduced proportions of microbiota compared to W and D hay (P < 0.001, df 3, F 13.91), viability was reduced within regimens (P = 0.017, df 1, F 5.73). Soaking reduced diversity within and between regimens. Core bacterial communities differed between hays and regimens, however pre-feeding regimen had the greatest effect on the bacterial community profile. W and HTS reduced viable bacteria (P< 0.05) known to cause respiratory disease, for HTS both respiratory and dental disease, with the greatest reductions overall from HTS without reducing bacterial diversity. Soaking increased Gram-negative bacteria and reduced bacterial diversity. Collectively these findings add to a body of evidence that suggest HTS is the most suitable pre-feeding regimen of hay for equid health.	[Daniels, Simon; Hepworth, Jacob; Moore-Colyer, Meriel] Royal Agr Univ, Sch Equine Management & Sci, Cirencester, Glos, England		Daniels, S (corresponding author), Royal Agr Univ, Sch Equine Management & Sci, Cirencester, Glos, England.	Simon.daniels@rau.ac.uk		Daniels, Simon/0000-0001-5270-0218	Haygain Ltd	Haygain Ltd	This study was funded by Haygain Ltd https://haygain.co.uk/.Jacob Hepworth was funded by Haygain Ltd through a studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afrikanova Tatiana, 2013, PLoS One, V8, pe54166, DOI 10.1371/journal.pone.0054166; Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2014, DIABETES CARE, V38, pS1; Argo CM, 2015, VET J, V206, P170, DOI 10.1016/j.tvjl.2015.07.027; Berry D, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01408; Blackman M, 1998, ANIM SCI, V66, P745, DOI 10.1017/S1357729800009334; Blumerich CA, 2012, P ANN ACVIM C; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Comeau AM, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00127-16; Dauvillier J, 2019, J VET INTERN MED, V33, P968, DOI 10.1111/jvim.15397; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Ellis RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054783; Emerson JB, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0285-3; Gao X, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1670-4; Harris PA, 2017, ANIMAL, V11, P958, DOI 10.1017/S1751731116002469; KAMPHEUS J, 1991, J EQUINE VET SCI, V11, P36, DOI 10.1016/S0737-0806(06)81245-1; Kamphues J, 2004, LECT EXERCISES ANI S, V10; Kennedy R, 2016, VET RES, V47, DOI 10.1186/s13567-016-0333-1; King L, 2012, THESIS; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kumar SS, 2019, MICROBIOL-SGM, V165, P593, DOI 10.1099/mic.0.000786; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee KCY, 2013, APPL ENVIRON MICROB, V79, P2484, DOI 10.1128/AEM.03333-12; Li R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02516-3; Longland AC, 2011, VET REC, V168, DOI 10.1136/vr.d157; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; McGorum BC, 2015, VET RES, V46, DOI 10.1186/s13567-015-0143-x; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; Mercier C, 2013, SUMATRA SUMACLUSTFAS; Moore-Colyer M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227151; Moore-Colyer MJS, 2016, J EQUINE VET SCI, V39, P62, DOI 10.1016/j.jevs.2015.09.006; Moore-Colyer MJS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114079; MooreColyer MJS, 1996, ANIM SCI, V63, P337, DOI 10.1017/S1357729800014892; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Ranjani A, 2016, ARAB J SCI ENG, V41, P25, DOI 10.1007/s13369-015-1782-y; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Roux-Michollet D, 2008, SOIL BIOL BIOCHEM, V40, P1836, DOI 10.1016/j.soilbio.2008.03.007; Russell A. D., 2003, Science Progress, V86, P115, DOI 10.3184/003685003783238699; Salem SE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26930-3; Salguero MV, 2019, EXP THER MED, V18, P3461, DOI 10.3892/etm.2019.7943; Scaturro M, 2016, DIAGN MICR INFEC DIS, V85, P283, DOI 10.1016/j.diagmicrobio.2016.04.009; Schoster A, 2016, EQUINE VET J, V48, P595, DOI 10.1111/evj.12479; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Seguin V, 2010, GRASS FORAGE SCI, V65, P304, DOI 10.1111/j.1365-2494.2010.00751.x; Seguin V, 2012, J SCI FOOD AGR, V92, P975, DOI 10.1002/jsfa.4680; Tian SN, 2017, WATER-SUI, V9, DOI 10.3390/w9030166; Wang Y, 2016, BIOINFORMATICS, V32, P3469, DOI 10.1093/bioinformatics/btw507; Warr E. M., 1993, Equine Veterinary Education, V5, P169, DOI 10.1111/j.2042-3292.1993.tb01031.x; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Winther L, 2010, VET J, V186, P358, DOI 10.1016/j.tvjl.2009.08.026	53	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242373	10.1371/journal.pone.0242373	http://dx.doi.org/10.1371/journal.pone.0242373			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201929	Green Published, gold, Green Accepted			2022-12-26	WOS:000595003900003
J	Li, YS; Dubick, MA; Yang, ZS; Barr, JL; Gremmer, BJ; Lucas, ML; Necsoiu, C; Jordan, BS; Batchinsky, AI; Cancio, LC				Li, Yansong; Dubick, Michael A.; Yang, Zhangsheng; Barr, Johnny L.; Gremmer, Brandon J.; Lucas, Michael L.; Necsoiu, Corina; Jordan, Bryan S.; Batchinsky, Andriy, I; Cancio, Leopoldo C.			Distal organ inflammation and injury after resuscitative endovascular balloon occlusion of the aorta in a porcine model of severe hemorrhagic shock	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION; MASSIVE HEMORRHAGE; THORACOTOMY; REBOA; DYSFUNCTION; MANAGEMENT; CYTOKINES; SURVIVAL; LUNG; RAT	Background and objective Resuscitative Endovascular Balloon Occlusion of Aorta (REBOA) has emerged as a potential life-saving maneuver for the management of non-compressible torso hemorrhage in trauma patients. Complete REBOA (cREBOA) is inherently associated with the burden of ischemia reperfusion injury (IRI) and organ dysfunction. However, the distal organ inflammation and its association with organ injury have been little investigated. This study was conducted to assess these adverse effects of cREBOA following massive hemorrhage in swine. Methods Spontaneously breathing and consciously sedated Sinclair pigs were subjected to exponential hemorrhage of 65% total blood volume over 60 minutes. Animals were randomized into 3 groups (n = 7): (1) Positive control (PC) received immediate transfusion of shed blood after hemorrhage, (2) 30min-cREBOA (A30) received Zone 1 cREBOA for 30 minutes, and (3) 60min-cREBOA (A60) given Zone 1 cREBOA for 60 minutes. The A30 and A60 groups were followed by resuscitation with shed blood post-cREBOA and observed for 4h. Metabolic and hemodynamic effects, coagulation parameters, inflammatory and end organ consequences were monitored and assessed. Results Compared with 30min-cREBOA, 60min-cREBOA resulted in (1) increased IL-6, TNF-alpha, and IL-1 beta in distal organs (kidney, jejunum, and liver) (p < 0.05) and decreased reduced glutathione in kidney and liver (p < 0.05), (2) leukopenia, neutropenia, and coagulopathy (p < 0.05), (3) blood pressure decline (p < 0.05), (4) metabolic acidosis and hyperkalemia (p < 0.05), and (5) histological injury of kidney and jejunum (p < 0.05) as well as higher levels of creatinine, AST, and ALT (p < 0.05). Conclusion 30min-cREBOA seems to be a feasible and effective adjunct in supporting central perfusion during severe hemorrhage. However, prolonged cREBOA (60min) adverse effects such as distal organ inflammation and injury must be taken into serious consideration.	[Li, Yansong; Yang, Zhangsheng; Gremmer, Brandon J.; Lucas, Michael L.; Necsoiu, Corina; Jordan, Bryan S.; Batchinsky, Andriy, I] US Army Inst Surg Res, Dept Expeditionary Crit Care Res, Ft Sam Houston, TX 78234 USA; [Dubick, Michael A.; Barr, Johnny L.] US Army Inst Surg Res, Dept Damage Control Resuscitat, Ft Sam Houston, TX USA; [Cancio, Leopoldo C.] US Army Inst Surg Res, US Army Burn Ctr, Ft Sam Houston, TX USA	United States Department of Defense; United States Army; United States Department of Defense; United States Army; United States Department of Defense; United States Army	Li, YS (corresponding author), US Army Inst Surg Res, Dept Expeditionary Crit Care Res, Ft Sam Houston, TX 78234 USA.	Yansong.li.ctr@mail.mil			Telemedicine and Advanced Technologies Research Center, Fort Detrick, MD; Prytime Medical; Geneva Foundation, Tacoma, WA; US Army Medical Research and Development Command	Telemedicine and Advanced Technologies Research Center, Fort Detrick, MD; Prytime Medical; Geneva Foundation, Tacoma, WA; US Army Medical Research and Development Command(United States Department of DefenseUnited States ArmyUnited States Army Medical Research & Development Command (USAMRDC))	This study was funded in part of a grant by the Telemedicine and Advanced Technologies Research Center, Fort Detrick, MD, to Prytime Medical, Inc., Boerne, TX, and via a subcontract between Prytime Medical and the Geneva Foundation, Tacoma, WA, for the work performed at the US Army Institute of Surgical Research. Funding was also provided by the US Army Medical Research and Development Command.	[Anonymous], 2014, Obesity (Silver Spring), V22 Suppl 2, pS40, DOI 10.1002/oby.20822; Ardizzone G, 2006, TRANSPL P, V38, P1076, DOI 10.1016/j.transproceed.2006.02.011; Armutcu F, 2019, INFLAMM RES, V68, P825, DOI 10.1007/s00011-019-01271-7; Avaro JP, 2011, J TRAUMA, V71, P720, DOI 10.1097/TA.0b013e318221a94a; BABBS CF, 1987, RESUSCITATION, V15, P37, DOI 10.1016/0300-9572(87)90096-7; Barie PS, 2009, SURG INFECT, V10, P369, DOI 10.1089/sur.2009.9935; Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Burns JW, 2011, J TRAUMA, V71, P148, DOI 10.1097/TA.0b013e3181eaaf6b; Butler FK Jr, 2018, J SPEC OPER MED, V18, P37; Cannistra M, 2016, INT J SURG, V33, pS57, DOI 10.1016/j.ijsu.2016.05.050; Colletti LM, 2001, SHOCK, V16, P312, DOI 10.1097/00024382-200116040-00014; Cruz RJ, 2004, EUR SURG RES, V36, P172, DOI 10.1159/000077260; Cuzick LM, 2011, THORACO-ABDOMINAL AORTA: SURGICAL AND ANESTHETIC MANAGEMENT, P65; Davenport A, 2017, KIDNEY INT, V92, P1058, DOI 10.1016/j.kint.2017.04.048; Davidson AJ, 2017, J TRAUMA ACUTE CARE, V83, P139, DOI 10.1097/TA.0000000000001502; Deftereos S, 2014, MED CHEM, V10, P653, DOI 10.2174/1573406410666140806103651; DUNN EL, 1982, ANN EMERG MED, V11, P238, DOI 10.1016/S0196-0644(82)80090-5; El-Abdellati E, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-8; Eliason JL, 2021, ANN SURG, V274, pE54, DOI 10.1097/SLA.0000000000003408; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; GarciaCriado FJ, 1997, TRANSPLANTATION, V64, P594, DOI 10.1097/00007890-199708270-00008; GELMAN S, 1995, ANESTHESIOLOGY, V82, P1026, DOI 10.1097/00000542-199504000-00027; Georges Q, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2076-z; Gourdin MJ, 2009, EUR J ANAESTH, V26, P537, DOI 10.1097/EJA.0b013e328324b7c2; HILL GE, 1995, J CARDIOTHOR VASC AN, V9, P515, DOI 10.1016/S1053-0770(05)80133-8; Hoehn MR, 2019, J TRAUMA ACUTE CARE, V86, P79, DOI 10.1097/TA.0000000000002075; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; ING VW, 1984, CAN FAM PHYSICIAN, V30, P1835; Jason Pasley U, 2014, RESUSCITATIVE ENDOVA; Kauvar DS, 2019, J SURG RES, V236, P247, DOI 10.1016/j.jss.2018.11.038; Kheirabadi BS, 2009, J TRAUMA, V67, P450, DOI 10.1097/TA.0b013e3181ac0c99; Kragh JF, 2009, ANN SURG, V249, P1, DOI 10.1097/SLA.0b013e31818842ba; Lee SA, 2018, AM J KIDNEY DIS, V72, P846, DOI 10.1053/j.ajkd.2018.03.028; Lelubre C, 2018, NAT REV NEPHROL, V14, P417, DOI 10.1038/s41581-018-0005-7; Levin A, 2010, SOUTH AFR J ANAESTH, V16, P62, DOI 10.1080/22201173.2010.10872666; Li JT, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-018-1199-4; Li X, 2009, CURR OPIN CRIT CARE, V15, P481, DOI 10.1097/MCC.0b013e328332f69e; Maggi G, 2012, Case Rep Crit Care, V2012, P603849, DOI 10.1155/2012/603849; Nunez RM, 2017, EUR J TRAUMA EMERG S, V43, P281, DOI 10.1007/s00068-017-0763-0; Marik PE, 2013, CRIT CARE, V17, DOI 10.1186/cc12514; Markov NP, 2013, SURGERY, V153, P848, DOI 10.1016/j.surg.2012.12.001; Meng M, 2017, CURR OPIN CRIT CARE, V23, P143, DOI 10.1097/MCC.0000000000000386; Mitteldorf C, 1998, SHOCK, V10, P141, DOI 10.1097/00024382-199808000-00010; Morrison JJ, 2014, J SURG RES, V191, P423, DOI 10.1016/j.jss.2014.04.012; Morrison JJ, 2014, SHOCK, V41, P130, DOI 10.1097/SHK.0000000000000085; Morrison JJ, 2012, J SURG RES, V177, P341, DOI 10.1016/j.jss.2012.04.035; Park TS, 2015, J TRAUMA ACUTE CARE, V79, P930, DOI 10.1097/TA.0000000000000877; Patel A, 2015, CURR OPIN CRIT CARE, V21, P586, DOI 10.1097/MCC.0000000000000256; Peoc'h K, 2018, CLIN CHEM LAB MED, V56, P373, DOI 10.1515/cclm-2017-0291; Reva VA, 2018, EUR J TRAUMA EMERG S, V44, P511, DOI 10.1007/s00068-016-0732-z; Sadeghi M, 2018, INJURY, V49, P2132, DOI 10.1016/j.injury.2018.09.052; SANKARAN S, 1975, J TRAUMA, V15, P290, DOI 10.1097/00005373-197504000-00005; Scaravilli V, 2016, ANESTHESIOLOGY, V124, P674, DOI 10.1097/ALN.0000000000000995; Scott DJ, 2013, J TRAUMA ACUTE CARE, V75, P122, DOI 10.1097/TA.0b013e3182946746; Slaughter AL, 2018, SHOCK, V49, P580, DOI 10.1097/SHK.0000000000000948; Stannard A, 2013, J TRAUMA ACUTE CARE, V74, P830, DOI 10.1097/TA.0b013e31827a3704; Stannard A, 2011, J TRAUMA, V71, P1869, DOI 10.1097/TA.0b013e31823fe90c; Tibbits EM, 2018, J TRAUMA ACUTE CARE, V85, P101, DOI 10.1097/TA.0000000000001858; van der Burg BLS, 2018, EUR J TRAUMA EMERG S, V44, P535, DOI 10.1007/s00068-018-0959-y; VIJ D, 1983, SURGERY, V94, P554; Wadei HM, 2016, AM J TRANSPLANT, V16, P850, DOI 10.1111/ajt.13527; Welborn MB, 2000, CRIT CARE MED, V28, P3191, DOI 10.1097/00003246-200009000-00013; White JM, 2011, SURGERY, V150, P400, DOI 10.1016/j.surg.2011.06.010; Zhang JX, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2040-y; ZHANG P, 1995, SHOCK, V4, P262, DOI 10.1097/00024382-199510000-00006	65	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242450	10.1371/journal.pone.0242450	http://dx.doi.org/10.1371/journal.pone.0242450			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201908	gold, Green Published			2022-12-26	WOS:000595003900002
J	Sun, MN; Gao, JL; Meng, T; Liu, SH; Chen, HY; Liu, Q; Xing, XS; Zhao, CY; Luo, Y				Sun, Manni; Gao, Jinlan; Meng, Tao; Liu, Shenghuan; Chen, Haiying; Liu, Qi; Xing, Xuesha; Zhao, Chenyang; Luo, Yang			Cyclin G2 upregulation impairs migration, invasion, and network formation through RNF123/Dvl2/JNK signaling in the trophoblast cell line HTR8/SVneo, a possible role in preeclampsia	FASEB JOURNAL			English	Article						CCNG2; Dvl2; RNF123; trophoblast; Wnt; PCP signaling	E3 UBIQUITIN LIGASE; BETA-CATENIN; C-JUN; EXPRESSION; PROTEIN; KINASE; CANCER; PHOSPHORYLATION; PROGRESSION; RESISTANCE	Disruption of extravillous trophoblast (EVT) migration and invasion is considered to be responsible for pathological placentation in preeclampsia (PE). Cyclin G2 (CCNG2) is an atypical cyclin that inhibits cell cycle progression. However, its biological function and underlying molecular mechanism in PE are poorly understood. In this study, clinical data demonstrated that CCNG2 was significantly upregulated in PE placenta and associated with invasive EVT dysfunction. Additionally, Ccng2 knockout led to an attenuation of PE-like symptoms in the PE mouse model produced via treatment with NG-nitro-L-arginine methyl ester (L-NAME). In vitro, CCNG2 inhibited the migration, invasion, and endothelial-like network formation of human trophoblast cell line HTR8/SVneo. Mechanically, CCNG2 suppressed JNK-dependent Wnt/PCP signaling and its downstream indicators including epithelial-to-mesenchymal transition (EMT) markers and matrix metalloproteinases (MMPs) via promoting the polyubiquitination degradation of dishevelled 2 (Dvl2) protein in HTR8/SVneo cells. We also discovered that the E3 ligase Ring finger protein 123 (RNF123), as a novel CCNG2 target among HTR8/SVneo cells, interacted with Dvl2 and participated in CCNG2-induced polyubiquitination degradation of Dvl2. Moreover, we verified that the treatment of HTR8/SVneo cells with RNF123-specific siRNA improved polyubiquitination-induced degradation of Dvl2 and the activity of Wnt/PCP-JNK signaling mediated by CCNG2. Taken together, our results reveal that the CCNG2/RNF123/Dvl2/JNK axis may be involved in the pathogenesis and progression of PE through trophoblastic cell function modulation, thus probably providing us with new therapeutic strategies for PE treatment.	[Sun, Manni; Gao, Jinlan; Liu, Shenghuan; Liu, Qi; Xing, Xuesha; Zhao, Chenyang; Luo, Yang] China Med Univ, Sch Life Sci, Res Ctr Med Genom, Key Lab Med Cell Biol,Minist Educ, Shenyang 110000, Liaoning, Peoples R China; [Meng, Tao; Chen, Haiying] China Med Univ, Affiliated Hosp 1, Dept Obstet, Shenyang, Peoples R China	China Medical University; China Medical University	Luo, Y (corresponding author), China Med Univ, Sch Life Sci, Res Ctr Med Genom, Key Lab Med Cell Biol,Minist Educ, Shenyang 110000, Liaoning, Peoples R China.	yluo@cmu.edu.cn		sun, manni/0000-0001-5823-6225	Foundation of Liaoning Educational Committee [LZDK201703, JC2019031]; National Natural Science Foundation of China [81871173]	Foundation of Liaoning Educational Committee; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially granted by the Foundation of Liaoning Educational Committee (contract grant numbers: LZDK201703 to Yang Luo and JC2019031 to Jinlan Gao) and the National Natural Science Foundation of China (contract grant numbers: 81871173 to Tao Meng).	Aguilar V, 2010, ENDOCRINOLOGY, V151, P5247, DOI 10.1210/en.2010-0461; ALBERTS AS, 1993, P NATL ACAD SCI USA, V90, P388, DOI 10.1073/pnas.90.2.388; Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; [Anonymous], OBSTET GYNECOL, V133, P211; Bennin DA, 2002, J BIOL CHEM, V277, P27449, DOI 10.1074/jbc.M111693200; Burton GJ, 2017, PLACENTA, V56, P14, DOI 10.1016/j.placenta.2017.01.130; Chaturvedi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047558; Davies M, 2005, J CELL BIOCHEM, V95, P918, DOI 10.1002/jcb.20458; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Ding XY, 2015, PLACENTA, V36, P1442, DOI 10.1016/j.placenta.2015.10.014; Ding Y, 2013, J BIOL CHEM, V288, P8289, DOI 10.1074/jbc.M112.433185; Fisher RP, 1997, CURR OPIN GENET DEV, V7, P32, DOI 10.1016/S0959-437X(97)80106-2; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao C, 2010, CELL SIGNAL, V22, P717, DOI 10.1016/j.cellsig.2009.11.021; Gao JL, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0973-2; Gates KC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174976; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Habas Raymond, 2005, J Biol, V4, P2, DOI 10.1186/jbiol22; Helmbrecht GD, 1996, AM J OBSTET GYNECOL, V175, P800, DOI 10.1016/S0002-9378(96)80002-0; Horne MC, 1996, J BIOL CHEM, V271, P6050, DOI 10.1074/jbc.271.11.6050; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Iorns E, 2008, CANCER CELL, V13, P91, DOI 10.1016/j.ccr.2008.01.001; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Kafka A, 2014, CROAT MED J, V55, P459, DOI 10.3325/cmj.2014.55.459; Kamura T, 2004, NAT CELL BIOL, V6, P1229, DOI 10.1038/ncb1194; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kasten M, 2001, ONCOGENE, V20, P1832, DOI 10.1038/sj.onc.1204295; Khanna R, 2018, FEBS J, V285, P2243, DOI 10.1111/febs.14477; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Kravtsova-Ivantsiv Y, 2015, CELL, V161, P333, DOI 10.1016/j.cell.2015.03.001; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; Lee HJ, 2015, ELIFE, V4, DOI 10.7554/eLife.08142; Lee H, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.143107; Lerner UH, 2015, J INTERN MED, V277, P630, DOI 10.1111/joim.12368; Li S, 2019, INT J BIOL SCI, V15, P544, DOI 10.7150/ijbs.30297; Li XJ, 2017, CELL PHYSIOL BIOCHEM, V44, P1741, DOI 10.1159/000485780; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Lin SS, 2018, CANCERS, V10, DOI 10.3390/cancers10080272; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Monaghan D, 2014, BIOCHEM BIOPH RES CO, V443, P761, DOI 10.1016/j.bbrc.2013.12.041; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Motta C, 2015, REPROD DOMEST ANIM, V50, P611, DOI 10.1111/rda.12536; Muralikrishna B, 2012, MOL CELL BIOCHEM, V365, P323, DOI 10.1007/s11010-012-1272-4; Musa J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12071-2; Nadeem U, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119065; Naito Y, 2013, CELL CYCLE, V12, P1773, DOI 10.4161/cc.24878; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Peng B, 2015, ENDOCRINOLOGY, V156, P2269, DOI 10.1210/en.2014-1871; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Roskoski R, 2019, PHARMACOL RES, V139, P471, DOI 10.1016/j.phrs.2018.11.035; Ruan C, 2021, AUTOPHAGY, V17, P1426, DOI 10.1080/15548627.2020.1763019; Salem M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081810; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Sharma M, 2018, CELL SIGNAL, V47, P52, DOI 10.1016/j.cellsig.2018.03.004; Shi XY, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20194513; Shiozawa S, 2009, CELL CYCLE, V8, P1539, DOI 10.4161/cc.8.10.8411; Sonderegger S, 2007, PLACENTA, V28, pS97, DOI 10.1016/j.placenta.2006.11.003; Thacker G, 2020, J CELL BIOCHEM, V121, P2839, DOI 10.1002/jcb.29516; Ujita M, 2018, PREGNANCY HYPERTENS, V13, P225, DOI 10.1016/j.preghy.2018.06.022; Uuskula L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049248; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Vilotic A, 2019, EXCLI J, V18, P1007, DOI 10.17179/excli2019-1630; Wald JH, 2017, ONCOGENE, V36, P5158, DOI 10.1038/onc.2017.126; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wei W, 2012, MOL CELL BIOL, V32, P3903, DOI 10.1128/MCB.00251-12; Weitzman Jonathan B, 2005, J Biol, V4, P1, DOI 10.1186/jbiol21; Whittaker SR, 2017, PHARMACOL THERAPEUT, V173, P83, DOI 10.1016/j.pharmthera.2017.02.008; Winn VD, 2007, ENDOCRINOLOGY, V148, P1059, DOI 10.1210/en.2006-0683; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yue LM, 2005, ENDOCRINOLOGY, V146, P2424, DOI 10.1210/en.2004-1605; Zhang DF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00255; Zhao CY, 2020, J CELL MOL MED, V24, P2749, DOI 10.1111/jcmm.14946; Zheng Q, 2018, J CELL BIOCHEM, V119, P6442, DOI 10.1002/jcb.26648; Zimmermann M, 2016, CELL CYCLE, V15, P3278, DOI 10.1080/15384101.2016.1243189; Zuckerwise L, 2016, ONCOTARGET, V7, P38398, DOI 10.18632/oncotarget.9534	80	1	1	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001559RR	http://dx.doi.org/10.1096/fj.202001559RR		NOV 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33205477				2022-12-26	WOS:000592661900001
J	Kataoka, H; Mochizuki, T; Iwadoh, K; Ushio, Y; Kawachi, K; Watanabe, S; Watanabe, K; Akihisa, T; Makabe, S; Manabe, S; Sato, M; Iwasa, N; Yoshida, R; Sawara, Y; Hanafusa, N; Tsuchiya, K; Nitta, K				Kataoka, Hiroshi; Mochizuki, Toshio; Iwadoh, Kazuhiro; Ushio, Yusuke; Kawachi, Keiko; Watanabe, Saki; Watanabe, Kentaro; Akihisa, Taro; Makabe, Shiho; Manabe, Shun; Sato, Masayo; Iwasa, Naomi; Yoshida, Rie; Sawara, Yukako; Hanafusa, Norio; Tsuchiya, Ken; Nitta, Kosaku			Visceral to subcutaneous fat ratio as an indicator of a >= 30% eGFR decline in chronic kidney disease	PLOS ONE			English	Article							OBESITY-RELATED GLOMERULOPATHY; METABOLIC SYNDROME; CLINICAL-SIGNIFICANCE; JAPANESE PATIENTS; ADIPOSE-TISSUE; RENAL-DISEASE; RISK; ACCUMULATION; ADIPONECTIN; INSULIN	Whether the visceral-to-subcutaneous fat ratio (V/S ratio) is associated with renal prognosis in patients with chronic kidney disease (CKD) remains unclear. Furthermore, little is known about the effect of sex and the absolute amount of visceral fat accumulation such as visceral fat area (VFA) >= 100 cm(2) on the V/S ratio in relation to renal prognosis. In this study, 200 patients with CKD were evaluated for renal prognosis. Survival analyses and logistic regression analyses were conducted, generating time-series pseudo-R-2 values. The mean and percent change of the pseudo-R-2 values from the 6(th) year to the 10(th) year (6Y-10Y Mean and 6Y-10Y Change, respectively) were calculated for determining the cut-off points for the medium-term renal prognosis. Multivariate Cox regression analysis revealed that the V/S ratio was significantly associated with renal outcomes and that the VFA category (VFA >= 100 cm(2)) had significant interactions with the V/S ratio regarding renal prognosis. The hazard ratio (HR) of the V/S ratio was higher in the sub-cohort of VFA < 100 cm(2) than in the sub-cohort of VFA >= 100 cm(2) (HR: 6.42 vs. 1.00). Regarding sex differences, a strong association was noted between the V/S ratio and renal prognosis in women but not in men (HR: 2.40 vs. 1.10). On the other hand, 6Y-10Y Mean of the pseudo-R-2 values indicated differences in the cut-off points of the V/S ratio between men and women (V/S ratio: 0.75 vs. 0.5). Our findings indicate that it may be clinically meaningful to consider the differences in sex and the amount of VFA >= 100 cm(2) for the V/S ratio in relation to renal outcomes in patients with CKD. The 6Y-10Y Mean of the pseudo-R-2 values contributed to determining the cut-off points of the V/S ratio according to the sex difference.	[Kataoka, Hiroshi; Mochizuki, Toshio; Ushio, Yusuke; Kawachi, Keiko; Watanabe, Saki; Watanabe, Kentaro; Akihisa, Taro; Makabe, Shiho; Manabe, Shun; Sato, Masayo; Iwasa, Naomi; Yoshida, Rie; Sawara, Yukako; Nitta, Kosaku] Tokyo Womens Med Univ, Dept Nephrol, Tokyo, Japan; [Kataoka, Hiroshi; Mochizuki, Toshio] Tokyo Womens Med Univ, Dept Nephrol, Clin Res Div Polycyst Kidney Dis, Tokyo, Japan; [Iwadoh, Kazuhiro; Hanafusa, Norio; Tsuchiya, Ken] Tokyo Womens Med Univ, Dept Blood Purificat, Tokyo, Japan	Tokyo Women's Medical University; Tokyo Women's Medical University; Tokyo Women's Medical University	Kataoka, H; Mochizuki, T (corresponding author), Tokyo Womens Med Univ, Dept Nephrol, Tokyo, Japan.; Kataoka, H; Mochizuki, T (corresponding author), Tokyo Womens Med Univ, Dept Nephrol, Clin Res Div Polycyst Kidney Dis, Tokyo, Japan.	kataoka@twmu.ac.jp; mtoshi@twmu.ac.jp	Iwadoh, Kazuhiro/HDM-0721-2022					Anderson PW, 1996, KIDNEY INT, V50, P745, DOI 10.1038/ki.1996.372; [Anonymous], 2005, Nihon Naika Gakkai Zasshi, V94, P794; Bagby SP, 2004, J AM SOC NEPHROL, V15, P2775, DOI 10.1097/01.ASN.0000141965.28037.EE; Bardes CL, 2012, NEW ENGL J MED, V366, P782, DOI 10.1056/NEJMp1200070; Bosma RJ, 2004, KIDNEY INT, V65, P259, DOI 10.1111/j.1523-1755.2004.00351.x; BRENNER BM, 1983, KIDNEY INT, V23, P647, DOI 10.1038/ki.1983.72; Figueroa AL, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004043; Fukuda T, 2018, J DIABETES INVEST, V9, P396, DOI 10.1111/jdi.12713; Hauber AB, 2016, VALUE HEALTH, V19, P300, DOI 10.1016/j.jval.2016.04.004; Hayashi T, 2003, CIRCULATION, V108, P1718, DOI 10.1161/01.CIR.0000087597.59169.8D; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Hiuge-Shimizu A, 2012, J ATHEROSCLER THROMB, V19, P657, DOI 10.5551/jat.13037; Hiuge-Shimizu A, 2012, ANN MED, V44, P82, DOI 10.3109/07853890.2010.526138; Iglesias P, 2010, NEPHROL DIAL TRANSPL, V25, P2066, DOI 10.1093/ndt/gfq246; Kaess BM, 2012, DIABETOLOGIA, V55, P2622, DOI 10.1007/s00125-012-2639-5; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kataoka H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232885; Kataoka H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010146; Kataoka H, 2019, J PERS MED, V9, DOI 10.3390/jpm9040052; Kataoka H, 2019, J CLIN MED, V8, DOI 10.3390/jcm8122105; Kataoka H, 2019, KIDNEY BLOOD PRESS R, V44, P362, DOI 10.1159/000501021; Kataoka H, 2018, CONTRIB NEPHROL, V195, P20, DOI 10.1159/000486931; Kataoka H, 2012, CLIN EXP NEPHROL, V16, P706, DOI 10.1007/s10157-012-0613-7; Kataoka H, 2011, NEPHROL DIAL TRANSPL, V26, P3937, DOI 10.1093/ndt/gfr139; Kawachi K, 2019, HEART VESSELS, V34, P1440, DOI 10.1007/s00380-019-01375-4; Kim S, 2011, DIABETES CARE, V34, P504, DOI 10.2337/dc10-1364; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2016, KIDNEY INT, V90, P1109, DOI 10.1016/j.kint.2016.08.003; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Miura Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226642; Navaneethan SD, 2013, CLIN J AM SOC NEPHRO, V8, P945, DOI 10.2215/CJN.09870912; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; RIBSTEIN J, 1995, HYPERTENSION, V26, P610, DOI 10.1161/01.HYP.26.4.610; Ryo M, 2014, WORLD J RADIOL, V6, P409, DOI 10.4329/wjr.v6.i7.409; Sacristan JA, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/1471-2288-15-4; Sacristan JA, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-6; Sawara Y, 2009, HEART VESSELS, V24, P199, DOI 10.1007/s00380-008-1107-0; Sharma K, 2009, KIDNEY INT, V76, P145, DOI 10.1038/ki.2009.137; Spoto B, 2016, AM J PHYSIOL-RENAL, V311, pF1087, DOI 10.1152/ajprenal.00340.2016; Tamei N, 2010, INTERNAL MED, V49, P299, DOI 10.2169/internalmedicine.49.2905; Tozawa M, 2007, HYPERTENS RES, V30, P937, DOI 10.1291/hypres.30.937; Ushio Y, 2020, CLIN EXP NEPHROL, V24, P500, DOI 10.1007/s10157-020-01856-1; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wang YT, 2019, CAN J DIABETES, V43, P415, DOI 10.1016/j.jcjd.2018.08.199; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641; Yamanaka Hisashi, 2012, Japan Med Assoc J, V55, P324; Yamashiro K, 2014, EUR J NEUROL, V21, P667, DOI 10.1111/ene.12374; YOSHIDA Y, 1989, KIDNEY INT, V36, P626, DOI 10.1038/ki.1989.239	49	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0241626	10.1371/journal.pone.0241626	http://dx.doi.org/10.1371/journal.pone.0241626			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196670	gold, Green Published			2022-12-26	WOS:000595266800042
J	Sjogren, KG; Olalde, I; Carver, S; Allentoft, ME; Knowles, T; Kroonen, G; Pike, AWG; Schroter, P; Brown, KA; Brown, KR; Harrison, RJ; Bertemes, F; Reich, D; Kristiansen, K; Heyd, V				Sjogren, Karl-Goran; Olalde, Inigo; Carver, Sophie; Allentoft, Morten E.; Knowles, Tim; Kroonen, Guus; Pike, Alistair W. G.; Schroeter, Peter; Brown, Keri A.; Brown, Kate Robson; Harrison, Richard J.; Bertemes, Francois; Reich, David; Kristiansen, Kristian; Heyd, Volker			Kinship and social organization in Copper Age Europe. A cross-disciplinary analysis of archaeology, DNA, isotopes, and anthropology from two Bell Beaker cemeteries	PLOS ONE			English	Article							EARLY BRONZE-AGE; SEX BIAS; MIGRATION; LINGUISTICS; LANGUAGE; MOBILITY; HISTORY; CULTURE; STEPPE	We present a high-resolution cross-disciplinary analysis of kinship structure and social institutions in two Late Copper Age Bell Beaker culture cemeteries of South Germany containing 24 and 18 burials, of which 34 provided genetic information. By combining archaeological, anthropological, genetic and isotopic evidence we are able to document the internal kinship and residency structure of the cemeteries and the socially organizing principles of these local communities. The buried individuals represent four to six generations of two family groups, one nuclear family at the Alburg cemetery, and one seemingly more extended at Irlbach. While likely monogamous, they practiced exogamy, as six out of eight non-locals are women. Maternal genetic diversity is high with 23 different mitochondrial haplotypes from 34 individuals, whereas all males belong to one single Y-chromosome haplogroup without any detectable contribution from Y-chromosomes typical of the farmers who had been the sole inhabitants of the region hundreds of years before. This provides evidence for the society being patrilocal, perhaps as a way of protecting property among the male line, while in-marriage from many different places secured social and political networks and prevented inbreeding. We also find evidence that the communities practiced selection for which of their children (aged 0-14 years) received a proper burial, as buried juveniles were in all but one case boys, suggesting the priority of young males in the cemeteries. This is plausibly linked to the exchange of foster children as part of an expansionist kinship system which is well attested from later Indo-European-speaking cultural groups.	[Sjogren, Karl-Goran; Kristiansen, Kristian] Univ Gothenburg, Dept Hist Studies, Gothenburg, Sweden; [Olalde, Inigo; Reich, David] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Olalde, Inigo] Univ Pompeu Fabra, CSIC, Inst Evolutionary Biol, Barcelona, Spain; [Carver, Sophie; Knowles, Tim; Brown, Kate Robson; Harrison, Richard J.] Univ Bristol, Dept Anthropol & Archaeol, Bristol, Avon, England; [Allentoft, Morten E.] Curtin Univ, Sch Mol & Life Sci, Trace & Environm DNA TrEnD Lab, Perth, WA, Australia; [Allentoft, Morten E.] Univ Copenhagen, GLOBE Inst, Lundbeck Fdn, GeoGenet Ctr, Copenhagen, Denmark; [Kroonen, Guus] Univ Copenhagen, Dept Nord Studies & Linguist, Copenhagen, Denmark; [Kroonen, Guus] Leiden Univ, Ctr Linguist, Leiden, Netherlands; [Pike, Alistair W. G.] Univ Southampton, Dept Archaeol, Southampton, Hants, England; [Schroeter, Peter] Staatssammlung Anthropol & Palaoanat, Munich, Germany; [Brown, Keri A.] Univ Manchester, Manchester Inst Biotechnol, Dept Earth & Environm Sci, Manchester, Lancs, England; [Bertemes, Francois] Martin Luther Univ Halle Wittenberg, Inst Kunstgeschichte & Archaol Europas, Halle, Saale, Germany; [Reich, David] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Reich, David] Howard Hughes Med Inst, Boston, MA 02115 USA; [Heyd, Volker] Univ Helsinki, Dept Cultures Archaeol, Helsinki, Finland	University of Gothenburg; Harvard University; Harvard Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; University of Bristol; Curtin University; Lundbeckfonden; University of Copenhagen; University of Copenhagen; Leiden University; Leiden University - Excl LUMC; University of Southampton; University of Manchester; Martin Luther University Halle Wittenberg; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; University of Helsinki	Kristiansen, K (corresponding author), Univ Gothenburg, Dept Hist Studies, Gothenburg, Sweden.; Heyd, V (corresponding author), Univ Helsinki, Dept Cultures Archaeol, Helsinki, Finland.	kristian.kristiansen@archaeology.gu.se; volker.heyd@helsinki.fi	Olalde, Iñigo/N-6928-2018	Olalde, Iñigo/0000-0002-2660-6807; Heyd, Volker/0000-0002-0889-6513; Kroonen, Guus/0000-0002-3708-0476; Knowles, Timothy/0000-0003-4871-5542; Sjogren, Karl-Goran/0000-0003-1791-3175; Allentoft, Morten/0000-0003-4424-3568	Fritz-Thyssen-Stiftung project [RR8322]; K-G S: Swedish Riksbanken [M16-0455:1]; VHeyd: ERC [788616]	Fritz-Thyssen-Stiftung project; K-G S: Swedish Riksbanken; VHeyd: ERC	FB, RH, KR-B, VH: Fritz-Thyssen-Stiftung project RR8322. KK, K-G S: Swedish Riksbanken grant M16-0455:1. VHeyd: ERC Advanced grant 788616. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; [Anonymous], 2016, LANCET HIV, V3, pE191, DOI 10.1016/S2352-3018(16)30020-0; [Anonymous], 2004, GUIDELINES STANDARDS; Anthony DW, 2017, J ANTHROPOL ARCHAEOL, V48, P134, DOI 10.1016/j.jaa.2017.07.004; Bass W.M., 1987, HUMAN OSTEOLOGY LAB, V2; BERRY AC, 1967, J ANAT, V101, P361; Bertemes F, 2015, 2200 BC CLIMATIC BRE, P561; Bosch T, 2009, THESIS; BREMMER J, 1976, J INDO-EUR STUD, V4, P65; Brothwell DR, 1981, DIGGING BONES, V3rd, DOI [10.1002/ajpa.1330560425, DOI 10.1002/AJPA.1330560425]; Brown KA, 2014, PAST MOBILITIES: ARCHAEOLOGICAL APPROACHES TO MOVEMENT AND MOBILITY, P155; Buikstra JC, 1994, ARKANSAS ARCHAEOLOGI, V44, DOI [10.1073/pnas.91.6.2091, DOI 10.1073/PNAS.91.6.2091]; Cameron CM, 2016, STOLEN PEOPLE CHANGE; Cassidy LM, 2016, P NATL ACAD SCI USA, V113, P368, DOI 10.1073/pnas.1518445113; Chamberlain A, 1994, INTERPRETING HUMAN R; Chenery CA, 2012, RAPID COMMUN MASS SP, V26, P309, DOI 10.1002/rcm.5331; Delbruck B, 1889, INDOGERMANISCHEN VER; Fox R, 1967, ANTHR PERSPECTIVE; Frei KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178834; Friedman J, 1975, MARXIST ANAL SOCIAL, P161; FRIEDRIC.P, 1966, ETHNOLOGY, V5, P1, DOI 10.2307/3772899; Fu Q, 2015, NATURE, V524, P216, DOI 10.1038/nature14558; Furholt M., 2019, P PREHIST SOC, V85, P115, DOI [10.1017/ppr.2019.4, DOI 10.1017/PPR.2019.4]; Gailey CW, 1987, GENDER HIERARCHY STA; Goldberg A, 2017, P NATL ACAD SCI USA, V114, pE3875, DOI 10.1073/pnas.1704442114; Goldberg A, 2017, P NATL ACAD SCI USA, V114, P2657, DOI 10.1073/pnas.1616392114; Green M., 1986, GODS CELTS; Grupe G, 1997, APPL GEOCHEM, V12, P517, DOI 10.1016/S0883-2927(97)00030-9; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haak W, 2008, P NATL ACAD SCI USA, V105, P18226, DOI 10.1073/pnas.0807592105; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hauser D, 1989, EPIGENETIC VARIANTS; Helms Mary W, 1998, ACCESS ORIGINS AFFIN; HETTRICH H, 1985, ANTHROPOL LINGUIST, V27, P453; Heyd V, 2004, BER BAYER BODENDENKM, V43/44, P109; Heyd V, 2007, P PREHIST SOC, V73, P321; Heyd V, 2000, SPATKUPFERZEIT SUDDE; Iversen R, 2017, AM J ARCHAEOL, V121, P511, DOI 10.3764/aja.121.4.0511; Johnson KM, 2016, J ARCHAEOL RES, V24, P75, DOI 10.1007/s10814-015-9086-z; Knipper C, 2017, P NATL ACAD SCI USA, V114, P10083, DOI 10.1073/pnas.1706355114; Knipper C, 2016, AM J PHYS ANTHROPOL, V159, P496, DOI 10.1002/ajpa.22892; Korotayev A, 2019, SOC EVOL HIST, V18, P286, DOI 10.30884/seh/2019.02.15; Kristiansen K, 2005, TRAVELS TRANSMISSION; Kristiansen K, 2017, ANTIQUITY, V91, P334, DOI 10.15184/aqy.2017.17; Lansing JS, 2017, P NATL ACAD SCI USA, V114, P12910, DOI 10.1073/pnas.1706416114; Lazaridis I, 2017, P NATL ACAD SCI USA, V114, pE3873, DOI 10.1073/pnas.1704308114; Levi-Strauss C., 1969, ELEMENTARY STRUCTURE; Lincoln B, 1981, WARRIORS CATTLE STUD; Lipson M, 2017, NATURE, V551, P368, DOI 10.1038/nature24476; Mallory J. P., 2006, OXFORD INTRO PROTO I; Mallory JP., 1989, SEARCH INDO EUROPEAN, DOI DOI 10.1038/nature11698; Mann R., 2016, PHOTOGRAPHIC REGIONA; Massy K., 2017, APPROPRIATING INNOVA, P241; Mathieson I, 2015, NATURE, V528, P499, DOI 10.1038/nature16152; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; Mittnik A, 2019, SCIENCE, V366, P731, DOI 10.1126/science.aax6219; Olalde I, 2019, SCIENCE, V363, P1230, DOI 10.1126/science.aav4040; Olalde I, 2018, NATURE, V555, P190, DOI 10.1038/nature25738; Olalde I, 2015, MOL BIOL EVOL, V32, P3132, DOI 10.1093/molbev/msv181; Olsen BA, 2019, INDO EUROPEAN LANGUA, P145; Olsen BA, 2019, KIN CLAN COMMUNITY P; Omrak A, 2016, CURR BIOL, V26, P270, DOI 10.1016/j.cub.2015.12.019; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pozzi Lucia, 2015, ANN DEMOGRAPHIE HIST, V129, P55, DOI DOI 10.3917/ADH.129.0055; Price T.D., 2004, EUR J ARCHAEOL, V7, P9, DOI [DOI 10.1177/1461957104047992, 10.1177/1461957104047992]; Pronk TC, MOBILITY KINSHIP MAR; Rebay-Salisbury K, 2018, ARCHAEOL AUSTRIACA, P71, DOI 10.1553/archaeologia102s71; Rohland N, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0624; Rowland M., 1980, SETTLEMENT SOC BRIT, P15; Sahajpal DT, 2006, CAN J SURG, V49, P363; Scheuer L., 2000, DEV JUVENILE OSTEOLO; Schroeder H, 2019, P NATL ACAD SCI USA, V116, P10705, DOI 10.1073/pnas.1820210116; Schwarz M, 2008, SAARBRUCKER BEITRAGE; Sjogren KG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155083; Skoglund P, 2013, J ARCHAEOL SCI, V40, P4477, DOI 10.1016/j.jas.2013.07.004; STEIGER RH, 1977, EARTH PLANET SC LETT, V36, P359, DOI 10.1016/0012-821X(77)90060-7; Szemerenyi O, 1977, ACTA IRANICA, V17; Thomsen E, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav8083; Trotter M., 1970, PERSONAL IDENTIFICAT, P71; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW58, DOI 10.1093/nar/gkw233; White T.D., 2005, HUMAN BONE MANUAL, DOI [DOI 10.1016/B978-0-12-088467-4.50018-1, 10.1016/B978-0-12-088467-4.50018-1]; Winterholler B, 2004, THESIS; Zeng TC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04375-6	83	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0241278	10.1371/journal.pone.0241278	http://dx.doi.org/10.1371/journal.pone.0241278			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VP	33196640	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000595266800034
J	Andersen, AB; Bejder, J; Bonne, T; Olsen, NV; Nordsborg, N				Breenfeldt Andersen, Andreas; Bejder, Jacob; Bonne, Thomas; Olsen, Niels Vidiendal; Nordsborg, Nikolai			Repeated Wingate sprints is a feasible high-quality training strategy in moderate hypoxia	PLOS ONE			English	Article							SUPRAMAXIMAL EXERCISE; SKELETAL-MUSCLE; PERFORMANCE; INTERVAL; INTENSITY; ADAPTATIONS; RESPONSES; CAPACITY; TRANSPORT; EXPOSURE	Sprint-interval training (SIT) is efficient at improving maximal aerobic capacity and anaerobic fitness at sea-level and may be a feasible training strategy at altitude. Here, it was evaluated if SIT intensity can be maintained in mild to moderate hypoxia. It was hypothesized that 6 x 30 s Wingate sprint performance with 2 min active rest between sprints can be performed in hypoxic conditions corresponding to similar to 3,000 m of altitude without reducing mean power output (MPO). In a single-blinded, randomized crossover design, ten highly-trained male endurance athletes with a maximal oxygen uptake (VO2max) of 68 +/- 5 mL O-2 x min(-1) x kg(-1) completed 6 x 30 s all-out Wingate cycling sprints separated by two-minute active recovery on four separate days in a hypobaric chamber. The ambient pressure within the chamber on each experimental day was 772 mmHg (similar to 0 m), 679 mmHg (similar to 915 m), 585 mmHg (similar to 2,150 m), and 522 mmHg (similar to 3,050 m), respectively. MPO was not different at sea-level and up to similar to 2,150 m (similar to 1% and similar to 3% non-significant decrements at similar to 915 and similar to 2,150 m, respectively), whereas MPO was similar to 5% lower (P<0.05) at similar to 3,050 m. Temporal differences between altitudes was not different for peak power output (PPO), despite a main effect of altitude. In conclusion, repeated Wingate exercise can be completed by highly-trained athletes at altitudes up to similar to 2,150 m without compromising MPO or PPO. In contrast, MPO was compromised in hypobaric hypoxia corresponding to similar to 3,050 m. Thus, SIT may be an efficient strategy for athletes sojourning to moderate altitude and aiming to maintain training quality.	[Breenfeldt Andersen, Andreas; Bejder, Jacob; Bonne, Thomas; Nordsborg, Nikolai] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Olsen, Niels Vidiendal] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Olsen, Niels Vidiendal] Rigshosp, Dept Neuroanesteshia, Neurosci Ctr, Copenhagen Univ Hosp, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Nordsborg, N (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark.	nbn@nexs.ku.dk	; Nordsborg, Nikolai/O-6173-2014	Andersen, Andreas Breenfeldt/0000-0003-3361-3009; Nordsborg, Nikolai/0000-0001-7077-9265; Bejder, Jacob/0000-0002-9698-9188; Bonne, Thomas/0000-0002-4714-1981				Alvarez-Herms J, 2015, PHYSIOL BEHAV, V143, P35, DOI 10.1016/j.physbeh.2015.02.020; [Anonymous], 2020, LANCET EDITORIAL, V2, pE268, DOI 10.1016/S2589-7500(20)30113-8; [Anonymous], 2015, EXP MOL MED; BALSOM PD, 1994, ACTA PHYSIOL SCAND, V152, P279, DOI 10.1111/j.1748-1716.1994.tb09807.x; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; BLAND JM, 1994, BRIT MED J, V308, P896, DOI 10.1136/bmj.308.6933.896; Bowtell JL, 2014, J SCI MED SPORT, V17, P399, DOI 10.1016/j.jsams.2013.05.016; Brocherie F, 2017, SPORTS MED, V47, P1651, DOI 10.1007/s40279-017-0685-3; Brocherie F, 2016, MED SCI SPORT EXER, V48, P1570, DOI 10.1249/MSS.0000000000000937; Buchheit M, 2013, SPORTS MED, V43, P313, DOI 10.1007/s40279-013-0029-x; Burgomaster KA, 2005, J APPL PHYSIOL, V98, P1985, DOI 10.1152/japplphysiol.01095.2004; Burgomaster KA, 2008, J PHYSIOL-LONDON, V586, P151, DOI 10.1113/jphysiol.2007.142109; Calbet JAL, 2003, J APPL PHYSIOL, V94, P668, DOI 10.1152/japplphysiol.00128.2002; Calbet JAL, 2015, J PHYSIOL-LONDON, V593, P4649, DOI 10.1113/JP270408; Christensen PM, 2011, MED SCI SPORT EXER, V43, P1716, DOI 10.1249/MSS.0b013e318211c01a; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Constantini K, 2017, HIGH ALT MED BIOL, V18, P93, DOI 10.1089/ham.2017.0020; Faiss R, 2013, BRIT J SPORT MED, V47, P45, DOI 10.1136/bjsports-2013-092741; Faiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056522; Galvin Harvey M, 2013, Br J Sports Med, V47 Suppl 1, pi74, DOI 10.1136/bjsports-2013-092826; Gatterer H, 2018, J SPORT SCI MED, V17, P339; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gibala MJ, 2013, NESTLE NUTR WORKS SE, V76, P51, DOI 10.1159/000350256; Girard O, 2017, EUR J APPL PHYSIOL, V117, P2171, DOI 10.1007/s00421-017-3705-y; Girard O, 2017, SPORTS MED, V47, P1931, DOI 10.1007/s40279-017-0733-z; Girard O, 2011, SPORTS MED, V41, P673, DOI 10.2165/11590550-000000000-00000; Goods PSR, 2014, INT J SPORT PHYSIOL, V9, P857, DOI 10.1123/ijspp.2013-0423; Gore CJ, 2001, ACTA PHYSIOL SCAND, V173, P275, DOI 10.1046/j.1365-201X.2001.00906.x; Gutierrez A, 2003, J SPORT MED PHYS FIT, V43, P554; Haseler LJ, 1999, J APPL PHYSIOL, V86, P2013, DOI 10.1152/jappl.1999.86.6.2013; Hopkins WG, 1997, NEW VIEW STAT SCALE; Jacob C, 2004, EUR J APPL PHYSIOL, V91, P35, DOI 10.1007/s00421-003-1002-4; Kon M, 2015, GROWTH HORM IGF RES, V25, P121, DOI 10.1016/j.ghir.2015.03.002; MacDougall JD, 1998, J APPL PHYSIOL, V84, P2138, DOI 10.1152/jappl.1998.84.6.2138; MCLELLAN TM, 1993, EUR J APPL PHYSIOL O, V66, P409, DOI 10.1007/BF00599613; MCLELLAN TM, 1990, EUR J APPL PHYSIOL O, V60, P155, DOI 10.1007/BF00846037; Millet GP, 2010, SPORTS MED, V40, P1, DOI 10.2165/11317920-000000000-00000; Mohr M, 2007, AM J PHYSIOL-REG I, V292, pR1594, DOI 10.1152/ajpregu.00251.2006; Montero D, 2017, INT J SPORT PHYSIOL, V12, P161, DOI 10.1123/ijspp.2015-0691; Nordsborg NB, 2012, J APPL PHYSIOL, V112, P2027, DOI 10.1152/japplphysiol.01353.2011; Oguri K, 2008, J SPORT SCI MED, V7, P512; Place N, 2015, P NATL ACAD SCI USA, V112, P15492, DOI 10.1073/pnas.1507176112; Puype J, 2013, MED SCI SPORT EXER, V45, P2166, DOI 10.1249/MSS.0b013e31829734ae; Smith KJ, 2010, EUR J APPL PHYSIOL, V109, P989, DOI 10.1007/s00421-010-1444-4; SPRIET LL, 1989, J APPL PHYSIOL, V66, P8, DOI 10.1152/jappl.1989.66.1.8; Stepto NK, 1999, MED SCI SPORT EXER, V31, P736, DOI 10.1097/00005768-199905000-00018; Takei N, 2020, J PHYS FIT SPORTS ME, V9, P31, DOI DOI 10.7600/JPFSM.9.31; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Weyand PG, 1999, J APPL PHYSIOL, V86, P2059, DOI 10.1152/jappl.1999.86.6.2059; Willis SJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00846; WITHERS RT, 1991, EUR J APPL PHYSIOL, V63, P354, DOI 10.1007/BF00364462; Wyatt FB, 2014, J EXERC PHYSL ONLINE, V17, P91	52	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242439	10.1371/journal.pone.0242439	http://dx.doi.org/10.1371/journal.pone.0242439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186393	Green Published, gold			2022-12-26	WOS:000593949800055
J	Lee, JH; Lee, DH				Lee, Jae Hee; Lee, Duk Hee			Acute chemical ingestion in the under 19 population in South Korea: A brief report	PLOS ONE			English	Article							ETHYLENE-GLYCOL	Background Most people are frequently exposed to chemicals and chemical products. This study provides basic information on the outcomes of acute chemical ingestion of patients aged under 19 years. Methods Patients aged under 19 years who had ingested chemicals and thus visited the emergency department between January 2011 and December 2016 were included in this study. Results In all, 1,247 patients included (1,145 in the unintentional group and 102 in the intentional group). The mean age was 3.27 +/- 4.77 in the unintentional ingestion group and 16.49 +/- 1.94 in the intentional group. In the unintentional group, detergents were most frequently ingested (by 219 patients), followed by hypochlorite-based agents, ethanol, sodium hydroxide, acetone, silica gel, and citric acid. Cases of boric acid (odds ratio [OR] = 6.131), ethylene glycol (OR = 6.541), glacial acetic acid (OR = 7.644), other hydrocarbons (OR = 4.496), hypochlorite-based agent (OR = 2.627), nicotine (OR = 5.635), and sodium peroxocarbonate (OR = 6.783) ingestion was associated with a significantly high admission rate. In the intentional group, there were 54 cases of ingestion of hypochlorite-based agent, followed by detergent, ethylene glycol, ethanol, methanol and sodium peroxycarbonate. The significant risk factors for admission in the intentional group were ingestion of ethylene glycol (OR = 37.333) and hypochlorite-based agent (OR = 5.026). There was no mortality case. Conclusion The most commonly ingested substances were sodium hypochlorite (hypochlorite-related agent), surfactants (detergent and soap), and ethanol. The ingestion of hypochlorite or ethylene glycol was the main risk factor for admission. Intentional ingestion was higher in adolescents than in children.	[Lee, Jae Hee; Lee, Duk Hee] Ewha Womans Univ, Dept Emergency Med, Seoul, South Korea	Ewha Womans University	Lee, DH (corresponding author), Ewha Womans Univ, Dept Emergency Med, Seoul, South Korea.	ewhain78@gmail.com		Lee, Jae Hee/0000-0002-3864-6929; Lee, Duk Hee/0000-0001-5992-5284	National Research Foundation of Korea (NRF) - Korea government (MSIT) [2018R1C1B5046096]; Research of Korea Centers for Disease Control and Prevention (Emergency Department-Based Injury In-depth Surveillance)	National Research Foundation of Korea (NRF) - Korea government (MSIT); Research of Korea Centers for Disease Control and Prevention (Emergency Department-Based Injury In-depth Surveillance)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2018R1C1B5046096), and a fund by Research of Korea Centers for Disease Control and Prevention (Emergency Department-Based Injury In-depth Surveillance). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay M, 2014, PEDIATR DENT, V36, P316; [Anonymous], 2017, J OBSTET GYNECOL NEO, V46, pe125; Choi S, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061162; Duncan MA, 2010, J MED TOXICOL, V6, P461, DOI 10.1007/s13181-010-0114-6; Eiffert S, 2017, TOXICS, V5, DOI 10.3390/toxics5030016; Gummin DD, 2018, CLIN TOXICOL, V56, P1213, DOI 10.1080/15563650.2018.1533727; Henretig FM, 2019, NEW ENGL J MED, V380, P1638, DOI 10.1056/NEJMra1504690; Lee J, 2019, PEDIATR NEONATOL, V60, P59, DOI 10.1016/j.pedneo.2018.04.001; Lee Tae-Hyung, 2018, 한국안전학회지, V33, P54; Lee Tae-Hyung, 2017, [Fire Science and Engineering, 한국화재소방학회 논문지], V31, P81, DOI 10.7731/KIFSE.2017.31.1.081; O'Donnell KA, 2017, PEDIATR ANN, V46, pE449, DOI 10.3928/19382359-20171120-04; Rietjens SJ, 2014, NETH J MED, V72, P73; Rosenthal M, 2017, J ENVIRON HEALTH, V80, P14; Schwerk N, 2007, ACTA PAEDIATR, V96, P461, DOI 10.1111/j.1651-2227.2007.00115.x; Urganci N, 2014, INDIAN J PEDIATR, V81, P675, DOI 10.1007/s12098-013-1170-0; Yin S, 2010, J PEDIATR-US, V157, P832, DOI 10.1016/j.jpeds.2010.05.040	16	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242430	10.1371/journal.pone.0242430	http://dx.doi.org/10.1371/journal.pone.0242430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186400	gold, Green Published			2022-12-26	WOS:000593949800033
J	Arias-Giraldo, LM; Munoz, M; Hernandez, C; Herrera, G; Velasquez-Ortiz, N; Cantillo-Barraza, O; Urbano, P; Ramirez, JD				Arias-Giraldo, Luisa M.; Munoz, Marina; Hernandez, Carolina; Herrera, Giovanny; Velasquez-Ortiz, Natalia; Cantillo-Barraza, Omar; Urbano, Plutarco; Ramirez, Juan David			Species-dependent variation of the gut bacterial communities across Trypanosoma cruzi insect vectors	PLOS ONE			English	Article							GEOGRAPHICAL-DISTRIBUTION; CHAGAS-DISEASE; MICROBIOTA; ACTINOBACTERIA; TRIATOMINAE; DIVERSITY; SYMBIONTS; HOST; TRANSMISSION; REDUVIIDAE	Triatomines (Hemiptera: Reduviidae) are the insect vectors of Trypanosoma cruzi, the causative agent of Chagas disease. The gut bacterial communities affect the development of T. cruzi inside the vector, making the characterization of its composition important in the understanding of infection development. We collected 54 triatomine bugs corresponding to four genera in different departments of Colombia. DNA extraction and PCR were performed to evaluate T. cruzi presence and to determine the discrete typing unit (DTU) of the parasite. PCR products of the bacterial 16S rRNA gene were pooled and sequenced. Resulting reads were denoised and QIIME 2 was used for the identification of amplicon sequence variants (ASVs). Diversity (alpha and beta diversity) and richness analyses, Circos plots, and principal component analysis (PCA) were also performed. The overall T. cruzi infection frequency was 75.9%, with TcI being the predominant DTU. Approximately 500,000 sequences were analyzed and 27 bacterial phyla were identified. The most abundant phyla were Proteobacteria (33.9%), Actinobacteria (32.4%), Firmicutes (19.6%), and Bacteroidetes (7.6%), which together accounted for over 90% of the gut communities identified in this study. Genera were identified for these main bacterial phyla, revealing the presence of important bacteria such as Rhodococcus, Serratia, and Wolbachia. The composition of bacterial phyla in the gut of the insects was significantly different between triatomine species, whereas no significant difference was seen between the state of T. cruzi infection. We suggest further investigation with the evaluation of additional variables and a larger sample size. To our knowledge, this study is the first characterization of the gut bacterial structure of the main triatomine genera in Colombia.	[Arias-Giraldo, Luisa M.; Munoz, Marina; Hernandez, Carolina; Herrera, Giovanny; Velasquez-Ortiz, Natalia; Ramirez, Juan David] Univ Rosario, Fac Ciencias Nat, Dept Biol, Grp Invest Microbiol UR GIMUR, Bogota, Colombia; [Cantillo-Barraza, Omar] Univ Antioquia, Grp Biol & Control Enfermedades Infecciosas, Medellin, Colombia; [Urbano, Plutarco] Fundac Univ Trop Amer Unitrop, Grp Invest Biol Orinoquia, Yopal, Colombia	Universidad del Rosario; Universidad de Antioquia	Ramirez, JD (corresponding author), Univ Rosario, Fac Ciencias Nat, Dept Biol, Grp Invest Microbiol UR GIMUR, Bogota, Colombia.	juand.ramirez@urosario.edu.co		Urbano, Plutarco/0000-0001-8564-3854	Direccion de Investigacion e Innovacion from Universidad del Rosario	Direccion de Investigacion e Innovacion from Universidad del Rosario	This work was funded by Direccion de Investigacion e Innovacion from Universidad del Rosario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2009, ACTA TROP, V110, P159, DOI 10.1016/j.actatropica.2008.06.005; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Arias-Giraldo LM, IDENTIFICATION BLOOD; Azambuja P, 2005, AN ACAD BRAS CIENC, V77, P397, DOI 10.1590/S0001-37652005000300004; Azambuja P, 2004, EXP PARASITOL, V107, P89, DOI 10.1016/j.exppara.2004.04.007; Azpurua J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000627; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bradley PH, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0244-z; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Castro DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036591; Cazorla-Perfetti D, 2015, PSAMMOLESTES ARTHURI, V27, P324; Cruz-Guzmán Pedro José, 2014, Saber, V26, P428; da Mota FF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001631; Ramirez JD, 2009, J CLIN MICROBIOL, V47, P3945, DOI 10.1128/JCM.01601-09; de Fuentes-Vicente JA, 2018, ACTA TROP, V183, P23, DOI 10.1016/j.actatropica.2018.04.008; Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102; Diaz S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1926-2; Duffy T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002000; Dumonteil E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22455-x; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eichler S, 2002, EXP PARASITOL, V100, P17, DOI 10.1006/expr.2001.4653; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Espino CI, 2009, APPL ENVIRON MICROB, V75, P547, DOI 10.1128/AEM.01665-08; Garcia ES, 2010, MEM I OSWALDO CRUZ, V105, P605, DOI 10.1590/S0074-02762010000500001; Garcia ES, 2010, TRENDS PARASITOL, V26, P499, DOI 10.1016/j.pt.2010.07.003; Guhl F, 2007, BIOMEDICA, V27, P143, DOI 10.7705/biomedica.v27i1.258; Guhl F, 2009, MEM I OSWALDO CRUZ, V104, P71, DOI 10.1590/S0074-02762009000900012; Gumiel M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0836-z; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Hernandez C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1907-5; Vivero RJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2031-x; Kieran TJ, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3761-8; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Villa LM, 2013, MEM I OSWALDO CRUZ, V108, P932, DOI 10.1590/0074-0276130201; Montoya-Porras LM, 2018, ACTA TROP, V178, P327, DOI 10.1016/j.actatropica.2017.11.004; Noireau F, 2002, MEM I OSWALDO CRUZ, V97, P61, DOI 10.1590/S0074-02762002000100009; Oliveira JL, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006709; Oliver KM, 2014, CURR OPIN INSECT SCI, V4, P1, DOI 10.1016/j.cois.2014.08.001; Olivera MJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210156; Orantes LC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006730; Otalora-Luna F, 2015, REV CHIL HIST NAT, V88, DOI [10.1186/S40693-014-0032-0, 10.1186/s40693-014-0032-0]; Pais R, 2008, APPL ENVIRON MICROB, V74, P5965, DOI 10.1128/AEM.00741-08; Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rodriguez-Ruano SM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01167; Sadowsky MJ, 2017, GUT MICROBES, V8, P268, DOI 10.1080/19490976.2016.1277313; Salem H, 2013, ENVIRON MICROBIOL, V15, P1956, DOI 10.1111/1462-2920.12001; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Skennerton CT, 2016, ISME J, V10, P2679, DOI 10.1038/ismej.2016.55; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; Velasquez-Ortiz N, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3422-y; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Vieira CS, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1398-4; Villegas LM, 2014, MEM I OSWALDO CRUZ, V109, P672, DOI 10.1590/0074-0276140194; Vivero Rafael J., 2019, Biotechnology Reports, V24, pe00379, DOI 10.1016/j.btre.2019.e00379; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang XM, 2018, MOL ECOL, V27, P2972, DOI 10.1111/mec.14732; Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001; Weiss BL, 2012, J IMMUNOL, V188, P3395, DOI 10.4049/jimmunol.1103691; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	65	2	2	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0240916	10.1371/journal.pone.0240916	http://dx.doi.org/10.1371/journal.pone.0240916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180772	Green Published, gold			2022-12-26	WOS:000593948000078
J	Graziadio, S; Urwin, SG; Cocco, P; Micocci, M; Winter, A; Yang, YL; Price, DA; Messenger, M; Allen, AJ; Shinkins, B				Graziadio, Sara; Urwin, Samuel G.; Cocco, Paola; Micocci, Massimo; Winter, Amanda; Yang, Yaling; Price, D. Ashley; Messenger, Mike; Allen, A. Joy; Shinkins, Bethany		CONDOR Steering Grp	Unmet clinical needs for COVID-19 tests in UK health and social care settings	PLOS ONE			English	Article								There is an urgent requirement to identify which clinical settings are in most need of COVID-19 tests and the priority role(s) for tests in these settings to accelerate the development of tests fit for purpose in health and social care across the UK. This study sought to identify and prioritize unmet clinical needs for COVID-19 tests across different settings within the UK health and social care sector via an online survey of health and social care professionals and policymakers. Four hundred and forty-seven responses were received between 22nd May and 15th June 2020. Hospitals and care homes were recognized as the settings with the greatest unmet clinical need for COVID-19 diagnostics, despite reporting more access to laboratory molecular testing than other settings. Hospital staff identified a need for diagnostic tests for symptomatic workers and patients. In contrast, care home staff expressed an urgency for screening at the front door to protect high-risk residents and limit transmission. The length of time to test result was considered a widespread problem with current testing across all settings. Rapid tests for staff were regarded as an area of need across general practice and dental settings alongside tests to limit antibiotics use.	[Graziadio, Sara; Urwin, Samuel G.; Winter, Amanda; Price, D. Ashley] Newcastle Upon Tyne Hosp Fdn Trust, NIHR Newcastle Vitro Diagnost Cooperat, Newcastle Upon Tyne, Tyne & Wear, England; [Cocco, Paola; Messenger, Mike; Shinkins, Bethany] Leeds Teaching Hosp NHS Trust, NIHR Leeds Vitro Diagnost Cooperat, Leeds, W Yorkshire, England; [Micocci, Massimo] Imperial Coll London, NIHR London Vitro Diagnost Cooperat, London, England; [Yang, Yaling] Univ Oxford, NIHR Community Healthcare MedTech & Vitro Diagnos, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Messenger, Mike] Univ Leeds, Leeds Ctr Personalised Hlth & Med, Leeds, W Yorkshire, England; [Allen, A. Joy] Newcastle Univ, NIHR Newcastle Vitro Diagnost Cooperat, Newcastle Upon Tyne, Tyne & Wear, England; [Shinkins, Bethany] Univ Leeds, Test Evaluat Grp, Inst Hlth Sci, Leeds, W Yorkshire, England	Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Leeds; Imperial College London; University of Oxford; University of Leeds; Newcastle University - UK; University of Leeds	Allen, AJ (corresponding author), Newcastle Univ, NIHR Newcastle Vitro Diagnost Cooperat, Newcastle Upon Tyne, Tyne & Wear, England.	Joy.Allen@newcastle.ac.uk	Body, Richard/C-2736-2010	Body, Richard/0000-0001-9089-8130; Allen, Joy/0000-0002-3222-0396; Reynard, Charles/0000-0002-7534-2668; Shinkins, Bethany/0000-0001-5350-1018; Price, David/0000-0002-0562-7326	UKRI; British Lung Foundation; National Institute for Health Research (NIHR) Newcastle In Vitro Diagnostics Co-operative; NIHR London In Vitro Diagnostics Co-operative; NIHR NIHR Community Healthcare MedTech and In vitro Diagnostics Co-operative; NIHR Leeds In Vitro Diagnostics Co-operative; Antimicrobial Resistance Cross Council Initiative [MR/N029976/1]; The Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Medical Research Council; Medical Research Foundation's National AMR Training Programme	UKRI(UK Research & Innovation (UKRI)); British Lung Foundation; National Institute for Health Research (NIHR) Newcastle In Vitro Diagnostics Co-operative(National Institute for Health Research (NIHR)); NIHR London In Vitro Diagnostics Co-operative; NIHR NIHR Community Healthcare MedTech and In vitro Diagnostics Co-operative; NIHR Leeds In Vitro Diagnostics Co-operative; Antimicrobial Resistance Cross Council Initiative; The Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Foundation's National AMR Training Programme	This study is part of the CONDOR platform (condor-platform.org), which is funded by the UKRI, Asthma UK and the British Lung Foundation. SG, SGU, AW, DAP and AJA are supported by the National Institute for Health Research (NIHR) Newcastle In Vitro Diagnostics Co-operative (http://www.newcastle.mic.nihr.ac.uk/).MaM is supported by the NIHR London In Vitro Diagnostics Co-operative (https://london.ivd.nihr.ac.uk/).YY is supported by the NIHR NIHR Community Healthcare MedTech and In vitro Diagnostics Co-operative (https://www.community.healthcare.mic.nihr.ac.uk/home_).BS and MM are supported by the NIHR Leeds In Vitro Diagnostics Co-operative (https://www.leedsmic.nihr.ac.uk/).PC, MMand BS are supported by the 'Antimicrobial Resistance Cross Council Initiative' (Grant number MR/N029976/1), Funding Partners: The Biotechnology and Biological Sciences Research Council (https://bbsrc.ukri.org/), the Engineering and Physical Sciences Research Council (https://epsrc.ukri.org/), and the Medical Research Council (https://mrc.ukri.org/).This work is also supported by the Medical Research Foundation's National AMR Training Programme (https://www.medicalresearchfoundation.org.uk/projects/national-phd-training-programme-inantimicrobial-resistance-research).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2020, GPLOTS VARIOUS R PRO; Bambra Clare, 2020, J Epidemiol Community Health, V74, P964, DOI 10.1136/jech-2020-214401; Banerjee A, 2020, LANCET, V395, P1715, DOI 10.1016/S0140-6736(20)30854-0; Brownstein NC, 2020, ARE ANTIBODIES TESTS, DOI [10.1101/2020.06.04.20122358, DOI 10.1101/2020.06.04.20122358]; Cocco P, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01582-1; COVID-19 National Diagnostic Research and Evaluation Platform, 2020, COVID 19 NATL DIAGNO; Department of Health and Social Care, 2020, WEEKL NHS TEST TRAC; Department of Health and Social Care, 2020, COR COVID 19 GETT TE; Enhancing the QUAlity and Transparency Of health Research (EQUATOR), 2020, EQUATOR NETW; Foundation for Innovative New Diagnostics (FIND),, 2020, SARS COV 2 DIAGN PIP; Graziadio S, 2020, MICROMACHINES-BASEL, V11, DOI 10.3390/mi11030291; Guglielmi G, 2020, NATURE, V583, P506, DOI 10.1038/d41586-020-02140-8; HE X, 2020, NAT MED, V26, P672, DOI DOI 10.1038/S41591-020-0869-5; Institute for Government, 2020, B JOHNS PLAN EAS COR; Kelley K, 2003, INT J QUAL HEALTH C, V15, P261, DOI 10.1093/intqhc/mzg031; Larremore DB, 2021, SCI ADV, V7, DOI [10.1101/2020.06.22.20136309, 10.1126/sciadv.abd5393]; Lohse S, 2020, LANCET INFECT DIS, V20, P1231, DOI 10.1016/S1473-3099(20)30362-5; Medicines and Healthcare Products Regulatory Agency, 2020, TARG PROD PROF ANT T; National Institute for Health and Care Excellence, 2020, EXPL EC MOD SARS COV; National Institute for Health and Clinical Excellence, 2011, DIAGN ASS PROGR MAN; Online Surveys (formerly BOS), 2020, ONLINE SURVEYS FORME; Public Health England, 2020, COVID 19 INV IN CLIN; R Core Team, 2021, R LANGUAGE ENV STAT; REMAP-CAP, 2020, RAND EMB MULT AD PLA; Thomas SJ, 2004, USING WEB PAPER QUES; van Teijlingen Edwin, 2002, Nurs Stand, V16, P33; Verbakel JY, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015760; World Health Organization, 2020, COVID 19 TARG PROD P	28	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242125	10.1371/journal.pone.0242125	http://dx.doi.org/10.1371/journal.pone.0242125			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0MJ	33180807	Green Published, gold			2022-12-26	WOS:000593948000099
J	Shiratori, T; Kobayashi, K; Takano, Y				Shiratori, Tomokaze; Kobayashi, Ken; Takano, Yuichi			Prediction of hierarchical time series using structured regularization and its application to artificial neural networks	PLOS ONE			English	Article							FORECASTS; RECONCILIATION; REGRESSION; SELECTION; BEHAVIOR; SPARSITY; LASSO	This paper discusses the prediction of hierarchical time series, where each upper-level time series is calculated by summing appropriate lower-level time series. Forecasts for such hierarchical time series should be coherent, meaning that the forecast for an upper-level time series equals the sum of forecasts for corresponding lower-level time series. Previous methods for making coherent forecasts consist of two phases: first computing base (incoherent) forecasts and then reconciling those forecasts based on their inherent hierarchical structure. To improve time series predictions, we propose a structured regularization method for completing both phases simultaneously. The proposed method is based on a prediction model for bottom-level time series and uses a structured regularization term to incorporate upper-level forecasts into the prediction model. We also develop a backpropagation algorithm specialized for applying our method to artificial neural networks for time series prediction. Experimental results using synthetic and real-world datasets demonstrate that our method is comparable in terms of prediction accuracy and computational efficiency to other methods for time series prediction.	[Shiratori, Tomokaze] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki, Japan; [Kobayashi, Ken] Fujitsu Labs Ltd, Artificial Intelligence Lab, Kawasaki, Kanagawa, Japan; [Takano, Yuichi] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan	University of Tsukuba; Fujitsu Ltd; Fujitsu Laboratories Ltd; University of Tsukuba	Kobayashi, K (corresponding author), Fujitsu Labs Ltd, Artificial Intelligence Lab, Kawasaki, Kanagawa, Japan.	ken-kobayashi@fujitsu.com						Ben Taieb S., 2017, P 34 INT C MACH LEAR, V70, P3348; Ben Taieb S, 2019, KDD'19: PROCEEDINGS OF THE 25TH ACM SIGKDD INTERNATIONAL CONFERENCCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1337, DOI 10.1145/3292500.3330976; Ben Taieb S, 2017, AAAI CONF ARTIF INTE, P4474; Bergmeir C, 2018, COMPUT STAT DATA AN, V120, P70, DOI 10.1016/j.csda.2017.11.003; Bertsimas D., 2019, ARXIV190206547; Bertsimas D, 2016, ANN STAT, V44, P813, DOI 10.1214/15-AOS1388; Bien J, 2013, ANN STAT, V41, P1111, DOI 10.1214/13-AOS1096; Bishop C. M, 2006, PATTERN RECOGNITION; Brockwell P.J., 1991, TIME SERIES THEORY M; Capistran C, 2010, ECON MODEL, V27, P666, DOI 10.1016/j.econmod.2010.01.006; Caruana R, 1997, MACH LEARN, V28, P41, DOI 10.1023/A:1007379606734; Fliedner G, 1999, COMPUT OPER RES, V26, P1133, DOI 10.1016/S0305-0548(99)00017-9; Gao J, 2018, APPL INTELL, V48, P3523, DOI 10.1007/s10489-018-1163-9; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Hastie T., 2015, STAT LEARNING SPARSI; Hsieh WW, 2004, REV GEOPHYS, V42, DOI 10.1029/2002RG000112; Hyndman R. J., 2018, FORECASTING PRINCIPL; Hyndman RJ, 2016, COMPUT STAT DATA AN, V97, P16, DOI 10.1016/j.csda.2015.11.007; Hyndman RJ, 2011, COMPUT STAT DATA AN, V55, P2579, DOI 10.1016/j.csda.2011.03.006; Jacob L., 2009, P 21TH NIPS, P745; Jenatton R, 2011, J MACH LEARN RES, V12, P2777; Karmy JP, 2019, EXPERT SYST APPL, V137, P59, DOI 10.1016/j.eswa.2019.06.060; Karsoliya S., 2012, INT J ENG TRENDS TEC, V3, P714; Khashei M, 2010, EXPERT SYST APPL, V37, P479, DOI 10.1016/j.eswa.2009.05.044; Kim S, 2012, ANN APPL STAT, V6, P1095, DOI 10.1214/12-AOAS549; Kremer M, 2016, MANAGE SCI, V62, P2745, DOI 10.1287/mnsc.2015.2259; Kudo K, 2020, IEICE T INF SYST, VE103D, P1693, DOI 10.1587/transinf.2019EDP7274; Lai GK, 2018, ACM/SIGIR PROCEEDINGS 2018, P95, DOI 10.1145/3209978.3210006; Lim M, 2015, J COMPUT GRAPH STAT, V24, P627, DOI 10.1080/10618600.2014.938812; Lippmann R. P., 1987, IEEE ASSP Magazine, V4, P4, DOI 10.1145/44571.44572; Lutkepohl H., 2010, OECD J J BUSINESS CY, V2, P1; Nicholson WB, 2017, INT J FORECASTING, V33, P627, DOI 10.1016/j.ijforecast.2017.01.003; Panagiotelis A, 2021, INT J FORECASTING, V37, P343, DOI 10.1016/j.ijforecast.2020.06.004; Park M., 2014, INT C MACH LEARN ICM; Pontil M, 2004, P 10 ACM SIGKDD INT, P109, DOI DOI 10.1145/1014052.1014067; Ruder Sebastian, 2017, ARXIV170605098; Sato T, 2019, ADV DATA ANAL CLASSI, V13, P621, DOI 10.1007/s11634-018-0327-0; Schimbinschi F, 2017, EXPERT SYST APPL, V82, P301, DOI 10.1016/j.eswa.2017.04.015; Takano Y, 2020, TOP, V28, P475, DOI 10.1007/s11750-020-00538-1; Tamura R., 2017, J OPERATIONS RES SOC, V60, P321, DOI DOI 10.15807/JORSJ.60.321; Tamura R, 2019, J GLOBAL OPTIM, V73, P431, DOI 10.1007/s10898-018-0713-3; van Erven T, 2015, LECT NOTES STAT, V217, P297, DOI 10.1007/978-3-319-18732-7_15; Wen W., 2016, ADV NEURAL INFORM PR, P2074; Wickramasuriya SL, 2019, J AM STAT ASSOC, V114, P804, DOI 10.1080/01621459.2018.1448825; Widiarta H, 2009, INT J PROD ECON, V118, P87, DOI 10.1016/j.ijpe.2008.08.013; Zhang GP, 2005, EUR J OPER RES, V160, P501, DOI 10.1016/j.ejor.2003.08.037; Zhang GP, 2003, NEUROCOMPUTING, V50, P159, DOI 10.1016/S0925-2312(01)00702-0; Zhang Y., 2017, IEEE T KNOWL DATA EN, DOI DOI 10.1109/TKDE.2021.3070203; Zhao P, 2009, ANN STAT, V37, P3468, DOI 10.1214/07-AOS584	50	4	4	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242099	10.1371/journal.pone.0242099	http://dx.doi.org/10.1371/journal.pone.0242099			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0MJ	33180811	Green Published, Green Submitted, gold			2022-12-26	WOS:000593948000056
J	Furstenau, TN; Cocking, JH; Hepp, CM; Fofanov, VY				Furstenau, Tara N.; Cocking, Jill H.; Hepp, Crystal M.; Fofanov, Viacheslav Y.			Sample pooling methods for efficient pathogen screening: Practical implications	PLOS ONE			English	Article							REAL-TIME; CHLAMYDIA-TRACHOMATIS; DEFECTIVE MEMBERS; DNA; SURVEILLANCE; INFECTION; VIRUS	Due to the large number of negative tests, individually screening large populations for rare pathogens can be wasteful and expensive. Sample pooling methods improve the efficiency of large-scale pathogen screening campaigns by reducing the number of tests and reagents required to accurately categorize positive and negative individuals. Such methods rely on group testing theory which mainly focuses on minimizing the total number of tests; however, many other practical concerns and tradeoffs must be considered when choosing an appropriate method for a given set of circumstances. Here we use computational simulations to determine how several theoretical approaches compare in terms of (a) the number of tests, to minimize costs and save reagents, (b) the number of sequential steps, to reduce the time it takes to complete the assay, (c) the number of samples per pool, to avoid the limits of detection, (d) simplicity, to reduce the risk of human error, and (e) robustness, to poor estimates of the number of positive samples. We found that established methods often perform very well in one area but very poorly in others. Therefore, we introduce and validate a new method which performs fairly well across each of the above criteria making it a good general use approach.	[Furstenau, Tara N.; Cocking, Jill H.; Hepp, Crystal M.; Fofanov, Viacheslav Y.] No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA; [Cocking, Jill H.; Hepp, Crystal M.; Fofanov, Viacheslav Y.] No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA	Northern Arizona University; Northern Arizona University	Fofanov, VY (corresponding author), No Arizona Univ, Sch Informat Comp & Cyber Syst, Flagstaff, AZ 86011 USA.; Fofanov, VY (corresponding author), No Arizona Univ, Pathogen & Microbiome Inst, Flagstaff, AZ 86011 USA.	Viacheslav.Fofanov@nau.edu		Furstenau, Tara/0000-0001-5233-7383	State of Arizona Technology and Research Initiative Fund (TRIF)	State of Arizona Technology and Research Initiative Fund (TRIF)	This work was funded under the State of Arizona Technology and Research Initiative Fund (TRIF), administered by the Arizona Board of Regents, through Northern Arizona University awarded to VYF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalhamid B, 2020, AM J CLIN PATHOL, V153, P715, DOI [10.1093/ajcp/aqaa064, 10.1093/AJCP/AQAA064, 10.1101/2020.04.03.20050195]; Abdurrahman ST, 2015, J CLIN MICROBIOL, V53, P2502, DOI 10.1128/JCM.00864-15; Aldridge M, 2019, FOUND TRENDS COMMUN, V15, P196, DOI 10.1561/0100000099; [Anonymous], 2012, ADV NEONATAL CARE, V12, P56; Cao HX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-603; Centers for Disease Control and Prevention, 2020, EV TEST PERS COR DIS; Centers for Disease Control and Prevention, 2013, W NIL VIR US GUID SU; Chi X, 2014, PLANT BIOTECHNOL J, V12, P709, DOI 10.1111/pbi.12174; Dorfman R, 1943, ANN MATH STAT, V14, P436, DOI 10.1214/aoms/1177731363; Du Dz, 1993, COMBINATORIAL GROUP; Edouard S, 2015, J CLIN MICROBIOL, V53, P1002, DOI 10.1128/JCM.03609-14; Erlich Y, 2009, GENOME RES, V19, P1243, DOI 10.1101/gr.092957.109; Garcia Z, 1996, J MED VIROL, V49, P218, DOI 10.1002/(SICI)1096-9071(199607)49:3&lt;218::AID-JMV10&gt;3.0.CO;2-8; Hepp CM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205801; Hogan CA, 2020, JAMA-J AM MED ASSOC, V323, P1967, DOI 10.1001/jama.2020.5445; HU MC, 1981, SIAM J ALGEBRA DISCR, V2, P81, DOI 10.1137/0602011; HWANG FK, 1972, J AM STAT ASSOC, V67, P605, DOI 10.2307/2284447; Johnson SJ, 2019, TRANSBOUND EMERG DIS, V66, P2318, DOI 10.1111/tbed.13288; Laurin E, 2019, J FISH DIS, V42, P1471, DOI 10.1111/jfd.13083; LI CH, 1962, J AM STAT ASSOC, V57, P455, DOI 10.2307/2281652; Loftis AD, 2006, EXP APPL ACAROL, V40, P67, DOI 10.1007/s10493-006-9025-2; Lohse S, 2020, LANCET INFECT DIS, V20, P1231, DOI 10.1016/S1473-3099(20)30362-5; Munoz-Zanzi CA, 2000, J VET DIAGN INVEST, V12, P195, DOI 10.1177/104063870001200301; Pannwitz G, 2009, J WILDLIFE DIS, V45, P512, DOI 10.7589/0090-3558-45.2.512; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Pilcher CD, 2002, JAMA-J AM MED ASSOC, V288, P216, DOI 10.1001/jama.288.2.216; Ramirez AL, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2901-x; Ray KJ, 2014, OPHTHAL EPIDEMIOL, V21, P86, DOI 10.3109/09286586.2014.884600; Riccio L, 2000, TAIWAN J MATH, V4, P669, DOI 10.11650/twjm/1500407300; Rours GIJG, 2005, J CLIN MICROBIOL, V43, P4684, DOI 10.1128/JCM.43.9.4684-4690.2005; SOBEL M, 1959, AT&T TECH J, V38, P1179, DOI 10.1002/j.1538-7305.1959.tb03914.x; SOBEL M, 1966, TECHNOMETRICS, V8, P631, DOI 10.2307/1266636; Stallknecht DE, 2007, CURR TOP MICROBIOL, V315, P445; Sutherland GL, 2007, J AM MOSQUITO CONTR, V23, P389, DOI 10.2987/5630.1; Taylor SM, 2010, J CLIN MICROBIOL, V48, P512, DOI 10.1128/JCM.01800-09; Yelin I, 2020, CLIN INFECT DIS, V71, P2073, DOI 10.1093/cid/ciaa531; Zuzarte PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093455	37	7	7	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0236849	10.1371/journal.pone.0236849	http://dx.doi.org/10.1371/journal.pone.0236849			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175841	Green Submitted, gold, Green Published			2022-12-26	WOS:000593946900070
J	Bitew, T; Birhan, W; Wolie, D				Bitew, Tesera; Birhan, Wohabie; Wolie, Demeke			Perceived learning difficulty associates with depressive symptoms and substance use among students of higher educational institutions in North Western Ethiopia: A cross sectional study	PLOS ONE			English	Article							PREVALENCE; DETERMINANTS	Background The potential role of perceived learning difficulty on depressive symptoms and substance use in the context of student population was seldom studied. This study aimed to investigate the association of perceived learning difficulty with depressive symptoms and substance use among university students in northwest Ethiopia. Methods A cross sectional study was conducted on 710 pre-engineering students. A locally validated version of Patient Health Questionnaire (PHQ-9) was used to assess depressive symptoms at a cut off 5-9 indicating mild depressive symptoms and at a cut off 10 for major depressive symptoms. Perceived difficulty in school work was assessed by items dealing about difficulties in areas of course work. The response alternatives of these items were 0 = not at all, 1 = not so much, 2 = quite much, 3 = very much. The types of substances that students had used in their life and in the last three months were assessed. Negative binomial regression and multinomial regressions were employed to investigate the predictors of number of substance use and depressive symptoms respectively. Results The prevalence of depressive symptoms was 71.4% (Mild: 30% and Major 41.4%). About 24.6% of participants had the experience of using at least one substance. Increment in perceived difficulties in learning score was associated with more use of substances (aRRR = 1.03, 95% CI: 1.01-1.06), mild level depressive symptoms (aOR = 1.10, 95% CI: 1.04, 1.56 and major depressive symptoms (aOR = 1.19, 95% CI: 1.13, 1.26). Every increment in anxiety score was associated with increased risk of mild level of depressive symptoms (aOR = 1.09, 95% CI: 1.01, 1.17) and major depressive symptoms (aOR = 1.28, 95% CI: 1.18, 1.37). Being male (aRRR = 5.54, 95% CI: 3.28, 9.36), urban residence (aRRR = 2.46, 95% CI: 1.62, 3.72) and increment in number of life threatening events (aRRR = 1.143, 95% CI: 1.08, 1.22) were associated with increased risk of substance use. Conclusion Perceived difficulties in learning independently predicted increased depressive symptoms as well as substance use among participants.	[Bitew, Tesera; Birhan, Wohabie] Debre Markos Univ, Inst Educ & Behav Sci, Dept Psychol, Debre Markos, Ethiopia; [Bitew, Tesera] Addis Ababa Univ, Dept Psychiat, African Mental Hlth Res Initiat AMARI, Addis Ababa, Ethiopia; [Wolie, Demeke] Bahir Dar Univ, Coll Educ & Behav Sci, Dept Psychol, Bahir Dar, Ethiopia	Addis Ababa University; Bahir Dar University	Bitew, T (corresponding author), Debre Markos Univ, Inst Educ & Behav Sci, Dept Psychol, Debre Markos, Ethiopia.; Bitew, T (corresponding author), Addis Ababa Univ, Dept Psychiat, African Mental Hlth Res Initiat AMARI, Addis Ababa, Ethiopia.	tesera2016@gmail.com		Fenta, Tesera/0000-0002-2270-9542	Debre Markos University; Africa Mental Health Research Initiative (AMARI) within the DELTAS Africa Initiative [DEL-15-01]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [DEL-15-01]; UK government	Debre Markos University; Africa Mental Health Research Initiative (AMARI) within the DELTAS Africa Initiative; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome Trust); UK government	This research was funded by Debre Markos University, 2016, Dr Tesera Bitew. TB is also financially supported by the Africa Mental Health Research Initiative (AMARI) within the DELTAS Africa Initiative [DEL-15-01] as a post-doctoral fellow. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust [DEL-15-01] and the UK government. But, the views in this study were fully that of the authors and were not that of the funder.	Akanbi, 2015, NIGERIA J ED PRACTIC, V6, P2222; Al-Busaidi Zakiya, 2011, Oman Med J, V26, P235, DOI 10.5001/omj.2011.58; [Anonymous], 2013, J THORAC DIS S2, V5, pS168; [Anonymous], 2018, LANCET DIABETES ENDO, V6, P1, DOI DOI 10.1080/08927022.2018.1510179; [Anonymous], 2009, PLASTIC RECONSTR SUR, V124, p427e; APA, 2005, DIAGN STAT MAN MENT; Bitew T, 2014, ETHIOP J HEALTH SCI, V24, P162, DOI 10.4314/ejhs.v24i2.9; Boscheck R, 2008, WORLD COMPET, V31, P485; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; Cruz T, 9 INT TECHN ED DEV C, P7749; Davis Noel M, 2005, J Sch Nurs, V21, P311; Espada J. P., 2011, INT J PSYCHOL PSYCHO, V11, P79; Fekadu A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-194; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; Hale W., 1993, DEPRESSION ASSESMENT, V49; Hartley M, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-9; Hunt J, 2010, J ADOLESCENT HEALTH, V46, P3, DOI 10.1016/j.jadohealth.2009.08.008; Kleinman A, OUT SHADOWS MAKING M, P2106; Krasniqi N., 2014, J ED SOCIAL RES, V4, P413; Muhammed K, 2018, INT J ED EVALUATION, V4, P2489; Othieno CJ, 2014, J AFFECT DISORDERS, V165, P120, DOI 10.1016/j.jad.2014.04.070; Respress BN, 2013, ISSUES MENT HEALTH N, V34, P539, DOI 10.3109/01612840.2012.758206; Ritakallio M, 2008, J ADOLESCENCE, V31, P355, DOI 10.1016/j.adolescence.2007.06.006; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Sidana S, 2012, AUSTRALAS MED J, V5, P247, DOI 10.4066/AMJ.2012.750; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; von Elm E, 2007, EPIDEMIOLOGY, V18, P800, DOI 10.1097/EDE.0b013e3181577654; Wagner S, 2015, EUR CHILD ADOLES PSY, V24, P5, DOI 10.1007/s00787-014-0559-2; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WHO, 2008, MILL DEV GOAL 5 IMPR; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; WIET SG, 1981, BIOL PSYCHOL, V12, P25, DOI 10.1016/0301-0511(81)90018-1; Wolie D, 2014, THESIS; 2001, AM J KIDNEY DIS, V39	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0240914	10.1371/journal.pone.0240914	http://dx.doi.org/10.1371/journal.pone.0240914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7KH	33170839	gold, Green Published			2022-12-26	WOS:000592383400031
J	Hajdu, D; Told, R; Angeli, O; Weigert, G; Pollreisz, A; Schmidt-Erfurth, U; Sacu, S				Hajdu, Dorottya; Told, Reinhard; Angeli, Orsolya; Weigert, Guenther; Pollreisz, Andreas; Schmidt-Erfurth, Ursula; Sacu, Stefan			Identification of microvascular and morphological alterations in eyes with central retinal non-perfusion	PLOS ONE			English	Article							FOVEAL AVASCULAR ZONE; COHERENCE TOMOGRAPHY ANGIOGRAPHY; VISUAL-ACUITY; HYPERREFLECTIVE FOCI; INNER LAYERS; DISORGANIZATION; ASSOCIATION; ISCHEMIA	Purpose To evaluate the characteristics and morphological alterations in central retinal ischemia caused by diabetic retinopathy (DR) or retinal vein occlusion (RVO) as seen in optical coherence tomography angiography (OCTA) and their relationship to visual acuity. Methods Swept-source optical coherence tomography (SSOCT) and OCTA (Topcon, Triton) data of patients with central involving retinal ischemia were analyzed in this cross-sectional study. The following parameters were evaluated: vessel parameters, foveal avascular zone (FAZ), intraretinal cysts (IRC), microaneurysms (MA), vascular collaterals in the superficial (SCP) and deep plexuses (DCP), hyperreflective foci (HRF), epiretinal membrane (ERM), external limiting membrane (ELM) and ellipsoid zone (EZ) disruption, as well as the disorganization of retinal inner layers (DRIL). Best-corrected visual acuity (BCVA), age, gender, disease duration and ocular history were also recorded. Results 44 eyes of 44 patients (22 with RVO, 22 with DR) were analyzed. The mean age was 60.55 +/- 11.38 years and mean BCVA 0.86 +/- 0.36 (Snellen, 6m). No significant difference was found between DR subgroups (non proliferative vs. proliferative). Between RVO subgroups (CRVO vs. BRVO) a significant difference was found in term of collateral vessel of the DCP (p = 0.014). A pooled DR and RVO group were created and compared. Significantly more MAs (p = 0.007) and ERM (p = 0.007) were found in the DR group. Statistically significant negative correlation was demonstrated between FAZ and BCVA (p = 0.45) when analyzing all patients with retinal ischemia. Conclusion This study has shown that the best predictor of visual outcome in center involved ischemic diseases is the size of FAZ. Besides the presence of MAs and ERM, all other OCT and OCTA parameters were present in a similar extent in DR and RVO group despite the completely different disease origins. Our results suggest that as soon as retinal ischemia in the macular region is present, it has a similar appearance and visual outcome independently of the underlying disease.	[Hajdu, Dorottya; Told, Reinhard; Angeli, Orsolya; Weigert, Guenther; Pollreisz, Andreas; Schmidt-Erfurth, Ursula; Sacu, Stefan] Med Univ Vienna, Vienna Clin Trial Ctr VTC, Dept Ophthalmol & Optometry, Vienna, Austria; [Angeli, Orsolya] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary; [Schmidt-Erfurth, Ursula] Med Univ Vienna, Vienna Reading Ctr, Dept Ophthalmol & Optometry, Christian Doppler Lab Ophthalm Image Anal, Vienna, Austria	Medical University of Vienna; Semmelweis University; Medical University of Vienna	Sacu, S (corresponding author), Med Univ Vienna, Vienna Clin Trial Ctr VTC, Dept Ophthalmol & Optometry, Vienna, Austria.	stefan.sacu@meduniwien.ac.at	Pollreisz, Andreas/AAJ-1538-2021	Told, Reinhard/0000-0003-2046-7081; Hajdu, Dorottya/0000-0002-8452-966X				Acar N, 2018, OCT APPL OPHTHALMOLO; Al-Sheikh M, 2016, INVEST OPHTH VIS SCI, V57, P3907, DOI 10.1167/iovs.16-19570; [Anonymous], 1991, Ophthalmology, V98, P786; [Anonymous], 2016, CANC DISCOV; [Anonymous], 2019, CIRCULATION, V2019; Antaki F, 2020, GRAEF ARCH CLIN EXP, V258, P2681, DOI 10.1007/s00417-020-04847-w; Artin E, 1988, GEOMETRIC ALGEBRA; Balaratnasingam C, 2016, OPHTHALMOLOGY, V123, P2352, DOI 10.1016/j.ophtha.2016.07.008; Berry D, 2018, OPHTHALMOL RETINA, V2, P1125, DOI 10.1016/j.oret.2018.04.019; Bolz M, 2009, OPHTHALMOLOGY, V116, P914, DOI 10.1016/j.ophtha.2008.12.039; BRESNICK GH, 1975, ARCH OPHTHALMOL-CHIC, V93, P1300; Chen XJ, 2012, INVEST OPHTH VIS SCI, V53, P8042, DOI 10.1167/iovs.12-10083; Conti FF, 2019, INT J RETINA VITR, V5, DOI 10.1186/s40942-019-0192-9; Coscas G, 2013, OPHTHALMOLOGICA, V229, P32, DOI 10.1159/000342159; Cuenca N, 2020, PROG RETIN EYE RES, V77, DOI 10.1016/j.preteyeres.2019.100828; Davidson CM, 2000, BRAIN RES, V859, P96, DOI 10.1016/S0006-8993(00)01937-5; Ghashut R, 2018, RETINA-J RET VIT DIS, V38, P1571, DOI 10.1097/IAE.0000000000001749; Hausler HR, 1961, OBSERVATIONS MICROAN; Kang JW, 2017, RETINA-J RET VIT DIS, V37, P1700, DOI 10.1097/IAE.0000000000001403; Lammer J, 2018, INVEST OPHTH VIS SCI, V59, P5633, DOI 10.1167/iovs.18-24386; Lee HE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215790; Mitchell P, 1997, OPHTHALMOLOGY, V104, P1033, DOI 10.1016/S0161-6420(97)30190-0; Mo B, 2017, INT J OPHTHALMOL-CHI, V10, P605, DOI 10.18240/ijo.2017.04.17; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Pereira F, 2019, INT J RETINA VITR, V5, DOI 10.1186/s40942-019-0176-9; Rezar S, 2015, ACTA OPHTHALMOL, V93, P719, DOI 10.1111/aos.12772; Shiozaki AA, 2013, J CARDIOVASC COMPUT, V7, P173, DOI 10.1016/j.jcct.2013.04.002; Sorour OA, 2019, INT OPHTHALMOL, V39, P2361, DOI 10.1007/s10792-019-01076-x; Stanga PE, 2016, DEV OPHTHALMOL, V56, P13, DOI 10.1159/000442771; Sun JK, 2014, JAMA OPHTHALMOL, V132, P1309, DOI 10.1001/jamaophthalmol.2014.2350; Suzuki N, 2019, BRIT J OPHTHALMOL, V103, P31, DOI 10.1136/bjophthalmol-2018-313322; Takase N, 2015, RETINA-J RET VIT DIS, V35, P2377, DOI 10.1097/IAE.0000000000000849; Wolff B, 2010, INVEST OPHTH VIS SCI, V51; Zahid S, 2016, INVEST OPHTH VIS SCI, V57, P4940, DOI 10.1167/iovs.16-19656; Zudaire E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027385	35	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241753	10.1371/journal.pone.0241753	http://dx.doi.org/10.1371/journal.pone.0241753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170872	Green Published, gold			2022-12-26	WOS:000592383400057
J	Sigglekow, F; Horsburgh, S; Parkin, L				Sigglekow, Finn; Horsburgh, Simon; Parkin, Lianne			Statin adherence is lower in primary than secondary prevention: A national follow-up study of new users	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; 14 RANDOMIZED-TRIALS; HEALTH-CARE COSTS; MEDICATION ADHERENCE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; THERAPY; CHOLESTEROL; MAINTENANCE; PREDICTORS	Background Maintaining adherence to statins reduces the risk of an initial cardiovascular disease (CVD) event in high-risk individuals (primary prevention) and additional CVD events following the first event (secondary prevention). The effectiveness of statin therapy is limited by the level of adherence maintained by the patient. We undertook a nationwide study to compare adherence and discontinuation in primary and secondary prevention patients. Methods Dispensing data from New Zealand community pharmacies were used to identify patients who received their first statin dispensing between 2006 and 2011. The Medication Possession Ratio (MPR) and proportion who discontinued statin medication was calculated for the year following first statin dispensing for patients with a minimum of two dispensings. Adherence was defined as an MPR. 0.8. Previous CVD was identified using hospital discharge records. Multivariable logistic regression was used to control for demographic and statin characteristics. Results Between 2006 and 2011 289,666 new statin users were identified with 238,855 (82.5%) receiving the statin for primary prevention compared to 50,811 (17.5%) who received it for secondary prevention. The secondary prevention group was 1.55 (95% CI 1.51-1.59) times as likely to be adherent and 0.67 (95% CI 0.65-0.69) times as likely to discontinue statin treatment than the primary prevention group. An early gap in statin coverage increased the odds of discontinuing statin treatment. Conclusion Adherence to statin medication is higher in secondary prevention than primary prevention. Within each group, a range of demographic and treatment factors further influences adherence.	[Sigglekow, Finn; Horsburgh, Simon; Parkin, Lianne] Univ Otago, Otago Med Sch, Dept Prevent & Social Med, Dunedin Campus, Dunedin, New Zealand; [Horsburgh, Simon; Parkin, Lianne] Univ Otago, Pharmacoepidemiol Res Network, Dunedin, New Zealand	University of Otago; University of Otago	Horsburgh, S (corresponding author), Univ Otago, Otago Med Sch, Dept Prevent & Social Med, Dunedin Campus, Dunedin, New Zealand.; Horsburgh, S (corresponding author), Univ Otago, Pharmacoepidemiol Res Network, Dunedin, New Zealand.	simon.horsburgh@otago.ac.nz	Horsburgh, Simon/C-9861-2009	Horsburgh, Simon/0000-0002-1011-7996; Sigglekow, Finn/0000-0002-7197-1512; Parkin, Lianne/0000-0002-6824-6176	Dunedin School of Medicine Summer Scholarship; University of Otago Research Grant	Dunedin School of Medicine Summer Scholarship; University of Otago Research Grant	This research was funded by a Dunedin School of Medicine Summer Scholarship (FS) and a University of Otago Research Grant (SH and LP). The funders had no role in the study design in the collection, analysis and interpretation of data, in the writing of the report; or in the decision to submit the article for publication.	Aarnio E, 2016, CIRC-CARDIOVASC QUAL, V9, P704, DOI 10.1161/CIRCOUTCOMES.116.002728; Aarnio EJ, 2014, J CLIN LIPIDOL, V8, P117, DOI 10.1016/j.jacl.2013.09.008; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Carey IM, 2012, NUTR METAB CARDIOVAS, V22, P400, DOI 10.1016/j.numecd.2010.09.010; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; Chodick G, 2008, CLIN THER, V30, P2167, DOI 10.1016/j.clinthera.2008.11.012; Cutler RL, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016982; Dragomir A, 2010, VALUE HEALTH, V13, P87, DOI 10.1111/j.1524-4733.2009.00583.x; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; Erickson SR, 2020, ANN PHARMACOTHER, V54, P1194, DOI 10.1177/1060028020934879; Gehi AK, 2007, ARCH INTERN MED, V167, P1798, DOI 10.1001/archinte.167.16.1798; Grenard JL, 2011, J GEN INTERN MED, V26, P1175, DOI 10.1007/s11606-011-1704-y; Grey C, 2018, NEW ZEAL MED J, V131, P21; Grey C, 2014, HEART, V100, P770, DOI 10.1136/heartjnl-2013-304960; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Hope HF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0201196; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jatrana S, 2011, J EPIDEMIOL COMMUN H, V65, P454, DOI 10.1136/jech.2009.099101; Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Kerr AJ, 2016, J PRIM HEALTH CARE, V8, P238, DOI 10.1071/HC16013; Mann DM, 2010, ANN PHARMACOTHER, V44, P1410, DOI 10.1345/aph.1P150; Martin-Ruiz E, 2018, J CARDIOVASC PHARM T, V23, P200, DOI 10.1177/1074248417745357; Ministry of Health, 2020, PHARM DAT WEB TOOL V; Ministry of Health, 2018, CARD DIS RISK ASS MA; Ministry of Health, 2019, ANN DAT EXPL 2018 19; Ministry of Health, 2017, HISO 100012017 ETHNI; Ministry of Health, 2016, HLTH LOSS NZ 1990 20; Muntner P, 2014, AM J CARDIOL, V114, P826, DOI 10.1016/j.amjcard.2014.06.009; New Zealand Guidelines Group, 2009, NZ CARDIOVASCULAR GU; New Zealand Guidelines Group, 2003, ASS MAN CARD RISK; New Zealand Guidelines Group, 2012, NZ PRIM CAR HDB 2012; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Palmer SC, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1057-4; Perreault S, 2005, BRIT J CLIN PHARMACO, V59, P564, DOI 10.1111/j.1365-2125.2005.02355.x; Pittman DG, 2011, AM J CARDIOL, V107, P1662, DOI 10.1016/j.amjcard.2011.01.052; Pylypchuk R, 2018, LANCET, V391, P1897, DOI [10.1016/s0140-6736(18)30664-0, 10.1016/S0140-6736(18)30664-0]; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Salmond C., 2007, NZDEP2006 INDEX DEPR; Slejko JF, 2014, J MANAGE CARE PHARM, V20, P51, DOI 10.18553/jmcp.2014.20.1.51; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Thornley S, 2012, EUR J PREV CARDIOL, V19, P349, DOI 10.1177/1741826711403069; Vinogradova Y, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3305; Vrijens B, 2012, BRIT J CLIN PHARMACO, V73, P691, DOI 10.1111/j.1365-2125.2012.04167.x; Waitangi Tribunal, 2019, HAUOR REP STAG ON HL; Watanabe JH, 2013, CURR MED RES OPIN, V29, P175, DOI 10.1185/03007995.2013.766164; Wells S, 2018, NEW ZEAL MED J, V131, P10; World Health Organization (WHO), 2018, DEF GEN CONS; Xie ZW, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212117	50	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0242424	10.1371/journal.pone.0242424	http://dx.doi.org/10.1371/journal.pone.0242424			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211724	Green Published			2022-12-26	WOS:000603518300055
J	Abuhammad, S				Abuhammad, Sawsan			Predictors of maternal parenting self-efficacy for infants and toddlers: A Jordanian study	PLOS ONE			English	Article							SOCIAL SUPPORT; POSTNATAL DEPRESSION; WOMEN	Aim This study aimed to investigate the predictors of maternal parenting self-efficacy when the children concerned are in the early years of life. Method A descriptive-analytical research study was carried out among 213 women who were in the early months of the postpartum period and attending healthcare facilities in Irbid, Jordan. The State Anxiety Inventory (SAI) and the Maternal Parenting Self-Efficacy (PMP S-E) tool were used to collect the data. Results A significant correlation was found between the scores in self-efficacy and the quality of marriage relations (B = 3.56, P = 001), family income (B = 1.97, P = .05), employment (B = 4.027, P = .027), education (B = 2.48, P = .004), and living with extended family (B = 5.28, P = .02). Conclusion The findings of this study show that MPSE is significantly associated with various predictors. These predictors are the mother's education, income, whether she lives with extended family, her quality of marriage, and her employment. Maternal anxiety was found not to be a predictor for MPSE and this may explain other factors such as social support and living with extended family. Implication It is essential for nurses to understand maternal parenting self-efficacy, therefore, including the concept of maternal parenting self-efficacy in nursing curricula can help raise awareness of this important concept. Understanding maternal parenting self-efficacy is necessary for nurses to evaluate the mothers' parenting self-efficacy.	[Abuhammad, Sawsan] Jordan Univ Sci & Technol, Fac Nursing, Irbid, Jordan	Jordan University of Science & Technology	Abuhammad, S (corresponding author), Jordan Univ Sci & Technol, Fac Nursing, Irbid, Jordan.	Shabuhammad@just.edu.jo	ABUHAMMAD, SAWSAN/AAW-1875-2020	ABUHAMMAD, SAWSAN/0000-0001-5817-8950				Abdel-Khalek AM, 2000, PSYCHOL REP, V87, P478, DOI 10.2466/PR0.87.6.478-492; Abuhammad S, 2021, NURS OPEN, V8, P123, DOI 10.1002/nop2.610; Abuhammad S, 2020, J PEDIATR NURS, V51, pE45, DOI 10.1016/j.pedn.2019.08.002; Abuhammad S, 2018, INT J PEDIATR-MASSHA, V6, P8655, DOI 10.22038/ijp.2018.33637.2975; Aliabadi F, 2013, IRAN REHABIL J, V11, P7; [Anonymous], 2020, Circulation, V141, pe59, DOI 10.1161/CIR.0000000000000754; [Anonymous], 2012, DIABETES METAB RES R, V28, pS1; [Anonymous], 2007, THESIS; Bandura, 1997, SELF EFFICACY EXERCI, P37; Bryanton J, 2008, NURS RES, V57, P252, DOI 10.1097/01.NNR.0000313490.56788.cd; Farkas C, 2010, INFANT BEHAV DEV, V33, P654, DOI 10.1016/j.infbeh.2010.09.001; Gao LL, 2014, MIDWIFERY, V30, P532, DOI 10.1016/j.midw.2013.06.007; Gharaibeh MK, 2012, J RES NURS, V17, P289, DOI 10.1177/1744987110395352; Holzmann-Pazgal G., 2010, Morbidity and Mortality Weekly Report, V59, P185; Koury AJ, 2020, APPL PSYCHOL-HLTH WE, V12, P432, DOI 10.1111/aphw.12191; Lawal AM, 2017, PSYCHOL HEALTH MED, V22, P1230, DOI 10.1080/13548506.2017.1317824; Leahy-Warren P, 2011, MIDWIFERY, V27, P802, DOI 10.1016/j.midw.2010.07.008; Salonen AH, 2009, J ADV NURS, V65, P2324, DOI 10.1111/j.1365-2648.2009.05113.x; Sari C, 2020, PUBLIC HEALTH NURS, V37, P380, DOI 10.1111/phn.12712; Sercekus P, 2016, MIDWIFERY, V34, P166, DOI 10.1016/j.midw.2015.11.016; Shorey S, 2015, J ADV NURS, V71, P1260, DOI 10.1111/jan.12590; Shorey S, 2014, J CLIN NURS, V23, P2272, DOI 10.1111/jocn.12507; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Stokes LO, PRENATAL ED POSTPART; Yap DFF, 2019, J APPL RES INTELLECT, V32, P841, DOI 10.1111/jar.12575; Zheng XJ, 2018, MIDWIFERY, V62, P151, DOI 10.1016/j.midw.2018.04.005	26	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241585	10.1371/journal.pone.0241585	http://dx.doi.org/10.1371/journal.pone.0241585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206672	gold, Green Published			2022-12-26	WOS:000595265900050
J	Domingo, MS; Martin-Perea, DM; Badgley, C; Cantero, E; Lopez-Guerrero, P; Oliver, A; Negro, JJ				Domingo, M. Soledad; Martin-Perea, David M.; Badgley, Catherine; Cantero, Enrique; Lopez-Guerrero, Paloma; Oliver, Adriana; Negro, Juan Jose			Taphonomic information from the modern vertebrate death assemblage of Donana National Park, Spain	PLOS ONE			English	Article							ECOLOGICAL FIDELITY; BONE ASSEMBLAGE; CONSERVATION; POPULATIONS; CONSUMPTION; CARCASSES; AMBOSELI; REMAINS; RECORD; SITE	Modern death assemblages provide insights about the early stages of fossilization and useful ecological information about the species inhabiting the ecosystem. We present the results of taphonomic monitoring of modern vertebrate carcasses and bones from Donana National Park, a Mediterranean coastal ecosystem in Andalusia, Spain. Ten different habitats were surveyed. Half of them occur in active depositional environments (marshland, lake margin, river margin, beach and dunes). Most of the skeletal remains belong to land mammals larger than 5 kg in body weight (mainly wild and feral ungulates). Overall, the Donana bone assemblage shows good preservation with little damage to the bones, partly as a consequence of the low predator pressure on large vertebrates. Assemblages from active depositional habitats differ significantly from other habitats in terms of the higher incidence of breakage and chewing marks on bones in the latter, which result from scavenging, mainly by wild boar and red fox. The lake-margin and river-margin death assemblages have high concentrations of well preserved bones that are undergoing burial and offer the greatest potential to produce fossil assemblages. The spatial distribution of species in the Donana death assemblage generally reflects the preferred habitats of the species in life. Meadows seem to be a preferred winter habitat for male deer, given the high number of shed antlers recorded there. This study is further proof that taphonomy can provide powerful insights to better understand the ecology of modern species and to infer past and future scenarios for the fossil record.	[Domingo, M. Soledad; Negro, Juan Jose] CSIC, Estn Biol Donana, Dept Ecol Evolut, Seville, Spain; [Martin-Perea, David M.; Cantero, Enrique] CSIC, Museo Nacl Ciencias Nat, Dept Paleobiol, Madrid, Spain; [Martin-Perea, David M.; Lopez-Guerrero, Paloma] Univ Complutense Madrid, Fac Ciencias Geol, Dept Geodinam Estratig & Paleontol, Madrid, Spain; [Martin-Perea, David M.] IDEA, Inst Human Evolut Africa, Madrid, Spain; [Badgley, Catherine] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Oliver, Adriana] Asociac Mujeres Con Pies Tierra, Madrid, Spain; [Domingo, M. Soledad] Univ Complutense Madrid, Dept Didact Ciencias Expt Ciencias Sociales & Mat, Fac Educ, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Complutense University of Madrid; University of Michigan System; University of Michigan; Complutense University of Madrid	Domingo, MS (corresponding author), CSIC, Estn Biol Donana, Dept Ecol Evolut, Seville, Spain.; Domingo, MS (corresponding author), Univ Complutense Madrid, Dept Didact Ciencias Expt Ciencias Sociales & Mat, Fac Educ, Madrid, Spain.	mariasod@ucm.es	Domingo, M. Soledad/I-1614-2014; Oliver, Adriana/L-8346-2016; Martin Perea, David Manuel/I-6979-2016	Oliver, Adriana/0000-0002-2583-8294; Domingo, M. Soledad/0000-0002-4755-8867; Martin Perea, David Manuel/0000-0002-3238-0904	European Union's Horizon 2020 research and innovation programme [MSCA-700196];  [CGL2015-68333-P]	European Union's Horizon 2020 research and innovation programme; 	MSD received funding for this project from the European Union's Horizon 2020 research and innovation programme under grant agreement MSCA-700196 (Marie Sklodowska-Curie Individual Fellowships programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MSD thanks David Paz (EBD-CSIC) and Miguel Angel Bravo (EBD-CSIC) for their invaluable help during our first visit to Donana National Park and continuous support. MSD also thanks Anna K. Behrensmeyer for the invitation to participate in the Amboseli 2016 bone survey; field methods used in this paper were learned there. Dr. Eloisa Bernaldez Sanchez provided advice about the Donana death-assemblage study. Isabel Afan (LAST-EBD service) put together the map shown in Fig 1B. DMMP is a predoctoral fellow of the 'Formacion Personal Investigador' program associated to Project CGL2015-68333-P. This study is part of the UCM 910607 research group.	ALCALA L, 1994, MACROMAMIFEROS NEOGE; Alunni Daniela, 2017, Journal of Taphonomy, V15, P1; Andres M, 2012, ARCHAEOL ANTHROP SCI, V4, P209, DOI 10.1007/s12520-012-0093-4; Andrews P, 1998, B SOC GEOL FR, V169, P433; [Anonymous], 2017, CONSEJERIA MEDIO AMB; Arilla M, 2019, ARCHAEOL ANTHROP SCI, V11, P2271, DOI 10.1007/s12520-018-0675-x; BADGLEY C, 1986, Palaios, V1, P328, DOI 10.2307/3514695; Behrensmeyer A.K., 1980, P72; Behrensmeyer A.K., 1980, FOSSILS MAKING; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; BEHRENSMEYER AK, 1985, PALEOBIOLOGY, V11, P105; Behrensmeyer AK, 2003, PALEOBIOLOGY, V29, P52, DOI 10.1666/0094-8373(2003)029<0052:TAEOMA>2.0.CO;2; Behrensmeyer AK, 2000, PALEOBIOLOGY, V26, P103, DOI 10.1666/0094-8373(2000)26[103:TAP]2.0.CO;2; Behrensmeyer AK, 2018, HIST BIOL, V30, P718, DOI 10.1080/08912963.2018.1432919; Behrensmeyer Anna K., 2012, P69; Behrensmeyer Anna K., 2007, P65; Behrensmeyer Anna K., 2002, P297; Sanchez EB, 2011, QUATERN INT, V243, P161, DOI 10.1016/j.quaint.2011.06.023; Bernaldez-Sanchez E, 2017, PALAIOS, V32, P288, DOI 10.2110/palo.2016.047; BRAZA F, 1987, Miscellania Zoologica (Barcelona), V11, P363; Braza F, 2017, ENCICLOPEDIA VIRTUAL; Carranza J., 2011, ENCICLOPEDIA VIRTUAL; Clemente L., 2004, INVESTIG CIENC, P72; Cruz I, 2008, QUATERN INT, V180, P30, DOI 10.1016/j.quaint.2007.08.008; Cutler AH, 1999, PALAEOGEOGR PALAEOCL, V149, P359, DOI 10.1016/S0031-0182(98)00212-0; de Ceballos Vazquez B, 2015, GUIA CAMPO AVES COMA; DELIBES M, 1980, ACTA THERIOL, V25, P309, DOI 10.4098/AT.arch.80-28; Diaz-Delgado R, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8090775; Diaz-Panigua C, 2016, PROYECTOS INVESTIGAC, P2011; Pesquero MD, 2013, LETHAIA, V46, P378, DOI 10.1111/let.12016; Dominguez-Solera SD, 2009, INT J OSTEOARCHAEOL, V19, P345, DOI 10.1002/oa.987; Dominguez-Solera S, 2011, ARCHAEOL ANTHROP SCI, V3, P385, DOI 10.1007/s12520-011-0071-2; Dumont ER, 2010, P ROY SOC B-BIOL SCI, V277, P2193, DOI 10.1098/rspb.2010.0117; European Commission, 2000, OFFICIAL METHODS OF, VC, P1, DOI 10.1108/03090550310770974; Fernandez N, 2010, REMOTE SENS ENVIRON, V114, P211, DOI 10.1016/j.rse.2009.09.001; Fernandez-Llario P., 1996, Miscellania Zoologica (Barcelona), V19, P9; Ferreras P, 2011, BASIC APPL ECOL, V12, P116, DOI 10.1016/j.baae.2011.01.005; Fillios M, 2011, ENVIRON ARCHAEOL, V16, P113, DOI 10.1179/174963111X13110803260895; Garrote G, 2011, EUR J WILDLIFE RES, V57, P355, DOI 10.1007/s10344-010-0440-7; GREENFIELD HJ, 1988, J FIELD ARCHAEOL, V15, P473, DOI 10.1179/jfa.1988.15.4.473; Gutierrez MA, 2018, QUATERN INT, V492, P40, DOI 10.1016/j.quaint.2017.09.025; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HAYNES G, 1988, J ARCHAEOL SCI, V15, P131, DOI 10.1016/0305-4403(88)90003-9; Haynes G., 1985, P53; Jimenez-Moreno G, 2010, REV PALAEOBOT PALYNO, V162, P403, DOI 10.1016/j.revpalbo.2009.08.001; KIDWELL SM, 1995, ANNU REV ECOL SYST, V26, P269, DOI 10.1146/annurev.es.26.110195.001413; Kidwell SM, 2013, ANNU REV ECOL EVOL S, V44, P539, DOI 10.1146/annurev-ecolsys-110512-135838; Liebig PM, 2003, PALAIOS, V18, P168, DOI 10.1669/0883-1351(2003)18<168:BOTBMM>2.0.CO;2; Lionello P, 2006, DEV EARTH ENV SCI, V4, P1, DOI 10.1016/s1571-9197(06)80003-0; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; Miller JH, 2014, PALEOBIOLOGY, V40, P560, DOI 10.1666/13062; Miller JH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0275; Miller JH, 2012, ECOLOGY, V93, P2474, DOI 10.1890/12-0272.1; Miller JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018057; Otaola C, 2016, ETHNOBIOL LETT, V7, P1, DOI 10.14237/ebl.7.1.2016.478; Plotnick RE, 2020, ANTHROPOCENE, V29, DOI 10.1016/j.ancene.2019.100233; Pyenson ND, 2010, PALEOBIOLOGY, V36, P453, DOI 10.1666/09018.1; Ramos B, 2003, PARQUE NACL DONANA, P317; Revilla E, 2001, CONSERV BIOL, V15, P148, DOI 10.1046/j.1523-1739.2001.99431.x; Rodriguez-Vidal J, 2014, WOR GEOMORPHOL LANDS, P229, DOI 10.1007/978-94-017-8628-7_19; SEPT JM, 1994, J ARCHAEOL SCI, V21, P217, DOI 10.1006/jasc.1994.1023; Serrano L., 2006, LIMNETICA, V25, P11, DOI DOI 10.1016/S1001-6058(15)60453-X; Soriguer RC, 2001, ORGANISMO AUTONOMO P; SUC JP, 1984, NATURE, V307, P429, DOI 10.1038/307429a0; TAPPEN M, 1995, CURR ANTHROPOL, V36, P223, DOI 10.1086/204353; Terry RC, 2010, PALEOBIOLOGY, V36, P137, DOI 10.1666/0094-8373-36.1.137; Tzedakis PC, 2007, QUATERNARY SCI REV, V26, P2042, DOI 10.1016/j.quascirev.2007.03.014; Venero Gonzales JL, 1984, DONANA ACTA VERTEBRA; Vicente J., 2011, INTEGRATED WASTE MAN, P97, DOI DOI 10.5772/21426; WEIGELT J, 1927, RECENT VERTEBRATE CA; Western D, 2009, SCIENCE, V324, P1061, DOI 10.1126/science.1171155; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Young A, 2015, J FORENSIC SCI, V60, P1426, DOI 10.1111/1556-4029.12839	73	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242082	10.1371/journal.pone.0242082	http://dx.doi.org/10.1371/journal.pone.0242082			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206694	Green Published, gold			2022-12-26	WOS:000595265900061
J	Dupree, A; Riess, HC; von Kroge, PH; Izbicki, JR; Debus, ES; Mann, O; Pinnschmidt, HO; Russ, D; Detter, C; Wipper, SH				Dupree, Anna; Riess, Henrik C.; von Kroge, Philipp H.; Izbicki, Jakob R.; Debus, Eike S.; Mann, Oliver; Pinnschmidt, Hans O.; Russ, Detlef; Detter, Christian; Wipper, Sabine H.			Validation of quantitative assessment of indocyanine green fluorescent imaging in a one-vessel model	PLOS ONE			English	Article							ANASTOMOTIC PERFUSION; INTRAOPERATIVE ASSESSMENT; GASTRIC CONDUIT; ANGIOGRAPHY; ISCHEMIA; LOCATION; SURGERY; GRAFT	Objectives Evaluation of intestinal perfusion remains subjective and depends on the surgeon ' s individual experience. Intraoperative quality assessment of tissue perfusion with indocyanine green (ICG) fluorescence using a near-infrared camera system has been described in different ways and for different indications. The aim of the present study was to evaluate fluorescent imaging (FI) in the quantitative assessment of intestinal perfusion in a gastric tube model in pigs and to compare the results to results obtained with florescent microspheres (FM), the gold standard for tissue perfusion. Methods Seven pigs (56.0 +/- 3.0 kg), both males and females, underwent gastric tube formation after transection and ligation of the gastric arteries, except the right gastroepiploic artery, to avoid collateral blood flow. After baseline assessment (T0), hypotension (T1) was induced by propofol (Karampinis et al 2017) (< 60 mmHg). Then, propofol was paused to obtain normotension (T2, Mean arterial pressure (MAP) 60-90 mmHg). Finally, hypertension (T3, MAP>90 mmHg) was induced by norepinephrine. Measurements were performed in three regions of interest (ROIs) under standardized conditions: the fundus (D1), corpus (D2), and prepyloric area (D3). Hemodynamic parameters and transit-time flow measurement (TTFM) in the right gastroepiploic artery were continuously assessed. FI, FM and the partial pressure of tissue oxygen (TpO(2)) were quantified in each ROI. Results The study protocol could successfully be performed during stable hemodynamics. Flow in the gastroepiploic artery measured by transit time flow measurement (TTFM) was related to hemodynamic changes between the measurements, indicating improved blood flow with increasing MAP. The distal part of the gastric tube (D1) showed significantly (p<0.05) impaired perfusion compared to the proximal parts D3 and D2 using FM. ICG-FI also showed the highest values in D3 and the lowest values in D1 at all hemodynamic levels (T1-T3; p<0,05). Conclusion Visual and quantitative assessment of gastric tube perfusion is feasible in an experimental setting using ICG-FI. This might be a promising tool for intraoperative assessment during visceral surgery in the future.	[Dupree, Anna; von Kroge, Philipp H.; Izbicki, Jakob R.; Mann, Oliver] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Riess, Henrik C.; Debus, Eike S.; Wipper, Sabine H.] Univ Med Ctr Hamburg Eppendorf, Univ Heart Ctr, Dept Vasc Med, Hamburg, Germany; [Pinnschmidt, Hans O.] Univ Hosp Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Russ, Detlef] Univ Ulm, Inst Laser Technol, Dept Dev Applicat, Ulm, Germany; [Detter, Christian] Univ Hosp Eppendorf, Ctr Cardiol & Cardiovasc Surg, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Dupree, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany.	adupree@uke.de						Boni L, 2015, SURG ENDOSC, V29, P2046, DOI 10.1007/s00464-014-3895-x; CHAN JCN, 1994, AUST NZ J MED, V24, P590, DOI 10.1111/j.1445-5994.1994.tb01777.x; CHERRICK GR, 1960, J CLIN INVEST, V39, P592, DOI 10.1172/JCI104072; Degett TH, 2016, LANGENBECK ARCH SURG, V401, P767, DOI 10.1007/s00423-016-1400-9; Detter C, 2002, HEART SURG FORUM, V5, P364; Detter C, 2007, CIRCULATION, V116, P1007, DOI 10.1161/CIRCULATIONAHA.106.655936; Diana M, 2014, SURG ENDOSC, V28, P3108, DOI 10.1007/s00464-014-3592-9; Diana M, 2014, ANN SURG, V259, P700, DOI 10.1097/SLA.0b013e31828d4ab3; FLOWER RW, 1973, INVEST OPHTH VISUAL, V12, P248; GLENNY RW, 1993, J APPL PHYSIOL, V74, P2585, DOI 10.1152/jappl.1993.74.5.2585; Hellan M, 2014, SURG ENDOSC, V28, P1695, DOI 10.1007/s00464-013-3377-6; HOPEROSS M, 1994, OPHTHALMOLOGY, V101, P529; Jafari MD, 2015, J AM COLL SURGEONS, V220, P82, DOI 10.1016/j.jamcollsurg.2014.09.015; Karampinis I, 2018, J GASTROINTEST SURG, V22, P2117, DOI 10.1007/s11605-018-3855-1; Kin C, 2015, DIS COLON RECTUM, V58, P582, DOI 10.1097/DCR.0000000000000320; Kudszus S, 2010, LANGENBECK ARCH SURG, V395, P1025, DOI 10.1007/s00423-010-0699-x; McCulloch AD, 1998, CARDIOVASC RES, V37, P636, DOI 10.1016/S0008-6363(97)00290-3; Murawa D, 2012, ACTA CHIR BELG, V112, P275, DOI 10.1080/00015458.2012.11680838; Pacheco PE, 2013, AM J SURG, V205, P349, DOI 10.1016/j.amjsurg.2012.11.005; Protyniak B, 2015, AM SURGEON, V81, P580; Schaafsma BE, 2011, J SURG ONCOL, V104, P323, DOI 10.1002/jso.21943; Sherwinter DA, 2013, COLORECTAL DIS, V15, P91, DOI 10.1111/j.1463-1318.2012.03101.x; Sherwinter DA, 2012, SURG LAPARO ENDO PER, V22, P433, DOI 10.1097/SLE.0b013e3182601eb8; Shimada Y, 2011, ESOPHAGUS-TOKYO, V8, P259, DOI 10.1007/s10388-011-0291-7; Siddaramappa S, 2012, STAND GENOMIC SCI, V6, P251, DOI 10.4056/sigs.2806097; Thompson SK, 2006, MICROSURG, V26, P131, DOI 10.1002/micr.20197; Toens C, 2006, INT J COLORECTAL DIS, V21, P332, DOI 10.1007/s00384-005-0017-1; Urbanavicius L, 2011, WORLD J GASTRO SURG, V3, P59, DOI 10.4240/wjgs.v3.i5.59; Wipper S, 2016, INT J CARDIOVAS IMAG, V32, P363, DOI 10.1007/s10554-015-0767-y; Zehetner J, 2015, ANN SURG, V262, P74, DOI 10.1097/SLA.0000000000000811; Zhang LH, 2005, WORLD J GASTROENTERO, V11, P2830, DOI 10.3748/wjg.v11.i18.2830	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0240188	10.1371/journal.pone.0240188	http://dx.doi.org/10.1371/journal.pone.0240188			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206647	Green Published, gold			2022-12-26	WOS:000595265900078
J	Liu, LY; Miller, HJ; Scheff, J				Liu, Luyu; Miller, Harvey J.; Scheff, Jonathan			The impacts of COVID-19 pandemic on public transit demand in the United States	PLOS ONE			English	Article							AFRICAN-AMERICANS; ACCESS	The COVID-19 pandemic and related restrictions led to major transit demand decline for many public transit systems in the United States. This paper is a systematic analysis of the dynamics and dimensions of this unprecedented decline. Using transit demand data derived from a widely used transit navigation app, we fit logistic functions to model the decline in daily demand and derive key parameters: base value, the apparent minimal level of demand and cliff and base points, representing the initial date when transit demand decline began and the final date when the decline rate attenuated. Regression analyses reveal that communities with higher proportions of essential workers, vulnerable populations (African American, Hispanic, Female, and people over 45 years old), and more coronavirus Google searches tend to maintain higher levels of minimal demand during COVID-19. Approximately half of the agencies experienced their decline before the local spread of COVID-19 likely began; most of these are in the US Midwest. Almost no transit systems finished their decline periods before local community spread. We also compare hourly demand profiles for each system before and during COVID-19 using ordinary Procrustes distance analysis. The results show substantial departures from typical weekday hourly demand profiles. Our results provide insights into public transit as an essential service during a pandemic.	[Liu, Luyu; Miller, Harvey J.] Ohio State Univ, Dept Geog, Columbus, OH 43210 USA; [Liu, Luyu; Miller, Harvey J.] Ohio State Univ, Ctr Urban & Reg Anal, Columbus, OH 43210 USA; [Scheff, Jonathan] Transit App Inc, Montreal, PQ, Canada	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Liu, LY (corresponding author), Ohio State Univ, Dept Geog, Columbus, OH 43210 USA.; Liu, LY (corresponding author), Ohio State Univ, Ctr Urban & Reg Anal, Columbus, OH 43210 USA.	liu.6544@osu.edu		Liu, Luyu/0000-0002-6684-5570; Miller, Harvey/0000-0001-5480-3421				Achenbach J., 2020, WASH POST; [Anonymous], 2020, TRANS SUBW BUS TIM; Bliss L., 2020, WORLD STOPS MOVING; Bloch M., 2020, NY TIMES 0402; Carleton P, 2019, TRANSPORT RES REC, V2673, P173, DOI 10.1177/0361198119851748; Centers for Disease Control and Prevention, 2020, COR 2019 COVID 19 SU; Cheng H-Y, 2020, HIGH TRANSMISSIBILIT; CJI Research Corporation Clark HM, 2017, WHO RID PUBL TRANSP; Cooke TJ, 1997, URBAN GEOGR, V18, P213, DOI 10.2747/0272-3638.18.3.213; Dong YY, 2020, PEDIATRICS, V145, DOI 10.1542/peds.2020-0702; Evans E., 2020, CITY COUNTY LEADERS; Giuliano G, 2005, TRANSPORT RES REC, V1927, P63, DOI 10.3141/1927-08; Golub A, 2013, URBAN GEOGR, V34, P699, DOI 10.1080/02723638.2013.778598; Iseki H., 2010, DEMOGRAPHICS PUBLIC; Kim C, 2017, KSCE J CIV ENG, V21, P2888, DOI 10.1007/s12205-017-0821-5; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Li CL, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.10.2000199; Lin YH, 2020, BRAIN BEHAV IMMUN, V87, P30, DOI 10.1016/j.bbi.2020.04.020; Ma XL, 2017, J TRANSP GEOGR, V58, P135, DOI 10.1016/j.jtrangeo.2016.12.001; McLauphlin EC, 2020, CDC OFFICIAL WARNS A; Mitteroecker P, 2013, HYSTRIX, V24, P59, DOI 10.4404/hystrix-24.1-6369; Pan XF, 2020, LANCET INFECT DIS, V20, P410, DOI 10.1016/S1473-3099(20)30114-6; Pathak R, 2017, REG SCI URBAN ECON, V66, P198, DOI 10.1016/j.regsciurbeco.2017.07.002; Polzin SE, 2000, TRANSPORT RES REC, P10; Popovich N., 2020, US CORONAVIRUS DIAGN; Porter JD, 2018, STATEWIDE DATA STAND; Tan S, 2020, WASHINGTON POST; Transit app, 2020, WHOS LEFT RID PUBL T; Transit app, 2020, TRANSIT BUS SUBWAY T; Transit app, 2020, COR IS DISR PUBL TRA; Transit app, 2020, WHOS ONB SURV TRANS; U.S. Bureau of Labor Statistics, 2018, LAB FORC CHAR RAC ET; US Bureau of Labor Statistics, 2019, TABL 1 WORK WHO COUL; USAFacts, 2020, COR LOC COVID 19 MAP; VIA Metropolitan Transit, 2020, 03 24 2020 VIA CONT; Wang KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089405; Weber H., 2020, AIR TRAFFIC DATA SHO; WMATA, 2020, METR COV 19 STEPS WE; Yuan GX, 2020, PREDICTION OUTBREAK; Zhao JH, 2014, TRANSPORT RES REC, P80, DOI 10.3141/2415-09; Zimmerman R, 2005, J URBAN HEALTH, V82, P21, DOI 10.1093/jurban/jti005	41	77	77	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242476	10.1371/journal.pone.0242476	http://dx.doi.org/10.1371/journal.pone.0242476			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206721	gold, Green Published			2022-12-26	WOS:000595265900049
J	McPherron, SP; Abdolahzadeh, A; Archer, W; Chan, A; Djakovic, I; Dogandzic, T; Leader, GM; Li, L; Lin, S; Magnani, M; Reeves, J; Rezek, Z; Weiss, M				McPherron, Shannon P.; Abdolahzadeh, Aylar; Archer, Will; Chan, Annie; Djakovic, Igor; Dogandzic, Tamara; Leader, George M.; Li, Li; Lin, Sam; Magnani, Matthew; Reeves, Jonathan; Rezek, Zeljko; Weiss, Marcel			Introducing platform surface interior angle (PSIA) and its role in flake formation, size and shape	PLOS ONE			English	Article							ATTRIBUTES EVIDENCE; PERCUSSION FLAKING; BRITTLE MATERIALS; MASS; MECHANICS	Four ways archaeologists have tried to gain insights into how flintknapping creates lithic variability are fracture mechanics, controlled experimentation, replication and attribute studies of lithic assemblages. Fracture mechanics has the advantage of drawing more directly on first principles derived from physics and material sciences, but its relevance to controlled experimentation, replication and lithic studies more generally has been limited. Controlled experiments have the advantage of being able to isolate and quantify the contribution of individual variables to knapping outcomes, and the results of these experiments have provided models of flake formation that when applied to the archaeological record of flintknapping have provided insights into past behavior. Here we develop a linkage between fracture mechanics and the results of previous controlled experiments to increase their combined explanatory and predictive power. We do this by documenting the influence of Herztian cone formation, a constant in fracture mechanics, on flake platforms. We find that the platform width is a function of the Hertzian cone constant angle and the geometry of the platform edge. This finding strengthens the foundation of one of the more influential models emerging from the controlled experiments. With additional work, this should make it possible to merge more of the experimental results into a more comprehensive model of flake formation.	[McPherron, Shannon P.; Archer, Will; Dogandzic, Tamara; Rezek, Zeljko; Weiss, Marcel] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany; [Abdolahzadeh, Aylar; Leader, George M.] Univ Penn, Dept Anthropol, Philadelphia, PA 19104 USA; [Archer, Will] Natl Museum, Dept Archaeol & Anthropol, Bloemfontein, South Africa; [Djakovic, Igor] Leiden Univ, Dept Archaeol, Leiden, Netherlands; [Li, Li; Reeves, Jonathan] Eberhard Karls Univ Tubingen, Dept Early Prehist & Quaternary Ecol, Tubingen, Germany; [Lin, Sam] Univ Wollongong, Sch Earth Atmospher & Life Sci, Ctr Archaeol Sci, Wollongong, NSW, Australia; [Leader, George M.] Coll New Jersey, Dept Sociol & Anthropol, Ewing, NJ USA; [Chan, Annie] Ludwig Maximilians Univ Munchen, Dept Asian Studies, Munich, Germany; [Magnani, Matthew] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Chan, Annie] Ctr Rech Civilisat Asie Orientale, Paris, France	Max Planck Society; University of Pennsylvania; Leiden University; Leiden University - Excl LUMC; Eberhard Karls University of Tubingen; University of Wollongong; College of New Jersey; University of Munich; Harvard University; UDICE-French Research Universities; Universite Paris Cite	McPherron, SP (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Leipzig, Germany.	mcpherron@eva.mpg.de	Lin, Sam C/F-6474-2012; Lin, Sam/AAE-5236-2020	Lin, Sam/0000-0001-6834-2646; Weiss, Marcel/0000-0002-0778-5520; Chan, Annie/0000-0002-4435-3209; Archer, Will/0000-0003-1174-0605	Max Planck Society; European Research Council (ERC) under the European Union [714658]; European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020) under the Marie SklodowskaCurie [751125]; European Union [751125]	Max Planck Society(Max Planck SocietyFoundation CELLEX); European Research Council (ERC) under the European Union(European Research Council (ERC)); European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020) under the Marie SklodowskaCurie; European Union(European Commission)	We thank the Max Planck Society for funding portions of this work. LL and JR received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no 714658; STONECULT project). TD received funding from the European Union's Framework Programme for Research and Innovation Horizon 2020 (2014-2020) under the Marie SklodowskaCurie grant agreement No. 751125. Specifically: SPM, MW, WA, and ZR receive salary from the Max Planck Society through the Max Plank Institute for Evolutionary Anthropology, the Department of Human Evolution. The department also paid equipment, travel money, and other expenses that allowed this study to be done. LL and LR have their salaries paid by European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement no 714658; STONECULT project. TD has her salary paid by her grant from the European Union's Framework Programme for Research and Innovation Horizon 2020 (20142020) under the Marie Sklodowska-Curie grant agreement No. 751125. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; AKIMUNE Y, 1990, J AM CERAM SOC, V73, P3607, DOI 10.1111/j.1151-2916.1990.tb04265.x; [Anonymous], 2018, VOX             0919; Archer S, 2013, ISLAMIC FINANCE: THE NEW REGULATORY CHALLENGE, 2ND EDITION, P3; Archer W, 2018, ARCHAEOL ANTHROP SCI, V10, P1991, DOI 10.1007/s12520-017-0517-2; BOURGUIGNON L., 2011, INVESTIGACION EXPT A, P53; Braun DR, 2010, NEW PERSPECTIVES ON OLD STONES: ANALYTICAL APPROACHES TO PALEOLITHIC TECHNOLOGIES, P167, DOI 10.1007/978-1-4419-6861-6_7; Brenet M., 2011, INVESTIG EXP APL ARQ, P77; Brenet M., 2009, NOUVELLES LARCH OLOG, V118, P60, DOI DOI 10.4000/NDA.941; Chai H, 2007, INT J FRACTURE, V145, P159, DOI 10.1007/s10704-007-9113-2; Chaudhri MM, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0135; Chen L-Y, 1989, 18 INT C HIGH SPEED, P955; CHEN SY, 1995, INT J SOLIDS STRUCT, V32, P329, DOI 10.1016/0020-7683(94)00127-I; Clarkson C, 2011, J ARCHAEOL SCI, V38, P1062, DOI 10.1016/j.jas.2010.12.001; COTTERELL B, 1985, INT J FRACTURE, V29, P205, DOI 10.1007/BF00125471; COTTERELL B, 1987, AM ANTIQUITY, V52, P675, DOI 10.2307/281378; Cotterell B, 1979, LITHIC USE WEAR ANAL, P97; Davis ZJ, 1998, J ARCHAEOL SCI, V25, P603, DOI 10.1006/jasc.1997.0255; Dibble HL, 2009, J ARCHAEOL SCI, V36, P1945, DOI 10.1016/j.jas.2009.05.004; DIBBLE HL, 1981, J ARCHAEOL SCI, V8, P283, DOI 10.1016/0305-4403(81)90004-2; DIBBLE HL, 1995, J ARCHAEOL SCI, V22, P429, DOI 10.1006/jasc.1995.0042; Dibble HL, 1997, LITHIC TECHNOL, V22, P150, DOI [10.1080/01977261.1997.11754540, DOI 10.1080/01977261.1997.11754540]; Dogandzic T, 2020, ARCHAEOL ANTHROP SCI, V12, DOI 10.1007/s12520-019-00963-9; Eren MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029273; Fischer-Cripps AC, 2007, INTRO CONTACT MECH; FRANK FC, 1967, PROC R SOC LON SER-A, V299, P291, DOI 10.1098/rspa.1967.0137; Hiscock P, 2010, WORLD ARCHAEOL, V42, P545, DOI 10.1080/00438243.2010.517669; Hu SF, 1996, INT J FRACTURE, V79, P295, DOI 10.1007/BF00019382; Jaubert, 2008, SOC PALEOLITHIQUE GR, P83; Kocer C, 1998, J AM CERAM SOC, V81, P1736, DOI 10.1111/j.1151-2916.1998.tb02542.x; LAWN BR, 1974, INT J FRACTURE, V10, P1, DOI 10.1007/BF00955075; Leader G, 2017, J ARCHAEOL SCI-REP, V16, P213, DOI 10.1016/j.jasrep.2017.09.026; Lin SC, 2013, AM ANTIQUITY, V78, P724, DOI 10.7183/0002-7316.78.4.724; Magnani M, 2014, J ARCHAEOL SCI, V46, P37, DOI 10.1016/j.jas.2014.02.029; Marimuthu KP, 2016, PROCEEDINGS OF 2016 7TH INTERNATIONAL CONFERENCE ON MECHANICAL AND AEROSPACE ENGINEERING, (ICMAE), P267, DOI 10.1109/ICMAE.2016.7549548; McElreath R, 2018, SIZING HUMAN BRAIN E, P496; Mourre V, 2010, SCIENCE, V330, P659, DOI 10.1126/science.1195550; Muller A, 2014, J ARCHAEOL SCI, V52, P31, DOI 10.1016/j.jas.2014.08.025; Ortega Cordellat I., 2013, EXPT ARQUEOLOGIA EST, P219; Pelcin A, 1997, J ARCHAEOL SCI, V24, P613, DOI 10.1006/jasc.1996.0145; Pelcin AW, 1997, J ARCHAEOL SCI, V24, P1107, DOI 10.1006/jasc.1996.0190; Pelcin AW, 1997, J ARCHAEOL SCI, V24, P749, DOI 10.1006/jasc.1996.0156; R Core Team, 2018, R LANG ENV STAT COMP; Rezek Z, 2011, J ARCHAEOL SCI, V38, P1346, DOI 10.1016/j.jas.2011.01.014; ROESLER FC, 1956, P PHYS SOC LOND B, V69, P981, DOI 10.1088/0370-1301/69/10/303; Shott MJ, 2000, J ARCHAEOL SCI, V27, P877, DOI 10.1006/jasc.1999.0499; SPETH JD, 1975, AM ANTIQUITY, V40, P203, DOI 10.2307/279616; SPETH JD, 1972, AM ANTIQUITY, V37, P34, DOI 10.2307/278884; Speth JD., 1974, TEBIWA, V17, P7; Speth John D, 1981, LITHIC TECHNOLOGY, V10, P16, DOI DOI 10.1080/01977261.1981.11720840; Wang XE, 2017, ENG STRUCT, V152, P493, DOI 10.1016/j.engstruct.2017.08.050	51	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241714	10.1371/journal.pone.0241714	http://dx.doi.org/10.1371/journal.pone.0241714			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206671	gold, Green Published			2022-12-26	WOS:000595265900013
J	Kawabata, R; Soma, Y; Kudo, Y; Yokoyama, J; Shimizu, H; Akaike, A; Suzuki, D; Katsuragi, Y; Totsuka, M; Nakaji, S				Kawabata, Ryosuke; Soma, Yuki; Kudo, Yutaro; Yokoyama, Junichi; Shimizu, Hiroyasu; Akaike, Arata; Suzuki, Daisuke; Katsuragi, Yoshihisa; Totsuka, Manabu; Nakaji, Shigeyuki			Relationships between body composition and pulmonary function in a community-dwelling population in Japan	PLOS ONE			English	Article							VISCERAL FAT ACCUMULATION; LUNG-FUNCTION; COMPUTED-TOMOGRAPHY; RESPIRATORY-FUNCTION; METABOLIC SYNDROME; OBESITY; ASSOCIATION; SPIROMETRY; PLASMA; IMPACT	Pulmonary diseases, including chronic obstructive pulmonary disease (COPD), are major chronic diseases that result in decreased pulmonary function. Relationships between body composition and pulmonary function have been reported. However, few epidemiological studies have used the visceral fat area (VFA) to measure body composition. This study aimed to examine the relationship between body composition and pulmonary function. A cross-sectional study was conducted between 2015 and 2016, using data obtained from 1,287 residents aged between 19 and 91 years living in the Iwaki area of Hirosaki City, a rural region in Aomori Prefecture, Japan. Pulmonary function was evaluated using the forced vital capacity (FVC) as a percentage of the predicted value (predicted FVC%) and the ratio of forced expiratory volume in one second (FEV1) to FVC. The measurements for evaluating body composition included the body fat percentage (BFP) of the whole body and trunk, skeletal muscle index (SMI), body mass index (BMI), VFA, waist circumference (WC) at the navel level, and waist-to-hip ratio (WHR). To adjust for potential confounders, Spearman's partial correlation analysis was used to examine the relationship between the measurements of body composition and pulmonary function. There were significant correlations between the predicted FVC% and the following parameters: BFP (whole body and trunk) in younger males; SMI in older males; WC, VFA, BMI, and SMI in younger females; and BFP (whole body and trunk) and VFA in older females. Contrastingly, WC and VFA in younger males and WC in younger females were correlated with the FEV1/FVC ratio. VFA was correlated with the FEV1/FVC ratio in younger males and predicted FVC% in older females. These findings suggest that visceral fat accumulation may increase the development of obstructive pulmonary disease in young males and accelerate the decline of pulmonary function (predicted FVC%) in older females.	[Kawabata, Ryosuke; Kudo, Yutaro; Yokoyama, Junichi; Shimizu, Hiroyasu; Akaike, Arata; Suzuki, Daisuke; Nakaji, Shigeyuki] Hirosaki Univ, Dept Social Med, Grad Sch Med, Aomori, Japan; [Kawabata, Ryosuke] Hachinohe Coll, Natl Inst Technol, Dept Gen Sci Educ, Hachinohe, Aomori, Japan; [Soma, Yuki] Iwate Prefectural Univ, Morioka Jr Coll, Dept Life Sci, Takizawa, Iwate, Japan; [Yokoyama, Junichi] Nippon Sport Sci Univ, Dept Phys Educ, Setagaya Ku, Tokyo, Japan; [Katsuragi, Yoshihisa] Hirosaki Univ, Dept Act Life Promot Sci, Grad Sch Med, Hirosaki, Aomori, Japan; [Katsuragi, Yoshihisa] Kao Corp, Hlth Care Food Res Labs, Sumida Ku, Tokyo, Japan; [Totsuka, Manabu] Hirosaki Univ, Dept Educ, Hirosaki, Aomori, Japan	Hirosaki University; Iwate Prefectural University; Nippon Sport Science University; Hirosaki University; KAO Corporation; Hirosaki University	Kawabata, R (corresponding author), Hirosaki Univ, Dept Social Med, Grad Sch Med, Aomori, Japan.; Kawabata, R (corresponding author), Hachinohe Coll, Natl Inst Technol, Dept Gen Sci Educ, Hachinohe, Aomori, Japan.	kawabata-g@hachinohe-ct.ac.jp			JST COI Grant [JPMJCE1302]	JST COI Grant	This work was supported by JST COI Grant Number JPMJCE1302. The author YK was employed by commercial company: Health Care Food Research Laboratories, Kao Corporation, Tokyo, Japan. However, the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding organization of YK only provided financial support in the form of YK's salaries and research materials.	Baffi CW, 2016, CHEST, V149, P1525, DOI 10.1016/j.chest.2015.12.034; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; BURROWS B, 1977, AM REV RESPIR DIS, V115, P195; Choe EK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193516; Choi HS, 2007, TUBERC RESPIR DIS, V62, P276, DOI 10.4046/trd.2007.62.4.276; de Oliveira PD, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0510-7; DeLorey DS, 2005, INT J OBESITY, V29, P1039, DOI 10.1038/sj.ijo.0803003; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; ENZI G, 1986, AM J CLIN NUTR, V44, P739, DOI 10.1093/ajcn/44.6.739; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; GRINER PF, 1981, ANN INTERN MED, V94, P553, DOI 10.7326/0003-4819-94-4-571; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Ida M, 2013, OBESITY, V21, pE350, DOI 10.1002/oby.20300; Inomoto Atsushi, 2016, J Phys Ther Sci, V28, P2883; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; JENSEN MD, 1995, AM J CLIN NUTR, V61, P274, DOI 10.1093/ajcn/61.2.274; Kadowaki T, 2006, INT J OBESITY, V30, P1163, DOI 10.1038/sj.ijo.0803248; Kadowaki Takashi, 2008, Journal of the Japan Diabetes Society, V51, P281; KOTANI K, 1994, INT J OBESITY, V18, P207; Kubota M, 2014, RESPIR INVESTIG, V52, P242, DOI 10.1016/j.resinv.2014.03.003; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Ministry of Health Labour and Welfare, OFF REP NAT HLTH NUT; Mohamed EI, 2002, LUNG, V180, P149, DOI 10.1007/s004080000089; Naka T, 2005, JIKEIKAI MED J, V120, P35; Park CH, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012281; Park YS, 2011, J KOREAN MED SCI, V26, P771, DOI 10.3346/jkms.2011.26.6.771; Poulain M, 2006, CAN MED ASSOC J, V174, P1293, DOI 10.1503/cmaj.051299; Rowe A, 2017, RESP MED, V131, P199, DOI 10.1016/j.rmed.2017.08.030; Ryo M, 2005, DIABETES CARE, V28, P451, DOI 10.2337/diacare.28.2.451; Ryo M, 2014, WORLD J RADIOL, V6, P409, DOI 10.4329/wjr.v6.i7.409; Salome CM, 2010, J APPL PHYSIOL, V108, P206, DOI 10.1152/japplphysiol.00694.2009; Tanaka S, 2003, ACTA DIABETOL, V40, pS302, DOI 10.1007/s00592-003-0093-z; Thijs W, 2014, RESP MED, V108, P351, DOI 10.1016/j.rmed.2013.10.003; Tojo Naoko, 2005, Rinsho Byori, V53, P77; van den Borst B, 2011, EUR RESPIR J, V38, P1887; van den Borst B, 2012, AM J CLIN NUTR, V96, P516, DOI 10.3945/ajcn.112.040774; VANDERKOOY K, 1993, BRIT J NUTR, V70, P47, DOI 10.1079/BJN19930104; W.H. Organization, 1999, DEFINITION DIAGNOSIS; Wannamethee SG, 2005, AM J CLIN NUTR, V82, P996, DOI 10.1093/ajcn/82.5.996; ZAMBONI M, 1992, INT J OBESITY, V16, P495	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242308	10.1371/journal.pone.0242308	http://dx.doi.org/10.1371/journal.pone.0242308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201904	gold, Green Published			2022-12-26	WOS:000595003900038
J	Sari, IN; Yang, YG; Wijaya, YT; Jun, N; Lee, S; Kim, KS; Bajaj, J; Oehler, VG; Kim, SH; Choi, SY; Park, SH; Kim, DW; Reya, T; Han, J; Kwon, HY				Sari, Ita Novita; Yang, Ying-Gui; Wijaya, Yoseph Toni; Jun, Nayoung; Lee, Sanghyun; Kim, Kwang Seock; Bajaj, Jeevisha; Oehler, Vivian G.; Kim, Soo-Hyun; Choi, Soo-Young; Park, Sa-Hee; Kim, Dong-Wook; Reya, Tannishtha; Han, Jaeseok; Kwon, Hyog Young			AMD1 is required for the maintenance of leukemic stem cells and promotes chronic myeloid leukemic growth	ONCOGENE			English	Article							POLYAMINE BIOSYNTHESIS INHIBITOR; PHASE-II TRIAL; GENE-EXPRESSION; ESCHERICHIA-COLI; CANCER; METABOLISM; SPERMINE; SAM486A; STRESS; TARGETS	Polyamines are critical elements in mammals, but it remains unknown whether adenosyl methionine decarboxylase (AMD1), a rate-limiting enzyme in polyamine synthesis, is required for myeloid leukemia. Here, we found that leukemic stem cells (LSCs) were highly differentiated, and leukemia progression was severely impaired in the absence of AMD1 in vivo. AMD1 was highly upregulated as chronic myeloid leukemia (CML) progressed from the chronic phase to the blast crisis phase, and was associated with the poor prognosis of CML patients. In addition, the pharmacological inhibition of AMD1 by AO476 treatment resulted in a robust reduction of the progression of leukemic cells both in vitro and in vivo. Mechanistically, AMD1 depletion induced loss of mitochondrial membrane potential and accumulation of reactive oxygen species (ROS), resulting in the differentiation of LSCs via oxidative stress and aberrant activation of unfolded protein response (UPR) pathway, which was partially rescued by the addition of polyamine. These results indicate that AMD1 is an essential element in the progression of myeloid leukemia and could be an attractive target for the treatment of the disease.	[Sari, Ita Novita; Yang, Ying-Gui; Wijaya, Yoseph Toni; Jun, Nayoung; Lee, Sanghyun; Kim, Kwang Seock; Han, Jaeseok; Kwon, Hyog Young] Soonchunhyang Univ, Soonchunhyang Inst Medibio Sci, Cheonan, South Korea; [Yang, Ying-Gui] Southern Med Univ, Shenzhen Hosp, Clin Innovat & Res Ctr CIRC, Shenzhen Key Lab Viral Oncol, Shenzhen, Peoples R China; [Bajaj, Jeevisha; Reya, Tannishtha] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Bajaj, Jeevisha; Reya, Tannishtha] Sanford Consortium Regenerat Med, La Jolla, CA USA; [Oehler, Vivian G.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA; [Kim, Soo-Hyun; Choi, Soo-Young; Park, Sa-Hee; Kim, Dong-Wook] Catholic Univ Korea, Catholic Leukemia Res Inst, Seoul, South Korea; [Kim, Dong-Wook] Catholic Univ Korea, Seoul St Marys Hosp, Dept Hematol, Seoul, South Korea; [Reya, Tannishtha] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Soonchunhyang University; Southern Medical University - China; University of California System; University of California San Diego; Fred Hutchinson Cancer Center; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital; Duke University	Kwon, HY (corresponding author), Soonchunhyang Univ, Soonchunhyang Inst Medibio Sci, Cheonan, South Korea.	hykwon@sch.ac.kr		KIM, Kwang Seock/0000-0002-3329-1225; Sari, Ita Novita/0000-0001-9475-7992; Wijaya, Yoseph Toni/0000-0003-3002-8592	National Research Foundation of Korea [NRF-2020R1A2C1003791, NRF-2019R1A5A8083404]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHID) - Ministry of Health & Welfare, Republic of Korea [HI15C1647]; Global Research Development Center [NRF-2016K1A4A3914725]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHID) - Ministry of Health & Welfare, Republic of Korea; Global Research Development Center	This work was supported by the National Research Foundation of Korea (NRF-2020R1A2C1003791 and NRF-2019R1A5A8083404), the grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHID), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI15C1647) and Global Research Development Center (NRF-2016K1A4A3914725).	Abreu RD, 2009, J BIOL CHEM, V284, P12125, DOI 10.1074/jbc.M809605200; Agostinelli E, 2007, AMINO ACIDS, V33, P175, DOI 10.1007/s00726-007-0510-7; Basuroy UK, 2006, J BIOCHEM, V139, P27, DOI 10.1093/jb/mvj022; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Ferreira AMC, 2016, J CHROMATOGR A, V1444, P32, DOI 10.1016/j.chroma.2016.03.054; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Das KC, 2004, MOL CELL BIOCHEM, V262, P127, DOI 10.1023/B:MCBI.0000038227.91813.79; delaVega AL, 1996, J BACTERIOL, V178, P3715, DOI 10.1128/jb.178.13.3715-3721.1996; Fujisawa S, 2005, ANTICANCER RES, V25, P965; Gamble LD, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00162; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Gugliucci A, 2004, CLIN CHIM ACTA, V344, P23, DOI 10.1016/j.cccn.2004.02.022; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Ji AR, 2010, EXP MOL MED, V42, P175, DOI 10.3858/emm.2010.42.3.018; Jung IL, 2003, BIOCHEM BIOPH RES CO, V301, P915, DOI 10.1016/S0006-291X(03)00064-0; Kabbarah O, 2003, AM J PATHOL, V162, P755, DOI 10.1016/S0002-9440(10)63872-2; Kim JS, 2006, ENVIRON TOXICOL PHAR, V22, P160, DOI 10.1016/j.etap.2006.02.003; Kwon HY, 2015, CELL STEM CELL, V17, P152, DOI 10.1016/j.stem.2015.06.006; Larque E, 2007, NUTRITION, V23, P87, DOI 10.1016/j.nut.2006.09.006; Liao CZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10754; Luo M, 2018, CELL METAB, V28, P69, DOI 10.1016/j.cmet.2018.06.006; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Millward MJ, 2005, INVEST NEW DRUG, V23, P253, DOI 10.1007/s10637-005-6734-z; MUSCARI C, 1995, MOL CELL BIOCHEM, V144, P125, DOI 10.1007/BF00944391; Paridaens R, 2000, BRIT J CANCER, V83, P594, DOI 10.1054/bjoc.2000.1305; Park SM, 2014, J EXP MED, V211, P71, DOI 10.1084/jem.20130736; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Pless M, 2004, CLIN CANCER RES, V10, P1299, DOI 10.1158/1078-0432.CCR-0977-03; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Rider JE, 2007, AMINO ACIDS, V33, P231, DOI 10.1007/s00726-007-0513-4; RUSSELL DH, 1971, NATURE-NEW BIOL, V233, P144, DOI 10.1038/newbio233144a0; Sagor GHM, 2013, TRANSGENIC RES, V22, P595, DOI 10.1007/s11248-012-9666-3; Sava IG, 2006, FREE RADICAL BIO MED, V41, P1272, DOI 10.1016/j.freeradbiomed.2006.07.008; Scuoppo C, 2012, NATURE, V487, P244, DOI 10.1038/nature11126; Segawa T, 2002, ONCOGENE, V21, P8749, DOI 10.1038/sj.onc.1205992; Seiler N, 1996, INT J BIOCHEM CELL B, V28, P843, DOI 10.1016/1357-2725(96)00021-0; SIMON MS, 1990, INVEST NEW DRUG, V8, pS79; Siu LL, 2002, CLIN CANCER RES, V8, P2157; Soda K, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-95; SOHAL RS, 1986, ADV FREE RADICAL BIO, V2, P117, DOI 10.1016/S8755-9668(86)80026-6; Stewart TM, 2018, J BIOL CHEM, V293, P18736, DOI 10.1074/jbc.TM118.003337; TIBURCIO AF, 1994, BIOCHEM SOC T, V22, pS455, DOI 10.1042/bst022455s; Tkachenko AG, 2003, BIOCHEMISTRY-MOSCOW+, V68, P850, DOI 10.1023/A:1025790729797; Urdiales JL, 2001, EUR J GASTROEN HEPAT, V13, P1015, DOI 10.1097/00042737-200109000-00003; van Zuylen L, 2004, CLIN CANCER RES, V10, P1949, DOI 10.1158/1078-0432.CCR-02-0995; Vu LP, 2017, NAT GENET, V49, P866, DOI 10.1038/ng.3854; Walker JA, 2017, JAIDS-J ACQ IMM DEF, V74, P583, DOI 10.1097/QAI.0000000000001297; Xu LJ, 2020, CARCINOGENESIS, V41, P214, DOI 10.1093/carcin/bgz098; Zimdahl B, 2014, NAT GENET, V46, P245, DOI 10.1038/ng.2889	52	6	6	0	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2021	40	3					603	617		10.1038/s41388-020-01547-x	http://dx.doi.org/10.1038/s41388-020-01547-x		NOV 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PU9SL	33203990				2022-12-26	WOS:000590200200001
J	Caccamo, D; Cannata, A; Ricca, S; Catalano, LM; Montalto, AF; Alibrandi, A; Ercoli, A; Granese, R				Caccamo, Daniela; Cannata, Attilio; Ricca, Sergio; Catalano, Liliana Maria; Montalto, Antonella Federica; Alibrandi, Angela; Ercoli, Alfredo; Granese, Roberta			Role of Vitamin-D Receptor (VDR) single nucleotide polymorphisms in gestational hypertension development: A case-control study	PLOS ONE			English	Article							RENIN-ANGIOTENSIN SYSTEM; GENE POLYMORPHISMS; PREECLAMPSIA; PREGNANCY; ASSOCIATION; MARKERS; BLOOD	Background Recent literature data have highlighted the important role of hypovitaminosis D in pregnancy complications and prenatal/perinatal health. Vitamin D action takes place through vitamin D receptor (VDR) activation. Two single nucleotide polymorphisms of VDR gene, FokI and BsmI, have been reported to affect VDR molecular signaling and be associated with several disorders, including hypertension. Methods We carried out a case-control study aimed to assess vitamin D serum levels together with the distribution of VDR FokI and BsmI in a population of 116 pregnant women with gestational hypertension (GH) and 69 normotensive pregnant women (CTR). Results Hypovitaminosis D was largely prevalent both in GH (81%) and CTR (69%) pregnant women. Vitamin D insufficiency (10-30 ng/ml) had a similar frequency in both cohorts (GH 60% vs CTR 58%), while vitamin D deficiency (<10 ng/ml) was more frequent in GH cohort than in CTR one (21% vs 11%). Regression analysis showed that GH was significantly (p = 0.031) linked to vitamin D status. Vitamin D deficiency was associated with a threefold-increased risk of developing GH, while a normal vitamin D status was protective against this pregnancy disorder. The VDR FF/bB haplotype was the most frequent in GH cohort, and resulted to increase by two folds the risk for GH. Notably, hypovitaminosis D was found in 92% of FF/bB GH pregnant women, 27% of which had deficient vitamin D levels compared with 11% of their normotensive counterparts. Conclusions Despite being preliminary, these findings suggest that genotyping of pregnant women for VDR polymorphisms may be useful for a tailored vitamin D supplementation strategy.	[Caccamo, Daniela; Cannata, Attilio; Ricca, Sergio] Univ Messina, Dept Biomed Sci Dent Sci & Morphofunct Imaging, Messina, Italy; [Catalano, Liliana Maria; Montalto, Antonella Federica; Ercoli, Alfredo; Granese, Roberta] Univ Messina, Dept Human Pathol Adult & Childhood G Barresi, Messina, Italy; [Alibrandi, Angela] Univ Messina, Sect Stat & Math Sci, Dept Econ, Messina, Italy	University of Messina; University of Messina; University of Messina	Granese, R (corresponding author), Univ Messina, Dept Human Pathol Adult & Childhood G Barresi, Messina, Italy.	rgranese@unime.it	Ercoli, Alfredo/AAO-3913-2021; Granese, Roberta/AFV-8048-2022	Ercoli, Alfredo/0000-0002-3377-2803; Granese, Roberta/0000-0003-0318-9390				ACOG, 2019, OBSTET GYNECOL; Caccamo D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030892; Serrano-Diaz NC, 2018, BIOMEDICA, V38, P43, DOI 10.7705/biomedica.v38i0.3683; Colonese F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/986281; Fichera M, 2020, INT J FOOD SCI NUTR, V71, P276, DOI 10.1080/09637486.2019.1661978; Furuya M, 2011, J PREGNANCY, V2011, DOI 10.1155/2011/123717; Irani RA, 2008, PLACENTA, V29, P763, DOI 10.1016/j.placenta.2008.06.011; Jamali N, 2018, AM J PHYSIOL-HEART C, V314, pH753, DOI 10.1152/ajpheart.00319.2017; Kiely ME, 2020, J STEROID BIOCHEM, V201, DOI 10.1016/j.jsbmb.2020.105669; Kiely ME, 2016, AM J CLIN NUTR, V104, P354, DOI 10.3945/ajcn.116.130419; Kim DH, 2020, NUTRIENTS, V12, DOI 10.3390/nu12020575; Lagana AS, 2018, J MATERN-FETAL NEO M, V31, P817, DOI 10.1080/14767058.2017.1296426; Lagana AS, 2017, ARCH GYNECOL OBSTET, V295, P867, DOI 10.1007/s00404-017-4296-x; Lagana AS, 2016, J MATERN-FETAL NEO M, V29, P3019, DOI 10.3109/14767058.2015.1113522; Lagana AS, 2017, EUR REV MED PHARM SC; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Lin L, 2019, CURR PROTEIN PEPT SC, V20, P984, DOI 10.2174/1389203720666190807130504; Lo TH, 2019, TZU CHI MED J, V31, P201, DOI 10.4103/tcmj.tcmj_32_19; Lumbers ER, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00563; Ma R, 2012, AM J PHYSIOL-ENDOC M, V303, pE928, DOI 10.1152/ajpendo.00279.2012; Marques FZ, 2011, PLACENTA, V32, P214, DOI 10.1016/j.placenta.2010.12.006; Muray S, 2003, J HYPERTENS; O'Callaghan KM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030294; Pall ML, 2003, ENVIRON HEALTH PERSP, V111, P1461, DOI 10.1289/ehp.5935; Purswani JM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1408-3; Rezavand N, 2019, J CELL BIOCHEM, V120, P6441, DOI 10.1002/jcb.27934; Rezende VB, 2012, MOL BIOL REP, V39, P10903, DOI 10.1007/s11033-012-1988-y; Rizzo G, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8110511; Santoro D, 2015, CLIN BIOCHEM, V48, P1028, DOI 10.1016/j.clinbiochem.2015.05.009; Santoro D, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/145828; Scholl TO, 2013, AM J CLIN NUTR, V98, P787, DOI 10.3945/ajcn.112.055871; Swapna N, 2011, Indian J Hum Genet, V17, P201, DOI 10.4103/0971-6866.92104; Vahedi Farnoosh Asghar, 2020, Nurs Womens Health, V24, P91, DOI 10.1016/j.nwh.2020.02.001; Vaidya A, 2011, CLIN ENDOCRINOL, V74, P783, DOI 10.1111/j.1365-2265.2011.03991.x; Valdivielso JM, 2006, CLIN CHIM ACTA, V371, P1, DOI 10.1016/j.cca.2006.02.016; Wagner CL, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00500; Wang L, 2013, EUR J NUTR, V52, P1771, DOI 10.1007/s00394-012-0480-8; Young BC, 2010, ANNU REV PATHOL-MECH, V5, P173, DOI 10.1146/annurev-pathol-121808-102149; Zhang J, 1997, EPIDEMIOL REV, V19, P218, DOI 10.1093/oxfordjournals.epirev.a017954; Zhu YB, 2019, EUR REV MED PHARMACO, V23, P9066, DOI 10.26355/eurrev_201910_19309	40	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0239407	10.1371/journal.pone.0239407	http://dx.doi.org/10.1371/journal.pone.0239407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186385	Green Published, gold			2022-12-26	WOS:000593949800012
J	Goyala, A; Baruah, A; Mukhopadhyay, A				Goyala, Anita; Baruah, Aiswarya; Mukhopadhyay, Arnab			The genetic paradigms of dietary restriction fail to extend life span in cep-1(gk138) mutant of C. elegans p53 due to possible background mutations	PLOS ONE			English	Article							DOMINANT-NEGATIVE DMP53; CAENORHABDITIS-ELEGANS; INDUCED LONGEVITY; EXPRESSION; PATHWAY; MICE	Dietary restriction (DR) increases life span and improves health in most model systems tested, including non-human primates. In C. elegans, as in other models, DR leads to reprogramming of metabolism, improvements in mitochondrial health, large changes in expression of cytoprotective genes and better proteostasis. Understandably, multiple global transcriptional regulators like transcription factors FOXO/DAF-16, FOXA/PHA-4, HSF1/HSF-1 and NRF2/SKN-1 are important for DR longevity. Considering the wide-ranging effects of p53 on organismal biology, we asked whether the C. elegans ortholog, CEP-1 is required for DR-mediated longevity assurance. We employed the widely-used TJ1 strain of cep-1(gk138). We show that cep-1(gk138) suppresses the life span extension of two genetic paradigms of DR, but two non-genetic modes of DR remain unaffected in this strain. We find that two aspects of DR, increased autophagy and up-regulation of the expression of cytoprotective xenobiotic detoxification program (cXDP) genes, are dampened in cep-1(gk138). Importantly, we find that background mutation(s) in the strain may be the actual cause for the phenotypic differences that we observed and cep-1 may not be directly involved in genetic DR-mediated longevity assurance in worms. Identifying these mutation(s) may reveal a novel regulator of longevity required specifically by genetic modes of DR.	[Goyala, Anita; Mukhopadhyay, Arnab] Natl Inst Immunol, Mol Aging Lab, Aruna Asaf Ali Marg, New Delhi, India; [Baruah, Aiswarya] Assam Agr Univ, Dept Agr Biotechnol, Jorhat, Assam, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Assam Agricultural University	Mukhopadhyay, A (corresponding author), Natl Inst Immunol, Mol Aging Lab, Aruna Asaf Ali Marg, New Delhi, India.	arnab@nii.ac.in	Mukhopadhyay, Arnab/N-6005-2016	Mukhopadhyay, Arnab/0000-0002-5266-7849	National Bioscience Award for Career Development [BT/HRD/NBA/38/04/2016]; SERB-STAR award [STR/2019/000064]; DBT's Twinning Programme [BT/PR16823/NER/95/304/2015]; National Institute of Immunology; National Institute of Health Office of Research Infrastructure Programs [P40 OD010440]	National Bioscience Award for Career Development; SERB-STAR award; DBT's Twinning Programme; National Institute of Immunology; National Institute of Health Office of Research Infrastructure Programs	The research was supported in part by the National Bioscience Award for Career Development (BT/HRD/NBA/38/04/2016) and SERB-STAR award (STR/2019/000064) to AM, DBT's Twinning Programme for the NE (BT/PR16823/NER/95/304/2015) to AM and AB, and core funding from the National Institute of Immunology to AM. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by National Institute of Health Office of Research Infrastructure Programs (P40 OD010440).	Arum O, 2007, J GERONTOL A-BIOL, V62, P951, DOI 10.1093/gerona/62.9.951; Baruah A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004097; Bauer JH, 2005, CURR BIOL, V15, P2063, DOI 10.1016/j.cub.2005.10.051; Bauer JH, 2007, P NATL ACAD SCI USA, V104, P13355, DOI 10.1073/pnas.0706121104; Bauer JH, 2010, MECH AGEING DEV, V131, P193, DOI 10.1016/j.mad.2010.01.007; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Chamoli M, 2014, AGING CELL, V13, P641, DOI 10.1111/acel.12218; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; de Keizer PLJ, 2010, AGING-US, V2, P377, DOI 10.18632/aging.100178; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Han SK, 2016, ONCOTARGET, V7, P56147, DOI 10.18632/oncotarget.11269; Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024; HOSONO R, 1989, EXP GERONTOL, V24, P251, DOI 10.1016/0531-5565(89)90016-8; Jolliffe AK, 2013, BRIEF FUNCT GENOMICS, V12, P129, DOI 10.1093/bfgp/els047; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lapierre LR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3267; Leung CK, 2012, FREE RADICAL BIO MED, V52, P937, DOI 10.1016/j.freeradbiomed.2011.12.009; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Matai L, 2019, P NATL ACAD SCI USA, V116, P17383, DOI 10.1073/pnas.1900055116; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Steinkraus KA, 2008, AGING CELL, V7, P394, DOI 10.1111/j.1474-9726.2008.00385.x; Stiernagle Theresa, 2006, WormBook, P1; Tabrez SS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00370-5; Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730; Tavernarakis N, 2008, TRENDS CELL BIOL, V18, P228, DOI 10.1016/j.tcb.2008.02.004; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Ventura N, 2009, AGING CELL, V8, P380, DOI 10.1111/j.1474-9726.2009.00482.x; Waskar M, 2009, AGING-US, V1, P903, DOI 10.18632/aging.100099; Williams AB, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026070; Wu ZY, 2019, CELL METAB, V29, P1192, DOI 10.1016/j.cmet.2019.02.013	36	0	0	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241478	10.1371/journal.pone.0241478	http://dx.doi.org/10.1371/journal.pone.0241478			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180887	Green Published, Green Submitted, gold			2022-12-26	WOS:000593948000044
J	Lilleri, D; Zavaglio, F; Gabanti, E; Gerna, G; Arbustini, E				Lilleri, Daniele; Zavaglio, Federica; Gabanti, Elisa; Gerna, Giuseppe; Arbustini, Eloisa			Analysis of the SARS-CoV-2 epidemic in Italy: The role of local and interventional factors in the control of the epidemic	PLOS ONE			English	Article								Containment measures have been applied in several countries in order to limit the diffusion of the SARS-CoV-2 epidemic. The scope of this study is to analyze the evolution of the first wave of the SARS-CoV-2 epidemic throughout Italy and factors associated to the different way it spread in the Italian Regions, starting from the day that the first indigenous cases were detected through day 81 (6 days after the end of the strict lockdown). Data were obtained from daily reports and are represented as number (and percentage) of cases/100,000 persons. A lockdown with movement restrictions, especially across Regions, was declared at day 20. At day 81, 219,070 cases (363/100,000 persons) were diagnosed. A regression analysis based on the Gompertz model predicts a total number 233,606 cases (386/100,000 persons) at the end of the epidemic. The 21 areas, divided into Italian Regions and autonomous Provinces, showed a wide range in the frequency of cases at day 81 (58-921, median 258/100,000 persons) and total predicted cases (58-946, median 267/100,000 persons). Similarly, the predicted time for the end of the wave of the epidemic (considering as surrogate marker the time at which 99% of the total cases are predicted to occur) was highly variable, ranging from 64 to 136 (median 99) days. We analyzed the impact of local and interventional variables on the epidemic curve in each Region. The number of cases correlated inversely with the distance from the area in which first cases were detected and directly also with the gross domestic product pro capite (as a marker of industrial activity) of the Region. Moreover, an earlier start of the lockdown (i.e. in the presence of a lower number of cases) and wider testing were associated with a lower final number of total cases. In conclusion, this analysis shows that population-wide testing and early lockdown enforcement appear effective in limiting the spreading of the SARS-CoV-2 epidemic.	[Lilleri, Daniele; Zavaglio, Federica; Gabanti, Elisa; Gerna, Giuseppe; Arbustini, Eloisa] Fdn IRCCS Policlin San Matteo, Lab Genet Trapiantol & Malattie Cardiovasc, Pavia, Italy; [Lilleri, Daniele; Zavaglio, Federica; Gabanti, Elisa] Fdn IRCCS Policlin San Matteo, Microbiol & Virol, Pavia, Italy	IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo	Lilleri, D (corresponding author), Fdn IRCCS Policlin San Matteo, Lab Genet Trapiantol & Malattie Cardiovasc, Pavia, Italy.; Lilleri, D (corresponding author), Fdn IRCCS Policlin San Matteo, Microbiol & Virol, Pavia, Italy.	d.lilleri@smatteo.pv.it	Arbustini, Eloisa/K-8174-2016; Zavaglio, Federica/ABB-2314-2021	Arbustini, Eloisa/0000-0003-2948-7994; Zavaglio, Federica/0000-0001-5471-1711; Gerna, Giuseppe/0000-0001-5956-2786; Gabanti, Elisa/0000-0003-4865-4006	Fondazione Cariplo, Milano, Italy	Fondazione Cariplo, Milano, Italy(Fondazione Cariplo)	This work was funded by Fondazione Cariplo, Milano, Italy (Grant CoVIM to DL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Bordi L, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104416; Cassaniti I, 2020, J MED VIROL, V92, P1724, DOI 10.1002/jmv.25800; Day M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m751; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; GERNA G, 1980, P SOC EXP BIOL MED, V163, P360; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Gompertz B., 1825, PHILOS T ROYAL SOC L, V115, P515, DOI [DOI 10.1098/RSTL.1825.0026, 10.1098/rstl.1825.0026]; Hale T., 2020, VARIATION GOVT RESPO; Lee SY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236860; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Li ZT, 2020, J MED VIROL, V92, P1518, DOI 10.1002/jmv.25727; Rong XM, 2020, MATH BIOSCI ENG, V17, P2725, DOI 10.3934/mbe.2020149; Tjorve E, 2010, J THEOR BIOL, V267, P417, DOI 10.1016/j.jtbi.2010.09.008; Tjorve KMC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178691; Vollmer Michaela AC, 2020, Using mobility to estimate thetransmission intensity of COVID-19 in Italy: a subnational analysis with future scenarios, DOI [10.25561/78677, DOI 10.25561/78677]; World Health Organization, COVID 19 EXPL; World Health Organization, 2020, CRIT PREP READ RESP; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	19	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242305	10.1371/journal.pone.0242305	http://dx.doi.org/10.1371/journal.pone.0242305			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180880	Green Published, gold			2022-12-26	WOS:000593948000074
J	Njoroge, MW; Rylance, S; Nightingale, R; Gordon, S; Mortimer, K; Burney, P; Rylance, J; Obasi, A; Niessen, L; Devereux, G				Njoroge, Martin W.; Rylance, Sarah; Nightingale, Rebecca; Gordon, Stephen; Mortimer, Kevin; Burney, Peter; Rylance, Jamie; Obasi, Angela; Niessen, Louis; Devereux, Graham		IMPALA Consortium	Cohort profile: The Chikwawa lung health cohort; a population-based observational non-communicable respiratory disease study of adults in Malawi	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CHILDHOOD ASTHMA; GLOBAL BURDEN; AIR-POLLUTION; RISK-FACTORS; PREVALENCE; EXPOSURE; INCOME	Purpose The aim of this article is to provide a detailed description of the Chikwawa lung health cohort which was established in rural Malawi to prospectively determine the prevalence and causes of lung disease amongst the general population of adults living in a low-income rural setting in Sub-Saharan Africa. Participants A total of 1481 participants were randomly identified and recruited in 2014 for the baseline study. We collected data on demographic, socio-economic status, respiratory symptoms and potentially relevant exposures such as smoking, household fuels, environmental exposures, occupational history/exposures, dietary intake, healthcare utilization, cost (medication, outpatient visits and inpatient admissions) and productivity losses. Spirometry was performed to assess lung function. At baseline, 56.9% of the participants were female, mean age was 43.8 (SD:17.8) and mean body mass index (BMI) was 21.6 Kg/m(2) (SD: 3.46) Findings to date The cohort has reported the prevalence of chronic respiratory symptoms (13.6%, 95% confidence interval [CI], 11.9-15.4), spirometric obstruction (8.7%, 95% CI, 7.0-10.7), and spirometric restriction (34.8%, 95% CI, 31.7-38.0). Additionally, an annual decline in forced expiratory volume in one second [FEV1] of 30.9mL/year (95% CI: 21.6 to 40.1) and forced vital capacity [FVC] by 38.3 mL/year (95% CI: 28.5 to 48.1) has been reported. Future plans The ongoing phases of follow-up will determine the annual rate of decline in lung function as measured through spirometry and the development of airflow obstruction and restriction, and relate these to morbidity, mortality and economic cost of airflow obstruction and restriction. Population-based mathematical models will be developed driven by the empirical data from the cohort and national population data for Malawi to assess the effects of interventions and programmes to address the lung burden in Malawi. The present follow-up study started in 2019.	[Njoroge, Martin W.; Rylance, Sarah; Nightingale, Rebecca; Gordon, Stephen; Mortimer, Kevin; Rylance, Jamie; Obasi, Angela; Niessen, Louis; Devereux, Graham] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [Njoroge, Martin W.; Nightingale, Rebecca; Gordon, Stephen; Rylance, Jamie] Malawi Liverpool Wellcome Trust Programme, Blantyre, Malawi; [Burney, Peter] Imperial Coll, Natl Heart & Lung Inst, London, England; [Niessen, Louis] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	Liverpool School of Tropical Medicine; University of Malawi; Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Njoroge, MW (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.; Njoroge, MW (corresponding author), Malawi Liverpool Wellcome Trust Programme, Blantyre, Malawi.	martin.njoroge@lstmed.ac.uk	Obasi, Angela/AAK-4395-2021; Niessen, Louis/F-6254-2015; Rylance, Jamie/ABD-9314-2021	Obasi, Angela/0000-0001-6801-8889; Niessen, Louis/0000-0002-8639-5191; Gordon, Stephen/0000-0001-6576-1116; Mortimer, Kevin/0000-0002-8118-8871; Rylance, Sarah/0000-0001-6459-9073; Burney, Peter/0000-0001-8635-5678; Njoroge, Martin W./0000-0002-9474-8698	National Institute for Health Research (NIHR) from the UK Government [16/136/35]; Medical Research Council [MR/L002515/1]; UK Department for International Development; Wellcome Trust [MR/K006533/1]; MRC [MR/L002515/1, MR/K006533/1, 1855152] Funding Source: UKRI	National Institute for Health Research (NIHR) from the UK Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was funded by the National Institute for Health Research (NIHR) (project reference 16/136/35) using UK aid from the UK Government to support global health research. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or the UK Department of Health and Social Care. Initial funding (between 2013 -2017) was provided by a New Investigator Research Grant from the Medical Research Council (Ref: MR/L002515/1), a Joint Global Health Trials Grant from the Medical Research Council, UK Department for International Development and Wellcome Trust (Ref: MR/K006533/1).	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Adab P, 2017, INT J EPIDEMIOL, V46, P23, DOI 10.1093/ije/dyv350; Andersen ZJ, 2011, AM J RESP CRIT CARE, V183, P455, DOI 10.1164/rccm.201006-0937OC; [Anonymous], 2019, OP DAT; Banda HT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188437; Boy E, 2002, ENVIRON HEALTH PERSP, V110, P109, DOI 10.1289/ehp.02110109; Buist A Sonia, 2005, COPD, V2, P277, DOI 10.1081/COPD-200057610; Buist AS, 1996, EUR RESPIR REV, V6, P253; Burney PGJ, 2015, EUR RESPIR J, V45, P1239, DOI 10.1183/09031936.00142414; Cooper BG, 2011, POSTGRAD MED J, V87, P724, DOI 10.1136/pgmj.2010.139881rep; D'Ambruoso L, 2017, LANCET GLOB HEALTH, V5, pE20, DOI 10.1016/S2214-109X(16)30332-1; Drummond MF, 2015, METHODS EC EVALUATIO; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; El Rhazi K, 2016, INT J TUBERC LUNG D, V20, P136, DOI 10.5588/ijtld.15.0029; Evaluation I for HM and Network HD Bank W, 2013, GLOB BURD DIS GEN EV; Finney LJ, 2013, INT J TUBERC LUNG D, V17, P583, DOI 10.5588/ijtld.12.0619; FLETCHER CM, 1952, P ROY SOC MED, V45, P577; Garden FL, 2018, INT J EPIDEMIOL, V47, P1736, DOI 10.1093/ije/dyy078; Gordon Stephen, 2006, Malawi Med J, V18, P134; Gowshall M, 2018, INT J GEN MED, V11, P255, DOI 10.2147/IJGM.S157987; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hooper R, 2012, EUR RESPIR J, V39, P1343, DOI 10.1183/09031936.00002711; Jan S, 2018, LANCET, V391, P2047, DOI 10.1016/S0140-6736(18)30323-4; Jaspers L, 2015, EUR J EPIDEMIOL, V30, P163, DOI 10.1007/s10654-014-9983-3; Lange P, 2015, NEW ENGL J MED, V373, P111, DOI 10.1056/NEJMoa1411532; Martins P, 2009, ALLERGY, V64, P1061, DOI 10.1111/j.1398-9995.2009.01956.x; Meghji J, 2020, THORAX, V75, P269, DOI [10.1136/thoraxjnl-2019-213808, 10.1136/thoraxjnl-2020-214580]; Meghji J, 2016, AM J RESP CRIT CARE, V194, P67, DOI 10.1164/rccm.201509-1807OC; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Ministry of Health, 2008, MULT IMP EV SCAL FIG; Ministry of Health Malawi and ICF, 2014, MAL SERV PROV ASS MS; Mortimer K, 2017, LANCET, V389, P167, DOI 10.1016/S0140-6736(16)32507-7; Mussa R., 2011, POVERTY MALAWI CURRE; National Statistical Office ICF Macro, 2017, MAL DEM HLTH SURV 20; Nightingale R, 2019, AM J RESP CRIT CARE, V199, P613, DOI 10.1164/rccm.201805-0936OC; North CM, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010434; Obaseki DO, 2017, ANN AM THORAC SOC, V14, P714, DOI [10.1513/AnnalsATS.201608-598OC, 10.1513/annalsats.201608-598oc]; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Republic of Malawi and Malawi NCDI Poverty Commission, 2018, MAL NONC DIS INJ REP; Romieu I, 2001, EPIDEMIOL REV, V23, P268, DOI 10.1093/oxfordjournals.epirev.a000806; Rylance S, 2020, THORAX, V75, P220, DOI 10.1136/thoraxjnl-2019-213941; Rylance S, 2019, THORAX, V74, P1070, DOI 10.1136/thoraxjnl-2018-212945; Siddharthan T, 2019, B WORLD HEALTH ORGAN, V97, P318, DOI 10.2471/BLT.18.216523; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; Tagiyeva N, 2016, AM J RESP CRIT CARE, V193, P23, DOI 10.1164/rccm.201505-0870OC; Tai A, 2014, THORAX, V69, P805, DOI 10.1136/thoraxjnl-2013-204815; Terzic A, 2011, CTS-CLIN TRANSL SCI, V4, P225, DOI 10.1111/j.1752-8062.2011.00295.x; World Health Organisation, 2017, CHRON OBSTR PULM DIS; World Health Organisation, 2021, NONC DIS; World Health Organization, 2017, ASTHM FACT SHEET; Zere E, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-27; 1960, BMJ BRIT MED J, V2, P1665	52	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242226	10.1371/journal.pone.0242226	http://dx.doi.org/10.1371/journal.pone.0242226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180873	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000593948000019
J	Camilleri, J; Borg, J; Damidot, D; Salvadori, E; Pilecki, P; Zaslansky, P; Darvell, BW				Camilleri, Josette; Borg, Joseph; Damidot, Denis; Salvadori, Enrico; Pilecki, Peter; Zaslansky, Paul; Darvell, Brian W.			Colour and chemical stability of bismuth oxide in dental materials with solutions used in routine clinical practice	PLOS ONE			English	Article							MINERAL TRIOXIDE AGGREGATE; CALCIUM HYDROXIDE; TOOTH; HYPOCHLORITE; CONTACT; RADIOPACITY; SPECTRA; MTA	Bismuth(III) oxide is included as a radio-opacifier in dental materials, including hydraulic silicate cements, the material of choice for several endodontic procedures. It has been implicated in tooth discoloration after contact with endodontic irrigants, in particular NaOCl solution, To date, there has been no work on the chemistry: all reports have been of clinical findings only. The purpose now was to report the reactions leading to colour change from Bi2O3 in contact with solutions used in routine endodontic practice. Ten-gram portions of Bi2O3 were immersed in either water, NaOH, NaCl, NaOCl or HCl solution, either in the dark or exposed to visible light, and samples retrieved at 1, 4, 12 and 24 weeks. After washing, these were exposed to either added CO2 or not, for 1 week while drying, and under the same dark or light conditions. Changes in appearance were monitored by photography and colour measurement, and chemically by X-ray diffraction and Fourier-transform infrared spectroscopy. 24-week material was studied using electron paramagnetic resonance and Raman spectroscopy; NaOCl-treated material was also examined by scanning electron microscopy. With water, NaCl and NaOH, bismuth subcarbonate was formed. With or without added carbon dioxide, discoloration occurred from pale yellow to light brown when exposed to light, and to a lesser extent in the dark, intensifying with time. In contrast, exposure to NaOCl rapidly formed a dark brown-black sodium bismuthate. With HCl, white BiOCl was formed. Bi2O3 is not at all inert in this context as is commonly believed, denying its principle of use. Previously unreported solution-mediated reaction occurs readily even in water and NaCl solution, forming new compounds that discolour. In contact with NaOCl sodium bismuthate is formed; severe darkening occurs rapidly. The reactivity is such that Bi2O3 is not indicated for dental materials and should be withdrawn from use.	[Camilleri, Josette; Darvell, Brian W.] Univ Birmingham, Sch Dent, Birmingham, W Midlands, England; [Borg, Joseph] Triq L Uqija Ta L Ibrag, Is Swieqi, Malta; [Damidot, Denis] Ecole Mines, LGCgE GCE, Fac Civil Engn, Dept Civil & Struct Engn, Douai, France; [Salvadori, Enrico] Univ Torino, Dept Chem, Turin, Italy; [Pilecki, Peter] Kings Coll London, Imaging & Microscopy, London, England; [Zaslansky, Paul] Charite Univ Med Berlin, Ctr Zahn Mund & Kieferheilkunde, Dept Operat & Prevent Dent, Berlin, Germany	University of Birmingham; IMT - Institut Mines-Telecom; IMT Nord Europe; Universite de Lille - ISITE; Universite de Lille; University of Turin; University of London; King's College London; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Camilleri, J; Darvell, BW (corresponding author), Univ Birmingham, Sch Dent, Birmingham, W Midlands, England.	J.Camilleri@bham.ac.uk; b.w.darvell@hku.hk	Damidot, Denis/G-3215-2011; zaslansky, paul/AAB-7322-2021; camilleri, josette/N-9409-2015	Damidot, Denis/0000-0001-6630-9607; zaslansky, paul/0000-0002-8714-4992; camilleri, josette/0000-0003-3556-6365				[Anonymous], 2019, COL PART 4 CIE 1976; Bai Y, 2014, RSC ADV, V4, P19456, DOI 10.1039/c4ra01629g; Barel A.O., 2010, HDB COSMETIC SCI TEC; Camilleri J, 2008, INT ENDOD J, V41, P408, DOI 10.1111/j.1365-2591.2007.01370.x; Camilleri J, 2014, J ENDODONT, V40, P436, DOI 10.1016/j.joen.2013.09.040; Dabbagh B, 2012, PEDIAT DENT, V46, P137; Demirkaya K, 2017, HUM EXP TOXICOL, V36, P1071, DOI 10.1177/0960327116679713; Demirkaya K, 2016, EUR J ORAL SCI, V124, P75, DOI 10.1111/eos.12238; Dummer PMH, 2019, INT ENDOD J, V52, P923, DOI 10.1111/iej.13080; Erdem AP, 2009, EUR ARCH PAEDIATR DE, V10, P110, DOI 10.1007/BF03321611; Feret F.R., 2003, ADV X-RAY ANAL, V46, P381; Guimaraes BM, 2015, J ENDODONT, V41, P947, DOI 10.1016/j.joen.2015.02.008; Duarte MAH, 2009, J ENDODONT, V35, P737, DOI 10.1016/j.joen.2009.02.006; Ioannidis K, 2013, INT ENDOD J, V46, P137, DOI 10.1111/j.1365-2591.2012.02098.x; Jacobovitz M, 2008, INT ENDOD J, V41, P905, DOI 10.1111/j.1365-2591.2008.01412.x; Jacobovitz M, 2009, DENT TRAUMATOL, V25, pE32, DOI 10.1111/j.1600-9657.2008.00745.x; Lavalilee C., 2001, PAINT COATINGS IND, V17, P64; LEVIN EM, 1964, J RES NBS A PHYS CH, VA 68, P189, DOI 10.6028/jres.068A.019; Li Q, 2015, DENT MATER J, V34, P458, DOI 10.4012/dmj.2014-309; Liu H, 2011, CHIN J DENT RES, V14, P121; Marciano MA, 2015, ENDO-ENDOD PRACT TOD, V9, P39; Marciano MA, 2017, J ENDODONT, V43, P1001, DOI 10.1016/j.joen.2017.01.029; Marciano MA, 2015, CLIN ORAL INVEST, V19, P2201, DOI 10.1007/s00784-015-1466-8; Marciano MA, 2014, J ENDODONT, V40, P1235, DOI 10.1016/j.joen.2014.01.044; Meraji N, 2018, DENT MATER, V34, pE236, DOI 10.1016/j.dental.2018.05.017; Moore A, 2011, DENT TRAUMATOL, V27, P166, DOI 10.1111/j.1600-9657.2011.00984.x; NOVAK L, 1961, Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove, V4, P297; POZNYAK SK, 1990, HIGH ENERG CHEM+, V24, P39; POZNYAK SK, 1990, ELECTROCHIM ACTA, V35, P1941, DOI 10.1016/0013-4686(90)87103-9; RAPPAPORT H M, 1964, Oral Surg Oral Med Oral Pathol, V18, P785, DOI 10.1016/0030-4220(64)90480-3; Sauro S, 2009, OPER DENT, V34, P166, DOI 10.2341/08-56; SCHEUFELE J, 1952, Dtsch Zahnarztl Z, V7, P913; Sharma G, 2003, EL EN AP SI, P1; Shokouhinejad N, 2018, CLIN ORAL INVEST, V22, P1725, DOI 10.1007/s00784-017-2266-0; Simsek N, 2016, J MATER SCI-MATER M, V27, P1; STEWART G G, 1958, Oral Surg Oral Med Oral Pathol, V11, P1174, DOI 10.1016/0030-4220(58)90302-5; Suzuki EM, 2014, J FORENSIC SCI, V59, P1205, DOI 10.1111/1556-4029.12414; Tapley MW, 1929, J AM PHARM ASSOC, V15, P46; Taylor Fw H., 1997, CEMENT CHEM, Vsecond; TAYLOR P, 1984, CAN J CHEM, V62, P2863, DOI 10.1139/v84-484; Ulrich I, 2015, CLIN ORAL INVEST, V19, P1473, DOI 10.1007/s00784-014-1372-5; Valles M, 2013, CLIN ORAL INVEST, V17, P1155, DOI 10.1007/s00784-012-0794-1; Valles M, 2013, J ENDODONT, V39, P525, DOI 10.1016/j.joen.2012.12.021; Voveraityte V, 2017, AUST ENDOD J, V43, P11, DOI 10.1111/aej.12149; Wismayer PS, 2016, SCI REP-UK, V6, DOI 10.1038/srep34547; Zehnder M, 2006, J ENDODONT, V32, P389, DOI 10.1016/j.joen.2005.09.014; Zehnder M, 2002, ORAL SURG ORAL MED O, V94, P756, DOI 10.1067/moe.2002.128961; 2013, ALSTOM GRID, V28, P31	48	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0240634	10.1371/journal.pone.0240634	http://dx.doi.org/10.1371/journal.pone.0240634			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33176336	Green Published, gold			2022-12-26	WOS:000593946900005
J	Vasquez-Gross, H; Kaur, S; Epstein, L; Dubcovsky, J				Vasquez-Gross, Hans; Kaur, Sukhwinder; Epstein, Lynn; Dubcovsky, Jorge			A haplotype-phased genome of wheat stripe rust pathogen Puccinia striiformis f. sp. tritici, race PST-130 from the Western USA	PLOS ONE			English	Article							UNITED-STATES; YELLOW RUST; ANNOTATION; DATABASE	More virulent and aggressive races of Puccinia striiformis f. sp. tritici (Pst), the pathogen causing wheat stripe rust, have been spreading around the world since 2000 causing large grain yield losses. A better understanding of the genome and genetic diversity of these new Pst races will be useful to develop new strategies to ameliorate these losses. In this study, we generated an improved genome assembly of a post-2000 virulent race from the Western USA designated as PST-130. We implemented a haplotype phasing strategy using the diploid-aware assembler, Falcon-Unzip and new long-read technology from PacBio to phase the two genomes of this dikaryotic organism. The combination of these new technologies resulted in an improved PST-130 assembly with only 151 contigs (85.4 Mb, N50 of 1.44 Mb), and a complementary assembly (haplotigs) with 458 contigs (65.9 Mb, N50 of 0.235 Mb, PRJNA650506). This new assembly improved gene predictions resulting in 228 more predicted complete genes than in the initial Illumina assembly (29,178 contigs, N50 of 5 kb). The alignment of the non-repetitive primary and haplotig contigs revealed and average of 5.22 SNP/kb, with 39.1% showing <2 SNP/kb and 15.9% >10 SNP/kb. This large divergent regions may represent introgressions of chromosome segments from more divergent Pst races in regions where a complete sexual cycle and recombination are possible. We hypothesize that some of the divergent regions in PST-130 may be related to the European "Warrior" race PST-DK0911 because this genome is more similar to PST-130 (3.18 SNP/kb) than to the older European race PST-104E (3.75 SNP/kb). Complete phasing of additional Pst genomes or sequencing individual nuclei will facilitate the tracing of the haploid genomes introduced by the new Pst races into local populations.	[Vasquez-Gross, Hans; Dubcovsky, Jorge] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Kaur, Sukhwinder; Epstein, Lynn] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Dubcovsky, Jorge] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of California System; University of California Davis; University of California System; University of California Davis; Howard Hughes Medical Institute	Dubcovsky, J (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.; Dubcovsky, J (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	jdubcovsky@ucdavis.edu	Dubcovsky, Jorge/A-4969-2008	Dubcovsky, Jorge/0000-0002-7571-4345	Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture, National Institute of Food and Agriculture [2017-67007-25939]; Howard Hughes Medical Institute; UC Davis DNA technologies	Agriculture and Food Research Initiative Competitive Grant from the United States Department of Agriculture, National Institute of Food and Agriculture; Howard Hughes Medical Institute(Howard Hughes Medical Institute); UC Davis DNA technologies	JD received funding for this study from the Agriculture and Food Research Initiative Competitive Grant 2017-67007-25939 from the United States Department of Agriculture, National Institute of Food and Agriculture (https://nifa.usda.gov/) and Howard Hughes Medical Institute (https://www.hhmi.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the UC Davis DNA technologies for the PacBio library prep and support.	Ali S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003903; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2012, INFORMATION, V1, P1, DOI DOI 10.5861/ijrsll.2012.117; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Blin K, 2019, NUCLEIC ACIDS RES, V47, pW81, DOI 10.1093/nar/gkz310; Bushnell B., BBMAP; Cantu Dario, 2013, BMC Genomics, V14, P270, DOI 10.1186/1471-2164-14-270; Cantu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024230; Chen XM, 2020, FOOD SECUR, V12, P239, DOI 10.1007/s12571-020-01016-z; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Cuomo CA, 2017, G3-GENES GENOM GENET, V7, P361, DOI 10.1534/g3.116.032797; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hovmoller MS, 2016, PLANT PATHOL, V65, P402, DOI 10.1111/ppa.12433; Hovmoller MS, 2010, SCIENCE, V329, P369, DOI 10.1126/science.1194925; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Jin Y, 2010, PHYTOPATHOLOGY, V100, P432, DOI 10.1094/PHYTO-100-5-0432; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Leskovec J, 2016, ACM T INTEL SYST TEC, V8, DOI 10.1145/2898361; LI F, 2019, NAT COMMUN, V10, DOI DOI 10.1038/S41467-019-12927-731699975; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; LITTLE R, 1967, NATURE, V213, P422, DOI 10.1038/213422a0; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Love J, 2020, FUNANNOTATE 1 7 4, DOI [10.5281/zenodo.3679386, DOI 10.5281/ZEN0D0.3679386]; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Marcais G, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005944; Nattestad M, 2016, BIOINFORMATICS, V32, P3021, DOI 10.1093/bioinformatics/btw369; Park RF, 2012, ANNU REV PHYTOPATHOL, V50, P219, DOI 10.1146/annurev-phyto-072910-095405; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Schwessinger B, 2020, GENOME BIOL EVOL, V12, P597, DOI 10.1093/gbe/evaa071; Schwessinger B, 2018, MBIO, V9, DOI [10.1128/mBio.02275-17, 10.1128/mbio.02275-17]; Schwessinger B, 2017, METHODS MOL BIOL, V1659, P49, DOI 10.1007/978-1-4939-7249-4_5; Seppey M, 2019, METHODS MOL BIOL, V1962, P227, DOI 10.1007/978-1-4939-9173-0_14; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; ter Steege MW, 2005, PLANT PHYSIOL, V139, P1078, DOI 10.1104/pp.105.063263; The Gene Ontology Consortium, 2019, NUCLEIC ACIDS RES, V47, pD330; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Wan A, 2017, VARIABILITY STRIPE R; Wan AM, 2014, PLANT DIS, V98, P1534, DOI 10.1094/PDIS-01-14-0071-RE; Wan AM, 2016, PLANT DIS, V100, P966, DOI 10.1094/PDIS-10-15-1122-RE; WANG M, 2012, PHYTOPATHOLOGY S4, V102, P132; Wang MN, 2015, PLANT DIS, V99, P1500, DOI 10.1094/PDIS-12-14-1280-RE; WRIGHT RG, 1980, T BRIT MYCOL SOC, V74, P283, DOI 10.1016/S0007-1536(80)80158-6; Xia CJ, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5041-y; Zheng WM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3673	48	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0238611	10.1371/journal.pone.0238611	http://dx.doi.org/10.1371/journal.pone.0238611			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175843	Green Published, gold, Green Submitted			2022-12-26	WOS:000593946900054
J	Martinez-Zaragoza, F; Benavides-Gil, G; Rovira, T; Martin-del-Rio, B; Edo, S; Garcia-Sierra, R; Solanes-Puchol, A; Fernandez-Castro, J				Martinez-Zaragoza, Fermin; Benavides-Gil, Gemma; Rovira, Tatiana; Martin-del-Rio, Beatriz; Edo, Silvia; Garcia-Sierra, Rosa; Solanes-Puchol, Angel; Fernandez-Castro, Jordi			When and how do hospital nurses cope with daily stressors? A multilevel study	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; MENTAL-HEALTH; WORKPLACE STRESSORS; WORK-ENVIRONMENT; DEMOGRAPHIC CHARACTERISTICS; COPING STRATEGIES; JOB STRESS; OCCUPATIONAL STRESS; PREDICTORS; FATIGUE	Background During their workday, nurses face a variety of stressors that are dealt with using different coping strategies. One criticism of the contextual models of work stress is that they fail to focus on individual responses like coping with stress. Neverthless, little is know about the momentary determinants of coping in nurses. Objectives To identify the momentary predictors of problem-focused approaching coping and emotion-focused approaching coping, as well as those for seeking social support and refusal coping strategies, during the working day in nurses. Design This study uses descriptive, correlational, two-level design with repeated measures. Settings Wards of two University hospitals. Participants A random cohort of 113 nurses was studied. Methods An ecological momentary assessment was made of demand, control, effort, reward, nursing task, coping, mood and fatigue, and of coping style by questionnaire. Multilevel two-level statistical analyses were performed in order to identify both within person and between person relationships. Results Different momentary types of coping were associated with different tasks. The problem-focused coping could be explained by the direct care and medication tasks, demand, planning coping style, mood, and negatively by acceptation coping style. Emotion-focused coping could be explained by documentation and medication tasks (negatively), mood, demand, distraction, and disengagement coping styles. Seeking social support coping could be explained by the task of communication, mood, fatigue (negatively), and seeking emotional support as a coping style. Refusal coping could be explained by mood, and the coping style of focusing and venting emotions. Refusal coping is not specific to any task. Conclusions The choice of the coping strategy depends on the task, of their appraisal and on the different styles of coping.	[Martinez-Zaragoza, Fermin; Benavides-Gil, Gemma; Martin-del-Rio, Beatriz; Solanes-Puchol, Angel] Univ Miguel Hernandez, Dept Behav Sci & Hlth, Elche, Spain; [Rovira, Tatiana; Edo, Silvia; Fernandez-Castro, Jordi] Univ Autonoma Barcelona, Dept Psicol Bas Evolut & Educ, Barcelona, Spain; [Garcia-Sierra, Rosa] Univ Autonoma Barcelona, Dept Nursing, Bellaterra, Spain	Universidad Miguel Hernandez de Elche; Autonomous University of Barcelona; Autonomous University of Barcelona	Martinez-Zaragoza, F (corresponding author), Univ Miguel Hernandez, Dept Behav Sci & Hlth, Elche, Spain.	f.martinez@umh.es	Edo, Silvia/AFM-0044-2022; García, Rosa/ADZ-0889-2022; del Río, Beatriz Martin/F-8352-2011; García-Sierra, Rosa/ABG-4332-2020; Edo, Silvia/AAH-2346-2022; Rovira, Tatiana/AAP-3044-2021; Gil, Gemma Benavides/AAS-8348-2021; Rovira, Tatiana/B-5420-2009	Edo, Silvia/0000-0002-6564-3475; del Río, Beatriz Martin/0000-0002-3917-4556; García-Sierra, Rosa/0000-0001-9220-610X; Edo, Silvia/0000-0002-6564-3475; Rovira, Tatiana/0000-0003-1317-1282; Rovira, Tatiana/0000-0003-1317-1282; Martinez-Zaragoza, Fermin/0000-0003-0874-0962	Ministry of Economy and Competitiveness (FEDER) [PSI201676411-R]	Ministry of Economy and Competitiveness (FEDER)	Ministry of Economy and Competitiveness (FEDER, grant number PSI201676411-R). http://www.ciencia.gob.es/portal/site/MICINN/(new name of de Ministry now, Ministry of Science and Innovation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al Barmawi MA, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1264; [Anonymous], 2017, EMISS CONTROL SCI TE, V3, P1; Arrogante O., 2016, METAS ENFERMERIA, V19, P71; Ato M, 2013, AN PSICOL-SPAIN, V29, P1038, DOI 10.6018/analesps.29.3.178511; Bakker A.B., 2007, J MANAGE PSYCHOL, V22 (3), P309, DOI [10.1108/02683940710733115, DOI 10.1108/02683940710733115]; Bakker AB, 2000, J ADV NURS, V31, P884, DOI 10.1046/j.1365-2648.2000.01361.x; Barker LM, 2011, J ADV NURS, V67, P1370, DOI 10.1111/j.1365-2648.2010.05597.x; Bartley CE, 2011, PERS INDIV DIFFER, V50, P79, DOI 10.1016/j.paid.2010.08.027; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bliese P, 2016, MULTILEVEL MODELING; Bliese PD, 2002, ORGAN RES METHODS, V5, P362, DOI 10.1177/109442802237116; Burgess L, 2010, NURS CRIT CARE, V15, P129, DOI 10.1111/j.1478-5153.2009.00384.x; Caruso CC, 2014, REHABIL NURS, V39, P16, DOI 10.1002/rnj.107; Carver CS, 2010, ANNU REV PSYCHOL, V61, P679, DOI 10.1146/annurev.psych.093008.100352; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; CESLOWITZ SB, 1989, J ADV NURS, V14, P553, DOI 10.1111/j.1365-2648.1989.tb01590.x; Chang EM, 2006, J PROF NURS, V22, P30, DOI 10.1016/j.profnurs.2005.12.002; Chang EML, 2007, INT J NURS STUD, V44, P1354, DOI 10.1016/j.ijnurstu.2006.06.003; Crespo M., 1997, ANALISIS MODIFICACIO, V23, P797, DOI DOI 10.6018/ANALESPS.29.1.124531; Deklava L, 2014, PROCD SOC BEHV, V159, P261, DOI 10.1016/j.sbspro.2014.12.369; Dragano N, 2017, EPIDEMIOLOGY, V28, P619, DOI 10.1097/EDE.0000000000000666; Ekedahl MA, 2010, EUR J CANCER CARE, V19, P530, DOI 10.1111/j.1365-2354.2009.01089.x; Fekry Ahmed M, 2015, IOSR J NURS HEAL SCI, V4, P2320, DOI [10.9790/1959-04358391, DOI 10.9790/1959-04358391]; Fernandez-Castro J, 2017, INT J NURS STUD, V75, P43, DOI 10.1016/j.ijnurstu.2017.07.002; Folkman S, 1997, SOC SCI MED, V45, P1207, DOI 10.1016/S0277-9536(97)00040-3; Fox J., 2018, R COMPANION APPL REG, VThird; Gellis ZD, 2002, ADMIN SOC WORK, V26, P37, DOI 10.1300/J147v26n03_03; Grace-Martin K, 2017, INTRACLASS CORRELATI; Harris L, 2012, THESIS; Hox J., 1995, APPL MULTILEVEL ANAL; Johnston DW, 2019, ANN BEHAV MED, V53, P551, DOI 10.1093/abm/kay065; Johnston DW, 2013, ANN BEHAV MED, V45, P348, DOI 10.1007/s12160-012-9458-2; Kakemam E, 2019, CONTEMP NURSE, V55, P237, DOI 10.1080/10376178.2019.1647791; Karasek R., 1991, HLTH WORK STRESS PRO; KARASEK RA, 1979, ADMIN SCI QUART, V24, P285, DOI 10.2307/2392498; Kikuchi Y, 2010, OCCUP MED-OXFORD, V60, P231, DOI 10.1093/occmed/kqp167; Kirchner T, 2008, PSICOTHEMA, V20, P902; Lambert VA, 2007, INT NURS REV, V54, P85, DOI 10.1111/j.1466-7657.2007.00512.x; Lambert VA, 2004, INT J NURS STUD, V41, P671, DOI 10.1016/j.ijnurstu.2004.02.003; Lambert VA, 2004, INT J NURS STUD, V41, P85, DOI 10.1016/S0020-7489(03)00080-4; Lambert VA, 2007, NURS HEALTH SCI, V9, P120, DOI 10.1111/j.1442-2018.2007.00316.x; Lambert VA, 2008, INDIAN J PALLIAT CAR, V14, P38, DOI 10.4103/0973-1075.41934; LATACK JC, 1992, J ORGAN BEHAV, V13, P479, DOI 10.1002/job.4030130505; Lazarus R. S., 1984, STRESS APPRAISAL COP; Lin HS, 2010, J CLIN NURS, V19, P2342, DOI 10.1111/j.1365-2702.2010.03216.x; Ludecke D., 2017, SJPLOT DATA VISUALIZ; Martin-Del-Rio B, 2018, J ADV NURS, V74, P1488, DOI 10.1111/jan.13566; Molina-Praena J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122800; Moustaka, 2010, HLTH SCI J, V4, P210; Nayomi, 2016, J SOC STAT, V3, P47; Neff KD, 2013, J CLIN PSYCHOL, V69, P28, DOI 10.1002/jclp.21923; PADILLA C, 2017, NURS RES, V66, P410, DOI DOI 10.1097/NNR.0000000000000239; PARKES KR, 1990, J APPL PSYCHOL, V75, P399, DOI 10.1037/0021-9010.75.4.399; Patrician PA, 2004, NURS RES, V53, P347, DOI 10.1097/00006199-200409000-00011; Penque Sue, 2019, Nurs Manage, V50, P38, DOI 10.1097/01.NUMA.0000557621.42684.c4; R Core Team, 2021, R LANGUAGE ENV STAT; Roelen CAM, 2018, INT ARCH OCC ENV HEA, V91, P195, DOI 10.1007/s00420-017-1268-1; ROTHBAUM F, 1982, J PERS SOC PSYCHOL, V42, P5, DOI 10.1037/0022-3514.42.1.5; Rovira T., 2016, EUROPEAN HLTH PSYCHO, V18, P758; Samaha E, 2007, J ADV NURS, V59, P221, DOI 10.1111/j.1365-2648.2007.04338.x; Schreuder JAH, 2011, INT J NURS STUD, V48, P838, DOI 10.1016/j.ijnurstu.2010.12.008; Schreuder JAH, 2012, NURS OUTLOOK, V60, P37, DOI 10.1016/j.outlook.2011.05.005; Schreuder JAH, 2010, INT J NURS STUD, V47, P569, DOI 10.1016/j.ijnurstu.2009.10.002; Siegrist J, 1996, J Occup Health Psychol, V1, P27, DOI 10.1037/1076-8998.1.1.27; Siegrist J, 2010, INT J OCCUP MED ENV, V23, P279, DOI 10.2478/v10001-010-0013-8; Skinner EA, 2003, PSYCHOL BULL, V129, P216, DOI 10.1037/0033-2909.129.2.216; Stellman, 1998, ENCY OCCUPATIONAL HL; Stone AA, 1998, J PERS SOC PSYCHOL, V74, P1670, DOI 10.1037/0022-3514.74.6.1670; Stress Tully A., 2004, J PSYCHIATR MENT HLT, V11, P43; Suls J, 1996, J PERS, V64, P993, DOI 10.1111/j.1467-6494.1996.tb00951.x; Swim JK, 2006, CLAR SYMP, P105; Trousselard M, 2016, INT ARCH OCC ENV HEA, V89, P221, DOI 10.1007/s00420-015-1065-7; van der Riet P, 2018, NURS EDUC TODAY, V65, P201, DOI 10.1016/j.nedt.2018.03.018; Walker LS, 2007, J PEDIATR PSYCHOL, V32, P206, DOI 10.1093/jpepsy/jsj124; Wang WR, 2011, APPL NURS RES, V24, P238, DOI 10.1016/j.apnr.2009.09.003; Westbrook Johanna I, 2009, Int J Med Inform, V78 Suppl 1, pS25, DOI 10.1016/j.ijmedinf.2008.09.003; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Yang SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171679; Yu JG, 2014, INT J CLIN EXP MED, V7, P3000; Zeidner M., 1996, HDB COPING THEORY RE, P505; Zeidner M, 2013, ANXIETY STRESS COPIN, V26, P595, DOI 10.1080/10615806.2013.777045	83	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0240725	10.1371/journal.pone.0240725	http://dx.doi.org/10.1371/journal.pone.0240725			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7KH	33170852	Green Published, gold			2022-12-26	WOS:000592383400044
J	Rink, JS; Lin, AY; McMahon, KM; Calvert, AE; Yang, S; Taxter, T; Moreira, J; Chadburn, A; Behdad, A; Karmali, R; Thaxton, CS; Gordon, LI				Rink, Jonathan S.; Lin, Adam Yuh; McMahon, Kaylin M.; Calvert, Andrea E.; Yang, Shuo; Taxter, Tim; Moreira, Jonathan; Chadburn, Amy; Behdad, Amir; Karmali, Reem; Thaxton, C. Shad; Gordon, Leo, I			Targeted reduction of cholesterol uptake in cholesterol-addicted lymphoma cells blocks turnover of oxidized lipids to cause ferroptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPROTEIN-LIKE NANOPARTICLES; HIGH-DENSITY-LIPOPROTEINS; SCAVENGER RECEPTOR; GLUTATHIONE-PEROXIDASE; CELLULAR CHOLESTEROL; SR-BI; BINDING; DEATH; IDENTIFICATION; METABOLISM	Normal human cells can either synthesize cholesterol or take it up from lipoproteins to meet their metabolic requirements. In some malignant cells, de novo cholesterol synthesis genes are transcriptionally silent or mutated, meaning that cholesterol uptake from lipoproteins is required for survival. Recent data suggest that lymphoma cells dependent upon lipoprotein-ediated cholesterol uptake are also subject to ferroptosis, an oxygen- and iron-dependent cell death mechanism triggered by accumulation of oxidized lipids in cell membranes unless the lipid hydroperoxidase, glutathione peroxidase 4 (GPX4), reduces these toxic lipid species. To study mechanisms linking cholesterol uptake with ferroptosis and determine the potential role of the high-density lipoprotein (HDL) receptor as a target for cholesterol depleting therapy, we treated lymphoma cell lines known to be sensitive to the reduction of cholesterol uptake with HDL-like nanoparticles (HDL NPs). HDL NPs are a cholesterol-poor ligand that binds to the receptor for cholesterol-rich HDLs, scavenger receptor type B1 (SCARB1). Our data reveal that HDL NP treatment activates a compensatory metabolic response in treated cells toward increased de novo cholesterol synthesis, which is accompanied by nearly complete reduction in expression of GPX4. As a result, oxidized membrane lipids accumulate, leading to cell death through a mechanism consistent with ferroptosis. We obtained similar results in vivo after systemic administration of HDL NPs in mouse lymphoma xenografts and in primary samples obtained from patients with lymphoma. In summary, targeting SCARB1 with HDL NPs in cholesterol uptake-addicted lymphoma cells abolishes GPX4, resulting in cancer cell death by a mechanism consistent with ferroptosis.	[Rink, Jonathan S.; Lin, Adam Yuh; Yang, Shuo; Moreira, Jonathan; Karmali, Reem; Gordon, Leo, I] Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hematol & Oncol, Chicago, IL 60611 USA; [Rink, Jonathan S.; McMahon, Kaylin M.; Calvert, Andrea E.; Thaxton, C. Shad] Northwestern Univ, Simpson Querrey Inst BioNanotechnol, Chicago, IL 60611 USA; [Rink, Jonathan S.; Lin, Adam Yuh; Yang, Shuo; Taxter, Tim; Moreira, Jonathan; Behdad, Amir; Karmali, Reem; Thaxton, C. Shad; Gordon, Leo, I] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [McMahon, Kaylin M.; Calvert, Andrea E.; Thaxton, C. Shad] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Taxter, Tim; Behdad, Amir] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Chadburn, Amy] Weill Cornell Med Ctr, Dept Pathol, New York, NY USA; [Thaxton, C. Shad] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Cornell University; Northwestern University	Gordon, LI (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Div Hematol & Oncol, Chicago, IL 60611 USA.; Thaxton, CS (corresponding author), Northwestern Univ, Simpson Querrey Inst BioNanotechnol, Chicago, IL 60611 USA.; Thaxton, CS; Gordon, LI (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.; Thaxton, CS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA.; Thaxton, CS (corresponding author), Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA.	cthaxton003@northwestern.edu; l-gordon@northwestern.edu		Lin, Adam/0000-0001-9359-882X; Karmali, Reem/0000-0003-0984-4376	Robert H. Lurie Comprehensive Cancer Center Cancer Center Support Grant (RHLCCC CCSG); National Institutes of Health/National Heart, Lung, and Blood Institute [T32HL094293]; American Society of Hematology Research Training Award; Department of Defense/Air Force Office of Scientific Research [FA95501310192]; CRN Regenerative Nanomedicine Catalyst Award Program at Northwestern University; National Institutes of Health/National Cancer Institute [R01CA167041]; Brookstone Foundation; Shannahan Foundation; Mander Foundation	Robert H. Lurie Comprehensive Cancer Center Cancer Center Support Grant (RHLCCC CCSG); National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Society of Hematology Research Training Award; Department of Defense/Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); CRN Regenerative Nanomedicine Catalyst Award Program at Northwestern University; National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brookstone Foundation; Shannahan Foundation; Mander Foundation	6 This work was supported by the Robert H. Lurie Comprehensive Cancer Center Cancer Center Support Grant (RHLCCC CCSG) (L. I. G. and C. S. T.), the National Institutes of Health/National Heart, Lung, and Blood Institute for a Vascular Surgery Scientist Training Program grant (T32HL094293) (J. S. R.), the American Society of Hematology Research Training Award for Fellows (A. L.), the Department of Defense/Air Force Office of Scientific Research (FA95501310192), the CRN Regenerative Nanomedicine Catalyst Award Program at Northwestern University, and the National Institutes of Health/National Cancer Institute (R01CA167041) (C. S. T.), and the Brookstone, Shannahan and Mander Foundations (L. I. G.).	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Bell JB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18100-8; Borchert A, 2003, J BIOL CHEM, V278, P2571, DOI 10.1074/jbc.M209064200; Breitling R, 2001, MOL CELL ENDOCRINOL, V171, P199, DOI 10.1016/S0303-7207(00)00416-0; Cabanillas F, 2017, CL LYMPH MYELOM LEUK, V17, P783, DOI 10.1016/j.clml.2017.10.007; Chen LF, 2013, CANCER CELL, V23, P826, DOI 10.1016/j.ccr.2013.05.002; Conrad M, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.995047; Cruz PMR, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00119; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Durham KK, 2018, BIOCHEM J, V475, P1253, DOI 10.1042/BCJ20170703; Eaton J.K., 2018, BIORXIV, DOI [10.1101/376764, DOI 10.1101/376764]; Foit L, 2016, BIOMATERIALS, V100, P67, DOI 10.1016/j.biomaterials.2016.05.021; Foit L, 2015, EXPERT REV ANTICANC, V15, P27, DOI 10.1586/14737140.2015.990889; Forcina GC, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800311; Garcia-Bermudez J, 2019, NATURE, V567, P118, DOI 10.1038/s41586-019-0945-5; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Grin PM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28777-0; Gutierrez-Pajares JL, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00338; Harkins RA, 2019, EXPERT REV PHARM OUT, V19, P645, DOI 10.1080/14737167.2019.1680288; Hattori H, 2005, BIOCHEM BIOPH RES CO, V337, P464, DOI 10.1016/j.bbrc.2005.09.076; Hayat MJ, 2007, ONCOLOGIST, V12, P20, DOI 10.1634/theoncologist.12-1-20; Heward JA, 2018, CURR OPIN HEMATOL, V25, P329, DOI 10.1097/MOH.0000000000000437; INNERARITY TL, 1978, J BIOL CHEM, V253, P6289; Intlekofer AM, 2019, NAT METAB, V1, P177, DOI 10.1038/s42255-019-0032-0; Jiang B, 2020, DIGEST DIS SCI, V65, P1999, DOI 10.1007/s10620-019-05929-4; King MA, 2016, ONCOGENE, V35, P4518, DOI 10.1038/onc.2015.511; Klop B, 2014, J BIOL CHEM, V289, P35421, DOI 10.1074/jbc.M114.573840; Limat S, 2014, J CLIN PHARM THER, V39, P168, DOI 10.1111/jcpt.12124; Luthi AJ, 2015, J LIPID RES, V56, P972, DOI 10.1194/jlr.M054635; McMahon KM, 2017, ONCOTARGET, V8, P11219, DOI 10.18632/oncotarget.14494; McMahon KM, 2016, ADV FUNCT MATER, V26, P7824, DOI 10.1002/adfm.201602600; McMahon Kaylin M, 2015, Cancer Treat Res, V166, P129, DOI 10.1007/978-3-319-16555-4_6; McMahon KM, 2011, NANO LETT, V11, P1208, DOI 10.1021/nl1041947; Mooberry LK, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00466; Morimoto Y, 2012, CANCER CAUSE CONTROL, V23, P1693, DOI 10.1007/s10552-012-0048-1; Pianko MJ, 2018, CLIN CANCER RES, V24, P1002, DOI 10.1158/1078-0432.CCR-17-0539; Plebanek MP, 2018, MOL CANCER THER, V17, P686, DOI 10.1158/1535-7163.MCT-17-0981; Plebanek MP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15724; Rink JS, 2018, ACS APPL MATER INTER, V10, P6904, DOI 10.1021/acsami.7b18525; Rink JS, 2017, MOL PHARMACEUT, V14, P4042, DOI 10.1021/acs.molpharmaceut.7b00710; Saddar S, 2010, ARTERIOSCL THROM VAS, V30, P144, DOI 10.1161/ATVBAHA.109.196170; Shimada K, 2016, NAT CHEM BIOL, V12, P497, DOI [10.1038/NCHEMBIO.2079, 10.1038/nchembio.2079]; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Stoytcheva ZR, 2009, BBA-GEN SUBJECTS, V1790, P1429, DOI 10.1016/j.bbagen.2009.05.012; Trigatti BL, 2016, J BIOMED RES, V30, P94, DOI 10.7555/JBR.30.20150079; Upton DC, 2011, JOVE-J VIS EXP, DOI 10.3791/3573; Xu GH, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3761-z; Xu GH, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317699110; Yang SO, 2013, P NATL ACAD SCI USA, V110, P2511, DOI 10.1073/pnas.1213657110; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zhang Y, 2016, CARDIOVASC THER, V34, P308, DOI 10.1111/1755-5922.12199; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079; Zou Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09277-9	54	9	10	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100100	10.1074/jbc.RA120.014888	http://dx.doi.org/10.1074/jbc.RA120.014888			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33208460	Green Published, gold			2022-12-26	WOS:000672866400080
J	Aloudah, N; Alhumsi, A; Alobeid, N; Aboheimed, N; Aboheimed, H; Aboheimed, G				Aloudah, Nouf; Alhumsi, Areej; Alobeid, Nada; Aboheimed, Nourah; Aboheimed, Hind; Aboheimed, Ghada			Factors impeding the supply of over-the-counter medications according to evidence-based practice: A mixed-methods study	PLOS ONE			English	Article							SAUDI-ARABIA; PHARMACISTS; MEDICINES	Objective Despite the positive attitudes pharmacists have toward evidence-based practices (EBPs), its application in community pharmacies in Saudi Arabia is lacking. Therefore, this study aimed to explore and assess EBPs by community pharmacists in Saudi Arabia when they dispense over-the-counter (OTC) medications for three minor ailments: diarrhea, cough, and the common cold. Research design and methods We used a mixed-methods approach consisting of two study parts. The first was a quantitative investigation that used mystery shoppers. Four researchers, posing as mystery shoppers, visited 214 randomly selected pharmacies in the Riyadh region of Saudi Arabia. They used 14 questions from a standardized checklist to examine EBPs by community pharmacists. The qualitative part of the study entailed three focus-group discussions with 13 pharmacists from different community practice settings and explored factors that affected the application of EBPs when supplying OTC medications from the pharmacists' point of view. Results The analysis indicated that 40% of pharmacists dispensed OTC medications according to EBPs. Logistic regression analysis showed that one question, "Describe your symptoms", predicted the correct supply of OTC medications (p = 0.021). The qualitative section of the study identified nine factors that affected EBP. Some of these factors facilitated EBP, such as established patient-pharmacist relationships, some acted as barriers such as conflicts between available evidence, while other factors could either facilitate or hinder EBPs, such as the health literacy of the patient. Conclusion Given that dispensing OTC medication is a core function of pharmacists, this study uncovered low adherence to EBPs by community pharmacists in Saudi Arabia when dispensing OTC medication for three minor ailments: diarrhea, cough, and the common cold. Furthermore, this study identified a number of explanatory factors for this low adherence. Targeting these factors could help change the behavior of pharmacists and decrease undesirable outcomes.	[Aloudah, Nouf; Aboheimed, Ghada] King Saud Univ, Dept Clin Pharm, Riyadh, Saudi Arabia; [Alhumsi, Areej] Becton Dickinson, Sales & Clin Specialist Oncol, Riyadh, Saudi Arabia; [Alobeid, Nada] Saudi Food & Drug Author, Benefit Risk Assessment Dept, Riyadh, Saudi Arabia; [Aboheimed, Nourah] Princess Nourah bint Abdulrahman Univ, Dept Pharm Practice, Riyadh, Saudi Arabia; [Aboheimed, Hind] King Abdulaziz Med City Riyadh, Natl Guard Hlth Affairs, Pharmaceut Care Serv, Riyadh, Saudi Arabia	King Saud University; Princess Nourah bint Abdulrahman University; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia	Aloudah, N (corresponding author), King Saud Univ, Dept Clin Pharm, Riyadh, Saudi Arabia.	naloudah@ksu.edu.sa	aboheimed, Nourah/GXV-2895-2022; Aboheimed, Ghada I./GXV-3323-2022; Aloudah, Nouf M/K-2061-2019	Aboheimed, Ghada I./0000-0002-4752-6363; Aloudah, Nouf M/0000-0002-7603-1642	"Research Center of the Female Scientific and Medical Colleges", Deanship of Scientific Research, King Saud University	"Research Center of the Female Scientific and Medical Colleges", Deanship of Scientific Research, King Saud University(King Saud University)	This research project was supported by a grant from the "Research Center of the Female Scientific and Medical Colleges", Deanship of Scientific Research, King Saud University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It was only provided financial support in the form of authors' salaries [Aloudah, N.; Abuheimd, G.]. The Becton Dickinson company had no role in study design, data collection and analysis, decision to publish, preparation of the manuscript and did not provided financial support in the form of author' salaries [Alhemsi, A.] at the time of study. The specific roles of these authors are articulated in the `author contributions' section."	Al-Mohamadi A, 2013, SAUDI PHARM J, V21, P13, DOI 10.1016/j.jsps.2011.11.003; Alaqeel S, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1220-6; Aljadhey H, 2015, SAUDI MED J, V36, P328, DOI 10.15537/smj.2015.3.10523; Bin Saleh G, 2015, SAUDI PHARM J, V23, P573, DOI 10.1016/j.jsps.2015.02.019; Burkiewicz JS, 2005, ANN PHARMACOTHER, V39, P1214, DOI 10.1345/aph.1E663; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Collins JC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-019462; Edwards D. J., 2018, CANADIAN PHARM J CPJ, V152, P16, DOI [10.1177/1715163518816646, DOI 10.1177/1715163518815717]; Halila Gerusa C., 2015, Pharmacy Pract (Granada), V13, DOI 10.18549/PharmPract.2015.04.597; Hanna Lezley-Anne, 2012, Int J Pharm Pract, V20, P275, DOI 10.1111/j.2042-7174.2012.00244.x; Hanna LA, 2010, DRUG SAFETY, V33, P245, DOI 10.2165/11319050-000000000-00000; Inch J, 2017, INT J PHARM PRACT, V25, P253, DOI 10.1111/ijpp.12305; Jacob S, 2018, INT REV ADM SCI, V84, P164, DOI 10.1177/0020852315618018; Johnson H, 2013, MED WRITING, V22, P275; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Morse J.M., 2009, MIXED METHOD DESIGN; Parnapy Jawaid, 2013, COMMUNITY CLIN PHARM; Paudyal V, 2013, RES SOC ADMIN PHARM, V9, P251, DOI 10.1016/j.sapharm.2012.05.001; Rutter P, 2014, J EVAL CLIN PRACT, V20, P425, DOI 10.1111/jep.12157; Seubert LJ, 2017, PHARMACY, V5, DOI 10.3390/pharmacy5040065; Tsoi SLNMTA, 2018, ADV HEALTH SCI EDUC, V23, P549, DOI 10.1007/s10459-018-9812-7; U.S. Food and Drug Administration, 2020, DRUG APPL OV THE COU; van Hoof JJ, 2014, HEALTH POLICY, V117, P353, DOI 10.1016/j.healthpol.2014.07.009; Wagner R, 2020, SAUDI WOMEN ENTER PH; Watson MC, 2008, PHARM WORLD SCI, V30, P526, DOI 10.1007/s11096-008-9202-y; WATSON MC, 2006, INT J PHARM PRACT, V14, P83; Xiong CG, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3011-3	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0240913	10.1371/journal.pone.0240913	http://dx.doi.org/10.1371/journal.pone.0240913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211738	Green Published, gold			2022-12-26	WOS:000603518300012
J	Fanous, M; Caputo, MP; Lee, YJ; Rund, LA; Best-Popescu, C; Kandel, ME; Johnson, RW; Das, T; Kuchan, MJ; Popescu, G				Fanous, Michael; Caputo, Megan P.; Lee, Young Jae; Rund, Laurie A.; Best-Popescu, Catherine; Kandel, Mikhail E.; Johnson, Rodney W.; Das, Tapas; Kuchan, Matthew J.; Popescu, Gabriel			Quantifying myelin content in brain tissue using color Spatial Light Interference Microscopy (cSLIM)	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; GROWTH RESTRICTION; PHASE MICROSCOPY; COGNITION; BREAKDOWN; DECLINE; CLARITY	Deficient myelination of the brain is associated with neurodevelopmental delays, particularly in high-risk infants, such as those born small in relation to their gestational age (SGA). New methods are needed to further study this condition. Here, we employ Color Spatial Light Interference Microscopy (cSLIM), which uses a brightfield objective and RGB camera to generate pathlength-maps with nanoscale sensitivity in conjunction with a regular brightfield image. Using tissue sections stained with Luxol Fast Blue, the myelin structures were segmented from a brightfield image. Using a binary mask, those portions were quantitatively analyzed in the corresponding phase maps. We first used the CLARITY method to remove tissue lipids and validate the sensitivity of cSLIM to lipid content. We then applied cSLIM to brain histology slices. These specimens are from a previous MRI study, which demonstrated that appropriate for gestational age (AGA) piglets have increased internal capsule myelination (ICM) compared to small for gestational age (SGA) piglets and that a hydrolyzed fat diet improved ICM in both. The identity of samples was blinded until after statistical analyses.	[Fanous, Michael; Lee, Young Jae; Kandel, Mikhail E.; Popescu, Gabriel] Univ Illinois, Beckman Inst Adv Sci & Technol, Quantitat Light Imaging Lab, Urbana, IL 61801 USA; [Fanous, Michael; Popescu, Gabriel] Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA; [Caputo, Megan P.; Johnson, Rodney W.] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [Lee, Young Jae; Best-Popescu, Catherine] Univ Illinois, Neurosci Program, Urbana, IL USA; [Rund, Laurie A.; Johnson, Rodney W.] Univ Illinois, Dept Anim Sci, Lab Integrat Immunol & Behav, Urbana, IL USA; [Kandel, Mikhail E.; Popescu, Gabriel] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA; [Das, Tapas] Discovery Res, Abbott Nutr, Columbus, OH USA; [Kuchan, Matthew J.] Strateg Res, Abbott Nutr, Columbus, OH USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Popescu, G (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Quantitat Light Imaging Lab, Urbana, IL 61801 USA.; Popescu, G (corresponding author), Univ Illinois, Dept Bioengn, Urbana, IL 61801 USA.; Popescu, G (corresponding author), Univ Illinois, Dept Elect & Comp Engn, Urbana, IL 61801 USA.	gpopescu@illinois.edu		Lee, Young Jae/0000-0003-2221-0853; rund, laurie/0000-0003-0761-7196; Best-Popescu, Catherine/0000-0003-3857-5953	National Institute of General Medical Sciences (NIGMS) [GM129709]; National Science Foundation (NSF) [CBET-0939511 STC]; National Institutes of Health [CA238191, NRT-UtB 1735252]; Abbott Nutrition [C3123]	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Nutrition(Abbott Laboratories)	This work was supported by the National Institute of General Medical Sciences (NIGMS - https://www.nigms.nih.gov/) grant GM129709, the National Science Foundation (NSF https://www.nsf.gov/) grant CBET-0939511 STC, the National Institutes of Health https://www.nih.gov/grant CA238191, and NRT-UtB 1735252, as well as Abbott Nutrition C3123. Tapas Das and Matthew Kuchan are affiliated with Abbott Nutrition, who provided support in the form of salaries and materials for authors C.B-P. and G.P. but did not have any role in data collection or analysis. The specific roles of these authors are articulated in the `author contributions' section.	Abraham H, 2010, INT J DEV NEUROSCI, V28, P401, DOI 10.1016/j.ijdevneu.2010.03.004; [Anonymous], 2012, NUTR REQ SWIN; BARER R, 1952, NATURE, V169, P366, DOI 10.1038/169366b0; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2007, BIOL PSYCHIAT, V62, P1380, DOI 10.1016/j.biopsych.2007.03.024; Bhaduri B, 2013, BIOMED OPT EXPRESS, V4, P1434, DOI 10.1364/BOE.4.001434; Bhaduri B, 2012, OPT LETT, V37, P1094, DOI 10.1364/OL.37.001094; BLAKEMORE WF, 1974, RES VET SCI, V17, P248, DOI 10.1016/S0034-5288(18)33691-9; Caputo MP, 2019, FRONTIERS PEDIAT NEO; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; de Onis M, 1998, EUR J CLIN NUTR, V52, pS5; Deoni S, 2018, NEUROIMAGE, V178, P649, DOI 10.1016/j.neuroimage.2017.12.056; Ding HF, 2009, OPT LETT, V34, P1372, DOI 10.1364/OL.34.001372; Eide MG, 2013, PSYCHOL MED, V43, P2057, DOI 10.1017/S003329171200267X; Eikenes L, 2012, PEDIATR RES, V72, P649, DOI 10.1038/pr.2012.129; Fields RD, 2008, SCI AM, V298, P54; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Hu CF, 2019, IEEE J SEL TOP QUANT, V25, DOI 10.1109/JSTQE.2018.2869613; Kandel ME, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12634-3; Kandel ME, 2018, BIOMED OPT EXPRESS, V9, P623, DOI 10.1364/BOE.9.000623; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Laule C, 2008, NEUROIMAGE, V40, P1575, DOI 10.1016/j.neuroimage.2007.12.008; Li YF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36551-5; Lue N, 2006, OPT LETT, V31, P2759, DOI 10.1364/OL.31.002759; Majeed H, 2019, SCI REPORTS, P9, DOI [10.1038/s41598-018-36956-2, DOI 10.1038/S41598-018-36956-2]; Majeed H, 2017, J BIOPHOTONICS, V10, P177, DOI 10.1002/jbio.201600113; Majeed H, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.11.111210; Mathews TJ, 2013, INFANT MORTALITY STA; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Nakagawa H, 1998, AM J NEURORADIOL, V19, P1129; Nguyen TH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00190-7; Nguyen TH, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.3.036015; Ong Ken K, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P30, DOI 10.1097/MED.0b013e328013da6c; Ozanne SE, 2004, SEMINARS PERINATOLOG; Park Y, 2018, NAT PHOTONICS, V12, P578, DOI 10.1038/s41566-018-0253-x; Popescu G., 2011, QUANTITATIVE PHASE I; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; Radlowski EC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091951; Rytych JL, 2012, J NUTR, V142, P2050, DOI 10.3945/jn.112.165522; SALTHOUSE TN, 1962, STAIN TECHNOL, V37, P313, DOI 10.3109/10520296209114492; Sridharan S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09976; Strauss RS, 2000, JAMA-J AM MED ASSOC, V283, P625, DOI 10.1001/jama.283.5.625; Stuber C, 2014, NEUROIMAGE, V93, P95, DOI 10.1016/j.neuroimage.2014.02.026; Takabayashi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194320; Tomer R, 2014, NAT PROTOC, V9, P1682, DOI 10.1038/nprot.2014.123; Wang Z, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3656732; Wang Z, 2011, OPT EXPRESS, V19, P19907, DOI 10.1364/OE.19.019907; Wang Z, 2011, OPT EXPRESS, V19, P1016, DOI 10.1364/OE.19.001016; Wilhelm MJ, 2012, P NATL ACAD SCI USA, V109, P9605, DOI 10.1073/pnas.1115107109; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	50	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0241084	10.1371/journal.pone.0241084	http://dx.doi.org/10.1371/journal.pone.0241084			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211727	Green Submitted, Green Published, gold			2022-12-26	WOS:000603518300015
J	Murugappan, M; Alshuaib, W; Bourisly, AK; Khare, SK; Sruthi, S; Bajaj, V				Murugappan, Murugappan; Alshuaib, Waleed; Bourisly, Ali K.; Khare, Smith K.; Sruthi, Sai; Bajaj, Varun			Tunable Q wavelet transform based emotion classification in Parkinson's disease using Electroencephalography	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; STATE CLASSIFICATION; EEG	Parkinson's disease (PD) is a severe incurable neurological disorder. It is mostly characterized by non-motor symptoms like fatigue, dementia, anxiety, speech and communication problems, depression, and so on. Electroencephalography (EEG) play a key role in the detection of the true emotional state of a person. Various studies have been proposed for the detection of emotional impairment in PD using filtering, Fourier transforms, wavelet transforms, and non-linear methods. However, these methods require a selection of basis and are confined in terms of accuracy. In this paper, tunable Q wavelet transform (TQWT) is proposed for the classification of emotions in PD and normal controls (NC). EEG signals of six emotional states namely happiness, sadness, fear, anger, surprise, and disgust are studied. Power, entropy, and statistical moments based features are elicited from the highpass and lowpass sub-bands of TQWT. Six features selected by statistical analysis are classified with a k-nearest neighbor, probabilistic neural network, random forest, decision tree, and extreme learning machine. Three performance measures are obtained, maximum mean accuracy, sensitivity, and specificity of 96.16%, 97.59%, and 88.51% for NC and 93.88%, 96.33%, and 81.67% for PD are achieved with a probabilistic neural network. The proposed method proved to be very effective such that it classifies emotions in PD and could be used as a potential tool for diagnosing emotional impairment in hospitals.	[Murugappan, Murugappan; Sruthi, Sai] Kuwait Coll Sci & Technol, Dept Elect & Commun Engn, Intelligent Signal Proc Res Lab, Doha, Kuwait; [Alshuaib, Waleed; Bourisly, Ali K.] Kuwait Univ, Fac Med, Dept Physiol, Kuwait, Kuwait; [Khare, Smith K.; Bajaj, Varun] PDPM Indian Inst Informat Technol Design & Mfg, Dept Elect & Commun, Jabalpur, India	Kuwait University; Indian Institute of Information Technology Design & Manufacturing, Jabalpur	Murugappan, M (corresponding author), Kuwait Coll Sci & Technol, Dept Elect & Commun Engn, Intelligent Signal Proc Res Lab, Doha, Kuwait.	m.murugappan@gmail.com	KHARE, SMITH KASHIRAM/AAS-4548-2020; Murugappan, M/E-2402-2014; Bajaj, Varun/AAP-4660-2020	KHARE, SMITH KASHIRAM/0000-0001-8365-1092; Murugappan, M/0000-0002-5839-4589; Bajaj, Varun/0000-0002-8721-1219	Kuwait Foundation for the Advancement of Sciences (KFAS), Kuwait [PR18-13 MM-08]	Kuwait Foundation for the Advancement of Sciences (KFAS), Kuwait	This work is financially supported by Kuwait Foundation for the Advancement of Sciences (KFAS), Kuwait. Grant Number: PR18-13 MM-08 received by Prof. Murugappan Murugappan. The funders had no role in study design, data collection and analysis, decision to publish, preparation of manuscript.	Bajaj V, 2020, APPL ACOUST, V163, DOI 10.1016/j.apacoust.2020.107224; Bajaj V, 2019, IEEE SENSOR LETT, V3, DOI 10.1109/LSENS.2019.2909119; Bek J, 2020, J NEUROSCI METH, V331, DOI 10.1016/j.jneumeth.2019.108524; Bhurane AA, EXPERT SYSTEMS; Borowska M, 2015, ENTROPY BASED ALGORI, V43; Budak U, 2019, IEEE SENS J, V19, P7624, DOI 10.1109/JSEN.2019.2917850; Chen T, 2018, COMPUT ELECTR ENG, V72, P383, DOI 10.1016/j.compeleceng.2018.09.022; Cousins R, 2021, J NEUROPSYCHOL, V15, P8, DOI 10.1111/jnp.12210; DEOLIVEIRA AM, 2020, RES BIOMED ENG, P397, DOI DOI 10.1016/B978-0-12-817998-7.00017-3; Folador JP, 2018, 11 S ENG BIOM JAN, P1; Gray HA, 2010, NEUROPSYCHOLOGY, V24, P176, DOI 10.1037/a0018104; Guntekin B, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00170; Hassan AR, 2016, COMPUT METH PROG BIO, V137, P247, DOI 10.1016/j.cmpb.2016.09.008; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Serrano JI, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00714; Khare SK, 2021, IEEE SENS J, V21, P2035, DOI 10.1109/JSEN.2020.3020915; Khare SK, 2020, COMPUT METH PROG BIO, V197, DOI 10.1016/j.cmpb.2020.105722; Khare SK, 2021, IEEE T NEUR NET LEAR, V32, P2901, DOI 10.1109/TNNLS.2020.3008938; Khare SK, 2020, APPL ACOUST, V163, DOI 10.1016/j.apacoust.2020.107234; Kim Hae-Young, 2013, Restor Dent Endod, V38, P52, DOI 10.5395/rde.2013.38.1.52; Kotsiantis SB, 2007, INFORM-J COMPUT INFO, V31, P249; Krishnan PT, 2020, BIOCYBERN BIOMED ENG, V40, P1124, DOI 10.1016/j.bbe.2020.05.008; Ly QT, 2017, DETECTION FREEZING G, P1; Marras C, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0058-0; Mattavelli G, 2021, J NEUROPSYCHOL, V15, P46, DOI 10.1111/jnp.12209; MOHR E, 1990, J NEUROL NEUROSUR PS, V53, P603, DOI 10.1136/jnnp.53.7.603; Murugappan M, 2020, 2020 16TH IEEE INTERNATIONAL COLLOQUIUM ON SIGNAL PROCESSING & ITS APPLICATIONS (CSPA 2020), P290, DOI 10.1109/CSPA48992.2020.9068709; Naghsh E, 2020, SIGNAL IMAGE VIDEO P, V14, P397, DOI 10.1007/s11760-019-01564-8; Pepa L, 2019, 2019 IEEE 23RD INTERNATIONAL SYMPOSIUM ON CONSUMER TECHNOLOGIES (ISCT), P23, DOI 10.1109/ISCE.2019.8901033; Peron J, 2012, MOVEMENT DISORD, V27, P186, DOI 10.1002/mds.24025; Pillon B, 2005, NO SHINKEI BRAIN NER, V2, P107; Poewe W, 2008, EUR J NEUROL, V15, P14, DOI 10.1111/j.1468-1331.2008.02056.x; Priya SJ, 2020, PR INT CONF DEVICE C, P198, DOI 10.1109/ICDCS48716.2020.243580; Qung QW, 2017, J MED SYST, V2, P1; Rejith K.N., 2018, BIOMED PHARMACOL J, V11, P333, DOI [10.13005/bpj/1377, DOI 10.13005/BPJ/1377]; Sarica A, 2007, NEUROSCIENCE, V9, P329, DOI [10.3389/fnagi.2017.00329, DOI 10.3389/FNAGI.2017.00329]; Selesnick IW, 2011, IEEE T SIGNAL PROCES, V59, P3560, DOI 10.1109/TSP.2011.2143711; Silva G., 2020, INT J APPL ENG RES, V15, P197; Siuly S, 2020, IEEE T NEUR SYS REH, V28, P2390, DOI 10.1109/TNSRE.2020.3022715; Sushkova OS, 2017, 2017 13TH INTERNATIONAL CONFERENCE ON SIGNAL-IMAGE TECHNOLOGY AND INTERNET-BASED SYSTEMS (SITIS), P168, DOI 10.1109/SITIS.2017.37; Taran S, 2019, NEURAL COMPUT APPL, V31, P6925, DOI 10.1007/s00521-018-3531-0; Tuncer T, 2020, BIOCYBERN BIOMED ENG, V40, P211, DOI 10.1016/j.bbe.2019.05.006; Yoshimura N, 1996, IMPAIRMENT SOCIAL CO, V2, P329; Yuvaraj R, 2016, COGN NEURODYNAMICS, V10, P225, DOI 10.1007/s11571-016-9375-3; Yuvaraj R, 2016, BEHAV BRAIN RES, V298, P248, DOI 10.1016/j.bbr.2015.10.036; Yuvaraj R, 2015, J NEURAL TRANSM, V122, P237, DOI 10.1007/s00702-014-1249-4; Yuvaraj R, 2014, BIOMED SIGNAL PROCES, V14, P108, DOI 10.1016/j.bspc.2014.07.005; Yuvaraj R, 2014, INT J PSYCHOPHYSIOL, V94, P482, DOI 10.1016/j.ijpsycho.2014.07.014; Yuvaraj R, 2018, NEURAL COMPUT APPL, V30, P1225, DOI 10.1007/s00521-016-2756-z; Yuvaraj R, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-12; Yuvraj R, 2013, INT J NEUROSCI, V7, P491; Yuvraj R, 2016, BRAIN TOPOGRAPHY, V9, P333	52	14	14	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0242014	10.1371/journal.pone.0242014	http://dx.doi.org/10.1371/journal.pone.0242014			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211717	Green Published, gold			2022-12-26	WOS:000603518300030
J	Choi, SW; Lee, CE; Kim, YC				Choi, Sung Won; Lee, Chong Eun; Kim, Yu Cheol			Intraocular pressure change with face-down positioning after macular hole surgery	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; CLOSURE; PRONE; TAMPONADE; DURATION	This study evaluated changes in intraocular pressure (IOP) with face-down positioning (FDP) following surgical treatment of idiopathic macular hole. We retrospectively reviewed the records of 130 patients diagnosed with idiopathic macular hole who underwent pars plana vitrectomy (PPV) with intravitreal gas injection after fluid-gas exchange. We analyzed IOP changes in both eyes following FDP over the course of 7 days. The mean IOP of the operated eyes was 14.98 +/- 2.95 mmHg preoperatively and 16.82 +/- 3.12 and 15.57 +/- 6.10 mmHg on postoperative days 2 and 7, respectively. In contralateral eyes, the mean IOP changed from 14.78 +/- 3.15 mmHg preoperatively to 16.27 +/- 1.87 and 14.40 +/- 4.14 mmHg on postoperative days 2 and 7, respectively. On postoperative day 2, the IOP increased in both eyes compared to the preoperative values, but the increase was significant only in operated eyes (p = 0.039). In contralateral eyes, the IOP on postoperative day 7 was significantly decreased compared with that on postoperative day 2 (p = 0.021) and in eyes with an axial length >= 23.0 mm, compared with the preoperative values (p = 0.042). The IOP of the operated eyes on postoperative day 7 was higher than that of the contralateral eyes (p = 0.039). Based on a short-term follow-up, FDP after PPV with intravitreal gas tamponade for the treatment of idiopathic macular hole may cause IOP elevation not only in the operated, but also in the contralateral eyes; the IOP increase in contralateral eyes was not as significant as that in operated eyes and was not maintained over 7 days after surgery; the IOP change seems to be affected by axial length and lens status.	[Choi, Sung Won; Lee, Chong Eun; Kim, Yu Cheol] Keimyung Univ, Sch Med, Dept Ophthalmol, Daegu, South Korea	Keimyung University	Kim, YC (corresponding author), Keimyung Univ, Sch Med, Dept Ophthalmol, Daegu, South Korea.	eyedr@dsmc.or.kr			National Research Foundation of Korea (NRF) - Korean government (MSIP) [2014R1A5A2010008]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This work was supported by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP)(No. 2014R1A5A2010008). The sponsor had no role in the design or conduct of this research. https://ernd.nrf.re.kr/index.do www.nrf.re.kr/index fund award: YCK.	Al-Jazzaf AM, 2005, J GLAUCOMA, V14, P40, DOI 10.1097/01.ijg.0000145811.62095.fa; Blondeau P, 2001, J GLAUCOMA, V10, P18, DOI 10.1097/00061198-200102000-00005; CARLSON KH, 1987, INVEST OPHTH VIS SCI, V28, P1346; Chen PP, 1997, OPHTHALMIC SURG LAS, V28, P37; Chen XS, 2018, PROCEEDINGS OF THE 2018 ACM MULTIMEDIA CONFERENCE (MM'18), P2018, DOI 10.1145/3240508.3266434; DUNHAM CN, 1994, BRIT J OPHTHALMOL, V78, P38, DOI 10.1136/bjo.78.1.38; Eckardt C, 2008, RETINA-J RET VIT DIS, V28, P1087, DOI 10.1097/IAE.0b013e318185fb5f; Ellis JD, 2002, OPHTHALMOLOGY, V109, P622; George R, 2003, BRIT J OPHTHALMOL, V87, P399, DOI 10.1136/bjo.87.4.399; Grant GP, 2010, ANESTHESIOLOGY, V112, P57, DOI 10.1097/ALN.0b013e3181c294e1; HAN DP, 1989, OPHTHALMOLOGY, V96, P1357; HARRIS LS, 1972, ARCH OPHTHALMOL-CHIC, V87, P493; Holekamp NM, 1999, ARCH OPHTHALMOL-CHIC, V117, P1607; HYAMS SW, 1968, AM J OPHTHALMOL, V66, P661, DOI 10.1016/0002-9394(68)91287-7; Iwase T, 2007, CLIN EXP OPHTHALMOL, V35, P214, DOI 10.1111/j.1442-9071.2007.01455.x; JAIN MR, 1976, BRIT J OPHTHALMOL, V60, P687, DOI 10.1136/bjo.60.10.687; JOHNSON RN, 1988, OPHTHALMOLOGY, V95, P917; KELLY NE, 1991, ARCH OPHTHALMOL-CHIC, V109, P654, DOI 10.1001/archopht.1991.01080050068031; Kim KS, 2009, J GLAUCOMA, V18, P399, DOI 10.1097/IJG.0b013e3181879e89; Lee Chong Eun, 2019, Korean J Ophthalmol, V33, P101, DOI 10.3341/kjo.2018.0061; Li F, 2020, BRIT J OPHTHALMOL, V104, P790, DOI 10.1136/bjophthalmol-2019-314418; Miele A, 2018, RETINA-J RET VIT DIS, V38, P883, DOI 10.1097/IAE.0000000000001651; Mittra RA, 2009, BRIT J OPHTHALMOL, V93, P664, DOI 10.1136/bjo.2008.148544; Nadal Jeroni, 2012, Retina, V32, P918, DOI 10.1097/IAE.0b013e318229b20e; Ohana E, 1998, OPHTHALMOLOGY, V105, P1398, DOI 10.1016/S0161-6420(98)98019-8; Piltz J, 2000, AM J OPHTHALMOL, V130, P441, DOI 10.1016/S0002-9394(00)00527-4; Sawada A, 2012, INVEST OPHTH VIS SCI, V53, P7631, DOI 10.1167/iovs.12-10454; Sedgewick JH, 2018, CLIN OPHTHALMOL, V12, P1347, DOI 10.2147/OPTH.S163319; Sherpa D, 2008, Kathmandu Univ Med J (KUMJ), V6, P361; Tatham A, 2010, BRIT J OPHTHALMOL, V94, P626, DOI 10.1136/bjo.2009.163741; Thompson JT, 1996, RETINA-J RET VIT DIS, V16, P373, DOI 10.1097/00006982-199616050-00002; TSUKAHARA S, 1984, BRIT J OPHTHALMOL, V68, P389, DOI 10.1136/bjo.68.6.389; ZIMMERMAN TJ, 1977, ARCH OPHTHALMOL-CHIC, V95, P601, DOI 10.1001/archopht.1977.04450040067008	33	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242567	10.1371/journal.pone.0242567	http://dx.doi.org/10.1371/journal.pone.0242567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201931	Green Published, gold			2022-12-26	WOS:000595003900049
J	Witt, RR; Beranek, CT; Howell, LG; Ryan, SA; Clulow, J; Jordan, NR; Denholm, B; Roff, A				Witt, Ryan R.; Beranek, Chad T.; Howell, Lachlan G.; Ryan, Shelby A.; Clulow, John; Jordan, Neil R.; Denholm, Bob; Roff, Adam			Real-time drone derived thermal imagery outperforms traditional survey methods for an arboreal forest mammal	PLOS ONE			English	Article							KOALAS PHASCOLARCTOS-CINEREUS; TREE SPECIES PREFERENCES; SOUTH-WEST QUEENSLAND; HABITAT USE; CONSERVATION; POPULATION; ABUNDANCE; MULGALANDS; SYDNEY; SHIRE	Koalas (Phascolarctos cinereus) are cryptic and currently face regional extinction. The direct detection (physical sighting) of individuals is required to improve conservation management strategies. We provide a comparative assessment of three survey methods for the direct detection of koalas: systematic spotlighting (Spotlight), remotely piloted aircraft system thermal imaging (RPAS), and the refined diurnal radial search component of the spot assessment technique (SAT). Each survey method was repeated on the same morning with independent observers (03:00-12:00 hrs) for a total of 10 survey occasions at sites with fixed boundaries (28-76 ha) in Port Stephens (n = 6) and Gilead (n = 1) in New South Wales between May and July 2019. Koalas were directly detected on 22 occasions during 7 of 10 comparative surveys (Spotlight: n = 7; RPAS: n = 14; and SAT: n = 1), for a total of 12 unique individuals (Spotlight: n = 4; RPAS: n = 11; SAT: n = 1). In 3 of 10 comparative surveys no koalas were detected. Detection probability was 38.9 +/- 20.03% for Spotlight, 83.3 +/- 11.39% for RPAS and 4.2 +/- 4.17% for SAT. Effective detectability per site was 1 +/- 0.44 koalas per 6.75 +/- 1.03 hrs for Spotlight (1 koala per 6.75 hrs), 2 +/- 0.38 koalas per 4.35 +/- 0.28 hrs for RPAS (1 koala per 2.18 hrs) and 0.14 +/- 0.14 per 6.20 +/- 0.93 hrs for SAT (1 koala per 43.39 hrs). RPAS thermal imaging technology appears to offer an efficient method to directly survey koalas comparative to Spotlight and SAT and has potential as a valuable conservation tool to inform on-ground management of declining koala populations.	[Witt, Ryan R.; Beranek, Chad T.; Howell, Lachlan G.; Ryan, Shelby A.; Clulow, John; Roff, Adam] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia; [Witt, Ryan R.; Beranek, Chad T.; Howell, Lachlan G.; Ryan, Shelby A.; Clulow, John] FAUNA Res Alliance, Kahibah, NSW, Australia; [Beranek, Chad T.; Denholm, Bob; Roff, Adam] NSW Dept Planning Ind & Environm, Sci Div, Newcastle, NSW, Australia; [Jordan, Neil R.] Univ New South Wales UNSW Sydney, Sch BEES, Ctr Ecosyst Sci, Sydney, NSW, Australia; [Jordan, Neil R.] Taronga Western Plains Zoo, Taronga Conservat Soc Australia, Taronga Inst Sci & Learning, Dubbo, NSW, Australia	University of Newcastle; University of New South Wales Sydney	Witt, RR (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW, Australia.; Witt, RR (corresponding author), FAUNA Res Alliance, Kahibah, NSW, Australia.	ryan.witt@newcastle.edu.au	Witt, Ryan/AAB-8070-2019	Witt, Ryan/0000-0003-3696-6395; Jordan, Neil/0000-0002-0712-8301; Clulow, John/0000-0001-8991-1449; Beranek, Chad/0000-0001-9747-2917; Roff, Adam/0000-0002-0457-8251; Ryan, Shelby/0000-0001-7958-2645	Remote Sensing and Landscape Science, Science Division, NSW Department of Planning, Industry and Environment; University of Newcastle Centre for Creative Industries; Taronga Conservation Society, Australia	Remote Sensing and Landscape Science, Science Division, NSW Department of Planning, Industry and Environment; University of Newcastle Centre for Creative Industries; Taronga Conservation Society, Australia	This work was funded by Remote Sensing and Landscape Science, Science Division, NSW Department of Planning, Industry and Environment and the University of Newcastle Centre for Creative Industries. Follow-up spotlighting line transect surveys used to calculate f(0) as per S1 were funded by Taronga Conservation Society, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [CTB, BD, NRJ, AR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2018, OBSTET GYNECOL, V13, pe49; Beranek CT, 2021, AUST MAMMAL, V43, P260, DOI 10.1071/AM20043; Berghout MJ, 1993, ECOLOGY KOALA PHASCO; Brown G, 2018, BIOL CONSERV, V227, P141, DOI 10.1016/j.biocon.2018.09.016; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Buckland ST, 2015, METH STAT ECOL, P1, DOI 10.1007/978-3-319-19219-2; Burke C, 2019, INT J REMOTE SENS, V40, P439, DOI 10.1080/01431161.2018.1558372; Callaghan, 2014, WHAT FAECAL PELLET S; Callaghan, 2007, KOALA HABITAT POPULA; Callaghan J, 2011, WILDLIFE RES, V38, P89, DOI 10.1071/WR07177; Corcoran E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39917-5; Cristescu RH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08349; Crowther MS, 2021, WILDLIFE RES, V48, P105, DOI 10.1071/WR19148; Curtin Alison, 2002, Australian Mammalogy, V23, P135; de Villiers D., 2017, FINAL TECHNICAL REPO; Dickman C., 2020, CATASTROPHE BLUEPRIN; Dique D, 2001, RES MANAGEMENT NONUR, P105; Dique DS, 2004, WILDLIFE RES, V31, P109, DOI 10.1071/WR02031; Dique DS, 2003, WILDLIFE RES, V30, P127, DOI 10.1071/WR02042; Ellis WAH, 1998, WILDLIFE RES, V25, P663, DOI 10.1071/WR97028; Ellis W, 2013, AUST MAMMAL, V35, P160, DOI 10.1071/AM12023; Ellis WA, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0632; Hamilton G, 2020, BIOL CONSERV, V247, DOI 10.1016/j.biocon.2020.108598; Hodgson JC, 2018, METHODS ECOL EVOL, V9, P1160, DOI 10.1111/2041-210X.12974; Howell Lachlan G., 2018, Pacific Conservation Biology, V24, P142, DOI 10.1071/PC17037; Kays R, 2019, INT J REMOTE SENS, V40, P407, DOI 10.1080/01431161.2018.1523580; Kleinig D.A., 2006, FIELD GUIDE EUCALYPT, V3; Law B, 2017, ECOL EVOL, V7, P7475, DOI 10.1002/ece3.3300; Legge S., 2018, MONITORING THREATENE; Leigh C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217809; Linchant J, 2015, MAMMAL REV, V45, P239, DOI 10.1111/mam.12046; Lunney D, 2000, CONSERV BIOL, V14, P669, DOI 10.1046/j.1523-1739.2000.99386.x; Lunney Daniel, 1998, Pacific Conservation Biology, V4, P186; Lunney D, 2009, WILDLIFE RES, V36, P262, DOI 10.1071/WR08079; Marsh KJ, 2013, WILDLIFE RES, V40, P639, DOI 10.1071/WR13104; Matthews A, 2007, WILDLIFE RES, V34, P84, DOI 10.1071/WR06075; Matthews A, 2016, AUST MAMMAL, V38, P91, DOI 10.1071/AM14010; McCallum H., 2000, METH ECOL; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Melzer A., 2011, Australian Zoologist, V35, P870; Parliament NSW, 2020, 3 PARL NSW; Phillips S, 2000, WILDLIFE RES, V27, P509, DOI 10.1071/WR98087; Phillips S, 2000, WILDLIFE RES, V27, P1, DOI 10.1071/WR98054; Phillips S, 2007, UTILITY REGULARISED; Phillips S., 2018, TOMAGO MEDOWIE KOALA; Phillips Stephen, 2011, Australian Zoologist, V35, P774; Reed P.C., 1990, P55; Reed Philip, 1990, P9; Rhodes J, 2011, ECOGRAPHY, V34, P141, DOI 10.1111/j.1600-0587.2010.05908.x; Rhodes JR, 2006, J WILDLIFE MANAGE, V70, P8, DOI 10.2193/0022-541X(2006)70[8:OPSFDP]2.0.CO;2; Robinson L., 2003, FIELD GUIDE NATIVE P; Sullivan BJ, 2002, WILDLIFE RES, V29, P455, DOI 10.1071/WR00110; Sullivana BJ, 2004, WILDLIFE RES, V31, P19, DOI 10.1071/WR02037; Wilmott L, 2019, AUST MAMMAL, V41, P157, DOI 10.1071/AM18006; 2019, BRAIN STIMUL MAR, V12	55	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242204	10.1371/journal.pone.0242204	http://dx.doi.org/10.1371/journal.pone.0242204			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196649	Green Published, gold			2022-12-26	WOS:000595266800028
J	Hirose, S; Matsumoto, K; Tatemichi, M; Tsuruya, K; Anzai, K; Arase, Y; Shiraishi, K; Suzuki, M; Ieda, S; Kagawa, T				Hirose, Shunji; Matsumoto, Koshi; Tatemichi, Masayuki; Tsuruya, Kota; Anzai, Kazuya; Arase, Yoshitaka; Shiraishi, Koichi; Suzuki, Michiko; Ieda, Satsuki; Kagawa, Tatehiro			Nineteen-year prognosis in Japanese patients with biopsy-proven nonalcoholic fatty liver disease: Lean versus overweight patients	PLOS ONE			English	Article							TERM-FOLLOW-UP; NATURAL-HISTORY; FIBROSIS STAGE; PREDICTS MORTALITY; ALL-CAUSE; RISK; EPIDEMIOLOGY; CANCER; STEATOHEPATITIS; PREVALENCE	Background Many studies have investigated the prognosis of nonalcoholic fatty liver disease (NAFLD); however, most studies had a relatively short follow-up. To elucidate the long-term outcome of NAFLD, we conducted a retrospective cohort study of patients with biopsy-proven NAFLD. Methods We re-evaluated 6080 patients who underwent liver biopsy from 1975 to 2012 and identified NAFLD patients without other etiologies. With follow-up these patients, we evaluated the outcome-associated factors. Results A total of 223 patients were enrolled, 167 (74.9%) was non-alcoholic steatohepatitis (NASH). The median follow-up was 19.5 (0.5-41.0) years and 4248.3 person-years. The risk of type 2 diabetes mellitus (T2DM) and hypertension was 11.7 (95% confidence interval [CI] 8.70-15.6) and 7.99 (95% CI 6.09-10.5) times higher, respectively, in NAFLD patients than in the general population. Twenty-three patients died, 22 of whom had NASH. Major causes of death were extrahepatic malignancy and cardiovascular disease (21.7%) followed by liver-related mortality (13.0%). All-cause mortality was significantly higher in NASH patients than in nonalcoholic fatty liver patients (P = 0.041). In multivariate analysis, older age (hazard ratio [HR] 1.09 [95% CI 1.05-1.14], P<0.001) and T2DM (HR 2.87 [95% CI 1.12-7.04], P = 0.021) were significantly associated with all-cause mortality. The factors significantly associated with liver-related events were older age, T2DM, milder hepatic steatosis, and advanced liver fibrosis. Body mass index wasn't associated with either mortality or liver-related events. Conclusions T2DM was highly prevalent in NAFLD patients and was significantly associated with both all-cause mortality and liver-related events. The lean patients' prognosis wasn't necessarily better than that of overweight patients.	[Hirose, Shunji; Tsuruya, Kota; Suzuki, Michiko; Ieda, Satsuki; Kagawa, Tatehiro] Tokai Univ, Sch Med, Dept Gastroenterol & Hepatol, Isehara, Kanagawa, Japan; [Matsumoto, Koshi] Ebina Gen Hosp, Dept Pathol, Ebina, Kanagawa, Japan; [Tatemichi, Masayuki] Tokai Univ, Sch Med, Dept Prevent Med, Isehara, Kanagawa, Japan; [Anzai, Kazuya] Tokai Univ, Hachioji Hosp, Dept Gastroenterol & Hepatol, Hachioji, Tokyo, Japan; [Arase, Yoshitaka] Tokai Univ, Oiso Hosp, Dept Gastroenterol & Hepatol, Oiso, Japan; [Shiraishi, Koichi] Tokai Univ, Tokyo Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Tokai University	Hirose, S (corresponding author), Tokai Univ, Sch Med, Dept Gastroenterol & Hepatol, Isehara, Kanagawa, Japan.	s-hirose@is.icc.u-tokai.ac.jp		Tsuruya, Kota/0000-0002-9884-8039	 [18K11002]		T.K. was supported, in part, by a Grants-in-Aid for Scientific Research (C) https://www.jsps.go.jp/english/e-grants/(18K11002) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other authors declare that they do not have anything to disclose with respect to the funding, sources of support or conflict of interest (whether external or internal to our organization) received during this study. There was no additional external funding received for this study.	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Bertot LC, 2018, LIVER INT, V38, P1793, DOI 10.1111/liv.13739; Bhala N, 2011, HEPATOLOGY, V54, P1208, DOI 10.1002/hep.24491; Caldwell SH, 2009, ANN HEPATOL, V8, P346, DOI 10.1016/S1665-2681(19)31748-X; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Dam-Larsen S, 2004, GUT, V53, P750, DOI 10.1136/gut.2003.019984; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Ekstedt Mattias, 2017, Curr Hepatol Rep, V16, P391, DOI 10.1007/s11901-017-0378-2; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fan JG, 2017, J HEPATOL, V67, P862, DOI 10.1016/j.jhep.2017.06.003; Gandini S, 2014, CANCER PREV RES, V7, P867, DOI 10.1158/1940-6207.CAPR-13-0424; Hagstrom H, 2017, J HEPATOL, V67, P1265, DOI 10.1016/j.jhep.2017.07.027; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Kanwal F, 2018, GASTROENTEROLOGY, V155, P1828, DOI 10.1053/j.gastro.2018.08.024; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Leung JCF, 2017, HEPATOLOGY, V65, P54, DOI 10.1002/hep.28697; Li ZZ, 2014, J GASTROEN HEPATOL, V29, P42, DOI 10.1111/jgh.12428; Liu Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47687-3; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Miura K, 2013, CIRC J, V77, P2226, DOI 10.1253/circj.CJ-13-0847; Neville SE, 2009, DIABETES-METAB RES, V25, P705, DOI 10.1002/dmrr.1012; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Rafiq N, 2009, CLIN GASTROENTEROL H, V7, P234, DOI 10.1016/j.cgh.2008.11.005; Sayiner M, 2016, CLIN LIVER DIS, V20, P205, DOI 10.1016/j.cld.2015.10.001; Seko Y, 2015, HEPATOL RES, V45, P728, DOI 10.1111/hepr.12407; Stepanova M, 2013, DIGEST DIS SCI, V58, P3017, DOI 10.1007/s10620-013-2743-5; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Szablewski L, 2014, DIABETES-METAB RES, V30, P543, DOI 10.1002/dmrr.2573; Tada T, 2019, J GASTROEN HEPATOL, V34, P2011, DOI 10.1111/jgh.14734; Tada T, 2017, HEPATOL COMMUN, V1, P899, DOI 10.1002/hep4.1105; Targher G, 2016, J HEPATOL, V65, P589, DOI 10.1016/j.jhep.2016.05.013; Taylor KS, 2013, DIABETES CARE, V36, P2366, DOI 10.2337/dc12-1513; Teli MR, 1995, HEPATOLOGY, V22, P1714, DOI 10.1002/hep.1840220616; Tobari M, 2019, J GASTROEN HEPATOL, V34, P1404, DOI 10.1111/jgh.14585; Trepo E, 2016, J HEPATOL, V65, P399, DOI 10.1016/j.jhep.2016.03.011; Vicentini M, 2018, DIABETES RES CLIN PR, V143, P398, DOI 10.1016/j.diabres.2018.04.036; Wu SQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33386; Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033; Younossi ZM, 2017, HEPATOL COMMUN, V1, P421, DOI 10.1002/hep4.1054; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Younossi ZM, 2011, HEPATOLOGY, V53, P1874, DOI 10.1002/hep.24268	48	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0241770	10.1371/journal.pone.0241770	http://dx.doi.org/10.1371/journal.pone.0241770			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186403	Green Published, gold			2022-12-26	WOS:000593949800015
J	Scarpa, E; De Pace, C; Joseph, AS; de Souza, SC; Poma, A; Liatsi-Douvitsa, E; Contini, C; De Matteis, V; Marti, JS; Battaglia, G; Rizzello, L				Scarpa, Edoardo; De Pace, Cesare; Joseph, Adrian Steve; de Souza, Senio Campos; Poma, Alessandro; Liatsi-Douvitsa, Eva; Contini, Claudia; De Matteis, Valeria; Marti, Josep Samitier; Battaglia, Giuseppe; Rizzello, Loris			Tuning cell behavior with nanoparticle shape	PLOS ONE			English	Article							SURFACE-CHEMISTRY; IN-VITRO; POLYMERSOMES; ENCAPSULATION; DELIVERY; PH; INTERNALIZATION; VESICLES; SIZE; DNA	We investigated how the shape of polymeric vesicles, made by the exact same material, impacts the replication activity and metabolic state of both cancer and non-cancer cell types. First, we isolated discrete geometrical structures (spheres and tubes) from a heterogeneous sample using density-gradient centrifugation. Then, we characterized the cellular internalization and the kinetics of uptake of both types of polymersomes in different cell types (either cancer or non-cancer cells). We also investigated the cellular metabolic response as a function of the shape of the structures internalized and discovered that tubular vesicles induce a significant decrease in the replication activity of cancer cells compared to spherical vesicles. We related this effect to the significant up-regulation of the tumor suppressor genes p21 and p53 with a concomitant activation of caspase 3/7. Finally, we demonstrated that combining the intrinsic shape-dependent effects of tubes with the delivery of doxorubicin significantly increases the cytotoxicity of the system. Our results illustrate how the geometrical conformation of nanoparticles could impact cell behavior and how this could be tuned to create novel drug delivery systems tailored to specific biomedical application.	[Scarpa, Edoardo; De Pace, Cesare; Joseph, Adrian Steve; de Souza, Senio Campos; Poma, Alessandro; Liatsi-Douvitsa, Eva; Contini, Claudia; Battaglia, Giuseppe; Rizzello, Loris] UCL, Dept Chem, London, England; [Contini, Claudia] Imperial Coll London, Dept Chem, Mol Sci Res Hub, London, England; [De Matteis, Valeria] Univ Salento, Dept Math & Phys, Lecce, Italy; [Marti, Josep Samitier; Battaglia, Giuseppe; Rizzello, Loris] Barcelona Inst Sci & Technol, Inst Bioengn Catalonia IBEC, Barcelona, Spain; [Marti, Josep Samitier; Battaglia, Giuseppe] Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain; [Marti, Josep Samitier; Battaglia, Giuseppe] Univ Barcelona UB, Barcelona, Spain; [Marti, Josep Samitier] Networking Biomed Res Ctr Bioengn Biomat & Nanome, Madrid, Spain; [Battaglia, Giuseppe] UCL, Inst Phys Living Syst, London, England; [Rizzello, Loris] Univ Milan, Dept Pharmaceut Sci, Milan, Italy	University of London; University College London; Imperial College London; University of Salento; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; ICREA; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of London; University College London; University of Milan	Battaglia, G; Rizzello, L (corresponding author), UCL, Dept Chem, London, England.; Battaglia, G; Rizzello, L (corresponding author), Barcelona Inst Sci & Technol, Inst Bioengn Catalonia IBEC, Barcelona, Spain.; Battaglia, G (corresponding author), Catalan Inst Res & Adv Studies ICREA, Barcelona, Spain.; Battaglia, G (corresponding author), Univ Barcelona UB, Barcelona, Spain.; Battaglia, G (corresponding author), UCL, Inst Phys Living Syst, London, England.; Rizzello, L (corresponding author), Univ Milan, Dept Pharmaceut Sci, Milan, Italy.	g.battaglia@ucl.ac.uk; loris.rizzello@unimi.it	Contini, Claudia/GRJ-9310-2022; Rizzello, Loris/HDM-2610-2022; Contini, Claudia/AAJ-1878-2021	Rizzello, Loris/0000-0002-8230-853X; Contini, Claudia/0000-0002-5282-2458; De Matteis, Valeria/0000-0003-2204-8817; Poma, Alessandro/0000-0003-2913-0389; Scarpa, Edoardo/0000-0002-5886-6929	ERC starting grant [MEVIC: 278793]; EPSRC [EP/N026322/1]; Children with Cancer UK; Astrazeneca; Programma Operativo Nazionale (PON) Ricerca e Innovazione 2014-2020 Asse I "Capitale Umano", Azione I.2, Avviso "A.I.M: Attraction and International Mobility" [CUP F88D18000070001]; Marie Sklodowska-Curie actions PHANTOM [795224]; ERC-2019-STG [850936]; Fondazione Cariplo [2019-4278]; EPSRC [EP/N010906/1] Funding Source: UKRI	ERC starting grant(European Research Council (ERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Children with Cancer UK; Astrazeneca(AstraZeneca); Programma Operativo Nazionale (PON) Ricerca e Innovazione 2014-2020 Asse I "Capitale Umano", Azione I.2, Avviso "A.I.M: Attraction and International Mobility"; Marie Sklodowska-Curie actions PHANTOM; ERC-2019-STG; Fondazione Cariplo(Fondazione Cariplo); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are grateful to Children with Cancer UK, ERC starting grant MEVIC: 278793 and EPSRC (EP/N026322/1) to sponsor the salary and the work of E.S., C.D.P., A.S.J., S.C.D.S., E.L.D., C.C., G.B, and L.R.; We thank British Technology Group (BTG) for donating the MPC monomer; G.B. and E. S. thank Children with Cancer UK for funding; S.C. D.S. thanks Astrazeneca for covering part of the stipend; V.D.M. kindly acknowledges Programma Operativo Nazionale (PON) Ricerca e Innovazione 2014-2020 Asse I "Capitale Umano", Azione I.2, Avviso "A.I.M: Attraction and International Mobility" CUP F88D18000070001. L.R. sincerely thanks the Marie Sklodowska-Curie actions PHANTOM (795224) for supporting part of his research activities, the ERC-2019-STG (grant number: 850936) and the Fondazione Cariplo (grant number 2019-4278) to sponsor the salary and this work. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Andon FT, 2013, ACCOUNTS CHEM RES, V46, P733, DOI 10.1021/ar300020b; Baalousha M, 2013, NAT NANOTECHNOL, V8, P308, DOI 10.1038/nnano.2013.78; Bahrami AH, 2013, SOFT MATTER, V9, P8642, DOI 10.1039/c3sm50885d; Banerjee A, 2016, J CONTROL RELEASE, V238, P176, DOI 10.1016/j.jconrel.2016.07.051; Barua S, PARTICLE SHAPE ENHAN, DOI [10.1073/pnas.1216893110, DOI 10.1073/PNAS.1216893110]; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Canton I, 2013, FASEB J, V27, P98, DOI 10.1096/fj.12-212183; Colley HE, 2014, MOL PHARMACEUT, V11, P1176, DOI 10.1021/mp400610b; Contini C, 2018, ISCIENCE, V7, P132, DOI 10.1016/j.isci.2018.08.018; FENECH M, 1985, MUTAT RES, V147, P29, DOI 10.1016/0165-1161(85)90015-9; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Ferrari M, 2008, NAT NANOTECHNOL, V3, P131, DOI 10.1038/nnano.2008.46; Gaitzsch J, 2016, POLYM CHEM-UK, V7, P3046, DOI 10.1039/c6py00518g; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Hinde E, 2017, NAT NANOTECHNOL, V12, P81, DOI [10.1038/nnano.2016.160, 10.1038/NNANO.2016.160]; Ji Z, 2012, ACS NANO, V6, P5366, DOI 10.1021/nn3012114; Kim JA, 2012, NAT NANOTECHNOL, V7, P62, DOI [10.1038/nnano.2011.191, 10.1038/NNANO.2011.191]; Kolhar P, 2013, P NATL ACAD SCI USA, V110, P10753, DOI 10.1073/pnas.1308345110; Leifert A, 2013, P NATL ACAD SCI USA, V110, P8004, DOI 10.1073/pnas.1220143110; Leong J, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201701276; Lewis AL, 2000, COLLOID SURFACE B, V18, P261, DOI 10.1016/S0927-7765(99)00152-6; Lomas H, 2007, ADV MATER, V19, P4238, DOI 10.1002/adma.200700941; Lomas H, 2010, MACROMOL BIOSCI, V10, P513, DOI 10.1002/mabi.201000083; LoPresti C, 2011, ACS NANO, V5, P1775, DOI 10.1021/nn102455z; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Messager L, 2014, CURR OPIN PHARMACOL, V18, P104, DOI 10.1016/j.coph.2014.09.017; Murdoch C, 2010, NANOMEDICINE-UK, V5, P1025, DOI 10.2217/NNM.10.97; Park KH, 2003, J BIOL CHEM, V278, P50212, DOI 10.1074/jbc.M310216200; Pearson RT, 2013, MACROMOLECULES, V46, P1400, DOI 10.1021/ma302228m; Robertson JD, 2016, SCI REP-UK, V6, DOI [10.1038/srep27494, 10.1038/srep22615]; Robertson JD, 2014, ACS NANO, V8, P4650, DOI 10.1021/nn5004088; Rodriguez-Arco L, 2019, BIOMATERIALS, V192, P26, DOI 10.1016/j.biomaterials.2018.10.044; Ruiz-Perez L, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500948; Scarpa E, 2018, NANOMED-NANOTECHNOL, V14, P1267, DOI 10.1016/j.nano.2018.02.014; Scarpa E, 2016, SCI REP-UK, V6, DOI 10.1038/srep29460; Smith BR, 2012, NANO LETT, V12, P3369, DOI 10.1021/nl204175t; Takano S, 2001, CELL RES, V11, P55, DOI 10.1038/sj.cr.7290066; Toy R, 2014, NANOMEDICINE-UK, V9, P121, DOI 10.2217/nnm.13.191; Tu YS, 2013, NAT NANOTECHNOL, V8, P594, DOI [10.1038/nnano.2013.125, 10.1038/NNANO.2013.125]; Wang LG, 2012, ANGEW CHEM INT EDIT, V51, P11122, DOI 10.1002/anie.201204169; Yun CW, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010060; Zhao JC, 2017, POLYM CHEM-UK, V8, P3317, DOI 10.1039/c7py00385d; Zhao Na, 2018, J Nanomed Nanotechnol, V9, DOI 10.4172/2157-7439.1000519	45	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0240197	10.1371/journal.pone.0240197	http://dx.doi.org/10.1371/journal.pone.0240197			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186380	gold, Green Published, Green Submitted			2022-12-26	WOS:000593949800004
J	Yang, LY; Wu, YS; Lin, SH; Dai, BB; Chen, H; Tao, X; Li, GP; Wan, JX; Pan, YB				Yang, Liyan; Wu, Yuansheng; Lin, Songhua; Dai, Binbin; Chen, Hong; Tao, Xuan; Li, Guoping; Wan, Jianxin; Pan, Yangbin			sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK/mTOR/ULK1(ser757) signaling pathway	FASEB JOURNAL			English	Article						idiopathic membranous nephropathy; PLA2R; podocyte autophagy; sPLA2&#8208; IB	PHOSPHOLIPASE A(2); P38 MAPK; APOPTOSIS; RECEPTOR; MTOR; ANGIOPOIETIN-1; REGULATOR; RITUXIMAB; DISEASES; CELLS	Secretory phospholipase A2 group IB (sPLA2-IB) and M-type phospholipase A2 receptor (PLA2R) are closely associated with proteinuria in idiopathic membranous nephropathy (IMN). Podocytes constitute an important component of glomerular filtration, and high basal autophagy is indispensable for podocyte function. The current study aimed to analyze the relationship between sPLA2-IB and podocyte autophagy in IMN and determine whether sPLA2-IB mediates abnormal autophagy regulation in podocytes. The serum sPLA2-IB level and podocyte autophagy were detected, and clinical data were collected from IMN patients with different proteinuria levels. Then, the effects of sPLA2-IB on autophagy signaling pathways were evaluated in cultured human podocytes treated with sPLA2-IB, rapamycin, p38 inhibition, and PLA2R-siRNA in vitro. We found that IMN patients with nephrotic-range proteinuria have a significantly higher level of sPLA2-IB and fewer autophagosomes than those with non-nephrotic-range proteinuria. In vitro sPLA2-IB-induced insufficient autophagy in podocytes and promoted podocyte injury via activation of the mTOR/ULK1(ser757) signaling pathway. Moreover, inhibition of p38 MAPK evidently abrogated sPLA2-IB-induced autophagy and the activation of mTOR/ULK1(ser757). Additionally, PLA2R silencing demonstrated that sPLA2-IB-induced abnormal autophagy was also PLA2R-dependent. In conclusion, the results revealed that sPLA2-IB downregulated autophagy and contributed to podocyte injury via PLA2R though activation of the p38MAPK/mTOR/ULK1(ser757) signaling pathway.	[Yang, Liyan; Lin, Songhua; Dai, Binbin; Wan, Jianxin; Pan, Yangbin] Fujian Med Univ, Affiliated Hosp 1, Dept Nephrol, 20th Chazhong Rd, Fuzhou, Fujian, Peoples R China; [Wu, Yuansheng] Fujian Med Univ, Affiliated Hosp 1, Dept Cardiol, Fuzhou, Peoples R China; [Chen, Hong; Tao, Xuan; Li, Guoping] Fujian Med Univ, Affiliated Hosp 1, Dept Pathol, Fuzhou, Peoples R China	Fujian Medical University; Fujian Medical University; Fujian Medical University	Wan, JX; Pan, YB (corresponding author), Fujian Med Univ, Affiliated Hosp 1, Dept Nephrol, 20th Chazhong Rd, Fuzhou, Fujian, Peoples R China.	wanjx@263.net; panyb9999@163.com			National Natural Science Foundation of China [81670635]; Family Planning for Young and Middle Aged Talents Training Project [2016-ZQN-36]; Qihang Fund Project of Fujian Medical University [2017XQ2038]; Natural Science Foundation of Fujian Province of China [2019J01441]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Family Planning for Young and Middle Aged Talents Training Project; Qihang Fund Project of Fujian Medical University; Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	National Natural Science Foundation of China, Grant/Award Number: 81670635; Family Planning for Young and Middle Aged Talents Training Project, Grant/Award Number: 2016-ZQN-36; Qihang Fund Project of Fujian Medical University, Grant/Award Number: 2017XQ2038; Natural Science Foundation of Fujian Province of China, Grant/Award Number: 2019J01441	Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; Audzeyenka I, 2017, MOL CELL BIOCHEM, V430, P11, DOI 10.1007/s11010-017-2949-5; Bork T, 2020, AUTOPHAGY, V16, P1932, DOI 10.1080/15548627.2019.1705007; Chen N, 2021, J CELL PHYSIOL, V236, P625, DOI 10.1002/jcp.29890; Couser WG, 2017, CLIN J AM SOC NEPHRO, V12, P983, DOI 10.2215/CJN.11761116; Debiec H, 2016, J AM SOC NEPHROL, V27, P1275, DOI 10.1681/ASN.2015101170; Granata F, 2006, EUR J IMMUNOL, V36, P1938, DOI 10.1002/eji.200535567; Hanasaki K, 2004, BIOL PHARM BULL, V27, P1165, DOI 10.1248/bpb.27.1165; Hanasaki K, 2002, PROSTAG OTH LIPID M, V68-9, P71, DOI 10.1016/S0090-6980(02)00022-9; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Hernandez M, 2002, CIRC RES, V90, P38, DOI 10.1161/hh0102.102978; Hollie NI, 2014, ATHEROSCLEROSIS, V234, P377, DOI 10.1016/j.atherosclerosis.2014.03.027; Hu MS, 2017, J CELL MOL MED, V21, P552, DOI 10.1111/jcmm.13001; Jin J, 2017, INT UROL NEPHROL, V49, P1025, DOI 10.1007/s11255-017-1555-5; Kao LY, 2015, J AM SOC NEPHROL, V26, P291, DOI 10.1681/ASN.2013121315; Kawakami T, 2015, J AM SOC NEPHROL, V26, P1040, DOI 10.1681/ASN.2013111202; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim KY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051088; Kucharewicz K, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0383-6; Li C, 2020, LIFE SCI, V243, DOI 10.1016/j.lfs.2020.117277; Li WH, 2018, CLIN CHIM ACTA, V482, P178, DOI 10.1016/j.cca.2018.04.009; Liang SK, 2016, INT UROL NEPHROL, V48, P2109, DOI 10.1007/s11255-016-1398-5; Liu BC, 2018, KIDNEY INT, V93, P568, DOI 10.1016/j.kint.2017.09.033; Liu WJ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2002-6; Liu WJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07889-z; Lu HJ, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-156; Maycotte P, 2012, AUTOPHAGY, V8, P200, DOI 10.4161/auto.8.2.18554; Moroni G, 2017, NEPHROL DIAL TRANSPL, V32, P1691, DOI 10.1093/ndt/gfw251; Pan YB, 2014, SCI REP-UK, V4, DOI 10.1038/srep06660; Polanco N, 2010, J AM SOC NEPHROL, V21, P697, DOI 10.1681/ASN.2009080861; Rheault MN, 2016, J PEDIATR GENET, V5, P15, DOI 10.1055/s-0035-1557109; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1416, DOI 10.1681/ASN.2012020181; Satchell SC, 2004, J AM SOC NEPHROL, V15, P566, DOI 10.1097/01.ASN.0000115397.22519.03; Satchell SC, 2002, J AM SOC NEPHROL, V13, P544, DOI 10.1681/ASN.V132544; Seong Su-Bin, 2019, Cell Physiol Biochem, V53, P747, DOI 10.33594/000000170; Song ZX, 2014, METABOLISM, V63, P1324, DOI 10.1016/j.metabol.2014.06.013; Wang QR, 2016, PHARMACOL RES, V111, P357, DOI 10.1016/j.phrs.2016.06.024; Wang RM, 2018, CELL PHYSIOL BIOCHEM, V45, P899, DOI 10.1159/000487285; Wang YN, 2018, EXP CELL RES, V363, P291, DOI 10.1016/j.yexcr.2018.01.019; Wang YY, 2018, MED SCI MONITOR, V24, P4823, DOI 10.12659/MSM.910868; Wodawek-Potocka I, 2009, REPRODUCTION, V137, P95, DOI 10.1530/REP-08-0209; Wong DWL, 2018, KIDNEY INT, V93, P1367, DOI 10.1016/j.kint.2017.12.017; Wu LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063799; Xiao TL, 2014, MOL CELL BIOCHEM, V394, P145, DOI 10.1007/s11010-014-2090-7; Xu J, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12738; Yagami T, 2014, MOL NEUROBIOL, V49, P863, DOI 10.1007/s12035-013-8565-9; Yang MT, 2016, ANTIVIR RES, V133, P223, DOI 10.1016/j.antiviral.2016.08.010; Zhao XC, 2018, J PATHOL, V245, P235, DOI 10.1002/path.5077	51	11	15	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001143R	http://dx.doi.org/10.1096/fj.202001143R		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33184968				2022-12-26	WOS:000590888400001
J	Bourdillon, N; Yazdani, S; Schmitt, L; Millet, GP				Bourdillon, Nicolas; Yazdani, Sasan; Schmitt, Laurent; Millet, Gregoire P.			Effects of COVID-19 lockdown on heart rate variability	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; DEPRESSION; EXERCISE; INDEXES; FATIGUE	Introduction Strict lockdown rules were imposed to the French population from 17 March to 11 May 2020, which may result in limited possibilities of physical activity, modified psychological and health states. This report is focused on HRV parameters kinetics before, during and after this lockdown period. Methods 95 participants were included in this study (27 women, 68 men, 37 +/- 11 years, 176 +/- 8 cm, 71 +/- 12 kg), who underwent regular orthostatic tests (a 5-minute supine followed by a 5-minute standing recording of heart rate (HR)) on a regular basis before (BSL), during (CFN) and after (RCV) the lockdown. HR, power in low- and high-frequency bands (LF, HF, respectively) and root mean square of the successive differences (RMSSD) were computed for each orthostatic test, and for each position. Subjective well-being was assessed on a 0-10 visual analogic scale (VAS). The participants were split in two groups, those who reported an improved well-being (WB+, increase >2 in VAS score) and those who did not (WB-) during CFN. Results Out of the 95 participants, 19 were classified WB+ and 76 WB-. There was an increase in HR and a decrease in RMSSD when measured supine in CFN and RCV, compared to BSL in WB-, whilst opposite results were found in WB+ (i.e. decrease in HR and increase in RMSSD in CFN and RCV; increase in LF and HF in RCV). When pooling data of the three phases, there were significant correlations between VAS and HR, RMSSD, HF, respectively, in the supine position; the higher the VAS score (i.e., subjective well-being), the higher the RMSSD and HF and the lower the HR. In standing position, HRV parameters were not modified during CFN but RMSSD was correlated to VAS. Conclusion Our results suggest that the strict COVID-19 lockdown likely had opposite effects on French population as 20% of participants improved parasympathetic activation (RMSSD, HF) and rated positively this period, whilst 80% showed altered responses and deteriorated well-being. The changes in HRV parameters during and after the lockdown period were in line with subjective well-being responses. The observed recordings may reflect a large variety of responses (anxiety, anticipatory stress, change on physical activity horizontal ellipsis ) beyond the scope of the present study. However, these results confirmed the usefulness of HRV as a non-invasive means for monitoring well-being and health in this population.	[Bourdillon, Nicolas; Millet, Gregoire P.] Univ Lausanne, Inst Sport Sci, Lausanne, Switzerland; [Bourdillon, Nicolas; Yazdani, Sasan] Be Care SA, Renens, Switzerland; [Schmitt, Laurent] Natl Ctr Nord Ski, Res & Performance, Premanon, France	University of Lausanne	Bourdillon, N (corresponding author), Univ Lausanne, Inst Sport Sci, Lausanne, Switzerland.; Bourdillon, N (corresponding author), Be Care SA, Renens, Switzerland.	nicolas.bourdillon@unil.ch		Millet, Gregoire/0000-0001-8081-4423				Bourdillon N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00456; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Brown HE, 2013, SPORTS MED, V43, P195, DOI 10.1007/s40279-012-0015-8; Buchheit M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00073; Camm AJ, 1996, EUR HEART J, V17, P354; DIXON EM, 1992, CARDIOVASC RES, V26, P713, DOI 10.1093/cvr/26.7.713; Goldberger JJ, 1999, AM J PHYSIOL-HEART C, V276, pH1273, DOI 10.1152/ajpheart.1999.276.4.H1273; Hayano J, 2019, J PHYSIOL ANTHROPOL, V38, DOI 10.1186/s40101-019-0193-2; Hnatkova K, 2019, INT J CARDIOL, V297, P126, DOI 10.1016/j.ijcard.2019.09.044; Holzman JB, 2017, NEUROSCI BIOBEHAV R, V74, P233, DOI 10.1016/j.neubiorev.2016.12.032; Hug B, 2014, INT J SPORTS MED, V35, P676, DOI 10.1055/s-0033-1361184; Hynynen E, 2011, EUR J APPL PHYSIOL, V111, P733, DOI 10.1007/s00421-010-1698-x; Jimenez-Pavon D, 2020, PROG CARDIOVASC DIS, V63, P386, DOI 10.1016/j.pcad.2020.03.009; Kim HG, 2018, PSYCHIAT INVEST, V15, P235, DOI 10.30773/pi.2017.08.17; Laborde S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00213; Lavie CJ, 2015, CIRC RES, V117, P207, DOI 10.1161/CIRCRESAHA.117.305205; Martinez-Ferran M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061549; Matias T, 2020, J HEALTH PSYCHOL, V25, P871, DOI 10.1177/1359105320925149; Medeiros AR, 2018, EUR J APPL PHYSIOL, V118, P1287, DOI 10.1007/s00421-018-3855-6; Pareja-Galeano H, 2015, JAMA PEDIATR, V169, P288, DOI 10.1001/jamapediatrics.2014.3501; Parouty J, 2010, EUR J APPL PHYSIOL, V109, P483, DOI 10.1007/s00421-010-1381-2; Plews DJ, 2017, INT J SPORT PHYSIOL, V12, P1324, DOI 10.1123/ijspp.2016-0668; POMERANZ B, 1985, AM J PHYSIOL, V248, pH151, DOI 10.1152/ajpheart.1985.248.1.H151; Scheffe H., 1959, ANAL VARIANCE, P227; Schmitt L, 2015, INT J SPORTS MED, V36, P999, DOI 10.1055/s-0035-1548885; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thorpe RT, 2016, INT J SPORT PHYSIOL, V11, P947, DOI 10.1123/ijspp.2015-0490; Wang Cuiyan, 2020, Int J Environ Res Public Health, V17, DOI 10.3390/ijerph17051729; Wang YP, 2016, EUR J APPL PHYSIOL, V116, P1281, DOI 10.1007/s00421-016-3332-z; Zar JH, 1999, BIOSTAT ANAL, P195	30	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242303	10.1371/journal.pone.0242303	http://dx.doi.org/10.1371/journal.pone.0242303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180839	Green Published, gold, Green Submitted			2022-12-26	WOS:000593948000075
J	Ong, KM; Phillips, MS; Peskin, CS				Ong, Karen M.; Phillips, Michael S.; Peskin, Charles S.			A mathematical model and inference method for bacterial colonization in hospital units applied to active surveillance data for carbapenem-resistant enterobacteriaceae	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE COLONIZATION; GRAM-NEGATIVE BACTERIA; RISK-FACTORS; STAPHYLOCOCCUS-AUREUS; TRANSMISSION DYNAMICS; BETA-LACTAMASE; NOSOCOMIAL INFECTION; BAYESIAN-INFERENCE; COST-EFFECTIVENESS; EPIDEMIC MODEL	Widespread use of antibiotics has resulted in an increase in antimicrobial-resistant microorganisms. Although not all bacterial contact results in infection, patients can become asymptomatically colonized, increasing the risk of infection and pathogen transmission. Consequently, many institutions have begun active surveillance, but in non-research settings, the resulting data are often incomplete and may include non-random testing, making conventional epidemiological analysis problematic. We describe a mathematical model and inference method for in-hospital bacterial colonization and transmission of carbapenem-resistant Enterobacteriaceae that is tailored for analysis of active surveillance data with incomplete observations. The model and inference method make use of the full detailed state of the hospital unit, which takes into account the colonization status of each individual in the unit and not only the number of colonized patients at any given time. The inference method computes the exact likelihood of all possible histories consistent with partial observations (despite the exponential increase in possible states that can make likelihood calculation intractable for large hospital units), includes techniques to improve computational efficiency, is tested by computer simulation, and is applied to active surveillance data from a 13-bed rehabilitation unit in New York City. The inference method for exact likelihood calculation is applicable to other Markov models incorporating incomplete observations. The parameters that we identify are the patient-patient transmission rate, pre-existing colonization probability, and prior-to-new-patient transmission probability. Besides identifying the parameters, we predict the effects on the total prevalence (0.07 of the total colonized patient-days) of changing the parameters and estimate the increase in total prevalence attributable to patient-patient transmission (0.02) above the baseline pre-existing colonization (0.05). Simulations with a colonized versus uncolonized long-stay patient had 44% higher total prevalence, suggesting that the long-stay patient may have been a reservoir of transmission. High-priority interventions may include isolation of incoming colonized patients and repeated screening of long-stay patients.	[Ong, Karen M.; Phillips, Michael S.] NYU, Sch Med, New York, NY 10003 USA; [Ong, Karen M.; Peskin, Charles S.] Courant Inst Math Sci, New York, NY 10012 USA	New York University	Ong, KM (corresponding author), NYU, Sch Med, New York, NY 10003 USA.; Ong, KM (corresponding author), Courant Inst Math Sci, New York, NY 10012 USA.	karen.ong@med.nyu.edu		Ong, Karen/0000-0003-1710-2401; Phillips, Michael/0000-0003-1040-9080	New York University Medical Scientist Training Program (NIH) [T32GM007308]; Minkowitz Scholarship	New York University Medical Scientist Training Program (NIH); Minkowitz Scholarship	Support was provided by the New York University Medical Scientist Training Program (NIH training grant T32GM007308) and the Minkowitz Scholarship (a private scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott IJ, 2015, PATHOLOGY, V47, P575, DOI 10.1097/PAT.0000000000000302; Allen L., 2011, INTRO STOCHASTIC PRO; [Anonymous], 2012, PHOTON INT, V4-2012, P148; Auranen K, 2000, J AM STAT ASSOC, V95, P1044, DOI 10.2307/2669741; Austin DJ, 1999, PHILOS T R SOC B, V354, P721, DOI 10.1098/rstb.1999.0425; Austin DJ, 1999, P NATL ACAD SCI USA, V96, P6908, DOI 10.1073/pnas.96.12.6908; Bar-Yoseph H, 2016, J ANTIMICROB CHEMOTH, V71, P2729, DOI 10.1093/jac/dkw221; Barbier F., 2016, J ANTIMICROB CHEMOTH, pdkv423; Bartsch SM, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2016.09.003; Becker NG, 1999, J ROY STAT SOC B, V61, P287, DOI 10.1111/1467-9868.00177; Ben-David D, 2010, INFECT CONT HOSP EP, V31, P620, DOI 10.1086/652528; Bertolazzi E., 2009, TECHNICAL REPORT; Bootsma MCJ, 2007, AM J EPIDEMIOL, V166, P841, DOI 10.1093/aje/kwm149; Borer A, 2012, AM J INFECT CONTROL, V40, P421, DOI 10.1016/j.ajic.2011.05.022; Bowers J. R., 2016, KLEBSEQ DIAGNOSTIC T, P043471; Brauer F, 2005, MATH BIOSCI, V198, P119, DOI 10.1016/j.mbs.2005.07.006; Brauer F., 2008, MATH EPIDEMIOLOGY, DOI [10.1007/978-3-540-78911-6, DOI 10.1007/978-3-540-78911-6]; Brodrick HJ, 2016, GENOME MED, V8, DOI 10.1186/s13073-015-0259-7; CDC, 2015, TECHNICAL REPORT; Cerqueira GC, 2017, P NATL ACAD SCI USA, V114, P1135, DOI 10.1073/pnas.1616248114; Cohen PR, 2005, SOUTH MED J, V98, P596, DOI 10.1097/01.SMJ.0000163302.72469.28; Cooper B, 2004, BIOSTATISTICS, V5, P223, DOI 10.1093/biostatistics/5.2.223; Cooper BS, 2008, AM J EPIDEMIOL, V168, P548, DOI 10.1093/aje/kwn176; Cooper BS, 2007, J HOSP INFECT, V65, P88, DOI 10.1016/S0195-6701(07)60022-X; Cooper BS, 1999, J HOSP INFECT, V43, P131, DOI 10.1053/jhin.1998.0647; Datta R, 2011, ARCH INTERN MED, V171, P491, DOI 10.1001/archinternmed.2011.64; Debby BD, 2012, EUR J CLIN MICROBIOL, V31, P1811, DOI 10.1007/s10096-011-1506-5; Dekking F. M, 2005, MODERN INTRO PROBABI, P167; Dobrow R. P, 2016, INTRO STOCHASTIC PRO, P265; Dobrow R. P., 2016, INTRO STOCHASTIC PRO, P40; Drovandi CC, 2008, BIOMETRICS, V64, P851, DOI 10.1111/j.1541-0420.2007.00933.x; Economoua A, 2015, PHYSICA A, V421, P78, DOI 10.1016/j.physa.2014.10.054; El Salabi A, 2013, CRIT REV MICROBIOL, V39, P113, DOI 10.3109/1040841X.2012.691870; Forrester ML, 2007, BIOSTATISTICS, V8, P383, DOI 10.1093/biostatistics/kxl017; Gibson GJ, 1998, IMA J MATH APPL MED, V15, P19; GILLESPIE DT, 1977, J STAT PHYS, V16, P311, DOI 10.1007/BF01020385; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GILLESPIE DT, 1978, J COMPUT PHYS, V28, P395, DOI 10.1016/0021-9991(78)90060-8; Gillespie S. H., 2014, MED MICROBIOLOGY ILL; Gomez-Simmonds A, 2016, J ANTIMICROB CHEMOTH, V71, P2351, DOI 10.1093/jac/dkw132; Graves N, 2008, JAMA-J AM MED ASSOC, V300, P1577, DOI 10.1001/jama.300.13.1577; Harris AD, 2007, CLIN INFECT DIS, V45, P1347, DOI 10.1086/522657; Hilty M, 2012, CLIN INFECT DIS, V55, P967, DOI 10.1093/cid/cis581; Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945; Karchmer TB, 2002, J HOSP INFECT, V51, P126, DOI 10.1053/jhin.2002.1200; Kelly AM, 2017, INT J ANTIMICROB AG, V50, P127, DOI 10.1016/j.ijantimicag.2017.03.012; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kolmogoroff A, 1931, MATH ANN, V104, P415, DOI 10.1007/BF01457949; Kramer A, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-130; Kypraios T, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-29; Lerner A, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.12.015; Logan LK, 2017, J INFECT DIS, V215, pS28, DOI 10.1093/infdis/jiw282; Lopez-Garcia M, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0060; Lubbert C, 2014, INFECTION, V42, P309, DOI 10.1007/s15010-013-0547-3; Maltezou HC, 2009, J INFECTION, V58, P213, DOI 10.1016/j.jinf.2009.01.010; Mathers AJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01823-16; Mathers AJ, 2015, CLIN MICROBIOL REV, V28, P565, DOI 10.1128/CMR.00116-14; McBryde ES, 2007, J R SOC INTERFACE, V4, P745, DOI 10.1098/rsif.2007.0224; Mills JP, 2016, INFECT CONT HOSP EP, V37, P55, DOI 10.1017/ice.2015.254; Moler C, 2003, SIAM REV, V45, P3, DOI 10.1137/S00361445024180; MOLER C, 1978, SIAM REV, V20, P801, DOI 10.1137/1020098; Muto CA, 2002, INFECT CONT HOSP EP, V23, P429, DOI 10.1086/502080; O'Fallon E, 2010, INFECT CONT HOSP EP, V31, P1148, DOI 10.1086/656590; O'Neill PD, 1999, J ROY STAT SOC A STA, V162, P121, DOI 10.1111/1467-985X.00125; Okamoto K, 2017, INFECT CONT HOSP EP, V38, P670, DOI 10.1017/ice.2017.62; Otter JA, 2011, INFECT CONT HOSP EP, V32, P687, DOI 10.1086/660363; Otto M, 2012, CELL MICROBIOL, V14, P1513, DOI 10.1111/j.1462-5822.2012.01832.x; Palmore TN, 2013, CLIN INFECT DIS, V57, P1593, DOI 10.1093/cid/cit531; Parker V. A., 2014, TECHNICAL REPORT AHR, V14-0028-E F; Pecor ND, 2015, MBIO, V6, DOI 10.1128/mBio.01030-15; Pelupessy I, 2002, P NATL ACAD SCI USA, V99, P5601, DOI 10.1073/pnas.082412899; Pittet D, 1999, ARCH INTERN MED, V159, P821, DOI 10.1001/archinte.159.8.821; Pournaras S, 2009, J ANTIMICROB CHEMOTH, V64, P348, DOI 10.1093/jac/dkp207; Sasieni P. D., 2014, HDB EPIDEMIOLOGY, P1195; Schechner V, 2011, INFECT CONT HOSP EP, V32, P497, DOI 10.1086/659762; Schwaber MJ, 2011, CLIN INFECT DIS, V52, P848, DOI 10.1093/cid/cir025; Schwaber MJ, 2008, JAMA-J AM MED ASSOC, V300, P2911, DOI 10.1001/jama.2008.896; Sevast'yanov BA, 2002, ENCY MATH; Shiryaev A. N, 2012, ENCY MATH; Simon PL, 2011, J MATH BIOL, V62, P479, DOI 10.1007/s00285-010-0344-x; Starr JM, 2009, J HOSP INFECT, V71, P49, DOI 10.1016/j.jhin.2008.09.013; Swaminathan M, 2013, INFECT CONT HOSP EP, V34, P809, DOI 10.1086/671270; Tacconelli E, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12427; Temkin E, 2014, ANN NY ACAD SCI, V1323, P22, DOI 10.1111/nyas.12537; Thaden JT, 2017, VIRULENCE, V8, P403, DOI 10.1080/21505594.2016.1207834; Tischendorf J, 2016, AM J INFECT CONTROL, V44, P539, DOI 10.1016/j.ajic.2015.12.005; Ulrich R., 2004, TECHNICAL REPORT; van Duin D, 2013, DIAGN MICR INFEC DIS, V75, P115, DOI 10.1016/j.diagmicrobio.2012.11.009; van Kleef E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-294; van Loon K, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01730-17; Vanhems P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073970; Wang Q, 2016, EUR J CLIN MICROBIOL, V35, P1679, DOI 10.1007/s10096-016-2710-0; Wei Y., 2016, STAT METHODS MED RES; Wiener-Well Y, 2010, J HOSP INFECT, V74, P344, DOI 10.1016/j.jhin.2009.07.022; Wolkewitz M, 2008, STAT MED, V27, P6522, DOI 10.1002/sim.3419; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Worby CJ, 2013, AM J EPIDEMIOL, V177, P1306, DOI 10.1093/aje/kws380; World Health Organization, 2009, WHO GUID HAND HYG HL; Wunderink RG, 2018, INFECT DIS THER, V7, P439, DOI 10.1007/s40121-018-0214-1; Zhou K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20840; 2008, FED REG, V73, P48434; 2015, SEWAGE DISPOSAL CLOV, V15	103	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0231754	10.1371/journal.pone.0231754	http://dx.doi.org/10.1371/journal.pone.0231754			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180781	Green Published, gold			2022-12-26	WOS:000593948000102
J	Yu, JQ; Wang, NZ; Gong, ZQ; Liu, LP; Yang, SL; Chen, GG; Lai, PBS				Yu, Jianqing; Wang, Nuozhou; Gong, Zhongqin; Liu, Liping; Yang, Shengli; Chen, George Gong; Lai, Paul Bo San			Cytochrome P450 1A2 overcomes nuclear factor kappa B-mediated sorafenib resistance in hepatocellular carcinoma	ONCOGENE			English	Article							PROTON PUMP INHIBITORS; TRANSCRIPTION; EXPRESSION; SURVIVAL; PROTEIN	Sorafenib resistance has become the main obstacle in the effective treatment of advanced hepatocellular carcinoma (HCC) patients. Activation of nuclear factor kappa B (NF-kappa B) is a newly identified mechanism that contributes to desensitized sorafenib. Cytochrome P450 1A2 (CYP1A2) functions as a tumor suppressor in HCC and its expression is negatively associated with NF-kappa B in the liver. This study aimed to study whether CYP1A2 could overcome sorafenib resistance. To investigate whether CYP1A2 and NF-kappa B p65 played roles in sorafenib desensitization, we established sorafenib-resistant (SR) HCC cells. SR cells decreased the expression of CYP1A2 along with the upregulation of NF-kappa B p65. CYP1A2 overexpression attenuated SR cell proliferation, increased sorafenib sensitivity, and inhibited the NF-kappa B pathway, whereas CYP1A2 silence showed opposite effects. Sorafenib, in combination with omeprazole, a CYP1A2 inducer, significantly hindered the growth and invasion of SR cells in vitro as well as decreased the tumor growth in vivo. The combination treatment markedly increased CYP1A2 expression and inhibited the sorafenib-induced NF-kappa B signaling. In addition, the overexpression of NF-kappa B p65 stimulated the SR cell growth and desensitized sorafenib in SR cells, where CYP1A2 overexpression reversed the phenomenon. Lastly, the majority of HCC tissue samples displayed decreased CYP1A2 but increased NF-kappa B p65 protein expression. Collectively, CYP1A2 can sensitize SR cells to sorafenib via inhibiting NF-kappa B p65 axis. Omeprazole in combination with sorafenib exerts a synergistic effect in alleviating acquired sorafenib resistance.	[Yu, Jianqing; Wang, Nuozhou; Gong, Zhongqin; Chen, George Gong; Lai, Paul Bo San] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Fac Med, Hong Kong, Peoples R China; [Liu, Liping] Jinan Univ, Shenzhen Peoples Hosp, Clin Med Coll 2, Dept Hepatobiliary & Pancreas Surg, Shenzhen 524000, Guangdong, Peoples R China; [Yang, Shengli] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Canc Ctr, Wuhan 430022, Peoples R China; [Chen, George Gong] Chinese Univ Hong Kong, Prince Walves Hosp, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Hong Kong, Peoples R China; [Chen, George Gong] Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Jinan University; Huazhong University of Science & Technology; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Chen, GG; Lai, PBS (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Fac Med, Hong Kong, Peoples R China.; Chen, GG (corresponding author), Chinese Univ Hong Kong, Prince Walves Hosp, Fac Med, Dept Otorhinolaryngol Head & Neck Surg, Hong Kong, Peoples R China.; Chen, GG (corresponding author), Chinese Univ Hong Kong, Shenzhen Res Inst, Shenzhen, Guangdong, Peoples R China.	gchen@cuhk.edu.hk; paullai@cuhk.edu.hk	Lai, Paul BS/K-8556-2015	Lai, Paul BS/0000-0002-9469-6728; Chen, George/0000-0001-7276-3830; Gong, Zhongqin/0000-0002-7030-0581	Research Grants Council of the Hong Kong SAR [CUHK14117015]	Research Grants Council of the Hong Kong SAR(Hong Kong Research Grants Council)	We thank technical supports from Dr. Jianwei Ren, Mr. Rocky Lok-kee Ho and Ms. Suk-ying Chun. This study was supported by a grant from the Research Grants Council of the Hong Kong SAR, CUHK14117015.	Abdel-Wahab AF, 2019, PHARMACOL RES, V150, DOI 10.1016/j.phrs.2019.104511; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen CH, 2019, J CLIN PHARMACOL, V59, P350, DOI 10.1002/jcph.1329; Chen H, 2014, WORLD J GASTROENTERO, V20, P8681, DOI 10.3748/wjg.v20.i26.8681; Chen JCH, 2016, ONCOTARGET, V7, P85450, DOI 10.18632/oncotarget.13398; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chirillo P, 1996, J VIROL, V70, P641, DOI 10.1128/JVI.70.1.641-646.1996; de Argila CM, 2005, DRUGS, V65, P97; Dudgeon C, 2012, ONCOGENE, V31, P4848, DOI 10.1038/onc.2011.644; FRUCHT H, 1991, DIGEST DIS SCI, V36, P394, DOI 10.1007/BF01298865; Galmiche A, 2014, CANCER LETT, V346, P159, DOI 10.1016/j.canlet.2013.12.028; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Hellum BH, 2007, BASIC CLIN PHARMACOL, V100, P23, DOI 10.1111/j.1742-7843.2007.00011.x; Jing HR, 2012, J SURG RES, V176, P63, DOI 10.1016/j.jss.2011.09.001; Kuo HP, 2013, CANCER CELL, V24, P423, DOI 10.1016/j.ccr.2013.08.019; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Li J, 2018, CANCER BIOL THER, V19, P1057, DOI 10.1080/15384047.2018.1480280; Liang L, 2020, ONCOL LETT, V19, P519, DOI 10.3892/ol.2019.11090; Lin WY, 2010, GASTROENTEROLOGY, V138, P2509, DOI 10.1053/j.gastro.2010.03.008; Liu ZZ, 2019, SAUDI J GASTROENTERO, V25, P167, DOI 10.4103/sjg.SJG_290_18; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lo J, 2015, HEPATOLOGY, V62, P534, DOI 10.1002/hep.27859; Luciani F, 2004, JNCI-J NATL CANCER I, V96, P1702, DOI 10.1093/jnci/djh305; MACNAB GM, 1976, BRIT J CANCER, V34, P509, DOI 10.1038/bjc.1976.205; Neelgundmath M, 2015, BIOORG MED CHEM LETT, V25, P893, DOI 10.1016/j.bmcl.2014.12.065; Papagerakis S, 2014, CANCER PREV RES, V7, P1258, DOI 10.1158/1940-6207.CAPR-14-0002; Qiu YX, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-1005-y; Ray EM, 2017, J HEPATOCELL CARCINO, V4, P131, DOI 10.2147/JHC.S124366; REN JW, 2016, PLOS ONE, V11, DOI DOI 10.1371/JOURNAL.PONE.0153863; Sainz B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-103; Shen ZT, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6312-y; Su F, 1996, J VIROL, V70, P4558, DOI 10.1128/JVI.70.7.4558-4566.1996; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Tatebe S, 2015, CIRC J, V79, P1215, DOI 10.1253/circj.CJ-15-0367; Taylor S, 2015, DRUG RESIST UPDATE, V23, P69, DOI 10.1016/j.drup.2015.08.004; Wang NZ, 2020, CANCER LETT, V472, P70, DOI 10.1016/j.canlet.2019.12.026; Wang YT, 2020, EXP CELL RES, V386, DOI 10.1016/j.yexcr.2019.111739; Waris G, 2003, J BIOL CHEM, V278, P40778, DOI 10.1074/jbc.M303248200; Weil R, 1999, MOL CELL BIOL, V19, P6345; Wu JM, 2009, CANCER LETT, V278, P145, DOI 10.1016/j.canlet.2008.12.031; Xie C, 2020, HEPATOLOGY, V71, P1660, DOI 10.1002/hep.30931; Xu YM, 2016, CANCER LETT, V371, P171, DOI 10.1016/j.canlet.2015.11.034; Yamada T, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1297-7; Zhang Q, 2017, CELL, V168, P37, DOI 10.1016/j.cell.2016.12.012; Zhu YJ, 2017, ACTA PHARMACOL SIN, V38, P614, DOI 10.1038/aps.2017.5	46	10	10	1	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2021	40	3					492	507		10.1038/s41388-020-01545-z	http://dx.doi.org/10.1038/s41388-020-01545-z		NOV 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PU9SL	33184472				2022-12-26	WOS:000588868700001
J	Zhou, HY; Simion, V; Pierce, JB; Haemmig, S; Chen, AF; Feinberg, MW				Zhou, Haoyang; Simion, Viorel; Pierce, Jacob B.; Haemmig, Stefan; Chen, Alex F.; Feinberg, Mark W.			LncRNA-MAP3K4 regulates vascular inflammation through the p38 MAPK signaling pathway and cis-modulation of MAP3K4	FASEB JOURNAL			English	Article						bidirectional promoter; vascular cells; ChIP&#8208; seq; atherosclerosis; eRNA	ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; LONG NONCODING RNAS; ENDOTHELIAL-CELLS; BIDIRECTIONAL PROMOTERS; DIVERGENT TRANSCRIPTION; HISTONE MODIFICATIONS; GENE-EXPRESSION; TATA-LESS; GC-RICH	Chronic vascular inflammation plays a key role in the pathogenesis of atherosclerosis. Long non-coding RNAs (lncRNAs) have emerged as essential inflammation regulators. We identify a novel lncRNA termed lncRNA-MAP3K4 that is enriched in the vessel wall and regulates vascular inflammation. In the aortic intima, lncRNA-MAP3K4 expression was reduced by 50% during the progression of atherosclerosis (chronic inflammation) and 70% during endotoxemia (acute inflammation). lncRNA-MAP3K4 knockdown reduced the expression of key inflammatory factors (eg, ICAM-1, E-selectin, MCP-1) in endothelial cells or vascular smooth muscle cells and decreased monocytes adhesion to endothelium, as well as reducing TNF-alpha, IL-1 beta, COX2 expression in macrophages. Mechanistically, lncRNA-MAP3K4 regulates inflammation through the p38 MAPK signaling pathway. lncRNA-MAP3K4 shares a bidirectional promoter with MAP3K4, an upstream regulator of the MAPK signaling pathway, and regulates its transcription in cis. lncRNA-MAP3K4 and MAP3K4 show coordinated expression in response to inflammation in vivo and in vitro. Similar to lncRNA-MAP3K4, MAP3K4 knockdown reduced the expression of inflammatory factors in several different vascular cells. Furthermore, lncRNA-MAP3K4 and MAP3K4 knockdown showed cooperativity in reducing inflammation in endothelial cells. Collectively, these findings unveil the role of a novel lncRNA in vascular inflammation by cis-regulating MAP3K4 via a p38 MAPK pathway.	[Zhou, Haoyang; Simion, Viorel; Pierce, Jacob B.; Haemmig, Stefan; Feinberg, Mark W.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Dept Med, Louis Pasteur Ave 77, Boston, MA 02115 USA; [Zhou, Haoyang; Chen, Alex F.] Cent South Univ, Dept Cardiol, Xiangya Hosp 3, Changsha, Peoples R China; [Pierce, Jacob B.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Central South University; Northwestern University; Feinberg School of Medicine	Feinberg, MW (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Dept Med, Louis Pasteur Ave 77, Boston, MA 02115 USA.	mfeinberg@bwh.harvard.edu		Feinberg, Mark/0000-0001-9523-3859; Pierce, Jacob B./0000-0001-9171-1673	American Heart Association (AHA) [20SFRN35200163]; National Institutes of Health (NIH) [HL115141, HL134849, HL148207, HL148355, HL153356]	American Heart Association (AHA)(American Heart Association); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	American Heart Association (AHA), Grant/Award Number: 18SFRN33900144; American Heart Association (AHA), Grant/Award Number: 20SFRN35200163; National Institutes of Health (NIH), Grant/Award Number: HL115141, HL134849, HL148207, HL148355 and HL153356	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Al-Salama ZT, 2018, DRUGS, V78, P761, DOI 10.1007/s40265-018-0908-4; Andersen RE, 2019, DEV CELL, V49, P632, DOI 10.1016/j.devcel.2019.04.032; Andersson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6336; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Aryal B, 2019, VASC PHARMACOL, V114, P64, DOI 10.1016/j.vph.2018.03.001; Back M, 2019, NAT REV CARDIOL, V16, P389, DOI 10.1038/s41569-019-0169-2; Baldassare JJ, 1999, J IMMUNOL, V162, P5367; Basatemur GL, 2019, NAT REV CARDIOL, V16, P727, DOI [10.1038/s41569-019-0227-9, 10.1161/CIRCRESAHA.115.306361]; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Blake GJ, 2001, CIRC RES, V89, P763, DOI 10.1161/hh2101.099270; Bornelov S, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1485-5; Brown RP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-110; Carlevaro-Fita J, 2019, MOL CELL, V73, P869, DOI 10.1016/j.molcel.2019.02.008; Charron CE, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00188-2017; Chen W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-3; Chi HB, 2004, EMBO J, V23, P1576, DOI 10.1038/sj.emboj.7600173; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Decano JL, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0585-2; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Du M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02229-1; Elling R, 2018, CELL REP, V25, P1511, DOI 10.1016/j.celrep.2018.10.027; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Fatkhullina AR, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1358, DOI 10.1134/S0006297916110134; Fleischmann R, 2012, NEW ENGL J MED, V367, P495, DOI 10.1056/NEJMoa1109071; Font-Cunill B, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00524; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Gil N, 2020, NAT REV GENET, V21, P102, DOI 10.1038/s41576-019-0184-5; Goebeler M, 1999, BLOOD, V93, P857, DOI 10.1182/blood.V93.3.857.403k03_857_865; Haemmig S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw1868; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hu P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05955-2; Huang LL, 2020, J CELL PHYSIOL, V235, P3815, DOI 10.1002/jcp.29276; Idel S, 2003, P NATL ACAD SCI USA, V100, P14235, DOI 10.1073/pnas.1835672100; Iyer SS, 2010, J IMMUNOL, V185, P6599, DOI 10.4049/jimmunol.1002041; Jangid RK, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4697-7; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kawai Y, 2003, BBA-GENE STRUCT EXPR, V1625, P246, DOI 10.1016/S0167-4781(02)00627-9; Khyzha N, 2019, P NATL ACAD SCI USA, V116, P16410, DOI 10.1073/pnas.1904108116; Koch F, 2011, NAT STRUCT MOL BIOL, V18, P956, DOI 10.1038/nsmb.2085; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lai F, 2020, MOL CELL, V77, P1032, DOI 10.1016/j.molcel.2019.12.029; Lam MTY, 2014, TRENDS BIOCHEM SCI, V39, P170, DOI 10.1016/j.tibs.2014.02.007; Lee JM, 2003, GENOME RES, V13, P875, DOI 10.1101/gr.737703; Lee JS, 2020, MOL CELL, V77, P1044, DOI 10.1016/j.molcel.2019.12.011; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li MN, 2018, FRONT CARDIOVASC MED, V5, DOI 10.3389/fcvm.2018.00151; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin JM, 2007, GENOME RES, V17, P818, DOI 10.1101/gr.5623407; Luo S, 2016, CELL STEM CELL, V18, P637, DOI 10.1016/j.stem.2016.01.024; Mahpour A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205608; Maranon DG, 2020, MOL CELL, V77, P932, DOI 10.1016/j.molcel.2020.02.010; Michalak P, 2008, GENOMICS, V91, P243, DOI 10.1016/j.ygeno.2007.11.002; Min W, 1997, J IMMUNOL, V159, P3508; Mobley RJ, 2017, CELL REP, V18, P2387, DOI 10.1016/j.celrep.2017.02.030; Mukherjee S, 2009, J BIOL CHEM, V284, P29391, DOI 10.1074/jbc.M109.005272; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Ng YK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-42; Pietersma A, 1997, BIOCHEM BIOPH RES CO, V230, P44, DOI 10.1006/bbrc.1996.5886; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Qvist H, 1998, BIOL CHEM, V379, P75; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Sarkisian MR, 2006, NEURON, V52, P789, DOI 10.1016/j.neuron.2006.10.024; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Semon M, 2006, MOL BIOL EVOL, V23, P1715, DOI 10.1093/molbev/msl034; SHIMIZU Y, 1991, J CELL BIOL, V113, P1203, DOI 10.1083/jcb.113.5.1203; Shirai T, 2015, AUTOIMMUNITY, V48, P139, DOI 10.3109/08916934.2015.1027815; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Simion V, 2019, VASC PHARMACOL, V114, P145, DOI 10.1016/j.vph.2018.01.003; Sollome JJ, 2014, CELL SIGNAL, V26, P70, DOI 10.1016/j.cellsig.2013.08.043; Sun XH, 2014, CIRC RES, V114, P32, DOI 10.1161/CIRCRESAHA.113.302089; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; Takai D, 2004, MOL BIOL EVOL, V21, P463, DOI 10.1093/molbev/msh040; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; van Gils JM, 2013, ARTERIOSCL THROM VAS, V33, P911, DOI 10.1161/ATVBAHA.112.301155; Verstrepen L, 2014, BIOCHEM PHARMACOL, V92, P519, DOI 10.1016/j.bcp.2014.10.017; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Ward AJ, 2014, NUCLEIC ACIDS RES, V42, P5871, DOI 10.1093/nar/gku184; Warr N, 2012, DEV CELL, V23, P1020, DOI 10.1016/j.devcel.2012.09.016; Wei W, 2011, TRENDS GENET, V27, P267, DOI 10.1016/j.tig.2011.04.002; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030; Yan WS, 2002, SHOCK, V17, P433, DOI 10.1097/00024382-200205000-00016; Yang LX, 2015, HEPATOLOGY, V62, P1804, DOI 10.1002/hep.28149	96	9	10	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.202001654RR	http://dx.doi.org/10.1096/fj.202001654RR		NOV 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33184917				2022-12-26	WOS:000590887700001
J	Cohen, AJ; Patino, G; Mirramezani, M; Srirangapatanam, S; Tresh, A; Cheema, B; Tai, J; Romero, D; Enriquez, A; Baskin, LS; Shadden, SC; Breyer, BN				Cohen, Andrew J.; Patino, German; Mirramezani, Mehran; Srirangapatanam, Sudarshan; Tresh, Anas; Cheema, Bhagat; Tai, Jenny; Romero, Dylan; Enriquez, Anthony; Baskin, Laurence S.; Shadden, Shawn C.; Breyer, Benjamin N.			Novel measurement tool and model for aberrant urinary stream in 3D printed urethras derived from human tissue	PLOS ONE			English	Article							MEATAL STENOSIS; URETHROPLASTY; TRACT	Background An estimated 10% of male adults have split or dribbled stream leading to poor hygiene, embarrassment, and inconvenience. There is no current metric that measures male stream deviation. Objective To develop a novel method to measure spray in normal and abnormal anatomical conformations. Design, setting, and participants We developed a novel platform to reliably describe spray. We used cadaveric tissues and 3D Printed models to study the impact of meatal shape on the urinary stream. Cadaveric penile tissue and 3D printed models were affixed to a fluid pump and used to simulate micturition. Dye captured on fabric allowed for spray detection. Outcome measurements and statistical analysis Spray pattern area, deviation from normal location, and flowrates were recorded. Computational fluid dynamic models were created to study fluid vorticity. Results and limitations Obstructions at the penile tip worsened spray dynamics and reduced flow. Ventral meatotomy improved flowrate (p<0.05) and reduced spray (p<0.05) compared to tips obstructed ventrally, dorsally or in the fossa navicularis. 3D models do not fully reproduce parameters of their parent cadaver material. The average flowrate from 3D model was 10ml/sec less than that of the penis from which it was derived (p = 0.03). Nonetheless, as in cadavers, increasing obstruction in 3D models leads to the same pattern of reduced flowrate and worse spray. Dynamic modeling revealed increasing distal obstruction was correlated to higher relative vorticity observed at the urethral tip. Conclusions We developed a robust method to measure urine spray in a research setting. Dynamic 3D printed models hold promise as a methodology to study common pathologies in the urethra and corrective surgeries on the urine stream that would not be feasible in patients. These novel methods require further validation, but offer promise as a research and clinical tool.	[Cohen, Andrew J.] Johns Hopkins Bayview Med Ctr, Brady Urol Inst, Baltimore, MD 21224 USA; [Patino, German] Hosp Univ San Ignacio, Bogota, Colombia; [Mirramezani, Mehran; Shadden, Shawn C.] Univ Calif Berkeley, Dept Mech Engn Berkeley, Berkeley, CA 94720 USA; [Srirangapatanam, Sudarshan; Tresh, Anas; Cheema, Bhagat; Enriquez, Anthony; Baskin, Laurence S.; Breyer, Benjamin N.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Tai, Jenny; Romero, Dylan] Univ Calif San Francisco, Makers Lab Lib, San Francisco, CA 94143 USA; [Breyer, Benjamin N.] Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins Medicine; Hospital Universitario San Ignacio; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Breyer, BN (corresponding author), Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA.; Breyer, BN (corresponding author), Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94143 USA.	Benjamin.Breyer@ucsf.edu		Cohen, Andrew/0000-0002-4508-6747; Enriquez, Anthony/0000-0002-0638-4100; Romero, Dylan/0000-0001-6814-3364	 [7028070]		Specific funding for this work came as a private gift from Anita and Kevan Del Grande, awarded to BB (gift project #7028070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194890; Baradaran N, 2018, CURR UROL REP, V19, DOI 10.1007/s11934-018-0797-9; Bastos AL, 2004, BJU INT, V94, P620, DOI 10.1111/j.1464-410X.2004.05012.x; Cohen AJ, 2019, J UROLOGY, V202, P347, DOI 10.1097/JU.0000000000000187; Coyne KS, 2009, BJU INT, V103, P4, DOI 10.1111/j.1464-410X.2009.08371.x; Gratzke C, 2015, EUR UROL, V67, P1099, DOI 10.1016/j.eururo.2014.12.038; Kranse R, 2003, UROLOGY, V61, P930, DOI 10.1016/S0090-4295(03)00010-4; Kwon JK, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111929; Meeks JJ, 2012, BJU INT, V109, P616, DOI 10.1111/j.1464-410X.2011.10248.x; Monda SM, 2018, UROLOGY, V114, P114, DOI 10.1016/j.urology.2018.01.030; Morris BJ, 2017, UROLOGY, V110, P16, DOI 10.1016/j.urology.2017.07.027; Morris PD, 2016, HEART, V102, P18, DOI 10.1136/heartjnl-2015-308044; Nelson CP, 2005, J UROLOGY, V174, P1075, DOI 10.1097/01.ju.0000169421.27043.f2; Nitti Victor W, 2005, Rev Urol, V7 Suppl 6, pS14; RITTER RC, 1976, IEEE T BIO-MED ENG, V23, P266, DOI 10.1109/TBME.1976.324642; Saeedi P, 2017, UROL J, V14, P3071; STERLING AM, 1976, UROL INT, V31, P321, DOI 10.1159/000280068; Updegrove A, 2017, ANN BIOMED ENG, V45, P525, DOI 10.1007/s10439-016-1762-8; Vieiralves RR, 2017, ADV UROL, V2017, DOI 10.1155/2017/6321702; von Rundstedt FC, 2017, BJU INT, V119, P598, DOI 10.1111/bju.13712; Wang Y, 2015, ASIAN J UROL, V2, P214, DOI 10.1016/j.ajur.2015.09.002; Wheeler APS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047133; Wong NC, 2017, CUAJ-CAN UROL ASSOC, V11, pE321, DOI 10.5489/cuaj.4262	23	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241507	10.1371/journal.pone.0241507	http://dx.doi.org/10.1371/journal.pone.0241507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175862	Green Published, gold			2022-12-26	WOS:000593946900068
J	Li, B; Zhou, Y; Chen, J; Wang, TT; Li, ZJ; Fu, YL; Zhai, AX; Bi, CL				Li, Bo; Zhou, Yue; Chen, Jing; Wang, Tingting; Li, Zhijuan; Fu, Yili; Zhai, Aixia; Bi, Changlong			Long noncoding RNA H19 acts as a miR-29b sponge to promote wound healing in diabetic foot ulcer	FASEB JOURNAL			English	Article						apoptosis; diabetic foot ulcer; fibrillin 1; long noncoding RNA H19; microRNA&#8208; 29b; proliferation; wound healing	COMPETING ENDOGENOUS RNA; EPITHELIAL-MESENCHYMAL TRANSITION; LNCRNA H19; TARGETING MIR-29B-3P; EXTRACELLULAR-MATRIX; SKIN FIBROBLASTS; BLADDER-CANCER; GASTRIC-CANCER; MOUSE MODEL; FIBRILLIN-1	Aberrant expression of long noncoding RNA (lncRNA) H19 and microRNA (miR)-29b has been implicated in the complications of diabetes mellitus (DM). As a common and important complication of DM, diabetic foot ulcer (DFU) is characterized by high incidence and poor prognosis. Herein, we explored the role of lncRNA H19 in wound healing of DFU. Differentially expressed DM-related lncRNAs were initially screened by microarray data analysis. DFU models were then induced in DM mouse models. The functional role and interaction of lncRNA H19, miR-29b and FBN1 in DFU were subsequently determined by examining the proliferation, migration, and apoptosis of fibroblasts after silencing H19, inhibiting or overexpressing miR-29b and FBN1. According to microarray-based analysis, lncRNA H19 was upregulated in DM. In the ulcerative edge tissues of DFU, high expression of lncRNA H19 and FBN1 and low expression of miR-29b were observed. FBN1 was identified to be a target gene of miR-29b. LncRNA H19 could competitively bind to miR-29b, and then, inhibited its expression, which consequently upregulating FBN1. Silencing of lncRNA H19 led to inhibited proliferation, migration, and enhanced apoptosis of fibroblasts, accompanied by downregulated FBN1 but upregulated miR-29b, which diminished the expression of TGF-beta 1, Smad3, FN, and Col-1 and reduced extracellular matrix accumulation. Altogether, upregulation of lncRNA H19 can elevate the expression of FBN1 through competitively binding to miR-29b, which enhances the proliferation, migration, and inhibits apoptosis of fibroblasts, thus facilitating the wound healing of DFU.	[Li, Bo] Harbin Med Univ, Affiliated Hosp 4, Dept Endocrinol, Harbin, Peoples R China; [Zhou, Yue; Chen, Jing; Wang, Tingting; Li, Zhijuan; Bi, Changlong] Harbin Med Univ, Affiliated Hosp 4, Comprehens Dept 2, 37 Yiyuan St, Harbin 150001, Heilongjiang, Peoples R China; [Fu, Yili] Harbin Inst Technol, Sch Life Sci & Technol, Harbin, Peoples R China; [Zhai, Aixia] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Lab Med, 3025 Shennan Middle Rd, Shenzhen 518033, Guangdong, Peoples R China; [Bi, Changlong] Sun Yat Sen Univ, Affiliated Hosp 8, Dept Endocrinol, Shenzhen, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Institute of Technology; Sun Yat Sen University; Sun Yat Sen University	Bi, CL (corresponding author), Harbin Med Univ, Affiliated Hosp 4, Comprehens Dept 2, 37 Yiyuan St, Harbin 150001, Heilongjiang, Peoples R China.; Zhai, AX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 8, Dept Lab Med, 3025 Shennan Middle Rd, Shenzhen 518033, Guangdong, Peoples R China.	aixiazhai@126.com; bichanglongdr@163.com			National Natural Science Foundation of China (NSFC) [81501737,81871562,81800739]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81501737,81871562,81800739	Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Cao TF, 2019, ONCOGENE, V38, P5356, DOI 10.1038/s41388-019-0808-4; Cao W, 2019, BIOL RES, V52, DOI 10.1186/s40659-019-0260-5; Cheng J, 2013, AM J MED SCI, V346, P98, DOI 10.1097/MAJ.0b013e318267680d; Cheng XW, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00263; Christner PJ, 2006, AMINO ACIDS, V30, P445, DOI 10.1007/s00726-005-0265-y; Driver VR, 2010, J VASC SURG, V52, p17S, DOI 10.1016/j.jvs.2010.06.003; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Funari VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084425; Galimov A, 2016, STEM CELLS, V34, P768, DOI 10.1002/stem.2281; Guo JR, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0290-6; Handa K, 2018, ARCH ORAL BIOL, V90, P53, DOI 10.1016/j.archoralbio.2018.02.017; Hartner A, 2006, AM J PHYSIOL-RENAL, V290, pF1329, DOI 10.1152/ajprenal.00284.2005; He Y, 2013, BIOCHIMIE, V95, P1355, DOI 10.1016/j.biochi.2013.03.010; Hicks CW, 2016, ANN VASC SURG, V33, P149, DOI 10.1016/j.avsg.2015.11.025; Hua QH, 2016, MUTAGENESIS, V31, P531, DOI 10.1093/mutage/gew018; Kogure T, 2012, J CELL MOL MED, V16, P2647, DOI 10.1111/j.1582-4934.2012.01578.x; Lavery LA, 2012, DIABETES-METAB RES, V28, P60, DOI 10.1002/dmrr.2241; Li JX, 2016, REPROD SCI, V23, P386, DOI 10.1177/1933719115602768; Liu CN, 2018, HEPATOLOGY, V67, P1768, DOI 10.1002/hep.29654; Liu LH, 2019, INT J ONCOL, V54, P929, DOI 10.3892/ijo.2019.4695; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Lu YF, 2017, FASEB J, V31, P954, DOI 10.1096/fj.201600722R; Luo Y, 2015, HYPERTENSION, V65, P414, DOI 10.1161/HYPERTENSIONAHA.114.04600; Lv MX, 2017, BBA-MOL CELL RES, V1864, P1887, DOI 10.1016/j.bbamcr.2017.08.001; Ma XF, 2016, BIOMED PHARMACOTHER, V80, P220, DOI 10.1016/j.biopha.2016.03.020; Merk DR, 2012, CIRC RES, V110, P312, DOI 10.1161/CIRCRESAHA.111.253740; Pastar I, 2012, J BIOL CHEM, V287, P29324, DOI 10.1074/jbc.M112.382135; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Ramirez HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137133; Schaefer L, 2007, AM J PATHOL, V170, P301, DOI 10.2353/ajpath.2007.060497; Shi RF, 2018, GENE THER, V25, P425, DOI 10.1038/s41434-018-0027-6; Singh KK, 2012, J NEGAT RESULTS BIOM, V11, DOI 10.1186/1477-5751-11-9; Su ZR, 2016, FEBS LETT, V590, P1354, DOI 10.1002/1873-3468.12171; Sun SF, 2018, DIABETES, V67, P731, DOI 10.2337/db17-0816; Tang YJ, 2016, BIOCHEM BIOPH RES CO, V479, P417, DOI 10.1016/j.bbrc.2016.09.028; Tao SC, 2018, DRUG DELIV, V25, P241, DOI 10.1080/10717544.2018.1425774; Teng YJ, 2010, DIABETES OBES METAB, V12, P307, DOI 10.1111/j.1463-1326.2009.01164.x; Thomas A, 2014, CAN J DIABETES, V38, pS61; Wang CJ, 2011, DIABETES RES CLIN PR, V94, P105, DOI 10.1016/j.diabres.2011.06.016; Wang ML, 2018, ASIAN PAC J TROP MED, V11, P245, DOI 10.4103/1995-7645.228441; Yang C, 2015, ONCOTARGET, V6, P15311, DOI 10.18632/oncotarget.3840; Yang DY, 2017, CANCER BIOMARK, V19, P425, DOI 10.3233/CBM-160421; Yoshiba N, 2012, J ENDODONT, V38, P177, DOI 10.1016/j.joen.2011.09.016; Zhang JY, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170036; Zhang XN, 2014, CELL BIOCHEM BIOPHYS, V70, P1105, DOI 10.1007/s12013-014-0029-y; Zhang Y, 2014, MOL THER, V22, P974, DOI 10.1038/mt.2014.25; Zilberberg L, 2012, J CELL PHYSIOL, V227, P3828, DOI 10.1002/jcp.24094	50	16	17	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2021	35	1								10.1096/fj.201900076RRRRR	http://dx.doi.org/10.1096/fj.201900076RRRRR		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	PP1KD	33174326				2022-12-26	WOS:000591080100001
J	Nanno, Y; Shajahan, A; Sonon, RN; Azadi, P; Hering, BJ; Burlak, C				Nanno, Yoshihide; Shajahan, Asif; Sonon, Roberto N.; Azadi, Parastoo; Hering, Bernhard J.; Burlak, Christopher			High-mannose type N-glycans with core fucosylation and complex-type N-glycans with terminal neuraminic acid residues are unique to porcine islets	PLOS ONE			English	Article							NONHUMAN-PRIMATES; IN-VIVO; XENOTRANSPLANTATION; PIG; TRANSPLANTATION; CELLS; SURVIVAL; DONORS; XENOGRAFTS; ANTIBODIES	Objectives Islet transplantation is an emerging treatment option for type 1 diabetes but its application is limited by the shortage of human pancreas donors. Characterization of the N- and O-glycan surface antigens that vary between human and genetically engineered porcine islet donors could shed light on targets of antibody mediated rejection. Methods N- and O-glycans were isolated from human and adult porcine islets and analyzed using matrix-assisted laser-desorption time-of-flight mass spectrometry (MALDI-TOF-MS) and electrospray ionization mass spectrometry (ESI-MS/MS). Results A total of 57 porcine and 34 human N-glycans and 21 porcine and 14 human O-glycans were detected from cultured islets. Twenty-eight of which were detected only from porcine islets, which include novel xenoantigens such as high-mannose type N-glycans with core fucosylation and complex-type N-glycans with terminal neuraminic acid residues. Porcine islets have terminal N-glycolylneuraminic acid (NeuGc) residue in bi-antennary N-glycans and sialyl-Tn O-glycans. No galactose-alpha-1,3-galactose (alpha-Gal) or Sd(a) epitope were detected on any of the islets. Conclusions These results provide important insights into the potential antigenic differences of N- and O-glycan profiles between human and porcine islets. Glycan differences may identify novel gene targets for genetic engineering to generate superior porcine islet donors.	[Nanno, Yoshihide; Hering, Bernhard J.; Burlak, Christopher] Univ Minnesota, Dept Surg, Schulze Diabet Inst, Box 242 UMHC, Minneapolis, MN 55455 USA; [Shajahan, Asif; Azadi, Parastoo] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Sonon, Roberto N.] Safe Food Alliance, Kingsburg, CA USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; University of Georgia	Burlak, C (corresponding author), Univ Minnesota, Dept Surg, Schulze Diabet Inst, Box 242 UMHC, Minneapolis, MN 55455 USA.	cburlak@umn.edu	Shajahan, Asif/J-2941-2019	Shajahan, Asif/0000-0002-4804-1130; Nanno, Yoshihide/0000-0002-9539-0560	University of Minnesota Department of Surgery; National Institutes of Health at the Complex Carbohydrate Research Center [1S10OD018530, P41GM10349010]	University of Minnesota Department of Surgery; National Institutes of Health at the Complex Carbohydrate Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by laboratory start-up funding from the University of Minnesota Department of Surgery and the National Institutes of Health grants 1S10OD018530 and P41GM10349010 at the Complex Carbohydrate Research Center. There was no additional external funding received for this study.	Akama TO, 2006, P NATL ACAD SCI USA, V103, P8983, DOI 10.1073/pnas.0603248103; ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C; Bottino R, 2014, AM J TRANSPLANT, V14, P2275, DOI 10.1111/ajt.12868; Burlak C, 2014, AM J TRANSPLANT, V14, P1895, DOI 10.1111/ajt.12744; Burlak C, 2020, XENOTRANSPLANTATION, V27, DOI 10.1111/xen.12629; Byrne G, 2018, XENOTRANSPLANTATION, V25, DOI 10.1111/xen.12394; Cardona K, 2006, NAT MED, V12, P304, DOI 10.1038/nm1375; Cowan PJ, 2017, AM J TRANSPLANT, V17, P2531, DOI 10.1111/ajt.14311; Eguchi H, 2016, TRANSPL P, V48, P1302, DOI 10.1016/j.transproceed.2015.10.071; Ekser B, 2017, CURR OPIN ORGAN TRAN, V22, P513, DOI 10.1097/MOT.0000000000000463; Ezzelarab M, 2005, IMMUNOL CELL BIOL, V83, P396, DOI 10.1111/j.1440-1711.2005.01344.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; GROTH CG, 1994, LANCET, V344, P1402, DOI 10.1016/S0140-6736(94)90570-3; Hawthorne WJ, 2014, AM J TRANSPLANT, V14, P1300, DOI 10.1111/ajt.12722; Hering BJ, 2016, DIABETES CARE, V39, P1230, DOI 10.2337/dc15-1988; Hering BJ, 2006, NAT MED, V12, P301, DOI 10.1038/nm1369; Kim YG, 2006, PROTEOMICS, V6, P1133, DOI 10.1002/pmic.200500275; Kim YG, 2009, J MASS SPECTROM, V44, P1489, DOI 10.1002/jms.1638; Kim YG, 2009, J MASS SPECTROM, V44, P1087, DOI 10.1002/jms.1587; Kirchhof N, 2004, XENOTRANSPLANTATION, V11, P396, DOI 10.1111/j.1399-3089.2004.00157.x; Komoda H, 2004, XENOTRANSPLANTATION, V11, P237, DOI 10.1111/j.1399-3089.2004.00121.x; Kuwaki K, 2005, NAT MED, V11, P29, DOI 10.1038/nm1171; Lablanche S, 2018, LANCET DIABETES ENDO, V6, P527, DOI 10.1016/S2213-8587(18)30078-0; LIN AI, 1994, GLYCOBIOLOGY, V4, P895, DOI 10.1093/glycob/4.6.895; Martens GR, 2017, TRANSPLANTATION, V101, pE86, DOI 10.1097/TP.0000000000001646; McKenzie IFC, 1998, J IMMUNOL, V161, P5116; MISAKI A, 1977, J BIOL CHEM, V252, P6995; Miyagawa S, 2014, TRANSPL IMMUNOL, V31, P48, DOI 10.1016/j.trim.2014.05.003; Miyagawa S, 2014, GLYCOBIOLOGY, V24, P125, DOI 10.1093/glycob/cwt088; Nagae M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020437; Rayat GR, 2003, J ENDOCRINOL, V177, P127, DOI 10.1677/joe.0.1770127; Shajahan A, 2017, ANAL BIOANAL CHEM, V409, P4483, DOI 10.1007/s00216-017-0406-7; Shin JS, 2018, XENOTRANSPLANTATION, V25, DOI 10.1111/xen.12356; Stanley P., 2017, ESSENTIALS GLYCOBIOL; Sterner E, 2016, ACS CHEM BIOL, V11, P1773, DOI 10.1021/acschembio.6b00244; TAKAHASHI T, 1983, J BIOL CHEM, V258, P2819; Thompson P, 2012, AM J TRANSPLANT, V12, P1765, DOI 10.1111/j.1600-6143.2012.04031.x; Thompson P, 2011, AM J TRANSPLANT, V11, P2593, DOI 10.1111/j.1600-6143.2011.03720.x; Thompson P, 2011, AM J TRANSPLANT, V11, P947, DOI 10.1111/j.1600-6143.2011.03509.x; Valdes-Gonzalez R, 2010, CLIN EXP IMMUNOL, V162, P537, DOI 10.1111/j.1365-2249.2010.04273.x; van der Windt DJ, 2009, AM J TRANSPLANT, V9, P2716, DOI 10.1111/j.1600-6143.2009.02850.x; Wang Wei, 2011, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V36, P1134, DOI 10.3969/j.issn.1672-7347.2011.12.002; Yamada K, 2005, NAT MED, V11, P32, DOI 10.1038/nm1172	43	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241249	10.1371/journal.pone.0241249	http://dx.doi.org/10.1371/journal.pone.0241249			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170858	gold, Green Published			2022-12-26	WOS:000592383400008
J	Peng, H; Chiu, TY; Liang, YJ; Lee, CJ; Liu, CS; Suen, CS; Yen, JJY; Chen, HT; Hwang, MJ; Hussain, MM; Yang, HC; Yang-Yen, HF				Peng, Hubert; Chiu, Tzu-Yuan; Liang, Yu-Jen; Lee, Chia-Jen; Liu, Chih-Syuan; Suen, Ching-Shu; Yen, Jeffrey J-Y; Chen, Hung-Ta; Hwang, Ming-Jing; Hussain, M. Mahmood; Yang, Hsin-Chou; Yang-Yen, Hsin-Fang			PRAP1 is a novel lipid-binding protein that promotes lipid absorption by facilitating MTTP-mediated lipid transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; TRIACYLGLYCEROL TRANSFER PROTEIN; WIDE ASSOCIATION; APO-B; EXPRESSION; LIPOPROTEIN; INTESTINE; MICE; SECRETION; LIVER	Microsomal triglyceride transfer protein (MTTP) is an endoplasmic reticulum resident protein that is essential for the assembly and secretion of triglyceride (TG)-rich, apoB-containing lipoproteins. Although the function and structure of mammalian MTTP have been extensively studied, how exactly MTTP transfers lipids to lipid acceptors and whether there are other biomolecules involved in MTTP-mediated lipid transport remain elusive. Here we identify a role in this process for the poorly characterized protein PRAP1. We report that PRAP1 and MTTP are partially colocalized in the endoplasmic reticulum. We observe that PRAP1 directly binds to TG and facilitates MTTP-mediated lipid transfer. A single amino acid mutation at position 85 (E85V) impairs PRAP1's ability to form a ternary complex with TG and MTTP, as well as impairs its ability to facilitate MTTP-mediated apoB-containing lipoprotein assembly and secretion, suggesting that the ternary complex formation is required for PRAP1 to facilitate MTTP-mediated lipid transport. PRAP1 is detectable in chylomicron/VLDL-rich plasma fractions, suggesting that MTTP recognizes PRAP1-bound TG as a cargo and transfers TG along with PRAP1 to lipid acceptors. Both PRAP1-deficient and E85V knock-in mutant mice fed a chow diet manifested an increase in the length of their small intestines, likely to compensate for challenges in absorbing lipid. Interestingly, both genetically modified mice gained significantly less body weight and fat mass when on high-fat diets compared with littermate controls and were prevented from hepatosteatosis. Together, this study provides evidence that PRAP1 plays an important role in MTTP-mediated lipid transport and lipid absorption.	[Peng, Hubert; Chiu, Tzu-Yuan; Lee, Chia-Jen; Liu, Chih-Syuan; Chen, Hung-Ta; Yang-Yen, Hsin-Fang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Liang, Yu-Jen; Yang, Hsin-Chou] Acad Sinica, Inst Stat Sci, Taipei, Taiwan; [Suen, Ching-Shu; Yen, Jeffrey J-Y; Hwang, Ming-Jing] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Hussain, M. Mahmood] NYU, Fdn Med, Long Isl Sch Med, Mineola, NY USA	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; New York University	Yang-Yen, HF (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	imbyy@gate.sinica.edu.tw	Chen, Hung-Ta/ABC-8094-2021; Yang-Yen, Hsin-Fang/ABA-5808-2021; Yen, Jeffrey Jong-Young/Q-5134-2018; Hwang, Ming-jing/E-9210-2012	Chen, Hung-Ta/0000-0003-1192-0382; Yang-Yen, Hsin-Fang/0000-0001-9048-4800; Yen, Jeffrey Jong-Young/0000-0001-6299-1995; Hwang, Ming-jing/0000-0002-9657-5663; Chiu, Tzu-Yuan/0000-0001-8702-9268; Peng, Hubert/0000-0003-4881-1331; Liang, Yu-Jen/0000-0003-3324-213X	Academia Sinica; Ministry of Science and Technology (MOST) of Taiwan [NSC-99-2311-B-001-015-MY3, NSC-102-2311-B-001-024-MY3]; MOST [MOST-103-102-2311-B-001-024-MY3]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan); MOST	This study was supported in part by an intramural fund from Academia Sinica and by grants NSC-99-2311-B-001-015-MY3 and NSC-102-2311-B-001-024-MY3 from the Ministry of Science and Technology (MOST) of Taiwan to H.-F. Y.-Y.; C.-J. L. was supported by a postdoctoral fellowship from MOST (MOST-103-102-2311-B-001-024-MY3).	Abumrad NA, 2012, PHYSIOL REV, V92, P1061, DOI 10.1152/physrev.00019.2011; ATZEL A, 1993, BIOCHEMISTRY-US, V32, P10444, DOI 10.1021/bi00090a021; ATZEL A, 1994, BIOCHEMISTRY-US, V33, P15382, DOI 10.1021/bi00255a019; Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562; Beck T, 2014, EUR J HUM GENET, V22, P949, DOI 10.1038/ejhg.2013.274; Biterova EI, 2019, P NATL ACAD SCI USA, V116, P17251, DOI 10.1073/pnas.1903029116; Cartwright IJ, 2001, J BIOL CHEM, V276, P48048, DOI 10.1074/jbc.M104229200; GORDON DA, 1994, P NATL ACAD SCI USA, V91, P7628, DOI 10.1073/pnas.91.16.7628; GREEVE J, 1993, J LIPID RES, V34, P1367; Gross DA, 2011, P NATL ACAD SCI USA, V108, P19581, DOI 10.1073/pnas.1110817108; Hooper AJ, 2005, CRIT REV CL LAB SCI, V42, P515, DOI 10.1080/10408360500295113; Hooper AJ, 2015, CIRC RES, V116, P193, DOI 10.1161/CIRCRESAHA.116.304637; Huang BH, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.180; Huang CR, 2010, FEBS LETT, V584, P3323, DOI 10.1016/j.febslet.2010.07.013; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-14; Innis-Whitehouse W, 1998, J LIPID RES, V39, P679; Iqbal J, 2003, J BIOL CHEM, V278, P31610, DOI 10.1074/jbc.M301177200; Iqbal J, 2015, J BIOL CHEM, V290, P25863, DOI 10.1074/jbc.M115.659110; Karpe F, 1996, METHOD ENZYMOL, V263, P95; Kasik J, 1997, AM J OBSTET GYNECOL, V176, P452, DOI 10.1016/S0002-9378(97)70514-3; Koscielny G, 2017, NUCLEIC ACIDS RES, V45, pD985, DOI 10.1093/nar/gkw1055; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Kraus D., 2015, BIOPROTOC, V5; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Lamberg A, 1996, BIOCHEM J, V315, P533, DOI 10.1042/bj3150533; Lepourcelet M, 2005, DEVELOPMENT, V132, P415, DOI 10.1242/dev.01579; Mera Y, 2011, J PHARMACOL EXP THER, V336, P321, DOI 10.1124/jpet.110.173807; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Raabe M, 1998, P NATL ACAD SCI USA, V95, P8686, DOI 10.1073/pnas.95.15.8686; Ramos EM, 2014, EUR J HUM GENET, V22, P144, DOI 10.1038/ejhg.2013.96; Rava P, 2007, BIOCHEMISTRY-US, V46, P12263, DOI 10.1021/bi700762z; Rustaeus S, 1999, J NUTR, V129, p463S, DOI 10.1093/jn/129.2.463S; SCHORDERET DF, 1991, AM J MED GENET, V39, P278, DOI 10.1002/ajmg.1320390307; Sirwi A, 2018, J LIPID RES, V59, P1094, DOI 10.1194/jlr.R083451; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; WETTERAU JR, 1992, SCIENCE, V258, P999; WETTERAU JR, 1986, BIOCHIM BIOPHYS ACTA, V875, P610, DOI 10.1016/0005-2760(86)90084-6; Wetterau JR, 1997, BBA-LIPID LIPID MET, V1345, P136, DOI 10.1016/S0005-2760(96)00168-3; WETTERAU JR, 1984, J BIOL CHEM, V259, P863; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Xie Y, 2006, J BIOL CHEM, V281, P4075, DOI 10.1074/jbc.M510622200; Xie Y, 2003, AM J PHYSIOL-GASTR L, V285, pG735, DOI 10.1152/ajpgi.00202.2003; Zamel R, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-19; Zhang JQ, 2003, CANCER RES, V63, P6658; Zhang JQ, 2000, BBA-GENE STRUCT EXPR, V1492, P526, DOI 10.1016/S0167-4781(00)00135-4	48	7	7	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100052	10.1074/jbc.RA120.015002	http://dx.doi.org/10.1074/jbc.RA120.015002			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33168624	Green Published, gold			2022-12-26	WOS:000672866400035
J	Meilerid, S; Hamer, OW; Schaible, J; Zeman, F; Zorger, N; Kleine, H; Rennert, J; Stroszczynski, C; Poschenrieder, F				Meilerid, Stefanie; Hamer, Okka Wilkea; Schaible, Jan; Zeman, Florian; Zorger, Niels; Kleine, Henning; Rennert, Janine; Stroszczynski, Christian; Poschenrieder, Florian			Computed tomography characterization and outcome evaluation of COVID-19 pneumonia complicated by venous thromboembolism	PLOS ONE			English	Article							COHORT; RISK	Background COVID-19 is frequently complicated by venous thromboembolism (VTE). Computed tomography (CT) of the chest-primarily usually conducted as low-dose, non-contrast enhanced CT-plays an important role in the diagnosis and follow-up of COVID-19 pneumonia. Performed as contrast-enhanced CT pulmonary angiography, it can reliably detect or rule-out pulmonary embolism (PE). Several imaging characteristics of COVID-19 pneumonia have been described for chest CT, but no study evaluated CT findings in the context of VTE/PE. Purpose In our retrospective study, we analyzed clinical, laboratory and CT imaging characteristics of 50 consecutive patients with RT-PCR proven COVID-19 pneumonia who underwent contrast-enhanced chest CT at two tertiary care medical centers. Material and methods All patients with RT-PCR proven COVID-19 pneumonia and contrast-enhanced chest CT performed at two tertiary care hospitals between March 1st and April 20th 2020 were retrospectively identified. Patient characteristics (age, gender, comorbidities), symptoms, date of symptom onset, RT-PCR results, imaging results of CT and leg ultrasound, laboratory findings (C-reactive protein, differential blood count, troponine, N-terminal pro-B-type natriuretic peptide (NT-proBNP), fibrinogen, interleukin-6, D-dimer, lactate dehydrogenase (LDH), creatine kinase (CK), creatine kinase muscle-brain (CKmb) and lactate,) and patient outcome (positive: discharge or treatment on normal ward; negative: treatment on intensive care unit (ICU), need for mechanical ventilation, extracorporeal membrane oxygenation (ECMO), or death) were analyzed. Follow-up was performed until May 10th. Patients were assigned to two groups according to two endpoints: venous thromboembolism (VTE) or no VTE. For statistical analysis, univariate logistic regression models were calculated. Results This study includes 50 patients. In 14 out of 50 patients (28%), pulmonary embolism was detected at contrast-enhanced chest CT. The majority of PE was detected on CTs performed on day 11-20 after symptom onset. Two patients (14%) with PE simultaneously had evidence of deep vein thrombosis. 15 patients (30%) had a negative outcome (need for intensive care, mechanical ventilation, extracorporeal membrane oxygenation, or death), and 35 patients (70%) had a positive outcome (transfer to regular ward, or discharge). Patients suffering VTE had a statistically significant higher risk of an unfavorable outcome (p = 0.028). In univariate analysis, two imaging characteristics on chest CT were associated with VTE: crazy paving pattern (p = 0.024) and air bronchogram (n = 0.021). Also, elevated levels of NT-pro BNP (p = 0.043), CK (p = 0.023) and D-dimers (p = 0.035) were significantly correlated with VTE. Conclusion COVID-19 pneumonia is frequently complicated by pulmonary embolism (incidence of 28% in our cohort), remarkably with lacking evidence of deep vein thrombosis in nearly all thus affected patients of our cohort. As patients suffering VTE had an adverse outcome, we call for a high level of alertness for PE and advocate a lower threshold for contrast-enhanced CT in COVID-19 pneumonia. According to our observations, this might be particularly justified in the second week of disease and if a crazy paving pattern and / or air bronchogram is present on previous non-enhanced CT.	[Meilerid, Stefanie; Hamer, Okka Wilkea; Schaible, Jan; Rennert, Janine; Stroszczynski, Christian; Poschenrieder, Florian] Regensburg Univ Med Ctr, Dept Radiol, Regensburg, Germany; [Hamer, Okka Wilkea] Hosp Donaustauf, Dept Radiol, Donaustauf, Germany; [Zeman, Florian] Regensburg Univ Med Ctr, Ctr Clin Studies, Regensburg, Germany; [Zorger, Niels] Hosp Barmherzige Brueder, Dept Radiol, Regensburg, Germany; [Kleine, Henning] Hosp Barmherzige Brueder, Dept Pneumol, Regensburg, Germany	University of Regensburg; University of Regensburg	Meilerid, S (corresponding author), Regensburg Univ Med Ctr, Dept Radiol, Regensburg, Germany.	stefanie.meiler@ukr.de	Zeman, Florian/GNH-3239-2022					Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Cavagna Enrico, 2020, Radiol Cardiothorac Imaging, V2, pe200289, DOI 10.1148/ryct.2020200289; Colombi D, 2020, RADIOLOGY, V296, pE86, DOI 10.1148/radiol.2020201433; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; Goyal N, 2020, J THORAC IMAG, V35, P211, DOI 10.1097/RTI.0000000000000527; Grillet F, 2020, RADIOLOGY, V296, pE186, DOI 10.1148/radiol.2020201544; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Kaminetzky Mark, 2020, Radiol Cardiothorac Imaging, V2, pe200308, DOI 10.1148/ryct.2020200308; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]; Leonard-Lorant I, 2020, RADIOLOGY, V296, pE189, DOI 10.1148/radiol.2020201561; Li KH, 2020, INVEST RADIOL, V55, P327, DOI 10.1097/RLI.0000000000000672; Li LL, 2020, THERANOSTICS, V10, P6113, DOI 10.7150/thno.46569; Liu FJ, 2020, THERANOSTICS, V10, P5613, DOI 10.7150/thno.45985; Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869; Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024; Mahdjoub E, 2020, INTENS CARE MED, V46, P1648, DOI 10.1007/s00134-020-06118-y; Meng H, 2020, J INFECTION, V81, pE33, DOI 10.1016/j.jinf.2020.04.004; Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888; Oudkerk M, 2020, RADIOLOGY, V297, pE216, DOI 10.1148/radiol.2020201629; Rubin GD, 2020, RADIOLOGY, V296, P172, DOI [10.1016/j.chest.2020.04.003, 10.1148/radiol.2020201365]; Vogel-Claussen J, 2020, ROFO-FORTSCHR RONTG, V192, P633, DOI 10.1055/a-1174-8378; Weiss P, 2020, LANCET, V395, P1014, DOI 10.1016/S0140-6736(20)30633-4; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Ye Z, 2020, EUR RADIOL, V30, P4381, DOI 10.1007/s00330-020-06801-0; Yu Q, 2020, THERANOSTICS, V10, P5641, DOI 10.7150/thno.46465	26	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0242475	10.1371/journal.pone.0242475	http://dx.doi.org/10.1371/journal.pone.0242475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211737	Green Published, gold			2022-12-26	WOS:000603518300061
J	Cunningham, GB; Wigfall, LT				Cunningham, George B.; Wigfall, Lisa T.			Race, explicit racial attitudes, implicit racial attitudes, and COVID-19 cases and deaths: An analysis of counties in the United States	PLOS ONE			English	Article							HEALTH-CARE; BIAS; PREJUDICE; METAANALYSIS; INSIGHTS; BLACKS	Objectives To examine the potential moderating effects of explicit racial attitudes and implicit racial attitudes on the relationship between percent of Black county residents and COVID-19 cases and deaths. Methods We collected data from a variety of publicly available sources for 817 counties in the US. (26% of all counties). Cumulative COVID-19 deaths and cases from January 22 to August 31, 2020 were the dependent variables; explicit racial attitudes and implicit racial attitudes served as the moderators; subjective poor or fair health, food insecurity, percent uninsured, percent unemployed, median family income, percent women, percent of Asian county resident, percent of Hispanic county residents, and percent of people 65 or older were controls. Results The percent of Black county residents was positively associated with COVID-19 cases and deaths at the county level. The relationship between percent of Black residents and COVID-19 cases was moderated by explicit racial attitudes and implicit racial attitudes. Conclusions Implicit racial attitudes can take on a shared property at the community level and effectively explain racial disparities. COVID-19 cases are highest when both the percent of Black county residents and implicit racial attitudes are high.	[Cunningham, George B.] Texas A&M Univ, Dept Hlth & Kinesiol, Ctr Sport Management Res & Educ, College Stn, TX 77843 USA; [Wigfall, Lisa T.] Texas A&M Univ, Dept Hlth & Kinesiol, Transdisciplinary Ctr Hlth Equ Res, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Cunningham, GB (corresponding author), Texas A&M Univ, Dept Hlth & Kinesiol, Ctr Sport Management Res & Educ, College Stn, TX 77843 USA.	gbcunningham@tamu.edu	Cunningham, George/AAG-7242-2019	Cunningham, George/0000-0002-1170-1780				Aguinis H, 2005, J APPL PSYCHOL, V90, P94, DOI 10.1037/0021-9010.90.1.94; Alkon AH, 2020, AGR HUM VALUES, V37, P535, DOI 10.1007/s10460-020-10110-z; Allport GW, 1954, NATURE PREJUDICE, DOI [10.1037/h0062678, DOI 10.1037/H0062678]; Blair I. V., 2015, HDB PERSONALITY SOCI, V1, P665, DOI [DOI 10.1037/14341-021, 10.1037/14341-021]; Blair IV, 2017, SOC SCI MED, V183, P169, DOI 10.1016/j.socscimed.2017.04.041; Bowleg L, 2020, AM J PUBLIC HEALTH, V110, P917, DOI 10.2105/AJPH.2020.305766; Chen E, 2013, ANNU REV CLIN PSYCHO, V9, P723, DOI 10.1146/annurev-clinpsy-050212-185634; Cohen J., 2003, APPL MULTIPLE REGRES; Coughlin SS, 2020, AM J PUBLIC HEALTH, V110, P1157, DOI 10.2105/AJPH.2020.305764; Crandall CS, 2002, J PERS SOC PSYCHOL, V82, P359, DOI 10.1037//0022-3514.82.3.359; Cunningham GB, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176272; Cunningham GB, 2019, MEAS PHYS EDUC EXERC, V23, P301, DOI 10.1080/1091367X.2018.1472095; Feagin J.R., 2006, SYSTEMIC RACISM THEO; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Gundersen C, 2015, HEALTH AFFAIR, V34, P1830, DOI 10.1377/hlthaff.2015.0645; Hahn A, 2014, J EXP PSYCHOL GEN, V143, P1369, DOI 10.1037/a0035028; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hall WJ, 2015, AM J PUBLIC HEALTH, V105, pE60, DOI 10.2105/AJPH.2015.302903; Harris RB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196476; Hehman E, 2018, SOC PSYCHOL PERS SCI, V9, P393, DOI 10.1177/1948550617711229; Hing LSS, 2008, J PERS SOC PSYCHOL, V94, P971, DOI 10.1037/0022-3514.94.6.971; Hopman J, 2020, JAMA-J AM MED ASSOC, V323, P1549, DOI 10.1001/jama.2020.4169; Hsu HE, 2020, MMWR-MORBID MORTAL W, V69, P864, DOI 10.15585/mmwr.mm6927a3; Kawohl W, 2020, LANCET PSYCHIAT, V7, P389, DOI 10.1016/S2215-0366(20)30141-3; Lassale C, 2020, BRAIN BEHAV IMMUN, DOI 10.1016/j.bbi.2020.05.074BottomofForm; Lee Y, 2015, AM J PUBLIC HEALTH, V105, P2349, DOI 10.2105/AJPH.2015.302776; Leitner JB, 2016, SOC SCI MED, V170, P220, DOI 10.1016/j.socscimed.2016.10.007; Leitner JB, 2016, PSYCHOL SCI, V27, P1299, DOI 10.1177/0956797616658450; Liu J, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16020278; Liu K, 2020, J INFECTION, V80, pE14, DOI 10.1016/j.jinf.2020.03.005; Nosek BA, 2009, P NATL ACAD SCI USA, V106, P10593, DOI 10.1073/pnas.0809921106; O'Brien R, 2020, SSM-POPUL HLTH, V11, DOI 10.1016/j.ssmph.2020.100564; O'Shea BA, 2020, SOC PSYCHOL PERS SCI, V11, P345, DOI 10.1177/1948550619862319; Obermeyer Z, 2019, SCIENCE, V366, P447, DOI 10.1126/science.aax2342; Orchard J, 2017, SOC SCI MED, V181, P191, DOI 10.1016/j.socscimed.2017.03.036; Oswald FL, 2013, J PERS SOC PSYCHOL, V105, P171, DOI 10.1037/a0032734; Payne BK, 2017, PSYCHOL INQ, V28, P233, DOI 10.1080/1047840X.2017.1335568; Payne BK, 2017, PSYCHOL INQ, V28, P306, DOI 10.1080/1047840X.2017.1380460; Pearson AR, 2009, SOC PERSONAL PSYCHOL, V3, P314, DOI 10.1111/j.1751-9004.2009.00183.x; Riddle T, 2019, P NATL ACAD SCI USA, V116, P8255, DOI 10.1073/pnas.1808307116; Selden TM, 2020, HEALTH AFFAIR, V39, P1624, DOI 10.1377/hlthaff.2020.00897; Shah M, 2020, J AM ACAD DERMATOL, V83, pE35, DOI 10.1016/j.jaad.2020.04.046; Sommers BD, 2017, NEW ENGL J MED, V377, P586, DOI 10.1056/NEJMsb1706645; Ssentongo P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238215; Stephens-Davidowitz S., 2017, EVERYBODY LIES BIG D, DOI [10.1016/j.socscimed.2017.04.019, DOI 10.1016/J.SOCSCIMED.2017.04.019]; Watanabe NM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226938; Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2; Williams DR, 2019, ANNU REV PUBL HEALTH, V40, P105, DOI 10.1146/annurev-publhealth-040218-043750; Woolhandler S, 2020, ANN INTERN MED, V173, P63, DOI 10.7326/M20-1491; Zestcott CA, 2016, GROUP PROCESS INTERG, V19, P528, DOI 10.1177/1368430216642029	51	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242044	10.1371/journal.pone.0242044	http://dx.doi.org/10.1371/journal.pone.0242044			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206679	gold, Green Published			2022-12-26	WOS:000595265900058
J	Lin, LY; McCarthy, S; Powell, BM; Manurung, Y; Xiang, IM; Dean, WL; Chaires, B; Yatsunyk, LA				Lin, Linda Yingqi; McCarthy, Sawyer; Powell, Barrett M.; Manurung, Yanti; Xiang, Irene M.; Dean, William L.; Chaires, Brad; Yatsunyk, Liliya A.			Biophysical and X-ray structural studies of the (GGGTT)(3)GGG G-quadruplex in complex with N-methyl mesoporphyrin IX	PLOS ONE			English	Article							HUMAN TELOMERIC DNA; CRYSTAL-STRUCTURE; BINDING; STABILITY; REPEAT; LIGAND; SPECIFICITY; SELECTIVITY	The G-quadruplex (GQ) is a well-studied non-canonical DNA structure formed by G-rich sequences found at telomeres and gene promoters. Biological studies suggest that GQs may play roles in regulating gene expression, DNA replication, and DNA repair. Small molecule ligands were shown to alter GQ structure and stability and thereby serve as novel therapies, particularly against cancer. In this work, we investigate the interaction of a G-rich sequence, 5'-GGGTTGGGTTGGGTTGGG-3' (T1), with a water-soluble porphyrin, N-methyl mesoporphyrin IX (NMM) via biophysical and X-ray crystallographic studies. UV-vis and fluorescence titrations, as well as a Job plot, revealed a 1:1 binding stoichiometry with an impressively tight binding constant of 30-50 mu M-1 and Delta G(298) of -10.3 kcal/mol. Eight extended variants of T1 (named T2 -T9) were fully characterized and T7 was identified as a suitable candidate for crystallographic studies. We solved the crystal structures of the T1- and T7-NMM complexes at 2.39 and 2.34 angstrom resolution, respectively. Both complexes form a 5'-5' dimer of parallel GQs capped by NMM at the 3' G-quartet, supporting the 1:1 binding stoichiometry. Our work provides invaluable details about GQ-ligand binding interactions and informs the design of novel anticancer drugs that selectively recognize specific GQs and modulate their stability for therapeutic purposes.	[Lin, Linda Yingqi; McCarthy, Sawyer; Powell, Barrett M.; Manurung, Yanti; Xiang, Irene M.; Yatsunyk, Liliya A.] Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA; [Dean, William L.; Chaires, Brad] Univ Louisville, Struct Biol Program, JG Brown Canc Ctr, Louisville, KY 40292 USA	Swarthmore College; University of Louisville	Yatsunyk, LA (corresponding author), Swarthmore Coll, Dept Chem & Biochem, Swarthmore, PA 19081 USA.	lyatsun1@swarthmore.edu		McCarthy, Sawyer/0000-0002-1063-1784; Lin, Linda Yingqi/0000-0001-5011-1305	National Institutes of Health [1R15CA20867601A1, GM077422]; Henry Dreyfus Teacher-Scholar award; National Institute of General Medical Sciences from the National Institutes of Health [P30 GM124165]; NIH-ORIP HEI grant [S10OD021527]; DOE Office of Science [DE-AC02-06CH11357]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry Dreyfus Teacher-Scholar award; National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; DOE Office of Science(United States Department of Energy (DOE))	This work is supported by the National Institutes of Health [grant number 1R15CA20867601A1 to LY; GM077422 to BC and WD] and Henry Dreyfus Teacher-Scholar award to LY. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P30 GM124165). The Eiger 16M detector on 24-ID-E beam line is funded by a NIH-ORIP HEI grant (S10OD021527). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Adam Olia (University of Pennsylvania), Daniela Fera (Swarthmore College), and Jack Nicoludis (University of California San Francisco) for their generous help and advice in our crystallographic studies. This work is based on research conducted at the Northeastern Collaborative Access Team using the Eiger 16M detector on 24-ID-E beam line. This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory.	[Anonymous], PYMOL MOL GRAPHICS S; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bazzicalupi C, 2016, ANGEW CHEM INT EDIT, V55, P4256, DOI 10.1002/anie.201511999; Bazzicalupi C, 2013, NUCLEIC ACIDS RES, V41, P632, DOI 10.1093/nar/gks1001; Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006; Bhattacharjee AJ, 2011, BIOCHIMIE, V93, P1297, DOI 10.1016/j.biochi.2011.05.038; Campbell NH, 2012, J MED CHEM, V55, P209, DOI 10.1021/jm201140v; Campbell NH, 2011, ORG BIOMOL CHEM, V9, P1328, DOI 10.1039/c0ob00886a; Campbell NH, 2009, BIOCHEMISTRY-US, V48, P1675, DOI 10.1021/bi802233v; Carle CM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005842; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Clark GR, 2012, NUCLEIC ACIDS RES, V40, P5731, DOI 10.1093/nar/gks193; Collie GW, 2012, J AM CHEM SOC, V134, P2723, DOI 10.1021/ja2102423; Dean WL, 2019, G QUADRUPLEX NUCLEIC; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujimoto T, 2013, J PHYS CHEM B, V117, P963, DOI 10.1021/jp308402v; Guedin A, 2018, NUCLEIC ACIDS RES, V46, P5297, DOI 10.1093/nar/gky290; Haider SM, 2003, J MOL BIOL, V326, P117, DOI 10.1016/S0022-2836(02)01354-2; Holt PA, 2011, DRUG DEVELOP RES, V72, P178, DOI 10.1002/ddr.20414; HUANG CY, 1982, METHOD ENZYMOL, V87, P509; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karlberg T, 2008, J MOL BIOL, V378, P1074, DOI 10.1016/j.jmb.2008.03.040; Karsisiotis AI, 2013, METHODS, V64, P28, DOI 10.1016/j.ymeth.2013.06.004; Krauss IR, 2016, J AM CHEM SOC, V138, P1226, DOI 10.1021/jacs.5b10492; Kypr J, 2009, NUCLEIC ACIDS RES, V37, P1713, DOI 10.1093/nar/gkp026; Largy E, 2016, J AM CHEM SOC, V138, P2780, DOI 10.1021/jacs.5b13130; Lecerof D, 2000, J MOL BIOL, V297, P221, DOI 10.1006/jmbi.2000.3569; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lipps HJ, 2009, TRENDS CELL BIOL, V19, P414, DOI 10.1016/j.tcb.2009.05.002; LU M, 1992, BIOCHEMISTRY-US, V31, P2455, DOI 10.1021/bi00124a003; Madden T, 2013, NCBI HDB, V2nd edition; Maizels N, 2015, EMBO REP, V16, P910, DOI 10.15252/embr.201540607; Marchand A, 2018, J AM CHEM SOC, V140, P12553, DOI 10.1021/jacs.8b07302; Marsico G, 2019, NUCLEIC ACIDS RES, V47, P3862, DOI 10.1093/nar/gkz179; McQuaid K, 2019, ANGEW CHEM INT EDIT, V58, P9881, DOI 10.1002/anie.201814502; Nicoludis JM, 2012, J AM CHEM SOC, V134, P20446, DOI 10.1021/ja3088746; Nicoludis JM, 2012, NUCLEIC ACIDS RES, V40, P5432, DOI 10.1093/nar/gks152; Nikolova EN, 2011, NATURE, V470, P498, DOI 10.1038/nature09775; Paramasivan S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn487; Parkinson GN, 2006, RSC BIOMOL SCI, P1; Qu XG, 2000, METHOD ENZYMOL, V321, P353; RAMSAY GD, 1994, METHOD ENZYMOL, V240, P615; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Reshetnikov RV, 2010, ACTA NATURAE, V2, P72, DOI 10.32607/20758251-2010-2-4-72-81; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Rochin L, 2013, P NATL ACAD SCI USA, V110, P10658, DOI 10.1073/pnas.1220748110; Sabharwal NC, 2014, FEBS J, V281, P1726, DOI 10.1111/febs.12734; Sacca B, 2005, NUCLEIC ACIDS RES, V33, P1182, DOI 10.1093/nar/gki257; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Spiegel J, 2020, TRENDS CHEM, V2, P123, DOI 10.1016/j.trechm.2019.07.002; Uddin MK, 2004, NUCLEIC ACIDS RES, V32, P4618, DOI 10.1093/nar/gkh766; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; WANG Y, 1994, STRUCTURE, V2, P1141, DOI 10.1016/S0969-2126(94)00117-0; Yett A, 2019, J PORPHYR PHTHALOCYA, V23, P1195, DOI [10.1142/s1088424619300179, 10.1142/S1088424619300179]	55	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241513	10.1371/journal.pone.0241513	http://dx.doi.org/10.1371/journal.pone.0241513			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206666	Green Submitted, Green Published, gold			2022-12-26	WOS:000595265900066
J	Tran, BN; Tanase, MA; Bennett, LT; Aponte, C				Tran, Bang Nguyen; Tanase, Mihai A.; Bennett, Lauren T.; Aponte, Cristina			High-severity wildfires in temperate Australian forests have increased in extent and aggregation in recent decades	PLOS ONE			English	Article							ESTIMATING BURN SEVERITY; YELLOWSTONE-NATIONAL-PARK; SOUTH-EASTERN AUSTRALIA; WESTERN UNITED-STATES; SUB-ALPINE FORESTS; FIRE SEVERITY; CLIMATE-CHANGE; SIERRA-NEVADA; SURFACE RUNOFF; CALIFORNIA	Wildfires have increased in size and frequency in recent decades in many biomes, but have they also become more severe? This question remains under-examined despite fire severity being a critical aspect of fire regimes that indicates fire impacts on ecosystem attributes and associated post-fire recovery. We conducted a retrospective analysis of wildfires larger than 1000 ha in south-eastern Australia to examine the extent and spatial pattern of high-severity burned areas between 1987 and 2017. High-severity maps were generated from Landsat remote sensing imagery. Total and proportional high-severity burned area increased through time. The number of high-severity patches per year remained unchanged but variability in patch size increased, and patches became more aggregated and more irregular in shape. Our results confirm that wildfires in southern Australia have become more severe. This shift in fire regime may have critical consequences for ecosystem dynamics, as fire-adapted temperate forests are more likely to be burned at high severities relative to historical ranges, a trend that seems set to continue under projections of a hotter, drier climate in south-eastern Australia.	[Tran, Bang Nguyen; Tanase, Mihai A.; Aponte, Cristina] Univ Melbourne, Sch Ecosyst & Forest Sci, Richmond, Vic, Australia; [Tran, Bang Nguyen] Vietnam Natl Univ Agr, Fac Environm, Hanoi, Vietnam; [Tanase, Mihai A.] Univ Alcala, Dept Geol Geog & Environm, Alcala De Henares, Spain; [Bennett, Lauren T.] Univ Melbourne, Sch Ecosyst & Forest Sci, Creswick, Vic, Australia; [Aponte, Cristina] Natl Inst Res & Dev Forestry Marin Dracea, Voluntari, Ilfov, Romania	University of Melbourne; Vietnam National University of Agriculture (VNUA); Universidad de Alcala; University of Melbourne; National Research & Development Institute in Forestry "Marin Dracea"	Tran, BN (corresponding author), Univ Melbourne, Sch Ecosyst & Forest Sci, Richmond, Vic, Australia.; Tran, BN (corresponding author), Vietnam Natl Univ Agr, Fac Environm, Hanoi, Vietnam.	ntran6@student.unimelb.edu.au	Bennett, Lauren/AGO-0700-2022; Aponte, Cristina/AAV-5567-2020; TRAN, BANG NGUYEN/M-2453-2016	Bennett, Lauren/0000-0003-2472-062X; Aponte, Cristina/0000-0002-8457-7573; TRAN, BANG NGUYEN/0000-0002-6005-7784	Melbourne Research Scholarship program; Vietnam International Education Cooperation Department (VIED) scholarship; Integrated Forest Ecosystem Research program - Victorian Department of Environment, Land, Water and Planning	Melbourne Research Scholarship program; Vietnam International Education Cooperation Department (VIED) scholarship; Integrated Forest Ecosystem Research program - Victorian Department of Environment, Land, Water and Planning	The authors would like to acknowledge the financial support of the Melbourne Research Scholarship program, the Vietnam International Education Cooperation Department (VIED) scholarship, and the Integrated Forest Ecosystem Research program, supported by the Victorian Department of Environment, Land, Water and Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzoglou JT, 2017, INT J WILDLAND FIRE, V26, P269, DOI [10.1071/wf16165, 10.1071/WF16165]; Abatzoglou JT, 2016, P NATL ACAD SCI USA, V113, P11770, DOI 10.1073/pnas.1607171113; Aponte C, 2016, INT J WILDLAND FIRE, V25, pI, DOI 10.1071/WFv25n8_FO; Ashton D. H., 1986, Australian Forestry, V49, P28; Baker AG, 2015, ECOL MANAG RESTOR, V16, P106, DOI 10.1111/emr.12161; Tran BN, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10111680; Bassett OD, 2015, FOREST ECOL MANAG, V342, P39, DOI 10.1016/j.foreco.2015.01.008; Batllori E, 2013, GLOBAL ECOL BIOGEOGR, V22, P1118, DOI 10.1111/geb.12065; BEER T, 1988, GREENHOUSE PLANNING, P421; Bennett LT, 2017, ECOL APPL, V27, P2497, DOI 10.1002/eap.1626; Bennett LT, 2016, FOREST ECOL MANAG, V380, P107, DOI 10.1016/j.foreco.2016.08.047; Boer M, 2005, EARTH SURF PROC LAND, V30, P149, DOI 10.1002/esp.1180; Boer MM, 2020, NAT CLIM CHANGE, V10, P171, DOI 10.1038/s41558-020-0716-1; Bond WJ, 2005, TRENDS ECOL EVOL, V20, P387, DOI 10.1016/j.tree.2005.04.025; Bowman DMJS, 2014, GLOBAL CHANGE BIOL, V20, P1008, DOI 10.1111/gcb.12433; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Bradstock RA, 2010, LANDSCAPE ECOL, V25, P607, DOI 10.1007/s10980-009-9443-8; Bradstock RA, 2009, INT J WILDLAND FIRE, V18, P932, DOI 10.1071/WF08133; Bradstock RA, 2010, GLOBAL ECOL BIOGEOGR, V19, P145, DOI 10.1111/j.1466-8238.2009.00512.x; Buckingham S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124556; Cansler CA, 2014, ECOL APPL, V24, P1037, DOI 10.1890/13-1077.1; Cawson JG, 2013, FOREST ECOL MANAG, V310, P219, DOI 10.1016/j.foreco.2013.08.016; Cawson JG, 2012, INT J WILDLAND FIRE, V21, P857, DOI 10.1071/WF11160; Cheal D., 2010, 84 DEP SUST ENV, P257; Cheal DC, 2010, 84 VICT GOV DEP SUST; Chia EK, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00327.1; Clarke H, 2013, INT J CLIMATOL, V33, P931, DOI 10.1002/joc.3480; Clarke J.M., 2019, VICTORIAN CLIMATE PR; Clarke PJ, 2015, SCI TOTAL ENVIRON, V534, P31, DOI 10.1016/j.scitotenv.2015.04.002; Collins BM, 2013, LANDSCAPE ECOL, V28, P1801, DOI 10.1007/s10980-013-9923-8; DELWP, 2017, FIR HIST REC FIR PRI; Dennison PE, 2014, GEOPHYS RES LETT, V41, P2928, DOI 10.1002/2014GL059576; Department of Environment Land Water & Planning-DELWP, 2017, AGGR FIR SEV CLASS 1; Department of Environment Land Water & Planning-DELWP, 2018, BIOR VC BENCHM; Dillon GK, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00271.1; Doerr SH, 2006, J HYDROL, V319, P295, DOI 10.1016/j.jhydrol.2005.06.038; Doerr SH, 2005, INT J WILDLAND FIRE, V14, P339, DOI 10.1071/WF05094; Doerrand S.H, 2016, PHILOS T R SOC B, V371, DOI DOI 10.1098/RSTB.2015.0345; Dutta R, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150241; Environment Australia, 2000, REV INT BIOG REG AUS; Etchells H, 2020, FOREST ECOL MANAG, V459, DOI 10.1016/j.foreco.2019.117850; Fairman TA, 2017, J VEG SCI, V28, P1151, DOI 10.1111/jvs.12575; Fairman TA, 2016, INT J WILDLAND FIRE, V25, P831, DOI 10.1071/WF15010; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; FLANNIGAN MD, 1991, CAN J FOREST RES, V21, P66, DOI 10.1139/x91-010; Flint A., 2007, MOUNTAIN ASH VICTORI; Girardin MP, 2008, ECOL APPL, V18, P391, DOI 10.1890/07-0747.1; Girardin MP, 2007, GLOBAL ECOL BIOGEOGR, V16, P557, DOI 10.1111/j.1466-8238.2007.00321.x; Hall RJ, 2008, INT J WILDLAND FIRE, V17, P476, DOI 10.1071/WF08013; Hammill K, 2016, PLANT ECOL, V217, P725, DOI 10.1007/s11258-016-0578-9; Hanson CT, 2014, INT J WILDLAND FIRE, V23, P1, DOI 10.1071/WF13016; Harvey BJ, 2016, GLOBAL ECOL BIOGEOGR, V25, P655, DOI 10.1111/geb.12443; Haywood A, 2009, GUIDELINE REFERENCE; Hennessy K., 2005, CLIMATE CHANGE IMPAC; Hesselbarth MHK, 2019, ECOGRAPHY, V42, P1648, DOI 10.1111/ecog.04617; Holz A, 2015, GLOBAL CHANGE BIOL, V21, P445, DOI 10.1111/gcb.12674; Hoy EE, 2008, INT J WILDLAND FIRE, V17, P500, DOI 10.1071/WF08107; Hughes Lesley, 2013, Proceedings of the Royal Society of Victoria, V125, P5; Johnstone JF, 2010, CAN J FOREST RES, V40, P1302, DOI 10.1139/X10-061; Jones CS, 2015, FOREST ECOL MANAG, V340, P153, DOI 10.1016/j.foreco.2014.12.006; Kasel S, 2017, LANDSCAPE ECOL, V32, P1613, DOI 10.1007/s10980-017-0526-7; Keane RE, 2003, INT J WILDLAND FIRE, V12, P309, DOI 10.1071/WF03017; Keeley JE, 2011, TRENDS PLANT SCI, V16, P406, DOI 10.1016/j.tplants.2011.04.002; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Keyser AR, 2019, FOREST ECOL MANAG, V432, P694, DOI 10.1016/j.foreco.2018.09.027; Kitzberger T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188486; Knapp EE, 2012, FIRE ECOL, V8, P32, DOI 10.4996/fireecology.0801032; Knox KJE, 2012, FOREST ECOL MANAG, V265, P47, DOI 10.1016/j.foreco.2011.10.025; Lacey GC, 1998, J HYDROL, V204, P231, DOI 10.1016/S0022-1694(97)00124-8; Lee DE, 2013, J WILDLIFE MANAGE, V77, P1327, DOI 10.1002/jwmg.581; Lentile L. B., 2007, FIRE ECOLOGY, V3, P91, DOI DOI 10.4996/FIREECOLOGY.0301091; Lentile LB, 2006, INT J WILDLAND FIRE, V15, P319, DOI 10.1071/WF05097; Leonard SWJ, 2014, FOREST ECOL MANAG, V314, P85, DOI 10.1016/j.foreco.2013.11.036; Littell JS, 2009, ECOL APPL, V19, P1003, DOI 10.1890/07-1183.1; McGarigal K., 2012, FRAGSTATS V4 SPATIAL; Miller JD, 2009, ECOSYSTEMS, V12, P16, DOI 10.1007/s10021-008-9201-9; Miller JD, 2012, FIRE ECOL, V8, P41, DOI 10.4996/fireecology.0803041; Miller JD, 2009, REMOTE SENS ENVIRON, V113, P645, DOI 10.1016/j.rse.2008.11.009; Mitchell SR, 2009, ECOL APPL, V19, P643, DOI 10.1890/08-0501.1; Murphy BF, 2008, INT J CLIMATOL, V28, P859, DOI 10.1002/joc.1627; Muscolo A, 2014, J FORESTRY RES, V25, P725, DOI 10.1007/s11676-014-0521-7; Nicolle D, 2006, AUST J BOT, V54, P391, DOI 10.1071/BT05061; Paritsis J, 2015, J VEG SCI, V26, P89, DOI 10.1111/jvs.12225; Parks SA, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/035002; Parks SA, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aab791; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Picotte JJ, 2016, INT J WILDLAND FIRE, V25, P413, DOI 10.1071/WF15039; Pinno BD, 2013, FOREST ECOL MANAG, V310, P517, DOI 10.1016/j.foreco.2013.08.055; Pitman AJ, 2007, CLIMATIC CHANGE, V84, P383, DOI 10.1007/s10584-007-9243-6; Potter C, 2017, J COAST CONSERV, V21, P393, DOI 10.1007/s11852-017-0519-3; Potts Brad M., 1997, P56; R Core Team, 2021, R LANGUAGE ENV STAT; Riano D, 2007, GLOBAL CHANGE BIOL, V13, P40, DOI 10.1111/j.1365-2486.2006.01268.x; Rocca ME, 2014, FOREST ECOL MANAG, V327, P265, DOI 10.1016/j.foreco.2014.06.007; Russell-Smith J, 2007, INT J WILDLAND FIRE, V16, P361, DOI 10.1071/WF07018; Santin C, 2012, EUR J FOREST RES, V131, P1245, DOI 10.1007/s10342-012-0595-8; Savage M, 2005, CAN J FOREST RES, V35, P967, DOI 10.1139/X05-028; Sharples JJ, 2016, CLIMATIC CHANGE, V139, P85, DOI 10.1007/s10584-016-1811-1; Soverel NO, 2010, REMOTE SENS ENVIRON, V114, P1896, DOI 10.1016/j.rse.2010.03.013; Spracklen DV, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010966; Steel ZL, 2018, LANDSCAPE ECOL, V33, P1159, DOI 10.1007/s10980-018-0665-5; Stevens-Rumann CS, 2018, ECOL LETT, V21, P243, DOI 10.1111/ele.12889; Stocks BJ, 1998, CLIMATIC CHANGE, V38, P1, DOI 10.1023/A:1005306001055; Tanase M, 2011, CAN J FOREST RES, V41, P863, DOI [10.1139/x11-011, 10.1139/X11-011]; Timbal B, 2016, 014 BUR MET; TORN MS, 1992, CLIMATIC CHANGE, V21, P257, DOI 10.1007/BF00139726; Tran NB, 2019, PROC SPIE, V11149, DOI 10.1117/12.2535616; Turner MG, 1999, INT J WILDLAND FIRE, V9, P21, DOI 10.1071/WF99003; Turner MG, 1997, ECOL MONOGR, V67, P411, DOI 10.1890/0012-9615(1997)067[0411:EOFSAP]2.0.CO;2; TURNER MG, 1994, J VEG SCI, V5, P731, DOI 10.2307/3235886; Turner MG, 2001, LANDSCAPE ECOLOGY TH, DOI DOI 10.1007/B97434; USGS, 2017, EARTH EXPL 2017; Veraverbeke S, 2010, INT J WILDLAND FIRE, V19, P558, DOI 10.1071/WF09069; Wang GG, 2005, CAN J FOREST RES, V35, P254, DOI [10.1139/x04-177, 10.1139/X04-177]; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; Westerling AL, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0178; Zhu Z, 2012, REMOTE SENS ENVIRON, V118, P83, DOI 10.1016/j.rse.2011.10.028	118	20	20	6	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242484	10.1371/journal.pone.0242484	http://dx.doi.org/10.1371/journal.pone.0242484			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206713	Green Published, gold			2022-12-26	WOS:000595265900057
J	Liu, Y; Gong, ZZ; Zhou, JF; Yan, JK; Cai, W				Liu, Yang; Gong, Zizhen; Zhou, Jiefei; Yan, Junkai; Cai, Wei			Lin 28A/Occludin axis: An aberrantly activated pathway in intestinal epithelial cells leading to impaired barrier function under total parenteral nutrition	FASEB JOURNAL			English	Article						intestinal barrier function; Lin 28A; Occludin; RNA binding protein; total parenteral nutrition	MOUSE MODEL; MESSENGER-RNA; TRANSLATION; EXPRESSION; ATROPHY; BINDING; DIFFERENTIATION; REGULATOR; APOPTOSIS; OCCLUDIN	Disassembly of tight junctions is a major cause of intestinal barrier dysfunction under total parenteral nutrition (TPN), but the precise mechanisms have not been fully understood. Normally, RNA binding protein Lin 28A is highly restricted to embryonic stem cells and dramatically decreases as differentiation progresses; however, in our preliminary study it was found aberrantly increased in the intestinal epithelial cells of TPN rats, and thus its mechanism of action needs to be addressed. Herein, we report a pivotal role of Lin 28A in the regulation of tight junctions, which induces a sustained translational repression of Occludin, leading to disruption of intestinal barrier function under TPN. Using a rat model of TPN, we found time-dependent upregulation of Lin 28A, negatively correlated with Occludin. Using mouse intestinal organoids and human gut-derived Caco-2 cells as in vitro models, we found that expression of Occludin could be significantly suppressed by ectopic overexpression of Lin 28A. The underlying mechanisms may be partially attributed to translational repression, as the abundance of Occludin transcripts in polysomes was dramatically reduced by Lin 28A (polysomal profiling). Furthermore, Lin 28A was found to directly bind to Occludin mRNA 3 ' untranslated coding region (UTR), thereby repressing the translation of Occludin transcripts through decapping enzyme 1A (DCP1a). Taken together, our findings revealed that Lin 28A/Occludin axis may be a novel mechanism accounting for the development of barrier dysfunction under TPN.	[Liu, Yang; Gong, Zizhen; Zhou, Jiefei; Yan, Junkai; Cai, Wei] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Shanghai, Peoples R China; [Gong, Zizhen; Zhou, Jiefei; Yan, Junkai; Cai, Wei] Shanghai Inst Pediat Res, Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Yan, JK; Cai, W (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Pediat Gastroenterol & Nutr, Shanghai Inst Pediat Res, Xin Hua Hosp,Sch Med, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China.	yanjunkai@xinhuamed.com.cn; caiw204@sjtu.edu.cn			Shanghai Municipal Commission of Health and Family [20184Y0337]; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition [17DZ2272000]; National Natural Science Foundation of China [81630039, 81700787]; Science and Technology Commission of Shanghai Municipality [19495810500]; Foundation of Shanghai Municipal Health Commission [shslczdzk05702, 2019ZB0101]	Shanghai Municipal Commission of Health and Family; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Foundation of Shanghai Municipal Health Commission	Shanghai Municipal Commission of Health and Family, Grant/Award Number: 20184Y0337; Shanghai Key Laboratory of Pediatric Gastroenterology and Nutrition, Grant/Award Number: 17DZ2272000; National Natural Science Foundation of China, Grant/Award Number: 81630039 and 81700787; Science and Technology Commission of Shanghai Municipality, Grant/Award Number: 19495810500; Foundation of Shanghai Municipal Health Commission, Grant/Award Number: shslczdzk05702 and 2019ZB0101	Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Broutier L, 2016, NAT PROTOC, V11, P1724, DOI 10.1038/nprot.2016.097; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Feng YJ, 2017, CELL MOL GASTROENTER, V3, P447, DOI 10.1016/j.jcmgh.2016.12.005; Feng YJ, 2013, J PHYSIOL-LONDON, V591, P3709, DOI 10.1113/jphysiol.2013.253518; Feng YJ, 2009, J PHYSIOL-LONDON, V587, P641, DOI 10.1113/jphysiol.2008.162719; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Freeman JJ, 2015, FASEB J, V29, P2943, DOI 10.1096/fj.14-269480; Hansraj NZ, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12858; Hartman C, 2018, CLIN NUTR, V37, P2418, DOI 10.1016/j.clnu.2018.06.956; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Liu L, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00574-16; Liu L, 2015, MOL BIOL CELL, V26, P1797, DOI 10.1091/mbc.E14-11-1500; Luhur A, 2015, FLY, V9, P173, DOI 10.1080/19336934.2016.1158366; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Nagy P, 2017, DEVELOPMENT, V144, P3990, DOI 10.1242/dev.147033; O'Driscoll MC, 2010, AM J HUM GENET, V87, P354, DOI 10.1016/j.ajhg.2010.07.012; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Pereira B, 2013, NUCLEIC ACIDS RES, V41, P3986, DOI 10.1093/nar/gkt087; Pironi L, 2019, CLIN LIVER DIS, V23, P279, DOI 10.1016/j.cld.2018.12.009; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Shyh-Chang N, 2013, CELL STEM CELL, V12, P395, DOI 10.1016/j.stem.2013.03.005; Sun XY, 2008, AM J PHYSIOL-GASTR L, V294, pG139, DOI 10.1152/ajpgi.00386.2007; Takizawa Y, 2013, INT J PHARMACEUT, V450, P31, DOI 10.1016/j.ijpharm.2013.04.026; Wessel Jacqueline, 2017, Adv Pediatr, V64, P253, DOI 10.1016/j.yapd.2017.03.010; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Xiao WD, 2014, FASEB J, V28, P2073, DOI 10.1096/fj.13-238311; Yan JK, 2019, FASEB J, V33, P3378, DOI [10.1096/fj.201801695r, 10.1096/fj.201801695R]; Yan JK, 2018, J CELL MOL MED, V22, P1562, DOI 10.1111/jcmm.13430; Yan JK, 2017, CELL PHYSIOL BIOCHEM, V41, P711, DOI 10.1159/000458430; Yan JK, 2016, CELL PHYSIOL BIOCHEM, V39, P1581, DOI 10.1159/000447860; Yokoyama S, 2008, GENE EXPR PATTERNS, V8, P155, DOI 10.1016/j.gep.2007.11.001; Yu TX, 2016, AM J PHYSIOL-CELL PH, V310, pC54, DOI 10.1152/ajpcell.00112.2015; Yu TX, 2013, MOL BIOL CELL, V24, P85, DOI 10.1091/mbc.E12-07-0531; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zhang T, 2019, JPEN-PARENTER ENTER, V43, P96, DOI 10.1002/jpen.1173; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593; Zhu J, 2018, JPEN-PARENTER ENTER, V42, P436, DOI 10.1177/0148607116677048	41	1	1	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001819R	http://dx.doi.org/10.1096/fj.202001819R		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33200449				2022-12-26	WOS:000592669100001
J	Tavanasefat, H; Li, F; Koyano, K; Gourtani, BK; Marty, V; Mulpuri, Y; Lee, SH; Shin, KH; Wong, DTW; Xiao, XS; Spigelman, I; Kim, Y				Tavanasefat, Honey; Li, Feng; Koyano, Kikuye; Gourtani, Bahar Khalilian; Marty, Vincent; Mulpuri, Yatendra; Lee, Sung Hee; Shin, Ki-Hyuk; Wong, David T. W.; Xiao, Xinshu; Spigelman, Igor; Kim, Yong			Molecular consequences of fetal alcohol exposure on amniotic exosomal miRNAs with functional implications for stem cell potency and differentiation	PLOS ONE			English	Article							ETHANOL EXPOSURE; OSTEOGENIC DIFFERENTIATION; CIRCULATING MICRORNAS; SPECTRUM DISORDERS; NUCLEIC-ACIDS; EXPRESSION; DNA; NEUROGENESIS; DIAGNOSIS; BLOOD	Alcohol (ethanol, EtOH) consumption during pregnancy can result in fetal alcohol spectrum disorders (FASDs), which are characterized by prenatal and postnatal growth restriction and craniofacial dysmorphology. Recently, cell-derived extracellular vesicles, including exosomes and microvesicles containing several species of RNAs (exRNAs), have emerged as a mechanism of cell-to-cell communication. However, EtOH's effects on the biogenesis and function of non-coding exRNAs during fetal development have not been explored. Therefore, we studied the effects of maternal EtOH exposure on the composition of exosomal RNAs in the amniotic fluid (AF) using rat fetal alcohol exposure (FAE) model. Through RNA-Seq analysis we identified and verified AF exosomal miRNAs with differential expression levels specifically associated with maternal EtOH exposure. Uptake of purified FAE AF exosomes by rBMSCs resulted in significant alteration of molecular markers associated with osteogenic differentiation of rBMSCs. We also determined putative functional roles for AF exosomal miRNAs (miR-199a-3p, miR-214-3p and let-7g) that are dysregulated by FAE in osteogenic differentiation of rBMSCs. Our results demonstrate that FAE alters AF exosomal miRNAs and that exosomal transfer of dysregulated miRNAs has significant molecular effects on stem cell regulation and differentiation. Our results further suggest the usefulness of assessing molecular alterations in AF exRNAs to study the mechanisms of FAE teratogenesis that should be further investigated by using an in vivo model.	[Tavanasefat, Honey; Gourtani, Bahar Khalilian; Kim, Yong] Univ Calif Los Angeles, Sch Dent, Lab Stem Cell & Canc Epigenet Res, Los Angeles, CA 90024 USA; [Tavanasefat, Honey] Calif State Univ Northridge, Dept Biol, CSUN UCLA Stem Cell Res Bridge Program, Northridge, CA 91330 USA; [Li, Feng; Marty, Vincent; Mulpuri, Yatendra; Wong, David T. W.; Spigelman, Igor; Kim, Yong] Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90024 USA; [Koyano, Kikuye; Xiao, Xinshu] Univ Calif Los Angeles, Inst Mol Biol, Dept Integrat Biol & Physiol, Los Angeles, CA 90024 USA; [Lee, Sung Hee; Shin, Ki-Hyuk] Univ Calif Los Angeles, Sch Dent, Shapiro Family Lab Viral Oncol & Aging Res, Los Angeles, CA 90024 USA; [Kim, Yong] Univ Calif Los Angeles, Broad Stem Cell Res Ctr, Los Angeles, CA 90032 USA	University of California System; University of California Los Angeles; California State University System; California State University Northridge; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Kim, Y (corresponding author), Univ Calif Los Angeles, Sch Dent, Lab Stem Cell & Canc Epigenet Res, Los Angeles, CA 90024 USA.; Kim, Y (corresponding author), Univ Calif Los Angeles, Sch Dent, Div Oral Biol & Med, Los Angeles, CA 90024 USA.; Kim, Y (corresponding author), Univ Calif Los Angeles, Broad Stem Cell Res Ctr, Los Angeles, CA 90032 USA.	thadyk@ucla.edu	Mulpuri, Yatendra/V-5481-2019; LEE, Sunghee/HCH-4510-2022	Mulpuri, Yatendra/0000-0003-1764-119X	NIAAA [AA024210]	NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by a grant award from NIAAA to Y.K. (AA024210).	Armant DR, 1996, SEMIN PERINATOL, V20, P127, DOI 10.1016/S0146-0005(96)80080-2; Asea A, 2008, J REPROD IMMUNOL, V79, P12, DOI 10.1016/j.jri.2008.06.001; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Balaraman S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165081; Balaraman S, 2014, ALCOHOL CLIN EXP RES, V38, P1390, DOI 10.1111/acer.12378; Balaraman S, 2013, ALCOHOL RES-CURR REV, V35, P18; Biancone L, 2012, NEPHROL DIAL TRANSPL, V27, P3037, DOI 10.1093/ndt/gfs168; Bobrie A, 2011, TRAFFIC, V12, P1659, DOI 10.1111/j.1600-0854.2011.01225.x; BRIEN JF, 1983, AM J OBSTET GYNECOL, V146, P181, DOI 10.1016/0002-9378(83)91050-5; Cao LH, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12814; Floris I, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121994; Gardiner AS, 2016, ALCOHOL CLIN EXP RES, V40, P826, DOI 10.1111/acer.13026; Gong ZD, 2004, ALCOHOL CLIN EXP RES, V28, P468, DOI 10.1097/01.ALC.0000118315.58404.C1; Hammond SM, 2015, ADV DRUG DELIVER REV, V87, P3, DOI 10.1016/j.addr.2015.05.001; Haycock PC, 2009, BIOL REPROD, V81, P618, DOI 10.1095/biolreprod.108.074682; Haycock PC, 2009, BIOL REPROD, V81, P607, DOI 10.1095/biolreprod.108.074690; Herrera DG, 2003, P NATL ACAD SCI USA, V100, P7919, DOI 10.1073/pnas.1230907100; Hipp JA, 2010, ALCOHOL CLIN EXP RES, V34, P1714, DOI 10.1111/j.1530-0277.2010.01258.x; Hoang M, 2016, STEM CELL RES, V17, P111, DOI 10.1016/j.scr.2016.05.021; Hoyme HE, 2005, PEDIATRICS, V115, P39, DOI 10.1542/peds.2004-0259; Hui L, 2011, HUM REPROD UPDATE, V17, P362, DOI 10.1093/humupd/dmq049; Hui LS, 2011, PRENATAL DIAG, V31, P735, DOI 10.1002/pd.2777; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Keller S, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-86; Khalid O, 2014, GENOM DATA, V2, P127, DOI 10.1016/j.gdata.2014.06.011; Khalid O, 2014, STEM CELL RES, V12, P791, DOI 10.1016/j.scr.2014.03.009; Kim JJ, 2014, GENOM DATA, V2, P156, DOI 10.1016/j.gdata.2014.06.021; Kim JJ, 2014, GENOM DATA, V2, P139, DOI 10.1016/j.gdata.2014.06.012; Kim JJ, 2012, J BIOL CHEM, V287, P41103, DOI 10.1074/jbc.M112.416545; Kokabu S, 2012, J ORAL BIOSCI, V54, P73, DOI 10.1016/j.job.2012.02.003; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lau C, 2013, J BIOL CHEM, V288, P26888, DOI 10.1074/jbc.M113.452458; Liang J, 2014, NEUROCHEM RES, V39, P1147, DOI 10.1007/s11064-014-1291-5; Lindoso RS, 2014, STEM CELLS DEV, V23, P1809, DOI 10.1089/scd.2013.0618; Lotvall J, 2007, CELL ADHES MIGR, V1, P156, DOI 10.4161/cam.1.3.5114; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maguire G, 2013, PROCEDIA ENGINEER, V59, P270, DOI 10.1016/j.proeng.2013.05.121; Malik ZA, 2013, AM J PHYSIOL-HEART C, V304, pH954, DOI 10.1152/ajpheart.00835.2012; Maron JL, 2007, AM J MED GENET C, V145C, P5, DOI 10.1002/ajmg.c.30115; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; Natarajan SK, 2015, BIOMOLECULES, V5, P3309, DOI 10.3390/biom5043309; Nava-Ocampo AA, 2004, REPROD TOXICOL, V18, P613, DOI 10.1016/j.reprotox.2004.02.012; Nixon K, 2002, J NEUROCHEM, V83, P1087, DOI 10.1046/j.1471-4159.2002.01214.x; Or Nick H. K., 2017, POLICY STUD J, V45, pS67; Orozco AE, 2006, ANN NY ACAD SCI, V1075, P57, DOI 10.1196/annals.1368.007; Palanisamy V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008577; Pappalardo-Carter DL, 2013, ALCOHOL CLIN EXP RES, V37, P1657, DOI 10.1111/acer.12139; PARK HW, 1994, TERATOLOGY, V49, P465, DOI 10.1002/tera.1420490606; PIKKARAINEN PH, 1971, LIFE SCI 2-BIOCH GEN, V10, P1359, DOI 10.1016/0024-3205(71)90187-1; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; RENFREE MB, 1975, J EMBRYOL EXP MORPH, V33, P435; Riley EP, 2011, NEUROPSYCHOL REV, V21, P73, DOI 10.1007/s11065-011-9166-x; Rosenberg MJ, 2010, ALCOHOL, V44, P673, DOI 10.1016/j.alcohol.2009.10.002; Sekizawa A, 2003, HUM GENET, V113, P307, DOI 10.1007/s00439-003-0987-4; Shepard TH, 1997, INT J DEV BIOL, V41, P307; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; SK AZ, 2016, DIABETOLOGIE STOFFWE, V11, pS01; Snow ME, 2007, BONE, V41, P181, DOI 10.1016/j.bone.2007.04.182; Sokol RJ, 2003, JAMA-J AM MED ASSOC, V290, P2996, DOI 10.1001/jama.290.22.2996; Tan CY, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt465; The Gene Ontology Consortium, 2008, NUCLEIC ACIDS RES, V36, pD440; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thomas JD, 1998, ALCOHOL HEALTH RES W, V22, P47; Tsai PC, 2014, BIOL OPEN, V3, P741, DOI 10.1242/bio.20147765; Tseng AM, 2019, ALCOHOL CLIN EXP RES, V43, P1414, DOI 10.1111/acer.14066; Varaschin RK, 2014, ALCOHOL CLIN EXP RES, V38, P1902, DOI 10.1111/acer.12430; Wang CG, 2019, EXP MOL PATHOL, V107, P77, DOI 10.1016/j.yexmp.2019.01.012; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Zhang XL, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01707-6; Zhu HY, 2011, AM J CARDIOVASC DIS, V1, P138	74	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242276	10.1371/journal.pone.0242276	http://dx.doi.org/10.1371/journal.pone.0242276			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196678	Green Published, gold			2022-12-26	WOS:000595266800001
J	Gunnels, T; Creswell, M; McFerrin, J; Whittall, JB				Gunnels, Tess; Creswell, Matthew; McFerrin, Janis; Whittall, Justen B.			The ITS region provides a reliable DNA barcode for identifying reishi/lingzhi (Ganoderma) from herbal supplements	PLOS ONE			English	Article							LUCIDUM; IDENTIFICATION; MORPHOLOGY; SEAFOOD; POLYPORALES; LINGZHI; HEALTH	The dietary supplement industry is rapidly growing yet, a recent study revealed that up to 60% of supplements may have substituted ingredients, some of which can be harmful contaminants or additives. When ingredients cannot be verified morphologically or biochemically, DNA barcoding complemented with a molecular phylogenetic analysis can be a powerful method for species authentication. We employed a molecular phylogenetic analysis for species authentication of the commonly used fungal supplement, reishi (Ganoderma lingzhi), by amplifying and sequencing the nuclear ribosomal internal transcribed spacer regions (ITS) with genus-specific primers. PCR of six powdered samples and one dried sample all sold as G. lucidum representing independent suppliers produced single, strong amplification products in the expected size-range for Ganoderma. Both best-hit BLAST and molecular phylogenetic analyses clearly identified the presence of G. lingzhi DNA in all seven herbal supplements. We detected variation in the ITS sequences among our samples, but all herbal supplement samples fall within a large clade of G. lingzhi ITS sequences. ITS-based phylogenetic analysis is a successful and cost-effective method for DNA-based species authentication that could be used in the herbal supplement industry for this and other fungal and plant species that are otherwise difficult to identify.	[Gunnels, Tess; Whittall, Justen B.] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA; [Gunnels, Tess; Creswell, Matthew; McFerrin, Janis] Oregons Wild Harvest, Redmond, OR USA	Santa Clara University	Whittall, JB (corresponding author), Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA.	jwhittall@scu.edu			Oregon's Wild Harvest, the herbal supplement company	Oregon's Wild Harvest, the herbal supplement company	Oregon's Wild Harvest, the herbal supplement company, provided funding for supplies, sequencing and hourly wages to an undergraduate researcher (TG). The specific roles of this author is articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Pardo MA, 2018, FOOD CONTROL, V92, P7, DOI 10.1016/j.foodcont.2018.04.044; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 1992, SAUDE SOC, V1, P3; [Anonymous], 2019, NEW DIET INGR DIET S; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Arora D, 1986, MUSHROOMS DEMYSTIFIE; Binns CW, 2018, ANNU REV PUBL HEALTH, V39, P403, DOI 10.1146/annurev-publhealth-040617-013638; Birch JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186259; Chae Y.K., 2009, PLOS ONE, V4, pe6523; Christiansen H, 2018, FOOD CONTROL, V85, P66, DOI 10.1016/j.foodcont.2017.09.005; Critical Art Ensemble, 2012, TDR-DRAMA REV-J PERF, V56, P49; Dai YC, 2017, MYCOL PROG, V16, P1051, DOI 10.1007/s11557-017-1347-4; Dodge T, 2011, J HEALTH COMMUN, V16, P230, DOI 10.1080/10810730.2010.529493; Du XH, 2012, MYCOLOGIA, V104, P1351, DOI 10.3852/12-056; Eisen JA, 1998, GENOME RES, V8, P163, DOI 10.1101/gr.8.3.163; Eisen JA, 1997, NAT MED, V3, P1076, DOI 10.1038/nm1097-1076; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gunther B, 2017, FOOD CONTROL, V73, P922, DOI 10.1016/j.foodcont.2016.10.016; Hapuarachchi KK, 2015, MYCOSPHERE, V6, P542, DOI 10.5943/mycosphere/6/5/4; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hennicke F, 2016, PHYTOCHEMISTRY, V127, P29, DOI 10.1016/j.phytochem.2016.03.012; HIBBETT DS, 1995, CAN J BOT, V73, pS853, DOI 10.1139/b95-331; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hu YX, 2018, FOOD CONTROL, V94, P38, DOI 10.1016/j.foodcont.2018.06.023; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jargalmaa S, 2017, PEERJ, V5, DOI 10.7717/peerj.3596; Jin X, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007731.pub2; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Liao BS, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0056-7; Loyd AL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01557; Luque GM, 2019, BIOL CONSERV; Matos AJFS, 2007, LETT APPL MICROBIOL, V45, P270, DOI 10.1111/j.1472-765X.2007.02181.x; McGuffin M, 2000, AM HERBAL PRODUCTS A; MIZUNO T, 1995, FOOD REV INT, V11, P151, DOI 10.1080/87559129509541025; MONCALVO JM, 1995, MYCOLOGIA, V87, P223, DOI 10.2307/3760908; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Newmaster SG, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-222; Nilsson RH, 2019, NUCLEIC ACIDS RES, V47, pD259, DOI 10.1093/nar/gky1022; Paterson RRM, 2015, PHYTOCHEMISTRY, V114, P16, DOI 10.1016/j.phytochem.2014.11.014; Pereira LHG, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-20; Raja HA, 2017, FOOD CHEM, V214, P383, DOI 10.1016/j.foodchem.2016.07.052; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shimada T, 2001, MARC MALPIG SYMP SER, V7, P203; Sliva D, 2004, MINI-REV MED CHEM, V4, P873, DOI 10.2174/1389557043403323; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Spouge JL, 2012, DNA BARCODES, P365; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sultana S, 2018, FOOD RES INT, V105, P19, DOI 10.1016/j.foodres.2017.10.065; VV.AA, 2012, COMPOSITE MAT HDB CM, V3, P1, DOI DOI 10.1007/S13244-011-0135-Y; Wachtel-Galor S., 2011, HERBAL MED BIOMOLECU, V2nd; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wu FF, 2020, J SYST EVOL, V58, P77, DOI 10.1111/jse.12474; Xu JP, 2016, GENOME, V59, P913, DOI 10.1139/gen-2016-0046; Zhou LW, 2015, PHYTOCHEMISTRY, V114, P7, DOI 10.1016/j.phytochem.2014.09.023	58	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0236774	10.1371/journal.pone.0236774	http://dx.doi.org/10.1371/journal.pone.0236774			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180770	gold, Green Submitted, Green Published			2022-12-26	WOS:000593948000067
J	Guo, BP; Tan, XH; Cen, H				Guo, Baoping; Tan, Xiaohong; Cen, Hong			EZH2 is a negative prognostic biomarker associated with immunosuppression in hepatocellular carcinoma	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE EZH2; REGULATORY T-CELLS; GENE-EXPRESSION; TARGETING EZH2; IFN-GAMMA; CANCER; SURVIVAL; PROGRESSION; SORAFENIB; NIVOLUMAB	The enhancer of zeste homolog 2 (EZH2) plays a critical role in different components of anti-tumor immunity. However, the specific role of EZH2 in modulating MHC Class I antigen presentation and T cell infiltration have not been investigated in HCC. This study analyzed the expression and clinical significance of EZH2 in HCC. The EZH2 genetic alterations were identified using cBioPortal. The EZH2 mRNA and protein levels were found to be significantly higher in HCC than in adjacent normal liver tissues in multiple datasets from the GEO and TCGA databases. High expression of EZH2 was significantly correlated with poor overall survival, disease-specific survival, progression-free survival, and relapse-free survival in almost all patients with HCC. The gene set variance analysis (GSVA) showed that the expression of EZH2 is positively correlated with an immunosuppressive microenvironment and negatively correlated with major MHC class I antigen presentation molecules. Gene set enrichment analysis (GSEA) showed that high EZH2 expression is positively associated with the MYC and glycolysis signaling pathway and negatively associated with the interferon-gamma signaling pathway in HCC tissues. These findings demonstrate that EZH2 is a potential prognostic biomarker and therapeutic target in HCC.	[Guo, Baoping; Tan, Xiaohong; Cen, Hong] Guangxi Med Univ, Dept Chemotherapy, Canc Hosp, Nanning, Guangxi, Peoples R China	Guangxi Medical University	Cen, H (corresponding author), Guangxi Med Univ, Dept Chemotherapy, Canc Hosp, Nanning, Guangxi, Peoples R China.	cenhong981@gxmu.edu.cn			Guangxi Natural Science Foundation [2016GXNSFDA380029]; Guangxi Science and Technology Project [2019GXNSFAA245086]; Guangxi Medical and Health Appropriate Technology Development and Promotion Application Project [S20170952018]	Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Guangxi Science and Technology Project; Guangxi Medical and Health Appropriate Technology Development and Promotion Application Project	This study was funded by the Guangxi Natural Science Foundation (Grant No.2016GXNSFDA380029), HC received the funding. URL: http://gkg.kjt.gxzf.gov.cn/egrantweb/This study was funded by the Guangxi Science and Technology Project (Grant No. 2019GXNSFAA245086), Guangxi Medical and Health Appropriate Technology Development and Promotion Application Project (Grant No. S20170952018), XHT received the funding. URL: http://gkg.kjt.gxzf.gov.cn/egrantweb/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, DTSCH ARZTEBL, V115, pA; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Beatty GL, 2001, IMMUNOL RES, V24, P201, DOI 10.1385/IR:24:2:201; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Cabibbo G, 2010, HEPATOLOGY, V51, P1274, DOI 10.1002/hep.23485; Cai MY, 2011, GUT, V60, P967, DOI 10.1136/gut.2010.231993; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Cui SC, 2017, MOL MED REP, V16, P9494, DOI 10.3892/mmr.2017.7828; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; Ennishi D, 2019, CANCER DISCOV, V9, P546, DOI 10.1158/2159-8290.CD-18-1090; Gan L, 2018, BIOMARK RES, V6, DOI 10.1186/s40364-018-0122-2; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goswami S, 2018, J CLIN INVEST, V128, P3813, DOI 10.1172/JCI99760; Grinchuk OV, 2018, MOL ONCOL, V12, P89, DOI 10.1002/1878-0261.12153; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Jiang ZH, 2019, EBIOMEDICINE, V42, P431, DOI 10.1016/j.ebiom.2019.03.068; Jones BA, 2018, MOL CANCER THER, V17, P591, DOI 10.1158/1535-7163.MCT-17-0437; Kim KH, 2016, NAT MED, V22, P128, DOI 10.1038/nm.4036; Kosaloglu-Yalcin Z, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1492508; Kugelberg E, 2015, NAT REV IMMUNOL, V15, P730, DOI 10.1038/nri3941; Leone P, 2013, JNCI-J NATL CANCER I, V105, P1172, DOI 10.1093/jnci/djt184; Lim HY, 2013, ANN SURG ONCOL, V20, P3747, DOI 10.1245/s10434-013-3070-y; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Lue JK, 2018, CURR HEMATOL MALIG R, V13, P369, DOI 10.1007/s11899-018-0466-6; Makowska Z, 2016, J PATHOL CLIN RES, V2, P80, DOI 10.1002/cjp2.37; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Peng DJ, 2015, NATURE, V527, P249, DOI 10.1038/nature15520; Roessler S, 2010, CANCER RES, V70, P10202, DOI 10.1158/0008-5472.CAN-10-2607; Ru BB, 2019, BIOINFORMATICS, V35, P4200, DOI 10.1093/bioinformatics/btz210; Sasaki M, 2008, LAB INVEST, V88, P873, DOI 10.1038/labinvest.2008.52; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Villa E, 2016, GUT, V65, P861, DOI 10.1136/gutjnl-2014-308483; Wang D, 2018, CELL REP, V23, P3262, DOI 10.1016/j.celrep.2018.05.050; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Yang XP, 2015, SCI REP-UK, V5, DOI 10.1038/srep10643; Zhou LY, 2020, CLIN CANCER RES, V26, P290, DOI 10.1158/1078-0432.CCR-19-1351; Zingg D, 2017, CELL REP, V20, P854, DOI 10.1016/j.celrep.2017.07.007; Zingg D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7051	47	13	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242191	10.1371/journal.pone.0242191	http://dx.doi.org/10.1371/journal.pone.0242191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180829	Green Published, gold			2022-12-26	WOS:000593948000091
J	Hasselberg, AE; Wessels, L; Aakre, I; Reich, F; Atter, A; Steiner-Asiedu, M; Amponsah, S; Pucher, J; Kjellevold, M				Hasselberg, Astrid Elise; Wessels, Laura; Aakre, Inger; Reich, Felix; Atter, Amy; Steiner-Asiedu, Matilda; Amponsah, Samuel; Pucher, Johannes; Kjellevold, Marian			Composition of nutrients, heavy metals, polycyclic aromatic hydrocarbons and microbiological quality in processed small indigenous fish species from Ghana: Implications for food security	PLOS ONE			English	Article							MERCURY MOLAR RATIOS; VITAMIN-D; PROXIMATE COMPOSITION; FRESH-WATER; PAH CONTAMINATION; NUTRITIVE-VALUE; METHODS COOKING; RISK-ASSESSMENT; HUMAN EXPOSURE; SMOKING	The triple burden of malnutrition is an incessant issue in low- and middle-income countries, and fish has the potential to mitigate this burden. In Ghana fish is a central part of the diet, but data on nutrients and contaminants in processed indigenous fish species, that are often eaten whole, are missing. Samples of smoked, dried or salted Engraulis encrasicolus (European anchovy), Brachydeuterus auritus (bigeye grunt), Sardinella aurita (round sardinella), Selene dorsalis (African moonfish), Sierrathrissa leonensis (West African (WA) pygmy herring) and Tilapia spp. (tilapia) were collected from five different regions in Ghana. Samples were analyzed for nutrients (crude protein, fat, fatty acids, several vitamins, minerals, and trace elements), microbiological quality (microbial loads of total colony counts, E. coli, coliforms, and Salmonella), and contaminants (PAH4 and heavy metals). Except for tilapia, the processed small fish species had the potential to significantly contribute to the nutrient intakes of vitamins, minerals, and essential fatty acids. High levels of iron, mercury and lead were detected in certain fish samples, which calls for further research and identification of anthropogenic sources along the value chains. The total cell counts in all samples were acceptable; Salmonella was not detected in any sample and E. coli only in one sample. However, high numbers of coliform bacteria were found. PAH4 in smoked samples reached high concentrations up to 1,300 mu g/kg, but in contrast salted tilapia samples had a range of PAH4 concentration of 1 mu g/kg to 24 mu g/kg. This endpoint oriented study provides data for the nutritional value of small processed fish as food in Ghana and also provides information about potential food safety hazards. Future research is needed to determine potential sources of contamination along the value chains in different regions, identify critical points, and develop applicable mitigation strategies to improve the quality and safety of processed small fish in Ghana.	[Hasselberg, Astrid Elise; Aakre, Inger; Kjellevold, Marian] Inst Marine Res, Bergen, Norway; [Wessels, Laura; Reich, Felix; Pucher, Johannes] German Fed Inst Risk Assessment, Berlin, Germany; [Atter, Amy; Amponsah, Samuel] CSIR, Food Res Inst, Accra, Ghana; [Steiner-Asiedu, Matilda] Univ Ghana, Sch Biol Sci, Dept Nutr & Food Sci, Legon, Accra, Ghana; [Amponsah, Samuel] Univ Energy & Nat Resources, Dept Fisheries & Water Resources, Sunyani, Ghana	Institute of Marine Research - Norway; Federal Institute for Risk Assessment; University of Ghana	Pucher, J (corresponding author), German Fed Inst Risk Assessment, Berlin, Germany.	Johannes.Pucher@bfr.bund.de	Reich, Felix/C-5636-2015; Kjellevold, Marian/C-2973-2012	Reich, Felix/0000-0001-7835-5328; Kjellevold, Marian/0000-0001-7070-5784; Amponsah, Samuel/0000-0001-5559-3139; Pucher, Johannes/0000-0001-5820-5293	Research Council of Norway; Federal Ministry of Food and Agriculture (BMEL); ERA-NET LEAP-Agri - European Unions EU Framework Programme for Research and Innovation Horizon 2020 under the ERA-NET-Cofund [727715]	Research Council of Norway(Research Council of Norway); Federal Ministry of Food and Agriculture (BMEL); ERA-NET LEAP-Agri - European Unions EU Framework Programme for Research and Innovation Horizon 2020 under the ERA-NET-Cofund	The here presented research activities were supported by funds of the Research Council of Norway and the Federal Ministry of Food and Agriculture (BMEL) based on a decision of the Parliament of the Federal Republic of Germany via the Federal Office for Agriculture and Food (BLE). The conducted work is part of the project "Small Fish and Food Security: Towards innovative integration of fish in African food systems to improve nutrition" (SmallFishFood) funded within the ERA-NET LEAP-Agri which was co-financed by the European Unions EU Framework Programme for Research and Innovation Horizon 2020 under the ERA-NET-Cofund under Grant Agreement No. 727715. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	a R-M, 2020, J CLIN MED, V9; a R-M, 2020, J CLIN MED, V9; Ababouch L, 2005, LIPIDS FAO FISHERIES; Adegunwa M., 2013, INT J MICROBIOLOGY R, V1, P85; Adekunle IM, 2004, FOOD CHEM TOXICOL, V42, P1463, DOI 10.1016/j.fct.2004.04.007; Adeyeye SAO, 2016, J CULIN SCI TECHNOL, V14, P198, DOI 10.1080/15428052.2015.1102785; Akinwumi F. O., 2015, Food and Public Health, V5, P122; Alimentarius C, 2019, 1931995 STAN; [Anonymous], 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.724; [Anonymous], 2014, CLIN INFECT DIS, V58, P44; [Anonymous], 2017, J BONE MINER RES, V32; [Anonymous], 2019, GAMB 2 GEN NAT AGR I; [Anonymous], 2020, 12020 GGS GS FPR, V2; AOAC, 1996, METH MICR AN SEL NUT, P63; AOAC Official Methods of Analysis, 1995, 99215 AOAC, V16th; Aryee BNA, 2003, J CLEAN PROD, V11, P131, DOI 10.1016/S0959-6526(02)00043-4; Avega B, 2015, AHOTOR OVEN CONSTUCT; Avega B, 2017, PERFORMANCE EVALUATI; Azad AM, 2019, SCI TOTAL ENVIRON, V652, P1482, DOI 10.1016/j.scitotenv.2018.10.405; BALOGUN AM, 1988, FOOD CHEM, V27, P1, DOI 10.1016/0308-8146(88)90031-3; Bansal V, 2015, ENVIRON INT, V84, P26, DOI 10.1016/j.envint.2015.06.016; Barany E, 2005, ENVIRON RES, V98, P215, DOI 10.1016/j.envres.2004.09.010; Bene C., 2005, NAGA WORLDFISH CTR Q, V28, P8; Bogard JR, 2015, J FOOD COMPOS ANAL, V42, P120, DOI 10.1016/j.jfca.2015.03.002; BOMFEH K, 2019, FAO FISH AQUAC CIRC, V1178, P1; Bomfeh K, 2019, J SCI FOOD AGR, V99, P5417, DOI 10.1002/jsfa.9802; Bose-O'Reilly S, 2010, CURR PROB PEDIATR AD, V40, P186, DOI 10.1016/j.cppeds.2010.07.002; Burger J, 2012, ENVIRON RES, V114, P12, DOI 10.1016/j.envres.2012.02.004; Chittchang Uraiporn, 1999, Food and Nutrition Bulletin, V20, P238; COOK JD, 1976, AM J CLIN NUTR, V29, P859, DOI 10.1093/ajcn/29.8.859; Domingo JL, 2015, FOOD CHEM TOXICOL, V86, P144, DOI 10.1016/j.fct.2015.10.002; EFSA Panel Contaminants Food, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.1975; Elmadfa I, 2010, EUR J CLIN NUTR, V64, pS4, DOI 10.1038/ejcn.2010.202; EMOKPAE AO, 1983, J FOOD TECHNOL, V18, P271, DOI 10.1108/01443579810196471; Essumang DK, 2013, FOOD CHEM TOXICOL, V58, P86, DOI 10.1016/j.fct.2013.04.014; Essumang DK, 2012, J FOOD COMPOS ANAL, V27, P128, DOI 10.1016/j.jfca.2012.04.007; European Committee for Standardization EN 12821, 2009, 12821 EN EUR COMM ST; European Committee for Standardization EN 1283-1, 2000, 12831 EN EUR COMM ST; FAO, 2018, FOOD BAL SHEETS 2018; FAO, 2010, NUTR COUNTR PROF GHA; FAO, 2003, PRODUCTION MANAGEMEN, V2nd; FAO, 2016, FISH AQ COUNTR PROF; FAO, 2017, FOOD COMP CHALL INFO; FAO (Food and Agriculture Organization of the United Nations) & WHO (World Health Organization), 2019, GEN STANDARD CONTAMI; FAO World Health Organization, 2004, VIT MIN REQ HUM NUTR, V2nd ed; Fauske KR, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060695; Feglo P K, 2004, East Afr Med J, V81, P358; Fischer PR, 2008, REV ENDOCR METAB DIS, V9, P181, DOI 10.1007/s11154-008-9085-1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gbogbo F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194682; Gewurtz SB, 2011, ENVIRON INT, V37, P425, DOI 10.1016/j.envint.2010.11.005; Ghana Statistical Service, 2014, GHAN DEM HLTH SURV 2, V14, P1; Hicks CC, 2019, NATURE, V574, P95, DOI 10.1038/s41586-019-1592-6; Hilson G, 2002, GEOGR J, V168, P57, DOI 10.1111/1475-4959.00038; Hogan LS, 2007, J GREAT LAKES RES, V33, P46, DOI 10.3394/0380-1330(2007)33[46:HNSILE]2.0.CO;2; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Idah P. A., 2013, International Journal of Fisheries and Aquaculture, V5, P29; Ikutegbe V, 2014, FOOD CHEM, V161, P332, DOI 10.1016/j.foodchem.2014.04.032; Immaculate J., 2012, International Food Research Journal, V19, P1699; Itai T, 2014, SCI TOTAL ENVIRON, V470, P707, DOI 10.1016/j.scitotenv.2013.10.037; Jakobsen J, 2014, FOOD CHEM, V148, P170, DOI 10.1016/j.foodchem.2013.10.043; Jakszyn P, 2004, J NUTR, V134, P2011, DOI 10.1093/jn/134.8.2011; JECFA, 2019, EV JOINT FAO WHO EXP; JECFA, 2019, EV JOINT FAO WHO EXP; Julshamn K, 2004, FOOD ADDIT CONTAM A, V21, P365, DOI 10.1080/02652030310001639512; Julshamn K, 2001, J AOAC INT, V84, P1976; Julshamn K, 2007, J AOAC INT, V90, P844; Julshamn K, 2011, MAR BIOL RES, V7, P733, DOI 10.1080/17451000.2011.594893; Kawarazuka N, 2011, PUBLIC HEALTH NUTR, V14, P1927, DOI 10.1017/S1368980011000814; Kelkitli E, 2016, ANN HEMATOL, V95, P751, DOI 10.1007/s00277-016-2628-8; Kiczorowska B, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071448; Kim Yangho, 2014, Korean J Pediatr, V57, P345, DOI 10.3345/kjp.2014.57.8.345; Kortei NK, 2020, TOXICOL REP, V7, P360, DOI 10.1016/j.toxrep.2020.02.011; Kumar V, 2010, FOOD CHEM, V120, P945, DOI 10.1016/j.foodchem.2009.11.052; Kuong K., 2016, NUTRIENTS, V8, P1; Kwaansa-Ansah EE, 2019, FOOD SCI BIOTECHNOL, V28, P569, DOI 10.1007/s10068-018-0485-z; Kwei E. A., 2005, FISHES COASTAL WATER; La Frano MR, 2018, INT J FOOD SCI NUTR, V69, P253, DOI 10.1080/09637486.2017.1358358; Likongwe MC, 2019, FOOD SCI NUTR, V7, P281, DOI 10.1002/fsn3.885; Lu JD, 1991, STORAGE CONDITIONS M; Mania Monika, 2015, Rocz Panstw Zakl Hig, V66, P203; Mensah P., 1999, GHANA MED J, V33, P19; Navas-Carretero S, 2008, J AM COLL NUTR, V27, P96, DOI 10.1080/07315724.2008.10719680; Nerhus I, 2018, FOOD NUTR RES, V62, DOI 10.29219/fnr.v62.1291; Nishioka M, 2011, J NUTR SCI VITAMINOL, V57, P432, DOI 10.3177/jnsv.57.432; Norwegian Food Safety Authority, NORW FOOD COMP DAT 2; Norwegian Standard, 1994, MEAS FAT COL, VFirst; Nti Christina A, 2008, Nutr Res Pract, V2, P35, DOI 10.4162/nrp.2008.2.1.35; ohrvik V, 2012, FISH SHELLFISH FISH; Olmedo P, 2013, ENVIRON INT, V59, P63, DOI 10.1016/j.envint.2013.05.005; Oppong SOB, 2010, B ENVIRON CONTAM TOX, V85, P324, DOI 10.1007/s00128-010-0059-0; Owusu D, 2019, FINAL REPORT AHOTOR; Pettifor JM, 2014, ANN NUTR METAB, V64, P15, DOI 10.1159/000365124; Plahar WA, 1999, FOOD CONTROL, V10, P15, DOI 10.1016/S0956-7135(98)00150-9; Polak-Juszczak Lucyna, 2008, Rocz Panstw Zakl Hig, V59, P187; Ralston NVC, 2008, NEUROTOXICOLOGY, V29, P802, DOI 10.1016/j.neuro.2008.07.007; Rana R, 2013, J FOOD SCI TECH MYS, V50, P1212, DOI 10.1007/s13197-011-0436-7; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Reksten AM, 2020, J FOOD COMPOS ANAL, V91, DOI 10.1016/j.jfca.2020.103508; Riabroy N, 2014, BRIT J NUTR, V111, P1373, DOI 10.1017/S0007114513003851; Roos N, 2002, INT J FOOD SCI NUTR, V53, P425, DOI 10.1080/0963748021000044778; Rosen CJ, 2012, ENDOCR REV, V33, P456, DOI 10.1210/er.2012-1000; Schlemmer U, 2009, MOL NUTR FOOD RES, V53, pS330, DOI 10.1002/mnfr.200900099; Simat V, 2012, ACTA ADRIAT, V53, P125; STEINERASIEDU M, 1993, J SCI FOOD AGR, V63, P439, DOI 10.1002/jsfa.2740630410; STEINERASIEDU M, 1991, FOOD CHEM, V41, P227, DOI 10.1016/0308-8146(91)90045-P; STEINERASIEDU M, 1991, FOOD CHEM, V40, P309, DOI 10.1016/0308-8146(91)90115-5; Stolyhwo A, 2006, FOOD CHEM, V94, P589, DOI 10.1016/j.foodchem.2004.11.050; Sumberg J, 2016, FOOD SECUR, V8, P909, DOI 10.1007/s12571-016-0606-6; The Lancet Hiv null, 2020, LANCET HIV, V7, pe75; Thiex N, 2009, J AOAC INT, V92, P61; Thilsted S.H., 2014, CN2 2 INT C NUTR; Tilami SK, 2018, REV FISH SCI AQUAC, V26, P243, DOI 10.1080/23308249.2017.1399104; Torstensen BE, 2005, J AGR FOOD CHEM, V53, P10166, DOI 10.1021/jf051308i; United Nations, 2015, SUST DEV GOALS 2015; University of Ghana GroundWork University of Wisconsin-Madison KEMRI-Wellcome Trust & UNICEF, 2017, GHAN MICR SURV 2017; Usydus Z, 2009, CHEMOSPHERE, V74, P1420, DOI 10.1016/j.chemosphere.2008.12.023; Usydus Z, 2009, FOOD CHEM, V112, P139, DOI 10.1016/j.foodchem.2008.05.050; van der Velden S, 2013, SCI TOTAL ENVIRON, V444, P531, DOI 10.1016/j.scitotenv.2012.11.099; Varlet V, 2007, FOOD ADDIT CONTAM A, V24, P744, DOI 10.1080/02652030601139946; Veyrand B, 2007, J CHROMATOGR A, V1149, P333, DOI 10.1016/j.chroma.2007.03.043; Voegborlo RB, 2011, FOOD CHEM, V124, P1244, DOI 10.1016/j.foodchem.2010.07.055; Voegborlo RB, 2004, B ENVIRON CONTAM TOX, V73, P1057, DOI 10.1007/s00128-004-0532-8; Watanabe F, 2007, EXP BIOL MED, V232, P1266, DOI 10.3181/0703-MR-67; Weichselbaum E, 2013, NUTR BULL, V38, P128, DOI 10.1111/nbu.12021; WHO, 2007, WHO TECH REP SER, V935, P1; Wittsiepe J, 2017, ENVIRON SCI POLLUT R, V24, P3097, DOI 10.1007/s11356-016-8002-5; Zaza S, 2015, J FOOD COMPOS ANAL, V40, P148, DOI 10.1016/j.jfca.2015.01.007; 2019, J CROHNS COLITIS S1, V13	129	5	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242086	10.1371/journal.pone.0242086	http://dx.doi.org/10.1371/journal.pone.0242086			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180860	gold, Green Published			2022-12-26	WOS:000593948000094
J	Kayamba, V; Kelly, P				Kayamba, Violet; Kelly, Paul			Estimated 24-hour urinary sodium excretion as a risk factor for oxidative stress in Zambian adults: A cross-sectional study	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; POTASSIUM EXCRETION; DIETARY EXPOSURE; GASTRIC-CANCER; BIOMASS SMOKE; BIOMARKERS; AFLATOXIN; 1-HYDROXYPYRENE; HYPERTENSION; OCHRATOXIN	Introduction Persistent oxidative stress predisposes to various non-communicable diseases (NCDs), whose occurrence is increasing in sub-Saharan Africa. The aim of this study was to evaluate the link between markers of oxidative stress and some risk factors for NCDs in a Zambian cohort. Methods We assessed oxidative stress by measuring 8-isoprostane (lipid oxidative stress) and 8-hydroxydeoxyguanosine (DNA oxidative stress). In addition, we measured mycotoxins (aflatoxin M1 and ochratoxin A), salt intake estimated from 24-hour sodium excretion calculated using the Tanaka and Kawaski formulae, and 1-hydroxypyrene (a metabolite of polycyclic aromatic hydrocarbons). Data on lifestyle risk factors were collected using questionnaires. Results Included were 244 participants; 128 (52%) were female and the median age was 48 years (IQR 39-58). The median level of 8-isoprostane was 0.13 ng/mg creatinine (IQR 0.08-0.23) while that of 8-hydroxydeoxyguanosine (8-OHdG) was 4 ng/mg creatinine (IQR 2-10). The median 24-hour sodium excretion was 21 g (IQR 16-25 g), with none being less than the 5 g recommended by WHO. Unadjusted urinary levels of 8-isoprostane were moderately correlated with 1-hydroxypyrene (Spearman r = 0.30, p<0.001) and estimated 24-hour urine sodium (Spearman r = 0.38, p<0.001). Urinary levels of 8-OHdG were not correlated with 1-hydroxypyrene, estimated 24-hour urine sodium, aflatoxin M1 or ochratoxin A (all p-values >0.05). Using logistic regression, adjusted and unadjusted 8-isoprostanes levels were associated with 1-hydroxypyrene (p = 0.02 and p = 0.001 respectively) and estimated 24-hour urine sodium method (p = 0.003 and p<0.001 respectively). However, only unadjusted 8-OHdG was associated with 1-hydroxypyrene (p = 0.03) and age (p = 0.007). Conclusions Estimated 24-hour urinary sodium is high among Zambians and it is associated with lipid but not DNA oxidative stress. High exposure to polycyclic aromatic hydrocarbons is also associated with oxidative stress.	[Kayamba, Violet; Kelly, Paul] Univ Zambia, Dept Internal Med, Trop Gastroenterol & Nutr Grp, Sch Med, Lusaka, Zambia; [Kelly, Paul] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England	University of Zambia; University of London; Queen Mary University London	Kayamba, V (corresponding author), Univ Zambia, Dept Internal Med, Trop Gastroenterol & Nutr Grp, Sch Med, Lusaka, Zambia.	viojole@yahoo.com	Kayamba, Violet/AEQ-9806-2022	Kayamba, Violet/0000-0002-6521-2501	Fogarty International Center of the United States National Institutes of Health (NIH) [D43 TW009744]; U.S Civilian Research & Development Foundation (CRDF Global) [DAA3-16-62699-1]	Fogarty International Center of the United States National Institutes of Health (NIH); U.S Civilian Research & Development Foundation (CRDF Global)	Research reported in this publication was supported by the Fogarty International Center of the United States National Institutes of Health (NIH) under award number D43 TW009744. The U.S Civilian Research & Development Foundation (CRDF Global) provided additional funding award number DAA3-16-62699-1. The content is solely the responsibility of the authors and does not necessarily represent the views of the NIH or CRDF Global.	[Anonymous], 2014, Health Promot Int, V29 Suppl 1, pi19, DOI 10.1093/heapro/dau035; [Anonymous], 2000, MMWR Recomm Rep, V49, P3; [Anonymous], 2017, LANCET HIV, V2017, pPE475; Aseervatham GSB, 2013, ENVIRON SCI POLLUT R, V20, P4356, DOI 10.1007/s11356-013-1748-0; Asiki G, 2014, TROP MED INT HEALTH, V19, P592, DOI 10.1111/tmi.12283; Banday AA, 2007, HYPERTENSION, V49, P664, DOI 10.1161/01.HYP.0000255233.56410.20; Barnes JL, 2018, BIOCHEM SOC T, V46, P1213, DOI 10.1042/BST20180519; Barre-Sinoussi F, 2015, FUTUR SCI OA, V1, DOI [10.4155/fso.15.63, 10.4155/FSO.15.63]; Birukov A, 2016, AM J CLIN NUTR, V104, P49, DOI 10.3945/ajcn.116.132951; Bonjour S, 2013, ENVIRON HEALTH PERSP, V121, P784, DOI 10.1289/ehp.1205987; Bragulat E, 2001, HYPERTENSION, V37, P444, DOI 10.1161/01.HYP.37.2.444; Bui-Klimke TR, 2015, CRIT REV FOOD SCI, V55, P1860, DOI 10.1080/10408398.2012.724480; Cavin C, 2007, TOXICOL SCI, V96, P30, DOI [10.1093/toxscikfl169, 10.1093/toxsci/kfl169]; Dabrowska N, 2017, ADV CLIN EXP MED, V26, P155, DOI 10.17219/acem/43272; Dmitrieva NI, 2011, P NATL ACAD SCI USA, V108, P20796, DOI 10.1073/pnas.1114677108; Ezekiel CN, 2014, ENVIRON INT, V66, P138, DOI 10.1016/j.envint.2014.02.003; Ferrer E, 2009, TOXICOL IN VITRO, V23, P1504, DOI 10.1016/j.tiv.2009.07.009; Freitas F, 2014, INT J ENV RES PUB HE, V11, P9024, DOI 10.3390/ijerph110909024; Griendling KK, 2016, CIRC RES, V119, pE39, DOI 10.1161/RES.0000000000000110; He FJ, 2020, J AM COLL CARDIOL, V75, P632, DOI 10.1016/j.jacc.2019.11.055; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2002, IARC Monogr Eval Carcinog Risks Hum, V82, P1; Il'yasova D, 2012, CLIN CHIM ACTA, V413, P1446, DOI 10.1016/j.cca.2012.06.012; Iwahori T, 2017, INT J EPIDEMIOL, V46, P1564, DOI 10.1093/ije/dyw287; Kachapulula PW, 2018, J FOOD PROTECT, V81, P1508, DOI 10.4315/0362-028X.JFP-17-527; Katerji M, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/1279250; Kawasaki T, 1991, Nihon Koshu Eisei Zasshi, V38, P567; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Kayamba V, 2020, JCO GLOB ONCOL, V6, P532, DOI 10.1200/GO.20.00002; Kayamba V, 2017, MALAWI MED J, V29, P212, DOI 10.4314/mmj.v29i2.25; Kitiyakara C, 2003, J AM SOC NEPHROL, V14, P2775, DOI 10.1097/01.ASN.0000092145.90389.65; Lerchl K, 2015, HYPERTENSION, V66, P850, DOI 10.1161/HYPERTENSIONAHA.115.05851; Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513; Montezano AC, 2014, ANTIOXID REDOX SIGN, V20, P164, DOI 10.1089/ars.2013.5302; Mudie K, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020409; Mupunga I, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121287; Njoroge SMC, 2017, MYCOTOXIN RES, V33, P113, DOI 10.1007/s12550-017-0270-5; Oyebode O, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-015-0068-7; Pan CH, 2008, OCCUP ENVIRON MED, V65, P732, DOI 10.1136/oem.2007.036970; Peng YG, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014575; Poetsch AR, 2020, COMPUT STRUCT BIOTEC, V18, P207, DOI 10.1016/j.csbj.2019.12.013; Roberts LJ, 2000, FREE RADICAL BIO MED, V28, P505, DOI 10.1016/S0891-5849(99)00264-6; Ruiz-Vera T, 2015, ENVIRON TOXICOL PHAR, V40, P423, DOI 10.1016/j.etap.2015.07.014; Shirima CP, 2013, MOL NUTR FOOD RES, V57, P1874, DOI 10.1002/mnfr.201300116; Smith J, 2019, TOXICOL REP, V6, P1176, DOI 10.1016/j.toxrep.2019.11.006; Sorensen M, 2003, MUTAT RES-REV MUTAT, V544, P255, DOI 10.1016/j.mrrev.2003.06.010; Sun Q, 2017, AM J CLIN NUTR, V105, P159, DOI 10.3945/ajcn.116.139758; Tanaka T, 2002, J HUM HYPERTENS, V16, P97, DOI 10.1038/sj.jhh.1001307; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Vetrani C, 2013, INT J FOOD SCI NUTR, V64, P312, DOI 10.3109/09637486.2012.738651; Watson S, 2017, CRIT REV FOOD SCI, V57, P1963, DOI 10.1080/10408398.2015.1040869; Wu YQ, 2016, HYPERTENS RES, V39, P210, DOI 10.1038/hr.2015.132; Yamano Y, 2014, INT ARCH OCC ENV HEA, V87, P705, DOI 10.1007/s00420-013-0913-6; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y	53	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242144	10.1371/journal.pone.0242144	http://dx.doi.org/10.1371/journal.pone.0242144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180810	Green Published, gold			2022-12-26	WOS:000593948000068
J	Camprubi, D; Almuedo-Riera, A; Marti-Soler, H; Soriano, A; Hurtado, JC; Subira, C; Grau-Pujol, B; Krolewiecki, A; Munoz, J				Camprubi, Daniel; Almuedo-Riera, Alex; Marti-Soler, Helena; Soriano, Alex; Hurtado, Juan Carlos; Subira, Carme; Grau-Pujol, Berta; Krolewiecki, Alejandro; Munoz, Jose			Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients	PLOS ONE			English	Article							SAFETY	Ivermectin has recently shown efficacy against SARS-CoV-2 in-vitro. We retrospectively reviewed severe COVID-19 patients receiving standard doses of ivermectin and we compared clinical and microbiological outcomes with a similar group of patients not receiving ivermectin. No differences were found between groups. We recommend the evaluation of high-doses of ivermectin in randomized trials against SARS-CoV-2.	[Camprubi, Daniel; Almuedo-Riera, Alex; Marti-Soler, Helena; Subira, Carme; Grau-Pujol, Berta; Munoz, Jose] Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain; [Soriano, Alex] Univ Barcelona, Hosp Clin, Infect Dis Dept, Barcelona, Spain; [Hurtado, Juan Carlos] Univ Barcelona, Hosp Clin, Microbiol Dept, Barcelona, Spain; [Krolewiecki, Alejandro] Univ Nacl Salta, CONICET, Inst Invest Enfermedades Trop, Oran, Argentina	ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Munoz, J (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Inst Global Hlth ISGlobal, Barcelona, Spain.	jose.munoz@isglobal.org	Krolewiecki, Alejandro/AAK-2047-2021; Hurtado, Juan Carlos/O-1064-2019; Gutierrez, Jose Muñoz/AAH-6954-2020; Gutiérrez, José/GSJ-1846-2022; Ferrer, Daniel/AFQ-6435-2022; Almuedo Riera, Alex/AAD-4957-2022; Soriano, Alex/I-1210-2017	Krolewiecki, Alejandro/0000-0001-9054-1211; Hurtado, Juan Carlos/0000-0001-9519-6082; Gutierrez, Jose Muñoz/0000-0002-0945-1735; Ferrer, Daniel/0000-0003-4215-6030; Almuedo Riera, Alex/0000-0003-4643-4456; Soriano, Alex/0000-0002-9374-0811; Marti-Soler, Helena/0000-0002-7127-205X; Subira, Carme/0000-0002-6246-8501; Grau-Pujol, Berta/0000-0002-7320-0965				Beigel JH, 2020, NEW ENGL J MED, V383, P1813, DOI 10.1056/NEJMoa2007764; Buonfrate D, 2019, LANCET INFECT DIS, V19, P1181, DOI 10.1016/S1473-3099(19)30289-0; Caly Leon, 2020, Antiviral Res, V178, P104787, DOI 10.1016/j.antiviral.2020.104787; Chaccour C, 2020, AM J TROP MED HYG, P1, DOI DOI 10.4269/AJTMH.20-0271; Guzzo CA, 2002, J CLIN PHARMACOL, V42, P1122, DOI 10.1177/009127002401382731; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Kamgno J, 2004, T ROY SOC TROP MED H, V98, P496, DOI 10.1016/j.trstmh.2003.10.018; Momekov G, 2020, BIOTECHNOL BIOTEC EQ, V34, P469, DOI 10.1080/13102818.2020.1775118; Munoz J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006020; Navarro M, 2020, J ANTIMICROB CHEMOTH, V75, P827, DOI 10.1093/jac/dkz524; Requena-Mendez A, 2017, AM J TROP MED HYG, V97, P645, DOI 10.4269/ajtmh.16-0923; Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019; Smit MR, 2019, CLIN INFECT DIS, V69, P1112, DOI 10.1093/cid/ciy1063; Wimmersberger D, 2018, CLIN INFECT DIS, V67, P1247, DOI 10.1093/cid/ciy246	14	38	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242184	10.1371/journal.pone.0242184	http://dx.doi.org/10.1371/journal.pone.0242184			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175880	Green Published, gold			2022-12-26	WOS:000593946900021
J	Chakravarthy, R; Stallings, SC; Williams, M; Hollister, M; Davidson, M; Canedo, J; Wilkins, CH				Chakravarthy, Rohini; Stallings, Sarah C.; Williams, Michael; Hollister, Megan; Davidson, Mario; Canedo, Juan; Wilkins, Consuelo H.			Factors influencing precision medicine knowledge and attitudes	PLOS ONE			English	Article							AFRICAN-AMERICAN; RESEARCH PARTICIPATION; SOCIOECONOMIC-STATUS; GENETIC TESTS; UNITED-STATES; INFORMATION; DIVERSITY; RECRUITMENT; BARRIERS; GENOMICS	Precision medicine holds great promise for improving health and reducing health disparities that can be most fully realized by advancing diversity and inclusion in research participants. Without engaging underrepresented groups, precision medicine could not only fail to achieve its promise but also further exacerbate the health disparities already burdening the most vulnerable. Yet underrepresentation by people of non-European ancestry continues in precision medicine research and there are disparities across racial groups in the uptake of precision medicine applications and services. Studies have explored possible explanations for population differences in precision medicine participation, but full appreciation of the factors involved is still developing. To better inform the potential for addressing health disparities through PM, we assessed the relationship of precision medicine knowledge and trust in biomedical research with sociodemographic variables. Using a series of linear regression models applied to survey data collected in a diverse sample, we analyzed variation in both precision medicine knowledge and trust in biomedical research with socioeconomic factors as a way to understand the range of precision medicine knowledge (PMK) in a broadly representative group and its relationship to trust in research and demographic characteristics. Our results demonstrate that identifying as Black, while significantly PMK, explains only 1.5% of the PMK variance in unadjusted models and 7% of overall variance in models adjusted for meaningful covariates such as age, marital status, employment, and education. We also found a positive association between PMK and trust in biomedical research. These results indicate that race is a factor affecting PMK, even after accounting for differences in sociodemographic variables. Additional work is needed, however, to identify other factors contributing to variation in PMK as we work to increase diversity and inclusion in precision medicine applications.	[Chakravarthy, Rohini] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Stallings, Sarah C.; Wilkins, Consuelo H.] Meharry Vanderbilt Alliance, Nashville, TN 37208 USA; [Williams, Michael; Hollister, Megan; Davidson, Mario] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Canedo, Juan; Wilkins, Consuelo H.] Vanderbilt Univ, Med Ctr, Dept Med, Div Geriatr, Nashville, TN 37232 USA	Vanderbilt University; Meharry Medical College; Vanderbilt University; Vanderbilt University; Vanderbilt University	Wilkins, CH (corresponding author), Meharry Vanderbilt Alliance, Nashville, TN 37208 USA.; Wilkins, CH (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Geriatr, Nashville, TN 37232 USA.	consuelo.h.wilkins@vanderbilt.edu	Davidson, Mario/AAX-1102-2021	Chakravarthy, Rohini/0000-0001-9640-8200	Patient-Centered Outcomes Research Institute [R-1306-04869]; Vanderbilt Institute for Clinical and Translational Research [5UL1TR000445-09]; Vanderbilt Medical Scholars Research Program; Vanderbilt-Meharry Alliance	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); Vanderbilt Institute for Clinical and Translational Research; Vanderbilt Medical Scholars Research Program; Vanderbilt-Meharry Alliance	This project was made possible via Patient-Centered Outcomes Research Institutefunded grant (R-1306-04869, https://www.pcori.org/) (CW), Vanderbilt Institute for Clinical and Translational Research (https://victr.vumc.org/about-victr-2/) 5UL1TR000445-09 (CW), The Vanderbilt Medical Scholars Research Program (https://medschool.vanderbilt.edu/curriculum/medical-scholars-program/) (RC), and the Vanderbilt-Meharry Alliance (https://www.vumc.org/meharry-vanderbilt/welcome) (SS).	Agurs-Collins T, 2015, J CANCER EDUC, V30, P799, DOI 10.1007/s13187-014-0784-x; All Us Res Program Investigators, 2019, NEW ENGL J MED, V381, P668, DOI 10.1056/NEJMsr1809937; [Anonymous], 2018, WHAT IS PREC MED; Aronson SJ, 2015, NATURE, V526, P336, DOI 10.1038/nature15816; Baty BJ, 2003, AM J MED GENET A, V118A, P146, DOI 10.1002/ajmg.a.10150; Bentley AR, 2017, J COMMUN GENET, V8, P255, DOI 10.1007/s12687-017-0316-6; Catz DS, 2005, COMMUNITY GENET, V8, P161, DOI 10.1159/000086759; Cheng JKY, 2018, J COMMUN GENET, V9, P263, DOI 10.1007/s12687-017-0350-4; Diaz VA, 2014, PUBLIC HEALTH GENOM, V17, P1, DOI 10.1159/000354785; Dye T, 2016, J AM MED INFORM ASSN, V23, P782, DOI 10.1093/jamia/ocv214; Erves J, J CLIN TRANSLATIONAL; Farmer DF, 2007, J HEALTH CARE POOR U, V18, P85, DOI 10.1353/hpu.2007.0008; Gadegbeku CA, 2008, CONTEMP CLIN TRIALS, V29, P837, DOI 10.1016/j.cct.2008.06.001; George S, 2014, AM J PUBLIC HEALTH, V104, pE16, DOI 10.2105/AJPH.2013.301706; Haga SB, 2012, PHARMACOGENOMICS J, V12, P197, DOI 10.1038/tpj.2011.1; Hahn S, 2010, PUBLIC HEALTH GENOM, V13, P63, DOI 10.1159/000218712; Hall MA, 2006, MED CARE, V44, P1048, DOI 10.1097/01.mlr.0000228023.37087.cb; Hauser D, 2018, HEALTH AFFAIR, V37, P793, DOI 10.1377/hlthaff.2017.1548; Heerman WJ, 2017, CONTEMP CLIN TRIALS, V62, P50, DOI 10.1016/j.cct.2017.08.006; Herring P, 2004, ETHNIC DIS, V14, P423; Hurle B, 2013, GENET MED, V15, P658, DOI 10.1038/gim.2013.14; Kaufman DJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160461; Landry LG, 2018, HEALTH AFFAIR, V37, P780, DOI 10.1377/hlthaff.2017.1595; Lennerz JK, 2016, J MOL DIAGN, V18, P697, DOI 10.1016/j.jmoldx.2016.04.003; Lewis KL, 2019, GENET MED, V21, P1355, DOI 10.1038/s41436-018-0341-9; Mainous AG, 2006, ANN FAM MED, V4, P247, DOI 10.1370/afm.541; Mamun A, 2019, ETHNIC DIS, V29, P517, DOI 10.18865/ed.29.3.517; McCarty CA, 2011, AM J MED GENET A, V155A, P737, DOI 10.1002/ajmg.a.33896; Molina Y, 2015, HEALTH EXPECT, V18, P2941, DOI 10.1111/hex.12278; Mouton CP, 1997, J NATL MED ASSOC, V89, P721; Moy E, 2014, PUBLIC HEALTH REP, V129, P62, DOI 10.1177/00333549141291S212; National Academies of Sciences Engineering and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Roundtable on Genomics and Precision Health., 2018, UND DISP ACC GEN MED; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; Papaz T, 2012, PEDIATRICS, V130, pE1198, DOI 10.1542/peds.2012-0687; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Rastogi S., 2011, BLACK POPULATION 201; Richardson A, 2012, J HEALTH CARE POOR U, V23, P1477, DOI 10.1353/hpu.2012.0181; Rothman R., 2019, NETWORK SUMMARY MID, P3; Roundtable on Health Literacy Board on Population Health and Public Health Practice Health and Medicine Division National Academies of Sciences Engineering and Medicine, 2016, REL HLTH LIT PREC ME; Scherr CL, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00548; Shields AE, 2008, GENET MED, V10, P404, DOI 10.1097/GIM.0b013e3181770184; Slomka J, 2008, AIDS CARE, V20, P1224, DOI 10.1080/09540120701866992; Smedley BD., 2003, COMMITTEE UNDERSTAND; Smith CE, 2016, HEALTH AFFAIR, V35, P1367, DOI 10.1377/hlthaff.2015.1476; Smith YR, 2007, J WOMENS HEALTH, V16, P423, DOI 10.1089/jwh.2006.0124; Spruill Ida, 2009, J Natl Black Nurses Assoc, V20, P20; Symonds RP, 2012, BRIT J CANCER, V107, P1017, DOI 10.1038/bjc.2012.240; The Mid-South Clinical Data Research Network-Phase I, 2014, MID S CLIN DATA RES; Thompson HS, 2003, PATIENT EDUC COUNS, V51, P217, DOI 10.1016/S0738-3991(02)00219-7; Trinh-Shevrin C, 2018, J RACIAL ETHN HEALTH, V5, P1, DOI 10.1007/s40615-016-0334-9; Viswanath K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014550; Wilkins CH, 2019, HEALTH AFFAIR, V38, P399, DOI 10.1377/hlthaff.2018.05046; Williams JR, 2019, J GENET COUNS, V28, P59, DOI 10.1007/s10897-018-0291-z; Wojcik GL, 2019, NATURE, V570, P514, DOI 10.1038/s41586-019-1310-4	54	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0234833	10.1371/journal.pone.0234833	http://dx.doi.org/10.1371/journal.pone.0234833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0LY	33175834	Green Submitted, gold, Green Published			2022-12-26	WOS:000593946900015
J	Courtney, TA; Kindeberg, T; Andersson, AJ				Courtney, Travis A.; Kindeberg, Theodor; Andersson, Andreas J.			Coral calcification responses to the North Atlantic Oscillation and coral bleaching in Bermuda	PLOS ONE			English	Article							HIGH-LATITUDE REEFS; GROWTH-RATES; OCEAN ACIDIFICATION; CLIMATE VARIABILITY; SKELETAL EXTENSION; PORITES-ASTREOIDES; SARGASSO SEA; RECORDS; DENSITY; STRATEGIES	The North Atlantic Oscillation (NAO) has been hypothesized to drive interannual variability in Bermudan coral extension rates and reef-scale calcification through the provisioning of nutritional pulses associated with negative NAO winters. However, the direct influence of the NAO on Bermudan coral calcification rates remains to be determined and may vary between species and reef sites owing to implicit differences in coral life history strategies and environmental gradients across the Bermuda reef platform. In this study, we investigated the connection between negative NAO winters and Bermudan Diploria labyrinthiformis, Pseudodiploria strigosa, and Orbicella franksi coral calcification rates across rim reef, lagoon, and nearshore reef sites. Linear mixed effects modeling detected an inverse correlation between D. labyrinthiformis calcification rates and the winter NAO index, with higher rates associated with increasingly negative NAO winters. Conversely, there were no detectable correlations between P. strigosa or O. franksi calcification rates and the winter NAO index suggesting that coral calcification responses associated with negative NAO winters could be species-specific. The correlation between coral calcification rates and winter NAO index was significantly more negative at the outer rim of the reef (Hog Reef) compared to a nearshore reef site (Whalebone Bay), possibly indicating differential influence of the NAO as a function of the distance from the reef edge. Furthermore, a negative calcification anomaly was observed in 100% of D. labyrinthiformis cores in association with the 1988 coral bleaching event with a subsequent positive calcification anomaly in 1989 indicating a post-bleaching recovery in calcification rates. These results highlight the importance of assessing variable interannual coral calcification responses between species and across inshore-offshore gradients to interannual atmospheric modes such as the NAO, thermal stress events, and potential interactions between ocean warming and availability of coral nutrition to improve projections for future coral calcification rates under climate change.	[Courtney, Travis A.; Kindeberg, Theodor; Andersson, Andreas J.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA; [Kindeberg, Theodor] Lund Univ, Dept Biol, Lund, Sweden	University of California System; University of California San Diego; Scripps Institution of Oceanography; Lund University	Courtney, TA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92103 USA.	traviscourtney@gmail.com	Kindeberg, Theodor/E-5017-2019	Kindeberg, Theodor/0000-0001-8151-8423	University of California, San Diego Academic Senate via a Marine Sciences Research Grant; National Science Foundation [OCE-1829778, DGE-1650112]	University of California, San Diego Academic Senate via a Marine Sciences Research Grant; National Science Foundation(National Science Foundation (NSF))	This work was funded by the University of California, San Diego Academic Senate via a Marine Sciences Research Grant (AJA) and the National Science Foundation via OCE-1829778 (AJA) and DGE-1650112 (TAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Jessica Carilli for guidance on coral drilling methods, Richard Walsh for assistance with compressed air fittings, Dr. Justin Baumann for guidance on analyzing coral skeletal densities and discussions regarding coral heterotrophy, Dr. Karl Castillo for loaning coral density standards, Donna Hutchinson at San Diego Imaging for scanning the cores, and Lark Starkey for copy editing the manuscript. We thank the staff at the Bermuda Institute of Ocean Sciences for logistical support and assistance with collection permits. The Government of Bermuda Department of Environment and Natural Resources is acknowledged for permitting collection and approving exports of the coral cores under license number 2015-05-26-46. We further thank the reviewers for improving this manuscript with their constructive comments and insights.	Andersson AJ, 2015, OCEANOGRAPHY, V28, P16; [Anonymous], 2014, SCI SIGNAL, V7, pra13; Barkley HC, 2016, CORAL REEFS, V35, P1407, DOI 10.1007/s00338-016-1483-3; BARNES DJ, 1993, J EXP MAR BIOL ECOL, V167, P91, DOI 10.1016/0022-0981(93)90186-R; BARNES DJ, 1992, J EXP MAR BIOL ECOL, V159, P113, DOI 10.1016/0022-0981(92)90261-8; Baumann JH, 2019, GLOBAL CHANGE BIOL, V25, P3932, DOI 10.1111/gcb.14784; BECKER M, 1994, ANN SCI FOREST, V51, P477, DOI 10.1051/forest:19940504; Buddemeier R.W., 1976, Oceanography and Marine Biology an Annual Review, V14, P183; BUDDEMEIER RW, 1974, J EXP MAR BIOL ECOL, V14, P179, DOI 10.1016/0022-0981(74)90024-0; Bunn A, 2019, **DATA OBJECT**; Cantin NE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088720; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carricart-Ganivet JP, 2011, J EXP MAR BIOL ECOL, V405, P73, DOI 10.1016/j.jembe.2011.05.020; Casey JR, 2013, DEEP-SEA RES PT II, V93, P58, DOI 10.1016/j.dsr2.2013.02.002; Castillo KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014615; Cohen AL, 2004, MAR ECOL PROG SER, V271, P147, DOI 10.3354/meps271147; Conti-Jerpe IE, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz5443; COOK CB, 1990, CORAL REEFS, V9, P45, DOI 10.1007/BF00686721; Courtney TA, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701356; Courtney TA, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00181; D Damayanti D., 2018, BULLWHIP EFFECT SUPP, V1, P1, DOI DOI 10.1080/09593330.2018.1526217; D'Alelio D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59989-y; Rico-Esenaro SD, 2019, SCI TOTAL ENVIRON, V650, P1576, DOI 10.1016/j.scitotenv.2018.08.397; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; DeCarlo TM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5493; DeCarlo TM, 2015, GEOLOGY, V43, P7, DOI 10.1130/G36147.1; Delworth TL, 2016, NAT GEOSCI, V9, P509, DOI [10.1038/ngeo2738, 10.1038/NGEO2738]; Dodge R, 1978, THESIS, P237; DODGE RE, 1984, B MAR SCI, V34, P288; DODGE RE, 1974, EARTH PLANET SC LETT, V23, P313, DOI 10.1016/0012-821X(74)90121-6; DODGE RE, 1975, NATURE, V258, P706, DOI 10.1038/258706a0; Donner SD, 2007, BIOSCIENCE, V57, P214, DOI 10.1641/B570302; Draschba S, 2000, INT J EARTH SCI, V88, P733, DOI 10.1007/s005310050301; Edmunds PJ, 2013, MAR ECOL PROG SER, V489, P107, DOI 10.3354/meps10424; Esposti LD, 2013, CLINICOECONOMIC OUTC, V5, P193, DOI 10.2147/CEOR.S41846; Flood VS, 2005, MAR POLLUT BULL, V51, P545, DOI 10.1016/j.marpolbul.2005.07.010; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GOREAU TF, 1963, ANN NY ACAD SCI, V109, P127, DOI 10.1111/j.1749-6632.1963.tb13465.x; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Groves SH, 2018, CORAL REEFS, V37, P345, DOI 10.1007/s00338-018-1660-7; Gruber N, 2002, SCIENCE, V298, P2374, DOI 10.1126/science.1077077; GUZMAN HM, 1991, CORAL REEFS, V10, P1, DOI 10.1007/BF00301900; Hart DE, 2007, CORAL REEFS, V26, P53, DOI 10.1007/s00338-006-0168-8; Helmle K. P., 2002, EUR M INT SOC REEF S; Hendy EJ, 2003, CORAL REEFS, V22, P207, DOI 10.1007/s00338-003-0304-7; Houlbreque F, 2009, BIOL REV, V84, P1, DOI 10.1111/j.1469-185X.2008.00058.x; Hughes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081172; Hurrell JW, 2009, J MARINE SYST, V78, P28, DOI 10.1016/j.jmarsys.2008.11.026; Iams WJ, 1969, BERMUDA BIOL STATION, V2, P65; Jackson J, 2014, GLOBAL CORAL REEF MO; JICKELLS T D, 1986, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V186, P251; Jones RJ, 2006, MARINE ENV PROGR MEP, P79; Kleypas JA, 1999, AM ZOOL, V39, P146; KNUTSON DW, 1972, SCIENCE, V177, P270, DOI 10.1126/science.177.4045.270; Lenth R, 2020, R PACKAGE VERSION, V1, P4; LEWIS JB, 1976, MAR BIOL, V36, P147, DOI 10.1007/BF00388437; LEWIS JB, 1975, J ZOOL, V176, P527, DOI 10.1111/j.1469-7998.1975.tb03219.x; LOGAN A, 1994, CORAL REEFS, V13, P225, DOI 10.1007/BF00303636; LOGAN A, 1991, CORAL REEFS, V10, P155, DOI 10.1007/BF00572174; Mallela J, 2016, CORAL REEFS, V35, P181, DOI 10.1007/s00338-015-1350-7; MENZEL DW, 1961, DEEP-SEA RES, V7, P282, DOI 10.1016/0146-6313(61)90046-6; Merian P, 2011, FOREST ECOL MANAG, V261, P1382, DOI 10.1016/j.foreco.2011.01.019; Mills MM, 2004, CORAL REEFS, V23, P311, DOI 10.1007/s00338-004-0380-3; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Mollica NR, 2019, CORAL REEFS, V38, P743, DOI 10.1007/s00338-019-01803-x; Moore JAY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051807; Morris B, 1977, BERMUDA MARINE ENV R, V15, P1977; Pandolfi JM, 2002, CORAL REEFS, V21, P13, DOI 10.1007/s00338-001-0204-7; Patzold J, 1992, CORAL RECORDS OCEAN, P24; Pinheiro J., 2019, R PACKAGE VERSION, V3, P1; Pinto JG, 2012, WIRES CLIM CHANGE, V3, P79, DOI 10.1002/wcc.150; Pratchett MS, 2015, OCEANOGR MAR BIOL, V53, P215; R Core Team, 2020, R LANG ENV STAT COMP; Reaka-Kudla Marjorie L., 1997, P83; Rippe JP, 2018, GLOBAL CHANGE BIOL, V24, P5205, DOI 10.1111/gcb.14422; Saenger C, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001572; Signorell A, 2020, **DATA OBJECT**; Silbiger NJ, 2019, MAR BIOL, V166, DOI 10.1007/s00227-019-3573-6; Sims ZC, 2020, CORAL REEFS, V39, P215, DOI 10.1007/s00338-019-01879-5; Smith I, 2013, STRUCTURES AND ARCHITECTURE: CONCEPTS: APPLICATIONS AND CHALLENGES, P173; Smith Sr, 1998, COAST REG SM ISL PA, P247; Smithers SG, 2001, EARTH PLANET SC LETT, V191, P173, DOI 10.1016/S0012-821X(01)00417-4; STANLEY GD, 1981, GEOLOGY, V9, P507, DOI 10.1130/0091-7613(1981)9<507:EHOSCA>2.0.CO;2; TOMASCIK T, 1990, B MAR SCI, V46, P799; van Hooidonk R, 2016, SCI REP-UK, V6, DOI 10.1038/srep39666; Venti A, 2014, CORAL REEFS, V33, P979, DOI 10.1007/s00338-014-1191-9; Visbeck MH, 2001, P NATL ACAD SCI USA, V98, P12876, DOI 10.1073/pnas.231391598; Wang XT, 2015, GEOCHIM COSMOCHIM AC, V148, P179, DOI 10.1016/j.gca.2014.09.017; Woodhead AJ, 2019, FUNCT ECOL, V33, P1023, DOI 10.1111/1365-2435.13331; Yeakel KL, 2015, P NATL ACAD SCI USA, V112, P14512, DOI 10.1073/pnas.1507021112	94	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241854	10.1371/journal.pone.0241854	http://dx.doi.org/10.1371/journal.pone.0241854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175884	Green Published, gold			2022-12-26	WOS:000593946900022
J	Ng, BP; Cheng, YLJ; Rutledge, S; Cannon, MJ; Zhang, P; Smith, BD				Ng, Boon Peng; Cheng, Yiling J.; Rutledge, Stephanie; Cannon, Michael J.; Zhang, Ping; Smith, Bryce D.			Estimated number of eligible Part B beneficiaries for the medicare diabetes prevention program at the county level and by urban-rural classification	PLOS ONE			English	Article							COST-EFFECTIVENESS; INTERVENTIONS; INDIVIDUALS; RISK	Introduction Diabetes imposes large health and financial burdens on Medicare beneficiaries. Type 2 diabetes can be prevented or delayed through lifestyle modification programs. In 2018, Medicare began to offer the Medicare Diabetes Prevention Program (MDPP), a lifestyle intervention, to eligible beneficiaries nationwide. The number of MDPP-eligible beneficiaries is not known, but this information is essential in efforts to expand the program and increase enrollment. This study aimed to estimate the number and spatial variation of MDPP-eligible Part B beneficiaries at the county level and by urban-rural classification. Methods Data from 2011-2016 National Health and Nutrition Examination Surveys and a survey-weighted logistic regression model were used to estimate proportions of prediabetes in the United States by sex, age, and race/ethnicity based on the MDPP eligibility criteria. The results from the predictive model were applied to 2015 Medicare Part B beneficiaries to estimate the number of MDPP-eligible beneficiaries. The National Center for Health Statistics' Urban-Rural Classification Scheme for Counties from 2013 were used to define urban and rural categories. Results An estimated 5.2 million (95% CI = 3.5-7.0 million) Part B beneficiaries were eligible for the MDPP. By state, estimates ranged from 13,000 (95% CI = 8,500-18,000) in Alaska to 469,000 (95% CI = 296,000-641,000) in California. There were 2,149 counties with <= 1,000 eligible beneficiaries and 11 with >25,000. Consistent with demographic patterns, urban counties had more eligible beneficiaries than rural counties. Conclusions These estimates could be used to plan locations for new MDPPs and reach eligible Part B beneficiaries for enrollment.	[Ng, Boon Peng] Univ Cent Florida, Coll Nursing & Disabil, Aging & Technol Cluster, Orlando, FL 32816 USA; [Ng, Boon Peng; Cheng, Yiling J.; Rutledge, Stephanie; Cannon, Michael J.; Zhang, Ping; Smith, Bryce D.] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA	State University System of Florida; University of Central Florida; Centers for Disease Control & Prevention - USA	Ng, BP (corresponding author), Univ Cent Florida, Coll Nursing & Disabil, Aging & Technol Cluster, Orlando, FL 32816 USA.; Ng, BP (corresponding author), Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA 30333 USA.	boonpeng.ng@ucf.edu						[Anonymous], 2019, OV MED; [Anonymous], 2016, IEEE-ASME T MECH, VPP, P1, DOI DOI 10.1109/IEEESTD.2016.7460875; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Caspersen CJ, 2012, AM J PUBLIC HEALTH, V102, P1482, DOI 10.2105/AJPH.2011.300616; Center for Disease Control and Prevention, 2019, NAT DIAB PREV PROGR; Centers for Disease Control and Prevention, 2018, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2017, NAT DIAB STAT REP 20; Centers for Disease Control and Prevention, 2017, NCHS URB RUR CLASS S; Centers for Disease Control and Prevention, 2020, PRED YOUR CHANC PREV; Centers for Medicare and Medicaid Services, 2019, MED DIAB PREV PROGR; Centers for Medicare & Medicaid Services, MED CURR BEN SURV; Centers for Medicare & Medicaid Services, 2018, CHRON COND DAT WAR D; Franco SJ, 2014, VITAL HLTH STAT, V2, P166; Grubesic TH, 2014, APPL GEOGR, V55, P117, DOI 10.1016/j.apgeog.2014.08.017; Khan T, 2017, POPUL HEALTH MANAG, V20, P389, DOI 10.1089/pop.2016.0134; Ku L, 2016, HEALTH AFFAIR, V35, P62, DOI 10.1377/hlthaff.2015.0756; Li R, 2010, DIABETES CARE, V33, P1872, DOI 10.2337/dc10-0843; Moin T, 2018, AM J PREV MED, V55, P583, DOI 10.1016/j.amepre.2018.06.028; Moin T, 2015, ANN INTERN MED, V162, P542, DOI 10.7326/M14-1773; Otiniano M, 2012, J DIABETES COMPLICAT, V26, P255, DOI 10.1016/j.jdiacomp.2012.05.004; Ritchey M, 2016, MMWR-MORBID MORTAL W, V65, P967, DOI 10.15585/mmwr.mm6536e1; Rossen LM, 2018, AM J PREV MED, V55, P72, DOI 10.1016/j.amepre.2018.03.020; US Census Bureau, CENS GEOC; Zhou XL, 2020, DIABETES CARE, V43, P1593, DOI 10.2337/dci20-0018	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241757	10.1371/journal.pone.0241757	http://dx.doi.org/10.1371/journal.pone.0241757			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7KH	33170867	Green Published, gold			2022-12-26	WOS:000592383400019
J	Peters, MH; Bastidas, O; Kokron, DS; Henze, CE				Peters, Michael H.; Bastidas, Oscar; Kokron, Daniel S.; Henze, Christopher E.			Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states	PLOS ONE			English	Article								The SARS-CoV-2 virion responsible for the current world-wide pandemic COVID-19 has a characteristic Spike protein (S) on its surface that embellishes both a prefusion state and fusion state. The prefusion Spike protein (S) is a large trimeric protein where each protomer may be in a so-called Up state or Down state, depending on the configuration of its receptor binding domain (RBD) within its distal, prefusion S1 domain. The Up state is believed to allow binding of the virion to ACE-2 receptors on human epithelial cells, whereas the Down state is believed to be relatively inactive or reduced in its binding behavior. We have performed detailed all-atom, dominant energy landscape mappings for noncovalent interactions (charge, partial charge, and van der Waals) of the SARS-CoV-2 Spike protein in its static prefusion state based on two recent and independent experimental structure publications. We included both interchain interactions and intrachain (domain) interactions in our mappings in order to determine any telling differences (different so-called "glue" points) between residues in the Up and Down state protomers. The S2 proximal, fusion domain demonstrated no appreciable energetic differences between Up and Down protomers, including interchain as well as each protomer's intrachain, S1-S2 interactions. However, the S1 domain interactions across neighboring protomers, which include the RBD-NTD cross chain interactions, showed significant energetic differences between Up-Down and Down-Down neighboring protomers. This included, for example, a key RBD residue ARG357 in the Up-Down interaction and a three residue sequence ALA520-PRO521-ALA522, associated with a turn structure in the RBD of the Up state protomer, acting as a stabilizing interaction with the NTD of its neighbor protomer. Additionally, our intra chain dominant energy mappings within each protomer, identified a significant "glue" point or possible "latch" for the Down state protomer between the S1 subdomain, SD1, and the RBD domain of the same protomer that was completely missing in the Up state protomer analysis. Ironically, this dominant energetic interaction in the Down state protomer involved the backbone atoms of the same three residue sequence ALA520-PRO521-ALA522 of the RBD with the amino acid R-group of GLN564 in the SD1 domain. Thus, this same three residue sequence acts as a stabilizer of the RBD in the Up conformation through its interactions with its neighboring NTD chain and a kind of latch in the Down state conformation through its interactions with its own SD1 domain. The dominant interaction energy residues identified here are also conserved across reported variations of SARS-CoV-2, as well as the closely related virions SARS-Cov and the bat corona virus RatG13. We conducted preliminary molecular dynamics simulations across 0.1 mu seconds to see if this latch provided structural stability and indeed found that a single point mutation (Q564G) resulted in the latch releasing transforming the protomer from the Down to the Up state conformation. Full trimeric Spike protein studies of the same mutation across all protomers, however, did not exhibit latch release demonstrating the critical importance of interchain interactions across the S1 domain, including RBD-NTD neighboring chain interactions. Therapies aimed at disrupting these noncovalent interactions could be a viable route for the physico-chemical mitigation of this deadly virion.	[Peters, Michael H.] Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA; [Bastidas, Oscar] Univ Minnesota, Coll Biol Sci, Minneapolis, MN USA; [Kokron, Daniel S.; Henze, Christopher E.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	Virginia Commonwealth University; University of Minnesota System; University of Minnesota Twin Cities; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Peters, MH (corresponding author), Virginia Commonwealth Univ, Dept Chem & Life Sci Engn, Richmond, VA 23284 USA.	mpeters@vcu.edu		peters, michael/0000-0002-9612-1055	V.C.U. Office of Vice President for Research; National Institutes of Health Institutional Research and Academic Career Development Award [K12GM119955]; COVID-19 HPC Consortium	V.C.U. Office of Vice President for Research; National Institutes of Health Institutional Research and Academic Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); COVID-19 HPC Consortium	M.H.P was partly supported by the V.C.U. Office of Vice President for Research. O.B. was supported by the National Institutes of Health Institutional Research and Academic Career Development Award K12GM119955. M.H.P and O. B. would like to acknowledge the support provided via the COVID-19 HPC Consortium (https://covid19-hpc-consortium.org/), which is a unique private-public effort to bring together government, industry, and academic leaders who are volunteering free compute time and resources, in support of COVID-19 research.	Bastidas OH, 2016, SCI REP-UK, V6, DOI 10.1038/srep36499; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Krall A, 2014, PROTEINS, V82, P2253, DOI 10.1002/prot.24592; Li T., 2020, CHARACTERIZATION SAR, DOI [DOI 10.1038/s41586-020-2381-y, 10.1101/2020.03.16.994152, DOI 10.1101/2020.03.16.994152]; McCallum M, 2020, NAT STRUCT MOL BIOL, V27, P942, DOI 10.1038/s41594-020-0483-8; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Shaw D. E., 2020, MOL DYNAMICS SIMULAT; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762	13	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241168	10.1371/journal.pone.0241168	http://dx.doi.org/10.1371/journal.pone.0241168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170884	gold, Green Published			2022-12-26	WOS:000592383400012
J	Halatoko, WA; Konu, YR; Gbeasor-Komlanvi, FA; Sadio, A; Tchankoni, MK; Komlanvi, KS; Salou, M; Dorkenoo, AM; Maman, I; Agbobli, A; Wateba, MI; Adjoh, KS; Goeh-Akue, E; Kao, YB; Kpeto, I; Pana, P; Kinde-Sossou, R; Tamekloe, A; Nayo-Apetsianyi, J; Assane, SPH; Prine-David, M; Awoussi, SM; Djibril, M; Mijiyawa, M; Dagnra, AC; Ekouevi, DK				Halatoko, Wemboo Afiwa; Konu, Yao Rodion; Gbeasor-Komlanvi, Fifonsi Adjidossi; Sadio, Arnold Junior; Tchankoni, Martin Kouame; Komlanvi, Koffi Segbeaya; Salou, Mounerou; Dorkenoo, Ameyo Monique; Maman, Issaka; Agbobli, Ametepe; Wateba, Majeste Ihou; Adjoh, Komi Seraphin; Goeh-Akue, Edem; Kao, Yem-bla; Kpeto, Innocent; Pana, Paul; Kinde-Sossou, Rebecca; Tamekloe, Agbeko; Nayo-Apetsianyi, Josee; Assane, Simon-Pierre Hamadi; Prine-David, Mireille; Awoussi, Sossinou Marcel; Djibril, Mohaman; Mijiyawa, Moustafa; Dagnra, Anoumou Claver; Ekouevi, Didier Koumavi			Prevalence of SARS-CoV-2 among high-risk populations in Lome (Togo) in 2020	PLOS ONE			English	Article								Background In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new coronavirus in the country. Objective This survey aimed to estimate the prevalence of SARS-CoV-2 in high-risk populations in Lome. Materials and methods From April 23, 2020, to May 8, 2020, we recruited a sample of participants from five sectors: health care, air transport, police, road transport and informal. We collected oropharyngeal swabs for direct detection through real-time reverse transcription polymerase chain reaction (rRT-PCR) and blood for antibody detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests. Results A total of 955 participants with a median age of 36 (IQR 32-43) were included, and 71.6% (n = 684) were men. Approximately 22.1% (n = 212) were from the air transport sector, 20.5% (n = 196) were from the police sector, and 38.7% (n = 370) were from the health sector. Seven participants (0.7%, 95% CI: 0.3-1.6%) had a positive rRT-PCR test result at the time of recruitment, and nine (0.9%, 95% CI: 0.4-1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n = 15), 95% CI: 0.9-2.6%. Conclusion The prevalence of SARS-CoV-2 infection among high-risk populations in Lome was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening.	[Halatoko, Wemboo Afiwa; Maman, Issaka] Inst Natl Hyg INH, Lome, Togo; [Konu, Yao Rodion; Gbeasor-Komlanvi, Fifonsi Adjidossi; Sadio, Arnold Junior; Ekouevi, Didier Koumavi] Univ Lome, Dept Sante Publ, Lome, Togo; [Konu, Yao Rodion; Gbeasor-Komlanvi, Fifonsi Adjidossi; Sadio, Arnold Junior; Tchankoni, Martin Kouame; Komlanvi, Koffi Segbeaya; Ekouevi, Didier Koumavi] Ctr Africain Rech Epidemiol & Sante Publ CARESP, Lome, Togo; [Salou, Mounerou; Prine-David, Mireille; Dagnra, Anoumou Claver] Univ Lome, Lab Biol Mol & Immunol BIOLIM, Lome, Togo; [Salou, Mounerou; Dorkenoo, Ameyo Monique; Agbobli, Ametepe; Wateba, Majeste Ihou; Adjoh, Komi Seraphin; Goeh-Akue, Edem; Prine-David, Mireille; Djibril, Mohaman; Mijiyawa, Moustafa; Dagnra, Anoumou Claver] Univ Lome, Fac Sci Sante, Lome, Togo; [Salou, Mounerou; Wateba, Majeste Ihou; Adjoh, Komi Seraphin; Goeh-Akue, Edem; Kao, Yem-bla; Kpeto, Innocent; Pana, Paul; Dagnra, Anoumou Claver; Ekouevi, Didier Koumavi] Conseil Sci Riposte Pandemie Covid 19, Lome, Togo; [Dorkenoo, Ameyo Monique; Kinde-Sossou, Rebecca; Tamekloe, Agbeko; Nayo-Apetsianyi, Josee; Assane, Simon-Pierre Hamadi; Awoussi, Sossinou Marcel; Mijiyawa, Moustafa; Dagnra, Anoumou Claver] Minist Sante & Hyg Publ, Lome, Togo; [Awoussi, Sossinou Marcel; Djibril, Mohaman] Coordinat Natl Gest Riposte Covid 19, Lome, Togo; [Ekouevi, Didier Koumavi] Inst Sante Publ & Dev, Ctr Inserm 1219, Bordeaux, France; [Ekouevi, Didier Koumavi] Univ Bordeaux, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Konu, YR (corresponding author), Univ Lome, Dept Sante Publ, Lome, Togo.; Konu, YR (corresponding author), Ctr Africain Rech Epidemiol & Sante Publ CARESP, Lome, Togo.	rodionko@yahoo.fr	Maman, Issaka/AAS-2169-2021	Sadio, Arnold Junior/0000-0001-5893-0663; GBEASOR-KOMLANVI, Fifonsi Adjidossi/0000-0002-1744-0454; TCHANKONI, Martin Kouame/0000-0001-9873-3293; Konu, Yao Rodion/0000-0002-0506-0008; SALOU, Mounerou/0000-0002-5749-9354; Maman, Issaka/0000-0002-6465-5116	Government of the Republic of Togo; Agence Nationale de Recherche sur le sida et les hepatites virales (ANRS)' in France	Government of the Republic of Togo; Agence Nationale de Recherche sur le sida et les hepatites virales (ANRS)' in France	This work was supported by the Government of the Republic of Togo. In addition, Dr Rodion KONU was supported by the Agence Nationale de Recherche sur le sida et les hepatites virales (ANRS)' in France for his training in Masters of Public Health degree at the 'Universite de Bordeaux' through the Francoise Barre Sinoussi Fellowship 2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, COVID 19 SIT UPD WHO; Bendavid E, 2020, COVID 19 ANTIBODY SE, DOI [10.1101/2020.04.14.20062463, DOI 10.1101/2020.04.14.20062463]; CDC, 2020, INT GUID COLL HANDL; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Direction Generale de la Statistique et de la Comptabilite Nationale du Togo (DGSCN), 2010, RES DEF 4 RE GEN POP; Elflein J, 2020, RATE COVID 19 TEST M; Government of Canada, 2020, RISK INF DEC MAK MAS; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; Hopitaux Universitaires Geneve (HUG), 2020, SER COVID 19 PREM ES; Kirkwood B, 2001, ESSENTIALS MED STAT, V2nd, P512; Lachmann, 2020, CORRECTING UNDER REP, DOI [10.1101/2020.03.14.20036178, DOI 10.1101/2020.03.14.20036178]; Mondiale Banque, 2020, BANQUE MONDIALE TOGO; Mosites E, 2020, MMWR-MORBID MORTAL W, V69, P521, DOI 10.15585/mmwr.mm6917e1; National COVID-19 Science Task Force (NCS-TF), 2020, ROL SER TEST COVID 1, V2020, p8p; Pan American Health Organization (PAHO) World Health Organization (WHO), 2020, EP UPD NOV COR COVID, V2020; Republique Togolaise Site d'information officiel du Gouvernement, 2020, COR TOG CHIFF MIS JO; Richterich P., 2020, MEDRXIV, DOI DOI 10.1101/2020.04.13.20064220; Rivett L, 2020, ELIFE, V9, DOI 10.7554/eLife.58728; Salje H, 2020, SCIENCE, V369, P208, DOI 10.1126/science.abc3517; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Stoecklin SB, 2020, EUROSURVEILLANCE, V25, P20, DOI 10.2807/1560-7917.ES.2020.25.6.2000094; Togolaise Republique, 2020, PROT NAT PRIS CHARG; Universite de Sherbrooke Ecole de politique appliquee, 2019, PERSP MOND OUT PED G; US Food & Drug Administration, 2020, EM US AUTH; Vasarhelyi B, 2020, ORVOSI HETILAP, V161, P807, DOI 10.1556/650.2020.31859; Wang H, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00334; Wang X, 2020, INT J INFECT DIS, V94, P107, DOI 10.1016/j.ijid.2020.04.023; WHO, 2019, REP WHO CHIN JOINT M; World Development Indicators database, 2019, COUNTR PROF, DOI 10.1111/obr.12850; World Health Organization, 2020, DIG TOOLS COVID 19 C; World Health Organization (WHO), 2020, POP BAS STRAT SER IN, V2020; World Health Organization (WHO) Health Emergencies Programmes, 2020, HLTH EM PROGR; Xie JJ, 2020, J MED VIROL, V92, P2004, DOI 10.1002/jmv.25930; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	34	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242124	10.1371/journal.pone.0242124	http://dx.doi.org/10.1371/journal.pone.0242124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166369	Green Published, gold			2022-12-26	WOS:000592382600075
J	Arunasri, K; Mahesh, M; Prashanthi, GS; Jayasudha, R; Chakravarthy, SK; Tyagi, M; Pappuru, RR; Shivaji, S				Arunasri, Kotakonda; Mahesh, Malleswarapu; Prashanthi, Gumpili Sai; Jayasudha, Rajagopalaboopathi; Chakravarthy, Sama Kalyana; Tyagi, Mudit; Pappuru, Rajeev R.; Shivaji, Sisinthy			Mycobiome changes in the vitreous of post fever retinitis patients	PLOS ONE			English	Article							FUNGAL RETINITIS; INFECTIONS; KERATITIS; ENDOPHTHALMITIS; MICROBIOME; COMMENSAL; DISEASE; HEALTH	Fungi have been associated with various diseases of the eye like keratitis, uveitis and endophthalmitis. Despite this fact, fungal microbiome (mycobiome) studies compared to the bacterial microbiome studies have remained neglected. In the present study, using metagenomic sequencing, the mycobiomes of the vitreous of healthy control individuals (VC, n = 15) and individuals with post fever retinitis + non-PFR uveitis (PFR+, n = 9) were analysed and compared. The results indicated that Ascomycota was the most predominant phylum in both VC and PFR+ groups. Further, at the genera level it was observed that the abundance of 17 fungal genera were significantly different in post fever retinitis (PFR, n = 6) group compared to control group. Of these 17 genera, it was observed that 14 genera were relatively more abundant in PFR group and the remaining 3 genera in the VC group. Genus Saccharomyces, a commensal of the gut and skin, was predominantly present in the vitreous of both the cohorts, however it was significantly less abundant in PFR group. Further, significant increase in the genera that have a pathogenic interaction with the host were observed in PFR group. On the whole the mycobiome in both the groups differed significantly and formed two distinct clusters in the heatmap and Principal co-ordinate analysis. These results demonstrate significant changes in the mycobiome from the vitreous of post fever retinitis patients compared to healthy controls thus implying that dysbiotic changes in the fungal vitreous microbiome are associated with PFR.	[Arunasri, Kotakonda; Mahesh, Malleswarapu; Prashanthi, Gumpili Sai; Jayasudha, Rajagopalaboopathi; Chakravarthy, Sama Kalyana; Shivaji, Sisinthy] LV Prasad Eye Inst, Prof Brien Holden Eye Res Ctr, Jhaveri Microbiol Ctr, LV Prasad Marg,Banjara Hills, Hyderabad, India; [Tyagi, Mudit; Pappuru, Rajeev R.] LV Prasad Eye Inst, Smt Kanuri Santhamma Ctr Vitreo Retinal Dis, LV Prasad Marg,Banjara Hills, Hyderabad, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute	Shivaji, S (corresponding author), LV Prasad Eye Inst, Prof Brien Holden Eye Res Ctr, Jhaveri Microbiol Ctr, LV Prasad Marg,Banjara Hills, Hyderabad, India.	shivas@lvpei.com		Sai Prashanthi, Gumpili/0000-0002-0870-5596; Kotakonda, Arunasri/0000-0001-6870-2541	Hyderabad Eye Research Foundation, Hyderabad	Hyderabad Eye Research Foundation, Hyderabad	Funding was provided by Hyderabad Eye Research Foundation, Hyderabad. Material support was provided by Prof Brien Holden, the Director of the Eye Research Centre at L V Prasad Eye Institute, Hyderabad, in the form of research facility access.	Abdallah MF, 2018, TOXINS, V10, DOI 10.3390/toxins10120493; Achermann Y, 2014, CLIN MICROBIOL REV, V27, P419, DOI 10.1128/CMR.00092-13; Ackerman AL, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.69; Ahuja Y, 2008, RETIN PHYS, P17; Aribandi M, 2007, RADIOGRAPHICS, V27, DOI 10.1148/rg.275065189; Bacher P, 2019, CELL, V176, P1340, DOI 10.1016/j.cell.2019.01.041; Behrouzi A, 2019, CLIN TRANSL MED, V8, DOI 10.1186/s40169-019-0232-y; Borroni D, 2019, BMJ OPEN OPHTHALMOL, V4, DOI 10.1136/bmjophth-2018-000248; Chakravarthy SK, 2018, INDIAN J MICROBIOL, V58, P457, DOI 10.1007/s12088-018-0746-9; Chakravarthy SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199640; Chouaki T, 2002, CLIN INFECT DIS, V35, P1360, DOI 10.1086/344270; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; de Oliveira HC, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.7015.00303, 10.3389/fmicb.2015.00303]; Deng L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168631; Dupuy AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090899; Faust Karoline, 2016, F1000Res, V5, P1519; Finamor LP, 2002, AM J OPHTHALMOL, V134, P456, DOI 10.1016/S0002-9394(02)01574-X; FITZSIMONS RB, 1980, BRIT J OPHTHALMOL, V64, P672, DOI 10.1136/bjo.64.9.672; Fuchs BB, 2018, VIRULENCE, V9, P1539, DOI 10.1080/21505594.2018.1518087; Gandhi J, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7100411; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Huffnagle GB, 2013, TRENDS MICROBIOL, V21, P334, DOI 10.1016/j.tim.2013.04.002; Hutchinson DS, 2015, MICROBIOME EYE, P400; Jayasudha R, 2018, INDIAN J MED MICROBI, V36, P564, DOI [10.4103/ijmm.IJMM_19_51, 10.4103/ijmm.ijmm_19_51]; Jayasudha R, 2018, J BIOSCIENCES, V43, P835, DOI 10.1007/s12038-018-9798-6; Juul S, 2015, WHATS MY POT REAL TI; Kashyap PC, 2017, MAYO CLIN PROC, V92, P1855, DOI 10.1016/j.mayocp.2017.10.004; Katragkou A, 2014, MED MYCOL, V52, P376, DOI 10.1093/mmy/myt030; Kawali A, 2019, OCUL IMMUNOL INFLAMM, V27, P571, DOI 10.1080/09273948.2017.1421670; Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116; Klotz SA, 2000, CLIN MICROBIOL REV, V13, P662, DOI 10.1128/CMR.13.4.662-685.2000; Lalitha P, 2007, AM J OPHTHALMOL, V144, P552, DOI 10.1016/j.ajo.2007.06.002; LIESEGANG TJ, 1980, AM J OPHTHALMOL, V90, P38, DOI 10.1016/S0002-9394(14)75075-5; Limon JJ, 2017, CELL HOST MICROBE, V22, P156, DOI 10.1016/j.chom.2017.07.002; Lin LY, 2015, JAMA DERMATOL, V151, P1383, DOI 10.1001/jamadermatol.2015.2102; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Menia NK, 2019, INDIAN J OPHTHALMOL, V67, P1483, DOI 10.4103/ijo.IJO_1691_18; Mukherjee S, 2009, CASE REPORTS, DOI [10.1136/bcr.06.2008.034518-26076, DOI 10.1136/BCR.06.2008.034518-26076]; Munoz P, 2005, CLIN INFECT DIS, V40, P1625, DOI 10.1086/429916; Palkar AH, 2018, INDIAN J OPHTHALMOL, V66, P1317, DOI 10.4103/ijo.IJO_549_18; Panchal B, 2018, INDIAN J OPHTHALMOL, V66, P1844, DOI 10.4103/ijo.IJO_1644_18; PATEL AS, 1994, AM J OPHTHALMOL, V117, P363, DOI 10.1016/S0002-9394(14)73147-2; Prabhushanker M, 2017, Int J Retina Vitreous, V3, P11, DOI 10.1186/s40942-017-0065-z; Raju, 2017, J CLIN OPHTHALMOL RE, V5, P77; Rizzetto L, 2014, EUR J IMMUNOL, V44, P3166, DOI 10.1002/eji.201344403; Sacheli R, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.11.012; Prashanthi GS, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090309; Sam QH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020330; Sandoval-Denis M, 2015, J CLIN MICROBIOL, V53, P2990, DOI 10.1128/JCM.01482-15; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shivaji S, 2019, INVEST OPHTH VIS SCI, V60, P451, DOI 10.1167/iovs.18-26076; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Taj-Aldeen SJ, 2014, MED MYCOL, V52, P549, DOI 10.1093/mmycol/myu016; Vilela RC, 2014, INT OPHTHALMOL, V34, P707, DOI 10.1007/s10792-013-9854-z; Vishwanath S, 2014, INT OPHTHALMOL, V34, P851, DOI 10.1007/s10792-013-9891-7; Weaver D, 2019, CURR FUNGAL INFECT R, V13, P109, DOI 10.1007/s12281-019-00347-5; WILSON LA, 1969, AM J OPHTHALMOL, V67, P52, DOI 10.1016/0002-9394(69)90007-5; Zhang H, 2009, MED MYCOL, V47, P539, DOI 10.1080/13693780802644627	58	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0242138	10.1371/journal.pone.0242138	http://dx.doi.org/10.1371/journal.pone.0242138			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211730	gold, Green Published			2022-12-26	WOS:000603518300037
J	Conti, C; Fontanesi, L; Lanzara, R; Rosa, I; Porcelli, P				Conti, Chiara; Fontanesi, Lilybeth; Lanzara, Roberta; Rosa, Ilenia; Porcelli, Piero			Fragile heroes. The psychological impact of the COVID-19 pandemic on health-care workers in Italy	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; GENDER-DIFFERENCES; HELP-SEEKING; DEPRESSION; STRESS; SYMPTOMS; RESILIENCE; VALIDATION; PHYSICIANS; SEVERITY	This survey-based study aimed to explore the mental health status and psychological care needs of 933 health-care workers in Italy during the COVID-19 outbreak. Sociodemographic data, exposure to COVID-19, perception of psychological care needs, depression, anxiety, somatization, and post-traumatic symptoms were concurrently assessed. The majority of the sample (71%) suffered from somatization and 55% of distress. Female care workers experienced higher levels of anxiety (d = 0.50) and somatization symptoms (d = 0.82) and stated they needed psychological care more than men (p < .001). Younger participants (aged <40 years-old) reported higher levels of somatization, depression, anxiety, and post-traumatic symptoms (effects size range from d = 0.22 to d = 0.31). Working in a high infected area (red-zones) and directly with COVID-19 patients (front-line) affected the psychological health of participants to a smaller degree. Health-care workers who lost one of their patients reported higher levels of depression (d = 0.22), anxiety (d = 0.19), post-traumatic symptoms (d = 0.30), and psychological care needs than those who did not have the same experience (p < .01). Health-care workers who perceived the need for psychological support scored above the clinical alarming level (cut-off scores) in all the psychological scales, ranging from 76% to 88%. Psychological distress (p < .01), anxiety (p < .05), depression (p < .05), and being women (p < .01) contribute to explain the need for psychological care and accounted for 32% of the variance in this sample. These findings point out the importance to consider the psychological impact of COVID-19 on Italian health-care workers and strongly suggest establishing psychological support services for providing adequate professional care.	[Conti, Chiara; Fontanesi, Lilybeth; Porcelli, Piero] Univ G dAnnunzio, Dept Psychol Hlth & Terr Sci, Chieti, Italy; [Lanzara, Roberta; Rosa, Ilenia] Sapienza Univ Rome, Dept Dynam & Clin Psychol, Rome, Italy	G d'Annunzio University of Chieti-Pescara; Sapienza University Rome	Conti, C (corresponding author), Univ G dAnnunzio, Dept Psychol Hlth & Terr Sci, Chieti, Italy.	cconti@unich.it	Porcelli, Piero/AAU-3921-2021					Abelson R., 2020, NYTIMES 0311; Ahn DG, 2020, J MICROBIOL BIOTECHN, V30, P313, DOI 10.4014/jmb.2003.03011; Alfian SD, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034507; [Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; [Anonymous], 2020, EPIDEMIOL INFECT, DOI DOI 10.1017/S0950268820001107; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Barello S, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113129; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Carton ER, 2014, J HOSP PALLIAT NURS, V16, P291, DOI 10.1097/NJH.0000000000000067; Chen C, 2020, J HOSP INFECT, V105, P98, DOI 10.1016/j.jhin.2020.03.008; Chen QN, 2020, LANCET PSYCHIAT, V7, pE15, DOI 10.1016/S2215-0366(20)30078-X; Chen Y, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.113005; Chew NWS, 2020, BRAIN BEHAV IMMUN, V88, P559, DOI 10.1016/j.bbi.2020.04.049; Cohen J.E., 1988, STAT POWER ANAL BEHA; Craparo G, 2013, NEUROPSYCH DIS TREAT, V9, P1427, DOI 10.2147/NDT.S51793; de Boer J, 2011, SOC SCI MED, V73, P316, DOI 10.1016/j.socscimed.2011.05.009; Del Canale S, 2012, ACAD MED, V87, P1243, DOI 10.1097/ACM.0b013e3182628fbf; Deng R, 2020, CHIN J INFECT CONTRO, V19, P1; Elbay RY, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113130; Esler M, 2017, NEUROSCI BIOBEHAV R, V74, P269, DOI 10.1016/j.neubiorev.2016.10.011; Faravelli C, 2013, PSYCHIAT RES, V210, P1301, DOI 10.1016/j.psychres.2013.09.027; Farr C, 2020, HOSPITALS HOPE KEEP; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; Gautam M, 2020, PSYCHOSOMATICS, V61, P579, DOI 10.1016/j.psym.2020.04.009; Geoffroy PA, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00511; Ghodse H, 2006, INT REV PSYCHIATR, V18, P289, DOI 10.1080/09540260600709149; Guo J, 2020, PSYCHOL EFFECTS COVI, DOI [DOI 10.2139/SSRN.3550050, 10.4103/VIT-2]; IBM Corp, 2016, IBM SPSS STAT WINDOW; Italian Health Ministry, NEW COR UPD; Joliat GR, 2019, BRIT J SURG, V106, P1429, DOI 10.1002/bjs.11264; Kang LJ, 2020, BRAIN BEHAV IMMUN, V87, P11, DOI 10.1016/j.bbi.2020.03.028; Kisely S, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1642; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2016, PSYCHOSOM MED, V78, P716, DOI 10.1097/PSY.0000000000000322; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lee SM, 2018, COMPR PSYCHIAT, V87, P123, DOI 10.1016/j.comppsych.2018.10.003; Levis B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1476; Liu S, 2020, LANCET PSYCHIAT, V7, pE17, DOI 10.1016/S2215-0366(20)30077-8; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936; Luo M, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113190; MONTGOMERY D. C, 2017, DESIGN ANAL EXPT, V9th; National Institute of Health, REP BAS AV DAT MAY 2; National Institute of Health. COVID-19 Epidemic, COVID 19 EP; Pan XF, 2020, LANCET INFECT DIS, V20, P410, DOI 10.1016/S1473-3099(20)30114-6; Privitera MR., 2015, J HOSP ADM, V4, P27, DOI [10.5430/jha.v4n1p27, DOI 10.5430/JHA.V4N1P27]; Ramsey SR, 2016, COMPUT HUM BEHAV, V58, P354, DOI 10.1016/j.chb.2015.12.049; Neto MLR, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112972; Romero CS, 2022, PSYCHOL MED, V52, P188, DOI 10.1017/S0033291720001671; Rossi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10185; Rutherford C, 2016, QUAL LIFE RES, V25, P559, DOI 10.1007/s11136-015-1110-8; Schrank B, 2016, PSYCHO-ONCOLOGY, V25, P808, DOI 10.1002/pon.4005; Seidler ZE, 2016, CLIN PSYCHOL REV, V49, P106, DOI 10.1016/j.cpr.2016.09.002; Smith EC, 2019, PREHOSP DISASTER MED, V34, P625, DOI 10.1017/S1049023X19004989; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sui J, 2017, TODAY NURSE, V12, P154; Tam CWC, 2004, PSYCHOL MED, V34, P1197, DOI 10.1017/S0033291704002247; Lima CKT, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112915; Tiemensma J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195229; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; van Geelen SM, 2015, J PSYCHOSOM RES, V79, P251, DOI 10.1016/j.jpsychores.2015.07.012; Wang YX, 2020, J MED VIROL, V92, P568, DOI 10.1002/jmv.25748; Washington KT, 2015, J PALLIAT MED, V18, P1048, DOI 10.1089/jpm.2015.0214; Weiss Daniel S., 1997, P399; WHO, 2020, WHO COR COVID 19 DAS; WHO (World Health Organization), 2020, COR DIS COVID 2019 R; World Health Organization (WHO), 2020, COR DIS COVID 19 OUT, DOI DOI 10.1016/S0140-6736(20)30566-3; Wu Y, 2020, J PAIN SYMPTOM MANAG, V60, pE60, DOI 10.1016/j.jpainsymman.2020.04.008; Wurm W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149913; Xing J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233145; Xu M.C., 2020, CHIN NURS RES, V34, P368, DOI DOI 10.12102/j.issn.1009-6493.2020.03.002; Yokoyama Yukari, 2014, PLoS One, V9, pe102497, DOI 10.1371/journal.pone.0102497; Zhang WR, 2020, PSYCHOTHER PSYCHOSOM, V89, P242, DOI 10.1159/000507639; Zhou JW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157013; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017; Zwack J, 2013, ACAD MED, V88, P382, DOI 10.1097/ACM.0b013e318281696b; Zwack J, 2011, PSYCHOTHER PSYCH MED, V61, P495, DOI 10.1055/s-0031-1291276	79	56	56	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242538	10.1371/journal.pone.0242538	http://dx.doi.org/10.1371/journal.pone.0242538			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206714	Green Published, gold			2022-12-26	WOS:000595265900034
J	Yogo, N; Hase, T; Kasama, T; Nishiyama, K; Ozawa, N; Hatta, T; Shibata, H; Sato, M; Komeda, K; Kawabe, N; Matsuoka, K; Chen-Yoshikawa, TF; Kaji, N; Tokeshi, M; Baba, Y; Hasegawa, Y				Yogo, Naoyuki; Hase, Tetsunari; Kasama, Toshihiro; Nishiyama, Keine; Ozawa, Naoya; Hatta, Takahiro; Shibata, Hirofumi; Sato, Mitsuo; Komeda, Kazuki; Kawabe, Nozomi; Matsuoka, Kohei; Chen-Yoshikawa, Toyofumi Fengshi; Kaji, Noritada; Tokeshi, Manabu; Baba, Yoshinobu; Hasegawa, Yoshinori			Development of an immuno-wall device for the rapid and sensitive detection of EGFR mutations in tumor tissues resected from lung cancer patients	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ANTIBODIES; IMMUNOHISTOCHEMISTRY; ADENOCARCINOMA; INHIBITORS; GEFITINIB	Detecting molecular targets in specimens from patients with lung cancer is essential for targeted therapy. Recently, we developed a highly sensitive, rapid-detection device (an immuno-wall device) that utilizes photoreactive polyvinyl alcohol immobilized with antibodies against a target protein via a streptavidin-biotin interaction. To evaluate its performance, we assayed epidermal growth factor receptor (EGFR) mutations, such as E746_A750 deletion in exon 19 or L858R substitution in exon 21, both of which are common in non-small cell lung cancer and important predictors of the treatment efficacy of EGFR tyrosine kinase inhibitors. The results showed that in 20-min assays, the devices detected as few as 1% (E746_A750 deletion) and 0.1% (L858R substitution) of mutant cells. Subsequent evaluation of detection of the mutations in surgically resected lung cancer specimens from patients with or without EGFR mutations and previously diagnosed using commercially available, clinically approved genotyping assays revealed diagnostic sensitivities of the immuno-wall device for E746_A750 deletion and L858R substitution of 85.7% and 87.5%, respectively, with specificities of 100% for both mutations. These results suggest that the immuno-wall device represents a good candidate next-generation diagnostic tool, especially for screening of EGFR mutations.	[Yogo, Naoyuki; Hase, Tetsunari; Ozawa, Naoya; Hatta, Takahiro; Shibata, Hirofumi; Sato, Mitsuo; Komeda, Kazuki; Hasegawa, Yoshinori] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi, Japan; [Yogo, Naoyuki; Baba, Yoshinobu] Nagoya Univ, Grad Sch Engn, Dept Biomol Engn, Nagoya, Aichi, Japan; [Yogo, Naoyuki; Hase, Tetsunari; Kasama, Toshihiro; Kaji, Noritada; Tokeshi, Manabu; Baba, Yoshinobu] Nagoya Univ, Inst Nano Life Syst, Inst Innovat Future Soc, Nagoya, Aichi, Japan; [Kasama, Toshihiro] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan; [Nishiyama, Keine] Hokkaido Univ, Grad Sch Chem Sci & Engn, Sapporo, Hokkaido, Japan; [Sato, Mitsuo; Kawabe, Nozomi; Matsuoka, Kohei] Nagoya Univ, Dept Pathophysiol Lab Sci, Grad Sch Med, Nagoya, Aichi, Japan; [Chen-Yoshikawa, Toyofumi Fengshi] Nagoya Univ, Dept Thorac Surg, Grad Sch Med, Nagoya, Aichi, Japan; [Kaji, Noritada] Kyushu Univ, Grad Sch Engn, Dept Appl Chem, Fukuoka, Japan; [Tokeshi, Manabu] Hokkaido Univ, Fac Engn, Div Appl Chem, Sapporo, Hokkaido, Japan; [Baba, Yoshinobu] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Takamatsu, Kagawa, Japan; [Hasegawa, Yoshinori] Natl Hosp Org, Nagoya Med Ctr, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; University of Tokyo; Hokkaido University; Nagoya University; Nagoya University; Kyushu University; Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST); Nagoya Medical Center	Hase, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi, Japan.; Hase, T (corresponding author), Nagoya Univ, Inst Nano Life Syst, Inst Innovat Future Soc, Nagoya, Aichi, Japan.	thase@med.nagoya-u.ac.jp	Hase, Tetsunari/I-7435-2014; Nishiyama, Keine/AAG-7971-2021; Tokeshi, Manabu/B-6257-2012	Nishiyama, Keine/0000-0002-7433-1019; Tokeshi, Manabu/0000-0002-4412-2144; Kasama, Toshihiro/0000-0001-6753-1509; Hase, Tetsunari/0000-0002-9653-8424; Yogo, Naoyuki/0000-0002-4461-5619	"Knowledge Hub Aichi" Priority Research Project from the Aichi Prefectural Government; Nagoya University Hospital Funding for Clinical Research; Translational Research Network Program from the Japan Agency for Medical Research and Development (AMED)	"Knowledge Hub Aichi" Priority Research Project from the Aichi Prefectural Government; Nagoya University Hospital Funding for Clinical Research; Translational Research Network Program from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by the "Knowledge Hub Aichi" Priority Research Project from the Aichi Prefectural Government, the Nagoya University Hospital Funding for Clinical Research, and the Translational Research Network Program from the Japan Agency for Medical Research and Development (AMED).	Bellevicine C, 2015, CYTOPATHOLOGY, V26, P99, DOI 10.1111/cyt.12155; Brevet M, 2010, J MOL DIAGN, V12, P169, DOI 10.2353/jmoldx.2010.090140; Dearden S, 2013, ANN ONCOL, V24, P2371, DOI 10.1093/annonc/mdt205; Eberhard DA, 2008, J CLIN ONCOL, V26, P983, DOI 10.1200/JCO.2007.12.9858; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Goto K, 2012, ANN ONCOL, V23, P2914, DOI 10.1093/annonc/mds121; Guo G, 2015, CANCER RES, V75, P3436, DOI 10.1158/0008-5472.CAN-15-0989; Hase T, 2011, CANCER SCI, V102, P1493, DOI 10.1111/j.1349-7006.2011.01973.x; Hofman P, 2012, ANN ONCOL, V23, P1738, DOI 10.1093/annonc/mdr535; Ikami M, 2010, LAB CHIP, V10, P3335, DOI [10.1039/c0lc00241k, 10.1039/c01c00241k]; Kato Y, 2010, J THORAC ONCOL, V5, P1551, DOI 10.1097/JTO.0b013e3181e9da60; Kawahara A, 2010, CLIN CANCER RES, V16, P3163, DOI 10.1158/1078-0432.CCR-09-3239; Kitamura A, 2010, CLIN CANCER RES, V16, P3349, DOI 10.1158/1078-0432.CCR-10-0129; Kozu Y, 2011, LUNG CANCER, V73, P45, DOI 10.1016/j.lungcan.2010.11.003; Lindeman NI, 2018, J MOL DIAGN, V20, P129, DOI 10.1016/j.jmoldx.2017.11.004; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Naoki K, 2011, INT J CLIN ONCOL, V16, P335, DOI 10.1007/s10147-011-0187-5; Oliner K, 2010, DIAGN PATHOL, V5, DOI 10.1186/1746-1596-5-23; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pirker Robert, 2010, J Thorac Oncol, V5, P1706, DOI 10.1097/JTO.0b013e3181f1c8de; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Seo AN, 2014, LUNG CANCER, V83, P316, DOI 10.1016/j.lungcan.2013.12.008; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Simonetti S, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-135; Suguitan Jr AL, 2011, PLOS ONE, V6; Xiong Y, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-27; Yamamichi A, 2016, SCI TECHNOL ADV MAT, V17, P618, DOI 10.1080/14686996.2016.1227222; Yatabe Y, 2015, J THORAC ONCOL, V10, P438, DOI 10.1097/JTO.0000000000000422; Yu J, 2009, CLIN CANCER RES, V15, P3023, DOI 10.1158/1078-0432.CCR-08-2739	31	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0241422	10.1371/journal.pone.0241422	http://dx.doi.org/10.1371/journal.pone.0241422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196648	Green Published, gold			2022-12-26	WOS:000595266800014
J	Goss, KL; Koppenhafer, SL; Waters, T; Terry, WW; Wen, KK; Wu, M; Ostergaard, J; Gordon, PM; Gordon, DJ				Goss, Kelli L.; Koppenhafer, Stacia L.; Waters, Torin; Terry, William W.; Wen, Kuo-Kuang; Wu, Meng; Ostergaard, Jason; Gordon, Peter M.; Gordon, David J.			The translational repressor 4E-BP1 regulates RRM2 levels and functions as a tumor suppressor in Ewing sarcoma tumors	ONCOGENE			English	Article							TARGETED PROTEIN-DEGRADATION; RIBONUCLEOTIDE REDUCTASE R2; REPLICATION STRESS; KINASE INHIBITOR; PHASE-I; CANCER; WEE1; HOMOHARRINGTONINE; GEMCITABINE; ACTIVATION	Ribonucleotide reductase (RNR), which is a heterodimeric tetramer composed of RRM1 and RRM2 subunits, is the rate-limiting enzyme in the synthesis of deoxyribonucleoside triphosphates (dNTPs) and essential for both DNA replication and the repair of DNA damage. The activity of RNR is coordinated with the cell cycle and regulated by fluctuations in the level of the RRM2 subunit. Multiple cancer types, including Ewing sarcoma tumors, are sensitive to inhibitors of RNR or a reduction in the levels of either the RRM1 or RRM2 subunits of RNR. Here, we show that the expression of the RRM2 protein is dependent on active protein synthesis and that 4E-BP1, a repressor of cap-dependent protein translation, specifically regulates the level of the RRM2 protein. Furthermore, inhibition of mTORC1/2, but not mTORC1, activates 4E-BP1, inhibits protein synthesis, and reduces the level of the RRM2 protein in multiple sarcoma cell lines. This effect of mTORC1/2 inhibitors on protein synthesis and RRM2 levels was rescued in cell lines with the CRISPR/Cas9-mediated knockout of 4E-BP1. In addition, the inducible expression of a mutant 4E-BP1 protein that cannot be phosphorylated by mTOR blocked protein synthesis and inhibited the growth of Ewing sarcoma cells in vitro and in vivo in a xenograft. Overall, these results provide insight into the multifaceted regulation of RRM2 protein levels and identify a regulatory link between protein translation and DNA replication.	[Goss, Kelli L.; Koppenhafer, Stacia L.; Waters, Torin; Terry, William W.; Gordon, David J.] Univ Iowa, Dept Pediat, Div Pediat Hematol Oncol, Iowa City, IA 52242 USA; [Wen, Kuo-Kuang; Wu, Meng] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA; [Ostergaard, Jason; Gordon, Peter M.] Univ Minnesota, Dept Pediat, Div Pediat Hematol Oncol, Minneapolis, MN 55455 USA	University of Iowa; University of Iowa; University of Minnesota System; University of Minnesota Twin Cities	Gordon, DJ (corresponding author), Univ Iowa, Dept Pediat, Div Pediat Hematol Oncol, Iowa City, IA 52242 USA.	david-j-gordon@uiowa.edu		Gordon, David/0000-0003-1830-4371; Wu, Meng/0000-0003-2222-0736	University of Iowa Dance Marathon Award; Holden Comprehensive Cancer Center Sarcoma Multidisciplinary Oncology Group Seed Grant; University of Iowa Oberley Seed Grant; St. Baldrick's Research Foundation; Aiming for a Cure Foundation; Matt Morrell and Natalie Sanchez Pediatric Cancer Research Foundation; NIH [R37-CA217910]; University of Iowa [NIH/NCI P30CA086862]; RPPA Core Facility at MD Anderson Cancer Center (NCI) [CA16672]	University of Iowa Dance Marathon Award; Holden Comprehensive Cancer Center Sarcoma Multidisciplinary Oncology Group Seed Grant; University of Iowa Oberley Seed Grant; St. Baldrick's Research Foundation; Aiming for a Cure Foundation; Matt Morrell and Natalie Sanchez Pediatric Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Iowa; RPPA Core Facility at MD Anderson Cancer Center (NCI)	DJG is supported by a University of Iowa Dance Marathon Award, a Holden Comprehensive Cancer Center Sarcoma Multidisciplinary Oncology Group Seed Grant, a University of Iowa Oberley Seed Grant, St. Baldrick's Research Foundation, Aiming for a Cure Foundation, The Matt Morrell and Natalie Sanchez Pediatric Cancer Research Foundation, and NIH Grant R37-CA217910. We would also like to acknowledge the use of the University of Iowa Flow Cytometry and High Throughput Screening Core Facilities (NIH/NCI P30CA086862), as well as the RPPA Core Facility at MD Anderson Cancer Center (NCI #CA16672).	Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Ayuso MI, 2010, J BIOL CHEM, V285, P34355, DOI 10.1074/jbc.M110.135103; Burslem GM, 2018, CELL CHEM BIOL, V25, P67, DOI 10.1016/j.chembiol.2017.09.009; Cerqueira NMFSA, 2005, CURR MED CHEM, V12, P1283, DOI 10.2174/0929867054020981; Cerqueira NMFSA, 2007, RECENT PAT ANTI-CANC, V2, P11; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chang LS, 2020, MOL CANCER THER, V19, P731, DOI 10.1158/1535-7163.MCT-19-0809; Chen R, 2011, BLOOD, V117, P156, DOI 10.1182/blood-2010-01-262808; Choi SH, 2019, GENE DEV, V33, P418, DOI 10.1101/gad.322339.118; Clark NA, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3689-3; De Gassart A, 2016, EMBO REP, V17, P1471, DOI 10.15252/embr.201642194; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Do K, 2015, J CLIN ONCOL, V33, P3409, DOI 10.1200/JCO.2014.60.4009; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Goss KL, 2017, ONCOTARGET, V8, P87016, DOI 10.18632/oncotarget.18776; Goss KL, 2016, ONCOTARGET, V7, P63003, DOI 10.18632/oncotarget.11416; Gurel G, 2009, J MOL BIOL, V389, P146, DOI 10.1016/j.jmb.2009.04.005; Guo XE, 2014, CURR DRUG TARGETS, V15, P2, DOI 10.2174/1389450114666140106095151; Hafner M, 2016, NAT METHODS, V13, P521, DOI [10.1038/NMETH.3853, 10.1038/nmeth.3853]; Hai J, 2017, CLIN CANCER RES, V23, P6993, DOI 10.1158/1078-0432.CCR-17-1098; He ZF, 2017, ONCOTARGET, V8, P41422, DOI 10.18632/oncotarget.17440; Hill SJ, 2018, CANCER DISCOV, V8, P1404, DOI 10.1158/2159-8290.CD-18-0474; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Ianevski A, 2017, BIOINFORMATICS, V33, P2413, DOI 10.1093/bioinformatics/btx162; Iyer DR, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020074; Jones SE, 2017, CANCER RES, V77, P7014, DOI 10.1158/0008-5472.CAN-17-2056; Ki DH, 2019, ONCOGENE, V38, P6585, DOI 10.1038/s41388-019-0965-5; Kim JR, 2018, INT J MOL SCI, V19, pE674, DOI [10.3390/ijms19030674, DOI 10.1186/s12881-018-0722-6]; Knott MML, 2019, CANCER METAST REV, V38, P625, DOI 10.1007/s10555-019-09839-9; Koppenhafer SL, 2020, MOL CANCER RES, V18, P91, DOI 10.1158/1541-7786.MCR-19-0585; Koppenhafer SL, 2018, MOL CANCER THER, V17, P2676, DOI 10.1158/1535-7163.MCT-18-0260; Kotova I, 2003, EUR J BIOCHEM, V270, P1791, DOI 10.1046/j.1432-1033.2003.03541.x; Lai AC, 2017, NAT REV DRUG DISCOV, V16, P101, DOI 10.1038/nrd.2016.211; Lam SSY, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3735; Laroche-Clary A, 2018, ANN ONCOL, V29, P1023, DOI 10.1093/annonc/mdy039; Larsson KM, 2004, NAT STRUCT MOL BIOL, V11, P1142, DOI 10.1038/nsmb838; Lecona E, 2014, EXP CELL RES, V329, P26, DOI 10.1016/j.yexcr.2014.09.019; Lee EYHP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003236; Lee JA, 2016, PEDIATR BLOOD CANCER, V63, P1552, DOI 10.1002/pbc.26058; Leijen S, 2016, J CLIN ONCOL, V34, P4371, DOI 10.1200/JCO.2016.67.5991; Li X., 2020, HAEMATOLOGICA, DOI [10.3324/haematol.2019.233445, DOI 10.3324/HAEMAT0L.2019.233445]; Li XY, 2019, HAEMATOLOGICA, V104, P2225, DOI 10.3324/haematol.2018.201343; Liu Y, 2017, CANCER RES, V77, P5068, DOI 10.1158/0008-5472.CAN-17-0567; Lowery CD, 2019, CLIN CANCER RES, V25, P2278, DOI 10.1158/1078-0432.CCR-18-2728; Lowery CD, 2017, CLIN CANCER RES, V23, P4354, DOI 10.1158/1078-0432.CCR-16-2876; Moorthy NSHN, 2013, MINI-REV MED CHEM, V13, P1862, DOI 10.2174/13895575113136660090; Muller D, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.121951; Murai J, 2019, PHARMACOL THERAPEUT, V201, P94, DOI 10.1016/j.pharmthera.2019.05.009; Musa J, 2016, ONCOGENE, V35, P4675, DOI 10.1038/onc.2015.515; Neklesa TK, 2017, PHARMACOL THERAPEUT, V174, P138, DOI 10.1016/j.pharmthera.2017.02.027; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Okimoto RA, 2019, J CLIN INVEST, V129, P3401, DOI 10.1172/JCI126366; Paiva SL, 2019, CURR OPIN CHEM BIOL, V50, P111, DOI 10.1016/j.cbpa.2019.02.022; Pettersson Mariell, 2019, Drug Discov Today Technol, V31, P15, DOI 10.1016/j.ddtec.2019.01.002; Pfister SX, 2015, CANCER CELL, V28, P557, DOI 10.1016/j.ccell.2015.09.015; Qin XY, 2016, CELL CYCLE, V15, P781, DOI 10.1080/15384101.2016.1151581; Rundle S, 2017, CANCERS, V9, DOI 10.3390/cancers9050041; Saini P, 2015, ONCOTARGET, V6, P13072, DOI 10.18632/oncotarget.3865; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Slotkin EK, 2015, MOL CANCER THER, V14, P395, DOI 10.1158/1535-7163.MCT-14-0711; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stewart E, 2018, CANCER CELL, V34, P411, DOI 10.1016/j.ccell.2018.07.012; Stewart E, 2017, NATURE, V549, P96, DOI 10.1038/nature23647; Tang RP, 2006, MOL CANCER THER, V5, P723, DOI 10.1158/1535-7163.MCT-05-0164; Tang SW, 2015, CLIN CANCER RES, V21, P4184, DOI 10.1158/1078-0432.CCR-14-2112; Truman AW, 2015, J PROTEOMICS, V112, P285, DOI 10.1016/j.jprot.2014.09.028; van der Donk WA, 1998, BIOCHEMISTRY-US, V37, P6419, DOI 10.1021/bi9729357; Wallez Y, 2018, MOL CANCER THER, V17, P1670, DOI 10.1158/1535-7163.MCT-18-0010; Wang H, 2006, SEMIN ONCOL, V33, P513, DOI 10.1053/j.seminoncol.2006.04.013; Wang XH, 2014, MOL CELL ENDOCRINOL, V382, P8, DOI 10.1016/j.mce.2013.09.003; Wang ZY, 2019, CANCER RES, V79, P1438, DOI 10.1158/0008-5472.CAN-18-1220; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhao JY, 2017, ONCOTARGET, V8, P6319, DOI 10.18632/oncotarget.14062; Zhou BS, 2013, CANCER RES, V73, P6484, DOI 10.1158/0008-5472.CAN-13-1094; Zoppoli G, 2012, P NATL ACAD SCI USA, V109, P15030, DOI 10.1073/pnas.1205943109	77	2	2	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2021	40	3					564	577		10.1038/s41388-020-01552-0	http://dx.doi.org/10.1038/s41388-020-01552-0		NOV 2020	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PU9SL	33191406	Green Accepted			2022-12-26	WOS:000589571100002
J	Ahuja, A; Journo, G; Eitan, R; Rubin, E; Shamay, M				Ahuja, Anuj; Journo, Guy; Eitan, Ron; Rubin, Eitan; Shamay, Meir			High levels of LINE-1 transposable elements expressed in Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma	ONCOGENE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ENDOGENOUS RETROVIRUS HERV-K18; ENCODED REVERSE-TRANSCRIPTASE; GENE-EXPRESSION; CELL-PROLIFERATION; DNA; RETROTRANSPOSITION; DIFFERENTIATION; HYPOMETHYLATION; IDENTIFICATION	Kaposi's sarcoma-associated herpesvirus (KSHV, HHV-8) is a gamma herpesvirus associated with several human malignancies. Transposable elements (TEs) are ubiquitous in eukaryotic genomes, occupying about 45% of the human genome. TEs have been linked with a variety of disorders and malignancies, though the precise nature of their contribution to many of them has yet to be elucidated. Global transcriptome analysis for differentially expressed TEs in KSHV-associated primary effusion lymphoma (PEL) cells (BCBL1 and BC3) revealed large number of differentially expressed TEs. These differentially expressed TEs include LTR transposons, long interspersed nuclear elements (LINEs), and short interspersed nuclear elements (SINEs). Further analysis of LINE-1 (L1) elements revealed expression upregulation, hypo-methylation, and transition into open chromatin in PEL. In agreement with high L1 expression, PEL cells express ORF1 protein and possess high reverse transcriptase (RT)-activity. Interestingly, inhibition of this RT-activity suppressed PEL cell growth. Collectively, we identified high expression of TEs, and specifically of L1 as a critical component in the proliferation of PEL cells. This observation is relevant for the treatment of KSHV-associated malignancies since they often develop in AIDS patients that are treated with RT inhibitors with potent inhibition for both HIV and L1 RT activity.	[Ahuja, Anuj; Journo, Guy; Eitan, Ron; Shamay, Meir] Bar Ilan Univ, Azrieli Fac Med, Daniella Lee Casper Lab Viral Oncol, Safed, Israel; [Rubin, Eitan] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol & Immunol, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Bar Ilan University; Ben Gurion University	Shamay, M (corresponding author), Bar Ilan Univ, Azrieli Fac Med, Daniella Lee Casper Lab Viral Oncol, Safed, Israel.	meir.shamay@biu.ac.il	Ahuja, Anuj/ABA-2550-2021; Rubin, Eitan/E-5256-2011	Ahuja, Anuj/0000-0002-0558-1356; Rubin, Eitan/0000-0002-7807-4005	Israel Science Foundation [1134/16]; Israel Cancer Association - Walter Bela foundation [20150095, 20161143]; Research Career Development Award from the Israel Cancer Research Fund [01282]; Elias, Genevieve, and Georgianna Atol Charitable Trust	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association - Walter Bela foundation; Research Career Development Award from the Israel Cancer Research Fund; Elias, Genevieve, and Georgianna Atol Charitable Trust	We would like to thank S. Diane hayward, Richard F. Ambinder, Jeffrey Vieira, Shou-Jiang (SJ) Gao, Milana Frenkel-Morgenstern, and Ronit Sarid for cell lines. This work was supported by grants from the Israel Science Foundation (https://www.isf.org.il) (1134/16), the Israel Cancer Association (20150095, 20161143) funded by the Walter Bela foundation, and a Research Career Development Award from the Israel Cancer Research Fund (https://www.icrfonline.org/) (01282) to MS. We are grateful for the support of the Elias, Genevieve, and Georgianna Atol Charitable Trust to the Daniella Lee Casper Laboratory in Viral Oncology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the paper.	Alisch RS, 2006, GENE DEV, V20, P210, DOI 10.1101/gad.1380406; Alves G, 1996, GENE, V176, P39, DOI 10.1016/0378-1119(96)00205-3; Ardeljan D, 2019, MOBILE DNA-UK, V11, DOI 10.1186/s13100-019-0191-2; Aschacher T, 2016, ONCOGENE, V35, P94, DOI 10.1038/onc.2015.65; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Beck CR, 2011, ANNU REV GENOM HUM G, V12, P187, DOI 10.1146/annurev-genom-082509-141802; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burger D, 2006, BRIT J CLIN PHARMACO, V61, P148, DOI 10.1111/j.1365-2125.2005.02536.x; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Collier AC, 1996, NEW ENGL J MED, V334, P1011, DOI 10.1056/NEJM199604183341602; Crauwels H, 2013, AIDS REV, V15, P87; Criscione SW, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2800-5; Dai LX, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-18; Dai L, 2018, ONCOGENE, V37, P4534, DOI 10.1038/s41388-018-0282-4; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Erichsen L, 2018, SAUDI J BIOL SCI, V25, P1220, DOI 10.1016/j.sjbs.2018.02.005; Goering W, 2011, CARCINOGENESIS, V32, P1484, DOI 10.1093/carcin/bgr181; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henke-Gendo C, 2004, CURR OPIN INFECT DIS, V17, P53, DOI 10.1097/00001432-200402000-00011; Johnson WE, 2015, ANNU REV VIROL, V2, P135, DOI 10.1146/annurev-virology-100114-054945; Jones RB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001547; Jonsson ME, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11150-8; Journo G, 2018, J VIROL, V92, DOI 10.1128/JVI.00008-18; Karijolich J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005260; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Klein U, 2003, BLOOD, V101, P4115, DOI 10.1182/blood-2002-10-3090; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landriscina M, 2005, J CLIN ENDOCR METAB, V90, P5663, DOI 10.1210/jc.2005-0367; Lee E, 2012, SCIENCE, V337, P967, DOI 10.1126/science.1222077; Lee J, 2007, GENE, V390, P18, DOI 10.1016/j.gene.2006.08.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Menendez L, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-12; Nakayama R, 2019, ONCOGENE, V38, P4340, DOI 10.1038/s41388-019-0726-5; Oakes CC, 2016, NAT GENET, V48, P253, DOI 10.1038/ng.3488; Oricchio E, 2007, ONCOGENE, V26, P4226, DOI 10.1038/sj.onc.1210214; Patnala R, 2014, BREAST CANCER RES TR, V143, P239, DOI 10.1007/s10549-013-2812-7; Pizzato M, 2009, J VIROL METHODS, V156, P1, DOI 10.1016/j.jviromet.2008.10.012; Poole LJ, 2002, J VIROL, V76, P3395, DOI 10.1128/JVI.76.7.3395-3420.2002; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sciamanna E, 2005, ONCOGENE, V24, P3923, DOI 10.1038/sj.onc.1208562; Sciamanna I, 2013, ONCOTARGET, V4, P2271, DOI 10.18632/oncotarget.1403; Shamay M, 2010, J BIOL CHEM, V285, P36377, DOI 10.1074/jbc.M110.155721; Sharma M, 2013, J ANTIMICROB CHEMOTH, V68, P250, DOI 10.1093/jac/dks404; Shukla R, 2013, CELL, V153, P101, DOI 10.1016/j.cell.2013.02.032; Sutkowski N, 2001, IMMUNITY, V15, P579, DOI 10.1016/S1074-7613(01)00210-2; Sutkowski N, 2004, J VIROL, V78, P7852, DOI 10.1128/JVI.78.14.7852-7860.2004; Tangkijvanich P, 2007, CLIN CHIM ACTA, V379, P127, DOI 10.1016/j.cca.2006.12.029; Tinari A, 2008, INT J IMMUNOPATH PH, V21, P999, DOI 10.1177/039463200802100425; Tolani B, 2014, ONCOGENE, V33, P2928, DOI 10.1038/onc.2013.242; Vermeire J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050859; Vieira J, 2004, VIROLOGY, V325, P225, DOI 10.1016/j.virol.2004.03.049; Viollet C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006143; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384; Xie Y, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1076; Zheng YN, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0733-y	61	0	1	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 21	2021	40	3					536	550		10.1038/s41388-020-01549-9	http://dx.doi.org/10.1038/s41388-020-01549-9		NOV 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PU9SL	33188297				2022-12-26	WOS:000589573800001
J	Golledge, J; Drovandi, A; Velu, R; Quigley, F; Moxon, J				Golledge, Jonathan; Drovandi, Aaron; Velu, Ramesh; Quigley, Frank; Moxon, Joseph			Survival following abdominal aortic aneurysm repair in North Queensland is not associated with remoteness of place of residence	PLOS ONE			English	Article							LATE RUPTURE; OUTCOMES; MORTALITY; METAANALYSIS; GUIDELINES; EVENTS; VOLUME	Objective To assess whether survival and clinical events following elective abdominal aortic aneurysm (AAA) repair were associated with remoteness of residence in North Queensland, Australia. Methods This retrospective cohort study included participants undergoing elective AAA repair between February 2002 and April 2020 at two hospitals in Townsville, North Queensland, Australia. Outcomes were all-cause survival and AAA-related events, defined as requirement for repeat AAA repair or AAA-related mortality. Remoteness of participant's place of residence was assessed by the Modified Monash Model classifications and estimated distance from the participants' home to the tertiary vascular centre. Cox proportional hazard analysis examined the association of remoteness with outcome. Results The study included 526 participants undergoing elective repair by open (n = 204) or endovascular (n = 322) surgery. Fifty-four (10.2%) participants had a place of residence at a remote or very remote location. Participants' were followed for a median of 5.2 (inter-quartile range 2.5-8.3) years, during which time there were 252 (47.9%) deaths. Survival was not associated with either measure of remoteness. Fifty (9.5%) participants had at least one AAA-related event, including 30 (5.7%) that underwent at least one repeat AAA surgery and 23 (4.4%) that had AAA-related mortality. AAA-related events were more common in participants resident in the most remote areas (adjusted hazard ratio 2.83, 95% confidence intervals 1.40, 5.70) but not associated with distance from the participants' residence to the tertiary vascular centre Conclusions The current study found that participants living in more remote locations were more likely to have AAA-related events but had no increased mortality following AAA surgery. The findings emphasize the need for careful follow-up after AAA surgery. Further studies are needed to examine the generalisability of the findings.	[Golledge, Jonathan; Drovandi, Aaron; Moxon, Joseph] James Cook Univ, Queensland Res Ctr Peripheral Vasc Dis, Coll Med & Dent, Townsville, Qld, Australia; [Golledge, Jonathan; Velu, Ramesh] Townsville Univ Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia; [Golledge, Jonathan; Drovandi, Aaron; Moxon, Joseph] James Cook Univ, Australian Inst Trop Med, Townsville, Qld, Australia; [Quigley, Frank] Mater Private Hosp, Townsville, Qld, Australia	James Cook University; James Cook University	Golledge, J (corresponding author), James Cook Univ, Queensland Res Ctr Peripheral Vasc Dis, Coll Med & Dent, Townsville, Qld, Australia.; Golledge, J (corresponding author), Townsville Univ Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia.; Golledge, J (corresponding author), James Cook Univ, Australian Inst Trop Med, Townsville, Qld, Australia.	Jonathan.Golledge@jcu.edu.au	; Moxon, Joseph/C-3585-2011	Drovandi, Aaron/0000-0002-8682-1218; Moxon, Joseph/0000-0002-2131-2068	National Health and Medical Research Council [1063476, 1000967, 1117061]; James Cook University; Queensland Government; Queensland Government, Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); James Cook University; Queensland Government; Queensland Government, Australia	This work was supported by funding from the National Health and Medical Research Council (1063476 and 1000967), James Cook University, and the Queensland Government. JG holds a Practitioner Fellowship from the National Health and Medical Research Council (1117061), and a Senior Clinical Research Fellowship from the Queensland Government, Australia. JM is supported by an Advance Queensland Fellowship from the Queensland Government.	[Anonymous], 2014, DIABETOL KLIN SA, V3, pA1; Antoniou GA, 2015, J ENDOVASC THER, V22, P734, DOI 10.1177/1526602815601405; Australian Bureau of Statistics, IND REL SOC ADV DIS; Australian Government Department of Health, 2020, MOD MON MOD; Australian Institute of Health and Welfare, RURAL REMOTE HLTH; Baade PD, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-493; Brady AR, 2002, NEW ENGL J MED, V346, P1445; Brattheim BJ, 2012, EUR J VASC ENDOVASC, V44, P267, DOI 10.1016/j.ejvs.2012.04.029; Chaikof EL, 2018, J VASC SURG, V67, P2, DOI 10.1016/j.jvs.2017.10.044; Chondur R, 2014, AUST NZ J PUBL HEAL, V38, P117, DOI 10.1111/1753-6405.12126; Edmonston C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051467; Geiger JT, 2020, J VASC SURG; Golledge J, 2007, J VASC SURG, V45, P40, DOI 10.1016/j.jvs.2006.09.006; Golledge J, 2018, INT J CARDIOL, V254, P316, DOI 10.1016/j.ijcard.2017.10.100; Golledge J, 2013, ATHEROSCLEROSIS, V229, P549, DOI 10.1016/j.atherosclerosis.2013.04.030; Holt PJE, 2007, BRIT J SURG, V94, P395, DOI 10.1002/bjs.5710; Manapurathe DT, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010748; Mell MW, 2012, J VASC SURG, V56, P608, DOI 10.1016/j.jvs.2012.02.051; Morris DR, 2017, BRIT J SURG, V104, P544, DOI 10.1002/bjs.10460; Moxon JV, 2017, ATHEROSCLEROSIS, V263, P301, DOI 10.1016/j.atherosclerosis.2017.06.925; Munday E, 2016, VASCULAR, V24, P449, DOI 10.1177/1708538115599315; Paraskevas KI, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.05.71; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Phillips P, 2017, EUR J VASC ENDOVASC, V53, P77, DOI 10.1016/j.ejvs.2016.10.007; Powell JT, 2017, BRIT J SURG, V104, P166, DOI 10.1002/bjs.10430; Queensland Health, QUEENSL HOSP ADM DAT; Rajendran S, 2017, J VASC SURG, V65, P52, DOI 10.1016/j.jvs.2016.05.090; Sampson UKA, 2014, GLOB HEART, V9, P171, DOI 10.1016/j.gheart.2013.12.010; Shiraev T, 2013, ANZ J SURG, V83, P838, DOI 10.1111/ans.12080; Song SH, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.0241; Tripodi P, 2020, EUR J VASC ENDOVASC, V60, P531, DOI 10.1016/j.ejvs.2020.03.009; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wanhainen A, 2019, EUR J VASC ENDOVASC, V57, P8, DOI 10.1016/j.ejvs.2018.09.020	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0241802	10.1371/journal.pone.0241802	http://dx.doi.org/10.1371/journal.pone.0241802			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186377	gold, Green Accepted, Green Published			2022-12-26	WOS:000593949800030
J	Boiza-Sanchez, M; Manso, R; Balague, O; Chamizo, C; Askari, E; Salgado, RN; Blas-Lopez, C; Aguirregoicoa-Garcia, E; Menarguez, J; Santonja, C; Adrados, M; Limeres-Gonzalez, MA; Piris, MA; Rodriguez-Pinilla, SM				Boiza-Sanchez, Macarena; Manso, Rebeca; Balague, Olga; Chamizo, Cristina; Askari, Elham; Salgado, Rocio Nieves; Blas-Lopez, Carlos; Aguirregoicoa-Garcia, Elena; Menarguez, Javier; Santonja, Carlos; Adrados, Magdalena; Limeres-Gonzalez, Miguel Angel; Piris, Miguel Angel; Rodriguez-Pinilla, Socorro Maria			Lymphoplasmacytic lymphoma associated with diffuse large B-cell lymphoma: Progression or divergent evolution?	PLOS ONE			English	Article							WALDENSTROM MACROGLOBULINEMIA; GENOMIC LANDSCAPE; MUTATIONS; IBRUTINIB; IMMUNOGLOBULIN; PATTERN; DESIGN	Aim Lymphoplasmacytic lymphoma (LPL) is an indolent mature B-cell-neoplasm with involvement of the bone marrow. At least 90% of LPLs carry MYD88-L265P mutation and some of them (similar to 10%) transform into diffuse large B-cell-lymphoma (DLBCL). Material and methods Over the past 15 years we have collected 7 cases where the both LPL and DLBCL were diagnosed in the same patient. Clinical records, analytical data and histopathological specimens were reviewed. FISH studies on paraffin-embedded tissue for MYC, BCL2 and BCL6 genes were performed, as well as MYD88-L265P mutation and IGH rearrangement analysis by PCR. A mutational study was done by massive next generation sequencing (NGS). Results There were 4 women and 3 men between 36-91 years of age. Diagnoses were made simultaneously in 4 patients. In two cases the LPL appeared before the DLBCL and in the remaining case the high-grade component was discovered 5 years before the LPL. In 6 cases both samples shared the MYD88-L265P mutation. IGH rearrangement analysis showed overlapping features in two of 6 cases tested. Mutational study was evaluable in three cases for both samples showing shared and divergent mutations. Conclusions These data suggest different mechanisms of DLBCL development in LPL patients.	[Boiza-Sanchez, Macarena; Manso, Rebeca; Chamizo, Cristina; Aguirregoicoa-Garcia, Elena; Santonja, Carlos; Piris, Miguel Angel; Rodriguez-Pinilla, Socorro Maria] Hosp Univ Fdn Jimenez Diaz, Pathol Dept, Madrid, Spain; [Balague, Olga] Hosp Clin Barcelona, Pathol Dept, Barcelona, Spain; [Askari, Elham] Hosp Univ, Hematol Dept, Madrid, Spain; [Salgado, Rocio Nieves; Blas-Lopez, Carlos] Hosp Univ Fdn Jimenez Diaz, Cytogenet Serv, Madrid, Spain; [Menarguez, Javier] Hosp Univ Gregorio Maranon, Pathol Dept, Madrid, Spain; [Adrados, Magdalena] Hosp Univ Princesa, Pathol Dept, Madrid, Spain; [Limeres-Gonzalez, Miguel Angel] Hosp Univ Gran Canaria Doctor Negrin, Pathol Dept, Las Palmas Gran Canaria, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Sevilla; General University Gregorio Maranon Hospital; Hospital de La Princesa	Rodriguez-Pinilla, SM (corresponding author), Hosp Univ Fdn Jimenez Diaz, Pathol Dept, Madrid, Spain.	smrodriguez@fjd.es	Balagué, Olga/AAF-4735-2021; Adrados, Magdalena/H-8123-2015	Adrados, Magdalena/0000-0003-3317-670X; Blas, Carlos/0000-0002-6737-1610; Balague, Olga/0000-0002-5099-3675	Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence (MINECO, RTICC ISCIII) [SAF2013-47416-R, RD06/0020/0107-RD012/0036/0060, PI16/01294, PIE15/0081]; Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence (MINECO, CIBERONC) [SAF2013-47416-R, RD06/0020/0107-RD012/0036/0060, PI16/01294, PIE15/0081]; Madrid Autonomous Community; TAKEDA; CNIO Tumour Bank [RD09/0076/00113]; IDIVAL Tumour Bank [RD09/0076/00076]; BioB-HVS-BioBank Tumour Bank [PT13/0010/0007]	Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence (MINECO, RTICC ISCIII); Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence (MINECO, CIBERONC); Madrid Autonomous Community; TAKEDA(Takeda Pharmaceutical Company Ltd); CNIO Tumour Bank; IDIVAL Tumour Bank; BioB-HVS-BioBank Tumour Bank	This work was supported by grants from the Instituto de Salud Carlos III (ISCIII) of the Spanish Ministry of Economy and Competence (MINECO, RTICC ISCIII and CIBERONC) (SAF2013-47416-R, RD06/0020/0107-RD012/0036/0060 and Plan Nacional I+D+I: PI16/01294 and PIE15/0081) and the Madrid Autonomous Community. Dr. Piris is being sponsored by TAKEDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the CNIO (RD09/0076/00113), IDIVAL (RD09/0076/00076), BioB-HVS-BioBank (PT13/0010/0007) Tumour Banks, especially Maria Jesus Artiga and Laura Cereceda.	Arber DA, 2016, BLOOD, V127, P2391, DOI 10.1182/blood-2016-03-643544; BONEWALD L, 1985, CLIN CHIM ACTA, V146, P53, DOI 10.1016/0009-8981(85)90123-8; Brandefors L, 2016, ACTA ONCOL, V55, P91, DOI 10.3109/0284186X.2015.1096019; Ciric B, 2001, BLOOD, V97, P321, DOI 10.1182/blood.V97.1.321; Durot E, 2017, BRIT J HAEMATOL, V179, P439, DOI 10.1111/bjh.14881; Fang H, 2018, AM J CLIN PATHOL, V150, P168, DOI [10.1093/AJCP/AQY041, 10.1093/ajcp/aqy041]; Franco F, 2017, ONCOTARGET, V8, P102888, DOI 10.18632/oncotarget.21986; Fukumura K, 2016, ACTA NEUROPATHOL, V131, P865, DOI 10.1007/s00401-016-1536-2; Groenen Patricia J T A, 2008, J Hematop, V1, P97, DOI 10.1007/s12308-008-0013-9; Growkova K, 2017, EUR J HAEMATOL, V99, P469, DOI 10.1111/ejh.12959; Hattori K, 2019, CANCER SCI, V110, P401, DOI 10.1111/cas.13848; Jimenez C, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.72; Jimenez C, 2014, APPL IMMUNOHISTO M M, V22, P768, DOI 10.1097/PAI.0000000000000020; Lin P, 2003, AM J CLIN PATHOL, V120, P246, DOI 10.1039/R01VXG46MFCDVNHL; Morra E, 2013, CL LYMPH MYELOM LEUK, V13, P700, DOI 10.1016/j.clml.2013.05.008; Morton Lindsay M., 2014, Journal of the National Cancer Institute Monographs, P1, DOI 10.1093/jncimonographs/lgu005; Poulain S, 2017, CLIN CANCER RES, V23, P6325, DOI 10.1158/1078-0432.CCR-17-0007; Poulain S, 2016, CLIN CANCER RES, V22, P1480, DOI 10.1158/1078-0432.CCR-15-0646; Prieto-Torres L, 2020, BRIT J HAEMATOL, V190, pe352, DOI 10.1111/bjh.16917; Rosenquist R, 2016, HAEMATOLOGICA, V101, P1002, DOI 10.3324/haematol.2015.134510; Schmitz R, 2018, NEW ENGL J MED, V378, P1396, DOI 10.1056/NEJMoa1801445; Schulz, 1996, Mol Diagn, V1, P159, DOI 10.1016/S1084-8592(96)70001-2; Shimizu S, 2003, EUR J HAEMATOL, V70, P119, DOI 10.1034/j.1600-0609.2003.00013.x; Swerdlow SH., 2017, WHO CLASSIFICATION T, V2, P453; Talaulikar D, 2019, BRIT J HAEMATOL, V185, P767, DOI 10.1111/bjh.15610; Treon SP, 2018, HEMATOL ONCOL CLIN N, V32, P745, DOI 10.1016/j.hoc.2018.05.003; Treon SP, 2018, BRIT J HAEMATOL, V180, P374, DOI 10.1111/bjh.15049; Treon SP, 2015, NEW ENGL J MED, V373, P584, DOI 10.1056/NEJMc1506192; Treon SP, 2015, NEW ENGL J MED, V372, P1430, DOI 10.1056/NEJMoa1501548; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Varettoni M, 2017, HAEMATOLOGICA, V102, P2077, DOI 10.3324/haematol.2017.172718; Vater I, 2015, LEUKEMIA, V29, P677, DOI 10.1038/leu.2014.264; Vermaat JS, 2020, HAEMATOLOGICA, V105, P424, DOI 10.3324/haematol.2018.214122; Xu L, 2017, BLOOD, V129, P2519, DOI 10.1182/blood-2017-01-761726; Yu XF, 2018, CANCER RES, V78, P2457, DOI 10.1158/0008-5472.CAN-18-0215; Zanwar S, 2020, AM J HEMATOL, V95, P274, DOI 10.1002/ajh.25697	36	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241634	10.1371/journal.pone.0241634	http://dx.doi.org/10.1371/journal.pone.0241634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180881	Green Published, gold			2022-12-26	WOS:000593948000041
J	Marialva, EF; Secundino, NF; Fernandes, FF; Araujo, HRC; Rios-Velasquez, CM; Pimenta, PFP; Pessoa, FAC				Marialva, Eric Fabricio; Secundino, Nagila F.; Fernandes, Fernando F.; Araujo, Helena R. C.; Rios-Velasquez, Claudia M.; Pimenta, Paulo F. P.; Pessoa, Felipe A. C.			Morphological aspects of immature stages of Migonemyia migonei (Diptera: Psychodidae, Phlebotominae), an important vector of Leishmaniosis in South America, described by scanning electron microscopy	PLOS ONE			English	Article							SAND FLIES DIPTERA; LUTZOMYIA NYSSOMYIA INTERMEDIA; 4TH INSTAR LARVAE; CUTANEOUS LEISHMANIASIS; EXTERNAL MORPHOLOGY; PATTERNS; EGGS; LONGIPALPIS; CHAETOTAXY; SPIRACLES	We describe the immature stages of Migonemyia migonei, which is the vector of Leishmania (Viannia) braziliensis, the etiological agent of cutaneous leishmaniasis in South America, and a putative vector of Leishmania infantum chagasi. Scanning Electron Microscopy (SEM) was used to refine the description of the structures of the egg, all instar larvae, and the pupa. The eggs have polygonal cells on the egg exochorion, and differences between larval and pupal chaetotaxy have been highlighted. Different sensillary subtypes-trichoidea, basiconica, coelonica and campanoformia-were observed in the larval stages. The results presented herein contribute to the taxonomy of Mg. migonei and may contribute to future studies on the phylogeny of this important vector species.	[Marialva, Eric Fabricio; Rios-Velasquez, Claudia M.; Pessoa, Felipe A. C.] Fiocruz Amazonia, Lab Ecol Doencas Transmissiveis Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil; [Marialva, Eric Fabricio] Fiocruz Amazonia, Programa Pos Grad Biol Interacao Patogeno Hospede, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil; [Secundino, Nagila F.; Fernandes, Fernando F.; Pimenta, Paulo F. P.] Fiocruz Minas Gerais, Lab Entomol Med, Inst Rene Rachou, Belo Horizonte, MG, Brazil; [Fernandes, Fernando F.] Univ Fed Goias, Div Entomol, Goiania, Go, Brazil; [Araujo, Helena R. C.] Inst Pesquisas Tecnol Estado Sao Paulo IPT, Lab Biotecnol Ind, Sao Paulo, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Goias; Institute Pesquisas Tecnol Estado Sao Paulo SA	Marialva, EF (corresponding author), Fiocruz Amazonia, Lab Ecol Doencas Transmissiveis Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.; Marialva, EF (corresponding author), Fiocruz Amazonia, Programa Pos Grad Biol Interacao Patogeno Hospede, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.	ericmarialva304@gmail.com	Araujo, Helena/J-9209-2015	Araujo, Helena/0000-0002-2021-2217; Marialva, Eric Fabricio/0000-0002-2193-4318	CNPq productive fellowship; CNPq [401262/2014-6]; CAPES [001]	CNPq productive fellowship; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	FACP, NFS, PFPP are CNPq productive fellowship. FACP received a CNPq Grant 401262/2014-6 EFM was CAPES fellowship Grant Number 001.	ABONNENC EMILE, 1956, ARCH INST PASTEUR ALGERIE, V34, P518; Alencar RB, 2018, NEOTROP ENTOMOL, V47, P668, DOI 10.1007/s13744-018-0587-6; Alencar RB, 2018, ACTA TROP, V187, P182, DOI 10.1016/j.actatropica.2018.07.023; [Anonymous], 2000, REV LATINOAM ENFERMA, V8, P33; Araujo Filho N., 1979, THESIS, P144; Arrivillaga Jazzmin, 1999, Boletin de Entomologia Venezolana, V14, P1; Bahia AC, 2007, J MED ENTOMOL, V44, P903, DOI 10.1603/0022-2585(2007)44[903:UCOEMO]2.0.CO;2; Barretto M, 1941, ANAIS FACULDADE MED, V17, P357; Carzola D, 2001, REV COLOMBIANA ENTOM; Cazorla-Perfetti Dalmiro, 2015, Saber, V27, P232; Pessoa FAC, 2008, ZOOTAXA, P1; Costa PL, 2018, ACTA TROP, V187, P144, DOI 10.1016/j.actatropica.2018.07.027; Costa Wagner Alexandre, 2012, Revista Pan-Amazonica de Saude, V3, P19; De Almeida DN, 2004, J MED ENTOMOL, V41, P819, DOI 10.1603/0022-2585-41.5.819; de Carvalho M, 2007, CAD SAUDE PUBLICA, V23, P1227, DOI 10.1590/S0102-311X2007000500024; Fausto AM, 1999, MED VET ENTOMOL, V13, P101, DOI 10.1046/j.1365-2915.1999.00146.x; Fausto AM, 2001, MEM I OSWALDO CRUZ, V96, P197, DOI 10.1590/S0074-02762001000200011; Fernandes F de F, 2020, J MED ENTOMOLOGY, ptjaa085, DOI 10.1093/jme/tjaa085; Fernandez-Calderon F, 2020, J PSYCHOACTIVE DRUGS, V52, P344, DOI 10.1080/02791072.2020.1752959; Galati E, 2019, CLASSIFICACAO IDENTI; Galati EAB, 2018, PHLEBOTOMINAE DIPTER, DOI [10.1007/978-3-319-75544-1, DOI 10.1007/978-3-319-75544-1_2]; Ghaninia M, 2008, J EXP BIOL, V211, P3020, DOI 10.1242/jeb.016360; Hallberg E, 2003, LEPIDOPTERA MOTHS BU, V2, P267, DOI DOI 10.1515/9783110893724.267; Hanson W, 1968, THESIS, P105; LANE RP, 1986, J MED ENTOMOL, V23, P263, DOI 10.1093/jmedent/23.3.263; Lawyer P, 2017, PARASITE, V24, DOI 10.1051/parasite/2017041; Leite ACR, 1996, MEM I OSWALDO CRUZ, V91, P571, DOI 10.1590/S0074-02761996000500007; Leite ACR, 1997, MEM I OSWALDO CRUZ, V92, P197, DOI 10.1590/S0074-02761997000200011; Marcondes CB, 2007, ENTOMOL NEWS, V118, P351, DOI 10.3157/0013-872X(2007)118[351:APOGAS]2.0.CO;2; De Oca-Aguilar ACM, 2017, NEOTROP ENTOMOL, V46, P66, DOI 10.1007/s13744-016-0439-1; de Oca-Aguilar ACM, 2016, ZOOTAXA, V4105, P455, DOI 10.11646/zootaxa.4105.5.3; De Oca-Aguilar ACM, 2014, ZOOTAXA, V3887, P251, DOI 10.11646/zootaxa.3887.3.1; Pereira AM, 2019, ZOOTAXA, V4691, P270, DOI 10.11646/zootaxa.4691.3.7; Perez JE, 1997, MED VET ENTOMOL, V11, P127, DOI 10.1111/j.1365-2915.1997.tb00301.x; Pessoa FAC, 2000, MEM I OSWALDO CRUZ, V95, P689, DOI 10.1590/S0074-02762000000500013; Pessoa FAC, 2001, MEM I OSWALDO CRUZ, V96, P1103, DOI 10.1590/S0074-02762001000800013; Queiroz RG., 1995, THESIS, P224; RANGEL EF, 1990, MEM I OSWALDO CRUZ, V85, P39, DOI 10.1590/S0074-02761990000100006; Rios Leite A.C., 1991, Parassitologia (Rome), V33, P477; Salomon OD, 2010, ACTA TROP, V113, P84, DOI 10.1016/j.actatropica.2009.08.024; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Steinbrecht Rudolf Alexander, 1999, P155; Torrellas A, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180323; WARD RD, 1976, SYST ENTOMOL, V1, P89, DOI 10.1111/j.1365-3113.1976.tb00035.x; WARD RD, 1975, J ENTOMOL SER A, V50, P127; Zacharuk R.Y., 1985, P1	46	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242163	10.1371/journal.pone.0242163	http://dx.doi.org/10.1371/journal.pone.0242163			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180853	Green Submitted, Green Published, gold			2022-12-26	WOS:000593948000036
J	Cruz-Miralles, A; Aviles, JM; Chastel, O; Exposito-Granados, M; Parejo, D				Cruz-Miralles, Angel; Aviles, Jesus M.; Chastel, Olivier; Exposito-Granados, Monica; Parejo, Deseada			Phaeomelanin matters: Redness associates with inter-individual differences in behaviour and feather corticosterone in male scops owls (Otus scops)	PLOS ONE			English	Article							MELANIN-BASED COLORATION; PHENOTYPIC INTEGRATION; ANTIPREDATOR BEHAVIOR; STRESS RESPONSES; PLUMAGE COLOR; BARN OWL; PERSONALITY; PIGMENTATION; SENSITIVITY; AGGRESSION	Individuals within populations often show consistent variation in behavioural and physiological traits which are frequently inter-correlated, potentially leading to phenotypic integration. Understanding the mechanisms behind such integration is a key task in evolutionary ecology, and melanin based colouration has been suggested to play a pivotal role. In birds, most of plumage colour variation is determined by two types of melanin, eumelanin and phaeomelanin, but the role of phaeomelanin in avian phenotype integration has been barely investigated. Here, we test for covariation between phaeomelanin-based colouration, behavioural traits (i.e. nest territoriality, aggressiveness, breath rate and parental behaviour) and corticosterone in feathers in the polymorphic scops owl Otus scops, a bird species in which more phaeomelanic individuals display reddish colourations. In males, we observed that reddish males took longer to return to their nests and showed higher levels of feather CORT than more greyish ones. Behaviour and feather CORT were not associated to plumage colour in females. The found associations between redness, behaviour and feather CORT in males, but not in females, might suggest the existence of a sex-specific integrated phaeomelanic phenotype in scops owls.	[Cruz-Miralles, Angel; Parejo, Deseada] Univ Extremadura, Fac Ciencias, Dept Anat Biol Celular & Zool, Badajoz, Spain; [Cruz-Miralles, Angel; Aviles, Jesus M.; Exposito-Granados, Monica; Parejo, Deseada] CSIC, EEZA, Dept Ecol Func & Evolut, Almeria, Spain; [Chastel, Olivier] CNRS, Ctr Etud Biol Chize, Villiers En Bois, France; [Exposito-Granados, Monica] Univ Almeria, Area Econ Aplicada, Dept Econ & Empresa, Almeria, Spain	Universidad de Extremadura; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Centre National de la Recherche Scientifique (CNRS); Universidad de Almeria	Cruz-Miralles, A (corresponding author), Univ Extremadura, Fac Ciencias, Dept Anat Biol Celular & Zool, Badajoz, Spain.; Cruz-Miralles, A; Aviles, JM (corresponding author), CSIC, EEZA, Dept Ecol Func & Evolut, Almeria, Spain.	javiles@eeza.csic.es; ancruzmi@unex.es		CRUZ-MIRALLES, ANGEL/0000-0003-4825-7262	Spanish Ministry of Economy and Competitiveness [BES-2015-074948, CGL2008-00718, CGL2011-27561, CGL2014-56769-P, CGL2017-83503-P]; government of Extremadura [TA13002]	Spanish Ministry of Economy and Competitiveness(Spanish Government); government of Extremadura	This work was founded by Spanish Ministry of Economy and Competitiveness by the projects CGL2008-00718, CGL2011-27561, CGL2014-56769-P and CGL2017-83503-P to JMA and DP. ACM was supported by the Spanish Ministry of Economy and Competitiveness (grant number BES-2015-074948). DP was supported by the government of Extremadura (TA13002). The funders had no role in study design data collection and analysis,decision to publish, or preparation of the manuscript.; We thank people who helped us during fieldwork in the different years and the staff of the Centre d'Etudes Biologiques of Chize '. We thank the constructive comments by two anonymous referees and R. Ambrosini on a previous draft of the manuscript. We acknowledge support of the publication fee by the CSIC Open Access Publication Support Initiative through its Unit of Information Resources for Research (URICI).	Abolins-Abols M, 2018, MOL ECOL, V27, P4501, DOI 10.1111/mec.14878; Almasi B, 2010, J EVOLUTION BIOL, V23, P987, DOI 10.1111/j.1420-9101.2010.01969.x; Almasi B, 2008, HORM BEHAV, V54, P217, DOI 10.1016/j.yhbeh.2008.02.021; Almasi B, 2013, HORM BEHAV, V64, P161, DOI 10.1016/j.yhbeh.2013.03.001; Angelier F, 2018, PHYSIOL BEHAV, V184, P261, DOI 10.1016/j.physbeh.2017.12.012; [Anonymous], 2018, STROKE, V49, pe233; Arai E, 2017, BEHAV ECOL, V28, P706, DOI 10.1093/beheco/arx012; Aviles JM, 2020, ARDEOLA, V67, P3, DOI 10.13157/arla.67.1.2020.ra1; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Boerner M, 2009, BEHAV ECOL, V20, P180, DOI 10.1093/beheco/arn132; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Burns CMB, 2013, J EVOLUTION BIOL, V26, P820, DOI 10.1111/jeb.12094; Carere C, 2003, HORM BEHAV, V43, P540, DOI 10.1016/S0018-506X(03)00065-5; Chang CM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-19; Costanzo A, 2018, BEHAV ECOL, V29, P1472, DOI 10.1093/beheco/ary102; Cramp S, 1998, COMPLETE BIRDS W PAL; Da Silva A, 2013, BEHAV ECOL SOCIOBIOL, V67, P1041, DOI 10.1007/s00265-013-1529-2; del Hoyo J, 1999, HDB BIRDS WORLD; Delhey K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011582; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Emaresi G, 2014, AM NAT, V183, P269, DOI 10.1086/674444; Fargallo JA, 2014, BEHAV ECOL, V25, P76, DOI 10.1093/beheco/art088; Figueiredo HF, 2007, AM J PHYSIOL-ENDOC M, V292, pE1173, DOI 10.1152/ajpendo.00102.2006; Fucikova E, 2009, ETHOLOGY, V115, P366, DOI 10.1111/j.1439-0310.2009.01618.x; Galvan I, 2018, BIOL J LINN SOC, V125, P760, DOI 10.1093/biolinnean/bly164; Galvan I, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040520; Galvan I, 2015, EVOLUTION, V69, P26, DOI 10.1111/evo.12549; Galvan I, 2011, OECOLOGIA, V165, P827, DOI 10.1007/s00442-010-1860-5; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Grunst AS, 2015, J AVIAN BIOL, V46, P9, DOI 10.1111/jav.00496; Gunnarsson U, 2007, GENETICS, V175, P867, DOI 10.1534/genetics.106.063107; HAASE E, 1992, J HERED, V83, P64, DOI 10.1093/oxfordjournals.jhered.a111160; Hanley D, 2013, BEHAV ECOL, V24, P1108, DOI 10.1093/beheco/art037; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Jenkins BR, 2013, HORM BEHAV, V64, P665, DOI 10.1016/j.yhbeh.2013.08.006; Karell P, 2013, J AVIAN BIOL, V44, P235, DOI 10.1111/j.1600-048X.2012.05868.x; Ketterson ED, 2009, INTEGR COMP BIOL, V49, P365, DOI 10.1093/icb/icp057; Kim SY, 2015, EVOLUTION, V69, P830, DOI 10.1111/evo.12600; Kimball RT, 2006, BIRD COLORATION, P137; Korte SM, 2005, NEUROSCI BIOBEHAV R, V29, P3, DOI 10.1016/j.neubiorev.2004.08.009; Kosower N S, 1978, Int Rev Cytol, V54, P109, DOI 10.1016/S0074-7696(08)60166-7; Kralj-Fiser S, 2007, HORM BEHAV, V51, P239, DOI 10.1016/j.yhbeh.2006.10.006; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Lehtonen PK, 2012, HEREDITY, V108, P431, DOI 10.1038/hdy.2011.93; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lormee H, 2003, IBIS, V145, P212, DOI 10.1046/j.1474-919X.2003.00106.x; McGraw KJ, 2005, FUNCT ECOL, V19, P816, DOI 10.1111/j.1365-2435.2005.01032.x; McGraw KJ, 2004, CONDOR, V106, P390, DOI 10.1650/7384; McGraw KJ., 2006, BIRD COLORATION, P243; Meunier J, 2011, BEHAV ECOL SOCIOBIOL, V65, P559, DOI 10.1007/s00265-010-1092-z; Minvielle F, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-15; Parejo D, 2012, P ROY SOC B-BIOL SCI, V279, P2135, DOI 10.1098/rspb.2011.2601; Piault R, 2009, AM NAT, V174, P548, DOI 10.1086/605374; Pigliucci M, 2003, ECOL LETT, V6, P265, DOI 10.1046/j.1461-0248.2003.00428.x; Prota G, 2012, MELANINS MELANOGENES; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rodriguez J, 2011, IBIS, V153, P735, DOI 10.1111/j.1474-919X.2011.01161.x; Rosvall KA, 2012, P ROY SOC B-BIOL SCI, V279, P3547, DOI 10.1098/rspb.2012.0442; Roulin A, 2004, IBIS, V146, P509, DOI 10.1111/j.1474-919x.2004.00292.x; Roulin A, 2016, BIOL REV, V91, P328, DOI 10.1111/brv.12171; Roulin A, 2011, OECOLOGIA, V166, P913, DOI 10.1007/s00442-011-1955-7; Saino N, 2013, EVOL BIOL, V40, P521, DOI 10.1007/s11692-013-9228-5; San-Jose LM, 2018, AM NAT, V192, P111, DOI 10.1086/698010; San-Jose LM, 2017, MOL ECOL, V26, P259, DOI 10.1111/mec.13861; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schoech SJ, 2009, GEN COMP ENDOCR, V163, P201, DOI 10.1016/j.ygcen.2008.09.009; Sih A, 2008, ADV STUD BEHAV, V38, P227, DOI 10.1016/S0065-3454(08)00005-3; Sternalski A, 2010, BEHAV ECOL SOCIOBIOL, V64, P1351, DOI 10.1007/s00265-010-0950-z; Szymkowiak J, 2016, OIKOS, V125, P1561, DOI 10.1111/oik.03052; van den Brink V, 2012, ETHOLOGY, V118, P673, DOI 10.1111/j.1439-0310.2012.02057.x; van den Brink V, 2012, BEHAV ECOL, V23, P473, DOI 10.1093/beheco/arr213; Garamszegi LZ, 2012, EVOL ECOL, V26, P1213, DOI 10.1007/s10682-012-9589-8; Zuur Alain F., 2009, P1	74	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241380	10.1371/journal.pone.0241380	http://dx.doi.org/10.1371/journal.pone.0241380			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175892	Green Published, gold			2022-12-26	WOS:000593946900043
J	Pepping, MY; O'Rourke, SM; Huang, CN; Katz, JVE; Jeffres, C; Miller, MR				Pepping, Michelle Y.; O'Rourke, Sean M.; Huang, Connie; Katz, Jacob V. E.; Jeffres, Carson; Miller, Michael R.			Rapture facilitates inexpensive and high-throughput parent-based tagging in salmonids	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; STOCK IDENTIFICATION; COHO SALMON; ONCORHYNCHUS; POPULATION; STEELHEAD; RIVER; SNPS; MICROSATELLITES; ADAPTATION	Accurate methods for tracking individuals are crucial to the success of fisheries and aquaculture management. Management of migratory salmonid populations, which are important for the health of many economies, ecosystems, and indigenous cultures, is particularly dependent on data gathered from tagged fish. However, the physical tagging methods currently used have many challenges including cost, variable marker retention, and information limited to tagged individuals. Genetic tracking methods combat many of the problems associated with physical tags, but have their own challenges including high cost, potentially difficult marker design, and incompatibility of markers across species. Here we show the feasibility of a new genotyping method for parent-based tagging (PBT), where individuals are tracked through the inherent genetic relationships with their parents. We found that Rapture sequencing, a combination of restriction-site associated DNA and capture sequencing, provides sufficient data for parentage assignment. Additionally, the same capture bait set, which targets specific restriction-site associated DNA loci, can be used for both Rainbow Trout Oncorhynchus mykiss and Chinook Salmon Oncorhynchus tshawytscha. We input 248 single nucleotide polymorphisms from 1,121 samples to parentage assignment software and compared parent-offspring relationships of the spawning pairs recorded in a hatchery. Interestingly, our results suggest sperm contamination during hatchery spawning occurred in the production of 14% of offspring, further confirming the need for genetic tagging in accurately tracking individuals. PBT with Rapture successfully assigned progeny to parents with a 98.86% accuracy with sufficient genetic data. Cost for this pilot study was approximately $3 USD per sample. As costs vary based on the number of markers used and individuals sequenced, we expect that when implemented at a large-scale, per sample costs could be further decreased. We conclude that Rapture PBT provides a cost-effective and accurate alternative to the physical coded wire tags, and other genetic-based methods.	[Pepping, Michelle Y.; O'Rourke, Sean M.; Huang, Connie; Miller, Michael R.] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Pepping, Michelle Y.; Jeffres, Carson; Miller, Michael R.] Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA; [Katz, Jacob V. E.] Calif Trout, San Francisco, CA USA	University of California System; University of California Davis; University of California System; University of California Davis	Pepping, MY (corresponding author), Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA.; Pepping, MY (corresponding author), Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA.	mypepping@ucdavis.edu		Jeffres, Carson/0000-0001-6532-6851; Pepping, Michelle/0000-0002-5378-6217	California Trout Inc.	California Trout Inc.	MYP, SMO and MRM received funding from California Trout Inc. (https://caltrout.org/).One contributing author is an employee of California Trout Inc. (JVEK). The contributing author was involved with conceptualization costeffective PBT and suggested the species and general location of theand analysis, decision to publish, or preparation of the manuscript. study population. The funders had no role in study design, data collection	Abadia-Cardoso A, 2013, MOL ECOL, V22, P4733, DOI 10.1111/mec.12426; Ali OA, 2016, GENETICS, V202, P389, DOI 10.1534/genetics.115.183665; Anderson EC, 2006, GENETICS, V172, P2567, DOI 10.1534/genetics.105.048074; Araki H, 2007, SCIENCE, V318, P100, DOI 10.1126/science.1145621; Ashton NK, 2016, NORTHWEST SCI, V90, P249, DOI 10.3955/046.090.0303; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Beacham TD, 2017, CAN J FISH AQUAT SCI, V74, P1391, DOI 10.1139/cjfas-2016-0452; Begg GA, 1999, FISH RES, V43, P1, DOI 10.1016/S0165-7836(99)00062-4; BERGMAN PK, 1992, FISHERIES, V17, P20, DOI 10.1577/1548-8446(1992)017<0020:PODUAM>2.0.CO;2; Berthelot C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4657; Boxberger Daniel L., 1988, AM INDIAN Q, V12, p299 302; Buerkle CA, 2013, MOL ECOL, V22, P3028, DOI 10.1111/mec.12105; Campbell MR, 2012, T AM FISH SOC, V141, P1310, DOI 10.1080/00028487.2012.690816; Campbell NR, 2015, MOL ECOL RESOUR, V15, P855, DOI 10.1111/1755-0998.12357; Cederholm CJ, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024&lt;0006:PSC&gt;2.0.CO;2; Chittenden C, 2009, ENVIRON BIOL FISH, V84, P129, DOI 10.1007/s10641-008-9396-9; Christie MR, 2012, P NATL ACAD SCI USA, V109, P238, DOI 10.1073/pnas.1111073109; Crete-Lafreniere A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046662; Denson MR, 2012, N AM J FISH MANAGE, V32, P32, DOI 10.1080/02755947.2011.649577; Fisheries N., 2018, ATL HERR MAN PLAN; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gibbons JW, 2004, BIOSCIENCE, V54, P447, DOI 10.1641/0006-3568(2004)054[0447:PTSTAI]2.0.CO;2; Gill P, 2001, INT J LEGAL MED, V114, P204, DOI 10.1007/s004149900117; Glaubitz JC, 2003, MOL ECOL, V12, P1039, DOI 10.1046/j.1365-294X.2003.01790.x; Gresh T, 2000, FISHERIES, V25, P15, DOI 10.1577/1548-8446(2000)025<0015:AEOHAC>2.0.CO;2; Gunther E, 1926, AM ANTHROPOL, V28, P605, DOI 10.1525/aa.1926.28.4.02a00020; Gustafson RG, 2007, CONSERV BIOL, V21, P1009, DOI 10.1111/j.1523-1739.2007.00693.x; Hammer SA, 2001, N AM J AQUACULT, V63, P171, DOI 10.1577/1548-8454(2001)063<0171:CCOMTA>2.0.CO;2; Hanna J., 2007, NATURAL RESOURCES EN, V22, P13; Hauser L, 2011, MOL ECOL RESOUR, V11, P150, DOI 10.1111/j.1755-0998.2010.02961.x; Johnson GE, 2013, N AM J FISH MANAGE, V33, P1000, DOI 10.1080/02755947.2013.822441; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Katz JVE, 2013, KNAGGS RANCH EXPT AG; Kelson SJ, 2020, MOL ECOL, V29, P870, DOI 10.1111/mec.15367; Kelson SJ, 2019, CAN J FISH AQUAT SCI, V76, P2080, DOI 10.1139/cjfas-2018-0394; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Levin PS, 2001, AM SCI, V89, P220, DOI 10.1511/2001.3.220; Lichatowich J, 1999, ICES J MAR SCI, V56, P467, DOI 10.1006/jmsc.1999.0457; Margres MJ, 2018, MOL ECOL, V27, P4189, DOI 10.1111/mec.14853; Miller MR, 2012, MOL ECOL, V21, P237, DOI 10.1111/j.1365-294X.2011.05305.x; Nandor GF, 2009, OVERVIEW CODED WIRE, P53; National Marine Fisheries Service, 2014, FISH EC US 2012; North Pacific Anadromous Fish Commission, 2017, NPAFC PAC SALM HATCH; Ozerov M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082434; Paris JR, 2018, J FISH BIOL, V92, P727, DOI 10.1111/jfb.13549; Pavey SA, 2015, MOL ECOL RESOUR, V15, P685, DOI 10.1111/1755-0998.12405; Prince DJ, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603198; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Rex JF, 2008, NAT GEOSCI, V1, P840, DOI 10.1038/ngeo364; Schwanke C.J., 2018, FISHERY DATA SERIES; Shaklee JB, 1999, FISH RES, V43, P45, DOI 10.1016/S0165-7836(99)00066-1; Sommer TR, FLOODPLAIN HABITAT N, V01, P7; State of California, 2018, FISHERIES BRANCH RES; STEARLEY RF, 1993, T AM FISH SOC, V122, P1, DOI 10.1577/1548-8659(1993)122<0001:POTPTA>2.3.CO;2; Steele CA, 2013, CAN J FISH AQUAT SCI, V70, P1046, DOI 10.1139/cjfas-2012-0451; Swezey SL, 1977, RITUAL MANAGEMENT SA, V30; Tsosie R., 2000, INDIAN LAW REV, V34, P1291; Vanstone JW, 1968, FIELDIANA ANTHR, V54, P149; Webster MS, 2005, METHOD ENZYMOL, V395, P222, DOI 10.1016/S0076-6879(05)95014-3; Whitlock SL, 2017, CAN J FISH AQUAT SCI, V74, P1646, DOI 10.1139/cjfas-2016-0154; Wolf KS, 2010, PACIFIC NW AQUATIC M	61	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0239221	10.1371/journal.pone.0239221	http://dx.doi.org/10.1371/journal.pone.0239221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175847	gold, Green Published			2022-12-26	WOS:000593946900041
J	Zu, GX; Sun, QQ; Chen, J; Liu, XJ; Sun, KY; Zhang, LK; Li, L; Han, T; Huang, HL				Zu, Guo-Xiu; Sun, Qian-Qian; Chen, Jian; Liu, Xi-Jian; Sun, Ke-Yun; Zhang, Liang-Kun; Li, Ling; Han, Tao; Huang, Hai-Liang			Urine metabolomics of rats with chronic atrophic gastritis	PLOS ONE			English	Article								Background/aim To use liquid chromatography-mass spectrometry (LC-MS) to identify endogenous differential metabolites in the urine of rats with chronic atrophic gastritis (CAG). Materials and methods Methylnitronitrosoguanidine (MNNG) was used to produce a CAG model in Wistar rats, and HE staining was used to determine the pathological model. LC-MS was used to detect the differential metabolic profiles in rat urine. Diversified analysis was performed by the statistical method. Results Compared with the control group, the model group had 68 differential metabolites, 25 that were upregulated and 43 that were downregulated. The main metabolic pathways were D-glutamine and D-glutamic acid metabolism, histidine metabolism and purine metabolism. Conclusion By searching for differential metabolites and metabolic pathways in the urine of CAG rats, this study provides effective experimental data for the pathogenesis and clinical diagnosis of CAG.	[Zu, Guo-Xiu; Sun, Qian-Qian; Chen, Jian; Liu, Xi-Jian; Sun, Ke-Yun; Zhang, Liang-Kun; Li, Ling] Shandong Univ Tradit Chinese Med, Dept Tradit Chinese Med, Jinan, Shandong, Peoples R China; [Chen, Jian] Shandong First Med Univ, Affiliated Cent Hosp, Jinan, Shandong, Peoples R China; [Han, Tao] Shandong Univ Tradit Chinese Med, Grad Off, Jinan, Shandong, Peoples R China; [Huang, Hai-Liang] Shandong Univ Tradit Chinese Med, Dept Rehabil Med, Jinan, Shandong, Peoples R China	Shandong University of Traditional Chinese Medicine; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University of Traditional Chinese Medicine; Shandong University of Traditional Chinese Medicine	Han, T (corresponding author), Shandong Univ Tradit Chinese Med, Grad Off, Jinan, Shandong, Peoples R China.; Huang, HL (corresponding author), Shandong Univ Tradit Chinese Med, Dept Rehabil Med, Jinan, Shandong, Peoples R China.	60012002@sdutcm.edu.cn; 06000031@sdutcm.edu.cn	hailiang, huang/HCG-9762-2022	huang, hailiang/0000-0003-1186-4501; zu, guoxiu/0000-0002-7773-0568	Preliminary Mechanism and Efficacy Evaluation by the excellent scientific research and innovation teams at Shandong University of Traditional Chinese Medicine in the treatment of major diseases [220316]; Shandong province key research and development plan [2016CYJS08A01-6]	Preliminary Mechanism and Efficacy Evaluation by the excellent scientific research and innovation teams at Shandong University of Traditional Chinese Medicine in the treatment of major diseases; Shandong province key research and development plan	The grant of the Preliminary Mechanism and Efficacy Evaluation by the excellent scientific research and innovation teams at Shandong University of Traditional Chinese Medicine in the treatment of major diseases No. 220316 and Shandong province key research and development plan 2016CYJS08A01-6"Establishment of Clinical Diagnosis and Treatment Standard System of Precise Prescription for the Prevention and Treatment of Gastric Precancerous Lesions by Jingfang Pinellia Xiexin Decoction.; The authors thank Suzhou BioNovoGene Biopharmaceutical Technology Co., Ltd., for their technical assistance. And the Editing and Manuscript Formatting service provided by American Journal Experts.	[Anonymous], 2020, J ULTRASOUND MED, V39, pE17; [Anonymous], 2017, KIDNEY INT S, V7, p[1, 1], DOI DOI 10.1016/j.kisu.2017.04.001; Chen D, 1988, SICHUAN J PHYSL SCI, P56; Cui JJ, 2017, J PHARMACEUT BIOMED, V132, P77, DOI 10.1016/j.jpba.2016.09.044; Escobar-Resendiz R, 2020, FASEB J, V34, DOI 10.1096/fasebj.2020.34.s1.00724; Gao C, 2003, CHIN J MED, P719; Gao S, 2004, J 3 MIL MED U, P1524; Geng Z, 2009, JILIN ZHONG MED, V29, P527; Hao H, 2017, CORRELATION PATHOLOG; Hirasawa T, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700612; Hu T, 2018, RES NEW METHODS STRA; Jiang YN, 2017, ONCOTARGET, V8, P33444, DOI 10.18632/oncotarget.16800; Jiaolong Chen, 2018, METABONOMICS BASED S; Kong X.R., 2015, CHINESE J INTEGRATED, V23, P381; Liu YT, 2020, J PHARM PHARMACOL, V72, P748, DOI 10.1111/jphp.13242; Qi X, 2019, HUBEI J TRADIT CHIN, V41, P3; Shu H, 2015, EXPT STUDY EFFECT ME; Si J, 2001, CHIN J DIG, P7; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Suguitan Jr AL, 2011, PLOS ONE, V6; Tozzi MG, 2013, CURR MED CHEM, V20, P4285; Vogel M, 2019, STEM CELLS, V37, P1606, DOI 10.1002/stem.3087; Want EJ, 2013, NAT PROTOC, V8, P17, DOI 10.1038/nprot.2012.135; Wu Q, 2017, CKD MBD RELATED BIOM; Yina Sun, 2017, PATHOGENESIS TRANSFO; Yuan Xiaobing, 2004, J ANHUI TRADITIONAL, V23, P62, DOI [10.3969/j.issn.1000-2219.2004.05.029, DOI 10.3969/J.ISSN.1000-2219.2004.05.029]	26	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0236203	10.1371/journal.pone.0236203	http://dx.doi.org/10.1371/journal.pone.0236203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175875	Green Published, gold, Green Submitted			2022-12-26	WOS:000593946900073
J	Cashion, T; Nguyen, T; ten Brink, T; Mook, A; Palacios-Abrantes, J; Roberts, SM				Cashion, Tim; Tu Nguyen; ten Brink, Talya; Mook, Anne; Palacios-Abrantes, Juliano; Roberts, Sarah M.			Shifting seas, shifting boundaries: Dynamic marine protected area designs for a changing climate	PLOS ONE			English	Article							IMPACTS; BIODIVERSITY; MANAGEMENT; BENEFITS; FRAMEWORK; FISHERIES; RESERVES; OCEAN	Marine protected areas (MPAs) are valuable tools for marine conservation that aim to limit human impacts on marine systems and protect valuable species or habitats. However, as species distributions shift due to ocean warming, acidification, and oxygen depletion from climate change, the areas originally designated under MPAs may bear little resemblance to their past state. Different approaches have been suggested for coping with species on the move in conservation. Here, we test the effectiveness of different MPA designs, including dynamic, network, and different directional orientations on protecting shifting species under climate change through ecosystem modeling in a theoretical ecosystem. Our findings suggest that dynamic MPAs may benefit some species (e.g., whiting and anchovy) and fishing fleets, and these benefits can inform the design or adaptation of MPAs worldwide. In addition, we find that it is important to design MPAs with specific goals and to account for the effects of released fishing pressure and species interactions in MPA design.	[Cashion, Tim] Univ British Columbia, Inst Oceans & Fisheries, Fisheries Econ Res Unit, Vancouver, BC, Canada; [Tu Nguyen] Oregon State Univ, Dept Appl Econ, Corvallis, OR 97331 USA; [ten Brink, Talya] NOAA, Greater Atlantic Reg Fisheries Off, Natl Marine Fisheries Serv, Gloucester, MA USA; [Mook, Anne] Nazarbayev Univ, Dept Sociol & Anthropol, Nur Sultan, Kazakhstan; [Palacios-Abrantes, Juliano] Univ British Columbia, Inst Oceans & Fisheries, Changing Ocean Res Unit, Vancouver, BC, Canada; [Roberts, Sarah M.] Duke Univ, Nicholas Sch Environm & Earth Sci, Marine Geospatial Ecol Lab, Durham, NC USA	University of British Columbia; Oregon State University; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Nazarbayev University; University of British Columbia; Duke University	Cashion, T (corresponding author), Univ British Columbia, Inst Oceans & Fisheries, Fisheries Econ Res Unit, Vancouver, BC, Canada.	t.cashion@oceans.ubc.ca		Cashion, Tim/0000-0002-2945-5397; Roberts, Sarah/0000-0001-5441-3458; Palacios-Abrantes, Juliano/0000-0001-8969-5416	National Socio-Environmental Synthesis Center (SESYNC); National Science Foundation [DBI-1639145]	National Socio-Environmental Synthesis Center (SESYNC)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the National Science Foundation DBI-1639145. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SK, 2013, SCIENCE; [Anonymous], 2019, REG ANESTH PAIN MED, V44, pe1; Asche F, 2005, SNF WORKING PAPER, V37, P44; Barange M, 2014, NAT CLIM CHANGE, V4, P211, DOI [10.1038/NCLIMATE2119, 10.1038/nclimate2119]; Baudron AR, 2020, ECOGRAPHY, V43, P494, DOI 10.1111/ecog.04864; Beattie A, 2001, MARINE PROTECTED ARE; Beattie Alasdair, 2002, Natural Resource Modeling, V15, P413; Bennett NJ, 2014, MAR POLICY, V44, P107, DOI 10.1016/j.marpol.2013.08.017; Bruno JF, 2018, NAT CLIM CHANGE, V8, P499, DOI 10.1038/s41558-018-0149-2; Burrows MT, 2019, NAT CLIM CHANGE, V9, P959, DOI 10.1038/s41558-019-0631-5; Cheung WWL, 2018, J FISH BIOL, V92, P790, DOI 10.1111/jfb.13558; Cheung WWL, 2016, SCIENCE, V354, P1591, DOI 10.1126/science.aag2331; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Christensen V, 2018, TUTORIAL 9 SPATIAL M; Colleter M, 2015, ECOL MODEL, V302, P42, DOI 10.1016/j.ecolmodel.2015.01.025; Costello C, 2010, P NATL ACAD SCI USA, V107, P18294, DOI 10.1073/pnas.0908057107; Davies TE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08758-5; Davies TE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195760; Erauskin-Extramiana M, 2019, GLOBAL CHANGE BIOL, V25, P2043, DOI 10.1111/gcb.14630; Fredston-Hermann A, 2018, ANN NY ACAD SCI, V1429, P5, DOI 10.1111/nyas.13597; Gaines SD, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao1378; Game ET, 2009, ECOL LETT, V12, P1336, DOI 10.1111/j.1461-0248.2009.01384.x; Gill DA, 2017, NATURE, V543, P665, DOI 10.1038/nature21708; Gruss A, 2011, BIOL CONSERV, V144, P692, DOI 10.1016/j.biocon.2010.12.015; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Hole DG, 2011, CONSERV BIOL, V25, P305, DOI 10.1111/j.1523-1739.2010.01633.x; Johnston A, 2013, NAT CLIM CHANGE, V3, P1055, DOI 10.1038/NCLIMATE2035; Jones MC, 2015, ICES J MAR SCI, V72, P741, DOI 10.1093/icesjms/fsu172; Kleisner KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149220; Lester SE, 2013, MAR POLICY, V38, P80, DOI 10.1016/j.marpol.2012.05.022; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Levin PS, 2009, J APPL ECOL, V46, P735, DOI 10.1111/j.1365-2664.2009.01667.x; Maxwell SM, 2020, SCIENCE, V367, P252, DOI 10.1126/science.aaz9327; Maxwell SM, 2015, MAR POLICY, V58, P42, DOI 10.1016/j.marpol.2015.03.014; Mitchell JD, 2018, MAR ECOL PROG SER, V587, P141, DOI 10.3354/meps12412; Pecl GT, 2017, SCIENCE, V355, DOI 10.1126/science.aai9214; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Poloczanska ES, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00062; Rees SE, 2013, J ENVIRON MANAGE, V114, P476, DOI 10.1016/j.jenvman.2012.10.048; Serpetti N, 2017, SCI REPORTS, P7, DOI [10.1038/s41598-017-00035-9, DOI 10.1038/S41598-017-00035-9]; Song A, 2017, CONTINENTAL ENV POLI, P156; Wabnitz CCC, 2018, MAR POLICY, V88, P323, DOI 10.1016/j.marpol.2017.07.022; Walters C, 1999, ECOSYSTEMS, V2, P539, DOI 10.1007/s100219900101; Walters CJ, 2005, ICES J MAR SCI, V62, P558, DOI 10.1016/j.icesjms.2004.12.005; Wielgus J, 2008, ECOL ECON, V67, P32, DOI 10.1016/j.ecolecon.2008.04.019	46	8	8	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241771	10.1371/journal.pone.0241771	http://dx.doi.org/10.1371/journal.pone.0241771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OV7KH	33170879	gold, Green Published			2022-12-26	WOS:000592383400029
J	Sandeu, MM; Mulamba, C; Weedall, GD; Wondji, CS				Sandeu, Maurice Marcel; Mulamba, Charles; Weedall, Gareth D.; Wondji, Charles S.			A differential expression of pyrethroid resistance genes in the malaria vector Anopheles funestus across Uganda is associated with patterns of gene flow	PLOS ONE			English	Article							POPULATION-STRUCTURE; INSECTICIDE RESISTANCE; F-STATISTICS; GAMBIAE; MICROSATELLITE; CULICIDAE; INFERENCE; MOSQUITOS; SOFTWARE; SAVANNA	Background Insecticide resistance is challenging the effectiveness of insecticide-based control interventions to reduce malaria burden in Africa. Understanding the molecular basis of insecticides resistance and patterns of gene flow in major malaria vectors such as Anopheles funestus are important steps for designing effective resistance management strategies. Here, we investigated the association between patterns of genetic structure and expression profiles of genes involved in the pyrethroid resistance in An. funestus across Uganda and neighboring Kenya. Methods Blood-fed mosquitoes An. funestus were collected across the four localities in Uganda and neighboring Kenya. A Microarray-based genome-wide transcription analysis was performed to identify the set of genes associated with permethrin resistance. 17 microsatellites markers were genotyped and used to establish patterns of genetic differentiation. Results Microarray-based genome-wide transcription profiling of pyrethroid resistance in four locations across Uganda (Arua, Bulambuli, Lira, and Tororo) and Kenya (Kisumu) revealed that resistance was mainly driven by metabolic resistance. The most commonly up-regulated genes in pyrethroid resistance mosquitoes include cytochrome P450s (CYP9K1, CYP6M7, CYP4H18, CYP4H17, CYP4C36). However, expression levels of key genes vary geographically such as the P450 CYP6M7 [Fold-change (FC) = 115.8 (Arua) vs 24.05 (Tororo) and 16.9 (Kisumu)]. In addition, several genes from other families were also over-expressed including Glutathione S-transferases (GSTs), carboxylesterases, trypsin, glycogenin, and nucleotide binding protein which probably contribute to insecticide resistance across Uganda and Kenya. Genotyping of 17 microsatellite loci in the five locations provided evidence that a geographical shift in the resistance mechanisms could be associated with patterns of population structure throughout East Africa. Genetic and population structure analyses indicated significant genetic differentiation between Arua and other localities (F(ST)0.03) and revealed a barrier to gene flow between Arua and other areas, possibly associated with Rift Valley. Conclusion The correlation between patterns of genetic structure and variation in gene expression could be used to inform future interventions especially as new insecticides are gradually introduced.	[Sandeu, Maurice Marcel; Wondji, Charles S.] Ctr Res Infect Dis CRID, Dept Med Entomol, LSTM Res Unit, Yaounde, Cameroon; [Sandeu, Maurice Marcel] Univ Ngaoundere, Sch Vet Med & Sci, Dept Microbiol & Infect Dis, Ngaoundere, Cameroon; [Mulamba, Charles; Weedall, Gareth D.; Wondji, Charles S.] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England; [Mulamba, Charles] Uganda Virus Res Inst, Entebbe, Uganda	Liverpool School of Tropical Medicine; Uganda Virus Research Institute	Sandeu, MM; Wondji, CS (corresponding author), Ctr Res Infect Dis CRID, Dept Med Entomol, LSTM Res Unit, Yaounde, Cameroon.; Sandeu, MM (corresponding author), Univ Ngaoundere, Sch Vet Med & Sci, Dept Microbiol & Infect Dis, Ngaoundere, Cameroon.; Wondji, CS (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England.	Marcel.Sandeu@crid-cam.net; Charles.Wondji@lstmed.ac.uk		SANDEU, Maurice Marcel/0000-0002-6780-5394	Wellcome Trust Master Fellowship in Public Health and Tropical Medicine [092794/Z/10/Z]; Wellcome Trust Research Career Development Fellowship [083515/Z/07/Z]	Wellcome Trust Master Fellowship in Public Health and Tropical Medicine(Wellcome Trust); Wellcome Trust Research Career Development Fellowship(Wellcome Trust)	This work was supported by a Wellcome Trust Master Fellowship in Public Health and Tropical Medicine to CM (092794/Z/10/Z) and a Wellcome Trust Research Career Development Fellowship to CSW (083515/Z/07/Z). Charles Mulamba, received a salary from a Wellcome Trust Master Fellowship in Public Health and Tropical Medicine (092794/Z/10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, WHOCDCMAL98; [Anonymous], 2017, LANCET HIV, V2017, pPE475; [Anonymous], 2019, FRONTIERS PLANT SCI; [Anonymous], 2008, POLANYIANA, V17, P19; Ayala D, 2006, ACTA TROP, V97, P292, DOI 10.1016/j.actatropica.2005.12.002; Ayala D, 2011, INFECT GENET EVOL, V11, P940, DOI 10.1016/j.meegid.2011.03.003; Barnes KG, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006539; Barnes KG, 2017, P NATL ACAD SCI USA, V114, P286, DOI 10.1073/pnas.1615458114; Belkhir K, 2004, 1996 2004 GENETIX 4; Besansky NJ, 1997, GENETICS, V147, P1817; Chen H, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-48; Cohuet A, 2005, GENETICS, V169, P301, DOI 10.1534/genetics.103.025031; Cohuet A, 2004, INSECT MOL BIOL, V13, P251, DOI 10.1111/j.0962-1075.2004.00482.x; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Fontaine MC, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-30; Gillies M, 1987, ANOPHELINAE AFRICA S; Gong YH, 2013, INT J BIOL SCI, V9, P863, DOI 10.7150/ijbs.6744; Goudet J, 1995, FSTAT VERSION 2 9 3; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; HOLM S, 1979, SCAND J STAT, V6, P65; Irving H, 2012, HEREDITY, V109, P383, DOI 10.1038/hdy.2012.53; Kaddumukasa MA, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-3962-1; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Kwiatkowska RM, 2013, GENE, V519, P98, DOI 10.1016/j.gene.2013.01.036; Lehmann T, 1999, J HERED, V90, P613, DOI 10.1093/jhered/90.6.613; Lehmann T, 2003, J HERED, V94, P133, DOI 10.1093/jhered/esg024; Lehmann T, 1996, HEREDITY, V77, P192, DOI 10.1038/hdy.1996.124; Lukindu M, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2826-4; Michel AP, 2006, GENETICS, V173, P1389, DOI 10.1534/genetics.106.059667; Michel AP, 2005, POPULATION GENETIC S; Morgan JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011872; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Mulamba C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110058; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Okoye PN, 2008, T ROY SOC TROP MED H, V102, P591, DOI 10.1016/j.trstmh.2008.02.022; Pinto J, 2013, EVOL APPL, V6, P910, DOI 10.1111/eva.12075; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Riveron JM, 2017, G3-GENES GENOM GENET, V7, P1819, DOI 10.1534/g3.117.040147; Riveron JM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1787-8; Riveron JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-817; Riveron JM, 2013, P NATL ACAD SCI USA, V110, P252, DOI 10.1073/pnas.1216705110; Rousset F, 1997, GENETICS, V145, P1219; Samb B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-188; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vontas J, 2018, P NATL ACAD SCI USA, V115, P4619, DOI 10.1073/pnas.1719663115; Weedall GD, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat7386; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wondji CS, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-34; Wondji CS, 2012, P NATL ACAD SCI USA, V109, P19063, DOI 10.1073/pnas.1217229109; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Wright S., 1978, EVOLUTION GENETIC PO	56	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0240743	10.1371/journal.pone.0240743	http://dx.doi.org/10.1371/journal.pone.0240743			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170837	Green Published, Green Accepted, gold			2022-12-26	WOS:000592383400053
J	Fan, TY; Qu, RM; Jiang, X; Yang, YC; Sun, B; Huang, XL; Zhou, ZT; Ouyang, J; Zhong, SZ; Dai, JX				Fan, Tingyu; Qu, Rongmei; Jiang, Xin; Yang, Yuchao; Sun, Bing; Huang, Xiaolan; Zhou, Zhitao; Ouyang, Jun; Zhong, Shizhen; Dai, Jingxing			Spatial organization and crosstalk of vimentin and actin stress fibers regulate the osteogenic differentiation of human adipose-derived stem cells	FASEB JOURNAL			English	Article						actin stress fibers; adipose&#8208; derived stem cells (ASCs); osteogenesis; spatial organization; vimentin	SHOCK-PROTEIN 27; INTERMEDIATE-FILAMENTS; BETA-CATENIN; DYNAMICS; PLECTIN; ARCHITECTURE; POLYMERIZATION; LOCALIZATION; CYTOSKELETON; EXPRESSION	Human adipose-derived stem cells (hASCs) are ideal seed cells for tissue engineering due to their multidirectional differentiation potential. Microfilaments, microtubules, and intermediate filaments are responsible for supporting the intracellular space. Vimentin, a type III intermediate filament protein that is specifically expressed in cells of mesenchymal origin, can function as a scaffold and endow cells with tension and shear stress resistance. Actin stress fibers (ASF) act as an important physical device in stress signal transduction, providing stiffness for cells, and promoting osteogenesis. Through direct physical contact, cross-linkers, and spatial interactions, vimentin and actin networks exist as intersecting entities. Spatial interactions occur in the overlapping area of cytoskeleton subsystems, which could affect cell morphology, cell mechanics, and cell fate. However, how does the spatial organization between the cytoskeletal subsystems changed during osteogenesis, especially between vimentin and ASF, is still not understood, and its mechanism effect on cell fate remains unclear. In our study, WB experiment was used to detect the expression changes in Vimentin, ASF, and other proteins. Cells were reconstructed by three-dimensional scanning with fluorescence microscope, and the spatial thickness of vimentin and ASF cytoskeletons and the thickness of the overlapping area between them were calculated, respectively, so as to observe the spatial reorganization of vimentin and ASF in cells. Cytochalasin D (an inhibitor of actin polymerization) and vimentin upregulated/downregulated cells were used to verify the change in the spatial organization between vimentin and ASF and its influence on osteogenesis. Then, heat shock protein 27 (HSP27) was downregulated to illuminate the regulatory mechanisms of spatial organization between vimentin and ASF during osteogenesis. The amounts and the spatial positions of vimentin and actin stress fiber exhibited opposite trends during osteogenesis. Through controlling the anchor sites on the nucleus, intermediate filaments vimentin can reduce the spatial proportion of actin stress fibers, which can be regulated by HSP27. In addition, depolymerization of actin stress fibers lead to lower osteogenic differentiation ability, resulting in osteogenesis and lipogenesis existed simultaneously, that can be resisted by vimentin. Our data indicate that the spatial reorganization of vimentin and actin stress fibers is a key factor in the regulation of the differentiation state of hASCs. And their spatial overlapping area is detrimental to hASCs osteogenesis, providing a new perspective for further exploring the mechanism underlying hASCs osteogenesis.	[Fan, Tingyu; Qu, Rongmei; Jiang, Xin; Yang, Yuchao; Sun, Bing; Huang, Xiaolan; Ouyang, Jun; Zhong, Shizhen; Dai, Jingxing] Southern Med Univ, Sch Basic Med Sci, Guangdong Prov Key Lab Med Biomech, Guangzhou, Peoples R China; [Fan, Tingyu; Qu, Rongmei; Jiang, Xin; Yang, Yuchao; Sun, Bing; Huang, Xiaolan; Ouyang, Jun; Zhong, Shizhen; Dai, Jingxing] Southern Med Univ, Sch Basic Med Sci, Dept Anat, Guangzhou, Peoples R China; [Yang, Yuchao; Sun, Bing; Huang, Xiaolan; Zhou, Zhitao] Southern Med Univ, Cent Lab, Guangzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Zhong, SZ; Dai, JX (corresponding author), Southern Med Univ, Sch Basic Med Sci, Guangdong Prov Key Lab Med Biomech, Guangzhou, Peoples R China.; Zhong, SZ; Dai, JX (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Anat, Guangzhou, Peoples R China.	zhszh@smu.edu.cn; daijx@smu.edu.cn	; dai, jingxing/N-8381-2016	qu, rongmei/0000-0002-4994-0613; Ouyang, Jun/0000-0002-8475-3696; dai, jingxing/0000-0002-9339-9174	National Key R&D Program of China [2017YFC1105000]; Sanming Project of Medicine in Shenzhen [SZSM201612019]	National Key R&D Program of China; Sanming Project of Medicine in Shenzhen	This study was financially supported by the National Key R&D Program of China (2017YFC1105000) and Sanming Project of Medicine in Shenzhen (SZSM201612019)	Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; Beggs JE, 2015, BIOCHEM J, V467, P63, DOI 10.1042/BJ20141066; Blanchoin L, 2014, PHYSIOL REV, V94, P235, DOI 10.1152/physrev.00018.2013; Block J, 2015, BBA-MOL CELL RES, V1853, P3053, DOI 10.1016/j.bbamcr.2015.05.009; Carlier MF, 2017, NAT REV MOL CELL BIO, V18, P389, DOI 10.1038/nrm.2016.172; Castanon MJ, 2013, HISTOCHEM CELL BIOL, V140, P33, DOI 10.1007/s00418-013-1102-0; Chambers JE, 2015, ELIFE, V4, DOI 10.7554/eLife.04872; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Han MKL, 2017, NAT CELL BIOL, V19, P14, DOI 10.1038/ncb3457; HAUS U, 1993, EMBO J, V12, P3763, DOI 10.1002/j.1460-2075.1993.tb06054.x; Havel LS, 2015, ONCOGENE, V34, P1979, DOI 10.1038/onc.2014.123; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; Hijikata T, 2003, HISTOCHEM CELL BIOL, V119, P109, DOI 10.1007/s00418-003-0496-5; Huber F, 2015, CURR OPIN CELL BIOL, V32, P39, DOI 10.1016/j.ceb.2014.10.005; Janmey PA, 2004, NAT REV MOL CELL BIO, V5, P658, DOI 10.1038/nrm1434; Jiu Y, 2017, J CELL SCI, V130, P892, DOI 10.1242/jcs.196881; Jiu YM, 2015, CELL REP, V11, P1511, DOI 10.1016/j.celrep.2015.05.008; Kayser J, 2013, BIOPHYS J, V105, P1778, DOI 10.1016/j.bpj.2013.09.007; Ketema M, 2013, MOL BIOL CELL, V24, P2454, DOI 10.1091/mbc.E13-02-0100; Ketema M, 2011, BIOCHEM SOC T, V39, P1719, DOI 10.1042/BST20110669; Kim S, 2010, NAT REV MOL CELL BIO, V11, P75, DOI 10.1038/nrm2818; KueperO T, 2007, J BIOL CHEM, V282, P23427, DOI 10.1074/jbc.M701586200; Kumar A, 2016, METHODS APPL FLUORES, V4, DOI [10.1088/2050-6120/4/4044008, 10.1088/2050-6120/4/4/044008]; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; Lee JS, 2005, EXP MOL MED, V37, P427, DOI 10.1038/emm.2005.53; Leube RE, 2015, CURR OPIN CELL BIOL, V32, P13, DOI 10.1016/j.ceb.2014.09.011; Lian N, 2009, J BIOL CHEM, V284, P30518, DOI 10.1074/jbc.M109.052373; Maninova M, 2017, PROTOPLASMA, V254, P1207, DOI 10.1007/s00709-017-1077-0; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Minton K, 2014, NAT REV MOL CELL BIO, V15, P631, DOI 10.1038/nrm3882; Muehlich S, 2017, CELL SIGNAL, V29, P31, DOI 10.1016/j.cellsig.2016.10.002; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Neuhofer W, 1998, KIDNEY INT, V54, pS165, DOI 10.1046/j.1523-1755.1998.06735.x; Perng MD, 1999, J CELL SCI, V112, P2099; Rajgor D, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.6; Ratheesh A, 2012, NAT REV MOL CELL BIO, V13, P673, DOI 10.1038/nrm3431; Rosado JA, 2002, CELL SIGNAL, V14, P547, DOI 10.1016/S0898-6568(01)00273-X; Satelli A, 2011, CELL MOL LIFE SCI, V68, P3033, DOI 10.1007/s00018-011-0735-1; Sen B, 2015, STEM CELLS, V33, P3065, DOI 10.1002/stem.2090; Serebryannyy LA, 2017, J CELL SCI, V130, P1717, DOI 10.1242/jcs.199893; Sliogeryte K, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101164; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Stavenschi E, 2019, FASEB J, V33, P4178, DOI 10.1096/fj.201801474RR; Tavares S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15237; Thievessen I, 2013, J CELL BIOL, V202, P163, DOI 10.1083/jcb.201303129; Tojkander S, 2012, J CELL SCI, V125, P1855, DOI 10.1242/jcs.098087; Tulgren ED, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004481; Walcott S, 2010, P NATL ACAD SCI USA, V107, P7757, DOI 10.1073/pnas.0912739107; Wang Y, 2008, MECH DEVELOP, V125, P142, DOI 10.1016/j.mod.2007.09.008; Wang YQ, 2015, EXP CELL RES, V338, P39, DOI 10.1016/j.yexcr.2015.08.002; Wei JC, 2008, ANTICANCER RES, V28, P327; Wiche G, 2015, CURR OPIN CELL BIOL, V32, P21, DOI 10.1016/j.ceb.2014.10.002; Yamazaki S, 2016, HISTOCHEM CELL BIOL, V145, P389, DOI 10.1007/s00418-016-1416-9	57	8	8	9	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202000378RR	http://dx.doi.org/10.1096/fj.202000378RR		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33205555				2022-12-26	WOS:000592661500001
J	Meschede, IP; Burgoyne, T; Tolmachova, T; Seabra, MC; Futter, CE				Meschede, Ingrid P.; Burgoyne, Thomas; Tolmachova, Tanya; Seabra, Miguel C.; Futter, Clare E.			Chronically shortened rod outer segments accompany photoreceptor cell death in Choroideremia	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; CHRONIC INFLAMMATORY REACTION; KNOCKOUT MOUSE MODELS; DEGENERATION; RHODOPSIN; MICROGLIA; RAB27A; MICE	X-linked choroideremia (CHM) is a disease characterized by gradual retinal degeneration caused by loss of the Rab Escort Protein, REP1. Despite partial compensation by REP2 the disease is characterized by prenylation defects in multiple members of the Rab protein family that are master regulators of membrane traffic. Remarkably, the eye is the only organ affected in CHM patients, possibly because of the huge membrane traffic burden of the post mitotic photoreceptors, which synthesise outer segments, and the adjacent retinal pigment epithelium that degrades the spent portions each day. In this study, we aimed to identify defects in membrane traffic that might lead to photoreceptor cell death in CHM. In a heterozygous null female mouse model of CHM (Chm(null/WT)), degeneration of the photoreceptor layer was clearly evident from increased numbers of TUNEL positive cells compared to age matched controls, small numbers of cells exhibiting signs of mitochondrial stress and greatly increased microglial infiltration. However, most rod photoreceptors exhibited remarkably normal morphology with well-formed outer segments and no discernible accumulation of transport vesicles in the inner segment. The major evidence of membrane trafficking defects was a shortening of rod outer segments that was evident at 2 months of age but remained constant over the period during which the cells die. A decrease in rhodopsin density found in the outer segment may underlie the outer segment shortening but does not lead to rhodopsin accumulation in the inner segment. Our data argue against defects in rhodopsin transport or outer segment renewal as triggers of cell death in CHM.	[Meschede, Ingrid P.; Burgoyne, Thomas; Seabra, Miguel C.; Futter, Clare E.] UCL Inst Ophthalmol, London, England; [Tolmachova, Tanya; Seabra, Miguel C.] Imperial Coll London, London, England; [Seabra, Miguel C.] NOVA Univ Nova Lisboa, CEDOC, Lisbon, Portugal	University of London; University College London; Imperial College London; Universidade Nova de Lisboa	Futter, CE (corresponding author), UCL Inst Ophthalmol, London, England.	c.futter@ucl.ac.uk	Burgoyne, Thomas/HCI-9054-2022	Burgoyne, Thomas/0000-0002-8428-720X; Futter, Clare/0000-0001-5559-9389	RETINA UK [GR577]; Wellcome Trust [212216, 093445]; Tommy Salisbury choroideremia fund/Fight for Sight [1936UCL]	RETINA UK; Wellcome Trust(Wellcome TrustEuropean Commission); Tommy Salisbury choroideremia fund/Fight for Sight	The study was funded by RETINA UK (https://retinauk.org.uk) awarded to CF (GR577), Tommy Salisbury choroideremia fund/Fight for Sight (https://www.fightforsight.org.uk) awarded to MS (1936UCL), and the Wellcome Trust (https://wellcome.ac.uk) awarded to CF (212216) and MS and CF (093445). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aleman TS, 2017, OPHTHALMOLOGY, V124, P359, DOI 10.1016/j.ophtha.2016.10.022; Burgoyne Thomas, 2015, Proc Natl Acad Sci U S A, V112, P15922, DOI 10.1073/pnas.1509285113; Chiang WC, 2015, MOL NEUROBIOL, V52, P679, DOI 10.1007/s12035-014-8881-8; CREMERS FPM, 1994, J BIOL CHEM, V269, P2111; Cunea A, 2007, VISUAL NEUROSCI, V24, P151, DOI 10.1017/S0952523807070204; Ding JD, 2015, J CELL BIOL, V211, P495, DOI 10.1083/jcb.201508093; Futter CE, 2004, MOL BIOL CELL, V15, P2264, DOI 10.1091/mbc.E03-10-0772; Gupta N, 2003, EXP EYE RES, V76, P463, DOI 10.1016/S0014-4835(02)00332-9; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Humphries MM, 1997, NAT GENET, V15, P216, DOI 10.1038/ng0297-216; Jacobson SG, 2006, INVEST OPHTH VIS SCI, V47, P4113, DOI 10.1167/iovs.06-0424; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Kohnke M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081758; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Lopes VS, 2007, MOL BIOL CELL, V18, P3914, DOI 10.1091/mbc.E07-03-0268; Lopes VS, 2010, MOL BIOL CELL, V21, P4076, DOI 10.1091/mbc.E10-08-0715; MacDonald IM, 2009, SURV OPHTHALMOL, V54, P401, DOI 10.1016/j.survophthal.2009.02.008; Nemet I, 2015, PROG MOL BIOL TRANSL, V132, P39, DOI 10.1016/bs.pmbts.2015.02.007; Pontikos N, 2020, OPHTHALMOLOGY, V127, P1384, DOI 10.1016/j.ophtha.2020.04.008; Price BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049889; Roque RS, 1996, INVEST OPHTH VIS SCI, V37, P196; Sakami S, 2011, J BIOL CHEM, V286, P10551, DOI 10.1074/jbc.M110.209759; SEABRA MC, 1993, SCIENCE, V259, P377, DOI 10.1126/science.8380507; SEABRA MC, 1995, J BIOL CHEM, V270, P24420, DOI 10.1074/jbc.270.41.24420; Seabra MC, 1996, OPHTHALMIC GENET, V17, P43, DOI 10.3109/13816819609057869; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Storck EM, 2019, NAT CHEM, V11, P552, DOI 10.1038/s41557-019-0237-6; Strunnikova NV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008402; Syed N, 2001, OPHTHALMOLOGY, V108, P711, DOI 10.1016/S0161-6420(00)00643-6; Tolmachova T, 2006, J CLIN INVEST, V116, P386, DOI 10.1172/JCI26617; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; Tolmachova T, 2010, INVEST OPHTH VIS SCI, V51, P4913, DOI 10.1167/iovs.09-4892; Volland S, 2015, P NATL ACAD SCI USA, V112, P14870, DOI 10.1073/pnas.1516309112; Wang J, 2014, PROG RETIN EYE RES, V38, P1, DOI 10.1016/j.preteyeres.2013.08.004; Wavre-Shapton ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057769; Ying GX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161236; Yoshida N, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.07.008; Yoshida N, 2013, OPHTHALMOLOGY, V120, P100, DOI 10.1016/j.ophtha.2012.07.006; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; Zeiss CJ, 2004, INVEST OPHTH VIS SCI, V45, P971, DOI 10.1167/iovs.03-0301; Zhao L, 2015, EMBO MOL MED, V7, P1179, DOI 10.15252/emmm.201505298	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242284	10.1371/journal.pone.0242284	http://dx.doi.org/10.1371/journal.pone.0242284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201897	Green Published, gold			2022-12-26	WOS:000595003900045
J	Nguyen, TT; Pham, TN; Van, TD; Nguyen, TT; Nguyen, DTN; Le, HNM; Eden, JS; Rockett, RJ; Nguyen, TTH; Vu, BTN; Tran, GV; Le, TV; Dwyer, DE; van Doorn, HR				Tam Thi Nguyen; Thach Ngoc Pham; Trang Dinh Van; Trang Thu Nguyen; Diep Thi Ngoc Nguyen; Hoa Nguyen Minh Le; Eden, John-Sebastian; Rockett, Rebecca J.; Thuong Thi Hong Nguyen; Bich Thi Ngoc Vu; Giang Van Tran; Tan Van Le; Dwyer, Dominic E.; van Doorn, H. Rogier		OUCRU COVID-19 Res Grp	Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam	PLOS ONE			English	Article							ALIGNMENT	A second cluster of COVID-19 cases imported from Europe occured in Vietnam from early March 2020. We describe 44 SARS-CoV-2 RT-PCR positive patients (cycle threshold value <30) admitted to the National Hospital for Tropical Diseases in Hanoi between March 6 and April 15 2020. Whole SARS-CoV-2 genomes from these patients were sequenced using Illumina Miseq and analysed for common genetic variants and relationships to local and globally circulating strains. Results showed that 32 cases were Vietnamese with a median age of 37 years (range 15-74 years), and 23 were male. Most cases were acquired outside Vietnam, mainly from the UK (n = 15), other European countries (n = 14), Russia (n = 6) and countries in Asia (n = 3). No cases had travelled from China. Forty-one cases had symptoms at admission, typically dry cough (n = 36), fever (n = 20), sore throat (n = 14) and diarrhoea (n = 12). Hospitalisation was long with a median of 25 days, most commonly from 20-29 days. All SARS-CoV-2 genomes were similar (92-100% sequence homology) to the reference sequence Wuhan_1 (NC_045512), and 32 strains belonged to the B.1.1 lineage. The three most common variants were linked, and included C3037T, C14408T (nsp12: P323L) and A23403G (S: D614G) mutations. This group of mutations often accompanied variant C241T (39/44 genomes) or GGG 28881..28883 AAC (33/44 genomes). The prevalence of the former reflected probable European origin of viruses, and the transition D614G was dominant in Vietnam. New variants were identified; however, none could be associated with disease severity.	[Tam Thi Nguyen; Trang Thu Nguyen; Diep Thi Ngoc Nguyen; Thuong Thi Hong Nguyen; Bich Thi Ngoc Vu; van Doorn, H. Rogier] Univ Oxford, Clin Res Unit OUCRU, Hanoi, Vietnam; [Thach Ngoc Pham; Trang Dinh Van; Hoa Nguyen Minh Le] Natl Hosp Trop Dis, Hanoi, Vietnam; [Eden, John-Sebastian; Rockett, Rebecca J.; Dwyer, Dominic E.] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Westmead, NSW, Australia; [Eden, John-Sebastian] Ctr Virus Res, Westmead Inst Med Res, Westmead, NSW, Australia; [Rockett, Rebecca J.; Dwyer, Dominic E.] Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Inst Clin Pathol & Med Res, Westmead, NSW, Australia; [Giang Van Tran] Hanoi Med Univ, Dept Infect Dis, Hanoi, Vietnam; [Giang Van Tran] Natl Hosp Trop Dis, Dept Virol & Parasitol, Hanoi, Vietnam; [Tan Van Le] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Dwyer, Dominic E.] Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol Lab Serv, New South Wales Hlth Pathol, Westmead, NSW, Australia; [van Doorn, H. Rogier] Univ Oxford, Nuffield Dept Clin Med, Oxford, England	University of Oxford; National Hospital of Tropical Diseases; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Hanoi Medical University; National Hospital of Tropical Diseases; University of Oxford; University of Oxford	Nguyen, TT; van Doorn, HR (corresponding author), Univ Oxford, Clin Res Unit OUCRU, Hanoi, Vietnam.; Dwyer, DE (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Westmead, NSW, Australia.; Dwyer, DE (corresponding author), Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Inst Clin Pathol & Med Res, Westmead, NSW, Australia.; Dwyer, DE (corresponding author), Inst Clin Pathol & Med Res, Ctr Infect Dis & Microbiol Lab Serv, New South Wales Hlth Pathol, Westmead, NSW, Australia.; van Doorn, HR (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Oxford, England.	tamnt@oucru.org; dominic.dwyer@sydney.edu.au; rvandoorn@oucru.org	van Doorn, H. Rogier/H-3080-2019	van Doorn, H. Rogier/0000-0002-9807-1821; Eden, John-Sebastian/0000-0003-1374-3551	Wellcome Trust of Great Britain [106680/Z/14/Z]	Wellcome Trust of Great Britain(Wellcome Trust)	This work was funded by Wellcome Trust of Great Britain (106680/Z/14/Z) awarded to RvD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, ZHONGHUA JIE HE HE H, V17, DOI 10.3760/cma.j.issn.1001-0939.2020.0020; Chau NVV., 2020, CLIN INFECT DIS, V71, P2679, DOI 10.1093/cid/ciaa711; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Eden J-S, 2020, SARS COV 2 GENOME SE; Eden JS, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa027; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Quach HL, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104379; Thanh HN, 2020, LANCET INFECT DIS, V20, P535, DOI 10.1016/S1473-3099(20)30159-6; Hoang VM, 2020, GLOBAL HEALTH ACTION, V13, DOI 10.1080/16549716.2020.1776526; Jacobs J., SARSCOV2 ILLUMINA CL; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Koyama T, 2020, B WORLD HEALTH ORGAN, V98, P495, DOI 10.2471/BLT.20.253591; Phan LT, 2020, J MED VIROL, V92, P2209, DOI 10.1002/jmv.26075; Le HT, 2020, LANCET CHILD ADOLESC, V4, P405, DOI 10.1016/S2352-4642(20)30091-2; Van Cuong L, 2020, LANCET INFECT DIS, V20, P408, DOI 10.1016/S1473-3099(20)30111-0; Le VT, 2020, J INFECT S; Pham NT, 2020, ASIAN J LAW ECON, V11, DOI 10.1515/ajle-2020-0001; Nguyen THD, 2020, INFECT CONT HOSP EP, V41, P984, DOI 10.1017/ice.2020.128; Thai PQ, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001259; Rambaut A., 2012, FIGTREE VERSION 1 4; Rambaut A, 2021, NAT MICROBIOL, V6, P415, DOI 10.1038/s41564-021-00872-5; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Thai PQ, 2021, CLIN INFECT, V72, pe334, DOI [DOI 10.1093/CID/CIAA1130, 10.1093/cid/ciaa1130]; Le TQM, 2020, EMERG INFECT DIS, V26, P1624, DOI 10.3201/eid2607.200591; Phan T, 2020, INFECT GENET EVOL, V81, DOI 10.1016/j.meegid.2020.104260; W.H. Organization, 73 WHO, P73; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; WHO, SIT REP 2020; World Health Organization, COR DIS COVID 19 PAN; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3	32	14	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242537	10.1371/journal.pone.0242537	http://dx.doi.org/10.1371/journal.pone.0242537			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201914	gold, Green Published			2022-12-26	WOS:000595003900007
J	Mac, S; O'Reilly, R; Adhikari, NKJ; Fowler, R; Sander, B				Mac, Stephen; O'Reilly, Ryan; Adhikari, Neill K. J.; Fowler, Robert; Sander, Beate			Point-of-care diagnostic tests for influenza in the emergency department: A cost-effectiveness analysis in a high-risk population from a Canadian perspective	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; INSTITUTIONAL OUTBREAK MANAGEMENT; CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; NET BENEFIT REGRESSION; ECONOMIC-EVALUATION; SEASONAL INFLUENZA; ADULTS; CHEMOPROPHYLAXIS; METAANALYSIS	Background Our objective was to assess the cost-effectiveness of novel rapid diagnostic tests: rapid influenza diagnostic tests (RIDT), digital immunoassays (DIA), rapid nucleic acid amplification tests (NAAT), and other treatment algorithms for influenza in high-risk patients presenting to hospital with influenza-like illness (ILI). Methods We developed a decision-analytic model to assess the cost-effectiveness of diagnostic test strategies (RIDT, DIA, NAAT, clinical judgement, batch polymerase chain reaction) preceding treatment; no diagnostic testing and treating everyone; and not treating anyone. We modeled high-risk 65-year old patients from a health payer perspective and accrued outcomes over a patient's lifetime. We reported health outcomes, quality-adjusted life years (QALYs), healthcare costs, and net health benefit (NHB) to measure cost-effectiveness per cohort of 100,000 patients. Results Treating everyone with no prior testing was the most cost-effective strategy, at a cost-effectiveness threshold of $50,000/QALY, in over 85% of simulations. This strategy yielded the highest NHB of 15.0344 QALYs, but inappropriately treats all patients without influenza. Of the novel rapid diagnostics, NAAT resulted in the highest NHB (15.0277 QALYs), and the least number of deaths (1,571 per 100,000). Sensitivity analyses determined that results were most impacted by the pretest probability of ILI being influenza, diagnostic test sensitivity, and treatment effectiveness. Conclusions Based on our model, treating high-risk patients presenting to hospital with influenza-like illness, without performing a novel rapid diagnostic test, resulted in the highest NHB and was most cost-effective. However, consideration of whether treatment is appropriate in the absence of diagnostic confirmation should be taken into account for decision-making by clinicians and policymakers.	[Mac, Stephen; O'Reilly, Ryan; Adhikari, Neill K. J.; Fowler, Robert; Sander, Beate] Univ Toronto, Inst Hlth Policy Management & Evaluat IHPME, Toronto, ON, Canada; [Mac, Stephen; O'Reilly, Ryan; Sander, Beate] Univ Hlth Network, Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada; [O'Reilly, Ryan] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Adhikari, Neill K. J.; Fowler, Robert] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada; [Adhikari, Neill K. J.; Fowler, Robert] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Sander, Beate] ICES, Toronto, ON, Canada; [Sander, Beate] Publ Hlth Ontario, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto	Mac, S (corresponding author), Univ Toronto, Inst Hlth Policy Management & Evaluat IHPME, Toronto, ON, Canada.; Mac, S (corresponding author), Univ Hlth Network, Toronto Hlth Econ & Technol Assessment THETA Coll, Toronto, ON, Canada.	sm.mac@mail.utoronto.ca		Mac, Stephen/0000-0003-4736-1770	World Health Organization; CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award [GSD-159274]; Canada Research Chair in Economics of Infectious Diseases [CRC-950232429]	World Health Organization(World Health Organization); CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Economics of Infectious Diseases	This work was partially supported by the World Health Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S. M. is supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship Doctoral Award GSD-159274. B.S. is supported by a Canada Research Chair in Economics of Infectious Diseases (CRC-950232429). There was no additional external funding received for this study.	[Anonymous], 2017, GUID EC EV HLTH TECH; Canada G of, 2020, FLUWATCH ANN REP 201; Coleman BL, 2018, INFLUENZA OTHER RESP, V12, P22, DOI 10.1111/irv.12504; D'Heilly SJ, 2008, J CLIN VIROL, V42, P124, DOI 10.1016/j.jcv.2007.12.014; Dugas AF, 2015, AM J EMERG MED, V33, P770, DOI 10.1016/j.ajem.2015.03.008; Dugas AF, 2013, ANN EMERG MED, V62, P80, DOI 10.1016/j.annemergmed.2013.01.005; Ebell MH, 2013, FAM PRACT, V30, P125, DOI 10.1093/fampra/cms059; Government of Canada, 2017, FLUWATCH REP AUG 20; Greiner W, 2006, Eur J Health Econ, V7, P290, DOI 10.1007/s10198-006-0376-8; Harper SA, 2009, CLIN INFECT DIS, V48, P1003, DOI 10.1086/598513; Hoch JS, 2008, CLIN NEUROPSYCHIATR, V5, P175; Hoch JS, 2009, J PAIN SYMPTOM MANAG, V38, P54, DOI 10.1016/j.jpainsymman.2009.04.010; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub3, 10.1002/14651858.CD008965.pub4]; Lee BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011284; Merckx J, 2017, ANN INTERN MED, V167, P394, DOI 10.7326/M17-0848; Mittmann N, 1999, PHARMACOECONOMICS, V15, P369, DOI 10.2165/00019053-199915040-00004; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Nelson RE, 2015, PEDIATR INFECT DIS J, V34, P577, DOI 10.1097/INF.0000000000000703; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Ng C, 2018, INFLUENZA OTHER RESP, V12, P232, DOI 10.1111/irv.12521; Nshimyumukiza L, 2016, INFLUENZA OTHER RESP, V10, P113, DOI 10.1111/irv.12359; Ontario Ministry of Health and Long-term Care, 2016, ONT DRUG BEN FORM; Paulden M, 2020, PHARMACOECONOMICS, V38, P781, DOI 10.1007/s40273-020-00915-5; Public Health Ontario, 2017, ONT RESP PATH B 2016; Sander B, 2009, VALUE HEALTH, V12, P226, DOI 10.1111/j.1524-4733.2008.00437.x; Schanzer DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080481; Soto M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146620; Turner David, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7350; Uyeki TM, 2019, CLIN INFECT DIS, V68, P895, DOI 10.1093/cid/ciy874; Vos LM, 2019, CLIN INFECT DIS, V69, P1243, DOI 10.1093/cid/ciz056; World Health Organization, 2018, INFL SEAS	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242255	10.1371/journal.pone.0242255	http://dx.doi.org/10.1371/journal.pone.0242255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196653	gold, Green Published			2022-12-26	WOS:000595266800018
J	Rohmann, JL; Longstreth, WT; Cushman, M; Fitzpatrick, AL; Heckbert, SR; Rice, K; Rosendaal, FR; Sitlani, CM; Psaty, BM; Siegerink, B				Rohmann, Jessica L.; Longstreth, W. T.; Cushman, Mary; Fitzpatrick, Annette L.; Heckbert, Susan R.; Rice, Kenneth; Rosendaal, Frits R.; Sitlani, Colleen M.; Psaty, Bruce M.; Siegerink, Bob			Coagulation factor VIII, white matter hyperintensities and cognitive function: Results from the Cardiovascular Health Study	PLOS ONE			English	Article							ELDERLY-PEOPLE; IMPAIRMENT; DISEASE; DEMENTIA; STROKE; DECLINE; MIDLIFE; MEMORY; RISK	Objective To investigate the relationship between high FVIII clotting activity (FVIII:C), MRI-defined white matter hyperintensities (WMH) and cognitive function over time. Methods Data from the population-based Cardiovascular Health Study (n = 5,888, aged >= 65) were used. FVIII:C was measured in blood samples taken at baseline. WMH burden was assessed on two cranial MRI scans taken roughly 5 years apart. Cognitive function was assessed annually using the Modified Mini-Mental State Examination (3MSE) and Digit Symbol Substitution Test (DSST). We used ordinal logistic regression models adjusted for demographic and cardiovascular factors in cross-sectional and longitudinal WMH analyses, and adjusted linear regression and linear mixed models in the analyses of cognitive function. Results After adjustment for confounding, higher levels of FVIII:C were not strongly associated with the burden of WMH on the initial MRI scan (OR>p75 = 1.20, 95% CI 0.99-1.45; N = 2,735) nor with WMH burden worsening over time (OR>p75 = 1.18, 95% CI 0.87-1.59; N = 1,527). High FVIII:C showed no strong association with cognitive scores cross-sectionally (3MSE>p75 beta = -0.06, 95%CI -0.45 to 0.32, N = 4,005; DSST>p75 beta = -0.69, 95%CI -1.52 to 0.13, N = 3,954) or over time (3MSE>p75 beta = -0.07,95% CI -0.58 to 0.44, N = 2,764; DSST>p75 beta = -0.22, 95% CI -0.97 to 0.53, N = 2,306) after confounding adjustment. Interpretation The results from this cohort study of older adult participants indicate no strong relationships between higher FVIII:C levels and WMH burden or cognitive function in cross-sectional and longitudinal analyses.	[Rohmann, Jessica L.; Siegerink, Bob] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany; [Rohmann, Jessica L.] Charite Univ Med Berlin, Inst Publ Hlth, Berlin, Germany; [Longstreth, W. T.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Longstreth, W. T.; Fitzpatrick, Annette L.; Heckbert, Susan R.; Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Cushman, Mary] Univ Vermont, Dept Med, Larner Coll Med, Burlington, VT USA; [Fitzpatrick, Annette L.] Univ Washington, Dept Family Med, Seattle, WA 98195 USA; [Fitzpatrick, Annette L.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Heckbert, Susan R.; Sitlani, Colleen M.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98195 USA; [Rice, Kenneth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Rosendaal, Frits R.; Siegerink, Bob] Leiden Univ Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Vermont; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Leiden University; Leiden University Medical Center (LUMC); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kaiser Permanente	Rohmann, JL (corresponding author), Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany.; Rohmann, JL (corresponding author), Charite Univ Med Berlin, Inst Publ Hlth, Berlin, Germany.	jessica.rohmann@charite.de	Siegerink, Bob/K-1323-2012	Siegerink, Bob/0000-0002-8454-9142; Rice, Kenneth/0000-0002-3071-7278; Rohmann, Jessica L./0000-0003-2420-5716	National Heart, Lung, and Blood Institute (NHLBI) [HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, U01HL080295, U01HL130114]; National Institute of Neurological Disorders and Stroke (NINDS); National Institute on Aging (NIA) [R01AG023629]; German Federal Ministry of Education and Research (BMBF) [BMBF 01 EO 08 01]; German Research Foundation (DFG); Charite Universitatsmedizin Berlin; CHS	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Charite Universitatsmedizin Berlin; CHS	This research was supported by contracts HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, and grants U01HL080295 and U01HL130114 from the National Heart, Lung, and Blood Institute (NHLBI; https://www.nhlbi.nih.gov/), with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS; https://www.ninds.nih.gov/).Additional support was provided by R01AG023629 from the National Institute on Aging (NIA; https://www.nia.nih.gov).A full list of principal CHS investigators and institutions can be found at CHS-NHLBI.org. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported by the German Federal Ministry of Education and Research (BMBF; https://www.bmbf.de/en/index.html, BMBF 01 EO 08 01). We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charite Universitatsmedizin Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to the participants of the Cardiovascular Health Study for their time and commitment. JLR is a PhD candidate at the Charite -Universitatsmedizin Berlin, and this submitted work is in partial fulfillment of her PhD requirements. BMP served as the CHS sponsor to JLR and BS.	Alexander KS, 2014, NEUROLOGY, V83, P1271, DOI 10.1212/WNL.0000000000000844; Arnold AM, 2009, NEUROEPIDEMIOLOGY, V33, P55, DOI 10.1159/000215830; Bath PMW, 2010, ARTERIOSCL THROM VAS, V30, P461, DOI 10.1161/ATVBAHA.109.200824; Black SE, 2011, J ROY COLL PHYS EDIN, V41, P49, DOI 10.4997/JRCPE.2011.121; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Chang TR, 2014, CLIN APPL THROMB-HEM, V20, P124, DOI 10.1177/1076029613488936; CUSHMAN M, 1995, CLIN CHEM, V41, P264; de Leeuw FE, 2001, J NEUROL NEUROSUR PS, V70, P9, DOI 10.1136/jnnp.70.1.9; Elkins JS, 2004, NEUROLOGY, V63, P793, DOI 10.1212/01.WNL.0000137014.36689.7F; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Gallacher J, 2010, ARTERIOSCL THROM VAS, V30, P599, DOI 10.1161/ATVBAHA.109.197368; Gillett SR, 2018, J THROMB HAEMOST, V16, P1259, DOI 10.1111/jth.14138; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; Loures CDG, 2019, SEMIN THROMB HEMOST, V45, P514, DOI 10.1055/s-0039-1688444; Kamphuisen PW, 2001, ARTERIOSCL THROM VAS, V21, P731, DOI 10.1161/01.ATV.21.5.731; Knecht S, 2008, EUR HEART J, V29, P2125, DOI 10.1093/eurheartj/ehn341; KOSTER T, 1995, LANCET, V345, P152, DOI 10.1016/S0140-6736(95)90166-3; Longstreth WT, 2005, STROKE, V36, P56, DOI 10.1161/01.STR.0000149625.99732.69; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Maino A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133523; MANOLIO TA, 1994, STROKE, V25, P318, DOI 10.1161/01.STR.25.2.318; Newman AB, 2005, J AM GERIATR SOC, V53, P1101, DOI 10.1111/j.1532-5415.2005.53360.x; OLEARY DH, 1991, STROKE, V22, P1155, DOI 10.1161/01.STR.22.9.1155; Psaty Bruce M., 1995, Annals of Epidemiology, V5, P270, DOI 10.1016/1047-2797(94)00092-8; Quinn TJ, 2011, J THROMB HAEMOST, V9, P1475, DOI 10.1111/j.1538-7836.2011.04403.x; SALTHOUSE TA, 1978, J GERONTOL, V33, P232, DOI 10.1093/geronj/33.2.232; Siegler JE, 2015, CLIN APPL THROMB-HEM, V21, P597, DOI 10.1177/1076029615571630; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Tracy R P, 1992, Ann Epidemiol, V2, P509; Tracy RP, 1999, ARTERIOSCL THROM VAS, V19, P1776, DOI 10.1161/01.ATV.19.7.1776; Walker KA, 2019, NEUROLOGY, V92, pE1256, DOI 10.1212/WNL.0000000000007094; Walker KA, 2017, NEUROLOGY, V89, P2262, DOI 10.1212/WNL.0000000000004688; Warsch JRL, 2010, J AM GERIATR SOC, V58, pS319, DOI 10.1111/j.1532-5415.2010.02983.x; Williams R, 2016, J MATH SOCIOL, V40, P7, DOI 10.1080/0022250X.2015.1112384; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242062	10.1371/journal.pone.0242062	http://dx.doi.org/10.1371/journal.pone.0242062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VP	33196677	Green Published, gold			2022-12-26	WOS:000595266800024
J	Del Chicca, F; Richter, H; Steger, GL; Salesov, E; Reusch, CE; Kircher, PR				Del Chicca, Francesca; Richter, Henning; Steger, Gian-Luca; Salesov, Elena; Reusch, Claudia E.; Kircher, Patrick R.			Sample strategies for quantification of hepatic fat fraction mean MRI in healthy cats during body weight gain	PLOS ONE			English	Article							LIVER FAT; NONINVASIVE QUANTIFICATION; VALIDATION; VARIABILITY; ACCURACY; FEATURES; BIOPSY; CT	Hepatic fat fraction (HFF) can be non-invasively estimated with magnetic resonance imaging (MRI) multiple echo gradient recalled echo (GRE) sequence. The aim of this study was to test different methods of sampling strategies to quantify the HFF in healthy cats during body weight gain. Twelve healthy adult male cats were examined in a 3 Tesla MRI unit. Sequences included morphological images, and multiple echo GRE sequence. Cats were scanned at the beginning of the study and twice, each 20 weeks apart during body weight gain. HFF was calculated with 5 different methods of sampling on the multiple echo GRE sequence with different number, size and position of regions of interest (ROIs) and by 2 operators. Results indicated that HFF increased with increasing body weight, and the increase was appreciated with all the 5 methods. There was overall excellent agreement (interclass correlation coefficient = 0.820 (95% confidence interval:0.775-0.856)) between the 2 operators. HFF in the left lateral hepatic lobe was lower than in the other analyzed lobes. HFF measured on large free-hand drawn ROIs was higher than HFF measured with smaller ROIs size. This study proves that different sampling methods for quantification of HFF on multiple echo GRE sequence have overall excellent repeatability and ability to appreciate increased HFF.	[Del Chicca, Francesca; Richter, Henning; Steger, Gian-Luca; Kircher, Patrick R.] Clin Diagnost Imaging, Dept Diagnost & Clin Serv, Vetsuisse Fac Zurich, Zurich, Switzerland; [Salesov, Elena; Reusch, Claudia E.] Clin Small Anim Internal Med, Vetsuisse Fac Zurich, Zurich, Switzerland		Del Chicca, F (corresponding author), Clin Diagnost Imaging, Dept Diagnost & Clin Serv, Vetsuisse Fac Zurich, Zurich, Switzerland.	fdelchicca@vetclinics.uzh.ch	Del Chicca, Francesca/A-6587-2018; Kircher, Patrick/I-2055-2013	Kircher, Patrick/0000-0002-9677-0522; Richter, Henning/0000-0003-3696-6993				Bannas P, 2015, HEPATOLOGY, V62, P1444, DOI 10.1002/hep.28012; Bohte AE, 2011, EUR RADIOL, V21, P87, DOI 10.1007/s00330-010-1905-5; Bonekamp S, 2014, J MAGN RESON IMAGING, V39, P1525, DOI 10.1002/jmri.24321; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Campo CA, 2017, AM J ROENTGENOL, V209, P592, DOI 10.2214/AJR.17.17812; Capitan V, 2012, EUR RADIOL, V22, P2161, DOI 10.1007/s00330-012-2468-4; Caussy C, 2018, HEPATOLOGY, V68, P763, DOI 10.1002/hep.29797; Choi Y, 2015, ANN SURG TREAT RES, V89, P37, DOI 10.4174/astr.2015.89.1.37; Clark MH, 2013, RES VET SCI, V95, P678, DOI 10.1016/j.rvsc.2013.04.004; Clarke CN, 2017, HPB, V19, P706, DOI 10.1016/j.hpb.2017.04.009; Del Chicca F, 2019, AM J VET RES, V80, P159, DOI 10.2460/ajvr.80.2.159; Del Chicca F, 2018, J VET SCI, V19, P570, DOI 10.4142/jvs.2018.19.4.570; Deng J, 2014, PEDIATR RADIOL, V44, P1379, DOI 10.1007/s00247-014-3024-y; DREYER B, 1954, Q J EXP PHYSIOL CMS, V39, P305, DOI 10.1113/expphysiol.1954.sp001083; ELHASSAN AY, 1992, BRIT J RADIOL, V65, P774, DOI 10.1259/0007-1285-65-777-774; Fujiwara M, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0519-1; GATES GF, 1973, J NUCL MED, V14, P79; Hatta T, 2010, J GASTROENTEROL, V45, P1263, DOI 10.1007/s00535-010-0277-6; Hines CDG, 2011, J MAGN RESON IMAGING, V33, P873, DOI 10.1002/jmri.22514; Hong CW, 2018, J MAGN RESON IMAGING, V47, P988, DOI 10.1002/jmri.25843; Ibrahim WH, 2003, AM J VET RES, V64, P1265, DOI 10.2460/ajvr.2003.64.1265; Idilman IS, 2013, RADIOLOGY, V267, P767, DOI 10.1148/radiol.13121360; Kang BK, 2018, BRIT J RADIOL, V91, DOI 10.1259/bjr.20170378; Kim KY, 2015, RADIOL MED, V120, P1083, DOI 10.1007/s11547-015-0545-x; Vu KN, 2016, J MAGN RESON IMAGING, V43, P1090, DOI 10.1002/jmri.25083; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Korpraphong P, 2015, HONG KONG J RADIOL, V18, P4, DOI 10.12809/hkjr1414261; Kuhn JP, 2011, INVEST RADIOL, V46, P783, DOI 10.1097/RLI.0b013e31822b124c; Larsow SP, 2007, CLIN GASTROENTEROL H, V5, P1329, DOI 10.1016/j.cgh.2007.06.005; Lee SS, 2010, J HEPATOL, V52, P579, DOI 10.1016/j.jhep.2010.01.008; NOMURA F, 1987, RADIOLOGY, V162, P845, DOI 10.1148/radiology.162.3.3809503; Peng XG, 2011, J LIPID RES, V52, P1847, DOI 10.1194/jlr.D016691; Procter AJ, 2019, BMC MED IMAGING, V19, DOI 10.1186/s12880-019-0311-y; Ratziu V, 2005, GASTROENTEROLOGY, V128, P1898, DOI 10.1053/j.gastro.2005.03.084; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Samii VF, 1998, VET RADIOL ULTRASOUN, V39, P504, DOI 10.1111/j.1740-8261.1998.tb01640.x; Serai SD, 2017, RADIOLOGY, V284, P244, DOI 10.1148/radiol.2017161786; Sofue K, 2015, J MAGN RESON IMAGING, V42, P1281, DOI 10.1002/jmri.24922; Springer F, 2010, WORLD J GASTROENTERO, V16, P1560, DOI 10.3748/wjg.v16.i13.1560; Steger GL, 2020, AM J VET RES, V81, P796, DOI 10.2460/ajvr.81.10.796	41	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241905	10.1371/journal.pone.0241905	http://dx.doi.org/10.1371/journal.pone.0241905			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180808	Green Accepted, gold, Green Published			2022-12-26	WOS:000593948000053
J	Ostrakhovitch, EA; Akakura, S; Tabibzadeh, S				Ostrakhovitch, Elena A.; Akakura, Shin; Tabibzadeh, Siamak			Hydrogen sulfide facilitates reprogramming and trans-differentiation in 3D dermal fibroblast	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; INDUCTION; METABOLISM; HOMEOSTASIS; PROMOTES; OCT4	The efficiency of cell reprogramming in two-dimensional (2D) cultures is limited. Given that cellular stemness is intimately related to microenvironmental changes, 3D cell cultures have the potential of overcoming this limited capacity by allowing cells to self-organize by aggregation. In 3D space, cells interact more efficiently, modify their cellular topology, gene expression, signaling, and metabolism. It is yet not clear as how 3D culture environments modify the reprogramming potential of fibroblasts. We demonstrate that 3D spheroids from dermal fibroblasts formed under ultra-low attachment conditions showed increased lactate production. This is a requisite for cell reprogramming, increase their expression of pluripotency genes, such as OCT4, NANOG and SOX2, and display upregulated cystathionine-beta-synthase (CBS) and hydrogen sulfide (H2S) production. Knockdown of CBS by RNAi suppresses lactic acid and H2S production and concomitantly decreases the expression of OCT4 and NANOG. On the contrary, H2S donors, NaHS and garlic-derived diallyl trisulfide (DATS), promote the expression of OCT4, and support osteogenic trans-differentiation of fibroblasts. These results demonstrate that CBS mediated release of H2S regulates the reprogramming of dermal fibroblasts grown in 3D cultures and supports their trans-differentiation.	[Ostrakhovitch, Elena A.; Akakura, Shin; Tabibzadeh, Siamak] Frontiers Biosci Res Inst Aging & Canc, Irvine, CA 92618 USA		Tabibzadeh, S (corresponding author), Frontiers Biosci Res Inst Aging & Canc, Irvine, CA 92618 USA.	fbsResearchInstitute@gmail.com						Ader M, 2014, CURR OPIN CELL BIOL, V31, P23, DOI 10.1016/j.ceb.2014.06.013; [Anonymous], 1996, FOOD CANADA, V56, P10; Bailey TS, 2014, J AM CHEM SOC, V136, P10573, DOI 10.1021/ja505371z; Benavides GA, 2007, P NATL ACAD SCI USA, V104, P17977, DOI 10.1073/pnas.0705710104; Chen MF, 2012, BIOMATERIALS, V33, P5514, DOI 10.1016/j.biomaterials.2012.04.001; Ciuffreda MC, 2016, METHODS MOL BIOL, V1416, P149, DOI 10.1007/978-1-4939-3584-0_8; DAI WG, 1994, BIO-TECHNOL, V12, P797, DOI 10.1038/nbt0894-797; Denu RA, 2016, ACTA HAEMATOL-BASEL, V136, P85, DOI 10.1159/000445096; Downing TL, 2013, NAT MATER, V12, P1154, DOI [10.1038/NMAT3777, 10.1038/nmat3777]; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Freberg CT, 2007, MOL BIOL CELL, V18, P1543, DOI 10.1091/mbc.E07-01-0029; Gerardo H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45352-3; Golipour A, 2012, CELL STEM CELL, V11, P769, DOI 10.1016/j.stem.2012.11.008; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jensen AR, 2020, SHOCK, V53, P737, DOI 10.1097/SHK.0000000000001420; Jensen EC, 2012, ANAT REC, V295, P1, DOI 10.1002/ar.21487; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee JH, 2014, BIOTECHNOL BIOENG, V111, P1038, DOI 10.1002/bit.25156; Li SS, 2015, ANTIOXID REDOX SIGN, V23, P630, DOI 10.1089/ars.2014.6186; Li W, 2012, P NATL ACAD SCI USA, V109, P20853, DOI 10.1073/pnas.1219181110; Liang M, 2015, NITRIC OXIDE-BIOL CH, V46, P114, DOI 10.1016/j.niox.2014.12.007; Lin YJ, 2012, MOL CELL, V48, P627, DOI 10.1016/j.molcel.2012.08.030; Liu Y, 2014, CELL STEM CELL, V15, P66, DOI 10.1016/j.stem.2014.03.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo LMR M, 2019, ADV BIOSYST, V3, P11; Ma J, 2020, J DRUG TARGET, V28, P176, DOI 10.1080/1061186X.2019.1624969; Maza I, 2015, NAT BIOTECHNOL, V33, P769, DOI 10.1038/nbt.3270; Mironov V, 2009, BIOMATERIALS, V30, P2164, DOI 10.1016/j.biomaterials.2008.12.084; Montoya LA, 2012, CHEM COMMUN, V48, P4767, DOI 10.1039/c2cc30730h; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Olariu V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25438; Ostrakhovitch EA, 2015, EXP CELL RES, V330, P135, DOI 10.1016/j.yexcr.2014.09.027; Pennock R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13113; Phillips CM, 2017, CANCER RES, V77, P5741, DOI 10.1158/0008-5472.CAN-16-3480; Pisciotta A, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00547; Pisciotta A, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0065-x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; RICKARD DJ, 1994, DEV BIOL, V161, P218, DOI 10.1006/dbio.1994.1022; Ryu NE, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121620; Soundararajan M, 2018, J CELL PHYSIOL, V233, P9099, DOI 10.1002/jcp.26860; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TAKEZAWA T, 1993, EXP CELL RES, V208, P430, DOI 10.1006/excr.1993.1265; Timmins Nicholas E., 2007, V140, P141; Tsankov AM, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.174722; Untereiner A, 2018, ANTIOXID REDOX SIGN, V28, P1463, DOI 10.1089/ars.2017.7046; Wrzesinski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106973; Yang R, 2016, J DENT RES, V95, P1445, DOI 10.1177/0022034516659041; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zheng Y, 2017, ANTIOXID REDOX SIGN, V27, P742, DOI 10.1089/ars.2016.6826; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099665	54	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241685	10.1371/journal.pone.0241685	http://dx.doi.org/10.1371/journal.pone.0241685			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180827	gold, Green Published			2022-12-26	WOS:000593948000060
J	Kashiwakura, J; Saitoh, K; Ihara, T; Sasaki, Y; Kagohashi, K; Enohara, S; Morioka, Y; Watarai, H; Muromoto, R; Kitai, Y; Iwabuchi, K; Oritani, K; Matsuda, T				Kashiwakura, Jun-ichi; Saitoh, Kodai; Ihara, Takeru; Sasaki, Yuto; Kagohashi, Kota; Enohara, Shiyo; Morioka, Yuka; Watarai, Hiroshi; Muromoto, Ryuta; Kitai, Yuichi; Iwabuchi, Kazuya; Oritani, Kenji; Matsuda, Tadashi			Expression of signal-transducing adaptor protein-1 attenuates experimental autoimmune hepatitis via down-regulating activation and homeostasis of invariant natural killer T cells	PLOS ONE			English	Article							NKT CELLS; MEDIATED ACTIVATION; IL-4 PRODUCTION; LIVER-INJURY; MICE; STAP1; MUTATIONS; ALPHA; MODEL	Objective Signal-transducing adaptor protein (STAP) family members function as adaptor molecules and are involved in several events during immune responses. Notably however, the biological functions of STAP-1 in other cells are not known. We aimed to investigate the functions of STAP-1 in invariant natural killer T (iNKT) cells and iNKT cell-dependent hepatitis. Methods We employed concanavalin A (Con A)-induced hepatitis and alpha-galactosylceramide (alpha-GalCer)-induced hepatitis mouse models, both are models of iNKT cell-dependent autoimmune hepatitis, and STAP-1 overexpressing 2E10 cells to investigate the role of STAP-1 in iNKT cell activation in vivo an in vitro, respectively. Results After Con A- or alpha-GalCer-injection, hepatocyte necrotic areas and plasma alanine aminotransferase elevation were more severe in STAP-1 knockout (S1KO) mice and milder in lymphocyte-specific STAP-1 transgenic (S1Tg) mice, as compared to wild-type (WT) mice. Two events that may be related to Con A-induced and/or alpha-GalCer-induced hepatitis were influenced by STAP-1 manipulation. One is that iNKT cell populations in the livers and spleens were increased in S1KO mice and were decreased in S1Tg mice. The other is that Con A-induced interleukin-4 and interferon-gamma production was attenuated by STAP-1 overexpression. These effects of STAP-1 were confirmed using 2E10 cells overexpressing STAP-1 that showed impairment of interleukin-4 and interferon-gamma production as well as phosphorylation of Akt and mitogen-activated protein kinases in response to Con A stimulation. Conclusions These results conclude that STAP-1 regulates iNKT cell maintenance/activation, and is involved in the pathogenesis of autoimmune hepatitis.	[Kashiwakura, Jun-ichi; Saitoh, Kodai; Ihara, Takeru; Sasaki, Yuto; Kagohashi, Kota; Enohara, Shiyo; Muromoto, Ryuta; Kitai, Yuichi; Matsuda, Tadashi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Sapporo, Hokkaido, Japan; [Morioka, Yuka] Hokkaido Univ, Inst Genet Med, Div Dis Model Innovat, Sapporo, Hokkaido, Japan; [Watarai, Hiroshi] Kanazawa Univ, Fac Med, Inst Med Pharmaceut & Hlth Sci, Dept Immunol & Stem Cell Biol, Kanazawa, Ishikawa, Japan; [Iwabuchi, Kazuya] Kitasato Univ, Grad Sch Med Sci, Dept Immunol, Sagamihara, Kanagawa, Japan; [Oritani, Kenji] Int Univ Hlth & Welf, Dept Hematol, Chiba, Japan	Hokkaido University; Hokkaido University; Kanazawa University; Kitasato University; International University of Health & Welfare	Kashiwakura, J; Matsuda, T (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Immunol, Sapporo, Hokkaido, Japan.	junkashi@pharm.hokudai.ac.jp; tmatsuda@pharm.hokudai.ac.jp	Matsuda, Tadashi/A-3835-2012; Muromoto, Ryuta/E-4203-2012; morioka, yuka/A-9926-2009; SASAKI, Yuto/GRY-2466-2022	Matsuda, Tadashi/0000-0002-3089-3757; Muromoto, Ryuta/0000-0002-7474-493X; SASAKI, Yuto/0000-0002-3243-9777; SASAKI, Yuto/0000-0003-0001-3605				Au-Yeung BB, 2007, J IMMUNOL, V179, P111, DOI 10.4049/jimmunol.179.1.111; Biburger M, 2005, J IMMUNOL, V175, P1540, DOI 10.4049/jimmunol.175.3.1540; Blanco-Vaca F, 2018, CLIN CHIM ACTA, V487, P270, DOI 10.1016/j.cca.2018.10.014; Fouchier SW, 2014, CIRC RES, V115, P552, DOI 10.1161/CIRCRESAHA.115.304660; Heymann F, 2015, LAB ANIM-UK, V49, P12, DOI 10.1177/0023677215572841; Hong F, 2002, J CLIN INVEST, V110, P1503, DOI 10.1172/JCI200215841; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Kaneko T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000796; Kaneko Y, 2000, J EXP MED, V191, P105, DOI 10.1084/jem.191.1.105; Kashiwakura J, 2019, INT IMMUNOL, V31, P349, DOI 10.1093/intimm/dxz013; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Lamiquiz-Moneo I, 2020, ATHEROSCLEROSIS, V292, P143, DOI 10.1016/j.atherosclerosis.2019.11.025; LANTZ O, 1994, J EXP MED, V180, P1097, DOI 10.1084/jem.180.3.1097; Liberal R, 2016, J AUTOIMMUN, V75, P6, DOI 10.1016/j.jaut.2016.07.005; Loaiza N, 2020, ARTERIOSCL THROM VAS, V40, P973, DOI 10.1161/ATVBAHA.119.313470; Masuhara M, 2000, BIOCHEM BIOPH RES CO, V268, P697, DOI 10.1006/bbrc.2000.2223; MATSUDA T, 1988, EUR J IMMUNOL, V18, P951, DOI 10.1002/eji.1830180618; Mieli-Vergani G, 2018, NAT REV DIS PRIMERS, V4, DOI [10.1038/nrdp.2018.17, 10.1038/nrdp.2018.18]; Nakaya M, 2009, J IMMUNOL, V183, P7047, DOI 10.4049/jimmunol.0900547; Nyambayar D, 2007, J CLIN EXP HEMATOP, V47, P1, DOI 10.3960/jslrt.47.1; Ohya K, 1999, P NATL ACAD SCI USA, V96, P11976, DOI 10.1073/pnas.96.21.11976; Saito T, 2004, J IMMUNOL, V173, P579, DOI 10.4049/jimmunol.173.1.579; Sekine Y, 2006, J IMMUNOL, V176, P380, DOI 10.4049/jimmunol.176.1.380; Sekine Y, 2007, J IMMUNOL, V179, P2397, DOI 10.4049/jimmunol.179.4.2397; Sekine Y, 2014, J IMMUNOL, V192, P3488, DOI 10.4049/jimmunol.1300886; Sekine Y, 2012, J IMMUNOL, V188, P6194, DOI 10.4049/jimmunol.1103467; Sekine Y, 2009, J IMMUNOL, V183, P7966, DOI 10.4049/jimmunol.0902096; Stoecker K, 2009, BIOCHEM BIOPH RES CO, V379, P121, DOI 10.1016/j.bbrc.2008.12.021; Takeda K, 2000, P NATL ACAD SCI USA, V97, P5498, DOI 10.1073/pnas.040566697; TIEGS G, 1992, J CLIN INVEST, V90, P196, DOI 10.1172/JCI115836; Toyabe S, 1997, J IMMUNOL, V159, P1537; Vinay DS, 2004, J IMMUNOL, V173, P4218, DOI 10.4049/jimmunol.173.6.4218; Ye TH, 2018, CELL PHYSIOL BIOCHEM, V46, P1241, DOI 10.1159/000489074; Yokohari K, 2001, BIOCHEM BIOPH RES CO, V289, P414, DOI 10.1006/bbrc.2001.6008; Zhu R, 2007, J IMMUNOL, V178, P5435, DOI 10.4049/jimmunol.178.9.5435	35	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241440	10.1371/journal.pone.0241440	http://dx.doi.org/10.1371/journal.pone.0241440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175848	gold, Green Published			2022-12-26	WOS:000593946900001
J	Krenzlin, H; Frenz, C; Schmitt, J; Masomi-Bornwasser, J; Wesp, D; Kalasauskas, D; Kerz, T; Lotz, J; Alessandri, B; Ringel, F; Keric, N				Krenzlin, Harald; Frenz, Christina; Schmitt, Jan; Masomi-Bornwasser, Julia; Wesp, Dominik; Kalasauskas, Darius; Kerz, Thomas; Lotz, Johannes; Alessandri, Beat; Ringel, Florian; Keric, Naureen			High CSF thrombin concentration and activity is associated with an unfavorable outcome in patients with intracerebral hemorrhage	PLOS ONE			English	Article							ANTITHROMBIN-III; ACTIVATED RECEPTORS; BRAIN; NEURONS; INJURY; DEATH	Background The cerebral thrombin system is activated in the early stage after intracerebral hemorrhage (ICH). Expression of thrombin leads to concentration dependent secondary neuronal damage and detrimental neurological outcome. In this study we aimed to investigate the impact of thrombin concentration and activity in the cerebrospinal fluid (CSF) of patients with ICH on clinical outcome. Methods Patients presenting with space-occupying lobar supratentorial hemorrhage requiring extra-ventricular drainage (EVD) were included in our study. The CSF levels of thrombin, its precursor prothrombin and the Thrombin-Antithrombin complex (TAT) were measured using enzyme linked immune sorbent assays (ELISA). The oxidative stress marker Superoxide dismutase (SOD) was assessed in CSF. Initial clot size and intraventricular hemorrhage (IVH) volume was calculated based on by computerized tomography (CT) upon admission to our hospital. Demographic data, clinical status at admission and neurological outcome were assessed using the modified Rankin Scale (mRS) at 6-weeks and 6-month after ICH. Results Twenty-two consecutive patients (9 females, 11 males) with supratentorial hemorrhage were included in this study. CSF concentrations of prothrombin (p < 0.005), thrombin (p = 0.005) and TAT (p = 0.046) were statistical significantly different in patients with ICH compared to non-hemorrhagic CSF samples. CSF concentrations of thrombin 24h after ICH correlated with the mRS index after 6 weeks (r(2) = 0.73; < 0.005) and 6 months (r(2) = 0.63; < 0.005) after discharge from hospital. Thrombin activity, measured via TAT as surrogate parameter of coagulation, likewise correlated with the mRS at 6 weeks (r(2) = 0.54; < 0.01) and 6 months (r(2) = 0.66; < 0.04). High thrombin concentrations coincide with higher SOD levels 24h after ICH (p = 0.01). Conclusion In this study we found that initial thrombin concentration and activity in CSF of ICH patients did not correlate with ICH and IVH volume but are associated with a poorer functional neurological outcome. These findings support mounting evidence of the role of thrombin as a contributor to secondary injury formation after ICH.	[Krenzlin, Harald; Frenz, Christina; Schmitt, Jan; Masomi-Bornwasser, Julia; Wesp, Dominik; Kalasauskas, Darius; Kerz, Thomas; Alessandri, Beat; Ringel, Florian; Keric, Naureen] Univ Med Ctr Mainz, Dept Neurosurg, Mainz, Germany; [Lotz, Johannes] Univ Med Ctr Mainz, Inst Clin Chem & Lab Med, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Krenzlin, H (corresponding author), Univ Med Ctr Mainz, Dept Neurosurg, Mainz, Germany.	harald.krenzlin@unimedizin-mainz.de	Ringel, Florian/E-4933-2014	Masomi-Bornwasser, Julia/0000-0003-1955-9827				[Anonymous], 2003, INT J IMPOT RES S7, V15, pS2; Antoniak S, 2018, J MOL CELL CARDIOL, V122, P80, DOI 10.1016/j.yjmcc.2018.08.008; Choi SH, 2005, J NEUROSCI, V25, P4082, DOI 10.1523/JNEUROSCI.4306-04.2005; Coughlin SR, 2003, J CLIN INVEST, V111, P25, DOI 10.1172/JCI200317564; DESCHEPPER CF, 1991, MOL BRAIN RES, V11, P355, DOI 10.1016/0169-328X(91)90045-Y; Garcia PS, 2015, NEUROCHEM RES, V40, P2220, DOI 10.1007/s11064-015-1711-1; Gong Y, 2008, ACTA NEUROCHIR SUPPL, V105, P47; Hirashima Y, 1997, STROKE, V28, P1666, DOI 10.1161/01.STR.28.9.1666; Hua Y, 2006, NEUROSURGERY, V58, P542, DOI 10.1227/01.NEU.0000197333.55473.AD; Kasuya H, 1998, ACTA NEUROCHIR, V140, P579, DOI 10.1007/s007010050143; Krenzlin H, 2020, J NEUROTRAUM, V37, P1481, DOI 10.1089/neu.2019.6582; Li XP, 2019, INT IMMUNOPHARMACOL, V72, P473, DOI 10.1016/j.intimp.2019.04.029; Ossovskaya VS, 2004, PHYSIOL REV, V84, P579, DOI 10.1152/physrev.00028.2003; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Qureshi AI, 2001, NEW ENGL J MED, V344, P1450, DOI 10.1056/NEJM200105103441907; Shikamoto Y, 1999, FEBS LETT, V463, P387, DOI 10.1016/S0014-5793(99)01657-9; Siddique MS, 2000, BRIT MED BULL, V56, P444, DOI 10.1258/0007142001903085; Smirnova IV, 1997, THROMB HAEMOSTASIS, V78, P1473; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Striggow F, 2000, P NATL ACAD SCI USA, V97, P2264, DOI 10.1073/pnas.040552897; VAUGHAN PJ, 1995, J NEUROSCI, V15, P5389; Wan S, 2021, NEUROCRIT CARE, V34, P423, DOI 10.1007/s12028-020-01031-0; Wang H, 2003, BIOL CHEM, V384, P193, DOI 10.1515/BC.2003.021; Xi GH, 2003, J NEUROCHEM, V84, P3, DOI 10.1046/j.1471-4159.2003.01268.x; Zetterberg H, 2009, J CLIN ONCOL, V27, P2302, DOI 10.1200/JCO.2008.19.8598	25	1	1	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241565	10.1371/journal.pone.0241565	http://dx.doi.org/10.1371/journal.pone.0241565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175864	Green Published, gold			2022-12-26	WOS:000593946900008
J	Smirnikhina, SA; Kondrateva, EV; Adilgereeva, EP; Anuchina, AA; Zaynitdinova, MI; Slesarenko, YS; Ershova, AS; Ustinov, KD; Yasinovsky, MI; Amelina, EL; Voronina, ES; Yakushina, VD; Tabakov, VY; Lavrov, AV				Smirnikhina, Svetlana A.; Kondrateva, Ekaterina V.; Adilgereeva, Elmira P.; Anuchina, Arina A.; Zaynitdinova, Milyausha I.; Slesarenko, Yana S.; Ershova, Angelina S.; Ustinov, Kirill D.; Yasinovsky, Matvei I.; Amelina, Elena L.; Voronina, Ekaterina S.; Yakushina, Valentina D.; Tabakov, Vyacheslav Yu.; Lavrov, Alexander V.			P.F508del editing in cells from cystic fibrosis patients	PLOS ONE			English	Article							REGULATOR MODULATORS; CFTR GENE; NUCLEASES; CRISPR/CAS9; IVACAFTOR; MUTATION; DEFECTS; THERAPY; REPAIR	Development of genome editing methods created new opportunities for the development of etiology-based therapies of hereditary diseases. Here, we demonstrate that CRISPR/Cas9 can correct p.F508del mutation in the CFTR gene in the CFTE29o- cells and induced pluripotent stem cells (iPSCs) derived from patients with cystic fibrosis (CF). We used several combinations of Cas9, sgRNA and ssODN and measured editing efficiency in the endogenous CFTR gene and in the co-transfected plasmid containing the CFTR locus with the p.F508del mutation. The non-homologous end joining (NHEJ) frequency in the CFTR gene in the CFTE29o- cells varied from 1.25% to 2.54% of alleles. The best homology-directed repair (HDR) frequency in the endogenous CFTR locus was 1.42% of alleles. In iPSCs, the NHEJ frequency in the CFTR gene varied from 5.5% to 12.13% of alleles. The best HDR efficacy was 2.38% of alleles. Our results show that p.F508del mutation editing using CRISPR/Cas9 in CF patient-derived iPSCs is a relatively rare event and subsequent cell selection and cultivation should be carried out.	[Smirnikhina, Svetlana A.; Kondrateva, Ekaterina V.; Adilgereeva, Elmira P.; Anuchina, Arina A.; Zaynitdinova, Milyausha I.; Slesarenko, Yana S.; Ustinov, Kirill D.; Yasinovsky, Matvei I.; Voronina, Ekaterina S.; Yakushina, Valentina D.; Tabakov, Vyacheslav Yu.; Lavrov, Alexander V.] Res Ctr Med Genet, Lab Genome Editing, Moscow, Russia; [Ershova, Angelina S.] Nazarbayev Univ, Sch Sci & Technol, Nur Sultan, Kazakhstan; [Amelina, Elena L.] Res Inst Pulmonol, Lab Cyst Fibrosis, Moscow, Russia	Research Centre for Medical Genetics; Nazarbayev University	Smirnikhina, SA (corresponding author), Res Ctr Med Genet, Lab Genome Editing, Moscow, Russia.	smirnikhinas@gmail.com	Voronina, Ekaterina/J-6444-2015; Anuchina, Arina/AAJ-5732-2021; Kondrateva, Ekaterina/AAK-1889-2021; Slesarenko, Yana/AAJ-5667-2021; Smirnikhina, Svetlana/A-9637-2016	Voronina, Ekaterina/0000-0002-5789-0927; Slesarenko, Yana/0000-0002-6976-3220; Adil'gereeva, El'mira/0000-0002-6440-0500; Smirnikhina, Svetlana/0000-0002-1558-3048	Russian Science Foundation [17-75-20095]; Ministry of Science and Higher Education of Russian Federation	Russian Science Foundation(Russian Science Foundation (RSF)); Ministry of Science and Higher Education of Russian Federation	The sections about iPSCs culture obtaining and editing were supported by the grant of the Russian Science Foundation (Agreement 1775-20095), the other sections were obtained within the state assignment of Ministry of Science and Higher Education of Russian Federation.; The authors are grateful to Prof. Natalia Kashirskaya (Research Centre for Medical Genetics, Moscow, Russian Federation) for critical reading and editing of the manuscript. The authors thank Genomics Core Facility at Skolkovo Institute of Science and Technology (Moscow, Russian Federation) for deep sequencing.	Bednarski C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161072; Castellani C, 2018, J CYST FIBROS, V17, P153, DOI 10.1016/j.jcf.2018.02.006; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3; Crane AM, 2015, STEM CELL REP, V4, P569, DOI 10.1016/j.stemcr.2015.02.005; Cystic Fibrosis Foundation, 2018, PAT REG ANN DAT REP; Derichs N, 2013, EUR RESPIR REV, V22, P58, DOI 10.1183/09059180.00008412; Dhooghe B, 2016, EXPERT OPIN INV DRUG, V25, P423, DOI 10.1517/13543784.2016.1154041; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; FDA, 2015, HIGHL PRESCR INF ORK; Firth AL, 2015, CELL REP, V12, P1385, DOI 10.1016/j.celrep.2015.07.062; Griesenbach U, 2015, HUM GENE THER, V26, P266, DOI 10.1089/hum.2015.027; Hollywood JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32230; Keating D, 2018, NEW ENGL J MED, V379, P1612, DOI 10.1056/NEJMoa1807120; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kondrateva E, 2020, STEM CELL RES, V48, DOI 10.1016/j.scr.2020.101933; Lee CM, 2012, BIORESEARCH OPEN ACC, V1, P99, DOI 10.1089/biores.2012.0218; Ma XT, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1659-6; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Maeder ML, 2016, MOL THER, V24, P430, DOI 10.1038/mt.2016.10; Merkert S, 2017, STEM CELL RES, V23, P95, DOI 10.1016/j.scr.2017.07.010; Middleton PG, 2019, NEW ENGL J MED, V381, P1809, DOI 10.1056/NEJMoa1908639; Mijnders M, 2017, CURR OPIN PHARMACOL, V34, P83, DOI 10.1016/j.coph.2017.09.014; Norman P, 2014, EXPERT OPIN THER PAT, V24, P829, DOI 10.1517/13543776.2014.876412; Peters-Hall JR, 2018, AM J PHYSIOL-LUNG C, V315, pL313, DOI 10.1152/ajplung.00355.2017; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Richardson CD, 2016, NAT BIOTECHNOL, V34, P339, DOI 10.1038/nbt.3481; Rowe SM, 2017, ANN AM THORAC SOC, V14, P213, DOI 10.1513/AnnalsATS.201609-689OC; Ruan JX, 2019, MOL THER-NUCL ACIDS, V16, P73, DOI 10.1016/j.omtn.2019.02.006; Sanz DJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184009; Schwank G, 2013, CELL STEM CELL, V13, P653, DOI 10.1016/j.stem.2013.11.002; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Smirnikhina SA, 2018, B RUSS STATE MED U, P14, DOI 10.24075/vrgmu.2018.022; Smirnikhina SA, 2016, LEUKEMIA LYMPHOMA, V57, P1669, DOI 10.3109/10428194.2015.1132420; Suzuki S, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2015.43; Takayama K, 2017, NUCLEIC ACIDS RES, V45, P5198, DOI 10.1093/nar/gkx130; Vaidyanathan S, 2020, CELL STEM CELL, V26, P161, DOI 10.1016/j.stem.2019.11.002; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0242094	10.1371/journal.pone.0242094	http://dx.doi.org/10.1371/journal.pone.0242094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175893	Green Published, gold			2022-12-26	WOS:000593946900004
J	Weldy, CS; Syed, SA; Amsallem, M; Hu, DQ; Ji, XH; Punn, R; Taylor, A; Navarre, B; Reddy, S				Weldy, Chad S.; Syed, Saad Ali; Amsallem, Myriam; Hu, Dong-Qing; Ji, Xuhuai; Punn, Rajesh; Taylor, Anne; Navarre, Brittany; Reddy, Sushma			Circulating whole genome miRNA expression corresponds to progressive right ventricle enlargement and systolic dysfunction in adults with tetralogy of Fallot	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; PULMONARY VALVE-REPLACEMENT; CELL-PROLIFERATION; REPAIRED TETRALOGY; MICRORNA; FAILURE; POPULATION; SIGNATURES; MIGRATION; FRACTION	Introduction The adult congenital heart disease population with repaired tetralogy of Fallot (TOF) is subject to chronic volume and pressure loading leading to a 40% probability of right ventricular (RV) failure by the 3(rd) decade of life. We sought to identify a non-invasive signature of adverse RV remodeling using peripheral blood microRNA (miRNA) profiling to better understand the mechanisms of RV failure. Methods Demographic, clinical data, and blood samples were collected from adults with repaired TOF (N = 20). RNA was isolated from the buffy coat of peripheral blood and whole genome miRNA expression was profiled using Agilent's global miRNA microarray platform. Fold change, pathway analysis, and unbiased hierarchical clustering of miRNA expression was performed and correlated to RV size and function assessed by echocardiography performed at or near the time of blood collection. Results MiRNA expression was profiled in the following groups: 1. normal RV size (N = 4), 2. mild/moderate RV enlargement (N = 11) and 3. severe RV enlargement (N = 5). 267 miRNAs were downregulated, and 66 were upregulated across the three groups (fold change >2.0, FDR corrected p<0.05) as RV enlargement increased and systolic function decreased. qPCR validation of a subset of these miRNAs identified increasing expression of miRNA 28-3p, 433-3p, and 371b-3p to be associated with increasing RV size and decreasing RV systolic function. Unbiased hierarchical clustering of all patients based on miRNA expression demonstrates three distinct patient clusters that largely coincide with progressive RV enlargement. Pathway analysis of dysregulated miRNAs demonstrates up and downregulation of cell cycle pathways, extracellular matrix proteins and fatty acid synthesis. HIF 1 alpha signaling was downregulated while p53 signaling was predicted to be upregulated. Conclusion Adults with TOF have a distinct miRNA profile with progressive RV enlargement and dysfunction implicating cell cycle dysregulation and upregulation in extracellular matrix and fatty acid metabolism. These data suggest peripheral blood miRNA can provide insight into the mechanisms of RV failure and can potentially be used for monitoring disease progression and to develop RV specific therapeutics to prevent RV failure in TOF.	[Weldy, Chad S.; Amsallem, Myriam] Stanford Univ, Dept Med, Div Cardiol, Stanford, CA 94305 USA; [Syed, Saad Ali] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Amsallem, Myriam; Hu, Dong-Qing; Punn, Rajesh; Taylor, Anne; Navarre, Brittany; Reddy, Sushma] Stanford Univ, Dept Pediat, Div Cardiol, Stanford, CA 94305 USA; [Ji, Xuhuai] Stanford Univ, Human Immune Monitoring Ctr, Stanford, CA 94305 USA; [Ji, Xuhuai] Stanford Univ, Funct Genom Facil, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Reddy, S (corresponding author), Stanford Univ, Dept Pediat, Div Cardiol, Stanford, CA 94305 USA.	sureddy@stanford.edu		Punn, Rajesh/0000-0001-9232-2231; Weldy, Chad/0000-0003-4652-6422; Syed, Saad/0000-0001-7239-3905	NIH [K08 HL127277]; U.S. Department of Defens [PR151448]; Reddy Foundation; American Heart Association [16GRNT31200008]; Stanford Cardiovascular Institute - MHRCI seed grant	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defens; Reddy Foundation; American Heart Association(American Heart Association); Stanford Cardiovascular Institute - MHRCI seed grant	SR was supported by grants from the NIH K08 HL127277, U.S. Department of Defens PR151448, Reddy Foundation, and American Heart Association 16GRNT31200008. MA was supported by a Stanford Cardiovascular Institute - MHRCI seed grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Halima M, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1255-z; Alshawabkeh Laith I, 2016, Curr Heart Fail Rep, V13, P247; Amsallem M, 2017, CIRC-CARDIOVASC IMAG, V10, DOI 10.1161/CIRCIMAGING.116.005771; Amsallem M, 2016, J AM SOC ECHOCARDIOG, V29, P93, DOI 10.1016/j.echo.2015.11.001; Apitz C, 2009, LANCET, V374, P1462, DOI 10.1016/S0140-6736(09)60657-7; Babu-Narayan SV, 2012, INT J CARDIOL, V154, P299, DOI 10.1016/j.ijcard.2010.09.057; Bernardo BC, 2012, P NATL ACAD SCI USA, V109, P17615, DOI 10.1073/pnas.1206432109; Bilchick K, 2019, CARDIOVASC RES; Book WM, 2014, HEART FAIL CLIN, V10, P167, DOI 10.1016/j.hfc.2013.09.006; Casares FM, 2016, MED SCI MONIT BASIC, V22, P45, DOI 10.12659/MSMBR.897644; Chen WD, 2017, PEDIATR CARDIOL, V38, P86, DOI 10.1007/s00246-016-1487-3; Doughan ARK, 2007, AM J CARDIOL, V99, P704, DOI 10.1016/j.amjcard.2006.10.025; Editorial Committee of Chinese Journal of Digestion, 2013, CHIN J PANCREATOL, V13, P73; Espinosa-Diez C, 2015, ANTIOXID REDOX SIGN, V23, P1092, DOI 10.1089/ars.2014.6025; Fomison-Nurse I, 2018, CELL DEATH DIFFER, V25, P1336, DOI 10.1038/s41418-017-0047-6; Girardot M, 2010, BLOOD, V116, P437, DOI 10.1182/blood-2008-06-165985; Grant JS, 2013, PULM CIRC, V3, P840, DOI 10.1086/674751; Heng EL, 2017, CIRCULATION, V136, P1703, DOI 10.1161/CIRCULATIONAHA.117.027402; Infante T, 2019, AM J CARDIOL, V124, P176, DOI 10.1016/j.amjcard.2019.04.016; Khairy P, 2010, J AM COLL CARDIOL, V56, P1149, DOI 10.1016/j.jacc.2010.03.085; Lai CTM, 2017, EUR J CLIN INVEST, V47, P574, DOI 10.1111/eci.12778; Li LH, 2018, MOL MED REP, V17, P4003, DOI 10.3892/mmr.2017.8299; Li Q, 2019, MOL MED REP, V20, P1167, DOI 10.3892/mmr.2019.10357; Lkhagva B, 2015, PHARMACOLOGY, V96, P184, DOI 10.1159/000438864; Marelli AJ, 2007, CIRCULATION, V115, P163, DOI 10.1161/CIRCULATIONAHA.106.627224; Norozi K, 2006, AM J CARDIOL, V97, P1238, DOI 10.1016/j.amjcard.2005.10.065; Nural-Guvener HF, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-10; Raissadati A, 2016, J AM COLL CARDIOL, V68, P487, DOI 10.1016/j.jacc.2016.05.038; Reddy S, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91625; Reddy S, 2012, PHYSIOL GENOMICS, V44, P562, DOI 10.1152/physiolgenomics.00163.2011; Rodriguez FH, 2014, HEART FAIL CLIN, V10, P1, DOI 10.1016/j.hfc.2013.09.008; Sahu N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12351; Schneider C, 2014, P NATL ACAD SCI USA, V111, P8185, DOI 10.1073/pnas.1322466111; Scrimgeour NR, 2020, AM J PHYSIOL-CELL PH, V318, pC94, DOI 10.1152/ajpcell.00204.2019; Silverman MG, 2020, JACC-CLIN ELECTROPHY, V6, P70, DOI 10.1016/j.jacep.2019.08.011; Stout KK, 2016, CIRCULATION, V133, P770, DOI 10.1161/CIR.0000000000000352; Su ZM, 2015, MOL MED REP, V11, P2248, DOI 10.3892/mmr.2014.2957; Therrien J, 2000, J AM COLL CARDIOL, V36, P1670, DOI 10.1016/S0735-1097(00)00930-X; Therrien J, 2005, AM J CARDIOL, V95, P779, DOI 10.1016/j.amjcard.2004.11.037; van der Bom T, 2013, CIRCULATION, V127, P322, DOI 10.1161/CIRCULATIONAHA.112.135392; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Vogel B, 2013, EUR HEART J, V34, P2812, DOI 10.1093/eurheartj/eht256; Wang A, 2017, ATHEROSCLEROSIS, V261, P19, DOI 10.1016/j.atherosclerosis.2017.03.041; Wang H, 2019, BMB REP, V52, P312, DOI 10.5483/BMBRep.2019.52.5.155; Watson CJ, 2015, EUR J HEART FAIL, V17, P405, DOI 10.1002/ejhf.244; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhang L, 2017, J MOL NEUROSCI, V61, P135, DOI 10.1007/s12031-016-0853-1; Zhou X, 2016, THROMB RES, V138, P91, DOI 10.1016/j.thromres.2015.12.006; Zomer AC, 2013, INT J CARDIOL, V168, P2487, DOI 10.1016/j.ijcard.2013.03.003; 2014, REG ANESTH PAIN MED, V9	50	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241476	10.1371/journal.pone.0241476	http://dx.doi.org/10.1371/journal.pone.0241476			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175850	gold, Green Published			2022-12-26	WOS:000593946900063
J	Alghamdi, A; Aldossary, W; Albahkali, S; Alotaibi, B; Alrfaei, BM				Alghamdi, Amani; Aldossary, Wadha; Albahkali, Sarah; Alotaibi, Batoul; Alrfaei, Bahauddeen M.			The loss of microglia activities facilitates glaucoma progression in association with CYP1B1 gene mutation (p.Gly61Glu)	PLOS ONE			English	Article							PRIMARY CONGENITAL GLAUCOMA; OPEN-ANGLE GLAUCOMA; EXTRACELLULAR-MATRIX; TYROSINE KINASE; EXPRESSION; INHIBITION; METABOLISM; ACTIVATION; CELLS	Background Glaucoma represents the second main cause of irreversible loss of eyesight worldwide. Progression of the disease is due to changes around the optic nerve, eye structure and optic nerve environment. Focusing on primary congenital glaucoma, which is not completely understood, we report an evaluation of an untested mutation (c.182G>A, p.Gly61Glu) within the CYP1B1 gene in the context of microglia, astrocytes and mesenchymal stem cells. We investigated the behaviours of these cells, which are needed to maintain eye homeostasis, in response to the CYP1B1 mutation. Methods and results CRISPR technology was used to edit normal CYP1B1 genes within normal astrocytes, microglia and stem cells in vitro. Increased metabolic activities were found in microglia and astrocytes 24 hours after CYP1B1 manipulation. However, these activities dropped by 40% after 72 hrs. In addition, the nicotinamide adenine dinucleotide phosphate (NADP)/NADPH reducing equivalent process decreased by 50% on average after 72 hrs of manipulation. The cytokines measured in mutated microglia showed progressive activation leading to apoptosis, which was confirmed with annexin-V. The cytokines evaluated in mutant astrocytes were abnormal in comparison to those in the control. Conclusions The results suggest a progressive inflammation that was induced by mutations (p.Gly61Glu) on CYP1B1. Furthermore, the mutations enhanced the microglia's loss of activity. We are the first to show the direct impact of the mutation on microglia. This progressive inflammation might be responsible for primary congenital glaucoma complications, which could be avoided via an anti-inflammatory regimen. This finding also reveals that progressive inflammation affects recovery failure after surgeries to relieve glaucoma. Moreover, microglia are important for the survival of ganglion cells, along with the clearing of pathogens and inflammation. The reduction of their activities may jeopardise homeostasis within the optic nerve environment and complicate the protection of optic nerve components (such as retinal ganglion and glial cells).	[Alghamdi, Amani; Aldossary, Wadha] King Saud Univ KSU, Biochem Dept, Riyadh, Saudi Arabia; [Albahkali, Sarah; Alotaibi, Batoul; Alrfaei, Bahauddeen M.] King Abdullah Int Med Res Ctr KAIMRC, Stem Cells & Regenerat Med, Riyadh, Saudi Arabia; [Alrfaei, Bahauddeen M.] King Saud Bin Abdulaziz Univ Hlth Sci KSAU HS, Riyadh, Saudi Arabia	King Saud University; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); King Saud Bin Abdulaziz University for Health Sciences	Alrfaei, BM (corresponding author), King Abdullah Int Med Res Ctr KAIMRC, Stem Cells & Regenerat Med, Riyadh, Saudi Arabia.; Alrfaei, BM (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci KSAU HS, Riyadh, Saudi Arabia.	alrfaeiba@ngha.med.sa	Alrfaei, Bahauddeen/P-7314-2018	Alrfaei, Bahauddeen/0000-0002-5740-9187; Alghamdi, Amani/0000-0002-7251-1972	King Abdulaziz City for Science and Technology (KACST) [MS-37-336]; King Abdullah International Medical Research Center (KAMRC) [RC17/038/R]	King Abdulaziz City for Science and Technology (KACST); King Abdullah International Medical Research Center (KAMRC)	We thank the King Abdulaziz City for Science and Technology (KACST) for grant No. MS-37-336 and its support and King Abdullah International Medical Research Center (KAMRC) grant (RC17/038/R) for BMA. The funding agencies had no influence on this research, and their role was solely to offer financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2018, CLIN OPHTHALMOL, V12, P1413, DOI 10.2147/OPTH.S169943; Ajmone-Cat MA, 2016, BRAIN BEHAV IMMUN, V55, P225, DOI 10.1016/j.bbi.2015.11.012; Alfadhel M, 2018, DISCOV MED, V26, P147; Alfares A, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00365; Alrfaei BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080865; Alsaif HS, 2019, HUM GENET, V138, P1043, DOI 10.1007/s00439-018-1878-z; Alsubait A, 2020, J CANCER, V11, P4652, DOI 10.7150/jca.42669; Anderson SR, 2019, J NEUROSCI, V39, P2025, DOI 10.1523/JNEUROSCI.1854-18.2018; Badeeb OM, 2014, BMC MED GENET, V15, DOI 10.1186/s12881-014-0109-2; Bejjani BA, 1998, AM J HUM GENET, V62, P325, DOI 10.1086/301725; Chavarria-Soley G, 2006, MOL VIS, V12, P523; Chouiter L, 2017, J PEDIATR GENET, V6, P205, DOI 10.1055/s-0037-1602695; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Faiq Muneeb A, 2015, J Curr Glaucoma Pract, V9, P77, DOI 10.5005/jp-journals-10008-1189; Gabrysova L, 2009, J EXP MED, V206, P1755, DOI 10.1084/jem.20082118; Gersch RP, 2020, AESTHET SURG J, V40, P108, DOI 10.1093/asj/sjz071; Gong B, 2015, BRIT J OPHTHALMOL, V99, P425, DOI 10.1136/bjophthalmol-2014-306054; Grigg J., 2013, 9 CONS M CHILDH GLAU; Gursel DB, 2015, J NEURO-ONCOL, V121, P19, DOI 10.1007/s11060-014-1602-3; Handel U, 2012, AM J PATHOL, V181, P163, DOI 10.1016/j.ajpath.2012.03.029; Krady JK, 2002, GLIA, V40, P11, DOI 10.1002/glia.10101; Lafuente JV, 1999, J MOL NEUROSCI, V13, P177, DOI 10.1385/JMN:13:1-2:177; Li F, 2017, PHARMACOL THERAPEUT, V178, P18, DOI 10.1016/j.pharmthera.2017.03.007; Lian Hong, 2016, Bio Protoc, V6, DOI 10.21769/BioProtoc.1989; Lundmark PO, 2006, VISUAL NEUROSCI, V23, P853, DOI 10.1017/S0952523806230189; Ma XC, 2005, DRUG METAB DISPOS, V33, P489, DOI 10.1124/dmd.104.002410; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Millan-Rivero JE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34527-z; Mitra SS, 2015, NEUROSURGERY, V77, P794, DOI 10.1227/NEU.0000000000000918; Motegi S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17630-5; Onphachanh X, 2017, J PINEAL RES, V63, DOI 10.1111/jpi.12427; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rittig N, 2018, ENDOCR CONNECT, V7, P107, DOI 10.1530/EC-17-0296; Ronco C, 2017, MEDCHEMCOMM, V8, P295, DOI 10.1039/c6md00439c; Safari I, 2016, OPHTHALMIC RES, V56, P98, DOI 10.1159/000443508; Santello M, 2019, NAT NEUROSCI, V22, P154, DOI 10.1038/s41593-018-0325-8; Sloan SA, 2014, CURR OPIN NEUROBIOL, V27, P75, DOI 10.1016/j.conb.2014.03.005; Souzeau E, 2015, JAMA OPHTHALMOL, V133, P826, DOI 10.1001/jamaophthalmol.2015.0980; Suh HS, 2005, J IMMUNOL, V174, P2712, DOI 10.4049/jimmunol.174.5.2712; Teixeira LBC, 2015, VET PATHOL, V52, P397, DOI 10.1177/0300985814535613; Tsuchiya Y, 2006, CANCER RES, V66, P9090, DOI 10.1158/0008-5472.CAN-06-1403; Vasiliou V, 2008, ANNU REV PHARMACOL, V48, P333, DOI 10.1146/annurev.pharmtox.48.061807.154729; Wang FS, 2017, BRAIN STRUCT FUNCT, V222, P1543, DOI 10.1007/s00429-016-1292-z; Wang J, 2017, CELL MOL NEUROBIOL, V37, P251, DOI 10.1007/s10571-016-0365-0; Wang SJ, 2015, P NATL ACAD SCI USA, V112, pE1926, DOI 10.1073/pnas.1417883112; Yang JM, 2014, NEUROSCIENCE, V275, P296, DOI 10.1016/j.neuroscience.2014.06.016; Yao XL, 2019, BIOCHEM BIOPH RES CO, V509, P624, DOI 10.1016/j.bbrc.2018.11.145; Zhang SC, 2001, NAT REV NEUROSCI, V2, P840, DOI 10.1038/35097593; Zhao Y, 2013, MOL CELL BIOL, V33, P4225, DOI 10.1128/MCB.00856-13; Zhu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27983; [No title captured]	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241902	10.1371/journal.pone.0241902	http://dx.doi.org/10.1371/journal.pone.0241902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170892	Green Published, gold			2022-12-26	WOS:000592383400065
J	Huang, YS; Lyu, XY; Li, D; Wang, L; Wang, YJ; Zou, WB; Wei, YX; Wu, XW				Huang, Yongsheng; Lyu, Xiaoyu; Li, Dan; Wang, Lin; Wang, Yujun; Zou, Wenbin; Wei, Yingxin; Wu, Xiaowei			A cohort study of 676 patients indicates D-dimer is a critical risk factor for the mortality of COVID-19	PLOS ONE			English	Article							CORONAVIRUS; PNEUMONIA	Coronavirus Disease 2019 (COVID-19) has recently become a public emergency and a worldwide pandemic. However, the information on the risk factors associated with the mortality of COVID-19 and of their prognostic potential is limited. In this retrospective study, the clinical characteristics, treatment and outcome data were collected and analyzed from 676 COVID-19 patients stratified into 140 non-survivors and 536 survivors. We found that the levels of Dimerized plasmin fragment D (D-dimer), C-reactive protein (CRP), lactate dehydrogenase (LDH), procalcitonin (PCT) were significantly higher in non-survivals on admission (non-survivors vs. survivors: D-Dimer >= 0.5 mg/L, 83.2% vs. 44.9%, P0.01; CRP >= 10 mg/L, 50.4% vs. 6.0%, P0.01; LDH >= 250 U/L, 73.8% vs. 20.1%, P0.01; PCT >= 0.5 ng/ml, 27.7% vs. 1.8%, P0.01). Moreover, dynamic tracking showed D-dimer kept increasing in non-survivors, while CRP, LDH and PCT remained relatively stable after admission. D-dimer has the highest C-index to predict in-hospital mortality, and patients with D-dimer levels >= 0.5 mg/L had a higher incidence of mortality (Hazard Ratio: 4.39, P0.01). Our study suggested D-dimer could be a potent marker to predict the mortality of COVID-19, which may be helpful for the management of patients.	[Huang, Yongsheng; Wang, Lin] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci, Beijing, Peoples R China; [Lyu, Xiaoyu] Huazhong Univ Sci & Technol, Tongji Med Coll, Cent Hosp Wuhan, Dept Endocrinol, Wuhan, Peoples R China; [Li, Dan] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China; [Wang, Yujun] Huazhong Univ Sci & Technol, Cent Hosp Wuhan, Tongji Med Coll, Dept Crit Care Med, Wuhan, Peoples R China; [Zou, Wenbin; Wu, Xiaowei] Huazhong Univ Sci & Technol, TongJi Hosp, TongJi Med Coll, Dept Thorac Surg, Wuhan, Peoples R China; [Wei, Yingxin] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital	Wu, XW (corresponding author), Huazhong Univ Sci & Technol, TongJi Hosp, TongJi Med Coll, Dept Thorac Surg, Wuhan, Peoples R China.; Wei, YX (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Gen Surg, Beijing, Peoples R China.	aaronwei1983@126.com; wuxiaowei119@126.com	李, 丹/HGE-6895-2022; Wang, Yu/GZL-9655-2022	李, 丹/0000-0002-5586-4055; , Xiaowei/0000-0001-8094-9117	National Key Research and Development Program of China [2016YFC1302203]; Beijing Nova Program [xx2018040]	National Key Research and Development Program of China; Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This study was supported by funding from the National Key Research and Development Program of China (2016YFC1302203); Beijing Nova Program (grant number: xx2018040). "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2020, DIAGNOSIS, V7, P91, DOI 10.1515/dx-2020-0046; Ashour HM, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9030186; Chang D, 2020, JAMA-J AM MED ASSOC, V323, P1092, DOI 10.1001/jama.2020.1623; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Ferner RE, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1610; Fihn SD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9035; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guastalegname M, 2020, CLIN INFECT DIS, V71, P888, DOI 10.1093/cid/ciaa321; Harris C.R., 2020, NATURE, V585, P357, DOI [10.1038/s41586-020-2649-2, DOI 10.1038/S41586-020-2649-2, DOI 10.1038/S41586-020-2423-5]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang I, 2020, THER ADV RESPIR DIS, V14, DOI 10.1177/1753466620937175; Johnson RM, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2648; Khunti K, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1548; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Malik YS, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9070519; Paiva HM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236386; Pareek M, 2020, LANCET, V395, P1421, DOI 10.1016/S0140-6736(20)30922-3; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Rayman G, 2021, DIABETIC MED, V38, DOI 10.1111/dme.14378; Tang DL, 2020, AUTOPHAGY, V16, P2273, DOI 10.1080/15548627.2020.1796014; Tang N, 2020, J THROMB HAEMOST, V18, P844, DOI 10.1111/jth.14768; Tomlins J, 2020, J INFECTION, V81, pE59, DOI 10.1016/j.jinf.2020.04.020; Toyoshima Y, 2020, J HUM GENET, V65, P1075, DOI 10.1038/s10038-020-0808-9; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9; WISE J, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M2610; World Health Organization, WH NOV COR COVID 19; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang JH, 2020, J INFECTION, V80, P681, DOI 10.1016/j.jinf.2020.02.025; Zhang JJ, 2020, ALLERGY, V75, P1730, DOI 10.1111/all.14238; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	34	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2020	15	11							e0242045	10.1371/journal.pone.0242045	http://dx.doi.org/10.1371/journal.pone.0242045			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7JZ	33166991	Green Published, gold			2022-12-26	WOS:000592382600065
J	Mukherjee, T; Ramaglia, V; Abdel-Nour, M; Bianchi, AA; Tsalikis, J; Chau, HN; Kalia, SK; Kalia, LV; Chen, JJ; Arnoult, D; Gommerman, JL; Philpott, DJ; Girardin, SE				Mukherjee, Tapas; Ramaglia, Valeria; Abdel-Nour, Mena; Bianchi, Athanasia A.; Tsalikis, Jessica; Chau, Hien N.; Kalia, Suneil K.; Kalia, Lorraine, V; Chen, Jane-Jane; Arnoult, Damien; Gommerman, Jennifer L.; Philpott, Dana J.; Girardin, Stephen E.			The eIF2 alpha kinase HRI triggers the autophagic clearance of cytosolic protein aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISCERAL PRIMARY AFFERENTS; INITIATION-FACTOR 2-ALPHA; SACRAL SPINAL-CORD; TRANSLATIONAL CONTROL; PATHWAY; PHOSPHORYLATION; SYNUCLEIN; SURVIVAL; NEURONS; SYSTEM	Large cytosolic protein aggregates are removed by two main cellular processes, autophagy and the ubiquitin-proteasome system, and defective clearance of these protein aggregates results in proteotoxicity and cell death. Recently, we found that the eIF2 alpha kinase heme-regulated inhibitory (HRI) induced a cytosolic unfolded protein response to prevent aggregation of innate immune signalosomes, but whether HRI acts as a general sensor of proteotoxicity in the cytosol remains unclear. Here we show that HRI controls autophagy to clear cytosolic protein aggregates when the ubiquitin-proteasome system is inhibited. We further report that silencing the expression of HRI resulted in decreased levels of BAG3 and HSPB8, two proteins involved in chaperone-assisted selective autophagy, suggesting that HRI may control proteostasis in the cytosol at least in part through chaperone-assisted selective autophagy. Moreover, knocking down the expression of HRI resulted in cytotoxic accumulation of overexpressed alpha-synuclein, a protein known to aggregate in Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. In agreement with these data, protein aggregate accumulation and microglia activation were observed in the spinal cord white matter of 7-month-old Hri(-/-) mice as compared with Hri(+/+) littermates. Moreover, aged Hri(-/-) mice showed accumulation of misfolded alpha-synuclein in the lateral collateral pathway, a region of the sacral spinal cord horn that receives visceral sensory afferents from the bladder and distal colon, a pathological feature common to a-synucleinopathies in humans. Together, these results suggest that HRI contributes to a general cytosolic unfolded protein response that could be leveraged to bolster the clearance of cytotoxic protein aggregates.	[Mukherjee, Tapas; Abdel-Nour, Mena; Bianchi, Athanasia A.; Tsalikis, Jessica; Girardin, Stephen E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mukherjee, Tapas; Ramaglia, Valeria; Gommerman, Jennifer L.; Philpott, Dana J.; Girardin, Stephen E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Chau, Hien N.; Kalia, Suneil K.; Kalia, Lorraine, V] Univ Hlth Network, Toronto Western Hosp, Krembil Res Inst, Toronto, ON, Canada; [Chen, Jane-Jane] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Arnoult, Damien] HOp Paul Brousse, INSERM, U1197, Batiment Lavoisier, Villejuif, France; [Arnoult, Damien] Univ Paris Saclay, Paris, France	University of Toronto; University of Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Massachusetts Institute of Technology (MIT); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Girardin, SE (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Girardin, SE (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	stephen.girardin@utoronto.ca		Kalia, Suneil/0000-0003-2054-1915; Arnoult, Damien/0000-0001-7718-1178	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from Canadian Institutes of Health Research (D. J. P. and S. E. G.). The authors declare no competing financial interests. We thank Drs Michael Schlossmacher and Julianna Tomlinson (University of Ottawa) for helpful discussions on a-synuclein biology along the way.	Abdel-Nour M, 2019, SCIENCE, V365, P47, DOI 10.1126/science.aaw4144; Adriaenssens E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65664-z; Alvarez-Castelao B, 2020, ELIFE, V9, DOI 10.7554/eLife.52714; ANAND P, 1983, NATURE, V305, P143, DOI 10.1038/305143a0; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bellato HM, 2016, CYTOSKELETON, V73, P551, DOI 10.1002/cm.21294; Berwal SK, 2018, INT J BIOL MACROMOL, V118, P1604, DOI 10.1016/j.ijbiomac.2018.06.204; Bond S, 2020, J NEUROPATH EXP NEUR, V79, P123, DOI 10.1093/jnen/nlz129; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Bretin A, 2016, AUTOPHAGY, V12, P770, DOI 10.1080/15548627.2016.1156823; Carra S, 2009, J BIOL CHEM, V284, P5523, DOI 10.1074/jbc.M807440200; Chen JJ, 2014, CURR OPIN HEMATOL, V21, P172, DOI 10.1097/MOH.0000000000000030; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; CHEN JJ, 1994, BIOCHIMIE, V76, P761, DOI 10.1016/0300-9084(94)90080-9; Ciechanover A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00185; Colonna M, 2017, ANNU REV IMMUNOL, V35, P441, DOI 10.1146/annurev-immunol-051116-052358; Cristofani R, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00796; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Guilbert SM, 2018, FASEB J, V32, P3518, DOI 10.1096/fj.201700558RR; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Hartl FU, 2017, ANNU REV BIOCHEM, V86, P21, DOI 10.1146/annurev-biochem-061516-044518; Hirai Y, 2004, FEBS LETT, V572, P227, DOI 10.1016/j.febslet.2004.07.046; Hou X, 2020, J MOL BIOL, V432, P2651, DOI 10.1016/j.jmb.2020.01.037; Humeau J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2642-6; Kalia LV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014695; KAWATANI M, 1983, NEUROSCI LETT, V42, P311, DOI 10.1016/0304-3940(83)90280-X; Killackey SA, 2019, MOL CELL BIOCHEM, V453, P187, DOI 10.1007/s11010-018-3444-3; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Liu SJ, 2007, J CLIN INVEST, V117, P3296, DOI 10.1172/JCI32084; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Mao DX, 2020, AM J HUM GENET, V106, P570, DOI 10.1016/j.ajhg.2020.02.016; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; McKinnon C, 2020, ACTA NEUROPATHOL COM, V8, DOI 10.1186/s40478-020-0894-0; Michailidou I, 2017, GLIA, V65, P264, DOI 10.1002/glia.23090; MORGAN C, 1981, J COMP NEUROL, V201, P415, DOI 10.1002/cne.902010308; NADELHAFT I, 1983, J COMP NEUROL, V216, P36, DOI 10.1002/cne.902160105; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Rusmini P, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00176; Seidel K, 2012, NEUROPATH APPL NEURO, V38, P39, DOI 10.1111/j.1365-2990.2011.01198.x; Shao J, 2001, J BIOL CHEM, V276, P206, DOI 10.1074/jbc.M007583200; Sturner E, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00177; Sweeney P, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0077-5; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Taniuchi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32886; Tsalikis J, 2015, J BIOL CHEM, V290, P20904, DOI 10.1074/jbc.M115.659466; Uma S, 1997, J BIOL CHEM, V272, P11648; van der Knaap MS, 2003, AM J HUM GENET, V73, P1199, DOI 10.1086/379524; VanderHorst VG, 2015, ANN NEUROL, V78, P142, DOI 10.1002/ana.24430; White MC, 2018, ONCOGENE, V37, P4413, DOI 10.1038/s41388-018-0227-y; Yerlikaya A, 2008, BIOCHEM J, V412, P579, DOI 10.1042/BJ20080324; Zhang SP, 2018, BLOOD, V131, P450, DOI 10.1182/blood-2017-08-799908	52	12	12	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100050	10.1074/jbc.RA120.014415	http://dx.doi.org/10.1074/jbc.RA120.014415			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33168630	Green Submitted, Green Published, gold			2022-12-26	WOS:000672866400033
J	Tong, X; Xu, DD; Mishra, RK; Jones, RD; Sun, LY; Schiltz, GE; Liao, J; Yang, GY				Tong, Xin; Xu, Dandan; Mishra, Rama K.; Jones, Ryan D.; Sun, Leyu; Schiltz, Gary E.; Liao, Jie; Yang, Guang-Yu			Identification of a druggable protein-protein interaction site between mutant p53 and its stabilizing chaperone DNAJA1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; TP53 GENE; CANCER; MUTATIONS; GAIN; MOLECULES; PARTNERS; DRIVES	The TP53 gene is the most frequently mutated gene in human cancers, and the majority of TP53 mutations are missense mutations. As a result, these mutant p53 (mutp53) either directly lose wildtype p53 (wtp53) tumor suppressor function or exhibit a dominant negative effect over wtp53. In addition, some mutp53 have acquired new oncogenic function (gain of function). Therefore, targeting mutp53 for its degradation may serve as a promising strategy for cancer prevention and therapy. Based on our previous finding that farnesylated DNAJA1 is a crucial chaperone in maintaining mutp53 stabilization, and by using an in silico approach, we built 3D homology models of human DNAJA1 and mutp53(R175H) proteins, identified the interacting pocket in the DNAJA1-mutp53(R175H) complex, and found one critical druggable small molecule binding site in the DNAJA1 glycine/phenylalanine-rich region. We confirmed that the interacting pocket in the DNAJA1-mutp53(R175H) complex was crucial for stabilizing mutp53R175H using a site-directed mutagenesis approach. We further screened a drug-like library to identify a promising small molecule hit (GY1-22) against the interacting pocket in the DNAJA1-mutp53(R175H) complex. The GY1-22 compound displayed an effective activity against the DNAJA1-mutp53(R175H) complex. Treatment with GY1-22 significantly reduced mutp53 protein levels, enhanced Waf1p21 expression, suppressed cyclin D1 expression, and inhibited mutp53-driven pancreatic cancer growth both in vitro and in vivo. Together, our results indicate that the interacting pocket in the DNAJA1-mutp53(R175H) complex is critical for mutp53's stability and oncogenic function, and DNAJA1 is a robust therapeutic target for developing the efficient small molecule inhibitors against oncogenic mutp53.	[Tong, Xin; Xu, Dandan; Jones, Ryan D.; Sun, Leyu; Liao, Jie; Yang, Guang-Yu] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Tong, Xin; Schiltz, Gary E.; Yang, Guang-Yu] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Mishra, Rama K.; Schiltz, Gary E.] Northwestern Univ, Feinberg Sch Med, Ctr Mol Innovat & Drug Discovery, Chicago, IL 60611 USA; [Mishra, Rama K.; Schiltz, Gary E.] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA; [Mishra, Rama K.] Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Yang, GY (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA.; Yang, GY (corresponding author), Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	g-yang@northwestern.edu		Tong, Xin/0000-0002-6618-3976	National Institutes of Health [R01 DK10776, CA172431, CA164041]; National Cancer Institute [P30CA060553]; Searle Funds at the Chicago Community Trust; Chicago Biomedical Consortium	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Searle Funds at the Chicago Community Trust; Chicago Biomedical Consortium	This study was supported by National Institutes of Health R01 DK10776, CA172431, and CA164041 (to G. Y.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. A part of this work was performed by the Northwestern University ChemCore, which is partially funded by Cancer Center Support Grant P30CA060553 from the National Cancer Institute awarded to the Robert H. Lurie Comprehensive Cancer Center, and the Chicago Biomedical Consortium with support from the Searle Funds at the Chicago Community Trust.	Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Barta JA, 2019, MOL CANCER RES, V17, P3, DOI 10.1158/1541-7786.MCR-18-0357; Baugh EH, 2018, CELL DEATH DIFFER, V25, P154, DOI 10.1038/cdd.2017.180; Boettcher S, 2019, SCIENCE, V365, P599, DOI 10.1126/science.aax3649; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; CAPLAN AJ, 1992, J BIOL CHEM, V267, P18890; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chene P, 1998, J MOL BIOL, V281, P205, DOI 10.1006/jmbi.1998.1897; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Datta A, 2017, EMBO REP, V18, P2030, DOI 10.15252/embr.201643347; Farid R, 2006, BIOORGAN MED CHEM, V14, P3160, DOI 10.1016/j.bmc.2005.12.032; Gumeni S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102036; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; HARVEY M, 1995, NAT GENET, V9, P305, DOI 10.1038/ng0395-305; Jain AN, 2003, J MED CHEM, V46, P499, DOI 10.1021/jm020406h; Jana NR, 2004, NEUROTOX RES, V6, P523, DOI 10.1007/BF03033448; Jeng W., 2015, F1000RES, V4; Joers A, 1998, ONCOGENE, V17, P2351, DOI 10.1038/sj.onc.1202146; Kakudo Y, 2005, CANCER RES, V65, P2108, DOI 10.1158/0008-5472.CAN-04-2935; Kanazawa M, 1997, J BIOCHEM-TOKYO, V121, P890; Kastenhuber ER, 2017, CELL, V170, P1062, DOI 10.1016/j.cell.2017.08.028; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kim MP, 2018, CELL DEATH DIFFER, V25, P161, DOI 10.1038/cdd.2017.185; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Lee MK, 2012, CANCER CELL, V22, P751, DOI 10.1016/j.ccr.2012.10.022; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Mishra RK, 2016, SCI REP-UK, V6, DOI 10.1038/srep30155; Mishra RK, 2015, CURR COMPUT-AID DRUG, V11, P152, DOI 10.2174/1573409911666150702100839; Mishra RK, 2015, J BIOL CHEM, V290, P14441, DOI 10.1074/jbc.M114.628826; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Nicholls CD, 2002, J BIOL CHEM, V277, P12937, DOI 10.1074/jbc.M108815200; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Parrales A, 2016, NAT CELL BIOL, V18, P1233, DOI 10.1038/ncb3427; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Rodicker F, 2003, CANCER RES, V63, P2737; ROLLEY N, 1995, ONCOGENE, V11, P763; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Terada K, 2010, J BIOL CHEM, V285, P16789, DOI 10.1074/jbc.M110.101501; Tracz-Gaszewska Z, 2017, ONCOTARGET, V8, P82123, DOI 10.18632/oncotarget.18899; Verdonk ML, 2005, J MED CHEM, V48, P6504, DOI 10.1021/jm050543p; Villa SR, 2017, J INVEST MED, V65, P1116, DOI 10.1136/jim-2017-000523; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Wan-Mamat WMF, 2009, IEEE ENG MED BIO, P6424, DOI 10.1109/IEMBS.2009.5333747; Wawrzynow B, 2018, BBA-REV CANCER, V1869, P161, DOI 10.1016/j.bbcan.2017.12.004; Wiehe K, 2005, PROTEINS, V60, P207, DOI 10.1002/prot.20559; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Xu DD, 2019, MOL CARCINOGEN, V58, P2052, DOI 10.1002/mc.23097	58	12	12	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100098	10.1074/jbc.RA120.014749	http://dx.doi.org/10.1074/jbc.RA120.014749			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33208462	Green Published, gold			2022-12-26	WOS:000672866400078
J	Wang, K; Maayah, M; Sweasy, JB; Alnajjar, KS				Wang, Katarina; Maayah, Marah; Sweasy, Joann B.; Alnajjar, Khadijeh S.			The role of cysteines in the structure and function of OGG1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE DNA-DAMAGE; BASE EXCISION-REPAIR; HUMAN 8-OXOGUANINE-DNA GLYCOSYLASE; PROINFLAMMATORY GENE-EXPRESSION; BINDING; 8-HYDROXY-2'-DEOXYGUANOSINE; TRANSCRIPTION; COORDINATION; STIMULATION; RECOGNITION	8-Oxoguanine glycosylase (OGG1) is a base excision repair enzyme responsible for the recognition and removal of 8-oxoguanine, a commonly occurring oxidized DNA modification. OGG1 prevents the accumulation of mutations and regulates the transcription of various oxidative stress-response genes. In addition to targeting DNA, oxidative stress can affect proteins like OGG1 itself, specifically at cysteine residues. Previous work has shown that the function of OGG1 is sensitive to oxidants, with the cysteine residues of OGG1 being the most likely site of oxidation. Due to the integral role of OGG1 in maintaining cellular homeostasis under oxidative stress, it is important to understand the effect of oxidants on OGG1 and the role of cysteines in its structure and function. In this study, we investigate the role of the cysteine residues in the function of OGG1 by mutating and characterizing each cysteine residue. Our results indicate that the cysteines in OGG1 fall into four functional categories: those that are necessary for (1) glycosylase activity (C146 and C255), (2) lyase activity (C140S, C163, C241, and C253), and (3) structural stability (C253) and (4) those with no known function (C28 and C75). These results suggest that under conditions of oxidative stress, cysteine can be targeted for modifications, thus altering the response of OGG1 and affecting its downstream cellular functions.	[Wang, Katarina; Maayah, Marah] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT USA; [Sweasy, Joann B.; Alnajjar, Khadijeh S.] Univ Arizona, Canc Ctr, Dept Cellular & Mol Med, Tucson, AZ 85719 USA	Yale University; University of Arizona	Alnajjar, KS (corresponding author), Univ Arizona, Canc Ctr, Dept Cellular & Mol Med, Tucson, AZ 85719 USA.	ksalnajjar@arizona.edu		Wang, Katarina/0000-0002-7804-4850; Alnajjar, Khadijeh/0000-0002-0219-6807	National Institutes of Health [K99-ES029555]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this work was provided by the National Institutes of Health grants K99-ES029555 to K. A. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguilera-Aguirre L, 2014, J IMMUNOL, V193, P4643, DOI 10.4049/jimmunol.1401625; Alam ZI, 1997, J NEUROCHEM, V69, P1196, DOI 10.1046/j.1471-4159.1997.69031196.x; Ali K, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/690878; Alnajjar KS, 2019, DNA REPAIR, V76, P60, DOI 10.1016/j.dnarep.2019.02.006; Anderson AP, 2020, NUCLEIC ACIDS RES, V48, P817, DOI 10.1093/nar/gkz1018; Ba XQ, 2018, REDOX BIOL, V14, P669, DOI 10.1016/j.redox.2017.11.008; Ba XQ, 2014, J IMMUNOL, V192, P2384, DOI 10.4049/jimmunol.1302472; Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; BASHIR S, 1993, ANN RHEUM DIS, V52, P659, DOI 10.1136/ard.52.9.659; Bjoras M, 1997, EMBO J, V16, P6314, DOI 10.1093/emboj/16.20.6314; Boiteux S, 1999, BIOCHIMIE, V81, P59, DOI 10.1016/S0300-9084(99)80039-X; Boldogh I, 2012, J BIOL CHEM, V287, P20769, DOI 10.1074/jbc.C112.364620; Bravard A, 2006, MOL CELL BIOL, V26, P7430, DOI 10.1128/MCB.00624-06; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Cadet J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012559; Collins AR, 1999, BIOESSAYS, V21, P238, DOI 10.1002/(SICI)1521-1878(199903)21:3<238::AID-BIES8>3.0.CO;2-3; Cuneo MJ, 2010, P NATL ACAD SCI USA, V107, P6805, DOI 10.1073/pnas.0914077107; Denver DR, 2003, MOL BIOL EVOL, V20, P1603, DOI 10.1093/molbev/msg177; Ebert F, 2011, MUTAT RES-FUND MOL M, V715, P32, DOI 10.1016/j.mrfmmm.2011.07.004; Fleming AM, 2019, J AM CHEM SOC, V141, P11036, DOI 10.1021/jacs.9b01847; Fleming AM, 2017, P NATL ACAD SCI USA, V114, P2604, DOI 10.1073/pnas.1619809114; Fouquerel E, 2019, MOL CELL, V75, P117, DOI 10.1016/j.molcel.2019.04.024; Freudenthal BD, 2015, NATURE, V517, P635, DOI 10.1038/nature13886; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hao WJ, 2020, FASEB J, V34, P7427, DOI 10.1096/fj.201902243R; Hill JW, 2006, NUCLEIC ACIDS RES, V34, P1620, DOI 10.1093/nar/gkl060; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; KASAI H, 1986, CARCINOGENESIS, V7, P1849, DOI 10.1093/carcin/7.11.1849; Kim Yun-Jeong, 2012, Curr Mol Pharmacol, V5, P3; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Lee HT, 2014, CLIN EXP IMMUNOL, V176, P66, DOI 10.1111/cei.12256; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; Lukina MV, 2013, J BIOL CHEM, V288, P28936, DOI 10.1074/jbc.M113.487322; LUNEC J, 1994, FEBS LETT, V348, P131, DOI 10.1016/0014-5793(94)00583-4; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Matsui M, 1999, J INVEST DERMATOL, V113, P26, DOI 10.1046/j.1523-1747.1999.00630.x; Mouzakis KD, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4111-9; Pan L, 2019, FASEB J, V33, P14159, DOI 10.1096/fj.201900993RR; Pan L, 2017, SCI REP-UK, V7, DOI 10.1038/srep43297; Pan L, 2016, J BIOL CHEM, V291, P25553, DOI 10.1074/jbc.M116.751453; Paulsen CE, 2013, CHEM REV, V113, P4633, DOI 10.1021/cr300163e; Perillo B, 2008, SCIENCE, V319, P202, DOI 10.1126/science.1147674; Sassa A, 2012, J BIOL CHEM, V287, P36702, DOI 10.1074/jbc.M112.397786; Shen SW, 2013, CHEM REV, V113, P7769, DOI 10.1021/cr300015c; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; Steenken S, 1997, J AM CHEM SOC, V119, P617, DOI 10.1021/ja962255b; Sugimura H, 1999, CANCER EPIDEM BIOMAR, V8, P669; Swenberg JA, 2011, TOXICOL SCI, V120, pS130, DOI 10.1093/toxsci/kfq371; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; van der Kemp PA, 2004, NUCLEIC ACIDS RES, V32, P570, DOI 10.1093/nar/gkh224; Visnes T, 2018, SCIENCE, V362, P834, DOI 10.1126/science.aar8048; Visnes T, 2018, DNA REPAIR, V71, P118, DOI 10.1016/j.dnarep.2018.08.015; Walsh C., 2006, POSTTRANSLATIONAL MO; Wang RX, 2018, CELL MOL LIFE SCI, V75, P3741, DOI 10.1007/s00018-018-2887-8; Xu JF, 2002, CANCER RES, V62, P2253; Yudkina AV, 2019, CRYSTALS, V9, DOI 10.3390/cryst9050269; Zharkov DO, 2000, J BIOL CHEM, V275, P28607, DOI 10.1074/jbc.M002441200	58	10	9	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100093	10.1074/jbc.RA120.016126	http://dx.doi.org/10.1074/jbc.RA120.016126			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33203705	Green Published, gold			2022-12-26	WOS:000672866400073
J	McLean, AHC; Parker, BJ				McLean, Ailsa H. C.; Parker, Benjamin J.			Variation in intrinsic resistance of pea aphids to parasitoid wasps: A transcriptomic basis	PLOS ONE			English	Article							NATURAL ENEMIES; SYMBIONTS; COEVOLUTION; GENERALIST; SPECIALIST; PREDATORS; PATHOGENS; SELECTION	Evolutionary interactions between parasitoid wasps and insect hosts have been well studied at the organismal level, but little is known about the molecular mechanisms that insects use to resist wasp parasitism. Here we study the interaction between a braconid wasp (Aphidius ervi) and its pea aphid host (Acyrthosiphon pisum). We first identify variation in resistance to wasp parasitism that can be attributed to aphid genotype. We then use transcriptome sequencing to identify genes in the aphid genome that are differentially expressed at an early stage of parasitism, and we compare these patterns in highly resistant and susceptible aphid host lines. We find that resistant genotypes are upregulating genes involved in carbohydrate metabolism and several key innate immune system genes in response to parasitism, but that this response seems to be weaker in susceptible aphid genotypes. Together, our results provide a first look into the complex molecular mechanisms that underlie aphid resistance to wasp parasitism and contribute to a broader understanding of how resistance mechanisms evolve in natural populations.	[McLean, Ailsa H. C.] Univ Oxford, Dept Zool, Oxford, England; [Parker, Benjamin J.] Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA	University of Oxford; University of Tennessee System; University of Tennessee Knoxville	Parker, BJ (corresponding author), Univ Tennessee, Dept Microbiol, Knoxville, TN 37996 USA.	bjp@utk.edu			NERC Biomolecular Analysis Facility Pilot Project Competition [NBAF916]; NERC [NBAF010003] Funding Source: UKRI	NERC Biomolecular Analysis Facility Pilot Project Competition; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	ACHM & BJP, NBAF916, NERC Biomolecular Analysis Facility Pilot Project Competition, http://nbaf.nerc.ac.uk, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arai I, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.12501; Brisson JA, 2006, BIOESSAYS, V28, P747, DOI 10.1002/bies.20436; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Colinet D, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001206; Corley LS, 2003, J INVERTEBR PATHOL, V83, P86, DOI 10.1016/S0022-2011(03)00041-7; Dennis AB, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6764-0; Doremus MR, 2018, MOL ECOL, V27, P2138, DOI 10.1111/mec.14399; Duffy MA, 2012, SCIENCE, V335, P1636, DOI 10.1126/science.1215429; Elderd BD, 2008, AM NAT, V172, P829, DOI 10.1086/592403; Ferrari J, 2001, EVOLUTION, V55, P1805, DOI 10.1111/j.0014-3820.2001.tb00829.x; Garafonova Olga, 2014, BRIT J SCI ED CULTUR, VIV, P488; Gerardo NM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r21; Gibson DG, 2017, LANCET GLOB HEALTH, V5, pE428, DOI [10.1016/S2214-109X(17)30072-4, 10.1016/s2214-109x(17)30072-4]; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; Gwynn DM, 2005, P ROY SOC B-BIOL SCI, V272, P1803, DOI 10.1098/rspb.2005.3089; Henry LM, 2013, CURR BIOL, V23, P1713, DOI 10.1016/j.cub.2013.07.029; Hrcek J, 2018, EVOLUTION, V72, P1488, DOI 10.1111/evo.13512; Hrcek J, 2016, J ANIM ECOL, V85, P1605, DOI 10.1111/1365-2656.12586; Jalvingh KM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2303; Kanost MR, 2015, CURR OPIN INSECT SCI, V11, P47, DOI 10.1016/j.cois.2015.09.003; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koskella B, 2009, EVOLUTION, V63, P2213, DOI 10.1111/j.1558-5646.2009.00711.x; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Martinez AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154670; Martinez AJ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-127; Mattila J, 2017, GENETICS, V207, P1231, DOI 10.1534/genetics.117.199885; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McGonigle JE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006683; McLean AHC, 2020, P ROY SOC B-BIOL SCI, V287, DOI 10.1098/rspb.2020.0562; McLean AHC, 2011, P ROY SOC B-BIOL SCI, V278, P760, DOI 10.1098/rspb.2010.1654; McLean AHC, 2017, FUNCT ECOL, V31, P927, DOI 10.1111/1365-2435.12781; McLean AHC, 2018, J ANIM ECOL, V87, P478, DOI 10.1111/1365-2656.12705; McLean AHC, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0977; Mortimer NT, 2013, P NATL ACAD SCI USA, V110, P9427, DOI 10.1073/pnas.1222351110; Oliver KM, 2005, P NATL ACAD SCI USA, V102, P12795, DOI 10.1073/pnas.0506131102; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Parker BJ, 2019, CURR BIOL, V29, P2098, DOI 10.1016/j.cub.2019.05.041; Parker BJ, 2017, EVOLUTION, V71, P1222, DOI 10.1111/evo.13216; Parker BJ, 2017, J ANIM ECOL, V86, P473, DOI 10.1111/1365-2656.12657; POWELL W, 1982, SYST ENTOMOL, V7, P465, DOI 10.1111/j.1365-3113.1982.tb00457.x; Rolff J, 2003, SCIENCE, V301, P472, DOI 10.1126/science.1080623; Sabri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018847; Sadd BM, 2009, EVOL APPL, V2, P113, DOI 10.1111/j.1752-4571.2008.00057.x; Schlenke TA, 2007, PLOS PATHOG, V3, P1486, DOI 10.1371/journal.ppat.0030158; Schmitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042114; Schulenburg H, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-49; Snyder WE, 2003, ECOLOGY, V84, P91, DOI 10.1890/0012-9658(2003)084[0091:IBSAGN]2.0.CO;2; The Abu Dhabi Declaration, 2010, J NATL COMPR CANC S3, V8, pS1; Van Veen FJF, 2008, J ANIM ECOL, V77, P191, DOI 10.1111/j.1365-2656.2007.01325.x; Vellichirammal NN, 2016, MOL ECOL, V25, P4146, DOI 10.1111/mec.13749; Xu L, 2019, INSECT MOL BIOL, V28, P176, DOI 10.1111/imb.12536	54	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242159	10.1371/journal.pone.0242159	http://dx.doi.org/10.1371/journal.pone.0242159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206703	Green Published			2022-12-26	WOS:000595265900044
J	Roshdy, WH; Rashed, HA; Kandeil, A; Mostafa, A; Moatasim, Y; Kutkat, O; Shama, NMA; Gomaa, MR; El-Sayed, IH; El Guindy, NM; Naguib, A; Kayali, G; Ali, MA				Roshdy, Wael H.; Rashed, Helmy A.; Kandeil, Ahmed; Mostafa, Ahmed; Moatasim, Yassmin; Kutkat, Omnia; Abo Shama, Noura M.; Gomaa, Mokhtar R.; El-Sayed, Ibrahim H.; El Guindy, Nancy M.; Naguib, Amal; Kayali, Ghazi; Ali, Mohamed A.			EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2	PLOS ONE			English	Article							FACTOR-KAPPA-B; INFLUENZA-VIRUS INFECTION; BETA-SITOSTEROL; CYTOKINE STORM; NECK-CANCER; CURCUMIN; KINASE; INHIBITION; CELLS; PROLIFERATION	Due to the challenges for developing vaccines in devastating pandemic situations of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), developing and screening of novel antiviral agents are peremptorily demanded. Herein, we developed EGYVIR as a potent immunomodulatory herbal extract with promising antiviral activity against SARS-CoV-2. It constitutes of a combination of black pepper extract with curcumin extract. The antiviral effect of EGYVIR extract is attributed to the two key phases of the disease in severe cases. First, the inhibition of the nuclear translocation of NF-k beta p50, attenuating the SARS-CoV-2 infection-associated cytokine storm. Additionally, the EGYVIR extract has an in vitro virucidal effect for SARS-CoV-2. The in vitro study of EGYVIR extract against SARS-CoV-2 on Huh-7 cell lines, revealed the potential role of NF-k beta/TNF alpha/IL-6 during the infection process. EGYVIR antagonizes the NF-k beta pathway in-silico and in-vitro studies. Consequently, it has the potential to hinder the release of IL-6 and TNF alpha, decreasing the production of essential cytokines storm elements.	[Roshdy, Wael H.; Rashed, Helmy A.; El Guindy, Nancy M.; Naguib, Amal] Minist Hlth & Populat, Cent Publ Hlth Lab, Cairo, Egypt; [Kandeil, Ahmed; Mostafa, Ahmed; Moatasim, Yassmin; Kutkat, Omnia; Abo Shama, Noura M.; Gomaa, Mokhtar R.; Ali, Mohamed A.] Natl Res Ctr, Ctr Sci Excellence Influenza Viruses, Giza, Egypt; [El-Sayed, Ibrahim H.] Kafr El Sheikh Univ, Fac Sci, Biochem Dept, Kafr El Shaikh, Egypt; [Kayali, Ghazi] Univ Texas Houston, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA; [Kayali, Ghazi] Human Link, Baabda, Lebanon	Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Kafrelsheikh University; University of Texas System; University of Texas Health Science Center Houston	Roshdy, WH (corresponding author), Minist Hlth & Populat, Cent Publ Hlth Lab, Cairo, Egypt.; Ali, MA (corresponding author), Natl Res Ctr, Ctr Sci Excellence Influenza Viruses, Giza, Egypt.; Kayali, G (corresponding author), Univ Texas Houston, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.; Kayali, G (corresponding author), Human Link, Baabda, Lebanon.	waelhamedroshdy@yahoo.com; ghazi@human-link.org; mohamedahmedali2004@yahoo.com	Gomaa, Mokhtar Rizk/N-9125-2018; Moatasim, Yassmin/AAQ-8426-2020; Kandeil, Ahmed/N-5473-2019; kutkat, omnia/AAU-5582-2020; Mostafa, Ahmed/S-7462-2016; Ali, Mohamed/N-8768-2017	Moatasim, Yassmin/0000-0003-2159-2511; Kandeil, Ahmed/0000-0003-3253-6961; kutkat, omnia/0000-0003-2256-2816; Mostafa, Ahmed/0000-0002-2878-5714; ElGuindy, Nancy/0000-0002-5876-237X; Ali, Mohamed/0000-0002-5615-3212; Roshdy, Wael/0000-0001-8412-3128; Gomaa, Mokhtar/0000-0001-7947-3609	National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services [HHSN272201400006C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)NIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services (under contract HHSN272201400006C). Also this work was funded by pure diagnostic company.	[Anonymous], 2018, EUR J PHYS REHAB MED, V54, P177; Arbab AH, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.30864; Behrens EM, 2017, ARTHRITIS RHEUMATOL, V69, P1135, DOI 10.1002/art.40071; Bharti AC, 2003, BLOOD, V101, P1053, DOI 10.1182/blood-2002-05-1320; Bouic PJD, 1996, INT J IMMUNOPHARMACO, V18, P693, DOI 10.1016/S0192-0561(97)85551-8; Cao J, 2006, TOXICOL SCI, V91, P476, DOI 10.1093/toxsci/kfj153; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Chen TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062482; Chen X, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05354-3; Cohen AN, 2009, ARCH OTOLARYNGOL, V135, P190, DOI 10.1001/archotol.135.2.190; Derosa G, 2016, PHARMACOL RES, V111, P394, DOI 10.1016/j.phrs.2016.07.004; Ferreira VH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124903; Fiehn Oliver, 2016, Curr Protoc Mol Biol, V114, DOI 10.1002/0471142727.mb3004s114; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Han SG, 2018, CLIN EXP PHARMACOL P, V45, P84, DOI 10.1111/1440-1681.12848; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V18, P536, DOI 10.1128/AAC.18.4.536; IVORRA MD, 1988, ARCH INT PHARMACOD T, V296, P224; Kasinski AL, 2008, MOL PHARMACOL, V74, P654, DOI 10.1124/mol.108.046201; Kim SG, 2011, CLIN CANCER RES, V17, P5953, DOI 10.1158/1078-0432.CCR-11-1272; Kong LB, 2013, ANTIVIR RES, V98, P44, DOI 10.1016/j.antiviral.2013.02.003; Kuo YC, 2002, ANTIMICROB AGENTS CH, V46, P2854, DOI 10.1128/AAC.46.9.2854-2864.2002; Lee EC, 2016, NANOSCALE, V8, P16192, DOI 10.1039/c6nr03878f; Li G, 2020, J MED VIROL, V92, P424, DOI 10.1002/jmv.25685; Li YH, 2016, ACS APPL MATER INTER, V8, P24385, DOI 10.1021/acsami.6b06613; LIU JY, 1993, CARCINOGENESIS, V14, P857, DOI 10.1093/carcin/14.5.857; Mayadevi M, 2012, BIOORGAN MED CHEM, V20, P6040, DOI 10.1016/j.bmc.2012.08.029; McGonagle D, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102537; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mostafa A, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8070991; Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014; Obata K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070225; Papp I, 2010, SMALL, V6, P2900, DOI 10.1002/smll.201001349; Perrone D, 2015, EXP THER MED, V10, P1615, DOI 10.3892/etm.2015.2749; Pradeep CR, 2004, INT IMMUNOPHARMACOL, V4, P1795, DOI 10.1016/j.intimp.2004.08.005; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; RAO GS, 1974, J PHARM SCI-US, V63, P471, DOI 10.1002/jps.2600630341; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Reuter S, 2009, ANN NY ACAD SCI, V1171, P436, DOI 10.1111/j.1749-6632.2009.04731.x; Schuhmacher A, 2003, PHYTOMEDICINE, V10, P504, DOI 10.1078/094471103322331467; Siddique HR, 2011, LIFE SCI, V88, P285, DOI 10.1016/j.lfs.2010.11.020; Tanaka T, 2004, CHEM PHARM BULL, V52, P1242, DOI 10.1248/cpb.52.1242; Toden Shusuke, 2017, J Restor Med, V6, P27, DOI 10.14200/jrm.2017.6.0101; Wang W, 2007, VIRUS RES, V128, P1, DOI 10.1016/j.virusres.2007.02.007; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Xu YM, 2017, INFLUENZA OTHER RESP, V11, P457, DOI 10.1111/irv.12459; Yang M, 2016, MOLECULES, V21, DOI 10.3390/molecules21101401; Yang XX, 2017, NANOSCALE, V9, P16086, DOI 10.1039/c7nr06520e; Yang XX, 2016, NANOSCALE, V8, P3040, DOI 10.1039/c5nr07918g; Ye Q, 2020, J INFECTION, V80, P607, DOI 10.1016/j.jinf.2020.03.037; Zhang BY, 2019, FASEB J, V33, P13294, DOI 10.1096/fj.201901047RR; Zhang J, 1995, Zhongguo Zhong Yao Za Zhi, V20, P556; Zhang L, 2009, CANCER INVEST, V27, P163, DOI 10.1080/07357900802210745; Zhang YL, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0199-1; Zhao L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117496	55	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241739	10.1371/journal.pone.0241739	http://dx.doi.org/10.1371/journal.pone.0241739			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206688	gold, Green Published			2022-12-26	WOS:000595265900052
J	Holmstrom, O; Stenman, S; Suutala, A; Moilanen, H; Kucukel, H; Ngasala, B; Martensson, A; Mhamilawa, L; Aydin-Schmidt, B; Lundin, M; Diwan, V; Linder, N; Lundin, J				Holmstrom, Oscar; Stenman, Sebastian; Suutala, Antti; Moilanen, Hannu; Kucukel, Hakan; Ngasala, Billy; Martensson, Andreas; Mhamilawa, Lwidiko; Aydin-Schmidt, Berit; Lundin, Mikael; Diwan, Vinod; Linder, Nina; Lundin, Johan			A novel deep learning-based point-of-care diagnostic method for detecting Plasmodium falciparum with fluorescence digital microscopy	PLOS ONE			English	Article							QUALITY ASSESSMENT	Background Malaria remains a major global health problem with a need for improved field-usable diagnostic tests. We have developed a portable, low-cost digital microscope scanner, capable of both brightfield and fluorescence imaging. Here, we used the instrument to digitize blood smears, and applied deep learning (DL) algorithms to detect Plasmodium falciparum parasites. Methods Thin blood smears (n = 125) were collected from patients with microscopy-confirmed P. falciparum infections in rural Tanzania, prior to and after initiation of artemisinin-based combination therapy. The samples were stained using the 4 ',6-diamidino-2-phenylindole fluorogen and digitized using the prototype microscope scanner. Two DL algorithms were trained to detect malaria parasites in the samples, and results compared to the visual assessment of both the digitized samples, and the Giemsa-stained thick smears. Results Detection of P. falciparum parasites in the digitized thin blood smears was possible both by visual assessment and by DL-based analysis with a strong correlation in results (r = 0.99, p < 0.01). A moderately strong correlation was observed between the DL-based thin smear analysis and the visual thick smear-analysis (r = 0.74, p < 0.01). Low levels of parasites were detected by DL-based analysis on day three following treatment initiation, but a small number of fluorescent signals were detected also in microscopy-negative samples. Conclusion Quantification of P. falciparum parasites in DAPI-stained thin smears is feasible using DL-supported, point-of-care digital microscopy, with a high correlation to visual assessment of samples. Fluorescent signals from artefacts in samples with low infection levels represented the main challenge for the digital analysis, thus highlighting the importance of minimizing sample contaminations. The proposed method could support malaria diagnostics and monitoring of treatment response through automated quantification of parasitaemia and is likely to be applicable also for diagnostics of other Plasmodium species and other infectious diseases.	[Holmstrom, Oscar; Stenman, Sebastian; Suutala, Antti; Kucukel, Hakan; Lundin, Mikael; Linder, Nina; Lundin, Johan] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Moilanen, Hannu] Univ Oulu, Ctr Microscopy & Nanotechnol, Oulu, Finland; [Ngasala, Billy; Martensson, Andreas; Mhamilawa, Lwidiko; Linder, Nina] Uppsala Univ, Dept Womens & Childrens Hlth, Int Maternal & Child Hlth IMCH, Uppsala, Sweden; [Ngasala, Billy; Mhamilawa, Lwidiko] Muhimbili Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Med Entomol & Parasitol, Dar Es Salaam, Tanzania; [Aydin-Schmidt, Berit] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Diwan, Vinod; Lundin, Johan] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden	University of Helsinki; University of Oulu; Uppsala University; Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Karolinska Institutet	Holmstrom, O (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland.	oscar.holmstrom@helsinki.fi	Lundin, Johan/AAC-8510-2020; Lundin, Johan/I-1843-2018	Lundin, Johan/0000-0002-2681-4139; Lundin, Johan/0000-0002-2681-4139; Stenman, Sebastian/0000-0001-5780-0285; Linder, Nina/0000-0003-3930-0513	Swedish Research Council; Swedish International Development Agency (SIDA); Sigrid Juselius Foundation; Finska Lakaresallskapet; Biomedicum Foundation; Medicinska Understodsforeningen Liv och Halsa rf; Nvidia Corporation; Wilhelm och Else Stockmanns stiftelse; Helsinki Institute of Life Science (HiLIFE); FIMM Digital Microscopy and Molecular Pathology Unit - Helsinki University and Biocenter Finland	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Agency (SIDA); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakaresallskapet; Biomedicum Foundation; Medicinska Understodsforeningen Liv och Halsa rf; Nvidia Corporation; Wilhelm och Else Stockmanns stiftelse; Helsinki Institute of Life Science (HiLIFE); FIMM Digital Microscopy and Molecular Pathology Unit - Helsinki University and Biocenter Finland	This work was funded by the Swedish Research Council, Swedish International Development Agency (SIDA) and Sigrid Juselius Foundation. In addition, the study has been supported by Finska Lakaresallskapet, Biomedicum Foundation, Medicinska Understodsforeningen Liv och Halsa rf, the Nvidia Corporation and Wilhelm och Else Stockmanns stiftelse. We furthermore greatly acknowledge the assistance and support from the Helsinki Institute of Life Science (HiLIFE) and the FIMM Digital Microscopy and Molecular Pathology Unit supported by Helsinki University and Biocenter Finland. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, P IEEE C COMP VIS PA, DOI DOI 10.1109/CVPR.2015.7298594; Bejon P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-104; Bera K, 2019, NAT REV CLIN ONCOL, V16, P703, DOI 10.1038/s41571-019-0252-y; Boppart SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009725; Charpentier E, 2020, CLIN MICROBIOL INFEC, V26, P115, DOI 10.1016/j.cmi.2019.05.010; Contreras-Naranjo JC, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2015.2478657; Digital Pathology Association, 2020, DIG PATH FAQ EL RES; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Frean J, 2012, B WORLD HEALTH ORGAN, V90, P191, DOI 10.2471/BLT.11.091876; Guy R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-89; Hassan SEH, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-88; Holmstrom O, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208366; Holmstrom O, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1337325; International Telecommunications Union, 2015, ICT FACTS FIG WORLD; Konsti J, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-29; Leski TA, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03163-2; Linder N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104855; Mathison BA, 2017, J CLIN MICROBIOL, V55, P2009, DOI [10.1128/JCM.02562-16, 10.1128/jcm.02562-16]; Mhamilawa LE, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03287-5; Mhamilawa LE, 2019, AM J TROP MED HYG, V101, P1144, DOI 10.4269/ajtmh.19-0298; Moon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061812; Natan A., 2013, FAST 2D PEAK FINDER; O'Meara WP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-118; O'Meara WP, 2005, AM J TROP MED HYG, V73, P593, DOI 10.4269/ajtmh.2005.73.593; Poostchi M, 2018, TRANSL RES, V194, P36, DOI 10.1016/j.trsl.2017.12.004; Sousa-Figueiredo JC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-245; Tajbakhsh N., 2016, IEEE T MED IMAGING, P1; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; WHO, WORLD MAL REP 2018; Wongsrichanalai C, 2021, ENCY MALAR, P1; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; World Health Organization, 2016, MAL MICR QUAL ASS MA; World Health Organization, 2016, MAL PAR COUNT MAL MI; World Health Organization, 2015, GUID TREATM MAL, Vthird	34	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242355	10.1371/journal.pone.0242355	http://dx.doi.org/10.1371/journal.pone.0242355			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201905	Green Published, gold, Green Submitted			2022-12-26	WOS:000595003900035
J	Zhang, T; Shibamoto, T; Tanida, M; Taniguchi, M; Kuda, Y; Yang, W; Kurata, Y				Zhang, Tao; Shibamoto, Toshishige; Tanida, Mamoru; Taniguchi, Makoto; Kuda, Yuhichi; Yang, Wei; Kurata, Yasutaka			Angiopoietin-2 is released during anaphylactic hypotension in anesthetized and unanesthetized rats	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; ENDOTHELIAL-CELL SURVIVAL; ACUTE LUNG INJURY; PLASMA ANGIOPOIETIN-2; FACTOR SECRETION; HISTAMINE; VASOPRESSIN; EPINEPHRINE; SHOCK	Angiopoietin (Angpt)-2, a permeability-increasing growth factor, is involved in vascular leakage of sepsis and acute lung injury, and could be released from endothelium in response to anaphylaxis-related secretagogues such as histamine and leukotrienes, or cytokines. However, roles of Angpt-2 in the hyperpermeability during systemic anaphylaxis are not known. Thus, we determined plasma levels of Angpt-2 and cytokines and vascular permeability during anaphylactic hypotension in unanesthetized rats. Anaphylaxis was induced by an intravenous injection of ovalbumin antigen. Mean arterial blood pressure (MBP) was measured, and hematocrit (Hct) and plasma levels of Angpt-2 and cytokines were assessed for 24 h after antigen injection. Separately, vascular permeability was measured in various organs using the Evans blue dye method, and Angpt-2 mRNA expression in liver was measured. After antigen injection, MBP decreased to the nadir at 6 min, and returned to baseline at 45 min, and Hct peaked at 20 min and thereafter progressively declined, suggesting that vascular leak and hypotension occurred within 20 min. Plasma Angpt-2 levels began to increase significantly at 1 h after antigen, reaching the peak 2.7-fold baseline at 6 h with a return to baseline at 24 h. Detected cytokines of IL-1 alpha, IL-1 beta, IL-6, IL-10, and TNF-alpha peaked 1 or 2 h after antigen. Angpt-2 mRNA increased at 2 h and showed an increasing tendency at 6 h. Vascular permeability in bronchus, trachea, intestines, mesentery and skeletal muscle was increased at 10 min but not at 6 h after antigen. In addition, we confirmed using anesthetized rat anaphylaxis models that plasma Angpt-2 levels increased at 1 h after antigen. In conclusion, plasma Angpt-2 is elevated presumably due to increased cytokines and enhanced gene transcription during anaphylaxis in anesthetized and unanesthetized rats.	[Zhang, Tao; Shibamoto, Toshishige; Tanida, Mamoru; Kuda, Yuhichi; Yang, Wei; Kurata, Yasutaka] Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa, Japan; [Zhang, Tao] China Med Univ, Dept Colorectal & Hernia Surg, Affiliated Hosp 4, Shenyang, Peoples R China; [Taniguchi, Makoto] Kanazawa Med Univ, Med Res Inst, Dept Life Sci, Uchinada, Ishikawa, Japan; [Yang, Wei] China Med Univ, Dept Infect Dis, Shengjing Hosp, Shenyang, Peoples R China	Kanazawa Medical University; China Medical University; Kanazawa Medical University; China Medical University	Shibamoto, T; Tanida, M (corresponding author), Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa, Japan.	shibamo@kanazawa-med.ac.jp; mtanida@kanazawa-med.ac.jp	Taniguchi, Makoto/L-5757-2019	Taniguchi, Makoto/0000-0001-5920-8285	JSPS KAKENHI [16K11428, 19K09445]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI Grant Number 16K11428 and 19K09445.	Agrawal A, 2013, AM J RESP CRIT CARE, V187, P736, DOI 10.1164/rccm.201208-1460OC; Akwii RG, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050471; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Benest AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070459; Calfee CS, 2012, CRIT CARE MED, V40, P1731, DOI 10.1097/CCM.0b013e3182451c87; Cauwels A, 2006, J CLIN INVEST, V116, P2244, DOI 10.1172/JCI25426; Cui H, 2013, J ALLERGY CLIN IMMUN, V132, P1205, DOI 10.1016/j.jaci.2013.07.026; DATTA YH, 1995, CIRCULATION, V92, P3304, DOI 10.1161/01.CIR.92.11.3304; David S, 2012, CRIT CARE MED, V40, P3034, DOI 10.1097/CCM.0b013e31825fdc31; Di Lorenzo A, 2009, P NATL ACAD SCI USA, V106, P14552, DOI 10.1073/pnas.0904073106; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fremont RD, 2010, J TRAUMA, V68, P1121, DOI 10.1097/TA.0b013e3181c40728; Gamble JR, 2000, CIRC RES, V87, P603, DOI 10.1161/01.RES.87.7.603; HAMILTON KK, 1987, J CLIN INVEST, V79, P600, DOI 10.1172/JCI112853; Harfouche R, 2006, AM J PHYSIOL-HEART C, V291, pH1635, DOI 10.1152/ajpheart.01318.2005; Hilbert T, 2013, BIOCHEM PHARMACOL, V86, P1452, DOI 10.1016/j.bcp.2013.09.004; Kaufmann JE, 2000, J CLIN INVEST, V106, P107, DOI 10.1172/JCI9516; Kim I, 2000, ONCOGENE, V19, P4549, DOI 10.1038/sj.onc.1203800; Kim M, 2016, J CLIN INVEST, V126, P3511, DOI 10.1172/JCI84871; Korhonen EA, 2016, J CLIN INVEST, V126, P3495, DOI 10.1172/JCI84923; Li L, 2016, J DIABETES INVEST, V7, P895, DOI 10.1111/jdi.12519; Lowenstein CJ, 2005, TRENDS CARDIOVAS MED, V15, P302, DOI 10.1016/j.tcm.2005.09.005; Mikelis CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7725; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Ricciuto DR, 2011, CRIT CARE MED, V39, P702, DOI 10.1097/CCM.0b013e318206d285; Rondaij MG, 2006, ARTERIOSCL THROM VAS, V26, P1002, DOI 10.1161/01.ATV.0000209501.56852.6c; Sampson HA, 2005, J ALLERGY CLIN IMMUN, V115, P584, DOI 10.1016/j.jaci.2005.01.009; Schluter T, 1999, BIOCHEM PHARMACOL, V57, P1191, DOI 10.1016/S0006-2952(99)00011-8; Shibamoto T, 2005, AM J PHYSIOL-HEART C, V289, pH1436, DOI 10.1152/ajpheart.00368.2005; Shibamoto T, 2007, AM J PHYSIOL-REG I, V293, pR2202, DOI 10.1152/ajpregu.00613.2007; Sun LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113945; Vischer UM, 1997, THROMB HAEMOSTASIS, V77, P1182; Wang M, 2014, EUR J PHARMACOL, V731, P38, DOI 10.1016/j.ejphar.2014.03.012; Yang W, 2018, ALLERGY ASTHMA IMMUN, V10, P52, DOI 10.4168/aair.2018.10.1.52; Yang XX, 2020, AM J PHYSIOL-RENAL, V318, pF338, DOI 10.1152/ajprenal.00319.2019; Zhang W, 2011, ANESTHESIOLOGY, V114, P614, DOI 10.1097/ALN.0b013e31820b8d34; Zhang W, 2011, EUR J PHARMACOL, V650, P303, DOI 10.1016/j.ejphar.2010.10.015; Ziegler T, 2013, J CLIN INVEST, V123, P3436, DOI 10.1172/JCI66549	40	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242026	10.1371/journal.pone.0242026	http://dx.doi.org/10.1371/journal.pone.0242026			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201925	gold, Green Published			2022-12-26	WOS:000595003900022
J	Takagi, Y; Kojima, T; Nishida, T; Nakamura, T; Ichikawa, K				Takagi, Yuki; Kojima, Takashi; Nishida, Tomoya; Nakamura, Tomoaki; Ichikawa, Kazuo			Prediction of anterior chamber volume after implantation of posterior chamber phakic intraocular lens	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ANGLE MEASUREMENTS; SEGMENT BIOMETRY; V4C PLACEMENT; CAUCASIANS; PENTACAM; CHINESE; VAULT	Purpose To predict the anterior chamber volume (ACV) after implantable collamer lens (ICL) implantation based on ICL size and parameters of anterior segment optical coherence tomography (AS-OCT). Design Retrospective study. Methods This study included 222 eyes of 222 patients who underwent ICL implantation at Nagoya Eye Clinic. The patients were divided into two groups: prediction group, for creating the prediction equation (148 eyes, mean age: 32.11 +/- 8.04 years), and verification group, for verifying the equation (74 eyes, mean age: 33.03 +/- 6.74 years). The angle opening distance (AOD), anterior chamber width (ACW), ACV, anterior chamber depth, lens vault, angle-to-angle distance, angle recess area, and trabecular iris space area were calculated using AS-OCT. A stepwise multiple regression analysis was performed. After the creation of the prediction equation, its accuracy was verified in the verification group. Results The ACV, AOD750, ACW, and ICL size were selected as explanatory variables to predict postoperative ACV. Mean predicted (114.2 +/- 21.83 mm(3)) and actual postoperative ACVs (116.1 +/- 25.41 mm(3)) were not significantly different (P = 0.269); absolute error was 10.59 +/- 9.13 mm(3). In addition, there was high correlation between actual and predictive ACV (adjusted R-2 = 0.6996, p < 0.0001). Bland-Altman plot revealed that there was no addition or proportional error between predicted and actual postoperative ACV. Conclusion Postoperative ACV was accurately predicted using AS-OCT parameters and ICL size. This prediction equation may be useful for making decisions regarding ICL size.	[Takagi, Yuki] Iida Municipal Hosp, Dept Ophthalmol, Nagano, Japan; [Kojima, Takashi; Nishida, Tomoya; Nakamura, Tomoaki] Nagoya Eye Clin, Nagoya, Aichi, Japan; [Kojima, Takashi] Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan; [Ichikawa, Kazuo] Chukyo Eye Clin, Nagoya, Aichi, Japan	Keio University	Kojima, T (corresponding author), Nagoya Eye Clin, Nagoya, Aichi, Japan.; Kojima, T (corresponding author), Keio Univ, Dept Ophthalmol, Sch Med, Tokyo, Japan.	kojkoj@me.com	Ichikawa, Kazuo/AAP-7082-2021					Alfonso JF, 2012, GRAEF ARCH CLIN EXP, V250, P1807, DOI 10.1007/s00417-012-1957-0; Almalki S, 2016, INT OPHTHALMOL, V36, P259, DOI 10.1007/s10792-015-0112-4; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Elmohamady MN, 2017, OPHTHALMOL THER, V6, P343, DOI 10.1007/s40123-017-0109-3; Fernandes P, 2011, J REFRACT SURG, V27, P765, DOI 10.3928/1081597X-20110617-01; Fernandez-Vigo JI, 2016, AM J OPHTHALMOL, V162, P43, DOI 10.1016/j.ajo.2015.11.010; Grewal DS, 2011, EYE, V25, P603, DOI 10.1038/eye.2011.14; Igarashi A, 2019, J CATARACT REFR SURG, V45, P1099, DOI 10.1016/j.jcrs.2019.02.020; Fernandez-Vigo JI, 2017, AM J OPHTHALMOL, V181, P37, DOI 10.1016/j.ajo.2017.06.018; Kamiya K, 2018, BRIT J OPHTHALMOL, V102, P177, DOI 10.1136/bjophthalmol-2017-310164; Kato S, 2019, CORNEA, V38, P217, DOI 10.1097/ICO.0000000000001785; Kojima T, 2012, AM J OPHTHALMOL, V153, P632, DOI 10.1016/j.ajo.2011.06.031; Kojima T, 2010, J REFRACT SURG, V26, P327, DOI 10.3928/1081597X-20090617-11; Kurita N, 2009, J GLAUCOMA, V18, P506, DOI 10.1097/IJG.0b013e318193c141; Leung CK, 2010, BRIT J OPHTHALMOL, V94, P1184, DOI 10.1136/bjo.2009.167296; Nakamura T, 2018, AM J OPHTHALMOL, V187, P99, DOI 10.1016/j.ajo.2017.12.015; Nam SW, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0663-4; Schmidinger G, 2010, OPHTHALMOLOGY, V117, P1506, DOI 10.1016/j.ophtha.2009.12.013; Wang DD, 2012, CLIN EXP OPHTHALMOL, V40, P542, DOI 10.1111/j.1442-9071.2011.02746.x; Zhu Y, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0830-2	20	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242434	10.1371/journal.pone.0242434	http://dx.doi.org/10.1371/journal.pone.0242434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196664	gold, Green Published			2022-12-26	WOS:000595266800012
J	Zinovieva, NA; Dotsev, AV; Sermyagin, AA; Deniskova, TE; Abdelmanova, AS; Kharzinova, VR; Solkner, J; Reyer, H; Wimmers, K; Brem, G				Zinovieva, Natalia Anatolievna; Dotsev, Arsen Vladimirovich; Sermyagin, Alexander Alexandrovich; Deniskova, Tatiana Evgenievna; Abdelmanova, Alexandra Sergeevna; Kharzinova, Veronika Ruslanovna; Soelkner, Johann; Reyer, Henry; Wimmers, Klaus; Brem, Gottfried			Selection signatures in two oldest Russian native cattle breeds revealed using high-density single nucleotide polymorphism analysis	PLOS ONE			English	Article							GENOMIC SIGNATURES; PROTEIN-SYNTHESIS; GENETIC-STRUCTURE; IMPORTANT TRAITS; FEED-EFFICIENCY; QUALITY TRAITS; CARCASS TRAITS; BOVINE; HOMOZYGOSITY; GROWTH	Native cattle breeds can carry specific signatures of selection reflecting their adaptation to the local environmental conditions and response to the breeding strategy used. In this study, we comprehensively analysed high-density single nucleotide polymorphism (SNP) genotypes to characterise the population structure and detect the selection signatures in Russian native Yaroslavl and Kholmogor dairy cattle breeds, which have been little influenced by introgression with transboundary breeds. Fifty-six samples of pedigree-recorded purebred animals, originating from different breeding farms and representing different sire lines, of the two studied breeds were genotyped using a genome-wide bovine genotyping array (Bovine HD BeadChip). Three statistical analyses-calculation of fixation index (F-ST) for each SNP for the comparison of the pairs of breeds, hapFLK analysis, and estimation of the runs of homozygosity (ROH) islands shared in more than 50% of animals-were combined for detecting the selection signatures in the genome of the studied cattle breeds. We confirmed nine and six known regions under putative selection in the genomes of Yaroslavl and Kholmogor cattle, respectively; the flanking positions of most of these regions were elucidated. Only two of the selected regions (localised on BTA 14 at 24.4-25.1 Mbp and on BTA 16 at 42.5-43.5 Mb) overlapped in Yaroslavl, Kholmogor and Holstein breeds. In addition, we detected three novel selection sweeps in the genome of Yaroslavl (BTA 4 at 4.74-5.36 Mbp, BTA 15 at 17.80-18.77 Mbp, and BTA 17 at 45.59-45.61 Mbp) and Kholmogor breeds (BTA 12 at 82.40-81.69 Mbp, BTA 15 at 16.04-16.62 Mbp, and BTA 18 at 0.19-1.46 Mbp) by using at least two of the above-mentioned methods. We expanded the list of candidate genes associated with the selected genomic regions and performed their functional annotation. We discussed the possible involvement of the identified candidate genes in artificial selection in connection with the origin and development of the breeds. Our findings on the Yaroslavl and Kholmogor breeds obtained using high-density SNP genotyping and three different statistical methods allowed the detection of novel putative genomic regions and candidate genes that might be under selection. These results might be useful for the sustainable development and conservation of these two oldest Russian native cattle breeds.	[Zinovieva, Natalia Anatolievna; Dotsev, Arsen Vladimirovich; Sermyagin, Alexander Alexandrovich; Deniskova, Tatiana Evgenievna; Abdelmanova, Alexandra Sergeevna; Kharzinova, Veronika Ruslanovna; Brem, Gottfried] Fed Agcy Sci Org, LK Ernst Fed Sci Ctr Anim Husb, Dubrovitzy, Moscow Province, Russia; [Soelkner, Johann] Univ Nat Resources & Life Sci, Div Livestock Sci, Vienna, Austria; [Reyer, Henry; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany; [Brem, Gottfried] Univ Vet Med VMU, Inst Anim Breeding & Genet, Vienna, Austria	L.K. Ernst Federal Science Center for Animal Husbandry; University of Natural Resources & Life Sciences, Vienna; Forschungsinstitut fur Nutztierbiologie (FBN)	Zinovieva, NA (corresponding author), Fed Agcy Sci Org, LK Ernst Fed Sci Ctr Anim Husb, Dubrovitzy, Moscow Province, Russia.	n_zinovieva@mail.ru	Veronika, Kharzinova/D-9658-2014; Dotsev, Arsen/AAU-8331-2021; Zinovieva, Natalia A/D-9194-2014; Abdelmanova, Alexandra/AAC-3769-2019; Dotsev, Arsen/AAC-2346-2019; Dotsev, Arsen V/H-1095-2017; Deniskova, Tatiana/J-6070-2018	Zinovieva, Natalia A/0000-0003-4017-6863; Dotsev, Arsen/0000-0003-3418-2511; Solkner, Johann/0000-0002-1517-5829; Kharzinova, Veronika/0000-0002-8067-0404	Russian Science Foundation [19-76-20012]; Russian Ministry of Science and Higher Education [19-76-20012]; Zinovieva NA [19-76-20012]	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Ministry of Science and Higher Education; Zinovieva NA	This work was supported by the Russian Science Foundation within Project No. 19-76-20012 (SNP genotyping) and the Russian Ministry of Science and Higher Education within theme 0445-2019-0024 (DNA collection and partly SNP genotyping). The URLshttp://grant.rscf.ru. PGrant receiver no. 19-76-20012 is Zinovieva NA. The https://minobrnauki.gov.ru. Theme supervisor is Dotsev A.V. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmanova AS, 2020, GENES-BASEL, V11, DOI 10.3390/genes11080940; Addoid S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225847; Adjaye J, 2007, PHYSIOL GENOMICS, V31, P315, DOI 10.1152/physiolgenomics.00041.2007; Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; An B, 2019, ANIM GENET, V50, P386, DOI 10.1111/age.12805; [Anonymous], 2015, LANCET NEUROL, V14, P1, DOI 10.1016/S1474-4422(14)70312-6; [Anonymous], 2014, ANIMAL GENETICS; [Anonymous], 2019, **NON-TRADITIONAL**, V28, P1, DOI DOI DOI:10.1017/S0954579419001159; Nanaei HA, 2020, REPROD DOMEST ANIM, V55, P200, DOI 10.1111/rda.13608; Bahbahani Hussain, 2017, Front Genet, V8, P68, DOI 10.3389/fgene.2017.00068; Bansal SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127007; Barbato M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00109; Bouwman AC, 2018, NAT GENET, V50, P362, DOI 10.1038/s41588-018-0056-5; Braz CU, 2019, BMC GENET, V20, DOI 10.1186/s12863-019-0713-4; Cadzow M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00293; Cesar ASM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3306-x; Cheruiyot EK, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00607; Cochran SD, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111260; Cochran SD, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-49; Corbin LJ, 2012, J ANIM BREED GENET, V129, P257, DOI 10.1111/j.1439-0388.2012.01003.x; De Cesaro MP, 2015, ANIM REPROD SCI, V159, P52, DOI 10.1016/j.anireprosci.2015.05.012; DELASHERASSALDANA, 2019, BMC GENOMICS, V0020, DOI DOI 10.1186/S12864-019-6270-4; Diomidov AM, 1934, RAZVEDENIE PORODY KR; Dmitriev N.G., 1989, ANIMAL GENETIC RESOU; Do DN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31427-0; Dolebo AT, 2019, MAMM GENOME, V30, P339, DOI 10.1007/s00335-019-09820-5; Dong JH, 2019, J DAIRY SCI, V102, P7536, DOI 10.3168/jds.2019-16544; Dotsev AV, 2018, VAVILOVSKII ZH GENET, V22, P742, DOI 10.18699/VJ18.418; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Fariello MI, 2013, GENETICS, V193, P929, DOI 10.1534/genetics.112.147231; Felius M., 1995, CATTLE BREEDS ENCY; Ferencakovic M, 2013, J ANIM BREED GENET, V130, P286, DOI 10.1111/jbg.12012; Ferencakovic M, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-42; Fink T, 2017, SCI REP-UK, V7, DOI 10.1038/srep44793; Fontanesi L, 2014, ANIM GENET, V45, P576, DOI 10.1111/age.12164; Foote AP, 2017, J ANIM SCI, V95, P4430, DOI 10.2527/jas2017.1804; Fortes MRS, 2013, ANIM GENET, V44, P636, DOI 10.1111/age.12075; Francis RM, 2017, MOL ECOL RESOUR, V17, P27, DOI 10.1111/1755-0998.12509; Francois O, 2016, MOL ECOL, V25, P454, DOI 10.1111/mec.13513; Gomes RC, 2013, GENET MOL RES, V12, P2923, DOI 10.4238/2013.August.12.8; Grigoletto L, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00123; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Gui LS, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5149-0; Gui LS, 2015, GENE, V559, P16, DOI 10.1016/j.gene.2015.01.008; Gutierrez-Gil B, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00167; Ha NT, 2017, J DAIRY SCI, V100, P9311, DOI 10.3168/jds.2016-12454; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; Hiltpold M, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008804; Hoffmann I, 2013, ANIMAL, V7, P346, DOI 10.1017/S1751731113000815; Holsinger KE, 2009, NAT REV GENET, V10, P639, DOI 10.1038/nrg2611; Hou J, 2020, ANIM GENET, V51, P87, DOI 10.1111/age.12872; Hu ZL, 2019, NUCLEIC ACIDS RES, V47, pD701, DOI 10.1093/nar/gky1084; Huang WL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05702-5; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson HJ, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00366; Ibeagha-Awemu EM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31109; Imumorin Ikhide G., 2011, Frontiers in Genetics, V2, P44, DOI 10.3389/fgene.2011.00044; Iso-Touru T, 2016, ANIM GENET, V47, P647, DOI 10.1111/age.12473; Jamin SP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14643-y; Jia HD, 2019, J DAIRY SCI, V102, P833, DOI 10.3168/jds.2018-15208; Karim L, 2011, NAT GENET, V43, P405, DOI 10.1038/ng.814; Kasimanickam RK, 2019, THERIOGENOLOGY, V126, P41, DOI 10.1016/j.theriogenology.2018.11.032; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kern RJ, 2017, ANIM GENET, V48, P90, DOI 10.1111/age.12490; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053419; Kim HJ, 2017, ANIM GENET, V48, P251, DOI 10.1111/age.12523; Lencz T, 2007, P NATL ACAD SCI USA, V104, P19942, DOI 10.1073/pnas.0710021104; Li MH, 2010, ANIM GENET, V41, P150, DOI 10.1111/j.1365-2052.2009.01980.x; Lindholm-Perry AK, 2012, ANIM GENET, V43, P216, DOI 10.1111/j.1365-2052.2011.02232.x; Liskun EF, 1928, RUSSKIE OTRODYA KRUP; Liskun EF, 1949, OTECHESTVENNYE POROD; Liskun EF, 1919, WHAT IS GOOD RUSSIAN; Littlejohn M, 2012, ANIM GENET, V43, P591, DOI 10.1111/j.1365-2052.2011.02293.x; Liu Y, 2019, CELL MOL BIOL LETT, V24, DOI 10.1186/s11658-019-0181-x; Luo CC, 2018, J AGR FOOD CHEM, V66, P13041, DOI 10.1021/acs.jafc.8b04508; Ma Y, 2015, HEREDITY, V115, P426, DOI 10.1038/hdy.2015.42; Magee DA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-93; Maiorano AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200694; Marques DBD, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0412-z; McLean KL, 2009, CAN J ANIM SCI, V89, P295, DOI 10.4141/CJAS08094; Menzies KK, 2009, FUNCT INTEGR GENOMIC, V9, P197, DOI 10.1007/s10142-008-0103-x; Meszaros G, 2015, ANIM GENET, V46, P65, DOI 10.1111/age.12249; Meuwissen T, 2009, ACTA AGR SCAND A-AN, V59, P71, DOI 10.1080/09064700903118148; Mezera MA, 2020, J DAIRY SCI, V103, P4846, DOI 10.3168/jds.2019-17526; Nayeri S, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0386-1; NEI M, 1978, GENETICS, V89, P583; Nishimura S, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-40; O'Brien AMP, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-19; Palombo V, 2018, J DAIRY SCI, V101, P11004, DOI 10.3168/jds.2018-14413; Pemberton TJ, 2012, AM J HUM GENET, V91, P275, DOI 10.1016/j.ajhg.2012.06.014; Peripolli E, 2017, ANIM GENET, V48, P255, DOI 10.1111/age.12526; Peripolli E, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-017-4365-3; Picard B, 2020, FOOD RES INT, V127, DOI 10.1016/j.foodres.2019.108739; Pintus E, 2014, ANIM GENET, V45, P1, DOI 10.1111/age.12076; Pryce JE, 2012, J DAIRY SCI, V95, P2108, DOI 10.3168/jds.2011-4628; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; Qanbari S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004148; Qanbari S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-318; R Core Team, 2018, R LANG ENV STAT COMP; Randhawa IAS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153013; Raza SHA, 2019, GENES-BASEL, V10, DOI 10.3390/genes10090717; Regassa A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-57; Roh SG, 2007, J ANIM SCI, V85, P395, DOI 10.2527/jas.2006-234; Sadkowski T, 2006, J PHYSIOL PHARMACOL, V57, P95; Sanchez MP, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0344-z; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Scherf BD, 2015, 2 REPORT STATE WORLD; Serao NVL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078530; Sermyagin AA, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0408-8; Silva-Vignato B, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-018-5345-y; Smith JL, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6231-y; Song HB, 2015, GENE, V573, P303, DOI 10.1016/j.gene.2015.07.057; Srikanth K, 2020, GENES-BASEL, V11, DOI 10.3390/genes11030316; Stella A, 2010, GENETICS, V185, P1451, DOI 10.1534/genetics.110.116111; Storey J.D., 2019, R PACKAGE VERSION 22; Stronen AV, 2019, EVOL APPL, V12, P1096, DOI 10.1111/eva.12783; SVED JA, 1973, THEOR POPUL BIOL, V4, P129, DOI 10.1016/0040-5809(73)90008-7; Taye M, 2018, GENES GENOM, V40, P63, DOI 10.1007/s13258-017-0610-z; Taye M, 2017, BMC GENET, V18, DOI 10.1186/s12863-016-0467-1; Utsunomiya YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088561; Venhoranta H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-890; Wang D, 2019, J DAIRY SCI, V102, P2378, DOI 10.3168/jds.2018-15298; Wang XG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159719; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weller JI, 2018, J DAIRY SCI, V101, P9089, DOI 10.3168/jds.2018-14816; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xu LY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53274-3; Xu LY, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-018-5403-5; Xu LY, 2015, MOL BIOL EVOL, V32, P711, DOI 10.1093/molbev/msu333; XU LY, 2019, BMC GENOMICS, V0020, DOI DOI 10.1186/S12864-019-5822-Y; Yurchenko A, 2018, HEREDITY, V120, P125, DOI 10.1038/s41437-017-0024-3; Yurchenko AA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31304-w; Zhang HY, 2019, BIOTECHNOL BIOTEC EQ, V33, P589, DOI 10.1080/13102818.2019.1596755; Zhao FP, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0127-3; Zhong JL, 2019, GENE, V689, P166, DOI 10.1016/j.gene.2018.12.018; Zhou CH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00072; Zhu B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3847-7; Zinovieva N. A., 2019, Sel'skokhozyaistvennaya Biologiya, V54, P631, DOI [10.15389/agrobiology.2019.4.631eng, 10.15389/agrobiology.2019.4.631rus]; Zinovieva N. A., 2016, Sel'skokhozyaistvennaya Biologiya, P788, DOI [10.15389/agrobiology.2016.6.788rus, 10.15389/agrobiology.2016.6.788eng]; **DATA OBJECT**; **DATA OBJECT**, DOI DOI 10.5061/DRYAD.38JP6	145	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242200	10.1371/journal.pone.0242200	http://dx.doi.org/10.1371/journal.pone.0242200			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196682	gold, Green Published			2022-12-26	WOS:000595266800036
J	Park, JH; Chung, YE; Seo, N; Choi, JY; Park, MS; Kim, MJ				Park, Jae Hyon; Chung, Yong Eun; Seo, Nieun; Choi, Jin-Young; Park, Mi-Suk; Kim, Myeong-Jin			Gadoxetic acid-enhanced MRI of hepatocellular carcinoma: Diagnostic performance of category-adjusted LR-5 using modified criteria	PLOS ONE			English	Article								The Liver Imaging Reporting and Data System (LI-RADS) is widely adopted for the noninvasive diagnosis of hepatocellular carcinoma (HCC). Herein, possible strategies to improve the diagnostic performance of LR-5 without reducing specificity for HCC were investigated. This retrospective study included 792 patients who underwent gadoxetate disodium-enhanced magnetic resonance imaging. Hepatic observations were categorized according to LI-RADS v2018 and categories were readjusted by upgrading LR4 to LR5 using ancillary features, arterial phase hyperenhancement (APHE) interpreted with subtraction images, indication of no washout when APHE was absent, extension of washout to the transitional phase, and subthreshold growth as a major feature. Based on LI-RADS v2018, LR-5 showed a sensitivity of 71.9% and a specificity of 97.9% for the diagnosis of HCC. Category-readjusted LR-5 after upgrading LR-4 to LR-5 using ancillary features favoring HCC in particular, subthreshold growth as a major feature, extending washout to transitional phase and APHE interpreted using subtraction images showed significantly increased sensitivity (P<0.001) without decreased specificity (Ps>0.05). The sensitivity of LR-5 can be improved without loss of specificity via category readjustment using AFs favoring HCC in particular, subthreshold growth as a major feature, extending washout to transitional phase and APHE interpreted with subtraction images.	[Park, Jae Hyon; Chung, Yong Eun; Seo, Nieun; Choi, Jin-Young; Park, Mi-Suk; Kim, Myeong-Jin] Yonsei Univ, Dept Radiol, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Chung, YE (corresponding author), Yonsei Univ, Dept Radiol, Coll Med, Seoul, South Korea.	yelv@yuhs.ac	; Kim, Myeong-Jin/E-1623-2011	Choi, Jin-Young/0000-0002-9025-6274; Chung, Yong Eun/0000-0003-0811-9578; Park, Mi-Suk/0000-0001-5817-2444; Kim, Myeong-Jin/0000-0001-7949-5402; Seo, Nieun/0000-0001-8745-6454	Yonsei University College of Medicine [6-2019-0118]	Yonsei University College of Medicine(General Electric)	Y.E.C. received faculty research grant of Yonsei University College of Medicine (No. 6-2019-0118). The funder did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alhasan A, 2019, ABDOM RADIOL, V44, P517, DOI 10.1007/s00261-018-1762-2; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cerny M, 2018, RADIOLOGY, V288, P118, DOI 10.1148/radiol.2018171678; Elsayes KM, 2019, J HEPATOCELL CARCINO, V6, P49, DOI 10.2147/JHC.S186239; Kim DH, 2019, RADIOLOGY, V292, P270, DOI 10.1148/radiol.2019194011; Kim YY, 2019, RADIOLOGY, V291, P71, DOI 10.1148/radiol.2019181995; Kim YY, 2019, EUR RADIOL, V29, P1124, DOI 10.1007/s00330-018-5641-6; Lee SM, 2019, RADIOLOGY, V292, P655, DOI 10.1148/radiol.2019182867; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; Radiology ACo, CT MRI LI RADS V2018; Rosenkrantz AB, 2015, RADIOLOGY, V274, P426, DOI 10.1148/radiol.14140069; Seo N, 2018, EUR RADIOL, V28, P2812, DOI 10.1007/s00330-017-5292-z	13	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242344	10.1371/journal.pone.0242344	http://dx.doi.org/10.1371/journal.pone.0242344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186378	Green Published, gold			2022-12-26	WOS:000593949800028
J	Herrera-Lopez, G; Griego, E; Galvan, EJ				Herrera-Lopez, Gabriel; Griego, Ernesto; Galvan, Emilio J.			Lactate induces synapse-specific potentiation on CA3 pyramidal cells of rat hippocampus	PLOS ONE			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE-RECEPTOR; HUMAN VISUAL-CORTEX; NMDA RECEPTORS; NEURONAL-ACTIVITY; DENTATE GYRUS; GLUCOSE; PLASTICITY; ASTROCYTES; METABOLISM	Neuronal activity within the physiologic range stimulates lactate production that, via metabolic pathways or operating through an array of G-protein-coupled receptors, regulates intrinsic excitability and synaptic transmission. The recent discovery that lactate exerts a tight control of ion channels, neurotransmitter release, and synaptic plasticity-related intracellular signaling cascades opens up the possibility that lactate regulates synaptic potentiation at central synapses. Here, we demonstrate that extracellular lactate (1-2 mM) induces glutamatergic potentiation on the recurrent collateral synapses of hippocampal CA3 pyramidal cells. This potentiation is independent of lactate transport and further metabolism, but requires activation of NMDA receptors, postsynaptic calcium accumulation, and activation of a G-protein-coupled receptor sensitive to cholera toxin. Furthermore, perfusion of 3,5- dihydroxybenzoic acid, a lactate receptor agonist, mimics this form of synaptic potentiation. The transduction mechanism underlying this novel form of synaptic plasticity requires G-protein beta gamma subunits, inositol-1,4,5-trisphosphate 3-kinase, PKC, and CaMKII. Activation of these signaling cascades is compartmentalized in a synapse-specific manner since lactate does not induce potentiation at the mossy fiber synapses of CA3 pyramidal cells. Consistent with this synapse-specific potentiation, lactate increases the output discharge of CA3 neurons when recurrent collaterals are repeatedly activated during lactate perfusion. This study provides new insights into the cellular mechanisms by which lactate, acting via a membrane receptor, contributes to the memory formation process.	[Herrera-Lopez, Gabriel; Griego, Ernesto; Galvan, Emilio J.] Cinvestav Sede Sur, Dept Farmacobiol, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Galvan, EJ (corresponding author), Cinvestav Sede Sur, Dept Farmacobiol, Mexico City, DF, Mexico.	ejgalvan@cinvestav.mx		Griego, Ernesto/0000-0003-2396-9271; Galvan, Emilio/0000-0002-9820-302X	Consejo Nacional de Ciencia y Tecnologia, Mexico [CB-2016-281617, 426505, 727269]	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	GHL, fellowship 426505 Consejo Nacional de Ciencia y Tecnologia, Mexico. EG, fellowship 727269 Consejo Nacional de Ciencia y Tecnologia, Mexico. EJG, Grant CB-2016-281617 Consejo Nacional de Ciencia y Tecnologia, Mexico.	Abi-Saab WM, 2002, J CEREBR BLOOD F MET, V22, P271, DOI 10.1097/00004647-200203000-00004; Abrantes HD, 2019, J NEUROSCI, V39, P4422, DOI 10.1523/JNEUROSCI.2092-18.2019; Ahmed K, 2009, TRENDS PHARMACOL SCI, V30, P557, DOI 10.1016/j.tips.2009.09.001; [Anonymous], 2014, J CLIN DIAGN RES, V8; Barros LF, 2010, BRAIN RES REV, V63, P149, DOI 10.1016/j.brainresrev.2009.10.002; Bergersen LH., 2012, FRONTIERS NEUROENERG, V4, P1; Bozzo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071721; Carrard A, 2018, MOL PSYCHIATR, V23, P392, DOI 10.1038/mp.2016.179; Castillo X, 2015, J CEREBR BLOOD F MET, V35, P1561, DOI 10.1038/jcbfm.2015.115; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Erlichman JS, 2008, J NEUROSCI, V28, P4888, DOI 10.1523/JNEUROSCI.5430-07.2008; Barros LF, 2013, TRENDS NEUROSCI, V36, P396, DOI 10.1016/j.tins.2013.04.002; Fellini L, 2009, LEARN MEMORY, V16, P387, DOI 10.1101/lm.1433209; Gilbert E, 2006, BRAIN RES, V1117, P213, DOI 10.1016/j.brainres.2006.07.107; Griego E, 2021, NEUROSCIENCE, V456, P95, DOI 10.1016/j.neuroscience.2019.12.016; HARADA M, 1992, ANESTHESIOLOGY, V77, P728, DOI 10.1097/00000542-199210000-00017; HARADA M, 1993, HORM METAB RES, V25, P560, DOI 10.1055/s-2007-1002177; Herrera-Lopez G, 2018, HIPPOCAMPUS, V28, P557, DOI 10.1002/hipo.22958; Hu YB, 1997, J NEUROCHEM, V69, P1484; Hussain RJ, 2005, CELL MOL NEUROBIOL, V25, P649, DOI 10.1007/s10571-005-4045-8; Hyun JH, 2013, J PHYSIOL-LONDON, V591, P5525, DOI 10.1113/jphysiol.2013.259002; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; Izumi Y, 1997, NEUROSCI LETT, V232, P17, DOI 10.1016/S0304-3940(97)00567-3; Izumi Y, 1997, J NEUROSCI, V17, P9448; Jorwal P, 2019, EPILEPSIA, V60, P2370, DOI 10.1111/epi.16389; KAMIYA H, 1988, EXP NEUROL, V102, P314, DOI 10.1016/0014-4886(88)90225-7; Kamiya H, 1999, J PHYSIOL-LONDON, V518, P497, DOI 10.1111/j.1469-7793.1999.0497p.x; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Kwon HB, 2008, NEURON, V57, P108, DOI 10.1016/j.neuron.2007.11.024; Lauritzen KH, 2014, CEREB CORTEX, V24, P2784, DOI 10.1093/cercor/bht136; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Li G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093041; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Liu CL, 2012, J PHARMACOL EXP THER, V341, P794, DOI 10.1124/jpet.112.192799; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Lu FM, 2006, P NATL ACAD SCI USA, V103, P4264, DOI 10.1073/pnas.0508162103; LUTTRELL LM, 1995, J BIOL CHEM, V270, P12984, DOI 10.1074/jbc.270.22.12984; MacDonald JF, 2007, BBA-BIOMEMBRANES, V1768, P941, DOI 10.1016/j.bbamem.2006.12.006; Maddock RJ, 2009, MOL PSYCHIATR, V14, P537, DOI 10.1038/sj.mp.4002137; MERBOLDT KD, 1992, MAGNET RESON MED, V25, P187, DOI 10.1002/mrm.1910250119; Moore KA, 2003, P NATL ACAD SCI USA, V100, P14397, DOI 10.1073/pnas.1835831100; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; PRICHARD J, 1991, P NATL ACAD SCI USA, V88, P5829, DOI 10.1073/pnas.88.13.5829; Requardt RP, 2012, J NEUROCHEM, V120, P1014, DOI 10.1111/j.1471-4159.2012.07645.x; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; SCHURR A, 1988, SCIENCE, V240, P1326, DOI 10.1126/science.3375817; Sotelo-Hitschfeld T, 2012, GLIA, V60, P674, DOI 10.1002/glia.22304; Steinman MQ, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2010.00010, 10.3389/fnint.2016.00010]; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Takata T, 2001, NEUROSCIENCE, V104, P371, DOI 10.1016/S0306-4522(01)00086-0; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Vodovozov W, 2018, PFLUG ARCH EUR J PHY, V470, P1377, DOI 10.1007/s00424-018-2156-6; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; Yang JY, 2014, P NATL ACAD SCI USA, V111, P12228, DOI 10.1073/pnas.1322912111; Yoshino M, 1996, NEUROSCI LETT, V207, P70, DOI 10.1016/0304-3940(96)12486-1	59	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242309	10.1371/journal.pone.0242309	http://dx.doi.org/10.1371/journal.pone.0242309			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180836	gold, Green Published			2022-12-26	WOS:000593948000032
J	Ledezma, AP; Blandon, R; Schijman, AG; Benatar, A; Saldana, A; Osuna, A				Ledezma, Alexa Prescilla; Blandon, Roberto; Schijman, Alejandro G.; Benatar, Alejandro; Saldana, Azael; Osuna, Antonio			Mixed infections by different Trypanosoma cruzi discrete typing units among Chagas disease patients in an endemic community in Panama	PLOS ONE			English	Article							LINEAGE-I; RHODNIUS-PALLESCENS; IMMUNE-RESPONSES; BLOOD PARASITISM; HEART-DISEASE; PREDOMINANCE; DIAGNOSIS; VARIABILITY; STOCKS; AREAS	Background Trypanosoma cruzi, the hemoparasite that causes Chagas disease, is divided into six Discrete Typing Units or DTUs: TcI-TcVI plus Tcbat. This genetic diversity is based on ecobiological and clinical characteristics associated with particular populations of the parasite. The main objective of this study was the identification of DTUs in patients with chronic chagasic infections from a mountainous rural community in the eastern region of Panama. Methods A total of 106 patients were tested for Chagas disease with three serological tests (ELISA, rapid test, and Western blot). Molecular diagnosis and DTU typing were carried out by conventional PCRs and qPCR targeting different genomic markers, respectively. As a control sample for the typing, 28 patients suspected to be chagasic from the metropolitan area of Panama City were included. Results Results showed a positivity in the evaluated patients of 42.3% (33/78); high compared to other endemic regions in the country. In the control group, 20/28 (71.43%) patients presented positive serology. The typing of samples from rural patients showed that 78.78% (26/33) corresponded to TcI, while 9.09% (3/33) were mixed infections (TcI plus TcII/V/VI). Seventy-five percent (15/20) of the patients in the control group presented TcI, and in five samples it was not possible to typify the T. cruzi genotype involved. Conclusions These results confirm that TcI is the main DTU of T. cruzi present in chronic chagasic patients from Panama. However, the circulation of other genotypes (TcII/V/VI) in this country is described for the first time. The eco-epidemiological characteristics that condition the circulation of TcII/V/VI, as well as the immune and clinical impact of mixed infections in this remote mountainous region should be investigated, which will help local action programs in the surveillance, prevention, and management of Chagas disease.	[Ledezma, Alexa Prescilla; Osuna, Antonio] Univ Granada, Inst Biotechnol, Dept Parasitol, Granada, Spain; [Ledezma, Alexa Prescilla; Saldana, Azael] Univ Panama, Fac Med, Ctr Res & Diag Parasit Dis CIDEP, Panama City, Panama; [Blandon, Roberto] Santo Tomas Hosp, Cardiol Serv, Panama City, Panama; [Schijman, Alejandro G.; Benatar, Alejandro] Inst Res Genet Engn & Mol Biol Dr Hector Torres I, Lab Mol Biol Chagas Dis, Buenos Aires, DF, Argentina; [Saldana, Azael] Gorgas Mem Inst Hlth Studies ICGES, Panama City, Panama	University of Granada; Universidad de Panama	Osuna, A (corresponding author), Univ Granada, Inst Biotechnol, Dept Parasitol, Granada, Spain.	aosuna@ugr.es		Osuna, Antonio/0000-0002-3818-1471; Benatar, Alejandro/0000-0003-1654-5374; Saldana, Azael/0000-0002-5653-1332	Instituto Carlos III, Ministerio de Sanidad, Gobierno de Espana through the ERANet program; Fundacion Ramon Areces; Ministerio de Ciencia y Tecnologia. Gobierno de Espana [PGC2018-099424-B-I00]; Secretaria Nacional de Ciencia Tecnologia e Innovacion (SENACYT); National Research System (SNISENACYT-PANAMA); Instituto para la Formacion y Aprovechamiento de Recursos Humanos (IFARHU), Government of Panama; project Research in Prevention of Congenital CHAGAS DISEASE: Parasitological, placental and immunological markers" [ELAC2014/HID-0328]; project "Research in prevention of Congenital Chagas Disease: Parasitological, placental and immunological markers" [ERANet17/HLH-0142]; Interactoma de las Exovesiculas de T. cruzi y de los inmunocomplejos que forman con las celulas del hospedador; Implicaciones en la patologia de la Enfermedad de Chagas	Instituto Carlos III, Ministerio de Sanidad, Gobierno de Espana through the ERANet program; Fundacion Ramon Areces; Ministerio de Ciencia y Tecnologia. Gobierno de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Secretaria Nacional de Ciencia Tecnologia e Innovacion (SENACYT); National Research System (SNISENACYT-PANAMA); Instituto para la Formacion y Aprovechamiento de Recursos Humanos (IFARHU), Government of Panama; project Research in Prevention of Congenital CHAGAS DISEASE: Parasitological, placental and immunological markers"; project "Research in prevention of Congenital Chagas Disease: Parasitological, placental and immunological markers"; Interactoma de las Exovesiculas de T. cruzi y de los inmunocomplejos que forman con las celulas del hospedador; Implicaciones en la patologia de la Enfermedad de Chagas	Financial Disclosure: Financial support from the Instituto Carlos III, Ministerio de Sanidad, Gobierno de Espana through the ERANet program and Fundacion Ramon Areces. Thanks to the funded projects Research in Prevention of Congenital CHAGAS DISEASE: Parasitological, placental and immunological markers". ELAC2014/HID-0328"and "Research in prevention of Congenital Chagas Disease: Parasitological, placental and immunological markers" ERANet17/HLH-0142 (Cochaco), and "Interactoma de las Exovesiculas de T. cruzi y de los inmunocomplejos que forman con las celulas del hospedador; Implicaciones en la patologia de la Enfermedad de Chagas", Fundacion Ramon Areces, 2019 and project PGC2018-099424-B-I00 from Ministerio de Ciencia y Tecnologia. Gobierno de Espana. APL thanks to the Excellence scholarship program of the Secretaria Nacional de Ciencia Tecnologia e Innovacion (SENACYT) and Instituto para la Formacion y Aprovechamiento de Recursos Humanos (IFARHU), Government of Panama. AS thanks To the National Research System (SNISENACYT-PANAMA) for the supporting.	Abel LCJ, 2001, J AUTOIMMUN, V17, P99, DOI 10.1006/jaut.2001.0523; Andrade DV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003010; Anez N, 2004, TROP MED INT HEALTH, V9, P1319, DOI 10.1111/j.1365-3156.2004.01333.x; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; [Anonymous], 2016, NEW ENGL J MED, V375, pe9; AVILA HA, 1991, MOL BIOCHEM PARASIT, V48, P211, DOI 10.1016/0166-6851(91)90116-N; Balouz V, 2017, ADV PARASIT, V97, P1, DOI 10.1016/bs.apar.2016.10.001; Bhattacharyya T, 2015, ACTA TROP, V151, P182, DOI 10.1016/j.actatropica.2015.06.017; Blandon R., 1969, ARQ GASTROENT, V6, P189; Bonney KM, 2014, PARASITE, V21, DOI 10.1051/parasite/2014012; Bosseno MF, 2002, J CLIN MICROBIOL, V40, P627, DOI 10.1128/JCM.40.2.627-632.2002; Brandao A, 2008, PARASITOL RES, V102, P523, DOI 10.1007/s00436-007-0775-5; Breniere SF, 2007, ACTA TROP, V101, P249, DOI 10.1016/j.actatropica.2007.02.007; Burgos JM, 2007, INT J PARASITOL, V37, P1319, DOI 10.1016/j.ijpara.2007.04.015; Burgos JM, 2010, CLIN INFECT DIS, V51, P485, DOI 10.1086/655680; Calzada JE, 2010, AM J TROP MED HYG, V82, P580, DOI 10.4269/ajtmh.2010.09-0397; Calzada JE, 2009, BIOMEDICA, V29, P133; Carrasco HJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001707; Ceballos LA, 2006, ACTA TROP, V98, P286, DOI 10.1016/j.actatropica.2006.06.003; Cortez M, 2006, MICROBES INFECT, V8, P1502, DOI 10.1016/j.micinf.2006.01.007; Coura JR, 1999, MEM I OSWALDO CRUZ, V94, P379, DOI 10.1590/S0074-02761999000700074; Cuervo P, 2002, MEM I OSWALDO CRUZ, V97, P877, DOI 10.1590/S0074-02762002000600023; Cura CI, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003765; Cura CI, 2010, INT J PARASITOL, V40, P1599, DOI 10.1016/j.ijpara.2010.06.006; Dario M, 2016, PARASITE VECTOR, V9, P1, DOI [10.1186/s13071-015-1291-6, DOI 10.1186/S13071-015-1291-6]; Vasquez Ana Maria de, 2004, Rev. Inst. Med. trop. S. Paulo, V46, P217, DOI 10.1590/S0036-46652004000400008; Duz ALC, 2014, MEM I OSWALDO CRUZ, V109, P1005, DOI 10.1590/0074-02760140208; Garisto-Risco JD, 2009, REV ESP CARDIOL, V62, P947, DOI 10.1016/S0300-8932(09)72083-4; Gascon J, 2007, REV ESP CARDIOL, V60, P285, DOI 10.1157/13100280; Gottdenker NL, 2011, AM J TROP MED HYG, V84, P70, DOI 10.4269/ajtmh.2011.10-0041; Gottdenker NL, 2012, PLOS NEGLECT TROP D, V6, P5; Gurtler RE, 2015, T ROY SOC TROP MED H, V109, P91, DOI 10.1093/trstmh/tru203; Guhl F, 2007, MEM I OSWALDO CRUZ, V102, P29, DOI 10.1590/S0074-02762007005000099; Hernandez C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1907-5; Hernandez C, 2016, PLOS NEGLECT TROP D, V10, DOI [10.1371/journal.pntd.0005112, 10.1371/journal.pntd.0004997]; Herrera C, 2007, INFECT GENET EVOL, V7, P535, DOI 10.1016/j.meegid.2006.12.003; Jansen AM, 1999, MEM I OSWALDO CRUZ, V94, P203, DOI 10.1590/S0074-02761999000700030; Llewellyn MS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000510; Llewellyn MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000410; Macedo AM, 1998, PARASITOL TODAY, V14, P119, DOI 10.1016/S0169-4758(97)01179-4; Mantilla JC, 2010, HUM PATHOL, V41, P610, DOI 10.1016/j.humpath.2009.11.005; Martinez I, 2013, VECTOR-BORNE ZOONOT, V13, P181, DOI 10.1089/vbz.2012.1072; MI NI, 2018, MED MYCOLOGY ISHAM, V56, pS1; Ministerio de Salud.(MINSA), 2018, B EP ENF CHAG 2017; Minning TA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-139; Monje-Rumi MM, 2015, INFECT GENET EVOL, V29, P53, DOI 10.1016/j.meegid.2014.11.001; Santos FLN, 2016, AM J TROP MED HYG, V94, P1034, DOI 10.4269/ajtmh.15-0820; Olivera MJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210156; Organizacion Panamericana de la Salud (OPS-PAHO), 2006, OPSHDMCD42506 OPSPAH; Panesso-Gomez S, 2018, AM J TROP MED HYG, V98, P717, DOI 10.4269/ajtmh.17-0417; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Pineda V, 2008, REV INST MED TROP SP, V50, P113, DOI 10.1590/S0036-46652008000200009; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rodriguez IG, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2380-5; Roellig DM, 2008, EMERG INFECT DIS, V14, P1123, DOI 10.3201/eid1407.080175; Romana CA, 2003, LANCET, V362, P579, DOI 10.1016/S0140-6736(03)14132-3; Ruiz-Sanchez R, 2005, MEM I OSWALDO CRUZ, V100, P281, DOI 10.1590/S0074-02762005000300012; Salazar A, 2006, ACTA TROP, V100, P110, DOI 10.1016/j.actatropica.2006.10.003; Saldana A, 2005, MEM I OSWALDO CRUZ, V100, P729, DOI 10.1590/S0074-02762005000700008; Saldana A, 1995, SCAND J IMMUNOL, V42, P644, DOI 10.1111/j.1365-3083.1995.tb03707.x; Saldana A, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3004-4; Saldana A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034657; Sales-Campos H, 2015, ACTA PARASITOL, V60, P435, DOI 10.1515/ap-2015-0060; Sales-Campos H, 2014, PARASITOL RES, V113, P375, DOI 10.1007/s00436-013-3665-z; Samudio F, 2007, ACTA TROP, V101, P178, DOI 10.1016/j.actatropica.2006.12.008; Sanchez-Montalva A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004416; Santi-Rocca J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08086-8; Sousa GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087082; SOUSA O E, 1972, Revista de Biologia Tropical, V20, P167; Sousa OE, 2006, MEM I OSWALDO CRUZ, V101, P455, DOI 10.1590/S0074-02762006000400018; SOUSA OE, 1973, AM J TROP MED HYG, V22, P18, DOI 10.4269/ajtmh.1973.22.18; Sousa OE, 1971, REV BIOL TROP, V20; Sturm NR, 2010, ACTA TROP, V115, P35, DOI 10.1016/j.actatropica.2009.08.018; Tanowitz HB, 2015, EXPERT REV CARDIOVAS, V13, P1393, DOI 10.1586/14779072.2015.1103648; Teixeira ARL, 2011, CLIN MICROBIOL REV, V24, P592, DOI 10.1128/CMR.00063-10; Triana O, 2006, EXP PARASITOL, V113, P62, DOI 10.1016/j.exppara.2005.11.016; Vago AR, 2000, AM J PATHOL, V156, P1805, DOI 10.1016/S0002-9440(10)65052-3; Velasquez-Ortiz N, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3422-y; Yeo M, 2005, INT J PARASITOL, V35, P225, DOI 10.1016/j.ijpara.2004.10.024; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021; Zulantay I, 2007, ANN TROP MED PARASIT, V101, P673, DOI 10.1179/136485907X241415	81	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241921	10.1371/journal.pone.0241921	http://dx.doi.org/10.1371/journal.pone.0241921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180799	Green Published, gold			2022-12-26	WOS:000593948000004
J	Lin, H; Wu, YX; Liang, GX; Chen, LM				Lin, Hong; Wu, Yanxuan; Liang, Guoxi; Chen, Liming			Establishing a predicted model to evaluate prognosis for initially diagnosed metastatic Her2-positive breast cancer patients and exploring the benefit from local surgery	PLOS ONE			English	Article							PRIMARY TUMOR; NOMOGRAM; SURVIVAL; IMPACT; OVEREXPRESSION; SUBTYPES; PATTERN; SCORE	Background For patients initially diagnosed with metastatic Her2-positive breast cancer (MHBC), we intended to construct a nomogram with risk stratification to predict prognosis and to explore the role of local surgery. Methods We retrieved data from the Surveillance, Epidemiology, and End Results (SEER) database. Kaplan-Meier (KM) method and log-rank test were used for the selection of significant variables. Cox regression analysis and Fine-Gray test were utilized to confirm independent prognostic factors of overall survival (OS) and breast cancer-specific survival (BCSS). A nomogram predicting 1-year, 3-year, and 5-year OS was developed and validated. Patients were stratified based on the optimal cut-off values of total personal score. KM method and log-rank test were used to estimate OS prognosis and benefit from local surgery and chemotherapy. Results There were 1680 and 717 patients in the training and validation cohort. Age, race, marriage, T stage, estrogen receptor (ER) status, visceral metastasis (bone, brain, liver and lung) were identified as independent prognostic factors for OS and BCSS, while histology was also corelated with OS. C-indexes in the training and validation cohort were 0.70 and 0.68, respectively. Calibration plots indicated precise predictive ability. The total population was divided into low- (<141 points), intermediate- (142-208 points), and high-risk (>208 points) prognostic groups. Local surgery and chemotherapy brought various degrees of survival benefit for patients with diverse-risk prognosis. Conclusions We constructed a model with accurate prediction and discrimination. It would provide a reference for clinicians' decision-making. Surgery on the primary lesion was recommended for patients with good physical performance status, while further study on optimal surgical opportunity was needed.	[Lin, Hong; Liang, Guoxi; Chen, Liming] Shantou Univ, Dept Oncol, Med Coll, Affiliated Hosp 1, Shantou, Guangdong, Peoples R China; [Lin, Hong; Wu, Yanxuan; Liang, Guoxi] Shantou Univ, Med Coll, Shantou, Guangdong, Peoples R China; [Wu, Yanxuan] Shantou Univ, Dept Radiat Oncol, Canc Hosp, Med Coll, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University	Chen, LM (corresponding author), Shantou Univ, Dept Oncol, Med Coll, Affiliated Hosp 1, Shantou, Guangdong, Peoples R China.	angelchen09@163.com		Lin, Hong/0000-0002-8311-9642; Chen, Liming/0000-0001-5965-8083				Leone BA, 2017, BREAST CANCER RES TR, V161, P537, DOI 10.1007/s10549-016-4066-7; [Anonymous], 2017, DIABETES CARE S1, V39, pS33; Bafford AC, 2009, BREAST CANCER RES TR, V115, P7, DOI 10.1007/s10549-008-0101-7; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Cardoso F, 2017, ANN ONCOL, V28, P3111, DOI 10.1093/annonc/mdx036; Chen L, 2012, BREAST CANCER RES TR, V136, P565, DOI 10.1007/s10549-012-2265-4; Chen MT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10166-8; Chen PY, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-589; Chia S, 2008, J CLIN ONCOL, V26, P5697, DOI 10.1200/JCO.2007.15.8659; Danna EA, 2004, CANCER RES, V64, P2205, DOI 10.1158/0008-5472.CAN-03-2646; DeSantis CE, 2016, CA-CANCER J CLIN, V66, P31, DOI 10.3322/caac.21320; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fitzal F, 2019, ANN SURG, V269, P1163, DOI 10.1097/SLA.0000000000002771; Fitzmaurice C, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.1568; Fujii T, 2017, BRIT J CANCER, V116, P509, DOI 10.1038/bjc.2016.444; Gerratana L, 2015, CLIN EXP METASTAS, V32, P125, DOI 10.1007/s10585-015-9697-2; Giuliano AE, 2017, CA-CANCER J CLIN, V67, P291, DOI 10.3322/caac.21393; Gradishar WJ, 2020, J NATL COMPR CANC NE, V18, P452, DOI 10.6004/jnccn.2020.0016; HORTOBAGYI GN, 1983, J CLIN ONCOL, V1, P776, DOI 10.1200/JCO.1983.1.12.776; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Li SR, 2017, CANCER MED-US, V6, P2586, DOI 10.1002/cam4.1224; Luo CX, 2019, INT J BIOL MARKER, V34, P41, DOI 10.1177/1724600818824786; Phung MT, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5442-6; Pagani O, 2010, JNCI-J NATL CANCER I, V102, P456, DOI 10.1093/jnci/djq029; Pons-Tostivint E, 2019, ANN SURG ONCOL, V26, P356, DOI 10.1245/s10434-018-6831-9; Redig AJ, 2013, J INTERN MED, V274, P113, DOI 10.1111/joim.12084; Sjogren S, 1998, J CLIN ONCOL, V16, P462; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Waks AG, 2019, JAMA-J AM MED ASSOC, V321, P288, DOI 10.1001/jama.2018.19323; Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984; Xiao WK, 2018, EJSO-EUR J SURG ONC, V44, P1504, DOI 10.1016/j.ejso.2018.08.002; Xiong ZC, 2018, CANCER RES TREAT, V50, P1260, DOI 10.4143/crt.2017.443; Zheng YJ, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00148	34	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0242155	10.1371/journal.pone.0242155	http://dx.doi.org/10.1371/journal.pone.0242155			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170907	gold, Green Published			2022-12-26	WOS:000592383400034
J	Jacobs, RQ; Ingram, ZM; Lucius, AL; Schneider, DA				Jacobs, Ruth Q.; Ingram, Zachariah M.; Lucius, Aaron L.; Schneider, David A.			Defining the divergent enzymatic properties of RNA polymerases I and II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ELONGATION; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE INCORPORATION; MECHANISM; INITIATION; CLEAVAGE; YEAST; NUCLEOLAR; SUBUNIT; TERMINATION	Eukaryotes express at least three nuclear DNA-dependent RNA polymerases (Pols) responsible for synthesizing all RNA required by the cell. Despite sharing structural homology, they have functionally diverged to suit their distinct cellular roles. Although the Pols have been studied extensively, direct comparison of their enzymatic properties is difficult because studies are often conducted under disparate experimental conditions and techniques. Here, we directly compare and reveal functional differences between Saccharomyces cerevisiae Pols I and II using a series of quantitative in vitro transcription assays. We find that Pol I single-nucleotide and multi-nucleotide addition rate constants are faster than those of Pol II. Pol I elongation complexes are less stable than Pol II elongation complexes, and Pol I is more error prone than Pol II. Collectively, these data show that the enzymatic properties of the Pols have diverged over the course of evolution, optimizing these enzymes for their unique cellular responsibilities.	[Jacobs, Ruth Q.; Schneider, David A.] Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Ingram, Zachariah M.; Lucius, Aaron L.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Schneider, DA (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.; Lucius, AL (corresponding author), Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA.	allucius@uab.edu; dschneid@uab.edu		Lucius, Aaron/0000-0001-8636-5411; Schneider, David/0000-0003-0635-5091; Carter, Zachariah/0000-0001-5717-7331; Jacobs, Ruth/0000-0002-7854-7941	National Institutes of Health [R01-GM084946, T32-GM109780]; NSF [MCB1817749]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This work was funded by National Institutes of Health grants #R01-GM084946 (to D. A. S.) and #T32-GM109780 (to R. Q. J.) and by NSF grant #MCB1817749 (to A. L. L. and D. A. S). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Appling FD, 2018, BIOPHYS J, V114, P2507, DOI 10.1016/j.bpj.2018.04.015; Appling FD, 2017, BIOCHEMISTRY-US, V56, P5654, DOI 10.1021/acs.biochem.7b00370; Appling FD, 2015, BIOPHYS J, V109, P2382, DOI 10.1016/j.bpj.2015.10.037; ARCHAMBAULT J, 1993, MICROBIOL REV, V57, P703, DOI 10.1128/MMBR.57.3.703-724.1993; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Burton ZF, 2014, TRANSCR-AUSTIN, V5, DOI 10.4161/trns.28674; Chedin S, 1998, GENE DEV, V12, P3857, DOI 10.1101/gad.12.24.3857; Cramer P, 2008, ANNU REV BIOPHYS, V37, P337, DOI 10.1146/annurev.biophys.37.032807.130008; Cramer P, 2002, CURR OPIN STRUC BIOL, V12, P89, DOI 10.1016/S0959-440X(02)00294-4; DAMMANN R, 1993, NUCLEIC ACIDS RES, V21, P2331, DOI 10.1093/nar/21.10.2331; Dangkulwanich M, 2013, ELIFE, V2, DOI 10.7554/eLife.00971; Donati G, 2011, J CELL SCI, V124, P3017, DOI 10.1242/jcs.086074; Dutta D, 2011, CELL, V146, P533, DOI 10.1016/j.cell.2011.07.034; Fazal FM, 2015, NATURE, V525, P274, DOI 10.1038/nature14882; FENG GH, 1994, J BIOL CHEM, V269, P22282; French SL, 2008, MOL CELL BIOL, V28, P4576, DOI 10.1128/MCB.00127-08; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Fujita T, 2010, J RECEPT SIG TRANSD, V30, P31, DOI 10.3109/10799890903517921; Gout JF, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701484; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Harismendy O, 2003, EMBO J, V22, P4738, DOI 10.1093/emboj/cdg466; Hausner W, 2000, J BIOL CHEM, V275, P12393, DOI 10.1074/jbc.275.17.12393; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Hou LM, 2019, P NATL ACAD SCI USA, V116, P14583, DOI 10.1073/pnas.1904324116; Hurowitz EH, 2004, GENOME BIOL, V5; HURWITZ J, 1972, BIOCHEM BIOPH RES CO, V48, P628, DOI 10.1016/0006-291X(72)90394-4; Imashimizu M, 2011, GENET RES INT, V2011, DOI 10.4061/2011/572689; Khatter H, 2017, CURR OPIN STRUC BIOL, V47, P88, DOI 10.1016/j.sbi.2017.05.008; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Kulaeva OI, 2013, BBA-GENE REGUL MECH, V1829, P76, DOI 10.1016/j.bbagrm.2012.08.015; Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106; Landrieux E, 2006, EMBO J, V25, P118, DOI 10.1038/sj.emboj.7600915; Layat E, 2012, PLANT CELL PHYSIOL, V53, P267, DOI 10.1093/pcp/pcr177; Levine M, 2011, CELL, V145, P502, DOI 10.1016/j.cell.2011.04.021; Lin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064477; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Lisica A, 2016, P NATL ACAD SCI USA, V113, P2946, DOI 10.1073/pnas.1517011113; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; Moss T, 2002, CELL, V109, P545, DOI 10.1016/S0092-8674(02)00761-4; Neyer S, 2016, NATURE, V540, P607, DOI 10.1038/nature20561; Osheim Yvonne N., 2008, V464, P55; Palangat M, 2012, BBA-GENE REGUL MECH, V1819, P667, DOI 10.1016/j.bbagrm.2012.02.024; Peltonen K, 2014, MOL CANCER THER, V13, P2537, DOI 10.1158/1535-7163.MCT-14-0256; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; ROEDER RG, 1970, P NATL ACAD SCI USA, V65, P675, DOI 10.1073/pnas.65.3.675; Roeder RG, 2019, NAT STRUCT MOL BIOL, V26, P783, DOI 10.1038/s41594-019-0287-x; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Schier AC, 2020, GENE DEV, V34, P465, DOI 10.1101/gad.335679.119; Schneider DA, 2007, MOL CELL, V26, P217, DOI 10.1016/j.molcel.2007.04.007; Schneider DA, 2012, METHODS MOL BIOL, V809, P579, DOI 10.1007/978-1-61779-376-9_37; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Schweikhard V, 2014, P NATL ACAD SCI USA, V111, P6642, DOI 10.1073/pnas.1405181111; Scull CE, 2019, BIOCHEMISTRY-US, V58, P2116, DOI 10.1021/acs.biochem.8b01256; Sekine S, 2012, CURR OPIN STRUC BIOL, V22, P110, DOI 10.1016/j.sbi.2011.11.006; Sulima SO, 2017, CANCER DISCOV, V7, P1069, DOI 10.1158/2159-8290.CD-17-0550; Todone F, 2001, MOL CELL, V8, P1137, DOI 10.1016/S1097-2765(01)00379-3; Ujvari A, 2011, J BIOL CHEM, V286, P23160, DOI 10.1074/jbc.M110.205658; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Veloso A, 2014, GENOME RES, V24, P896, DOI 10.1101/gr.171405.113; Viktorovskaya OV, 2013, CELL REP, V4, P974, DOI 10.1016/j.celrep.2013.07.044; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Werner F, 2007, MOL MICROBIOL, V65, P1395, DOI 10.1111/j.1365-2958.2007.05876.x; Werner F, 2011, NAT REV MICROBIOL, V9, P85, DOI 10.1038/nrmicro2507; White R. J, 2013, RNA POLYMERASE 3 TRA; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Zhang YF, 2017, BBA-GENE REGUL MECH, V1860, P246, DOI 10.1016/j.bbagrm.2016.10.010	73	4	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100051	10.1074/jbc.RA120.015904	http://dx.doi.org/10.1074/jbc.RA120.015904			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33168625	Green Published, gold			2022-12-26	WOS:000672866400034
J	Mostafa, MM; Bansal, A; Michi, AN; Sasse, SK; Proud, D; Gerber, AN; Newton, R				Mostafa, Mahmoud M.; Bansal, Akanksha; Michi, Aubrey N.; Sasse, Sarah K.; Proud, David; Gerber, Anthony N.; Newton, Robert			Genomic determinants implicated in the glucocorticoid-mediated induction of KLF9 in pulmonary epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; KRUPPEL-LIKE FACTORS; RECEPTOR-BINDING; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CHROMATIN ACCESSIBILITY; DISTINCT; SITES; TRANSACTIVATION; COOPERATION	Ligand-activated glucocorticoid receptor (GR) elicits variable glucocorticoid-modulated transcriptomes in different cell types. However, some genes, including Kruppel-like factor 9 (KLF9), a putative transcriptional repressor, demonstrate conserved responses. We show that glucocorticoids induce KLF9 expression in the human airways in vivo and in differentiated human bronchial epithelial (HBE) cells grown at air-liquid interface (ALI). In A549 and BEAS-2B pulmonary epithelial cells, glucocorticoids induce KLF9 expression with similar kinetics to primary HBE cells in submersion culture. A549 and BEAS-2B ChIP-seq data reveal four common glucocorticoid-induced GR binding sites (GBSs). Two GBSs mapped to the 5'-proximal region relative to KLF9 transcription start site (TSS) and two occurred at distal sites. These were all confirmed in primary HBE cells. Global run-on (GRO) sequencing indicated robust enhancer RNA (eRNA) production from three of these GBSs in BEAS-2B cells. This was confirmed in A549 cells, plus submersion, and ALI culture of HBE cells. Cloning each GBS into luciferase reporters revealed glucocorticoid-induced activity requiring a glucocorticoid response element (GRE) within each distal GBS. While the proximal GBSs drove modest reporter induction by glucocorticoids, this region exhibited basal eRNA production, RNA polymerase II enrichment, and looping to the TSS, plausibly underlying constitutive KLF9 expression. Post glucocorticoid treatment, interactions between distal and proximal GBSs and the TSS correlated with KLF9 induction. CBP/P300 silencing reduced proximal GBS activity, but negligibly affected KLF9 expression. Overall, a model for glucocorticoid-mediated regulation of KLF9 involving multiple GBSs is depicted. This work unequivocally demonstrates that mechanistic insights gained from cell lines can translate to physiologically relevant systems.	[Mostafa, Mahmoud M.; Bansal, Akanksha; Michi, Aubrey N.; Proud, David; Newton, Robert] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Mostafa, Mahmoud M.; Bansal, Akanksha; Michi, Aubrey N.; Proud, David; Newton, Robert] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Calgary, AB, Canada; [Sasse, Sarah K.; Gerber, Anthony N.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Gerber, Anthony N.] Univ Colorado, Dept Med, Aurora, CO 80309 USA	University of Calgary; University of Calgary; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Newton, R (corresponding author), Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada.; Newton, R (corresponding author), Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Calgary, AB, Canada.	rnewton@ucalgary.ca	; Newton, Robert/C-6814-2012	Gerber, Anthony/0000-0002-5280-8218; Newton, Robert/0000-0002-4919-8498; Michi, Aubrey/0000-0001-7333-2610	Canadian Institutes for Health Research (CIHR) [MOP 125918, PJT 156310]; Natural Sciences and Engineering Research Council (NSERC) [RGPIN-2016-04549]; Queen Elizabeth II Doctoral scholarship; Lung Association-Alberta & NWT studentship awards; NSERC	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Doctoral scholarship; Lung Association-Alberta & NWT studentship awards; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was supported by Canadian Institutes for Health Research (CIHR) project grants (MOP 125918, PJT 156310) and by a Natural Sciences and Engineering Research Council (NSERC) Discovery Grant (RGPIN-2016-04549). M. M. M. received NSERC Postgraduate Scholarship-Doctoral, Queen Elizabeth II Doctoral scholarship, and The Lung Association-Alberta & NWT studentship awards. The funding bodies played no role in the design of the study and collection, analysis, and interpretation of data.	Ai FL, 2020, ONCOL REP, V43, P427, DOI 10.3892/or.2019.7434; Almlof T, 1998, BIOCHEMISTRY-US, V37, P9586, DOI 10.1021/bi973029x; Altonsy MO, 2014, J BIOL CHEM, V289, P8231, DOI 10.1074/jbc.M113.545178; Ambrosini G, 2018, BIOINFORMATICS, V34, P2483, DOI 10.1093/bioinformatics/bty127; Azofeifa JG, 2018, GENOME RES, V28, P334, DOI 10.1101/gr.225755.117; Bagamasbad P, 2012, ENDOCRINOLOGY, V153, P5334, DOI 10.1210/en.2012-1303; Bagamasbad PD, 2015, MOL ENDOCRINOL, V29, P856, DOI 10.1210/me.2014-1349; Bai XY, 2018, CANCER LETT, V412, P224, DOI 10.1016/j.canlet.2017.10.027; Barnes PJ, 2006, EUR J PHARMACOL, V533, P2, DOI 10.1016/j.ejphar.2005.12.052; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bonett RM, 2009, ENDOCRINOLOGY, V150, P1757, DOI 10.1210/en.2008-1441; Burd CJ, 2013, MOL CELL ENDOCRINOL, V380, P25, DOI 10.1016/j.mce.2013.03.020; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Catley MC, 2004, J BIOL CHEM, V279, P18457, DOI 10.1074/jbc.M400765200; CHANDLER VL, 1983, CELL, V33, P489, DOI 10.1016/0092-8674(83)90430-0; Chinenov Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-656; Conway-Campbell BL, 2011, MOL ENDOCRINOL, V25, P944, DOI 10.1210/me.2010-0073; Cui AF, 2019, J CLIN INVEST, V129, P2266, DOI 10.1172/JCI66062; D Ippolito A. M., 2018, CELL SYST, V7, P1; Datson NA, 2011, ENDOCRINOLOGY, V152, P3749, DOI 10.1210/en.2011-0287; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fonte C, 2007, J STEROID BIOCHEM, V104, P220, DOI 10.1016/j.jsbmb.2007.03.034; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Franco LM, 2019, J EXP MED, V216, P384, DOI 10.1084/jem.20180595; Gertz J, 2013, MOL CELL, V52, P25, DOI 10.1016/j.molcel.2013.08.037; Gupte R, 2013, P NATL ACAD SCI USA, V110, P14616, DOI 10.1073/pnas.1309898110; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hudy MH, 2010, EUR RESPIR J, V35, P1256, DOI 10.1183/09031936.00128809; John S, 2008, MOL CELL, V29, P611, DOI 10.1016/j.molcel.2008.02.010; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Joshi T, 2015, BRIT J PHARMACOL, V172, P1360, DOI 10.1111/bph.13014; Kadiyala V, 2016, J BIOL CHEM, V291, P12673, DOI 10.1074/jbc.M116.721217; Kan MY, 2019, AM J RESP CELL MOL, V61, P110, DOI 10.1165/rcmb.2018-0385OC; Kasper LH, 2010, EMBO J, V29, P3660, DOI 10.1038/emboj.2010.235; Kaur M, 2008, AM J PHYSIOL-LUNG C, V295, pL505, DOI 10.1152/ajplung.00046.2008; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; Klassen C, 2017, J IMMUNOL, V199, P48, DOI 10.4049/jimmunol.1601691; Knoedler JR, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3640-7; Knoedler JR, 2014, GEN COMP ENDOCR, V203, P49, DOI 10.1016/j.ygcen.2014.03.003; Kuo TY, 2012, P NATL ACAD SCI USA, V109, P11160, DOI 10.1073/pnas.1111334109; Kuznetsova T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0832-9; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Leigh R, 2016, PHARMACOL RES PERSPE, V4, DOI 10.1002/prp2.243; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Love MI, 2017, NUCLEIC ACIDS RES, V45, P1805, DOI 10.1093/nar/gkw1163; McDowell IC, 2018, GENOME RES, V28, P1272, DOI 10.1101/gr.233346.117; Morsczeck C, 2009, CLIN ORAL INVEST, V13, P383, DOI 10.1007/s00784-009-0260-x; Mostafa MM, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-018-0467-2; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Park YK, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00260-16; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Petta Ioanna, 2016, Microbiol Mol Biol Rev, V80, P495, DOI 10.1128/MMBR.00064-15; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; Reddy TE, 2012, MOL CELL BIOL, V32, P3756, DOI 10.1128/MCB.00062-12; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rider CF, 2018, MOL PHARMACOL, V94, P1031, DOI 10.1124/mol.118.112755; Robinson JT, 2018, CELL SYST, V6, P256, DOI 10.1016/j.cels.2018.01.001; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Sacta MA, 2016, ANNU REV PHYSIOL, V78, P155, DOI 10.1146/annurev-physiol-021115-105323; Sacta MS, 2018, ELIFE, V7, DOI 10.7554/eLife.34864; Sasse SK, 2019, GENOME RES, V29, P1753, DOI 10.1101/gr.248187.119; Sasse SK, 2015, J BIOL CHEM, V290, P19756, DOI 10.1074/jbc.M115.668558; Sasse SK, 2013, MOL CELL BIOL, V33, P2104, DOI 10.1128/MCB.01474-12; Simmen RCM, 2010, J ENDOCRINOL, V204, P223, DOI 10.1677/JOE-09-0329; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Sporl F, 2012, P NATL ACAD SCI USA, V109, P10903, DOI 10.1073/pnas.1118641109; Velarde MC, 2006, ENDOCRINOLOGY, V147, P1969, DOI 10.1210/en.2005-1419; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Vockley CM, 2016, CELL, V166, P1269, DOI 10.1016/j.cell.2016.07.049; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Warner SM, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1120-0; Weikum ER, 2017, NAT REV MOL CELL BIO, V18, P159, DOI 10.1038/nrm.2016.152; Yu CY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015188	77	3	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100065	10.1074/jbc.RA120.015755	http://dx.doi.org/10.1074/jbc.RA120.015755			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33184061	Green Published, gold			2022-12-26	WOS:000672866400046
J	Yalew, M; Adane, B; Damtie, Y; Kefale, B; Arefaynie, M; Yasin, T				Yalew, Melaku; Adane, Bezawit; Damtie, Yitayish; Kefale, Bereket; Arefaynie, Mastewal; Yasin, Toyeb			Trend and determinants of anemia change among pregnant and/or lactating women in Ethiopia: A multivariate decomposition analysis	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; POPULATION; CHILDREN; IRON; CARE	Background Even though anemia was highly targeted in different global strategies, many pregnant and/or lactating women and children were suffering from it and its complications. Besides this, prior trend analysis has not been conducted among pregnant and/or lactating women in Ethiopia. Therefore, this study aimed to assess the trend and determinants of anemia change among pregnant and/or lactating women in Ethiopia. Methods The study utilized two consecutive Ethiopia Demographic and Health Survey (EDHS) datasets. A total of 6,106 and 5,641 pregnant and/or lactating women in 2011 and 2016 survey respectively were included in the analysis. The data were analyzed by using Stata version 14.0. Logit based decomposition analysis was done to identify contributing factors for anemia change and statistical significance was determined by using P-value. Results The trend of anemia was increased from 19% in 2011 to 29% in 2016 EDHS. The analysis revealed that, 8% of the overall change in anemia was because of the change in women's composition. Changes in the composition of pregnant and/or lactating women according to region, economic status and tobacco and/or cigarette use were the major sources of the change. Greater than 90% of the increase in anemia was due to differences in the coefficient. Mostly, the change in behaviors of the Amhara population, those who had a history of terminated pregnancy and use tobacco and/or cigarette were the sources of the change. Conclusions Anemia among pregnant and/or lactating women was increased against government interventions over the last half-decade in Ethiopia. Programmatic interventions targeting Somali and Dire Dawa regions are still needed to decrease anemia.	[Yalew, Melaku; Damtie, Yitayish; Kefale, Bereket; Arefaynie, Mastewal] Wollo Univ, Dept Reprod & Family Hlth, Sch Publ Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia; [Adane, Bezawit] Wollo Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia; [Yasin, Toyeb] Wollo Univ, Dept Hlth Serv Management, Sch Publ Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Yalew, M (corresponding author), Wollo Univ, Dept Reprod & Family Hlth, Sch Publ Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia.	meleya7@gmail.com	Arefaynie, Mastewal/AAZ-8374-2021	Arefaynie, Mastewal/0000-0001-9525-0552; Kefale Abitew, Bereket/0000-0003-1795-9886				Abebaw A, 2020, ANEMIA, V2020, DOI 10.1155/2020/8979740; Abriha Abrehet, 2014, BMC Res Notes, V7, P888, DOI 10.1186/1756-0500-7-888; Acheampong K., 2018, GHANA INT J HLTH SCI, V8, P186; Adam I, 2005, T ROY SOC TROP MED H, V99, P739, DOI 10.1016/j.trstmh.2005.02.008; Alemu T, 2016, ETHIOP J HEALTH SCI, V26, P243, DOI 10.4314/ejhs.v26i3.7; Ampiah MKM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7603-6; [Anonymous], 2012, ANN NIGERIAN MED, DOI DOI 10.4103/0331-3131.100213; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], 2009, HEALTHC INFORM, V26, P20; [Anonymous], 2016, LANCET ONCOL, V17, pe198; [Anonymous], 2018, DIABETES CARE S1, V2018, pS1; Ayano B., 2018, J GYNECOLOGY OBSTET, V6, P31, DOI DOI 10.11648/J.JGO.20180603.11; Basu S, 2018, J PERINATOL, V38, P233, DOI 10.1038/s41372-017-0023-5; Berhe B, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4347-4; Berhie Kidanemariam Alem, 2016, Matern Health Neonatol Perinatol, V2, P10, DOI 10.1186/s40748-016-0038-5; Bharati S, 2015, ASIA-PAC J PUBLIC HE, V27, pNP1193, DOI 10.1177/1010539512442567; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; Central statistical agency (CSA) [Ethiopia] and ICF, 2016, ETH DEM HLTH SURV 20; Cusick SE, 2008, AM J CLIN NUTR, V88, P1611, DOI 10.3945/ajcn.2008.25926; Demisse TL, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0758-x; Gebremariam AD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210086; Gebresilassie HG., 2017, TURKIYE KLIN BIYOIST, V9, P121; Geneva S, 2011, NMHNHDMNM111 WHO; Getiye Y, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1420-7; Habte Dereje, 2013, Afr J Reprod Health, V17, P110; Haidar J, 2010, J HEALTH POPUL NUTR, V28, P359; Heydarpour F, 2019, MATERNAL ANEMIA VARI; Iftikhar A, BIOMED J, V2, P4; Jeong SM, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0322-2; Khalil AK, 2007, PAK ARMED FORCES J, V57, P273; Kibret KT, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027276; Kumera G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206880; Lin L, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1739-8; Lone FW, 2004, TROP MED INT HEALTH, V9, P486, DOI 10.1111/j.1365-3156.2004.01222.x; Mackness M, 2015, GENE, V567, P12, DOI 10.1016/j.gene.2015.04.088; Mardones F, 2003, REV MED CHILE, V131, P520; Maskey M, 2014, NEPAL J EPIDEMIOL, V4, P386, DOI 10.3126/nje.v4i4.11358; Mekonnen FA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202734; Nguyen PH, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001010; Obse N, 2013, ETHIOP J HEALTH SCI, V23, P165; Poggi SB, 2007, POSTPARTUM HEMORRHAG, P477; Powers DA, 2011, STATA J, V11, P556, DOI 10.1177/1536867X1101100404; Rukuni R, 2016, ACTA OBSTET GYN SCAN, V95, P555, DOI 10.1111/aogs.12862; S BE, 2018, J CROHNS COLITIS, V12, pS049; Sendeku FW, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-2835-0; Siddiqui MZ, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017725555; Sinha D, INT J REPROD CONTRAC, V8, P846; Siza J E, 2008, Tanzan J Health Res, V10, P1; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Uche-Nwachi EO, 2010, AFR HEALTH SCI, V10, P66; United Nations, 2016, SUST DEV GOAL; [WHO UNICEF], 2004, FOC AN INT APPR EFF; WHO UNFPA, 2014, TRENDS MAT MORT 1990; World Health Organization, 2015, GLOB PREV AN 2011; World Health Organization (WHO), 2007, MICR DEF BATTL IR DE; Yang F, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2899; Zillmer Krista, 2017, BMC Nutr, V3, P65, DOI 10.1186/s40795-017-0166-y	57	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241975	10.1371/journal.pone.0241975	http://dx.doi.org/10.1371/journal.pone.0241975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206682	Green Published, gold			2022-12-26	WOS:000595265900019
J	de Avilla, JC; Giugliani, C; Bizon, AMBL; Martins, ACM; de Senna, AFK; Giugliani, ERJ				Castro de Avilla, Juliana; Giugliani, Camila; Branco Leria Bizon, Agnes Meire; Magnus Martins, Ana Claudia; Kroll de Senna, Andrea Francis; Justo Giugliani, Elsa Regina			Association between maternal satisfaction with breastfeeding and postpartum depression symptoms	PLOS ONE			English	Article							POSTNATAL DEPRESSION; EPIDEMIOLOGY; BIRTH	Background Due to the multiple health benefits of breastfeeding, it is essential to identify factors that may negatively interfere with this healthy practice. Among such factors are postpartum depression (PPD) and maternal satisfaction with breastfeeding. The objective of this study was to evaluate the association between maternal satisfaction with breastfeeding and symptoms of PPD in the first month after childbirth. Methods This cross-sectional study nested in a cohort study was conducted in Porto Alegre, Brazil, with 287 puerperal women selected at two maternity hospitals, one public and one private. Women were interviewed at their homes the week after the infant completed 30 days of life. A structured questionnaire was applied, as well as instruments to evaluate maternal satisfaction with breastfeeding (Maternal Breastfeeding Evaluation Scale) and to screen for PPD (Edinburgh Postnatal Depression Scale). The association between higher satisfaction with breastfeeding (outcome) and negative PPD screening test was assessed using Poisson regression with robust variance, adjusting for specific covariables. Adjusted prevalence ratios (aPR) and respective 95% confidence intervals (95%CI) were estimated. Results The prevalence of increased satisfaction with breastfeeding (defined as women with scores above the median) was 47% higher among women who screened negative for PPD when compared to those with a positive result (aPR 1.47; 95%CI 1.01-2.16). This result was adjusted for maternal age and skin color, cohabitation with the infant's father, planned pregnancy, type of delivery, exclusive breastfeeding, and occurrence of breastfeeding problems. Conclusions The findings of this study showed an association between higher maternal satisfaction with breastfeeding and absence of PPD symptoms, reinforcing the importance of caring for the mental health of pregnant and puerperal women and paying attention to their satisfaction with breastfeeding.	[Castro de Avilla, Juliana; Branco Leria Bizon, Agnes Meire; Kroll de Senna, Andrea Francis; Justo Giugliani, Elsa Regina] Univ Fed Rio Grande Do Sul UFRGS, Fac Med, Grad Program Child & Adolescent Hlth, Porto Alegre, RS, Brazil; [Giugliani, Camila; Magnus Martins, Ana Claudia] Univ Fed Rio Grande Do Sul UFRGS, Fac Med, Grad Program Epidemiol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Giugliani, ERJ (corresponding author), Univ Fed Rio Grande Do Sul UFRGS, Fac Med, Grad Program Child & Adolescent Hlth, Porto Alegre, RS, Brazil.	elsag@ufrgs.br	Giugliani, Camila/AHD-3590-2022	Giugliani, Elsa/0000-0001-6569-6473	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [448186/2014-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; Universal Notice 448186/2014-4) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) via research grants given to the following authors: AFKS, AMBLB, and ACMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AssociacAo Brasileira de Empresas de Pesquisa, 2016, CRIT BRAS 2015 E AT; Boccolini CS, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005971; Borra C, 2015, MATERN CHILD HLTH J, V19, P897, DOI 10.1007/s10995-014-1591-z; Brown A, 2016, J ADV NURS, V72, P273, DOI 10.1111/jan.12832; Colombo L, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010048; Cooke Margaret, 2003, J Hum Lact, V19, P145, DOI 10.1177/0890334403019002003; Dias CC, 2015, J AFFECT DISORDERS, V171, P142, DOI 10.1016/j.jad.2014.09.022; Santo LCD, 2007, BIRTH-ISS PERINAT C, V34, P212, DOI 10.1111/j.1523-536X.2007.00173.x; Edwards R, 2018, J HUM LACT, V34, P93, DOI 10.1177/0890334417722509; Gelaye B, 2016, LANCET PSYCHIAT, V3, P973, DOI 10.1016/S2215-0366(16)30284-X; Hahn-Holbrook J, 2013, ARCH WOMEN MENT HLTH, V16, P411, DOI 10.1007/s00737-013-0348-9; Hongo H, 2015, MATERN CHILD HLTH J, V19, P1252, DOI 10.1007/s10995-014-1631-8; Ko JY, 2017, MMWR-MORBID MORTAL W, V66, P153, DOI 10.15585/mmwr.mm6606a1; de Senna AFK, 2020, J PEDIAT-BRAZIL, V96, P84, DOI 10.1016/j.jped.2018.08.008; de Senna AFK, 2020, INT BREASTFEED J, V15, DOI 10.1186/s13006-020-00312-w; Labarere J, 2012, J HUM LACT, V28, P203, DOI 10.1177/0890334411429114; Leff E W, 1994, J Hum Lact, V10, P105, DOI 10.1177/089033449401000217; Matthews M K, 1991, J Obstet Gynecol Neonatal Nurs, V20, P49, DOI 10.1111/j.1552-6909.1991.tb01676.x; Pope Carley J, 2016, Depress Res Treat, V2016, P4765310, DOI 10.1155/2016/4765310; Rollins NC, 2016, LANCET, V387, P491, DOI 10.1016/S0140-6736(15)01044-2; Santos IS, 2007, CAD SAUDE PUBLICA, V23, P2577, DOI 10.1590/S0102-311X2007001100005; Sharifi Farangis, 2016, Electron Physician, V8, P3234, DOI 10.19082/3234; Silva CS, 2017, J PEDIAT-BRAZIL, V93, P356, DOI 10.1016/j.jped.2016.08.005; Tanganhito DD, 2020, WOMEN BIRTH, V33, P231, DOI 10.1016/j.wombi.2019.05.012; Filha MMT, 2016, J AFFECT DISORDERS, V194, P159, DOI 10.1016/j.jad.2016.01.020; Viacava F, 2018, CIENC SAUDE COLETIVA, V23, P1751, DOI 10.1590/1413-81232018236.06022018; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Woolhouse H, 2016, WOMEN BIRTH, V29, P381, DOI 10.1016/j.wombi.2016.05.008; World Health Organization, 2017, PROTECTING PROMOTING; Xiao-hu Z, 2020, ASIAN J PSYCHIATR, V53, DOI 10.1016/j.ajp.2020.102353	30	6	7	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242333	10.1371/journal.pone.0242333	http://dx.doi.org/10.1371/journal.pone.0242333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ5ZL	33201903	gold, Green Published			2022-12-26	WOS:000595003900010
J	Misra, S; van Middelaar, CE; Jordan, K; Upton, J; Quinn, AJ; de Boer, IJM; O'Driscoll, K				Misra, Shilpi; van Middelaar, Corina E.; Jordan, Kieran; Upton, John; Quinn, Amy J.; de Boer, Imke J. M.; O'Driscoll, Keelin			Effect of different cleaning procedures on water use and bacterial levels in weaner pig pens	PLOS ONE			English	Article							FOOTPRINT; DISINFECTION; FARMS	Pork is one of the most globally eaten meats and the pig production chain contributes significantly to the water footprint of livestock production. However, very little knowledge is available about the on-farm factors that influence freshwater use in the pig production chain. An experiment was conducted to quantify the effect of three different washing treatments on freshwater use, bacterial levels [(total bacterial counts; TBC), Enterobacteriaceae and Staphylococcus] and cleaning time in washing of pens for weaning pigs. Three weaner rooms were selected with each room having 10 pens and a capacity to hold up to 14 pigs each. Pigs were weaned and kept in the pens for 7 weeks. Finally, the pens were cleaned before the next batch of pigs moved in. The washing treatments used were power washing and disinfection (WASH); presoaking followed by power washing and disinfection (SOAK), and presoaking followed by detergent, power washing and disinfection (SOAK + DETER). A water meter was used to collect water use data and swab samples were taken to determine the bacterial levels. The results showed that there was no overall effect of washing treatments on water use. However, there was an effect of treatment on the washing time (p<0.01) with SOAK and SOAK+DETER reducing the washing time per pen by 2.3 minutes (14%) and 4.2 minutes (27%) compared to WASH. Nonetheless, there was an effect of sampling time (before or after washing) (p<0.001) on the levels of TBC and Staphylococcus, but no effect was seen on Enterobacteriaceae levels. Thus, the washing treatments used in this study had no effect on the water use of the pork production chain. Although there was no difference in both water use and bacterial load, from a producer perspective, presoaking and detergent use can save time and labour costs, so this would be the preferred option.	[Misra, Shilpi; Quinn, Amy J.; O'Driscoll, Keelin] TEAGASC, Pig Dev Dept, Anim & Grassland Res & Innovat Ctr, Moorepk, Fermoy, Cork, Ireland; [Misra, Shilpi; van Middelaar, Corina E.; de Boer, Imke J. M.] Wageningen Univ & Res, Anim Prod Syst Grp, Wageningen, Netherlands; [Jordan, Kieran] TEAGASC, Food Res Ctr, Moorepk, Fermoy, Cork, Ireland; [Upton, John] TEAGASC, Livestock Syst Dept, Anim & Grassland Res Innovat Ctr, Moorepk, Fermoy, Cork, Ireland	Teagasc; Wageningen University & Research; Teagasc; Teagasc	Misra, S (corresponding author), TEAGASC, Pig Dev Dept, Anim & Grassland Res & Innovat Ctr, Moorepk, Fermoy, Cork, Ireland.; Misra, S (corresponding author), Wageningen Univ & Res, Anim Prod Syst Grp, Wageningen, Netherlands.	shilpi.misra@teagasc.ie	de Boer, Imke/P-7107-2014	de Boer, Imke/0000-0002-0675-7528; Misra, Shilpi/0000-0002-4190-6867	Teagasc Walsh Fellowship [2017147]; Teagasc internal fund [0182]	Teagasc Walsh Fellowship; Teagasc internal fund	This project was funded by the Teagasc Walsh Fellowship (2017147) and Teagasc internal funding (project code 0182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, PROG RETIN EYE RES; Arguello H., 2011, P INT C SAF 2011 MAA, P254, DOI DOI 10.31274/SAFEPORK-180809-636; Cherchi C, 2011, WATER SCI TECHNOL, V64, P7, DOI 10.2166/wst.2011.536; de Miguel A, 2015, ECOL INDIC, V57, P465, DOI 10.1016/j.ecolind.2015.05.023; Ercin AE, 2012, ECOL INDIC, V18, P392, DOI 10.1016/j.ecolind.2011.12.009; Fairbrother JM, 2012, DIS SWINE, P723; Frana TS, 2012, DIS SWINE, V10th, P834; Gonzalez-Garcia S, 2015, J CLEAN PROD, V100, P126, DOI 10.1016/j.jclepro.2015.03.048; Gosling R. J., 2018, Livestock, V23, P232, DOI 10.12968/live.2018.23.5.232; Hancox LR, 2013, VET REC, V173, P167, DOI 10.1136/vr.101392; Heinemann C, 2020, J ANIM SCI, V98, DOI 10.1093/jas/skz389; Henchion M, 2014, MEAT SCI, V98, P561, DOI 10.1016/j.meatsci.2014.06.007; Hurnik D., 2005, 5th London Swine Conference Proceedings. Production at the leading edge, London, Ontario, Canada, 6-7 April 2005, P135; Luyckx K, 2015, POULTRY SCI, V94, P740, DOI 10.3382/ps/pev019; Mannion C, 2007, VET REC, V161, P371, DOI 10.1136/vr.161.11.371; Martelli F, 2017, AVIAN PATHOL, V46, P131, DOI 10.1080/03079457.2016.1223835; Matlock M, 2014, PORKCHECKOFF, V67; Mekonnen MM, 2012, ECOSYSTEMS, V15, P401, DOI 10.1007/s10021-011-9517-8; Noya I, 2016, J ENVIRON MANAGE, V171, P133, DOI 10.1016/j.jenvman.2016.01.039; Poore J, 2018, SCIENCE, V360, P987, DOI 10.1126/science.aaq0216; Ran Y, 2016, LIVEST SCI, V187, P68, DOI 10.1016/j.livsci.2016.02.012; Rodgers A, 2019, FOOD BIOPROD PROCESS, V113, P118, DOI 10.1016/j.fbp.2018.11.003; Small D., 2001, DGH ENG LTD MAN CAN; Willson P, 2000, SUSTAINABILITY WATER, P6	24	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242495	10.1371/journal.pone.0242495	http://dx.doi.org/10.1371/journal.pone.0242495			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201932	gold, Green Published			2022-12-26	WOS:000595003900001
J	Gori, A; Topino, E; Di Fabio, A				Gori, Alessio; Topino, Eleonora; Di Fabio, Annamaria			The protective role of life satisfaction, coping strategies and defense mechanisms on perceived stress due to COVID-19 emergency: A chained mediation model	PLOS ONE			English	Article							POSITIVE EMOTIONS; HEALTH; WORK; RESILIENCE; HAPPINESS; DISTRESS; DISEASE; SARS	The coronavirus disease-19 (COVID-19) pandemic represents a worldwide emergency, which may have harmful consequences on people's mental health. Parallel to research focused on risk factors, it could be useful to investigate the factors that help to cope with such crises at an emotional level. Therefore, this study aimed to strengthen the role of variables that protect from subjective distress during the COVID-19 pandemic, explore the pathways between satisfaction with life and perceived stress, and consider the role of coping strategies and defense mechanisms in this relationship. A sample of 1102 Italian participants who were experiencing the COVID-19 lockdown measures (Mage = 34.91, SD = 11.91) completed an online survey in which the Ten Item Perceived Stress Scale, Satisfaction with Life Scale, Coping Orientation to Problems Experienced Inventory and Forty-Item Defense Style Questionnaire were included. The data were analyzed using Pearson's r correlations and moderation analysis. A chained-mediation model showed that the relationship between life satisfaction and perceived stress is partially mediated by approach coping, positive attitude and mature defenses. This study contributes toward gaining a better understanding of a protective pathway for mental health outcomes during the COVID-19 pandemic. The findings could be useful from both a preventive and an intervention perspective.	[Gori, Alessio] Univ Florence, Dept Hlth Sci, Florence, Italy; [Topino, Eleonora] LUMSA Univ Rome, Dept Human Sci, Rome, Italy; [Di Fabio, Annamaria] Univ Florence, Dept Educ Languages Interculture Letters & Psycho, Psychol Sect, Florence, Italy	University of Florence; Universita LUMSA; University of Florence	Gori, A (corresponding author), Univ Florence, Dept Hlth Sci, Florence, Italy.	gori.alessio@gmail.com		Topino, Eleonora/0000-0003-0849-1249				Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; ANDREWS G, 1993, J NERV MENT DIS, V181, P246, DOI 10.1097/00005053-199304000-00006; [Anonymous], 2000, KINTOP, V9, P11; Azoulay E, 2020, LANCET RESP MED, V8, pE52, DOI 10.1016/S2213-2600(20)30223-X; Babore A, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113366; Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3; Bohlken J, 2020, PSYCHIAT PRAX, V47, P190, DOI 10.1055/a-1159-5551; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Cohen S, SOCIAL PSYCHOL HLTH, V198, P31; Cortinovis I., 2000, RIC PSICOL, V24, P127, DOI DOI 10.3280/RIP2000-003007; Cramer P., 2006, PROTECTING SELF DEFE; Cramer P, 2007, J PERS, V75, P1, DOI 10.1111/j.1467-6494.2006.00430.x; Di Fabio A, 2016, J PSYCHOEDUC ASSESS, V34, P501, DOI 10.1177/0734282915621223; Di Giuseppe M, 2018, J PSYCHOSOM RES, V115, P76, DOI 10.1016/j.jpsychores.2018.10.016; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DIENER E, 1994, SOC INDIC RES, V31, P103, DOI 10.1007/BF01207052; DIFABIO A, 2020, SUSTAINABILITY-BASEL, V12, DOI DOI 10.3390/SU12145860; Erdogan B, 2012, J MANAGE, V38, P1038, DOI 10.1177/0149206311429379; Fossati, 2010, ITALIAN TRANSLATION; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; Gillespie CF, 2009, DEPRESS ANXIETY, V26, P984, DOI 10.1002/da.20605; Grant N, 2009, INT J BEHAV MED, V16, P259, DOI 10.1007/s12529-009-9032-x; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; He F, 2020, J MED VIROL, V92, P719, DOI 10.1002/jmv.25766; Hooker SA, 2018, REV GEN PSYCHOL, V22, P11, DOI 10.1037/gpr0000115; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Mondragon NI, 2017, J HEALTH PSYCHOL, V22, P951, DOI 10.1177/1359105315620294; Italian Ministry of Health, 2020, COV 19 SIT REP UPD 1; Jayawickreme E, 2012, REV GEN PSYCHOL, V16, P327, DOI 10.1037/a0027990; Kemeny ME, 2003, CURR DIR PSYCHOL SCI, V12, P124, DOI 10.1111/1467-8721.01246; Kivimaki M, 2006, SCAND J WORK ENV HEA, V32, P431, DOI 10.5271/sjweh.1049; Larsen A, 2010, INT J SOC PSYCHIATR, V56, P563, DOI 10.1177/0020764008099555; Lee AM, 2007, CAN J PSYCHIAT, V52, P233, DOI 10.1177/070674370705200405; Liang LL, 2020, PSYCHIAT QUART, V91, P841, DOI 10.1007/s11126-020-09744-3; Lippi G, 2020, CLIN CHIM ACTA, V506, P145, DOI 10.1016/j.cca.2020.03.022; Liu NQ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112921; Loeser JD, 1999, LANCET, V353, P1607, DOI 10.1016/S0140-6736(99)01311-2; Lyubomirsky S, 2005, PSYCHOL BULL, V131, P803, DOI 10.1037/0033-2909.131.6.803; Maricutoiu LP, 2016, INT J PSYCHOL, V51, P83, DOI 10.1002/ijop.12113; Maunder RG, 2008, CAN J PUBLIC HEALTH, V99, P486, DOI 10.1007/BF03403782; Mohammed A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2167-6; Ong AD, 2006, J PERS SOC PSYCHOL, V91, P730, DOI 10.1037/0022-3514.91.4.730; Ozamiz-Etxebarria N, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01491; Peterson C., 2005, J HAPPINESS STUD, V6, P25, DOI [https://doi.org/10.1007/s10902-004-1278-z, DOI 10.1007/S10902-004-1278-Z]; Pidgeon A.M., 2014, OPEN J SOC SCI, V2, P23, DOI [DOI 10.4236/JSS.2014.211004, 10.4236/jss.2014.211004]; Proctor C, 2010, SOC INDIC RES, V98, P519, DOI 10.1007/s11205-009-9562-2; Rabenu E, 2017, CURR PSYCHOL, V36, P875, DOI 10.1007/s12144-016-9477-4; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Ryu S, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020006; Sagone E., 2014, AM J ED RES, V2, P463, DOI [DOI 10.12691/EDUCATION-2-7-5, 10.12691/education-2-7-5]; Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00620-0; Salovey P, 2000, AM PSYCHOL, V55, P110, DOI 10.1037/0003-066X.55.1.110; Shanahan L, 2022, PSYCHOL MED, V52, P824, DOI 10.1017/S003329172000241X; Sica C., 2008, PSICOTER COGN COMPOR, V14, P27; Slavich GM, 2016, TEACH PSYCHOL, V43, P346, DOI 10.1177/0098628316662768; Sliter M, 2014, J ORGAN BEHAV, V35, P257, DOI 10.1002/job.1868; Smedema SM, 2010, REHABIL COUNS BULL, V53, P131, DOI 10.1177/0034355209358272; Smyth JM, 2017, J BEHAV MED, V40, P320, DOI 10.1007/s10865-016-9790-2; Stewart-Brown S, 2000, J PUBLIC HEALTH MED, V22, P492, DOI 10.1093/pubmed/22.4.492; Taylor S, 2020, DEPRESS ANXIETY, V37, P706, DOI 10.1002/da.23071; Trzebinski J, 2020, J LOSS TRAUMA, V25, P544, DOI 10.1080/15325024.2020.1765098; Vaillant G. E., 1992, EGO MECH DEFENSE GUI; Veenhoven R, 2008, J HAPPINESS STUD, V9, P449, DOI 10.1007/s10902-006-9042-1; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072459; Wang CY, 2020, BRAIN BEHAV IMMUN, V87, P40, DOI 10.1016/j.bbi.2020.04.028; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001; Xu C, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00858	68	40	40	9	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242402	10.1371/journal.pone.0242402	http://dx.doi.org/10.1371/journal.pone.0242402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0NB	33186367	Green Published, gold			2022-12-26	WOS:000593949800048
J	Somnuke, P; Ramlee, R; Ratanapaiboon, W; Thommaaksorn, P; Iramaneerat, C; Duangekanong, S; Siriussawakul, A				Somnuke, Pawit; Ramlee, Rachaneekorn; Ratanapaiboon, Waratchaya; Thommaaksorn, Passorn; Iramaneerat, Cherdsak; Duangekanong, Somsit; Siriussawakul, Arunotai			Factors influencing preoperative chest radiography request for elective endoscopic procedures among medical personnel	PLOS ONE			English	Article							PREDICTIVE-VALUE; X-RAYS; TESTS; PREVALENCE; SURGERY	Background Chest radiography is not routinely recommended before elective endoscopies. A high incidence of perioperative chest radiography requests was observed at our institution. This study aims to investigate factors influencing preoperative chest radiography request for patients undergoing elective gastrointestinal (GI) endoscopies. Methods This cross-sectional clinical study recruited 264 participants from different medical specialties who were responsible for preoperative endoscopic chest x-ray (CXR) ordering including anesthesiologists, surgeons and gastroenterologists. They completed questionnaires exploring their general knowledge and attitudes about preoperative chest radiography. Demographic characteristic of the participants affecting the knowledge on preoperative chest radiography was determined. A Structural Equation Model (SEM) was constructed from validated conceptual framework to find causal relationships between hypothesized factors and intention for preoperative endoscopic chest radiography request. Statistical analyses were performed using the SPSS software version 18.0 and Analysis of Moment Structures (AMOS) version 18.0. Results The questionnaire response rate was 53.79%. Baseline general knowledge on preoperative chest radiography of the participants was comparable. The SEM results showed unsupported relationship between hypothesized factors and the intention for preprocedural GI endoscopic CXR request (p < 0.1). Conclusions General knowledge of medical personnel on tuberculosis needs improvement. To rectify the unnecessary chest radiography request before elective GI endoscopic procedures, awareness of the patients' health conditions, adherence to the hospital's policy and realizing of possible patient-related mishaps are not the determinants for preprocedural endoscopic chest radiography request. Future works are required to explore other alternative factors involved for reducing chest radiography requests which are not indicated.	[Somnuke, Pawit; Thommaaksorn, Passorn; Siriussawakul, Arunotai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anesthesiol, Bangkok, Thailand; [Ramlee, Rachaneekorn; Siriussawakul, Arunotai] Mahidol Univ, Siriraj Hosp, Fac Med, Integrated Perioperat Geriatr Excellent Res Ctr, Bangkok, Thailand; [Ratanapaiboon, Waratchaya] Vet Gen Hosp, Dept Anesthesiol, Bangkok, Thailand; [Iramaneerat, Cherdsak] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Surg, Bangkok, Thailand; [Duangekanong, Somsit] Assumption Univ, Fac Informat Technol & Management, Grad Sch Adv Technol Management, Bangkok, Samuthprakarn, Thailand	Mahidol University; Mahidol University; Mahidol University	Siriussawakul, A (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Anesthesiol, Bangkok, Thailand.; Siriussawakul, A (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Integrated Perioperat Geriatr Excellent Res Ctr, Bangkok, Thailand.	arunotai.sir@mahidol.ac.th	Iramaneerat, Cherdsak/AAH-9572-2021	Iramaneerat, Cherdsak/0000-0002-2750-3981	Faculty of Medicine, Siriraj Hospital, Mahidol University [R016131009]	Faculty of Medicine, Siriraj Hospital, Mahidol University	This research project was supported by the Faculty of Medicine, Siriraj Hospital, Mahidol University, grant number [IO] R016131009 on 29 November 2017 to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali Irum Sabir, 2013, J Ayub Med Coll Abbottabad, V25, P23; Amer Soc Anesthesiolgists, 2012, ANESTHESIOLOGY, V116, P522, DOI 10.1097/ALN.0b013e31823c1067; [Anonymous], 2017, LANCET HIV, V2017, pPE475; Benarroch-Gampel J, 2012, ANN SURG, V256, P518, DOI 10.1097/SLA.0b013e318265bcdb; Brown SR, 2011, FAM MED, V43, P338; Chinachot T, 2016, THAI J ANAESTHESIOL, V42, P69; Chung F, 2009, ANESTH ANALG, V108, P467, DOI 10.1213/ane.0b013e318176bc19; Dej-arkom Sukanya, 2016, Journal of the Medical Association of Thailand, V99, P491; Dzankic S, 2001, ANESTH ANALG, V93, P301, DOI 10.1097/00000539-200108000-00013; Feely MA, 2013, AM FAM PHYSICIAN, V87, P414; Ramos LWF, 2018, REV BRAS ANESTESIOL, V68, P154, DOI [10.1016/j.bjan.2017.10.004, 10.1016/j.bjane.2017.10.005]; Fritsch G, 2012, ACTA ANAESTH SCAND, V56, P339, DOI 10.1111/j.1399-6576.2011.02593.x; Hajjaj FM, 2010, J ROY SOC MED, V103, P178, DOI 10.1258/jrsm.2010.100104; Haug RH, 1999, J ORAL MAXIL SURG, V57, P16, DOI 10.1016/S0278-2391(99)90623-7; Joo HS, 2005, CAN J ANAESTH, V52, P568, DOI 10.1007/BF03015764; KAPLAN EB, 1985, JAMA-J AM MED ASSOC, V253, P3576, DOI 10.1001/jama.253.24.3576; Keshavan VH, 2016, INDIAN J ANAESTH, V60, P838, DOI 10.4103/0019-5049.193678; Kovacevic M, 2012, EUROPEAN J ANAESTHES, V29, P16, DOI DOI 10.1097/00003643-201206001-00052; Lim E. H. L., 2003, SMJ Singapore Medical Journal, V44, P340; MacNeil A, 2017, MMWR-MORBID MORTAL W, V68, P263; O'Neill F, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3292; Ongkanchana N, 2019, THAI J ANESTHESIOL, V45, P137; Pasha SF, 2014, GASTROINTEST ENDOSC, V80, P28, DOI 10.1016/j.gie.2014.01.019; Pasternak L Reuven, 2004, Anesthesiol Clin North Am, V22, P13, DOI 10.1016/S0889-8537(03)00115-9; Richman Deborah C, 2010, Anesthesiol Clin, V28, P185, DOI 10.1016/j.anclin.2010.03.001; Robinson TN, 2003, SURG ENDOSC, V17, P438, DOI 10.1007/s00464-002-8540-4; Schein OD, 2000, NEW ENGL J MED, V342, P168, DOI 10.1056/NEJM200001203420304; Silvestri L, 1999, EUR J ANAESTH, V16, P749, DOI 10.1046/j.1365-2346.1999.00577.x; Smetana GW, 2003, MED CLIN N AM, V87, P7, DOI 10.1016/S0025-7125(02)00147-5; Soper D.S., 2020, A PRIORI SAMPLE SIZE; World Health Organisation (WHO), 2016, GLOB TUB REP 2016	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242140	10.1371/journal.pone.0242140	http://dx.doi.org/10.1371/journal.pone.0242140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186394	gold, Green Published			2022-12-26	WOS:000593949800020
J	Cho, JH; Lim, YC; Han, KD; Lee, JY; Choi, JH				Cho, Jae Hoon; Lim, Young Chang; Han, Kyung-Do; Lee, Jae Yong; Choi, Ji Ho			The incidence of malignant brain tumors is increased in patients with obstructive sleep apnea: A national health insurance survey	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CANCER-MORTALITY; PREVALENCE; DISEASE; RISK	The association between obstructive sleep apnea (OSA) and malignant brain tumors has yet to be fully investigated. Therefore, the purpose of this study was to elucidate the effect of OSA on brain tumor incidence based on the Korea National Health Insurance Service (KNHIS) dataset. The KNHIS data between 2007 and 2014 were analyzed, and the primary endpoint was newly diagnosed malignant brain tumor. A total of 198,574 subjects aged >= 20 years with newly diagnosed OSA were enrolled in the study, and 992,870 individuals were selected as a control group based on propensity score matching (PSM) by gender and age. The average follow-up duration was 4.8 +/- 2.3 years. The hazard ratios (HRs) for brain tumor for patients with OSA were 1.78 (95% confidence interval [CI]: 1.42-2.21) in Model 1 (not adjusted with any covariate) and 1.67 (95% CI: 1.34-2.09) in Model 2 (adjusted for income level, diabetes, hypertension, dyslipidemia, and COPD). In subgroup analysis by gender, the odds ratios (OR) of OSA were 1.82 (95% CI: 1.41-2.33) in men and 1.26 (95% CI: 0.74-2.03) in women. The ORs were 1.97 (95% CI: 1.15-3.24) in the older (age >= 65 years) group, 1.66 (95% CI: 1.25-2.17) in the middle-aged (40 <= age < 65 years) group, and 1.41 (0.78-2.44) in the young (20 <= age < 40 years) group. In conclusion, OSA may increase the incidence of brain tumors.	[Cho, Jae Hoon; Lim, Young Chang] Konkuk Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Han, Kyung-Do] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea; [Lee, Jae Yong; Choi, Ji Ho] Soonchunhyang Univ, Bucheon Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Bucheon, South Korea	Konkuk University; Konkuk University Medical Center; Soongsil University; Soonchunhyang University	Choi, JH (corresponding author), Soonchunhyang Univ, Bucheon Hosp, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Bucheon, South Korea.	handsomemd@hanmail.net		Choi, Ji Ho/0000-0002-5194-930X	National Research Foundation of Korea - Korean Government [NRF-2016R1C1B2015652]; Soonchunhyang University Research Fund	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government); Soonchunhyang University Research Fund	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2016R1C1B2015652). The study was supported by the Soonchunhyang University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendros I, 2018, RESP PHYSIOL NEUROBI, V256, P79, DOI 10.1016/j.resp.2017.08.008; [Anonymous], 2014, INT CLASSIFICATION S; Brenner R, 2019, RESPIRATION, V97, P15, DOI 10.1159/000486577; Buerki RA, 2018, FUTURE ONCOL, V14, P2161, DOI 10.2217/fon-2018-0006; Campos-Rodriguez F, 2013, AM J RESP CRIT CARE, V187, P99, DOI 10.1164/rccm.201209-1671OC; Chen JC, 2014, SLEEP MED, V15, P749, DOI 10.1016/j.sleep.2013.11.782; Choi JH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55551-7; Eckert DJ, 2018, SLEEP MED REV, V37, P45, DOI 10.1016/j.smrv.2016.12.003; Fang HF, 2015, J CANCER, V6, P1140, DOI 10.7150/jca.12490; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gaines J, 2018, SLEEP MED REV, V42, P211, DOI 10.1016/j.smrv.2018.08.009; Gaoatswe G, 2015, SLEEP, V38, P1629, DOI 10.5665/sleep.5062; Gildeh N, 2016, J THORAC DIS, V8, pE901, DOI 10.21037/jtd.2016.09.23; Gozal D, 2016, SLEEP, V39, P1493, DOI 10.5665/sleep.6004; Hunyor I, 2018, AM J PHYSIOL-REG I, V315, pR669, DOI 10.1152/ajpregu.00036.2018; Jung KW, 2017, CANCER RES TREAT, V49, P292, DOI 10.4143/crt.2017.118; Kendzerska T, 2014, CAN MED ASSOC J, V186, P985, DOI 10.1503/cmaj.140238; Marshall NS, 2014, J CLIN SLEEP MED, V10, P355, DOI 10.5664/jcsm.3600; Martinez-Garcia MA, 2014, SLEEP MED, V15, P742, DOI 10.1016/j.sleep.2014.01.020; McNeill KA, 2016, NEUROL CLIN, V34, P981, DOI 10.1016/j.ncl.2016.06.014; Nanduri J, 2008, RESP PHYSIOL NEUROBI, V164, P277, DOI 10.1016/j.resp.2008.07.006; Nieto FJ, 2012, AM J RESP CRIT CARE, V186, P190, DOI 10.1164/rccm.201201-0130OC; Ostrom QT, 2019, NEURO-ONCOLOGY, V21, pV1, DOI 10.1093/neuonc/noz150; Ralls FM, 2012, CURR OPIN PULM MED, V18, P568, DOI 10.1097/MCP.0b013e328358be05; Rivas M, 2015, ANATOL J CARDIOL, V15, P944, DOI 10.5152/AnatolJCardiol.2015.6607; Sillah A, 2018, CANCER CAUSE CONTROL, V29, P987, DOI 10.1007/s10552-018-1073-5; Song SJ, 2018, J DIABETES INVEST, V9, P173, DOI 10.1111/jdi.12655; Sun T, 2015, CELL MOL LIFE SCI, V72, P3323, DOI 10.1007/s00018-015-1930-2; Vakil M, 2018, MED HYPOTHESES, V110, P138, DOI 10.1016/j.mehy.2017.12.004; Wang X, 2013, INT J CARDIOL, V169, P207, DOI 10.1016/j.ijcard.2013.08.088; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zinchuk AV, 2017, SLEEP MED REV, V35, P113, DOI 10.1016/j.smrv.2016.10.002	32	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241598	10.1371/journal.pone.0241598	http://dx.doi.org/10.1371/journal.pone.0241598			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180841	gold, Green Published			2022-12-26	WOS:000593948000047
J	Fernandez-Fernandez, J; Martinez-Martin, I; Garcia-Tormo, V; Garcia-Lopez, J; Centeno-Esteban, M; Pereira, LA; Loturco, I				Fernandez-Fernandez, Jaime; Martinez-Martin, Isidoro; Garcia-Tormo, Vicente; Garcia-Lopez, Juan; Centeno-Esteban, Mario; Pereira, Lucas A.; Loturco, Irineu			Age differences in selected measures of physical fitness in young handball players	PLOS ONE			English	Article							BIOLOGICAL MATURATION; HEIGHT VELOCITY; SOCCER PLAYERS; PERFORMANCE; EXERCISE; MATURITY; U-20	Objective The aims of the present study were: 1) to calculate the change of direction (COD) deficit (using a modified version of the 505 test and 10 m sprint time), and (2) to examine the differences in linear sprint, jump and COD performances, as well as COD deficit, between under-13 (U13) and under-15 (U15) male handball players. Methods One hundred and nineteen young male handball players (under-13 [U13; n = 82] and under-15 [U15; n = 37]). Tests included anthropometric measurements, countermovement jump (CMJ), triple leg-hop for distance, linear sprint test (5, 10 and 20 m), and a modified version of the 505 COD test. Results Results showed moderate to very large differences (P < 0.05) in age, predicted age at peak height velocity (APHV), distance from PHV (DPHV), height, and body mass between the age categories. Moreover, U15 players demonstrated higher performances in all jump tests and lower sprint times in 10- (ES = 0.84) and 20-m (ES = 0.51) and a higher 505 deficit (ES = 0.38) than the U13 players (P < 0.05). However, no significant differences were observed for the 505 COD test between groups (ES = 0.12; P > 0.05). Conclusions Our results suggest that during the transition from pre- to post-puberty, young handball players should focus on transferring their progressive improvements in strength, speed, and power capacities to COD performance.	[Fernandez-Fernandez, Jaime; Martinez-Martin, Isidoro; Garcia-Tormo, Vicente; Garcia-Lopez, Juan; Centeno-Esteban, Mario] Univ Leon, Fac Phys Act & Sports Sci, Leon, Spain; [Fernandez-Fernandez, Jaime; Martinez-Martin, Isidoro; Garcia-Tormo, Vicente; Garcia-Lopez, Juan; Centeno-Esteban, Mario] Univ Leon, Movement & Sports Performance Anal, AMRED, Leon, Spain; [Pereira, Lucas A.; Loturco, Irineu] NAR Nucl High Performance Sport, Sao Paulo, Brazil; [Pereira, Lucas A.; Loturco, Irineu] Univ Fed Sao Paulo, Dept Human Movement Sci, Sao Paulo, Brazil; [Loturco, Irineu] Univ South Wales, Pontypridd, M Glam, Wales	Universidad de Leon; Universidad de Leon; Universidade Federal de Sao Paulo (UNIFESP); University of South Wales	Fernandez-Fernandez, J (corresponding author), Univ Leon, Fac Phys Act & Sports Sci, Leon, Spain.; Fernandez-Fernandez, J (corresponding author), Univ Leon, Movement & Sports Performance Anal, AMRED, Leon, Spain.	jaime.fernandez@unileon.es	Garcia-Tormo, Jose Vicente JVG/P-5773-2017; Fernandez, Jaime/AAE-1568-2022; Garcia-Lopez, Juan/A-1191-2009; PEREIRA, LUCAS/HHZ-5877-2022	Garcia-Tormo, Jose Vicente JVG/0000-0002-8127-5393; Fernandez, Jaime/0000-0002-5284-303X; Garcia-Lopez, Juan/0000-0003-2834-3366; Centeno-Esteban, Mario/0000-0002-9740-3927; LOTURCO, IRINEU/0000-0003-1309-2568; Pereira, Lucas Adriano/0000-0003-1079-2446				Beunen G., 2008, YOUNG ATHL, P3, DOI DOI 10.1002/9780470696255.CH1; Chtara M, 2017, BIOL SPORT, V34, P137, DOI 10.5114/biolsport.2017.64587; Condello G, 2013, INT J SPORT PHYSIOL, V8, P52, DOI 10.1123/ijspp.8.1.52; Dos'Santos T, 2019, SPORTS, V7, DOI 10.3390/sports7090205; Dos'Santos T, 2019, SPORTS MED, V49, P1837, DOI 10.1007/s40279-019-01171-0; Faude O, 2012, J SPORT SCI, V30, P625, DOI 10.1080/02640414.2012.665940; Fernandez-Fernandez J, 2022, J STRENGTH COND RES, V36, P1426, DOI 10.1519/JSC.0000000000003484; Fernandez-Fernandez J, 2018, J STRENGTH COND RES, V32, P849, DOI 10.1519/JSC.0000000000002319; Ford P, 2011, J SPORT SCI, V29, P389, DOI 10.1080/02640414.2010.536849; Freitas TT, 2019, SPORTS, V7, DOI 10.3390/sports7010002; Gallo-Salazar C, 2017, APPL PHYSIOL NUTR ME, V42, P750, DOI 10.1139/apnm-2016-0540; Hermassi S, 2018, J SPORT MED PHYS FIT, V58, P1625, DOI 10.23736/S0022-4707.17.07551-X; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Lloyd RS, 2014, J STRENGTH COND RES, V28, P1454, DOI 10.1519/JSC.0000000000000391; Loturco I, 2018, J HUM KINET, V64, P205, DOI 10.1515/hukin-2017-0195; Loturco I, 2018, GER J EXERC SPORT RE, V48, P228, DOI 10.1007/s12662-018-0502-7; Loturco I, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01034; Loturco I, 2015, J SPORT SCI, V33, P1283, DOI 10.1080/02640414.2015.1022574; Madruga-Parera M, 2021, J STRENGTH COND RES, V35, P3482, DOI 10.1519/JSC.0000000000003328; Malina RM, 2015, BRIT J SPORT MED, V49, P852, DOI 10.1136/bjsports-2015-094623; McBride JM, 2010, INT J SPORT PHYSIOL, V5, P484, DOI 10.1123/ijspp.5.4.484; Michalsik LB, 2013, INT J SPORTS MED, V34, P590, DOI 10.1055/s-0032-1329989; Mirwald RL, 2002, MED SCI SPORT EXER, V34, P689, DOI 10.1097/00005768-200204000-00020; Myburgh GK, 2016, PEDIATR EXERC SCI, V28, P542, DOI 10.1123/pes.2016-0035; Nakamuraura FY, 2016, J SPORT MED PHYS FIT, V56, P1289; Nimphius S, 2018, STRENGTH COND J, V40, P26, DOI 10.1519/SSC.0000000000000309; Nimphius S, 2016, J STRENGTH COND RES, V30, P3024, DOI 10.1519/JSC.0000000000001421; Pereira LA, 2018, J STRENGTH COND RES, V32, P2987, DOI 10.1519/JSC.0000000000002494; Philippaerts RM, 2006, J SPORT SCI, V24, P221, DOI 10.1080/02640410500189371; Povoas SCA, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6204603; Requena B, 2011, J STRENGTH COND RES, V25, P2193, DOI 10.1519/JSC.0b013e3181e86132; Sherar LB, 2005, J PEDIATR-US, V147, P508, DOI 10.1016/j.jpeds.2005.04.041; Stewart A., 2006, KINANTHROPOMETRY; Wagner H, 2019, J STRENGTH COND RES, V33, P1056, DOI 10.1519/JSC.0000000000003026; Williams M, 2017, STRENGTH COND J, V39, P94, DOI 10.1519/SSC.0000000000000304; 2019, CAN J KIDNEY HLTH DI, V6, P1	36	3	3	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242385	10.1371/journal.pone.0242385	http://dx.doi.org/10.1371/journal.pone.0242385			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180872	gold, Green Published			2022-12-26	WOS:000593948000069
J	Suarez, M; Canclini, L; Esteves, A				Suarez, Mariana; Canclini, Lucia; Esteves, Adriana			Identification of a non-classical three-dimensional nuclear localization signal in the intestinal fatty acid binding protein	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; SURFACE LYSINE RESIDUES; COLLISIONAL TRANSFER; CELLULAR UPTAKE; L-FABP; LIGAND; TRANSPORT; LIVER; LIPIDS; ABSORPTION	The intestinal fatty acid binding protein (FABP) is a small protein expressed along the small intestine that bind long-chain fatty acids and other hydrophobic ligands. Several lines of evidence suggest that, once in the nucleus, it interacts with nuclear receptors, activating them and thus transferring the bound ligand into the nucleus. Previous work by our group suggests that FABP2 would participate in the cytoplasm-nucleus translocation of fatty acids. Because the consensus NLS is absent in the sequence of FABP2, we propose that a 3D signal could be responsible for its nuclear translocation. The results obtained by transfection assays of recombinant wild type and mutated forms of Danio rerio Fabp2 in Caco-2 cell cultures, showed that lysine 17, arginine 29 and lysine 30 residues, which are located in the helix-turn-helix region, would constitute a functional non-classical three-dimensional NLS.	[Suarez, Mariana; Esteves, Adriana] Univ Republica, Secc Bioquim, Fac Ciencias, Montevideo, Uruguay; [Canclini, Lucia] Inst Invest Biol Clemente Estable, Dept Genet, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay	Esteves, A (corresponding author), Univ Republica, Secc Bioquim, Fac Ciencias, Montevideo, Uruguay.	aesteves@fcien.edu.uy	Canclini, Lucía/AAH-4792-2021	Canclini, Lucía/0000-0001-7421-611X	PEDECIBA	PEDECIBA	We did not received funds for this work, except our salaries. MS received a scholarship from PEDECIBA.	Agulleiro MJ, 2007, BIOL REPROD, V77, P504, DOI 10.1095/biolreprod.107.061598; Alpers DH, 2000, BBA-MOL CELL BIOL L, V1483, P352, DOI 10.1016/S1388-1981(99)00200-0; Amber-Vitos O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132138; Andre M, 2000, INT J DEV BIOL, V44, P249; [Anonymous], 2014, J CLIN GASTROENTE S1, V48, pS96; Armstrong EH, 2014, J BIOL CHEM, V289, P14941, DOI 10.1074/jbc.M113.514646; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Babin PJ, 2009, PROG LIPID RES, V48, P73, DOI 10.1016/j.plipres.2008.11.002; Cifarelli V, 2018, COMPR PHYSIOL, V8, P493, DOI 10.1002/cphy.c170026; Clerico EM, 2000, BBA-PROTEIN STRUCT M, V1476, P203, DOI 10.1016/S0167-4838(99)00247-2; Clerico EM, 2001, ARCH BIOCHEM BIOPHYS, V395, P215, DOI 10.1006/abbi.2001.2554; Corsico B, 2005, J LIPID RES, V46, P1765, DOI 10.1194/jlr.M500140-JLR200; Corsico B, 1998, P NATL ACAD SCI USA, V95, P12174, DOI 10.1073/pnas.95.21.12174; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Eskandari E, 2018, GENE, V679, P150, DOI 10.1016/j.gene.2018.09.003; Esteves A, 2016, J LIPID RES, V57, P219, DOI 10.1194/jlr.M062232; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Glatz JFC, 2018, J LIPID RES, V59, P1084, DOI 10.1194/jlr.R082933; Glatz JFC, 2015, PROSTAG LEUKOTR ESS, V93, P45, DOI 10.1016/j.plefa.2014.07.011; Glatz JFC, 1997, PROSTAG LEUKOTR ESS, V57, P3, DOI 10.1016/S0952-3278(97)90485-3; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hamilton JA, 2007, PROSTAG LEUKOTR ESS, V77, P355, DOI 10.1016/j.plefa.2007.10.020; Han TK, 2019, CENT EUR J PUBL HEAL, V27, P37, DOI 10.21101/cejph.a5077; Haunerland NH, 2004, ADV MOL CEL, V33, P99; Herr FM, 1996, BIOCHEMISTRY-US, V35, P1296, DOI 10.1021/bi952204b; HERR FM, 1995, BIOCHEMISTRY-US, V34, P11840, DOI 10.1021/bi00037a023; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hofer P, 2015, J BIOL CHEM, V290, P18438, DOI 10.1074/jbc.M114.628958; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Huang H, 2004, BIOCHEMISTRY-US, V43, P2484, DOI 10.1021/bi0352318; Hughes MLR, 2015, J BIOL CHEM, V290, P13895, DOI 10.1074/jbc.M114.605998; Josephrajan A, 2019, DIABETES, V68, P1767, DOI 10.2337/db18-1367; Kaczocha M, 2012, J BIOL CHEM, V287, P3415, DOI 10.1074/jbc.M111.304907; Kagawa Yoshiteru, 2019, Advances in Biological Regulation, V71, P206, DOI 10.1016/j.jbior.2018.09.006; KIM HK, 1992, J BIOL CHEM, V267, P20051; KIM HK, 1992, J BIOL CHEM, V267, P77; Lagrutta LC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170608; Lawrence JW, 2000, J LIPID RES, V41, P1390; Levy E, 2009, HISTOCHEM CELL BIOL, V132, P351, DOI 10.1007/s00418-009-0608-y; Liou HL, 2001, BIOCHEMISTRY-US, V40, P6475, DOI 10.1021/bi0101042; Luiken JJFP, 2002, PROSTAG LEUKOTR ESS, V67, P73, DOI 10.1054/plef.2002.0401; Mate SM, 2007, LIPIDS, V42, P589, DOI 10.1007/s11745-007-3063-3; McArthur MJ, 1999, J LIPID RES, V40, P1371; OCKNER RK, 1972, SCIENCE, V177, P56, DOI 10.1126/science.177.4043.56; Patil R, 2014, ACS CHEM BIOL, V9, P2526, DOI 10.1021/cb5005178; Prentice KJ, 2019, J LIPID RES, V60, P734, DOI [10.1194/jlr.S091793, 10.1194/jlr.s091793]; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schroeder F, 2008, LIPIDS, V43, P1, DOI 10.1007/s11745-007-3111-z; Schwenk RW, 2010, PROSTAG LEUKOTR ESS, V82, P149, DOI 10.1016/j.plefa.2010.02.029; Senga S, 2018, BBA-MOL CELL BIOL L, V1863, P1057, DOI 10.1016/j.bbalip.2018.06.010; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; SMITH AE, 1985, PROC R SOC SER B-BIO, V226, P43, DOI 10.1098/rspb.1985.0078; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; STREMMEL W, 1988, J CLIN INVEST, V82, P2001, DOI 10.1172/JCI113820; Trotter PJ, 1996, J LIPID RES, V37, P336; Velkov T, 2013, PPAR RES, V2013, DOI 10.1155/2013/938401; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Weisiger RA, 2007, J MOL NEUROSCI, V33, P42, DOI 10.1007/s12031-007-0047-y; Wolfrum C, 2001, FATTY ACIDS HYPOLIPI; Xu HL, 2019, CURR OPIN CLIN NUTR, V22, P407, DOI 10.1097/MCO.0000000000000600	63	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242312	10.1371/journal.pone.0242312	http://dx.doi.org/10.1371/journal.pone.0242312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180886	Green Published, gold			2022-12-26	WOS:000593948000030
J	Zhou, L; Lapping, S; Liao, XD; Lu, Y; Zhou, GJ; Matoba, K; Vasudevan, N; Wang, LM; Nayak, L				Zhou, Lin; Lapping, Stephanie; Liao, Xudong; Lu, Yuan; Zhou, Guangjin; Matoba, Keiichiro; Vasudevan, Neelakantan; Wang, Lemin; Nayak, Lalitha			The thromboprotective effect of traditional Chinese medicine Tongji 2 granules is dependent on anti-inflammatory activity by suppression of NF-kappa B pathways	PLOS ONE			English	Article							INFLAMMATION; INHIBITION; TISSUE	Inflammation is a vital physiological response of the immune system meant to protect against the invasion of pathogens. However, accumulating evidence describes an intimate link between inflammation and thrombosis and cellular elements of the immune system of the immune system such as neutrophils and monocytes/macrophages are emerging as key players in the generation of a prothrombotic milieu suggesting that anti-inflammatory therapy may have a role in the management of thrombosis that is driven by inflammation. Tongji 2 (TJ2) is a traditional Chinese medication manufactured as granules by Tongji hospital of Tongji University (Shanghai, China) with known anti-inflammatory properties. In this study, we examine the effects of TJ2 on inflammation and thrombosis. Our study shows that TJ2 modulates NF-kappa B activation and thus generates a prominent anti-inflammatory effect. Further, we use mouse models of thrombosis to demonstrate that TJ2 has a beneficial effect in both arterial and venous thrombosis that occurs in the absence of alterations in platelet activation or coagulation.	[Zhou, Lin; Wang, Lemin] Tongji Univ, Tongji Hosp, Dept Cardiol, Shanghai, Peoples R China; [Lapping, Stephanie; Liao, Xudong; Lu, Yuan; Zhou, Guangjin; Vasudevan, Neelakantan] Case Western Reserve Univ, Sch Med, Univ Hosp Cleveland Med Ctr, Case Cardiovasc Res Inst, Cleveland, OH 44106 USA; [Matoba, Keiichiro] Jikei Univ, Sch Med, Dept Internal Med, Div Diabet Endocrinol & Metab, Tokyo, Japan; [Nayak, Lalitha] Case Western Reserve Univ, Sch Med, Div Hematol & Oncol, Univ Hosp Cleveland Med Ctr, Cleveland, OH 44106 USA	Tongji University; Case Western Reserve University; University Hospitals of Cleveland; Jikei University; Case Western Reserve University; University Hospitals of Cleveland	Nayak, L (corresponding author), Case Western Reserve Univ, Sch Med, Div Hematol & Oncol, Univ Hosp Cleveland Med Ctr, Cleveland, OH 44106 USA.	lxn64@case.edu			NIH/NHLBI [HL142647, HL143402]	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	LN is supported by the NIH/NHLBI: HL142647 and HL143402 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyut BR, 2016, ONCOTARGETS THER, V9, P1047, DOI 10.2147/OTT.S102907; [Anonymous], 1997, REVIJA SOCIJALNU POL, V4, P41; [Anonymous], 2015, DIABETES CARE, V38, P394; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Chao LK, 2010, J AGR FOOD CHEM, V58, P3472, DOI 10.1021/jf904207m; Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x; Holmqvist ME, 2012, JAMA-J AM MED ASSOC, V308, P1350, DOI 10.1001/2012.jama.11741; Jou IM, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/316482; Khan S, 2013, J ETHNOPHARMACOL, V145, P626, DOI 10.1016/j.jep.2012.12.001; Khan S, 2011, J CELL BIOCHEM, V112, P2179, DOI 10.1002/jcb.23137; Makarov SS, 2000, MOL MED TODAY, V6, P441, DOI 10.1016/S1357-4310(00)01814-1; Nagareddy P, 2013, CURR OPIN HEMATOL, V20, P457, DOI 10.1097/MOH.0b013e328364219d; Nayak L, 2014, BLOOD, V123, P3828, DOI 10.1182/blood-2014-01-547448; Nikzad-Langerodi R, 2017, TALANTA, V175, P264, DOI 10.1016/j.talanta.2017.07.045; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; Qiu LH, 2017, EXP THER MED, V14, P2401, DOI 10.3892/etm.2017.4739; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wadleigh DJ, 2000, J BIOL CHEM, V275, P6259, DOI 10.1074/jbc.275.9.6259; WROBLESKI SK, 2011, JOVE J VIS EXP JUN, DOI DOI 10.3791/2738; YANG X, 2014, EVID-BASED COMPL ALT, V2014, DOI DOI 10.1155/2014/204840; Yau JW, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0124-z	22	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241607	10.1371/journal.pone.0241607	http://dx.doi.org/10.1371/journal.pone.0241607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180821	Green Published, gold			2022-12-26	WOS:000593948000080
J	Carannante, A; Fazio, C; Neri, A; Lista, F; Fillo, S; Ciammaruconi, A; Vacca, P; Stefanelli, P				Carannante, Anna; Fazio, Cecilia; Neri, Arianna; Lista, Florigio; Fillo, Silvia; Ciammaruconi, Andrea; Vacca, Paola; Stefanelli, Paola			Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014-2017	PLOS ONE			English	Article							SEROGROUP-B; MENB-FHBP; BINDING; PREVALENCE; CANDIDATE	Background Typing of Neisseria meningitidis isolates is crucial for the surveillance of invasive meningococcal disease (IMD). We performed a molecular epidemiology study of N. meningitidis serogroup B (MenB) causing IMD in Italy between 2014 and 2017 to describe circulating strains belonging to this serogroup, with particular regards to the two factor H-binding protein (FHbp) subfamilies present in the bivalent MenB vaccine. Materials and methods A total of 109 culture positive and 46 culture negative MenB samples were collected within the National Surveillance System (NSS) of IMD in Italy and molecularly analyzed by conventional methods. Results Overall, 71 MenB samples showed the FHbp subfamily A and 83 the subfamily B. The subfamily variants were differently distributed by age. The most frequent variants, A05 and B231, were associated with cc213 and cc162, respectively. All MenB with the FHbp A05 variant displayed the PorA P1.22,14 and 85.7% of them the FetA F5-5. The majority of MenB with the FHbp B231 variant showed the PorA P1.22,14 (65.4%) and 84.6%, the FetA F3-6. Conclusion MenB circulating in Italy were characterized by a remarkable association between clonal complex and FHbp variants, although a high degree of genetic diversity observed over time. A dynamic trend in clonal complexes distribution within MenB was detected. Our results stress the importance of continued meningococcal molecular surveillance to evaluate the potential vaccine coverage of the available MenB vaccines.	[Carannante, Anna; Fazio, Cecilia; Neri, Arianna; Vacca, Paola; Stefanelli, Paola] Ist Super Sanita, Dept Infect Dis, Rome, Italy; [Lista, Florigio; Fillo, Silvia; Ciammaruconi, Andrea] Army Med Ctr, Sci Dept, Rome, Italy	Istituto Superiore di Sanita (ISS)	Stefanelli, P (corresponding author), Ist Super Sanita, Dept Infect Dis, Rome, Italy.	paola.stefanelli@iss.it	FAZIO, CECILIA/ABA-8534-2021; Carannante, Anna/B-8720-2016; NERI, ARIANNA/B-8726-2016; STEFANELLI, PAOLA/B-8729-2016; Vacca, Paola/I-4796-2018; Fillo, silvia/K-5190-2018	Carannante, Anna/0000-0002-2073-1869; STEFANELLI, PAOLA/0000-0003-1620-4385; Vacca, Paola/0000-0003-3076-1604; Fillo, silvia/0000-0001-5100-2573; lista, florigio/0000-0001-5700-4772; Neri, Arianna/0000-0001-5748-880X	Pfizer Italia srl [W78]	Pfizer Italia srl	Funded study Initials of the authors who received each award= PS Grant number awarded to each author= W78 The full name of each funder= Pfizer Italia srl The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderfer J, 2019, HUM VACC IMMUNOTHER, V15, P2205, DOI 10.1080/21645515.2019.1581542; Andrews S., 2010, FAST QC QUALITY CONT; [Anonymous], 2018, 18SC0055 REC; [Anonymous], 2019, ANN EP REP 2017; [Anonymous], AD CAL VACC REG PIAN; Bambini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065043; Beernink PT, 2007, J INFECT DIS, V195, P1472, DOI 10.1086/514821; Bettinger JA, 2020, VACCINE, V38, P2026, DOI 10.1016/j.vaccine.2019.12.051; Borrow R, 2017, EXPERT REV VACCINES, V16, P313, DOI 10.1080/14760584.2017.1258308; Clark SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089921; Fazio C, 2019, EUROSURVEILLANCE, V24, P33, DOI 10.2807/1560-7917.ES.2019.24.4.1800183; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; Gandhi A, 2016, POSTGRAD MED, V128, P548, DOI 10.1080/00325481.2016.1203238; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Jacobsson S, 2006, VACCINE, V24, P2161, DOI 10.1016/j.vaccine.2005.11.006; Jolley KA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-595; Joshi N. A., 2011, SICKLE SLIDING WINDO; Krizova P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219477; Marshall HS, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027233; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; McNeil LK, 2018, MBIO, V9, DOI 10.1128/mBio.00036-18; Ministero della Salute, 2017, PIAN NAZ PREV VACC P; Murphy E, 2009, J INFECT DIS, V200, P379, DOI 10.1086/600141; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; Rappuoli R, 2001, VACCINE, V19, P2688, DOI 10.1016/S0264-410X(00)00554-5; Regione Campania, 2017, COMM AD ACT ATT PIAN; Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033; Shi FL, 2017, VACCINE, V35, P2343, DOI 10.1016/j.vaccine.2017.03.057; Shirley M, 2018, DRUGS, V78, P257, DOI 10.1007/s40265-018-0869-7; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stefanelli P, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2018.07.014; Zhu HF, 2012, J CLIN MICROBIOL, V50, P46, DOI 10.1128/JCM.00918-11	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241793	10.1371/journal.pone.0241793	http://dx.doi.org/10.1371/journal.pone.0241793			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33176334	gold, Green Published			2022-12-26	WOS:000593946900067
J	Schmidt, AK; Pudelko, K; Boekenkamp, JE; Berger, K; Kschischo, M; Bastians, H				Schmidt, Ann-Kathrin; Pudelko, Karoline; Boekenkamp, Jan-Eric; Berger, Katharina; Kschischo, Maik; Bastians, Holger			The p53/p73-p21(CIP1) tumor suppressor axis guards against chromosomal instability by restraining CDK1 in human cancer cells	ONCOGENE			English	Article							DNA-REPLICATION; CYCLE; P53; P21; ARREST; KINASE; PROLIFERATION; INACTIVATION; EXPRESSION; P21(WAF1)	Whole chromosome instability (W-CIN) is a hallmark of human cancer and contributes to the evolvement of aneuploidy. W-CIN can be induced by abnormally increased microtubule plus end assembly rates during mitosis leading to the generation of lagging chromosomes during anaphase as a major form of mitotic errors in human cancer cells. Here, we show that loss of the tumor suppressor genes TP53 and TP73 can trigger increased mitotic microtubule assembly rates, lagging chromosomes, and W-CIN. CDKN1A, encoding for the CDK inhibitor p21(CIP1), represents a critical target gene of p53/p73. Loss of p21(CIP1) unleashes CDK1 activity which causes W-CIN in otherwise chromosomally stable cancer cells. Consequently, induction of CDK1 is sufficient to induce abnormal microtubule assembly rates and W-CIN. Vice versa, partial inhibition of CDK1 activity in chromosomally unstable cancer cells corrects abnormal microtubule behavior and suppresses W-CIN. Thus, our study shows that the p53/p73 - p21(CIP1) tumor suppressor axis, whose loss is associated with W-CIN in human cancer, safeguards against chromosome missegregation and aneuploidy by preventing abnormally increased CDK1 activity.	[Schmidt, Ann-Kathrin; Pudelko, Karoline; Berger, Katharina; Bastians, Holger] Georg August Univ Gottingen, Gottingen Ctr Mol Biosci GZMB, D-37077 Gottingen, Germany; [Schmidt, Ann-Kathrin; Pudelko, Karoline; Berger, Katharina; Bastians, Holger] Univ Med Ctr Gottingen UMG, Inst Mol Oncol, Sect Cellular Oncol, D-37077 Gottingen, Germany; [Boekenkamp, Jan-Eric; Kschischo, Maik] Univ Appl Sci Koblenz, Dept Math & Technol, D-53424 Remagen, Germany	University of Gottingen	Bastians, H (corresponding author), Georg August Univ Gottingen, Gottingen Ctr Mol Biosci GZMB, D-37077 Gottingen, Germany.; Bastians, H (corresponding author), Univ Med Ctr Gottingen UMG, Inst Mol Oncol, Sect Cellular Oncol, D-37077 Gottingen, Germany.	holger.bastians@uni-goettingen.de		Boekenkamp, Jan-Eric/0000-0002-1662-0349; Bastians, Holger/0000-0001-7915-3648; Schmidt, Ann-Kathrin/0000-0001-8100-5177	Wilhelm Sander-Stiftung; Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft [FOR2800]; Projekt DEAL	Wilhelm Sander-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Projekt DEAL	We thank Magdalena Hennecke for technical assistance. We are grateful to Thorsten Stiewe, Linda Wordeman, Matthias Schmidt, Makato Iimori, and Lienhard Schmitz for providing plasmids and cell lines. This work was supported by grants from the Wilhelm Sander-Stiftung, from the Deutsche Krebshilfe, and from the Deutsche Forschungsgemeinschaft to HB and by the FOR2800 funded by the Deutsche Forschungsgemeinschaft (MK and HB). Open Access funding enabled and organized by Projekt DEAL.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Bakhoum SF, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a029611; Bakhoum SF, 2009, CURR BIOL, V19, P1937, DOI 10.1016/j.cub.2009.09.055; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Bates S, 1998, ONCOGENE, V17, P1691, DOI 10.1038/sj.onc.1202104; Bohly N, 2019, CELL CYCLE, V18, P2770, DOI 10.1080/15384101.2019.1658477; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Bunz F, 2002, CANCER RES, V62, P1129; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Crncec A, 2019, FEBS LETT, V593, P2868, DOI 10.1002/1873-3468.13635; Di CX, 2013, CELL CYCLE, V12, P1861, DOI 10.4161/cc.24967; Dong SM, 2002, INT J CANCER, V98, P370, DOI 10.1002/ijc.10204; Engelmann D, 2015, ONCOGENE, V34, P4287, DOI 10.1038/onc.2014.365; Ertych N, 2016, P NATL ACAD SCI USA, V113, P1817, DOI 10.1073/pnas.1525129113; Ertych N, 2014, NAT CELL BIOL, V16, P779, DOI 10.1038/ncb2994; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Garcia-Gutierrez L, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030244; Gregan J, 2011, TRENDS CELL BIOL, V21, P374, DOI 10.1016/j.tcb.2011.01.003; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hirai H, 2009, MOL CANCER THER, V8, P2992, DOI 10.1158/1535-7163.MCT-09-0463; Kreis NN, 2014, ONCOGENE, V33, P5716, DOI 10.1038/onc.2013.518; Kreis NN, 2019, CANCERS, V11, DOI 10.3390/cancers11091220; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Li JX, 2020, WORLD J SURG ONCOL, V18, DOI 10.1186/s12957-020-01817-8; Luddecke S, 2016, ONCOGENE, V35, P2398, DOI 10.1038/onc.2015.290; Maas AM, 2013, CANCER LETT, V332, P229, DOI 10.1016/j.canlet.2011.07.030; Maia ARR, 2012, J CELL BIOL, V199, P285, DOI 10.1083/jcb.201203091; Medema RH, 1998, ONCOGENE, V16, P431, DOI 10.1038/sj.onc.1201558; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nam HJ, 2014, NAT CELL BIOL, V16, P535, DOI 10.1038/ncb2952; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Ogino S, 2006, J PATHOL, V210, P147, DOI 10.1002/path.2030; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sansregret L, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a028373; Santaguida S, 2017, DEV CELL, V41, P638, DOI 10.1016/j.devcel.2017.05.022; Schmidt M, 2000, ONCOGENE, V19, P2423, DOI 10.1038/sj.onc.1203546; Schmidt M, 2017, MOLECULES, V22, DOI 10.3390/molecules22122045; Sheltzer JM, 2011, TRENDS GENET, V27, P446, DOI 10.1016/j.tig.2011.07.003; Silkworth WT, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-19; Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564; Stepanova T, 2003, J NEUROSCI, V23, P2655; Stolz A, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723548.2014.960768; Stolz A, 2015, EMBO REP, V16, P490, DOI 10.15252/embr.201439410; Stolz A, 2010, BIOCHEM SOC T, V38, P1704, DOI 10.1042/BST0381704; Stolz A, 2010, NAT CELL BIOL, V12, P492, DOI 10.1038/ncb2051; Sur S, 2016, MOL CELL BIOCHEM, V416, P33, DOI 10.1007/s11010-016-2693-2; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Turajlic S, 2019, NAT REV GENET, V20, P404, DOI 10.1038/s41576-019-0114-6; Umbreit NT, 2020, SCIENCE, V368, P282, DOI 10.1126/science.aba0712; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; WALDMAN T, 1995, CANCER RES, V55, P5187; Warfel NA, 2013, CURR OPIN ONCOL, V25, P52, DOI 10.1097/CCO.0b013e32835b639e; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Zhang CZ, 2015, NATURE, V522, P179, DOI 10.1038/nature14493	60	9	9	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 14	2021	40	2					436	451		10.1038/s41388-020-01524-4	http://dx.doi.org/10.1038/s41388-020-01524-4		NOV 2020	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	PS4WP	33168930	Green Published, hybrid			2022-12-26	WOS:000587997700001
J	Sun, WK; Li, H; Zhao, YH; Bai, LW; Qin, YK; Wang, Q; Li, WW				Sun, Weikang; Li, Hao; Zhao, Yuehong; Bai, Longwei; Qin, Yukai; Wang, Qun; Li, Weiwei			Distinct vitellogenin domains differentially regulate immunological outcomes in invertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERIC IMMUNOGLOBULIN RECEPTOR; IG RECEPTOR; RESPONSES; PROTEIN; INNATE	The classical role of Vitellogenin (Vg) is providing energy reserves for developing embryos, but its roles appear to extend beyond this nutritional function, and its importance in host immune defense is garnering increasing research attention. However, Vg-regulated immunological functions are dependent on three different domains within different species and remain poorly understood. In the present study, we confirmed three conserved VG domains-LPD_N, DUF1943, and VWD-in the Chinese mitten crab (Eriocheir sinensis), highlighting functional similarities of Vg in vertebrates and invertebrates. Of these three domains, DUF1943 and VWD showed definitive bacterial binding activity via interaction with the signature components on microbial surfaces, but this activity was not exhibited by the LPD_N domain. Antibacterial assays indicated that only the VWD domain inhibits bacterial proliferation, and this function may be conserved between different species due to the conserved amino acid residues. To further explore the relationship between Vg and polymeric immunoglobulin receptor (pIgR), we expressed EspIgR and the three E. sinensis Vg (EsVg) domains in HEK293T cells, and coimmunoprecipitation assay demonstrated that only the DUF1943 domain interacts with EspIgR. Subsequent experiments demonstrated that EsVg regulates hemocyte phagocytosis by binding with EspIgR through the DUF1943 domain, thus promoting bacterial clearance and protecting the host from bacterial infection. To the best of our knowledge, our work is the first to report distinct domains in Vg inducing different immunological outcomes in invertebrates, providing new evidence that pIgR acts as a phagocytic receptor for Vg.	[Sun, Weikang; Li, Hao; Zhao, Yuehong; Bai, Longwei; Qin, Yukai; Wang, Qun; Li, Weiwei] East China Normal Univ, Sch Life Sci, Lab Invertebrate Immunol Def & Reprod Biol, Shanghai, Peoples R China	East China Normal University	Li, WW (corresponding author), East China Normal Univ, Sch Life Sci, Lab Invertebrate Immunol Def & Reprod Biol, Shanghai, Peoples R China.	wwli@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013	Wang, Qun/0000-0001-7929-7692	National Natural Science Foundation of China [31672639, 31970490, 31972820]; Shanghai Rising-Star Program [20QA1403000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported by National Natural Science Foundation of China (31672639 and 31970490 to Q. W., 31972820 to W. L.) and Shanghai Rising-Star Program (20QA1403000 to W. L.).	Arukwe Augustine, 2003, Comp Hepatol, V2, P4; Avarre JC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-3; Babin PJ, 2009, PROG LIPID RES, V48, P73, DOI 10.1016/j.plipres.2008.11.002; Du XY, 2017, DEV COMP IMMUNOL, V67, P485, DOI 10.1016/j.dci.2016.10.006; Garcia J, 2010, FISH SHELLFISH IMMUN, V29, P293, DOI 10.1016/j.fsi.2010.04.010; Hamuro K, 2007, J IMMUNOL, V178, P5682, DOI 10.4049/jimmunol.178.9.5682; Huo Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006909; Hystad EM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184108; Ibanez F, 2018, INSECT MOL BIOL, V27, P166, DOI 10.1111/imb.12361; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; Kaetzel CS, 2001, CURR BIOL, V11, pR35, DOI 10.1016/S0960-9822(00)00041-5; Li D, 2019, J BIOL CHEM, V294, P16440, DOI 10.1074/jbc.RA119.010247; Li HY, 2017, RESULTS PROBL CELL D, V63, P389, DOI 10.1007/978-3-319-60855-6_17; Li L, 2017, FISH SHELLFISH IMMUN, V69, P6, DOI 10.1016/j.fsi.2017.08.002; Li ZJ, 2009, MOL IMMUNOL, V46, P3232, DOI 10.1016/j.molimm.2009.08.006; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Liu M, 2011, MOL IMMUNOL, V49, P211, DOI 10.1016/j.molimm.2011.08.011; MOSTOV KE, 1994, ANNU REV IMMUNOL, V12, P63, DOI 10.1146/annurev.immunol.12.1.63; Niu GJ, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007558; PAN ML, 1969, SCIENCE, V165, P393, DOI 10.1126/science.165.3891.393; Park HG, 2018, DEV COMP IMMUNOL, V85, P51, DOI 10.1016/j.dci.2018.04.001; Phalipon A, 2002, IMMUNITY, V17, P107, DOI 10.1016/S1074-7613(02)00341-2; Piulachs MD, 2003, INSECT BIOCHEM MOLEC, V33, P459, DOI 10.1016/S0965-1748(03)00021-3; Robinson JK, 2001, J IMMUNOL, V166, P3688, DOI 10.4049/jimmunol.166.6.3688; Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434; Salmela H, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005015; Singh J, 2017, MBIO, V8, DOI [10.1128/mBio.00778-17, 10.1128/mbio.00778-17]; Sun C, 2013, DEV COMP IMMUNOL, V41, P469, DOI 10.1016/j.dci.2013.07.005; Tong Z, 2010, IMMUNOBIOLOGY, V215, P898, DOI 10.1016/j.imbio.2009.10.001; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Turula H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050237; Yang L, 2019, J BIOL CHEM, V294, P14704, DOI 10.1074/jbc.RA119.009559; Yang SS, 2017, FISH SHELLFISH IMMUN, V63, P394, DOI 10.1016/j.fsi.2016.12.001; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003	35	1	1	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100060	10.1074/jbc.RA120.015686	http://dx.doi.org/10.1074/jbc.RA120.015686			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33177064	gold, Green Published			2022-12-26	WOS:000672866400042
J	Mukherjee, G; Bag, S; Chakraborty, P; Dey, D; Roy, S; Jain, P; Roy, P; Soong, R; Majumder, PP; Dutt, S				Mukherjee, Geetashree; Bag, Swarnendu; Chakraborty, Prasenjit; Dey, Debdeep; Roy, Samrat; Jain, Prateek; Roy, Paromita; Soong, Richie; Majumder, Partha Pratim; Dutt, Suparna			Density of CD3(+) and CD8(+) cells in gingivobuccal oral squamous cell carcinoma is associated with lymph node metastases and survival	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; STANDARDIZED METHOD; PROGNOSTIC VALUE; SOLID TUMORS; IMMUNE CELLS; T-CELLS; CANCER; HEAD; NECK; MICROENVIRONMENT	The tumor immune microenvironment is emerging as a critical player in predicting cancer prognosis and response to therapies. However, the prognostic value of tumor-infiltrating immune cells in Gingivo-Buccal Oral Squamous Cell Carcinoma (GBOSCC) and their association with tumor size or lymph node metastases status require further elucidation. To study the relationship of tumor-infiltrating immune cells with tumor size (T stage) and lymph node metastases (N stages), we analyzed the density of tumor-infiltrating immune cells in archived, whole tumor resections from 94 patients. We characterized these sections by immune-histochemistry using 12 markers and enumerated tumor-infiltrating immune cells at the invasive margins (IM) and centers of tumors (CT). We observed that a higher density of CD3(+) cells in the IM and CT was associated with smaller tumor size (T1-T2 stage). Fewer CD3(+) cells was associated with larger tumor size (T3-T4 stage). High infiltration of CD3(+) and CD8(+) cells in IM and CT as well as high CD4(+) cell infiltrates in the IM was significantly associated with the absence of lymph node metastases. High infiltrates of CD3(+) and CD8(+) cells in CT was associated with significantly improved survival. Our results illustrate that the densities and spatial distribution of CD3(+) and CD8(+) cell infiltrates in primary GBOSCC tumors is predictive of disease progression and survival. Based on our findings, we recommend incorporating immune cell quantification in the TNM classification and routine histopathology reporting of GBOSCC. Immune cell quantification in CT and IM may help predict the efficacy of future therapies.	[Mukherjee, Geetashree; Bag, Swarnendu; Chakraborty, Prasenjit; Dey, Debdeep; Roy, Samrat; Jain, Prateek; Roy, Paromita] Tata Med Ctr, Kolkata, India; [Soong, Richie] Pacific Labs, Singapore, Singapore; [Majumder, Partha Pratim] Natl Inst Biomed Genom, Kalyani, W Bengal, India; [Dutt, Suparna] Stanford Univ, Dept Med, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA	Department of Biotechnology (DBT) India; National Institute of Biomedical Genomics (NIBMG); Stanford University	Mukherjee, G (corresponding author), Tata Med Ctr, Kolkata, India.; Dutt, S (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA.	mukherjeegeeta@yahoo.co.in; sdutt@stanford.edu	; /O-7828-2017	Mukherjee, Geetashree/0000-0003-4954-0035; Dutt, Suparna/0000-0002-6613-2984; /0000-0003-2811-482X	Department of Biotechnology, Government of India [BT/Med-II/NIBMG/SyMeC/2014/Vol. II]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This study was funded by Department of Biotechnology, Government of India, for funding the project under Systems Medicine Cluster (Project name: "Multi-dimensional Research to Enable Systems Medicine: Acceleration Using a Cluster Approach". Reference No: BT/Med-II/NIBMG/SyMeC/2014/Vol. II, dated 09/01/2017) to Dr. Partha Pratim Majumder. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Prasenjit Chakraborty and Dr. Swarnendu Bag received salary support from the above-mentioned funding.	Badoual C, 2006, CLIN CANCER RES, V12, P465, DOI 10.1158/1078-0432.CCR-05-1886; Barnes TA, 2017, BRIT J CANCER, V117, P451, DOI 10.1038/bjc.2017.220; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Biswas NK, 2019, INT J CANCER, V145, P2568, DOI 10.1002/ijc.32305; Blank CU, 2016, SCIENCE, V352, P658, DOI 10.1126/science.aaf2834; Boxberg M, 2019, J IMMUNOL, V202, P278, DOI 10.4049/jimmunol.1800242; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; Chatterjee D, 2019, ENT-EAR NOSE THROAT, V98, pE112, DOI 10.1177/0145561319848669; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chocolatewala NM, 2009, J CANCER RES THER, V5, P71, DOI 10.4103/0973-1482.52788; Costa NL, 2010, ORAL ONCOL, V46, P185, DOI 10.1016/j.oraloncology.2009.11.016; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Curry JM, 2014, SEMIN ONCOL, V41, P217, DOI 10.1053/j.seminoncol.2014.03.003; D'cruz A, 2013, ORAL ONCOL, V49, P872, DOI 10.1016/j.oraloncology.2013.05.010; de Abreu PM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4247-3; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fang JA, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3317-2; Gajewski TF, 2017, ADV EXP MED BIOL, V1036, P19, DOI 10.1007/978-3-319-67577-0_2; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Galon J, 2019, NAT REV DRUG DISCOV, V18, P197, DOI 10.1038/s41573-018-0007-y; Galon J, 2013, IMMUNITY, V39, P11, DOI 10.1016/j.immuni.2013.07.008; Hadler-Olsen E, 2019, BRIT J CANCER, V120, P714, DOI 10.1038/s41416-019-0409-6; Hammerman PS, 2015, CANCER DISCOV, V5, P239, DOI 10.1158/2159-8290.CD-14-1205; He KF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/838632; Hendry S, 2017, ADV ANAT PATHOL, V24, P311, DOI 10.1097/PAP.0000000000000161; Hendry S, 2017, ADV ANAT PATHOL, V24, P235, DOI 10.1097/PAP.0000000000000162; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Huang SH, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0484-y; Huang ZX, 2019, J ORAL PATHOL MED, V48, P788, DOI 10.1111/jop.12927; Jardim JF, 2015, INT J ORAL MAX SURG, V44, P23, DOI 10.1016/j.ijom.2014.10.006; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kather JN, 2018, ELIFE, V7, DOI 10.7554/eLife.36967; Konig L, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5320-2; Kolenda T, 2018, REP PRACT ONCOL RADI, V23, P143, DOI 10.1016/j.rpor.2018.01.004; Koontongkaew S, 2013, J CANCER, V4, P66, DOI 10.7150/jca.5112; Lanitis E, 2017, ANN ONCOL, V28, P18, DOI 10.1093/annonc/mdx238; Laupeze B, 1999, HUM IMMUNOL, V60, P591, DOI 10.1016/S0198-8859(99)00025-7; Leemans CR, 2018, NAT REV CANCER, V18, P269, DOI 10.1038/nrc.2018.11; Li HC, 2007, J CELL BIOCHEM, V101, P805, DOI 10.1002/jcb.21159; Machado J, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-6; Mandlik DS, 2018, J HEAD NECK PHYSICIA, V6, P18, DOI 10.4103/jhnps.jhnps_19_18; Manjula BV, 2015, INDIAN J OTOLARYNGOL, V67, pS98, DOI 10.1007/s12070-014-0787-2; Massi D, 2019, LANCET ONCOL, V20, P891, DOI 10.1016/S1470-2045(19)30391-2; Mathur P, 2018, LANCET ONCOL, V19, pE664, DOI 10.1016/S1470-2045(18)30857-X; Mlecnik B, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6352; Ohman J, 2015, ANTICANCER RES, V35, P311; Pages F, 2018, LANCET, V391, P2128, DOI 10.1016/S0140-6736(18)30789-X; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Pathak KA, 2005, HEAD NECK-J SCI SPEC, V27, P597, DOI 10.1002/hed.20195; Peltanova B, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0983-5; Pfister DG, 2015, J NATL COMPR CANC NE, V13, P847, DOI 10.6004/jnccn.2015.0102; Pinto ML, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01875; Quan HZ, 2020, CANCER IMMUNOL IMMUN, V69, P465, DOI 10.1007/s00262-020-02479-x; Sahoo A, 2020, CLIN ORAL INVEST, V24, P747, DOI 10.1007/s00784-019-02921-0; Salazar CR, 2014, HEAD NECK PATHOL, V8, P77, DOI 10.1007/s12105-013-0486-4; Saltz J, 2018, CELL REP, V23, P181, DOI 10.1016/j.celrep.2018.03.086; Schoenberger SP, 2012, P NATL ACAD SCI USA, V109, P8358, DOI 10.1073/pnas.1204616109; Shaban M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49710-z; Shimizu S, 2019, CANCER MED-US, V8, P80, DOI 10.1002/cam4.1889; Si Y, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw9159; Singel KL, 2016, IMMUNOL REV, V273, P329, DOI 10.1111/imr.12459; Singhania V, 2015, INDIAN J CANCER, V52, P605, DOI 10.4103/0019-509X.178383; Stack EC, 2014, METHODS, V70, P46, DOI 10.1016/j.ymeth.2014.08.016; Tonella L, 2017, CURR TREAT OPTION ON, V18, DOI 10.1007/s11864-017-0472-2; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Van den Eynde M, 2018, CANCER CELL, V34, P1012, DOI 10.1016/j.ccell.2018.11.003; Walvekar RR, 2009, ORAL ONCOL, V45, P135, DOI 10.1016/j.oraloncology.2008.04.007; Wirsing AM, 2018, MODERN PATHOL, V31, P910, DOI 10.1038/s41379-018-0019-5; Wolf GT, 2015, ORAL ONCOL, V51, P90, DOI 10.1016/j.oraloncology.2014.09.006; Zhang XM, 2018, HUM PATHOL, V82, P104, DOI 10.1016/j.humpath.2018.07.012; Zhou C, 2018, J ORAL PATHOL MED, V47, P359, DOI 10.1111/jop.12698	72	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0242058	10.1371/journal.pone.0242058	http://dx.doi.org/10.1371/journal.pone.0242058			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211709	gold, Green Published			2022-12-26	WOS:000603518300032
J	Sohn, A; Speier, W; Lan, E; Aoki, K; Fonarow, GC; Ong, MK; Arnold, CW				Sohn, Albert; Speier, William; Lan, Esther; Aoki, Kymberly; Fonarow, Gregg C.; Ong, Michael K.; Arnold, Corey W.			Integrating remote monitoring into heart failure patients' care regimen: A pilot study	PLOS ONE			English	Article							OLDER-ADULTS; MANAGEMENT; HOSPITALIZATIONS; INTERVENTION; READMISSION; PERFORMANCE; OUTCOMES	Background Around 50% of hospital readmissions due to heart failure are preventable, with lack of adherence to prescribed self-care as a driving factor. Remote tracking and reminders issued by mobile health devices could help to promote self-care, which could potentially reduce these readmissions. Objective We sought to investigate two factors: (1) feasibility of enrolling heart failure patients in a remote monitoring regimen that uses wireless sensors and patient-reported outcome measures; and (2) their adherence to using the study devices and completing patient-reported outcome measures. Methods Twenty heart failure patients participated in piloting a remote monitoring regimen. Data collection included: (1) physical activity using wrist-worn activity trackers; (2) body weight using bathroom scales; (3) medication adherence using smart pill bottles; and (4) patient-reported outcomes using patient-reported outcome measures. Results We evaluated 150 hospitalized heart failure patients and enrolled 20 individuals. Two factors contributed to 50% (65/130) being excluded from the study: smartphone ownership and patient discharge. Over the course of the study, 60.0% of the subjects wore the activity tracker for at least 70% of the hours, and 45.0% used the scale for more than 70% of the days. The pill bottle was used less than 10% of the days by 55.0% of the subjects. Conclusions Our method of recruiting heart failure patients prior to hospital discharge may not be feasible as the enrollment rate was low. Once enrolled, the majority of subjects maintained a high adherence to wearing the activity tracker but low adherence to using the pill bottle and completing the follow-up surveys. Scale usage was fair, but it received positive reviews from most subjects. Given the observed usage and feedback, we suggest mobile health-driven interventions consider including an activity tracker and bathroom scale. We also recommend administering a shorter survey more regularly and through an easier interface.	[Sohn, Albert; Speier, William; Arnold, Corey W.] Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90032 USA; [Lan, Esther; Aoki, Kymberly; Ong, Michael K.] Univ Calif Los Angeles, Dept Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA 90024 USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90024 USA; [Arnold, Corey W.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90032 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Arnold, CW (corresponding author), Univ Calif Los Angeles, Dept Radiol Sci, Los Angeles, CA 90032 USA.; Arnold, CW (corresponding author), Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90032 USA.	cwarnold@ucla.edu	Ong, Michael/AAR-3310-2020	Ong, Michael/0000-0001-8530-7754; Sohn, Albert/0000-0001-8825-7561	National Institutes of Health; National Heart, Lung, and Blood Institute [R56HL135425]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (https://www.nih.gov) and the National Heart, Lung, and Blood Institute (https://www.nhlbi.nih.gov) under grant R56HL135425 awarded to C.W.A., PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LA, 2007, CAN MED ASSOC J, V176, P797, DOI 10.1503/cmaj.051620; Anderson M., 2019, TECHNOLOGY USE SENIO; Arozullah AM, 2007, MED CARE, V45, P1026, DOI 10.1097/MLR.0b013e3180616c1b; Behlouli H, 2009, IEEE ENG MED BIO, P6242, DOI 10.1109/IEMBS.2009.5334659; Blecker S, 2013, J AM COLL CARDIOL, V61, P1259, DOI 10.1016/j.jacc.2012.12.038; Broderick Joan E, 2013, EGEMS (Wash DC), V1, P1015, DOI 10.13063/2327-9214.1015; Burke W J, 1991, J Geriatr Psychiatry Neurol, V4, P173, DOI 10.1177/089198879100400310; Del Gobbo LC, 2015, JACC-HEART FAIL, V3, P520, DOI 10.1016/j.jchf.2015.02.009; Desai AS, 2012, CIRCULATION, V126, P501, DOI 10.1161/CIRCULATIONAHA.112.125435; Dolgin M, 1994, NOM CRIT DIAGN DIS H; Downey RG, 1998, J GEN PSYCHOL, V125, P175, DOI 10.1080/00221309809595542; Dunlay SM, 2011, CIRC-CARDIOVASC QUAL, V4, P68, DOI 10.1161/CIRCOUTCOMES.110.957225; Dunlay SM, 2009, J AM COLL CARDIOL, V54, P1695, DOI 10.1016/j.jacc.2009.08.019; Evangelista LS, 2008, J CARDIOVASC NURS, V23, P250, DOI 10.1097/01.JCN.0000317428.98844.4d; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Fonarow GC, 2008, ARCH INTERN MED, V168, P847, DOI 10.1001/archinte.168.8.847; Fudim M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006817; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; Hays RD, 2009, QUAL LIFE RES, V18, P873, DOI 10.1007/s11136-009-9496-9; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 1997, ARCH INTERN MED, V157, P99, DOI 10.1001/archinte.157.1.99; Kumar S, 2013, AM J PREV MED, V45, P228, DOI 10.1016/j.amepre.2013.03.017; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Morcillo C, 2005, REV ESP CARDIOL, V58, P618, DOI 10.1016/S1885-5857(06)60247-8; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Riegel B, 2009, J CARDIOVASC NURS, V24, P485, DOI 10.1097/JCN.0b013e3181b4baa0; Roque NA, 2018, J APPL GERONTOL, V37, P131, DOI 10.1177/0733464816642582; Rutten LJF, 2012, J HEALTH COMMUN, V17, P979, DOI 10.1080/10810730.2012.700998; Sandhu AT, 2016, JACC-HEART FAIL, V4, P368, DOI 10.1016/j.jchf.2015.12.015; Shaw RJ, 2016, J AM MED INFORM ASSN, V23, P462, DOI 10.1093/jamia/ocv186; Speier W, 2018, J AM MED INFORM ASSN, V25, P1386, DOI 10.1093/jamia/ocy067; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; Steinhubl SR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3487; Suh MK, 2011, J MED SYST, V35, P1165, DOI 10.1007/s10916-011-9733-y; Tsuyuki RT, 2001, ARCH INTERN MED, V161, P2337, DOI 10.1001/archinte.161.19.2337; Wakefield BJ, 2009, J TELEMED TELECARE, V15, P46, DOI 10.1258/jtt.2008.080701; Ware P, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/13259; Windham BG, 2003, AM J MANAG CARE, V9, P447; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zan SY, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3789	42	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0242210	10.1371/journal.pone.0242210	http://dx.doi.org/10.1371/journal.pone.0242210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	PM0RU	33211733	Green Published, Green Submitted, gold			2022-12-26	WOS:000603518300042
J	Zhu, SD; Zhu, Y; Li, H; Wang, QW; Wang, KS; Baska, K; Zhang, DZ				Zhu, Shudong; Zhu, Yan; Li, Hao; Wang, Qiuwen; Wang, Kuansong; Baska, Katelynn; Zhang, Dianzheng			Long-term consumption of recycled cooking oil induces cell death and tissue damage	FASEB JOURNAL			English	Article						apoptosis; C57 mice; DNA damage; recycled cooking oil; toxicity	DNA-DAMAGE	Recycled cooking oil (RCO) is widely used in many small restaurants. However, the health risk posed by long-term consumption of RCO is unclear. In this study, C57 mice were treated with RCO for 34 weeks. Organ coefficients of the liver, stomach, and kidney were found to be decreased. H&E staining revealed overt lesions in the pancreas, liver, kidney, esophagus, duodenum, and ileum of RCO-treated mice. Immunohistochemistry showed significant DNA damage in the duodenum and ileum and apoptosis in the lungs of the RCO-treated mice. Immunoblotting showed elevated levels of gamma-H2AX, Bcl-2/Bax, TNF alpha, cleaved Caspase-3 and poly ADP-ribose polymerase (PARP). Increased levels of lactate dehydrogenase (LDH) and decreased levels of succinate dehydrogenase (SDH) were also detected. These findings suggest that long-term consumption of RCO produces various toxicities in mice with important implications for humans. DNA damage followed by mitochondria-associated apoptosis, and necrosis is likely to contribute to the toxicities.	[Zhu, Shudong; Zhu, Yan] Nantong Univ, Sch Med, 19 Qixiu Rd, Nantong, Jiangsu, Peoples R China; [Zhu, Shudong; Li, Hao; Wang, Qiuwen] Cent South Univ, Sch Life Sci, Dept Biochem & Mol Biol, Changsha, Peoples R China; [Zhu, Yan] Xuzhou Hlth Res Inst Co Ltd, Xuzhou, Jiangsu, Peoples R China; [Wang, Kuansong] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha, Peoples R China; [Baska, Katelynn; Zhang, Dianzheng] Philadelphia Coll Osteopath Med, Dept Biomed Sci, Philadelphia, PA USA	Nantong University; Central South University; Central South University	Zhu, SD (corresponding author), Nantong Univ, Sch Med, 19 Qixiu Rd, Nantong, Jiangsu, Peoples R China.	1125537080@qq.com		Zhu, Shudong/0000-0001-8605-3354	HNBRJH program; NTU startup grant	HNBRJH program; NTU startup grant(Nanyang Technological University)	This study was funded by HNBRJH program and NTU startup grant (to SZ).	[Anonymous], 2014, NY TIMES; Bassil K L, 2007, Can Fam Physician, V53, P1704; Bhardwaj S, 2016, FOOD CHEM, V212, P663, DOI 10.1016/j.foodchem.2016.06.021; CAO WM, 2011, GRAIN SCI TECHNOLOGY, V36, P41; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Dsouza Herman S, 2002, Indian J Clin Biochem, V17, P9, DOI 10.1007/BF02867934; Guchi E., 2015, J APPL ENV MICROBIOL, V3, P11, DOI DOI 10.12691/JAEM-3-1-3; Jurewicz J, 2008, INT J OCCUP MED ENV, V21, P121, DOI 10.2478/v10001-008-0014-z; Kucukcakan Basak, 2015, Open Access Maced J Med Sci, V3, P363, DOI 10.3889/oamjms.2015.032; Li J, 2017, GLOB HEALTH PROMOT, V24, P75, DOI 10.1177/1757975915623733; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Point Carbon, 2012, CDM JI MONITOR, V9, P1, DOI DOI 10.1186/1742-9994-9-34; Port CM, 2011, ESSENTIALS PATHOPHYS; Rothkamm K, 2015, ENVIRON MOL MUTAGEN, V56, P491, DOI 10.1002/em.21944	14	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202000825R	http://dx.doi.org/10.1096/fj.202000825R		NOV 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33210326				2022-12-26	WOS:000592746200001
J	Pakwan, C; Chitov, T; Chantawannakul, P; Manasam, M; Bovonsombut, S; Disayathanoowat, T				Pakwan, Chonthicha; Chitov, Thararat; Chantawannakul, Panuwan; Manasam, Manop; Bovonsombut, Sakunnee; Disayathanoowat, Terd			Bacterial compositions of indigenous Lanna (Northern Thai) fermented foods and their potential functional properties	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; MIANG; DIVERSITY; IDENTIFICATION; LACTOBACILLI; PROBIOTICS; DATABASE; FLORA	Many indigenous fermented foods of Northern Thailand and neighbouring regions have traditionally been known for their health benefits. In this study, we explored the communities of bacteria in selected fermented foods which are commonly consumed among ethnic groups around Northern Thailand, for which information on their microbial compositions or their functional properties is still limited. The selected food groups included Thua Nao (alkaline fermented soybean product), Nham (fermented pork sausage/loaf), Nam phak (fermented Chinese cabbage) and Miang (fermented leaves from Miang Tea trees). Bacteria in these fermented foods were isolated and enumerated. Bacterial communities were determined using a culture-independent (pyrosequencing) approach. Lactic acid bacteria were recovered from all of these fermented food samples, with levels ranging from 3.1 to 7.5 log CFU/g throughout the fermentation processes. Analysis of the 16S rRNA gene from the fermented food samples using 454-pyrosequencing resulted in 113,844 sequences after quality evaluation. Lactic acid bacteria were found in high proportions in Nham, Nam phak and Miang. Bacillus was predominant in Thua nao, in which significant proportions of Lactic acid bacteria of the family Leuconostocaceae were also found. Groups of lactic acid bacteria found varied among different food samples, but three genera were predominant: Lactococcus, Lactobacillus and Leuconostoc, of which many members are recognised as probiotics. The results showed that these traditional Thai fermented food products are rich sources of beneficial bacteria and can potentially be functional/probiotic foods.	[Pakwan, Chonthicha; Chitov, Thararat; Chantawannakul, Panuwan; Bovonsombut, Sakunnee; Disayathanoowat, Terd] Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand; [Chitov, Thararat; Chantawannakul, Panuwan; Bovonsombut, Sakunnee] Chiang Mai Univ, Environm Sci Res Ctr ESRC, Chiang Mai, Thailand; [Manasam, Manop] Chiang Mai Univ, Fac Fine Art, Dept Thai Art, Chiang Mai, Thailand; [Disayathanoowat, Terd] Chiang Mai Univ, Res Ctr Bioresources Agr Ind & Med, Chiang Mai, Thailand; [Disayathanoowat, Terd] Chiang Mai Univ, Res Ctr Microbial Divers & Sustainable Utilizat, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University; Chiang Mai University	Bovonsombut, S; Disayathanoowat, T (corresponding author), Chiang Mai Univ, Dept Biol, Fac Sci, Chiang Mai, Thailand.; Bovonsombut, S (corresponding author), Chiang Mai Univ, Environm Sci Res Ctr ESRC, Chiang Mai, Thailand.; Disayathanoowat, T (corresponding author), Chiang Mai Univ, Res Ctr Bioresources Agr Ind & Med, Chiang Mai, Thailand.; Disayathanoowat, T (corresponding author), Chiang Mai Univ, Res Ctr Microbial Divers & Sustainable Utilizat, Chiang Mai, Thailand.	sakunnee.b@cmu.ac.th; terd.dis@gmail.com		Disayathanoowat, Terd/0000-0002-6416-2266	Center of Excellence on Biodiversity (BDC), Office of Higher Education Commission [BDC-PG3-163006]; Chiang Mai University	Center of Excellence on Biodiversity (BDC), Office of Higher Education Commission; Chiang Mai University	This research was funded by the Center of Excellence on Biodiversity (BDC), Office of Higher Education Commission (BDC-PG3-163006) and partially supported by Chiang Mai University and the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara AA, 2015, SAUDI PHARM J, V23, P107, DOI 10.1016/j.jsps.2013.07.001; Bhithakpol B, 1995, TRADITIONAL FERMENTE; Burintramart U, 2014, ASIA PAC J SCI TECHN, V19, P19; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaikaew S, 2017, J MICROBIOL, V55, P720, DOI 10.1007/s12275-017-7195-8; Chakravarty K, 2019, CURR PHARM BIOTECHNO, V20, P137, DOI 10.2174/1389201020666190227203107; Chang TS, 2007, BIOSCI BIOTECH BIOCH, V71, P1330, DOI 10.1271/bbb.60573; Chantawannakul P., 2002, SCI ASIA, V28, P241, DOI [10.2306/scienceasia1513-1874.2002.28.241, DOI 10.2306/SCIENCEASIA1513-1874.2002.28.241]; Chao SH, 2008, INT J FOOD MICROBIOL, V123, P134, DOI 10.1016/j.ijfoodmicro.2007.12.010; Chettri R., 2014, INT J FERMENT FOODS, V3, P87, DOI [10.5958/2321-712X.2014.01311.8, DOI 10.5958/2321-712X.2014.01311.8]; Chukeatirote E., 2010, Research Journal of Microbiology, V5, P309; Chukeatirote Ekachai, 2015, Journal of Ethnic Foods, V2, P115; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cui SM, 2019, FOOD SCI NUTR, V7, P2214, DOI 10.1002/fsn3.1010; de Vrese M, 2008, ADV BIOCHEM ENG BIOT, V111, P1, DOI 10.1007/10_2008_097; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ercolini D, 2013, APPL ENVIRON MICROB, V79, P3148, DOI 10.1128/AEM.00256-13; Garcia MC, 1997, CRIT REV FOOD SCI, V37, P361, DOI 10.1080/10408399709527779; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Inatsu Y, 2006, LETT APPL MICROBIOL, V43, P237, DOI 10.1111/j.1472-765X.2006.01966.x; Jung JY, 2011, APPL ENVIRON MICROB, V77, P2264, DOI 10.1128/AEM.02157-10; Khanongnuch Chartchai, 2017, Journal of Ethnic Foods, V4, P135; Khare A, 2020, CURR MICROBIOL, V77, P638, DOI 10.1007/s00284-020-01903-w; Klayraung S., 2008, Research Journal of Biological Sciences, V3, P1119; Klayraung S., 2008, Scientia Pharmaceutica, V76, P485, DOI 10.3797/scipharm.0806-11; Leejeerajumnean A., 2003, SILPAKORN U INT J, V3, P277, DOI DOI 10.1016/j.jef.2015.08.004; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu ML, 2019, FOOD FUNCT, V10, P1132, DOI 10.1039/c8fo02301h; Lopez HW, 2002, INT J FOOD SCI TECH, V37, P727, DOI 10.1046/j.1365-2621.2002.00618.x; Makhloufi KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070484; Miyashita M, 2012, MICROBIOL CULT COLL, V28, P1; Noonpakdee W, 2003, INT J FOOD MICROBIOL, V81, P137, DOI 10.1016/S0168-1605(02)00219-2; Nyanga-Koumou AP, 2012, CRIT REV MICROBIOL, V38, P185, DOI 10.3109/1040841X.2011.640978; OKADA S, 1986, J GEN APPL MICROBIOL, V32, P57, DOI 10.2323/jgam.32.57; Ouoba LII, 2010, J APPL MICROBIOL, V108, P2019, DOI 10.1111/j.1365-2672.2009.04603.x; Paludan-Muller C, 1999, INT J FOOD MICROBIOL, V46, P219, DOI 10.1016/S0168-1605(98)00204-9; Patel A, 2014, J MICROBIOL IMMUNOL, V47, P429, DOI 10.1016/j.jmii.2013.03.010; Rhee SJ, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S5; Rungrassamee W, 2012, J MICROBIOL METH, V91, P341, DOI 10.1016/j.mimet.2012.09.016; Shao ZX, 2020, NUCL INSTRUM METH A, V953, DOI 10.1016/j.nima.2019.163083; Smit G, 2005, FEMS MICROBIOL REV, V29, P591, DOI 10.1016/j.femsre.2005.04.002; Steele J, 2013, CURR OPIN BIOTECH, V24, P135, DOI 10.1016/j.copbio.2012.12.001; Suzuki T, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030763; Tamang Jyoti Prakash, 2015, Journal of Ethnic Foods, V2, P8; Tanasupawat S, 2007, J GEN APPL MICROBIOL, V53, P7, DOI 10.2323/jgam.53.7; Thiravattanamontri P, 1998, FOOD BIOTECHNOL, V12, P221, DOI 10.1080/08905439809549954; Unban K, 2019, J FOOD SCI TECH MYS, V56, P2687, DOI 10.1007/s13197-019-03758-x; Vandenplas Y, 2015, J PEDIAT-BRAZIL, V91, P6, DOI 10.1016/j.jped.2014.08.005; Viesser JA, 2020, FOOD RES INT, V136, DOI 10.1016/j.foodres.2020.109478; Wang YP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02987; Xiong T, 2012, FOOD CONTROL, V26, P178, DOI 10.1016/j.foodcont.2012.01.027	52	6	6	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242560	10.1371/journal.pone.0242560	http://dx.doi.org/10.1371/journal.pone.0242560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206720	gold, Green Published			2022-12-26	WOS:000595265900059
J	Uebbing, S; Kreiss, M; Scholl, F; Hafner, AK; Surun, D; Garscha, U; Werz, O; Basavarajappa, D; Samuelsson, B; Radmark, O; Suess, B; Steinhilber, D				Uebbing, Stella; Kreiss, Marius; Scholl, Friederike; Haefner, Ann-Kathrin; Sueruen, Duran; Garscha, Ulrike; Werz, Oliver; Basavarajappa, Devaraj; Samuelsson, Bengt; Radmark, Olof; Suess, Beatrix; Steinhilber, Dieter			Modulation of microRNA processing by 5-lipoxygenase	FASEB JOURNAL			English	Article						cancer; Dicer; inflammation; leukotriene; miRNA; 5&#8208; lipoxygenase	HUMAN DICER; RNA-BINDING; CELLS; EXPRESSION; TARGET; GENE; IDENTIFICATION; BIOGENESIS; PROTEINS; MIRNAS	The miRNA biogenesis is tightly regulated to avoid dysfunction and consequent disease development. Here, we describe modulation of miRNA processing as a novel noncanonical function of the 5-lipoxygenase (5-LO) enzyme in monocytic cells. In differentiated Mono Mac 6 (MM6) cells, we found an in situ interaction of 5-LO with Dicer, a key enzyme in miRNA biogenesis. RNA sequencing of small noncoding RNAs revealed a functional impact, knockout of 5-LO altered the expression profile of several miRNAs. Effects of 5-LO could be observed at two levels. qPCR analyses thus indicated that (a) 5-LO promotes the transcription of the evolutionarily conserved miR-99b/let-7e/miR-125a cluster and (b) the 5-LO-Dicer interaction downregulates the processing of pre-let-7e, resulting in an increase in miR-125a and miR-99b levels by 5-LO without concomitant changes in let-7e levels in differentiated MM6 cells. Our observations suggest that 5-LO regulates the miRNA profile by modulating the Dicer-mediated processing of distinct pre-miRNAs. 5-LO inhibits the formation of let-7e which is a well-known inducer of cell differentiation, but promotes the generation of miR-99b and miR-125a known to induce cell proliferation and the maintenance of leukemic stem cell functions.	[Uebbing, Stella; Scholl, Friederike; Suess, Beatrix] Tech Univ, Dept Biol, Darmstadt, Germany; [Uebbing, Stella; Kreiss, Marius; Scholl, Friederike; Haefner, Ann-Kathrin; Steinhilber, Dieter] Goethe Univ, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany; [Uebbing, Stella; Scholl, Friederike; Basavarajappa, Devaraj; Samuelsson, Bengt; Radmark, Olof] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden; [Sueruen, Duran] Tech Univ Dresden, UCC, Med Fac Carl Gustav Carus, Med Syst Biol, Dresden, Germany; [Garscha, Ulrike; Werz, Oliver] Friedrich Schiller Univ, Inst Pharm, Dept Pharmaceut Med Chem, Jena, Germany	Technical University of Darmstadt; Goethe University Frankfurt; Karolinska Institutet; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Schiller University of Jena	Steinhilber, D (corresponding author), Goethe Univ, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany.	steinhilber@em.uni-frankfurt.de	Garscha, Ulrike/G-3559-2018	Garscha, Ulrike/0000-0002-3645-7833	Else Kroner-Fresenius Stiftung (Else Kroner-Fresenius-Graduiertenkolleg) [A187]; Deutsche Forschungsgemeinschaft [SFB 1039, TP A02]; Fraunhofer ITMP; Karolinska Institute	Else Kroner-Fresenius Stiftung (Else Kroner-Fresenius-Graduiertenkolleg); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Fraunhofer ITMP; Karolinska Institute(Karolinska Institutet)	Work of the authors was supported by the Else Kroner-Fresenius Stiftung (Else Kroner-Fresenius-Graduiertenkolleg, A187), the Deutsche Forschungsgemeinschaft (SFB 1039, TP A02) and Fraunhofer ITMP, and by the Karolinska Institute. The authors thank Sven George for technical assistance and purification of recombinant wild-type 5-LO.	Basavarajappa D, 2020, P NATL ACAD SCI USA, V117, P8573, DOI 10.1073/pnas.1916249117; Basavarajappa D, 2014, P NATL ACAD SCI USA, V111, P11371, DOI 10.1073/pnas.1410983111; Brand S, 2018, CELL CHEM BIOL, V25, P1095, DOI 10.1016/j.chembiol.2018.05.016; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; Busch S, 2015, J IMMUNOL, V194, P1646, DOI 10.4049/jimmunol.1402163; Catalano A, 2004, FASEB J, V18, P1740, DOI 10.1096/fj.04-2258fje; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Chen ZH, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113223; Curtale G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02037; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; DeKelver RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003765; Dincbas-Renqvist V, 2009, BBA-GENE REGUL MECH, V1789, P99, DOI 10.1016/j.bbagrm.2008.10.002; Fontemaggi G, 2015, RNA BIOL, V12, P690, DOI 10.1080/15476286.2015.1044194; Gerrits A, 2012, BLOOD, V119, P377, DOI 10.1182/blood-2011-01-331686; Gerstmeier J, 2016, FASEB J, V30, P276, DOI 10.1096/fj.15-278010; Gilbert B, 2015, BBA-GENE REGUL MECH, V1849, P1003, DOI 10.1016/j.bbagrm.2015.06.004; Gonsalves CS, 2010, J IMMUNOL, V184, P3878, DOI 10.4049/jimmunol.0902594; Guo SQ, 2010, P NATL ACAD SCI USA, V107, P14229, DOI 10.1073/pnas.0913574107; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hafner AK, 2019, PROSTAG OTH LIPID M, V142, P24, DOI 10.1016/j.prostaglandins.2019.03.003; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Hildebrand D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01224; Khalaj M, 2017, J EXP MED, V214, P2453, DOI 10.1084/jem.20161595; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kretschmer SBM, 2016, FUTURE MED CHEM, V8, P149, DOI 10.4155/fmc.15.174; Lau PW, 2012, NAT STRUCT MOL BIOL, V19, P436, DOI 10.1038/nsmb.2268; Lee H, 2016, PROTEIN CELL, V7, P100, DOI 10.1007/s13238-015-0212-y; Liu ZM, 2018, CELL, V173, P1191, DOI 10.1016/j.cell.2018.03.080; Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005; Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009; Michlewski G, 2019, RNA, V25, P1, DOI 10.1261/rna.068692.118; Mueller S, 2013, BIOINFORMATICS, V29, P2651, DOI 10.1093/bioinformatics/btt457; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Provost P, 1999, P NATL ACAD SCI USA, V96, P1881, DOI 10.1073/pnas.96.5.1881; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Roos J, 2014, CANCER RES, V74, P5244, DOI 10.1158/0008-5472.CAN-13-3012; Saul MJ, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00824; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Steinhilber D, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00143; Surun D, 2018, MOL THER-NUCL ACIDS, V10, P1, DOI 10.1016/j.omtn.2017.11.001; Takeshita D, 2007, J MOL BIOL, V374, P106, DOI 10.1016/j.jmb.2007.08.069; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Treiber T, 2019, NAT REV MOL CELL BIO, V20, P5, DOI 10.1038/s41580-018-0059-1; Witwer KW, 2016, RNA BIOL, V13, P1103, DOI 10.1080/15476286.2016.1236172; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	50	6	6	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202002108R	http://dx.doi.org/10.1096/fj.202002108R		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33205517	Green Published, hybrid			2022-12-26	WOS:000592661600001
J	Wommack, EA; Marrack, LC; Mambelli, S; Hull, JM; Dawson, TE				Wommack, Elizabeth A.; Marrack, Lisa C.; Mambelli, Stefania; Hull, Joshua M.; Dawson, Todd E.			Using oxygen and hydrogen stable isotopes to track the migratory movement of Sharp-shinned Hawks (Accipiter striatus) along Western Flyways of North America	PLOS ONE			English	Article							DELTA-D; DRINKING-WATER; NEOTROPICAL MIGRANT; POPULATION TRENDS; AUTUMN MIGRATION; CLIMATE-CHANGE; FEATHERS; ORIGINS; RAPTORS; BIRDS	The large-scale patterns of movement for the Sharp-shinned Hawk (Accipiter striatus), a small forest hawk found throughout western North America, are largely unknown. However, based on field observations we set out to test the hypothesis that juvenile migratory A. striatus caught along two distinct migration routes on opposite sides of the Sierra Nevada Mountains of North America (Pacific Coast and Intermountain Migratory Flyways) come from geographically different natal populations. We applied stable isotope analysis of hydrogen (H) and oxygen (O) of feathers, and large scale models of spatial isotopic variation (isoscapes) to formulate spatially explicit predictions of the origin of the migrant birds. Novel relationships were assessed between the measured hydrogen and oxygen isotope values of feathers from A. striatus museum specimens of known origin and the isoscape modeled hydrogen and oxygen isotope values of precipitation at those known locations. We used these relationships to predict the origin regions for birds migrating along the two flyways from the measured isotope values of migrant's feathers and the associated hydrogen and oxygen isotopic composition of precipitation where these feathers were formed. The birds from the two migration routes had overlap in their natal/breeding origins and did not differentiate into fully separate migratory populations, with birds from the Pacific Coast Migratory Flyway showing broader natal geographic origins than those from the Intermountain Flyway. The methodology based on oxygen isotopes had, in general, less predictive power than the one based on hydrogen. There was broad agreement between the two isotope approaches in the geographic assignment of the origins of birds migrating along the Pacific Coast Flyway, but not for those migrating along the Intermountain Migratory Flyway. These results are discussed in terms of their implications for conservation efforts of A. striatus in western North America, and the use of combined hydrogen and oxygen stable isotope analysis to track the movement of birds of prey on continental scales.	[Wommack, Elizabeth A.] Univ Wyoming, Dept Zool & Physiol, Museum Vertebrates, Laramie, WY 82071 USA; [Wommack, Elizabeth A.; Hull, Joshua M.] Golden Gate Raptor Observ, Sausalito, CA 94123 USA; [Wommack, Elizabeth A.; Mambelli, Stefania; Dawson, Todd E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Marrack, Lisa C.; Dawson, Todd E.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA USA; [Mambelli, Stefania; Dawson, Todd E.] Univ Calif Berkeley, Ctr Stable Isotope Biogeochem, Berkeley, CA USA; [Hull, Joshua M.] Univ Calif Davis, Dept Anim Sci, Davis, CA USA; [Marrack, Lisa C.] Univ Hawaii, Trop Conservat Biol & Environm Sci TCBES Grad Pro, Hilo, HI 96720 USA	University of Wyoming; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Davis; University of Hawaii System; University Hawaii Hilo	Wommack, EA (corresponding author), Univ Wyoming, Dept Zool & Physiol, Museum Vertebrates, Laramie, WY 82071 USA.; Wommack, EA (corresponding author), Golden Gate Raptor Observ, Sausalito, CA 94123 USA.; Wommack, EA (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	ewommack@uwyo.edu			Center for Stable Isotope Biogeochemistry	Center for Stable Isotope Biogeochemistry	This research received partial funding from the Center for Stable Isotope Biogeochemistry, (website: https://nature.berkeley.edu/stableisotopelab/).There was no additional external funding received for this study. There was no additional internal funding received for this study. Funding was acquired and administered by SM and TED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, IAEA WMO GLOBAL NETW; Bairlein F, 2015, J ORNITHOL, V156, pS3, DOI 10.1007/s10336-015-1224-3; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; Bent AC, 1937, US NATL MUS B, V167, P95, DOI [10.5479/si.03629236.167.i, DOI 10.5479/SI.03629236.167.I]; Berthold P, 1999, OSTRICH, V70, P1, DOI 10.1080/00306525.1999.9639744; BERTHOLD P, 1992, IBIS, V134, P35, DOI 10.1111/j.1474-919X.1992.tb04731.x; Bildstein Keith L., 2008, P5; Bildstein Keith L., 2007, P101; Bildstein KL, 2000, BIRDS N AM; Birchall J, 2005, J ANIM ECOL, V74, P877, DOI 10.1111/j.1365-2656.2005.00979.x; BirdLife International & NatureServe, 2015, BIRD SPEC DISTR MAPS; Bontempo L, 2014, METHODS ECOL EVOL, V5, P363, DOI 10.1111/2041-210X.12165; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Boulet Marylene, 2006, P1; Bowen GJ, 2014, METHODS ECOL EVOL, V5, P201, DOI 10.1111/2041-210X.12147; Bowen GJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P425, DOI 10.1007/978-90-481-3354-3_20; Bowen GJ, 2008, TERR ECOL SER, V2, P79, DOI 10.1016/S1936-7961(07)00004-8; Bowen GJ, 2010, ANNU REV EARTH PL SC, V38, P161, DOI 10.1146/annurev-earth-040809-152429; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2019, GRIDDED MAPS ISOTOPI; Briggs CW, 2017, J RAPTOR RES, V51, P107, DOI 10.3356/JRR-15-00002.1; Brown DE, 2007, CANOTIA, V3, P1; Campbell Caitlin J., 2020, Animal Migration, V7, P27, DOI 10.1515/ami-2020-0004; Carlson JE, 2015, J RAPTOR RES, V49, P450, DOI 10.3356/rapt-49-04-450-457.1; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Clegg SM, 2003, MOL ECOL, V12, P819, DOI 10.1046/j.1365-294X.2003.01757.x; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; Crowley BE, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00127; DANSGAARD W, 1964, TELLUS, V16, P436; De Ruyck C, 2013, CONDOR, V115, P366, DOI 10.1525/cond.2013.120019; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; EPSTEIN S, 1953, GEOCHIM COSMOCHIM AC, V4, P213, DOI 10.1016/0016-7037(53)90051-9; Faaborg J, 2010, ECOL APPL, V20, P398, DOI 10.1890/09-0397.1; FARMER C.J., 2008, SERIES ORNITHOLOGY, V3, P303; Farmer CJ, 2010, AUK, V127, P863, DOI 10.1525/auk.2010.09152; FRIEDMAN I, 1953, GEOCHIM COSMOCHIM AC, V4, P89, DOI 10.1016/0016-7037(53)90066-0; Goodrich Laurie J., 2008, P37; Gow EA, 2012, CAN J ZOOL, V90, P585, DOI 10.1139/Z2012-024; Greenwood JL, 2011, CONDOR, V113, P555, DOI 10.1525/cond.2011.100213; Harn L, 2009, PACIFIC RAPTOR REPOR, V31, P14; Hedenstrom A, 2008, PHILOS T R SOC B, V363, P287, DOI 10.1098/rstb.2007.2140; HELBIG AJ, 1991, BEHAV ECOL SOCIOBIOL, V28, P9; Hobson KA, 2005, DIVERS DISTRIB, V11, P157, DOI 10.1111/j.1366-9516.2005.00149.x; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; Hobson KA, 2003, OECOLOGIA, V136, P302, DOI 10.1007/s00442-003-1271-y; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2015, ECOL EVOL, V5, P799, DOI 10.1002/ece3.1383; Hobson KA, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P273, DOI 10.1007/978-90-481-3354-3_13; Hobson KA, 2009, J RAPTOR RES, V43, P325, DOI 10.3356/JRR-08-74.1; Hoffman SW, 2002, J RAPTOR RES, V36, P97; Hull AC., 2008, PACIFIC RAPTOR REPOR, P29; Hull JM, 2005, MOL ECOL, V14, P159, DOI 10.1111/j.1365-294X.2004.02366.x; Hull JM, 2008, MOL ECOL, V17, P810, DOI 10.1111/j.1365-294X.2007.03632.x; Hull JM, 2009, AUK, V126, P389, DOI 10.1525/auk.2009.08120; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Kjellen N, 2000, BIRD STUDY, V47, P195, DOI 10.1080/00063650009461175; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; Lott CA, 2006, AUK, V123, P822, DOI 10.1642/0004-8038(2006)123[822:AGATET]2.0.CO;2; Marrack LC, 2017, ISOMAP JOB KEY 63026; Marrack LC, 2015, ISOMAP JOB KEY 50333; Meier-Augenstein W, 2013, BIOANALYSIS, V5, P751, DOI [10.4155/BIO.13.36, 10.4155/bio.13.36]; Morganti Michelangelo, 2016, AVOCETTA, V40, P23; Nagy AC, 1977, WORLD C BIRDS PREY, P243; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P19; Nielson KE, 2010, GEOCHIM COSMOCHIM AC, V74, P1812, DOI 10.1016/j.gca.2009.12.025; Oppel S, 2015, IBIS, V157, P545, DOI 10.1111/ibi.12258; Palmer RS, 1988, HDB N AM BIRDS, V4, P304; Panuccio M, 2017, IBIS, V159, P55, DOI 10.1111/ibi.12420; Paritte JM, 2009, AUK, V126, P165, DOI 10.1525/auk.2009.07187; Pekarsky S, 2015, DIVERS DISTRIB, V21, P416, DOI 10.1111/ddi.12306; Pietsch SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024601; Pulido F, 2001, P ROY SOC B-BIOL SCI, V268, P953, DOI 10.1098/rspb.2001.1602; Pyle P, 2008, IDENTIFICATION GUIDE, P415; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rappole J., 2013, AVIAN MIGRANT BIOL B; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; Rubenstein DR, 2004, TRENDS ECOL EVOL, V19, P256, DOI 10.1016/j.tree.2004.03.017; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Rushing CS, 2014, ECOL APPL, V24, P445, DOI 10.1890/13-1091.1; Seifert N, 2016, J AVIAN BIOL, V47, P275, DOI 10.1111/jav.00751; Sergio F, 2014, NATURE, V515, P410, DOI 10.1038/nature13696; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Smith AD, 2005, CONDOR, V107, P547, DOI 10.1650/0010-5422(2005)107[0547:VITSIC]2.0.CO;2; Smith AD, 2008, CONDOR, V110, P500, DOI 10.1525/cond.2008.8515; Smith RB, 2003, J AVIAN BIOL, V34, P387, DOI 10.1111/j.0908-8857.2003.03107.x; Soto DX, 2017, RAPID COMMUN MASS SP, V31, P1193, DOI 10.1002/rcm.7893; Soto DX, 2013, FUNCT ECOL, V27, P535, DOI 10.1111/1365-2435.12054; Storm-Suke A, 2012, FUNCT ECOL, V26, P1111, DOI 10.1111/j.1365-2435.2012.02014.x; Studds CE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14895; van Dijk JGB, 2014, J AVIAN BIOL, V45, P103, DOI 10.1111/j.1600-048X.2013.00232.x; Vander Zanden HB, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00020; Viverette CB, 1996, AUK, V113, P32; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wassenaar LI, 2010, 7 INT C APPL STABL I; Wolf N, 2013, AUK, V130, P323, DOI 10.1525/auk.2013.12075; Wolf N, 2011, J EXP BIOL, V214, P98, DOI 10.1242/jeb.050211; Wunder MB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P251, DOI 10.1007/978-90-481-3354-3_12	97	3	3	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0226318	10.1371/journal.pone.0226318	http://dx.doi.org/10.1371/journal.pone.0226318			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201878	Green Published, gold			2022-12-26	WOS:000595003900018
J	Oliveira, CM; Almeida, NO; da Rocha, MR; Rezende, MH; Carneiro, RGD; Ulhoa, CJ				Oliveira, Camilla Martins; Almeida, Nayane Oliveira; da Rocha, Mara Rubia; Rezende, Maria Helena; Carneiro, Rene Goncalves da Silva; Ulhoa, Cirano Jose			Anatomical changes induced by isolates of Trichoderma spp. in soybean plants	PLOS ONE			English	Article							FUNGI	In the current work we evaluated the anatomical changes induced by T. harzianum and T. asperellum in two soybean cultivars, BRSGO Caiaponia and NA 5909 RG. Soybean production represents a growing market worldwide, and new methods aimed at increasing its productivity and yield are constantly being sought. Fungi of the genus Trichoderma have been widely used in agriculture as a promising alternative for the promotion of plant growth and for biological control of various pathogens. It is known that Trichoderma spp. colonize plant roots, but the anatomical changes that this fungus can cause are still less studied. Experiment was conducted in a greenhouse to collect leaves and soybean roots to perform analysis of growth parameters, enzymatic activity of defense-related enzymes and anatomical changes. It was observed that inoculation of Trichoderma spp. caused anatomical alterations, among them, increase in stomatal index at the abaxial leaf surface, thickness of the root cortex, thickness of adaxial epidermis, mean diameter of the vascular cylinder, thickness of the mesophyll, and thickness of the spongy parenchyma of the soybean plants. These results indicate that the alterations in these factors may be related to the process of plant resistance to pathogens, and better performance against adverse conditions. This study demonstrates that the anatomical study of plants is an important tool to show the effects that are induced by biological control agents.	[Oliveira, Camilla Martins; Ulhoa, Cirano Jose] Univ Fed Goias, Dept Bioquim & Biol Mol, Goiania, Go, Brazil; [Almeida, Nayane Oliveira; da Rocha, Mara Rubia] Univ Fed Goias, Escola Agron, Goiania, Go, Brazil; [Rezende, Maria Helena; Carneiro, Rene Goncalves da Silva] Univ Fed Goias, Dept Bot, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Ulhoa, CJ (corresponding author), Univ Fed Goias, Dept Bioquim & Biol Mol, Goiania, Go, Brazil.	cjulhoa@gmail.com		Ulhoa, Cirano/0000-0002-4171-6465; Oliveira, Camilla Martins de/0000-0001-6489-5657	Brazilian National Council for Scientific and Technological Development (CNPq) [304272/2015-9]; Coordination of Superior Level Staff Improvement (CAPES)	Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Superior Level Staff Improvement (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by he Brazilian National Council for Scientific and Technological Development (CNPq)(Grant no. 304272/2015-9). NOA and CMO are supported by Coordination of Superior Level Staff Improvement (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alunni S, 2003, ARCH BIOCHEM BIOPHYS, V412, P170, DOI 10.1016/S0003-9861(03)00007-9; Baliza D. P., 2012, Coffee Science, V7, P250; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camargo F. R. T. de, 2017, American Journal of Plant Sciences, V8, P2748; Canadian Tuberculosis Committee (CTC), 2008, Can Commun Dis Rep, V34, P1; Lopes FAC, 2012, FUNGAL BIOL-UK, V116, P815, DOI 10.1016/j.funbio.2012.04.015; CONAB-Companhia Nacional de Abastecimento, 2020, AC SAFR BRAS CAN DE, P1; Dietrich R, 2005, PLANT CELL ENVIRON, V28, P211, DOI 10.1111/j.1365-3040.2004.01265.x; Doni F, 2017, SYMBIOSIS, V72, P45, DOI 10.1007/s13199-016-0438-3; DORNHOFF GM, 1976, CROP SCI, V16, P377, DOI 10.2135/cropsci1976.0011183X001600030015x; Druzhinina IS, 2011, NAT REV MICROBIOL, V9, P749, DOI 10.1038/nrmicro2637; Fischer IH, 2010, REV BRAS FRUTIC, V32, P709, DOI 10.1590/S0100-29452010005000090; Franklin GL, 1946, AUSTR J BOT, V33, P393; Gitz DC, 2005, ENVIRON EXP BOT, V53, P343, DOI 10.1016/j.envexpbot.2004.04.005; Govea K.P, 2018, BIOTEMAS, V31, P15, DOI [10.5007/2175-7925, DOI 10.5007/2175-7925.2018v31n3p15]; Grisi FA, 2008, CIENC AGROTEC, V32, P1730, DOI 10.1590/S1413-70542008000600008; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; HAUPT ARTHUR W., 1930, STAIN TECH, V5, P97; Henning AA, 2014, MANUAL IDENTIFICACAO; Henrique PD, 2010, CIENC RURAL, V40, P70, DOI 10.1590/S0103-84782009005000221; JOHANSEN DONALD ALEXANDER, 1940; LEAL-COSTA M.V, 2008, REV BRASILEIRA BIOCI, V14, P23; Liu-Gitz L, 2000, PLANT CELL ENVIRON, V23, P883, DOI 10.1046/j.1365-3040.2000.00608.x; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; MOTT KA, 1982, PLANT CELL ENVIRON, V5, P455, DOI 10.1111/1365-3040.ep11611750; Mussury R.M., 2012, Rev. bras. plantas med., V14, P18, DOI 10.1590/S1516-05722012000100004; Paradiso R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00674; Passalacqua Franco, 2011, ENTHYMEMA, V4, P37; Pereira-Neto AB, 1997, PESQUI AGROPECU BRAS, V32, P689, DOI [10.1590/S0100-204X1999000800006, DOI 10.1590/S0100-204X1999000800006]; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Prasannath K., 2017, AGRIEAST, V11, P38, DOI [10.4038/agrieast.v11i1.33, DOI 10.4038/AGRIEAST.V11I1.33]; Schmidt Denise, 2017, Rev. Ceres, V64, P368, DOI 10.1590/0034-737x201764040005; Silva Lenir Maristela, 2005, Acta Bot. Bras., V19, P183, DOI 10.1590/S0102-33062005000100018; Silva RN, 2019, FUNGAL BIOL-UK, V123, P565, DOI 10.1016/j.funbio.2019.06.010; Stangarlin JR., 2011, SCI AGRARIA PARANAEN, V6, P18, DOI DOI 10.1818/SAP.V10I1.5268; Struminska O, 2014, CHEM CHEM TECHOL, V8, P81, DOI 10.23939/chcht08.01.081; Vannucci AL, 2003, ANATOMIA VEGETAL NOC; Vinale F, 2008, SOIL BIOL BIOCHEM, V40, P1, DOI 10.1016/j.soilbio.2007.07.002; Woo S.L., 2014, OPEN MYCOL J, V8, P71, DOI [10.2174/1874437001408010071, DOI 10.2174/1874437001408010071]; Yadav A, 2013, J PURE APPL MICROBIO, V7, P505; Zhang FL, 2016, PLANT PHYSIOL BIOCH, V100, P64, DOI 10.1016/j.plaphy.2015.12.017	41	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242480	10.1371/journal.pone.0242480	http://dx.doi.org/10.1371/journal.pone.0242480			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196686	gold, Green Published			2022-12-26	WOS:000595266800023
J	Arora, K; Liyanage, P; Zhong, Q; Naren, AP				Arora, Kavisha; Liyanage, Pramodha; Zhong, Qing; Naren, Anjaparavanda P.			A SNARE protein Syntaxin 17 captures CFTR to potentiate autophagosomal clearance under stress	FASEB JOURNAL			English	Article						autophagy; cystic fibrosis; cystic fibrosis transmembrane conductance regulator; SNARE proteins; lysosomal clearance	TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; THERAPEUTIC TARGET; CHLORIDE CHANNELS; ACIDIFICATION; MECHANISMS; DYNAMICS; DIARRHEA; FUSION	Autophagy, a cellular stress response to starvation and bacterial infection, is executed by double-membrane-bound organelles called autophagosomes. Autophagosomes transfer cytosolic material to acidified lysosomes for degradation following soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE)-dependent fusion processes. Many of the autophagy-related disorders stem from defective end-step proteolysis inside lysosomes. The role of epithelial cystic fibrosis (CF) transmembrane conductance regulator (CFTR) chloride channel has been argued to be critical for efficient lysosomal clearance; however, its context to autophagic clearance and the underlying mechanism is poorly defined. Here, we report that syntaxin17 (Stx17), an autophagic SNARE protein interacts with CFTR under nutritional stress and bacterial infection and incorporates it into mature autophagosomes to mediate an efficient lysosomal clearance. Lack of CFTR function and Stx17 and loss of CFTR-Stx17 interaction impairs bacterial clearance. We discover a specialized role of the Stx17-CFTR protein complex that is critical to prevent defective autophagy as has been the reported scenario in CF airway epithelial cells, infectious diseases, and lysosomal clearance disorders.	[Arora, Kavisha; Liyanage, Pramodha; Naren, Anjaparavanda P.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Dept Pediat, 3333 Burnet Ave MLC 2021, Cincinnati, OH 45229 USA; [Zhong, Qing] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Ctr Autophagy Res, Dallas, TX USA	Cincinnati Children's Hospital Medical Center; University of Texas System; University of Texas Southwestern Medical Center Dallas	Naren, AP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Dept Pediat, 3333 Burnet Ave MLC 2021, Cincinnati, OH 45229 USA.	anaren@cchmc.org	Liyanage, Pramodha/ABE-9075-2020; Zhong, Qing/GLT-4858-2022	Zhong, Qing/0000-0001-6979-955X	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Heart and Lung Institute (NHLBI); Cystic Fibrosis Foundation (CF Foundation)	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart and Lung Institute (NHLBI); Cystic Fibrosis Foundation (CF Foundation)	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Heart and Lung Institute (NHLBI); Cystic Fibrosis Foundation (CF Foundation)	Arora K, 2015, AM J PATHOL, V185, P2790, DOI 10.1016/j.ajpath.2015.06.007; Arora K, 2014, BIOCHEMISTRY-US, V53, P4169, DOI 10.1021/bi401263h; Bajmoczi M, 2009, AM J PHYSIOL-CELL PH, V297, pC263, DOI 10.1152/ajpcell.00527.2008; BARASCH J, 1991, NATURE, V352, P70, DOI 10.1038/352070a0; Barnaby R, 2018, AM J PHYSIOL-LUNG C, V314, pL432, DOI 10.1152/ajplung.00461.2017; Barriere H, 2009, MOL BIOL CELL, V20, P3125, DOI 10.1091/mbc.E09-01-0061; Bonfield TL, 2015, AM J RESP CRIT CARE, V192, P1406, DOI 10.1164/rccm.201509-1811ED; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Campoy E, 2009, BBA-MOL CELL RES, V1793, P1465, DOI 10.1016/j.bbamcr.2009.03.003; Cui GY, 2019, DEV CELL, V51, P421, DOI 10.1016/j.devcel.2019.09.017; Davies Jane C, 2002, Paediatr Respir Rev, V3, P128, DOI 10.1016/S1526-0550(02)00003-3; De Stefano D, 2014, AUTOPHAGY, V10, P2053, DOI 10.4161/15548627.2014.973737; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Diao JJ, 2015, NATURE, V520, P563, DOI 10.1038/nature14147; Festa BP, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02536-7; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Garai P, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007812; Garcia-Medina R, 2005, INFECT IMMUN, V73, P8298, DOI 10.1128/IAI.73.12.8298-8305.2005; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Haggie PM, 2009, J BIOL CHEM, V284, P7681, DOI 10.1074/jbc.M809161200; Hamasaki M, 2013, NATURE, V495, P389, DOI 10.1038/nature11910; Hoiby N, 2010, FUTURE MICROBIOL, V5, P1663, DOI [10.2217/fmb.10.125, 10.2217/FMB.10.125]; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Itakura E, 2013, AUTOPHAGY, V9, P917, DOI 10.4161/auto.24109; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Junkins RD, 2014, AUTOPHAGY, V10, P538, DOI 10.4161/auto.27750; Junkins RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072263; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li CY, 2007, CELL, V131, P940, DOI 10.1016/j.cell.2007.09.037; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Lieberman AP, 2012, AUTOPHAGY, V8, P719, DOI 10.4161/auto.19469; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Lovewell RR, 2014, AM J PHYSIOL-LUNG C, V306, pL591, DOI 10.1152/ajplung.00335.2013; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Luo LJ, 2018, FISH SHELLFISH IMMUN, V83, P416, DOI 10.1016/j.fsi.2018.09.016; Ma JJ, 1997, J BIOL CHEM, V272, P28133, DOI 10.1074/jbc.272.44.28133; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Naren AP, 1998, P NATL ACAD SCI USA, V95, P10972, DOI 10.1073/pnas.95.18.10972; Naren AP, 1997, NATURE, V390, P302, DOI 10.1038/36882; Penmatsa H, 2010, MOL BIOL CELL, V21, P1097, DOI 10.1091/mbc.E09-08-0655; Pier GB, 1997, P NATL ACAD SCI USA, V94, P12088, DOI 10.1073/pnas.94.22.12088; Ravikumar B, 2010, NAT CELL BIOL, V12, P747, DOI 10.1038/ncb2078; Royle SJ, 2013, NAT REV MOL CELL BIO, V14, P592, DOI 10.1038/nrm3641; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Russell RC, 2014, CELL RES, V24, P42, DOI 10.1038/cr.2013.166; Schroeder TH, 2001, J IMMUNOL, V166, P7410, DOI 10.4049/jimmunol.166.12.7410; Shrestha CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186169; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Tosco A, 2016, CELL DEATH DIFFER, V23, P1380, DOI 10.1038/cdd.2016.22; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; Yuan KF, 2012, J CELL SCI, V125, P507, DOI 10.1242/jcs.094573	55	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.201903210R	http://dx.doi.org/10.1096/fj.201903210R		NOV 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33191543	Green Accepted			2022-12-26	WOS:000592667900001
J	Serricchio, M; Hierro-Yap, C; Schadeli, D; Ben Hamidane, H; Hemphill, A; Graumann, J; Zikova, A; Butikofer, P				Serricchio, Mauro; Hierro-Yap, Carolina; Schadeli, David; Ben Hamidane, Hisham; Hemphill, Andrew; Graumann, Johannes; Zikova, Alena; Butikofer, Peter			Depletion of cardiolipin induces major changes in energy metabolism in Trypanosoma brucei bloodstream forms	FASEB JOURNAL			English	Article						ATP synthase; cardiolipin; electron transport chain; mitochondria; protein complexes; trypanosomes	ADP/ATP CARRIER PROTEIN; ESCHERICHIA-COLI; ATP SYNTHASE; HEART-MITOCHONDRIA; BARTH-SYNDROME; CYTOCHROME-C; CELL-CULTURE; COMPLEX; GROWTH; EXPRESSION	The mitochondrial inner membrane glycerophospholipid cardiolipin (CL) associates with mitochondrial proteins to regulate their activities and facilitate protein complex and supercomplex formation. Loss of CL leads to destabilized respiratory complexes and mitochondrial dysfunction. The role of CL in an organism lacking a conventional electron transport chain (ETC) has not been elucidated. Trypanosoma brucei bloodstream forms use an unconventional ETC composed of glycerol-3-phosphate dehydrogenase and alternative oxidase (AOX), while the mitochondrial membrane potential (Delta psi m) is generated by the hydrolytic action of the FoF1-ATP synthase (aka FoF1-ATPase). We now report that the inducible depletion of cardiolipin synthase (TbCls) is essential for survival of T brucei bloodstream forms. Loss of CL caused a rapid drop in ATP levels and a decline in the Delta psi m. Unbiased proteomic analyses revealed a reduction in the levels of many mitochondrial proteins, most notably of FoF1-ATPase subunits and AOX, resulting in a strong decline of glycerol-3-phosphate-stimulated oxygen consumption. The changes in cellular respiration preceded the observed decrease in FoF1-ATPase stability, suggesting that the AOX-mediated ETC is the first pathway responding to the decline in CL. Select proteins and pathways involved in glucose and amino acid metabolism were upregulated to counteract the CL depletion-induced drop in cellular ATP.	[Serricchio, Mauro; Schadeli, David; Butikofer, Peter] Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland; [Hierro-Yap, Carolina; Zikova, Alena] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Hierro-Yap, Carolina; Zikova, Alena] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic; [Schadeli, David] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Ben Hamidane, Hisham; Graumann, Johannes] Weill Cornell Med Qatar, Doha, Qatar; [Hemphill, Andrew] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Graumann, Johannes] Max Planck Inst Heart & Lung Res, Biomol Mass Spectrometry, Bad Nauheim, Germany	University of Bern; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Bern; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Bern; Max Planck Society	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland.; Zikova, A (corresponding author), Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic.	azikova@paru.cas.cz; peter.buetikofer@ibmm.unibe.ch	Zikova, Alena/G-7855-2014	Zikova, Alena/0000-0002-8686-0225; Hemphill, Andrew/0000-0002-0622-2128; Serricchio, Mauro/0000-0002-7094-9807	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF) [169355]; Czech Science Foundation [18-17529S]; ERD fund [CZ.02.1.01/0.0/0.0/1 6_019/0000759]	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF); Czech Science Foundation(Grant Agency of the Czech Republic); ERD fund	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung (SNF), Grant/Award Number: 169355; Czech Science Foundation, Grant/Award Number: 18-17529S; ERD fund, Grant/Award Number: CZ.02.1.01/0.0/0.0/1 6_019/0000759	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Baker N, 2015, P NATL ACAD SCI USA, V112, P9112, DOI 10.1073/pnas.1505411112; Bakker BM, 1997, J BIOL CHEM, V272, P3207, DOI 10.1074/jbc.272.6.3207; BELEZNAI Z, 1989, BIOCHEM BIOPH RES CO, V159, P132, DOI 10.1016/0006-291X(89)92414-5; Beltran-Heredia E, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0471-x; BEYER K, 1985, BIOCHEMISTRY-US, V24, P3821, DOI 10.1021/bi00336a001; Cade WT, 2013, J INHERIT METAB DIS, V36, P91, DOI 10.1007/s10545-012-9486-x; Charriere F, 2006, P NATL ACAD SCI USA, V103, P6847, DOI 10.1073/pnas.0602362103; Chinopoulos C, 2009, BIOPHYS J, V96, P2490, DOI 10.1016/j.bpj.2008.12.3915; Cirovic O, 2014, METHODS MOL BIOL, V1188, P47, DOI 10.1007/978-1-4939-1142-4_4; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Creek DJ, 2013, ANTIMICROB AGENTS CH, V57, P2768, DOI 10.1128/AAC.00044-13; Dean S, 2013, P NATL ACAD SCI USA, V110, P14741, DOI 10.1073/pnas.1305404110; Duncan AL, 2016, P NATL ACAD SCI USA, V113, P8687, DOI 10.1073/pnas.1608396113; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Friedman JR, 2015, ELIFE, V4, DOI 10.7554/eLife.07739; Gahura O, 2018, FEBS J, V285, P614, DOI 10.1111/febs.14364; Gloaguen Y, 2017, BIOINFORMATICS, V33, P4007, DOI 10.1093/bioinformatics/btx499; Hannaert Veronique, 2003, Kinetoplastid Biology and Disease, V2, pUnpaginated; Huang GZ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004555; Intlekofer AM, 2017, NAT CHEM BIOL, V13, P494, DOI [10.1038/NCHEMBIO.2307, 10.1038/nchembio.2307]; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 1999, MOL MICROBIOL, V31, P373, DOI 10.1046/j.1365-2958.1999.01181.x; Johnston K, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181601; Joshi AS, 2012, J BIOL CHEM, V287, P17589, DOI 10.1074/jbc.M111.330167; KADENBACH B, 1982, FEBS LETT, V139, P109, DOI 10.1016/0014-5793(82)80498-5; Kim DH, 2015, METABOLOMICS, V11, P1721, DOI 10.1007/s11306-015-0827-2; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Kovarova J, 2016, TRENDS PARASITOL, V32, P622, DOI 10.1016/j.pt.2016.04.010; Lai DH, 2008, P NATL ACAD SCI USA, V105, P1999, DOI 10.1073/pnas.0711799105; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Li YR, 2019, J BIOL CHEM, V294, P11568, DOI 10.1074/jbc.RA119.009037; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Muhleip A, 2019, ELIFE, V8, DOI 10.7554/eLife.51179; Nejad LD, 2018, MOL MICROBIOL, V109, P105, DOI 10.1111/mmi.13976; NISHIJIMA S, 1988, J BACTERIOL, V170, P775, DOI 10.1128/jb.170.2.775-780.1988; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; OPPERDOES FR, 1977, EUR J BIOCHEM, V76, P29, DOI 10.1111/j.1432-1033.1977.tb11567.x; Panigrahi AK, 2008, MOL CELL PROTEOMICS, V7, P534, DOI 10.1074/mcp.M700430-MCP200; Paradies G, 1997, BBA-MOL BASIS DIS, V1362, P193, DOI 10.1016/S0925-4439(97)00075-6; Patil VA, 2013, J BIOL CHEM, V288, P1696, DOI 10.1074/jbc.M112.428938; Pereira CA, 2002, J EUKARYOT MICROBIOL, V49, P82, DOI 10.1111/j.1550-7408.2002.tb00346.x; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Pineau B, 2013, PLANT CELL, V25, P4195, DOI 10.1105/tpc.113.118018; PRIEST JW, 1994, J BIOENERG BIOMEMBR, V26, P179, DOI 10.1007/BF00763067; Raemy E, 2016, CELL DEATH DIFFER, V23, P1165, DOI 10.1038/cdd.2015.166; Raja V, 2019, BBA-MOL CELL BIOL L, V1864, P654, DOI 10.1016/j.bbalip.2019.02.001; Raja V, 2014, CHEM PHYS LIPIDS, V179, P49, DOI 10.1016/j.chemphyslip.2013.12.009; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Santucci R, 2019, INT J BIOL MACROMOL, V136, P1237, DOI 10.1016/j.ijbiomac.2019.06.180; Schadeli D, 2019, FASEB J, V33, P13161, DOI 10.1096/fj.201901184RR; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2009, BBA-BIOMEMBRANES, V1788, P2080, DOI 10.1016/j.bbamem.2009.04.019; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Schnaufer A, 2002, INT J PARASITOL, V32, P1071, DOI 10.1016/S0020-7519(02)00020-6; Serricchio M, 2013, MOL MICROBIOL, V87, P569, DOI 10.1111/mmi.12116; Serricchio M, 2012, P NATL ACAD SCI USA, V109, pE954, DOI 10.1073/pnas.1121528109; Shah TD, 2011, MOL BIOCHEM PARASIT, V179, P100, DOI 10.1016/j.molbiopara.2011.07.001; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Singha UK, 2009, EUKARYOT CELL, V8, P1418, DOI 10.1128/EC.00132-09; Smith Terry K, 2017, F1000Res, V6, DOI 10.12688/f1000research.10342.2; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Subrtova K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004660; Tielens AGM, 2009, TRENDS PARASITOL, V25, P482, DOI 10.1016/j.pt.2009.07.007; Uzcategui NL, 2004, J BIOL CHEM, V279, P42669, DOI 10.1074/jbc.M404518200; VICKERMAN K, 1985, BRIT MED BULL, V41, P105, DOI 10.1093/oxfordjournals.bmb.a072036; Voncken F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065908; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Zikova A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006679; Zikova A, 2016, MOL BIOCHEM PARASIT, V209, P46, DOI 10.1016/j.molbiopara.2016.02.007	77	8	9	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202001579RR	http://dx.doi.org/10.1096/fj.202001579RR		NOV 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33184899				2022-12-26	WOS:000590888700001
J	Kujawska, J; Pawlowska, M				Kujawska, Justyna; Pawlowska, Malgorzata			Effect of drill cuttings addition on physicochemical and chemical properties of soil and red clover (Trifolium pretense L.) growth	PLOS ONE			English	Article							CRUDE-OIL; MUD APPLICATION; FLUIDS; PLANTS	The most economical method of drill cuttings disposal may be their application in land reclamation which allows for the wastes recovery. However, the wastes application into the soil should ensure that the quality of the environment would not be deteriorated. These investigations were aimed at identifying the effect of drill cuttings, which were the mixture of different types of drilling wastes, on the physicochemical properties of acidic soil and growth of red clover (Trifolium pratense L.). The experimental design comprised 5 treatments, which differed in a dose of the drill cuttings: 0% (control), 2.5%, 5%, 10% and 15% of dry weight. A six-week pot experiment was conducted to determine the influence of the wastes on the plant growth. The results showed that the drill cuttings addition significantly changed the chemical and physicochemical properties of the soil, such as: electrical conductivity (EC), pH, base saturation, content of carbonate, alkaline cations (Ca2+, Na+, K+, Mg2+), organic matter, total organic carbon (TOC), and available phosphorus form. However, the most important factors that influenced the growth of red clover were pH, base saturation, content of Mg2+ and plant available phosphorus. The red clover biomass was increased from 1.5 to 2.5 times depending on the dose of wastes. We concluded that the examined wastes can be used for reclamation of the acid and unfertile degraded soils, but the amount of wastes should not exceed 5% of the soil, because the highest total clover biomass was observed just at this dose.	[Kujawska, Justyna; Pawlowska, Malgorzata] Lublin Univ Technol, Fac Environm Engn, Lublin, Poland	Lublin University of Technology	Kujawska, J (corresponding author), Lublin Univ Technol, Fac Environm Engn, Lublin, Poland.	j.kujawska@pollub.pl	Kujawska, Justyna/B-6869-2017	Kujawska, Justyna/0000-0002-4809-2472	Polish Ministry of Science & Higher Education's Research Project [BLUE GAS-BG1/SOIL/2013]	Polish Ministry of Science & Higher Education's Research Project	This study was supported by the Polish Ministry of Science & Higher Education's Research Project no. BLUE GAS-BG1/SOIL/2013, which was conducted as a part of joint program between the National Centre for Research & Development and the Industrial Development Agency JSC.	Adedokun OM, 2007, SCI RES ESSAYS, V2, P147; Alba A, 2007, INT OIL C EXH MEX; [Anonymous], 103901997 PNISO; Babko R, 2016, DESALIN WATER TREAT, V57, P1490, DOI 10.1080/19443994.2015.1033137; Ball AS, 2012, WASTE MANAGE RES, V30, P457, DOI [10.1177/0734242X11419892, 10.1177/0734242x11419892]; Bauder TA, 2005, J ENVIRON QUAL, V34, P1687, DOI 10.2134/jeq2004.0384; Berthrong ST, 2009, ECOL APPL, V19, P2228, DOI 10.1890/08-1730.1; Brust GE, 2019, SAFETY AND PRACTICE FOR ORGANIC FOOD, P193, DOI 10.1016/B978-0-12-812060-6.00009-X; Chaineau CH, 1996, J ENVIRON QUAL, V25, P858, DOI 10.2134/jeq1996.00472425002500040030x; Chen T.L., 2007, E P ENV SAF C; FERRELL RE, 1984, J EXP MAR BIOL ECOL, V83, P27, DOI 10.1016/0022-0981(84)90115-1; Franks DM, 2011, RESOUR POLICY, V36, P114, DOI 10.1016/j.resourpol.2010.12.001; Gonet A, 2006, METODY PRZETWARZANIA; Issoufi I, 2006, J AGRON CROP SCI, V192, P310, DOI 10.1111/j.1439-037X.2006.00212.x; Jackson ML., 1963, SOIL CHEM ANAL; Kisic L, 2009, GEODERMA, V149, P209, DOI 10.1016/j.geoderma.2008.11.041; Magalhaes MOL, 2014, B ENVIRON CONTAM TOX, V92, P311, DOI 10.1007/s00128-014-1196-7; Lityski T., 1976, ANALIZA CHEMICZNO RO; Liu G. D., 2015, NUTR MANAGEMENT VEGE; Loveland P, 2003, SOIL TILL RES, V70, P1, DOI 10.1016/S0167-1987(02)00139-3; MCFARLAND ML, 1994, J RANGE MANAGE, V47, P475, DOI 10.2307/4003000; Mikos-Szymanska M, 2018, ENVIRON SCI POLLUT R, V25, P35990, DOI 10.1007/s11356-018-2365-8; MILLER RW, 1980, J ENVIRON QUAL, V9, P547, DOI 10.2134/jeq1980.00472425000900040002x; Oleszczuk P, 2010, ENVIRON TOXICOL, V25, P38, DOI 10.1002/tox.20470; Onwukwe S., 2012, INT J ENVIRON SUSTAI, V3, P252, DOI DOI 10.7763/IJESD.2012.V3.226; Page P W, 2003, SPE80583, P1; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Pietrzykowski M, 2018, RECLAMATION MINE LAN, P493; Piszcz-Karas K, 2016, APPL GEOCHEM, V72, P136, DOI 10.1016/j.apgeochem.2016.07.006; PN-EN, 278881999 PNEN; PN-EN ISO, 1468822006 PNEN ISO; Shahriari M. H., 2007, Research Journal of Agriculture and Biological Sciences, V3, P46; Shokanov TA, 2011, CAN UNC RES C; Siebielec G, 2017, RAPORT 3 ETAPU REALI; Starzycka A, WASTE MANAGEMENT 1; Tuncan A, 2000, WASTE MANAGE RES, V18, P489, DOI 10.1177/0734242X0001800511; Yao LJ, 2014, WATER AIR SOIL POLL, V225, DOI 10.1007/s11270-014-2156-x; Zvomuya F, 2011, RANGELAND ECOL MANAG, V64, P375, DOI 10.2111/REM-D-10-00028.1; Zvomuya F, 2009, SOIL SCI SOC AM J, V73, P1108, DOI 10.2136/sssaj2008.0166; 2015, PEDIAT DERMATOL, V32	40	3	3	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242081	10.1371/journal.pone.0242081	http://dx.doi.org/10.1371/journal.pone.0242081			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180857	Green Published, gold			2022-12-26	WOS:000593948000103
J	Rajaraman, S; Sornapudi, S; Alderson, PO; Folio, LR; Antani, SK				Rajaraman, Sivaramakrishnan; Sornapudi, Sudhir; Alderson, Philip O.; Folio, Les R.; Antani, Sameer K.			Analyzing inter-reader variability affecting deep ensemble learning for COVID-19 detection in chest radiographs	PLOS ONE			English	Article							CLASSIFICATION	Data-driven deep learning (DL) methods using convolutional neural networks (CNNs) demonstrate promising performance in natural image computer vision tasks. However, their use in medical computer vision tasks faces several limitations, viz., (i) adapting to visual characteristics that are unlike natural images; (ii) modeling random noise during training due to stochastic optimization and backpropagation-based learning strategy; (iii) challenges in explaining DL black-box behavior to support clinical decision-making; and (iv) inter-reader variability in the ground truth (GT) annotations affecting learning and evaluation. This study proposes a systematic approach to address these limitations through application to the pandemic-caused need for Coronavirus disease 2019 (COVID-19) detection using chest X-rays (CXRs). Specifically, our contribution highlights significant benefits obtained through (i) pretraining specific to CXRs in transferring and fine-tuning the learned knowledge toward improving COVID-19 detection performance; (ii) using ensembles of the fine-tuned models to further improve performance over individual constituent models; (iii) performing statistical analyses at various learning stages for validating results; (iv) interpreting learned individual and ensemble model behavior through class-selective relevance mapping (CRM)-based region of interest (ROI) localization; and, (v) analyzing inter-reader variability and ensemble localization performance using Simultaneous Truth and Performance Level Estimation (STAPLE) methods. We find that ensemble approaches markedly improved classification and localization performance, and that inter-reader variability and performance level assessment helps guide algorithm design and parameter optimization. To the best of our knowledge, this is the first study to construct ensembles, perform ensemble-based disease ROI localization, and analyze inter-reader variability and algorithm performance for COVID-19 detection in CXRs.	[Rajaraman, Sivaramakrishnan; Antani, Sameer K.] Natl Lib Med, Lister Hill Natl Ctr Biomed Commun, Bethesda, MD 20894 USA; [Sornapudi, Sudhir] Missouri Univ Sci & Technol, Dept Elect & Comp Engn, Rolla, MO 65409 USA; [Alderson, Philip O.] St Louis Univ, Sch Med, St Louis, MO USA; [Folio, Les R.] NIH, Radiol & Imaging Sci, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Missouri System; Missouri University of Science & Technology; Saint Louis University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Rajaraman, S (corresponding author), Natl Lib Med, Lister Hill Natl Ctr Biomed Commun, Bethesda, MD 20894 USA.	sivaramakrishnan.rajaraman@nih.gov	Folio, Les R./AAO-5456-2021; Antani, Sameer/GVS-8371-2022	Antani, Sameer/0000-0002-0040-1387; Sornapudi, Sudhir/0000-0001-5305-7797; Alderson, Philip/0000-0003-3617-7433	Intramural Research Program (IRP) of the National Library of Medicine (NLM); National Institutes of Health (NIH)	Intramural Research Program (IRP) of the National Library of Medicine (NLM); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study is supported by the Intramural Research Program (IRP) of the National Library of Medicine (NLM) and the National Institutes of Health (NIH). The intramural research scientists (authors) at the NIH dictated study design, data collection, data analysis, decision to publish and preparation of the manuscript.	ACR, 2020, RECOMMENDATIONS USE; Acuff NV, 2017, J IMMUNOL, V198, P4539, DOI 10.4049/jimmunol.1602077; Al-Khawari H, 2010, ANN SAUDI MED, V30, P129, DOI 10.4103/0256-4947.60518; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 2020, WORLD HLTH ORG WHO S; Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823; Balabanova Y, 2005, BMJ-BRIT MED J, V331, P379, DOI 10.1136/bmj.331.7513.379; Baldi P, 2014, ARTIF INTELL, V210, P78, DOI 10.1016/j.artint.2014.02.004; Candemir S, 2019, INT J COMPUT ASS RAD, V14, P563, DOI 10.1007/s11548-019-01917-1; Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195; Chowdhury AK, 2017, MED SCI SPORT EXER, V49, P1965, DOI 10.1249/MSS.0000000000001291; Cohen J. P., 2020, ARXIV PREPRINT ARXIV; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Diong J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202121; Dosovitskiy A, 2016, PROC CVPR IEEE, P4829, DOI 10.1109/CVPR.2016.522; Dutta A, 2019, PROCEEDINGS OF THE 27TH ACM INTERNATIONAL CONFERENCE ON MULTIMEDIA (MM'19), P2276, DOI 10.1145/3343031.3350535; Hesamian MH, 2019, J DIGIT IMAGING, V32, P582, DOI 10.1007/s10278-019-00227-x; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Irvin J, 2019, AAAI CONF ARTIF INTE, P590; Islam M. T., 2017, ARXIV170509850; Jiang Yuting, 2020, Radiol Infect Dis, V7, P71, DOI 10.1016/j.jrid.2020.05.001; Kaiming He, 2016, 2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR), P770, DOI 10.1109/CVPR.2016.90; Kao LS, 2008, J SURG RES, V144, P158, DOI 10.1016/j.jss.2007.02.053; Karim M.R., 2020, ARXIV PREPRINT ARXIV; Kermany DS, 2018, CELL, V172, P1122, DOI 10.1016/j.cell.2018.02.010; Kim I, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9020038; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; Li L., 2020, RADIOLOGY, V296, pe65, DOI 10.1148/radiol.2020200905; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Pham H, 2018, PR MACH LEARN RES, V80; Platzer A, 2018, J INTEGR BIOINFORMAT, V15, DOI 10.1515/jib-2017-0063; Rajaraman S, 2019, IEEE ENG MED BIO, P3689, DOI 10.1109/EMBC.2019.8856715; Rajaraman S, 2020, IEEE ACCESS, V8, P115041, DOI [10.1109/access.2020.3003810, 10.1109/ACCESS.2020.3003810]; Rajaraman S, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10060358; Rajaraman S, 2020, IEEE ACCESS, V8, P27318, DOI [10.1109/ACCESS.2020.2971257, 10.1109/access.2020.2971257]; Rubin GD, 2020, RADIOLOGY, V296, P172, DOI [10.1016/j.chest.2020.04.003, 10.1148/radiol.2020201365]; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Shih G., 2019, RADIOL ARTIF INTELL, V1, P1; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Wang YB, 2017, PROC CVPR IEEE, P2097, DOI 10.1109/CVPR.2017.226; Warfield SK, 2004, IEEE T MED IMAGING, V23, P903, DOI 10.1109/TMI.2004.828354; Yadav O, 2018, IEEE INT C BIOINFORM, P2368, DOI 10.1109/BIBM.2018.8621525; Zahery M, 2017, TWIN RES HUM GENET, V20, P290, DOI 10.1017/thg.2017.28; Zeiler M.D., 2014, ECCV; Zerhouni E, 2017, I S BIOMED IMAGING, P924, DOI 10.1109/ISBI.2017.7950667; Zhao BS, 2013, EUR J RADIOL, V82, P959, DOI 10.1016/j.ejrad.2013.02.018; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319	49	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242301	10.1371/journal.pone.0242301	http://dx.doi.org/10.1371/journal.pone.0242301			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180877	gold, Green Published			2022-12-26	WOS:000593948000077
J	Vogler, T; Andreou, D; Gosheger, G; Kurpiers, N; Velmans, C; Ameziane, Y; Schneider, K; Rickert, C; Liem, D; Schorn, D				Vogler, Tim; Andreou, Dimosthenis; Gosheger, Georg; Kurpiers, Nico; Velmans, Clara; Ameziane, Yacine; Schneider, Kristian; Rickert, Carolin; Liem, Dennis; Schorn, Dominik			Long-term outcome of arthroscopic debridement of massive irreparable rotator cuff tears	PLOS ONE			English	Article							PARTIAL REPAIR; SUBACROMIAL DECOMPRESSION; SHOULDER ARTHROPLASTY; RECONSTRUCTION; ARTHROPATHY; MANAGEMENT; BICEPS	Objectives To evaluate the clinical and radiographic outcome of low-demand patients with massive rotator cuff tears undergoing arthroscopic debridement in mid- and long-term follow-up, as well as the rate of conversion to reverse shoulder arthroplasty. Methods We performed a retrospective analysis of 19 patients with a mean age at surgery of 68 years (range, 55-80 years) from a previously described consecutive cohort and after a mean follow up of 47 month (FU1) and 145 month (FU2). The functional outcome was evaluated with the VAS score, the American Shoulder and Elbow Surgeons (ASES) score, and the age- and gender-adjusted Constant (aCS) score. The radiographic outcome was classified according to the Hamada classification. Non-parametric analyses were carried out with the Mann-Whitney U for independent samples and the Wilcoxon signed-rank test for related samples. Results Five patients (26%) developed symptomatic cuff tear arthropathy and underwent reverse shoulder arthroplasty after a mean time of 63 months (range, 45-97 months). These patients were excluded from further analyses. The mean VAS score of the remaining 14 patients at FU1 was significantly lower compared to preoperatively (P = .041), while there were no significant differences between the VAS score at FU1 and FU2 (P = 1.0). The ASES score of the affected shoulder at FU1 was significantly higher compared to prior to surgery (P = .028), while there were no significant differences between the scores of the affected shoulder between FU1 and FU2 (P = .878). While the ASES score of the contralateral shoulder at FU1 was significantly higher than the score of the affected shoulder (P = .038), there were no significant differences in the ASES scores of the affected and the healthy shoulder at FU2 (P = .575). The evaluation of the aCS produced similar results. A progression of the Hamada grade was documented in 6 patients. Conclusions Arthroscopic debridement is a safe and valid option for low-demand middle-age or elderly patients with symptomatic massive rotator cuff tears, leading to a significant pain relief and significantly improved functional outcome at mid- and long-term follow up. However, about a quarter of the patients in our cohort had to undergo reverse shoulder arthroplasty due to symptomatic cuff tear arthropathy. Furthermore, some of the remaining patients continued to undergo radiographic progression. This might be due to the natural history of their disease and/or the surgical procedure, and the clinical relevance of this finding should be evaluated in further studies.	[Vogler, Tim; Andreou, Dimosthenis; Gosheger, Georg; Velmans, Clara; Ameziane, Yacine; Schneider, Kristian; Rickert, Carolin; Liem, Dennis; Schorn, Dominik] Munster Univ Hosp, Dept Gen Orthoped & Tumor Orthoped, Munster, Germany; [Kurpiers, Nico] Univ Hildesheim, Inst Sports Sci, Hildesheim, Germany	University of Munster; University of Hildesheim	Vogler, T (corresponding author), Munster Univ Hosp, Dept Gen Orthoped & Tumor Orthoped, Munster, Germany.	voglerti@gmx.de	Kurpiers, Nico/AAT-2066-2021	Kurpiers, Nico/0000-0002-3622-5282				BURKHART SS, 1994, ARTHROSCOPY, V10, P363, DOI 10.1016/S0749-8063(05)80186-0; Burkhart SS, 1997, ORTHOP CLIN N AM, V28, P125, DOI 10.1016/S0030-5898(05)70270-4; Burkhart SS, 1996, ARTHROSCOPY, V12, P335, DOI 10.1016/S0749-8063(96)90070-5; Burkhart SS, 2001, CLIN ORTHOP RELAT R, P107; BURKHART SS, 1991, CLIN ORTHOP RELAT R, P45; Cofield RH, 2001, J BONE JOINT SURG AM, V83A, P71, DOI 10.2106/00004623-200101000-00010; Duralde XA, 2005, J SHOULDER ELB SURG, V14, P121, DOI 10.1016/j.jse.2004.06.015; ELLMAN H, 1993, ARTHROSCOPY, V9, P195, DOI 10.1016/S0749-8063(05)80374-3; Euler SA, 2016, Z ORTHOP UNFALLCHIR, V154, P28, DOI 10.1055/s-0035-1558056; Gartsman GM, 1997, J BONE JOINT SURG AM, V79A, P715, DOI 10.2106/00004623-199705000-00011; Gerber C, 2000, J BONE JOINT SURG AM, V82A, P505, DOI 10.2106/00004623-200004000-00006; Gerber C, 2011, J SHOULDER ELB SURG, V20, pS20, DOI 10.1016/j.jse.2010.11.028; Gleyze P, 2000, REV CHIR ORTHOP, V86, P566; Habermeyer P, 2006, J BONE JOINT SURG BR, V88B, P208, DOI 10.1302/0301-620X.88B2.16830; HAMADA K, 1990, CLIN ORTHOP RELAT R, P92; Heuberer PR, 2016, KNEE SURG SPORT TR A, V24, P3828, DOI 10.1007/s00167-015-3739-9; Hoffmann F, 2000, ORTHOPADE, V29, P888, DOI 10.1007/s001320050539; Jobin CM, 2012, J SHOULDER ELB SURG, V21, P1269, DOI 10.1016/j.jse.2011.08.049; Karas SE, 1996, J BONE JOINT SURG AM, V78A, P239, DOI 10.2106/00004623-199602000-00011; Klinger HM, 2005, ACTA CHIR BELG, V105, P297, DOI 10.1080/00015458.2005.11679720; LEVY H J, 1991, Arthroscopy, V7, P8, DOI 10.1016/0749-8063(91)90071-5; Liem D, 2008, ARTHROSCOPY, V24, P743, DOI 10.1016/j.arthro.2008.03.007; Liem D, 2014, AM J SPORT MED, V42, P826, DOI 10.1177/0363546513519324; Mazzocca AD, 2011, ARTHROSCOPY, V27, P330, DOI 10.1016/j.arthro.2010.09.003; Mihata T, 2016, AM J SPORT MED, V44, P1423, DOI 10.1177/0363546516631751; Nolan BM, 2011, CLIN ORTHOP RELAT R, V469, P2476, DOI 10.1007/s11999-010-1683-z; Pander P, 2018, INT ORTHOP, V42, P2633, DOI 10.1007/s00264-018-3991-y; Resch H, 2000, J BONE JOINT SURG AM, V82A, P372, DOI 10.2106/00004623-200003000-00008; ROCKWOOD CA, 1995, J BONE JOINT SURG AM, V77A, P857, DOI 10.2106/00004623-199506000-00006; SAMILSON RL, 1983, J BONE JOINT SURG AM, V65, P456, DOI 10.2106/00004623-198365040-00005; Scheibel M, 2004, J SHOULDER ELB SURG, V13, P272, DOI 10.1016/j.jse.2004.01.007; Senekovic Vladimir, 2013, Eur J Orthop Surg Traumatol, V23, P311, DOI 10.1007/s00590-012-0981-4; SHER JS, 1995, J BONE JOINT SURG AM, V77A, P10, DOI 10.2106/00004623-199501000-00002; Stechel A, 2010, ACTA ORTHOP, V81, P367, DOI 10.3109/17453674.2010.487242; Tauro JC, 1998, ARTHROSCOPY, V14, P45, DOI 10.1016/S0749-8063(98)70119-7; Verhelst L, 2010, J SHOULDER ELB SURG, V19, P601, DOI 10.1016/j.jse.2009.10.001; Walch G, 2005, J SHOULDER ELB SURG, V14, P238, DOI 10.1016/j.jse.2004.07.008; Wolf EM, 2004, ARTHROSCOPY, V20, P5, DOI 10.1016/j.arthro.2003.11.001; Zandi HM, 2006, J SHOULDER ELB SURG, V15, P135, DOI 10.1016/j.jse.2005.06.008; Zingg PO, 2007, J BONE JOINT SURG AM, V89A, P1928, DOI 10.2106/JBJS.F.01073; Zumstein MA, 2008, J BONE JOINT SURG AM, V90A, P2423, DOI 10.2106/JBJS.G.00677	41	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241277	10.1371/journal.pone.0241277	http://dx.doi.org/10.1371/journal.pone.0241277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180802	Green Published, gold			2022-12-26	WOS:000593948000100
J	Lee, KJ; Ryoo, I; Choi, D; Sunwoo, L; You, SH; Jung, HN				Lee, Kyong Joon; Ryoo, Inseon; Choi, Dongjun; Sunwoo, Leonard; You, Sung-Hye; Jung, Hye Na			Performance of deep learning to detect mastoiditis using multiple conventional radiographs of mastoid	PLOS ONE			English	Article							3-DIMENSIONAL RECONSTRUCTION; COMPUTED-TOMOGRAPHY; VOLUME; OTOMASTOIDITIS; PNEUMATIZATION; COMPLICATIONS	Objectives This study aimed to compare the diagnostic performance of deep learning algorithm trained by single view (anterior-posterior (AP) or lateral view) with that trained by multiple views (both views together) in diagnosis of mastoiditis on mastoid series and compare the diagnostic performance between the algorithm and radiologists. Methods Total 9,988 mastoid series (AP and lateral views) were classified as normal or abnormal (mastoiditis) based on radiographic findings. Among them 792 image sets with temporal bone CT were classified as the gold standard test set and remaining sets were randomly divided into training (n = 8,276) and validation (n = 920) sets by 9:1 for developing a deep learning algorithm. Temporal (n = 294) and geographic (n = 308) external test sets were also collected. Diagnostic performance of deep learning algorithm trained by single view was compared with that trained by multiple views. Diagnostic performance of the algorithm and two radiologists was assessed. Inter-observer agreement between the algorithm and radiologists and between two radiologists was calculated. Results Area under the receiver operating characteristic curves of algorithm using multiple views (0.971, 0.978, and 0.965 for gold standard, temporal, and geographic external test sets, respectively) showed higher values than those using single view (0.964/0.953, 0.952/0.961, and 0.961/0.942 for AP view/lateral view of gold standard, temporal external, and geographic external test sets, respectively) in all test sets. The algorithm showed statistically significant higher specificity compared with radiologists (p = 0.018 and 0.012). There was substantial agreement between the algorithm and two radiologists and between two radiologists (kappa = 0.79, 0.8, and 0.76). Conclusion The deep learning algorithm trained by multiple views showed better performance than that trained by single view. The diagnostic performance of the algorithm for detecting mastoiditis on mastoid series was similar to or higher than that of radiologists.	[Lee, Kyong Joon; Choi, Dongjun; Sunwoo, Leonard] Seoul Natl Univ, Dept Radiol, Bundang Hosp, Gyeonggi Do, South Korea; [Ryoo, Inseon; Jung, Hye Na] Korea Univ, Guro Hosp, Dept Radiol, Coll Med, Seoul, South Korea; [You, Sung-Hye] Korea Univ, Dept Radiol, Anam Hosp, Seoul, South Korea	Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Ryoo, I (corresponding author), Korea Univ, Guro Hosp, Dept Radiol, Coll Med, Seoul, South Korea.	isryoo@gmail.com		Lee, Kyong Joon/0000-0002-0658-433X; Sunwoo, Leonard/0000-0003-0374-8658	National Research Foundation of Korea [2017R1C1B5076240];  [13-2019-006]	National Research Foundation of Korea(National Research Foundation of Korea); 	IR, Grant No: 2017R1C1B5076240, National Research Foundation of Korea, URL: www.nrf.re.kr; KJL, Grant No: 13-2019-006, Seoul National University Bundang Hospital Research Fund, URL: www.snubh.org.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldoj N, 2020, EUR RADIOL, V30, P1243, DOI 10.1007/s00330-019-06417-z; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Glorot Xavier, 2010, P MACHINE LEARNING R, P249; Grovik E, 2020, J MAGN RESON IMAGING, V51, P175, DOI 10.1002/jmri.26766; Gulshan V, 2016, JAMA-J AM MED ASSOC, V316, P2402, DOI 10.1001/jama.2016.17216; Hinton G., 2012, NEURAL NETWORKS MACH, V264, P1; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hong AS, 2020, RADIOLOGY, V294, P342, DOI 10.1148/radiol.2019191116; Hu J., 2018, CVPR, P7132, DOI [10.1109/CVPR.2018.00745, DOI 10.1109/CVPR.2018.00745]; Kamel SI, 2017, J AM COLL RADIOL, V14, P337, DOI 10.1016/j.jacr.2016.09.039; Kim HG, 2019, QUANT IMAG MED SURG, V9, P942, DOI 10.21037/qims.2019.05.15; Kim Y, 2019, INVEST RADIOL, V54, P7, DOI 10.1097/RLI.0000000000000503; Kiryu S, 2019, EUR RADIOL, V29, P6891, DOI 10.1007/s00330-019-06327-0; Ko SY, 2019, HEAD NECK-J SCI SPEC, V41, P885, DOI 10.1002/hed.25415; Koc A, 2003, J LARYNGOL OTOL, V117, P595, DOI 10.1258/002221503768199906; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; Lee DH, 2005, SURG RADIOL ANAT, V27, P37, DOI 10.1007/s00276-004-0274-7; Lee JH, 2018, THYROID, V28, P1332, DOI 10.1089/thy.2018.0082; Lee SM, 2019, J THORAC IMAG, V34, P75, DOI 10.1097/RTI.0000000000000387; Leung MKK, 2014, BIOINFORMATICS, V30, P121, DOI 10.1093/bioinformatics/btu277; Luntz M, 2001, ANN OTO RHINOL LARYN, V110, P486, DOI 10.1177/000348940111000516; MAFEE MF, 1985, RADIOLOGY, V155, P391, DOI 10.1148/radiology.155.2.3983389; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Oestreicher-Kedem Y, 2005, ANN OTO RHINOL LARYN, V114, P147, DOI 10.1177/000348940511400212; Palma S, 2014, EUR ARCH OTO-RHINO-L, V271, P925, DOI 10.1007/s00405-013-2454-8; Popescu C, 2009, ROM J MORPHOL EMBRYO, V50, P453; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Rho MH, 2007, AM J NEURORADIOL, V28, P493; Singh R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204155; TODD NW, 1987, ACTA OTO-LARYNGOL, V103, P226, DOI 10.3109/00016488709107788; van den Aardweg MTA, 2008, OTOL NEUROTOL, V29, P751, DOI 10.1097/MAO.0b013e31817f736b; Yala A, 2019, RADIOLOGY, V293, P38, DOI 10.1148/radiol.2019182908; Yao Li, 2018, ARXIV180307703; Yosinski J, 2014, ADV NEUR IN, V27; Zhao R, 2019, MECH SYST SIGNAL PR, V115, P213, DOI 10.1016/j.ymssp.2018.05.050; Zhou Bolei, 2016, IEEE CVF C COMP VIS, DOI DOI 10.1109/CVPR.2016.319	37	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241796	10.1371/journal.pone.0241796	http://dx.doi.org/10.1371/journal.pone.0241796			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33176335	Green Published, gold			2022-12-26	WOS:000593946900062
J	Strayer, EC; Lu, S; Ribeiro, J; Andersen, JF				Strayer, Ethan C.; Lu, Stephen; Ribeiro, Jose; Andersen, John F.			Salivary complement inhibitors from mosquitoes: Structure and mechanism of action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANOPHELINE ANTIPLATELET PROTEIN; PLATELET-AGGREGATION; ALTERNATIVE PATHWAY; PROPERDIN; SYSTEM; IDENTIFICATION; GLAND	Inhibition of the alternative pathway (AP) of complement by saliva from Anopheles mosquitoes facilitates feeding by blocking production of the anaphylatoxins C3a and C5a, which activate mast cells leading to plasma extravasation, pain, and itching. We have previously shown that albicin, a member of the SG7 protein family from An. Albimanus, blocks the AP by binding to and inhibiting the function of the C3 convertase, C3bBb. Here we show that SG7.AF, the albicin homolog from An. freeborni, has a similar potency to albicin but is more active in the presence of properdin, a plasma protein that acts to stabilize C3bBb. Conversely, albicin is highly active in the absence or presence of properdin. Albicin and SG7.AF stabilize the C3bBb complex in a form that accumulates on surface plasmon resonance (SPR) surfaces coated with properdin, but SG7.AF binds with lower affinity than albicin. Albicin induces oligomerization of the complex in solution, suggesting that it is oligomerization that leads to stabilization on SPR surfaces. Anophensin, the albicin ortholog from An. stephensi, is only weakly active as an inhibitor of the AP, suggesting that the SG7 family may play a different functional role in this species and other species of the subgenus Cellia, containing the major malaria vectors in Africa and Asia. Crystal structures of albicin and SG7.AF reveal a novel four-helix bundle arrangement that is stabilized by an N-terminal hydrogen bonding network. These structures provide insight into the SG7 family and related mosquito salivary proteins including the platelet-inhibitory 30 kDa family.	[Strayer, Ethan C.; Lu, Stephen; Ribeiro, Jose; Andersen, John F.] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Andersen, JF (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	john.andersen@nih.gov	Lu, Stephen/K-3162-2016	Strayer, Ethan/0000-0003-3612-741X; Ribeiro, Jose/0000-0002-9107-0818; Lu, Stephen/0000-0001-6893-3710	NIAID, National Institutes of Health	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the intramural research program of the NIAID, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarenga PH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000547; Arca B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3579-8; Calvo L., 2007, J BIOL CHEM, V282, P26928; Champagne D. E., 1995, P NATL ACAD SCI USA, V11, P694; Couvreur B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001400; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; ELLATI SG, 1994, J INVEST DERMATOL, V102, P803, DOI 10.1111/1523-1747.ep12378589; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira VP, 2016, SCI REP-UK, V6, DOI 10.1038/srep19300; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; Hartmann K, 1997, BLOOD, V89, P2863, DOI 10.1182/blood.V89.8.2863; Hayashi H, 2013, PLATELETS, V24, P324, DOI 10.3109/09537104.2012.698430; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Hourcade DE, 2016, MOL IMMUNOL, V69, P62, DOI 10.1016/j.molimm.2015.11.008; Isawa H, 2007, INSECT BIOCHEM MOLEC, V37, P466, DOI 10.1016/j.ibmb.2007.02.002; Jablonka W, 2016, ACS CHEM BIOL, V11, P1934, DOI 10.1021/acschembio.6b00032; Jore MM, 2016, NAT STRUCT MOL BIOL, V23, P378, DOI 10.1038/nsmb.3196; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kemper C, 2010, ANNU REV IMMUNOL, V28, P131, DOI 10.1146/annurev-immunol-030409-101250; Khattab A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003513; Kotsyfakis M, 2006, J BIOL CHEM, V281, P26298, DOI 10.1074/jbc.M513010200; LEPOW IH, 1970, AM J PATHOL, V61, P13; Ma DY, 2011, THROMB HAEMOSTASIS, V105, P1032, DOI 10.1160/TH11-01-0029; Mans BJ, 2007, J BIOL CHEM, V282, P36626, DOI 10.1074/jbc.M706410200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendes-Sousa AF, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01065; Mendes-Sousa AF, 2016, J IMMUNOL, V197, P599, DOI 10.4049/jimmunol.1600020; Mendes-Sousa AF, 2018, INSECT BIOCHEM MOLEC, V92, P12, DOI 10.1016/j.ibmb.2017.11.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park DH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01007; Qureshi AA, 1996, AM J TROP MED HYG, V54, P665, DOI 10.4269/ajtmh.1996.54.665; Reichhardt MP, 2020, P NATL ACAD SCI USA, V117, P362, DOI 10.1073/pnas.1909973116; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rooijakkers SHM, 2007, J IMMUNOL, V179, P2989, DOI 10.4049/jimmunol.179.5.2989; Rooijakkers SHM, 2009, NAT IMMUNOL, V10, P721, DOI 10.1038/ni.1756; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Tyson KR, 2008, J IMMUNOL, V180, P3964, DOI 10.4049/jimmunol.180.6.3964; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; van den Bos RM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02097; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Woodruff TM, 2011, MOL IMMUNOL, V48, P1631, DOI 10.1016/j.molimm.2011.04.014; Yoshida S, 2008, BLOOD, V111, P2007, DOI 10.1182/blood-2007-06-097824	46	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100083	10.1074/jbc.RA120.015230	http://dx.doi.org/10.1074/jbc.RA120.015230			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33199367	Green Published, gold			2022-12-26	WOS:000672866400064
J	Bera, A; Subramanian, M; Karaian, J; Eklund, M; Radhakrishnan, S; Gana, N; Rothwell, S; Pollard, H; Hu, H; Shriver, CD; Srivastava, M				Bera, Alakesh; Subramanian, Madhan; Karaian, John; Eklund, Michael; Radhakrishnan, Surya; Gana, Nahbuma; Rothwell, Stephen; Pollard, Harvey; Hu, Hai; Shriver, Craig D.; Srivastava, Meera			Functional role of vitronectin in breast cancer	PLOS ONE			English	Article							UROKINASE RECEPTOR; EXPRESSION; INTEGRINS; DIAGNOSIS; BINDING; CELLS	Breast Cancer is the most common form of cancer in women worldwide, impacting nearly 2.1 million women each year. Identification of new biomarkers could be key for early diagnosis and detection. Vitronectin, a glycoprotein that is abundantly found in serum, extracellular matrix, and bone, binds to integrin alpha v beta 3, and promotes cell adhesion and migration. Current studies indicate that patients with amplified vitronectin levels have lower survival rates than patients without amplified vitronectin levels. In this study, we focused on the role of vitronectin in breast cancer survival and its functional role as a non-invasive biomarker for early stage and stage specific breast cancer detection. To confirm that the expression of vitronectin is amplified in breast cancer, a total of 240 serum samples (n = 240), 200 from breast cancer patients and 40 controls were analyzed using the Reverse Phase Protein Array (RPPA) technique. Of the 240 samples, 120 samples were of African American (AA) descent, while the other 120 were of White American (WA) descent. Data indicated that there were some possible racial disparities in vitronectin levels and, differences also seen in the recurrent patient samples. Next, we tried to uncover the underlying mechanism which plays a critical role in vitronectin expression. The cellular data from four different breast cancer cell lines- MCF7, MDA-MB-231, MDA-MB-468, and HCC1599 indicated that the PI3K/AKT axis is modulating the expression of vitronectin. We believe that vitronectin concentration levels are involved and connected to the metastasis of breast cancer in certain patients, specifically based on recurrence or ethnicity, which is detrimental for poor prognosis. Therefore, in this current study we showed that the serum vitronectin levels could be an early marker for the breast cancer survival and we also determine the cellular signaling factors which modulate the expression and concentration of vitronectin.	[Bera, Alakesh; Subramanian, Madhan; Karaian, John; Eklund, Michael; Radhakrishnan, Surya; Gana, Nahbuma; Rothwell, Stephen; Pollard, Harvey; Srivastava, Meera] Uniformed Serv Univ Hlth Sci USUHS, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA; [Hu, Hai] Chan Soon Shiong Inst Mol Med, Windber, PA USA; [Shriver, Craig D.] Walter Reed Natl Mil Med Ctr, Murtha Canc Ctr, Bethesda, MD USA	Windber Research Institute; Walter Reed National Military Medical Center	Srivastava, M (corresponding author), Uniformed Serv Univ Hlth Sci USUHS, Dept Anat Physiol & Genet, Bethesda, MD 20814 USA.	meera.srivastava@usuhs.edu		Bera, Alakesh/0000-0002-2690-8178	Collaborative Health Initiative Research Program (CHIRP) [IAA-A-HL-14-007];  [DAMD17-03-1-0107]	Collaborative Health Initiative Research Program (CHIRP); 	This work was supported by the grant to Dr. Meera Srivastava (DoD, DAMD17-03-1-0107). The work was also supported by the Collaborative Health Initiative Research Program (CHIRP) funding (CHIRP ID#IAA-A-HL-14-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bera A, 2020, MIL MED, V185, P669, DOI 10.1093/milmed/usz254; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Burgos-Panadero R, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5693-2; Carriero MV, 1999, CANCER RES, V59, P5307; Carriero MV, 1997, CLIN CANCER RES, V3, P1299; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; DeSantis CE, 2019, CA-CANCER J CLIN, V69, P438, DOI 10.3322/caac.21583; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Ghandi M, 2019, NATURE, V569, P503, DOI 10.1038/s41586-019-1186-3; Hao WD, 2016, TUMOR BIOL, V37, P8909, DOI 10.1007/s13277-015-4750-y; Heyman L, 2008, TUMOR BIOL, V29, P231, DOI 10.1159/000152941; Horton MA, 1997, INT J BIOCHEM CELL B, V29, P721, DOI 10.1016/S1357-2725(96)00155-0; Kadowaki M, 2011, J CANCER RES CLIN, V137, P1105, DOI 10.1007/s00432-010-0974-9; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Liu ZF, 2008, DRUG DEVELOP RES, V69, P329, DOI 10.1002/ddr.20265; Malmgren JA, 2018, BREAST CANCER RES TR, V167, P579, DOI 10.1007/s10549-017-4529-5; Matsuoka T, 2012, BRIT J CANCER, V106, P1535, DOI 10.1038/bjc.2012.107; Meyer T, 1998, BRIT J CANCER, V77, P530, DOI 10.1038/bjc.1998.86; Niu Y, 2016, UROL J, V13, P2527; Nounou MI, 2015, BREAST CANCER-BASIC, V9, P17, DOI 10.4137/BCBCR.S29420; Paplomata E, 2014, THER ADV MED ONCOL, V6, P154, DOI 10.1177/1758834014530023; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Radwan AF, 2019, CLIN LAB, V65, P1185, DOI 10.7754/Clin.Lab.2019.181219; Rea VEA, 2013, MOL CANCER THER, V12, P1402, DOI 10.1158/1535-7163.MCT-12-1249; Reuning U, 2011, J CELL BIOCHEM, V112, P1909, DOI 10.1002/jcb.23111; Revathidevi S, 2019, SEMIN CANCER BIOL, V59, P80, DOI 10.1016/j.semcancer.2019.06.002; Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9; Srivastava M, 2019, MIL MED, V184, P652, DOI 10.1093/milmed/usy417; Takayama S, 2005, ANTICANCER RES, V25, P79; The World Health Organization, STAT BREAST CANC; Tugcu D, 2016, CLIN APPL THROMB-HEM, V22, P28, DOI 10.1177/1076029614531450; Xu N, 2012, ADV EDUC RES, V4, P7; Zhang B, 2016, INT J CLIN EXP MED, V9, P14247	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0242141	10.1371/journal.pone.0242141	http://dx.doi.org/10.1371/journal.pone.0242141			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211735	Green Published, gold			2022-12-26	WOS:000603518300039
J	Hao, JF; Huang, JH; Zhang, AL; Ai, HJ; Zhang, Q; Yang, B				Hao, Junfang; Huang, Jinhai; Zhang, Ailing; Ai, Hongjie; Zhang, Qun; Yang, Bo			Optimal coordinated control of hybrid AC/VSC-HVDC system integrated with DFIG via cooperative beetle antennae search algorithm	PLOS ONE			English	Article							POWER POINT TRACKING; SLIDING-MODE CONTROL; VSC MTDC MODEL; NONLINEAR CONTROL; CONTROL DESIGN; PV SYSTEMS; WIND FARM; EXTRACTION; ENERGY; OPERATION	Nowadays, with the significant integration of various renewable energy, hybrid alternating current/ voltage source converter based high voltage direct current (AC/VSC-HVDC) system integrated with doubly-fed induction generator (DFIG) has achieved rapidly development in smart grid. A proper control system design for hybrid AC/VSC-HVDC system plays a very crucial role for a reliable and effective power transmission. Hence, this paper designs a novel cooperative beetle antenna search (CBAS) algorithm for optimal coordinated control of hybrid AC/VSC-HVDC system integrated with DFIG. Compared with original beetle antennae search (BAS) algorithm, CBAS algorithm can significantly improve searching efficiency via an efficient cooperation with a group of multiple beetles instead of a single beetle. Particularly, CBAS algorithm can effectively escape from local optimums thanks to its dynamic balance mechanism, which can maintain appropriate trade-off between global exploration and local exploitation. Moreover, three case studies are undertaken to validate the effectiveness and superiorities and effectiveness of CBAS algorithm compared against that of other traditional meta-heuristic algorithms. Especially, the average results of fitness function acquired by CBAS algorithm is merely 46.05%, 41.18%, and 47.82% of that of PSO, GA, and BAS algorithm, respectively.	[Hao, Junfang; Huang, Jinhai; Zhang, Ailing; Ai, Hongjie; Zhang, Qun] XJ Elect Co Ltd, Xuchang, Peoples R China; [Yang, Bo] Kunming Univ Sci & Technol, Fac Elect Power Engn, Kunming, Yunnan, Peoples R China	Kunming University of Science & Technology	Huang, JH (corresponding author), XJ Elect Co Ltd, Xuchang, Peoples R China.	huangjinhaigood@163.com						[Anonymous], 2019, PROTECT CONTROL MODE; Beerten J, 2012, IEEE T POWER SYST, V27, P821, DOI 10.1109/TPWRS.2011.2177867; Cai HZ, 2003, COMPUT ELECTR ENG, V29, P135, DOI 10.1016/S0045-7906(01)00019-2; Cole S, 2010, IEEE T POWER SYST, V25, P1655, DOI 10.1109/TPWRS.2010.2040846; Dash PK, 2014, ISA T, V53, P1268, DOI 10.1016/j.isatra.2014.03.011; Durrant M, 2006, IEEE DECIS CONTR P, P3990, DOI 10.1109/CDC.2006.377807; Eriksson R, 2010, ELECTR POW SYST RES, V80, P1406, DOI 10.1016/j.epsr.2010.06.001; Guan L, 2015, IEEE T POWER DELIVER, V30, P1686, DOI 10.1109/TPWRD.2014.2382711; Haileselassie TM, 2012, IEEE T POWER SYST, V27, P1441, DOI 10.1109/TPWRS.2012.2186988; He JH, 2020, PROT CONTR MOD POW, V5, DOI 10.1186/s41601-020-00157-9; He X, 2020, IEEE T POWER SYST, V35, P1846, DOI 10.1109/TPWRS.2019.2935739; HSU YY, 1988, IEEE T ENERGY CONVER, V3, P540, DOI 10.1109/60.8065; Jiang X, 2017, INT J ROBOTICS CONTR, V1, DOI [10.5430/ijrc.v1n1p1, DOI 10.5430/ijrc.v1n1p1]; Jovcic D, 1999, IEE P-GENER TRANSM D, V146, P235, DOI 10.1049/ip-gtd:19990055; Kumar M, 2015, IEEE T SMART GRID, V6, P1588, DOI 10.1109/TSG.2015.2394490; Li BJ, 2019, GREEN ENERGY ENVIRON, V4, P3, DOI 10.1016/j.gee.2018.08.002; Li GD, 2019, PROT CONTR MOD POW, V4, DOI 10.1186/s41601-019-0115-7; Li YJ, 2017, IEEE T ENERGY CONVER, V32, P843, DOI 10.1109/TEC.2017.2663664; Li YJ, 2014, INT J ELEC POWER, V59, P79, DOI 10.1016/j.ijepes.2014.02.003; Logenthiran T, 2012, IEEE T SMART GRID, V3, P925, DOI 10.1109/TSG.2012.2189028; Murty VVSN, 2020, PROT CONTR MOD POW, V5, DOI 10.1186/s41601-019-0147-z; Narendra KG, 1998, IEEE T POWER SYST, V13, P1076, DOI 10.1109/59.709102; Narendra KG, 1997, IEEE T POWER SYST, V12, P1425, DOI 10.1109/59.627837; Peng XT, 2020, IEEE T POWER SYST, V35, P962, DOI 10.1109/TPWRS.2019.2943520; Radwan AAA, 2012, IEEE T SMART GRID, V3, P1382, DOI 10.1109/TSG.2012.2201965; Ruan SY, 2007, INT J ELEC POWER, V29, P565, DOI 10.1016/j.ijepes.2007.01.008; Song DR, 2021, J MOD POWER SYST CLE, V9, P684, DOI 10.35833/MPCE.2019.000240; Song DR, 2018, APPL ENERG, V224, P267, DOI 10.1016/j.apenergy.2018.04.114; Song GB, 2020, PROT CONTR MOD POW, V5, DOI 10.1186/s41601-020-0152-2; Sun K, 2020, IEEE J EM SEL TOP P, V8, P1375, DOI 10.1109/JESTPE.2019.2901747; Vrana TK, 2013, ELECTR POW SYST RES, V103, P137, DOI 10.1016/j.epsr.2013.05.001; Wang Guoqiang, 2011, Proceedings of the CSEE, V31, P8; Yamaji K., 2002, IEEE T POWER SYSTEMS, V14, P629; Yang B, 2018, INT J ELEC POWER, V98, P496, DOI 10.1016/j.ijepes.2017.12.028; Yang B, 2020, ENERG CONVERS MANAGE, V208, DOI 10.1016/j.enconman.2020.112595; Yang B, 2019, J CLEAN PROD, V215, P1203, DOI 10.1016/j.jclepro.2019.01.150; Yang B, 2019, ENERG CONVERS MANAGE, V179, P286, DOI 10.1016/j.enconman.2018.10.074; Yang B, 2018, IET GENER TRANSM DIS, V12, P678, DOI 10.1049/iet-gtd.2016.1768; Yang B, 2018, RENEW ENERG, V119, P577, DOI 10.1016/j.renene.2017.12.047; Yang B, 2018, APPL ENERG, V210, P711, DOI 10.1016/j.apenergy.2017.08.027; Yang B, 2017, ENERG CONVERS MANAGE, V133, P427, DOI 10.1016/j.enconman.2016.10.062; Yang B, 2016, INT J ELEC POWER, V74, P429, DOI 10.1016/j.ijepes.2015.07.036; Young-Moon Park, 1995, Power System Technology, V19, P8; Zhang HX, 2019, APPL ENERG, V242, P883, DOI 10.1016/j.apenergy.2019.03.064; Zhang XS, 2021, INT J ELEC POWER, V124, DOI 10.1016/j.ijepes.2020.106371; Zhang XS, 2020, IEEE T POWER SYST, V35, P2516, DOI 10.1109/TPWRS.2020.2966509; [赵睿 ZHAO Rui], 2011, [电力系统保护与控制, Power System Protection and Control], V39, P7	47	5	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242316	10.1371/journal.pone.0242316	http://dx.doi.org/10.1371/journal.pone.0242316			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206662	Green Published, gold			2022-12-26	WOS:000595265900042
J	Lecorps, B; Nogues, E; von Keyserlingk, MAG; Weary, DM				Lecorps, Benjamin; Nogues, Emeline; von Keyserlingk, Marina A. G.; Weary, Daniel M.			Pessimistic dairy calves are more vulnerable to pain-induced anhedonia	PLOS ONE			English	Article							SOCIAL STRESS; BEHAVIOR; DEPRESSION; OPTIMISM; SUCROSE; REWARD; ANXIETY; CALF; MICE	Pain induces deficits in appreciation of rewards (i.e. anhedonia) and variation in response to pain may be partly explained by individual differences in general expectations (i.e. optimism). Dairy calves are routinely subjected to painful procedures such as hot-iron disbudding. We tested if female Holstein calves (n = 17) display signs of anhedonia (as evidenced by reduced consumption of a sweet solution) after hot-iron disbudding (performed under general and local anesthesia), and whether individual differences in optimism explain the variation in this response. Individual variation in optimism was measured using responses to two judgment bias tests (performed when calves were 25 d old), and anhedonia was measured by comparing consumption of a sweet solution before and after hot-iron disbudding. We found that intake of the sweet solution declined (by mean +/- SD: 48.4 +/- 44.3%) on the day after disbudding, and that more pessimistic calves were more affected. Sweet solution consumption did not return to baseline for the duration of the study (i.e. 5 days). Calves reduced their intake of a sweet solution after hot-iron disbudding, consistent with pain-induced anhedonia, and more pessimistic calves showed stronger evidence of anhedonia, suggesting that they were more affected by the procedure. However, our results cannot rule out the possibility that calf responses were driven by anorexia.	[Lecorps, Benjamin; Nogues, Emeline; von Keyserlingk, Marina A. G.; Weary, Daniel M.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada	University of British Columbia	Weary, DM (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada.	danweary@mail.ubc.ca	Lecorps, Benjamin/GPW-6859-2022; Lecorps, Benjamin/I-3478-2019; Weary, Daniel/A-8868-2010	Lecorps, Benjamin/0000-0001-5973-7152; Lecorps, Benjamin/0000-0001-5973-7152; Weary, Daniel/0000-0002-0917-3982; Nogues, Emeline/0000-0001-6040-5833	Natural Sciences and Engineering Research Council [RGPIN-2016-04620, RGPIN-201506219]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	The study was funded by the Natural Sciences and Engineering Research Council to DW (RGPIN-2016-04620) and M.v.K (RGPIN-201506219). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGMO A, 1995, PHARMACOL BIOCHEM BE, V52, P403, DOI 10.1016/0091-3057(95)00128-J; Alessandro M, 2018, PHYSIOL BEHAV, V184, P248, DOI 10.1016/j.physbeh.2017.11.031; Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; Bargiel-Matusiewicz K, 2009, EUR J MED RES, V14, P271, DOI 10.1186/2047-783X-14-S4-271; Barrot M, 2012, NEUROSCIENCE, V211, P39, DOI 10.1016/j.neuroscience.2011.12.041; Borsook D, 2016, NEUROSCI BIOBEHAV R, V68, P282, DOI 10.1016/j.neubiorev.2016.05.033; Carter AJ, 2013, BIOL REV, V88, P465, DOI 10.1111/brv.12007; Carver CS, 2014, TRENDS COGN SCI, V18, P293, DOI 10.1016/j.tics.2014.02.003; Casoni D, 2019, PHYSIOL BEHAV, V199, P47, DOI 10.1016/j.physbeh.2018.11.010; Clegg ILK, 2017, BEHAV BRAIN RES, V322, P115, DOI 10.1016/j.bbr.2017.01.026; Coghill RC, 2010, HEADACHE, V50, P1531, DOI 10.1111/j.1526-4610.2010.01763.x; CONAB-Companhia Nacional de Abastecimento, 2017, CONAB, V5, P1; Cozzi G, 2015, LIVEST SCI, V179, P4, DOI 10.1016/j.livsci.2015.05.011; Daros RR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098429; Destrez A, 2013, APPL ANIM BEHAV SCI, V148, P28, DOI 10.1016/j.applanim.2013.07.016; Ede T, 2019, VET J, V247, P57, DOI 10.1016/j.tvjl.2019.02.012; Ede T, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0642; Ede T, 2019, J DAIRY SCI, V102, P10677, DOI 10.3168/jds.2019-16325; Ede T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41798-7; Figueroa J, 2015, PHYSIOL BEHAV, V151, P509, DOI 10.1016/j.physbeh.2015.08.027; Finan P, 2008, PSYCHOL HEALTH, V23, P551, DOI 10.1080/08870440802108892; Fureix C, 2015, APPL ANIM BEHAV SCI, V162, P26, DOI 10.1016/j.applanim.2014.11.007; Geers AL, 2010, J PAIN, V11, P1165, DOI 10.1016/j.jpain.2010.02.014; Ginane C, 2011, PHYSIOL BEHAV, V104, P666, DOI 10.1016/j.physbeh.2011.07.011; Hanssen MM, 2013, PAIN, V154, P53, DOI 10.1016/j.pain.2012.08.006; HELLEKANT G, 1994, PHYSIOL BEHAV, V56, P555, DOI 10.1016/0031-9384(94)90301-8; Hoskin R, 2019, COGNITION, V182, P127, DOI 10.1016/j.cognition.2018.08.022; Lecorps B, J DAIRY SCI COMMUN, DOI [10.3168/jdsc.2020-0023, DOI 10.3168/JDSC.2020-0023]; Lecorps B, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00054; Lecorps B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34281-2; Lecorps B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17214-3; National health commission National administration of traditional Chinese medicine, 2020, CHIN J VIRAL DIS, V10, P1, DOI [10.1016/j.joim.2020.04.001, DOI 10.1038/S41598-019-56847-4]; Navratilova E, 2016, J COMP NEUROL, V524, P1646, DOI 10.1002/cne.23968; Neave HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080556; Nielsen CS, 2009, J PAIN, V10, P231, DOI 10.1016/j.jpain.2008.09.010; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; Piardi LN, 2020, J AFFECT DISORDERS, V274, P759, DOI 10.1016/j.jad.2020.05.144; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Refsgaard LK, 2016, J NEUROSCI METH, V262, P85, DOI 10.1016/j.jneumeth.2016.01.019; Roelofs S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00119; Rygula R, 2018, NEUROSCI BIOBEHAV R, V95, P336, DOI 10.1016/j.neubiorev.2018.10.008; Rygula R, 2013, NEUROPSYCHOPHARMACOL, V38, P2188, DOI 10.1038/npp.2013.116; SCHEIER MF, 1992, COGNITIVE THER RES, V16, P201, DOI 10.1007/BF01173489; Simons LE, 2014, NEUROSCI BIOBEHAV R, V39, P61, DOI 10.1016/j.neubiorev.2013.12.006; Stafford KJ, 2011, APPL ANIM BEHAV SCI, V135, P226, DOI 10.1016/j.applanim.2011.10.018; Sutherland MA, 2018, J DAIRY SCI, V101, P8208, DOI 10.3168/jds.2017-14207; Thompson SJ, 2018, PAIN, V159, P1856, DOI 10.1097/j.pain.0000000000001282; Todd CG, 2010, J ANIM SCI, V88, P2019, DOI 10.2527/jas.2009-2340; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Wiech K, 2018, AJOB NEUROSCIENCE, V9, P196, DOI DOI 10.1080/21507740.2018.1496180; Williams ACD, 2016, PAIN, V157, P2420, DOI 10.1097/j.pain.0000000000000613; Winder CB, 2016, J DAIRY SCI, V99, P10161, DOI 10.3168/jds.2016-11270; Zhang C, 2013, PHYSIOL BEHAV, V112, P8, DOI 10.1016/j.physbeh.2013.02.002	53	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242100	10.1371/journal.pone.0242100	http://dx.doi.org/10.1371/journal.pone.0242100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206707	Green Published, gold			2022-12-26	WOS:000595265900015
J	Nitta, JH; Ebihara, A; Smith, AR				Nitta, Joel H.; Ebihara, Atsushi; Smith, Alan R.			A taxonomic and molecular survey of the pteridophytes of the Nectandra Cloud Forest Reserve, Costa Rica	PLOS ONE			English	Article							NEOTROPICAL GENUS; SPECIES RICHNESS; FERNS; DNA; EVOLUTION; TREE; CHLOROPLAST; INHERITANCE; PHYLOGENY; PATTERNS	Floristic surveys are crucial to the conservation of biodiversity, but the vast majority of such surveys are limited to listing species names, and few take into account the evolutionary history of species. Here, we combine classical taxonomic and molecular phylogenetic (DNA barcoding) approaches to catalog the biodiversity of pteridophytes (ferns and lycophytes) of the Nectandra Cloud Forest Reserve, Costa Rica. Surveys were carried out over three field seasons (2008, 2011, and 2013), resulting in 176 species representing 69 genera and 22 families of pteridophytes. Our literature survey of protected areas in Costa Rica shows that Nectandra has an exceptionally diverse pteridophyte flora for its size. Plastid rbcL was selected as a DNA barcode marker and obtained for >95% of pteridophyte taxa at this site. Combined molecular and morphological analyses revealed two previously undescribed taxa that appear to be of hybrid origin. The utility of rbcL for species identification was assessed by calculating minimum interspecific distances and found to have a failure rate of 18%. Finally we compared the distribution of minimum interspecific rbcL distances with two other areas that have been the focus of pteridophyte molecular surveys: Japan and Tahiti. The comparison shows that Nectandra is more similar to Japan than Tahiti, which may reflect the biogeographic history of these floras.	[Nitta, Joel H.] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan; [Ebihara, Atsushi] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan; [Smith, Alan R.] Univ Calif Berkeley, Univ Herbarium, Berkeley, CA 94720 USA	University of Tokyo; National Museum of Nature and Science; University of California System; University of California Berkeley	Nitta, JH (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan.	joelnitta@gmail.com			Nectandra Institute; Japan Society for the Promotion of Science (JSPS) Kakenhi grant [15K07204]; Alan R. Smith Fern Research and Curation Fund	Nectandra Institute; Japan Society for the Promotion of Science (JSPS) Kakenhi grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Alan R. Smith Fern Research and Curation Fund	Field work and publication fees were funded in part by the Nectandra Institute, which was consulted and approved the decision to publish but had no other role in study design, data collection and analysis, or preparation of the manuscript. Molecular work was funded by a Japan Society for the Promotion of Science (JSPS) Kakenhi grant to AE (15K07204). Publication fees were funded in part by a grant to JHN from the Alan R. Smith Fern Research and Curation Fund. Neither JSPS nor the Alan R. Smith Fern Research and Curation Fund had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida TE, 2016, J SYST EVOL, V54, P679, DOI 10.1111/jse.12223; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barthlott W, 2005, NOVA ACT LC, V92, P61; Bigelow S, 1991, FERNS MONTEVERDE; BRAITHWAITE AF, 1964, NEW PHYTOL, V63, P293, DOI 10.1111/j.1469-8137.1964.tb07383.x; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Chao A, 2014, ECOL MONOGR, V84, P45, DOI 10.1890/13-0133.1; Consortium for Spatial Information (CGIAR-CSI), 2020, SRTM 90M DEM DIG EV; Coomes DA, 2005, J ECOL, V93, P918, DOI 10.1111/j.1365-2745.2005.01012.x; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; Delrieu-Trottin E, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0123-5; Ebihara A, 2019, J PLANT RES, V132, P723, DOI 10.1007/s10265-019-01137-3; Ebihara A, 2013, AM J BOT, V100, P735, DOI 10.3732/ajb.1200555; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; GASTONY GJ, 1992, AM J BOT, V79, P716, DOI 10.2307/2444887; George LO, 1999, ECOLOGY, V80, P833, DOI 10.1890/0012-9658(1999)080[0833:TFUAAE]2.0.CO;2; Gonzales J, 2011, PHYTOTAXA, V31, P1; GRAYUM MH, 1987, AM FERN J, V77, P73, DOI 10.2307/1547496; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hirai RY, 2011, TAXON, V60, P1123, DOI 10.1002/tax.604015; Holdridge LR, 1967, LIFE ZONE ECOLOGY, DOI DOI 10.1016/0010-406X(67)90766-9; Janzen DH, 2016, GENOME, V59, P641, DOI 10.1139/gen-2016-0005; JIMENEZ JE, 2016, CHECK LIST, V12, pNIL43, DOI DOI 10.15560/12.2.1859; Kappelle M., 2000, ACTA BOT MEX, V51, P1; Karger DN, 2011, J BIOGEOGR, V38, P1177, DOI 10.1111/j.1365-2699.2010.02468.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kessler M, 2011, GLOBAL ECOL BIOGEOGR, V20, P868, DOI 10.1111/j.1466-8238.2011.00653.x; Kessler M, 2011, BRITTONIA, V63, P233, DOI 10.1007/s12228-010-9156-y; Kuo LY, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00486; Silva VL, 2018, ECOL INDIC, V93, P669, DOI 10.1016/j.ecolind.2018.05.029; Lehtonen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024851; Lellinger D. B., 1989, PTERIDOLOGIA A, V2A, P1, DOI DOI 10.5962/BHL.TITLE.124533; Lennette ET, 2011, CONSERV LETT, V4, P402, DOI 10.1111/j.1755-263X.2011.00193.x; Leon B, 1992, THESIS; Leopold A., 1933, GAME MANAGEMENT; Mickel JT., 2004, PTERIDOPHYTES MEXICO, V88, P1; Moran R, 1995, HASELTONIA, P1; Moran RC, 2018, BRITTONIA, V70, P383, DOI 10.1007/s12228-018-9545-1; Moran Robbin C., 2010, Kew Bulletin, V65, P137, DOI 10.1007/s12225-010-9214-3; Mueller-Dombois D, 2013, BIOGEOSCIENCES, V10, P5171, DOI 10.5194/bg-10-5171-2013; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Nitta J, 2020, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.bnzs7h477, DOI 10.5061/DRYAD.BNZS7H477]; Nitta JH, 2017, ECOL MONOGR, V87, P278, DOI 10.1002/ecm.1246; Norris DH, 2017, BIODIVERS DATA J, V5, DOI 10.3897/BDJ.5.e11778; Organizacion para Estudios Tropicales, 2019, SELV FLOR DIG; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; R Core Team, 2021, R LANGUAGE ENV STAT; Rojas A, 2008, COSTA RICA MES, V3, P1; Rojas-Alvarado A. F., 2017, American Journal of Plant Sciences, V8, P921, DOI 10.4236/ajps.2017.84062; Rovito Sean M., 2015, Check List, V11, P1570; Schuettpelz Eric, 2006, Selbyana, V27, P65; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Schuettpelz E, 2016, J SYST EVOL, V54, P563, DOI 10.1111/jse.12229; Suguitan Jr AL, 2011, PLOS ONE, V6; Sundue MA, 2014, BRITTONIA, V66, P174, DOI 10.1007/s12228-013-9322-0; Telfer AC, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e6313; Testo W, 2016, MOL PHYLOGENET EVOL, V105, P200, DOI 10.1016/j.ympev.2016.09.003; Thiers B, 2020, INDEX HERBARIORUM GL; Vogel JC, 1998, BOT ACTA, V111, P247, DOI 10.1111/j.1438-8677.1998.tb00704.x; Watkins JE, 2006, AM J BOT, V93, P73, DOI 10.3732/ajb.93.1.73; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4	71	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0241231	10.1371/journal.pone.0241231	http://dx.doi.org/10.1371/journal.pone.0241231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206674	gold, Green Published			2022-12-26	WOS:000595265900056
J	OlaOlorun, FM; Anglewicz, P; Moreau, C				OlaOlorun, Funmilola M.; Anglewicz, Philip; Moreau, Caroline			From non-use to covert and overt use of contraception: Identifying community and individual factors informing Nigerian women's degree of contraceptive empowerment	PLOS ONE			English	Article								Objective In Nigeria, unmet need for contraception is high despite improved access to modern contraception. To identify factors that support Nigerian women's contraceptive decisions to achieve their reproductive goals, in the presence or absence of their partner's support, we seek to identify individual/couple and community level determinants of a spectrum of contraceptive practices, from non-use to covert and overt use of contraception. Methods Data were drawn from a national probability survey conducted by Performance Monitoring and Accountability 2020 in Nigeria in 2017-2018. A sample of 12,948 women 15-49 years was included, 6433 of whom were in need of contraception at the time of the survey. We conducted bivariate and multivariate analysis to identify individual/couple and community level factors associated with covert use relative to non-use and to overt use of contraception. Results Altogether, 58.0% of women in need of contraception were non-users, 4.5% were covert users and 37.5% used contraception overtly. Covert users were more educated and wealthier than non-users, but less educated and less wealthy than overt users. Covert users were less likely to cohabitate with their partner compared to non-users [AOR = 4.60 (95%CI: 3.06-6.93)] and overt users [AOR = 5.01 (95%CI: 3.24-7.76)] and more likely to reside in urban areas. At the community level, covert users were more likely to live in communities with higher contraceptive prevalence and higher levels of female education relative to non-users. They were also more likely to live in communities with higher female employment [AOR = 1.62, (95%CI: 0.96-2.73)] compared to overt users. Conclusion By identifying individual and community level factors associated with the spectrum from non-use to covert use and overt use of contraception, this study highlights the importance of integrating individual and community interventions to support women's realization of their reproductive goals.	[OlaOlorun, Funmilola M.] Univ Ibadan, Coll Med, Dept Community Med, Ibadan, Nigeria; [Anglewicz, Philip; Moreau, Caroline] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Baltimore, MD USA; [Moreau, Caroline] INSERM, Soins & Sante Primaire, CESP Ctr Res Epidemiol & Populat Hlth U1018, Villejuif, France	University of Ibadan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Institut National de la Sante et de la Recherche Medicale (Inserm)	OlaOlorun, FM (corresponding author), Univ Ibadan, Coll Med, Dept Community Med, Ibadan, Nigeria.	fmolaolorun@gmail.com	OlaOlorun, Funmilola/ABN-6506-2022	OlaOlorun, Funmilola/0000-0001-5544-2875	Bill and Melinda Gates Foundation [OPP1079004]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	PMA2020 was supported by a grant (OPP1079004) from the Bill and Melinda Gates Foundation (https://www.gatesfoundation.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adanikin AI, 2019, CULT HEALTH SEX, V21, P1439, DOI 10.1080/13691058.2019.1568576; Ajah LO, 2015, J OBSTET GYNAECOL, V35, P628, DOI 10.3109/01443615.2014.991287; Alvergne A, 2017, CONTRACEP REPROD MED, V2, DOI 10.1186/s40834-017-0052-7; [Anonymous], 2020, DIABETES TECHNOL THE, V22, pA, DOI 10.1089/dia.2020.2525.abstracts; Ashraf N, 2014, AM ECON REV, V104, P2210, DOI 10.1257/aer.104.7.2210; Awolude OA., 2019, NIGERIA NIGER J MED, V28, P56, DOI [10.4103/1115-2613.278617, DOI 10.4103/1115-2613.278617]; Ayanore MA, 2017, AFR J REPROD HEALTH, V21, P81, DOI 10.29063/ajrh2017/v21i2.10; Baiden F, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0310-x; Balogun O, 2016, ETHIOP J HEALTH SCI, V26, P439, DOI 10.4314/ejhs.v26i5.5; Biddlecom AE, 1998, STUD FAMILY PLANN, V29, P360, DOI 10.2307/172249; Blackstone SR, 2017, INT Q COMMUNITY HEAL, V37, P79, DOI 10.1177/0272684X16685254; Blanc Ann.K., 1996, NEGOTIATING REPROD O; Choiriyyah I, 2018, STUD FAMILY PLANN, V49, P143, DOI 10.1111/sifp.12053; Ejembi C.L., 2015, CONTEXTUAL FACTORS I; Gasca NC, 2018, J BIOSOC SCI, V50, P326, DOI 10.1017/S0021932017000256; Harris L, 2018, CONTRACEPTION, V98, P357, DOI 10.1016/j.contraception.2018.07.088; Heck CJ, 2018, CONTRACEPTION, V98, P41, DOI 10.1016/j.contraception.2018.02.017; Irani L, 2014, INT PERSPECT SEX R H, V40, DOI 10.1363/4001114; Islam MK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230143; Karp C, 2020, SOC SCI MED, V258, DOI 10.1016/j.socscimed.2020.113086; Kibira SPS, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08977-y; Kriel Y, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0749-y; McCarraher DR, 2006, J BIOSOC SCI, V38, P169, DOI 10.1017/S0021932005025897; Medhanyie AA, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0281-x; Okwor EU, 2010, INT Q COMMUNITY HEAL, V30, P223, DOI 10.2190/IQ.30.3.d; Sundararajan R, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0802-6; Uysal J, 2020, REPROD HEALTH, V17, DOI 10.1186/s12978-020-00916-9; Wolff B, 2000, STUD FAMILY PLANN, V31, P124, DOI 10.1111/j.1728-4465.2000.00124.x; Zimmerman L, 2017, STUD FAMILY PLANN, V48, P293, DOI 10.1111/sifp.12031	29	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242345	10.1371/journal.pone.0242345	http://dx.doi.org/10.1371/journal.pone.0242345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ9VG	33206705	Green Published, gold			2022-12-26	WOS:000595265900026
J	Luo, H; Ma, C				Luo, Huan; Ma, Chao			Identification of prognostic genes in uveal melanoma microenvironment	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; TUMOR-SUPPRESSOR; METASTASIS; EXPRESSION; PROTEIN; CELLS; ABNORMALITIES; MIGRATION; DIAGNOSIS; MARKERS	Background Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Many previous studies have demonstrated that the infiltrating of immune and stromal cells in the tumor microenvironment contributes significantly to prognosis. Methods Dataset TCGA-UVM, download from TCGA portal, was taken as the training cohort, and GSE22138, obtained from GEO database, was set as the validation cohort. ESTIMATE algorithm was applied to find intersection differentially expressed genes (DEGs) among tumor microenvironment. Kaplan-Meier analysis and univariate Cox regression model were performed on intersection DEGs to initial screen for potential prognostic genes. Then these genes entered into the validation cohort for validation using the same methods as that in the training cohort. Moreover, we conducted correlation analyses between the genes obtained in the validation cohort and the status of chromosome 3, chromosome 8q, and tumor metastasis to get prognosis genes. At last, the immune infiltration analysis was performed between the prognostic genes and 6 main kinds of tumor-infiltrating immune cells (TICs) for understanding the role of the genes in the tumor microenvironment. Results 959 intersection DEGs were found in the UM microenvironment. Kaplan-Meier and Cox analysis was then performed in the training and validation cohorts on these DEGs, and 52 genes were identified with potential prognostic value. After comparing the 52 genes to chromosome 3, chromosome 8q, and metastasis, we obtained 21 genes as the prognostic genes. The immune infiltration analysis showed that Neutrophil had the potential prognostic ability, and almost every prognostic gene we had identified was correlated with abundances of Neutrophil and CD8+ T Cell. Conclusions Identifying 21 prognosis genes (SERPINB9, EDNRB, RAPGEF3, HFE, RNF43, ZNF415, IL12RB2, MTUS1, NEDD9, ZNF667, AZGP1, WARS, GEM, RAB31, CALHM2, CA12, MYEOV, CELF2, SLCO5A1, ISM1, and PAPSS2) could accurately identify patients' prognosis and had close interactions with Neutrophil in the tumor environment, which may provide UM patients with personalized prognosis prediction and new treatment insights.	[Luo, Huan; Ma, Chao] Charite Univ Med Berlin, Berlin, Germany; [Luo, Huan; Ma, Chao] Free Univ Berlin, Berlin, Germany; [Luo, Huan; Ma, Chao] Humboldt Univ, Berlin, Germany; [Luo, Huan; Ma, Chao] Berlin Inst Hlth, Berlin, Germany; [Luo, Huan] Charite Univ Med Berlin, Klin Augenheilkunde, Berlin, Germany; [Ma, Chao] Charite Univ Med Berlin, BCRT Berlin Inst Hlth Ctr Regenerat Therapies, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ma, C (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Ma, C (corresponding author), Free Univ Berlin, Berlin, Germany.; Ma, C (corresponding author), Humboldt Univ, Berlin, Germany.; Ma, C (corresponding author), Berlin Inst Hlth, Berlin, Germany.; Ma, C (corresponding author), Charite Univ Med Berlin, BCRT Berlin Inst Hlth Ctr Regenerat Therapies, Berlin, Germany.	chao.ma@charite.de			Zhengzhou University Overseas Virtual Research Institute; China Scholarship Council [201708410121]; German Research Foundation (DFG); Charite - Universitatsmedizin Berlin	Zhengzhou University Overseas Virtual Research Institute; China Scholarship Council(China Scholarship Council); German Research Foundation (DFG)(German Research Foundation (DFG)); Charite - Universitatsmedizin Berlin	Huan Luo and Chao Ma received support from Zhengzhou University Overseas Virtual Research Institute for pursuing doctorates in Germany. Chao Ma received funding from the China Scholarship Council (No. 201708410121) for studying in Germany. We acknowledge support from the German Research Foundation (DFG) and the Open Access Publication Fund of Charite - Universitatsmedizin Berlin for paying publishing fees.	American Cancer Society, 2018, SURV RAT CHRON MYEL; Andrews LP, 2017, IMMUNOL REV, V276, P80, DOI 10.1111/imr.12519; [Anonymous], 2016, THE TOTAL AUDIENCE R; Arnouk H, 2009, PROTEOM CLIN APPL, V3, P516, DOI 10.1002/prca.200800068; Augsburger JJ, 2008, INVEST OPHTH VIS SCI, V49, P2823, DOI 10.1167/iovs.07-1603; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Barnes TA, 2017, BRIT J CANCER, V117, P451, DOI 10.1038/bjc.2017.220; Bronkhorst IHG, 2013, EYE, V27, P217, DOI 10.1038/eye.2012.253; Bronkhorst IHG, 2012, J INNATE IMMUN, V4, P454, DOI 10.1159/000334576; Byrne-Hoffman CN, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00547-4; Cassoux N, 2014, BRIT J OPHTHALMOL, V98, P769, DOI 10.1136/bjophthalmol-2013-303867; Chattopadhyay C, 2016, CANCER-AM CANCER SOC, V122, P2299, DOI 10.1002/cncr.29727; Chen CG, 2017, ANN CLIN LAB SCI, V47, P260; Coffelt SB, 2015, NATURE, V522, P345, DOI 10.1038/nature14282; Damato B, 2010, CLIN CANCER RES, V16, P6083, DOI 10.1158/1078-0432.CCR-10-2076; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Durante MA, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14256-1; Figueiredo CR, 2020, J PATHOL, V250, P420, DOI 10.1002/path.5384; Fridman WH, 2011, CANCER RES, V71, P5601, DOI 10.1158/0008-5472.CAN-11-1316; Ghanipour A, 2009, CANCER EPIDEM BIOMAR, V18, P2949, DOI 10.1158/1055-9965.EPI-09-0456; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Gnana-Prakasam JP, 2013, INVEST OPHTH VIS SCI, V54, P63, DOI 10.1167/iovs.12-10312; Grismayer B, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-62; Gu YY, 2017, PROTEIN CELL, V8, P455, DOI 10.1007/s13238-017-0393-7; Harbour J William, 2013, PLoS Curr, V5, DOI 10.1371/currents.eogt.af8ba80fc776c8f1ce8f5dc485d4a618; Huang JLY, 2015, CANCER RES, V75, P3384, DOI 10.1158/0008-5472.CAN-14-3229; Isidor B, 2010, AM J HUM GENET, V87, P95, DOI 10.1016/j.ajhg.2010.05.012; Jablonska J, 2010, J CLIN INVEST, V120, P1151, DOI 10.1172/JCI37223; Janssen JWG, 2002, INT J CANCER, V102, P608, DOI 10.1002/ijc.10765; Jia D, 2018, AGING-US, V10, P592, DOI 10.18632/aging.101415; Jiang XJ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0928-4; Jin YJ, 2014, INT J CANCER, V134, P2294, DOI 10.1002/ijc.28568; Jun M, 2018, MOL PSYCHIATR, V23, P883, DOI 10.1038/mp.2017.229; Kong B, 2010, ONCOGENE, V29, P5146, DOI 10.1038/onc.2010.258; Krantz BA, 2017, CLIN OPHTHALMOL, V11, P279, DOI 10.2147/OPTH.S89591; Kuang DM, 2011, J HEPATOL, V54, P948, DOI 10.1016/j.jhep.2010.08.041; Kumar N, 2017, MOL CELL BIOCHEM, V430, P115, DOI 10.1007/s11010-017-2959-3; Lane AM, 2018, JAMA OPHTHALMOL, V136, P981, DOI 10.1001/jamaophthalmol.2018.2466; Lee CW, 2015, ONCOTARGET, V6, P21979, DOI 10.18632/oncotarget.4273; Lee HC, 2019, J VIROL, V93, DOI 10.1128/JVI.01291-18; Leone A, 2001, ONCOGENE, V20, P3217, DOI 10.1038/sj.onc.1204420; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Li Y, 2019, J CELL BIOCHEM, V120, P8630, DOI 10.1002/jcb.28151; Long Long, 2018, Genes Cancer, V9, P176, DOI 10.18632/genesandcancer.180; Lu SL, 2020, APPL IMMUNOHISTO M M, V28, P360, DOI 10.1097/PAI.0000000000000761; McCully KS, 2016, COMPR PHYSIOL, V6, P471, DOI 10.1002/cphy.c150021; McKenna KC, 2010, OCUL IMMUNOL INFLAMM, V18, P80, DOI 10.3109/09273941003669950; Meng WX, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0506-0; Morita A, 2006, PROTEOMICS, V6, P5880, DOI 10.1002/pmic.200500708; Narasimhaiah D, 2019, CANCER MED-US, V8, P3036, DOI 10.1002/cam4.2122; Omura N, 2008, CANCER BIOL THER, V7, P1146, DOI 10.4161/cbt.7.7.6208; Onken MD, 2008, CLIN CANCER RES, V14, P3737, DOI 10.1158/1078-0432.CCR-07-5144; Onken MD, 2012, OPHTHALMOLOGY, V119, P1596, DOI 10.1016/j.ophtha.2012.02.017; Onken MD, 2010, J MOL DIAGN, V12, P461, DOI 10.2353/jmoldx.2010.090220; Paley EL, 2011, PANCREAS, V40, P1043, DOI 10.1097/MPA.0b013e318222e635; Pan XB, 2019, AGING-US, V11, P10154, DOI 10.18632/aging.102429; Pique L, 2019, ONCOGENE, V38, P7106, DOI 10.1038/s41388-019-0936-x; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Rohr-Udilova N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24437-5; Rousalova I, 2010, INT J ONCOL, V36, P275, DOI 10.3892/ijo_00000498; Scholes AGM, 2003, INVEST OPHTH VIS SCI, V44, P1008, DOI 10.1167/iovs.02-0159; Singh AD, 2011, OPHTHALMOLOGY, V118, P1881, DOI 10.1016/j.ophtha.2011.01.040; Sisley K, 1997, GENE CHROMOSOME CANC, V19, P22, DOI 10.1002/(SICI)1098-2264(199705)19:1<22::AID-GCC4>3.0.CO;2-2; Smith SL, 2002, BRIT J CANCER, V87, P1308, DOI 10.1038/sj.bjc.6600620; Souri Z, 2019, CANCERS, V11, DOI 10.3390/cancers11081132; Versluis M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116371; White VA, 1998, CANCER, V83, P354, DOI 10.1002/(SICI)1097-0142(19980715)83:2<354::AID-CNCR20>3.3.CO;2-C; Xiong YF, 2018, CANCER MED-US, V7, P4496, DOI 10.1002/cam4.1745; Xu WH, 2019, AGING-US, V11, P6999, DOI 10.18632/aging.102233; Yang PP, 2020, BIOSCI BIOTECH BIOCH, V84, P471, DOI 10.1080/09168451.2019.1686967; Yang S, 2020, J CELL PHYSIOL, V235, P1025, DOI 10.1002/jcp.29018; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zeng D, 2018, BRIT J SURG, V105, P1338, DOI 10.1002/bjs.10871; Zhang PP, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2625-1; Zhang YH, 2019, CELL DEATH DIFFER, V26, P565, DOI 10.1038/s41418-018-0147-y; Zheng YS, 2019, MOL CELL PROBE, V48, DOI 10.1016/j.mcp.2019.101445; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	79	13	13	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242263	10.1371/journal.pone.0242263	http://dx.doi.org/10.1371/journal.pone.0242263			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196683	gold, Green Published			2022-12-26	WOS:000595266800022
J	Shahshahani, PM; Ashton-Miller, JA				Mirshams Shahshahani, Payam; Ashton-Miller, James A.			On the importance of the hip abductors during a clinical one legged balance test: A theoretical study	PLOS ONE			English	Article							FRONTAL PLANE; POSTURAL CONTROL; ANKLE; MOTION; AGE; PRESSURE; STRENGTH; DISPLACEMENT; MECHANISMS; STABILITY	Background The ability to balance on one foot for a certain time is a widely used clinical test to assess the effects of age and diseases like peripheral neuropathy on balance. While state-space methods have been used to explore the mechanical demands and achievable accelerations for balancing on two feet in the sagittal plane, less is known about the requirements for sustaining one legged balance (OLB) in the frontal plane. Research question While most studies have focused on ankle function in OLB, can age and/or disease-related decreases in maximum hip abduction strength also affect OLB ability? Methods A two-link frontal plane state space model was used to define and explore the 'feasible balance region' which helps reveal the requirements for maintaining and restoring OLB, given the adverse effects of age and peripheral neuropathy on maximum hip and ankle strengths. Results Maintaining quasistatic OLB required 50%-106% of the maximum hip abduction strength in young and older adults, and older patients with peripheral neuropathy. Effectiveness of a 'hip strategy' in recovering OLB was heavily dependent on the maximum hip abduction strength, and for healthy older women was as important as ankle strength. Natural reductions of strength due to healthy aging did not show a meaningful reduction in meeting the strength requirement of clinical OLB. However deficits in hip strength typical of patients with peripheral neuropathy did adversely affect both quasistatic OLB and recoverable OLB states. Significance The importance of hip muscle strength has been underappreciated in the clinical OLB test. This is partly because the passive tissues of the hip joint can mask moderate deficits in hip abduction strength until it is needed for recovering OLB. Adding a follow up OLB test with a slightly raised pelvis would be a simple way to check for adequate hip abductor muscle strength.	[Mirshams Shahshahani, Payam; Ashton-Miller, James A.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Ashton-Miller, James A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Ashton-Miller, James A.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Ashton-Miller, James A.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Shahshahani, PM (corresponding author), Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA.	mirshams@umich.edu		Mirshams Shahshahani, Payam/0000-0001-6930-6225	National Institute of Aging [P30 AG024824]	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	JAAM: National Institute of Aging P30 AG024824 Research Grant (Biomechanics Core) https://www.nia.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allet L, 2012, MUSCLE NERVE, V45, P578, DOI 10.1002/mus.22325; Anderson DE, 2007, J BIOMECH, V40, P3105, DOI 10.1016/j.jbiomech.2007.03.022; BOHANNON RW, 1994, PERCEPT MOTOR SKILL, V78, P801, DOI 10.2466/pms.1994.78.3.801; Burdet C, 2007, J APPL BIOMECH, V23, P63, DOI 10.1123/jab.23.1.63; CAHALAN TD, 1989, CLIN ORTHOP RELAT R, P136; Enoka RM, 2003, J ELECTROMYOGR KINES, V13, P1, DOI 10.1016/S1050-6411(02)00084-6; Fujimoto M, 2015, J BIOMECH, V48, P963, DOI 10.1016/j.jbiomech.2015.02.012; HARDCASTLE P, 1985, J BONE JOINT SURG BR, V67, P741, DOI 10.1302/0301-620X.67B5.4055873; Harry G, 1988, ANTHROPOMETRY MASS D, VI; Hibbeler R. C., 2016, ENG MECH STATICS DYN; Hof AL, 2007, J BIOMECH, V40, P451, DOI 10.1016/j.jbiomech.2005.12.016; Hoogvliet P, 1997, ARCH PHYS MED REHAB, V78, P284, DOI 10.1016/S0003-9993(97)90035-6; Hoogvliet P, 1997, GAIT POSTURE, V6, P39, DOI 10.1016/S0966-6362(96)01096-X; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hurvitz EA, 2000, ARCH PHYS MED REHAB, V81, P587, DOI 10.1016/S0003-9993(00)90039-X; INMAN VT, 1947, J BONE JOINT SURG, V29, P607; Isman R, 1969, B PROSTHET RES; Kendall KD, 2013, CLIN J SPORT MED, V23, P45, DOI 10.1097/JSM.0b013e31825e66a1; King DL, 2002, GAIT POSTURE, V15, P172, DOI 10.1016/S0966-6362(01)00189-8; KING MB, 1994, J GERONTOL, V49, pM258, DOI 10.1093/geronj/49.6.M258; KUO AD, 1993, J BIOMECH, V26, P137, DOI 10.1016/0021-9290(93)90085-S; Law LAF, 2010, ERGONOMICS, V53, P109, DOI 10.1080/00140130903389068; MACKINNON CD, 1993, J BIOMECH, V26, P633, DOI 10.1016/0021-9290(93)90027-C; MCLEISH RD, 1970, J BIOMECH, V3, P191, DOI 10.1016/0021-9290(70)90006-0; Morioka S, 2012, CURRENT GERONTOLOGY, DOI [10.1155/2012/516283, DOI 10.1155/2012/516283]; NEUMANN DA, 1988, PHYS THER, V68, P496, DOI 10.1093/ptj/68.4.496; Nussbaumer S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-194; Otten E, 1999, PHILOS T ROY SOC B, V354, P869, DOI 10.1098/rstb.1999.0439; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Porto JM, 2019, AGING CLIN EXP RES, V31, P621, DOI 10.1007/s40520-018-1025-7; Prior S, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-13; RIACH CL, 1993, GAIT POSTURE, V1, P105, DOI 10.1016/0966-6362(93)90021-R; RICHARDSON JK, 1995, J GERONTOL A-BIOL, V50, pM211, DOI 10.1093/gerona/50A.4.M211; Rogers MW, 2003, EXERC SPORT SCI REV, V31, P182, DOI 10.1097/00003677-200310000-00005; SEPIC SB, 1986, AM J PHYS MED REHAB, V65, P75; Thelen DG, 1996, J GERONTOL A-BIOL, V51, pM226, DOI 10.1093/gerona/51A.5.M226; TROPP H, 1988, J ORTHOPAED RES, V6, P833, DOI 10.1002/jor.1100060607; van Arkel RJ, 2015, J BIOMECH, V48, P3803, DOI 10.1016/j.jbiomech.2015.09.002; Vellas BJ, 1997, J AM GERIATR SOC, V45, P735, DOI 10.1111/j.1532-5415.1997.tb01479.x; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; YOON YS, 1982, J BIOMECH, V15, P905, DOI 10.1016/0021-9290(82)90008-2	41	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242454	10.1371/journal.pone.0242454	http://dx.doi.org/10.1371/journal.pone.0242454			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0NB	33186397	Green Published, gold			2022-12-26	WOS:000593949800010
J	Golledge, J; Moxon, JV; Rowbotham, S; Pinchbeck, J; Quigley, F; Jenkins, J				Golledge, Jonathan; Moxon, Joseph V.; Rowbotham, Sophie; Pinchbeck, Jenna; Quigley, Frank; Jenkins, Jason			High ankle brachial index predicts high risk of cardiovascular events amongst people with peripheral artery disease	PLOS ONE			English	Article							MORTALITY; ASSOCIATION; VALIDATION	Ankle-brachial pressure index (ABPI) is commonly measured in people referred to vascular specialists. This study aimed to assess the association of high ABPI (>= 1.4) with cardiovascular events in people with peripheral artery disease (PAD). 1533 participants with PAD diagnosed by a vascular specialist were prospectively recruited from four out-patient clinics in Australia. ABPI was measured at recruitment and the occurrence of myocardial infarction (MI), stroke or cardiovascular death (major cardiovascular events; MACE) and any amputation were recorded over a median (inter-quartile range) follow-up of 3.3 (1.0-7.1) years. The association of high, compared to normal, low (0.5-0.9) or very low (<0.5), ABPI with clinical events was estimated using Cox proportional hazard analyses, adjusting for traditional risk factors and reported as hazard ratio with 95% confidence intervals. 596 (38.9%), 676 (44.1%), 157 (10.2%) and 104 (6.8%) participants had normal, low, very low and high ABPI, respectively. Participants with high ABPI had increased risk of MACE, MI and death by comparison to those with either normal ABPI [1.69 (1.07, 2.65), 1.93 (1.07, 3.46) and 1.67 (1.09, 2.56)] or either low or very low ABPI [1.51 (1.02, 2.23), 1.92 (1.16, 3.19) and 1.47 (1.02, 2.14)] after adjusting for other risk factors. Findings were similar in a sensitivity analysis excluding people with ABPI only measured in one leg (n = 120). Participants with high ABPI also had an increased risk of MACE and MI compared to those with very low ABPI alone. High ABPI is a strong indicator of excess risk of cardiovascular events amongst people with PAD.	[Golledge, Jonathan; Moxon, Joseph V.; Rowbotham, Sophie; Pinchbeck, Jenna] James Cook Univ, Coll Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld, Australia; [Golledge, Jonathan; Moxon, Joseph V.] James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Mol Therapeut, Townsville, Qld, Australia; [Golledge, Jonathan] Townsville Univ Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia; [Rowbotham, Sophie] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Quigley, Frank] Mater Hosp, Townsville, Qld, Australia; [Jenkins, Jason] Royal Brisbane & Womens Hosp, Dept Vasc & Endovasc Surg, Herston, Qld, Australia	James Cook University; James Cook University; University of Queensland; Royal Brisbane & Women's Hospital	Golledge, J (corresponding author), James Cook Univ, Coll Med & Dent, Queensland Res Ctr Peripheral Vasc Dis, Townsville, Qld, Australia.; Golledge, J (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Mol Therapeut, Townsville, Qld, Australia.; Golledge, J (corresponding author), Townsville Univ Hosp, Dept Vasc & Endovasc Surg, Townsville, Qld, Australia.	Jonathan.Golledge@jcu.edu.au	; Moxon, Joseph/C-3585-2011	Saratzis, Athanasios/0000-0002-3399-094X; Moxon, Joseph/0000-0002-2131-2068	National Health and Medical Research Council [1063476, 1000967, 1117061]; James Cook University; Queensland Government; Queensland Government, Australia; Advance Queensland Fellowship from the Queensland Government	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); James Cook University; Queensland Government; Queensland Government, Australia; Advance Queensland Fellowship from the Queensland Government	This work was supported by funding from the National Health and Medical Research Council (1063476 and 1000967), James Cook University and the Queensland Government. JG holds a Practitioner Fellowship from the National Health and Medical Research Council (1117061) and a Senior Clinical Research Fellowship from the Queensland Government, Australia. JVM supported by an Advance Queensland Fellowship from the Queensland Government. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aboyans V, 2018, EUR J VASC ENDOVASC, V55, P305, DOI 10.1016/j.ejvs.2017.07.018; Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Allison MA, 2008, J AM COLL CARDIOL, V51, P1292, DOI 10.1016/j.jacc.2007.11.064; [Anonymous], 2018, FOCUS CATAL, V2018, P4, DOI DOI 10.1016/S0306-3747(18)30166-0; Bin Hong J, 2016, STROKE, V47, P317, DOI 10.1161/STROKEAHA.115.011321; Criqui MH, 2010, J AM COLL CARDIOL, V56, P1506, DOI 10.1016/j.jacc.2010.04.060; Fernando ME, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0057-7; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Fowkes FGR, 2014, EUR J PREV CARDIOL, V21, P310, DOI 10.1177/2047487313516564; Gerhard-Herman MD, 2017, CIRCULATION, V135, pE726, DOI 10.1161/CIR.0000000000000471; Golledge J, 2018, BRIT J SURG, V105, P699, DOI 10.1002/bjs.10765; Golledge J, 2007, J VASC SURG, V45, P40, DOI 10.1016/j.jvs.2006.09.006; Golledge J, 2013, ATHEROSCLEROSIS, V229, P549, DOI 10.1016/j.atherosclerosis.2013.04.030; Hendriks EJE, 2016, ARTERIOSCL THROM VAS, V36, P412, DOI 10.1161/ATVBAHA.115.306657; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Magee R, 2010, EUR J VASC ENDOVASC, V39, P606, DOI 10.1016/j.ejvs.2009.12.031; Manapurathe DT, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010748; Morris DR, 2017, BRIT J SURG, V104, P544, DOI 10.1002/bjs.10460; Morris DR, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009943; Morris DR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001105; Moxon JV, 2017, ATHEROSCLEROSIS, V263, P301, DOI 10.1016/j.atherosclerosis.2017.06.925; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Palamuthusingam D, 2011, ANN VASC SURG, V25, P1050, DOI 10.1016/j.avsg.2011.05.015; Parr A, 2010, AM J CARDIOL, V105, P895, DOI 10.1016/j.amjcard.2009.10.067; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Queensland Health, QUEENSL HOSP ADM DAT; Resnick HE, 2004, CIRCULATION, V109, P733, DOI 10.1161/01.CIR.0000112642.63927.54; Wattanakit K, 2007, ATHEROSCLEROSIS, V190, P459, DOI 10.1016/j.atherosclerosis.2006.02.039; Yang Y, 2020, INT ANGIOL, V39, P131, DOI 10.23736/S0392-9590.19.04276-7	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242228	10.1371/journal.pone.0242228	http://dx.doi.org/10.1371/journal.pone.0242228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180875	Green Accepted, Green Published, gold			2022-12-26	WOS:000593948000017
J	Kesely, K; Noomuna, P; Vieth, M; Hipskind, P; Haldar, K; Pantaleo, A; Turrini, F; Low, PS				Kesely, Kristina; Noomuna, Panae; Vieth, Michal; Hipskind, Philip; Haldar, Kasturi; Pantaleo, Antonella; Turrini, Francesco; Low, Philip S.			Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; OXIDATIVE STRESS; ERYTHROCYTE BAND-3; MALARIA; PROTEIN; PHOSPHORYLATION; MEMBRANE; PHOSPHATASE; DRUGS; RESISTANCE	Although current malaria therapies inhibit pathways encoded in the parasite's genome, we have looked for anti-malaria drugs that can target an erythrocyte component because development of drug resistance might be suppressed if the parasite cannot mutate the drug's target. In search for such erythrocyte targets, we noted that human erythrocytes express tyrosine kinases, whereas the Plasmodium falciparum genome encodes no obvious tyrosine kinases. We therefore screened a library of tyrosine kinase inhibitors from Eli Lilly and Co. in a search for inhibitors with possible antimalarial activity. We report that although most tyrosine kinase inhibitors exerted no effect on parasite survival, a subset of tyrosine kinase inhibitors displayed potent anti-malarial activity. Moreover, all inhibitors found to block tyrosine phosphorylation of band 3 specifically suppressed P. falciparum survival at the parasite egress stage of its intra-erythrocyte life cycle. Conversely, tyrosine kinase inhibitors that failed to block band 3 tyrosine phosphorylation but still terminated the parasitemia were observed to halt parasite proliferation at other stages of the parasite's life cycle. Taken together these results suggest that certain erythrocyte tyrosine kinases may be important to P. falciparum maturation and that inhibitors that block these kinases may contribute to novel therapies for P. falciparum malaria.	[Kesely, Kristina; Noomuna, Panae; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Kesely, Kristina; Noomuna, Panae; Low, Philip S.] Purdue Univ, Inst Drug Discovery, W Lafayette, IN 47907 USA; [Vieth, Michal] Eli Lilly & Co, San Diego, CA USA; [Hipskind, Philip] Indiana Univ Sch Med, Bloomington, IN USA; [Hipskind, Philip] Clin Pharmacol R2 402 MDEP, Indianapolis, IN USA; [Haldar, Kasturi] Univ Notre Dame, Galvin Life Sci Ctr, Notre Dame, IN USA; [Pantaleo, Antonella] Univ Sassari, Sassari, Italy; [Turrini, Francesco] Univ Torino, Turin, Italy	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Eli Lilly; Indiana University System; Indiana University Bloomington; University of Notre Dame; University of Sassari; University of Turin	Low, PS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.; Low, PS (corresponding author), Purdue Univ, Inst Drug Discovery, W Lafayette, IN 47907 USA.	plow@purdue.edu		Noomuna, Panae/0000-0001-7696-4488	National Institutes of Health, USA [GM24417-39/40]	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a grant from the National Institutes of Health, USA (GM24417-39/40 to PSL). The funder provided support in the form of salaries for authors KK and PN, and purchase of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors PH and MV are employed by Eli Lilly and Company. Eli Lilly and Company provided the test drugs, but did not have any role in the study design, data collection, funding, or decision to publish. The roles of the authors are clearly defined in the authors' contribution section.	Abossie A, 2020, INFECT DRUG RESIST, V13, P363, DOI 10.2147/IDR.S223873; Adderley JD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17829-7; Ahuja LG, 2019, P NATL ACAD SCI USA, V116, P15052, DOI 10.1073/pnas.1900163116; Anong WA, 2009, BLOOD, V114, P1904, DOI 10.1182/blood-2009-02-203216; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Bazie VB., 2020, J BIOSCI MED, V8, P82, DOI [10.4236/jbm.2020.82007, DOI 10.4236/JBM.2020.82007]; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Bordin L, 2002, BLOOD, V100, P276, DOI 10.1182/blood.V100.1.276; Borhani DW, 2012, J COMPUT AID MOL DES, V26, P15, DOI 10.1007/s10822-011-9517-y; Cibulskis RE, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0151-8; Conrad MD, 2019, LANCET INFECT DIS, V19, pE338, DOI 10.1016/S1473-3099(19)30261-0; Conroy AL, 2012, EXPERT REV ANTI-INFE, V10, P1331, DOI [10.1586/eri.12.123, 10.1586/ERI.12.123]; Crans DC, 2004, CHEM REV, V104, P849, DOI 10.1021/cr020607t; Cunha-Rodrigues M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002732; Dluzewski AR, 1996, EXPERIENTIA, V52, P621, DOI 10.1007/BF01969742; Dondorp AM, 2003, REDOX REP, V8, P292, DOI 10.1179/135100003225002934; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Early JV, 2016, ANTIMICROB AGENTS CH, V60, P3608, DOI 10.1128/AAC.02896-15; 2019, J AM COLL RADIOL, V16, pS141, DOI 10.1016/j.jacr.2019.02.015; Fairhurst RM, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0013-2016; Ferru E, 2011, BLOOD, V117, P5998, DOI 10.1182/blood-2010-11-317024; Gao C, 2017, J COMPUT CHEM, V38, P1229, DOI 10.1002/jcc.24714; Gilge JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004015; Hafen E, 1998, SCIENCE, V280, P1212, DOI 10.1126/science.280.5367.1212; HARRISON ML, 1994, J BIOL CHEM, V269, P955; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Karisch R, 2011, CELL, V146, P826, DOI 10.1016/j.cell.2011.07.020; Kesely KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164895; Klinkert MQ, 2006, MINI-REV MED CHEM, V6, P131, DOI 10.2174/138955706775475939; Lovera S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004578; Lu F, 2017, NEW ENGL J MED, V376, P991, DOI 10.1056/NEJMc1612765; Martin E, 2015, BBA-PROTEINS PROTEOM, V1854, P1595, DOI 10.1016/j.bbapap.2015.03.014; Meng YL, 2018, J CHEM THEORY COMPUT, V14, P2721, DOI 10.1021/acs.jctc.7b01170; MINETTI M, 1993, ARCH BIOCHEM BIOPHYS, V302, P233, DOI 10.1006/abbi.1993.1205; MONTEIRO HP, 1991, FEBS LETT, V295, P146, DOI 10.1016/0014-5793(91)81405-W; Murphy SC, 2006, PLOS MED, V3, P2403, DOI 10.1371/journal.pmed.0030528; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Noomuna P, 2020, BRIT J HAEMATOL, V190, P599, DOI 10.1111/bjh.16671; Ouji M, 2018, PARASITE, V25, DOI 10.1051/parasite/2018021; Pabon A, 2003, CLIN BIOCHEM, V36, P71, DOI 10.1016/S0009-9120(02)00423-X; Pacheco MA, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03247-z; Pantaleo A, 2017, BLOOD, V130, P1031, DOI 10.1182/blood-2016-11-748053; Pantaleo A, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6051093; Pantaleo A, 2010, PROTEOMICS, V10, P3469, DOI 10.1002/pmic.201000269; Pantaleo A, 2009, BIOCHEM J, V418, P359, DOI 10.1042/BJ20081557; Peters KG, 2003, J INORG BIOCHEM, V96, P321, DOI 10.1016/S0162-0134(03)00236-8; Puchulu-Campanella E, 2016, P NATL ACAD SCI USA, V113, P13732, DOI 10.1073/pnas.1611904113; Rosenthal PJ, 2020, LANCET, V395, P1316, DOI 10.1016/S0140-6736(20)30560-2; Sicard A, 2011, CELL MICROBIOL, V13, P836, DOI 10.1111/j.1462-5822.2011.01582.x; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Sutherland JJ, 2013, BBA-PROTEINS PROTEOM, V1834, P1425, DOI 10.1016/j.bbapap.2012.12.023; The Lancet, 2020, LANCET PLANET HLTH, V4, pe168; Thellier M, 2020, MED MALADIES INFECT, V50, P99, DOI 10.1016/j.medmal.2019.06.002; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tsamesidis I, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9080753; Wang L, 2015, J AM CHEM SOC, V137, P2695, DOI 10.1021/ja512751q; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WHO, 2019, MALARIA; Woodring JL, 2015, MEDCHEMCOMM, V6, P339, DOI 10.1039/c4md00441h; World Health Organization, 2018, TOP 10 CAUS DEATH; World Health Organization, 2003, WORLD MALARIA REPORT; Zipser Y, 1997, FEBS LETT, V406, P126, DOI 10.1016/S0014-5793(97)00263-9; Zipser Y, 2002, BIOCHEM J, V368, P137, DOI 10.1042/BJ20020359	63	7	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0242372	10.1371/journal.pone.0242372	http://dx.doi.org/10.1371/journal.pone.0242372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180822	Green Published, gold			2022-12-26	WOS:000593948000057
J	Yang, HK; Kim, DH; Hwang, JM				Yang, Hee Kyung; Kim, Dong Hyun; Hwang, Jeong-Min			Botulinum toxin injection without electromyographic guidance in consecutive esotropia	PLOS ONE			English	Article							PRISMATIC CORRECTION; SUBTENON INJECTION; EXTRAOCULAR-MUSCLE; CHILDREN; STRABISMUS; MANAGEMENT; EXOTROPIA; INFANTILE; RECESSION	Purpose To investigate the efficacy of botulinum toxin injection without electromyographic guidance for the treatment of consecutive esotropia. Methods A retrospective study was performed on 49 subjects with consecutive esotropia who received botulinum toxin injection in the medial rectus muscles without the use of electromyographic guidance. Treatment was considered successful if the final ocular alignment was orthotropic or esodeviation was <= 10 prism diopters (PD) during distant fixation. Results The mean age was 15.2 +/- 8.3 years. The mean esodeviation before injection was 21.8 +/- 9.1 PD at distance and 21.3 +/- 8.3 PD at near. The mean number of injections per patient was 1.3 +/- 0.7, and 46 patients (93.9%) received two or fewer injections. At 6 months after the final injection, the mean angle of esodeviation was 7.3 +/- 6.0 PD at distance and 7.5 +/- 6.6 PD at near (all p<0.001), and 69.4% showed successful alignment. By multivariate analysis, an initial postoperative esodeviation of <= 18 PD at one month after exotropia surgery was considered to be a predictive factor for successful botulinum toxin injection (P = 0.007). Vertical deviation and/or ptosis occurred in 4 patients (8.2%) at two weeks after injection, which all resolved within three months. There was no recurrence of exotropia up to the final follow-up examination. Conclusion Botulinum toxin injection without electromyographic guidance is safe and effective in the treatment of consecutive esotropia without causing recurrent exotropia. Successful botulinum toxin injection is likely in patients with an initial postoperative esodeviation of 18PD or less at one month after exotropia surgery.	[Yang, Hee Kyung; Kim, Dong Hyun; Hwang, Jeong-Min] Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Coll Med, Seongnam, South Korea	Seoul National University (SNU)	Hwang, JM (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Ophthalmol, Coll Med, Seongnam, South Korea.	hjm@snu.ac.kr		Kim, Dong Hyun/0000-0003-3179-3122	National Research Foundation of Korea(NRF) - Korean government, Ministry of Science and ICT(MSIT) [2020R1F1A1074481]	National Research Foundation of Korea(NRF) - Korean government, Ministry of Science and ICT(MSIT)	This work was supported by the National Research Foundation of Korea(NRF) grant funded by the Korean government, Ministry of Science and ICT(MSIT) (No. 2020R1F1A1074481). The funding organization had no role in study design, data collection and analysis, or decision to publish.	Adamopoulou C, 2015, J PEDIAT OPHTH STRAB, V52, P344, DOI 10.3928/01913913-20150929-16; Benabent EC, 2002, J PEDIAT OPHTH STRAB, V39, P231, DOI 10.3928/0191-3913-20020701-12; BIGLAN AW, 1989, OPHTHALMOLOGY, V96, P935; Chen J, 2013, EYE, V27, P382, DOI 10.1038/eye.2012.264; Couser NL, 2012, STRABISMUS, V20, P158, DOI 10.3109/09273972.2012.702324; Dawson ELM, 1999, J AAPOS, V3, P269, DOI 10.1016/S1091-8531(99)70021-2; Erichsen JT, 2014, J COMP NEUROL, V522, P626, DOI 10.1002/cne.23437; Kao LY, 2003, J PEDIAT OPHTH STRAB, V40, P27, DOI 10.3928/0191-3913-20030101-09; Kim DW, 2015, EYE, V29, P776, DOI 10.1038/eye.2015.16; Kim TW, 2005, OPHTHALMOLOGICA, V219, P237, DOI 10.1159/000085734; Kowal L, 2007, DISABIL REHABIL, V29, P1823, DOI 10.1080/09638280701568189; Lee DH, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0649-2; Lee EK, 2015, BRIT J OPHTHALMOL, V99, P342, DOI 10.1136/bjophthalmol-2014-305861; Lee EK, 2013, OPHTHALMOLOGY, V120, P504, DOI 10.1016/j.ophtha.2012.08.026; Liu MM, 2004, AM J OPHTHALMOL, V137, P201, DOI 10.1016/S0002-9394(03)00837-7; MAGOON EH, 1989, OPHTHALMOLOGY, V96, P931; McNeer K W, 1990, J Pediatr Ophthalmol Strabismus, V27, P3; Mohan M, 1999, BRIT J OPHTHALMOL, V83, P503; Oh JY, 2006, EYE, V20, P1268, DOI 10.1038/sj.eye.6702091; Paik HJ, 2009, JPN J OPHTHALMOL, V53, P229, DOI 10.1007/s10384-009-0658-7; Park Hoon, 2016, Korean J Ophthalmol, V30, P60, DOI 10.3341/kjo.2016.30.1.60; Pehere Niranjan, 2011, J Pediatr Ophthalmol Strabismus, V48 Online, pe1, DOI 10.3928/01913913-20110118-06; Rayner S A, 1999, Strabismus, V7, P103, DOI 10.1076/stra.7.2.103.650; Rowe FJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006499.pub4; Sanjari MS, 2008, J AAPOS, V12, P259, DOI 10.1016/j.jaapos.2007.11.006; SCOTT AB, 1990, OPHTHALMOLOGY, V97, P1434; SPENCER RF, 1987, ARCH OPHTHALMOL-CHIC, V105, P1703, DOI 10.1001/archopht.1987.01060120101035; Wutthiphan Sorot, 2008, J Med Assoc Thai, V91 Suppl 1, pS86; Yam JCS, 2012, J AAPOS, V16, P274, DOI 10.1016/j.jaapos.2012.01.005	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241588	10.1371/journal.pone.0241588	http://dx.doi.org/10.1371/journal.pone.0241588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180838	gold, Green Published			2022-12-26	WOS:000593948000027
J	King, JT; Yoon, JS; Rentsch, CT; Tate, JP; Park, LS; Kidwai-Khan, F; Skanderson, M; Hauser, RG; Jacobson, DA; Erdos, J; Cho, K; Ramoni, R; Gagnon, DR; Justice, AC				King, Joseph T., Jr.; Yoon, James S.; Rentsch, Christopher T.; Tate, Janet P.; Park, Lesley S.; Kidwai-Khan, Farah; Skanderson, Melissa; Hauser, Ronald G.; Jacobson, Daniel A.; Erdos, Joseph; Cho, Kelly; Ramoni, Rachel; Gagnon, David R.; Justice, Amy C.			Development and validation of a 30-day mortality index based on pre-existing medical administrative data from 13,323 COVID-19 patients: The Veterans Health Administration COVID-19 (VACO) Index	PLOS ONE			English	Article							MILITARY	Background Available COVID-19 mortality indices are limited to acute inpatient data. Using nationwide medical administrative data available prior to SARS-CoV-2 infection from the US Veterans Health Administration (VA), we developed the VA COVID-19 (VACO) 30-day mortality index and validated the index in two independent, prospective samples. Methods and findings We reviewed SARS-CoV-2 testing results within the VA between February 8 and August 18, 2020. The sample was split into a development cohort (test positive between March 2 and April 15, 2020), an early validation cohort (test positive between April 16 and May 18, 2020), and a late validation cohort (test positive between May 19 and July 19, 2020). Our logistic regression model in the development cohort considered demographics (age, sex, race/ethnicity), and pre-existing medical conditions and the Charlson Comorbidity Index (CCI) derived from ICD-10 diagnosis codes. Weights were fixed to create the VACO Index that was then validated by comparing area under receiver operating characteristic curves (AUC) in the early and late validation cohorts and among important validation cohort subgroups defined by sex, race/ethnicity, and geographic region. We also evaluated calibration curves and the range of predictions generated within age categories. 13,323 individuals tested positive for SARS-CoV-2 (median age: 63 years; 91% male; 42% non-Hispanic Black). We observed 480/3,681 (13%) deaths in development, 253/2,151 (12%) deaths in the early validation cohort, and 403/7,491 (5%) deaths in the late validation cohort. Age, multimorbidity described with CCI, and a history of myocardial infarction or peripheral vascular disease were independently associated with mortality-no other individual comorbid diagnosis provided additional information. The VACO Index discriminated mortality in development (AUC = 0.79, 95% CI: 0.77-0.81), and in early (AUC = 0.81 95% CI: 0.78-0.83) and late (AUC = 0.84, 95% CI: 0.78-0.86) validation. The VACO Index allows personalized estimates of 30-day mortality after COVID-19 infection. For example, among those aged 60-64 years, overall mortality was estimated at 9% (95% CI: 6-11%). The Index further discriminated risk in this age stratum from 4% (95% CI: 3-7%) to 21% (95% CI: 12-31%), depending on sex and comorbid disease. Conclusion Prior to infection, demographics and comorbid conditions can discriminate COVID-19 mortality risk overall and within age strata. The VACO Index reproducibly identified individuals at substantial risk of COVID-19 mortality who might consider continuing social distancing, despite relaxed state and local guidelines.	[King, Joseph T., Jr.; Yoon, James S.; Rentsch, Christopher T.; Tate, Janet P.; Kidwai-Khan, Farah; Skanderson, Melissa; Hauser, Ronald G.; Erdos, Joseph; Justice, Amy C.] US Dept Vet Affairs, VA Connecticut Healthcare Syst, West Haven, CT 06516 USA; [King, Joseph T., Jr.; Yoon, James S.; Gagnon, David R.] Yale Sch Med, Dept Neurosurg, New Haven, CT USA; [Yoon, James S.] Yale Sch Med, New Haven, CT USA; [Rentsch, Christopher T.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Tate, Janet P.; Kidwai-Khan, Farah; Justice, Amy C.] Yale Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Park, Lesley S.] Stanford Univ, Sch Med, Stanford Ctr Populat Hlth Sci, Stanford, CA 94305 USA; [Hauser, Ronald G.] Yale Sch Med, Dept Lab Med, New Haven, CT USA; [Jacobson, Daniel A.] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA; [Jacobson, Daniel A.] Univ Tennessee, Bredesen Ctr Interdisciplinary Res & Grad Educ, Knoxville, TN USA; [Jacobson, Daniel A.] Univ Tennessee, Dept Psychol, Knoxville, TN 37996 USA; [Erdos, Joseph] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Cho, Kelly] US Dept Vet Affairs, VA Boston Healthcare Syst, Boston, MA USA; [Cho, Kelly] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Cho, Kelly] Brigham & Womens Hosp, Div Aging, 75 Francis St, Boston, MA 02115 USA; [Ramoni, Rachel] US Dept Vet Affairs, Off Res & Dev, Vet Hlth Adm, Washington, DC USA; [Gagnon, David R.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Justice, Amy C.] Yale Sch Publ Hlth, New Haven, CT 06510 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University; University of London; London School of Hygiene & Tropical Medicine; Yale University; Stanford University; Yale University; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Boston University; Yale University	Justice, AC (corresponding author), US Dept Vet Affairs, VA Connecticut Healthcare Syst, West Haven, CT 06516 USA.; Justice, AC (corresponding author), Yale Sch Med, Dept Internal Med, New Haven, CT 06510 USA.; Justice, AC (corresponding author), Yale Sch Publ Hlth, New Haven, CT 06510 USA.	amy.justice@yale.edu		Park, Lesley S./0000-0002-3848-7753; Rentsch, Christopher/0000-0002-1408-7907; Jacobson, Daniel/0000-0002-9822-8251; Hauser, Ronald/0000-0002-7361-7162	Department of Veterans Affairs, Office of Research and Development, Million Veteran Program Core [MVP000]; National Institute on Alcohol Abuse and Alcoholism [U01-AA026224, U24-AA020794, U01-AA020790, U10-AA013566]; US Department of Energy [LOIS:10074]	Department of Veterans Affairs, Office of Research and Development, Million Veteran Program Core(US Department of Veterans Affairs); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); US Department of Energy(United States Department of Energy (DOE))	ACJ: Department of Veterans Affairs, Office of Research and Development, Million Veteran Program Core (#MVP000; https://www.research.va.gov/).ACJ: National Institute on Alcohol Abuse and Alcoholism (U01-AA026224, U24-AA020794, U01-AA020790, U10-AA013566; https://www.niaaa.nih.gov/).DAJ: Laboratory Directed Research and Development Program of Oak Ridge National Laboratory, managed by UTBattelle, LLC for the US Department of Energy (LOIS:10074). The views and opinions expressed in this manuscript are those of the authors and do not necessarily represent those of the Department of Veterans Affairs, Department of Energy, or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, OSGOODE HALL LAW J, V44, pii; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Driggin E, 2020, J AM COLL CARDIOL, V75, P2352, DOI 10.1016/j.jacc.2020.03.031; Eibner Christine, 2016, Rand Health Q, V5, P13; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Fried JA, 2020, CIRCULATION, V141, P1930, DOI 10.1161/CIRCULATIONAHA.120.047164; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319; Havers FP, 2020, JAMA INTERN MED, V180, P1576, DOI 10.1001/jamainternmed.2020.4130; Henry BM, 2020, CLIN CHEM LAB MED, V58, P1021, DOI 10.1515/cclm-2020-0369; Hoerster KD, 2012, AM J PREV MED, V43, P483, DOI 10.1016/j.amepre.2012.07.029; Jordan Rachel E, 2020, BMJ, V368, pm1198, DOI 10.1136/bmj.m1198; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Lehavot K, 2012, AM J PREV MED, V42, P473, DOI 10.1016/j.amepre.2012.01.006; Li XC, 2020, J ALLERGY CLIN IMMUN, V146, P110, DOI 10.1016/j.jaci.2020.04.006; Liang WH, 2020, JAMA INTERN MED, V180, P1081, DOI 10.1001/jamainternmed.2020.2033; Njei B, 2019, MED CARE, V57, P279, DOI 10.1097/MLR.0000000000001071; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Statistics USBoL, 2020, LAB FORC STAT CURR P; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wu JM, 2022, CRIT REV FOOD SCI, V62, P783, DOI [10.1080/10408398.2020.1828813, 10.1038/s41591-020-0822-7]; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Yan L, 2020, NAT MACH INTELL, V2, P283, DOI 10.1038/s42256-020-0180-7; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; 2020, MMWR MORBID MORTAL W, V69, P343	29	48	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241825	10.1371/journal.pone.0241825	http://dx.doi.org/10.1371/journal.pone.0241825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175863	gold, Green Accepted, Green Published			2022-12-26	WOS:000593946900069
J	Orton, F; Svanholm, S; Jansson, E; Carlsson, Y; Eriksson, A; Webster, TU; McMillan, T; Leishman, M; Verbruggen, B; Economou, T; Tyler, CR; Berg, C				Orton, Frances; Svanholm, Sofie; Jansson, Erika; Carlsson, Ylva; Eriksson, Andreas; Uren Webster, Tamsyn; McMillan, Tamara; Leishman, Martin; Verbruggen, Bas; Economou, Theo; Tyler, Charles R.; Berg, Cecilia			A laboratory investigation into features of morphology and physiology for their potential to predict reproductive success in male frogs	PLOS ONE			English	Article							XENOPUS-TROPICALIS; CORTICOSTERONE; HISTOCHEMISTRY; TESTOSTERONE; EXTINCTION; BEHAVIOR; TOADS	Amphibian populations are declining globally, however, the contribution of reduced reproduction to declines is unknown. We investigated associations between morphological (weight/snout-vent length, nuptial pad colour/size, forelimb width/size) and physiological (nuptial pad/testis histomorphology, plasma hormones, gene expression) features with reproductive success in males as measured by amplexus success and fertility rate (% eggs fertilised) in laboratory maintained Silurana/Xenopus tropicalis. We explored the robustness of these features to predict amplexus success/fertility rate by investigating these associations within a sub-set of frogs exposed to anti-androgens (flutamide (50 mu g/L)/linuron (9 or 45 mu g/L)). In unexposed males, nuptial pad features (size/colour/number of hooks/androgen receptor mRNA) were positively associated with amplexus success, but not with fertility rate. In exposed males, many of the associations with amplexus success differed from untreated animals (they were either reversed or absent). In the exposed males forelimb width/nuptial pad morphology were also associated with fertility rate. However, a more darkly coloured nuptial pad was positively associated with amplexus success across all groups and was indicative of androgen status. Our findings demonstrate the central role for nuptial pad morphology in reproductive success in S. tropicalis, however, the lack of concordance between unexposed/exposed frogs complicates understanding of the utility of features of nuptial pad morphology as biomarkers in wild populations. In conclusion, our work has indicated that nuptial pad and forelimb morphology have potential for development as biomarkers of reproductive health in wild anurans, however, further research is needed to establish this.	[Orton, Frances; McMillan, Tamara; Leishman, Martin] Univ West Scotland, Sch Hlth & Life Sci, Paisley, Renfrew, Scotland; [Svanholm, Sofie; Jansson, Erika; Carlsson, Ylva; Eriksson, Andreas; Berg, Cecilia] Uppsala Univ, Dept Environm Toxicol, Uppsala, Sweden; [Uren Webster, Tamsyn] Swansea Univ, Swansea, W Glam, Wales; [Verbruggen, Bas; Economou, Theo; Tyler, Charles R.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England	University of West Scotland; Uppsala University; Swansea University; University of Exeter	Orton, F (corresponding author), Univ West Scotland, Sch Hlth & Life Sci, Paisley, Renfrew, Scotland.	frances.orton@uws.ac.uk		Orton, Frances/0000-0003-4829-5074	Swedish Research Council Formas; Carl Trygger Foundation; MistraPharma; Swedish Foundation for Strategic Environmental Research, Mistra; Department for the Environment, Food and Rural Affairs; University of the West of Scotland; University of Exeter	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Carl Trygger Foundation; MistraPharma; Swedish Foundation for Strategic Environmental Research, Mistra(Swedish Foundation for Strategic Research); Department for the Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); University of the West of Scotland; University of Exeter	This work was supported by the Swedish Research Council Formas (CB), the Carl Trygger Foundation (CB), and MistraPharma, a research programme supported by the Swedish Foundation for Strategic Environmental Research, Mistra (CB), Department for the Environment, Food and Rural Affairs (FO), the University of the West of Scotland (FO) and the University of Exeter (CRT).; The authors thank Moa Safholm, Department of Environmental Toxicology, Uppsala University, for contributing to planning and execution of the study; Margareta Mattsson, Department of Environmental Toxicology, Uppsala University, for support producing histological slides; Jenny Kreuger, The Centre for Chemical Pesticides (CKB), Swedish University of Agricultural Sciences, Uppsala, for collaboration regarding the linuron analyses; and Jerker Fick, Umea University, for collaboration regarding the flutamide analyses.	[Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; Arak A., 1983, P181; Berg C, 2009, J TOXICOL ENV HEAL A, V72, P219, DOI 10.1080/15287390802539079; Bernanke J, 2009, REV ENVIRON CONTAM T, V198, P1, DOI 10.1007/978-0-387-09647-6_1; Bokony V, 2018, SCI TOTAL ENVIRON, V634, P1335, DOI 10.1016/j.scitotenv.2018.03.363; Brizzi R, 2003, REPROD BIOL PHYLOGEN, V2, P253; Carr JA, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 2: AMPHIBIANS, P99; Diaz SJ, 2019, STATUS TRENDS DRIVER; Emerson SB, 1999, GEN COMP ENDOCR, V114, P173, DOI 10.1006/gcen.1999.7251; Epstein MS, 1997, CAN J ZOOL, V75, P472, DOI 10.1139/z97-057; Greene AE, 2009, J HERPETOL, V43, P244, DOI 10.1670/08-112R.1; Gyllenhammar I, 2009, AQUAT TOXICOL, V91, P171, DOI 10.1016/j.aquatox.2008.06.019; Harland R, 2003, HARLAND XENOPUS TROP; Herrel A, 2012, J ZOOL, V287, P311, DOI 10.1111/j.1469-7998.2012.00919.x; Iguchi T, 2011, ISAREN 7 INT S AMPH; Zamora-Carnacho FJ, 2017, PEERJ, V5, DOI 10.7717/peerj.3791; Kanda R, 2019, ASIAN INTERNET ENGINEERING CONFERENCE (AINTEC 2019), P47, DOI 10.1145/3340422.3343641; Leary CJ, 2006, HORM BEHAV, V49, P425, DOI 10.1016/j.yhbeh.2005.09.004; Loman Jon, 2002, Journal for Nature Conservation (Jena), V10, P95, DOI 10.1078/1617-1381-00011; Lynch Laura C., 1995, Amphibia-Reptilia, V16, P113, DOI 10.1163/156853895X00299; Marler CA, 1996, J ZOOL, V240, P397, DOI 10.1111/j.1469-7998.1996.tb05294.x; Measey GJ, 1997, COPEIA, P601, DOI 10.2307/1447567; MULLER ERA, 1969, GEN COMP ENDOCR, V13, P275, DOI 10.1016/0016-6480(69)90249-4; Narayan EJ, 2013, GEN COMP ENDOCR, V191, P225, DOI 10.1016/j.ygcen.2013.06.018; Orton F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27161-2; Orton F, 2020, ECOTOXICOLOGY; Orton F, 2015, BIOL REV, V90, P1100, DOI 10.1111/brv.12147; Orton F, 2011, ENVIRON HEALTH PERSP, V119, P794, DOI [10.1289/ehp.1002895, 10.1289/ehp.1002897]; Orton F, 2011, ECOTOXICOLOGY, V20, P901, DOI 10.1007/s10646-011-0658-5; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Rastogi R.K., 1976, Bollettino Zool, V43, P151; Rastogi RK, 2011, HORMONES AND REPRODUCTION OF VERTEBRATES, VOL 2: AMPHIBIANS, P171; Roberts JD, 2011, ADV STUD BEHAV, V43, P1, DOI 10.1016/B978-0-12-380896-7.00001-0; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; SWISHER JE, 1969, AM ZOOL, V9, P573; Sztatecsny M, 2006, J ZOOL, V270, P517, DOI 10.1111/j.1469-7998.2006.00120.x; THOMAS EO, 1993, COPEIA, P133, DOI 10.2307/1446304; Wyk JHv, 2003, ARCH ENV CONTAMINATI, V44, P247	40	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241625	10.1371/journal.pone.0241625	http://dx.doi.org/10.1371/journal.pone.0241625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0LY	33175903	Green Published, gold			2022-12-26	WOS:000593946900072
J	Glaza, P; Ranaweera, CB; Shiva, S; Roy, A; Geisbrecht, BV; Schoenen, FJ; Zolkiewski, M				Glaza, Przemyslaw; Ranaweera, Chathurange B.; Shiva, Sunitha; Roy, Anuradha; Geisbrecht, Brian, V; Schoenen, Frank J.; Zolkiewski, Michal			Repurposing p97 inhibitors for chemical modulation of the bacterial ClpB-DnaK bichaperone system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; PLUS ATPASE CLPB; ESCHERICHIA-COLI; STRESS TOLERANCE; MOLECULAR CHAPERONES; BIOFILM FORMATION; TERMINAL DOMAIN; SUBSTRATE; VIRULENCE; HOST	The ClpB-DnaK bichaperone system reactivates aggregated cellular proteins and is essential for survival of bacteria, fungi, protozoa, and plants under stress. AAA+ ATPase ClpB is a promising target for the development of antimicrobials because a loss of its activity is detrimental for survival of many pathogens and no apparent ClpB orthologs are found in metazoans. We investigated ClpB activity in the presence of several compounds that were previously described as inhibitor leads for the human AAA+ ATPase p97, an antitumor target. We discovered that N-2,N-4-dibenzylquinazoline-2,4-diamine (DBeQ), the least potent among the tested p97 inhibitors, binds to ClpB with a K-d similar to 60 mu M and inhibits the casein-activated, but not the basal, ATPase activity of ClpB with an IC50 similar to 5 mu M. The remaining p97 ligands, which displayed a higher affinity toward p97, did not affect the ClpB ATPase. DBeQ also interacted with DnaK with a K-d similar to 100 mu M and did not affect the DnaK ATPase but inhibited the DnaK chaperone activity in vitro. DBeQ inhibited the reactivation of aggregated proteins by the ClpB-DnaK bichaperone system in vitro with an IC50 similar to 5 mu M and suppressed the growth of cultured Escherichia coli. The DBeQ-nduced loss of E. coli proliferation was exacerbated by heat shock but was nearly eliminated in a ClpB-deficient E. coli strain, which demonstrates a significant selectivity of DBeQ toward ClpB in cells. Our results provide chemical validation of ClpB as a target for developing novel antimicrobials. We identified DBeQ as a promising lead compound for structural optimization aimed at selective targeting of ClpB and/or DnaK.	[Glaza, Przemyslaw; Ranaweera, Chathurange B.; Shiva, Sunitha; Geisbrecht, Brian, V; Zolkiewski, Michal] Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA; [Roy, Anuradha] Univ Kansas, High Throughput Screening Lab, Lawrence, KS 66045 USA; [Roy, Anuradha; Schoenen, Frank J.] Univ Kansas, Higuchi Biosci Ctr, Lawrence, KS 66045 USA; [Schoenen, Frank J.] Univ Kansas Canc Ctr, Lead Dev & Optimizat Shared Resource, Kansas City, KS USA	Kansas State University; University of Kansas; University of Kansas	Zolkiewski, M (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, Manhattan, KS 66506 USA.	michalz@ksu.edu		Ranaweera, Chathuranga/0000-0003-4173-0547; Glaza, Przemyslaw/0000-0003-3532-1085; Roy, Anuradha/0000-0002-1057-1443; Schoenen, Frank/0000-0003-2711-1117	National Institutes of Health [AI121366, AI141586, GM121511]; Kansas Agricultural Experiment Station [19-063-J]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kansas Agricultural Experiment Station	This study was supported by grants from the National Institutes of Health, AI121366 and AI141586 (to M. Z.) and GM121511 (to B. V. G.), and by the Kansas Agricultural Experiment Station (contribution 19-063-J). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604; Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Avellaneda MJ, 2020, NATURE, V578, P317, DOI 10.1038/s41586-020-1964-y; Barnett ME, 2000, J BIOL CHEM, V275, P37565, DOI 10.1074/jbc.M005211200; Barnett ME, 2005, J BIOL CHEM, V280, P34940, DOI 10.1074/jbc.M505653200; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; Buchberger A, 1999, J BIOL CHEM, V274, P38017, DOI 10.1074/jbc.274.53.38017; Capestany CA, 2008, J BACTERIOL, V190, P1436, DOI 10.1128/JB.01632-07; Chamera T, 2019, J MOL BIOL, V431, P2180, DOI 10.1016/j.jmb.2019.04.014; Chapman E, 2015, MOLECULES, V20, P3027, DOI 10.3390/molecules20023027; Chou TF, 2013, CHEMMEDCHEM, V8, P297, DOI 10.1002/cmdc.201200520; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; DEGRAW JI, 1974, J MED CHEM, V17, P762, DOI 10.1021/jm00253a026; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Erives AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117192; Estorninho M, 2010, MICROBIOL-SGM, V156, P3445, DOI 10.1099/mic.0.042275-0; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Garcia BL, 2017, J IMMUNOL, V198, P3705, DOI 10.4049/jimmunol.1601932; GEORGOPOULOS CP, 1977, MOL GEN GENET, V151, P35, DOI 10.1007/BF00446910; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Harbut MB, 2012, P NATL ACAD SCI USA, V109, P21486, DOI 10.1073/pnas.1216016110; Haslberger T, 2007, MOL CELL, V25, P247, DOI 10.1016/j.molcel.2006.11.008; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; HESS HH, 1975, ANAL BIOCHEM, V63, P607, DOI 10.1016/0003-2697(75)90388-7; Hoskins JR, 2009, P NATL ACAD SCI USA, V106, P22233, DOI 10.1073/pnas.0911937106; Jones AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34701; Kalanon M, 2010, BIOCHEM SOC T, V38, P775, DOI 10.1042/BST0380775; Kannan TR, 2008, INFECT IMMUN, V76, P5082, DOI 10.1128/IAI.00698-08; Krobitsch S, 1999, CELL STRESS CHAPERON, V4, P191; Kuczynska-Wisnik D, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx059; Kuntumalla S, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-147; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; LeBel R.G., 1962, J CHEM ENG DATA, V7, P100, DOI [DOI 10.1021/JE60012A032, 10.1021/je60012a032]; Lehoux DE, 2002, FEMS MICROBIOL LETT, V210, P73, DOI 10.1111/j.1574-6968.2002.tb11162.x; Lipinska N, 2013, J BIOL CHEM, V288, P2857, DOI 10.1074/jbc.M112.387589; Lourdault K, 2011, INFECT IMMUN, V79, P3711, DOI 10.1128/IAI.05168-11; Magnaghi P, 2013, NAT CHEM BIOL, V9, P548, DOI [10.1038/nchembio.1313, 10.1038/NCHEMBIO.1313]; Martin I, 2013, J MED CHEM, V56, P7177, DOI 10.1021/jm400499k; Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x; de Oliveira NEM, 2011, MICROBIOL-SGM, V157, P656, DOI 10.1099/mic.0.041897-0; Nagy M, 2006, ARCH BIOCHEM BIOPHYS, V453, P63, DOI 10.1016/j.abb.2006.03.004; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; Neuwald AF, 1999, GENOME RES, V9, P27; Ngansop F, 2013, BIOCHEM BIOPH RES CO, V439, P191, DOI 10.1016/j.bbrc.2013.08.064; Oguchi Y, 2012, NAT STRUCT MOL BIOL, V19, P1338, DOI 10.1038/nsmb.2441; Pieper R, 2009, PROTEOMICS, V9, P5029, DOI 10.1002/pmic.200900196; Ranaweera CB, 2018, ARCH BIOCHEM BIOPHYS, V655, P12, DOI 10.1016/j.abb.2018.08.002; Rizo AN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10150-y; Rodriguez-Aliaga P, 2016, NAT STRUCT MOL BIOL, V23, P974, DOI 10.1038/nsmb.3298; Schlieker C, 2004, NAT STRUCT MOL BIOL, V11, P607, DOI 10.1038/nsmb787; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; SPENCE J, 1990, J BACTERIOL, V172, P7157, DOI 10.1128/jb.172.12.7157-7166.1990; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stewart GR, 2004, CURR OPIN IMMUNOL, V16, P506, DOI 10.1016/j.coi.2004.05.007; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Turner AK, 1998, INFECT IMMUN, V66, P2099, DOI 10.1128/IAI.66.5.2099-2106.1998; Van Horn KS, 2014, J MED CHEM, V57, P5141, DOI 10.1021/jm5000408; Van Horn KS, 2014, J MED CHEM, V57, P3075, DOI 10.1021/jm500039e; Vaubourgeix J, 2015, CELL HOST MICROBE, V17, P178, DOI 10.1016/j.chom.2014.12.008; Vekaria PH, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00181; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Weibezahn J, 2003, J BIOL CHEM, V278, P32608, DOI 10.1074/jbc.M303653200; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Winkler J, 2010, EMBO J, V29, P910, DOI 10.1038/emboj.2009.412; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062454; Zhang T, 2012, PROTEINS, V80, P2758, DOI 10.1002/prot.24159; Zolkiewski M, 1999, J BIOL CHEM, V274, P28083, DOI 10.1074/jbc.274.40.28083; Zolkiewski M, 2012, ARCH BIOCHEM BIOPHYS, V520, P1, DOI 10.1016/j.abb.2012.01.012	73	6	6	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100079	10.1074/jbc.RA120.015413	http://dx.doi.org/10.1074/jbc.RA120.015413			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33187983	Green Published, gold			2022-12-26	WOS:000672866400060
J	Hedman, AC; Li, ZG; Gorisse, L; Parvathaneni, S; Morgan, CJ; Sacks, DB				Hedman, Andrew C.; Li, Zhigang; Gorisse, Laetitia; Parvathaneni, Swetha; Morgan, Chase J.; Sacks, David B.			IQGAP1 binds AMPK and is required for maximum AMPK activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE KINASE-BETA; PROTEIN-KINASE; INTEGRATES CA2+/CALMODULIN; GLUCOSE-HOMEOSTASIS; HEPATIC STEATOSIS; MICE LACKING; CALMODULIN; LIVER; CDC42; IDENTIFICATION	AMP-activated protein kinase (AMPK) is a fundamental component of a protein kinase cascade that is an energy sensor. AMPK maintains energy homeostasis in the cell by promoting catabolic and inhibiting anabolic pathways. Activation of AMPK requires phosphorylation by the liver kinase B1 or by the Ca2+/calmodulin-dependent protein kinase 2 (CaMKK2). The scaffold protein IQGAP1 regulates intracellular signaling pathways, such as the mitogen-activated protein kinase and AKT signaling cascades. Recent work implicates the participation of IQGAP1 in metabolic function, but the molecular mechanisms underlying these effects are poorly understood. Here, using several approaches including binding analysis with fusion proteins, siRNA-mediated gene silencing, RT-PCR, and knockout mice, we investigated whether IQGAP1 modulates AMPK signaling. In vitro analysis reveals that IQGAP1 binds directly to the a1 subunit of AMPK. In addition, we observed a direct interaction between IQGAP1 and CaMKK2, which is mediated by the IQ domain of IQGAP1. Both CaMKK2 and AMPK associate with IQGAP1 in cells. The ability of metformin and increased intracellular free Ca2+ concentrations to activate AMPK is reduced in cells lacking IQGAP1. Importantly, Ca2+-stimulated AMPK phosphorylation was rescued by re-expression of IQGAP1 in IQGAP1-null cell lines. Comparison of the fasting response in wild-type and IQGAP1-null mice revealed that transcriptional regulation of the gluconeogenesis genes PCK1 and G6PC and the fatty acid synthesis genes FASN and ACC1 is impaired in IQGAP1-null mice. Our data disclose a previously unidentified functional interaction between IQGAP1 and AMPK and suggest that IQGAP1 modulates AMPK signaling.	[Hedman, Andrew C.; Li, Zhigang; Gorisse, Laetitia; Parvathaneni, Swetha; Morgan, Chase J.; Sacks, David B.] NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Sacks, DB (corresponding author), NIH, Dept Lab Med, Bldg 10, Bethesda, MD 20892 USA.	david.sacks2@nih.gov		Sacks, David/0000-0003-3100-0735; Morgan, Chase/0000-0002-7498-8678	Intramural Research Program of the National Institutes of Health	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by the Intramural Research Program of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson KA, 2008, CELL METAB, V7, P377, DOI 10.1016/j.cmet.2008.02.011; Anderson KA, 2012, MOL ENDOCRINOL, V26, P281, DOI 10.1210/me.2011-1299; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Caron A, 2015, ANNU REV NUTR, V35, P321, DOI 10.1146/annurev-nutr-071714-034355; Chawla B, 2017, J BIOL CHEM, V292, P3273, DOI 10.1074/jbc.M116.752642; Chen F, 2010, EXP MOL MED, V42, P477, DOI 10.3858/emm.2010.42.7.049; Chiariello CS, 2012, REGUL PEPTIDES, V173, P36, DOI 10.1016/j.regpep.2011.09.003; Choi S, 2016, NAT CELL BIOL, V18, P1324, DOI 10.1038/ncb3441; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Dong SL, 2017, J BIOL CHEM, V292, P16833, DOI 10.1074/jbc.M117.784256; Erdemir HH, 2014, J BIOL CHEM, V289, P9100, DOI 10.1074/jbc.M114.553511; Erickson HL, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99866; Foretz M, 2019, NAT REV ENDOCRINOL, V15, P569, DOI 10.1038/s41574-019-0242-2; Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032; Gerich JE, 2000, DIABETES OBES METAB, V2, P345, DOI 10.1046/j.1463-1326.2000.00085.x; Gorisse L, 2018, BIOCHEM J, V475, P3073, DOI 10.1042/BCJ20180594; Gormand A, 2011, J CELL BIOCHEM, V112, P1364, DOI 10.1002/jcb.23053; Green MF, 2011, J BIOL CHEM, V286, P28066, DOI 10.1074/jbc.M111.251504; Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004; Hardie DG, 2013, DIABETES, V62, P2164, DOI 10.2337/db13-0368; Hardie David Grahame, 2017, F1000Res, V6, P1724, DOI 10.12688/f1000research.11960.1; Hardie DG, 2001, BIOESSAYS, V23, P1112, DOI 10.1002/bies.10009; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81; Jeong HW, 2007, J BIOL CHEM, V282, P20752, DOI 10.1074/jbc.M700487200; Joyal JL, 1997, J BIOL CHEM, V272, P15419, DOI 10.1074/jbc.272.24.15419; Jufvas A, 2016, BIOCHEM J, V473, P3177, DOI 10.1042/BCJ20160581; Kajita K, 2008, DIABETES RES CLIN PR, V81, P144, DOI 10.1016/j.diabres.2008.05.003; Kazgan N, 2010, MOL BIOL CELL, V21, P3433, DOI 10.1091/mbc.E10-04-0347; Ke R, 2018, CELL BIOL INT, V42, P384, DOI 10.1002/cbin.10915; Lee JM, 2016, DIABETES, V65, P62, DOI 10.2337/db15-0249; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Li ZG, 1999, J BIOL CHEM, V274, P37885, DOI 10.1074/jbc.274.53.37885; Logue JS, 2011, J BIOL CHEM, V286, P39269, DOI 10.1074/jbc.M111.277756; Madeo F, 2019, CELL METAB, V29, P592, DOI 10.1016/j.cmet.2019.01.018; Marcelo KL, 2016, TRENDS ENDOCRIN MET, V27, P706, DOI 10.1016/j.tem.2016.06.001; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; McNulty DE, 2011, J BIOL CHEM, V286, P15010, DOI 10.1074/jbc.M111.227694; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moon S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04376; Ren JG, 2005, J BIOL CHEM, V280, P34548, DOI 10.1074/jbc.M507321200; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Rittmeyer EN, 2008, J CELL SCI, V121, P391, DOI 10.1242/jcs.016881; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shinozaki F, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0534-2; Smith JM, 2015, TRENDS CELL BIOL, V25, P171, DOI 10.1016/j.tcb.2014.12.005; Steinberg GR, 2019, NAT REV DRUG DISCOV, V18, P527, DOI 10.1038/s41573-019-0019-2; Sun H, 2016, GENE THER, V23, P349, DOI 10.1038/gt.2016.4; Uchida S, 2011, P NATL ACAD SCI USA, V108, P1681, DOI 10.1073/pnas.1016424108; White CD, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-125; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Wu N, 2013, MOL CELL, V49, P1167, DOI 10.1016/j.molcel.2013.01.035	66	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100075	10.1074/jbc.RA120.016193	http://dx.doi.org/10.1074/jbc.RA120.016193			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33191271	gold, Green Published			2022-12-26	WOS:000672866400056
J	At Thobari, J; Satria, CD; Ridora, Y; Watts, E; Handley, A; Standish, J; Bachtiar, NS; Buttery, JP; Soenarto, Y; Bines, JE				At Thobari, Jarir; Satria, Cahya Dewi; Ridora, Yohanes; Watts, Emma; Handley, Amanda; Standish, Jane; Bachtiar, Novilia S.; Buttery, Jim P.; Soenarto, Yati; Bines, Julie E.			Non-antibiotic medication use in an Indonesian community cohort 0-18 months of age	PLOS ONE			English	Article							COLD MEDICATIONS; CHILDREN; SAFETY; COUGH; PRESCRIPTION	Background Rational medication use for treatment is mandatory, particularly in children as they are vulnerable to possible hazards of drugs. Understanding the medication use pattern is of importance to identify the problems of drug therapy and to improve the appropriate use of medication among this population. Methods A post-hoc study of the RV3-BB Phase IIb trial to children aged 0-18 months which was conducted in Indonesia during January 2013 to July 2016. Any concomitant medication use and health events among 1621 trial participants during the 18 months of follow-up were documented. Information on medication use included the frequency, formulation, indication, duration of usage, number of regimens, medication types, and therapeutic classes. Results The majority of participants (N = 1333/1621; 82.2%) used at least one non-antibiotic medication for treatment during the 18-month observation period. A total of 7586 medication uses were recorded, mostly in oral formulation (90.5%). Of all illnesses recorded, 24.7% were treated with a single drug regimen of non-antibiotic medication. The most common therapeutic classes used were analgesics/antipyretics (30.1%), antihistamines for systemic use (17.4%), cough and cold preparations (13.5%), vitamins (8.6%), and antidiarrheals (6.6%). The main medication types used were paracetamol (29.9%), chlorpheniramine (16.8%), guaifenesin (8.9%), zinc (4.6%), and ambroxol (4.1%). Respiratory system disorder was the most common reason for medication use (51.9%), followed by gastrointestinal disorders (19.2%), pyrexia (16.9%), and skin disorders (7.0%). Conclusion A large number of children were exposed to at least one medication during their early life, including those where evidence of efficacy and safety in a pediatric population is lacking. This supports the need for further research on pediatric drug therapy to improve the appropriate use of medication in this population.	[At Thobari, Jarir] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Pharmacol & Therapy, Yogyakarta, Special Region, Indonesia; [At Thobari, Jarir; Satria, Cahya Dewi; Ridora, Yohanes; Soenarto, Yati] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Pediat Res Off, Yogyakarta, Special Region, Indonesia; [At Thobari, Jarir; Satria, Cahya Dewi; Soenarto, Yati] Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Paediat, Yogyakarta, Special Region, Indonesia; [Watts, Emma; Handley, Amanda; Standish, Jane; Buttery, Jim P.; Bines, Julie E.] Murdoch Childrens Res Inst, RV3 Rotavirus Vaccine Program, Parkville, Vic, Australia; [Handley, Amanda] Med Dev Global Hlth, Melbourne, Vic, Australia; [Standish, Jane] Royal Childrens Hosp Melbourne, Dept Gen Med, Parkville, Vic, Australia; [Bachtiar, Novilia S.] PT Bio Farma, Bandung, West Java, Indonesia; [Buttery, Jim P.; Bines, Julie E.] Univ Melbourne, Dept Pediat, Melbourne, Vic, Australia; [Buttery, Jim P.] Monash Univ, Dept Paediat, Clayton, Vic, Australia; [Buttery, Jim P.] Monash Univ, Sch Publ Hlth & Prevent Med, Clayton, Vic, Australia; [Buttery, Jim P.] Monash Childrens Hosp, Dept Infect & Immun, Clayton, Vic, Australia; [Bines, Julie E.] Royal Childrens Hosp Melbourne, Dept Gastroenterol & Clin Nutr, Parkville, Vic, Australia	Gadjah Mada University; Gadjah Mada University; Gadjah Mada University; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Monash University; Monash University; Royal Children's Hospital Melbourne	At Thobari, J (corresponding author), Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Pharmacol & Therapy, Yogyakarta, Special Region, Indonesia.; At Thobari, J (corresponding author), Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Pediat Res Off, Yogyakarta, Special Region, Indonesia.; At Thobari, J (corresponding author), Univ Gadjah Mada, Fac Med Publ Hlth & Nursing, Dept Paediat, Yogyakarta, Special Region, Indonesia.	j.atthobari@ugm.ac.id	At Thobari, Jarir/GOP-2379-2022	At Thobari, Jarir/0000-0002-7035-4846; Ridora, Yohanes/0000-0002-7104-9595; Bines, Julie/0000-0002-5452-6601	PT Biofarma; Murdoch Children's Research Institute	PT Biofarma; Murdoch Children's Research Institute	The vaccine company PT Bio Farma provided support for this study in the form of a salary for the author NSB. The specific role of this author is articulated in the 'author contributions' section. Additionally, PT Biofarma was one of the funders of the RV3-BB Phase IIb trial. Another funding source of the RV3-BB Phase IIb trial was Murdoch Children's Research Institute. The funders had roles in the study design, decision to publish, and preparation of the manuscript.	Allen S. J., 2011, COCHRANE REV J, V6, P1894, DOI DOI 10.1002/EBCH.873; At Thobari J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219097; Batchelor HK, 2015, BRIT J CLIN PHARMACO, V79, P395, DOI 10.1111/bcp.12267; beda A., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0127296; Bines JE, 2018, NEW ENGL J MED, V378, P719, DOI 10.1056/NEJMoa1706804; Briars Leslie A, 2009, J Pediatr Pharmacol Ther, V14, P127, DOI 10.5863/1551-6776-14.3.127; Cazzato T, 2001, EUR J CLIN PHARMACOL, V57, P611, DOI 10.1007/s002280100356; Cheung K, 2018, INT J CLIN PHARM-NET, V40, P1137, DOI 10.1007/s11096-018-0717-6; Clavenna A, 2009, EUR J PEDIATR, V168, P173, DOI 10.1007/s00431-008-0725-y; Cruz Maria J.B., 2014, J. Pediatr. (Rio J.), V90, P608, DOI 10.1016/j.jped.2014.03.004; DALTON K, 1987, ACTA NEUROL SCAND, V76, P8, DOI 10.1111/j.1600-0404.1987.tb03536.x; Dart RC, 2009, ANN EMERG MED, V53, P411, DOI 10.1016/j.annemergmed.2008.09.015; Ernie HP, 2007, MEDIA LITBANG KESEHA, VXVII, P26; Fangky SM, 2017, KAJIAN INTERAKSI OBA, V6, P2302; Ferro A, 2015, BRIT J CLIN PHARMACO, V79, P351, DOI 10.1111/bcp.12540; Joseph F, 2015, ETHIOP J HEALTH SCI, V25, P73, DOI 10.4314/ejhs.v25i1.10; Kanabar DJ, 2017, INFLAMMOPHARMACOLOGY, V25, P1, DOI 10.1007/s10787-016-0302-3; Lowry JA, 2015, PEDIATR REV, V36, P286, DOI 10.1542/pir.36-7-286; Lubis IND, 2016, SARI PEDIAT, V12, P409; Luedtke Kyle E, 2014, J Pediatr Pharmacol Ther, V19, P296, DOI 10.5863/1551-6776-19.4.296; Mahmood I, 2006, BRIT J CLIN PHARMACO, V61, P545, DOI 10.1111/j.1365-2125.2006.02622.x; Nazarian LF, 1996, PEDIATRICS, V97, P424; Niclasen BVL, 2006, ACTA PAEDIATR, V95, P1456, DOI 10.1080/08035250600686946; OP026, 2016, J CROHNS COLITIS, V10, pS21; Pandey Anuja A, 2010, Indian J Community Med, V35, P70, DOI 10.4103/0970-0218.62564; Pudjiadi AH, 2009, DIARE AKUT PEDOMAN P, P58; Rahmawati F, 2006, MAJ FARM INDONES, V17, P177; Rashed Asia N, 2015, Drugs Real World Outcomes, V2, P397; RASMUSSEN F, 1989, J EPIDEMIOL COMMUN H, V43, P140, DOI 10.1136/jech.43.2.140; Rimsza ME, 2009, PEDIATRICS, V123, pe318; Rukmini S., 2004, B PENELITIAN SISTEM, V7, P130; Saraswat A, 2011, COCHRANE DB SYST REV, P2; Schaefer MK, 2008, PEDIATRICS, V121, P783, DOI 10.1542/peds.2007-3638; Schirm E, 2000, BRIT J CLIN PHARMACO, V50, P473, DOI 10.1046/j.1365-2125.2000.00275.x; Sharma A, 2016, NATL J PHYSL PHARM P, V6, P74, DOI [10.5455/njppp.2015.5.1110201581, DOI 10.5455/NJPPP.2015.5.1110201581]; Shefrin AE, 2009, CAN FAM PHYSICIAN, V55, P1081; Smith SM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001831.pub3; Soedibyo S, 2013, SARI PEDIAT, V14, P398, DOI 10.1016/j.jamda.2013.01.014; Sturkenboom MCJM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2245; Ten Eick AP, 2001, DRUG SAFETY, V24, P119, DOI 10.2165/00002018-200124020-00003; Thiruthopu Nimbagiri Swamy, 2014, Perspect Clin Res, V5, P178, DOI 10.4103/2229-3485.140558; Thrane N, 1999, ACTA PAEDIATR, V88, P1131, DOI 10.1080/08035259950168216; van Riet-Nales DA, 2016, ARCH DIS CHILD, V101, P662, DOI 10.1136/archdischild-2015-308227; Vohora D, 2012, ACAD SCI ASIAN J PHA, V5, P146; Vorilhon P, 2019, EUR J CLIN PHARMACOL, V75, P303, DOI 10.1007/s00228-018-2601-7; Wimmer S, 2015, DTSCH ARZTEBL INT, V112, P781, DOI 10.3238/arztebl.2015.0781; World Health Organization, 2014, INTEGRATED MANAGEMEN	47	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242410	10.1371/journal.pone.0242410	http://dx.doi.org/10.1371/journal.pone.0242410			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206684	Green Published, gold			2022-12-26	WOS:000595265900010
J	Ramasamy, T; Chen, XC; Qin, B; Johnson, DE; Grandis, JR; Villanueva, FS				Ramasamy, Thiruganesh; Chen, Xucai; Qin, Bin; Johnson, Daniel E.; Grandis, Jennifer R.; Villanueva, Flordeliza S.			STAT3 decoy oligonucleotide-carrying microbubbles with pulsed ultrasound for enhanced therapeutic effect in head and neck tumors	PLOS ONE			English	Article							LIPOSOMAL DOXORUBICIN; HUMAN-PAPILLOMAVIRUS; GENE DELIVERY; CANCER; FORMULATION; INSIGHT; TARGET; DNA	Signal transducer and activator of transcription-3 (STAT3) is an oncogenic transcription factor implicated in carcinogenesis, tumor progression, and drug resistance in head and neck squamous cell carcinoma (HNSCC). A decoy oligonucleotide targeting STAT3 offers a promising anti-tumor strategy, but achieving targeted tumor delivery of the decoy with systemic administration poses a significant challenge. We previously showed the potential for STAT3 decoy-loaded microbubbles, in conjunction with ultrasound targeted microbubble cavitation (UTMC), to decrease tumor growth in murine squamous cell carcinoma. As a next step towards clinical translation, we sought to determine the anti-tumor efficacy of our STAT3 decoy delivery platform against human HNSCC and the effect of higher STAT3 decoy microbubble loading on tumor cell inhibition. STAT3 decoy was loaded on cationic lipid microbubbles (STAT3-MB) or loaded on liposome-conjugated lipid microbubbles to form STAT3-loaded liposome-microbubble complexes (STAT3-LPX). UTMC treatment efficacy with these two formulations was evaluated in vitro using viability and apoptosis assays in CAL33 (human HNSCC) cells. Anti-cancer efficacy in vivo was performed in a CAL33 tumor murine xenograft model. UTMC with STAT3-MB caused significantly lower CAL33 cell viability compared to UTMC with STAT3-LPX (56.8 +/- 8.4% vs 84.5 +/- 8.8%, respectively, p<0.05). In vivo, UTMC with STAT3-MB had strong anti-tumor effects, with significantly less tumor burden and greater survival compared to that of UTMC with microbubbles loaded with a mutant control decoy and untreated control groups (p<0.05). UTMC with STAT3 decoy-loaded microbubbles significantly decreases human HNSSC tumor progression. These data set the stage for clinical translation of our microbubble platform as an imaged-guided, targeted delivery strategy for STAT3 decoy, or other nucleotide-based therapeutics, in human cancer treatment.	[Ramasamy, Thiruganesh; Chen, Xucai; Qin, Bin; Villanueva, Flordeliza S.] Univ Pittsburgh, Pittsburgh Heart Lung Blood & Vasc Med Inst, Ctr Ultrasound Mol Imaging & Therapeut, Pittsburgh, PA 15213 USA; [Johnson, Daniel E.; Grandis, Jennifer R.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco	Villanueva, FS (corresponding author), Univ Pittsburgh, Pittsburgh Heart Lung Blood & Vasc Med Inst, Ctr Ultrasound Mol Imaging & Therapeut, Pittsburgh, PA 15213 USA.	villanuevafs@upmc.edu		Villanueva, Flordeliza/0000-0003-3980-9176	National Institutes of Health [3P50CA097190, R01EB016516, R01EB026966, S10 RR027383]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	TR, XC, BQ, JRG, FSV 3P50CA097190, R01EB016516, R01EB026966, S10 RR027383 National Institutes of Health The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chai EZP, 2016, PHARMACOL THERAPEUT, V162, P86, DOI 10.1016/j.pharmthera.2015.10.004; Chaturvedi AK, 2008, J CLIN ONCOL, V26, P612, DOI 10.1200/JCO.2007.14.1713; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; Dasgupta Anshuman, 2016, Drug Discov Today Technol, V20, P41, DOI 10.1016/j.ddtec.2016.07.007; de Lima MCP, 2001, ADV DRUG DELIVER REV, V47, P277, DOI 10.1016/S0169-409X(01)00110-7; Dewitte H, 2019, METHODS MOL BIOL, V1943, P241, DOI 10.1007/978-1-4939-9092-4_16; Fan CH, 2015, ACTA BIOMATER, V15, P89, DOI 10.1016/j.actbio.2014.12.026; Fujii H, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.20; Geiger JL, 2016, ORAL ONCOL, V56, P84, DOI 10.1016/j.oraloncology.2015.11.022; Haghiralsadat F, 2018, ARTIF CELL NANOMED B, V46, pS684, DOI 10.1080/21691401.2018.1434533; Helfield B, 2016, P NATL ACAD SCI USA, V113, P9983, DOI 10.1073/pnas.1606915113; Helfield B, 2016, ULTRASOUND MED BIOL, V42, P782, DOI 10.1016/j.ultrasmedbio.2015.10.023; Helfield BL, 2017, ULTRASOUND MED BIOL, V43, P2678, DOI 10.1016/j.ultrasmedbio.2017.07.017; Hu YX, 2013, ULTRASOUND MED BIOL, V39, P2393, DOI 10.1016/j.ultrasmedbio.2013.08.003; Huynh J, 2019, NAT REV CANCER, V19, P82, DOI 10.1038/s41568-018-0090-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jia CX, 2018, ULTRASOUND MED BIOL, V44, P1074, DOI 10.1016/j.ultrasmedbio.2018.01.006; Johnson DE, 2012, CHIN J CANCER, V31, P319, DOI 10.5732/cjc.011.10404; Johnston PA, 2011, MOL INTERV, V11, P18, DOI 10.1124/mi.11.1.4; Klein JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081819; Kopechek JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159751; Kopechek JA, 2015, THERANOSTICS, V5, P1378, DOI 10.7150/thno.12822; Lai SY, 2010, DRUG RESIST UPDATE, V13, P67, DOI 10.1016/j.drup.2010.04.001; Lin LZ, 2018, THERANOSTICS, V8, P1923, DOI 10.7150/thno.22834; Luo DD, 2016, BIOMATERIALS, V75, P193, DOI 10.1016/j.biomaterials.2015.10.027; Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7; Njatcha C, 2018, MOL CANCER THER, V17, P1917, DOI 10.1158/1535-7163.MCT-17-1194; Panje CM, 2012, THERANOSTICS, V2, P1078, DOI 10.7150/thno.4240; Pore SK, 2013, BIOMATERIALS, V34, P6804, DOI 10.1016/j.biomaterials.2013.05.054; Qin P, 2018, J CONTROL RELEASE, V272, P169, DOI 10.1016/j.jconrel.2018.01.001; Ramasamy T, 2018, NPG ASIA MATER, V10, P197, DOI 10.1038/s41427-018-0034-5; Rivera E, 2002, CANCER CHEMOTH PHARM, V49, P299, DOI 10.1007/s00280-001-0405-3; Rychak JJ, 2014, ADV DRUG DELIVER REV, V72, P82, DOI 10.1016/j.addr.2014.01.009; Sen M, 2014, MOL MED, V20, P46, DOI 10.2119/molmed.2013.00104; Sen M, 2012, CANCER DISCOV, V2, P694, DOI 10.1158/2159-8290.CD-12-0191; Sharma S, 2017, INT J PHARMACEUT, V530, P387, DOI 10.1016/j.ijpharm.2017.07.079; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Villanueva FS, 2020, JACC-CARDIOVASC IMAG, V13, P652, DOI 10.1016/j.jcmg.2019.08.010; Xiong AL, 2014, CANCERS, V6, P926, DOI 10.3390/cancers6020926; Yu FTH, 2016, MOL PHARMACEUT, V13, P55, DOI 10.1021/acs.molpharmaceut.5b00421; Zang XL, 2016, INT J NANOMED, V11, P3951, DOI 10.2147/IJN.S107952	42	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2020	15	11							e0242264	10.1371/journal.pone.0242264	http://dx.doi.org/10.1371/journal.pone.0242264			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VG	33206698	Green Published, gold			2022-12-26	WOS:000595265900017
J	Kundury, KK; Hathur, B				Kundury, Kanakavalli K.; Hathur, Basavanagowdappa			Intervention through Short Messaging System (SMS) and phone call alerts reduced HbA1C levels in similar to 47% type-2 diabetics-results of a pilot study	PLOS ONE			English	Article							SELF-MANAGEMENT; BLOOD-GLUCOSE	Purpose Despite extensive research and newer methods of interventions, the incidence and prevalence of diabetes is increasing at an alarming rate. Currently, according to world health organization (WHO) statistics, 422 million individuals are suffering from diabetes worldwide. In India, recent estimates have reported a significant increase in the number of diabetics in the last decade. Poor dietary habits, minimal adherence to treatment regimens, lack of timely education are some of the contributing factors for increasing incidence and huge economic burden; which can be handled by life style behavior modifications backed up by hand holding through continuous education. Prior studies have demonstrated the efficacy of various self-management tools and educational programs in better disease management behaviors among individuals with diabetes. Among various self-management tools, educating the individuals and alerting them using mobile phone calls and short messaging system (SMS) are widely accepted due to (a) the increasing mobile phone users and (b) availability of short messaging systems in local languages in the recent years. Therefore, a pilot study was conducted to determine the benefit of educating patients through phone calls and SMS in the self-management of diabetes. Objectives The objective of the study is to determine the feasibility and utility of SMS and phone call-based interventions in the management of diabetes by comparing the HbA1c values. Methodology The study was conducted for a period of 14 months from December 2017 till Feb 2019. Out of 380 individuals initially enrolled into the study, 120 had completed the 14-months period. Diabetes education through SMS and phone calls was provided on regular basis, and HbA1C levels at baseline, 8-months and 14-months quantified. In addition, feedback on patients' satisfaction and utility of the SMS / Phone calls was collected using questionnaires. Results Data from our study demonstrated that after 8-months of intervention through phone calls, a significant increase in the number of individuals with HbA1c in the range of 5.1 to 7.0 was observed (from 27 individuals at base line to 37 individuals after 8-months intervention). Much more significant improvement in the number of individuals with lower HbA1c was observed at 14-months of intervention, indicating the benefit of regular phone call-based system in managing diabetes. A Chi square (chi(2)) test was performed to examine if the frequencies in the cells varied at baseline and at 8 and 14 months. Conclusion Chronic diseases like diabetes needs awareness and education to patients in adopting disease self-management practices. As mobile phone users are increasing in number, providing diabetes management education through mobile phone intervention could be a viable strategy for controlling diabetes.	[Kundury, Kanakavalli K.] JSS Acad Higher Educ & Res JSS AHER, Dept Hlth Syst Management Studies, Mysore, Karnataka, India; [Kundury, Kanakavalli K.] Special Interest Grp Patient Care Management SIG, Mysore, Karnataka, India; [Hathur, Basavanagowdappa] JSS Med Coll & Hosp, Dept Med, Mysore, Karnataka, India; [Hathur, Basavanagowdappa] JSS Med Coll, Mysore, Karnataka, India; [Hathur, Basavanagowdappa] JSS AHER, Special Interest Grp Patient Care Management SIG, Mysore, Karnataka, India	JSS Academy of Higher Education & Research; JSS Academy of Higher Education & Research; JSS Medical College, Mysuru; JSS Academy of Higher Education & Research; JSS Medical College, Mysuru; JSS Academy of Higher Education & Research	Hathur, B (corresponding author), JSS Med Coll & Hosp, Dept Med, Mysore, Karnataka, India.; Hathur, B (corresponding author), JSS Med Coll, Mysore, Karnataka, India.; Hathur, B (corresponding author), JSS AHER, Special Interest Grp Patient Care Management SIG, Mysore, Karnataka, India.	hbgowda@gmail.com	Kundury, Kanakavalli K./AAF-3998-2021	Basavanagowdappa, Hathur/0000-0003-0789-7511				Abaza H, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4973-5; [Anonymous], 2017, LANCET GLOB HEALTH, V5, pe428; [Anonymous], 2017, LANCET HIV, V2, pe115; [Anonymous], 2015, BUSINESS ETHICS Q, V25, pv; [Anonymous], 2018, DIABETES CARE S1, V4, pS4, DOI 10.2337/dc18-Srev01; [Anonymous], 2017, J PEDIAT REHAB MED, V10, ps1; [Anonymous], 2013, JHL, V16, pD46; [Anonymous], 2017, J PROSTHET DENT, V11, pe1; [Anonymous], 2019, CIRCULATION, V2019; [Anonymous], 2012, J OPT COMMUN NETW, V4, pB94; Berard LD, 2018, CAN J DIABETES, V42, pS47, DOI 10.1016/j.jcjd.2017.10.007; Bonger Z, 2018, PATIENT PREFER ADHER, V12, P963, DOI 10.2147/PPA.S156043; Bonora E, 2001, DIABETES CARE, V24, P2023, DOI 10.2337/diacare.24.12.2023; Buowari O. Y., 2013, DIABETES MELLITUS DE; Carpenter R, 2019, INT J NURS SCI, V6, P70, DOI 10.1016/j.ijnss.2018.12.002; Committee on Strategies for Small-Number-Participant Clinical Research Trials B. o. H. S. P, 2001, SMALL CLIN TRIALS IS; Czupryniak L, 2014, DIABETES TECHNOL THE, V16, P460, DOI 10.1089/dia.2013.0302; Diabetes.co.uk, 2019, DIAB EYE PROBL; Diabetes.co.uk, 2020, DIAB COMPL FOOT ULC; Evans Scott R, 2010, J Exp Stroke Transl Med, V3, P8; Fu SH, 2011, PLOS NEGL TROP DIS, V5, pe1231; Glasgow RE, 2003, PREV MED, V36, P410, DOI 10.1016/S0091-7435(02)00056-7; IDF, 2019, DIAB FACTS FIG; Melissa Conrad Stoppler C. P. D, 2019, DIAB FOOT PROBL TREA; Mellitus ECotDaCoD, 2003, DIABETES CARE S1, V26, pS5; Ong WM, 2014, PATIENT PREFER ADHER, V8, P237, DOI 10.2147/PPA.S57567; Rise MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064009; Rosal MC, 2005, ANN BEHAV MED, V29, P225, DOI 10.1207/s15324796abm2903_9; Shafiee G, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-17; Sharma B., 2015, JIACM, V16, P227; Shrivastava SR, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-14; Statista, 2019, STAT PORTAL; Tang TS, 2008, DIABETES EDUCATOR, V34, P266, DOI 10.1177/0145721708315680; The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7; Thiese MS, 2014, BIOCHEM MEDICA, V24, P199, DOI 10.11613/BM.2014.022; TRAI T. R. A. o. I, 2018, IND TEL SERV PERF IN; Upadhyay RP, 2012, IRAN J PUBLIC HEALTH, V41, P1; Vargas G, 2017, J CARDIOVASC NURS, V32, P260, DOI 10.1097/JCN.0000000000000336; WHO, 2020, DIAB 2020 DIAB 2020; WHO,, DIAB 2020; Zheng L, 2013, AIDS RES HUM RETROV, V29, P652, DOI [10.1089/aid.2012.0180, 10.1089/AID.2012.0180]	41	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0241830	10.1371/journal.pone.0241830	http://dx.doi.org/10.1371/journal.pone.0241830			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201926	Green Published, gold			2022-12-26	WOS:000595003900048
J	Ronoh, M; Chirove, F; Wairimu, J; Ogana, W				Ronoh, Marilyn; Chirove, Faraimunashe; Wairimu, Josephine; Ogana, Wandera			Evidence-based modeling of combination control on Kenyan youth HIV/AIDS dynamics	PLOS ONE			English	Article							CONDOM USE; HIV; TRANSMISSION; SPREAD; BEHAVIOR; IMPACT	We formulate a sex-structured deterministic model to study the effects of varying HIV testing rates, condom use rates and ART adherence rates among Adolescent Girls and Young Women (AGYW) and, Adolescent Boys and Young Men (ABYM) populations in Kenya. Attitudes influencing the Kenyan youth HIV/AIDS control measures both positively and negatively were considered. Using the 2012 Kenya AIDS Indicator Survey (KAIS) microdata we constructed our model, which we fitted to the UNAIDS-Kenya youth prevalence estimates to understand factors influencing Kenyan youth HIV/AIDS prevalence trends. While highly efficacious combination control approach significantly reduces HIV/AIDS prevalence rates among the youth, the disease remains endemic provided infected unaware sexual interactions persist. Disproportional gender-wise attitudes towards HIV/AIDS control measures play a key role in reducing the Kenyan youth HIV/AIDS prevalence trends. The female youth HIV/AIDS prevalence trend seems to be directly linked to increased male infectivity with decreased female infectivity while the male youth prevalence trend seems to be directly associated with increased female infectivity and reduced male infectivity.	[Ronoh, Marilyn; Wairimu, Josephine; Ogana, Wandera] Univ Nairobi, Sch Math, Nairobi, Kenya; [Chirove, Faraimunashe] Univ Johannesburg, Dept Math & Appl Math, Johannesburg, South Africa	University of Nairobi; University of Johannesburg	Ronoh, M (corresponding author), Univ Nairobi, Sch Math, Nairobi, Kenya.	mcronoh1@gmail.com		Chirove, Faraimunashe/0000-0001-6820-688X; Ronoh, Marilyn/0000-0002-7406-1856; KAGUNDA, Josephine/0000-0003-2440-327X	Organization for Women in Science for the Developing World (OWSD); Simons Foundation; University of KwaZulu-Natal (South Africa)	Organization for Women in Science for the Developing World (OWSD); Simons Foundation; University of KwaZulu-Natal (South Africa)	The authors appreciate the support from the Organization for Women in Science for the Developing World (OWSD), the Simons Foundation, Mawazo Institute, University of Nairobi (Kenya) and University of KwaZulu-Natal (South Africa). We thank Mr. Innocent B. Mboya of University of KwaZulu-Natal for his guidance in data analysis.	Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1; Adams BM, 2015, MODEL FITTING PREDIC; Americans for the Arts, 2016, ARTS ACTION NEWS, V1, P3; [Anonymous], 2018, LANCET HAEMATOL, V5, P378; Birkhoff G., 1989, ORDINARY DIFFERENTIA; Case KK, 2012, B WORLD HEALTH ORGAN, V90, P831, DOI 10.2471/BLT.12.102574; Cui JG, 2008, J DYN DIFFER EQU, V20, P31, DOI 10.1007/s10884-007-9075-0; Diekmann O., 2000, MATH COMPUT BIOL, V5; Diekmann Odo, 1993, Lecture Notes in Biomathematics, V96, P162; Dorrington R., 2018, THEMBISA VERSION 4 1; Eaton L, 2003, SOC SCI MED, V56, P149, DOI 10.1016/S0277-9536(02)00017-5; Gachanja G, 2015, PEERJ, V3, DOI 10.7717/peerj.956; Gates, MANN GLOB HLTH HEALT; Glick P, 2007, J POPUL ECON, V20, P383, DOI 10.1007/s00148-006-0085-8; Gronlie AA, 2017, SOC INDIC RES, V131, P1251, DOI 10.1007/s11205-016-1280-y; Halliwell L.J, 2011, CONDITIONAL PROBABIL; Hyman JM, 2003, MATH BIOSCI, V181, P17, DOI 10.1016/S0025-5564(02)00128-1; Joshi H, 2008, MATH BIOSCI ENG, V5, P757, DOI 10.3934/mbe.2008.5.757; Kabiru C, 2005, THESIS; Kabiru CW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-685; Kabogo Joseph, 2018, BMC Res Notes, V11, P134, DOI 10.1186/s13104-018-3205-0; Karei EM, 2012, AFRICAN J REPROD HLT, V16, P241; Kgosimore M, 2006, MATH BIOSCI ENG, V3, P297; Khan A, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0043-3; Kim S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230964; Kimera E, 2019, SYST REV-LONDON, V8, DOI 10.1186/s13643-019-0980-1; KNBS, 2015, KEN DEM HLTH SURV; Lypen KD, 2015, AJAR-AFR J AIDS RES, V14, P275, DOI 10.2989/16085906.2015.1082145; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Maticka-Tyndale E, 2010, SOC SCI MED, V71, P616, DOI 10.1016/j.socscimed.2010.03.049; MATLAB, 2020, EV GOODN FIT; MOH, 2016, POL PREV HIV INF KEY; Mwangi Mary, 2018, East Afr J Appl Health Monitor Eval, V2, P25; NACC, KEN AIDS STRAT FRAM; NACC, 2018, KEN HIV EST; NACC, 2015, KEN FAST TRACK PLAN; NACC, 2016, KEN AIDS PROGR REP; NACC, 2015, KEN AIDS RESP PROGR; NACC, 2014, KEN AIDS RESP REP; NASCOP, 2005, AIDS KEN; NCAPD, 2003, AS REPR HLTH DEV POL; Nyabadza F, 2011, NONLINEAR ANAL-REAL, V12, P2091, DOI 10.1016/j.nonrwa.2010.12.024; Nyabadza F, 2006, J BIOL SYST, V14, P357, DOI 10.1142/S0218339006001866; PMA, 2014, PERF MON ACC 2020 KE; Rueda S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011453; SANAC, NAT STRAT PLAN HIV S; Schmitz SFH, 2000, MATH BIOSCI, V167, P1, DOI 10.1016/S0025-5564(00)00021-3; Tavrow Paula, 2012, Afr J Reprod Health, V16, P241; Tripathi A, 2007, APPL MATH COMPUT, V184, P1053, DOI 10.1016/j.amc.2006.07.007; UNAIDS, 2018, UNAIDS KEN HIV AIDS; UNAIDS, 2016, PREV GAP REP; UNAIDS, 2017, WOM LEAD CHANG HAPP; UNAIDS, 2018, UND UNTR PUBL HLTH H; UNAIDS, 2013, THEM SEGM HIV AD YOU; UNAIDS, 2017, KEN LAUCH SELF TEST; UNAIDS, 2016, METHODS DERIVING UNA; UNAIDS, 2014, 90 90 90 AMB TREATM; UNICEF, 2002, YOUNG PEOPLE HIV AID; United Nations, 2016, DEF YOUTH; USAID, 2015, COND FACT SHEET; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Williams B, R0 ELIMINATION HIV A; Williams BG, 2014, FITTING PROJECTING H; Yuan RX, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33431-w; 2003, MICROMEGA, V5, P171	65	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242491	10.1371/journal.pone.0242491	http://dx.doi.org/10.1371/journal.pone.0242491			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OZ5ZL	33201934	gold, Green Published			2022-12-26	WOS:000595003900004
J	Wang, DD; Mo, JQ; Zhou, G; Xu, L; Liu, YJ				Wang, Dingding; Mo, Jiaqing; Zhou, Gang; Xu, Liang; Liu, Yajun			An efficient mixture of deep and machine learning models for COVID-19 diagnosis in chest X-ray images	PLOS ONE			English	Article								A newly emerged coronavirus (COVID-19) seriously threatens human life and health worldwide. In coping and fighting against COVID-19, the most critical step is to effectively screen and diagnose infected patients. Among them, chest X-ray imaging technology is a valuable imaging diagnosis method. The use of computer-aided diagnosis to screen X-ray images of COVID-19 cases can provide experts with auxiliary diagnosis suggestions, which can reduce the burden of experts to a certain extent. In this study, we first used conventional transfer learning methods, using five pre-trained deep learning models, which the Xception model showed a relatively ideal effect, and the diagnostic accuracy reached 96.75%. In order to further improve the diagnostic accuracy, we propose an efficient diagnostic method that uses a combination of deep features and machine learning classification. It implements an end-to-end diagnostic model. The proposed method was tested on two datasets and performed exceptionally well on both of them. We first evaluated the model on 1102 chest X-ray images. The experimental results show that the diagnostic accuracy of Xception + SVM is as high as 99.33%. Compared with the baseline Xception model, the diagnostic accuracy is improved by 2.58%. The sensitivity, specificity and AUC of this model reached 99.27%, 99.38% and 99.32%, respectively. To further illustrate the robustness of our method, we also tested our proposed model on another dataset. Finally also achieved good results. Compared with related research, our proposed method has higher classification accuracy and efficient diagnostic performance. Overall, the proposed method substantially advances the current radiology based methodology, it can be very helpful tool for clinical practitioners and radiologists to aid them in diagnosis and follow-up of COVID-19 cases.	[Wang, Dingding; Mo, Jiaqing; Zhou, Gang; Liu, Yajun] Xinjiang Univ, Coll Informat Sci & Engn, Key Lab Signal Detect & Proc, Urumqi, Peoples R China; [Xu, Liang] Tianjin Univ Technol, Sch Elect & Elect Engn, Tianjin, Peoples R China	Xinjiang University; Tianjin University of Technology	Mo, JQ (corresponding author), Xinjiang Univ, Coll Informat Sci & Engn, Key Lab Signal Detect & Proc, Urumqi, Peoples R China.	2226966386@qq.com			Natural Science Foundation of Xinjiang Uygur Autonomous Region [2019D01C072]	Natural Science Foundation of Xinjiang Uygur Autonomous Region	This work was supported by the Natural Science Foundation of Xinjiang Uygur Autonomous Region (Grant No. 2019D01C072).	Aarti Bagul, 2017, Arxiv, DOI arXiv:1711.05225; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; [Anonymous], 1996, REGULATORY TOXICOLOG, V24, pS188; [Anonymous], 2020, LANCET EDITORIAL, V2, pE268, DOI 10.1016/S2589-7500(20)30113-8; [Anonymous], 2020, LANCET MICROBE, V1, pe99, DOI 10.1016/S2666-5247(20)30054-9; Apostolopoulos ID, 2020, PHYS ENG SCI MED, V43, P635, DOI 10.1007/s13246-020-00865-4; Breiman L., 2001, J CLIN MICROBIOL, V2, P199; C S, 2020, INT J SURG, V76, P71, DOI [10.1016/j.ijsu.2020.02.034, DOI 10.1016/J.IJSU.2020.02.034]; Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195; Chung A., 2020, FIGURE1 COVID CHESTX; Cohen J. P., 2020, ARXIV PREPRINT ARXIV; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Deng J, 2009, IMAGENET LARGE SCALE, V255; Farooq M., 2020, ARXIV; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Hemdan E.E.-D., 2020, ARXIV200311055; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Huang PK, 2020, RADIOLOGY, V295, P22, DOI 10.1148/radiol.2020200330; Khan AI, 2020, COMPUT METH PROG BIO, V196, DOI 10.1016/j.cmpb.2020.105581; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Liu HH, 2020, J INFECTION, V80, pE7, DOI 10.1016/j.jinf.2020.03.007; Mooney P, 2020, KAGGLE KAGGLES CHEST; Narin A., 2020, ARXIV200310849; Ozturk T, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103792; Panwar H, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109944; Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Wang L., 2020, ARXIV200309871, DOI 10.1038/s41598-020-76550-z; Wang S, 2020, DEEP LEARNING ALGORI, DOI DOI 10.1101/2020.02.14.20023028%JMEDRXIV; Wang X, 2017, CHESTX RAY8 HOSP SCA, P3471; Zheng C., 2020, DEEP LEARNING BASED, DOI DOI 10.1101/2020.03.12.20027185%JMEDRXIV	32	37	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2020	15	11							e0242535	10.1371/journal.pone.0242535	http://dx.doi.org/10.1371/journal.pone.0242535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ5ZL	33201919	gold, Green Published			2022-12-26	WOS:000595003900008
J	Bernal, HD; de Abreu, LC; Bezerra, IMP; Adami, F; Takasu, JM; Suh, JVJY; Ribeiro, SD; Santos, EFD				de Moraes Bernal, Henrique; de Abreu, Luiz Carlos; Pinheiro Bezerra, Italla Maria; Adami, Fernando; Takasu, Jessica Miwa; Ji Young Suh, Joao Victor; de Lira Ribeiro, Silmara; de Sousa Santos, Edige Felipe			Incidence of hospitalization and mortality due to stroke in young adults, residents of developed regions in Brazil, 2008-2018	PLOS ONE			English	Article							RISK-FACTORS; GLOBAL BURDEN; HEALTH; DISEASE; TRENDS; AGE	Introduction We evaluated trends in hospitalization incidence and mortality due to hemorrhagic and ischemic stroke in young adults, according to gender and developed regions in Brazil. Methods Between 2008-2018, we performed a population-based time-series study using official hospitalization and death data due to stroke, in individuals aged 10-49 years, from Southeast and South, Brazil. Data were based on reports from the Unified Health System of Hospital Information System and Mortality Information System. Stroke was defined by the International Classification of Diseases, 10(th) revision (I60-I63). A Prais-Winsten regression model was performed and the Annual Percentage Change was calculated. Results In total, 78,123 hospitalizations of individuals aged 10-49 years were recorded, of which 59,448 (76%) resulted from hemorrhagic stroke (HS). The hospitalizations for HS was significantly decreased (- 4.37%) among men and women in both regions. The hospitalizations for ischemic stroke (IS) was flat, except between 2011 and 2018, when IS hospitalization rates increased. In the analysis by states, HS hospitalizations declined across all states, except for Espirito Santo, where it remained unchanged (p > 0.05). IS flat hospitalizations were observed in all states, except Espirito Santo, where it increased by 24.93%. In terms of mortality, 28,625 deaths were recorded, of which 26,548 (92.7%) resulted from HS. HS mortality decreased significantly by -3.48%and IS mortality by -3.84%. Decreases also occurred in all Southeast and South states (p < 0.05). IS remained unchanged across all states, except Minas Gerais, where it decreased by -14.95%. Conclusions We identified a decline in the hospitalizations and mortality of HS and a flat trend for IS in developed regions of Brazil. The recent period (2011-2018) demonstrated increasing rates in the hospitalizations of IS in both regions and genders. The mortality rates for HS and IS decreased between 2008-2018 in Southeast and South Brazil for both genders.	[de Moraes Bernal, Henrique; de Abreu, Luiz Carlos; Pinheiro Bezerra, Italla Maria; Adami, Fernando; Takasu, Jessica Miwa; Ji Young Suh, Joao Victor; de Lira Ribeiro, Silmara; de Sousa Santos, Edige Felipe] Ctr Univ Saude ABC, Lab Delineamento Estudos & Escrita Cient, Santo Andre, SP, Brazil; [de Abreu, Luiz Carlos; Pinheiro Bezerra, Italla Maria] Escola Super Ciencias Santa Casa Misericordia, Programa Mestrado Polit Publ Desenvolvimento Loca, Vitoria, ES, Brazil; [de Abreu, Luiz Carlos] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [de Sousa Santos, Edige Felipe] Univ Sao Paulo, Fac Saude Publ, Sao Paulo, SP, Brazil	Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria; University of Limerick; Universidade de Sao Paulo	Bernal, HD (corresponding author), Ctr Univ Saude ABC, Lab Delineamento Estudos & Escrita Cient, Santo Andre, SP, Brazil.	henrique.bernal@aluno.fmabc.net	de Abreu, Luiz Carlos/AAL-8219-2021	de Abreu, Luiz Carlos/0000-0002-7618-2109; de Moraes Bernal, Henrique/0000-0001-5899-8633	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [800308/2018-2, 165364/2019-0]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2017/21424-4]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) provided funds for the study by granting a two-year Scientific Initiation scholarship to Henrique de Moraes Bernal (process number: 800308/2018-2 and 165364/2019-0). Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) provided funds for the study by granting a Scientific Initiation scholarship to Jessica Miwa Takasu (process number: 2017/21424-4).	Abdalla RR, 2014, ADDICT BEHAV, V39, P297, DOI 10.1016/j.addbeh.2013.10.019; Adami F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152739; Ahmad OB, 2001, PAPER SERIES GENEVA, V31, P1; Andrade Mônica Viegas, 2013, Econ. Apl., V17, P623, DOI 10.1590/S1413-80502013000400005; [Anonymous], 2004, Am J Transplant, V4 Suppl 10, P95; [Anonymous], 2019, CIRCULATION, V2019; Bhatnagar A, 2017, CIRC RES, V121, P162, DOI 10.1161/CIRCRESAHA.117.306458; Boo S, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013713; Cabral NL, 2017, STROKE, V48, P2925, DOI 10.1161/STROKEAHA.117.018531; Santos EFD, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00227718, 10.1590/0102-311x00227718]; de Souza W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224889; Ekker MS, 2019, NEUROLOGY, V92, pE2444, DOI 10.1212/WNL.0000000000007533; Feigin VL, 2017, CIRC RES, V120, P439, DOI 10.1161/CIRCRESAHA.116.308413; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Antunes JLF, 2015, EPIDEMIOL SERV SAUDE, V24, P565, DOI 10.5123/S1679-49742015000300024; Fullerton HJ, 2002, NEUROLOGY, V59, P34, DOI 10.1212/WNL.59.1.34; Geldsetzer P, 2019, LANCET, V394, P652, DOI 10.1016/S0140-6736(19)30955-9; Hathidara MY, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-1004-1; IBGE, 2012, CENS DEM 2010 RES GE; IPEA, ATL DES HUM BRAS; Kissela BM, 2012, NEUROLOGY, V79, P1781, DOI 10.1212/WNL.0b013e318270401d; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI 10.1016/S2214-109X(13)70089-5; Lecoffre C, 2017, STROKE, V48, P2939, DOI 10.1161/STROKEAHA.117.017640; Lessa I, 1998, EPIDEMIOLOGIA DOENCA, P97; Li Wenwen, 2018, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V43, P1246, DOI 10.11817/j.issn.1672-7347.2018.11.013; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lotufo PA, 2000, REV BRAS HIPERTENS, V4, P387; Maaijwee NAMM, 2014, NAT REV NEUROL, V10, P315, DOI 10.1038/nrneurol.2014.72; Marini C, 2001, STROKE, V32, P52, DOI 10.1161/01.STR.32.1.52; Marini C, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/535672; Minelli C, 2020, NEUROEPIDEMIOLOGY, V54, P75, DOI 10.1159/000503005; Ministerio da Saude do Brasil, 2013, CONS BAS DAD 2011, P0; Monteiro CN, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00078015, 10.1590/0102-311x00078015]; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; QURESHI AI, 1995, STROKE, V26, P1995, DOI 10.1161/01.STR.26.11.1995; Rolim Cristina Lúcia Rocha Cubas, 2012, Rev. bras. epidemiol., V15, P179, DOI 10.1590/S1415-790X2012000100016; Sipila JOT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201633; Smajlovic D, 2015, VASC HEALTH RISK MAN, V11, P157, DOI 10.2147/VHRM.S53203; Steglich RB, 2018, AN BRAS DERMATOL, V93, P507, DOI 10.1590/abd1806-4841.20185767; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	40	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2020	15	11							e0242248	10.1371/journal.pone.0242248	http://dx.doi.org/10.1371/journal.pone.0242248			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OZ9VP	33196650	Green Published, gold			2022-12-26	WOS:000595266800032
J	Tabak, S; Hadad, U; Schreiber-Avissar, S; Beit-Yannai, E				Tabak, Saray; Hadad, Uzi; Schreiber-Avissar, Sofia; Beit-Yannai, Elie			Non-pigmented ciliary epithelium derived extracellular vesicles uptake mechanism by the trabecular meshwork	FASEB JOURNAL			English	Article						endocytosis; extracellular vesicles; non&#8208; pigmented ciliary epithelium; phagocytosis; trabecular meshwork; Wnt&#8208; TGF&#946; 2	RECEPTOR-MEDIATED ENDOCYTOSIS; DEPENDENT ENDOCYTOSIS; POLYETHYLENE-GLYCOL; EXOSOME UPTAKE; IN-VITRO; GLAUCOMA; CELLS; DELIVERY; TEMPERATURE; SECRETION	Consistent with increasing findings, extracellular vesicles (EVs), consider as a major constituents of the aqueous humor, have a role as signaling mediators in glaucoma. Following secretion, EVs hold immense promise for utilization as bio-therapeutics and drug delivery vehicles due to their nature as biological nanoparticles that facilitate intercellular molecular transport. Yet, the specific pathway utilizing for transferring signals by EVs in the ocular drainage system is not fully understood. Hence, the objective of this study was to examine internalization mechanisms by which Non-Pigmented Ciliary Epithelium (NPCE)-derived EVs deliver their signals to the Trabecular Meshwork (TM) cells. EVs were isolated and size and concentration were determined. Internalization study of treated EVs with Proteinase-K to achieve removal of surface membrane proteins on EVs was conducted. Energy dependent uptake mechanism was examined under various temperatures. Using uptake inhibitors endocytosis, phagocytosis, and Wnt-TGF beta 2 signaling were investigated. TM cells exposed to NPCE EVs demonstrate a significant decrease in the levels of two proteins in two Wnt-TGFb2 signaling proteins levels: p-GSK3 beta and beta-catenin. A significant decrease in the uptake by TM cells of Proteinase-K-treated EVs was found, followed by attenuation of the Wnt-TGF beta 2 proteins expression. Energy dependent uptake revealed a significant decrease in EVs internalization. The exposure of TM cells to endocytosis uptake inhibitors abolished the decrease of the Wnt-TGF beta 2 proteins levels. Exposure to phagocytosis uptake inhibitor resulted in a partial inhibition of NPCE EVs effect in TM cells. The attenuation of proteins expression levels following uptake inhibitors treatment or EVs membrane proteins removal indicates that Wnt-TGF beta 2 signaling in TM cells is mediated through NPCE EVs surface proteins in an active manner that involves endocytosis-dependent routes.	[Tabak, Saray; Schreiber-Avissar, Sofia; Beit-Yannai, Elie] Ben Gurion Univ Negev, Clin Biochem & Pharmacol Dept, POB 653, IL-84105 Beer Sheva, Israel; [Hadad, Uzi] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Beer Sheva, Israel	Ben Gurion University	Beit-Yannai, E (corresponding author), Ben Gurion Univ Negev, Clin Biochem & Pharmacol Dept, POB 653, IL-84105 Beer Sheva, Israel.	bye@bgu.ac.il		Beit-Yannai, Elie/0000-0001-9347-822X	Israel Science Foundation (ISF) [1545/20]	Israel Science Foundation (ISF)(Israel Science Foundation)	Israel Science Foundation (ISF), Grant/Award Number: 1545/20	Abu-Hassan Diala W, 2014, J Ocul Biol, V2; Alvarez-Erviti L, 2011, NAT BIOTECHNOL, V29, P341, DOI 10.1038/nbt.1807; Boon RA, 2015, NAT REV CARDIOL, V12, P135, DOI 10.1038/nrcardio.2014.207; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caponnetto F, 2017, NANOMED-NANOTECHNOL, V13, P1011, DOI 10.1016/j.nano.2016.12.009; Carter GC, 2011, VIROLOGY, V409, P234, DOI 10.1016/j.virol.2010.10.018; Cesi G, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-016-0136-z; Chen CC, 2016, CELL MOL BIOENG, V9, P509, DOI 10.1007/s12195-016-0458-3; Chen RH, 2000, J BIOL CHEM, V275, P17894, DOI 10.1074/jbc.M905336199; Chowdhury UR, 2015, INVEST OPHTH VIS SCI, V56, P2993, DOI 10.1167/iovs.15-16744; Coca-Prados M, 2007, PROG RETIN EYE RES, V26, P239, DOI 10.1016/j.preteyeres.2007.01.002; de Jong OG, 2016, J CELL MOL MED, V20, P342, DOI 10.1111/jcmm.12730; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; El-Andaloussi S, 2012, NAT PROTOC, V7, P2112, DOI 10.1038/nprot.2012.131; Escrevente C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-108; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Gangalum RK, 2011, J BIOL CHEM, V286, P3261, DOI 10.1074/jbc.M110.160135; GOLDENTHAL KL, 1984, EXP CELL RES, V152, P558, DOI 10.1016/0014-4827(84)90658-X; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; He ZL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23262-0; Holder B, 2016, TRAFFIC, V17, P168, DOI 10.1111/tra.12352; Howard S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023899; Klingeborn M, 2017, PROG RETIN EYE RES, V59, P158, DOI 10.1016/j.preteyeres.2017.04.004; Lee HM, 2010, BIOCHEM BIOPH RES CO, V397, P251, DOI 10.1016/j.bbrc.2010.05.094; Lerner N, 2020, J CELL MOL MED, V24, P4646, DOI 10.1111/jcmm.15129; Lerner N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171153; Lobb RJ, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27031; Ludwig AK, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1528109; Lv CY, 2018, INT UROL NEPHROL, V50, P973, DOI 10.1007/s11255-017-1779-4; Mathieu M, 2019, NAT CELL BIOL, V21, P9, DOI 10.1038/s41556-018-0250-9; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McKelvey Kelly J, 2015, J Circ Biomark, V4, P7, DOI 10.5772/61186; McQuate A, 2017, CELL REP, V21, P60, DOI 10.1016/j.celrep.2017.09.023; Menck K, 2013, ONCOTARGET, V4, P2057, DOI 10.18632/oncotarget.1336; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Nagai N, 2019, INT J NANOMED, V14, P1213, DOI 10.2147/IJN.S196681; Nanbo A, 2013, J VIROL, V87, P10334, DOI 10.1128/JVI.01310-13; Ofir-Birin Y, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01011; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Qu JL, 2009, DIGEST LIVER DIS, V41, P875, DOI 10.1016/j.dld.2009.04.006; Quigley HA, 2016, ANNU REV VIS SCI, V2, P235, DOI 10.1146/annurev-vision-111815-114417; Ramteke A, 2015, MOL CARCINOGEN, V54, P554, DOI 10.1002/mc.22124; Resende FA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-203; Rider MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep23978; Safdar A, 2016, NAT REV ENDOCRINOL, V12, P504, DOI 10.1038/nrendo.2016.76; SAID HM, 1994, AM J PHYSIOL, V266, pG15, DOI 10.1152/ajpgi.1994.266.1.G15; Schmidl D, 2015, J OCUL PHARMACOL TH, V31, P63, DOI 10.1089/jop.2014.0067; Stamer WD, 2011, J PROTEOMICS, V74, P796, DOI 10.1016/j.jprot.2011.02.024; Surgucheva I, 2012, BIOCHEMISTRY-US, V51, P4743, DOI 10.1021/bi300478w; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Tabak S, 2018, J CELL MOL MED, V22, P1992, DOI 10.1111/jcmm.13505; Tham YC, 2018, BRIT J OPHTHALMOL, V102, P1402, DOI 10.1136/bjophthalmol-2017-311359; Tian T, 2014, J BIOL CHEM, V289, P22258, DOI 10.1074/jbc.M114.588046; WEIGEL PH, 1981, J BIOL CHEM, V256, P2615; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Weng YJ, 2016, ANALYST, V141, P4640, DOI 10.1039/c6an00892e; Xue W, 2007, INVEST OPHTH VIS SCI, V48, P3184, DOI 10.1167/iovs.06-1403; Yu B, 2014, INT J MOL SCI, V15, P4142, DOI 10.3390/ijms15034142; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	62	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2021	35	2								10.1096/fj.202002040R	http://dx.doi.org/10.1096/fj.202002040R		NOV 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	RY3BC	33200492				2022-12-26	WOS:000592668900001
J	Gebremeskel, MG; Mulugeta, A; Bekele, A; Lemma, L; Gebremichael, M; Gebremedhin, H; Etsay, B; Tsegay, T; Haileslasie, Y; Kinfe, Y; Gebremeskel, F; Mezgebo, L; Shushay, S				Gebremeskel, Menaseb Gebrehaweria; Mulugeta, Afework; Bekele, Abate; Lemma, Lire; Gebremichael, Muzey; Gebremedhin, Haftay; Etsay, Berhe; Tsegay, Tesfay; Haileslasie, Yared; Kinfe, Yohannes; Gebremeskel, Fre; Mezgebo, Letemichael; Shushay, Selam			Individual and community level factors associated with anemia among children 6-59 months of age in Ethiopia: A further analysis of 2016 Ethiopia demographic and health survey	PLOS ONE			English	Article							RISK-FACTORS; DETERMINANTS	Background Anemia is a global public health problem; but its burden is disproportionately borne among children in the African Regions. The 2016 Ethiopia Demographic and Health Survey report showed that the prevalence of anemia among children 6-59 months of age was 57%; far exceeding the national target of 25% set for 2015. Although studies have been conducted in Ethiopia, multilevel analysis has rarely been used to identify factors associated with anemia among children. Therefore, this study aimed to identify individual and community-level factors associated with anemia among children 6-59 months of age by fitting a multilevel logistic regression model. Methods The data was obtained from the 2016 Ethiopia Demographic and Health Survey, conducted from January to June 2016, and downloaded from the website . The sample was taken using two-stage stratified sampling. In stage one, 645 Enumeration Areas and in stage two 28 households per Enumeration Area were selected. A sample of 7790 children 6-59 months of age was included. Data were analyzed using STATA version 14. A multilevel logistic regression model was fitted and an adjusted odds ratio with a 95% confidence interval was obtained. Result From the individual-level factors, anemia was associated most strongly with child age, wealth index, maternal anemia and child stunting followed by child underweight, child fever and birth order whereas from the community-level, the strongest odds of anemia occurred among children from Somali, Harari, Dire Dawa and Afar region followed by Oromia and Addis Ababa. Low community-poverty is a protective factor for anemia. The odds of anemia were 0.81 (95% CI: 0.66, 0.99) times lower for children who were living in communities of lower poverty status than children who were living in communities of higher poverty status. Children from Somali and Dire Dawa had 3.38 (95% CI: 3.25, 5.07) and 2.22 (95% CI: 1.42, 3.48) times higher odds of anemia, respectively than children from the Tigray region. Conclusions This study shows that anemia among children 6-59 months of age is affected both by the individual and community level factors. It is better to strengthen the strategies of early detection and management of stunted and underweight children. At the same time, interventions should be strengthened to address maternal anemia, child fever and poverty, specifically targeting regions identified to have a high risk of anemia.	[Gebremeskel, Menaseb Gebrehaweria; Gebremichael, Muzey; Gebremedhin, Haftay; Etsay, Berhe; Gebremeskel, Fre; Mezgebo, Letemichael] Adigrat Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Tigray, Ethiopia; [Mulugeta, Afework] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Nutr, Tigray, Ethiopia; [Bekele, Abate] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Biostat, Tigray, Ethiopia; [Lemma, Lire] Wachamo Univ, Coll Med & Hlth Sci, Sothern Nations Nationalities & Peoples Ethiopia, Dept Publ Hlth, Tigray, Ethiopia; [Tsegay, Tesfay; Haileslasie, Yared] Adigrat Univ, Coll Med & Hlth Sci, Dept Nursing, Tigray, Ethiopia; [Kinfe, Yohannes] Aksum Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Tigray, Ethiopia; [Shushay, Selam] Adigrat Univ, Coll Med & Hlth Sci, Dept Midwifery, Tigray, Ethiopia	Mekelle University; Mekelle University	Gebremeskel, MG (corresponding author), Adigrat Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Tigray, Ethiopia.	menasebgh@gmail.com		Belachew, Abate/0000-0003-2583-9913; kinfe, yohannes/0000-0001-8529-9424; Mulugeta, Afework/0000-0003-0707-4363				Ai Zhao YZ, 2012, PREVALENCE ANEMIA IT; Ali S, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/7329158; Allen LH, 2001, J NUTR, V131, p581S, DOI 10.1093/jn/131.2.581S; [Anonymous], 1993, HIST PUBLIC HLTH; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953; [Anonymous], 2008, WORLDW PREV AN 1993; Brabin BJ, 2001, J NUTR, V131, p636S, DOI 10.1093/jn/131.2.636S; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency [Ethiopia] ICF, 2016, ETH DEM HLTH SURV 20; Dey S, 2016, COGENT MATH, V3, DOI 10.1080/23311835.2016.1159798; Federal Democratic Republic of Ethiopia, 2015, NAT NUTR PROGR JUN 2; Fosu MO, 2014, J BIOL AGR HEALTHCAR, V4, P2; Gayawan E, 2014, INT HEALTH, V6, P35, DOI 10.1093/inthealth/iht034; Gebreegziabiher G, 2014, DETERMINANTS ANEMIA; Heck RH, 2010, QUANT METH SER, P1; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Jemal Y, 2017, S AFR J CLIN NUTR, V30, P1, DOI 10.1080/16070658.2017.1237446; Kawo KN, 2016, MULTILEVEL ANAL DETE; Kejo D, 2018, PREVALENCE PREDICTOR; Khan JR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-015-0536-z; Magalhaes RJS, 2011, B WORLD HEALTH ORGAN, V89, P459, DOI 10.2471/BLT.10.083568; Muchie K.F., 2016, BMC NUTR, V2, P51, DOI [DOI 10.1186/s40795-016-0093-3, DOI 10.1186/S40795-016-0093-3]; Ngnie-Teta I, 2007, FOOD NUTR BULL, V28, P76, DOI 10.1177/156482650702800109; Ngwira A., 2016, OPEN ACCESS MED STAT, V6, P9, DOI DOI 10.2147/0AMS.S9515912; Quintero JP, 2011, MEM I OSWALDO CRUZ, V106, P91, DOI 10.1590/S0074-02762011000900012; Ray S, 2016, J CONT PEDIAT, V3, P403; Semba RD, 2008, INT J INFECT DIS, V12, P62, DOI 10.1016/j.ijid.2007.04.011; Singh RK, 2014, EXTENT ANAEMIA PRESC; Steenbergen MR, 2012, MULTILEVEL LOGIT MOD; Stoltzfus JC, 2011, ACAD EMERG MED, V18, P1099, DOI 10.1111/j.1553-2712.2011.01185.x; Tengco LW, 2008, J AM COLL NUTR, V27, P229, DOI 10.1080/07315724.2008.10719695; WHO, 2001, IR DEC AN ASS PREV C; WHO, 2014, WHONMHNHD144; Williams R., 2015, MULTICOLLINEARITY; Woldie H, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/928632; World Health Organization, 2015, GLOB PREV AN 2011; World Health Organization (WHO), 2011, HEAM CONC DIAGN AN A	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0241720	10.1371/journal.pone.0241720	http://dx.doi.org/10.1371/journal.pone.0241720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186370	gold, Green Published			2022-12-26	WOS:000593949800007
J	Luukkonen, T; Yliniemi, J; Kinnunen, P; Illikainen, M				Luukkonen, Tero; Yliniemi, Juho; Kinnunen, Paivo; Illikainen, Mirja			Sustainable batching water options for one-part alkali-activated slag mortar: Sea water and reverse osmosis reject water	PLOS ONE			English	Article							MICROSTRUCTURAL DEVELOPMENT; PERFORMANCE ANALYSIS; HYDRATION KINETICS; CEMENT PASTES; WASTE-WATER; FLY-ASH; CONCRETE; DESALINATION; CHLORIDE; SEAWATER	Concrete production is globally a major water consumer, and in general, drinking-quality water is mixed in the binder. In the present study, simulated sea water and reverse osmosis reject water were used as batching water for one-part (dry-mix) alkali-activated blast furnace slag mortar. Alkali-activated materials are low-CO2 alternative binders gaining world-wide acceptance in construction. However, their production requires approximately similar amount of water as regular Portland cement concrete. The results of the present study revealed that the use of saline water did not hinder strength development, increased setting time, and did not affect workability. The salts incorporated in the binder decreased the total porosity of mortar, but they did not form separate phases detectable with X-ray diffraction or scanning electron microscopy. Leaching tests for monolithic materials revealed only minimal leaching. Furthermore, results for crushed mortars (by a standard two-stage leaching test) were within the limits of non-hazardous waste. Thus, the results indicated that high-salinity waters can be used safely in one-part alkali-activated slag to prepare high-strength mortars. Moreover, alkali-activation technology could be used as a novel stabilization/solidification method for reverse osmosis reject waters, which frequently pose disposal problems.	[Luukkonen, Tero; Yliniemi, Juho; Kinnunen, Paivo; Illikainen, Mirja] Univ Oulu, Fibre & Particle Engn Res Unit, Oulu, Finland	University of Oulu	Luukkonen, T (corresponding author), Univ Oulu, Fibre & Particle Engn Res Unit, Oulu, Finland.	tero.luukkonen@oulu.fi	Luukkonen, Tero/K-7140-2015; Luukkonen, Tero/AAT-6327-2021	Luukkonen, Tero/0000-0002-1124-775X; Illikainen, Mirja/0000-0001-7545-4574; Yliniemi, Juho/0000-0003-0013-8598	Academy of Finland [292526, 315103, 322786]	Academy of Finland(Academy of Finland)	Author name not applicable, grant number #292526, Academy of Finland, https://www.aka.fi/en/, funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Tero Luukkonen, grant number #315103, Academy of Finland, https://www.aka.fi/en/, funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Juho Yliniemi, grant number #322786, Academy of Finland, https://www.aka.fi/en/, funder did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2001, DESALINATION, V134, P37, DOI 10.1016/S0011-9164(01)00113-8; Al-Obaidi MA, 2018, DESALINATION, V443, P272, DOI 10.1016/j.desal.2018.06.010; Alonso S, 2001, MATER LETT, V47, P55, DOI 10.1016/S0167-577X(00)00212-3; ASTM, 2003, D114198 ASTM ASTN IN; Babu GR, 2018, MATER TODAY-PROC, V5, P1313; Ben Haha M, 2011, CEMENT CONCRETE RES, V41, P955, DOI 10.1016/j.cemconres.2011.05.002; Ben Haha M, 2011, CEMENT CONCRETE RES, V41, P301, DOI 10.1016/j.cemconres.2010.11.016; Bernal SA, 2014, CEMENT CONCRETE RES, V57, P33, DOI 10.1016/j.cemconres.2013.12.003; Brough AR, 2000, CEMENT CONCRETE RES, V30, P1375, DOI 10.1016/S0008-8846(00)00356-2; Cheung J, 2011, CEMENT CONCRETE RES, V41, P1289, DOI 10.1016/j.cemconres.2011.03.005; Chini AR, 2001, MAG CONCRETE RES, V53, P311; Council European, 2003, OFFICIAL J EUROPEA L, VL11, P27; Criado M, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10124709; Deng G, 2020, CONSTR BUILD MATER, V235, DOI 10.1016/j.conbuildmat.2019.117451; El-Didamony H, 2013, CERAM INT, V39, P171, DOI 10.1016/j.ceramint.2012.06.007; El-Nawawy OA, 1991, CEMENT CONCRETE COMP, V13, P137, DOI [10.1016/0958-9465(91)90009-7, DOI 10.1016/0958-9465(91)90009-7]; EN, 2002, 124573 EN EUR COMM S; EN, 2016, 19632016 EN EUR COMM; European Committee for Standardization, 2016, 1961 EN; Fattah Kazi P., 2017, International Journal of Sustainable Built Environment, V6, P183, DOI 10.1016/j.ijsbe.2017.02.004; Ghrair AM, 2016, WATER-SUI, V8, DOI 10.3390/w8090366; Han FH, 2017, THERMOCHIM ACTA, V655, P202, DOI 10.1016/j.tca.2017.07.002; Hoang M., 2009, WATER, V36, P67; International Desalination Association (IDA), 2016, IDA DES YB 2016 2017; Jahnke C, 2019, APPL GEOCHEM, V100, P64, DOI 10.1016/j.apgeochem.2018.11.001; Kaushik S.K., 1995, CEMENT CONCRETE COMP, V17, P177, DOI [10.1016/0958-9465(95)00015-5, DOI 10.1016/0958-9465(95)00015-5]; Ke XY, 2017, CEMENT CONCRETE RES, V100, P1, DOI 10.1016/j.cemconres.2017.05.015; Ke XY, 2016, CEMENT CONCRETE RES, V81, P24, DOI 10.1016/j.cemconres.2015.11.012; Kumar S, 2010, J MATER SCI, V45, P607, DOI 10.1007/s10853-009-3934-5; Liu JZ, 2016, CONSTR BUILD MATER, V122, P619, DOI 10.1016/j.conbuildmat.2016.06.101; Lu YY, 2019, CONSTR BUILD MATER, V199, P138, DOI 10.1016/j.conbuildmat.2018.11.187; Luukkonen T, 2018, CEMENT CONCRETE RES, V103, P21, DOI 10.1016/j.cemconres.2017.10.001; Lv W, 2020, CEMENT CONCRETE COMP, V106, DOI 10.1016/j.cemconcomp.2019.103484; Machner A, 2018, CEMENT CONCRETE RES, V107, P163, DOI 10.1016/j.cemconres.2018.02.002; Meena K, 2019, J BUILD ENG, V21, P106, DOI 10.1016/j.jobe.2018.10.003; Miller SA, 2018, NAT SUSTAIN, V1, P69, DOI 10.1038/s41893-017-0009-5; Mills SJ, 2012, MINERAL MAG, V76, P1289, DOI 10.1180/minmag.2012.076.5.10; MIYATA S, 1980, CLAY CLAY MINER, V28, P50, DOI 10.1346/CCMN.1980.0280107; Morillo J, 2014, DESALINATION, V336, P32, DOI 10.1016/j.desal.2013.12.038; NEN, 1995, 7345 NEN NETH STAND; Pinto HB, 2018, J CLEAN PROD, V201, P1061, DOI 10.1016/j.jclepro.2018.08.113; Provis J.L., 2014, ALKALI ACTIVATED MAT, P1, DOI [10.1007/978-94-007-7672-2_1, DOI 10.1007/978-94-007-7672-2_1]; Provis JL, 2018, CEMENT CONCRETE RES, V114, P40, DOI 10.1016/j.cemconres.2017.02.009; Puertas F, 2004, CEMENT CONCRETE RES, V34, P139, DOI 10.1016/S0008-8846(03)00254-0; Puligilla S, 2013, CEMENT CONCRETE RES, V43, P70, DOI 10.1016/j.cemconres.2012.10.004; Qasim M, 2019, DESALINATION, V459, P59, DOI 10.1016/j.desal.2019.02.008; Ruiz-Garcia A, 2015, DESALINATION, V375, P81, DOI 10.1016/j.desal.2015.07.022; SFS-EN, 2009, 123505 SFSEN FINN ST; SFS-EN, 2006, 1936 SFSEN EUR COMM; Siddique S, 2020, MATERIALS, V13, DOI 10.3390/ma13061467; Su N, 2002, CEMENT CONCRETE RES, V32, P777, DOI 10.1016/S0008-8846(01)00762-1; Tanaka M, 2005, J SOLUTION CHEM, V34, P617, DOI 10.1007/s10953-005-4488-z; Tanaka M, 2007, J SOLUTION CHEM, V36, P27, DOI 10.1007/s10953-006-9101-6; Todorovi J, 2004, DIFFUSION TESTS ASSE; World Health Organization, 2017, DEPR OTH COMM MENT D; Xiao JZ, 2017, CONSTR BUILD MATER, V155, P1101, DOI 10.1016/j.conbuildmat.2017.08.130; Yang ST, 2019, CONSTR BUILD MATER, V196, P395, DOI 10.1016/j.conbuildmat.2018.11.113; Yang ZQ, 2020, CONSTR BUILD MATER, V232, DOI 10.1016/j.conbuildmat.2019.117219; Yin H, 2019, PROCESSES, V7, DOI 10.3390/pr7010034; Yoon S, 2016, MATERIALS, V9, DOI 10.3390/ma9050401	60	5	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2020	15	11							e0242462	10.1371/journal.pone.0242462	http://dx.doi.org/10.1371/journal.pone.0242462			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0NB	33186392	Green Published, gold			2022-12-26	WOS:000593949800017
J	Kampfen, F; Kohler, IV; Ciancio, A; de Bruin, WB; Maurer, J; Kohler, HP				Kampfen, Fabrice; Kohler, Iliana V.; Ciancio, Alberto; Bruine de Bruin, Wandi; Maurer, Jurgen; Kohler, Hans-Peter			Predictors of mental health during the Covid-19 pandemic in the US: Role of economic concerns, health worries and social distancing	PLOS ONE			English	Article							GENDER-DIFFERENCES; DEPRESSION; DISORDERS; PREVALENCE; INFLUENZA; SARS	Despite the profound health and economic implications of Covid-19, there is only limited knowledge to date about the role of economic concerns, health worries and social distancing for mental health outcomes during the pandemic. We analyze online survey data from the nationally representative "Understanding America Study" (UAS) covering the period of March 10-31st 2020 (sample size: 6,585). Mental health is assessed by the validated PHQ-4 instrument for measuring symptoms of depression and anxiety. About 29% (CI:27.4-.30.4%) of the US adult population reported some depression/anxiety symptoms over the study period, with symptoms deteriorating over the month of March. Worsening mental health was most strongly associated with concerns about the economic consequences of the pandemic, while concerns about the potential implications of the virus for respondents' own health and social distancing also predicted increases in symptoms of depression and anxiety during the early stages of the pandemic in the US, albeit less strongly. Our findings point towards the possibility of a major mental health crisis unfolding simultaneously with the pandemic, with economic concerns being a key driving force of this crisis. These results highlight the likely importance of economic countermeasures and social policy for mitigating the impact of Covid-19 on adult mental health in the US over and above an effective public health response.	[Kampfen, Fabrice; Kohler, Iliana V.; Kohler, Hans-Peter] Univ Penn, Populat Studies Ctr, Philadelphia, PA 19104 USA; [Kampfen, Fabrice; Kohler, Iliana V.; Kohler, Hans-Peter] Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA; [Ciancio, Alberto; Maurer, Jurgen] Univ Lausanne, Dept Econ, Lausanne, Switzerland; [Bruine de Bruin, Wandi] Univ Southern Calif, Sol Price Sch Publ Policy, Los Angeles, CA 90007 USA; [Bruine de Bruin, Wandi] Univ Southern Calif, Dornsife Dept Psychol, Los Angeles, CA 90007 USA; [Bruine de Bruin, Wandi] Univ Southern Calif, Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA 90007 USA; [Bruine de Bruin, Wandi] Univ Southern Calif, Ctr Econ & Social Res, Los Angeles, CA 90007 USA	University of Pennsylvania; University of Pennsylvania; University of Lausanne; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Kampfen, F (corresponding author), Univ Penn, Populat Studies Ctr, Philadelphia, PA 19104 USA.; Kampfen, F (corresponding author), Univ Penn, Dept Sociol, Philadelphia, PA 19104 USA.	kampfenf@sas.upenn.edu	Bruine de Bruin, Wandi/N-8588-2018	Bruine de Bruin, Wandi/0000-0002-1601-789X; Ciancio, Alberto/0000-0001-5346-0885; Kampfen, Fabrice/0000-0001-7304-7473; Kohler, Hans-Peter/0000-0003-0639-4349	Population Aging Research Center (PARC) at the University of Pennsylvania - U.S. National Institutes of Health [NIA P30,AG12836, NICHD R24 HD044964]; Population Studies Center (PSC) at the University of Pennsylvania - U.S. National Institutes of Health [NIA P30,AG12836, NICHD R24 HD044964]; Bill & Melinda Gates Foundation; National Institute on Aging [U01AG054580]; National Science Foundation [2028683]; Swedish Riksbankens Jubileumsfond Program on Science and Proven Experience 'Science and Proven Experience'	Population Aging Research Center (PARC) at the University of Pennsylvania - U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Population Studies Center (PSC) at the University of Pennsylvania - U.S. National Institutes of Health; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science Foundation(National Science Foundation (NSF)); Swedish Riksbankens Jubileumsfond Program on Science and Proven Experience 'Science and Proven Experience'	We gratefully acknowledge the support of the Population Aging Research Center (PARC) and Population Studies Center (PSC) at the University of Pennsylvania, which are funded by the U.S. National Institutes of Health through grants NIA P30,AG12836 and NICHD R24 HD044964 respectively. The project described in this paper relies on data from survey(s) administered by the Understanding America Study (UAS), which is maintained by the Center for Economic and Social Research at the University of Southern California (USC). The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of USC or UAS. The collection of the UAS Covid-19 survey data is supported in part by the Bill & Melinda Gates Foundation, the National Institute on Aging (U01AG054580), and the National Science Foundation (#2028683). Wa<spacing diaeresis>ndi Bruine de Bruin was partially supported by the Swedish Riksbankens Jubileumsfond Program on Science and Proven Experience 'Science and Proven Experience'.	Alattar L., 2018, SOC SECUR B, V78, P13; Angrisani M., 2019, ADV ECONOMETRICS, V39; Ansseau M, 2004, J AFFECT DISORDERS, V78, P49, DOI 10.1016/S0165-0327(02)00219-7; Bailey RK, 2019, NEUROPSYCH DIS TREAT, V15, P603, DOI 10.2147/NDT.S128584; Brooks M., 2020, MEDSCAPE PSYCHIAT NE; Brune de Bruin W., 2020, AM J PREVENTIVE MED; Chater N, 2020, NATURE HUMAN BEHAV, P1; Cheng C, 2005, J PERS, V73, P261, DOI 10.1111/j.1467-6494.2004.00310.x; Ciancio A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238341; de Bruin WB, 2018, RISK ANAL, V38, P2128, DOI 10.1111/risa.13138; de Bruin WB, 2021, J GERONTOL B-PSYCHOL, V76, pE24, DOI 10.1093/geronb/gbaa074; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Galea S, 2020, JAMA INTERN MED, V180, P817, DOI 10.1001/jamainternmed.2020.1562; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Gili Margalida, 2014, Gac Sanit, V28 Suppl 1, P104, DOI 10.1016/j.gaceta.2014.02.005; Goldmann E, 2014, ANNU REV PUBL HEALTH, V35, P169, DOI 10.1146/annurev-publhealth-032013-182435; Hawryluck L, 2004, EMERG INFECT DIS, V10, P1206, DOI 10.3201/eid1007.030703; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Kahnemann Daniel., 1999, WELL BEING FDN HEDON; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kohler IV, 2017, DEMOGRAPHY, V54, P1529, DOI 10.1007/s13524-017-0596-9; Kroenke K, 2009, PSYCHOSOMATICS, V50, P613, DOI 10.1176/appi.psy.50.6.613; Leon A C, 1995, Arch Fam Med, V4, P857, DOI 10.1001/archfami.4.10.857; Lowe B, 2010, J AFFECT DISORDERS, V122, P86, DOI 10.1016/j.jad.2009.06.019; Lynch Julia., 2015, OXFORD HDB US SOCIAL; McCrae R. R., 1999, HDB PERSONALITY THEO, V2, P139; McTernan WP, 2013, WORK STRESS, V27, P321, DOI 10.1080/02678373.2013.846948; Mervosh S., 2020, NEW YORK TIMES; Mucci N, 2016, NEUROPSYCH DIS TREAT, V12, P983, DOI 10.2147/NDT.S98525; National Institutes of Health (U.S.), 2001, NIH Consens Statement, V18, P1; Nazroo JY, 1997, PSYCHOL MED, V27, P9, DOI 10.1017/S0033291796004187; Nazroo JY, 1998, SOCIOL HEALTH ILL, V20, P312, DOI 10.1111/1467-9566.00104; Neria Y, 2008, PSYCHOL MED, V38, P467, DOI 10.1017/S0033291707001353; Nunnally JC, 1994, PSYCHOMETRIC THEORY; Paul KI, 2009, J VOCAT BEHAV, V74, P264, DOI 10.1016/j.jvb.2009.01.001; Perrin PC, 2009, PREHOSPITAL DISASTER, V24, P223, DOI 10.1017/S1049023X00006853; Rohde N, 2016, SOC SCI MED, V151, P250, DOI 10.1016/j.socscimed.2015.12.014; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; The New York Times, 2022, NEW YORK TIMES; UAS, 2020, UND AM STUD MARCH 20; United Nations, 2020, COVID 19 NEED ACT ME; Ursano RJ, 2005, PSYCHIAT SERV, V56, P7, DOI 10.1176/appi.ps.56.1.7; Uutela A, 2010, CURR OPIN PSYCHIATR, V23, P127, DOI 10.1097/YCO.0b013e328336657d; Vandoros S, 2019, SOC SCI MED, V220, P403, DOI 10.1016/j.socscimed.2018.11.035; Venti S, 2011, FORUM HLTH EC POLICY, V14; Wahlbeck K, 2012, WORLD PSYCHIATRY, V11, P139; Wang JY, 2017, SOC PSYCH PSYCH EPID, V52, P1451, DOI 10.1007/s00127-017-1446-1	48	64	64	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2020	15	11							e0241895	10.1371/journal.pone.0241895	http://dx.doi.org/10.1371/journal.pone.0241895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0LY	33175894	Green Published, gold, Green Submitted			2022-12-26	WOS:000593946900025
J	de Barros, CF; Felisberto, RM; Nucci, KCA; de Albuquerque, ALP; Paulin, E; de Brito, CMM; Yamaguti, WP				de Barros, Cassia Fabiane; Felisberto, Rosimeire Marcos; Albanezi Nucci, Kelly Cristina; Pereira de Albuquerque, Andre Luis; Paulin, Elaine; Moran de Brito, Christina May; Yamaguti, Wellington Pereira			Dynamic hyperinflation induced by the 6-minute pegboard and ring test in hospitalized patients with exacerbated COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ARM EXERCISE; DYSPNEA; CAPACITY; PERFORMANCE; ENDURANCE; VERSION	Background The six-minute pegboard and ring test (6-PBRT) has been used to evaluate functional capacity of the upper limbs in stable chronic obstructive pulmonary disease (COPD) patients. To the best of our knowledge, no studies have evaluated dynamic hyperinflation (DH) during exercise with upper limbs in the hospital setting. The aim of this study was to evaluate physiological responses and DH induced by 6-PBRT in hospitalized patients with acute exacerbation of COPD (AECOPD). Methods A cross-sectional study was conducted in a tertiary hospital enrolling patients who were hospitalized due to AECOPD. All included participants underwent an evaluation of lung function and 6-PBRT when they reached minimum clinical criteria. Ventilatory and hemodynamics parameters were monitored during 6-PBRT and until 6 minutes of rest after the test. Symptoms of dyspnea and upper limb fatigue were also measured. Results Eighteen patients (71.3 +/- 5.1 years) with a mean FEV1 of 43.2 +/- 18.3% were included in the study (11 females). Prevalence of DH after 6-PBRT was 50% (considering the drop of 150 ml or 10% of inspiratory capacity, immediately after the end of the test). There was a significant increase in respiratory rate, minute volume, dyspnea, and upper limb fatigue after the end of 6-PBRT (p<0.05). Dyspnea recovered more precociously than the perception of fatigue, being reestablished within four minutes of rest. An increase in heart rate, systolic and diastolic blood pressures was also induced by 6-PBRT (p<0.05), requiring 6 minutes of recovery to return to baseline. No adverse events were observed during 6-PBRT. We concluded that 6-PBRT induces physiological changes during its execution, at safe levels, requiring a maximum of 6 minutes for recovery. Finally, the test proved to be safe and applicable for patients hospitalized due to AECOPD.	[de Barros, Cassia Fabiane; Felisberto, Rosimeire Marcos; Albanezi Nucci, Kelly Cristina; Pereira de Albuquerque, Andre Luis; Moran de Brito, Christina May; Yamaguti, Wellington Pereira] Hosp Sirio Libanes, Sao Paulo, SP, Brazil; [Paulin, Elaine] Univ Estado Santa Catarina UDESC, Florianopolis, SC, Brazil	Hospital Sirio Libanes; Universidade do Estado de Santa Catarina	Yamaguti, WP (corresponding author), Hosp Sirio Libanes, Sao Paulo, SP, Brazil.	wellington.psyamaguti@hsl.org.br	Brito, Christina M/I-7269-2012; Albuquerque, Andre/C-8835-2012	Yamaguti, Wellington/0000-0003-4943-2085; Albuquerque, Andre/0000-0003-3486-5240; Paulin, Elaine/0000-0001-7306-2817; Moran de Brito, Christina May/0000-0003-3775-6533; Felisberto, Rosimeire/0000-0002-2034-7509; Barros, Cassia/0000-0001-9301-867X	Brazilian Scientific Agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [18/16832-9]	Brazilian Scientific Agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Brazilian Scientific Agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, number 18/16832-9).	Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Bendixen HJ, 2014, SCAND J OCCUP THER, V21, P313, DOI 10.3109/11038128.2014.899621; Burtin C, 2011, EUR RESPIR J, V38, P702, DOI 10.1183/09031936.00079111; Castro AAM, 2013, ARCH BRONCONEUMOL, V49, P241, DOI 10.1016/j.arbres.2012.12.009; CELLI BR, 1986, NEW ENGL J MED, V314, P1485, DOI 10.1056/NEJM198606053142305; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Colucci M, 2010, CHEST, V138, P39, DOI 10.1378/chest.09-2878; Coronell C, 2004, EUR RESPIR J, V24, P129, DOI 10.1183/09031936.04.00079603; Costi S, 2009, CHEST, V136, P387, DOI 10.1378/chest.09-0165; Felisberto RM, 2018, INT J CHRONIC OBSTR, V13, P1663, DOI 10.2147/COPD.S161463; da Silva GPF, 2013, J BRAS PNEUMOL, V39, P402, DOI 10.1590/S1806-37132013000400002; Garcia-Aymerich J, 2011, THORAX, V66, P585, DOI 10.1136/thx.2010.152876; Gigliotti F, 2005, CHEST, V128, P1225, DOI 10.1378/chest.128.3.1225; Hill CJ, 2008, J CARDIOPULM REHABIL, V28, P402, DOI 10.1097/HCR.0b013e31818c3c65; Holland AE, OFFICIAL EUROPEAN RE; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Janaudis-Ferreira T, 2013, PHYSIOTHER CAN, V65, P40, DOI 10.3138/ptc.2011-49; Janaudis-Ferreira T, 2011, CHEST, V139, P151, DOI 10.1378/chest.10-1292; Kovelis Demetria, 2008, J. bras. pneumol., V34, P1008; Lareau SC, 1998, HEART LUNG, V27, P159, DOI 10.1016/S0147-9563(98)90003-6; Lima VP, 2018, J BRAS PNEUMOL, V44, P190, DOI [10.1590/S1806-37562017000000388, 10.1590/s1806-37562017000000388]; Marin JM, 2001, AM J RESP CRIT CARE, V163, P1395, DOI 10.1164/ajrccm.163.6.2003172; McKeough ZJ, 2012, CHRON RESP DIS, V9, P153, DOI 10.1177/1479972312440814; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Nyberg A, 2016, PHYSIOTHER CAN, V68, P46, DOI 10.3138/ptc.2014-93; Nyberg A, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-114; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; Pan L, 2012, RESP MED, V106, P1517, DOI 10.1016/j.rmed.2012.08.002; Parker CM, 2005, EUR RESPIR J, V26, P420, DOI 10.1183/09031936.05.00136304; Pitta F, 2006, CHEST, V129, P536, DOI 10.1378/chest.129.3.536; Porto EF, 2009, RESP MED, V103, P251, DOI 10.1016/j.rmed.2008.08.018; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Satake M, 2015, INT J CHRONIC OBSTR, V10, P153, DOI 10.2147/COPD.S73717; Stevenson NJ, 2005, AM J RESP CRIT CARE, V172, P1510, DOI 10.1164/rccm.200504-595OC; Takahashi Tetsuya, 2003, J Cardiopulm Rehabil, V23, P430, DOI 10.1097/00008483-200311000-00007; Takeda K, 2013, INT J CHRONIC OBSTR, V8, P347, DOI 10.2147/COPD.S45081; van Geffen WH, 2018, INT J CHRONIC OBSTR, V13, P1269, DOI 10.2147/COPD.S154878; van Geffen WH, 2015, LANCET RESP MED, V3, pE43, DOI 10.1016/S2213-2600(15)00459-2; Velloso M, 2003, CHEST, V123, P1047, DOI 10.1378/chest.123.4.1047; Zhan Su, 2006, J Cardiopulm Rehabil, V26, P180, DOI 10.1097/00008483-200605000-00013	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241639	10.1371/journal.pone.0241639	http://dx.doi.org/10.1371/journal.pone.0241639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170878	gold, Green Published			2022-12-26	WOS:000592383400015
J	Ndiabamoh, CMC; Ekali, GL; Esemu, L; Lloyd, YM; Djontu, JC; Mbacham, W; Bigoga, J; Taylor, DW; Leke, RGF				Ndiabamoh, Crespo'o Mbe-cho; Ekali, Gabriel Loni; Esemu, Livo; Lloyd, Yukie Michelle; Djontu, Jean Claude; Mbacham, Wilfred; Bigoga, Jude; Taylor, Diane Wallace; Leke, Rose Gana Fomban			The immunoglobulin G antibody response to malaria merozoite antigens in asymptomatic children co-infected with malaria and intestinal parasites	PLOS ONE			English	Article							ASCARIS-LUMBRICOIDES; COINFECTION; PREVALENCE; PROTECTION; IMMUNITY; VACCINE	Background Co-infection with malaria and intestinal parasites is common in children in Africa and may affect their immune response to a malaria parasite infection. Prior studies suggest that co-infections may lead to increased susceptibility to malaria infection and disease severity; however, other studies have shown the reverse. Knowledge on how co-morbidities specifically affect the immune response to malaria antigens is limited. Therefore, this study sought to determine the prevalence of co-infection of malaria and intestinal parasites and its association with antibody levels to malaria merozoite antigens. Methods A cross sectional study was carried out in two villages with high transmission of malaria in Cameroon (Ngali II and Mfou) where mass drug administration (MDA) had been administered at similar to 6-month intervals (generally with albendazole or mebendazole). Children aged 1-15 years were enrolled after obtaining parental consent. A malaria rapid diagnostic test was used on site. Four (4) ml of peripheral blood was collected from each participant to determine Plasmodium falciparum infections by microscopy, haemoglobin levels and serology. Fresh stool samples were collected and examined by wet mount, Kato-Katz method and modified Ritchie concentration techniques. A Multiplex Analyte Platform assay was used to measure antibody levels. Results A total of 320 children were enrolled. The prevalence of malaria by blood smear was 76.3% (244/320) and prevalence of malaria and intestinal parasites was 16.9% (54/320). Malaria prevalence was highest in young children; whereas, intestinal parasites (IP+) were not present until after 3 years of age. All children positive for malaria had antibodies to MSP1(42), MSP2, MSP3 and EBA175. No difference in antibody levels in children with malaria-co infections compared to malaria alone were found, except for antibody levels to EBA-175 were higher in children co-infected with intestinal protozoa (p = 0.018), especially those with Entamoeba histolytica infections (p = 0.0026). Conclusion Antibody levels to EBA175 were significantly higher in children co-infected with malaria and E. histolytica compared to children infected with malaria alone. It is important to further investigate why and how the presence of these protozoans might modulate the immune response to malaria antigens.	[Ndiabamoh, Crespo'o Mbe-cho; Mbacham, Wilfred] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Ndiabamoh, Crespo'o Mbe-cho; Ekali, Gabriel Loni; Esemu, Livo; Djontu, Jean Claude; Mbacham, Wilfred; Bigoga, Jude; Leke, Rose Gana Fomban] Univ Yaounde I, Biotechnol Ctr, Nkolbisson, Yaounde, Cameroon; [Ekali, Gabriel Loni] Minist Publ Hlth, Natl AIDS Control Comm, Yaounde, Cameroon; [Esemu, Livo; Mbacham, Wilfred; Bigoga, Jude] Univ Yaounde I, Dept Biochem, Yaounde, Cameroon; [Lloyd, Yukie Michelle; Taylor, Diane Wallace] Univ Hawaii, John A Burns Sch Med, Manoa, HI USA	University of Yaounde I; University of Yaounde I; University of Yaounde I; University of Hawaii System; University of Hawaii Manoa	Ndiabamoh, CMC (corresponding author), Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon.; Ndiabamoh, CMC; Leke, RGF (corresponding author), Univ Yaounde I, Biotechnol Ctr, Nkolbisson, Yaounde, Cameroon.	cndiabamoh@gmail.com; roseleke@yahoo.com		ndiabamoh, crespo'o mbe-cho/0000-0002-7070-552X; Bigoga, Jude/0000-0001-7206-3308; Lloyd, Yukie/0000-0003-4597-3626	Centers of Biomedical Research Excellence, National Institute of General Medical Sciences, NIH [P30GM11473]	Centers of Biomedical Research Excellence, National Institute of General Medical Sciences, NIH	The Luminex MAGpix was provided by grant P30GM11473, Centers of Biomedical Research Excellence, National Institute of General Medical Sciences, NIH. GFLR provided the funds for the field work and analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Anna Babakhanyan, University of Hawaii, provided the recombinant proteins (beads) used for the assays. The recombinant MSP antigens were contributed by the Malaria Vaccine Development Branch, NIAID, NIH and EBA-175 was provided by W. Bancroft through the PIBP, NIAID, NIH, Contracts Program.	Achonduh-Atijegbe OA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1996-y; Akinbo FO., 2009, FOOYIN J HLTH SCI, V1, P81, DOI [10.1016/S1877-8607(10)60004-5, DOI 10.1016/S1877-8607(10)60004-5]; [Anonymous], 2017, LANCET HIV, V2, pe115; [Anonymous], 2017, AMEBIASIS BACKGROUND; [Anonymous], 2016, GIARDIASIS BACKGROUN; [Anonymous], 2016, HEMOGLOBIN CONCENTRA; [Anonymous], 2014, OBESITY SILVER SP S2, V22, pS40; [Anonymous], ENT HIST OV; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Ateba-Ngoa U, 2016, AM J TROP MED HYG, V95, P394, DOI 10.4269/ajtmh.15-0703; Babakhanyan A, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1023-6; Bediako Y, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1292-y; Beeson JG, 2016, FEMS MICROBIOL REV, V40, P343, DOI 10.1093/femsre/fuw001; Brutus L, 2007, AM J TROP MED HYG, V77, P1091, DOI 10.4269/ajtmh.2007.77.1091; Chen I, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001942; Courtin D, 2011, PARASITE IMMUNOL, V33, P124, DOI 10.1111/j.1365-3024.2010.01267.x; Degarege A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1594-2; Diallo TO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012764; Dunn JC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006591; Fletcher SM, 2011, J PUBLIC HEALTH AFR, V2, P127, DOI 10.4081/jphia.2011.e30; Fodjo BAY, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1585-y; Fouda GG, 2006, CLIN VACCINE IMMUNOL, V13, P1307, DOI 10.1128/CVI.00183-06; Fusi-Ngwa C, 2014, OPEN ACCESS LIB J, V1, P1, DOI DOI 10.4236/oalib.1101081; Griffin JT, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2657; Haldar Kasturi, 2009, Hematology Am Soc Hematol Educ Program, P87, DOI 10.1182/asheducation-2009.1.87; Hartgers FC, 2006, PARASITE IMMUNOL, V28, P497, DOI 10.1111/j.1365-3024.2006.00901.x; Hartgers FC, 2009, J INFECT DIS, V199, P1528, DOI 10.1086/598687; Hopkin J, 2009, PARASITE IMMUNOL, V31, P267, DOI 10.1111/j.1365-3024.2009.01104.x; Hurlimann E, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-81; Kovalszki A, 2016, PRIMARY CARE, V43, P607, DOI 10.1016/j.pop.2016.07.010; Kuitcha D., 2012, ARCH APPL SCI RES, V4, P2591; Kwenti TE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004673; Kwenti TE, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2654-9; Leke RFG, 2010, AM J TROP MED HYG, V83, P996, DOI 10.4269/ajtmh.2010.10-0249; Lemaitre M, 2014, AM J TROP MED HYG, V90, P329, DOI 10.4269/ajtmh.12-0431; Lindholz CG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006274; Lo AC, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2948-8; Lorenzo PJ, 2019, INFECT DIS POVERTY, V8, DOI 10.1186/s40249-019-0595-8; Lyke KE, 2005, AM J TROP MED HYG, V73, P1124, DOI 10.4269/ajtmh.2005.73.1124; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; Mbuh JV, 2012, J HELMINTHOL, V86, P30, DOI 10.1017/S0022149X1000091X; Mbuh JV, 2009, REV J INFECT DEV CTR, V4, P38, DOI DOI 10.3855/JIDC.82; Melo GC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011206; Mwangi TW, 2006, ANN TROP MED PARASIT, V100, P551, DOI 10.1179/136485906X118468; Nacher M, 2000, PARASITE IMMUNOL, V22, P107, DOI 10.1046/j.1365-3024.2000.00284.x; Nacher M, 2001, TRENDS PARASITOL, V17, P563, DOI 10.1016/S1471-4922(01)02117-1; Nacher M., INTESTINAL HELMINTH, DOI [10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2, DOI 10.1645/0022-3395(2002)088[0055:IHIAAW]2.0.CO;2]; Njunda AL, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0078-5; Nkuo-Akenji TK, 2006, J PARASITOL, V92, P1191, DOI 10.1645/GE-895R.1; O'Connell EM, 2015, IMMUNOL ALLERGY CLIN, V35, P493, DOI 10.1016/j.iac.2015.05.003; Ondigo BN, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01402; Ortu G, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1794-9; Pampiglione S, 1987, Parassitologia, V29, P15; Richardson DJ, 2011, COMP PARASITOL, V78, P180, DOI 10.1654/4461.1; Roetynck S, 2006, M S-MED SCI, V22, P739, DOI 10.1051/medsci/20062289739; Sokhna C, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-43; Su Z, 2006, INFECT IMMUN, V74, P2138, DOI 10.1128/IAI.74.4.2138-2144.2006; Thomas K., 2015, AM J EPIDEMIOLOGY IN, V3, P36; Yanet Fresco-Sampedro, 2017, J Parasit Dis, V41, P718, DOI 10.1007/s12639-016-0876-0; Zeukeng F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003236	60	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0242012	10.1371/journal.pone.0242012	http://dx.doi.org/10.1371/journal.pone.0242012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170876	Green Published, gold			2022-12-26	WOS:000592383400001
J	Yilmaz, S; Dudkina, E; Bin, M; Crisostomi, E; Ferraro, P; Murray-Smith, R; Parisini, T; Stone, L; Shorten, R				Yilmaz, Serife; Dudkina, Ekaterina; Bin, Michelangelo; Crisostomi, Emanuele; Ferraro, Pietro; Murray-Smith, Roderick; Parisini, Thomas; Stone, Lewi; Shorten, Robert			Kemeny-based testing for COVID-19	PLOS ONE			English	Article							CONSTANT; CENTRALITY; NETWORKS; DYNAMICS	Testing, tracking and tracing abilities have been identified as pivotal in helping countries to safely reopen activities after the first wave of the COVID-19 virus. Contact tracing apps give the unprecedented possibility to reconstruct graphs of daily contacts, so the question is: who should be tested? As human contact networks are known to exhibit community structure, in this paper we show that the Kemeny constant of a graph can be used to identify and analyze bridges between communities in a graph. Our 'Kemeny indicator' is the value of the Kemeny constant in the new graph that is obtained when a node is removed from the original graph. We show that testing individuals who are associated with large values of the Kemeny indicator can help in efficiently intercepting new virus outbreaks, when they are still in their early stage. Extensive simulations provide promising results in early identification and in blocking the possible 'super-spreaders' links that transmit disease between different communities.	[Yilmaz, Serife; Ferraro, Pietro; Shorten, Robert] Imperial Coll London, Dyson Sch Design Engn, London, England; [Dudkina, Ekaterina; Crisostomi, Emanuele] Univ Pisa, Dept Energy Syst Terr & Construct Engn, Pisa, Italy; [Bin, Michelangelo; Parisini, Thomas] Imperial Coll London, Dept Elect & Elect Engn, London, England; [Murray-Smith, Roderick] Univ Glasgow, Sch Comp Sci, Glasgow, Lanark, Scotland; [Parisini, Thomas] Univ Trieste, Dept Engn & Architecture, Trieste, Italy; [Parisini, Thomas] Univ Cyprus, KIOS Res & Innovat Ctr Excellence, Nicosia, Cyprus; [Stone, Lewi] Tel Aviv Univ, George S Wise Fac Life Sci, Tel Aviv, Israel	Imperial College London; University of Pisa; Imperial College London; University of Glasgow; University of Trieste; University of Cyprus; Tel Aviv University	Crisostomi, E (corresponding author), Univ Pisa, Dept Energy Syst Terr & Construct Engn, Pisa, Italy.	emanuele.crisostomi@unipi.it	; Crisostomi, Emanuele/G-8216-2015; Bin, Michelangelo/G-1069-2017	Ferraro, Pietro/0000-0002-9195-3880; Murray-Smith, Roderick/0000-0003-4228-7962; Crisostomi, Emanuele/0000-0002-7973-6357; Bin, Michelangelo/0000-0003-2645-1064; Shorten, Robert/0000-0002-9239-2499	Engineering and Physical Sciences Research Council (EPSRC) [EP/R018634/1]; European Union's Horizon 2020 Research and Innovation Programme [739551]; Science Foundation Ireland [16/IA/4610]; EPSRC [EP/V018450/1]; EPSRC [EP/R018634/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Union's Horizon 2020 Research and Innovation Programme; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding for this study was provided by the following organizations in the form of grants: the Engineering and Physical Sciences Research Council (EPSRC), grant EP/R018634/1, Closedloop Data Science, awarded to RMS; the European Union's Horizon 2020 Research and Innovation Programme, Grant Agreement No 739551 (KIOS CoE), awarded to MB and TP; Science Foundation Ireland, grant 16/IA/4610, awarded to RS; and the EPSRC, grant EP/V018450/1, awarded to RS, RMS, and TP.	[Anonymous], 2020, BMC MED, DOI 10.1186/s12916-020-01597-8; Berkhout J, 2019, OPER RES, V67, P892, DOI 10.1287/opre.2018.1813; Bi QF, 2020, LANCET INFECT DIS, V20, P911, DOI 10.1016/S1473-3099(20)30287-5; Breen J, 2019, ELECTRON J LINEAR AL, V35, P583, DOI 10.13001/1081-3810.4095; Cho GE, 2001, LINEAR ALGEBRA APPL, V335, P137, DOI 10.1016/S0024-3795(01)00320-2; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Crisostomi E, 2011, INT J CONTROL, V84, P633, DOI 10.1080/00207179.2011.568005; Dahlel M., 2020, KEYNOTE TALK WORKSHO; Doyle PG, 2009, ARXIV09092636; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Fouss F., 2016, ALGORITHMS MODELS NE; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Grolmusz V, 2015, INFORM PROCESS LETT, V115, P633, DOI 10.1016/j.ipl.2015.02.015; Gudbjartsson DF, 2020, NEW ENGL J MED, V382, P2302, DOI 10.1056/NEJMoa2006100; He B, 2020, 3 DELVE; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kemeny J. G., 1960, FINITE MARKOV CHAINS; Kirkland S, 2016, ELECTRON J LINEAR AL, V31, P444, DOI 10.13001/1081-3810.3222; Kucharski J, 2020, ROUTL MONOGR CLASS S, P1; Langville A., 2006, GOOGLES PAGERANK SCI; Lavezzo E, 2020, NATURE, V584, P425, DOI 10.1038/s41586-020-2488-1; Levene M, 2002, AM MATH MON, V109, P741, DOI 10.2307/3072398; Marcel S, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20225; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; OECD, 2020, TEST COVID 19 WAY LI; Overko R, 2019, INT CONF CONNECT VEH; Royal Society DELVE Initiative, REV INT APPR TEST TR; Salathe M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000736; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yaesoubi R, 2011, EUR J OPER RES, V215, P679, DOI 10.1016/j.ejor.2011.07.016	33	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2020	15	11							e0242401	10.1371/journal.pone.0242401	http://dx.doi.org/10.1371/journal.pone.0242401			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	PM0RU	33211725	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000603518300054
J	Gomes, JM; Silva, BM; Santos, EFD; Kelly, PJ; Costa, AD; Takiuti, AD; de Abreu, LC; Soares, JM; Baracat, EC; Sorpreso, ICE				Gomes, Jessica Menezes; Silva, Beatriz Machado; Santos, Edige Felipe de Sousa; Kelly, Patricia Jane; Costa, Annielson de Souza; Takiuti, Albertina Duarte; de Abreu, Luiz Carlos; Soares Junior, Jose Maria; Baracat, Edmund Chada; Sorpreso, Isabel Cristina Esposito			Human Papillomavirus (HPV) and the quadrivalent HPV Vaccine among Brazilian adolescents and parents: Factors associated with and divergences in knowledge and acceptance	PLOS ONE			English	Article							ACCEPTABILITY; ATTITUDES; HEALTH	Background Low national immunization coverage (44.64%) requires strengthening the vaccination campaign to improve knowledge about HPV and its vaccine among adolescents and parents/guardians. Our aim is to evaluate factors related to knowledge about HPV, its vaccine, acceptability and divergences among Brazilian adolescents and parents/guardians. Methods A cross-sectional study was performed at a health unit of Sao Paulo University, Brazil, from 2015 to 2016. The convenience sample comprised 1047 individuals, including 74% (n = 776) adolescents and 26% (n = 271) parents/guardians, who answered a survey (knowledge about HPV, its vaccine, barriers and acceptability). Results The main source of information for adolescents was school (39%, n = 298); for parents/guardians, it was health professionals (55%, n = 153). Parents/guardians were 2.48 times more likely than adolescents to know that HPV caused changes in the Pap smear test [RR 2.48, 95% CI 2.03-3.01 (p < 0.001)], 1.43 times likely to be aware that HPV was a sexually transmitted infection [RR 1.43, 95% CI 1.22-1.68 (p < 0.001)], and 2.77 times likely to be informed that the HPV vaccine decreased the chance of having genital warts [RR 2.77, 95% CI 2.22-2.47 (p < 0.001)]. Girls knew more about the topic than boys (RR 1.67; 95% CI 1.10-2.60); education increased parents' knowledge [(RR 3.38; 95% CI 1.71-6.69)]. Conclusion Female adolescents and parents/guardians with a higher level of education are factors related to suitable knowledge about HPV and its vaccine among Brazilian respondents. There were differences between parents/guardians and adolescents in HPV awareness, clinical implications, vaccine knowledge and vaccine acceptance.	[Gomes, Jessica Menezes; Silva, Beatriz Machado; Costa, Annielson de Souza; Takiuti, Albertina Duarte; Soares Junior, Jose Maria; Baracat, Edmund Chada; Sorpreso, Isabel Cristina Esposito] Univ Sao Paulo, Disciplina Ginecol, Fac Med, Sao Paulo, SP, Brazil; [Santos, Edige Felipe de Sousa; de Abreu, Luiz Carlos] ABC Med Sch, Study Design & Sci Writing Lab, Santo Andre, SP, Brazil; [Kelly, Patricia Jane] Univ Missouri, Sch Nursing & Hlth Studies, Kansas City, MO 64110 USA	Universidade de Sao Paulo; Faculdade de Medicina do ABC; University of Missouri System; University of Missouri Kansas City	Sorpreso, ICE (corresponding author), Univ Sao Paulo, Disciplina Ginecol, Fac Med, Sao Paulo, SP, Brazil.	icesorpreso@usp.br	Sorpreso, Isabel Cristina Esposito/C-4054-2013; Baracat, Edmund C/H-3800-2012; de Abreu, Luiz Carlos/AAL-8219-2021; Takiuti, Albertina/GQA-7233-2022; Soares-Jr, Jose Maria/G-1467-2012	Sorpreso, Isabel Cristina Esposito/0000-0002-5475-5957; Baracat, Edmund C/0000-0003-0111-9030; de Abreu, Luiz Carlos/0000-0002-7618-2109; Soares-Jr, Jose Maria/0000-0003-0774-9404	Foundation School of Medicine and Adolescent Health -Secretary of Health -State of Sao Paulo [BR/LOA/1300039.001]; Pan American Health Organization/World Health Organization in Brazil of the Pan American Health Organization - PAHO-BR	Foundation School of Medicine and Adolescent Health -Secretary of Health -State of Sao Paulo; Pan American Health Organization/World Health Organization in Brazil of the Pan American Health Organization - PAHO-BR	Letter Agreement number: BR/LOA/1300039.001 Foundation School of Medicine and Adolescent Health -Secretary of Health -State of Sao Paulo. Project with support from the Pan American Health Organization/World Health Organization in Brazil of the Pan American Health Organization - PAHO-BR. Funders did not have a role in the design, collection, analysis, interpretation of data, and/or writing of this manuscript.	Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; [Anonymous], 2017, ADHD ATTENTION DE S1, V9, pS1, DOI 10.1007/s12402-017-0224-y; [Anonymous], 2016, STORIE LINGUAGGI, V2, P71; Arrossi S, 2012, VACCINE, V30, P2467, DOI 10.1016/j.vaccine.2012.01.032; Blodt S, 2012, EUR J PUBLIC HEALTH, V22, P808, DOI 10.1093/eurpub/ckr188; Brasil, 1990, ESTATUTO CRIANCA ADO; Brazil. Ministerio da Saude. Datasus. Informacoes de Saude, DAT INF SAUD MORB IN; Brazil. Ministerio da Saude. Secretaria de Vigilancia em saude. Departamento de vigilancia de doencas transmissiveis, 2018, COORD GER PROGR NAC; Brazil. Ministry of Health. Instituto Nacional de Cancer (INCA), 2020, QUEM POD SER VAC HPV; Brazil-Ministerio da Saude, 2015, DATASUS VAC; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Bruni L, 2017, LANCET GLOB HEALTH, V5, pE662; Bruni L.A.G., 2019, HUMAN PAPILLOMAVIRUS; Carneiro RF, 2015, SANARE, V14, P104; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; De Groot AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171631; Division of Cancer Prevention and Control Centers for Disease Control and Prevention, 2019, CANC ASS HUM PAP HPV; Farias CC, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1677-y; Figueroa-Downing D, 2017, INT J GYNECOL OBSTET, V136, P33, DOI 10.1002/ijgo.12004; Freire P, 1997, EDUCACAO COMO PRATIC; Fuller KM, 2017, J COMMUN HEALTH, V42, P1127, DOI 10.1007/s10900-017-0361-4; Pereira JEG, 2019, CLINICS, V74, DOI 10.6061/clinics/2019/e1166; Gorjana R, 2017, PREV MED, V95, P26, DOI 10.1016/j.ypmed.2016.11.019; Gualano M R, 2016, J Prev Med Hyg, V57, pE121; Instituto do cancer, 2019, FAK NEWS SAO EMP AUM; Instituto Nacional de Cancer Jose Alencar Gomes da Silva. (INCA/MS), 2015, TIP CANC COL UT; Kornfeld J, 2013, J PRIM PREV, V34, P59, DOI 10.1007/s10935-013-0297-0; Kose D, 2014, ASIAN PAC J CANCER P, V15, P7263, DOI 10.7314/APJCP.2014.15.17.7263; Markowitz LE, 2014, MMWR RECOMM REP, V63, P1; Nogueira-Rodrigues A, 2017, CANCER-AM CANCER SOC, V123, P2193, DOI 10.1002/cncr.30647; OPAS/WHO, 1978, C INT CUID PRIM SAUD; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Patel H, 2016, SEX TRANSM INFECT, V92, P474, DOI 10.1136/sextrans-2015-052341; SAEDE: Portal de estatisticas de SAo Paulo, SAEDE PORT EST SAO P; Silva ATM, 2017, J HUM GROWTH DEV, V27, P117, DOI DOI 10.7322/JHGD.127686; Sorpreso IC, 2018, J HUM GROWTH DEV, V28, P5, DOI [10.7322/jhgd.143887, DOI 10.7322/JHGD.143887]; Sousa PDL., 2018, J HUM GROWTH DEV, V28, P58, DOI [10.7322/jhgd.143856, DOI 10.7322/JHGD.143856]; Tafuri S, 2014, VACCINE, V32, P4860, DOI 10.1016/j.vaccine.2013.11.006; The Lancet HIV, 2017, LANCET HIV, V4, pe51; Voidazan S, 2016, CENT EUR J PUBL HEAL, V24, P29, DOI 10.21101/cejph.a4287; WHO, 2017, WKLY EPIDEMIOL REC, P241, DOI DOI 10.1016/j.vaccine.2017.05.069	41	3	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241674	10.1371/journal.pone.0241674	http://dx.doi.org/10.1371/journal.pone.0241674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	OY0MJ	33180790	Green Published, gold			2022-12-26	WOS:000593948000098
J	Priyadarshana, C; Setiawan, R; Tajima, A; Asano, A				Priyadarshana, Chathura; Setiawan, Rangga; Tajima, Atsushi; Asano, Atsushi			Src family kinases-mediated negative regulation of sperm acrosome reaction in chickens (Gallus gallus domesticus)	PLOS ONE			English	Article							TYROSINE KINASE; ZONA-PELLUCIDA; SER/THR PHOSPHATASES; FOWL SPERMATOZOA; PKA ACTIVATION; LIPID RAFTS; CAPACITATION; MEMBRANE; EXOCYTOSIS; HYPERPOLARIZATION	The acrosome reaction (AR) is a strictly-regulated, synchronous exocytosis that is required for sperm to penetrate ova. This all-or-nothing process occurs only once in the sperm lifecycle through a sequence of signaling pathways. Spontaneous, premature AR therefore compromises fertilization potential. Although protein kinase A (PKA) pathways play a central role in AR across species, the signaling network used for AR induction is poorly understood in birds. Mechanistic studies of mammalian sperm AR demonstrate that PKA activity is downstreamly regulated by Src family kinases (SFKs). Using SFK inhibitors, our study shows that in chicken sperm, SFKs play a role in the regulation of PKA activity and spontaneous AR without affecting motility. Furthermore, we examined the nature of SFK phosphorylation using PKA and protein tyrosine phosphatase inhibitors, which demonstrated that unlike in mammals, SFK phosphorylation in birds does not occur downstream of PKA and is primarily regulated by calcium-dependent tyrosine phosphatase activity. Functional characterization of SFKs in chicken sperm showed that SFK activation modulates the membrane potential and plays a role in inhibiting spontaneous AR. Employing biochemical isolation, we also found that membrane rafts are involved in the regulation of SFK phosphorylation. This study demonstrates a unique mechanism for regulating AR induction inherent to avian sperm that ensure fertilization potential despite prolonged storage.	[Priyadarshana, Chathura; Setiawan, Rangga] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Tajima, Atsushi; Asano, Atsushi] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba	Asano, A (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	asano.atsushi.ft@u.tsukuba.ac.jp	Setiawan, Rangga/AAR-7786-2021	Setiawan, Rangga/0000-0002-0361-7079; Priyadarshana, Chathura/0000-0002-5001-8298	Japan Society of the Promotion of Science (JSPS) [15K07761, 17KK0150]; National University Corporation, Japan	Japan Society of the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National University Corporation, Japan	AA received funding for this work from the Japan Society of the Promotion of Science (JSPS) (Project No. 15K07761 and 17KK0150) and from the Sustainable Food Security Research Project in the form of an operational grant from the National University Corporation, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrisani A, 2015, MAR DRUGS, V13, P5533, DOI 10.3390/md13095533; [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI [10.1055/s-0043-115953, DOI 10.1055/S-0043-115953]; Arabaci G, 1999, J AM CHEM SOC, V121, P5085, DOI 10.1021/ja9906756; Asano A, 2013, J BIOL CHEM, V288, P28104, DOI 10.1074/jbc.M113.450981; Asano A, 2009, J CELL PHYSIOL, V218, P537, DOI 10.1002/jcp.21623; Ashizawa K, 2006, REPRODUCTION, V131, P1017, DOI 10.1530/rep.1.01069; Ashizawa K, 2006, REPRODUCTION, V131, P71, DOI 10.1530/rep.1.00588; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; BABCOCK DF, 1983, J BIOL CHEM, V258, P6380; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Bakst MR, 2010, POULTRY SCI, V89, P986, DOI 10.3382/ps.2009-00481; BAKST MR, 1977, BIOL REPROD, V17, P370, DOI 10.1095/biolreprod17.3.370; Battistone MA, 2013, MOL HUM REPROD, V19, P570, DOI 10.1093/molehr/gat033; Ben-Aharon I, 2005, REPRODUCTION, V129, P435, DOI 10.1530/rep.1.00255; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Boschelli DH, 2001, J MED CHEM, V44, P3965, DOI 10.1021/jm0102250; Bragado MJ, 2012, REPRODUCTION, V144, P67, DOI 10.1530/REP-11-0075; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Buffone MG, 2014, BBA-MOL BASIS DIS, V1842, P2610, DOI 10.1016/j.bbadis.2014.07.013; BURROWS W. H., 1937, POULTRY SCI, V16, P19, DOI 10.3382/ps.0160019; Cary LA, 2000, NATURE, V404, P945, DOI 10.1038/35010257; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; CHRISTENSEN VL, 1989, POULTRY SCI, V68, P724, DOI 10.3382/ps.0680724; Davis MJ, 2001, AM J PHYSIOL-HEART C, V281, pH1835, DOI 10.1152/ajpheart.2001.281.5.H1835; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Finkelstein M, 2010, J BIOL CHEM, V285, P39702, DOI 10.1074/jbc.M110.170951; FLORMAN HM, 1982, DEV BIOL, V91, P121, DOI 10.1016/0012-1606(82)90015-X; Fraser LR, 2005, J REPROD DEVELOP, V51, P37, DOI 10.1262/jrd.51.37; Fuss H, 2008, BIOPHYS J, V94, P1995, DOI 10.1529/biophysj.107.115022; Horrocks AJ, 2000, BIOCHEM BIOPH RES CO, V278, P84, DOI 10.1006/bbrc.2000.3766; Khalil MB, 2006, DEV BIOL, V290, P220, DOI 10.1016/j.ydbio.2005.11.030; Kim KS, 2003, DEV BIOL, V264, P141, DOI 10.1016/j.ydbio.2003.08.006; Kon S, 2017, MOL REPROD DEV, V84, P1314, DOI 10.1002/mrd.22932; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; Kumagai T, 2014, AM J PATHOL, V184, P2211, DOI 10.1016/j.ajpath.2014.05.005; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson C, 2008, BIOL REPROD, V79, P657, DOI 10.1095/biolreprod.108.070367; Leclerc P, 2002, BIOL REPROD, V67, P301, DOI 10.1095/biolreprod67.1.301; Lemoine M, 2008, REPRODUCTION, V136, P391, DOI 10.1530/REP-08-0094; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; Nahed RA, 2018, REPRODUCTION, V156, P463, DOI [10.1530/rep-18-0075, 10.1530/REP-18-0075]; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; OKAMURA F, 1978, CELL TISSUE RES, V188, P497; Overmiller AM, 2016, ONCOTARGET, V7, P37536, DOI 10.18632/oncotarget.7675; Ozaki Y, 2001, BIOL CHEM, V382, P831, DOI 10.1515/BC.2001.101; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; PIERSON EEM, 1988, BRIT POULTRY SCI, V29, P199, DOI 10.1080/00071668808417044; Priyadarshana C, 2018, BIOL REPROD, V99, P1000, DOI 10.1093/biolre/ioy120; Rajamanickam GD, 2017, MOL REPROD DEV, V84, P1168, DOI 10.1002/mrd.22879; Rock MT, 1997, J BIOL CHEM, V272, P33377, DOI 10.1074/jbc.272.52.33377; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Shabtay O, 2016, DEV BIOL, V415, P64, DOI 10.1016/j.ydbio.2016.05.008; Shi L, 2014, J BIOL CHEM, V289, P8432, DOI 10.1074/jbc.M113.517466; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Singh DK, 2017, REPRODUCTION, V153, P655, DOI 10.1530/REP-16-0591; Stival C, 2015, J BIOL CHEM, V290, P18855, DOI 10.1074/jbc.M115.640326; TESARIK J, 1995, FERTIL STERIL, V63, P153, DOI 10.1016/S0015-0282(16)57311-7; Nguyen TMD, 2019, THERIOGENOLOGY, V140, P1, DOI 10.1016/j.theriogenology.2019.07.031; Nguyen TMD, 2016, FEBS J, V283, P1902, DOI 10.1111/febs.13710; Nguyen TMD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147559; Tomes CN, 2004, DEV BIOL, V265, P399, DOI 10.1016/j.ydbio.2003.09.032; Ushiyama A, 2019, BIOL REPROD, V100, P1482, DOI 10.1093/biolre/ioz015; Vicens A, 2017, FEBS OPEN BIO, V7, P382, DOI 10.1002/2211-5463.12186; Visconti PE, 1999, BIOL REPROD, V61, P76, DOI 10.1095/biolreprod61.1.76; Visconti PE, 1998, BIOL REPROD, V59, P1, DOI 10.1095/biolreprod59.1.1; ZENG Y, 1995, DEV BIOL, V171, P554, DOI 10.1006/dbio.1995.1304	67	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2020	15	11							e0241181	10.1371/journal.pone.0241181	http://dx.doi.org/10.1371/journal.pone.0241181			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OY0MJ	33180820	Green Published, gold			2022-12-26	WOS:000593948000025
J	Fazeli, S; Motovali-Bashi, M; Peymani, M; Hashemi, MS; Etemadifar, M; Nasr-Esfahani, MH; Ghaedi, K				Fazeli, Soudabeh; Motovali-Bashi, Majid; Peymani, Maryam; Hashemi, Motahare-Sadat; Etemadifar, Masoud; Nasr-Esfahani, Mohammad Hossein; Ghaedi, Kamran			A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; EXPRESSION ANALYSIS; MIRNA EXPRESSION; MICRORNA; IDENTIFICATION; NETWORKS; SYSTEM; SCALE	Parkinson's disease (PD) is diagnosed when motor symptoms emerges, which almost 70% of dopamine neurons are lost. Therefore, early diagnosis of PD is crucial to prevent the progress of disease. Blood-based biomarkers, which are minimally invasive, potentially used for diagnosis of PD, including miRNAs. The aim of this study was to assess whether SRRM2 and miR-27a/b-3p could act as early diagnostic biomarkers for PD. Total RNAs from PBMCs of 30 PD's patients and 14 healthy age and gender matched subjects was extracted. The expression levels of respective genes were assessed. Data were presented applying a two-tailed unpaired t-test and one-way ANOVA. We observed significant down-regulation of SRRM2 (p = 0.0002) and miR-27a-3p (p = 0.0001), and up-regulation of miR-27b-3p (p = 0.02) in PBMCs of Parkinson's patients. Down-regulation of miR-27a-3p is associated with increasing disease severity, whereas the up-regulation of miR-27b-3p was observed mostly at HY-1 and disease duration between 3-5 years. There was a negative correlation between SRRM2 and miR-27b-3p expressions, and miR-27a-3p positively was correlated with miR-27b-3p. Based on functional enrichment analysis, SRRM2 and miR-27a/b-3p acted on common functional pathways. miR-27a/b-3p could potentially predict the progression and severity of PD. Although both miRs had no similarity on expression, a positive correlation between both miRs was identified, supporting their potential role as biomarkers in clinical PD stages. Of note that SRRM2 and miR-27a-3p were able to distinguish PD patients from healthy individuals. Functional analysis of the similarity between genes associated with SRRM2 and miR-27a/b-3p indicates common functional pathways and their dysfunction correlates with molecular etiopathology mechanisms of PD onset.	[Fazeli, Soudabeh; Motovali-Bashi, Majid; Ghaedi, Kamran] Univ Isfahan, Fac Biol Sci & Technol, Dept Cell & Mol Biol & Microbiol, Esfahan, Iran; [Peymani, Maryam] Islamic Azad Univ, Fac Basic Sci, Dept Biol, Shahrekord, Iran; [Peymani, Maryam; Hashemi, Motahare-Sadat; Nasr-Esfahani, Mohammad Hossein; Ghaedi, Kamran] ACECR, Royan Inst Biotechnol, Dept Anim Biotechnol, Cell Sci Res Ctr, Esfahan, Iran; [Etemadifar, Masoud] Isfahan Univ Med Sci, Dept Neurol, Sch Med, Esfahan, Iran; [Etemadifar, Masoud] Isfahan Univ Med Sci, Isfahan Neurosurg Res Ctr, Sch Med, Esfahan, Iran	University of Isfahan; Islamic Azad University; Academic Center for Education, Culture & Research (ACECR); Isfahan University Medical Science; Isfahan University Medical Science	Motovali-Bashi, M; Ghaedi, K (corresponding author), Univ Isfahan, Fac Biol Sci & Technol, Dept Cell & Mol Biol & Microbiol, Esfahan, Iran.; Peymani, M (corresponding author), Islamic Azad Univ, Fac Basic Sci, Dept Biol, Shahrekord, Iran.; Peymani, M; Ghaedi, K (corresponding author), ACECR, Royan Inst Biotechnol, Dept Anim Biotechnol, Cell Sci Res Ctr, Esfahan, Iran.	mbashi@sci.ui.ac.ir; m.peymani@iaushk.ac.ir; kamranghaedi@sci.ui.ac.ir	Peymani, Maryam/AAN-2134-2021; , Nasr-Esfahani/AAR-2434-2021; Ghaedi, Kamran/X-9824-2018	Peymani, Maryam/0000-0001-5075-5661; Ghaedi, Kamran/0000-0002-9790-5644; Nasr-Esfahani, Mohammad-Hossein/0000-0003-1983-3435				[Anonymous], 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-018-0474-7; [Anonymous], 2017, J OBSTET GYNECOL NEO, V46, pe125; [Anonymous], 2004, ITAL HEART J S3, V5, p49S; [Anonymous], 2015, DIABETOL KLIN SA, V4, pA1; [Anonymous], 2016, GLASNIK UNIVERZITETA, V54, P1; Arshad AR, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00352; Atif H, 2019, J EXP NEUROSCI, V13, DOI 10.1177/1179069519832286; Backes C, 2017, NUCLEIC ACIDS RES, V45, pD90, DOI 10.1093/nar/gkw926; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Butovsky O, 2012, J CLIN INVEST, V122, P3063, DOI 10.1172/JCI62636; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; Choi WS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44989; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Colombo C, 2003, ANN NY ACAD SCI, V1010, P679, DOI 10.1196/annals.1299.124; Diaz G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1971-9; Dos Santos Marcia Cristina T, 2018, Oncotarget, V9, P17455, DOI 10.18632/oncotarget.24736; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fu RH, 2013, CELL TRANSPLANT, V22, P653, DOI 10.3727/096368912X655154; Gennarino VA, 2012, GENOME RES, V22, P1163, DOI 10.1101/gr.130435.111; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; GOLDMAN JE, 1983, SCIENCE, V221, P1082, DOI 10.1126/science.6308771; Hasegawa Y, 2000, ACTA NEUROL SCAND, V101, P159, DOI 10.1034/j.1600-0404.2000.101003159.x; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; ISSIDORIDES MR, 1975, NATURE, V258, P612, DOI 10.1038/258612a0; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; La Cognata V, 2015, NEUROGENETICS, V16, P245, DOI 10.1007/s10048-015-0449-x; Li X, 2018, BIOMED RES INT, P2018; Liew CC, 2006, J LAB CLIN MED, V147, P126, DOI 10.1016/j.lab.2005.10.005; Liguori M, 2018, HUM MOL GENET, V27, P66, DOI 10.1093/hmg/ddx385; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Liu WJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1629-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116; Ma M, 2018, GENOMICS; Martins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025443; Marz M, 2015, MICRORNAS BIOMARKER; Marziali G, 2017, MOL ONCOL, V11, P1115, DOI 10.1002/1878-0261.12047; Meldgaard M, 2006, J NEUROSCI METH, V156, P101, DOI 10.1016/j.jneumeth.2006.02.008; Mills JD, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.10.030; Mutez E, 2014, NEUROBIOL DIS, V63, P165, DOI 10.1016/j.nbd.2013.11.007; Park CY, 2015, BIOINFORMATICS, V31, P1093, DOI 10.1093/bioinformatics/btu786; Rosas-Hernandez H, 2018, NEUROSCI LETT, V687, P1, DOI 10.1016/j.neulet.2018.07.022; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Schwienbacher C, 2017, J MOL NEUROSCI, V62, P244, DOI 10.1007/s12031-017-0926-9; Shehadeh LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009104; Smith-Vikos T, 2012, J CELL SCI, V125, P7, DOI 10.1242/jcs.099200; Song RH, 2015, J THEOR BIOL, V380, P271, DOI 10.1016/j.jtbi.2015.05.025; Sorensen SS, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0053-5; Soreq L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003517; Soreq L, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00010; Stefan Teodora Cristina, 2018, Ment Health Clin, V8, P159, DOI 10.9740/mhc.2018.05.159; Sticht C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206239; Tibar H, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00170; Tinelli M., 2016, VALUE EARLY DIAGNOSI; Tomsic J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10566; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Ward AJ, 2010, J PATHOL, V220, P152, DOI 10.1002/path.2649; Xi TY, 2018, J BIOL CHEM, V293, P20041, DOI 10.1074/jbc.RA118.001858	66	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0240855	10.1371/journal.pone.0240855	http://dx.doi.org/10.1371/journal.pone.0240855			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33171483	Green Published, gold			2022-12-26	WOS:000592383400067
J	Huang, X; Li, ZL; Jiang, YQ; Li, XM; Porter, D				Huang, Xiao; Li, Zhenlong; Jiang, Yuqin; Li, Xiaoming; Porter, Dwayne			Twitter reveals human mobility dynamics during the COVID-19 pandemic	PLOS ONE			English	Article							SOCIAL MEDIA; EVACUATION; IMPACT	The current COVID-19 pandemic raises concerns worldwide, leading to serious health, economic, and social challenges. The rapid spread of the virus at a global scale highlights the need for a more harmonized, less privacy-concerning, easily accessible approach to monitoring the human mobility that has proven to be associated with viral transmission. In this study, we analyzed over 580 million tweets worldwide to see how global collaborative efforts in reducing human mobility are reflected from the user-generated information at the global, country, and U.S. state scale. Considering the multifaceted nature of mobility, we propose two types of distance: the single-day distance and the cross-day distance. To quantify the responsiveness in certain geographic regions, we further propose a mobility-based responsive index (MRI) that captures the overall degree of mobility changes within a time window. The results suggest that mobility patterns obtained from Twitter data are amenable to quantitatively reflect the mobility dynamics. Globally, the proposed two distances had greatly deviated from their baselines after March 11, 2020, when WHO declared COVID-19 as a pandemic. The considerably less periodicity after the declaration suggests that the protection measures have obviously affected people's travel routines. The country scale comparisons reveal the discrepancies in responsiveness, evidenced by the contrasting mobility patterns in different epidemic phases. We find that the triggers of mobility changes correspond well with the national announcements of mitigation measures, proving that Twitter-based mobility implies the effectiveness of those measures. In the U.S., the influence of the COVID-19 pandemic on mobility is distinct. However, the impacts vary substantially among states.	[Huang, Xiao; Li, Zhenlong; Jiang, Yuqin] Univ South Carolina, Dept Geog, Geoinformat & Big Data Res Lab, Columbia, SC 29208 USA; [Huang, Xiao] Univ Arkansas, Dept Geosci, Fayetteville, AR USA; [Li, Xiaoming] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Porter, Dwayne] Univ South Carolina, Dept Environm Hlth Sci, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia; University of Arkansas System; University of Arkansas Fayetteville; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia	Li, ZL (corresponding author), Univ South Carolina, Dept Geog, Geoinformat & Big Data Res Lab, Columbia, SC 29208 USA.	zhenlong@sc.edu	Huang, Xiao/AAS-4608-2020; Li, Zhenlong/M-1065-2017	Huang, Xiao/0000-0002-4323-382X; Li, Zhenlong/0000-0002-8938-5466; Li, Xiaoming/0000-0002-5555-9034	National Science Foundation [2028791]; University of South Carolina COVID-19 Internal Funding Initiative [135400-20-54176]	National Science Foundation(National Science Foundation (NSF)); University of South Carolina COVID-19 Internal Funding Initiative	The research is supported by National Science Foundation, https://www.nsf.gov/, (2028791) to ZL, XL and DP; and University of South Carolina COVID-19 Internal Funding Initiative, https://sc.edu/about/offices_and_ divisions/research, (135400-20-54176) to ZL and XL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	2005 Nov 29., 2020, DIGITAL 2020 APRIL G; [Anonymous], 2019, NAT MED, V25, P1, DOI 10.1038/s41591-018-0322-1; [Anonymous], OP AM AG; [Anonymous], 2020, COMMUN BIOL, V3, P1; [Anonymous], COR DIS COVID 19 SIT; [Anonymous], 2020, ARAB NEWS; [Anonymous], THE JAPAN TIMES; Beiro MG, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0092-2; Bengtsson L, 2015, SCI REP-UK, V5, DOI 10.1038/srep08923; Buckee CO, 2020, SCIENCE, V368, P145, DOI 10.1126/science.abb8021; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Du EH, 2017, WATER RESOUR RES, V53, P9164, DOI 10.1002/2017WR021192; Engle S., 2020, STAYING HOME MOBILIT, DOI [10.2139/ssrn.3565703, DOI 10.2139/SSRN.3565703]; Fisher D, 2020, LANCET, V395, P1109, DOI 10.1016/S0140-6736(20)30679-6; Gatto M, 2020, P NATL ACAD SCI USA, V117, P10484, DOI 10.1073/pnas.2004978117; Giglio M, 2020, ATLANTIC; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Goodchild MF, 2007, GEOJOURNAL, V69, P211, DOI 10.1007/s10708-007-9111-y; Hasan S., 2013, P 2 ACM SIGKDD INT W, P1; Hawelka B, 2014, CARTOGR GEOGR INF SC, V41, P260, DOI 10.1080/15230406.2014.890072; Huang X, 2021, INT J DIGIT EARTH, V14, P424, DOI 10.1080/17538947.2021.1886358; Huang X, 2018, IEEE T GEOSCI REMOTE, V56, P4691, DOI 10.1109/TGRS.2018.2835306; Jarv O, 2014, TRANSPORT RES C-EMER, V38, P122, DOI 10.1016/j.trc.2013.11.003; Jiang YQ, 2019, ANN AM ASSOC GEOGR, V109, P1795, DOI 10.1080/24694452.2019.1592660; Jun SW, 2020, MALAY MAIL; Kass-Hout TA, 2013, BRIT MED BULL, V108, P5, DOI 10.1093/bmb/ldt028; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Kuniya T, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030789; Leguay J, 2005, CS0511102 ARXIV; Lenormand M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105407; Lin Y., 2020, 10 TWITTER STAT EVER; Liu XY, 2019, INT J GEOGR INF SCI, V33, P1196, DOI 10.1080/13658816.2018.1563301; Livingston Edward, 2020, JAMA, V323, P1335, DOI 10.1001/jama.2020.4344; Lyons K., 2020, VERGE; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1089; Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557; Martin Y, 2020, NAT HAZARDS REV, V21, DOI 10.1061/(ASCE)NH.1527-6996.0000354; Martin Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181701; McAfee A, 2012, HARVARD BUS REV, V90, P60; Mervosh S., 2020, NEW YORK TIMES; Mislove A, P 5 INT AAAI C WEBLO; Normile D, 2020, SCIENCE; O'Reilly T., 2007, COMMUNICATIONS STRAT, V65, P17, DOI DOI 10.1109/KIMAS.2003.1245106; Oliver Nuria, 2020, ARXIV200312347; Park S, 2020, JAMA-J AM MED ASSOC, V323, P2129, DOI 10.1001/jama.2020.6602; Pepe E, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00575-2; Pollnow S, 2018, COMPUT BIOL MED, V102, P267, DOI 10.1016/j.compbiomed.2018.05.029; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Raman A, 2016, INFORM TECHNOL DEV, V22, P400, DOI 10.1080/02681102.2014.992002; Roberts S, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0550; Schradie J, 2011, POETICS, V39, P145, DOI 10.1016/j.poetic.2011.02.003; Scott M, POLITICO; Shim E, 2020, INT J INFECT DIS, V93, P339, DOI 10.1016/j.ijid.2020.03.031; Song Gao, 2020, SIGSPATIAL Special, V12, P16, DOI 10.1145/3404820.3404824; Soucheray S, 2020, US COVID 19 CASES SU; Valkanas G, 2014, 2014 IEEE/WIC/ACM INTERNATIONAL JOINT CONFERENCES ON WEB INTELLIGENCE (WI) AND INTELLIGENT AGENT TECHNOLOGIES (IAT), VOL 1, P157, DOI 10.1109/WI-IAT.2014.29; Warren M. S., 2020, ARXIV200314228; Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112; Wesolowski A, 2012, SCIENCE, V338, P267, DOI 10.1126/science.1223467; World Health Organization, COR DIS COVID 19 SIT; World Health Organization (WHO), COR DIS COVID 19 EV; Xu SQ, 2020, LANCET, V395, P1321, DOI 10.1016/S0140-6736(20)30845-X; Zou L, 2019, INT J DIGIT EARTH, V12, P1300, DOI 10.1080/17538947.2018.1545878	64	81	82	10	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241957	10.1371/journal.pone.0241957	http://dx.doi.org/10.1371/journal.pone.0241957			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170889	Green Published, gold			2022-12-26	WOS:000592383400017
J	Islam, SKS; Rumi, TB; Kabir, SML; van der Zanden, AGM; Kapur, V; Rahman, AKMA; Ward, MP; Bakker, D; Ross, AG; Rahim, Z				Islam, S. K. Shaheenur; Rumi, Tanzida Begum; Kabir, S. M. Lutful; van der Zanden, Adri G. M.; Kapur, Vivek; Rahman, A. K. M. Anisur; Ward, Michael P.; Bakker, Douwe; Ross, Allen G.; Rahim, Zeaur			Bovine tuberculosis prevalence and risk factors in selected districts of Bangladesh	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; DAIRY-CATTLE; DIAGNOSIS; INFECTION; OUTBREAK; DISEASE; ORYGIS; AREAS; HERDS	A cross-sectional survey was conducted in selected districts of Bangladesh to estimate the prevalence of bovine tuberculosis (bTB), and to identify the risk factors for bTB. We included 1865 farmed cattle from 79 herds randomly selected from five districts. Herd and animal level data were collected using semi-structured interviews with cattle herd owners. The single intradermal comparative tuberculin test (SICTT) was used to estimate the prevalence of bTB. The risk factors were identified using mixed-effect multiple logistic regression analyses. The overall herd and animal level prevalences of bTB were estimated to be 45.6% (95% Confidence Interval [CI] = 34.3-57.2%) and 11.3 (95% CI = 9.9-12.8%), respectively, using the OIE recommended >4 mm cut-off. The true animal level prevalence of bTB was estimated to be 11.8 (95% Credible Interval = 2.1-20.3%). At the herd level, farm size, bTB history of the farm and type of husbandry were significantly associated with bTB status in univariable analysis. Similarly, age group, sex, pregnancy status and parity were significantly associated with bTB at cattle level. However, in multivariable analysis only herd size at the herd level and age group and pregnancy status at the cattle level were significant. Compared to a herd size of 1-10, the odds of bTB were 22.8 (95% CI: 5.2-100.9) and 45.6 times (95% CI: 5.0-417.7) greater in herd sizes of >20-50 and >50, respectively. The odds of bTB were 2.2 (95% CI: 1.0-4.5) and 2.5 times (95% CI: 1.1-5.4) higher in cattle aged >3-6 years and > 6 years, compared to cattle aged <= 1 year. Pregnancy increased the odds of bTB by 1.7 times (95% CI: 1.2-2.4) compared to non-pregnant cattle. Taken together, the results suggest high herd and animal level prevalence of bTB in these 5 districts, with the greatest risk of bTB in older and pregnant cattle within large herds (>20), and highlight an urgent need for continued surveillance and implementation of bTB control programs in Bangladesh.	[Islam, S. K. Shaheenur; Kabir, S. M. Lutful] Bangladesh Agr Univ, Dept Microbiol & Hyg, Mymensingh, Bangladesh; [Islam, S. K. Shaheenur] Minist Fisheries & Livestock, Dept Livestock Serv, Dhaka, Bangladesh; [Rumi, Tanzida Begum; Ross, Allen G.; Rahim, Zeaur] Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh; [van der Zanden, Adri G. M.] LAB MICTA, Hengelo, Netherlands; [Kapur, Vivek] Penn State Univ, Dept Anim Sci, University Pk, PA USA; [Rahman, A. K. M. Anisur] Bangladesh Agr Univ, Dept Med, Mymensingh, Bangladesh; [Ward, Michael P.] Univ Sydney, Sydney Sch Vet Sci, Camden, NSW, Australia	Bangladesh Agricultural University (BAU); International Centre for Diarrhoeal Disease Research (ICDDR); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Bangladesh Agricultural University (BAU); University of Sydney	Rahim, Z (corresponding author), Int Ctr Diarrhoeal Dis Res, Dhaka, Bangladesh.	zeaur@icddrb.org	Rahman, Dr. A. K. M. Anisur/P-1998-2017; Ward, Michael Patrick/W-1897-2019; Ward, Michael Patrick/GRX-1851-2022	Rahman, Dr. A. K. M. Anisur/0000-0001-9660-4949; Ward, Michael Patrick/0000-0002-9921-4986; Kabir, S. M. Lutful/0000-0003-3684-3387; ISLAM, SK SHAHEENUR/0000-0002-0939-5948; Ross, Allen/0000-0002-2329-0907; Rahim, Zeaur/0000-0002-8301-3514	Krishi Gobeshona Foundation (KGF) [TF-45-L/17, 1624]; Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	Krishi Gobeshona Foundation (KGF); Government of Bangladesh; Government of Canada(CGIAR); Government of Sweden; Government of UK	This research was funded by Krishi Gobeshona Foundation (KGF, Project ID: TF-45-L/17 and Grant No. 1624). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Currently, core/unrestricted funds are given by the Governments of Bangladesh, Canada, Sweden and the UK. icddr,b is grateful to these donors for their support of its research efforts.	Alvarez J, 2008, VET MICROBIOL, V128, P72, DOI 10.1016/j.vetmic.2007.08.034; Amadori M, 2002, J VET MED B, V49, P89, DOI 10.1046/j.1439-0450.2002.00513.x; Ameni G, 2007, REV SCI TECH OIE, V26, P711, DOI 10.20506/rst.26.3.1778; Ameni G., 2003, International Journal of Applied Research in Veterinary Medicine, V1, P253; Ameni G., 2003, International Journal of Applied Research in Veterinary Medicine, V1, P17; Ameni G, 2007, CLIN VACCINE IMMUNOL, V14, P1356, DOI 10.1128/CVI.00205-07; [Anonymous], 2007, PIAZZA SAN PIETRO ME, V19, P1; [Anonymous], 2020, LANCET MICROBE, V1, pe99, DOI [10.1016/S2666-5247(20)30054-9, DOI 10.1016/S2666-5247(20)30054-9]; Aranaz A, 2006, VET RES, V37, P593, DOI 10.1051/vetres:2006021; Bates D, 2016, R PACKAGE VERSION, V1, P1, DOI DOI 10.2196/MEDINF0RM.4221; Bennett S, 1991, SIMPLIFIED GEN METHO, V40; Best N., 2007, MESQUITE MODULAR SYS, V3; Buddle BM, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00259; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; Clegg TA, 2015, PREV VET MED, V118, P71, DOI 10.1016/j.prevetmed.2014.11.013; Collins JD, 2006, VET MICROBIOL, V112, P369, DOI 10.1016/j.vetmic.2005.11.041; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; Department of Agriculture, 2018, TUB DIS STAT NO IR; Department of Livestock Services, 2019, DISTR WIS AN DAT BAS; Department of Livestock Services Ministry of Fisheries and Livestock People's Republic of Bangladesh, 2007, NAT LIV DEV POL; Directorate General of Health Services Bangladesh, 2019, HDB TUB MED STUD PHY; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; FRANCIS J, 1978, VET REC, V103, P420, DOI 10.1136/vr.103.19.420; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Griffin JM, 1996, PREV VET MED, V27, P75, DOI 10.1016/0167-5877(95)00548-X; Hamid MA., 2017, ASIAN J ANIM SCI, V11, P54, DOI DOI 10.3923/ajas.2017.54.64; Hope JC, 2005, CLIN EXP IMMUNOL, V141, P432, DOI 10.1111/j.1365-2249.2005.02882.x; Hossain M., 2015, THESIS; Houlihan MG, 2008, VET REC, V163, P357, DOI 10.1136/vr.163.12.357; Humphry RW, 2004, PREV VET MED, V65, P173, DOI 10.1016/j.prevetmed.2004.07.003; Inangolet FO, 2008, TROP ANIM HEALTH PRO, V40, P501, DOI 10.1007/s11250-007-9126-x; Kemal J, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-018-3628-1; Kostoulas P, 2018, PRIORGEN GENERATES P, V365.; Mahmud M. A. A., 2014, Bangladesh Journal of Veterinary Medicine, V12, P141; Mamo G, 2013, J VET MED ANIM HLTH, V5, P171; Maudlin I, 2009, PHILOS T R SOC B, V364, P2777, DOI 10.1098/rstb.2009.0067; Mekonnen GA, 2019, PREV VET MED, V168, P81, DOI 10.1016/j.prevetmed.2019.04.010; Meyer D, 2017, PACKAGE VCD; Mondal M. A. H., 2014, Bangladesh Journal of Veterinary Medicine, V12, P179; Muller B, 2013, EMERG INFECT DIS, V19, P899, DOI 10.3201/eid1906.120543; Munyeme M, 2008, PREV VET MED, V85, P317, DOI 10.1016/j.prevetmed.2008.03.006; Nickbakhsh S, 2011, BMC VET RES, V7, DOI [10.1186/1746-6148-7-66, 10.1186/1746-6148-8-51]; Office international des Epizootics, 2020, BOV TUB; Office international des Epizootics, 2019, OFF INT EP PAN B; Office international des Epizootics, 2018, OIE TERR MAN CHAPT 3; Pharo HJ, 1981, BANGLADESH VET J, V15, P53; Picasso C, 2017, PREV VET MED, V138, P156, DOI 10.1016/j.prevetmed.2017.01.010; R Core Team, 2021, R LANGUAGE ENV STAT; Radostits OM, 2000, TXB DIS CATTLE SHEEP, V9th; Rahim Z, 2017, TRANSBOUND EMERG DIS, V64, P1965, DOI 10.1111/tbed.12596; Rahman AKMA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2168-7; Sekula Allan, 1986, OCTOBER, V39, P3; Singhla T, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-1905-x; Speybroeck N, 2013, INT J PUBLIC HEALTH, V58, P791, DOI 10.1007/s00038-012-0439-9; Srinivasan S, 2018, TRANSBOUND EMERG DIS, V65, P1627, DOI 10.1111/tbed.12915; Thakur A, 2010, VET WORLD, V3, P409, DOI 10.5455/vetworld.2010.408-413; Tschopp R, 2013, CURR TOP MICROBIOL, V365, P249, DOI 10.1007/82_2012_245; Tschopp R, 2009, PREV VET MED, V89, P205, DOI 10.1016/j.prevetmed.2009.02.006; van Ingen J, 2012, EMERG INFECT DIS, V18, P653, DOI 10.3201/eid1804.110888; Vial F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018058; Walravens K, 2002, VET IMMUNOL IMMUNOP, V87, P401, DOI 10.1016/S0165-2427(02)00092-2; Welburn SC, 2015, CLIN MICROBIOL INFEC, V21, P433, DOI 10.1016/j.cmi.2015.04.011; Winthrop KL, 2005, INT J TUBERC LUNG D, V9, P809; WOOD PR, 1991, AUST VET J, V68, P286, DOI 10.1111/j.1751-0813.1991.tb03254.x; World Bank, 2018, PIDISDSA24172 WORLD; World Health Organization, 2021, 10 THREATS GLOB HLTH; Wright DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13062; Azami HY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203360	68	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241717	10.1371/journal.pone.0241717	http://dx.doi.org/10.1371/journal.pone.0241717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170869	Green Published, gold			2022-12-26	WOS:000592383400014
J	Mo, WJ; Ding, YQ; Zhao, S; Zou, DH; Ding, XW				Mo, Wenju; Ding, Yuqin; Zhao, Shuai; Zou, Dehong; Ding, Xiaowen			Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis	PLOS ONE			English	Article							CELL-FREE DNA; EXPRESSION; VULNERABILITY; MUTATIONS; LANDSCAPE; GENES	Purpose To identify a gene signature for the prognosis of breast cancer using high-throughput analysis. Methods RNASeq, single nucleotide polymorphism (SNP), copy number variation (CNV) data and clinical follow-up information were downloaded from The Cancer Genome Atlas (TCGA), and randomly divided into training set or verification set. Genes related to breast cancer prognosis and differentially expressed genes (DEGs) with CNV or SNP were screened from training set, then integrated together for feature selection of identify robust biomarkers using RandomForest. Finally, a gene-related prognostic model was established and its performance was verified in TCGA test set, Gene Expression Omnibus (GEO) validation set and breast cancer subtypes. Results A total of 2287 prognosis-related genes, 131 genes with amplified copy numbers, 724 gens with copy number deletions, and 280 genes with significant mutations screened from Genomic Variants were closely correlated with the development of breast cancer. A total of 120 candidate genes were obtained by integrating genes from Genomic Variants and those related to prognosis, then 6 characteristic genes (CD24, PRRG1, IQSEC3, MRGPRX, RCC2, and CASP8) were top-ranked by RandomForest for feature selection, noticeably, several of these have been previously reported to be associated with the progression of breast cancer. Cox regression analysis was performed to establish a 6-gene signature, which can stratify the risk of samples from training set, test set and external validation set, moreover, the five-year survival AUC of the model in the training set and validation set was both higher than 0.65. Thus, the 6-gene signature developed in the current study could serve as an independent prognostic factor for breast cancer patients. Conclusion This study constructed a 6-gene signature as a novel prognostic marker for predicting the survival of breast cancer patients, providing new diagnostic/prognostic biomarkers and therapeutic targets for breast cancer patients.	[Mo, Wenju; Ding, Yuqin; Zhao, Shuai; Zou, Dehong; Ding, Xiaowen] Chinese Acad Sci, Univ Chinese Acad Sci, Inst Canc & Basic Med ICBM, Canc Hosp,Zhejiang Canc Hosp, Beijing, Peoples R China; [Mo, Wenju; Ding, Yuqin; Zhao, Shuai; Zou, Dehong; Ding, Xiaowen] Univ Chinese Acad Sci, Dept Breast Surg, Canc Hosp, Beijing, Peoples R China; [Mo, Wenju; Ding, Yuqin; Zhao, Shuai; Zou, Dehong; Ding, Xiaowen] Zhejiang Canc Hosp, Dept Breast Surg, Hangzhou, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang Cancer Hospital; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang Cancer Hospital	Ding, XW (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Inst Canc & Basic Med ICBM, Canc Hosp,Zhejiang Canc Hosp, Beijing, Peoples R China.; Ding, XW (corresponding author), Univ Chinese Acad Sci, Dept Breast Surg, Canc Hosp, Beijing, Peoples R China.; Ding, XW (corresponding author), Zhejiang Canc Hosp, Dept Breast Surg, Hangzhou, Peoples R China.	ppfit2008@126.com			Zhejiang Provincial Health and Health Commission General Project [2020KY068]	Zhejiang Provincial Health and Health Commission General Project	This work was supported by Zhejiang Provincial Health and Health Commission General Project (2020KY068).	Akram M, 2017, BIOL RES, V50, DOI 10.1186/s40659-017-0140-9; Biswas NK, 2019, INT J CANCER, V145, P2568, DOI 10.1002/ijc.32305; Blank PR, 2010, BREAST CANCER RES TR, V124, P497, DOI 10.1007/s10549-010-0862-7; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brown KK, 2017, CANCER DISCOV, V7, P391, DOI 10.1158/2159-8290.CD-16-0611; Ciriello G, 2013, NAT GENET, V45, P1127, DOI 10.1038/ng.2762; Dang YW, 2018, PATHOL RES PRACT, V214, P631, DOI 10.1016/j.prp.2018.03.029; Farid RM, 2019, CANCER MANAG RES, V11, P4677, DOI 10.2147/CMAR.S198348; Foulds GA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02028; Guo JC, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0277-0; Hsu TYT, 2015, NATURE, V525, P384, DOI 10.1038/nature14985; Ishwaran H, 2010, STAT PROBABIL LETT, V80, P1056, DOI 10.1016/j.spl.2010.02.020; Lai JG, 2019, AGING-US, V11, P649, DOI 10.18632/aging.101767; Lv XM, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0884-0; Makena MR, 2020, CELL CALCIUM, V85, DOI 10.1016/j.ceca.2019.102109; Marsden CG, 2017, METHOD ENZYMOL, V591, P119, DOI 10.1016/bs.mie.2017.03.003; Matsumoto A, 2016, JPN J CLIN ONCOL, V46, P99, DOI 10.1093/jjco/hyv153; Meng J, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0084-7; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Page K, 2017, CLIN CHEM, V63, P532, DOI 10.1373/clinchem.2016.261834; Pang B, 2017, CLIN CANCER RES, V23, P5598, DOI 10.1158/1078-0432.CCR-16-2909; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Shi M, 2009, CANCER TREAT REV, V35, P328, DOI 10.1016/j.ctrv.2008.12.002; Singh R, 2018, BBA-GEN SUBJECTS, V1862, P669, DOI 10.1016/j.bbagen.2017.12.004; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Su J, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014617; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun XQ, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1908-1; Tan Betty, 2019, Open Access Maced J Med Sci, V7, P526, DOI 10.3889/oamjms.2019.182; Vasan N, 2014, ONCOLOGIST, V19, P453, DOI 10.1634/theoncologist.2013-0377; Wagner S, 2019, BLOOD ADV, V3, P1330, DOI 10.1182/bloodadvances.2018030726; Wang PL, 2016, CLIN CANCER RES, V22, P1130, DOI 10.1158/1078-0432.CCR-15-1534; Wang XC, 2014, IET SYST BIOL, V8, P47, DOI 10.1049/iet-syb.2013.0041; Yang X, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5698-x; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yuan L, 2019, IEEE ACM T COMPUT BI, V16, P782, DOI 10.1109/TCBB.2018.2866836	38	5	6	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241924	10.1371/journal.pone.0241924	http://dx.doi.org/10.1371/journal.pone.0241924			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170908	gold, Green Published			2022-12-26	WOS:000592383400033
J	Sewell, DK; Miller, A				Sewell, Daniel K.; Miller, Aaron		CDC MInD-Healthcare Program	Simulation-free estimation of an individual-based SEIR model for evaluating nonpharmaceutical interventions with an application to COVID-19 in the District of Columbia	PLOS ONE			English	Article							MATHEMATICAL-MODELS; AGE-GROUPS; HETEROGENEITY; OUTBREAKS; DYNAMICS; PATTERNS; SPREAD; CARE	The ongoing COVID-19 pandemic has overwhelmingly demonstrated the need to accurately evaluate the effects of implementing new or altering existing nonpharmaceutical interventions. Since these interventions applied at the societal level cannot be evaluated through traditional experimental means, public health officials and other decision makers must rely on statistical and mathematical epidemiological models. Nonpharmaceutical interventions are typically focused on contacts between members of a population, and yet most epidemiological models rely on homogeneous mixing which has repeatedly been shown to be an unrealistic representation of contact patterns. An alternative approach is individual based models (IBMs), but these are often time intensive and computationally expensive to implement, requiring a high degree of expertise and computational resources. More often, decision makers need to know the effects of potential public policy decisions in a very short time window using limited resources. This paper presents a computation algorithm for an IBM designed to evaluate nonpharmaceutical interventions. By utilizing recursive relationships, our method can quickly compute the expected epidemiological outcomes even for large populations based on any arbitrary contact network. We utilize our methods to evaluate the effects of various mitigation measures in the District of Columbia, USA, at various times and to various degrees. Rcode for our method is provided in the supplementry material, thereby allowing others to utilize our approach for other regions.	[Sewell, Daniel K.] Univ Iowa, Dept Biostat, Iowa City, IA 52242 USA; [Miller, Aaron] Univ Iowa, Dept Epidemiol, Iowa City, IA USA	University of Iowa; University of Iowa	Sewell, DK (corresponding author), Univ Iowa, Dept Biostat, Iowa City, IA 52242 USA.	daniel-sewell@uiowa.edu		Sewell, Daniel/0000-0002-9238-4026; Miller, Aaron/0000-0002-6828-8966	US Centers for Disease Control and Prevention [5 U01 CK000531-02, 1 U01 CK000594-01-00]	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the US Centers for Disease Control and Prevention (5 U01 CK000531-02, 1 U01 CK000594-01-00) as part of the MInd-Healthcare Program (Rachel Slayton: via3@cdc.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abueg M, 2020, MODELING COMBINED EF, DOI [DOI 10.1101/2020.08.29.20184135, 10.1101/2020.08.29.20184135]; Aktay A, 2020, ARXIV200404145; Aleta Alberto, 2020, medRxiv, DOI 10.1101/2020.05.06.20092841; Anastassopoulou C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230405; [Anonymous], SHORT TERM FOR COVID; [Anonymous], DELPHI EP CAS PRED; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Bioglio L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2003-3; Bisset KR, 2014, ACM T MODEL COMPUT S, V24, DOI 10.1145/2501602; Branas CC., 2020, FLATTENING CURVE IT, DOI [10.1101/2020.04.01.20049759, DOI 10.1101/2020.04.01.20049759]; Brauer Fred, 2017, Infect Dis Model, V2, P113, DOI 10.1016/j.idm.2017.02.001; Braun B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238412; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Burghardt K, 2016, SCI REP-UK, V6, DOI 10.1038/srep34598; Chang SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19393-6; Chao DL, 2020, MODELING LAYERED NON, DOI [10.1101/2020.04.08. 20058487, DOI 10.1101/2020.04.08.20058487]; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chowell G, 2016, PHYS LIFE REV, V18, P66, DOI 10.1016/j.plrev.2016.07.005; Coibion O., 2020, COST COVID 19 CRISIS; Colman ER, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012817; Cronin CJ, 2020, NBER WORKING PAPERS; Cuevas E, 2020, COMPUT BIOL MED, V121, DOI 10.1016/j.compbiomed.2020.103827; Cui JG, 2019, J BIOL DYNAM, V13, P31, DOI 10.1080/17513758.2018.1484186; Currie CSM, 2020, J SIMUL, V14, P83, DOI 10.1080/17477778.2020.1751570; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1250, DOI 10.15585/mmwr.mm6936a4; D'Orazio M, 2020, ARXIV200412927; De Vincentiis L, 2021, J CLIN PATHOL, V74, P187, DOI 10.1136/jclinpath-2020-206833; Del Valle SY, 2007, SOC NETWORKS, V29, P539, DOI 10.1016/j.socnet.2007.04.005; Del Valle SY, 2013, MATH BIOSCI ENG, V10, P1475, DOI 10.3934/mbe.2013.10.1475; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Fang YQ, 2020, J MED VIROL, V92, P645, DOI 10.1002/jmv.25750; Fang Z., 2020, ARXIV PREPRINT ARXIV, DOI 10.48550/arXiv.2010.04365; Feng ZL, 2020, THEOR POPUL BIOL, V132, P24, DOI 10.1016/j.tpb.2020.01.005; Feng ZL, 2015, J THEOR BIOL, V386, P177, DOI 10.1016/j.jtbi.2015.09.006; Ferguson N. M., 2020, REPORT 9 IMPACT NONP, V10, DOI [10.25561/77482, DOI 10.1007/S11538-020-00726-X]; Gopalan A, 2020, J INDIAN I SCI, V100, P863, DOI 10.1007/s41745-020-00210-4; Hamadani JD, 2020, LANCET GLOB HEALTH, V8, pE1380, DOI 10.1016/S2214-109X(20)30366-1; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Hoertel N, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1001-6; Hornbeck T, 2012, J INFECT DIS, V206, P1549, DOI 10.1093/infdis/jis542; Jaffry SW, AGENT BASED POPULATI; Karsai M, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.025102; Kerr CC, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009149; Kim Reynolds. Iowa Gov, 2020, COMMUNICATION 0401; Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6; Kretzschmar M, 2021, NEUROMODULATION, V24, P700, DOI 10.1111/ner.13222; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P1151, DOI 10.1016/S1473-3099(20)30457-6; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Kwok KO, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0838; Lazzerini M, 2020, LANCET CHILD ADOLESC, V4, pE10, DOI 10.1016/S2352-4642(20)30108-5; Leonenko VN, 2015, PROCEDIA COMPUT SCI, V51, P150, DOI 10.1016/j.procs.2015.05.214; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Loopstra R., 2020, VULNERABILITY FOOD I; Los Alamos National Laboratory, COVID 19 CONF FOR CA; Menachemi N, 2020, MMWR-MORBID MORTAL W, V69, P960, DOI 10.15585/mmwr.mm6929e1; Moghadas SM, 2020, P NATL ACAD SCI USA, V117, P9122, DOI 10.1073/pnas.2004064117; Murray, 2020, FORECASTING IMPACT 1, DOI [10.1101/2020.04.21.20074732, DOI 10.1101/2020.04.21.20074732]; Neher R, COVID 19 SCENARIOS; Parker J, 2011, ACM T MODEL COMPUT S, V22, DOI 10.1145/2043635.2043637; Peak CM, 2017, P NATL ACAD SCI USA, V114, P4023, DOI 10.1073/pnas.1616438114; Pei S, 2020, INITIAL SIMULATION S, DOI [10.1101/2020.03.21.20040303v2, DOI 10.1101/2020.03.21.20040303, 10.1101/2020.03.21.20040303]; Prem K, 2020, LANCET PUBLIC HEALTH, V5, pE261, DOI 10.1016/S2468-2667(20)30073-6; Rahmandad H, 2008, MANAGE SCI, V54, P998, DOI 10.1287/mnsc.1070.0787; Raifman J., 2021, COVID 19 US STATE PO, DOI DOI 10.3886/E119446V143; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Rockett RJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-1000-7., 10.1038/s41591-020-1000-7]; Rotkirch, 2020, ARXIV200413553; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Santoli JM, 2020, MMWR-MORBID MORTAL W, V69, P591, DOI 10.15585/mmwr.mm6919e2; Shamil MS, 2020, AGENT BASED MODELING, DOI [10.1101/2020.07.05.20146977, DOI 10.1101/2020.07.05.20146977]; Shoukat A, 2020, CAN MED ASSOC J, V192, pE489, DOI 10.1503/cmaj.200457; Silva PCL, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110088; Song PX, 2020, EPIDEMIOLOGICAL FORE, DOI [10.1101/2020.02.29.20029421, DOI 10.1101/2020.02.29.20029]; Stein RA, 2011, INT J INFECT DIS, V15, pE510, DOI 10.1016/j.ijid.2010.06.020; Stutt ROJH, 2020, P ROY SOC A-MATH PHY, V476, DOI 10.1098/rspa.2020.0376; Tang B, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020462; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Weissman GE, 2020, ANN INTERN MED, V173, P21, DOI 10.7326/M20-1260; Woody S, 2020, PROJECTIONS 1 WAVE C, DOI 10.1101/2020.04.16.20068163; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050; Zhaoyang RX, 2018, PSYCHOL AGING, V33, P607, DOI 10.1037/pag0000242; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	82	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241949	10.1371/journal.pone.0241949	http://dx.doi.org/10.1371/journal.pone.0241949			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170871	gold, Green Submitted, Green Published			2022-12-26	WOS:000592383400063
J	Sudrajad, P; Subiharta, S; Adinata, Y; Lathifah, A; Lee, JH; Lenstra, JA; Lee, SH				Sudrajad, Pita; Subiharta, Subiharta; Adinata, Yudi; Lathifah, Af'idatul; Lee, Jun Heon; Lenstra, Johannes A.; Lee, Seung Hwan			An insight into the evolutionary history of Indonesian cattle assessed by whole genome data analysis	PLOS ONE			English	Article							GENETIC DIVERSITY; LINKAGE DISEQUILIBRIUM; MITOCHONDRIAL-DNA; DOMESTIC CATTLE; BOS-JAVANICUS; HYBRIDIZATION; ANCESTRY; PACKAGE; ORIGIN; SNP	The domestication of Indonesian cattle was investigated through a study of their genetic diversity, up to the genome level. Little documentation exists regarding the history of domestication of Indonesian cattle and questions remain despite a growing body of molecular evidence. In this study, we genotyped seven Indonesian cattle breeds using an Illumina BovineSNP50 Bead Chip to provide insight into their domestication and demographic history in a worldwide population context. Our analyses indicated the presence of hybrid cattle, with Bos javanicus and Bos indicus ancestries being most prevalent, as well as purebred cattle. We revealed that all the breeds were interconnected through several migration events. However, their demographic status varied widely. Although almost all the Indonesian cattle had an effective population size higher than the minimum level required to ensure breed fitness, efforts are still needed to maintain their genetic variability and purity.	[Sudrajad, Pita; Subiharta, Subiharta] Minist Agr, Assessment Inst Agr Technol Cent Java, Indonesian Agcy Agr Res & Dev, Kabupaten Semarang, Indonesia; [Adinata, Yudi] Minist Agr, Indonesian Agcy Agr Res & Dev, Beef Cattle Res Stn, Kabupaten Semarang, Indonesia; [Lathifah, Af'idatul] Diponegoro Univ, Dept Anthropol, Semarang, Indonesia; [Lee, Jun Heon; Lee, Seung Hwan] Chungnam Natl Univ, Div Anim & Dairy Sci, Daejeon, South Korea; [Lenstra, Johannes A.] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands	Indonesian Agency for Agricultural Research & Development; Indonesian Agency for Agricultural Research & Development; Diponegoro University; Chungnam National University; Utrecht University	Sudrajad, P (corresponding author), Minist Agr, Assessment Inst Agr Technol Cent Java, Indonesian Agcy Agr Res & Dev, Kabupaten Semarang, Indonesia.	pitasudrajad@pertanian.go.id		Lenstra, Johannes A./0000-0003-1745-7739; Sudrajad, Pita/0000-0001-8148-9095; Adinata, Yudi/0000-0002-9770-0737	Indonesian Ministry of Research Technology and Higher Education [13/E/KPT/2018]	Indonesian Ministry of Research Technology and Higher Education(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	PS received funding from the Indonesian Ministry of Research Technology and Higher Education under the INSINAS project No.13/E/KPT/2018 in the year 2018-2019. Funder have no any role in the study design, data collection and analysis.	Ajmone-Marsan P, 2010, EVOL ANTHROPOL, V19, P148, DOI 10.1002/evan.20267; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; [Anonymous], 2009, FEED IND, V30, P40, DOI DOI 10.1016/j.indcrop.2009.01.003; Barbato M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00109; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; de Roos APW, 2008, GENETICS, V179, P1503, DOI 10.1534/genetics.107.084301; Decker JE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004254; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Felius Marleen, 2014, Diversity-Basel, V6, P705, DOI 10.3390/d6040705; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Groves CP, 2006, AUSTRONESIANS: HISTORICAL AND COMPARATIVE PERSPECTIVES, P161; Hardjosubroto W., 1994, APLIKASI PEMULIABIAK; Hartati H, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0229-5; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; KIKKAWA Y, 1995, BIOCHEM GENET, V33, P51, DOI 10.1007/BF00554558; Kumar P, 2003, HEREDITY, V91, P43, DOI 10.1038/sj.hdy.6800277; Leake J., 1980, Bulletin of Indonesian Economic Studies, V16, P65, DOI 10.1080/00074918012331333709; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Lenstra J. A., 2014, Diversity, V6, P178, DOI 10.3390/d6010178; Lu Duc, 2012, Frontiers in Genetics, V3, P152, DOI 10.3389/fgene.2012.00152; Martojo H, 2012, REPROD DOMEST ANIM, V47, P10, DOI 10.1111/j.1439-0531.2011.01958.x; McTavish EJ, 2013, P NATL ACAD SCI USA, V110, pE1398, DOI 10.1073/pnas.1303367110; Mohamad K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005490; NEI M, 1978, GENETICS, V89, P583; Nijman IJ, 2003, HEREDITY, V90, P10, DOI 10.1038/sj.hdy.6800174; Orozco-terWengel P, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00191; Pembleton LW, 2013, MOL ECOL RESOUR, V13, P946, DOI 10.1111/1755-0998.12129; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; POPESCU CP, 1988, ZUCHTHYGIENE, V23, P145; Neto LRP, 2010, ANIM PROD SCI, V50, P792, DOI 10.1071/AN10073; R Core Team, 2013, R LANG ENV STAT COMP; Rambaut A., 2018, FIGTREE V1 4 2 GRAPH; Rasyid A, 2009, P SEM NAS TEKN PET D, P60; Ray HP., 2003, ARCHAEOLOGY SEAFARIN; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Scheurleer PL, 1988, ANCIENT INDONESIAN B; Sharma R, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0221-0; Sudrajad P, 2014, WIDYARISET, V17, P283; Sutarno, 2016, Biodiversitas: Journal of Biological Diversity, V17, P275; SVED J A, 1971, Theoretical Population Biology, V2, P125; Uzzaman MR, 2014, ASIAN AUSTRAL J ANIM, V27, P1381, DOI 10.5713/ajas.2014.14160; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Wangkumhang P, 2015, PEERJ, V3, DOI 10.7717/peerj.1318; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yonesaka R, 2016, ANIM SCI J, V87, P190, DOI 10.1111/asj.12416; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	50	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0241038	10.1371/journal.pone.0241038	http://dx.doi.org/10.1371/journal.pone.0241038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170846	Green Published, gold			2022-12-26	WOS:000592383400056
J	Thomos, M; Wurzel, P; Scharf, S; Koch, I; Hansmann, ML				Thomos, Miguel; Wurzel, Patrick; Scharf, Sonja; Koch, Ina; Hansmann, Martin-Leo			3D investigation shows walls and wall-like structures around human germinal centres, probably regulating T- and B-cell entry and exit	PLOS ONE			English	Article							FIBROBLASTIC RETICULAR CELLS; FUNCTIONAL LIGAND; CHEMOKINE; TRAFFICKING; MOTILITY	This study deals with 3D laser investigation on the border between the human lymph node T-zone and germinal centre. Only a few T-cells specific for antigen selected B-cells are allowed to enter germinal centres. This selection process is guided by sinus structures, chemokine gradients and inherent motility of the lymphoid cells. We measured gaps and wall-like structures manually, using IMARIS, a 3D image software for analysis and interpretation of microscopy datasets. In this paper, we describe alpha-actin positive and semipermeable walls and wall-like structures that may hinder T-cells and other cell types from entering germinal centres. Some clearly defined holes or gaps probably regulate lymphoid traffic between T- and B-cell areas. In lymphadenitis, the morphology of this border structure is clearly defined. However, in case of malignant lymphoma, the wall-like structure is disrupted. This has been demonstrated exemplarily in case of angioimmunoblastic T-cell lymphoma. We revealed significant differences of lengths of the wall-like structures in angioimmunoblastic T-cell lymphoma in comparison with wall-like structures in reactive tissue slices. The alterations of morphological structures lead to abnormal and less controlled T- and B-cell distributions probably preventing the immune defence against tumour cells and infectious agents by dysregulating immune homeostasis.	[Thomos, Miguel; Hansmann, Martin-Leo] Goethe Univ Frankfurt Main, Reference & Consultant Ctr Lymph Node & Lymphoma, Dr Senckenberg Inst Pathol, Frankfurt, Hessen, Germany; [Wurzel, Patrick; Scharf, Sonja; Koch, Ina] Johann Wolfgang Goethe Univ Frankfurt Main, Dept Mol Bioinformat, Frankfurt, Hessen, Germany; [Wurzel, Patrick; Scharf, Sonja; Hansmann, Martin-Leo] Frankfurt Inst Adv Studies FIAS, Frankfurt, Hessen, Germany	Goethe University Frankfurt; Goethe University Frankfurt	Thomos, M (corresponding author), Goethe Univ Frankfurt Main, Reference & Consultant Ctr Lymph Node & Lymphoma, Dr Senckenberg Inst Pathol, Frankfurt, Hessen, Germany.	miguel.thomos@web.de		Thomos, Miguel/0000-0002-5216-0634; Koch, Ina/0000-0002-3621-003X	BMBF [COMPLS2-087]; Control-T consortium [HA1284/7-2]	BMBF(Federal Ministry of Education & Research (BMBF)); Control-T consortium	funded by: BMBF, COMPLS2-087: Machine learning driven multidimensional imaging analysis of reactive and neoplastic lymph nodesPatho234. And by the Control-T consortium, Grants HA1284/7-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Feng Y., 2019, ARXIV190710121; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Katakai T, 2004, J EXP MED, V200, P783, DOI 10.1084/jem.20040254; Liebers J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224156; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lorensen W.E., 1987, ACM SIGGRAPH COMPUTE, V21, P163, DOI [DOI 10.1145/37402.37422, 10.1145/37401.37422]; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Oswald MS, 2019, ACTA HISTOCHEM, V121, P769, DOI 10.1016/j.acthis.2019.07.002; Stein JV, 2005, IMMUNOLOGY, V116, P1, DOI 10.1111/j.1365-2567.2005.02183.x; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wei SH, 2003, IMMUNOL REV, V195, P136, DOI 10.1034/j.1600-065X.2003.00076.x; Xie MM, 2017, EUR J IMMUNOL, V47, P1136, DOI 10.1002/eji.201747034; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118; Yoshida R, 1997, J BIOL CHEM, V272, P13803, DOI 10.1074/jbc.272.21.13803	22	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2020	15	11							e0242177	10.1371/journal.pone.0242177	http://dx.doi.org/10.1371/journal.pone.0242177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	OV7KH	33170900	Green Published, gold			2022-12-26	WOS:000592383400002
J	Goppner, C; Soria, AH; Hoegg-Beiler, MB; Jentsch, TJ				Goppner, Corinna; Soria, Audrey H.; Hoegg-Beiler, Maja B.; Jentsch, Thomas J.			Cellular basis of ClC-2 Cl- channel-related brain and testis pathologies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED ANION CHANNELS; CRE RECOMBINASE ACTIVITY; CENTRAL-NERVOUS-SYSTEM; MALE GERM-CELLS; CHLORIDE CHANNEL; MEGALENCEPHALIC LEUKOENCEPHALOPATHY; ESSENTIAL COMPONENT; MEMBRANE-PROTEIN; SUBUNIT; GLIALCAM	The ClC-2 chloride channel is expressed in the plasma membrane of almost all mammalian cells. Mutations that cause the loss of ClC-2 function lead to retinal and testicular degeneration and leukodystrophy, whereas gain-of-function mutations cause hyperaldosteronism. Leukodystrophy is also observed with a loss of GlialCAM, a cell adhesion molecule that binds to ClC-2 in glia. GlialCAM changes the localization of ClC-2 and opens the channel by altering its gating. We now used cell type-specific deletion of ClC-2 in mice to show that retinal and testicular degeneration depend on a loss of ClC-2 in retinal pigment epithelial cells and Sertoli cells, respectively, whereas leukodystrophy was fully developed only when ClC-2 was disrupted in both astrocytes and oligodendrocytes. The leukodystrophy of Glialcam(-/-) mice could not be rescued by crosses with Clcn2(op/op) mice in which a mutation mimics the "opening" of ClC-2 by GlialCAM. These data indicate that GlialCAM-induced changes in biophysical properties of ClC-2 are irrelevant for GLIALCAM-related leukodystrophy. Taken together, our findings suggest that the pathology caused by Clcn2 disruption results from disturbed extracellular ion homeostasis and identifies the cells involved in this process.	[Goppner, Corinna; Soria, Audrey H.; Hoegg-Beiler, Maja B.; Jentsch, Thomas J.] Charite, Leibniz Forschungsinst Mol Pharmakol FMP, Berlin, Germany; [Goppner, Corinna; Soria, Audrey H.; Hoegg-Beiler, Maja B.; Jentsch, Thomas J.] Charite, Max Delbruck Ctr Mol Med MDC, Berlin, Germany; [Jentsch, Thomas J.] Charite, NeuroCure Cluster Excellence, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Jentsch, TJ (corresponding author), Charite, Leibniz Forschungsinst Mol Pharmakol FMP, Berlin, Germany.; Jentsch, TJ (corresponding author), Charite, Max Delbruck Ctr Mol Med MDC, Berlin, Germany.; Jentsch, TJ (corresponding author), Charite, NeuroCure Cluster Excellence, Berlin, Germany.	Jentsch@fmp-berlin.de		Jentsch, Thomas/0000-0002-3509-2553; Soria, Audrey/0000-0003-4764-3903	BMBF [Era-Net 01GM1403]; Deutsche Forschungsgemeinschaft [DFG JE164/15-1]; Prix Louis Jeantet de Medecine	BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Prix Louis Jeantet de Medecine	This work was supported, in part, by a grant from the BMBF Era-Net 01GM1403 and the Deutsche Forschungsgemeinschaft DFG JE164/15-1 and the Prix Louis Jeantet de Medecine to T. J. J.	Bao JQ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99767; Bernardino RL, 2019, CELL TISSUE RES, V378, P333, DOI 10.1007/s00441-019-03028-4; Blanz J, 2007, J NEUROSCI, V27, P6581, DOI 10.1523/JNEUROSCI.0338-07.2007; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Boussouar F, 2004, TRENDS ENDOCRIN MET, V15, P345, DOI 10.1016/j.tem.2004.07.003; Butt AM, 2006, J CELL MOL MED, V10, P33, DOI 10.1111/j.1582-4934.2006.tb00289.x; Caceres PS, 2020, CURR OPIN CELL BIOL, V62, P37, DOI 10.1016/j.ceb.2019.08.001; Capdevila-Nortes X, 2015, J PHYSIOL-LONDON, V593, P4165, DOI 10.1113/JP270467; Catalan M, 2004, GASTROENTEROLOGY, V126, P1104, DOI 10.1053/j.gastro.2004.01.010; Catalan M, 2002, AM J PHYSIOL-GASTR L, V283, pG1004, DOI 10.1152/ajpgi.00158.2002; Catalan MA, 2012, GASTROENTEROLOGY, V142, P346, DOI 10.1053/j.gastro.2011.10.037; Cortez MA, 2010, NEUROSCIENCE, V167, P154, DOI 10.1016/j.neuroscience.2010.01.042; De Jesus-Perez JJ, 2016, J GEN PHYSIOL, V147, P25, DOI 10.1085/jgp.201511424; Depienne C, 2013, LANCET NEUROL, V12, P659, DOI 10.1016/S1474-4422(13)70053-X; Di Bella D, 2014, NEUROLOGY, V83, P1217, DOI 10.1212/WNL.0000000000000812; Edwards MM, 2010, INVEST OPHTH VIS SCI, V51, P3264, DOI 10.1167/iovs.09-4887; Felmlee MA, 2020, PHARMACOL REV, V72, P466, DOI 10.1124/pr.119.018762; Fernandes-Rosa FL, 2018, NAT GENET, V50, P355, DOI 10.1038/s41588-018-0053-8; Foldy C, 2010, NAT NEUROSCI, V13, P1047, DOI 10.1038/nn.2609; Franca LR, 2016, ANDROLOGY-US, V4, P189, DOI 10.1111/andr.12165; Giorgio E, 2017, J NEUROL NEUROSUR PS, V88, P895, DOI 10.1136/jnnp-2016-315525; Goppner C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12113-9; Griswold MD, 2018, BIOL REPROD, V99, P87, DOI 10.1093/biolre/ioy027; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Guo ZX, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1390-7; Haj-Yasein NN, 2011, GLIA, V59, P1635, DOI 10.1002/glia.21205; Hanagasi HA, 2015, PARKINSONISM RELAT D, V21, P544, DOI 10.1016/j.parkreldis.2015.02.013; Hoegg-Beiler MB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4475; Jentsch TJ, 2018, PHYSIOL REV, V98, P1493, DOI 10.1152/physrev.00047.2017; Jentsch TJ, 2016, NAT REV MOL CELL BIO, V17, P293, DOI 10.1038/nrm.2016.29; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; Jeworutzki E, 2014, BIOPHYS J, V107, P1105, DOI 10.1016/j.bpj.2014.07.040; Jeworutzki E, 2012, NEURON, V73, P951, DOI 10.1016/j.neuron.2011.12.039; Johnson AA, 2017, PROG RETIN EYE RES, V58, P45, DOI 10.1016/j.preteyeres.2017.01.006; Jordt SE, 1997, EMBO J, V16, P1582, DOI 10.1093/emboj/16.7.1582; JUTTE NHPM, 1982, J REPROD FERTIL, V65, P431, DOI 10.1530/jrf.0.0650431; Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Leegwater PAJ, 2002, HUM GENET, V110, P279, DOI 10.1007/s00439-002-0682-x; Leegwater PAJ, 2001, AM J HUM GENET, V68, P831, DOI 10.1086/319519; Lopez-Hernandez T, 2011, AM J HUM GENET, V88, P422, DOI 10.1016/j.ajhg.2011.02.009; Luck JC, 2018, J BIOL CHEM, V293, P11796, DOI 10.1074/jbc.RA118.003853; Lundgaard I, 2014, NEUROSCIENCE, V276, P161, DOI 10.1016/j.neuroscience.2013.10.050; Lutter D, 2017, J CELL SCI, V130, P1122, DOI 10.1242/jcs.196253; Maduke MC, 2012, NEURON, V73, P855, DOI 10.1016/j.neuron.2012.02.012; Makara JK, 2003, MOL CELL NEUROSCI, V23, P521, DOI 10.1016/S1044-7431(03)00080-0; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; Menichella DM, 2006, J NEUROSCI, V26, P10984, DOI 10.1523/JNEUROSCI.0304-06.2006; Menichella DM, 2003, J NEUROSCI, V23, P5963, DOI 10.1523/jneurosci.23-13-05963.2003; Mital P, 2011, BIOL REPROD, V84, P851, DOI 10.1095/biolreprod.110.087452; Mori M, 2002, INVEST OPHTH VIS SCI, V43, P1384; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; MORTIMER D, 1987, J REPROD FERTIL, V81, P127; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Nehrke K, 2002, J BIOL CHEM, V277, P23604, DOI 10.1074/jbc.M202900200; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Neusch C, 2001, J NEUROSCI, V21, P5429, DOI 10.1523/JNEUROSCI.21-15-05429.2001; Niemeyer MI, 2003, J PHYSIOL-LONDON, V553, P873, DOI 10.1113/jphysiol.2003.055988; Nilius B, 1998, PFLUG ARCH EUR J PHY, V436, P742, DOI 10.1007/s004240050697; Nilius B, 1997, PROG BIOPHYS MOL BIO, V68, P69, DOI 10.1016/S0079-6107(97)00021-7; Orthmann-Murphy JL, 2008, J MOL NEUROSCI, V35, P101, DOI 10.1007/s12031-007-9027-5; Penberthy KK, 2018, TRENDS CELL BIOL, V28, P317, DOI 10.1016/j.tcb.2018.01.004; Planells-Cases R, 2015, EMBO J, V34, P2993, DOI 10.15252/embj.201592409; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Rinke I, 2010, J NEUROSCI, V30, P4776, DOI 10.1523/JNEUROSCI.6299-09.2010; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Schirmer L, 2018, ELIFE, V7, DOI 10.7554/eLife.36428; Scholl UI, 2018, NAT GENET, V50, P349, DOI 10.1038/s41588-018-0048-5; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sik A, 2000, NEUROSCIENCE, V101, P51, DOI 10.1016/S0306-4522(00)00360-2; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Thanos A, 2012, AM J PATHOL, V180, P1917, DOI 10.1016/j.ajpath.2012.01.017; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Walz W, 2002, GLIA, V40, P1, DOI 10.1002/glia.10125; Winchenbach Jan, 2016, F1000Res, V5, P2934, DOI 10.12688/f1000research.10509.1; Xiao QH, 2010, PFLUG ARCH EUR J PHY, V460, P559, DOI 10.1007/s00424-010-0821-5; Zdebik AA, 2004, J BIOL CHEM, V279, P22276, DOI 10.1074/jbc.M309899200; Zhang Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05616-4; Zhou C, 2020, IMMUNITY, V52, P767, DOI 10.1016/j.immuni.2020.03.016	82	6	6	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100074	10.1074/jbc.RA120.016031	http://dx.doi.org/10.1074/jbc.RA120.016031			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33410413	gold, Green Accepted, Green Published			2022-12-26	WOS:000672866400055
